Citrus Sinensis ID: 046438

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-
Protein Sequence
LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN
Secondary Structure (PSIPRED)
ccccccccccccccccccccEEEcccccccccccHHccccccccEEEccccccEEEccccccccccEEEcccccccEEccHHHHcccccccEEEccccccEEcccccccccccccccccccccccccccHHHHccccccccccccccccccccHHHHcccccccEEccccccEEcccHHHHHccccccEEEccccEEcccccHHHHccccccEEccccccccccccccccccccccEEEcccccccccccccccccccccccccccEEccccccccccccHHHHccccccccEEEcccEEEEEccccccccccccEEEccccEEcccccccccccccccEEEcccccccccccHHHHHccccccEEccccccccccccccccccccccEEccccccccccHHHHccccccccccccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEccccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccEEccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEccccccccHHHHHHHHHHHcccccccccEEEEEEccccEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHccccccccccccccHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEEccccccccccccccccccEEEEccccccccccHHHHHccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEccccccccccHHHHHccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccccccccHHccccccEEEEccccccccccccHHHcccccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEccccccccccHHHcccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHcccccEEEccccccEEEccccccHHHccHHHcccccEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHEccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHcccc
Coil and Loop (DISEMBL)
lqsfltgtvpsqlgslsslQYLDLSFnqllgtipssifsINTLEILdlsnnqlsgsfpffnmsslqvidlsdnrlsgelpanifsylPFVQFLSLAFNQFAghlpreignltsltsidlsenhlmgeipheigNLRNlqalgllsnnlvgvvpatlfnISTLKILQLtnntlsgsisssirlalpnlelfslannnfsgkipsfifnasklsicelpdnsfsgfipnrfhnmRNLKELNLEynyitssnheLSFISSLANSKKLKVLsltgnplldcvlpssignlsLSMERFYLHncnirgsipKEMGNLINLIIIRLgynklngsipstLSRLEKLQILGLENNQLEGRILDDICRLARLSsvyldhnklsgsipacfgNLASLRklsfasneltfvpstfwNLTNILMVdlssnplsgslpleigNLKVLVELYLSrnnlsgdipttigglknlqnlslgdnnlqgsipnsigDLISLECldlsnnilsgiipsSLEKLLYLKYLNVSFnrlegeiprggtlanftsesfmgndllcgsphlqvppckstktrtnqksRKVVILLGVALPLSAAFIIISILAFKFGListcrkgdtklsniQANMPLVAWRRFSYQELLQATdqfnvnnligsgsfgsvyrgrfLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLdympkgsleaclysdnsnldiFKRLNIVIDIALALEylhfghpnpvvhcdikpsnvlldeDMVARLGDFGIAkllsgdesmkhtqTLATigymapeygregqistegdvYSFGIMLMEIFtrkrptdeifsgemslkrwvndslpisimn
Flexible Loop (DISEMBL)
lqsfltgtvpsqlgSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCkstktrtnqksrkVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKllsgdesmKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPtdeifsgemslkrwvndslpisimn
Low Complexity Region (SEG)
LQSFLTGTVPsqlgslsslqyldlsFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAlgllsnnlvgvvPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGnlinliiiRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDlssnplsgslplEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPsslekllylkylNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGValplsaafiiisilafKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN
Disordered region (IsUnstruct)
**************SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQ***************RKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN*********
Disordered Region (DISOPRED)
LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPH**********************LLGVALPLSAAFIIISILAFKFG***********************WRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES*KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIM*
Disordered Region (DISEMBL)
LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPP**********KSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN
Disordered Region (DISPRO)
**SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVP***********KSRKVVILLGVALPLSAAFIIISILAFKFGLISTC************NMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPIS***
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	851	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.985	0.830	0.393	1e-149
C0LGT6	1031	LRR receptor-like serine/	no	no	0.975	0.805	0.382	1e-140
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.918	0.797	0.390	1e-127
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.988	0.673	0.341	1e-126
Q9FL28	1173	LRR receptor-like serine/	no	no	0.971	0.705	0.348	1e-124
Q9SD62	1025	Putative receptor-like pr	no	no	0.981	0.814	0.375	1e-124
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.971	0.660	0.340	1e-123
Q9LP24	1120	Probable leucine-rich rep	no	no	0.957	0.727	0.316	1e-115
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.925	0.754	0.331	1e-110
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.970	0.749	0.319	1e-109

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  530 bits (1364), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 345/876 (39%), Positives = 501/876 (57%), Gaps = 37/876 (4%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPF--FNM 62
           L G +   +G+LS L  LDL  N   GTIP  +  ++ LE LD+  N L G  P   +N 
Sbjct: 78  LGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNC 137

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           S L  + L  NRL G +P+ + S    VQ L+L  N   G LP  +GNLT L  + LS N
Sbjct: 138 SRLLNLRLDSNRLGGSVPSELGSLTNLVQ-LNLYGNNMRGKLPTSLGNLTLLEQLALSHN 196

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
           +L GEIP ++  L  + +L L++NN  GV P  L+N+S+LK+L +  N  SG +   + +
Sbjct: 197 NLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGI 256

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
            LPNL  F++  N F+G IP+ + N S L    + +N+ +G IP  F N+ NLK L L  
Sbjct: 257 LLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHT 315

Query: 243 NYITS-SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR 301
           N + S S+ +L F++SL N  +L+ L + G   L   LP SI NLS  +    L    I 
Sbjct: 316 NSLGSDSSRDLEFLTSLTNCTQLETLGI-GRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374

Query: 302 GSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR 361
           GSIP ++GNLINL  + L  N L+G +P++L +L  L+ L L +N+L G I   I  +  
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLS 420
           L ++ L +N   G +P   GN + L +L    N+L   +P     +  +L +D+S N L 
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494

Query: 421 GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLIS 480
           GSLP +IG L+ L  L L  N LSG +P T+G    +++L L  N   G IP+  G L+ 
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVG 553

Query: 481 LECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
           ++ +DLSNN LSG IP        L+YLN+SFN LEG++P  G   N T+ S +GN+ LC
Sbjct: 554 VKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613

Query: 541 GS-PHLQVPPCKSTKTRTNQKS----RKVVILLGVALPLSAAFIIISILAFKFGLISTCR 595
           G     Q+ PC S      +K     +KVVI + V + L     + S+           R
Sbjct: 614 GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWL----RKR 669

Query: 596 KGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVA 654
           K + + +N   +   V   + SY +L  AT+ F+ +N++GSGSFG+VY+   L +   VA
Sbjct: 670 KKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVA 729

Query: 655 IKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD-----FKALVLDYMPKGSL 709
           +KV ++Q  GA++SF AECE L+ IRHRNLV+++++C++ D     F+AL+ ++MP GSL
Sbjct: 730 VKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSL 789

Query: 710 EACLYSD--------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE 761
           +  L+ +        +  L + +RLNI ID+A  L+YLH     P+ HCD+KPSNVLLD+
Sbjct: 790 DMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDD 849

Query: 762 DMVARLGDFGIAK-LLSGDE-----SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGI 815
           D+ A + DFG+A+ LL  DE      +       TIGY APEYG  GQ S  GDVYSFGI
Sbjct: 850 DLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGI 909

Query: 816 MLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN 851
           +L+E+FT KRPT+E+F G  +L  +   +LP  I++
Sbjct: 910 LLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILD 945

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  498 bits (1282), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 332/868 (38%), Positives = 492/868 (56%), Gaps = 38/868 (4%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           LTG +   +G+LS L+ L+L+ N    TIP  +  +  L+ L++S N L G  P    N 
Sbjct: 85  LTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNC 144

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           S L  +DLS N L   +P+ + S L  +  L L+ N   G+ P  +GNLTSL  +D + N
Sbjct: 145 SRLSTVDLSSNHLGHGVPSELGS-LSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYN 203

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
            + GEIP E+  L  +    +  N+  G  P  L+NIS+L+ L L +N+ SG++ +    
Sbjct: 204 QMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGY 263

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE- 241
            LPNL    L  N F+G IP  + N S L   ++  N  SG IP  F  +RNL  L +  
Sbjct: 264 LLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRN 323

Query: 242 YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR 301
            +   +S+  L FI ++AN  +L+ L + G   L   LP+SI NLS ++   +L    I 
Sbjct: 324 NSLGNNSSSGLEFIGAVANCTQLEYLDV-GYNRLGGELPASIANLSTTLTSLFLGQNLIS 382

Query: 302 GSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR 361
           G+IP ++GNL++L  + L  N L+G +P +  +L  LQ++ L +N + G I      + R
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLS 420
           L  ++L+ N   G IP   G    L  L   +N L   +P     + ++  +DLS+N L+
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502

Query: 421 GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLIS 480
           G  P E+G L++LV L  S N LSG +P  IGG  +++ L +  N+  G+IP+ I  L+S
Sbjct: 503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVS 561

Query: 481 LECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
           L+ +D SNN LSG IP  L  L  L+ LN+S N+ EG +P  G   N T+ S  GN  +C
Sbjct: 562 LKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621

Query: 541 GS-PHLQVPPC---KSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRK 596
           G    +Q+ PC    S + R     RK V+  G+ + +++  +II I+A     +   +K
Sbjct: 622 GGVREMQLKPCIVQASPRKRKPLSVRKKVV-SGICIGIASLLLII-IVASLCWFMKRKKK 679

Query: 597 GDTKLSNIQANMPLVAWR-RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME--- 652
            +    N   +  L  +  + SY+EL  AT +F+  NLIGSG+FG+V++G  L G E   
Sbjct: 680 NNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKG--LLGPENKL 737

Query: 653 VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN-----DDFKALVLDYMPKG 707
           VA+KV +L   GA +SF AECE  + IRHRNLV++I+ C++     +DF+ALV ++MPKG
Sbjct: 738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797

Query: 708 SLEACL-------YSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL 759
           SL+  L        +D+S +L   ++LNI ID+A ALEYLH    +PV HCDIKPSN+LL
Sbjct: 798 SLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILL 857

Query: 760 DEDMVARLGDFGIAKLLSGDE------SMKHTQTLATIGYMAPEYGREGQISTEGDVYSF 813
           D+D+ A + DFG+A+LL   +               TIGY APEYG  GQ S +GDVYSF
Sbjct: 858 DDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSF 917

Query: 814 GIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
           GI+L+E+F+ K+PTDE F+G+ +L  + 
Sbjct: 918 GILLLEMFSGKKPTDESFAGDYNLHSYT 945

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  456 bits (1174), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 329/843 (39%), Positives = 471/843 (55%), Gaps = 61/843 (7%)

Query: 61  NMSSLQVI--DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNL-TSLTSI 117
           N  S QVI  D+S   L GE+  +I + L  +  L L+ N F G +P EIG+L  +L  +
Sbjct: 62  NKESTQVIELDISGRDLGGEISPSI-ANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQL 120

Query: 118 DLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF---NISTLKILQLTNNTLSG 174
            LSEN L G IP E+G L  L  L L SN L G +P  LF   + S+L+ + L+NN+L+G
Sbjct: 121 SLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTG 180

Query: 175 SISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR-FHNMR 233
            I  +    L  L    L +N  +G +PS + N++ L   +L  N  SG +P++    M 
Sbjct: 181 EIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMP 240

Query: 234 NLKELNLEYNYITSSNHELS---FISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSM 290
            L+ L L YN+  S N+  +   F +SLANS  L+ L L GN L    + SS+ +LS+++
Sbjct: 241 QLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSL-GGEITSSVRHLSVNL 299

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG 350
            + +L    I GSIP E+ NL+NL ++ L  N L+G IP  L +L KL+ + L NN L G
Sbjct: 300 VQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTG 359

Query: 351 RILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNI 409
            I  ++  + RL  + +  N LSGSIP  FGNL+ LR+L    N L+  VP +     N+
Sbjct: 360 EIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINL 419

Query: 410 LMVDLSSNPLSGSLPLEI-GNLKVL-VELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL 467
            ++DLS N L+G++P+E+  NL+ L + L LS N+LSG IP  +  +  + ++ L  N L
Sbjct: 420 EILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNEL 479

Query: 468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG----- 522
            G IP  +G  I+LE L+LS N  S  +PSSL +L YLK L+VSFNRL G IP       
Sbjct: 480 SGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSS 539

Query: 523 -------------------GTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRK 563
                              G+ +  T ESF+G+ LLCGS    +  CK  K         
Sbjct: 540 TLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACK--KKHKYPSVLL 596

Query: 564 VVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQ 623
            V+L  +A P+   F    +   +FG   T    +      + N     + R SYQ+L+ 
Sbjct: 597 PVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIA 656

Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           AT  FN ++LIGSG FG VY+G   +  +VA+KV  L  + ALE   SF  EC++L+  R
Sbjct: 657 ATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKV--LDPKTALEFSGSFKRECQILKRTR 714

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALE 737
           HRNL+RII++C+   F ALVL  MP GSLE  LY     + NLD+ + +NI  D+A  + 
Sbjct: 715 HRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIA 774

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-------DESMKHTQT--- 787
           YLH   P  VVHCD+KPSN+LLD++M A + DFGI++L+ G       D+S+    T   
Sbjct: 775 YLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGL 834

Query: 788 -LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
              ++GY+APEYG   + ST GDVYSFG++L+EI + +RPTD + +   SL  ++    P
Sbjct: 835 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYP 894

Query: 847 ISI 849
            S+
Sbjct: 895 DSL 897

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  452 bits (1164), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 330/967 (34%), Positives = 502/967 (51%), Gaps = 126/967 (13%)

Query: 2    QSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--F 59
            ++ L GT+P++LG L +L+ L+L+ N L G IPS +  ++ L+ L L  NQL G  P   
Sbjct: 224  ENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSL 283

Query: 60   FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSID 118
             ++ +LQ +DLS N L+GE+P   ++    +  L LA N  +G LP+ I  N T+L  + 
Sbjct: 284  ADLGNLQTLDLSANNLTGEIPEEFWNMSQLLD-LVLANNHLSGSLPKSICSNNTNLEQLV 342

Query: 119  LSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS 178
            LS   L GEIP E+   ++L+ L L +N+L G +P  LF +  L  L L NNTL G++S 
Sbjct: 343  LSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSP 402

Query: 179  SIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL 238
            SI   L NL+   L +NN  GK+P  I    KL +  L +N FSG IP    N  +LK +
Sbjct: 403  SIS-NLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMI 461

Query: 239  NL-----------------EYNYITSSNHEL--SFISSLANSKKLKVLSLTGNPLLDCVL 279
            ++                 E N +    +EL     +SL N  +L +L L  N L   + 
Sbjct: 462  DMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSI- 520

Query: 280  PSSIGNLSLSMERFYLHNCNIRGS------------------------------------ 303
            PSS G L   +E+  L+N +++G+                                    
Sbjct: 521  PSSFGFLK-GLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLS 579

Query: 304  -----------IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
                       IP E+GN  NL  +RLG N+L G IP TL ++ +L +L + +N L G I
Sbjct: 580  FDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTI 639

Query: 353  LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNE-LTFVPSTFWNLTNILM 411
               +    +L+ + L++N LSG IP   G L+ L +L  +SN+ +  +P+  +N T +L+
Sbjct: 640  PLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLV 699

Query: 412  VDLSSNPLSGSLPLEIGNLKV------------------------LVELYLSRNNLSGDI 447
            + L  N L+GS+P EIGNL                          L EL LSRN+L+G+I
Sbjct: 700  LSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759

Query: 448  PTTIGGLKNLQN-LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLK 506
            P  IG L++LQ+ L L  NN  G IP++IG L  LE LDLS+N L+G +P S+  +  L 
Sbjct: 760  PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819

Query: 507  YLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVI 566
            YLNVSFN L G++ +    + + ++SF+GN  LCGSP  +    +S   +    +R VVI
Sbjct: 820  YLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVI 877

Query: 567  LLGVALPLSAAFIIISILAF---KFGLISTCRKGDTKLS----NIQA-NMPL----VAWR 614
            +  ++   +   +I+ I  F   +         G T  +    + QA + PL     +  
Sbjct: 878  ISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKS 937

Query: 615  RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE-GALESFNAEC 673
               ++++++AT   +   +IGSG  G VY+    +G  VA+K    + +  + +SF+ E 
Sbjct: 938  DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREV 997

Query: 674  EVLRSIRHRNLVRIISSCT--NDDFKALVLDYMPKGSLEACLYSDNSNLDIFK------- 724
            + L  IRHR+LV+++  C+  ++    L+ +YM  GS+   L+ D   L+  K       
Sbjct: 998  KTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEA 1057

Query: 725  RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD---ES 781
            RL I + +A  +EYLH     P+VH DIK SNVLLD +M A LGDFG+AK+L+ +    +
Sbjct: 1058 RLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNT 1117

Query: 782  MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
              +T    + GY+APEY    + + + DVYS GI+LMEI T K PTD +F  EM + RWV
Sbjct: 1118 DSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWV 1177

Query: 842  NDSLPIS 848
               L ++
Sbjct: 1178 ETHLEVA 1184

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  446 bits (1147), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 325/932 (34%), Positives = 503/932 (53%), Gaps = 105/932 (11%)

Query: 5    LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
            LTG +P  LG L  LQ    + N L G+IP SI ++  L  LDLS NQL+G  P  F N+
Sbjct: 180  LTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNL 239

Query: 63   SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNL----------- 111
             +LQ + L++N L G++PA I +    VQ L L  NQ  G +P E+GNL           
Sbjct: 240  LNLQSLVLTENLLEGDIPAEIGNCSSLVQ-LELYDNQLTGKIPAELGNLVQLQALRIYKN 298

Query: 112  -------------TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN 158
                         T LT + LSENHL+G I  EIG L +L+ L L SNN  G  P ++ N
Sbjct: 299  KLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITN 358

Query: 159  ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPD 218
            +  L +L +  N +SG + + + L L NL   S  +N  +G IPS I N + L + +L  
Sbjct: 359  LRNLTVLTVGFNNISGELPADLGL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSH 417

Query: 219  NSFSGFIPNRFHNMRNLKELNLEYNYITS---------SNHELSFISS----------LA 259
            N  +G IP  F  M NL  +++  N+ T          SN E   ++           + 
Sbjct: 418  NQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIG 476

Query: 260  NSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRL 319
              +KL++L ++ N L   + P  IGNL   +   YLH+    G IP+EM NL  L  +R+
Sbjct: 477  KLQKLRILQVSYNSLTGPI-PREIGNLK-DLNILYLHSNGFTGRIPREMSNLTLLQGLRM 534

Query: 320  GYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPAC 379
              N L G IP  +  ++ L +L L NN+  G+I     +L  L+ + L  NK +GSIPA 
Sbjct: 535  YSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPAS 594

Query: 380  FGNL----------------------ASLRK----LSFASNELT-FVPSTFWNLTNILMV 412
              +L                      ASL+     L+F++N LT  +P     L  +  +
Sbjct: 595  LKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEI 654

Query: 413  DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSI 471
            DLS+N  SGS+P  +   K +  L  S+NNLSG IP  +  G+  + +L+L  N+  G I
Sbjct: 655  DLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714

Query: 472  PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSE 531
            P S G++  L  LDLS+N L+G IP SL  L  LK+L ++ N L+G +P  G   N  + 
Sbjct: 715  PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774

Query: 532  SFMGNDLLCGSPHLQVPPC--KSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFG 589
              MGN  LCGS    + PC  K   +  ++++R ++I+LG       +   + ++     
Sbjct: 775  DLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILG-------SAAALLLVLLLVL 826

Query: 590  LISTCRKGDTKLSN-IQANMP----LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYR 644
            +++ C+K + K+ N  ++++P     +  +RF  +EL QATD FN  N+IGS S  +VY+
Sbjct: 827  ILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYK 886

Query: 645  GRFLDGMEVAIKVFHLQLEGALES---FNAECEVLRSIRHRNLVRIIS-SCTNDDFKALV 700
            G+  DG  +A+KV +L+ E + ES   F  E + L  ++HRNLV+I+  +  +   KALV
Sbjct: 887  GQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALV 945

Query: 701  LDYMPKGSLEACLYSDNSNL-DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL 759
            L +M  G+LE  ++   + +  + +++++ + IA  ++YLH G+  P+VHCD+KP+N+LL
Sbjct: 946  LPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILL 1005

Query: 760  DEDMVARLGDFGIAKLLSGDESMKHTQTLA----TIGYMAPEYGREGQISTEGDVYSFGI 815
            D D VA + DFG A++L   E    T + +    TIGY+APE+    +++T+ DV+SFGI
Sbjct: 1006 DSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGI 1065

Query: 816  MLMEIFTRKRPT--DEIFSGEMSLKRWVNDSL 845
            ++ME+ T++RPT  ++  S +M+L++ V  S+
Sbjct: 1066 IMMELMTKQRPTSLNDEDSQDMTLRQLVEKSI 1097

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  446 bits (1147), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 327/870 (37%), Positives = 480/870 (55%), Gaps = 35/870 (4%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF--NM 62
           LTG V   +G+LS L+ L+L+ N   G IPS + ++  L+ L++SNN   G  P    N 
Sbjct: 93  LTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNC 152

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           SSL  +DLS N L   +P   F  L  +  LSL  N   G  P  +GNLTSL  +D   N
Sbjct: 153 SSLSTLDLSSNHLEQGVPLE-FGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYN 211

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
            + GEIP +I  L+ +    +  N   GV P  ++N+S+L  L +T N+ SG++      
Sbjct: 212 QIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGS 271

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRF-HNMRNLKELNLE 241
            LPNL++  +  N+F+G IP  + N S L   ++P N  +G IP  F      L      
Sbjct: 272 LLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNN 331

Query: 242 YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR 301
            +    S+ +L F+ +L N  +L+ L++  N  L   LP  I NLS  +    L    I 
Sbjct: 332 NSLGNYSSGDLDFLGALTNCSQLQYLNVGFNK-LGGQLPVFIANLSTQLTELSLGGNLIS 390

Query: 302 GSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR 361
           GSIP  +GNL++L  + LG N L G +P +L  L +L+ + L +N L G I   +  ++ 
Sbjct: 391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLS 420
           L+ +YL +N   GSIP+  G+ + L  L+  +N+L   +P     L +++++++S N L 
Sbjct: 451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510

Query: 421 GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLIS 480
           G L  +IG LK L+ L +S N LSG IP T+    +L+ L L  N+  G IP+ I  L  
Sbjct: 511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTG 569

Query: 481 LECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
           L  LDLS N LSG IP  +     L+ LN+S N  +G +P  G   N ++ S  GN  LC
Sbjct: 570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629

Query: 541 GS-PHLQVPPCKSTKTRTNQKSRKVV-ILLGVALPLSAAFIIISILAFKFGL-ISTCRKG 597
           G  P LQ+ PC     R +   RK++ I +   +       +  +    + L + + R  
Sbjct: 630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689

Query: 598 DTKLSNIQANMPLVA-WRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL--DGMEVA 654
           + +  N ++  P+ + + + SY EL + T  F+ +NLIGSG+FG+V++G FL      VA
Sbjct: 690 NNE--NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG-FLGSKNKAVA 746

Query: 655 IKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN-----DDFKALVLDYMPKGSL 709
           IKV +L   GA +SF AECE L  IRHRNLV++++ C++     +DF+ALV ++MP G+L
Sbjct: 747 IKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNL 806

Query: 710 EACLYSD--------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE 761
           +  L+ D        +  L +F RLNI ID+A AL YLH    NP+ HCDIKPSN+LLD+
Sbjct: 807 DMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDK 866

Query: 762 DMVARLGDFGIAK-LLSGDESMKHTQ-----TLATIGYMAPEYGREGQISTEGDVYSFGI 815
           D+ A + DFG+A+ LL  D    H Q        TIGY APEYG  G  S  GDVYSFGI
Sbjct: 867 DLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGI 926

Query: 816 MLMEIFTRKRPTDEIFSGEMSLKRWVNDSL 845
           +L+EIFT KRPT+++F   ++L  +   +L
Sbjct: 927 VLLEIFTGKRPTNKLFVDGLTLHSFTKSAL 956

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  442 bits (1136), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 320/939 (34%), Positives = 493/939 (52%), Gaps = 112/939 (11%)

Query: 5    LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF--PFFNM 62
             +G +PSQLG L S+QYL+L  NQL G IP  +  +  L+ LDLS+N L+G     F+ M
Sbjct: 252  FSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRM 311

Query: 63   SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
            + L+ + L+ NRLSG LP  I S    ++ L L+  Q +G +P EI N  SL  +DLS N
Sbjct: 312  NQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNN 371

Query: 123  HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
             L G+IP  +  L  L  L L +N+L G + +++ N++ L+   L +N L G +   I  
Sbjct: 372  TLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGF 431

Query: 183  ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
             L  LE+  L  N FSG++P  I N ++L   +   N  SG IP+    +++L  L+L  
Sbjct: 432  -LGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRE 490

Query: 243  NYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRG 302
            N +  +       +SL N  ++ V+ L  N L   + PSS G L+ ++E F ++N +++G
Sbjct: 491  NELVGN-----IPASLGNCHQMTVIDLADNQLSGSI-PSSFGFLT-ALELFMIYNNSLQG 543

Query: 303  S-----------------------------------------------IPKEMGNLINLI 315
            +                                               IP E+G   NL 
Sbjct: 544  NLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLD 603

Query: 316  IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGS 375
             +RLG N+  G IP T  ++ +L +L +  N L G I  ++    +L+ + L++N LSG 
Sbjct: 604  RLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGV 663

Query: 376  IPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKV-- 432
            IP   G L  L +L  +SN+    +P+  ++LTNIL + L  N L+GS+P EIGNL+   
Sbjct: 664  IPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALN 723

Query: 433  ----------------------LVELYLSRNNLSGDIPTTIGGLKNLQN-LSLGDNNLQG 469
                                  L EL LSRN L+G+IP  IG L++LQ+ L L  NN  G
Sbjct: 724  ALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTG 783

Query: 470  SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFT 529
             IP++I  L  LE LDLS+N L G +P  +  +  L YLN+S+N LEG++ +    + + 
Sbjct: 784  RIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQ 841

Query: 530  SESFMGNDLLCGSPHLQVPPCKSTKTRTNQKS---RKVVILLGV-ALPLSAAFIIISILA 585
            +++F+GN  LCGSP   +  C    ++ NQ+S   + VVI+  + +L   A  +++ IL 
Sbjct: 842  ADAFVGNAGLCGSP---LSHCNRAGSK-NQRSLSPKTVVIISAISSLAAIALMVLVIILF 897

Query: 586  FK--FGLISTCRKG--DTKLSNIQANMPLV----AWRRFSYQELLQATDQFNVNNLIGSG 637
            FK    L    R G      ++  +  PL     A     + ++++AT   N   +IGSG
Sbjct: 898  FKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSG 957

Query: 638  SFGSVYRGRFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTN--D 694
              G VY+    +G  +A+K    + +  + +SFN E + L +IRHR+LV+++  C++  D
Sbjct: 958  GSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017

Query: 695  DFKALVLDYMPKGSLEACLYSDNSN-----LDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
                L+ +YM  GS+   L+++ +      L    RL I + +A  +EYLH+    P+VH
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVH 1077

Query: 750  CDIKPSNVLLDEDMVARLGDFGIAKLLSGD---ESMKHTQTLATIGYMAPEYGREGQIST 806
             DIK SNVLLD ++ A LGDFG+AK+L+G+    +  +T    + GY+APEY    + + 
Sbjct: 1078 RDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATE 1137

Query: 807  EGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSL 845
            + DVYS GI+LMEI T K PT+ +F  E  + RWV   L
Sbjct: 1138 KSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVL 1176

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  415 bits (1066), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 305/963 (31%), Positives = 457/963 (47%), Gaps = 148/963 (15%)

Query: 4    FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFN 61
             L+GT+P Q G+LS L Y DLS N L G I  S+ ++  L +L L  N L+   P    N
Sbjct: 113  LLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGN 172

Query: 62   MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE 121
            M S+  + LS N+L+G +P+++   L  +  L L  N   G +P E+GN+ S+T + LS+
Sbjct: 173  MESMTDLALSQNKLTGSIPSSL-GNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQ 231

Query: 122  NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
            N L G IP  +GNL+NL  L L  N L GV+P  + N+ ++  L L+ N L+GSI SS+ 
Sbjct: 232  NKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLG 291

Query: 182  LALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
              L NL L SL  N  +G IP  + N   +   EL +N  +G IP+   N++NL  L L 
Sbjct: 292  -NLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLY 350

Query: 242  YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL------------- 288
             NY+T           L N + +  L L  N L   + PSS GNL               
Sbjct: 351  ENYLTGV-----IPPELGNMESMIDLQLNNNKLTGSI-PSSFGNLKNLTYLYLYLNYLTG 404

Query: 289  ----------SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKL 338
                      SM    L    + GS+P   GN   L  + L  N L+G+IP  ++    L
Sbjct: 405  VIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHL 464

Query: 339  QILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT- 397
              L L+ N   G   + +C+  +L ++ LD+N L G IP    +  SL +  F  N+ T 
Sbjct: 465  TTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTG 524

Query: 398  ------------------------------------------------FVPSTFWNLTNI 409
                                                             +P+  WN+T +
Sbjct: 525  DIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQL 584

Query: 410  LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN--- 466
            + +DLS+N L G LP  IGNL  L  L L+ N LSG +P  +  L NL++L L  NN   
Sbjct: 585  VELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSS 644

Query: 467  --------------------------------------------LQGSIPNSIGDLISLE 482
                                                        L G IP+ +  L SL+
Sbjct: 645  EIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLD 704

Query: 483  CLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS 542
             LDLS+N LSG+IP++ E ++ L  +++S N+LEG +P   T    T+++   N  LC +
Sbjct: 705  KLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSN 764

Query: 543  -PHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRK---GD 598
             P  ++ PC+  K      +  V IL    +P+    +I+SI A  F      RK   G 
Sbjct: 765  IPKQRLKPCRELKKPKKNGNLVVWIL----VPILGVLVILSICANTFTYCIRKRKLQNGR 820

Query: 599  TKLSNIQANMPLVAWR-RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKV 657
                    NM + +   +F YQ+++++T++F+  +LIG+G +  VYR    D + +A+K 
Sbjct: 821  NTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKR 879

Query: 658  FHLQLEGAL------ESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA 711
             H  ++  +      + F  E + L  IRHRN+V++   C++     L+ +YM KGSL  
Sbjct: 880  LHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNK 939

Query: 712  CLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
             L +D     L   KR+N+V  +A AL Y+H     P+VH DI   N+LLD D  A++ D
Sbjct: 940  LLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISD 999

Query: 770  FGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
            FG AKLL  D S   +    T GY+APE+    +++ + DVYSFG++++E+   K P D 
Sbjct: 1000 FGTAKLLKTDSS-NWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDL 1058

Query: 830  IFS 832
            + S
Sbjct: 1059 VSS 1061

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  398 bits (1023), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 286/864 (33%), Positives = 436/864 (50%), Gaps = 76/864 (8%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           L G +P +LG LS+L  L L  N+L G+IPS I  +  +  + + +N L+G  P  F N+
Sbjct: 154 LVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNL 213

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           + L  + L  N LSG +P+ I   LP ++ L L  N   G +P   GNL ++T +++ EN
Sbjct: 214 TKLVNLYLFINSLSGSIPSEI-GNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFEN 272

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI-- 180
            L GEIP EIGN+  L  L L +N L G +P+TL NI TL +L L  N L+GSI   +  
Sbjct: 273 QLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGE 332

Query: 181 ------------RLALP---------NLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
                       +L  P          LE   L +N  SG IP  I N+++L++ +L  N
Sbjct: 333 MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392

Query: 220 SFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVL 279
           +F+GF+P+       L+ L L+ N+      E     SL + K L  +   GN       
Sbjct: 393 NFTGFLPDTICRGGKLENLTLDDNHF-----EGPVPKSLRDCKSLIRVRFKGN------- 440

Query: 280 PSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQ 339
                              +  G I +  G    L  I L  N  +G + +   + +KL 
Sbjct: 441 -------------------SFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLV 481

Query: 340 ILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-F 398
              L NN + G I  +I  + +LS + L  N+++G +P    N+  + KL    N L+  
Sbjct: 482 AFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGK 541

Query: 399 VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQ 458
           +PS    LTN+  +DLSSN  S  +P  + NL  L  + LSRN+L   IP  +  L  LQ
Sbjct: 542 IPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQ 601

Query: 459 NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGE 518
            L L  N L G I +    L +LE LDLS+N LSG IP S + +L L +++VS N L+G 
Sbjct: 602 MLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGP 661

Query: 519 IPRGGTLANFTSESFMGNDLLCGSPHLQ--VPPCKSTKTRTNQKSRKVVILLGVALPLSA 576
           IP      N   ++F GN  LCGS +    + PC  T ++ + K R ++I   + +P+  
Sbjct: 662 IPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIY--ILVPIIG 719

Query: 577 AFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFS----YQELLQATDQFNVNN 632
           A II+S+ A  F       K   + ++ ++    ++   F     YQE+++AT +F+   
Sbjct: 720 AIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKY 779

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL------ESFNAECEVLRSIRHRNLVR 686
           LIG+G  G VY+ +  + + +A+K  +   + ++      + F  E   L  IRHRN+V+
Sbjct: 780 LIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVK 838

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHP 744
           +   C++     LV +YM +GSL   L +D+    LD  KR+N+V  +A AL Y+H    
Sbjct: 839 LFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRS 898

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI 804
             +VH DI   N+LL ED  A++ DFG AKLL  D S   +    T GY+APE     ++
Sbjct: 899 PAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSS-NWSAVAGTYGYVAPELAYAMKV 957

Query: 805 STEGDVYSFGIMLMEIFTRKRPTD 828
           + + DVYSFG++ +E+   + P D
Sbjct: 958 TEKCDVYSFGVLTLEVIKGEHPGD 981

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  396 bits (1017), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 303/948 (31%), Positives = 462/948 (48%), Gaps = 122/948 (12%)

Query: 5    LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
            L+G +   +G L  L+ LDLS+N L G IP  I + ++LEIL L+NNQ  G  P     +
Sbjct: 85   LSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKL 144

Query: 63   SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTS------ 116
             SL+ + + +NR+SG LP  I + L   Q ++ + N  +G LPR IGNL  LTS      
Sbjct: 145  VSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYS-NNISGQLPRSIGNLKRLTSFRAGQN 203

Query: 117  ------------------IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN 158
                              + L++N L GE+P EIG L+ L  + L  N   G +P  + N
Sbjct: 204  MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263

Query: 159  ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPD 218
             ++L+ L L  N L G I   +   L +LE   L  N  +G IP  I N S     +  +
Sbjct: 264  CTSLETLALYKNQLVGPIPKELG-DLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSE 322

Query: 219  NSFSGFIPNRFHNMRNLKELNLEYNYITSS-NHELSFISSLANSKKLKVLSLTGN-PL-- 274
            N+ +G IP    N+  L+ L L  N +T +   ELS + +L+    L + +LTG  PL  
Sbjct: 323  NALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLS-KLDLSINALTGPIPLGF 381

Query: 275  ---------------LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRL 319
                           L   +P  +G  S  +    + + ++ G IP  +    N+II+ L
Sbjct: 382  QYLRGLFMLQLFQNSLSGTIPPKLGWYS-DLWVLDMSDNHLSGRIPSYLCLHSNMIILNL 440

Query: 320  GYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPAC 379
            G N L+G+IP+ ++  + L  L L  N L GR   ++C+   ++++ L  N+  GSIP  
Sbjct: 441  GTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPRE 500

Query: 380  FGNLASLRKLSFASNELTF-------------------------VPSTFWNLTNILMVDL 414
             GN ++L++L  A N  T                          VPS  +N   +  +D+
Sbjct: 501  VGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDM 560

Query: 415  SSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS 474
              N  SG+LP E+G+L  L  L LS NNLSG IP  +G L  L  L +G N   GSIP  
Sbjct: 561  CCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRE 620

Query: 475  IGDLISLE-CLDLSNNILSGIIPSSLEKLLYLKY------------------------LN 509
            +G L  L+  L+LS N L+G IP  L  L+ L++                         N
Sbjct: 621  LGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYN 680

Query: 510  VSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQV------PPCKSTKTRTNQKSRK 563
             S+N L G IP    L N +  SF+GN+ LCG P  Q        P +ST      +S K
Sbjct: 681  FSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSK 737

Query: 564  VV-----ILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSY 618
            ++     ++ GV+L L A  +I+ ++      +++  + D + S +  ++       F++
Sbjct: 738  IIAITAAVIGGVSLMLIA--LIVYLMRRPVRTVASSAQ-DGQPSEMSLDIYFPPKEGFTF 794

Query: 619  QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA-----LESFNAEC 673
            Q+L+ ATD F+ + ++G G+ G+VY+     G  +A+K      EG        SF AE 
Sbjct: 795  QDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEI 854

Query: 674  EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
              L +IRHRN+V++   C +     L+ +YMPKGSL   L+  + NLD  KR  I +  A
Sbjct: 855  LTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAA 914

Query: 734  LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
              L YLH      + H DIK +N+LLD+   A +GDFG+AK++    S   +    + GY
Sbjct: 915  QGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGY 974

Query: 794  MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
            +APEY    +++ + D+YS+G++L+E+ T K P   I  G   +  WV
Sbjct: 975  IAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWV 1021

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	851
224116832	1061	predicted protein [Populus trichocarpa]	0.969	0.777	0.521	0.0
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.968	0.683	0.501	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.968	0.670	0.502	0.0
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.967	0.566	0.490	0.0
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.978	0.678	0.494	0.0
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.978	0.666	0.495	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.983	0.770	0.512	0.0
224139658	1019	predicted protein [Populus trichocarpa]	0.985	0.823	0.497	0.0
147852480	1229	hypothetical protein VITISV_039533 [Viti	0.968	0.670	0.501	0.0
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.968	0.663	0.497	0.0

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  806 bits (2081), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/838 (52%), Positives = 567/838 (67%), Gaps = 13/838 (1%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNR 74
           S+L+ L+L +NQL G IPS++     L +LDL +N+ +GS P     ++ L+ + L  N 
Sbjct: 163 STLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNN 222

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGN 134
           L+G++P  I + L  ++ L L  N   G++PREIGN T L  I +  N+L G IP+E+GN
Sbjct: 223 LTGQIPGEI-ARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGN 281

Query: 135 LRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN 194
           L  LQ L L  NN+ G +P+T FN S L+ + +  N LSG + S+  L LPNLE   L  
Sbjct: 282 LHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEK 341

Query: 195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSF 254
           N  SG IP  I NASKL + +L  NSFSG IP+   N+RNL++LNL  N +TS +     
Sbjct: 342 NELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSEL 401

Query: 255 ISSLA--NSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI 312
               +  N + L  L   GNPL    LP SIGNLS S+E  Y  +C I G+IP+ +GNL 
Sbjct: 402 SFLSSLSNCRSLAYLRFNGNPLRG-RLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLS 460

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKL 372
           NLI + L  N+L G+IPS + RL+ LQ   L +N+L+G I ++IC L RLS +YL  N  
Sbjct: 461 NLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGF 520

Query: 373 SGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKV 432
           SGS+PAC  N+ SLR+L   SN  T +P+TFW+L ++L ++LS N L+G+LPLEIGNLKV
Sbjct: 521 SGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKV 580

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS 492
           +  +  S N LSGDIPT+I  L+NL + SL DN +QG IP+S GDL+SLE LDLS N LS
Sbjct: 581 VTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLS 640

Query: 493 GIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKS 552
           G IP SLEKL++LK  NVSFNRL+GEI  GG  ANF+  SFM N+ LCG   +QVPPCKS
Sbjct: 641 GAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKS 700

Query: 553 TKT-RTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLV 611
             T R +++ R+ VI   V    + AFII   L     +I   R    KLS  +  +P  
Sbjct: 701 ISTHRQSKRPREFVIRYIVP---AIAFII---LVLALAVIIFRRSHKRKLSTQEDPLPPA 754

Query: 612 AWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNA 671
            WR+ SY EL +AT+ FN  NL+G+GS GSVY+G   DG+ +A+KVFHLQLEG L  F++
Sbjct: 755 TWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDS 814

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           ECEVLR +RHRNLV+IISSC N DFKAL+L+++P GSLE  LYS N  LDI +RLNI+ID
Sbjct: 815 ECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMID 874

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           +A ALEYLH G   PVVHCD+KPSNVL++EDMVA + DFGI++LL   +++  T TLATI
Sbjct: 875 VASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVTQTLTLATI 934

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
           GYMAPEYG EG +S +GDVYS+GI LME FTRK+PTD++F GEMSLK WV  SLP +I
Sbjct: 935 GYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAI 992

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  793 bits (2048), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/870 (50%), Positives = 577/870 (66%), Gaps = 46/870 (5%)

Query: 6    TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMS 63
            TG +P  +GSL +L+ L L+FN+L G IP  I +++ L IL L +N +SG  P   FN+S
Sbjct: 281  TGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNIS 340

Query: 64   SLQVIDLSDNRLSGELPANIFSYLPFVQ------------------------FLSLAFNQ 99
            SLQVID ++N LSG LP  I  +LP +Q                        FLSL+FN+
Sbjct: 341  SLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNK 400

Query: 100  FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
            F G +PREIGNL+ L  IDL  N L+G IP   GNL+ L+ L L  N L G VP  +FNI
Sbjct: 401  FRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFNI 460

Query: 160  STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
            S L+ L L  N LSGS+ SSI   LP+LE   +  N FSG IP  I N SKL++  L DN
Sbjct: 461  SELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDN 520

Query: 220  SFSGFIPNRFHNMRNLKELNLEYNYITSSN--HELSFISSLANSKKLKVLSLTGNPLLDC 277
            SF+G +P    N+  LK LNL +N +T  +    + F++SL N K L+ L +  NPL   
Sbjct: 521  SFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPL-KG 579

Query: 278  VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEK 337
             LP+S+GNL +++E F  + C  RG+IP  +GNL NLI + LG N L GSIP+TL RL+K
Sbjct: 580  TLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQK 639

Query: 338  LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT 397
            LQ L +  N++ G I +D+C L  L  + L  NKLSGS P+CFG+L +LR+L   SN L 
Sbjct: 640  LQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALA 699

Query: 398  F-VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
            F +P++ W+L ++L+++LSSN L+G+LP E+GN+K +  L LS+N +SG IP+ +G L+ 
Sbjct: 700  FNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQY 759

Query: 457  LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            L  LSL  N LQG I    GDL+SLE LDLS+N LSG IP SLE L+YLKYLNVSFN+L+
Sbjct: 760  LITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQ 819

Query: 517  GEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSA 576
            GEIP GG    FT+ESFM N+ LCG+PH QV  C     RT     K  IL  + LP+ +
Sbjct: 820  GEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYILLPVGS 878

Query: 577  AFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNVN 631
               ++  +          R+ D    N++   P+ +W      + S+Q+LL AT+ F  +
Sbjct: 879  TVTLVVFIVLWI------RRRD----NMEIPTPIDSWLLGTHEKISHQQLLYATNDFGED 928

Query: 632  NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
            NLIG GS G VY+G   +G+ VAIKVF+L+ +GAL SF++ECEV++ IRHRNLVRII+ C
Sbjct: 929  NLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCC 988

Query: 692  TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            +N DFKALVL+YMP GSLE  LYS N  LD+ +RLNI+ID+A ALEYLH    + VVHCD
Sbjct: 989  SNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCD 1048

Query: 752  IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
            +KPSNVLLD+DMVA + DFGIAKLL+  ESM+ T+TL TIGYMAPE+G  G +ST+ DVY
Sbjct: 1049 LKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVY 1108

Query: 812  SFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
            S+GI+LME+F RK+P DE+F+G+++LK WV
Sbjct: 1109 SYGILLMEVFARKKPMDEMFTGDLTLKTWV 1138

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  791 bits (2043), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/870 (50%), Positives = 582/870 (66%), Gaps = 46/870 (5%)

Query: 6    TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMS 63
            TG +P  +GSLS+L+ L LS N+L G IP  I +++ L IL LS+N +SG  P   FN+S
Sbjct: 305  TGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLSNLNILQLSSNGISGPIPAEIFNVS 364

Query: 64   SLQVIDLSDNRLSGELPANIFSYLPFVQ------------------------FLSLAFNQ 99
            SLQVI  +DN LSG LP +I  +LP +Q                        FLSL+FN+
Sbjct: 365  SLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSLCGELLFLSLSFNK 424

Query: 100  FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
            F G +P+EIGNL+ L  I L  N L+G IP   GNL+ L+ L L  NNL G VP  +FNI
Sbjct: 425  FRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNI 484

Query: 160  STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
            S L+ L +  N LSGS+ SSI   L +LE   +A N FSG IP  I N SKL++  L  N
Sbjct: 485  SKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSAN 544

Query: 220  SFSGFIPNRFHNMRNLKELNLEYNYITSSN--HELSFISSLANSKKLKVLSLTGNPLLDC 277
            SF+G +P    N+  LK L+L  N +T  +   E+ F++SL N K LK L +  NP    
Sbjct: 545  SFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPF-KG 603

Query: 278  VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEK 337
             LP+S+GNL +++E F    C  RG+IP  +GNL NLI + LG N L GSIP+TL RL+K
Sbjct: 604  TLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKK 663

Query: 338  LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT 397
            LQ L +  N+L G I +D+C L  L  ++L  NKLSGSIP+CFG+L +L++L   SN L 
Sbjct: 664  LQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLA 723

Query: 398  F-VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
            F +P++ W+L ++L+++LSSN L+G+LP E+GN+K +  L LS+N +SG IP  +G  +N
Sbjct: 724  FNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQN 783

Query: 457  LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            L  LSL  N LQG IP   GDL+SLE LDLS N LSG IP SLE L+YLKYLNVS N+L+
Sbjct: 784  LAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQ 843

Query: 517  GEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSA 576
            GEIP GG   NFT+ESFM N+ LCG+PH QV  C     RT     K  IL  + LP+ +
Sbjct: 844  GEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYILLPVGS 902

Query: 577  AFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNVN 631
               I++++ F   ++   R+ D    N++   P+ +W      + S+Q+LL AT+ F  +
Sbjct: 903  ---IVTLVVF---IVLWIRRRD----NMEIPTPIDSWLPGTHEKISHQQLLYATNDFGED 952

Query: 632  NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
            NLIG GS G VY+G   +G+ VAIKVF+L+ +GAL SF++ECEV++ IRHRNLVRII+ C
Sbjct: 953  NLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCC 1012

Query: 692  TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            +N DFKALVL+YMP GSLE  LYS N  LD+ +RLNI+ID+A ALEYLH    + VVHCD
Sbjct: 1013 SNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCD 1072

Query: 752  IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
            +KP+NVLLD+DMVA + DFGI KLL+  ESM+ T+TL TIGYMAPE+G +G +ST+ DVY
Sbjct: 1073 LKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVY 1132

Query: 812  SFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
            S+GI+LME+F+RK+P DE+F+G+++LK WV
Sbjct: 1133 SYGILLMEVFSRKKPMDEMFTGDLTLKTWV 1162

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  788 bits (2035), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 427/871 (49%), Positives = 592/871 (67%), Gaps = 48/871 (5%)

Query: 6    TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMS 63
            TG +P  +GSLS+L+ L L++N L+G IP  I +++ L ILD  ++ +SG  P   FN+S
Sbjct: 530  TGGIPQAIGSLSNLEELYLAYNNLVGGIPREIGNLSNLNILDFGSSGISGPIPPEIFNIS 589

Query: 64   SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQ------------------------ 99
            SLQ+ DL+DN L G LP +I+ +LP +Q L L++N+                        
Sbjct: 590  SLQIFDLTDNSLLGSLPMDIYKHLPNLQELYLSWNKLSGQLPSTLSLCGQLQSLSLWGNR 649

Query: 100  FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
            F G++P   GNLT+L  ++L +N++ G IP+E+GNL NLQ L L  NNL G++P  +FNI
Sbjct: 650  FTGNIPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQNLKLSENNLTGIIPEAIFNI 709

Query: 160  STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
            S L+ L L  N  SGS+ SS+   LP+LE  ++  N FSG IP  I N S+L+  ++ DN
Sbjct: 710  SKLQSLSLAQNHFSGSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDN 769

Query: 220  SFSGFIPNRFHNMRNLKELNLEYNYITS--SNHELSFISSLANSKKLKVLSLTGNPLLDC 277
             F+G +P    N+R L+ LNL  N +T   S  E+ F++SL N   L+ L +  NPL   
Sbjct: 770  FFTGDVPKDLGNLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPL-KG 828

Query: 278  VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEK 337
            +LP+S+GNLS+S+E F    C  RG+IP  +GNL +LI + LG N L G IP+TL +L+K
Sbjct: 829  ILPNSLGNLSISLESFDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKK 888

Query: 338  LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL- 396
            LQ LG+  N+L G I +D+CRL  L  ++L  N+L+GSIP+C G L  LR+L   SN L 
Sbjct: 889  LQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALA 948

Query: 397  TFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
            + +P + W L  +L+++LSSN L+G LP E+GN+K +  L LS+N +SG IP T+G L+N
Sbjct: 949  SNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQN 1008

Query: 457  LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            L++LSL  N LQG IP   GDL+SL+ LDLS N LSG+IP SL+ L YLKYLNVSFN+L+
Sbjct: 1009 LEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQ 1068

Query: 517  GEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPC-KSTKTRTNQKSRKVVILLGVALPLS 575
            GEIP GG   NFT+ESF+ N+ LCG+PH QV  C KST++R+    R  + +L   LP  
Sbjct: 1069 GEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRS---WRTKLFILKYILP-- 1123

Query: 576  AAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNV 630
                +ISI+     L+   R+      N++   P+ +W      + S+Q+LL AT+ F  
Sbjct: 1124 ---PVISIITLVVFLVLWIRRR----KNLEVPTPIDSWLPGSHEKISHQQLLYATNYFGE 1176

Query: 631  NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
            +NLIG GS   VY+G   +G+ VA+KVF+L+ +GA  SF++ECEV++SIRHRNLV+II+ 
Sbjct: 1177 DNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITC 1236

Query: 691  CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
            C+N DFKALVL+YMPKGSL+  LYS N  LD+ +RLNI+ID+A ALEYLH   P+ VVHC
Sbjct: 1237 CSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHC 1296

Query: 751  DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
            D+KP+N+LLD+DMVA +GDFGIA+LL+  ESM+ T+TL TIGYMAPEYG +G +ST+GDV
Sbjct: 1297 DLKPNNILLDDDMVAHVGDFGIARLLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDV 1356

Query: 811  YSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
            +S+GIMLME+F RK+P DE+F+G+++LK WV
Sbjct: 1357 FSYGIMLMEVFARKKPMDEMFNGDLTLKSWV 1387

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  787 bits (2032), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/880 (49%), Positives = 588/880 (66%), Gaps = 47/880 (5%)

Query: 5    LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
             TG +P  LGSLS L+ L L +N+L G IP  I +++ L IL L+++ ++G  P   FN+
Sbjct: 303  FTGGIPKALGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILHLASSGINGPIPAEIFNI 362

Query: 63   SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA------------------------FN 98
            SSL  ID ++N LSG LP +I  +LP +Q L L+                         N
Sbjct: 363  SSLHRIDFTNNSLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCGELLLLSLSIN 422

Query: 99   QFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN 158
            +F G +PR+IGNL+ L  I LS N L+G IP   GNL+ L+ L L SNNL G +P  +FN
Sbjct: 423  KFTGSIPRDIGNLSKLEKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLTGTIPEDIFN 482

Query: 159  ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPD 218
            IS L+ L L  N LSG + SSI   LP+LE   +  N FSG IP  I N SKL    + D
Sbjct: 483  ISKLQTLALAQNHLSGGLPSSIGTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISD 542

Query: 219  NSFSGFIPNRFHNMRNLKELNLEYNYITSSN--HELSFISSLANSKKLKVLSLTGNPLLD 276
            N F+G +P    N+R L+ LNL  N +T  +   E+ F++SL N K L+ L +  NPL  
Sbjct: 543  NYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPL-K 601

Query: 277  CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLE 336
              LP+S+GNLS+++E F    C+ RG+IP  +GNL NLI + LG N L GSIP+TL  L+
Sbjct: 602  GTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGHLQ 661

Query: 337  KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL 396
            KLQ L +  N+++G I +D+C L  L  ++L  NKLSGSIP+CFG+L +LR+LS  SN L
Sbjct: 662  KLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVL 721

Query: 397  TF-VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK 455
             F +P +FW+L +++++ LSSN L+G+LP E+GN+K +  L LS+N +SG IP  +G L+
Sbjct: 722  AFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQ 781

Query: 456  NLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
            NL NL L  N LQGSIP   GDL+SLE +DLS N L G IP SLE L+YLK+LNVSFN+L
Sbjct: 782  NLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLKHLNVSFNKL 841

Query: 516  EGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLS 575
            +GEIP GG   NFT+ESF+ N+ LCG+PH QV  C     RT     K  IL  + LP+ 
Sbjct: 842  QGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNN-RTQSWKTKSFILKYILLPVG 900

Query: 576  AAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNV 630
            +A   ++++AF   ++   R+ D    N +   P+ +W      + S Q+LL AT+ F  
Sbjct: 901  SA---VTLVAF---IVLWIRRRD----NTEIPAPIDSWLPGAHEKISQQQLLYATNGFGE 950

Query: 631  NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
            +NLIG GS G VY+G   +G+ VAIKVF+L+ +GAL SF++ECEV++ I HRNL+RII+ 
Sbjct: 951  DNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITC 1010

Query: 691  CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
            C+N DFKALVL+YMPKGSL+  LYS N  LD+F+RLNI+ID+A ALEYLH    + VVHC
Sbjct: 1011 CSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHC 1070

Query: 751  DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
            D+KPSNVLLD +MVA + DFGIA+LL+  ESM+ T+TL TIGYMAPEYG +G +ST+GDV
Sbjct: 1071 DLKPSNVLLDNNMVAHVADFGIARLLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDV 1130

Query: 811  YSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIM 850
            YS+GI+LME+F RK+P DE+F+G+++LK WV +SL  S++
Sbjct: 1131 YSYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVI 1169

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  784 bits (2024), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/880 (49%), Positives = 589/880 (66%), Gaps = 47/880 (5%)

Query: 5    LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
             TG +P  LGSLS L+ L L +N+L G IP  I  ++ L IL L+++ ++G  P   FN+
Sbjct: 303  FTGGIPKALGSLSDLEELYLGYNKLTGGIPREIGILSNLNILHLASSGINGPIPAEIFNI 362

Query: 63   SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLP----------------- 105
            SSL  ID ++N LSG LP +I  +LP +Q L L+ N  +G LP                 
Sbjct: 363  SSLHRIDFTNNSLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCGELLLLSLSIN 422

Query: 106  -------REIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN 158
                   R+IGNL+ L  I LS N L+G IP   GNL+ L+ L L SNNL+G +P  +FN
Sbjct: 423  KFTRSIPRDIGNLSKLKKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLIGTIPEDIFN 482

Query: 159  ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPD 218
            IS L+ L L  N LSG + SSI   LP+LE   +  N FSG IP  I N SKL    + D
Sbjct: 483  ISKLQTLALAQNHLSGGLPSSISTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISD 542

Query: 219  NSFSGFIPNRFHNMRNLKELNLEYNYITSSN--HELSFISSLANSKKLKVLSLTGNPLLD 276
            N F G +P    N+R L+ LNL  N +T  +   E+ F++SL N K L+ L +  NPL  
Sbjct: 543  NYFIGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPL-K 601

Query: 277  CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLE 336
              LP+S+GNLS+++E F    C+ RG+IP  +GNL NLI + LG N L GSIP+TL +L+
Sbjct: 602  GTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQ 661

Query: 337  KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL 396
            KLQ L +  N+++G I +D+  L  L  ++L  NKLSGSIP+CFG+L +LR+LS  SN L
Sbjct: 662  KLQRLYIAGNRIQGSIPNDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVL 721

Query: 397  TF-VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK 455
             F +P +FW+L ++L++ LSSN L+G+LP E+GN+K +  L LS+N +SG IP  +G L+
Sbjct: 722  AFNIPMSFWSLRDLLVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQ 781

Query: 456  NLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
            NL NL L  N LQGSIP   GDL+SLE +DLS N LSG IP SLE L+YLK+LNVSFN+L
Sbjct: 782  NLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSFNKL 841

Query: 516  EGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLS 575
            +GEIP GG   NFT+ESF+ N+ LCG+PH QV  C       + K+ K  IL  + LP+ 
Sbjct: 842  QGEIPDGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNHTQSWKT-KSFILKYILLPVG 900

Query: 576  AAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNV 630
            +   I++++AF   ++   R+ D    N +   P+ +W      + S Q+LL AT+ F  
Sbjct: 901  S---IVTLVAF---IVLWIRRQD----NTEIPAPIDSWLPGAHEKISQQQLLYATNDFGE 950

Query: 631  NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
            +NLIG GS G VY+G   +G+ VAIKVF+L+ +GAL SF++ECEV++ I HRNL+RII+ 
Sbjct: 951  DNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITC 1010

Query: 691  CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
            C+N DFKALVL+YMPKGSL+  LYS N  LD+F+RLNI+ID+ALALEYLH    + VVHC
Sbjct: 1011 CSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHC 1070

Query: 751  DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
            D+KPSNVLLD +MVA + DFGIA+LL+  ESM+ T+TL TIGYMAPEYG +G +ST+GDV
Sbjct: 1071 DLKPSNVLLDNNMVAHVADFGIARLLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDV 1130

Query: 811  YSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIM 850
            YS+GI+LME+F RK+P DE+F+G+++LK WV +SL  S++
Sbjct: 1131 YSYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVI 1169

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  782 bits (2019), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/854 (51%), Positives = 587/854 (68%), Gaps = 17/854 (1%)

Query: 5    LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPF----F 60
            L G +P ++G LS+++ LD+  NQL+G IPS+IF+I++L+ + L+ N LSG  P      
Sbjct: 182  LQGNIPEEIGKLSTMKILDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNH 241

Query: 61   NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS 120
             +S+L+ I LS NR +G +P+N+ S    +Q L L+FN+F G +PR I +LT LT + L+
Sbjct: 242  ELSALRGIRLSANRFTGPIPSNL-SKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLA 300

Query: 121  ENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
             N L GE+P EIG+L  L  L +  N+L G +P  +FNIS++    LT N LSG++  + 
Sbjct: 301  ANSLSGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNF 360

Query: 181  RLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL 240
               LPNLE   L  N  SG IPS I NASKL   +   N  +G IP+   ++R L+ LNL
Sbjct: 361  GSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNL 420

Query: 241  EYNYITSSNH--ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNC 298
              N +   ++  ELSF++SL N K+L++L L+ NPL+  +LP SIGNLS S++RF  + C
Sbjct: 421  GVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIG-ILPISIGNLSTSLQRFEANTC 479

Query: 299  NIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICR 358
             ++G+IP E+GNL NL ++ L  N L G+IP ++ +L+KLQ L L +N+L+G I +DIC+
Sbjct: 480  KLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQ 539

Query: 359  LARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL-TFVPSTFWNLTNILMVDLSSN 417
            L  L  ++L +N+LSGSIPAC G L  LR L   SN+L + +PST W+L +IL +D+SSN
Sbjct: 540  LRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSN 599

Query: 418  PLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD 477
             L G LP ++GNLKVLV++ LSRN LSG+IP+ IGGL++L +LSL  N  +G I +S  +
Sbjct: 600  FLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSN 659

Query: 478  LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGND 537
            L SLE +DLS+N L G IP SLE L+YLKYL+VSFN L GEIP  G  ANF++ESFM N 
Sbjct: 660  LKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNK 719

Query: 538  LLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKG 597
             LCGSP L++PPC+   T T   +    +LL   LP   + ++   L F +   + CRK 
Sbjct: 720  ALCGSPRLKLPPCR---TGTRWSTTISWLLLKYILPAILSTLLFLALIFVW---TRCRKR 773

Query: 598  DTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKV 657
            +  L     ++    WRR SYQE+ QAT+ F+  NL+G GS GSVYRG   DG   AIKV
Sbjct: 774  NAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKV 833

Query: 658  FHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALVLDYMPKGSLEACLYS 715
            F+LQ E A +SF+AECEV+  IRHRNL++I+SSC+N   DFKALVL+Y+P GSLE  LYS
Sbjct: 834  FNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYS 893

Query: 716  DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
             N  LDI +RLNI+ID+ALA+EYLH G   PVVHCD+KPSN+LLDED    +GDFGIAKL
Sbjct: 894  HNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKL 953

Query: 776  LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM 835
            L  +ES++ TQTLATIGYMAP+Y   G ++T GDVYS+GI+LME FTR+RPTDEIFS EM
Sbjct: 954  LREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEM 1013

Query: 836  SLKRWVNDSLPISI 849
            S+K WV D L  SI
Sbjct: 1014 SMKNWVWDWLCGSI 1027

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  781 bits (2016), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/878 (49%), Positives = 592/878 (67%), Gaps = 39/878 (4%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS---------- 54
           L GT+P QLG+LS LQYL L  N   G +PS I ++  L+++D+ +N+LS          
Sbjct: 85  LLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGN 144

Query: 55  ---------------GSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAF 97
                          G+ P   FN+SSL+V+DL  N L G LP N+  +LP ++ L L+ 
Sbjct: 145 LHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLLSS 204

Query: 98  NQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF 157
           NQ +G +P ++     L  + L  N+  G IP E+G L  L+ L L  N L G +P ++F
Sbjct: 205 NQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSIF 264

Query: 158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP 217
           N+++L+ +Q+  N LSGSI     + LPNLE   L  N  +G +P F+ N S+L I +L 
Sbjct: 265 NMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLS 324

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITS--SNHELSFISSLANSKKLKVLSLTGNPLL 275
            N  +G +   F N+R L+ L+L+ N  T+  S+  L+FI+SL NS++LK L +  NPL 
Sbjct: 325 YNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPL- 383

Query: 276 DCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL 335
           D +LP+S+GNLS  + +FY++   ++G+IP E+GNL NLI++ L  N L G IP+T+  L
Sbjct: 384 DGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGL 443

Query: 336 EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNE 395
            K+Q+L L  N L G I  DIC   RL  + L++N LSG IP+C GNL SLR L    N 
Sbjct: 444 RKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNI 503

Query: 396 LT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGL 454
           L+  +P   W+L ++L+++L SN L GSLP ++G ++  + + LS N LSG+IP+TIG L
Sbjct: 504 LSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSL 563

Query: 455 KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNR 514
           +NL   SL  N+ QGSIP + G L+SLE LDLS N LSG IP SLE L YL++ +VSFN 
Sbjct: 564 QNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNG 623

Query: 515 LEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPL 574
           L+GEIPRGG  ANFT+ SF+ N  LCG   LQVPPC S ++R + K++    LL  +LP 
Sbjct: 624 LQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPC-SIESRKDSKTKSR--LLRFSLPT 680

Query: 575 SAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVA-WRRFSYQELLQATDQFNVNNL 633
            A+ +++  +AF F L+  CR+   K   I   +P+ A  RR SY ELL AT++F+ +NL
Sbjct: 681 VASILLV--VAFIF-LVMGCRRRYRK-DPIPEALPVTAIQRRISYLELLHATNEFHESNL 736

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G GSFGSVY+GR  DG+ VA+K+F+LQL+ A  SF+ ECE++R+IRHRNLV+II SC+N
Sbjct: 737 LGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSN 796

Query: 694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIK 753
            DFKALVL+YMPKGSLE  LYS N  LDI +R+NI+ID+A ALEYLH G+P+PVVHCD+K
Sbjct: 797 LDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLK 856

Query: 754 PSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSF 813
           PSNVLLDEDMVA + DFGIAKLL  +ES   T+TLATIGYMAPEYG +G +ST+ DVYSF
Sbjct: 857 PSNVLLDEDMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSF 916

Query: 814 GIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN 851
           GIMLME+ TRKRPTDE+F GEMSLKR V +SLP S+++
Sbjct: 917 GIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVID 954

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera]

 Score =  779 bits (2011), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/870 (50%), Positives = 575/870 (66%), Gaps = 46/870 (5%)

Query: 6    TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMS 63
            TG +P  +GSLS L+ L L +N+L G IP  I +++ L IL L +N +SG  P   FN+S
Sbjct: 305  TGGIPQAIGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNIS 364

Query: 64   SLQVIDLSDNRLSGELPANIFSYLPFVQFL------------------------SLAFNQ 99
            SLQ I  S+N LSG LP +I  +LP +Q+L                        SL+FN+
Sbjct: 365  SLQGIGFSNNSLSGSLPMDICKHLPNLQWLDLALNHLSGQLPTTLSLCRELLVLSLSFNK 424

Query: 100  FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
            F G +PREIGNL+ L  IDLS N L+G IP   GNL  L+ L L  NNL G VP  +FNI
Sbjct: 425  FRGSIPREIGNLSKLEWIDLSSNSLVGSIPTSFGNLMALKFLNLGINNLTGTVPEAIFNI 484

Query: 160  STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
            S L+ L +  N LSGS+ SSI   LP+LE   +  N FSG IP  I N SKL+  ++  N
Sbjct: 485  SKLQSLAMAINHLSGSLPSSIGTWLPDLEGLFIGGNEFSGIIPVSISNMSKLTQLDVSRN 544

Query: 220  SFSGFIPNRFHNMRNLKELNLEYNYITSSN--HELSFISSLANSKKLKVLSLTGNPLLDC 277
            SF G +P    N+  L+ LNL  N  T+ +   E+SF++SL N K LK L +  NP    
Sbjct: 545  SFIGNVPKDLGNLTKLEVLNLAGNQFTNEHLASEVSFLTSLTNCKFLKNLWIGNNPF-KG 603

Query: 278  VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEK 337
             LP+S+GNL +++E F    C  RG+IP  +GNL NLI + LG N L GSIP+ L RL+K
Sbjct: 604  TLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTILGRLKK 663

Query: 338  LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT 397
            LQ L +  N+L G I +D+C L  L  ++L  NKLSGSIP+CFG+L +L++L   SN L 
Sbjct: 664  LQRLHIAGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLA 723

Query: 398  F-VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
            F +P++ W+L ++L+++LSSN L+G+LP E+GN+K +  L LS+N +SG IP  +G  +N
Sbjct: 724  FNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQN 783

Query: 457  LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            L  LSL  N LQG IP   GDL+SLE LDLS N LSG IP SLE L+YLKYLNVS N+L+
Sbjct: 784  LAKLSLSQNRLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQ 843

Query: 517  GEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSA 576
            GEIP GG   NFT+ESFM N+ LCG+PH QV  C     RT     K  IL  + LP+ +
Sbjct: 844  GEIPNGGPFVNFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYILLPVGS 902

Query: 577  AFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNVN 631
                I+++ F   ++   R+ D    N++   P+ +W      + S+Q LL AT+ F  +
Sbjct: 903  T---ITLVVF---IVLWIRRRD----NMEIPTPIDSWLPGTHEKISHQRLLYATNDFGED 952

Query: 632  NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
            NLIG GS G VY+G   +G+ VAIKVF+L+ +GAL SF++ECEV++ IRHRNLVRII+ C
Sbjct: 953  NLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCC 1012

Query: 692  TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            +N DFKALVL YMP GSLE  LYS N  LD+ +RLNI+ID+A ALEYLH    + VVHCD
Sbjct: 1013 SNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCD 1072

Query: 752  IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
            +KPSNVLLD+DMVA + DFGI KLL+  ESM+ T+TL TIGYMAPE+G +G +ST+ DVY
Sbjct: 1073 LKPSNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVY 1132

Query: 812  SFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
            S+GI+LME+F RK+P DE+F+G+++LK WV
Sbjct: 1133 SYGILLMEVFARKKPMDEMFTGDLTLKTWV 1162

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  778 bits (2010), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/870 (49%), Positives = 578/870 (66%), Gaps = 46/870 (5%)

Query: 6    TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMS 63
            TG +P  +GSLS+L+ L LS+N+L G IP  I +++ L IL L +N +SG  P   FN+S
Sbjct: 317  TGGIPQAIGSLSNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNIS 376

Query: 64   SLQVIDLSDNRLSGELPANIFSYLPFVQ------------------------FLSLAFNQ 99
            SLQ+ID S+N LSG LP +I  +LP +Q                        +LSLA N+
Sbjct: 377  SLQIIDFSNNSLSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLSLCGELLYLSLAVNK 436

Query: 100  FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
            F G +PREIGNL+ L  I L  N L+G IP   GNL  L+ L L  N L G VP  +FNI
Sbjct: 437  FRGSIPREIGNLSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGMNFLTGTVPEAIFNI 496

Query: 160  STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
            S L+IL L  N LSGS+  SI   LP+LE   + +N FSG IP  I N SKL   ++ DN
Sbjct: 497  SELQILVLVQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSISNMSKLIQLQVWDN 556

Query: 220  SFSGFIPNRFHNMRNLKELNLEYNYITSSN--HELSFISSLANSKKLKVLSLTGNPLLDC 277
            SF+G +P    N+  L+ LNL  N +T+ +    + F++SL N K L+ L +  NP    
Sbjct: 557  SFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFLRHLWIDDNPF-KG 615

Query: 278  VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEK 337
             LP+S+GNL +++E F    C  RG+IP  +GNL NLI + LG N L  SIP+TL RL+K
Sbjct: 616  TLPNSLGNLPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDLTRSIPTTLGRLQK 675

Query: 338  LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT 397
            LQ L +  N++ G I +D+C L  L  ++L  NKLSGSIP+CFG+L +L++L   SN L 
Sbjct: 676  LQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPALQELFLDSNVLA 735

Query: 398  F-VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
            F +P++ W+L ++L+++LSSN L+G+LP E+GN+K +  L LS+N +SG IP  +G  +N
Sbjct: 736  FNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQN 795

Query: 457  LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            L  LSL  N LQG IP   GDL+SLE LDLS N LSG IP SLE L+YLKYLNVS N+L+
Sbjct: 796  LAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQ 855

Query: 517  GEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRKVVILLGVALPLSA 576
            GEIP GG   NFT+ESFM N+ LCG+PH QV  C     RT     K  IL  + LP+ +
Sbjct: 856  GEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYILLPVGS 914

Query: 577  AFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAW-----RRFSYQELLQATDQFNVN 631
                I+++ F   ++   R+ D    N++   P+ +W      + S+Q+LL AT+ F  +
Sbjct: 915  T---ITLVVF---IVLWIRRRD----NMEIXTPIDSWLPGTHEKISHQQLLYATNDFGED 964

Query: 632  NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
            NLIG GS G VY+G   +G+ VAIKVF+L+ +GAL SF++ECEV++ IRHRNLVRII+ C
Sbjct: 965  NLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCC 1024

Query: 692  TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            +N DFKALVL YMP GSLE  LYS N  LD+ +RLNI+ID+A ALEYLH    + VVHCD
Sbjct: 1025 SNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCD 1084

Query: 752  IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
            +KPSNVLLD+BMVA + DFGIAKLL+  ESM+ T+TL TIGYMAPE+G +G +ST+ DVY
Sbjct: 1085 LKPSNVLLDDBMVAHVTDFGIAKLLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVY 1144

Query: 812  SFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
            S+GI+LME+F RK+P DE+F+G+++LK WV
Sbjct: 1145 SYGILLMEVFARKKPMDEMFTGDLTLKTWV 1174

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	851
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.871	0.735	0.339	3.1e-140
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.942	0.782	0.394	1.9e-138
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.887	0.747	0.357	2.5e-113
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.967	0.701	0.313	2.6e-111
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.975	0.809	0.334	4.2e-111
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.917	0.796	0.342	1.4e-103
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.891	0.750	0.321	4.7e-103
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.801	0.838	0.355	5.4e-102
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.945	0.642	0.325	1.9e-99
TAIR|locus:2122239	1136	AT4G36180 [Arabidopsis thalian	0.567	0.425	0.344	6.8e-98

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1020 (364.1 bits), Expect = 3.1e-140, Sum P(2) = 3.1e-140
 Identities = 262/772 (33%), Positives = 393/772 (50%)

Query:    27 NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIF 84
             N   GTIP  + ++  L+ L +  N L G  P    N S L  +DL  N L   +P+ + 
Sbjct:   100 NSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELG 159

Query:    85 SYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXX 144
             S L  + +L L  N   G  P  I NLTSL  ++L  NHL GEIP +I  L  + +    
Sbjct:   160 S-LRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLT 218

Query:   145 XXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSF 204
                     P   +N+S+L+ L L  N  SG++       LPN+   SL  N  +G IP+ 
Sbjct:   219 MNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTT 278

Query:   205 IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS-SNHELSFISSLANSKK 263
             + N S L +  +  N  +G I   F  + NL  L L  N + S S  +L+F+ +L N   
Sbjct:   279 LANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSH 338

Query:   264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNK 323
             L  LS++ N L    LP+SI N+S  +    L    I GSIP ++G         L  N 
Sbjct:   339 LHGLSVSYNRL-GGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNL 397

Query:   324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
             L G +P++L  L  L  L L +N+  G I   I  L +L  +YL +N   G +P   G+ 
Sbjct:   398 LTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDC 457

Query:   384 ASLRKLSFASNELT-FVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNN 442
             + +  L    N+L   +P     +  ++ ++            +IG L+ LVEL L  NN
Sbjct:   458 SHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNN 517

Query:   443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXXX 502
             LSG +P T+G   +++ + L +N+  G+IP+  G L+ ++ +DLSNN LSG I       
Sbjct:   518 LSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENF 576

Query:   503 XXXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS-PHLQVPPC--KSTKTRTNQ 559
                   N+S N  EG +P  G   N T  S  GN  LCGS   L++ PC  ++    T  
Sbjct:   577 SKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRH 636

Query:   560 KSRKVVILLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANMPL-VAWRRFSY 618
              S    + +GV                 F      RK + K++N  A   L +   + SY
Sbjct:   637 PSLLKKVAIGVSVGIALLLLLFIVSLSWFKK----RKNNQKINN-SAPFTLEIFHEKLSY 691

Query:   619 QELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLR 677
              +L  ATD F+ +N++GSGSFG+V++     +   VA+KV ++Q  GA++SF AECE L+
Sbjct:   692 GDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLK 751

Query:   678 SIRHRNLVRIISSCTNDDF-----KALVLDYMPKGSLEACLYSD--------NSNLDIFK 724
              IRHRNLV+++++C + DF     +AL+ ++MP GSL+  L+ +        +  L + +
Sbjct:   752 DIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLE 811

Query:   725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL 776
             RLNI ID+A  L+YLH     P+ HCD+KPSN+LLD+D+ A + DFG+A+LL
Sbjct:   812 RLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLL 863

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
 Identities = 331/838 (39%), Positives = 464/838 (55%)

Query:    27 NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIF 84
             N L G IP  +  ++ L++L+LS+N + GS P      + L  +DLS N+L G +P  I 
Sbjct:   113 NYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIG 172

Query:    85 SYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXX 144
             + L  +  L L  N  +G +P  +GNLTSL   DLS N L G IP  +G L +L      
Sbjct:   173 ASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLG 232

Query:   145 XXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSF 204
                     P +++N+S+L+   +  N L G I ++    L  LE+  +  N F GKIP+ 
Sbjct:   233 QNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPAS 292

Query:   205 IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN-YITSSNHELSFISSLANSKK 263
             + NAS L++ ++  N FSG I + F  +RNL EL L  N + T    +  FIS L N  K
Sbjct:   293 VANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSK 352

Query:   264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNK 323
             L+ L+L G   L  VLP+S  NLS S+    L    I GSIPK++G         L  N 
Sbjct:   353 LQTLNL-GENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNN 411

Query:   324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
               GS+PS+L RL+ L IL    N L G I   I  L  L+ + L  NK SG IP    NL
Sbjct:   412 FRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNL 471

Query:   384 ASLRKLSFASNELTF-VPSTFWNLTNI-LMVDXXXXXXXXXXXXEIGNLKVLVELYLSRN 441
              +L  L  ++N L+  +PS  +N+  + +M++            EIG+LK LVE +   N
Sbjct:   472 TNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESN 531

Query:   442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXX 501
              LSG IP T+G  + L+ L L +N L GSIP+++G L  LE LDLS+N LSG IP     
Sbjct:   532 RLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLAD 591

Query:   502 XXXXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS-PHLQVPPCKSTKTRTNQK 560
                    N+SFN   GE+P  G  A  +  S  GN  LCG  P L +P C         +
Sbjct:   592 ITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLL-----E 646

Query:   561 SRKVVILLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQE 620
             +RK   +L +                        +KG    ++++ + PLV     SY +
Sbjct:   647 NRKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGH-PLV-----SYSQ 700

Query:   621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
             L++ATD F   NL+GSGSFGSVY+G+      VA+KV  L+   AL+SF AECE LR++R
Sbjct:   701 LVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMR 760

Query:   681 HRNLVRIISSCTN-----DDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIV 729
             HRNLV+I++ C++     +DFKA+V D+MP GSLE  ++      +D  +L++ +R+ I+
Sbjct:   761 HRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTIL 820

Query:   730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-- 787
             +D+A AL+YLH   P PVVHCDIK SNVLLD DMVA +GDFG+A++L    S+    T  
Sbjct:   821 LDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSS 880

Query:   788 ---LATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
                + TIGY APEYG  G I ST GD+YS+GI+++EI T KRPTD  F  ++ L+++V
Sbjct:   881 MGFIGTIGYAAPEYG-VGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYV 937

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 280/784 (35%), Positives = 417/784 (53%)

Query:    31 GTIPSSIFSINTLEILDLSNNQLSGSFPF--FNMSSLQVIDLSDNRLSGELPANIFSYLP 88
             GTIP  +  ++ LE LD+  N L G  P   +N S L  + L  NRL G +P+ + S   
Sbjct:   104 GTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTN 163

Query:    89 FVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXXXXXX 148
              VQ L+L  N   G LP  +GNLT L  + LS N+L GEIP ++  L  + +        
Sbjct:   164 LVQ-LNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNF 222

Query:   149 XXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNA 208
                 P  L+N+S+LK+L +  N  SG +   + + LPNL  F++  N F+G IP+ + N 
Sbjct:   223 SGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNI 282

Query:   209 SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS-SNHELSFISSLANSKKLKVL 267
             S L    + +N+ +G IP  F N+ NLK L L  N + S S+ +L F++SL N  +L+ L
Sbjct:   283 STLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETL 341

Query:   268 SLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNKLNGS 327
              + G   L   LP SI NLS  +    L    I GSIP ++G         L  N L+G 
Sbjct:   342 GI-GRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGP 400

Query:   328 IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR 387
             +P++L +L  L+ L L +N+L G I   I  +  L ++ L +N   G +P   GN + L 
Sbjct:   401 LPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLL 460

Query:   388 KLSFASNELT-FVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNNLSGD 446
             +L    N+L   +P     +  +L +D            +IG L+ L  L L  N LSG 
Sbjct:   461 ELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGK 520

Query:   447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXXXXXXX 506
             +P T+G    +++L L  N   G IP+  G L+ ++ +DLSNN LSG IP          
Sbjct:   521 LPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLE 579

Query:   507 XXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS-PHLQVPPCKSTKTRTNQK--SRK 563
               N+SFN LEG++P  G   N T+ S +GN+ LCG     Q+ PC S      +K  SR 
Sbjct:   580 YLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRL 639

Query:   564 VVILLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQ 623
               +++GV                   L    RK + + +N   +   V   + SY +L  
Sbjct:   640 KKVVIGVSVGITLLLLLFMASVTLIWLRK--RKKNKETNNPTPSTLEVLHEKISYGDLRN 697

Query:   624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLRSIRHR 682
             AT+ F+ +N++GSGSFG+VY+   L   +V A+KV ++Q  GA++SF AECE L+ IRHR
Sbjct:   698 ATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHR 757

Query:   683 NLVRIISSCTNDDF-----KALVLDYMPKGSLEACLYSD--------NSNLDIFKRLNIV 729
             NLV+++++C++ DF     +AL+ ++MP GSL+  L+ +        +  L + +RLNI 
Sbjct:   758 NLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIA 817

Query:   730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTL 788
             ID+A  L+YLH     P+ HCD+KPSNVLLD+D+ A + DFG+A+LL   DE     Q L
Sbjct:   818 IDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQ-L 876

Query:   789 ATIG 792
             ++ G
Sbjct:   877 SSAG 880

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
 Identities = 273/870 (31%), Positives = 457/870 (52%)

Query:     2 QSFLTGTVPXXXXXXXXXXXXXXXFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--F 59
             ++ L G +P                NQL G IP+ + ++  L+ L +  N+L+ S P   
Sbjct:   249 ENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSL 308

Query:    60 FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDL 119
             F ++ L  + LS+N L G +   I  +L  ++ L+L  N F G  P+ I NL +LT + +
Sbjct:   309 FRLTQLTHLGLSENHLVGPISEEI-GFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTV 367

Query:   120 SENHLMGEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSS 179
               N++ GE+P ++G L NL+             P+++ N + LK+L L++N ++G I   
Sbjct:   368 GFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRG 427

Query:   180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
                   NL   S+  N+F+G+IP  IFN S L    + DN+ +G +      ++ L+ L 
Sbjct:   428 F--GRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQ 485

Query:   240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCN 299
             + YN +T           + N K L +L L  N     + P  + NL+L ++   +++ +
Sbjct:   486 VSYNSLTGP-----IPREIGNLKDLNILYLHSNGFTGRI-PREMSNLTL-LQGLRMYSND 538

Query:   300 IRGSIPKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRL 359
             + G IP+EM          L  NK +G IP+  S+LE L  L L+ N+  G I   +  L
Sbjct:   539 LEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSL 598

Query:   360 ARLSSVYLDHNKLSGSIPACFGNLASLRK----LSFASNELT-FVPSTFWNLTNILMVDX 414
             + L++  +  N L+G+IP     LASL+     L+F++N LT  +P     L  +  +D 
Sbjct:   599 SLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDL 656

Query:   415 XXXXXXXXXXXEIGNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPN 473
                         +   K +  L  S+NNLSG IP  +  G+  + +L+L  N+  G IP 
Sbjct:   657 SNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQ 716

Query:   474 SIGDLISLECLDLSNNILSGIIPXXXXXXXXXXXXNVSFNRLEGEIPRGGTLANFTSESF 533
             S G++  L  LDLS+N L+G IP             ++ N L+G +P  G   N  +   
Sbjct:   717 SFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDL 776

Query:   534 MGNDLLCGSPHLQVPPC--KSTKTRTNQKSRKVVILLGVXXXXXXXXXXXXXXXXKFGLI 591
             MGN  LCGS    + PC  K   +  ++++R ++I+LG                    ++
Sbjct:   777 MGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVL-------IL 828

Query:   592 STCRKGDTKLSNI-QANMP----LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGR 646
             + C+K + K+ N  ++++P     +  +RF  +EL QATD FN  N+IGS S  +VY+G+
Sbjct:   829 TCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQ 888

Query:   647 FLDGMEVAIKVFHLQLEGALES---FNAECEVLRSIRHRNLVRIIS-SCTNDDFKALVLD 702
               DG  +A+KV +L+ E + ES   F  E + L  ++HRNLV+I+  +  +   KALVL 
Sbjct:   889 LEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLP 947

Query:   703 YMPKGSLEACLYSDNSNL-DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE 761
             +M  G+LE  ++   + +  + +++++ + IA  ++YLH G+  P+VHCD+KP+N+LLD 
Sbjct:   948 FMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDS 1007

Query:   762 DMVARLGDFGIAKLLSGDESMKHTQTLA----TIGYMAPEYGREGQISTEGDVYSFGIML 817
             D VA + DFG A++L   E    T + +    TIGY+APE+    +++T+ DV+SFGI++
Sbjct:  1008 DRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIM 1067

Query:   818 MEIFTRKRPT--DEIFSGEMSLKRWVNDSL 845
             ME+ T++RPT  ++  S +M+L++ V  S+
Sbjct:  1068 MELMTKQRPTSLNDEDSQDMTLRQLVEKSI 1097

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1097 (391.2 bits), Expect = 4.2e-111, P = 4.2e-111
 Identities = 291/869 (33%), Positives = 437/869 (50%)

Query:     5 LTGTVPXXXXXXXXXXXXXXXFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF--NM 62
             LTG V                 N   G IPS + ++  L+ L++SNN   G  P    N 
Sbjct:    93 LTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNC 152

Query:    63 SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
             SSL  +DLS N L   +P   F  L  +  LSL  N   G  P  +GNLTSL  +D   N
Sbjct:   153 SSLSTLDLSSNHLEQGVPLE-FGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYN 211

Query:   123 HLMGEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRL 182
              + GEIP +I  L+ +              P  ++N+S+L  L +T N+ SG++      
Sbjct:   212 QIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGS 271

Query:   183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
              LPNL++  +  N+F+G IP  + N S L   ++P N  +G IP  F  ++NL  L L  
Sbjct:   272 LLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNN 331

Query:   243 NYITS-SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR 301
             N + + S+ +L F+ +L N  +L+ L++  N L    LP  I NLS  +    L    I 
Sbjct:   332 NSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKL-GGQLPVFIANLSTQLTELSLGGNLIS 390

Query:   302 GSIPKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR 361
             GSIP  +G         LG N L G +P +L  L +L+ + L +N L G I   +  ++ 
Sbjct:   391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450

Query:   362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDXXXXXXX 420
             L+ +YL +N   GSIP+  G+ + L  L+  +N+L   +P     L ++++++       
Sbjct:   451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510

Query:   421 XXXXXEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLIS 480
                  +IG LK L+ L +S N LSG IP T+    +L+ L L  N+  G IP+  G L  
Sbjct:   511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTG 569

Query:   481 LECLDLSNNILSGIIPXXXXXXXXXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
             L  LDLS N LSG IP            N+S N  +G +P  G   N ++ S  GN  LC
Sbjct:   570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629

Query:   541 GS-PHLQVPPCKSTKTRTNQKSRKVV-ILLGVXXXXXXXXXXXXXXXXKFGL-ISTCRKG 597
             G  P LQ+ PC     R +   RK++ I +                   + L + + R  
Sbjct:   630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689

Query:   598 DTKLSNIQANMPLVA-WRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME--VA 654
             + +  N ++  P+ + + + SY EL + T  F+ +NLIGSG+FG+V++G FL      VA
Sbjct:   690 NNE--NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG-FLGSKNKAVA 746

Query:   655 IKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN-----DDFKALVLDYMPKGSL 709
             IKV +L   GA +SF AECE L  IRHRNLV++++ C++     +DF+ALV ++MP G+L
Sbjct:   747 IKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNL 806

Query:   710 EACLYSD--------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE 761
             +  L+ D        +  L +F RLNI ID+A AL YLH    NP+ HCDIKPSN+LLD+
Sbjct:   807 DMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDK 866

Query:   762 DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFG---IMLM 818
             D+ A + DFG+A+LL     +K  +    I + +   G  G I      Y  G    ++ 
Sbjct:   867 DLTAHVSDFGLAQLL-----LKFDRDTFHIQFSSA--GVRGTIGYAAPEYGMGGHPSIMG 919

Query:   819 EIFTRKRPTDEIFSGEMSLKRWVNDSLPI 847
             ++++      EIF+G+    +   D L +
Sbjct:   920 DVYSFGIVLLEIFTGKRPTNKLFVDGLTL 948

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1026 (366.2 bits), Expect = 1.4e-103, P = 1.4e-103
 Identities = 293/856 (34%), Positives = 436/856 (50%)

Query:    31 GTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM-SSLQVIDLSDNRLSGELPANIFSYL 87
             G I  SI ++  L +LDLS N   G  P    ++  +L+ + LS+N L G +P  +   L
Sbjct:    80 GEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQEL-GLL 138

Query:    88 PFVQFLSLAFNQFAGHLPREI---GNLTSLTSIDLSENHLMGEIPHEIG-NLRNLQAXXX 143
               + +L L  N+  G +P ++   G+ +SL  IDLS N L GEIP     +L+ L+    
Sbjct:   139 NRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLL 198

Query:   144 XXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNF------ 197
                      P++L N + LK + L +N LSG + S +   +P L+   L+ N+F      
Sbjct:   199 WSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNN 258

Query:   198 SGKIPSF--IFNASKLSICELPDNSFSGFIPNRFHNMR-NLKELNLEYNYITSSNHELSF 254
             +   P F  + N+S L   EL  NS  G I +   ++  NL +++L+ N I  S      
Sbjct:   259 TNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPE-- 316

Query:   255 ISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXX 314
             IS+L N   L +L+L+ N LL   +P  +  LS  +ER YL N ++ G IP E+G     
Sbjct:   317 ISNLLN---LTLLNLSSN-LLSGPIPRELCKLS-KLERVYLSNNHLTGEIPMELGDIPRL 371

Query:   315 XXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG 374
                 +  N L+GSIP +   L +L+ L L  N L G +   + +   L  + L HN L+G
Sbjct:   372 GLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTG 431

Query:   375 SIPA-CFGNLASLRK-LSFASNELTF-VPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLK 431
             +IP     NL +L+  L+ +SN L+  +P     +  +L VD                  
Sbjct:   432 TIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVD------------------ 473

Query:   432 VLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNIL 491
                   LS N LSG IP  +G    L++L+L  N    ++P+S+G L  L+ LD+S N L
Sbjct:   474 ------LSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRL 527

Query:   492 SGIIPXXXXXXXXXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCK 551
             +G IP            N SFN L G +   G+ +  T ESF+G+ LLCGS    +  CK
Sbjct:   528 TGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACK 586

Query:   552 STKTRTNQKSRKVVILLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANMPLV 611
               K +       V++ L +                +FG   T    +      + N    
Sbjct:   587 K-KHKYPSVLLPVLLSL-IATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP 644

Query:   612 AWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFH----LQLEGALE 667
              + R SYQ+L+ AT  FN ++LIGSG FG VY+G   +  +VA+KV      L+  G   
Sbjct:   645 KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSG--- 701

Query:   668 SFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS---DNSNLDIFK 724
             SF  EC++L+  RHRNL+RII++C+   F ALVL  MP GSLE  LY     + NLD+ +
Sbjct:   702 SFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQ 761

Query:   725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG------ 778
              +NI  D+A  + YLH   P  VVHCD+KPSN+LLD++M A + DFGI++L+ G      
Sbjct:   762 LVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVS 821

Query:   779 -DESMKHTQT----LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG 833
              D+S+    T      ++GY+APEYG   + ST GDVYSFG++L+EI + +RPTD + + 
Sbjct:   822 TDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNE 881

Query:   834 EMSLKRWVNDSLPISI 849
               SL  ++    P S+
Sbjct:   882 GSSLHEFMKSHYPDSL 897

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
 Identities = 254/789 (32%), Positives = 401/789 (50%)

Query:    27 NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIF 84
             N   G IP  + ++  LE L ++ N L G  P    N S L  +DL  N L   +P+ + 
Sbjct:   100 NAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELG 159

Query:    85 SYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXX 144
             S    V  L L  N   G LPR +GNLTSL S+  ++N++ GE+P E+  L  +      
Sbjct:   160 SLTKLV-ILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLS 218

Query:   145 XXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSF 204
                     P  ++N+S L+ L L  +  SGS+       LPN+   +L  N+  G IP+ 
Sbjct:   219 MNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTT 278

Query:   205 IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH-ELSFISSLANSKK 263
             + N S L    +  N  +G I   F  + +L+ L+L  N + S    +L FI SL N   
Sbjct:   279 LSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTH 338

Query:   264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNK 323
             L++LS+ G   L   LP+SI N+S  +    L   +  GSIP+++G        +LG N 
Sbjct:   339 LQLLSV-GYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNM 397

Query:   324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
             L G +P++L +L +L +L L +N++ G I   I  L +L  +YL +N   G +P   G  
Sbjct:   398 LTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKC 457

Query:   384 ASLRKLSFASNELT-FVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNN 442
             + +  L    N+L   +P     +  ++ +             +IG+L+ LV+L L  N 
Sbjct:   458 SHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNK 517

Query:   443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXXX 502
              SG +P T+G    ++ L L  N+  G+IPN  G L+ +  +DLSNN LSG IP      
Sbjct:   518 FSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANF 576

Query:   503 XXXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS-PHLQVPPCKS----TKTRT 557
                   N+S N   G++P  G   N T     GN  LCG    L++ PC +     +T+ 
Sbjct:   577 SKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKH 636

Query:   558 NQKSRKVVILLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANMPLVAWRRFS 617
             +   +KV IL+ +                 F      R+ + + +N+  +   +   + S
Sbjct:   637 SSHLKKVAILVSIGIALLLLLVIASMVLCWFRK----RRKNQQTNNLVPSKLEIFHEKIS 692

Query:   618 YQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVL 676
             Y +L  AT+ F+ +N++GSGSFG+V++     +   VA+KV ++Q  GA++SF AECE L
Sbjct:   693 YGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESL 752

Query:   677 RSIRHRNLVRIISSCTNDDF-----KALVLDYMPKGSLEACLYSDN--------SNLDIF 723
             +  RHRNLV+++++C + DF     +AL+ +Y+P GS++  L+ +           L + 
Sbjct:   753 KDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLL 812

Query:   724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK 783
             +RLNIVID+A  L+YLH     P+ HCD+KPSNVLL++D+ A + DFG+A+LL   +   
Sbjct:   813 ERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKES 872

Query:   784 HTQTLATIG 792
                 L++ G
Sbjct:   873 FLNQLSSAG 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
 Identities = 252/709 (35%), Positives = 384/709 (54%)

Query:    27 NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIF 84
             + L G I  S+ +++ L  L LS+N LSG  P     +S LQ + L+ N LSGE+PA + 
Sbjct:    88 SNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALG 147

Query:    85 SYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXX 144
             + L  +  L L  N  +G +P  +G LT LT + L+EN L G IP   G LR L      
Sbjct:   148 N-LTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLA 206

Query:   145 XXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSF 204
                     P  ++NIS+L I ++ +N LSG++ ++    LP+L+   +  N F G+IP+ 
Sbjct:   207 FNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPAS 266

Query:   205 IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL-EYNYITSSNHELSFISSLANSKK 263
             I NAS +SI  +  NSFSG +P     MRNL+ L L E        ++  F+++L N   
Sbjct:   267 IGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCSN 326

Query:   264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNK 323
             L+ + L G      VLP S+ NLS S+    + +  I GS+P+++G         L  N 
Sbjct:   327 LQEVEL-GGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANNS 385

Query:   324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
             L GS+PS+ S+L+ L+ L ++NN+L G +   I  L +L+++ +  N   G+IP+  GNL
Sbjct:   386 LTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNL 445

Query:   384 ASLRKLSFASNE-LTFVPSTFWNLTNIL-MVDXXXXXXXXXXXXEIGNLKVLVELYLSRN 441
               L +++   N  +  +P   +++  +  ++D            EIG LK +VE +   N
Sbjct:   446 TKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSN 505

Query:   442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXX 501
              LSG+ P+TIG  + LQ+L L +N L GSIP ++  L  L+ LDLS N LSG IP     
Sbjct:   506 KLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGD 565

Query:   502 XXXXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS-PHLQVPPCKSTKTRTNQK 560
                    N+SFN   GE+P  G  AN +     GN  +CG  P L +P C S K+R  +K
Sbjct:   566 MPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTC-SLKSR-KKK 623

Query:   561 SRKVVILLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANMPLVAWRRFSYQE 620
               ++++L+ V                   ++ TC K   K   + A   +      +Y++
Sbjct:   624 KHQILLLVVVICLVSTLAVFSLLY-----MLLTCHKRRKK--EVPATTSMQGHPMITYKQ 676

Query:   621 LLQATDQFNVNNLIGSGSFGSVYRGRF--LDG---MEVAIKVFHLQLEGALESFNAECEV 675
             L++ATD F+ ++L+GSGSFGSVY+G F   DG     VA++V  L+   AL+SF AECE 
Sbjct:   677 LVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECET 736

Query:   676 LRSIRHRNLVRIISSCTN-----DDFKALVLDYMPKGSLEACLYSDNSN 719
             LR+ RHRNLV+I++ C++     +DFKA+V D+MP GSLE  L+ + ++
Sbjct:   737 LRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETND 785

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
 Identities = 274/842 (32%), Positives = 413/842 (49%)

Query:    28 QLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS 85
             QL G IP+ I +  +L++LDLSNN L+G  P   F +  L  + L++N L G L ++I S
Sbjct:   348 QLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSI-S 406

Query:    86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXXX 145
              L  +Q  +L  N   G +P+EIG L  L  + L EN   GE+P EIGN   LQ      
Sbjct:   407 NLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYG 466

Query:   146 XXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFI 205
                    P+++  +  L  L L  N L G+I +S+      + +  LA+N  SG IPS  
Sbjct:   467 NRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNC-HQMTVIDLADNQLSGSIPSSF 525

Query:   206 FNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLK 265
                + L +  + +NS  G +P+   N++NL  +N   N    S      IS L  S    
Sbjct:   526 GFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS------ISPLCGSSSYL 579

Query:   266 VLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNKLN 325
                +T N   +  +P  +G  S +++R  L      G IP+  G         +  N L+
Sbjct:   580 SFDVTENGF-EGDIPLELGK-STNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLS 637

Query:   326 GSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLAS 385
             G IP  L   +KL  + L NN L G I   + +L  L  + L  NK  GS+P    +L +
Sbjct:   638 GIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTN 697

Query:   386 LRKLSFASNELT-FVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNNLS 444
             +  L    N L   +P    NL  +  ++             IG L  L EL LSRN L+
Sbjct:   698 ILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALT 757

Query:   445 GDIPTTIGGLKNLQN-LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXXXX 503
             G+IP  IG L++LQ+ L L  NN  G IP++I  L  LE LDLS+N L G +P       
Sbjct:   758 GEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMK 817

Query:   504 XXXXXNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSRK 563
                  N+S+N LEG++ +    + + +++F+GN  LCGSP        S   R+      
Sbjct:   818 SLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTV 875

Query:   564 VVI--LLGVXXXXXXXXXXXXXXXXKFGLISTCRKGDTKLSNIQANM--PLV----AWRR 615
             V+I  +  +                   L    R G++  S+  ++   PL     A   
Sbjct:   876 VIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSD 935

Query:   616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAEC 673
               + ++++AT   N   +IGSG  G VY+    +G  +A+K   L  +  +  +SFN E 
Sbjct:   936 IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI-LWKDDLMSNKSFNREV 994

Query:   674 EVLRSIRHRNLVRIISSCTN--DDFKALVLDYMPKGSLEACLYSDNSN-----LDIFKRL 726
             + L +IRHR+LV+++  C++  D    L+ +YM  GS+   L+++ +      L    RL
Sbjct:   995 KTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRL 1054

Query:   727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD---ESMK 783
              I + +A  +EYLH+    P+VH DIK SNVLLD ++ A LGDFG+AK+L+G+    +  
Sbjct:  1055 KIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTES 1114

Query:   784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND 843
             +T    + GY+APEY    + + + DVYS GI+LMEI T K PT+ +F  E  + RWV  
Sbjct:  1115 NTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVET 1174

Query:   844 SL 845
              L
Sbjct:  1175 VL 1176

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)]

 Score = 664 (238.8 bits), Expect = 6.8e-98, Sum P(2) = 6.8e-98
 Identities = 172/499 (34%), Positives = 254/499 (50%)

Query:    27 NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIF 84
             N   GTIP+S+     L  + L  N LSG  P    N++SL+V +++ NRLSGE+P  + 
Sbjct:   102 NSFNGTIPTSLAYCTRLLSVFLQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEIPVGLP 161

Query:    85 SYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXX 144
             S L   QFL ++ N F+G +P  + NLT L  ++LS N L GEIP  +GNL++LQ     
Sbjct:   162 SSL---QFLDISSNTFSGQIPSGLANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLD 218

Query:   145 XXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSF 204
                     P+ + N S+L  L  + N + G I ++   ALP LE+ SL+NNNFSG +P  
Sbjct:   219 FNLLQGTLPSAISNCSSLVHLSASENEIGGVIPAAYG-ALPKLEVLSLSNNNFSGTVPFS 277

Query:   205 IFNASKLSICELPDNSFSGFI-PNRFHNMRN-LKELNLEYNYITSSNHELSFISSLANSK 262
             +F  + L+I +L  N+FS  + P    N R  L+ L+L+ N I+       F   L N  
Sbjct:   278 LFCNTSLTIVQLGFNAFSDIVRPETTANCRTGLQVLDLQENRISGR-----FPLWLTNIL 332

Query:   263 KLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYN 322
              LK L ++GN L    +P  IGNL   +E   L N ++ G IP E+             N
Sbjct:   333 SLKNLDVSGN-LFSGEIPPDIGNLK-RLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGN 390

Query:   323 KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
              L G IP  L  ++ L++L L  N   G +   +  L +L  + L  N L+GS P     
Sbjct:   391 SLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMA 450

Query:   383 LASLRKLSFASNELT-FVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRN 441
             L SL +L  + N  +  VP +  NL+N+  ++             +GNL  L  L LS+ 
Sbjct:   451 LTSLSELDLSGNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQ 510

Query:   442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXX 501
             N+SG++P  + GL N+Q ++L  NN  G +P     L+SL  ++LS+N  SG IP     
Sbjct:   511 NMSGEVPVELSGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGF 570

Query:   502 XXXXXXXNVSFNRLEGEIP 520
                    ++S N + G IP
Sbjct:   571 LRLLVSLSLSDNHISGSIP 589

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.3938	0.9858	0.8306	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00110705 hypothetical protein (1061 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	851
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-99
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-41
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-38
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-27
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-23
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-22
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	4e-04
pfam03109	117	pfam03109, ABC1, ABC1 family	5e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.004
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  329 bits (845), Expect = 8e-99
 Identities = 261/850 (30%), Positives = 406/850 (47%), Gaps = 102/850 (12%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF--NM 62
            TG++P   GS+ +L+ LDLS N L G IP+ I S ++L++LDL  N L G  P    N+
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           +SL+ + L+ N+L G++P  +   +  ++++ L +N  +G +P EIG LTSL  +DL  N
Sbjct: 188 TSLEFLTLASNQLVGQIPREL-GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
           +L G IP  +GNL+NLQ L L  N L G +P ++F++  L  L L++N+LSG I   + +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-I 305

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
            L NLE+  L +NNF+GKIP  + +  +L + +L  N FSG IP       NL  L+L  
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365

Query: 243 NYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRG 302
           N +T    E      L +S  L  L L  N L                           G
Sbjct: 366 NNLTGEIPE-----GLCSSGNLFKLILFSNSL--------------------------EG 394

Query: 303 SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
            IPK +G   +L  +RL  N  +G +PS  ++L  +  L + NN L+GRI      +  L
Sbjct: 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGS 422
             + L  NK  G +P  FG+                          +  +DLS N  SG+
Sbjct: 455 QMLSLARNKFFGGLPDSFGS------------------------KRLENLDLSRNQFSGA 490

Query: 423 LPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLE 482
           +P ++G+L  L++L LS N LSG+IP  +   K L +L L  N L G IP S  ++  L 
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550

Query: 483 CLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGS 542
            LDLS N LSG IP +L  +  L  +N+S N L G +P  G      + +  GN  LCG 
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610

Query: 543 PHLQ-VPPCKSTKTRTNQKSRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKL 601
                +PPCK        + RK             AF++++++AF F  I      + K 
Sbjct: 611 DTTSGLPPCK--------RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR 662

Query: 602 SNIQANMPLVAW----------RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DG 650
              +       W          +  +  ++L +  +    N+I  G  G+ Y+G+ + +G
Sbjct: 663 VENEDGT----WELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNG 715

Query: 651 MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE 710
           M+  +K  +  +     S  A+   +  ++H N+V++I  C ++    L+ +Y+   +L 
Sbjct: 716 MQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771

Query: 711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF 770
             L     NL   +R  I I IA AL +LH      VV  ++ P  +++D      L   
Sbjct: 772 EVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RL 826

Query: 771 GIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
            +  LL  D     T+   +  Y+APE      I+ + D+Y FG++L+E+ T K P D  
Sbjct: 827 SLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881

Query: 831 FSGEMSLKRW 840
           F    S+  W
Sbjct: 882 FGVHGSIVEW 891

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  215 bits (549), Expect = 2e-58
 Identities = 166/465 (35%), Positives = 244/465 (52%), Gaps = 18/465 (3%)

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLT-SLTSIDL 119
           N S +  IDLS   +SG++ + IF  LP++Q ++L+ NQ +G +P +I   + SL  ++L
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 120 SENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSS 179
           S N+  G IP   G++ NL+ L L +N L G +P  + + S+LK+L L  N L G I +S
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
           +   L +LE  +LA+N   G+IP  +     L    L  N+ SG IP     + +L  L+
Sbjct: 184 LT-NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS--LSMERFYLHN 297
           L YN +T         SSL N K L+ L L  N L   + P SI +L   +S++   L +
Sbjct: 243 LVYNNLTG-----PIPSSLGNLKNLQYLFLYQNKLSGPI-PPSIFSLQKLISLD---LSD 293

Query: 298 CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDIC 357
            ++ G IP+ +  L NL I+ L  N   G IP  L+ L +LQ+L L +N+  G I  ++ 
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353

Query: 358 RLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL-TFVPSTFWNLTNILMVDLSS 416
           +   L+ + L  N L+G IP    +  +L KL   SN L   +P +     ++  V L  
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413

Query: 417 NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIG 476
           N  SG LP E   L ++  L +S NNL G I +    + +LQ LSL  N   G +P+S G
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473

Query: 477 DLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR 521
               LE LDLS N  SG +P  L  L  L  L +S N+L GEIP 
Sbjct: 474 S-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  166 bits (422), Expect = 7e-47
 Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 8/191 (4%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG+VY  R    G +VAIK+   +     LE    E E+L+ + H N+V++    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            +++   LV++Y   GSL+  L  +   L   + L I++ I   LEYLH    N ++H D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117

Query: 752 IKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR-EGQISTEGD 809
           +KP N+LLD D    +L DFG++KLL+ D+S+  T  + T  YMAPE    +G  S + D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176

Query: 810 VYSFGIMLMEI 820
           ++S G++L E+
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (424), Expect = 1e-46
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 12/214 (5%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ-LEGALESFNAECEVLRSIRHRNLV 685
           + +   +G GSFG VY  R    G  VAIKV   + ++   E    E ++L+ ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R+     ++D   LV++Y   G L   L      L   +    +  I  ALEYLH     
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLH---SK 116

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            +VH D+KP N+LLDED   +L DFG+A+ L  D   K T  + T  YMAPE        
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
              D++S G++L E+ T K P    F G+  L  
Sbjct: 175 KAVDIWSLGVILYELLTGKPP----FPGDDQLLE 204

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (413), Expect = 3e-45
 Identities = 74/211 (35%), Positives = 108/211 (51%), Gaps = 13/211 (6%)

Query: 628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNL 684
           + +   +GSGSFG+VY+ +    G  VA+K+   +       ++   E  +LR + H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           VR+I +  + D   LV++Y   G L     S    L   +   I + I   LEYLH    
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYLH---S 116

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ- 803
           N ++H D+KP N+LLDE+ V ++ DFG+AK L    S   T    T  YMAPE    G  
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
              + DV+S G++L E+ T K P    FSGE
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP----FSGE 202

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  156 bits (398), Expect = 4e-43
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 9/199 (4%)

Query: 631 NNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNL 684
              +G G+FG VY+G+         +EVA+K       E  +E F  E  ++R + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           V+++  CT ++   +V++YM  G L + L  +   L +   L+  + IA  +EYL     
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES--- 120

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI 804
              +H D+   N L+ E++V ++ DFG+++ L  D+  +       I +MAPE  +EG+ 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 805 STEGDVYSFGIMLMEIFTR 823
           +++ DV+SFG++L EIFT 
Sbjct: 181 TSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  151 bits (383), Expect = 4e-41
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 10/200 (5%)

Query: 631 NNLIGSGSFGSVYRGRFLDG-----MEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNL 684
              +G G+FG VY+G          +EVA+K       E  +E F  E  ++R + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACL-YSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           V+++  CT ++   +V++YMP G L   L  +    L +   L+  + IA  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-- 121

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
               +H D+   N L+ E++V ++ DFG+++ L  D+  K       I +MAPE  +EG+
Sbjct: 122 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 804 ISTEGDVYSFGIMLMEIFTR 823
            +++ DV+SFG++L EIFT 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (383), Expect = 4e-41
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 16/200 (8%)

Query: 634 IGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRNL 684
           +G G+FG VY+G           +VA+K      EGA     E F  E  +++ + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           VR++  CT  +   +V +YMP G L   L      L +   L + + IA  +EYL     
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQ 803
              VH D+   N L+ E++V ++ DFG+++ +  D+   K       I +MAPE  ++G+
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 804 ISTEGDVYSFGIMLMEIFTR 823
            +++ DV+SFG++L EIFT 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  158 bits (402), Expect = 7e-40
 Identities = 109/338 (32%), Positives = 175/338 (51%), Gaps = 24/338 (7%)

Query: 2   QSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--F 59
           Q+ L+G +P  + SL  L  LDLS N L G IP  +  +  LEIL L +N  +G  P   
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328

Query: 60  FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDL 119
            ++  LQV+ L  N+ SGE+P N+  +      L L+ N   G +P  + +  +L  + L
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-VLDLSTNNLTGEIPEGLCSSGNLFKLIL 387

Query: 120 SENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSS 179
             N L GEIP  +G  R+L+ + L  N+  G +P+    +  +  L ++NN L G I+S 
Sbjct: 388 FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447

Query: 180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
            +  +P+L++ SLA N F G +P   F + +L   +L  N FSG +P +  ++  L +L 
Sbjct: 448 -KWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLK 505

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSS------IGNLSLSMERF 293
           L  N ++           L++ KKL  L L+ N  L   +P+S      +  L LS  + 
Sbjct: 506 LSENKLSG-----EIPDELSSCKKLVSLDLSHNQ-LSGQIPASFSEMPVLSQLDLSQNQ- 558

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPST 331
                 + G IPK +GN+ +L+ + + +N L+GS+PST
Sbjct: 559 ------LSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  146 bits (371), Expect = 2e-39
 Identities = 72/207 (34%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 632 NLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRII 688
            L+G GSFGSVY     D G  +A+K   L    E  LE+   E  +L S++H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 689 SSCTNDDFKAL--VLDYMPKGSLEACLYSDNSNLDIFKRLNI------VIDIALALEYLH 740
            S  +++   L   L+Y+  GSL + L         F +L           I   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPEYG 799
               N +VH DIK +N+L+D D V +L DFG AK L   E+ + T ++  T  +MAPE  
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRP 826
           R  +     D++S G  ++E+ T K P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  144 bits (365), Expect = 1e-38
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 17/206 (8%)

Query: 632 NLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQ-LEGALESFNAECEVLRSIRHRNLVR 686
             +G G+FG VY+G+         EVA+K       E   + F  E  V++ + H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 687 IISSCTNDDFKALVLDYMPKGSL--------EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           ++  CT ++   LVL+YM  G L              + S L +   L+  I IA  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLATIGYMAPE 797
           L        VH D+   N L+ ED+V ++ DFG+++ +   D   K T     I +MAPE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTR 823
             ++G  +++ DV+SFG++L EIFT 
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (329), Expect = 6e-34
 Identities = 68/194 (35%), Positives = 102/194 (52%), Gaps = 10/194 (5%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
            IG G FG V  G +  G +VA+K        A ++F AE  V+ ++RH NLV+++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFK-RLNIVIDIALALEYLHFGHPNPVVHCD 751
             +   +V +YM KGSL   L S    +     +L   +D+   +EYL        VH D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   NVL+ ED+VA++ DFG+AK    + S         + + APE  RE + ST+ DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 812 SFGIMLMEIFTRKR 825
           SFGI+L EI++  R
Sbjct: 184 SFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  136 bits (345), Expect = 7e-33
 Identities = 107/291 (36%), Positives = 156/291 (53%), Gaps = 16/291 (5%)

Query: 232 MRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSME 291
           M + +EL L  ++ +S N  L ++S+  +S    V    G   + C   S + ++ LS +
Sbjct: 25  MLHAEELELLLSFKSSINDPLKYLSNWNSSAD--VCLWQG---ITCNNSSRVVSIDLSGK 79

Query: 292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL-EKLQILGLENNQLEG 350
                  NI G I   +  L  +  I L  N+L+G IP  +      L+ L L NN   G
Sbjct: 80  -------NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132

Query: 351 RILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNI 409
            I      +  L ++ L +N LSG IP   G+ +SL+ L    N L   +P++  NLT++
Sbjct: 133 SIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSL 190

Query: 410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG 469
             + L+SN L G +P E+G +K L  +YL  NNLSG+IP  IGGL +L +L L  NNL G
Sbjct: 191 EFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250

Query: 470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
            IP+S+G+L +L+ L L  N LSG IP S+  L  L  L++S N L GEIP
Sbjct: 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  126 bits (319), Expect = 1e-32
 Identities = 60/198 (30%), Positives = 107/198 (54%), Gaps = 5/198 (2%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +F +   +GSG FG V+ G + + + VAIK+         + F  E + L+ +RH++L+ 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           + + C+  +   ++ + M KGSL A L S +   L +   +++   +A  + YL      
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQ 123

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
             +H D+   N+L+ ED+V ++ DFG+A+L+  D  +   + +    + APE    G  S
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP-YKWTAPEAASHGTFS 182

Query: 806 TEGDVYSFGIMLMEIFTR 823
           T+ DV+SFGI+L E+FT 
Sbjct: 183 TKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (299), Expect = 6e-30
 Identities = 64/197 (32%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G FG VY+ R    G EVAIKV  L+ +   E    E ++L+  +H N+V+   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI--VIDIAL-ALEYLHFGHPNPVVH 749
             D   +V+++   GSL+  L    S         I  V    L  LEYLH      ++H
Sbjct: 68  KKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIH 121

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            DIK +N+LL  D   +L DFG++  LS  ++      + T  +MAPE         + D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT--MVGTPYWMAPEVINGKPYDYKAD 179

Query: 810 VYSFGIMLMEIFTRKRP 826
           ++S GI  +E+   K P
Sbjct: 180 IWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (299), Expect = 7e-30
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHRNLVRII 688
             IG GSFG VY  R   DG    +K   L    E   E    E ++L+ + H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALEYLHFGHPN 745
            S        +V++Y   G L   +         F     L+  + + LAL+YLH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            ++H DIKP N+ L  + + +LGDFGI+K+LS    +  T  + T  Y++PE  +    +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKPYN 181

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
            + D++S G +L E+ T K P    F GE
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 4e-29
 Identities = 61/195 (31%), Positives = 106/195 (54%), Gaps = 9/195 (4%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VA+K       G +  E+F  E ++++ +RH  LV++ + C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + ++   +V +YM KGSL   L S     L + + +++   IA  + YL   +    +H 
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D+   N+L+ E++V ++ DFG+A+L+  DE          I + APE    G+ + + DV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L EI T  R
Sbjct: 188 WSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 7e-29
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 26/212 (12%)

Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRN 683
            + + +LIG G+FG VY+G     G  VAIK   L+   E AL+S   E ++L++++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-----NIVID----IAL 734
           +V+ I S    D   ++L+Y   GSL            I K+      ++V      +  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL----------RQIIKKFGPFPESLVAVYVYQVLQ 110

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
            L YLH      V+H DIK +N+L  +D V +L DFG+A  L+       +  + T  +M
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWM 166

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE       ST  D++S G  ++E+ T   P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (284), Expect = 6e-28
 Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 35/210 (16%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKV---FHLQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G GSFG V   R  D G   A+KV     +     +E    E  +L  I H  +V++  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------------IVIDIALALE 737
           +   ++   LVL+Y P G L             F  L+               +I LALE
Sbjct: 61  AFQTEEKLYLVLEYAPGGEL-------------FSHLSKEGRFSEERARFYAAEIVLALE 107

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAP 796
           YLH      +++ D+KP N+LLD D   +L DFG+AK LS + S   T T   T  Y+AP
Sbjct: 108 YLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAP 162

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           E           D +S G++L E+ T K P
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (279), Expect = 4e-27
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 34/217 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRN 683
                  ++G GS G VY+ R    G   A+K  H+  +         E + LRS     
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 684 LVRIISSCTNDDFK----ALVLDYMPKGSLEACLYSDNSNLDIFKRLN---------IVI 730
           +V+    C    +K    ++VL+YM  GSL           D+ K++          I  
Sbjct: 61  VVK----CYGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIAR 106

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LA 789
            I   L+YLH      ++H DIKPSN+L++     ++ DFGI+K+L    ++    T + 
Sbjct: 107 QILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVG 162

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T+ YM+PE  +    S   D++S G+ L+E    K P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (277), Expect = 9e-27
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 13/206 (6%)

Query: 632 NLIGSGSFGSVYRGR--FLD---GMEVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
             +G G FG V   R   L    G +VA+K   H   E     F  E E+LR++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 686 RIISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +    C     ++  L+++Y+P GSL   L      +++ + L     I   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL--ATIGYMAPEYGRE 801
               +H D+   N+L++ + + ++ DFG+AK+L  D+   + +    + I + APE  R 
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPT 827
            + S+  DV+SFG+ L E+FT   P+
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 73/194 (37%), Positives = 106/194 (54%), Gaps = 12/194 (6%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           IG G FG V  G +  G +VA+K   ++ +   ++F AE  V+  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 694 DDFKA-LVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           +     +V +YM KGSL   L S   S L     L   +D+  A+EYL     N  VH D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   NVL+ ED VA++ DFG+ K  S   S + T  L  + + APE  RE + ST+ DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLP-VKWTAPEALREKKFSTKSDVW 183

Query: 812 SFGIMLMEIFTRKR 825
           SFGI+L EI++  R
Sbjct: 184 SFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  107 bits (268), Expect = 1e-25
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 30/213 (14%)

Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRNLVR 686
           +G G+FG V+ G         D   VA+K         A + F  E E+L + +H N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR-------------LNIVIDIA 733
               CT  D   +V +YM  G L   L S   +    K              L I + IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 734 LALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLA 789
             + YL   HF      VH D+   N L+  D+V ++GDFG+++ + + D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            I +M PE     + +TE DV+SFG++L EIFT
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVRIISSC 691
            IG G+FG VY+G      EVA+K     L   L   F  E E+L+   H N+V++I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  +V++ +P GSL   L    + L + K L + +D A  +EYL        +H D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRD 118

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATIGYMAPEYGREGQISTEG 808
           +   N L+ E+ V ++ DFG+++   G     S    Q    I + APE    G+ ++E 
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTSES 176

Query: 809 DVYSFGIMLMEIFT 822
           DV+S+GI+L E F+
Sbjct: 177 DVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  105 bits (263), Expect = 3e-25
 Identities = 59/200 (29%), Positives = 111/200 (55%), Gaps = 12/200 (6%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +  +  +IG G FG+V +G +  G +VA+K   ++ +   ++F  E  V+  + H+NLVR
Sbjct: 7   KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVR 63

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNL-DIFKRLNIVIDIALALEYLHFGHPN 745
           ++    ++    +V++ M KG+L   L +    L  + + L   +D+A  +EYL      
Sbjct: 64  LLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SK 119

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            +VH D+   N+L+ ED VA++ DFG+A++     SM    +   + + APE  +  + S
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFS 175

Query: 806 TEGDVYSFGIMLMEIFTRKR 825
           ++ DV+S+G++L E+F+  R
Sbjct: 176 SKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  108 bits (269), Expect = 4e-25
 Identities = 77/214 (35%), Positives = 105/214 (49%), Gaps = 20/214 (9%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG---ALESFNAECEVLRSIRH-RN 683
           + +   +G GSFG VY  R  D   VA+KV   +LE     +E F  E ++L S+ H  N
Sbjct: 2   YRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEA--CLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
           +V++     ++    LV++Y+  GSLE           L   + L I+  I  ALEYLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118

Query: 742 GHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLA-----TIGYMA 795
                ++H DIKP N+LLD D  V +L DFG+AKLL    S      L      T GYMA
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 796 PEY---GREGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE          S+  D++S GI L E+ T   P
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (262), Expect = 6e-25
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 15/205 (7%)

Query: 632 NLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRII 688
           N IG G+FG VY    LD  E+ A+K   +Q      ++    E +VL  ++H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 689 SSCTNDDFKALVLDYMPKGSLEA-CLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
               + +   + ++Y   G+LE    +    +  + +     + +   L YLH    + +
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLH---SHGI 120

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPEYGREGQI 804
           VH DIKP+N+ LD + V +LGDFG A  L  + +    +  +  G   YMAPE    G+ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 805 STEG---DVYSFGIMLMEIFTRKRP 826
              G   D++S G +++E+ T KRP
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  104 bits (260), Expect = 7e-25
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 9/205 (4%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EGA+  E F  E +V+  + H  LV++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      LV ++M  G L   L +          L + +D+   + YL     + V+H D
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 812 SFGIMLMEIFTR-KRPTDEIFSGEM 835
           SFG+++ E+F+  K P +   + E+
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  104 bits (263), Expect = 9e-25
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 18/194 (9%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G VY+      G EVAIK   L+ +      N E  +++  +H N+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALALEYLHFGHPNP 746
             D   +V++YM  GSL   +  +      F R+N      +  ++   LEYLH  +   
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLEYLHSQN--- 136

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIST 806
           V+H DIK  N+LL +D   +L DFG A  L+ ++S +++  + T  +MAPE  +      
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYGP 195

Query: 807 EGDVYSFGIMLMEI 820
           + D++S GIM +E+
Sbjct: 196 KVDIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (259), Expect = 1e-24
 Identities = 65/209 (31%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIRH 681
            F +  +IG G+FG V   +  D      M+   K   ++        N E  +L+ + H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK----RLNIVIDIALALE 737
             LV +  S  +++   LV+D +  G L   L    S    F     +   + +I LALE
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKF-WICEIVLALE 114

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           YLH      ++H DIKP N+LLDE     + DF IA  ++ D     T T  T GYMAPE
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                  S   D +S G+   E    KRP
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  103 bits (260), Expect = 1e-24
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 11/210 (5%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRN 683
            + V   IG GSFG+V + R   DG  +  K        E   +   +E  +LR ++H N
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 684 LVRIISSCTNDDFKAL--VLDYMPKGSLEACL---YSDNSNLDIFKRLNIVIDIALALEY 738
           +VR      +   + L  V++Y   G L   +     +   ++      I+  + LAL  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 739 LHFG-HPNPVV-HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
            H    P   V H D+KP+N+ LD +   +LGDFG+AK+L  D S   T  + T  YM+P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSP 179

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           E         + D++S G ++ E+     P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 6e-24
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 9/195 (4%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G + +   VA+K       G +  + F AE ++++ +RH  L+++ + C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           T ++   +V + M  GSL   L       L + + +++   +A  + YL   +    +H 
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D+   NVL+ E+ + ++ DFG+A+++  D           I + APE     + S + DV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L EI T  R
Sbjct: 188 WSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  102 bits (256), Expect = 7e-24
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 28/225 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVL-RSIR 680
           D F    +IG GSF +V   +      E AIK+     L  E  ++    E EVL R   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H  ++++  +  +++    VL+Y P G L   +     +LD         +I LALEYLH
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG-------- 792
                 ++H D+KP N+LLD+DM  ++ DFG AK+L  + S +  +  AT          
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 793 -----------YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                      Y++PE   E       D+++ G ++ ++ T K P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 9e-24
 Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 17/211 (8%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +GSG FG V+ G++   ++VAIK+     EGA+  + F  E +V+  + H NLV++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V +YM  G L   L      L     L++  D+  A+EYL     N  +H D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ ED V ++ DFG+A+ +  D+      T   + +  PE     + S++ DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           SFG+++ E+F+          G+M  +R+ N
Sbjct: 186 SFGVLMWEVFS---------EGKMPYERFSN 207

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 9e-24
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)

Query: 634 IGSGSFGSVYRGRFL-DG----MEVAIKVFHLQLEGALESFNA---ECEVLRSIRHRNLV 685
           +GSG+FG+VY+G ++ +G    + VAIKV  L+ E + ++      E  V+ S+ H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R++  C +     L+   MP G L   + +   N+     LN  + IA  + YL      
Sbjct: 73  RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR-- 129

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH-TQTLATIGYMAPEYGREGQI 804
            +VH D+   NVL+      ++ DFG+AKLL  DE   H       I +MA E       
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 805 STEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
           + + DV+S+G+ + E+ T   +P + I + E+ 
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 9e-24
 Identities = 72/253 (28%), Positives = 109/253 (43%), Gaps = 58/253 (22%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNA----ECEVLRSIRHRNLVRII 688
           IG G++G VY+ R    G  VA+K   +++E   E F      E ++L+ +RH N+VR+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALK--KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 689 SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLD------IFKRLNIVIDIALALEYLH 740
              T+    +  +V +YM    L   L S              K+L         LE L 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL---------LEGLQ 114

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--- 797
           + H N ++H DIK SN+L++ D V +L DFG+A+  +   S  +T  + T+ Y  PE   
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 798 ----YGREGQISTEGDVYSFGIMLMEIFTRK--------------------RPTDEIFSG 833
               YG       E D++S G +L E+F  K                     PTDE + G
Sbjct: 175 GATRYG------PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228

Query: 834 EMSLKRWVNDSLP 846
              L  + N    
Sbjct: 229 VSKLPWFENLKPK 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  101 bits (252), Expect = 1e-23
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D M VA+K      E A + F  E E+L  ++H+++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR--------------LNIVIDIA 733
              CT      +V +YM  G L   L S   +  I                 L I   IA
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 734 LALEY---LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLA 789
             + Y   LHF      VH D+   N L+ + +V ++GDFG+++ + S D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            I +M PE     + +TE D++SFG++L EIFT  K+P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEG-----ALESFNAECEVLRSIRHRNLVR 686
           L+GSGSFGSVY G  LD G   A+K   L  +G     A++    E  +L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
            + +   +D   + L+ +P GSL   L     +            I L LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAK---LLSGDESMKHTQTLATIGYMAPEY-GREG 802
            VH DIK +N+L+D + V +L DFG+AK     S  +S K +       +MAPE   ++G
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-----WMAPEVIAQQG 177

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D++S G  ++E+ T K P
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)

Query: 632 NLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
           + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 691 CTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           CT +    ++ ++M  G+L   L   +   ++    L +   I+ A+EYL   +    +H
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE     + S + D
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 810 VYSFGIMLMEIFT 822
           V++FG++L EI T
Sbjct: 188 VWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 5e-23
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 634 IGSGSFGSVYRGRF--LDGME----VAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVR 686
           +G G+FG VY+G     +       VAIK      E  + + F  E E++  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVID 731
           ++  CT +    ++ +Y+  G L   L  ++               S+LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLAT 790
           IA  +EYL   H    VH D+   N L+ E +  ++ DFG+++ + S D     +++L  
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +M PE    G+ +TE D++SFG++L EIF+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 33/219 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           + F++   +G GS+GSVY+    + G  VAIKV  + +E  L+    E  +L+      +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYI 60

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID---IA-------L 734
           V+   S   +    +V++Y   GS+           DI K  N  +    IA        
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQTLK 110

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG-- 792
            LEYLH    N  +H DIK  N+LL+E+  A+L DFG++  L+   +M    T+  IG  
Sbjct: 111 GLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTV--IGTP 163

Query: 793 -YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
            +MAPE  +E   + + D++S GI  +E+   K P  +I
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 75/221 (33%), Positives = 115/221 (52%), Gaps = 34/221 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA----ECEVLRSIR 680
           D+F++   IG G++G VY+ R  D G  VA+K   ++L+   E F      E ++LR + 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKILRQLN 64

Query: 681 HRNLVRIISSCTND----DFKA------LVLDYMPK---GSLEACL--YSDNSNLDIFKR 725
           HRN+V +    T+     DFK       LV +YM     G LE+ L  +S++      K+
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
           L         LE L++ H    +H DIK SN+LL+     +L DFG+A+L + +ES  +T
Sbjct: 125 L---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 786 QTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
             + T+ Y  PE   G E +     DV+S G +L E+FT+K
Sbjct: 176 NKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 187 WSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  102 bits (255), Expect = 2e-22
 Identities = 58/152 (38%), Positives = 83/152 (54%), Gaps = 12/152 (7%)

Query: 436 LYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII 495
           L L    L G IP  I  L++LQ+++L  N+++G+IP S+G + SLE LDLS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 496 PSSLEKLLYLKYLNVSFNRLEGEIPR--GGTLANFTSESFMGNDLLCGSPHLQVPPCKST 553
           P SL +L  L+ LN++ N L G +P   GG L +  S +F  N  LCG P L    C   
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPH 540

Query: 554 KTRTNQKSRKVVILLGVALPLSAAFIIISILA 585
            +        V   +G+A  +S AF+ + I A
Sbjct: 541 LS--------VGAKIGIAFGVSVAFLFLVICA 564

Length = 623

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VAIK      +G++  E+F AE  +++ ++H  LVR+ +  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           T +    ++ +YM  GSL   L +     L I K +++   IA  + ++   +    +H 
Sbjct: 71  TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHR 126

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E +  ++ DFG+A+L+  +E          I + APE    G  + + DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L EI T  R
Sbjct: 187 WSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 14/218 (6%)

Query: 628 FNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNL 684
           F + N IG GSFG V++  R  D    A+K   L      E   A  E  VL  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDN----SNLDIFKRLNIVIDIALALEYLH 740
           +R   S  +     +V++Y   G L   L            +++     I I L L +LH
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR---FFIQILLGLAHLH 118

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 ++H DIK  N+ LD     ++GD G+AKLLS + +  +T  + T  Y++PE   
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           +   + + DV++ G++L E  T K P D    G + LK
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 7e-22
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
           D + +  +IG G+   VY    L    +VAIK   L + + +++    E + +    H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI--VID---IAL---- 734
           +V+  +S    D   LV+ Y+  GSL          LDI K       +D   IA     
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSL----------LDIMKSSYPRGGLDEAIIATVLKE 110

Query: 735 ---ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLA 789
               LEYLH    N  +H DIK  N+LL ED   ++ DFG++  L   GD + K  +T  
Sbjct: 111 VLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 790 -TIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRP 826
            T  +MAPE   +        D++SFGI  +E+ T   P
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 55/190 (28%), Positives = 104/190 (54%), Gaps = 5/190 (2%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G + +  +VA+K        ++++F  E  ++++++H  LVR+ +  T 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 694 DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           ++   ++ +YM KGSL   L SD    + + K ++    IA  + Y+        +H D+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +NVL+ E ++ ++ DFG+A+++  +E          I + APE    G  + + DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189

Query: 813 FGIMLMEIFT 822
           FGI+L EI T
Sbjct: 190 FGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 633 LIGSGSFGSVYRGRFLDG-MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           ++G G++G VY  R L   + +AIK    +    ++  + E  +   ++HRN+V+ + S 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 692 TNDDFKALVLDYMPKGSLEACLYS------DNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           + + F  + ++ +P GSL A L S      DN    IF    I       LE L + H N
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-------LEGLKYLHDN 127

Query: 746 PVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ- 803
            +VH DIK  NVL++    V ++ DFG +K L+G      T T  T+ YMAPE   +G  
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAPEVIDKGPR 186

Query: 804 -ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
                 D++S G  ++E+ T K P  E+
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 2e-21
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)

Query: 633 LIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGA---------LESFNAECEVLRSIRHR 682
           LIGSGSFGSVY G     G  +A+K   L    A         L++   E  +L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+ + S  + D   + L+Y+P GS+ A L +  +  +   R N V  I   L YL   
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL--- 122

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-----LLSGDESMKHTQTLATIGYMAPE 797
           H   ++H DIK +N+L+D     ++ DFGI+K      LS   +        ++ +MAPE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             ++   + + D++S G +++E+ T K P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)

Query: 631 NNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLV 685
              IG G FG VY+G ++      + VA+K        ++ E F  E  ++R   H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           ++I   T ++   +V++  P G L + L  +  +LD+   +     ++ AL YL      
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
             VH DI   NVL+      +LGDFG+++ L  +   K ++    I +MAPE     + +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 806 TEGDVYSFGIMLMEIFTR-KRP 826
           +  DV+ FG+ + EI     +P
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VA+K       G +  ESF  E ++++ +RH  LV++ +  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 692 TNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L   +   L +   +++   +A  + Y+   +    +H 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ + +V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 94.1 bits (235), Expect = 5e-21
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 52/219 (23%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFH----LQLEGALESFNAECEVLRSIR 680
           D F     +G+GSFG V   R     +  A+K+      ++L   +E    E  +L+SIR
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-KQVEHVLNEKRILQSIR 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
           H  LV +  S  +D    LV++Y+P G L              A  Y+            
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ---------- 109

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
               + LALEYLH      +V+ D+KP N+LLD D   ++ DFG AK + G      T T
Sbjct: 110 ----VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYT 157

Query: 788 L-ATIGYMAPEYGREGQISTEG-----DVYSFGIMLMEI 820
           L  T  Y+APE      I ++G     D ++ GI++ E+
Sbjct: 158 LCGTPEYLAPEI-----ILSKGYGKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 34/211 (16%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           + + +   IGSG++G VY+ R    G  VAIKV  L+     E    E  +L+  RH N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID---IA-------L 734
           V    S    D   +V++Y   GSL+          DI++     +    IA        
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLK 112

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG-- 792
            L YLH       +H DIK +N+LL ED   +L DFG++  L+   ++   ++   IG  
Sbjct: 113 GLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSF--IGTP 165

Query: 793 -YMAPEYG---REGQISTEGDVYSFGIMLME 819
            +MAPE     R+G    + D+++ GI  +E
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 18/205 (8%)

Query: 633 LIGSGSFGSVYRGRF----LDGME--VAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
            +G G FG V+  +      +G E  V +K     + E     F  E ++ R + H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK--------RLNIVIDIALALE 737
           R++  C   +   ++L+Y   G L+  L +  S  +  K        ++ +   IAL ++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           +L        VH D+   N L+      ++    ++K +   E  K    L  + ++APE
Sbjct: 132 HLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 798 YGREGQISTEGDVYSFGIMLMEIFT 822
             +E   ST+ DV+SFG+++ E+FT
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 29/214 (13%)

Query: 632 NLIGSGSFGSVYRGRFLD-------GMEVAIKVFHLQLEGALES----FNAECEVLRSIR 680
           N +GSG+FG VY G   D        + VA+K      +GA +     F  E  ++ +  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN------LDIFKRLNIVIDIAL 734
           H N+V+++  C  ++ + ++++ M  G L + L            L + + L+I +D+A 
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDE-----DMVARLGDFGIAK-LLSGDESMKHTQTL 788
              YL   H    +H D+   N L+ E     D V ++GDFG+A+ +   D   K  + L
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             + +MAPE   +G+ +T+ DV+SFG+++ EI T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 19/223 (8%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNA---ECEVLRSIRHRNLVRIIS 689
           +G+G+ G V +      G  +A+K   L++  A+        E ++L       +V    
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI--QKQILRELDILHKCNSPYIVGFYG 66

Query: 690 SCTNDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
           +  N+   ++ ++YM  GSL+  L          I  +  I + +   L YLH  H   +
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--I 122

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H D+KPSN+L++     +L DFG++  L    +     T +   YMAPE  +    S +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMAPERIQGNDYSVK 179

Query: 808 GDVYSFGIMLMEIFTRKRPTDEIFSGEMS----LKRWVNDSLP 846
            D++S G+ L+E+ T + P              L+  VN+  P
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 56/195 (28%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +    +VAIK       G +  E+F  E ++++ +RH  LV + +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 692 TNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V ++M KGSL   L   D   L + + +++   IA  + Y+   +    +H 
Sbjct: 71  SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHR 126

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ +++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 8/193 (4%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRNLVRIISSC 691
           L+G G+FG V++G   D   VA+K     L   L+  F +E  +L+   H N+V++I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V++ +P G   + L      L   + +   +D A  + YL   +    +H D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI--GYMAPEYGREGQISTEGD 809
           +   N L+ E+ V ++ DFG+++    D+ +  +  L  I   + APE    G+ S+E D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 810 VYSFGIMLMEIFT 822
           V+S+GI+L E F+
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+ G V++ +  + G  VA+K   L+    G       E + L++ +H  +V+++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSN---LDIFKRLNIVIDIALALEYLHFGHPNPV 747
             +     LV++YMP   L + +  D          K    ++     L+ + + H N +
Sbjct: 68  FPHGSGFVLVMEYMP-SDL-SEVLRDEERPLPEAQVKSYMRML-----LKGVAYMHANGI 120

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREGQIS 805
           +H D+KP+N+L+  D V ++ DFG+A+L S +E   ++  +AT  Y APE  YG   +  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYD 179

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
              D+++ G +  E+     P   +F GE
Sbjct: 180 PGVDLWAVGCIFAELL-NGSP---LFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 627 QFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRN 683
            F V   +G GS+GSVY+  R  D    A+K   L      E  +A  E  +L S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-------NIVIDIALAL 736
           ++    +  + +   +V++Y P G L   +    S     ++L        I I +   L
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAI----SKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
           + LH      ++H D+K +N+LL  + + ++GD GI+K+L    +M  TQ   T  YMAP
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK--NMAKTQI-GTPHYMAP 170

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           E  +    S + D++S G +L E+ T   P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 14/196 (7%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRIISSC 691
           IG G+FG V+ GR   D   VA+K     L   L++ F  E  +L+   H N+VR+I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V++ +  G     L ++   L + + + +V + A  +EYL   H    +H D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 752 IKPSNVLLDEDMVARLGDFGIAK-----LLSGDESMKHTQTLATIGYMAPEYGREGQIST 806
           +   N L+ E  V ++ DFG+++     + +    MK       + + APE    G+ S+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI----PVKWTAPEALNYGRYSS 175

Query: 807 EGDVYSFGIMLMEIFT 822
           E DV+SFGI+L E F+
Sbjct: 176 ESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRHRNLVRII 688
           ++G G++G V + R    G  VAIK F  + E   +       E +VLR +RH N+V + 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
            +        LV +Y+ +  LE  L +    L      + +  +  A+ Y H    + ++
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122

Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-------YGRE 801
           H DIKP N+L+ E  V +L DFG A+ L    +   T  +AT  Y APE       YG+ 
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK- 181

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
                  DV++ G ++ E+     P   +F G+
Sbjct: 182 -----PVDVWAIGCIMAELLD-GEP---LFPGD 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)

Query: 634 IGSGSFGSVYRGRFL--DG--MEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRII 688
           +G G+FGSV +G +L   G  +EVA+K    +   A +  F  E  V+  + H  +VR+I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPN 745
             C  +    LV++  P G L   L      + +     +   +A+ + YL   HF    
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQ 803
             VH D+   NVLL     A++ DFG+++ L          T     + + APE    G+
Sbjct: 117 --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 804 ISTEGDVYSFGIMLMEIFTR 823
            S++ DV+S+G+ L E F+ 
Sbjct: 175 FSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
           + F +   IG GSFG VY+         VAIKV  L + E  +E    E + L   R   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK--RLN------IVIDIALA 735
           + +   S        ++++Y   GS           LD+ K  +L+      I+ ++ L 
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREVLLG 110

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           LEYLH       +H DIK +N+LL E+   +L DFG++  L+   S ++T  + T  +MA
Sbjct: 111 LEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMA 166

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE  ++     + D++S GI  +E+   + P
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.1 bits (227), Expect = 6e-20
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 34/216 (15%)

Query: 627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNA----ECEVLRSIR 680
           ++     +G G++  VY+ R    G  VAIK +   + + A +  N     E ++L+ ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA------- 733
           H N++ ++    +     LV ++M    LE           + K  +IV+  A       
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEK----------VIKDKSIVLTPADIKSYML 109

Query: 734 ---LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
                LEYLH    N ++H D+KP+N+L+  D V +L DFG+A+   G  + K T  + T
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVT 165

Query: 791 IGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
             Y APE  +G         D++S G +  E+  R 
Sbjct: 166 RWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)

Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D M VA+K        A + F  E E+L +++H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYS---------------DNSNLDIFKRLNIVIDI 732
              C + D   +V +YM  G L   L +                   L + + L+I   I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATI 791
           A  + YL   H    VH D+   N L+  +++ ++GDFG+++ + S D       T+  I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            +M PE     + +TE DV+SFG++L EIFT  K+P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)

Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAIK  +LQ +   E    E  V+R  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R     +   ALE+LH    N V
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCR-----ECLQALEFLH---SNQV 136

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 633 LIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
            +G G+FGSV   R+ D      G  VA+K         L  F  E E+L+S++H N+V+
Sbjct: 11  QLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 687 IISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
               C +   +   LV++Y+P GSL   L      LD  K L     I   +EYL     
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---S 126

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREG 802
              VH D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + S   DV+SFG++L E+FT
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 55/193 (28%), Positives = 103/193 (53%), Gaps = 6/193 (3%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+   +    +VA+K        ++E+F AE  V+++++H  LV++ +  T 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 694 DDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ ++M KGSL   L SD  +   + K ++    IA  + ++        +H D+
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128

Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+   +V ++ DFG+A+++  +E          I + APE    G  + + DV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188

Query: 813 FGIMLMEIFTRKR 825
           FGI+LMEI T  R
Sbjct: 189 FGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 89.9 bits (224), Expect = 2e-19
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 38/219 (17%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIK----VFHLQLEG--ALESFNAECEVLRSIR 680
           + +   IGSG++G V        G +VAIK    VF   ++    L     E ++LR +R
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLR 57

Query: 681 HRNLVR---IISSCTNDDFKAL--VLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIAL 734
           H N++    I+   + +DF  +  V + M    L   + S      D  +    +  I  
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY--FLYQILR 114

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIG 792
            L+YLH  +   V+H D+KPSN+L++ +   ++ DFG+A+ +  DE  K   T  + T  
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 793 YMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRK 824
           Y APE       Y      +   D++S G +  E+ TRK
Sbjct: 172 YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 634 IGSGSFGSVYRG---RFLDG---MEVAIKVFHLQLEGALES----FNAECEVLRSIRHRN 683
           +G GSFG VY G     + G     VAIK  +   E A       F  E  V++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYS------DNSNLDIFKR---LNIVIDIAL 734
           +VR++   +      +V++ M KG L++ L S      +N  L        + +  +IA 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLATIGY 793
            + YL        VH D+   N ++ ED+  ++GDFG+ + +   D   K  + L  + +
Sbjct: 131 GMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           MAPE  ++G  +T+ DV+SFG++L E+ T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.0 bits (220), Expect = 3e-19
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)

Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D + VA+K      + A + F+ E E+L +++H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 688 ISSCTNDDFKALVLDYMPKGSL---------EACLYSDN---SNLDIFKRLNIVIDIALA 735
              C   D   +V +YM  G L         +A L ++    + L   + L+I   IA  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           + YL   H    VH D+   N L+ E+++ ++GDFG+++ + S D       T+  I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEIFSGEM 835
            PE     + +TE DV+S G++L EIFT  K+P  ++ + E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 16/202 (7%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRH---RNLVRI 687
           LIG G++G+VYRG+    G  VA+K+ +L   +  +     E  +L  +R     N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI--DIALALEYLHFGHPN 745
             S        ++++Y   GS+   + +      I ++   VI  ++ +AL+Y+H     
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVALKYIH---KV 120

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI- 804
            V+H DIK +N+L+      +L DFG+A LL+ + S K +  + T  +MAPE   EG+  
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 805 STEGDVYSFGIMLMEIFTRKRP 826
            T+ D++S GI + E+ T   P
Sbjct: 180 DTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 3e-19
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 25/203 (12%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAEC--EV--LRSIRHRNLVRII 688
           +G G++G VY+ R    G  VA+K   L  E   E   +    E+  L+ ++H N+V+++
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLL 64

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
                +    LV +Y     L+  L      L      +I+  +   L Y H    + ++
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRIL 120

Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-------YGRE 801
           H D+KP N+L++ D V +L DFG+A+   G     +T  + T+ Y APE       Y   
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVVTLWYRAPEILLGSKHY--- 176

Query: 802 GQISTEGDVYSFGIMLMEIFTRK 824
              ST  D++S G +  E+ T K
Sbjct: 177 ---STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           I  G++G V+  +    G   AIKV     +  +  ++    E ++L   +   +V++  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S        LV++Y+P G L + L +  S LD       + +I LALEYLH    N ++H
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAK-------LLSGDESMKHTQTLATIGYMAPEYGREG 802
            D+KP N+L+D +   +L DFG++K       +   D+  +  + + T  Y+APE     
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 803 QISTEGDVYSFGIMLMEIFT 822
             S   D +S G +L E   
Sbjct: 177 GHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 12/198 (6%)

Query: 633 LIGSGSFGSVYRGRFL----DGMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRNLVRI 687
            +G GSFG V RG +       + VA+K     +L   ++ F  E  ++ S+ H NL+R+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
                      +V +  P GSL   L  D   +  I    +  + IA  + YL       
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLAT-IGYMAPEYGREGQI 804
            +H D+   N+LL  D   ++GDFG+ + L   ++     + L     + APE  R    
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+ FG+ L E+FT
Sbjct: 178 SHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 634 IGSGSFGSVYRGR-FLDGME----VAIKVFH-LQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G  +FG +Y+G  +L GM+    VAIK    +        F  E  ++  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACL-----YSD-----------NSNLDIFKRLNIVID 731
           +   T +    ++ +Y+ +G L   L     +SD            S+LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 732 IALALEYL--HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTL 788
           IA  +EYL  HF      VH D+   N+L+ E +  ++ D G+++ + S D      ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             I +M PE    G+ S++ D++SFG++L EIF+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.5 bits (217), Expect = 7e-19
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 632 NLIGSGSFGSVYRG--RFLDG----MEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNL 684
             +G G+FG VY G  R  DG    ++VA+K          ES F  E  ++    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEY 738
           VR+I        + ++L+ M  G L++ L          S+L +   L    D+A   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 739 LHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           L   H    +H DI   N LL       VA++ DFG+A+ +       K  + +  I +M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFT 822
            PE   +G  +++ DV+SFG++L EIF+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 632 NLIGSGSFGSVYRGRFLDGMEVAIK--VFH----LQLEGALESFNAECEVLRSIRHRNLV 685
            ++G G++G+VY G    G  +A+K         L  E   E    E ++L+S++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA------LEYL 739
           + + +C +D+  ++ ++++P GS+ +          I  R   + +          L+ +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISS----------ILNRFGPLPEPVFCKYTKQILDGV 115

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-----SGDESMKHTQTLATIGYM 794
            + H N VVH DIK +NV+L  + + +L DFG A+ L      G  S        T  +M
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE   E     + D++S G  + E+ T K P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 8/194 (4%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +GSG FG V+ G++   ++VAIK  +   EGA+  E F  E +V+  + H  LV++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V ++M  G L   L      L     L++  D+   +EYL     N  +H D
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+    V ++ DFG+ + +  DE    +     + +  PE     + S++ DV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+FT  +
Sbjct: 186 SFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 9/208 (4%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+  + H  LV++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V +YM  G L   L          + L +  D+   + YL        +H D
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+D+    ++ DFG+++ +  DE      +   + +  PE     + S++ DV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 812 SFGIMLMEIFTR-KRPTDEIFSGEMSLK 838
           +FG+++ E+++  K P +   + E   K
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHL-----QLEGALESFNAECEVLRSIRHRNLVR 686
           L+G G+FG VY    +D G E+A+K         + +  + +   E ++L++++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
                 +D+  ++ ++YMP GS++  L +  +  +   R      I   +EYL   H N 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYL---HSNM 124

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPE------ 797
           +VH DIK +N+L D     +LGDFG +K L        T   +  G   +M+PE      
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           YGR      + DV+S G  ++E+ T K P
Sbjct: 184 YGR------KADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           IG G++G VY+ R  L G  VAIK   L+ E       A  E ++L+ + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
             +     LV ++M    L   +      L      + +  +   L + H    + ++H 
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREGQISTEG 808
           D+KP N+L++ + V +L DFG+A+         +T  + T  Y APE   G +   ST  
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELLLG-DKGYSTPV 180

Query: 809 DVYSFGIMLMEIFTRK 824
           D++S G +  E+ +R+
Sbjct: 181 DIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.0 bits (213), Expect = 4e-18
 Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 24/204 (11%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRIIS 689
           IG GSFG+VY  R       VAIK      + + E +     E   L+ +RH N +    
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPN 745
               +    LV++Y        CL S +  L++ K+    ++IA     AL+ L + H +
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY---GREG 802
             +H DIK  N+LL E    +L DFG A L+S   S      + T  +MAPE      EG
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVILAMDEG 189

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           Q   + DV+S GI  +E+  RK P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRI 687
           +G G FG V    +       G  VA+K    +      S +  E  +L+++ H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 688 ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              C+    K   L+++Y+P GSL    Y     L++ + L     I   + YLH  H  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLHSQH-- 127

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQT-LATIGYMAPEYGREGQ 803
             +H D+   NVLLD D + ++GDFG+AK +  G E  +  +   + + + A E  +E +
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 804 ISTEGDVYSFGIMLMEIFTR 823
            S   DV+SFG+ L E+ T 
Sbjct: 187 FSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           +G G+FG VY+ +  + G+  A K+  ++ E  LE F  E ++L   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN---IVIDIALALEYLHFGHPNPVVH 749
            ++   +++++   G+L      D+  L++ + L    I       LE L+F H + V+H
Sbjct: 73  YENKLWILIEFCDGGAL------DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126

Query: 750 CDIKPSNVLLDEDMVARLGDFGI-AKLLSGDESMKHTQTLATIGYMAPEY-----GREGQ 803
            D+K  N+LL  D   +L DFG+ AK  S  +  K    + T  +MAPE       ++  
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
              + D++S GI L+E+   + P  E+
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.8 bits (207), Expect = 9e-18
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 633 LIGSGSFGSVYRGRFL-DGMEVAIKVF--HLQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           ++G G+FG V+  R   D   V IK        +    +   EC+VL+ + H N++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
           +   D    +V++Y P G+L   +    NS LD    L+  + I LAL ++   H   ++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLIL 123

Query: 749 HCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           H D+K  N+LLD+  MV ++GDFGI+K+LS     K    + T  Y++PE       + +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQK 181

Query: 808 GDVYSFGIMLMEIFTRKRPTD 828
            D+++ G +L E+ + KR  +
Sbjct: 182 SDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.3 bits (211), Expect = 1e-17
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRNLVRIIS 689
           N IGSG+ G+VY+      G   A+KV +   E  +      E E+LR + H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
              ++    ++L++M  GSLE    +D   L    R      I   + YLH  H   +VH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIAYLHRRH---IVH 191

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH-TQTLATIGYMAPEYGREGQISTE- 807
            DIKPSN+L++     ++ DFG++++L+  ++M     ++ TI YM+PE     +I+T+ 
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPE-----RINTDL 244

Query: 808 ---------GDVYSFGIMLMEIFTRKRP 826
                    GD++S G+ ++E +  + P
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 628 FNVNNLIGSGSFGSVYRGRF-LDGMEVAIK---VFHLQLEGALESFNAECEVLRSIRHRN 683
           F +   IG G F  VYR    LDG+ VA+K   +F L    A      E ++L+ + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALALEYLH 740
           +++  +S   D+   +VL+    G L   +        +     +    + +  ALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 V+H DIKP+NV +    V +LGD G+ +  S   +  H+  + T  YM+PE   
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 179

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
           E   + + D++S G +L E+   + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 24/225 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVA---IKVFHLQLEGALESFNAECEVLRSIR 680
              F +   IG G F  VY+    LDG  VA   +++F +    A +    E ++L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-------NIVIDIA 733
           H N+++ ++S   ++   +VL+    G L   +          KRL          + + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ----KRLIPERTIWKYFVQLC 116

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
            ALE++H      ++H DIKP+NV +    V +LGD G+ +  S   +  H+  + T  Y
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYY 172

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE-MSL 837
           M+PE   E   + + D++S G +L E+   + P    F G+ M+L
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 15/199 (7%)

Query: 633 LIGSGSFGSVYRGRFL-DG----MEVAIKVFHLQLEGALESFNAECE---VLRSIRHRNL 684
           L+GSG FG+V++G ++ +G    + VAIK   +Q     ++F    +    + S+ H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           VR++  C     + LV    P GSL   +     +LD  + LN  + IA  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLATIGYMAPEYGREGQ 803
           + +VH ++   N+LL  D + ++ DFG+A LL   D+   +++    I +MA E    G+
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 804 ISTEGDVYSFGIMLMEIFT 822
            + + DV+S+G+ + E+ +
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 12/204 (5%)

Query: 632 NLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVR 686
            +IG G FG VY G  +D     +  A+K  +   +   +E F  E  +++   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 687 IISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           ++  C   +   LV L YM  G L   + S+  N  +   +   + +A  +EYL      
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK---HTQTLATIGYMAPEYGREG 802
             VH D+   N +LDE    ++ DFG+A+ +   E      HT     + +MA E  +  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           + +T+ DV+SFG++L E+ TR  P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQ------LEGALESFNAECEVLRSIRHRNLV 685
            +G+G+F S Y+ R    G  +A+K            E  +E+   E  ++  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI----DIALALEYLHF 741
           R++ +   D    L +++M  GS+   L    S    FK   ++I     +   L YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKE-AVIINYTEQLLRGLSYLH- 120

Query: 742 GHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGD---ESMKHTQTLATIGYMAPE 797
              N ++H D+K +N+L+D      R+ DFG A  L+           Q L TI +MAPE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             R  Q     DV+S G +++E+ T K P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 630 VNNLIGSGSFGSVYRGRF-LDG---MEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNL 684
           +  +IG+G FG V  GR  L G   + VAIK       E     F +E  ++    H N+
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH-FGH 743
           + +    T      +V +YM  GSL+A L   +    + + + ++  IA  ++YL   G+
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG--YMAPEYGRE 801
               VH D+   N+L++ ++V ++ DFG++++L  D    +T     I   + APE    
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 802 GQISTEGDVYSFGIMLMEIFTR-KRP 826
            + ++  DV+S+GI++ E+ +  +RP
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           +G G+FG VY+ +  + G   A KV   + E  LE +  E E+L +  H  +V+++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
            D    +++++ P G+++A +   +  L       I +     LE L + H   ++H D+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL----ATIG---YMAPEY-----GR 800
           K  NVLL  D   +L DFG+        S K+ +TL    + IG   +MAPE       +
Sbjct: 137 KAGNVLLTLDGDIKLADFGV--------SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +     + D++S GI L+E+   + P  E+
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 27/221 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQ-LEGALESFNAECEVLRS 678
           D+  +   +G G+FG V +   +          VA+K+      E  L    +E E+++ 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 679 I-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKRLNI 728
           I +H+N++ ++  CT +    +V++Y   G+L   L          S +      + L  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 729 V------IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDES 781
                    +A  +E+L        +H D+   NVL+ ED V ++ DFG+A+ +   D  
Sbjct: 132 KDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVR 686
           +G   FG VY+G             VAIK    + EG L E F  E  +   ++H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACL-----YSD----------NSNLDIFKRLNIVID 731
           ++   T +   +++  Y     L   L     +SD           S L+    ++IV  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLAT 790
           IA  +E+L   H   VVH D+   NVL+ + +  ++ D G+ + + + D       +L  
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           I +M+PE    G+ S + D++S+G++L E+F+
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 18/221 (8%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DG----MEVAIKVFHLQLEGALESFNAE----CEVLR 677
           +F    ++GSG+FG+VY+G ++ +G    + VAIK      E      N E      V+ 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMA 64

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           S+ + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + 
Sbjct: 65  SVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAP 796
           YL       +VH D+   NVL+      ++ DFG+AKLL  DE   H +     I +MA 
Sbjct: 124 YLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
           E       + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 14/212 (6%)

Query: 633 LIGSGSFGSVYRGRFLDGME-----VAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLV 685
           ++GSG+FG+VY+G ++   E     VAIK+ + +  G  A   F  E  ++ S+ H +LV
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R++  C +   + LV   MP G L   ++    N+     LN  + IA  + YL      
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 128

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYGREGQI 804
            +VH D+   NVL+      ++ DFG+A+LL GDE   +       I +MA E     + 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 805 STEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM 835
           + + DV+S+G+ + E+ T   +P D I + E+
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 54/211 (25%), Positives = 109/211 (51%), Gaps = 11/211 (5%)

Query: 633 LIGSGSFGSVYRGRF-LDGM-EVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRI 687
           +IG+G FG V+RG   + G  EVA+ +  L+    E   + F +E  ++    H N++R+
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
               T      ++ +YM  G+L+  L   +     ++ + ++  IA  ++YL        
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG--YMAPEYGREGQIS 805
           VH D+   N+L++ ++  ++ DFG++++L  D    +T +   I   + APE     + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 806 TEGDVYSFGIMLMEIFTR-KRPTDEIFSGEM 835
           +  DV+SFGI++ E+ +  +RP  ++ + E+
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 14/217 (6%)

Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIK---VFHLQLEGALESFNAECEVLRSIRHRN 683
           F +   IG G F  VYR    LD   VA+K   +F +    A +    E ++L+ + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL-EACLYSDNSNLDIFKRL--NIVIDIALALEYLH 740
           +++ + S   D+   +VL+    G L +   Y       I +R      + +  A+E++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 V+H DIKP+NV +    V +LGD G+ +  S   +  H+  + T  YM+PE   
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 179

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
           E   + + D++S G +L E+   + P    +  +M+L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 82.6 bits (204), Expect = 2e-16
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 30/220 (13%)

Query: 630 VNNLIGSGSFGSV-YRGRFLDGMEVAIKVFHLQLEGALES----FNAECEVLRSIRHRNL 684
           ++ ++GSG+ G+V    R  DG   A+KV  + +EG  E+      AE   L +    ++
Sbjct: 36  ISRVLGSGATGTVLCAKRVSDGEPFAVKV--VDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 685 VRIISSCTNDDFK------------ALVLDYMPKGSLEACLYSDNSNLDIFKRLN---IV 729
           V+    C  D  K            ALVLDY   G L   + S       F+      + 
Sbjct: 94  VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL- 788
           I + LA+ ++H  H   ++H DIK +N+LL  + + +LGDFG +K+ +   S    +T  
Sbjct: 150 IQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
            T  Y+APE  R    S + D++S G++L E+ T KRP D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 23/212 (10%)

Query: 627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEV--LRSIRHRN 683
           ++ +   IG GSFG +Y  +   D     IK   L      E   ++ EV  L  ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL-------EACLYSDNSNLDIFKRLNIVIDIALAL 736
           +V   +S   +    +V++Y   G L          L+S++  L  F      + I+L L
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGL 114

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLA-TIGYM 794
           +++H      ++H DIK  N+ L ++ MVA+LGDFGIA+ L  ++SM+   T   T  Y+
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYL 169

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +PE  +    + + D++S G +L E+ T K P
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 634 IGSGSFGSVYRGRFLDGME---VAIKVFHLQ-LEGALESFNAECEVLRSIRHRNLVRIIS 689
           IG GSFG V++G  +D      VAIK+  L+  E  +E    E  VL       + +   
Sbjct: 12  IGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S   D    ++++Y+  GS    L  +   LD  +   I+ +I   L+YLH       +H
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SEKKIH 124

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE  ++    ++ D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183

Query: 810 VYSFGIMLMEIFTRKRPTDEI 830
           ++S GI  +E+   + P  E+
Sbjct: 184 IWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.4 bits (195), Expect = 5e-16
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAI+  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALEFLHSNQV 137

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 10/195 (5%)

Query: 634 IGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVRIIS 689
           +GSG+FG V +G +      ++VAIKV   + E ++ +    E E++  + +  +VR+I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
            C  +    LV++    G L   L      + +   + ++  +++ ++YL        VH
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQISTE 807
            D+   NVLL     A++ DFG++K L  D+S    ++     + + APE     + S+ 
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 808 GDVYSFGIMLMEIFT 822
            DV+S+GI + E F+
Sbjct: 179 SDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.9 bits (194), Expect = 7e-16
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 632 NLIGSGSFGSVYRGRFL-DG--MEVAIKVF-HLQLEGALESFNAECEVLRSI-RHRNLVR 686
           ++IG G+FG V R     DG  M  AIK+      E     F  E EVL  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACL---------------YSDNSNLDIFKRLNIVID 731
           ++ +C N  +  + ++Y P G+L   L               +   S L   + L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLAT 790
           +A  ++YL        +H D+   NVL+ E++ +++ DFG+++   G+E  +K T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MA E       +T+ DV+SFG++L EI +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 9e-16
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)

Query: 628 FNVNNLIGSGSFGSVYRGRFL--DGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRH 681
             +  ++G G FGSV  G+    DG ++ + V  ++L+      +E F +E   ++   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 682 RNLVRIISSC-TNDDFKAL-----VLDYMPKGSLEACLYS----DNS-NLDIFKRLNIVI 730
            N++++I  C      + +     +L +M  G L + L           L +   L  ++
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLA 789
           DIAL +EYL        +H D+   N +L EDM   + DFG++ K+ SGD   +      
Sbjct: 121 DIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
            + ++A E   +   +++ DV++FG+ + EI TR
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.6 bits (193), Expect = 9e-16
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAIK  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALDFLHSNQV 136

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRIIS 689
           IG GSFG+VY  R +   EV AIK      + + E +     E   L+ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPN 745
               +    LV++Y        CL S +  L++ K+    ++IA     AL+ L + H +
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY---GREG 802
            ++H D+K  N+LL E  + +LGDFG A +++          + T  +MAPE      EG
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDEG 189

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           Q   + DV+S GI  +E+  RK P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 29/223 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQ-LEGALESFNAECEVL 676
           D+  +   +G G FG V     L        + + VA+K+      E  L    +E E++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 135 TFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 66/230 (28%), Positives = 97/230 (42%), Gaps = 37/230 (16%)

Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSI 679
           L   T  F +  +IG G++G VY+ R    G  VAIK+  +  +   E    E  +LR  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKY 59

Query: 680 -RHRNLVRII------SSCTNDDFKALVLDYMPKGSLEACLYSD--NSNLDIFKRLN--- 727
             H N+          +   NDD   LV++    GS+     +D         KRL    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKGKRLKEEW 114

Query: 728 ---IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH 784
              I+ +    L YLH    N V+H DIK  N+LL ++   +L DFG++  L      ++
Sbjct: 115 IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 785 TQTLATIG---YMAPE-----YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T     IG   +MAPE        +       DV+S GI  +E+   K P
Sbjct: 172 T----FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 31/226 (13%)

Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAEC 673
             D+  +   +G G FG V     + G++         VA+K+      E  L    +E 
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 674 EVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDN------ 717
           E+++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         Y  N      
Sbjct: 75  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 718 SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS 777
             L     ++    +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ + 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 778 G-DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 634 IGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLEGA-LESFNAECEVLRSIRHRNLVRI 687
           +G G FG V   R+       G +VA+K    +  G  +     E E+LR++ H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 688 ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              CT D      L+++++P GSL+  L  + + +++ ++L   + I   ++YL  G   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSRQ 129

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATIGYMAPEYGREG 802
             VH D+   NVL++ +   ++GDFG+ K +  D+   ++K         Y APE   + 
Sbjct: 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQS 187

Query: 803 QISTEGDVYSFGIMLMEIFT 822
           +     DV+SFG+ L E+ T
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 23/224 (10%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME--VAIK---VFHLQL-------EGALESFNAECEV 675
           + V   +GSG+FG VY+ R  +  +  +A+K   V +          + ++    +E  +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 676 LR-SIRHRNLVRIISSCTNDDFKALVLDYM---PKGSLEACLYSDNSNLDIFKRLNIVID 731
           ++  +RH N+VR   +   +D   +V+D +   P G     L          +  NI + 
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           + LAL YLH      +VH D+ P+N++L ED    + DFG+AK        K T  + TI
Sbjct: 122 MVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTI 177

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM 835
            Y  PE  +      + DV++FG +L ++ T + P    +S  M
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNM 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 34/228 (14%)

Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G G FG V   +        A+K     H+   G  E   +E E+L    H  +V++  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           +  +  +  ++++Y   G L   L  D    D +     +  + LA EYLH      +++
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVLAFEYLH---NRGIIY 116

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGREGQISTEG 808
            D+KP N+LLD +   +L DFG AK L   +    T T   T  Y+APE      I  +G
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPE-----IILNKG 168

Query: 809 -----DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIMN 851
                D +S GI+L E+ T + P    F  +        D  P+ I N
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYN 204

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 22/233 (9%)

Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 62

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 123 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T      +  S E  L+
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 3e-15
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+V+    +  G EVAIK  +LQ +   E    E  V++ +++ N+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D + +    R          L+ L F H N V
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRE--------CLQALEFLHANQV 136

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  NVLL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 23/214 (10%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDG--------MEVAIKVFHLQLEGALESFNAECEVLRSI 679
           F +  ++G+G++G V+  R + G        M+V  K   +Q     E    E +VL  I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 680 RHRNLVRIISSCTNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALA 735
           R    +  +      D K  L+LDY+  G L    ++  S  + FK   + I   +I LA
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLA 117

Query: 736 LEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE+LH  G    +++ DIK  N+LLD +    L DFG++K    DE  +      TI YM
Sbjct: 118 LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 795 APEYGREGQISTEG--DVYSFGIMLMEIFTRKRP 826
           AP+  R G    +   D +S G+++ E+ T   P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 57/218 (26%), Positives = 110/218 (50%), Gaps = 26/218 (11%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHL----------QLEGALESFNAECEVLRSIRH 681
           LIG G++G VY    +   E+ A+K   L          + +  +++  +E E L+ + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+V+ +   T +++ ++ L+Y+P GS+ +CL         F+   +       LE L +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK----LLSGDESMKHTQTLATIGYMAPE 797
            H   ++H D+K  N+L+D D + ++ DFGI+K    +   D++M       ++ +MAPE
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAPE 180

Query: 798 --YGREGQISTEGDVYSFGIMLMEIFTRKRP--TDEIF 831
             +      S + D++S G +++E+F  +RP   +E  
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 634 IGSGSFGSVYRGRFLDGME---VAIKVFHLQ-LEGALESFNAECEVLRSIRHRNLVRIIS 689
           IG GSFG V++G  +D      VAIK+  L+  E  +E    E  VL       + +   
Sbjct: 12  IGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S        ++++Y+  GS    L +     D F+   ++ +I   L+YLH       +H
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIH 124

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE  ++    ++ D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 810 VYSFGIMLMEIFTRKRPTDEI 830
           ++S GI  +E+   + P  ++
Sbjct: 184 IWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 42/212 (19%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H N+V+++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIV----IDIALALEYLH------ 740
              ++   LV +++              + D+ K ++      I + L   YL       
Sbjct: 68  IHTENKLYLVFEFL--------------HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 741 -FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-- 797
            F H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE  
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEIL 172

Query: 798 -----YGREGQISTEGDVYSFGIMLMEIFTRK 824
                Y      ST  D++S G +  E+ TR+
Sbjct: 173 LGCKYY------STAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 634 IGSGSFGSVYRGRFLDGMEVA-IKVFHLQLEGALES---FNAECEVLRSIRHRNLVRIIS 689
           IG+G FG V  G    G   A + V  L++  +++    F  E +  RS++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 690 SCTNDDFKALVLDYMP----KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            CT      LV+++ P    KG L +C  ++    D      +  +IAL L +LH    N
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGRE--G 802
             +H D+   N LL  D+  ++GD+G++      D  +   Q    + ++APE   E  G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 803 QI-----STEGDVYSFGIMLMEIF 821
            +     + E +V+S G+ + E+F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 52/200 (26%), Positives = 98/200 (49%), Gaps = 11/200 (5%)

Query: 630 VNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNL 684
           +  +IG G FG V RGR        ++VAIK       +     F  E  ++    H N+
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL-HFGH 743
           +R+    T      ++ +YM  GSL+  L  ++    + + + ++  IA  ++YL    +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEYGREG 802
               VH D+   N+L++ ++V ++ DFG+++ L   E+   T+     I + APE     
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + ++  DV+SFGI++ E+ +
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 17/193 (8%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G +VA+K   L+ +   E    E  ++R  +H N+V + SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI----VIDIALA-LEYLHFGHPNPV 747
             D   +V++++  G+L           DI     +    +  + LA L+ L F H   V
Sbjct: 87  VGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  ++LL  D   +L DFG    +S  E  +    + T  +MAPE        TE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTE 195

Query: 808 GDVYSFGIMLMEI 820
            D++S GIM++E+
Sbjct: 196 VDIWSLGIMVIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 49/214 (22%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---------ECEVLRSIRHR 682
           L+G GS+G V + +  + G  VAIK F       LES +          E  +L+ +RH 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-------LESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH-- 740
           NLV +I          LV +++           D++ LD  ++    +D +   +YL   
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFV-----------DHTVLDDLEKYPNGLDESRVRKYLFQI 109

Query: 741 -----FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
                F H + ++H DIKP N+L+ +  V +L DFG A+ L+    + +T  +AT  Y A
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRA 168

Query: 796 PE-------YGREGQISTEGDVYSFGIMLMEIFT 822
           PE       YGR        D+++ G ++ E+ T
Sbjct: 169 PELLVGDTKYGR------AVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 13/207 (6%)

Query: 630 VNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-QLEGALESFNAECEVLRSIRHRNL 684
           +  +IG+G FG V RGR  L G     VAIK       E     F +E  ++    H N+
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           + +    T      ++ ++M  G+L++ L  ++    + + + ++  IA  ++YL     
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---E 124

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLA---TIGYMAPEYGR 800
              VH D+   N+L++ ++V ++ DFG+++ L  D S   +T +L     I + APE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
             + ++  DV+S+GI++ E+ +  +RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDG--------MEVAIKVFHLQLEGALESFNAECEVLRSI 679
           F +  ++G+G++G V+  R + G        M+V  K   +Q     E    E +VL ++
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 680 RHRN-LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK--RLNIVI-DIALA 735
           R    LV +  +   D    L+LDY+  G L   LY        F    + + I +I LA
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESEVRVYIAEIVLA 117

Query: 736 LEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           L++LH  G    +++ DIK  N+LLD +    L DFG++K    +E  +      TI YM
Sbjct: 118 LDHLHQLG----IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 795 APEYGREGQI--STEGDVYSFGIMLMEIFTRKRP 826
           APE  R G        D +S G++  E+ T   P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVFHLQ-LEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG GSFG VY+G      EV AIK+  L+  E  +E    E  VL       + R   S 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR--------LNIVIDIALALEYLHFGH 743
                  ++++Y+  GS           LD+ K           I+ +I   L+YLH   
Sbjct: 72  LKGTKLWIIMEYLGGGSA----------LDLLKPGPLEETYIATILREILKGLDYLH--- 118

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
               +H DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE  ++  
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
              + D++S GI  +E+   + P  ++
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 632 NLIGSGSFGSVYRGRFL-DGMEVAIK--VFHLQLEGALESFNAECEVLRSIR---HRNLV 685
             IG G++G+VY+ R L  G  VA+K     L  EG   S   E  +L+ +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 686 RIISSCTNDDFK-----ALVLDYMPK---GSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           R++  C            LV +++ +     L  C       L      +++  +   ++
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC---PKPGLPPETIKDLMRQLLRGVD 121

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           +LH    + +VH D+KP N+L+  D   ++ DFG+A++      M  T  + T+ Y APE
Sbjct: 122 FLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAPE 176

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRK 824
              +   +T  D++S G +  E+F R+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 24/204 (11%)

Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRIIS 689
           IG GSFG+VY  R +   EV AIK      + + E +     E + L+ I+H N +    
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPN 745
               +    LV++Y        CL S +  L++ K+    ++IA     AL+ L + H +
Sbjct: 93  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY---GREG 802
            ++H DIK  N+LL E    +L DFG A + S   S      + T  +MAPE      EG
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVILAMDEG 199

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           Q   + DV+S GI  +E+  RK P
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 63/235 (26%), Positives = 112/235 (47%), Gaps = 31/235 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGAL---ESFNAECEVLRSIRH 681
           D       +G+G+FG V+  R  +     A+KV  +     L   +  + E  VL+ + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEY 738
             ++R+  +  +  F  ++++Y+P G L + L +    +++  +F    IV     ALEY
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEY 116

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPE 797
           LH      +V+ D+KP N+LLD++   +L DFG AK L        T TL  T  Y+APE
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-----DRTWTLCGTPEYLAPE 168

Query: 798 -YGREGQISTEGDVYSFGIMLMEIFTRKRP---------TDEIFSGEMSLKRWVN 842
               +G  +   D ++ GI++ E+     P          ++I +G++   R ++
Sbjct: 169 VIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLD 222

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.4 bits (185), Expect = 2e-14
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDG--------MEVAIKVFHLQLEGALESFNAECEVLRSI 679
           F +  ++G+G++G V+  R + G        M+V  K   +Q    +E    E  VL  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 680 RHRNLVRIISSCTNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALA 735
           R    +  +      + K  L+LDY+  G +   LY      D F    +     +I LA
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILA 117

Query: 736 LEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE+LH  G    +V+ DIK  N+LLD +    L DFG++K    +E  +      TI YM
Sbjct: 118 LEHLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 795 APEYGR-EGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE  R +G      D +S GI++ E+ T   P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHL---QLEGALESFNAECEV--LRSIRHRNLVR 686
           L+G G+FG VY    +D G E+A K         E + E    ECE+  L++++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 687 IISSCTNDDFKALV--LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
                 +   K L   ++YMP GS++  L +  +  +   R      I   + YLH    
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPE---- 797
           N +VH DIK +N+L D     +LGDFG +K L     M  T   +  G   +M+PE    
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 798 --YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
             YGR      + DV+S G  ++E+ T K P  E
Sbjct: 184 EGYGR------KADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 632 NLIGSGSFGSVYRGRFL-DG--MEVAIKVF-HLQLEGALESFNAECEVLRSI-RHRNLVR 686
           ++IG G+FG V + R   DG  M+ AIK       +     F  E EVL  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACL---------------YSDNSNLDIFKRLNIVID 731
           ++ +C +  +  L ++Y P G+L   L                S  S L   + L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLAT 790
           +A  ++YL        +H D+   N+L+ E+ VA++ DFG+++   G E  +K T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MA E       +T  DV+S+G++L EI +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 634 IGSGSFGS--VYRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           +G G+FG   +YR R  D   V  K  +L      E  +A  E  +L  ++H N++   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIV---IDIALALEYLHFGHPNP 746
              +D+   + ++Y   G+L   +      L  F+   ++     I  A+ Y+H      
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIH---KAG 121

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIST 806
           ++H DIK  N+ L +  + +LGDFGI+K+L  + SM  T  + T  YM+PE  +  + + 
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNF 180

Query: 807 EGDVYSFGIMLMEIFTRKR 825
           + D+++ G +L E+ T KR
Sbjct: 181 KSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 36/223 (16%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALES--FNA-ECEV--LRSIRH 681
           + +  L+G G+FG VY     D G E+A+K      E    S   NA ECE+  L+++ H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 682 RNLVRIISSCTNDDFK---ALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALE 737
             +V+    C  D  +   ++ +++MP GS++  L S  +   ++ ++    I     LE
Sbjct: 64  ERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LE 117

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-----LLSGDESMKHTQTLATIG 792
            + + H N +VH DIK +N+L D     +LGDFG +K      LSG      T    T  
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPY 174

Query: 793 YMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
           +M+PE      YGR      + D++S G  ++E+ T K P  E
Sbjct: 175 WMSPEVISGEGYGR------KADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 36/240 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           +       IGSG+ G VY+ RF   G  +A+K           + N E E  R +     
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR-------RTGNKE-ENKRILMD--- 63

Query: 685 VRIISSCTNDDFKALVLDY---MPKGSLEACLYSDNSNLD-IFKRLN----------IVI 730
           + ++      D   +V  Y   +    +  C+   ++ LD + KR+           + +
Sbjct: 64  LDVVLKS--HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTV 121

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
            I  AL YL   H   V+H D+KPSN+LLD     +L DFGI+  L   +S   T++   
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGC 177

Query: 791 IGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
             YMAPE         +     DV+S GI L+E+ T + P     +    L + + +  P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 40/214 (18%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQL--EGALESFNAECEVLRSIR---HRNLVRI 687
           IG G++G+VY+ R    G  VA+K   +Q   +G   S   E  +L+ +    H N+VR+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 688 ISSCT-----------------NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI 730
           +  C                  + D +   LD +P   L A      +  D+ ++     
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTY-LDKVPPPGLPA-----ETIKDLMRQF---- 117

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
                L  L F H N +VH D+KP N+L+      +L DFG+A++ S    M  T  + T
Sbjct: 118 -----LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVT 170

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
           + Y APE   +   +T  D++S G +  E+F RK
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 50/235 (21%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF-----HLQLEGALESFNAECEVLRSI 679
           D F V  +IG G+FG V+  R  D  +V A+KV        + + A     AE ++L   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADA 58

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK----RLNIVIDIALA 735
               +V++  S  +++   LV++YMP G L   L       D+F     R  I  ++ LA
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFYIA-ELVLA 113

Query: 736 LEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESM----------- 782
           L+ +H  G     +H DIKP N+L+D D   +L DFG+  K+    +             
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 783 ---------KHTQ-------TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF 821
                     H Q       T+ T  Y+APE  R      E D +S G++L E+ 
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 39/235 (16%)

Query: 609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DG--MEVAIK-VFHLQLEG 664
           P++ W    +Q++            IG G+FG V + R   DG  M+ AIK +     + 
Sbjct: 2   PVLEWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 49

Query: 665 ALESFNAECEVL-RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE------------- 710
               F  E EVL +   H N++ ++ +C +  +  L ++Y P G+L              
Sbjct: 50  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 109

Query: 711 --ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG 768
             A   S  S L   + L+   D+A  ++YL        +H D+   N+L+ E+ VA++ 
Sbjct: 110 AFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 166

Query: 769 DFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           DFG+++   G E  +K T     + +MA E       +T  DV+S+G++L EI +
Sbjct: 167 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 58/233 (24%), Positives = 108/233 (46%), Gaps = 22/233 (9%)

Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEV 675
           + ++  +   +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASV 62

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---CLYSDNSN------LDIFKRL 726
           ++     ++VR++   +      +V++ M  G L++    L  +  N        + + +
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+       VH D+   N ++  D   ++GDFG+ + +   D   K  
Sbjct: 123 QMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           + L  + +MAPE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALE---SFNAECEVLRSIRHRNL 684
           IG G+FG V++ R            VA+K+  L+ E + +    F  E  ++    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 685 VRIISSCTNDDFKALVLDYMPKGSL--------------------EACLYSDN-SNLDIF 723
           V+++  C       L+ +YM  G L                     A     N   L   
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESM 782
           ++L I   +A  + YL        VH D+   N L+ E+MV ++ DFG++  + S D   
Sbjct: 131 EQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
                   I +M PE     + +TE DV+++G++L EIF+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 634 IGSGSFGSVYRGRFLDG---MEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRII 688
           +G G FGSV  G+       ++VA+K   + +     +E F +E   ++   H N++R+I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 689 SSC----TNDDFKA--LVLDYMPKGSLEA-CLYSDNSNLDIFKRLNIVI----DIALALE 737
             C     ++ + +  ++L +M  G L +  LYS   +   +    +++    DIA  +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIGYMAP 796
           YL        +H D+   N +L+E+M   + DFG++ K+ +GD   +       + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTR 823
           E   +   +T+ DV+SFG+ + EI TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)

Query: 634 IGSGSFGSVYRGRFLD--GMEVAIKVFHLQL--EGALESFNAECEVLR---SIRHRNLVR 686
           IG G++G V++ R L   G  VA+K   +Q   EG   S   E  VLR   +  H N+VR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 687 IISSCT-----NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLH 740
           +   CT      +    LV +++ +   +   Y D    +       + D+   L   L 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVP-EPGVPTETIKDMMFQLLRGLD 124

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
           F H + VVH D+KP N+L+      +L DFG+A++ S    M  T  + T+ Y APE   
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLL 182

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
           +   +T  D++S G +  E+F R++P
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 33/217 (15%)

Query: 634 IGSGSFGSVY--------RGRFLDGMEVAIKVFHLQLEGA---LESFNAECEVLRSI-RH 681
           +G G FG V         + +    + VA+K+  L+ +     L    +E E+++ I +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YS------DNSNLDIFKRL 726
           +N++ ++ +CT D    ++++Y  KG+L   L         YS          L     +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-DESMKHT 785
           +    +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   D   K T
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
                + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 30/213 (14%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           +G G+FG VY+ +  + G+  A KV   + E  LE +  E ++L S  H N+V+++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALALEYLHFGHPNPVVH 749
            ++   +++++   G+++A +      L++ + L    I +     LE L++ H N ++H
Sbjct: 73  YENNLWILIEFCAGGAVDAVM------LELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-------ATIGYMAPEY---- 798
            D+K  N+L   D   +L DFG+        S K+T+T+        T  +MAPE     
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 799 -GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
             ++     + DV+S GI L+E+   + P  E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 75.7 bits (186), Expect = 7e-14
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 21/191 (10%)

Query: 650 GMEVAIKVF---HLQLEGALESFNAECEVLRSIRHRNLVRIISS-CTNDDFKALVLDYMP 705
           G EVAIK+      + E     F  E  +   + H N+V ++ S          V +Y+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 706 KGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---D 760
             +L   L +D      +  + +  V+D ALA       H   +VH D+KP N+++    
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLD-ALAC-----AHNQGIVHRDLKPQNIMVSQTG 116

Query: 761 EDMVARLGDFGIAKLLSGDESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFG 814
               A++ DFGI  LL G          + T+ L T  Y APE  R   ++   D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 815 IMLMEIFTRKR 825
           ++ +E  T +R
Sbjct: 177 LIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.1 bits (179), Expect = 7e-14
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 37/232 (15%)

Query: 634 IGSGSFGSVYRGRFLDGME---------VAIKVFHLQ-LEGALESFNAECEVLRSI-RHR 682
           +G G FG V R     G++         VA+K+      +  L    +E E+++ I +H+
Sbjct: 20  LGEGCFGQVVRAEAY-GIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSD-----NSNLDI---------FKRL-N 727
           N++ ++  CT +    ++++Y  KG+L   L +      +   DI         FK L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-DESMKHTQ 786
               +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   D   K + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKR------PTDEIFS 832
               + +MAPE   +   + + DV+SFGI++ EIFT         P +E+F 
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 628 FNVNNLIGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGA--LESFNAECEVLRSIR 680
           F +  ++G G FGSV R   L        +VA+K+    +  +  +E F  E   ++   
Sbjct: 1   FTLGRMLGKGEFGSV-REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 681 HRNLVRIISSCTNDDFKA------LVLDYMPKGSLEACLY----SDNS-NLDIFKRLNIV 729
           H N++++I        K       ++L +M  G L   L      +    L +   +  +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTL 788
           IDIA  +EYL        +H D+   N +L+E+M   + DFG++ K+ SGD   +   + 
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
             + ++A E   +   +T  DV++FG+ + EI TR
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 13/216 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFH--LQLEGALESFNAECEVLRSIRHR 682
           ++F V  ++G G++G V + R  +  E VAIK F    + E   E+   E ++LR+++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V +  +        LV +Y+ K  LE  L  +  N    +++   I     ++ +H+ 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYI--YQLIKAIHWC 116

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H N +VH DIKP N+L+  + V +L DFG A+ LS   +  +T+ +AT  Y +PE     
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 803 QISTEGDVYSFGIMLME------IFTRKRPTDEIFS 832
                 D++S G +L E      +F  +   D++F+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 55/200 (27%), Positives = 82/200 (41%), Gaps = 14/200 (7%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVF---HLQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G G FG V   +    G   A K      L+     +    E ++L  +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALEYLHFGHPNP 746
           +    D   LV+  M  G L+  +Y  N     F     +     I   LE+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIY--NVGEPGFPEARAIFYAAQIICGLEHLH---QRR 115

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIST 806
           +V+ D+KP NVLLD+    R+ D G+A  L G +  K      T GYMAPE  +      
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 807 EGDVYSFGIMLMEIFTRKRP 826
             D ++ G  L E+   + P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECE--VLRSIRHRNLVRIISS 690
           +G GS+G V   R   DG +  IK  +L+     E   AE E  +L  ++H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 691 CTNDD-FKALVLDYMPKGSL-------EACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
              +D    +V+ +   G L       +  L  +N  ++ F      + IA+AL+YLH  
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF------VQIAMALQYLHEK 121

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+K  NV L    + ++GD GIA++L     M  T  + T  YM+PE     
Sbjct: 122 H---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNK 177

Query: 803 QISTEGDVYSFGIMLMEIFTRK 824
             + + DV++ G  + E+ T K
Sbjct: 178 PYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 9e-14
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 40/238 (16%)

Query: 627 QFNVNNLIGSGSFGSVY-----------RGRFLDGME------VAIKVFHLQL-EGALES 668
             N    +G G FG V+              F +         VA+KV      + A E 
Sbjct: 6   PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 669 FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS---DNSNLDIFKR 725
           F  E ++L  +   N+ R++  CT D    ++++YM  G L   L     + S L    +
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 726 -------LNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK- 774
                  L +   IA  + YL   +F      VH D+   N L+ ++   ++ DFG+++ 
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNF------VHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRPTDEI 830
           L S D      +    I +MA E    G+ +T+ DV++FG+ L EI T  R++P + +
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 21/159 (13%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIV 729
           E E+ +S +   +V+   +  ++      + ++Y   GSL++ +Y       + KR   +
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK-----VKKRGGRI 102

Query: 730 IDIAL------ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD--ES 781
            +  L       L+ L + H   ++H DIKPSN+LL      +L DFG+    SG+   S
Sbjct: 103 GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNS 158

Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEI 820
           +  T T  T  YMAPE  +    S   DV+S G+ L+E+
Sbjct: 159 LAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 634 IGSGSFGSVYRGRFLDGME-VAIKVFHL---QLEGALESFNAECEVLRSIRHRNLVRIIS 689
           IG GSFG+VY        E VA+K       Q     +    E + L+ ++H N +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPN 745
               +    LV++Y        CL S +  L++ K+    ++IA     AL+ L + H +
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY---GREG 802
            ++H DIK  N+LL E    +L DFG A   S   S      + T  +MAPE      EG
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDEG 195

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           Q   + DV+S GI  +E+  RK P
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 26/214 (12%)

Query: 634 IGSGSFGSVYRG-RFLDGMEVAIK----VFHLQLEGALESFNAECEVLRSIRHRNLVRI- 687
           IGSG++G V        G +VAIK     F +    A  +   E ++LR  +H N++ I 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLR-ELKILRHFKHDNIIAIR 70

Query: 688 -ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
            I      DFK   +V+D M +  L   ++SD    +   R   +  +   L+Y+H  + 
Sbjct: 71  DILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIHSAN- 127

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH----TQTLATIGYMAPEYGR 800
             V+H D+KPSN+L++ED   R+GDFG+A+ LS     +H    T+ +AT  Y APE   
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLS-SSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 801 E-GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG 833
              + +T  D++S G +  E+  R+    ++F G
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 58/261 (22%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISS 690
           IG G++G VY+GR    G  VA+K   L+ E  G   +   E  +L+ ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIV-----IDIALALEYLH----- 740
              +    L+ +++              ++D+ K L+ +     +D  L   YL+     
Sbjct: 68  LMQESRLYLIFEFL--------------SMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 741 --FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
             F H   V+H D+KP N+L+D   V +L DFG+A+   G     +T  + T+ Y APE 
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEV 172

Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRK--------------------RPTDEIFSGEMSL 837
                  ST  D++S G +  E+ T+K                     PT++++ G  SL
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232

Query: 838 K-------RWVNDSLPISIMN 851
                   +W   SL  ++ N
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKN 253

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 16/198 (8%)

Query: 634 IGSGSFGSVYRG--RFLDGME-VAIKVFHLQLEGALESFN----AECEVLRSIRHRNLVR 686
           +GSG+FG+V +G  +     + VA+K+  L+ +    +       E  V++ + +  +VR
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKI--LKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +I  C  + +  LV++    G L   L   N ++       +V  +++ ++YL       
Sbjct: 61  MIGICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETN 115

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQI 804
            VH D+   NVLL     A++ DFG++K L  DE+    +T     + + APE     + 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 805 STEGDVYSFGIMLMEIFT 822
           S++ DV+SFG+++ E F+
Sbjct: 176 SSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 13/216 (6%)

Query: 634 IGSGSFGSV-YRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G +VA+K   L+ +   E    E  ++R   H N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +  +   + + +  AL YLH      V+H DI
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  K    + T  +MAPE        TE D++S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLP 846
            GIM++E+   + P    +  E  L+  R + D+LP
Sbjct: 204 LGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLP 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKV--FHLQLEGALESFNA-ECEV--LRSIRHRNLVR 686
           L+G G+FG VY     D G E+A+K   F    +   +  NA ECE+  L+++RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 687 IISSCTNDDFKALVL--DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
                 + + K L +  +YMP GS++  L +  +  +   R      I   + YLH    
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPE---- 797
           N +VH DIK +N+L D     +LGDFG +K +     M  T   +  G   +M+PE    
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ-TICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 798 --YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
             YGR      + DV+S    ++E+ T K P  E
Sbjct: 184 EGYGR------KADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.3 bits (180), Expect = 2e-13
 Identities = 34/79 (43%), Positives = 52/79 (65%), Gaps = 2/79 (2%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           L G +P+ +  L  LQ ++LS N + G IP S+ SI +LE+LDLS N  +GS P     +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 63  SSLQVIDLSDNRLSGELPA 81
           +SL++++L+ N LSG +PA
Sbjct: 490 TSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           IG GSFG     +   DG +  IK  ++      E   +  E  VL +++H N+V+   S
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 691 CTNDDFKALVLDYMPKGSL-------EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
              +    +V+DY   G L          L+ ++  LD F      + I LAL+++H   
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHVH--- 118

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H DIK  N+ L +D   +LGDFGIA++L+    +  T  + T  Y++PE      
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRP 177

Query: 804 ISTEGDVYSFGIMLMEIFTRK 824
            + + D+++ G +L E+ T K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 19/224 (8%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V   R    G +VA+K+  L+ +   E    E  ++R  +H+N+V +  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN---IVIDIALALEYLHFGHPNPVVH 749
             +   ++++++  G+L        +++    RLN   I       L+ L + H   V+H
Sbjct: 89  VGEELWVLMEFLQGGAL--------TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIH 140

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            DIK  ++LL  D   +L DFG    +S D   K    + T  +MAPE        TE D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 810 VYSFGIMLMEIFTRKRPTDEIFSGE--MSLKRWVNDSLPISIMN 851
           ++S GIM++E+   + P    FS     ++KR + DS P  + N
Sbjct: 200 IWSLGIMVIEMVDGEPP---YFSDSPVQAMKR-LRDSPPPKLKN 239

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 24/214 (11%)

Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVF----HLQLEGALESFNA 671
           +F  NNL     +G+G+FG V         +    M+VA+K+     H     AL S   
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87

Query: 672 ECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIV 729
           E +++  +  H N+V ++ +CT      ++ +Y   G L   L     S L +   L+  
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTL 788
             +A  + +L   +    +H D+   NVLL    + ++ DFG+A+ +  D + +      
Sbjct: 148 YQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             + +MAPE       + E DV+S+GI+L EIF+
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 45/218 (20%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNA----ECEVLRSIRHRNLVRII 688
           IG G+FG V++ R       VA+K   + +E   E F      E ++L+ ++H N+V +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 689 SSCTN-----DDFKA---LVLDYMPKGSLEACLY-----SDNSNLDIFKRLNIVIDIALA 735
             C       + +K    LV ++        C +       N N+  F    I   + + 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEF--------CEHDLAGLLSNKNVK-FTLSEIKKVMKML 128

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLATIG 792
           L  L++ H N ++H D+K +N+L+ +D + +L DFG+A+  S     +  ++T  + T+ 
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 793 YMAPE-------YGREGQISTEGDVYSFGIMLMEIFTR 823
           Y  PE       YG         D++  G ++ E++TR
Sbjct: 189 YRPPELLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 28/208 (13%)

Query: 634 IGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G+ GSV +      G  +A KV H+  + ++ +    E +++   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK-----RLNIVIDIALA----LEYLHFG 742
            N++   + +++M  GSL+           I+K      + I+  IA+A    L YL+  
Sbjct: 73  LNENNICMCMEFMDCGSLDR----------IYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEYGRE 801
           H   ++H DIKPSN+L++     +L DFG+    SG+       T + T  YM+PE  + 
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVGTSTYMSPERIQG 176

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTDE 829
           G+ + + DV+S GI ++E+   K P   
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVA-IKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           + F +   IGSG++G VY+ R ++  E+A IKV  L+          E  +++  +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA------LEY 738
           V    S    D   + +++   GSL+          DI+     + +  +A      L+ 
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQ----------DIYHVTGPLSESQIAYVSRETLQG 118

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L++ H    +H DIK +N+LL ++   +L DFG++  ++   + K    + T  +MAPE 
Sbjct: 119 LYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEV 177

Query: 799 G---REGQISTEGDVYSFGIMLMEIFTRKRP 826
               R+G  +   D+++ GI  +E+   + P
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 41/215 (19%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV----AIKVFH---LQLEGALESFNAECEVLRSIRHRNLV 685
           ++G GSFG V+  R + G +     A+KV     L++   + +   E ++L  + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------------IVIDIA 733
           ++  +   +    L+LD++  G             D+F RL+             + ++A
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 108

Query: 734 LALEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
           LAL++LH  G    +++ D+KP N+LLDE+   +L DFG++K  S D   K      T+ 
Sbjct: 109 LALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVE 163

Query: 793 YMAPE-YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           YMAPE   R G  +   D +SFG+++ E+ T   P
Sbjct: 164 YMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 35/206 (16%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN---------AECEVLRSIRHRN 683
           IG GS+G V++ R  + G  VAIK F       +ES +          E  +L+ ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           LV +I          LV +Y     L   L  +   +       I+     A+    F H
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVN---FCH 117

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE------ 797
            +  +H D+KP N+L+ +    +L DFG A++L+G     +T  +AT  Y APE      
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDT 176

Query: 798 -YGREGQISTEGDVYSFGIMLMEIFT 822
            YG         DV++ G +  E+ T
Sbjct: 177 QYG------PPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 42/222 (18%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G++G VY+ R  L G  VA+K   L+   EG   +   E  +L+ + H N+VR++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN----IVIDIALALEYLH------ 740
             +++   LV +++              +LD+ K ++      +D  L   YL+      
Sbjct: 67  VHSENKLYLVFEFL--------------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 741 -FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY- 798
            + H + V+H D+KP N+L+D +   +L DFG+A+   G     +T  + T+ Y APE  
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEIL 171

Query: 799 --GREGQISTEGDVYSFGIMLMEIFTRKRP-------TDEIF 831
              R  Q ST  D++S G +  E+  R RP        D++F
Sbjct: 172 LGSR--QYSTPVDIWSIGCIFAEMVNR-RPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.2 bits (172), Expect = 2e-12
 Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 23/114 (20%)

Query: 341 LGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP 400
           LGL+N  L G I +DI +L  L S+ L  N + G+IP   G++ SL  L           
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471

Query: 401 STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGL 454
                       DLS N  +GS+P  +G L  L  L L+ N+LSG +P  +GG 
Sbjct: 472 ------------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 10/194 (5%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G++ +VY+GR    G  VA+K  HL   EG   +   E  +++ ++H N+VR+    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 692 TNDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
             ++   LV +YM K  L+  +  +     LD     +    +   L+ + F H N V+H
Sbjct: 68  HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI-STEG 808
            D+KP N+L+++    +L DFG+A+   G      +  + T+ Y AP+     +  ST  
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182

Query: 809 DVYSFGIMLMEIFT 822
           D++S G ++ E+ T
Sbjct: 183 DIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNA----ECEVLRSIR 680
           D++   N I  G++G VYR R     E VA+K   L++E   E F      E  +L  ++
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQ 62

Query: 681 HRNLVRI--ISSCTNDDFKALVLDYMP---KGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           H N+V +  +   +N D   +V++Y+    K  +E    +        +   +++ +   
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLME----TMKQPFLQSEVKCLMLQLLSG 118

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           + +LH    N ++H D+K SN+LL+   + ++ DFG+A+   G     +TQ + T+ Y A
Sbjct: 119 VAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRA 174

Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
           PE   G   + ST  D++S G +  E+ T+K
Sbjct: 175 PELLLG-AKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 50/236 (21%)

Query: 633 LIGSGSFGSVYRGRFLDG--------MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           ++G G +G V++ R + G        M+V  K   ++ +       AE  +L +++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 685 VRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVID 731
           V +I +        L+L+Y+  G L              AC Y              + +
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--------------LSE 108

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           I+LALE+LH      +++ D+KP N+LLD     +L DFG+ K    + ++ HT    TI
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTI 164

Query: 792 GYMAPE-YGREGQISTEGDVYSFGIMLMEIFT---------RKRPTDEIFSGEMSL 837
            YMAPE   R G      D +S G ++ ++ T         RK+  D+I  G+++L
Sbjct: 165 EYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 32/194 (16%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFL---DGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           ++ +   IG G++G VY+ +     DG E AIK F     Q  G  +S   E  +LR ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 681 HRNLVRIISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALA 735
           H N+V ++        K+  L+ DY      +   +   +           +++  I   
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI--- 117

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAK--------LLSGDESMK 783
           L  +H+ H N V+H D+KP+N+L+     E  V ++GD G+A+        L   D    
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---- 173

Query: 784 HTQTLATIGYMAPE 797
               + TI Y APE
Sbjct: 174 --PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 3e-12
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 47/224 (20%)

Query: 634 IGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAEC----EV--LRSI-RHRNLV 685
           +G G+FGSVY  R  +  E VAIK    +++    S+  EC    EV  LR +  H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDN-----SNLDIFKRLNIVIDIALALEYLH 740
           ++      +D    V +YM +G+L   L  D      S   I    +I+  I   L ++H
Sbjct: 62  KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIR---SIIYQILQGLAHIH 116

Query: 741 ----FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTLATIGYMA 795
               F       H D+KP N+L+    V ++ DFG+A+ +    S   +T  ++T  Y A
Sbjct: 117 KHGFF-------HRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRA 166

Query: 796 PE-YGREGQISTEGDVYSFGIMLMEIFTRKRP-------TDEIF 831
           PE   R    S+  D+++ G ++ E++T  RP        D+++
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLY 209

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 33/216 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLE--GALESFNAECEVLRSIRHR 682
           DQ+     IG G++G VY+ R     E +A+K   L+ E  G   +   E  +L+ ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA----LALEY 738
           N+VR+     ++    LV +Y+              +LD+ K ++   D A    L   Y
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL--------------DLDLKKHMDSSPDFAKNPRLIKTY 107

Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLAT 790
           L+       + H + V+H D+KP N+L+D    A +L DFG+A+   G      T  + T
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVT 166

Query: 791 IGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
           + Y APE   G     ST  D++S G +  E+  +K
Sbjct: 167 LWYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 18/231 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALES---FNAECEVLRSIRH 681
             F+V +L+G G FG V   R     ++ A+KV    +  A E+   F  E ++L     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             + ++  +  + D   LV++Y P G L + L   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--- 798
            H    VH DIKP NVL+D     +L DFG A  L+ ++ +     + T  Y+APE    
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177

Query: 799 ---GREGQISTEGDVYSFGIMLMEIFTRKRPTDE-----IFSGEMSLKRWV 841
                +G    E D +S G++  E+   + P  E      ++  M+ +R++
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 30/228 (13%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVL--RSI---- 679
            F +   +G G +G V+  +  D  E VA+K     L   L   N    VL  R I    
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL---LFKLNEVRHVLTERDILTTT 58

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           +   LV+++ +  +D++  L ++Y+P G     L +     +   R  +  ++  A++ L
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-AEMFEAVDAL 117

Query: 740 H-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMAPE 797
           H  G+    +H D+KP N L+D     +L DFG++K +++   S+     + +  YMAPE
Sbjct: 118 HELGY----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPE 168

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIFSGEMSLKRW 840
             R        D +S G ML E      P      +E +    +LK W
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 45/240 (18%)

Query: 628 FNVNNLIGSGSFGSV----YRGRFLDGMEVAIKVFH----LQLEGALESFNAECEVLRSI 679
           F +   +G+GSFG V    ++G    G   AIK       L+++  ++    E  +L  +
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMK-QVQHVAQEKSILMEL 75

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALE 737
            H  +V ++ S  +++    +L+++  G L   L       N D+ K  +   ++ LA E
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYHA--ELVLAFE 132

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAP 796
           YLH      +++ D+KP N+LLD     ++ DFG AK +        T TL  T  Y+AP
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----DRTFTLCGTPEYLAP 184

Query: 797 EYGREGQISTEG-----DVYSFGIMLMEIF---------TRKRPTDEIFSGEMSLKRWVN 842
           E      I ++G     D ++ G++L E           T  R  ++I +G +    W +
Sbjct: 185 EV-----IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239

Length = 329

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 92/350 (26%), Positives = 150/350 (42%), Gaps = 18/350 (5%)

Query: 155 TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSIC 214
              ++S L  L L + +   S+  S  L           N N      S +   + L+  
Sbjct: 62  LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSL 121

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
           +L +N+ +   P       NLKEL+L  N I       S  S L N   LK L L+ N L
Sbjct: 122 DLDNNNITDIPPLIGLLKSNLKELDLSDNKIE------SLPSPLRNLPNLKNLDLSFNDL 175

Query: 275 LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSR 334
            D  LP  + NLS ++    L    I   +P E+  L  L  + L  N +   + S+LS 
Sbjct: 176 SD--LPKLLSNLS-NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230

Query: 335 LEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASN 394
           L+ L  L L NN+LE  + + I  L+ L ++ L +N++  S  +  G+L +LR+L  + N
Sbjct: 231 LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGN 287

Query: 395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGL 454
            L+        L  +L+  L +  L+    LE+    +L+   +  N      P  +  L
Sbjct: 288 SLSNAL-PLIALLLLLLELLLNLLLT-LKALELKLNSILLNNNILSNGE-TSSPEALSIL 344

Query: 455 KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY 504
           ++L NL   DN L  S  N    + +   +    +++   +   LEK+ Y
Sbjct: 345 ESLNNLWTLDNALDESNLNRY-IVKNPNAIGSLLDLVKKHVNQLLEKVNY 393

Length = 394

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLV 685
           F +  ++G+G++G VY+GR +  G   AIKV  +  E   E    E  +L+    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 686 RII------SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALAL 736
                    S   +DD   LV+++   GS+   +   N+  +  K      I  +I   L
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGL 134

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMA 795
            +LH      V+H DIK  NVLL E+   +L DFG++  L  D ++    T + T  +MA
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMA 189

Query: 796 PEY-----GREGQISTEGDVYSFGIMLMEI 820
           PE        +       D++S GI  +E+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 12/211 (5%)

Query: 633 LIGSGSFGSVYRGRFL-DG----MEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVR 686
           ++GSG+FG+VY+G ++ DG    + VAIKV        A +    E  V+  +    + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           ++  C     + LV   MP G L   +  +   +     LN  + IA  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYGREGQIS 805
           +VH D+   NVL+      ++ DFG+A+LL  DE+  H       I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 806 TEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM 835
            + DV+S+G+ + E+ T   +P D I + E+
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 43/123 (34%), Positives = 63/123 (51%), Gaps = 8/123 (6%)

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
           I + I  ALEYLH      V+H D+KPSNVL++ +   +L DFGI+  L   +S+  T  
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTID 163

Query: 788 LATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND 843
                YMAPE       +     + DV+S GI ++E+ T + P D   +    LK+ V +
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223

Query: 844 SLP 846
             P
Sbjct: 224 PSP 226

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.7 bits (168), Expect = 7e-12
 Identities = 35/107 (32%), Positives = 60/107 (56%)

Query: 89  FVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNL 148
           F+  L L      G +P +I  L  L SI+LS N + G IP  +G++ +L+ L L  N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 149 VGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANN 195
            G +P +L  +++L+IL L  N+LSG + +++   L +   F+  +N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 634 IGSGSFGSVYRGRFLDGMEVA-IKVFHLQLEGALE---SFNAECEVLRSIRHRNLVRIIS 689
           IG+G FG V  G    GM  A + V  L+     +    F  E +  R + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDN------SNLDIFKRLNIVIDIALALEYLHFGH 743
            C       LVL++ P G L+  L S+       +  D+ +R+    ++A  L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGREG 802
               +H D+   N  L  D+  ++GD+G+A +    D  +        + ++APE     
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 803 Q-------ISTEGDVYSFGIMLMEIFT 822
                    + + +++S G+ + E+FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 25/211 (11%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVL--RSIRHR-----NLV 685
           I  G+FGSVY  +    G   AIKV     +  + + N    V   R+I         + 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLK---KSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           ++  S  + D+  LV++Y+  G   + L      L        + ++ L +E LH     
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLH---QR 116

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            ++H DIKP N+L+D+    +L DFG+++   G E+ K    + T  Y+APE        
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKKF---VGTPDYLAPETILGVGDD 171

Query: 806 TEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
              D +S G ++ E      P      D +F
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 31/225 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYR------GRFL-------DGMEVAIKVFHLQLE---GALESF 669
            Q  +   +G G FG V+         FL       DG  V + V  L+ +    A   F
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 670 NAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL--------YSDNSNLD 721
             E +++  +++ N++R++  C +DD   ++ +YM  G L   L        ++  +N+ 
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 722 IFKRLNIV---IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLS 777
                N++   + IA  ++YL   +    VH D+   N L+      ++ DFG+++ L S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           GD      + +  I +MA E    G+ +T  DV++FG+ L E+FT
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LKALSVLHAQGVIHRDI 142

Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201

Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 202 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPKLKN 238

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)

Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIK--VFHLQLEGALESFNAECEVLRSIR 680
               + +   +G G+FG VY+ R +  G  VA+K  + H + +G   +   E ++L+ ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 681 HRNLVRII------SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
           H N+V +I         +     +  +V  YM    L   L + +  L   +    ++ +
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM---------- 782
              + YLH  H   ++H DIK +N+L+D   + ++ DFG+A+   G              
Sbjct: 125 LEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 783 KHTQTLATIGYMAPEY--GREGQISTEGDVYSFGIMLMEIFTRK 824
           K+T  + T  Y  PE   G E + +T  D++  G +  E+FTR+
Sbjct: 182 KYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 65/198 (32%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALES-----FNAECEVL-RSIRHRNLVR 686
           IG GSFG V   +   DG   A+KV  LQ +  L+        AE  VL ++++H  LV 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +  S    D    VLDY+  G L   L  + S  +   R     +IA AL YLH      
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPEYGREG 802
           +++ D+KP N+LLD      L DFG+ K     E ++H++T +T      Y+APE  R+ 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 803 QISTEGDVYSFGIMLMEI 820
                 D +  G +L E+
Sbjct: 172 PYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 2e-11
 Identities = 31/87 (35%), Positives = 57/87 (65%), Gaps = 1/87 (1%)

Query: 117 IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI 176
           + L    L G IP++I  LR+LQ++ L  N++ G +P +L +I++L++L L+ N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 177 SSSIRLALPNLELFSLANNNFSGKIPS 203
             S+   L +L + +L  N+ SG++P+
Sbjct: 483 PESLGQ-LTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)

Query: 632 NLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRII 688
           N IG G++G VYR R     E VA+K   +  E  G   S   E  +L ++RH N+V + 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 689 SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
                    +  LV++Y  +  L + L +  +     +   +++ +   L+YLH    N 
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENF 128

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREGQI 804
           ++H D+K SN+LL +    ++ DFG+A+   G  +   T  + T+ Y APE   G     
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTLWYRAPELLLGCTTY- 186

Query: 805 STEGDVYSFGIMLMEIFTRK 824
           +T  D+++ G +L E+   K
Sbjct: 187 TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 26/231 (11%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIRHRNLVRI-- 687
           LI      S+Y+G F +  EV I+ F   H   +  ++    E + LR I   N+++I  
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 688 --ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
             I    +    +L+L+Y  +G L   L     +L    +L++ ID    L  L+     
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE--GQ 803
           P  + ++   + L+ E+   ++   G+ K+LS     K+   +    Y + +   +   +
Sbjct: 145 P--YKNLTSVSFLVTENYKLKIICHGLEKILS-SPPFKNVNFMV---YFSYKMLNDIFSE 198

Query: 804 ISTEGDVYSFGIMLMEIFTRKRP-----TDEIFSGEMSLKRWVNDSLPISI 849
            + + D+YS G++L EIFT K P     T EI+  ++ + +  N+SL + +
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY--DLIINK--NNSLKLPL 245

Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 40/223 (17%)

Query: 634 IGSGSFGSVYRGRF--LDGM----EVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +G G FG V +     L G      VA+K+     E A    L    +E  +L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACL--------------------YSDNSN---L 720
           ++++  +C+ D    L+++Y   GSL + L                    Y DN +   L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 721 DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE 780
            +   ++    I+  ++YL       +VH D+   NVL+ E    ++ DFG+++ +  ++
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 781 S-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           S +K ++    + +MA E   +   +T+ DV+SFG++L EI T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 25/222 (11%)

Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--------FN 670
           ++L    + + V  +IG G+FG V   R     +   KV+ ++L    E         F 
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRH----KSTRKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--I 728
            E +++       +V++  +  +D +  +V++YMP G L   +    SN D+ ++     
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFY 147

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             ++ LAL+ +H       +H D+KP N+LLD+    +L DFG    ++ +  ++    +
Sbjct: 148 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 789 ATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            T  Y++PE     G +G    E D +S G+ L E+     P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 627 QFNVNNLIGSGSFG-SVYRGRFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNL 684
           Q+NV  ++G GSFG ++         + A+K   L     A+E    E  +L  ++H N+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 685 VRIISSCTNDDFKALVLDYMPKGSL-------EACLYSDNSNLDIFKRLNIVIDIALALE 737
           V    S   D    +V++Y   G L          L+ +++ L  F      + + L ++
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQ 114

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           ++H      V+H DIK  N+ L ++   +LGDFG A+LL+   +   T  + T  Y+ PE
Sbjct: 115 HIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPE 170

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                  + + D++S G +L E+ T K P
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 6/156 (3%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVI 730
           E ++L  +  R +V +  +    D   LVL  M  G L+  +Y    +  +  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +I   LE LH      +V+ D+KP N+LLD+    R+ D G+A  +   +++K    + T
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRVGT 164

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +GYMAPE  +  + +   D ++ G +L E+   + P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 44/221 (19%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHR 682
           D++   + +GSG++G V        G +VAIK      + A+ +     E  +L+ + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 683 NLVRIIS-------SCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLN------ 727
           N   +I        + + +DF+   LV   M          +D +N+   ++L+      
Sbjct: 75  N---VIGLLDVFTPASSLEDFQDVYLVTHLMG---------ADLNNIVKCQKLSDDHIQF 122

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
           +V  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  
Sbjct: 123 LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEM--TGY 175

Query: 788 LATIGYMAPE----YGREGQISTEGDVYSFGIMLMEIFTRK 824
           +AT  Y APE    +    Q     D++S G ++ E+ T K
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 6e-11
 Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 4/101 (3%)

Query: 59  FFNMSSLQVID---LSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLT 115
           F +      ID   L +  L G +P +I S L  +Q ++L+ N   G++P  +G++TSL 
Sbjct: 411 FDSTKGKWFIDGLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLE 469

Query: 116 SIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATL 156
            +DLS N   G IP  +G L +L+ L L  N+L G VPA L
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 6e-11
 Identities = 27/74 (36%), Positives = 39/74 (52%)

Query: 324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
           L G IP+ +S+L  LQ + L  N + G I   +  +  L  + L +N  +GSIP   G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 384 ASLRKLSFASNELT 397
            SLR L+   N L+
Sbjct: 490 TSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)

Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--------FN 670
           ++L    + ++V  +IG G+FG V   R     + + KV+ ++L    E         F 
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRH----KSSQKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--I 728
            E +++       +V++  +  +D +  +V++YMP G L   +    SN D+ ++     
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFY 147

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQT 787
             ++ LAL+ +H      ++H D+KP N+LLD+    +L DFG    +  DE+ M    T
Sbjct: 148 TAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDT 202

Query: 788 -LATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            + T  Y++PE     G +G    E D +S G+ L E+     P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 9e-11
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 41/220 (18%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
            IG G+FG+V +      G  +A+K         + S   E E  R +   ++V   S C
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVK--------RIRSTVDEKEQKRLLMDLDVVMRSSDC 62

Query: 692 TNDDFKALVLDY---MPKGSLEACLYSDNSNLDIFKRL-----------NIVIDIAL--- 734
                  +V  Y     +G    C+   + +LD F +             I+  IA+   
Sbjct: 63  PY-----IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 735 -ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
            AL YL       ++H D+KPSN+LLD +   +L DFGI+  L   +S+  T+      Y
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAKTRDAGCRPY 173

Query: 794 MAPE----YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
           MAPE      R+G      DV+S GI L E+ T K P  +
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 25/234 (10%)

Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGM-----EVAIKVFHLQLEGALES----FNA 671
           +  + D+  +++L+  G+FG ++ G  +D       EV +K      + A E        
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQ 57

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVL-DYMPKGSL----EACLYSDNSNLDIFKRL 726
           E  +L  + H+N++ I+  C  D     VL  YM  G+L    + C   + +N       
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 727 NIV---IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESM 782
            +V   I IA  + YLH      V+H DI   N ++DE++  ++ D  +++ L   D   
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174

Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM 835
                   + +MA E     + S+  DV+SFG++L E+ T  + P  EI   EM
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 634 IGSGSFGSVYRGRFLDGME-VAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G++G+V++ +  +  E VA+K   L    EG   S   E  +L+ ++H+N+VR+   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVH 749
             +D    LV +Y  +  L+    S N ++D      IV      L + L F H + V+H
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDID----PEIVKSFMFQLLKGLAFCHSHNVLH 122

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREGQISTE 807
            D+KP N+L++++   +L DFG+A+   G     ++  + T+ Y  P+  +G +   ST 
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKL-YSTS 180

Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S G +  E+    RP
Sbjct: 181 IDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 6/156 (3%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVI 730
           E ++L  +  + +V +  +    D   LVL  M  G L+  +Y+  N   +  + L    
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +I   LE LH       V+ D+KP N+LLD+    R+ D G+A  +   ES++    + T
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR--GRVGT 164

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +GYMAPE     + +   D +  G ++ E+   + P
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 55/204 (26%), Positives = 107/204 (52%), Gaps = 10/204 (4%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRN 683
           D F   + +G+G+ G V + +    G+ +A K+ HL+++ A+ +    E +VL       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L  +     +I  +++I +   LA  YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 122

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 177

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             S + D++S G+ L+E+   + P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 8/190 (4%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G++ +V++GR  L    VA+K   L+ E GA  +   E  +L+ ++H N+V +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
             D    LV +Y+ K   +   Y D+   +I    N+ I +   L  L + H   V+H D
Sbjct: 74  HTDKSLTLVFEYLDKDLKQ---YMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGDV 810
           +KP N+L++E    +L DFG+A+  S   +  ++  + T+ Y  P+      + ST+ D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188

Query: 811 YSFGIMLMEI 820
           +  G +  E+
Sbjct: 189 WGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV---FHLQLEGALESFNAECEVLRSIRH 681
           + F+V  +IG G+FG V   R     +V A+K+   F +        F  E +++     
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI--VIDIALALEYL 739
             +V++  +  +D +  +V++YMP G L   +    SN DI ++       ++ LAL+ +
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLALDAI 158

Query: 740 H-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           H  G     +H D+KP N+LLD+    +L DFG    +  +  ++    + T  Y++PE 
Sbjct: 159 HSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214

Query: 799 ----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
               G +G    E D +S G+ L E+     P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 624 ATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIR 680
           AT   N+  L G GS+ +VY+G   ++G  VA+KV  ++ E  +  F A  E  +L+ ++
Sbjct: 4   ATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLK 61

Query: 681 HRNLVRIISSCTNDDFKALVLDYM-----------PKGSLEACLYSDNSNLDIFKRLNIV 729
           H N+V +       +    V +YM           P G     L+  N  L +F+ L   
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR-- 114

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA 789
                 L Y+H  H   ++H D+KP N+L+      +L DFG+A+  S   S  ++  + 
Sbjct: 115 -----GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS-IPSQTYSSEVV 165

Query: 790 TIGYMAPE-YGREGQISTEGDVYSFGIMLMEIF 821
           T+ Y  P+        S+  D++  G + +E+ 
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLV 685
           F +  L+G+G++G VY+GR +  G   AIKV  +  +   E    E  +L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 686 RIISSCTN------DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
               +         DD   LV+++   GS+   +   N+  +  K   I       L  L
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEY 798
              H + V+H DIK  NVLL E+   +L DFG++  L  D ++    T + T  +MAPE 
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEV 182

Query: 799 -----GREGQISTEGDVYSFGIMLMEI 820
                  +     + D++S GI  +E+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 634 IGSGSFGSVYRGRFLDGMEVA-IKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           +GSG++G VY+ R L   E+A +K+  L+          E  +++  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA------LEYLHFGHPNP 746
           + +   + ++Y   GSL+          DI+     + ++ +A      L+ L + H   
Sbjct: 77  SREKLWICMEYCGGGSLQ----------DIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG---REGQ 803
            +H DIK +N+LL ++   +L DFG+A  ++   + K    + T  +MAPE     + G 
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 804 ISTEGDVYSFGIMLMEIFTRKRP 826
            +   D+++ GI  +E+   + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 16/212 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFH---LQLEGALESFNAECEVLRSIRH 681
           D F +  +IG G+FG V   +  +  +V A+K+ +   +        F  E +VL +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDIALALEYL 739
           R +  +  +  +++   LV+DY   G L   L  + D    D+ +    + ++ LA++ +
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVLAIDSV 118

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H       VH DIKP NVLLD++   RL DFG    L  D +++    + T  Y++PE  
Sbjct: 119 HQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 800 R-----EGQISTEGDVYSFGIMLMEIFTRKRP 826
           +     +G+   E D +S G+ + E+   + P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 77/232 (33%)

Query: 634 IGSGSFGSVYRGRFLD---GMEVAIK-VFHLQLEGALESFNAECEVLRSIR--------- 680
           +G G++G V++   +D      VA+K +F        ++F    +  R+ R         
Sbjct: 15  LGKGAYGIVWKA--IDRRTKEVVALKKIF--------DAFRNATDAQRTFREIMFLQELG 64

Query: 681 -HRNLVRIISSCTNDDFKA-------LVLDYMP--------KGSLEACLYSDNSNLDIFK 724
            H N+V+++     +  KA       LV +YM            LE          D+ K
Sbjct: 65  DHPNIVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRANILE----------DVHK 109

Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH 784
           R  I+  +  AL+Y+H G+   V+H D+KPSN+LL+ D   +L DFG+A+ LS  E    
Sbjct: 110 RY-IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 785 TQTL----ATIGYMAPE-------YGREGQISTEG-DVYSFGIMLMEIFTRK 824
              L    AT  Y APE       Y       T+G D++S G +L E+   K
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRY-------TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 46/235 (19%)

Query: 634 IGSGSFGSVYRGRFLDGME------------------VAIKVFHLQL-EGALESFNAECE 674
           +G G FG V+     +GME                  VA+K+      + A   F  E +
Sbjct: 13  LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL----------EACLYSDNSNLDIFK 724
           ++  ++  N++R+++ C   D   ++ +YM  G L          EA   +D   +    
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 725 RLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDE 780
            + +   IA  ++YL   +F      VH D+   N L+ ++   ++ DFG+++ L SGD 
Sbjct: 132 LIFMATQIASGMKYLSSLNF------VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRP----TDE 829
                + +  I +M+ E    G+ +T  DV++FG+ L EI T  +++P    +DE
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG--MEVAIKVFH---LQLEGALESFNAECEVLRSIR 680
           + FN    +G+GSFG V    + +     VAIK F    +  +  ++   +E ++L  I 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN---SNLDIFKRLNIVIDIALALE 737
           H   V +  S  ++ +  LVL+++  G     L  +    +++  F    IV    L  E
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV----LIFE 145

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAP 796
           YL   +   +V+ D+KP N+LLD+D   ++ DFG AK++        T TL  T  Y+AP
Sbjct: 146 YLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAP 197

Query: 797 EYGREGQISTEGDVYSFGIMLMEIF 821
           E           D ++ GI + EI 
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 9/132 (6%)

Query: 699 LVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPS 755
           LV+  M  G L   +Y+   +N      +       I   LE+LH      +++ D+KP 
Sbjct: 70  LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPE 126

Query: 756 NVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFG 814
           NVLLD D   R+ D G+A +L  G    K      T G+MAPE  +  +     D ++ G
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELLQGEEYDFSVDYFALG 184

Query: 815 IMLMEIFTRKRP 826
           + L E+   + P
Sbjct: 185 VTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.5 bits (152), Expect = 5e-10
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 46  LDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGH 103
           L L N  L G  P     +  LQ I+LS N + G +P ++ S +  ++ L L++N F G 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGS 481

Query: 104 LPREIGNLTSLTSIDLSENHLMGEIPHEIG 133
           +P  +G LTSL  ++L+ N L G +P  +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 54/204 (26%), Positives = 105/204 (51%), Gaps = 10/204 (4%)

Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+ +    E +VL       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 122

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 177

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             S + D++S G+ L+E+   + P
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 61.9 bits (150), Expect = 5e-10
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 7/152 (4%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA-CLYSDNSNLDIFKRLNIVI 730
           E  +LR+I H +++++  + T + F  L+L   P+   +  C  +   N+ I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
            +  A++YLH    N ++H DIK  N+ ++      LGDFG A       + K+     T
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           I   APE           D++S GI+L E+ T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 24/216 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALE--------SFNAECEVLR 677
           + F +  +IG G+FG V   +    ++ A KVF +++    E         F  E +VL 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVK----LKNADKVFAMKILNKWEMLKRAETACFREERDVLV 56

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDIALA 735
           +  ++ +  +  +  +++   LV+DY   G L   L  + D    D+ +    + ++ +A
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVIA 114

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           ++ +H  H    VH DIKP N+L+D +   RL DFG    L  D +++ +  + T  Y++
Sbjct: 115 IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 796 PEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE  +     +G+   E D +S G+ + E+   + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 38/226 (16%)

Query: 630 VNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA---------------EC 673
               +G G++G V +    L G  VAIK   + +E + +                   E 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           +++  I+H N++ ++      DF  LV+D M    L+  +      L   +   I++ I 
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQIL 129

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK---------LLSGDESMK- 783
             L  LH  +    +H D+ P+N+ ++   + ++ DFG+A+          LS DE+M+ 
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 784 ---HTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
               T  + T+ Y APE   G E +     D++S G +  E+ T K
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 8e-10
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 1/81 (1%)

Query: 272 NPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPST 331
           N  L   +P+ I  L   ++   L   +IRG+IP  +G++ +L ++ L YN  NGSIP +
Sbjct: 427 NQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485

Query: 332 LSRLEKLQILGLENNQLEGRI 352
           L +L  L+IL L  N L GR+
Sbjct: 486 LGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 9e-10
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 32/202 (15%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +G GS+ +VY+G+  ++G  VA+KV  LQ E     F A  E  +L+ ++H N+V +   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71

Query: 691 CTNDDFKALVLDYM-----------PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
               +   LV +Y+           P G     L+ +N  L +F+ L         L Y+
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLR-------GLSYI 119

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-Y 798
           H  +   ++H D+KP N+L+ +    +L DFG+A+  S   S  ++  + T+ Y  P+  
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVL 175

Query: 799 GREGQISTEGDVYSFGIMLMEI 820
               + ST  D++  G + +E+
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 39/214 (18%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVF---HLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +IG G FG VY  R  D G   A+K      ++++          E L ++  R ++ ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETL-ALNERIMLSLV 51

Query: 689 SS-------CTNDDFK-----ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIA 733
           S+       C +  F      + +LD M  G L   L    S   +F    +     +I 
Sbjct: 52  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEII 107

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           L LE++H      VV+ D+KP+N+LLDE    R+ D G+A   S     K   ++ T GY
Sbjct: 108 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGY 161

Query: 794 MAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRP 826
           MAPE  ++G    +  D +S G ML ++     P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 30/219 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFN-AECEVLRSIRHRNL 684
           D F +  +IG G+FG V   +    M+   +++ +++    E    AE    R  R+   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVK----MKHTERIYAMKILNKWEMLKRAETACFREERN--- 53

Query: 685 VRIISSCT----------NDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDI 732
           V +   C           ++++  LV+DY   G L   L  + D    D+ +    + ++
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--IAEM 111

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
            LA+  +H  H    VH DIKP NVLLD +   RL DFG    ++ D +++ +  + T  
Sbjct: 112 VLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168

Query: 793 YMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRP 826
           Y++PE  +      G+   E D +S G+ + E+   + P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 61/195 (31%), Positives = 90/195 (46%), Gaps = 12/195 (6%)

Query: 633 LIGSGSFGSVYRG-RFLDGMEVAIKVFHLQL---EGALESFNAECEVL-RSIRHRNLVRI 687
           +IG GSFG V    R  DG   A+KV   +    +       AE  VL ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             S    +    VLDY+  G L   L  +   L+   R     ++A A+ YLH  +   +
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN---I 117

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGREGQIST 806
           ++ D+KP N+LLD      L DFG+ K   G E  + T T   T  Y+APE  R+     
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 807 EGDVYSFGIMLMEIF 821
             D +  G +L E+ 
Sbjct: 176 TVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 18/198 (9%)

Query: 634 IGSGSFGSVY--------RGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG+VY            L  ++  I V  L     +++ N E ++L  + H  +V
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK-EIPVGELNPNETVQA-NQEAQLLSKLDHPAIV 65

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIV---IDIALALEYLHFG 742
           +  +S    D   ++ +Y     L+  L              +    I + L + Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
               ++H D+K  N+ L  +++ ++GDFG+++LL G   +  T T  T  YM+PE  +  
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQ 180

Query: 803 QISTEGDVYSFGIMLMEI 820
              ++ D++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 25/206 (12%)

Query: 634 IGSGSFGSVYRG---RFLDG-----MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+F  +++G      D       EV +KV         ESF     ++  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
                C   D   +V +Y+  GSL+  L  + + ++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDK 119

Query: 746 PVVHCDIKPSNVLL--DEDMVA------RLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
            + H ++   NVLL  +ED         +L D GI+  +   E +     L  I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-----LERIPWVPPE 174

Query: 798 YGREGQ-ISTEGDVYSFGIMLMEIFT 822
                Q +S   D +SFG  L EIF+
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 84/256 (32%), Positives = 126/256 (49%), Gaps = 12/256 (4%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS-GSFPFFNMSSLQVIDLS 71
           L  L++L  LDL  N +    P      + L+ LDLS+N++     P  N+ +L+ +DLS
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLS 171

Query: 72  DNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHE 131
            N LS +LP  + + L  +  L L+ N+ +  LP EI  L++L  +DLS N ++ E+   
Sbjct: 172 FNDLS-DLPKLLSN-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSS 227

Query: 132 IGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFS 191
           + NL+NL  L  LSNN +  +P ++ N+S L+ L L+NN +S   S S   +L NL    
Sbjct: 228 LSNLKNLSGLE-LSNNKLEDLPESIGNLSNLETLDLSNNQIS---SISSLGSLTNLRELD 283

Query: 192 LANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHE 251
           L+ N+ S  +P     A  L + EL  N               L   N+  N  TSS   
Sbjct: 284 LSGNSLSNALPL---IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340

Query: 252 LSFISSLANSKKLKVL 267
           LS + SL N   L   
Sbjct: 341 LSILESLNNLWTLDNA 356

Length = 394

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRNLVRIISSC 691
           +G G+ G+VY+    L    +A+KV  L +   L+    +E E+L       ++    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------NIVIDIALALEYLHFGHPN 745
             ++  ++  ++M  GSL           D+++++       I + +   L YL      
Sbjct: 69  FVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYLW---SL 114

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            ++H D+KPSN+L++     +L DFG++  L    +  +  T A   YMAPE     Q  
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA---YMAPERISGEQYG 171

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
              DV+S GI  ME+   + P  +I   + SL
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 17/207 (8%)

Query: 630 VNNLIGSGSFGSVYRGRF-LDG---MEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRNL 684
           +  ++G+G FG + RG   L     + VAI              F AE   L    H N+
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL-HFGH 743
           VR+    T  +   +V +YM  G+L++ L      L   + + ++  +A  ++YL   G+
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY 128

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL---ATIGYMAPEYGR 800
               VH  +    VL++ D+V ++  F     L  D+S     T+   + + + APE  +
Sbjct: 129 ----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
               S+  DV+SFGI++ E+ +  +RP
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G++ +VY+GR  L    VA+K   L+ E GA  +   E  +L+ ++H N+V +    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
             +    LV +Y+ K   +   Y D+   +     N+ + +   L  L++ H   V+H D
Sbjct: 74  HTEKSLTLVFEYLDKDLKQ---YLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGDV 810
           +KP N+L++E    +L DFG+A+  S   +  ++  + T+ Y  P+        ST+ D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188

Query: 811 YSFGIMLMEIFTRKRP 826
           +  G +  E+ T  RP
Sbjct: 189 WGVGCIFYEMST-GRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS-- 690
           +IG G FG VY  R  D      K++ ++          + E L ++  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55

Query: 691 -----CTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALALE 737
                C    F        +LD M  G L   L    S   +F    +     +I L LE
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLE 111

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           ++H      VV+ D+KP+N+LLDE    R+ D G+A   S     K   ++ T GYMAPE
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPE 165

Query: 798 YGREGQI-STEGDVYSFGIMLMEIFTRKRP 826
             ++G    +  D +S G ML ++     P
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLR------SIRHRNLV 685
           ++G GSFG V         E  AIK   L+ +  LE  + EC ++       +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            +  +    +    V++Y+  G L   +   +   D  +      +I   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEIICGLQFLH---KK 115

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            +++ D+K  NVLLD+D   ++ DFG+ K     E    T    T  Y+APE   +GQ  
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI-LKGQKY 173

Query: 806 TEG-DVYSFGIMLMEIFTRKRPTDEIFSGE 834
            E  D +SFG++L E+   + P    F GE
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP----FHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 6/156 (3%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVI 730
           E ++L  +  R +V +  +    D   LVL  M  G L+  +Y+  N   D  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +I   LE LH      +V+ D+KP N+LLD+    R+ D G+A  +   E+++    + T
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR--GRVGT 164

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +GYMAPE  +  + +   D +  G ++ E+   K P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 33/236 (13%)

Query: 634 IGSGSFGSVYRGRF-----LDG------MEVAIKVFHLQLEGALESFNAECEVLRSIRHR 682
           +G G+F ++Y+G       LD       + V +KV       +L  F     ++  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +LV++   C  D+   +V +Y+  G L+  L+ + +N+ +  +L++   +A AL YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117

Query: 743 HPNPVVHCDIKPSNVLLDED-------MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
               +VH ++   N+L+             +L D GI   +LS +E       +  I ++
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPWI 171

Query: 795 APEYGREGQ--ISTEGDVYSFGIMLMEIFTR-KRPTDEIFSGEMSLKRWVNDSLPI 847
           APE  R GQ  ++   D +SFG  L+EI +  + P   + S E          LP+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 634 IGSGSFG---SVYRGRFLDGMEVAIK----VFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           IG G+FG   SV   R  DG  VA+K    VF   L      F  E ++L   +H N++ 
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQ-NLVSCKRVFR-ELKMLCFFKHDNVLS 63

Query: 687 ---IISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
              I+     D F+ + V+  + +  L   + S         ++  +  I   L+YLH  
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLHSA 122

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
               ++H DIKP N+L++ + V ++ DFG+A++   DES   TQ + T  Y APE     
Sbjct: 123 G---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 803 QISTEG-DVYSFGIMLMEIFTRK 824
           +  T   D++S G +  E+  R+
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 9/196 (4%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G++ +V++GR  L    VA+K   L+  EGA  +   E  +L++++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
             +    LV +Y+     +   Y DN   ++    N+ I +   L  L + H   ++H D
Sbjct: 73  HTERCLTLVFEYLDSDLKQ---YLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGDV 810
           +KP N+L++E    +L DFG+A+  S   +  ++  + T+ Y  P+      + ST  D+
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKS-VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187

Query: 811 YSFGIMLMEIFTRKRP 826
           +  G +L E+ T  RP
Sbjct: 188 WGVGCILYEMAT-GRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 12/195 (6%)

Query: 633 LIGSGSFGSVYRG-RFLDGMEVAIKVFHLQL---EGALESFNAECEVL-RSIRHRNLVRI 687
           +IG GSFG V    R LDG   A+KV   ++       +   AE  VL ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             S    +    VLD++  G L   L  + S  +   R     +IA AL YLH      +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGREGQIST 806
           V+ D+KP N+LLD      L DFG+ K   G      T T   T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 807 EGDVYSFGIMLMEIF 821
             D +  G +L E+ 
Sbjct: 176 TVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 31/204 (15%)

Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLRSIRHRN-LVR-IISS 690
           IG G+FG VY+ R  D   + A+KV   +         A+ EV  +I  RN LVR ++  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERNILVRTLLDE 54

Query: 691 C-----------TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
                       T+ D   LV DYM  G L   L  +    +   +  I  ++ LALE+L
Sbjct: 55  SPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTL-ATIGYMAPE 797
           H      +V+ D+KP N+LLD      L DFG++K  L+ +++   T T   T  Y+APE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPE 166

Query: 798 YGREGQISTEG-DVYSFGIMLMEI 820
              + +  T+  D +S G+++ E+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 5e-09
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 6/156 (3%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E ++L++I HR ++ +I +      K+ V   MPK   +   Y D S     ++  I I 
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA-ITIQ 191

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLAT 790
             L LE L + H   ++H D+K  N+ LDE   A LGDFG A KL +  ++ +      T
Sbjct: 192 RRL-LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +   +PE         + D++S G++L E+  +   
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 6/129 (4%)

Query: 699 LVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNV 757
           LV+  M  G L+  +Y+     L++ + ++    I   + +LH      +V+ D+KP NV
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126

Query: 758 LLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
           LLD+    RL D G+A  L   +++  TQ   T GYMAPE  +E   S   D ++ G  +
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184

Query: 818 MEIFTRKRP 826
            E+   + P
Sbjct: 185 YEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 29/203 (14%)

Query: 653 VAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA 711
           VA+K+      + A   F  E ++L  ++  N++R++  C ++D   ++ +YM  G L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 712 CLYS-------DNSNLDIFKR-----------LNIVIDIALALEYLHFGHPNPVVHCDIK 753
            L S       +N N  +              L++ + IA  ++YL   +    VH D+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165

Query: 754 PSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
             N L+ E++  ++ DFG+++ L +GD      + +  I +MA E    G+ +T  DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 813 FGIMLMEIFT--RKRP----TDE 829
           FG+ L EI    +++P    TDE
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 20/209 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRN 683
           D F     +G+G+ G V +      G+ +A K+ HL+++ A+ +    E +VL       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL--NIVIDIALA----LE 737
           +V    +  +D   ++ +++M  GSL+  L           R+  NI+  I++A    L 
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLRGLT 113

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           YL   H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE
Sbjct: 114 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPE 168

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             +    + + D++S G+ L+E+   + P
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 6e-09
 Identities = 25/55 (45%), Positives = 37/55 (67%)

Query: 4   FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP 58
            + G +P  LGS++SL+ LDLS+N   G+IP S+  + +L IL+L+ N LSG  P
Sbjct: 453 SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 7e-09
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 3/116 (2%)

Query: 276 DCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL 335
           DC   S+ G   +      L N  +RG IP ++  L +L  I L  N + G+IP +L  +
Sbjct: 408 DCQFDSTKGKWFID--GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465

Query: 336 EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF 391
             L++L L  N   G I + + +L  L  + L+ N LSG +PA  G    L + SF
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASF 520

Length = 623

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 6/156 (3%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVI 730
           E  +L  +  R +V +  +    D   LVL  M  G L+  +Y+  N   D  + +    
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           ++   LE L       +V+ D+KP N+LLD+    R+ D G+A  +   E+++    + T
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR--GRVGT 164

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +GYMAPE     + +   D +  G ++ E+   + P
Sbjct: 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 619 QELLQATDQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALESFNAECEVLR 677
           + L   TD + +   IG G++G VY+     DG   A+K+    +    E   AE  +L+
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQ 73

Query: 678 SI-RHRNLVRIISSCTNDDFKA-----LVLDYMPKGS---LEACLYSDNSNLDIFKRLNI 728
           S+  H N+V+        D        LVL+    GS   L   L      LD      I
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           +    L L++LH    N ++H D+K +N+LL  +   +L DFG++  L+     ++T ++
Sbjct: 134 LYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SV 189

Query: 789 ATIGYMAPEY-----GREGQISTEGDVYSFGIMLMEI 820
            T  +MAPE        +       DV+S GI  +E+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 9e-09
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 53/246 (21%)

Query: 634 IGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
           +G GS G V+    +D      VA+K   L    +++    E +++R + H N+V++   
Sbjct: 13  LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--- 67

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIV-----IDIALALEY------- 738
                ++ L     P GS    L  D  +L     + IV      D+A  LE        
Sbjct: 68  -----YEVL----GPSGSD---LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH 115

Query: 739 -----------LHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKH-- 784
                      L + H   V+H D+KP+NV ++ ED+V ++GDFG+A+++    S K   
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175

Query: 785 TQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSG--EMSLKRWV 841
           ++ L T  Y +P         T+  D+++ G +  E+ T K     +F+G  E+   + +
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGAHELEQMQLI 231

Query: 842 NDSLPI 847
            +S+P+
Sbjct: 232 LESVPV 237

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 25/169 (14%)

Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--- 727
           +E   L +  H  +V+      +DD   L+++Y   G L         N  I +RL    
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL---------NKQIKQRLKEHL 164

Query: 728 ---------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                    +   I LAL+ +H      ++H D+K +N+ L    + +LGDFG +K  S 
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221

Query: 779 DESMKHTQTL-ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             S+    +   T  Y+APE     + S + D++S G++L E+ T  RP
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 26/166 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV--AIKVFHLQLEGALESFN------AECEVLR 677
             F    L+G G  G V+  R L G     A+KV   +    +   N       E E+L 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVR-LKGTGKLFALKVLDKK---EMIKRNKVKRVLTEQEILA 56

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI------D 731
           ++ H  L  + +S   + +  LV+DY P G L   L          K L+  +      +
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAE 111

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS 777
           + LALEYLH      +V+ D+KP N+LL E     L DF ++K   
Sbjct: 112 VLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 49/233 (21%)

Query: 612 AWR-RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALE 667
            W     Y++L Q          +GSG++G+V     LD   G +VAIK  +   +  L 
Sbjct: 10  IWEVPDRYRDLKQ----------VGSGAYGTVCSA--LDRRTGAKVAIKKLYRPFQSELF 57

Query: 668 SFNA--ECEVLRSIRHRNLVRIISSCTND-------DFKALVLDYMPKGSLEACLYSDNS 718
           +  A  E  +L+ ++H N++ ++   T D       DF  LV+ +M          +D  
Sbjct: 58  AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF-YLVMPFMG---------TDLG 107

Query: 719 NLDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
            L   ++L+      +V  +   L+Y+H      ++H D+KP N+ ++ED   ++ DFG+
Sbjct: 108 KLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164

Query: 773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
           A+    D  M  T  + T  Y APE        T+  D++S G ++ E+ T K
Sbjct: 165 AR--QTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 40/227 (17%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLRS-------- 678
           F    ++G G FG V    +    E+ AIK   L+    +     E E L          
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIA--RDEVESLMCEKRIFETA 56

Query: 679 --IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA--- 733
              RH  LV + +    +D    V++Y   G L   +++D     +F     V   A   
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVV 111

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI-- 791
           L L+YLH    N +V+ D+K  N+LLD +   ++ DFG+ K     E M      +T   
Sbjct: 112 LGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCG 163

Query: 792 --GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
              ++APE   E   +   D +  G+++ E+   + P      +E+F
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 625 TDQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HR 682
           +D + +   IG G++G V++     +G + A+K+    +    E   AE  +L+++  H 
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHP 75

Query: 683 NLVRIISSCTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           N+V+        D K      LVL+    GS+   +       +  +   I   +  AL 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
            L   H N  +H D+K +N+LL  +   +L DFG++  L+     ++T ++ T  +MAPE
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPE 194

Query: 798 Y-GREGQIST----EGDVYSFGIMLMEI 820
               E Q+ +      DV+S GI  +E+
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 58/237 (24%)

Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA---------ECEV 675
            ++   + IG G++G V        G++VAIK         +  F           E ++
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--------KISPFEHQTFCQRTLREIKI 56

Query: 676 LRSIRHRNLVRI---ISSCTNDDFKA--LVLDYMPKGSLEACLYSDN-SNLDI--FKRLN 727
           LR  +H N++ I   I   + + F    +V + M    L   + + + SN  I  F    
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYF---- 111

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
            +  I   L+Y+H  +   V+H D+KPSN+LL+ +   ++ DFG+A+    D    HT  
Sbjct: 112 -LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGF 165

Query: 788 L----ATIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG 833
           L    AT  Y APE       Y      +   D++S G +L E+ +  RP   +F G
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGY------TKAIDIWSVGCILAEMLSN-RP---LFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLR----SIRHRN--LVR 686
           ++G GSFG V     L G      V  L+ +  L   + EC ++     ++   N  L  
Sbjct: 2   VLGKGSFGKVLLAE-LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +  +    +    V++++  G L   +  D    D+++      +I   L++LH      
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREGQIS 805
           +++ D+K  NV+LD D   ++ DFG+ K  + GD   + +    T  Y+APE  +  + +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYT 174

Query: 806 TEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
              D +SFG++L E+   + P      DE+F
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 21/212 (9%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLR------SIRHRNLV 685
           ++G GSFG V         EV AIKV  L+ +  L+  + +C +        + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            +       D    V++Y+  G L   +   +   D  +      ++ LAL +LH    +
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLH---RH 115

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGREGQI 804
            V++ D+K  N+LLD +   +L DFG+ K   G  +   T T   T  Y+APE  +E + 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 805 STEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
               D ++ G+++ E+   + P      D++F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 90/337 (26%), Positives = 135/337 (40%), Gaps = 67/337 (19%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSD 72
           L +L  L  LDL+ N+L   I S +  +  L  LDL NN ++                  
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT------------------ 129

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI 132
                ++P  I      ++ L L+ N+    LP  + NL +L ++DLS N L  ++P  +
Sbjct: 130 -----DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL 182

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL 192
            NL NL  L  LS N +  +P  +  +S L+ L                           
Sbjct: 183 SNLSNLNNL-DLSGNKISDLPPEIELLSALEEL--------------------------D 215

Query: 193 ANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHEL 252
            +NN   ++ S + N   LS  EL +N     +P    N+ NL+ L+L       SN+++
Sbjct: 216 LSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL-------SNNQI 267

Query: 253 SFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI 312
           S ISSL +   L+ L L+GN L +  LP     L L      L        +      L 
Sbjct: 268 SSISSLGSLTNLRELDLSGNSLSN-ALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLE 349
           N I+          S P  LS LE L  L   +N L+
Sbjct: 327 NNILSNGET-----SSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.9 bits (134), Expect = 4e-08
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRII 688
           L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
            S    D    V++Y+  G L   L  +    +   R     +I  AL+YLH G    +V
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK---IV 117

Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPEYGREGQI 804
           + D+K  N++LD+D   ++ DFG+ K     E +    T+ T      Y+APE   +   
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 805 STEGDVYSFGIMLMEIFTRKRP 826
               D +  G+++ E+   + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)

Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNA--ECEVLRSIRHRNLVRIIS 689
           +G GS+ +VY+GR  L G  VA+K   L+  EGA   F A  E  +L+ ++H N+V +  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHD 70

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
                    LV +Y+     +   Y D+         N+ + +   L  L + H   V+H
Sbjct: 71  IIHTKKTLTLVFEYLDT---DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP-------EYGREG 802
            D+KP N+L+ E    +L DFG+A+  S   S  ++  + T+ Y  P       EY    
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKS-VPSKTYSNEVVTLWYRPPDVLLGSTEY---- 181

Query: 803 QISTEGDVYSFGIMLMEIFT 822
             ST  D++  G +  E+ T
Sbjct: 182 --STSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 9/198 (4%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRII 688
           L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
            +    D    V++Y   G L   L  +    +   R     +I  ALEYLH      VV
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           + DIK  N++LD+D   ++ DFG+ K    D +   T    T  Y+APE   +       
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176

Query: 809 DVYSFGIMLMEIFTRKRP 826
           D +  G+++ E+   + P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 633 LIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALES------FNAECEVLRSIRHRNLV 685
           +IG GSFG V   R   +    A+KV  LQ +  L+        +    +L++++H  LV
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            +  S    D    VLDY+  G L   L  +   L+   R     +IA AL YLH  +  
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN-- 116

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPEYGRE 801
            +V+ D+KP N+LLD      L DFG+ K     E+++H  T +T      Y+APE   +
Sbjct: 117 -IVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 802 GQISTEGDVYSFGIMLMEIF 821
                  D +  G +L E+ 
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 28/212 (13%)

Query: 634 IGSGSFGSVYRGRFLDG---MEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +G G++G VY+ +  DG    E A+K    Q+EG   S +A  E  +LR ++H N++ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 689 SS-CTNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY-----LHF 741
               ++ D K  L+ DY          +   S  +  K + +   +  +L Y     +H+
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANK-KPMQLPRSMVKSLLYQILDGIHY 123

Query: 742 GHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDESMKHTQTL----ATIGY 793
            H N V+H D+KP+N+L+     E    ++ D G A+L   +  +K    L     T  Y
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWY 181

Query: 794 MAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
            APE     +  T+  D+++ G +  E+ T +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 628 FNVNNLIGSGSFGSVYRGRFL---DGMEVAIK----VFH--LQLEGALESFNAECEVLRS 678
           + +   +G G++G V   R     +   VAIK    VF   +  + AL     E ++LR 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRH 57

Query: 679 IR-HRNLVRIISS--CTNDDFKALVLDYMP--KGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            R H+N+  +         +F  L L Y    +  L   + S    L      + +  I 
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQP-LTDAHFQSFIYQIL 115

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLAT 790
             L+Y+H  +   V+H D+KP N+L++ D   ++ DFG+A+  S   G+ +   T+ +AT
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 791 IGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGE 834
             Y APE     Q  T+  DV+S G +L E+  RK     +F G+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 31/207 (14%)

Query: 633 LIGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRI 687
            +GSG++GSV     +D   G +VAIK      +  + +  A  E  +L+ ++H N++ +
Sbjct: 22  QVGSGAYGSVCSA--IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 688 I----SSCTNDDFKA--LVLDYMPKGSLEACL---YSDNSNLDIFKRLNIVIDIALALEY 738
           +    S+ + D+F+   LV+ YM +  L+  +    S++      K   +V  +   L+Y
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSED------KVQYLVYQMLCGLKY 132

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           +H      ++H D+KP N+ ++ED   ++ DFG+A+    D  M  T  + T  Y APE 
Sbjct: 133 IH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM--TGYVVTRWYRAPEV 185

Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRK 824
                   +  D++S G ++ E+ T K
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 26/204 (12%)

Query: 634 IGSGSFGSV---YRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +GSG++GSV   Y  R     +VA+K      +  + +     E  +L+ ++H N++ ++
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 689 S----SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALALEYLHF 741
                + + ++F  + L       +   + +D +N+   ++L   ++   I   L  L +
Sbjct: 81  DVFTPATSIENFNEVYL-------VTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
            H   ++H D+KPSNV ++ED   R+ DFG+A+    D+ M  T  +AT  Y APE    
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEM--TGYVATRWYRAPEIMLN 189

Query: 802 G-QISTEGDVYSFGIMLMEIFTRK 824
               +   D++S G ++ E+   K
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 633 LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLR------SIRHRNLV 685
           ++G GSFG V+           AIK   L+ +  L   + EC ++       +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            +  +    +    V++Y+  G L   + S +   D+ +      +I   L++LH     
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SK 115

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM----KHTQTLATIGYMAPEYGRE 801
            +V+ D+K  N+LLD D   ++ DFG+ K     E+M    K      T  Y+APE    
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP 826
            + +T  D +SFG++L E+   + P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 28/228 (12%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           + + N+IG+GSFG VY    +D  E VAIK    ++    +  N E  +++++ H N++ 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIF 123

Query: 687 IISSCTNDDFKA--------LVLDYMPKGSLEACLY--SDNSNLDIFKRLNIVIDIALAL 736
           +      + FK         +V++++P+   +   +   +N  L +F        +  AL
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
            Y+   H   + H D+KP N+L+D +    +L DFG AK LL+G  S+ +   + +  Y 
Sbjct: 184 AYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYR 237

Query: 795 APEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
           APE        +T  D++S G ++ E+         IFSG+ S+ + V
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGY----PIFSGQSSVDQLV 281

Length = 440

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 4/119 (3%)

Query: 705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV 764
           P+ +    L +++  L     +     +A  +E+L        VH D+   NVL+ E  +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277

Query: 765 ARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            ++ DFG+A+ +  D + +    T   + +MAPE       +T  DV+SFGI+L EIFT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 91/315 (28%), Positives = 139/315 (44%), Gaps = 20/315 (6%)

Query: 103 HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL 162
                + NL  L S+DL+ N L   I   +  L NL +L L +NN+  + P      S L
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNL 142

Query: 163 KILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFS 222
           K L L++N +  S+ S +R  LPNL+   L+ N+ S  +P  + N S L+  +L  N  S
Sbjct: 143 KELDLSDNKIE-SLPSPLRN-LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199

Query: 223 GFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSS 282
             +P     +  L+EL+L      S+N  +  +SSL+N K L  L L+ N L D  LP S
Sbjct: 200 D-LPPEIELLSALEELDL------SNNSIIELLSSLSNLKNLSGLELSNNKLED--LPES 250

Query: 283 IGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILG 342
           IGNLS        +N   + S    +G+L NL  + L  N L+ ++P     L  L++L 
Sbjct: 251 IGNLSNLETLDLSNN---QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307

Query: 343 LENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPST 402
                L      ++   + L +  +  N    S P     L SL  L    N L      
Sbjct: 308 NLLLTL---KALELKLNSILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALDESNLN 363

Query: 403 FWNLTNILMVDLSSN 417
            + + N   +    +
Sbjct: 364 RYIVKNPNAIGSLLD 378

Length = 394

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 72/210 (34%), Positives = 101/210 (48%), Gaps = 7/210 (3%)

Query: 328 IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR 387
           +PS+LSRL  L +L            + +  L  L S+ L+ N+L  +I      L +L 
Sbjct: 62  LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLP-LPSLDLNLNRLRSNISELL-ELTNLT 119

Query: 388 KLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGD 446
            L   +N +T   P      +N+  +DLS N +  SLP  + NL  L  L LS N+LS D
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177

Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLK 506
           +P  +  L NL NL L  N +   +P  I  L +LE LDLSNN +   + SSL  L  L 
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235

Query: 507 YLNVSFNRLEGEIPRGGTLANFTSESFMGN 536
            L +S N+LE      G L+N  +     N
Sbjct: 236 GLELSNNKLEDLPESIGNLSNLETLDLSNN 265

Length = 394

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 2e-07
 Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 18/178 (10%)

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + N +++  S T      L++DY+  G L   L  +   L   +   I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMV-ARLGDFGIAKLLSGDESMKHTQTL--ATIGYMAPE 797
             +   ++H DIK  NVL D       L D+G+ K       +  T +    T+ Y +PE
Sbjct: 127 KHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYFSPE 176

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP----TDEIFSGEMSLKRWVNDSLPISIMN 851
             +        D ++ G++  E+ T K P     DE    E  LKR       I  ++
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.7 bits (131), Expect = 2e-07
 Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 37/234 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVFHLQLEGALESFNAECEVLRSIRH 681
           +++ V   IG+G FG V+  +     E     AI    L+ E        E  V+R ++H
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKH 71

Query: 682 RNLVRIISSCTNDDFKAL--VLDYMPKGSL----EACLYSDNSNLDIFKRLNIVIDIALA 735
           +N+VR I    N   + L  ++++   G L    + C Y     ++    ++I   +  A
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGKIEEHAIVDITRQLLHA 130

Query: 736 LEYLHFGHPNP----VVHCDIKPSNVLLDEDM-----------------VARLGDFGIAK 774
           L Y H     P    V+H D+KP N+ L   +                 +A++GDFG++K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 775 LLSGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            + G ESM H+  + T  Y +PE           + D+++ G ++ E+ + K P
Sbjct: 191 NI-GIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 5/121 (4%)

Query: 704 MPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED 762
                ++  L  D S  L     L+    +A  +E+L        VH D+   NVLL + 
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQG 273

Query: 763 MVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF 821
            + ++ DFG+A+ +  D + +    T   + +MAPE   +   +T  DV+S+GI+L EIF
Sbjct: 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Query: 822 T 822
           +
Sbjct: 334 S 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 39/212 (18%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVR---I 687
           IG G++G V   +  +   +VAIK      +  +++     E ++LR + H N++    I
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 688 ISSCTNDDFKA--LVLDYMPKG------SLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           +     + F    +V + M         S +  L  D+    +++ L         L+Y+
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLR-------GLKYI 124

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-- 797
           H  +   V+H D+KPSN+LL+ +   ++ DFG+A+  S       T+ + T  Y APE  
Sbjct: 125 HSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVTRWYRAPELL 180

Query: 798 -----YGREGQISTEGDVYSFGIMLMEIFTRK 824
                Y       T  DV+S G +  E+  RK
Sbjct: 181 LNCSEYT------TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 64/230 (27%)

Query: 634 IGSGSFGSVYRGRFLDG---MEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +G G++G VY+ +  DG    + A+K    Q+EG   S +A  E  +LR ++H N++ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 64

Query: 689 SS-CTNDDFKA-LVLDY-----------------------MPKGSLEACLYSDNSNLDIF 723
               ++ D K  L+ DY                       +P+G +++ LY         
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116

Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGD 779
                       L+ +H+ H N V+H D+KP+N+L+     E    ++ D G A+L   +
Sbjct: 117 -----------ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--N 163

Query: 780 ESMKHTQTL----ATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
             +K    L     T  Y APE     +  T+  D+++ G +  E+ T +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 31/217 (14%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAEC-----EVLR-SIRHRNLV 685
           ++G GSFG V         E+ A+KV  L+ +  L+  + EC      VL  + +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALEYLHFG 742
           ++ S     D    V++Y+  G L   +         F          +I L L++LH  
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLH-- 113

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTL-ATIGYMAPEYG 799
               +++ D+K  NVLLD +   ++ DFG+ K  +L G      T T   T  Y+APE  
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEIL 168

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
                    D ++ G++L E+   + P      DE+F
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 34/229 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           D+  V + +G G++GSVY+      G+ +A+K   L+L+ +   FN    E ++L     
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--KFNQIIMELDILHKAVS 58

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA----LE 737
             +V    +   +    + ++YM  GSL+  LY+     +     +++  I  A    L+
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPE-DVLRRITYAVVKGLK 116

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YM 794
           +L   H   ++H D+KP+NVL++ +   +L DFG+    SG+      +T   IG   YM
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKT--NIGCQSYM 168

Query: 795 APEYGREGQISTEG------DVYSFGIMLMEIFTRKRP-----TDEIFS 832
           APE  + G  +         DV+S G+ ++E+   + P        IF+
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA 217

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 26/76 (34%), Positives = 47/76 (61%), Gaps = 1/76 (1%)

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGREGQIST 806
           +H D+   N+LL E+ V ++ DFG+A+ +  D + ++       + +MAPE   +   +T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG++L EIF+
Sbjct: 256 QSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 6e-07
 Identities = 26/76 (34%), Positives = 47/76 (61%), Gaps = 1/76 (1%)

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGREGQIST 806
           +H D+   N+LL E+ V ++ DFG+A+ +  D + ++       + +MAPE   +   +T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG++L EIF+
Sbjct: 255 QSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 38/241 (15%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRN-LVRIIS 689
           IG G++G VY+ R  + G  VA+K   L++  EG   +   E  +L+ +     +VR++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 690 --SCTNDDFKA---LVLDYMP---KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
                  + K    LV +Y+    K  +++        L      + +  +   + + H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH- 127

Query: 742 GHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
            H   V+H D+KP N+L+D+   + ++ D G+ +  S      +T  + T+ Y APE   
Sbjct: 128 KHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIVTLWYRAPEVLL 184

Query: 801 EG-QISTEGDVYSFGIMLMEIFTRK--------------------RPTDEIFSGEMSLKR 839
                ST  D++S G +  E+  ++                     PT++++ G   L+ 
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD 244

Query: 840 W 840
           W
Sbjct: 245 W 245

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 6/118 (5%)

Query: 707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR 766
            S +     D+  LD+   L     +A  +++L        +H D+   NVLL +  VA+
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAK 252

Query: 767 LGDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + DFG+A+ +  D +  +K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLP-VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.1 bits (123), Expect = 9e-07
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 37/207 (17%)

Query: 634 IGSGSFGSVYRGRFL-DGMEVAIK----VFHLQLEGALESFNAECEVLRSIR-HRNLVRI 687
           IG G+F  V + +    G   AIK     F   LE        E + LR +  H N++R+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQVNNL--REIQALRRLSPHPNILRL 63

Query: 688 I-------SSCTNDDFKALVLDYMPKGSLEACLYSDNSN----LDIFKRLNIVIDIALAL 736
           I       +        ALV + M     +  LY         L   +  + +  +  +L
Sbjct: 64  IEVLFDRKTGRL-----ALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
           +++H    N + H DIKP N+L+ +D++ +L DFG  +         +T+ ++T  Y AP
Sbjct: 114 DHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCR--GIYSKPPYTEYISTRWYRAP 167

Query: 797 E-YGREGQISTEGDVYSFGIMLMEIFT 822
           E    +G    + D+++ G +  EI +
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 18/203 (8%)

Query: 634 IGSGSFGSVYRGRFLDGMEVA-IKVFHLQLEGAL---ESFNAECEVLRSIRHRNLVRIIS 689
           IG+G FG V          VA + V  L+   +      F  + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDN---SNLDIFKRLNIVIDIALALEYLHFGHPNP 746
            C       LV +Y   G L++ L  +     N  +     +  +IA  + ++H  +   
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGRE---G 802
            +H D+   N  L  D+  ++GD+GI       D           + ++APE   E   G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 803 QISTE----GDVYSFGIMLMEIF 821
            I+ E     +V++ G+ L E+F
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 39/217 (17%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA---------ECE 674
           T+++     +G G+FG V   R  L G  VAIK         ++ F+          E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61

Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------I 728
           +L+ +RH N++       +D F + + D      L   L +D   L   + L        
Sbjct: 62  LLKHLRHENII-----SLSDIFISPLEDIYFVTEL---LGTDLHRLLTSRPLEKQFIQYF 113

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           +  I   L+Y+H      VVH D+KPSN+L++E+   ++ DFG+A++   D  M  T  +
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI--QDPQM--TGYV 166

Query: 789 ATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRK 824
           +T  Y APE     Q    E D++S G +  E+   K
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 16/202 (7%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRII 688
           L+G G+FG V   +    G   A+K+   ++  A +       E  VL++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
            S    D    V++Y   G L   L  +    +   R     +I  AL+YLH      VV
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNVV 118

Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPEYGREGQI 804
           + D+K  N++LD+D   ++ DFG+ K     E +K   T+ T      Y+APE   +   
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 805 STEGDVYSFGIMLMEIFTRKRP 826
               D +  G+++ E+   + P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 25/76 (32%), Positives = 46/76 (60%), Gaps = 1/76 (1%)

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGREGQIST 806
           +H D+   N+LL E+ V ++ DFG+A+ +  D + ++       + +MAPE   +   + 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG++L EIF+
Sbjct: 261 QSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 634 IGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           IGSG+ G V      D   G+ VA+K      +    +  A  E  +L+ + H+N++ ++
Sbjct: 29  IGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 689 SSCTN----DDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +  T     ++F+   LV++ M   +L   ++ +   LD  +   ++  +   +++LH  
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSA 142

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
               ++H D+KPSN+++  D   ++ DFG+A+    +  M  T  + T  Y APE     
Sbjct: 143 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRYYRAPEVILGM 197

Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                 D++S G ++ E+         IF G   + +W
Sbjct: 198 GYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 52/231 (22%), Positives = 108/231 (46%), Gaps = 42/231 (18%)

Query: 613 WRRFSYQELLQATDQFNVNNLIGSGSFGSV---YRGRFLDGMEVAIKVFHLQLEGALESF 669
           +R+   + + +  +++   + +GSG++GSV   +  +   G+ VA+K      +  + + 
Sbjct: 4   YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAK 61

Query: 670 NA--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNS 718
               E  +L+ ++H N++ ++              + P  SLE           + +D +
Sbjct: 62  RTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLN 109

Query: 719 NLDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
           N+   ++L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+
Sbjct: 110 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 166

Query: 773 AKLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           A+    D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 167 AR--HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 9/193 (4%)

Query: 634 IGSGSFGSVYRGRFLDGMEV----AIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           IG GSFG V + R  D   +     I+  H+     +    AE  VL  +    +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S  + +   LVL ++  G L   L  +    D+ +      ++  ALE LH      V++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIY 116

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            D+KP N+LLD      L DFG+ KL   D+   +T    T  Y+APE       +   D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAVD 175

Query: 810 VYSFGIMLMEIFT 822
            ++ G++L E+ T
Sbjct: 176 WWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 52/222 (23%), Positives = 82/222 (36%), Gaps = 29/222 (13%)

Query: 6   TGTVPSQLGSLSSLQYLDLSFNQLLGTIP---SSIFSINTLEILDLSNNQLSGSFPFF-- 60
             ++   L     LQ LDLS N L         S+   ++L+ L L+NN L         
Sbjct: 70  LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129

Query: 61  -----NMSSLQVIDLSDNRLSGELP---ANIFSYLPFVQFLSLAFNQFAG----HLPREI 108
                   +L+ + L  NRL G      A        ++ L+LA N         L   +
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189

Query: 109 GNLTSLTSIDLSENHLMGE----IPHEIGNLRNLQALGLLSNNLVGVVPATLFNI----- 159
               +L  +DL+ N L  E    +   + +L++L+ L L  NNL     A L +      
Sbjct: 190 KANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPN 249

Query: 160 STLKILQLTNNTLSGSISSSIRLALPN---LELFSLANNNFS 198
            +L  L L+ N ++   +  +   L     L    L  N F 
Sbjct: 250 ISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 28/153 (18%)

Query: 634 IGSGSFGSVYRGRFLDGMEV-AIK------VFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           IG G+FG V   R +D   + A+K      V        ++   AE ++L    +  +V+
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEADNEWVVK 65

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK----RLNIVIDIALALEYLH-- 740
           +  S  + D    V+DY+P G + + L      L IF+    R  I  ++  A+E +H  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIA-ELTCAIESVHKM 120

Query: 741 -FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
            F      +H DIKP N+L+D D   +L DFG+
Sbjct: 121 GF------IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G G+FG V   R +D     A+K    +   L   +    AE ++L    +  +VR+  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S  + D    V+DY+P G + + L       +   R  I  ++  A+E +H       +H
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH---KMGFIH 124

Query: 750 CDIKPSNVLLDEDMVARLGDFGI 772
            DIKP N+L+D D   +L DFG+
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRN 683
           ++ +  +IG GS+G V        G +VAIK  +   E   ++     E ++LR +RH +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 684 LV---RIISSCTNDDFKAL--VLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALE 737
           +V    I+   +  +FK +  V + M     E+ L+    +N D+    +      L L 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQL-LR 114

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD--ESMKHTQTLATIGYMA 795
            L + H   V H D+KP N+L + D   ++ DFG+A++   D   ++  T  +AT  Y A
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 796 PEYGRE--GQISTEGDVYSFGIMLMEIFTRK 824
           PE       + +   D++S G +  E+ T K
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 6/122 (4%)

Query: 703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED 762
           Y+ +      L  D   LD    L+    +A  + +L        +H D+   N+LL   
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHG 250

Query: 763 MVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEI 820
            + ++ DFG+A+ +  D +  +K    L  + +MAPE       + E DV+S+GI+L EI
Sbjct: 251 RITKICDFGLARDIRNDSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Query: 821 FT 822
           F+
Sbjct: 310 FS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 8/106 (7%)

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTL 788
           +I+LAL YLH      +++ D+K  NVLLD +   +L D+G+ K  L  GD +   +   
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFC 157

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
            T  Y+APE  R        D ++ G+++ E+   + P D + S +
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 14/205 (6%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
           +IG GS+  V   R     ++ A+KV   +L   +  ++    E  V         +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 689 SSCTNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
            SC     +  LV++Y+  G L   +       +   R     +I +AL +LH      +
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
           ++ D+K  NVLLD D   +L D+G+ K  L  GD +   +    T  Y+APE  R  +  
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYG 174

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEI 830
              D ++ G+++ E+   + P D I
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 6e-06
 Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 20/118 (16%)

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE----- 780
           L+I   I   +EY+H      V+H D+KP N+LL       + D+G A     +E     
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 781 -------SMKHTQT-----LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                      + T     + T  YMAPE       S   D+Y+ G++L ++ T   P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 52/185 (28%), Positives = 79/185 (42%), Gaps = 29/185 (15%)

Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRII 688
           L+G G+FG V   R     +  A+K+   ++  A +       E  VL++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALEYLHFGHPN 745
            S    D    V++Y   G L    +   S   +F          +I  AL YLH     
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPE---- 797
            VV+ D+K  N++LD+D   ++ DFG+ K     E +    T+ T      Y+APE    
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED 169

Query: 798 --YGR 800
             YGR
Sbjct: 170 NDYGR 174

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 33/227 (14%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLR------SIR 680
           FN   ++G GSFG V         E+ AIK+  L+ +  ++  + EC ++       S +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALE 737
              L ++ S     D    V++Y+  G L   +Y     +  FK  + V    +IA+ L 
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQ-QVGRFKEPHAVFYAAEIAIGLF 115

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH---TQTL-ATIGY 793
           +LH      +++ D+K  NV+LD +   ++ DFG+ K     E+M     T+T   T  Y
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDY 167

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIFSGEM 835
           +APE           D ++FG++L E+   + P      DE+F   M
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G G+FG V     +D     A+K    +       +    AE ++L    +  +V++  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S  + D    V+DY+P G + + L       ++  R  I  ++ LA+E +H       +H
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH---KMGFIH 124

Query: 750 CDIKPSNVLLDEDMVARLGDFGI 772
            DIKP N+L+D D   +L DFG+
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 17/191 (8%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFN-MSSLQ 66
           ++PS L +L +L+ LDLSFN L   +P  + +++ L  LDLS N++S   P    +S+L+
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALE 212

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG 126
            +DLS+N +   L +   S L  +  L L+ N+    LP  IGNL++L ++DLS N    
Sbjct: 213 ELDLSNNSIIELLSS--LSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNN--QI 267

Query: 127 EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPN 186
                +G+L NL+ L L  N+L           + L ++ L    L   ++  + L    
Sbjct: 268 SSISSLGSLTNLRELDLSGNSL----------SNALPLIALLLLLLELLLNLLLTLKALE 317

Query: 187 LELFSLANNNF 197
           L+L S+  NN 
Sbjct: 318 LKLNSILLNNN 328

Length = 394

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 47/225 (20%)

Query: 633 LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAEC-----EVLRSIR-HRNLV 685
           ++G GSFG V   R    G   A+KV  L+ +  L+  + EC      +L   R H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 686 RIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVIDI 732
           ++       D    V++++  G L              A  Y+               +I
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA--------------AEI 105

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
             AL +LH      +++ D+K  NVLLD +   +L DFG+ K   G  + K T T   T 
Sbjct: 106 TSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTP 160

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
            Y+APE  +E       D ++ G++L E+     P      D++F
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 1e-05
 Identities = 24/57 (42%), Positives = 27/57 (47%)

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN 489
           L  L LS N L+        GL NL+ L L  NNL    P +   L SL  LDLS N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 2e-05
 Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 1/82 (1%)

Query: 165 LQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGF 224
           L L N  L G I + I   L +L+  +L+ N+  G IP  + + + L + +L  NSF+G 
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 225 IPNRFHNMRNLKELNLEYNYIT 246
           IP     + +L+ LNL  N ++
Sbjct: 482 IPESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 39/230 (16%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVL--RSIRHRN- 683
           FN   ++G GSFG V         E+ AIK+  L+ +  ++  + EC ++  R +  ++ 
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59

Query: 684 ---LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
              L ++ S     D    V++Y+  G L   +Y     +  FK    V   A     L 
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQ-QVGKFKEPQAVFYAAEISVGLF 115

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH---TQTL-ATIGYMAP 796
           F H   +++ D+K  NV+LD +   ++ DFG+ K     E M     T+T   T  Y+AP
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAP 170

Query: 797 E------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIFSGEM 835
           E      YG+        D +++G++L E+   + P      DE+F   M
Sbjct: 171 EIIAYQPYGK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 10/101 (9%)

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTL 788
           +I+LAL +LH      +++ D+K  NVLLD +   +L D+G+ K  +  GD     T T 
Sbjct: 104 EISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT----TSTF 156

Query: 789 -ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
             T  Y+APE  R        D ++ G+++ E+   + P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 3e-05
 Identities = 22/60 (36%), Positives = 33/60 (55%)

Query: 456 NLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
           NL++L L +N L      +   L +L+ LDLS N L+ I P +   L  L+ L++S N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 17/178 (9%)

Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  +L+++ H +++R+  +  +     +VL +     L   L   +  L I + L I   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLL-DEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           I   L YLH      ++H D+K  N+ + D D V  +GD G A+      +        T
Sbjct: 166 ILEGLRYLH-AQR--IIHRDVKTENIFINDVDQVC-IGDLGAAQFPVVAPAF--LGLAGT 219

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLME-------IFTRKR--PTDEIFSGEMSLKR 839
           +   APE     + +++ D++S GI+L E       IF      P + + S    L +
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277

Length = 357

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 40/230 (17%)

Query: 627 QFNVNNLIGSGSFGSVY----RGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR 682
           ++ ++ LIG G FG VY            +   K+ +L+ E    +   E  V  +I   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDI 68

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEAC-----------LYSDNSNLDIFKRL----- 726
           + + +  +  N D   +   Y   GS + C           L  +N+  +IFKR+     
Sbjct: 69  DKIALWKNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLV-ENTK-EIFKRIKCKNK 125

Query: 727 ----NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGD- 779
               NI+ D+   LEY+H    + + H DIKP N+++D +    + D+GIA   ++ G  
Sbjct: 126 KLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182

Query: 780 -ESMKHTQTL--ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            E  K  + L   T+ Y   +      ++  GD+ S G  +++    K P
Sbjct: 183 IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 4e-05
 Identities = 36/116 (31%), Positives = 49/116 (42%), Gaps = 10/116 (8%)

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
            L N    G IP+ I     L    L  NS  G IP    ++ +L+ L+L YN    S  
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHN----CNIRG 302
           E     SL     L++L+L GN L   V P+++G   L    F   +    C I G
Sbjct: 484 E-----SLGQLTSLRILNLNGNSLSGRV-PAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 48/226 (21%)

Query: 626 DQFNVNNLIGSGSFGSVY-------RGRFLDGMEVAIKVFHLQ---LEGALESFNAECEV 675
           + F    LI +G++G+VY       R RF      A+K  + Q   L   ++    E ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRF------AMKKINKQNLILRNQIQQVFVERDI 54

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           L    +  +V +  S        +V++Y+  G   A L  +   L +        +  LA
Sbjct: 55  LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARMYFAETVLA 113

Query: 736 LEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESM------KHT- 785
           LEYLH +G    +VH D+KP N+L+      +L DFG++K  L+S   ++      K T 
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 786 -----QTLATIGYMAPE------YGREGQISTEGDVYSFGIMLMEI 820
                Q   T  Y+APE      YG+        D ++ GI+L E 
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYEF 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 6/162 (3%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVI 68
           + S L +L +L  L+LS N+L   +P SI +++ LE LDLSNNQ+S      ++++L+ +
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLREL 282

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI 128
           DLS N LS  LP      L     L+L     A  L      L +    +          
Sbjct: 283 DLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET-----SS 337

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNN 170
           P  +  L +L  L  L N L           +   I  L + 
Sbjct: 338 PEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLDL 379

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 5e-05
 Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 1/60 (1%)

Query: 361 RLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPL 419
            L S+ L +N+L+      F  L +L+ L  + N LT +    F  L ++  +DLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 45/233 (19%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLR------SIR 680
           FN   ++G GSFG V         E+ AIK+  L+ +  ++  + EC ++         +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALE 737
              L ++ S     D    V++Y+  G L   +Y     +  FK  + V    +IA+ L 
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQ-QVGKFKEPHAVFYAAEIAIGLF 115

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM---KHTQTL-ATIGY 793
           +LH      +++ D+K  NV+LD +   ++ DFG+ K     E++   K T+T   T  Y
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPDY 167

Query: 794 MAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIFSGEM 835
           +APE      YG+        D ++FG++L E+   + P      DE+F   M
Sbjct: 168 IAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 27/197 (13%)

Query: 651 MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE 710
           + V +KV          +F     ++  + H +L  +   C       +V +++  G L+
Sbjct: 45  LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA----- 765
            CL  +   + +  ++ +   +A AL YL       +VH ++   N+LL    +A     
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEGTSP 161

Query: 766 --RLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIF 821
             +L D G++   LS +E ++       I ++APE    G  +ST  D +SFG  L+EI 
Sbjct: 162 FIKLSDPGVSFTALSREERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI- 214

Query: 822 TRKRPTDEIFSGEMSLK 838
                    F GE+ LK
Sbjct: 215 --------CFDGEVPLK 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 8e-05
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 3/60 (5%)

Query: 43  LEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF 100
           L+ LDLSNN+L+      F  + +L+V+DLS N L+  +    FS LP ++ L L+ N  
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 46/197 (23%), Positives = 87/197 (44%), Gaps = 27/197 (13%)

Query: 651 MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE 710
           ++V +KV          +F     ++R + H+++V +   C  D    +V +++  G L+
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV------ 764
             ++  +  L    +  +   +A AL YL       +VH ++   N+LL  + +      
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGP 149

Query: 765 -ARLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIF 821
             +L D GI   +LS  E ++       I ++APE   + + +S   D +SFG  L EI 
Sbjct: 150 FIKLSDPGIPITVLSRQECVER------IPWIAPECVEDSKNLSIAADKWSFGTTLWEI- 202

Query: 822 TRKRPTDEIFSGEMSLK 838
                    ++GE+ LK
Sbjct: 203 --------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 2e-04
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 18 SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRL 75
          +L+ LDLS N+L      +   +  L++LDLS N L+   P  F  + SL+ +DLS N L
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 20/158 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLE----GALESFNAECEVLRSIR 680
           + F+   +IG G+FG V   +  D G   A+K   L+ E      L    AE +VL    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK----RLNIVIDIALAL 736
              +V +  S  +  +  L+++++P G L   L       D F     R  +  +  LA+
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMA-ECVLAI 114

Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           E +H  G     +H DIKP N+L+D     +L DFG++
Sbjct: 115 EAVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 25  IGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 690 SCTN----DDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 84  VFTPQKSLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 139

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 16/150 (10%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVRIIS 689
           I  G+FG VY GR   +    A+KV     +  +  +    AE + L   +   +V +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 690 SCTNDDFKALVLDYMPKGSLEACL----YSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           S  + +   LV++Y+  G +++ L    Y D         +  + ++ALAL+YLH    +
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLH---RH 123

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
            ++H D+KP N+L+  +   +L DFG++K+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 43.7 bits (103), Expect = 4e-04
 Identities = 77/285 (27%), Positives = 120/285 (42%), Gaps = 30/285 (10%)

Query: 220 SFSGFIPNRFHNMRNLKEL-------NLEYNYITSSNHELSFISSLANSKKLKVLSLTGN 272
           S +G         +NLKE+       NLE   ++  +  +   SS+    KL+ L ++  
Sbjct: 632 SLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691

Query: 273 PLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTL 332
             L+ +LP+ I NL  S+ R  L  C+   S P    N+  L +      +     PS L
Sbjct: 692 ENLE-ILPTGI-NLK-SLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEE----FPSNL 744

Query: 333 SRLEKLQILGL---ENNQLEGRILDDICRLARLS----SVYLDHNKLSGSIPACFGNLAS 385
            RLE L  L L   ++ +L  R+      +  LS     ++L        +P+   NL  
Sbjct: 745 -RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHK 803

Query: 386 LRKLSFAS-NELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLS 444
           L  L   +   L  +P+   NL ++  +DLS      + P    N+    +L LSR  + 
Sbjct: 804 LEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNIS---DLNLSRTGIE 859

Query: 445 GDIPTTIGGLKNLQNLSL-GDNNLQGSIPNSIGDLISLECLDLSN 488
            ++P  I    NL  L + G NNLQ    N I  L  LE +D S+
Sbjct: 860 -EVPWWIEKFSNLSFLDMNGCNNLQRVSLN-ISKLKHLETVDFSD 902

syringae 6; Provisional. Length = 1153

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 40.3 bits (95), Expect = 5e-04
 Identities = 11/26 (42%), Positives = 14/26 (53%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFH 659
           I + S   V+R    DG EVA+KV  
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKVQR 44

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE     
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200

Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                 D++S G ++ E+         +F G   + +W
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 31/153 (20%), Positives = 68/153 (44%), Gaps = 17/153 (11%)

Query: 633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV--RIISS 690
           L+  G    VY     D  +  +K+   + +GA      E  +L+ +  + L   ++++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV-H 749
             +D +  L+++++   +L+         +   ++ +I   +A  L  LH   P  V+ H
Sbjct: 62  GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLH-QLPLLVLCH 112

Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
            D+ P N+L+D+  +  + D+  A    G  + 
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY--GPPAF 143

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 8/153 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ--LE-GALESFNAECEVLRSIRH 681
           D F    +IG G+FG V   +  D G   A+K       LE   +    AE ++L    +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             +V++  S  ++++  L+++Y+P G +   L       D F        IA  +  +  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDS 116

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
            H    +H DIKP N+LLD     +L DFG+  
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           D F    +IG G+FG V   +  D      M++  K   L+ E  +    AE ++L    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
              +V++  S  +     L+++++P G +   L   ++  +   +  I  +  LA++ +H
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH 118

Query: 741 -FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
             G     +H DIKP N+LLD     +L DFG+
Sbjct: 119 QLG----FIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 35/113 (30%), Positives = 52/113 (46%), Gaps = 11/113 (9%)

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGDESMK-HTQTLATI 791
           A++Y+H      ++H DIK  NVL++  ED+   LGDFG A    G  S   H     T+
Sbjct: 272 AIDYIH---GEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDS 844
              APE       +   D++S G++   IF     T  +FS     +R   D+
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLV---IFEAAVHTASLFSASRGDERRPYDA 376

Length = 461

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 1/60 (1%)

Query: 385 SLRKLSFASNELTFVP-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNL 443
           +L+ L  ++N LT +P   F  L N+ ++DLS N L+   P     L  L  L LS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.1 bits (94), Expect = 0.004
 Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 20/174 (11%)

Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           IGSG+ G V      + G  VAIK      +    +  A  E  +++ + H+N++ +++ 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83

Query: 691 CTN----DDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL-ALEYLHFGH 743
            T     ++F+   LV++ M   +L   +  D   LD  +R++ ++   L  +++LH   
Sbjct: 84  FTPQKSLEEFQDVYLVMELM-DANLCQVIQMD---LD-HERMSYLLYQMLCGIKHLHSAG 138

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
              ++H D+KPSN+++  D   ++ DFG+A+       M  T  + T  Y APE
Sbjct: 139 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPE 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 12/153 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           + F    +IG G+FG V   +  D      M++  K   L+ E  +    AE ++L    
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEAD 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
              +V++  S  +     L+++++P G +   L   ++  +   +  I  +  LA++ +H
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH 118

Query: 741 -FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
             G     +H DIKP N+LLD     +L DFG+
Sbjct: 119 QLG----FIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	851
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.98
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.98
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.98
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.98
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.98
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.98
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.98
PTZ00267	478	NIMA-related protein kinase; Provisional	99.98
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.83
PLN00181	793	protein SPA1-RELATED; Provisional	99.82
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.81
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.7
smart00090	237	RIO RIO-like kinase.	99.7
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.69
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.58
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
PLN03150	623	hypothetical protein; Provisional	99.5
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.48
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.46
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
PLN03150	623	hypothetical protein; Provisional	99.38
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.35
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.32
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.3
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.26
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.25
KOG3087	229	consensus Serine/threonine protein kinase [General	99.24
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.23
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.22
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.12
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.06
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.93
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.86
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.86
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.84
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.84
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.83
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.81
COG4248	637	Uncharacterized protein with protein kinase and he	98.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.73
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.68
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.62
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.59

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.7e-100  Score=937.97  Aligned_cols=807  Identities=31%  Similarity=0.489  Sum_probs=685.9

Q ss_pred             CCcccccCCCCCCCCCCCEEeCcCCCCccCCCcccc-CCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCc
Q 046438            3 SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPA   81 (851)
Q Consensus         3 ~~~~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~   81 (851)
                      +.++|.+|+.+..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|...+++|++|||++|.+++.+|.
T Consensus        79 ~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~  158 (968)
T PLN00113         79 KNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPN  158 (968)
T ss_pred             CCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCCh
Confidence            457889999999999999999999999988888766 9999999999999999988988999999999999999977776


Q ss_pred             chhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCc
Q 046438           82 NIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNIST  161 (851)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  161 (851)
                      . ++.+++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|++++|++.+..|..+.++++
T Consensus       159 ~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~  237 (968)
T PLN00113        159 D-IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS  237 (968)
T ss_pred             H-HhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCC
Confidence            5 788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEecc
Q 046438          162 LKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE  241 (851)
Q Consensus       162 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  241 (851)
                      |++|++++|.+++.+|..+ ..+++|++|++++|.+++..|..+.++++|+.|++++|.+++..|..+.++++|++|+++
T Consensus       238 L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~  316 (968)
T PLN00113        238 LNHLDLVYNNLTGPIPSSL-GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLF  316 (968)
T ss_pred             CCEEECcCceeccccChhH-hCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECC
Confidence            9999999999998777764 489999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecC
Q 046438          242 YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGY  321 (851)
Q Consensus       242 ~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~  321 (851)
                      +|.++...     ...+..+++|+.|++++|.+. ..+|..++.+. +|+.|++++|++.+.+|..+..+++|+.|++++
T Consensus       317 ~n~~~~~~-----~~~~~~l~~L~~L~L~~n~l~-~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~  389 (968)
T PLN00113        317 SNNFTGKI-----PVALTSLPRLQVLQLWSNKFS-GEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS  389 (968)
T ss_pred             CCccCCcC-----ChhHhcCCCCCEEECcCCCCc-CcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcC
Confidence            99987633     345778999999999999986 45777777765 899999999999999999999999999999999


Q ss_pred             CCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCch
Q 046438          322 NKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS  401 (851)
Q Consensus       322 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~  401 (851)
                      |.+.+..|..+..+++|+.|++++|.+++..|..+..++.|+.|++++|.+.+.++..+..+++|+.|++++|++....+
T Consensus       390 n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p  469 (968)
T PLN00113        390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP  469 (968)
T ss_pred             CEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999984433


Q ss_pred             hhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCC
Q 046438          402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL  481 (851)
Q Consensus       402 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  481 (851)
                      .....++|+.|++++|++++..|..+..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|
T Consensus       470 ~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  549 (968)
T PLN00113        470 DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVL  549 (968)
T ss_pred             cccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccC
Confidence            34467899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC-CCCCCCCCCCCCCCccc
Q 046438          482 ECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP-HLQVPPCKSTKTRTNQK  560 (851)
Q Consensus       482 ~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~-~~~~~~c~~~~~~~~~~  560 (851)
                      +.|||++|++++.+|..+..+++|+.|++++|+++|.+|..+++..+...++.||+.+||.+ ....++|....     +
T Consensus       550 ~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-----~  624 (968)
T PLN00113        550 SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-----K  624 (968)
T ss_pred             CEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-----c
Confidence            99999999999999999999999999999999999999999999999999999999999865 33456774321     1


Q ss_pred             ccceeeehhhhhhHHHHHHHHHHHHHhheeeeeeccCCcccccccc--CCc---chhhccccHHHHHHHhcCCCccceec
Q 046438          561 SRKVVILLGVALPLSAAFIIISILAFKFGLISTCRKGDTKLSNIQA--NMP---LVAWRRFSYQELLQATDQFNVNNLIG  635 (851)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~lg  635 (851)
                      ...+.+++++++++++++++++++++.+ + ++++....+.+....  ...   ....+.+.++++   ...|+..+.||
T Consensus       625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig  699 (968)
T PLN00113        625 TPSWWFYITCTLGAFLVLALVAFGFVFI-R-GRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVIS  699 (968)
T ss_pred             cceeeeehhHHHHHHHHHHHHHHHHHHH-H-hhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEc
Confidence            1112222222222222222222222211 1 111100011000000  000   000112233333   34577788999


Q ss_pred             cccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChhHHhh
Q 046438          636 SGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY  714 (851)
Q Consensus       636 ~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  714 (851)
                      +|+||.||+|++ .+++.||+|.++....    ...+|++++++++|||||++++++.+++..++||||+++|+|.++++
T Consensus       700 ~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~  775 (968)
T PLN00113        700 RGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR  775 (968)
T ss_pred             cCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh
Confidence            999999999987 4789999998864322    22356889999999999999999999999999999999999999984


Q ss_pred             cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCcccc
Q 046438          715 SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM  794 (851)
Q Consensus       715 ~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~  794 (851)
                          .+++..+..++.||++|++|||+.++++|+|||+||+||+++.++..++. ||.+......     ....+++.|+
T Consensus       776 ----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~  845 (968)
T PLN00113        776 ----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYV  845 (968)
T ss_pred             ----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcccccccc
Confidence                37889999999999999999965558899999999999999999888876 6655433211     1236789999


Q ss_pred             CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcc
Q 046438          795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN  842 (851)
Q Consensus       795 aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  842 (851)
                      |||++.+..++.++|||||||++|||++|+.||+........+.+|++
T Consensus       846 aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  893 (968)
T PLN00113        846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR  893 (968)
T ss_pred             CcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHH
Confidence            999999999999999999999999999999999766555555666654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.5e-60  Score=583.22  Aligned_cols=515  Identities=35%  Similarity=0.550  Sum_probs=478.8

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc---CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccc
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFL   93 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L   93 (851)
                      .+++.|||++|.+++.+|.++..+++|++|+|++|++++..|   +..+++|++|||++|++++.+|.   ..+++|++|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L  145 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL  145 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence            479999999999999999999999999999999999997666   45899999999999999988885   458999999


Q ss_pred             cccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccc
Q 046438           94 SLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLS  173 (851)
Q Consensus        94 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  173 (851)
                      +|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|++++|++.+..|..+.++++|+.|+|++|.++
T Consensus       146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcch
Q 046438          174 GSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELS  253 (851)
Q Consensus       174 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  253 (851)
                      +.+|..+ ..+++|++|++++|.+++..|..+.++++|+.|++++|.+.+..|..+.++++|++|++++|.+....    
T Consensus       226 ~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~----  300 (968)
T PLN00113        226 GEIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI----  300 (968)
T ss_pred             CcCChhH-hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC----
Confidence            8888765 48999999999999999999999999999999999999999999999999999999999999987532    


Q ss_pred             hhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCcccc
Q 046438          254 FISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLS  333 (851)
Q Consensus       254 ~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~  333 (851)
                       ...+..+++|+.|++++|.+.. ..|..+..++ +|+.|++++|++.+.+|..++.+++|+.|++++|.+.+..|..+.
T Consensus       301 -p~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~  377 (968)
T PLN00113        301 -PELVIQLQNLEILHLFSNNFTG-KIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC  377 (968)
T ss_pred             -ChhHcCCCCCcEEECCCCccCC-cCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence             3457789999999999999863 5677777665 899999999999999999999999999999999999999999999


Q ss_pred             CCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCc-cCchhhcccCcceEE
Q 046438          334 RLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMV  412 (851)
Q Consensus       334 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~l~~L~~L  412 (851)
                      .+++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|+++ .+|..+..+++|+.|
T Consensus       378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  457 (968)
T PLN00113        378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML  457 (968)
T ss_pred             CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEE
Confidence            9999999999999999999999999999999999999999999999999999999999999998 556778899999999


Q ss_pred             EecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc
Q 046438          413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       413 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +|++|++.+.+|..++ .++|+.|++++|++++..|..|..+++|+.|+|++|++.+.+|..+..+++|++|+|++|+++
T Consensus       458 ~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        458 SLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             ECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            9999999988888764 589999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccccccccceeccCccccccCCCC-CcccccCcccccCCcCccCCC
Q 046438          493 GIIPSSLEKLLYLKYLNVSFNRLEGEIPRG-GTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       493 ~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      +.+|..+..+++|+.|+|++|++++.+|.. ..+..+..+++.+|+..+..|
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            999999999999999999999999999865 446778888899998877555

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=351.33  Aligned_cols=199  Identities=33%  Similarity=0.549  Sum_probs=179.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeec--chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..+|.+.+.||+|+||+||+|+++ ++.+||||.+...  .....+.+..|+.+++.++|||||.++++++.++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467899999999999999999984 5899999999766  3445567899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC------CcEEEeeccCccc
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED------MVARLGDFGIAKL  775 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~------~~~kl~Dfg~a~~  775 (851)
                      |||+||+|.+++... +.+++..++.++.|++.|+++|   |+++||||||||.||+++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999999999654 4788999999999999999999   99999999999999999764      5689999999998


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ....  ....+.+|+|-|||||++....|+.|+|+||+|+|+|||++|+.||+.
T Consensus       165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            8632  244567999999999999999999999999999999999999999984

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=371.95  Aligned_cols=393  Identities=25%  Similarity=0.262  Sum_probs=256.1

Q ss_pred             EeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccccccc
Q 046438          117 IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN  196 (851)
Q Consensus       117 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~  196 (851)
                      ||+|+|++....+..|.++++|+++++.+|.++ .+|..-....+|+.|+|.+|.|+ ++...-...+|.|+.||||.|.
T Consensus        83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~  160 (873)
T KOG4194|consen   83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNL  160 (873)
T ss_pred             eeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhch
Confidence            444444444444444444444444444444444 23322222333444444444444 3333333344555555555555


Q ss_pred             ccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccC
Q 046438          197 FSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD  276 (851)
Q Consensus       197 i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  276 (851)
                      |+...-..|..-.+++.|+|++|.|+.+....|.++.+|..|.|++|+|+.+|.     ..|+++++|+.|+|..|++..
T Consensus       161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~-----r~Fk~L~~L~~LdLnrN~iri  235 (873)
T KOG4194|consen  161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ-----RSFKRLPKLESLDLNRNRIRI  235 (873)
T ss_pred             hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCH-----HHhhhcchhhhhhccccceee
Confidence            544433344444455555555555555555555555566666666666655542     245555555555555555421


Q ss_pred             CCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccc
Q 046438          277 CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI  356 (851)
Q Consensus       277 ~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  356 (851)
                                                .--..|.++++|+.|.|..|.+.....++|..+.++++|+|+.|+++.....++
T Consensus       236 --------------------------ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~l  289 (873)
T KOG4194|consen  236 --------------------------VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWL  289 (873)
T ss_pred             --------------------------ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccc
Confidence                                      001235666677777777777776667777777777777777777777777777


Q ss_pred             cccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCch-hhcccCcceEEEecCCCCCCCCccccccchhhhh
Q 046438          357 CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVE  435 (851)
Q Consensus       357 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  435 (851)
                      .+++.|+.|+||+|.|..+.+..+...++|++|+|++|+|+.+++ .|..+..|++|+|++|++...-...|.++++|++
T Consensus       290 fgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~  369 (873)
T KOG4194|consen  290 FGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHK  369 (873)
T ss_pred             cccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhh
Confidence            777777777788877777777777777788888888888887754 6777788888888888887666667888888888


Q ss_pred             hhccCCcccccCC---cccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccC
Q 046438          436 LYLSRNNLSGDIP---TTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSF  512 (851)
Q Consensus       436 L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~  512 (851)
                      |||++|.|+..+.   ..|.+|++|+.|+|.+|+|..+...+|.++++||+|||.+|.|..+-|..|..+ .|+.|-+..
T Consensus       370 LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  370 LDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             hcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            8888888876553   357889999999999999986666789999999999999999998999999999 999999998


Q ss_pred             ccccccCCCCCcccccCccccc-CCcCccCCC
Q 046438          513 NRLEGEIPRGGTLANFTSESFM-GNDLLCGSP  543 (851)
Q Consensus       513 N~l~~~~p~~~~~~~l~~~~~~-~n~~~c~~~  543 (851)
                      -.+-|+|...+..+++....+. .-...|+-|
T Consensus       449 ssflCDCql~Wl~qWl~~~~lq~sv~a~CayP  480 (873)
T KOG4194|consen  449 SSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYP  480 (873)
T ss_pred             cceEEeccHHHHHHHHHhcccccceeeeccCC
Confidence            8888998755444444443332 122367765

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.1e-45  Score=367.14  Aligned_cols=454  Identities=31%  Similarity=0.444  Sum_probs=341.9

Q ss_pred             cCCCCCCEEEcCCCccccccc-CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccE
Q 046438           38 FSINTLEILDLSNNQLSGSFP-FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTS  116 (851)
Q Consensus        38 ~~l~~L~~L~Ls~n~l~~~~~-~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~  116 (851)
                      +....|+.|++++|.++...+ ..++..|++|++++|+++ .+|+. .+.+.+++.|+.++|++. .+|..++.+.+|++
T Consensus        42 W~qv~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~a-ig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~  118 (565)
T KOG0472|consen   42 WEQVDLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAA-IGELEALKSLNVSHNKLS-ELPEQIGSLISLVK  118 (565)
T ss_pred             hhhcchhhhhhccCchhhccHhhhcccceeEEEeccchhh-hCCHH-HHHHHHHHHhhcccchHh-hccHHHhhhhhhhh
Confidence            345667777777777765333 667777777777777776 66665 455677777777777776 66777777777777


Q ss_pred             EeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccccccc
Q 046438          117 IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN  196 (851)
Q Consensus       117 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~  196 (851)
                      |++++|.+. ..|+.++.+..|+.|+..+|+++ ..|+.+..+.+|..|++.+|+++ ..+.... .+..|++||...|-
T Consensus       119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~  194 (565)
T KOG0472|consen  119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNL  194 (565)
T ss_pred             hhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccchhh
Confidence            777777776 56667777777777777777776 44556667777777777777777 4444444 26777777777777


Q ss_pred             ccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccC
Q 046438          197 FSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD  276 (851)
Q Consensus       197 i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  276 (851)
                      ++ .+|..++.+.+|..|+|.+|+|... | .|.++..|++|+++.|.|..++.+     .++.++++.+||+.+|+++ 
T Consensus       195 L~-tlP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae-----~~~~L~~l~vLDLRdNklk-  265 (565)
T KOG0472|consen  195 LE-TLPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAE-----HLKHLNSLLVLDLRDNKLK-  265 (565)
T ss_pred             hh-cCChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHH-----Hhcccccceeeeccccccc-
Confidence            75 5666677777777777777777743 3 677777777777777777765532     3567777777777777774 


Q ss_pred             CCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCC-----------------------------
Q 046438          277 CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGS-----------------------------  327 (851)
Q Consensus       277 ~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------------------  327 (851)
                       .+|+.+..+. +|++|++++|.|+ .+|..++++ .|+.|-+.+|.+..+                             
T Consensus       266 -e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se  341 (565)
T KOG0472|consen  266 -EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSE  341 (565)
T ss_pred             -cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCc
Confidence             3666666654 6777777777777 566677777 777777777755210                             


Q ss_pred             ---------cCc---cccCCCCCcEEEcccccccccccccccccCC---CCEEEccCcccCCCCCccccCCccc-cceec
Q 046438          328 ---------IPS---TLSRLEKLQILGLENNQLEGRILDDICRLAR---LSSVYLDHNKLSGSIPACFGNLASL-RKLSF  391 (851)
Q Consensus       328 ---------~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L  391 (851)
                               .+.   ........+.|++++-+++.+ |+....-.+   .+..+++.|++. .+|..+..+..+ +.+.+
T Consensus       342 ~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~V-PdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~l  419 (565)
T KOG0472|consen  342 GGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLV-PDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVL  419 (565)
T ss_pred             ccccccCCCCCCcccchhhhhhhhhhcccccccccC-CHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHh
Confidence                     001   122345788899999999854 444433333   788999999998 678777777665 45778


Q ss_pred             ccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCC
Q 046438          392 ASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI  471 (851)
Q Consensus       392 ~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  471 (851)
                      ++|.+..+|..++.+++|..|+|++|.+. .+|.+++.+..|+.|++|.|++. .+|..+..+..|+.+-.++|++....
T Consensus       420 snn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd  497 (565)
T KOG0472|consen  420 SNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD  497 (565)
T ss_pred             hcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence            88899999999999999999999999998 88999999999999999999998 89999988899999999999998666


Q ss_pred             cccccCCCCCCEEECCCCcccccCCccccccccccceeccCcccc
Q 046438          472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE  516 (851)
Q Consensus       472 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  516 (851)
                      |..+.+|.+|.+|||.+|.+. .+|..++++++|+.|+++|||+.
T Consensus       498 ~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  498 PSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            777999999999999999999 89999999999999999999998

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=360.79  Aligned_cols=388  Identities=25%  Similarity=0.296  Sum_probs=318.4

Q ss_pred             CCCEEeCcCCCCccCCCccccCC--CCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccc
Q 046438           18 SLQYLDLSFNQLLGTIPSSIFSI--NTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFL   93 (851)
Q Consensus        18 ~L~~L~ls~n~l~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L   93 (851)
                      +-..||.+.+.+..+.-..+.+.  ..-+.||+|+|++.++.+  |.++++|+++++.+|.++ .+|.. -.-..+|+.|
T Consensus        53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f-~~~sghl~~L  130 (873)
T KOG4194|consen   53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRF-GHESGHLEKL  130 (873)
T ss_pred             CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccc-cccccceeEE
Confidence            35678899998875433344433  344569999999987544  789999999999999998 88873 2345569999


Q ss_pred             cccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccc
Q 046438           94 SLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLS  173 (851)
Q Consensus        94 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  173 (851)
                      +|.+|.|+.+-.+++..++.|+.||||.|.|+...-..|..-.++++|+|++|.|+.+....|.++.+|..|.|++|+++
T Consensus       131 ~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit  210 (873)
T KOG4194|consen  131 DLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT  210 (873)
T ss_pred             eeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc
Confidence            99999999888889999999999999999999666667888889999999999999998999999999999999999998


Q ss_pred             cccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcch
Q 046438          174 GSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELS  253 (851)
Q Consensus       174 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  253 (851)
                       .+|...|..+|+|+.|+|..|+|.-.--..|.++.+|+.|.|..|.|......+|-.|.++++|+|+.|+++.+..+  
T Consensus       211 -tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g--  287 (873)
T KOG4194|consen  211 -TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG--  287 (873)
T ss_pred             -ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc--
Confidence             88888998899999999999999866577888999999999999999999999999999999999999999987654  


Q ss_pred             hhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCcccc
Q 046438          254 FISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLS  333 (851)
Q Consensus       254 ~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~  333 (851)
                         ++.++++|+.|++|+|.|.                          .+-++...-.++|++|+|++|+|+...+..|.
T Consensus       288 ---~lfgLt~L~~L~lS~NaI~--------------------------rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~  338 (873)
T KOG4194|consen  288 ---WLFGLTSLEQLDLSYNAIQ--------------------------RIHIDSWSFTQKLKELDLSSNRITRLDEGSFR  338 (873)
T ss_pred             ---cccccchhhhhccchhhhh--------------------------eeecchhhhcccceeEeccccccccCChhHHH
Confidence               4667777777777777663                          23455666677788888888888877777888


Q ss_pred             CCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCC---CccccCCccccceecccCcCccCch-hhcccCcc
Q 046438          334 RLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSI---PACFGNLASLRKLSFASNELTFVPS-TFWNLTNI  409 (851)
Q Consensus       334 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L  409 (851)
                      .+..|++|+|++|.+.......|..+++|+.|||++|.++..+   ...|.++++|+.|+|.+|+|+.+|. +|.++++|
T Consensus       339 ~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L  418 (873)
T KOG4194|consen  339 VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL  418 (873)
T ss_pred             HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccc
Confidence            8888888888888887766677777888888888888877443   3467788888888888888888875 78888888


Q ss_pred             eEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       410 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      +.|||.+|.|..+-|++|..+ .|++|.+..
T Consensus       419 E~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  419 EHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             ceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            888888888887788888877 777776553

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=355.84  Aligned_cols=233  Identities=43%  Similarity=0.751  Sum_probs=203.2

Q ss_pred             hhccccHHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeee
Q 046438          612 AWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC  691 (851)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  691 (851)
                      ..+.|+++++..|++.|.-...||+|+||.||+|...+|..||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999988899999988765433135599999999999999999999999


Q ss_pred             ecCC-eeEEEEeccCCCChhHHhhcCCC-CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEee
Q 046438          692 TNDD-FKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD  769 (851)
Q Consensus       692 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~D  769 (851)
                      .+.+ +.++|||||++|+|++.++.... .++|..+.+||.++|+|++|||+.....|+|||||++||++|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999987665 899999999999999999999877767899999999999999999999999


Q ss_pred             ccCccccCCCCCcccccc-ccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC-cCccchhhhccccc
Q 046438          770 FGIAKLLSGDESMKHTQT-LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF-SGEMSLKRWVNDSL  845 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~  845 (851)
                      ||+|+..... ....... .||.+|+|||+...+..+.|+|||||||++.|+++|+.|.+... .++..+..|+...+
T Consensus       221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            9999665331 2122222 79999999999999999999999999999999999999998754 45556778765443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1e-44  Score=360.40  Aligned_cols=482  Identities=25%  Similarity=0.342  Sum_probs=338.4

Q ss_pred             cCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc-CCCCCCCcEEeCCCCCCCCCCCcchhcCC
Q 046438            9 VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-FFNMSSLQVIDLSDNRLSGELPANIFSYL   87 (851)
Q Consensus         9 ~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l   87 (851)
                      +-+.+..+..|..|++++|++. ..|.+++.+..++.|+.|+|++...++ ...+.+|..||+++|.+. ++|++ ++.+
T Consensus        60 l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~-i~~~  136 (565)
T KOG0472|consen   60 LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDS-IGRL  136 (565)
T ss_pred             ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCch-HHHH
Confidence            3445666677777777777776 566677777777777777777765443 566677777777777776 66665 3456


Q ss_pred             cccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEe
Q 046438           88 PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQL  167 (851)
Q Consensus        88 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  167 (851)
                      -.|+.|+..+|+|+ ..|.++..+.+|..|++.+|+++...|..+. ++.|++||+.+|-+. .+|..++.+.+|..|+|
T Consensus       137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL  213 (565)
T KOG0472|consen  137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYL  213 (565)
T ss_pred             hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHh
Confidence            66777777777776 5666677777777777777777744444333 777777777776666 45666777777777777


Q ss_pred             eccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccC
Q 046438          168 TNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS  247 (851)
Q Consensus       168 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~  247 (851)
                      ..|+|. ..|  -|.++..|++|+++.|.|.-.......++.++.+|||.+|++.. .|+.++-+++|.+||+|+|.|++
T Consensus       214 ~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is~  289 (565)
T KOG0472|consen  214 RRNKIR-FLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDISS  289 (565)
T ss_pred             hhcccc-cCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc-CchHHHHhhhhhhhcccCCcccc
Confidence            777776 455  24466677777777777764333444467777777777777774 35666677777777777777776


Q ss_pred             CCCcchhhhhccccccccEEeccCCCccCCCCCCccccccc--cccEE--EeecCccc---------cC----CCccccc
Q 046438          248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL--SMERF--YLHNCNIR---------GS----IPKEMGN  310 (851)
Q Consensus       248 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~--~L~~L--~L~~n~i~---------~~----~p~~l~~  310 (851)
                      ++.      .++++ .|+.|.+.+|++...  -..+-....  -|+.|  ++..-.++         +.    .......
T Consensus       290 Lp~------sLgnl-hL~~L~leGNPlrTi--Rr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~  360 (565)
T KOG0472|consen  290 LPY------SLGNL-HLKFLALEGNPLRTI--RREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYA  360 (565)
T ss_pred             CCc------ccccc-eeeehhhcCCchHHH--HHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhh
Confidence            654      35566 677777777776321  000000000  00000  00000000         00    1112344


Q ss_pred             ccCCcEEEecCCCCCCCcCccccCCC---CCcEEEcccccccccccccccccCCCCE-EEccCcccCCCCCccccCCccc
Q 046438          311 LINLIIIRLGYNKLNGSIPSTLSRLE---KLQILGLENNQLEGRILDDICRLARLSS-VYLDHNKLSGSIPACFGNLASL  386 (851)
Q Consensus       311 l~~L~~L~L~~n~l~~~~~~~~~~l~---~L~~L~L~~n~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L  386 (851)
                      +.+.++|+++.-+++ .+|+......   -.+..+++.|++. ..|..+..+..+.+ +.+++|.++ .+|..+..+++|
T Consensus       361 ~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kL  437 (565)
T KOG0472|consen  361 IITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKL  437 (565)
T ss_pred             hhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcc
Confidence            677899999999998 5555443333   4889999999999 56777777776654 566666666 889999999999


Q ss_pred             cceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcc
Q 046438          387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN  466 (851)
Q Consensus       387 ~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  466 (851)
                      ..|+|++|-+..+|..++.+..|+.||+|.|++. ..|+++-.+..++.+-.++|++....|+.+.++.+|.+|||.+|.
T Consensus       438 t~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNd  516 (565)
T KOG0472|consen  438 TFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNND  516 (565)
T ss_pred             eeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCc
Confidence            9999999999999999999999999999999998 899998888888888888899997667779999999999999999


Q ss_pred             cCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccc
Q 046438          467 LQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL  515 (851)
Q Consensus       467 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l  515 (851)
                      |. .+|..+++|++|++|+|++|.+. .++..+-..+....|..-++++
T Consensus       517 lq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdrI  563 (565)
T KOG0472|consen  517 LQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRDRI  563 (565)
T ss_pred             hh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhcccC
Confidence            98 89999999999999999999999 5555544444555555444543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=332.90  Aligned_cols=200  Identities=33%  Similarity=0.459  Sum_probs=180.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|+++++||+|+||+||.++.+ .++.||+|+++++.   ..+.+....|..++.+++||.||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999875 58889999997654   33567789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      +||+.||.|...+.++ +.+++..+.-++.+|+.|+.||   |++||||||+||+|||+|++|+++|+|||+|+.....+
T Consensus       104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999888544 5688888888999999999999   99999999999999999999999999999998654443


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      . ...+++||+.|||||++.+.+|+.++|.||+|+++|||++|.+||..
T Consensus       180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~  227 (357)
T KOG0598|consen  180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA  227 (357)
T ss_pred             C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence            3 34458999999999999999999999999999999999999999975

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-40  Score=350.02  Aligned_cols=200  Identities=28%  Similarity=0.435  Sum_probs=185.9

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+|+..+.||+|+|+.||++++ ..|+.||+|++.+..   ....+.+.+|++|.+.++|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999998 789999999997642   456688999999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+|+.++|..+++ +++.+++.+++.+.+||+.|+.||   |+++|+|||||..|++++++..|||+|||+|.....++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999886 678899999999999999999999   999999999999999999999999999999999876544


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ...+.+|||.|+|||++....++..+||||+||++|-|+.|++||+..
T Consensus       174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence             556789999999999999999999999999999999999999999764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-41  Score=317.81  Aligned_cols=204  Identities=28%  Similarity=0.451  Sum_probs=176.5

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceee-eeecC-CeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIIS-SCTND-DFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~-~~~~lv  700 (851)
                      .+|++.++||+|+||+||+|.. .+|..+|.|.++-..  ....++...|+.++++++|||||++++ .+.++ ...++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4588899999999999999976 579999999886432  345567889999999999999999998 34444 458999


Q ss_pred             EeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          701 LDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ||+|++|+|..+++.   ..+.+++..+|+++.|++.|+.++|+.-.+ -|.||||||.||+++.+|.||++|||+++..
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998754   567799999999999999999999542222 2999999999999999999999999999988


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..... ...+++|||.||+||.+.+.+|++|+||||+||++|||..-+.||.+.
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            76544 344679999999999999999999999999999999999999999874

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=324.59  Aligned_cols=198  Identities=27%  Similarity=0.413  Sum_probs=176.8

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCC-eeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDD-FKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  703 (851)
                      +.+.++.||+|..|+||+++++ +++.+|+|.+....+ ...+.+.+|+++++..+||+||.+||.|..++ .+.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3456689999999999999995 578899999965543 34567999999999999999999999999998 59999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      |++|+|++++... +.+++.....++.++++||.|||  ++++|+||||||+|||++..|+|||||||.+..+...   .
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~  233 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I  233 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence            9999999988654 56889999999999999999995  3589999999999999999999999999999876432   4


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||...
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            56789999999999999999999999999999999999999999774

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-40  Score=329.44  Aligned_cols=203  Identities=28%  Similarity=0.421  Sum_probs=174.6

Q ss_pred             HhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchh-------hHHHHHHHHHHHhhcCCCcccceeeeeecCC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG-------ALESFNAECEVLRSIRHRNLVRIISSCTNDD  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  695 (851)
                      ..+.|.+.+.+|+|+||.|-+|.. .+|+.||||++++....       ......+|+++|++++|||||+++++++.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            457799999999999999999976 46999999999765311       1234679999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---CcEEEeeccC
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDFGI  772 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---~~~kl~Dfg~  772 (851)
                      ..|||||||+||+|.+.+... +.+.+.....+++|++.|+.||   |++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999988543 4566777788999999999999   99999999999999999655   7899999999


Q ss_pred             ccccCCCCCccccccccCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQ---ISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      |+...  ......+.+|||.|.|||++.+..   +..++|+||+||++|-+++|.+||.+.-.
T Consensus       326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~  386 (475)
T KOG0615|consen  326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT  386 (475)
T ss_pred             hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence            99874  233456789999999999997654   33478999999999999999999987543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=335.05  Aligned_cols=200  Identities=34%  Similarity=0.581  Sum_probs=175.5

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCC-eeEEEEeccC
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDD-FKALVLDYMP  705 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~  705 (851)
                      .+.+.+|+|+||+||+|.+.....||+|++......  ..+.|.+|+.++.+++|||||+++|++.++. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            444669999999999999954444999999765422  2468999999999999999999999999887 7999999999


Q ss_pred             CCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCCEEECCCC-cEEEeeccCccccCCCCCc
Q 046438          706 KGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNP-VVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       706 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~-ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +|+|..+++. ....+++..+..++.+||+|+.||   |+++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999987 478899999999999999999999   8888 99999999999999997 99999999998764321 2


Q ss_pred             cccccccCccccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          783 KHTQTLATIGYMAPEYGR--EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            333367999999999999  66999999999999999999999999988665

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.6e-39  Score=309.36  Aligned_cols=202  Identities=27%  Similarity=0.357  Sum_probs=176.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      +.|+.+.++|+|+||+|||++++ +|+.||||++....+.  ..+-..+|++++++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888899999999999999996 5999999999755432  34557899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ||+..-|.+ +.......+...+..+.+|++.|+.|+   |+++++||||||+||+++.+|.+|+||||+|+....++. 
T Consensus        82 ~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            998766554 444556688889999999999999999   999999999999999999999999999999999876444 


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ..+.++.|.+|.|||.+.+ ..|+..+||||.||++.||++|.+-|.+..+
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD  207 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD  207 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence            4567889999999999877 7899999999999999999999988866443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=304.34  Aligned_cols=197  Identities=29%  Similarity=0.428  Sum_probs=179.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++++.+|.|+||+|-.++.+ +|..+|+|++++..   ..+.+...+|..+++.+.||.++++++.+.+.+..||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56889999999999999999885 58889999997653   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++||.+.++++.. +.+++..++.+|.||+.|++||   |+.+|++||+||+|||+|.+|.+||+|||+|+.+.+   
T Consensus       124 eyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            999999999998654 5688889999999999999999   899999999999999999999999999999998754   


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ...+.+|||.|+|||++..++|..++|.|||||++|||+.|++||-..
T Consensus       197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence             245679999999999999999999999999999999999999999653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=326.73  Aligned_cols=202  Identities=29%  Similarity=0.492  Sum_probs=179.2

Q ss_pred             HhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  698 (851)
                      ...+|.+.+.||+|+|++||+|+. .+++.||+|++.+..   +.....+.+|-++|.++ .||.|++++..|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346799999999999999999987 468999999987653   23345678899999999 7999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +|+||+++|+|.+++.+. +.+++...+.++.+|+.|++||   |++|||||||||+|||+|+|++++|.|||.|..+.+
T Consensus       151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            999999999999999654 5688888899999999999999   999999999999999999999999999999987643


Q ss_pred             CC------------CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          779 DE------------SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       779 ~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..            ...+..++||..|.+||++.+...++.+|+||||||+|+|+.|++||.+
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra  289 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA  289 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence            11            1122568999999999999999999999999999999999999999975

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-38  Score=322.75  Aligned_cols=201  Identities=30%  Similarity=0.422  Sum_probs=179.9

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  700 (851)
                      +.|+.++.||+|.||.||+|++ .+|+.||+|+++...  ++...-..+|+.|++++.||||+++.+...+.  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4567778999999999999987 568999999997654  44556678999999999999999999998876  689999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      +|||+. +|.-++....-.+++.++..++.|+++|++|+   |.+||.|||||.+|||||.+|.+||+|||+|+++....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999964 77777777777899999999999999999999   99999999999999999999999999999999888777


Q ss_pred             CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....+..+.|.+|.|||.+.+. .|+.++|+||.|||+.||+.|++.|.+.
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~  323 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR  323 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence            6667788999999999998874 6999999999999999999999998764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=329.96  Aligned_cols=202  Identities=32%  Similarity=0.583  Sum_probs=180.6

Q ss_pred             CCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      .++.++.||+|.||.||.|++.....||+|.++... ...+.|.+|+++|++++|++||+++++|..++.++||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            345678999999999999999777799999998652 3347788999999999999999999999998899999999999


Q ss_pred             CChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          707 GSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       707 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      |+|.+++.. .+..+...+...++.|||+|++||   .++++|||||.++|||++++..+||+|||+|+...++......
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            999999986 677789999999999999999999   9999999999999999999999999999999966555444444


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      ...-+..|.|||.+....++.|||||||||++|||+| |+.||.+...
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn  410 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN  410 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence            4556889999999999999999999999999999999 9999876543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-37  Score=293.26  Aligned_cols=199  Identities=26%  Similarity=0.425  Sum_probs=177.4

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|...+++|+|.||.||+|++ .+|+.||+|+++...  ++......+|++.++.++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688889999999999999988 569999999998653  3334568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      || ..+|+..++.+...++..++..++.++++|++||   |++.|+|||+||.|++++++|.+||+|||+|+.+..+...
T Consensus        82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            99 5699999998888999999999999999999999   9999999999999999999999999999999988654433


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       ....+.|.+|.|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+
T Consensus       158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG  204 (318)
T KOG0659|consen  158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG  204 (318)
T ss_pred             -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence             333478999999998876 4689999999999999999999877655

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-37  Score=319.90  Aligned_cols=214  Identities=26%  Similarity=0.407  Sum_probs=183.2

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ..++|++++.||+|+||.||.|+-+ +|..+|+|++++..   .++.+....|-.+|....+|+||++|..|++.+.+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999764 59999999998764   4566788999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC-
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-  778 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~-  778 (851)
                      ||||++||++..++.. .+.+++..+..++.+++-|++.+   |+.||+||||||+|+|||..|++||+|||+|..... 
T Consensus       219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999865 45788888899999999999999   999999999999999999999999999999853210 


Q ss_pred             --------------------CCCcc-------------------------ccccccCccccCccccccCCCCcchhhHHH
Q 046438          779 --------------------DESMK-------------------------HTQTLATIGYMAPEYGREGQISTEGDVYSF  813 (851)
Q Consensus       779 --------------------~~~~~-------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl  813 (851)
                                          +....                         ....+|||.|+|||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                00000                         012479999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCcCcc--chhhhc
Q 046438          814 GIMLMEIFTRKRPTDEIFSGEM--SLKRWV  841 (851)
Q Consensus       814 G~il~el~~g~~pf~~~~~~~~--~~~~~~  841 (851)
                      |||+|||+.|.+||....+.+.  .+..|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr  404 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWR  404 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999999999987544443  445554

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=357.37  Aligned_cols=472  Identities=29%  Similarity=0.353  Sum_probs=313.8

Q ss_pred             cCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccc-ccCCCCCCCcEEeCCCCCCCCCCCcchhcCC
Q 046438            9 VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGS-FPFFNMSSLQVIDLSDNRLSGELPANIFSYL   87 (851)
Q Consensus         9 ~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l   87 (851)
                      ||..+..-..++.|+++.|-+....-+.+.+--+|+.||+|+|++... .++..+++|+.|.++.|.|. ..|.+ ...+
T Consensus        13 ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s-~~~~   90 (1081)
T KOG0618|consen   13 IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSS-CSNM   90 (1081)
T ss_pred             cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchh-hhhh
Confidence            555554445566677777766532223333444477777777776632 22556667777777777776 56643 5566


Q ss_pred             cccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEe
Q 046438           88 PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQL  167 (851)
Q Consensus        88 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  167 (851)
                      .+|++|+|.+|.+. ..|..+..+.+|++||+|.|++. .+|..+..+..++++..++|......    +.. ..+.++|
T Consensus        91 ~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l----g~~-~ik~~~l  163 (1081)
T KOG0618|consen   91 RNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL----GQT-SIKKLDL  163 (1081)
T ss_pred             hcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh----ccc-cchhhhh
Confidence            77777777777666 66667777777777777777766 56666667777777777666222121    111 2666666


Q ss_pred             eccccccccchhHhhhcccccc-cccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCcccc
Q 046438          168 TNNTLSGSISSSIRLALPNLEL-FSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYIT  246 (851)
Q Consensus       168 ~~n~l~~~~~~~~~~~l~~L~~-L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  246 (851)
                      ..|.+.+.++..+.    .+++ |+|++|.++   ...+.++.+|+.+....|+++.+.    -.-++|+.|+.++|.++
T Consensus       164 ~~n~l~~~~~~~i~----~l~~~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~  232 (1081)
T KOG0618|consen  164 RLNVLGGSFLIDIY----NLTHQLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLT  232 (1081)
T ss_pred             hhhhcccchhcchh----hhheeeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcce
Confidence            66666655554432    3333 777777765   233455667777777777776432    12356777777777776


Q ss_pred             CCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCC
Q 046438          247 SSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG  326 (851)
Q Consensus       247 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~  326 (851)
                      ....       ...-.+|+.+++++|++.  .+|++++... +|+.+...+|++. .+|..+...++|+.|.+..|.+. 
T Consensus       233 ~~~~-------~p~p~nl~~~dis~n~l~--~lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-  300 (1081)
T KOG0618|consen  233 TLDV-------HPVPLNLQYLDISHNNLS--NLPEWIGACA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-  300 (1081)
T ss_pred             eecc-------ccccccceeeecchhhhh--cchHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-
Confidence            4322       223456777888887774  4666666665 7777888887775 67777777777888888877777 


Q ss_pred             CcCccccCCCCCcEEEcccccccccccccccccCC-CCEEEccCcccCCCCCccccCCccccceecccCcCc-cCchhhc
Q 046438          327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR-LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFW  404 (851)
Q Consensus       327 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~  404 (851)
                      .+|....+++.|++|+|..|+|...+...+.-+.. |..|+.+.|++.......=..++.|+.|.+.+|.++ ..-+.+-
T Consensus       301 yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~  380 (1081)
T KOG0618|consen  301 YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLV  380 (1081)
T ss_pred             hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhc
Confidence            55666777778888888888877444333333332 566666667666333222234567888888888887 3334567


Q ss_pred             ccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEE
Q 046438          405 NLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECL  484 (851)
Q Consensus       405 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  484 (851)
                      +...|+.|+|++|++.......+.++..|++|+||+|+++ .+|+.+..++.|++|...+|+|. ..| .+..++.|+.+
T Consensus       381 ~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~l  457 (1081)
T KOG0618|consen  381 NFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVL  457 (1081)
T ss_pred             cccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEE
Confidence            7888888888888888555556788888888888888888 67888888888888888888887 677 78888888888


Q ss_pred             ECCCCcccccCCccccccccccceeccCccc
Q 046438          485 DLSNNILSGIIPSSLEKLLYLKYLNVSFNRL  515 (851)
Q Consensus       485 ~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l  515 (851)
                      |+|.|+|+...-..-...++|++|||+||.+
T Consensus       458 DlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  458 DLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             ecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            8888888854333333337888888888885

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.8e-37  Score=318.73  Aligned_cols=197  Identities=34%  Similarity=0.506  Sum_probs=177.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+..  +.+.+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888899999999999999764 57889999997654  4456779999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+.| +|..++.. .+.++++.+..++.++..|+.||   |+.+|.|||+||.||+++..+.+|+||||+|+.+.... .
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S  155 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence            9976 99998854 56789999999999999999999   99999999999999999999999999999999876533 3


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      ..+...|||.|||||+..+++|+..+|+||+|||+||++.|++||-
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence            4455789999999999999999999999999999999999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=322.01  Aligned_cols=201  Identities=27%  Similarity=0.439  Sum_probs=178.8

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeec----ch-hhHHHHHHHHHHHhhcC-CCcccceeeeeecCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ----LE-GALESFNAECEVLRSIR-HRNLVRIISSCTNDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  696 (851)
                      ....|++.+.||+|+||+|+.|++. +++.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999874 6899999987654    11 23456778999999998 9999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccCccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKL  775 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~a~~  775 (851)
                      .++||||+.||+|.+++.. .+.+.+.....+++|++.|++||   |++||+||||||+|++++.+ +.+||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999987 67788899999999999999999   99999999999999999999 9999999999987


Q ss_pred             cCCCCCccccccccCccccCccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQ-IS-TEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .. .......+.+||+.|+|||++.+.. |+ .++||||+||++|-|++|+.||++
T Consensus       171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            64 1223456689999999999999877 75 678999999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=316.15  Aligned_cols=199  Identities=26%  Similarity=0.388  Sum_probs=177.1

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhH-HHHHHHHHHHhhcC-CCcccceeeeeecCC-eeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIR-HRNLVRIISSCTNDD-FKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv  700 (851)
                      -++|.+++++|.|.||.||+|+. .+|..||||.++.+...+. ..-.+|+..+++++ ||||+++.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            36799999999999999999987 4688999999987654432 23458999999998 999999999999888 99999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||| ..+|+++++.+.+.+++..++.|+.||++||+|+   |++|++|||+||+|||+.....+||+|||+|+.+....
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccCC
Confidence            9999 5689999999999999999999999999999999   99999999999999999988899999999999885433


Q ss_pred             CccccccccCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                        ..+.++.|.+|.|||++. ...|+.+.|+||+|||++|+.+-++-|.+
T Consensus       165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG  212 (538)
T KOG0661|consen  165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG  212 (538)
T ss_pred             --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence              456788999999999865 56789999999999999999999988865

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-37  Score=303.19  Aligned_cols=199  Identities=26%  Similarity=0.414  Sum_probs=180.7

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..+|++.+.+|+|.||+|-+|+. ..|+.||||.+++..   +++.-.+++|++||..++||||+++|++|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45788999999999999999976 679999999987643   45566789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||..+|.|++|+.+ .+.+++.+.+++++||..|+.|+   |+.+++|||+|.+||++|+++.+||+|||++-.+... 
T Consensus       132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-  206 (668)
T ss_pred             EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence            999999999999954 56789999999999999999999   9999999999999999999999999999999887543 


Q ss_pred             CccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       ....+++|+|-|.+||++.+.+| ++.+|-||+||++|.++.|..||++
T Consensus       207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence             34567899999999999999998 5779999999999999999999986

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=321.18  Aligned_cols=212  Identities=25%  Similarity=0.383  Sum_probs=184.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|.+.+++|+|+||+|+.|..+ +++.+|||++++..   +.+.+..+.|.+|+... +||.++.++..|++.++.|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467999999999999999999885 57889999998764   45677889999999888 49999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+.||++.  .+...+.+++..+.-++..|+.||.||   |++||++||||.+||++|.+|++||+|||+|+.....
T Consensus       447 vmey~~Ggdm~--~~~~~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  447 VMEYVAGGDLM--HHIHTDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEecCCCcEE--EEEecccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999943  334567799999999999999999999   9999999999999999999999999999999876544


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhccc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND  843 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  843 (851)
                      +. ..++++|||.|+|||++.+..|+.++|.|||||++|||+.|..||.+. +.++.+...+.+
T Consensus       522 g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI~~d  583 (694)
T KOG0694|consen  522 GD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSIVND  583 (694)
T ss_pred             CC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC
Confidence            44 567899999999999999999999999999999999999999999752 233344444443

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=353.58  Aligned_cols=483  Identities=27%  Similarity=0.351  Sum_probs=410.2

Q ss_pred             EEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccc-c-CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccccc
Q 046438           21 YLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF-P-FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFN   98 (851)
Q Consensus        21 ~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~-~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N   98 (851)
                      .+|+|..+++ .+|.-+..-..++.|+++.|-+...+ + ....-+|+.||+++|+++ ..|.. ...+++|+.|+++.|
T Consensus         2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~-it~l~~L~~ln~s~n   78 (1081)
T KOG0618|consen    2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQ-ITLLSHLRQLNLSRN   78 (1081)
T ss_pred             CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCch-hhhHHHHhhcccchh
Confidence            5788999998 78887777777999999999887522 1 344556999999999998 77876 455899999999999


Q ss_pred             ccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccch
Q 046438           99 QFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS  178 (851)
Q Consensus        99 ~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~  178 (851)
                      .|. .+|.+..++.+|++|+|.+|++. ..|..+..+++|+.|+++.|++. ..|..+..++.+..+..++|....... 
T Consensus        79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg-  154 (1081)
T KOG0618|consen   79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG-  154 (1081)
T ss_pred             hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc-
Confidence            998 77889999999999999999998 89999999999999999999998 678899999999999999993221221 


Q ss_pred             hHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhc
Q 046438          179 SIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSL  258 (851)
Q Consensus       179 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l  258 (851)
                           -..++.++|..|.+.+.++..+..++.  .|+|++|.+..   -.+..+.+|+.|....|++..+.         
T Consensus       155 -----~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~---------  215 (1081)
T KOG0618|consen  155 -----QTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELE---------  215 (1081)
T ss_pred             -----cccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEE---------
Confidence                 122889999999999888888887777  89999999982   35678889999999999988643         


Q ss_pred             cccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCC
Q 046438          259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKL  338 (851)
Q Consensus       259 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  338 (851)
                      ...++|+.|+.++|.+...    .....+..++.++++.|+++ .+|++++.+.+|+.++..+|++. ..|..+...++|
T Consensus       216 ~~g~~l~~L~a~~n~l~~~----~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L  289 (1081)
T KOG0618|consen  216 ISGPSLTALYADHNPLTTL----DVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSL  289 (1081)
T ss_pred             ecCcchheeeeccCcceee----ccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhH
Confidence            2458999999999998621    11223347999999999999 56799999999999999999996 788889999999


Q ss_pred             cEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcc-ccceecccCcCccCchhh-cccCcceEEEecC
Q 046438          339 QILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLAS-LRKLSFASNELTFVPSTF-WNLTNILMVDLSS  416 (851)
Q Consensus       339 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~p~~~-~~l~~L~~L~Ls~  416 (851)
                      +.|.+..|.+. .+|....+++.|++|+|..|+|....+..|.-+.. |+.|+.+.|++...|..= ..+..|+.|.+.+
T Consensus       290 ~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lylan  368 (1081)
T KOG0618|consen  290 VSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLAN  368 (1081)
T ss_pred             HHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhc
Confidence            99999999999 56777888999999999999999655555555544 889999999999888422 3467799999999


Q ss_pred             CCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCC
Q 046438          417 NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIP  496 (851)
Q Consensus       417 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  496 (851)
                      |.+++..-..+.+.++|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+..+..|++|...+|+|. ..|
T Consensus       369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP  446 (1081)
T KOG0618|consen  369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP  446 (1081)
T ss_pred             CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence            9999888778889999999999999998443457899999999999999999 89999999999999999999999 788


Q ss_pred             ccccccccccceeccCcccccc-CCCCCcccccCcccccCCcCc
Q 046438          497 SSLEKLLYLKYLNVSFNRLEGE-IPRGGTLANFTSESFMGNDLL  539 (851)
Q Consensus       497 ~~l~~l~~L~~l~l~~N~l~~~-~p~~~~~~~l~~~~~~~n~~~  539 (851)
                       ++..++.|+.+|+|.|+|+-. +|....++++...++.||.++
T Consensus       447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence             999999999999999999754 466556689999999999863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=307.60  Aligned_cols=202  Identities=34%  Similarity=0.516  Sum_probs=174.2

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--eeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD--FKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  702 (851)
                      .+|...+.||+|+||+||.+.+.+ |+.+|||.+........+.+.+|+.++++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            457778999999999999998854 8999999987664333677999999999999999999999754444  6899999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCccccCC--C
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSG--D  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a~~~~~--~  779 (851)
                      |+++|+|.+++...+..+++..+..+.+||++|++||   |++||+|+||||+||+++. ++.+||+|||++.....  .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            9999999999987655799999999999999999999   9999999999999999999 79999999999987653  2


Q ss_pred             CCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .........||+.|||||++..+ ...+++||||+||++.||+||+.||.+.
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence            22233457899999999999963 3345899999999999999999999873

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=315.23  Aligned_cols=197  Identities=30%  Similarity=0.434  Sum_probs=180.1

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ..|...++||+|+.|.||.|+. ..++.||+|.+........+-+.+|+.+|+..+|+|||.+++.|...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4578889999999999999976 468889999998877666778999999999999999999999998889999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +||+|.+.+..  ..+++.++..|++++++||+||   |.+||+|||||.+||+++.+|.+||+|||+|..+..... ..
T Consensus       353 ~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  353 EGGSLTDVVTK--TRMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             CCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            99999988754  3488999999999999999999   999999999999999999999999999999988765433 56


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      .+.+|||+|||||++....|++|+||||||++++||+.|++||-
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl  470 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL  470 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence            67899999999999999999999999999999999999999985

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.9e-36  Score=292.47  Aligned_cols=200  Identities=26%  Similarity=0.345  Sum_probs=173.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  700 (851)
                      ++|+.+..|++|+||.||+|+++ +++.||+|+++...+.  ..-...+|+.++.+++|||||.+-.+....  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45788899999999999999984 5888999999866432  223457899999999999999998877553  479999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      ||||+ .+|.+.+..-..++...++..++.|+++|++||   |...|+|||+|++|+++...|.+||+|||+|+.+..+.
T Consensus       156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99995 588888887777899999999999999999999   88999999999999999999999999999999987653


Q ss_pred             CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ..+..+.|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.
T Consensus       232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence            3 45567889999999998774 6899999999999999999999888663

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.7e-38  Score=329.85  Aligned_cols=364  Identities=25%  Similarity=0.425  Sum_probs=200.1

Q ss_pred             CCcEEeCCCCCCCC-CCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEE
Q 046438           64 SLQVIDLSDNRLSG-ELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALG  142 (851)
Q Consensus        64 ~L~~L~Ls~n~l~~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  142 (851)
                      -.+-+|+++|.++| ..|.+ ...++.+++|.|...++. .+|+.++.|.+|++|.+++|++. .+-+.++.++.|+.+.
T Consensus         8 FVrGvDfsgNDFsg~~FP~~-v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHD-VEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             eeecccccCCcCCCCcCchh-HHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            34455666666653 33332 344555555555555554 44555555555555555555554 3333444444444444


Q ss_pred             ccCcccc-CCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCC
Q 046438          143 LLSNNLV-GVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSF  221 (851)
Q Consensus       143 L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l  221 (851)
                      +..|++. +-+|..++.+                         ..|..||||+|+++ ..|..+...+++-+|+|++|+|
T Consensus        85 ~R~N~LKnsGiP~diF~l-------------------------~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I  138 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIFRL-------------------------KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI  138 (1255)
T ss_pred             hhccccccCCCCchhccc-------------------------ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence            4444442 1233344444                         44444444444444 4556666677777788888888


Q ss_pred             ccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccc
Q 046438          222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR  301 (851)
Q Consensus       222 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~  301 (851)
                      ..++...|.+++.|-.||||+|++..+|++      ...+..|++|+|++|++....                       
T Consensus       139 etIPn~lfinLtDLLfLDLS~NrLe~LPPQ------~RRL~~LqtL~Ls~NPL~hfQ-----------------------  189 (1255)
T KOG0444|consen  139 ETIPNSLFINLTDLLFLDLSNNRLEMLPPQ------IRRLSMLQTLKLSNNPLNHFQ-----------------------  189 (1255)
T ss_pred             ccCCchHHHhhHhHhhhccccchhhhcCHH------HHHHhhhhhhhcCCChhhHHH-----------------------
Confidence            777777777888888888888887766543      344555666666666552110                       


Q ss_pred             cCCCcccccccCCcEEEecCCCCC-CCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccc
Q 046438          302 GSIPKEMGNLINLIIIRLGYNKLN-GSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACF  380 (851)
Q Consensus       302 ~~~p~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  380 (851)
                         -..+.++++|.+|.+++.+-+ .-+|                        ..+..+.+|..+|+|.|.+. ..|+++
T Consensus       190 ---LrQLPsmtsL~vLhms~TqRTl~N~P------------------------tsld~l~NL~dvDlS~N~Lp-~vPecl  241 (1255)
T KOG0444|consen  190 ---LRQLPSMTSLSVLHMSNTQRTLDNIP------------------------TSLDDLHNLRDVDLSENNLP-IVPECL  241 (1255)
T ss_pred             ---HhcCccchhhhhhhcccccchhhcCC------------------------CchhhhhhhhhccccccCCC-cchHHH
Confidence               011223445555555553321 2334                        44444555555555555554 455555


Q ss_pred             cCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccc-cCCcccCCCCCccE
Q 046438          381 GNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG-DIPTTIGGLKNLQN  459 (851)
Q Consensus       381 ~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~  459 (851)
                      .++++|+.|+||+|+|+.+........+|+.|+||.|+++ .+|+++.+++.|+.|++.+|+++- -+|..+++|.+|+.
T Consensus       242 y~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Lev  320 (1255)
T KOG0444|consen  242 YKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEV  320 (1255)
T ss_pred             hhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHH
Confidence            5555555555555555555555555555555566666555 555555556666666666665542 24555566666666


Q ss_pred             EEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCcccc
Q 046438          460 LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE  516 (851)
Q Consensus       460 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  516 (851)
                      +..++|.+. ..|+.+..+..|+.|.|+.|++- .+|+.+.-++.|+.||+..|+=-
T Consensus       321 f~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  321 FHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             HHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            666665555 55555665666666666666555 45555555566666666655533

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=314.68  Aligned_cols=204  Identities=32%  Similarity=0.580  Sum_probs=177.2

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      +++....++..+.+.||+|.||+||+|+|-  ..||||+++...  +...+.|+.|+.++++-+|.||+-+.|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444445556678899999999999999883  369999997654  4467889999999999999999999999998877


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                       .||+.||+|.+|+.+++....+++..+...|++||++|+.||   |.++|+|||||..||++.++++|||+|||++...
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             999999999999999998888899999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCC-CCccccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          777 SGD-ESMKHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       777 ~~~-~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      ..- +........|...|||||+++.   .+|++.+||||||+|+|||++|..||.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            321 1222233457889999999864   579999999999999999999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=296.34  Aligned_cols=210  Identities=27%  Similarity=0.408  Sum_probs=182.1

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .+.|++.++||.|..++||+|+. ..++.||||++.... ....+.+.+|+..++.++||||++++..|..+..+|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            36799999999999999999987 458999999998654 3346889999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||.+|++.++++.. ...+++..+..|.+++++||.||   |++|.+|||||+.||+|+.+|.|||+|||.+..+-..+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999998763 44588889999999999999999   999999999999999999999999999998765533332


Q ss_pred             --ccc-cccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccch
Q 046438          782 --MKH-TQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL  837 (851)
Q Consensus       782 --~~~-~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  837 (851)
                        ... .+++||++|||||++..  ..|+.|+||||||+...|+.+|..||....+.+.-+
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl  242 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL  242 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence              112 45789999999999543  579999999999999999999999998866555433

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.5e-37  Score=324.31  Aligned_cols=384  Identities=28%  Similarity=0.407  Sum_probs=280.7

Q ss_pred             CCCCCCEEEcCCCcccc-ccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCcc
Q 046438           39 SINTLEILDLSNNQLSG-SFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLT  115 (851)
Q Consensus        39 ~l~~L~~L~Ls~n~l~~-~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~  115 (851)
                      -++-.+-.|+|+|.++| .+|  ...+++++.|-|...++. .+|.. ++.+.+|++|.+++|++. .+...++.|+.|+
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeE-L~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEE-LSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHH-HHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            34556778999999995 445  678999999999999998 88887 788999999999999998 5667889999999


Q ss_pred             EEecccccccc-ccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccccc
Q 046438          116 SIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN  194 (851)
Q Consensus       116 ~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  194 (851)
                      .+++..|++.. -+|..+-.+..|+.|||++|++. ..|..+..-+++-.|+||+|+|. .+|..+|..+..|-+||||+
T Consensus        82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~  159 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN  159 (1255)
T ss_pred             HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence            99999999973 37777888999999999999999 67889999999999999999998 89999998999999999999


Q ss_pred             ccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCc
Q 046438          195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL  274 (851)
Q Consensus       195 N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  274 (851)
                      |++. ..|..+..+..|++|+|++|.+...-                             +..+-.++.|++|.+++.+-
T Consensus       160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ-----------------------------LrQLPsmtsL~vLhms~TqR  209 (1255)
T KOG0444|consen  160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ-----------------------------LRQLPSMTSLSVLHMSNTQR  209 (1255)
T ss_pred             chhh-hcCHHHHHHhhhhhhhcCCChhhHHH-----------------------------HhcCccchhhhhhhcccccc
Confidence            9987 44545555555555555555444321                             22334455666666666543


Q ss_pred             cCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccc
Q 046438          275 LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD  354 (851)
Q Consensus       275 ~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  354 (851)
                      +.                         ..+|.++.++.+|..+|+|.|.+. ..|+.+.++++|+.|+||+|+|+.. .-
T Consensus       210 Tl-------------------------~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~  262 (1255)
T KOG0444|consen  210 TL-------------------------DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NM  262 (1255)
T ss_pred             hh-------------------------hcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-ec
Confidence            21                         246778888999999999999998 8899999999999999999988832 22


Q ss_pred             cccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCC-CCccccccchhh
Q 046438          355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSG-SLPLEIGNLKVL  433 (851)
Q Consensus       355 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L  433 (851)
                      .....                        .+|+.|+||.|+++.+|++++.++.|+.|.+.+|++.- -+|..++++.+|
T Consensus       263 ~~~~W------------------------~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L  318 (1255)
T KOG0444|consen  263 TEGEW------------------------ENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL  318 (1255)
T ss_pred             cHHHH------------------------hhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence            22233                        34555555555555555555555555555555555542 356666677777


Q ss_pred             hhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceec
Q 046438          434 VELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNV  510 (851)
Q Consensus       434 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l  510 (851)
                      +.+..++|++. ..|+.++.+.+|+.|.|++|++. ++|+++.-|+.|+.|||..|.=---+|.--..-++|+.-++
T Consensus       319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI  393 (1255)
T KOG0444|consen  319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI  393 (1255)
T ss_pred             HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence            77777777766 66777777777777777777776 67777777777777777777433234433333344544443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-35  Score=313.00  Aligned_cols=198  Identities=27%  Similarity=0.407  Sum_probs=177.0

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..|+..+.+|.|+.|.|-.|++ .+|+.+|||++.+..   +.....+++|+-+|+.+.|||++.+|++|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            5689999999999999999998 469999999997652   334577999999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++||.|.+++..+ +++++.++.++++||+.|+.|+   |..+|+|||+||+|+++|..+.+||+|||+|..-.+ +.
T Consensus        92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-GK  166 (786)
T ss_pred             EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecccC-Cc
Confidence            999999999998654 5678888999999999999999   888999999999999999999999999999986432 22


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       -..+.+|+|.|+|||++.+.+| +.++||||+|||+|-|++|+.||++
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence             3445799999999999999988 5679999999999999999999985

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=297.58  Aligned_cols=201  Identities=29%  Similarity=0.474  Sum_probs=168.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--------------hhhHHHHHHHHHHHhhcCCCccccee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--------------EGALESFNAECEVLRSIRHRNLVRII  688 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~~~  688 (851)
                      ..++|++.+.||+|.||+|-+|++. +++.||+|++.+..              ....++..+|+.++++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999984 68999999996532              11246789999999999999999999


Q ss_pred             eeeecC--CeeEEEEeccCCCChhHHhhcCCCC-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          689 SSCTND--DFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       689 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      ++..+.  +.+|||+|||+.|.+.+.-  ..+. ++..+++.+++++..||+||   |.+||+||||||+|+|++++|+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCCcE
Confidence            998775  4899999999999886543  2334 88999999999999999999   99999999999999999999999


Q ss_pred             EEeeccCccccCCC----CCccccccccCccccCccccccC---C-CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          766 RLGDFGIAKLLSGD----ESMKHTQTLATIGYMAPEYGREG---Q-ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       766 kl~Dfg~a~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~---~-~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||+|||.+......    ........+|||.|+|||.+.++   . .+.+.||||+||.+|+|+.|+.||-+
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999998765211    11122236899999999988763   2 34567999999999999999999965

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=305.27  Aligned_cols=194  Identities=27%  Similarity=0.497  Sum_probs=172.0

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD  695 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  695 (851)
                      ++++++.+       ++-+|+|+.|.||.|+. .++.||||+++.       --+.+++-+++++||||+++.|+|...-
T Consensus       121 iPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  121 IPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             CCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence            45555544       35699999999999998 778999998752       2345788899999999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      .++||||||..|.|+..++. +..+.......+..+||.|+.||   |.++|+|||||.-||+|..+..|||+|||-++.
T Consensus       186 cyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e  261 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFGTSKE  261 (904)
T ss_pred             eeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEeccccchHh
Confidence            99999999999999999965 45677788889999999999999   888999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  .....++||..|||||++...+.++|+||||||||+|||+||..||.+.
T Consensus       262 ~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV  314 (904)
T KOG4721|consen  262 LSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV  314 (904)
T ss_pred             hhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence            7543  3566789999999999999999999999999999999999999999764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.5e-35  Score=321.83  Aligned_cols=204  Identities=32%  Similarity=0.557  Sum_probs=177.1

Q ss_pred             cCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      .+.+..+.||+|+||+||+|+...      ...||||.++...+. ...+|++|++.+..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            345667899999999999997632      345999999887766 6788999999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcC---------CCC----cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          699 LVLDYMPKGSLEACLYSD---------NSN----LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~---------~~~----~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      ||+|||..|+|.+|+...         +..    ++..+.+.||.|||.|++||   -++.+|||||.++|.+|.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceEE
Confidence            999999999999998642         222    77788999999999999999   78889999999999999999999


Q ss_pred             EEeeccCccccCCCCCcccc-ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          766 RLGDFGIAKLLSGDESMKHT-QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      ||+|||+++.+-..+.++.. ...-+.+||+||.+..+.++.+||||||||++||+++ |+.||.+..+
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            99999999865433333333 4456889999999999999999999999999999999 9999977544

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-34  Score=288.42  Aligned_cols=200  Identities=28%  Similarity=0.416  Sum_probs=173.0

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCc-ccceeeeeecCC------
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRN-LVRIISSCTNDD------  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  695 (851)
                      ..|+.+++||+|+||+||+|+. .+|+.||+|+++...+  +......+|+.+++.++|+| ||.+++++.+..      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3466678899999999999987 4688999999987654  34556789999999999999 999999998776      


Q ss_pred             eeEEEEeccCCCChhHHhhcCC---CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          696 FKALVLDYMPKGSLEACLYSDN---SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      ..++||||+ ..+|..++....   ...+...+..+++||+.|++||   |+++|+||||||.||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccch
Confidence            789999999 568888887654   3577788999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+...-+.. ..+..++|.+|.|||++.+. .|+...|+||+|||++||++++.-|.+.
T Consensus       167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~  224 (323)
T KOG0594|consen  167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD  224 (323)
T ss_pred             HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence            997653322 35567899999999998876 7899999999999999999999888764

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-35  Score=273.00  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=180.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.+|+|.||.||.|+.+ ++..||+|++.+..   .+....+++|++|-+.++||||.++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467999999999999999999874 57789999987553   22345689999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          701 LDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      +||.+.|++...+... ...+++.....++.|+|.|+.|+   |.++|+||||||+|++++.++.+||+|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            9999999999988753 45688888999999999999999   99999999999999999999999999999986542  


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||....
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence             345667899999999999999999999999999999999999999998755

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.6e-34  Score=311.78  Aligned_cols=201  Identities=24%  Similarity=0.350  Sum_probs=174.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   ......+.+|++++.+++||+|+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46899999999999999999875 58899999997543   223456888999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+|+.......
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999988653 5688999999999999999999   889999999999999999999999999999875432100


Q ss_pred             ----------------------------------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          782 ----------------------------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       782 ----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                                                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0012357999999999999999999999999999999999999999


Q ss_pred             Ccc
Q 046438          828 DEI  830 (851)
Q Consensus       828 ~~~  830 (851)
                      ...
T Consensus       237 ~~~  239 (363)
T cd05628         237 CSE  239 (363)
T ss_pred             CCC
Confidence            754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-34  Score=285.03  Aligned_cols=204  Identities=26%  Similarity=0.382  Sum_probs=176.7

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +.|++++.||.|.-|+||.|+..+ +..+|+|++.+..   .....+++.|.+||+.+.||.++.+|..++.++..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346778999999999999999854 5889999998664   334567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC--
Q 046438          702 DYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG--  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~--  778 (851)
                      |||+||+|....+. ..+.+++..++.++.+++-||+||   |-.|||.|||||+|||+.++|++.++||.++.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999988765 466789999999999999999999   999999999999999999999999999998642110  


Q ss_pred             -----------------------------------------------------CCCccccccccCccccCccccccCCCC
Q 046438          779 -----------------------------------------------------DESMKHTQTLATIGYMAPEYGREGQIS  805 (851)
Q Consensus       779 -----------------------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~  805 (851)
                                                                           +.......++||-.|+|||++.+..++
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                                                 000112246899999999999999999


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          806 TEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       806 ~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      .++|.|+|||++|||+.|+.||.+...
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~  340 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNN  340 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence            999999999999999999999977443

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-35  Score=290.59  Aligned_cols=193  Identities=31%  Similarity=0.483  Sum_probs=162.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC-----eeEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD-----FKALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  700 (851)
                      .|+..+.+|+|+||.||+|... +++.||||++-...    +.-.+|+++|+++.|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666799999999999999884 47899999875442    23457999999999999999998875432     44589


Q ss_pred             EeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccCcccc
Q 046438          701 LDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLL  776 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~a~~~  776 (851)
                      ||||+ .+|...++.   .....+...+.-+.+||++|++||   |+.||+||||||.|+++|.+ |.+||||||.|+..
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99995 578777764   356677788889999999999999   88999999999999999976 99999999999987


Q ss_pred             CCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....  ..++.+|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+
T Consensus       177 ~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG  228 (364)
T KOG0658|consen  177 VKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG  228 (364)
T ss_pred             ccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence            65443  3567899999999998875 699999999999999999999998876

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-35  Score=312.22  Aligned_cols=217  Identities=26%  Similarity=0.491  Sum_probs=186.6

Q ss_pred             hccccHHHHHHHhcC---------CCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhh
Q 046438          613 WRRFSYQELLQATDQ---------FNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRS  678 (851)
Q Consensus       613 ~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~  678 (851)
                      ...++|++--++..+         .+|.++||.|.||.||+|+.+-    ...||+|.++... +.+..+|..|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            344556554444333         3678999999999999998742    3459999998664 4566789999999999


Q ss_pred             cCCCcccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEE
Q 046438          679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVL  758 (851)
Q Consensus       679 l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nil  758 (851)
                      +.||||+++.|+........||+|||++|+|+.|++...+++++.+...|.++|+.|+.||   ..+++|||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhhee
Confidence            9999999999999999999999999999999999999989999999999999999999999   8999999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCcccccc--ccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          759 LDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       759 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      ++.+..+|++|||+++...++.....++.  --+.+|.|||.+....++.++||||+|++|||.++ |+.||.+-..
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence            99999999999999998866553333332  23679999999999999999999999999999988 9999876443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=284.10  Aligned_cols=202  Identities=28%  Similarity=0.367  Sum_probs=172.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec-----C
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN-----D  694 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~  694 (851)
                      .....|...+.||+|+||.|+.|.+ .+|+.||+|++....  ....++..+|+++++.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3445677789999999999999988 468999999987433  3456788999999999999999999998765     2


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ...|+|+|+| +.+|...++. ...++..++..++.||++|+.|+   |+.+|+|||+||+|++++.++.+||||||+|+
T Consensus        99 ~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEecccccee
Confidence            4789999999 6788888754 34488999999999999999999   99999999999999999999999999999999


Q ss_pred             ccCCC-CCccccccccCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          775 LLSGD-ESMKHTQTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       775 ~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..... .....+.++.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG  230 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG  230 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence            87532 122345678999999999875 46799999999999999999999988865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=276.94  Aligned_cols=200  Identities=27%  Similarity=0.448  Sum_probs=174.8

Q ss_pred             HhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..++|++.+.||+|.|+.||++.+ .+|+.+|+|++....  ....+++.+|++|.+.++|||||++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            356788999999999999999866 468999999886442  23567899999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---CCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---~~~~~kl~Dfg~a~~~~  777 (851)
                      +|+|+|++|-.-+..+ ..+++..+...++||++|+.|+   |.+||||||+||+|+++.   ....+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999996555333 4567778889999999999999   999999999999999994   34579999999999887


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                        +......+.|||+|+|||++...+|+..+|||+.|||+|-++.|+.||.+
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence              33345668999999999999999999999999999999999999999976

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=299.30  Aligned_cols=197  Identities=27%  Similarity=0.399  Sum_probs=174.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46899999999999999999885 58899999987542   123456889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            999999999988654 4678888899999999999999   8899999999999999999999999999999865332  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .....|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  201 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD  201 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              22356899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.2e-34  Score=309.52  Aligned_cols=202  Identities=23%  Similarity=0.378  Sum_probs=174.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999985 57889999986432   2234567889999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|.+++...  .+++..+..++.||+.|++||   |++||+||||||+||++++++.+||+|||+|......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999988543  478888899999999999999   8899999999999999999999999999999876443


Q ss_pred             CCccccccccCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREG----QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .........||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            33333456799999999998654    3788999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-33  Score=310.28  Aligned_cols=201  Identities=24%  Similarity=0.329  Sum_probs=172.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .|++++.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999874 58899999997542   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  781 (851)
                      |+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            99999999988653 4578888888999999999999   889999999999999999999999999999753311000 


Q ss_pred             ---------------------------------------------ccccccccCccccCccccccCCCCcchhhHHHHHH
Q 046438          782 ---------------------------------------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIM  816 (851)
Q Consensus       782 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~i  816 (851)
                                                                   .......||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123479999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCccC
Q 046438          817 LMEIFTRKRPTDEIF  831 (851)
Q Consensus       817 l~el~~g~~pf~~~~  831 (851)
                      +|||++|+.||....
T Consensus       238 l~elltG~~Pf~~~~  252 (381)
T cd05626         238 LFEMLVGQPPFLAPT  252 (381)
T ss_pred             HHHHHhCCCCCcCCC
Confidence            999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=302.36  Aligned_cols=201  Identities=28%  Similarity=0.403  Sum_probs=174.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999885 58899999997532   223456888999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999876566788999999999999999999   899999999999999999999999999999876543333


Q ss_pred             ccccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .......||+.|+|||++..     ..++.++||||+||++|||++|+.||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            22233468999999999863     4578899999999999999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=308.91  Aligned_cols=201  Identities=25%  Similarity=0.384  Sum_probs=174.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46899999999999999999885 58899999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.++|+|||++........
T Consensus        81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999988654 4688999999999999999999   889999999999999999999999999999875422110


Q ss_pred             c-------------------------------------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCC
Q 046438          782 M-------------------------------------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK  824 (851)
Q Consensus       782 ~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  824 (851)
                      .                                     .....+||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     011246899999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 046438          825 RPTDEI  830 (851)
Q Consensus       825 ~pf~~~  830 (851)
                      .||...
T Consensus       237 ~Pf~~~  242 (364)
T cd05599         237 PPFCSD  242 (364)
T ss_pred             CCCCCC
Confidence            999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.2e-33  Score=293.90  Aligned_cols=198  Identities=25%  Similarity=0.383  Sum_probs=172.8

Q ss_pred             CCccceeccccceEEEEEEE-cCCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |++.+.||+|+||+||+|++ .+|+.||+|++.....   .....+.+|++++++++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            77889999999999999987 4689999999875431   2234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++|+|.+.+... ...+++..+..++.|++.|++||   |++||+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            9999998877543 34688899999999999999999   88999999999999999999999999999998653322  


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  204 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR  204 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence            223457899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-33  Score=303.33  Aligned_cols=197  Identities=27%  Similarity=0.389  Sum_probs=173.6

Q ss_pred             cCCCccceeccccceEEEEEEEcC--CcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||.||+|++..  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            569999999999999999998643  3689999986542   22345688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++...... 
T Consensus       110 ~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999988654 4688888999999999999999   8899999999999999999999999999999865322 


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  231 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN  231 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence               23457899999999999888999999999999999999999999753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-33  Score=302.80  Aligned_cols=197  Identities=24%  Similarity=0.369  Sum_probs=174.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56899999999999999999885 58899999997542   223456889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++......  
T Consensus        98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            999999999988653 4578888889999999999999   8899999999999999999999999999999865332  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .....|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  218 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD  218 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence              22357899999999999999999999999999999999999999653

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-33  Score=306.88  Aligned_cols=207  Identities=23%  Similarity=0.370  Sum_probs=177.0

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecC
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      .+.....++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|.++++.++||||+++++.+.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344445578999999999999999999885 57889999986432   22345578899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ...++||||+++|+|.+++..  ..++...+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            999999999999999998854  3477888888999999999999   88999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREG----QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..............||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            7654333333456799999999998653    3788999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=309.18  Aligned_cols=201  Identities=25%  Similarity=0.347  Sum_probs=172.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46899999999999999999874 68899999986542   223466888999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999988643 5678888889999999999999   899999999999999999999999999999864321000


Q ss_pred             ------------c----------------------------------cccccccCccccCccccccCCCCcchhhHHHHH
Q 046438          782 ------------M----------------------------------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGI  815 (851)
Q Consensus       782 ------------~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~  815 (851)
                                  .                                  .....+||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                        0                                  001246899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCcc
Q 046438          816 MLMEIFTRKRPTDEI  830 (851)
Q Consensus       816 il~el~~g~~pf~~~  830 (851)
                      ++|||++|+.||...
T Consensus       237 il~elltG~~Pf~~~  251 (377)
T cd05629         237 IMFECLIGWPPFCSE  251 (377)
T ss_pred             hhhhhhcCCCCCCCC
Confidence            999999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=303.76  Aligned_cols=197  Identities=25%  Similarity=0.390  Sum_probs=175.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++...   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999985 58899999997543   223456888999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999988543 4678888999999999999999   889999999999999999999999999999976533   


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence             233457899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-33  Score=309.55  Aligned_cols=201  Identities=24%  Similarity=0.327  Sum_probs=172.5

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .|++++.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999874 58889999987543   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC--
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE--  780 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~--  780 (851)
                      |+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+......  
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999988654 4578888889999999999999   88999999999999999999999999999975321000  


Q ss_pred             --------------------------------------------CccccccccCccccCccccccCCCCcchhhHHHHHH
Q 046438          781 --------------------------------------------SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIM  816 (851)
Q Consensus       781 --------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~i  816 (851)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccC
Q 046438          817 LMEIFTRKRPTDEIF  831 (851)
Q Consensus       817 l~el~~g~~pf~~~~  831 (851)
                      +|||++|+.||....
T Consensus       238 l~elltG~~Pf~~~~  252 (382)
T cd05625         238 LYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHhCCCCCCCCC
Confidence            999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-33  Score=300.29  Aligned_cols=193  Identities=26%  Similarity=0.351  Sum_probs=168.9

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||.||+|++. +|+.||+|+++...   ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999874 68899999997643   233456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT  787 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  787 (851)
                      +|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  155 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence            99888754 35678899999999999999999   88999999999999999999999999999987542222 123345


Q ss_pred             ccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       788 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence            799999999999999999999999999999999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=291.04  Aligned_cols=202  Identities=30%  Similarity=0.433  Sum_probs=180.0

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ..|...+.||+|+||.||+|.+ ..++.||+|++.... +.+.+++++|+.++.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577779999999999999987 468889999998764 44568899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      |.||++.+.+... ..+++.....+.+++..|+.||   |.++.+|||||+.||++.++|.+|++|||.+..+...... 
T Consensus        93 ~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-  167 (467)
T ss_pred             hcCcchhhhhccC-CCCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence            9999999988543 3347777888999999999999   8999999999999999999999999999999877655443 


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ..+++|||.|||||++....|+.|+|+||||++.+||.+|.+|+....+
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence            3678999999999999999999999999999999999999999987544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=283.35  Aligned_cols=197  Identities=30%  Similarity=0.459  Sum_probs=165.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc--CCCcccceeeeeecCC----eeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSCTNDD----FKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~----~~~  698 (851)
                      .+..+..+.||+|.||.||||+. +++.||||++..   .+.+.+.+|.+|.+..  +|+||++++++-....    .++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45677889999999999999998 669999999974   4567888998888765  7999999998865544    889


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh------cCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF------GHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~------~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      +|+||.+.|+|.+++..  ..++|....+|+..+++|++|||+      .|+.+|+|||||++|||+.+|+++.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999999964  458999999999999999999995      5778999999999999999999999999999


Q ss_pred             ccccCCCCC-ccccccccCccccCccccccCC-CC-----cchhhHHHHHHHHHHHhCCCCC
Q 046438          773 AKLLSGDES-MKHTQTLATIGYMAPEYGREGQ-IS-----TEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       773 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~-----~~~DvwslG~il~el~~g~~pf  827 (851)
                      |..+..... ......+||.+|||||++.+.. +.     .+.||||+|.|+|||+++-.-+
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            988764322 1223368999999999998753 22     2479999999999999866443

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-33  Score=301.82  Aligned_cols=202  Identities=26%  Similarity=0.381  Sum_probs=175.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999885 57889999987532   223455788999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999976556788889999999999999999   889999999999999999999999999999987654433


Q ss_pred             ccccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......|++.|+|||++.+     ..++.++||||+||++|||++|+.||...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            33334578999999998865     46788999999999999999999999653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-33  Score=309.14  Aligned_cols=201  Identities=24%  Similarity=0.319  Sum_probs=172.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      +|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999874 58899999986532   2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC---
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD---  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~---  779 (851)
                      |+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|......   
T Consensus        82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999999998653 4578888888999999999999   8899999999999999999999999999997532100   


Q ss_pred             ---------------------------------------CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHH
Q 046438          780 ---------------------------------------ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEI  820 (851)
Q Consensus       780 ---------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el  820 (851)
                                                             .........||+.|+|||++.+..++.++||||+||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00001134689999999999999999999999999999999


Q ss_pred             HhCCCCCCccC
Q 046438          821 FTRKRPTDEIF  831 (851)
Q Consensus       821 ~~g~~pf~~~~  831 (851)
                      ++|+.||....
T Consensus       238 l~G~~Pf~~~~  248 (376)
T cd05598         238 LVGQPPFLADT  248 (376)
T ss_pred             hhCCCCCCCCC
Confidence            99999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-34  Score=296.77  Aligned_cols=200  Identities=30%  Similarity=0.447  Sum_probs=181.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe-eEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF-KALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  701 (851)
                      ++|..++.+|+|+||.++.++++ ++..||+|.+....  +...+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999874 57789999987654  3344578999999999999999999999999988 99999


Q ss_pred             eccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      +|++||++.+.+.... ..+++..+..++.||+.|+.||   |+..|+|||||+.||+++.++.|||+|||+|+....+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999987654 7789999999999999999999   88999999999999999999999999999999887654


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      . ...+.+||+.|++||.+.+.+|..|+|+||+||++|||.+-+.+|..
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a  208 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA  208 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence            3 34567899999999999999999999999999999999999999976

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-32  Score=296.61  Aligned_cols=194  Identities=27%  Similarity=0.362  Sum_probs=168.6

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999874 68999999997643   233456778999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT  787 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  787 (851)
                      +|..++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++....... ......
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  155 (323)
T cd05595          81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence            998877543 4688899999999999999999   88999999999999999999999999999987542221 122345


Q ss_pred             ccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       788 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            7899999999999999999999999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.5e-33  Score=292.34  Aligned_cols=200  Identities=24%  Similarity=0.389  Sum_probs=172.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56999999999999999999875 588999999875432 2335678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++ +|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~  159 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T  159 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence            975 88888866666678889999999999999999   889999999999999999999999999999876432221 2


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            234567999999998865 56899999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-33  Score=303.70  Aligned_cols=201  Identities=24%  Similarity=0.386  Sum_probs=173.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457999999999999999999885 58899999987532   22334577899999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++..  ..++...+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus       122 ~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         122 MEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999998854  3477788888999999999999   88999999999999999999999999999998764433


Q ss_pred             CccccccccCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREG----QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  250 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence            3333456799999999988653    4788999999999999999999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1e-32  Score=294.55  Aligned_cols=202  Identities=24%  Similarity=0.387  Sum_probs=172.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999885 688999999875432 223467789999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++ +++.+++......++...+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++....... .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence            995 677777766666788889999999999999999   88999999999999999999999999999987543222 1


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            2234568999999998865 458889999999999999999999997643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-33  Score=302.58  Aligned_cols=202  Identities=28%  Similarity=0.407  Sum_probs=176.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999884 688999999986432   23456889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999877666789999999999999999999   889999999999999999999999999999987654433


Q ss_pred             ccccccccCccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGR------EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......+|+.|+|||++.      ...++.++||||+||++|||++|+.||...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            3333457899999999986      456789999999999999999999999753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.6e-33  Score=298.66  Aligned_cols=202  Identities=25%  Similarity=0.373  Sum_probs=174.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||++++. .++.||+|++....   ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999885 47789999986432   223345788999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999976566788889999999999999999   889999999999999999999999999999876543333


Q ss_pred             ccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            2333457899999999885     346889999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-33  Score=304.30  Aligned_cols=202  Identities=24%  Similarity=0.353  Sum_probs=174.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|++++..++||+|+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999885 58899999997542   223466888999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999988543 4678889999999999999999   889999999999999999999999999999875421100


Q ss_pred             ----------------------------------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          782 ----------------------------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       782 ----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                                                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                              0012347899999999999999999999999999999999999999


Q ss_pred             CccC
Q 046438          828 DEIF  831 (851)
Q Consensus       828 ~~~~  831 (851)
                      ....
T Consensus       237 ~~~~  240 (360)
T cd05627         237 CSET  240 (360)
T ss_pred             CCCC
Confidence            7643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-32  Score=295.64  Aligned_cols=194  Identities=26%  Similarity=0.363  Sum_probs=168.9

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||.||+|++. +++.||+|+++...   ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999874 58999999997542   234466788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT  787 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  787 (851)
                      +|...+.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  155 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF  155 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence            99887754 34688899999999999999999   88999999999999999999999999999987543221 122345


Q ss_pred             ccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       788 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence            7899999999999999999999999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=316.89  Aligned_cols=205  Identities=28%  Similarity=0.412  Sum_probs=182.9

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeec---chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          621 LLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       621 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      +.--.++|+++++||+|+||.|..++++ +++.||+|++.+-   .....+-|+.|-++|..-..+.|++++..|+++.+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3334578999999999999999999985 4788999998752   13344678999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      +|+|||||+||+|-.++.... .+++.-++.++..|.-|+.-+   |+.|+|||||||+||++|..|++|++|||.|-.+
T Consensus       150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence            999999999999999886655 788888888899999999999   9999999999999999999999999999999988


Q ss_pred             CCCCCccccccccCccccCccccc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGR----E-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..++.......+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||-.
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            888888888899999999999874    3 5789999999999999999999999853

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=294.71  Aligned_cols=191  Identities=29%  Similarity=0.342  Sum_probs=167.5

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||+|+||+||+|++. +++.||+|+++...   ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999885 57889999987542   23446678899999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA  789 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  789 (851)
                      .+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++...... .......|
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g  155 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG  155 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence            9988653 4688899999999999999999   88999999999999999999999999999987543222 12334578


Q ss_pred             CccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       790 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence            9999999999999999999999999999999999999965

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=294.08  Aligned_cols=201  Identities=28%  Similarity=0.394  Sum_probs=180.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchh---hHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEG---ALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  698 (851)
                      ..+.|++.+.||+|.||.||+++... |+.+|+|++.+....   ..+.+.+|+++|++++ |||||++++++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34679999999999999999998865 999999999766532   3468999999999998 999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC----CCcEEEeeccCcc
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE----DMVARLGDFGIAK  774 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~----~~~~kl~Dfg~a~  774 (851)
                      +|||++.||.|.+.+...  .+++..+..++.||++|++||   |+.||+|||+||+|+++..    ++.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999998766  389999999999999999999   8899999999999999953    3589999999999


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....  .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+..
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            8765  335566799999999999999999999999999999999999999998744

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-32  Score=299.09  Aligned_cols=204  Identities=25%  Similarity=0.473  Sum_probs=169.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC-
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD-  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  695 (851)
                      .++|++.+.||+|+||.||+|++.      .++.||+|+++... ....+.+.+|+++++++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999751      35679999987543 23346788999999999 8999999999887654 


Q ss_pred             eeEEEEeccCCCChhHHhhcCC----------------------------------------------------------
Q 046438          696 FKALVLDYMPKGSLEACLYSDN----------------------------------------------------------  717 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  717 (851)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6889999999999998886421                                                          


Q ss_pred             ---CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCccc
Q 046438          718 ---SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGY  793 (851)
Q Consensus       718 ---~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y  793 (851)
                         ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++....... .......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               2366778888999999999999   889999999999999999999999999999986533222 122233456889


Q ss_pred             cCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          794 MAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       794 ~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +|||++.+..++.++|||||||++|||++ |..||....
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=299.48  Aligned_cols=202  Identities=32%  Similarity=0.490  Sum_probs=174.4

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC------eeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDD------FKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~  698 (851)
                      .|...+.+|+|+||.||+|++ ..|+.||||.++... ....++..+|++++++++|||||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            456678999999999999997 469999999997643 234577889999999999999999999866543      568


Q ss_pred             EEEeccCCCChhHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC--CCC--cEEEeeccC
Q 046438          699 LVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD--EDM--VARLGDFGI  772 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~--~~~--~~kl~Dfg~  772 (851)
                      +|||||.||+|+..+.+  ....+++.+.+.+...+..|+.||   |..||+||||||.||++-  ++|  ..||+|||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999975  356689999999999999999999   889999999999999983  334  579999999


Q ss_pred             ccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccCcC
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG  833 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  833 (851)
                      |+...++.  ...+.+||+.|.+||+... +.|+..+|.|||||++||.+||..||......
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99986544  5677899999999999984 88999999999999999999999999765443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-32  Score=290.82  Aligned_cols=201  Identities=28%  Similarity=0.366  Sum_probs=174.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...  +...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36899999999999999999985 57889999987543  2234668899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++.+..+. .....+++..+..++.|++.|++||   |+.||+||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99988776544 3345688889999999999999999   8899999999999999999999999999999876433332


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            333457899999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=303.24  Aligned_cols=202  Identities=29%  Similarity=0.440  Sum_probs=177.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999885 68999999997543   234467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-  780 (851)
                      ||+++++|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999988655 5688899999999999999999   88999999999999999999999999999997654332 


Q ss_pred             ---------------------------CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 ---------------------------SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                                                 ........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                       112234578999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-32  Score=296.54  Aligned_cols=199  Identities=30%  Similarity=0.411  Sum_probs=171.4

Q ss_pred             CCCccceeccccceEEEEEEEc----CCcEEEEEEEeecc----hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCee
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL----EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  697 (851)
                      +|++.+.||+|+||+||+|+..    +++.||+|+++...    ....+.+.+|+++++.+ +||+|+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999763    57889999987532    22345678899999999 489999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            9999999999999988653 4578899999999999999999   88999999999999999999999999999998654


Q ss_pred             CCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...........||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            3333333346799999999998765 478899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=297.95  Aligned_cols=202  Identities=30%  Similarity=0.508  Sum_probs=174.6

Q ss_pred             cCCCccceeccccceEEEEEEEcC--C---cEEEEEEEeec---chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD--G---MEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      ++..+.+.||+|+||.||+|+...  +   ..||+|..+..   ......++.+|++++++++|||||++||+......+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            444556899999999999998743  2   23899998853   255678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++|||+|.||+|.+++......++..+...++.+.|.||+||   |+++++||||.++|+|++.++.+||+|||+++.-.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            999999999999999988777899999999999999999999   99999999999999999999999999999987543


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      . .......-.-+..|+|||.+....|++++|||||||++||+++ |..||.+..
T Consensus       314 ~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~  367 (474)
T KOG0194|consen  314 Q-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK  367 (474)
T ss_pred             c-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence            1 1111111235789999999999999999999999999999999 899997743

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.9e-32  Score=293.69  Aligned_cols=199  Identities=25%  Similarity=0.320  Sum_probs=170.6

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCC-CcccceeeeeecCCeeEEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRH-RNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  701 (851)
                      +|++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4889999999999999999875 47889999997542   2344667889999999976 46888999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            999999999887543 4578889999999999999999   88999999999999999999999999999987532211 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  204 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            1233457899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.8e-32  Score=293.81  Aligned_cols=197  Identities=25%  Similarity=0.402  Sum_probs=168.8

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHH---hhcCCCcccceeeeeecCCeeEEE
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVL---RSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      |++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|.+++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999874 58899999997542   22345566676655   456799999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|...+..  ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999887743  4688999999999999999999   88999999999999999999999999999987543222


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            1 233467899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=271.88  Aligned_cols=199  Identities=26%  Similarity=0.349  Sum_probs=176.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|..++++|+|.||+|-.++-+ .++.||+|++++..   ..+.+....|-++++..+||.+..+-..|+..+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56888999999999999999764 68999999998764   345566778999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+.||.|...+.. .+.+++...+.+-.+|..|+.||   |+++||.||+|.+|.++|.||++||.|||+|+.-...+.
T Consensus       248 eyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  248 EYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            99999999877744 44577777788999999999999   889999999999999999999999999999986544333


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       ...+++|||.|.|||++.+..|+.++|.|.+||++|||++|+.||-.
T Consensus       324 -t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  324 -TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             -eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence             45578999999999999999999999999999999999999999965

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-32  Score=293.54  Aligned_cols=194  Identities=27%  Similarity=0.393  Sum_probs=167.2

Q ss_pred             ceeccccceEEEEEEEc----CCcEEEEEEEeecc----hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          632 NLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL----EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +.||+|+||.||+|+..    .++.||+|+++...    ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999763    47889999987532    12335678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+.+... ..+.+..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (323)
T cd05584          82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V  156 (323)
T ss_pred             CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence            9999999888553 4567788888999999999999   889999999999999999999999999999875432222 2


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~  203 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE  203 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence            23356899999999999888999999999999999999999999763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.4e-32  Score=292.94  Aligned_cols=199  Identities=25%  Similarity=0.335  Sum_probs=170.5

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+..|.+++... +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999885 47889999987543   22334566778888777 5799999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+.+... ..+++..+..++.||+.|++||   |++||+||||||+||++++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            999999999887543 4578889999999999999999   88999999999999999999999999999987543222 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~  204 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  204 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence            1233457899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.98  E-value=4.4e-32  Score=292.58  Aligned_cols=193  Identities=24%  Similarity=0.354  Sum_probs=167.9

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999884 58899999998643   22345678899999888 699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++.. ...+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence            999887754 35689999999999999999999   899999999999999999999999999999875322221 2334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..||+.|+|||++.+..++.++|+||+||++|||++|+.||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            6789999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.98  E-value=4.3e-32  Score=290.86  Aligned_cols=194  Identities=26%  Similarity=0.396  Sum_probs=165.3

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +++.||+|+++...   ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999884 57889999997643   22334556677777654 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            9999887543 4688889999999999999999   88999999999999999999999999999997543222 22334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            57899999999999989999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=1.5e-32  Score=294.13  Aligned_cols=194  Identities=27%  Similarity=0.374  Sum_probs=171.0

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-C-----CcccceeeeeecCCeeEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-H-----RNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  699 (851)
                      +|++.+.||+|+||.|.+|.+ .+++.||||+++.... ..+....|+.+++.++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            799999999999999999987 4599999999987643 3466778999999996 4     389999999999999999


Q ss_pred             EEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC--CcEEEeeccCcccc
Q 046438          700 VLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED--MVARLGDFGIAKLL  776 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~--~~~kl~Dfg~a~~~  776 (851)
                      |+|.+ ..+|+++++.. ...++...++.|+.||+.||.+|   |+.||||+||||+|||+.+-  ..|||+|||.|+..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 67999999864 55688999999999999999999   89999999999999999643  47999999999875


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..    ...+++.+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus       342 ~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            32    23377899999999999999999999999999999999999877754

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.98  E-value=3e-34  Score=274.98  Aligned_cols=201  Identities=27%  Similarity=0.422  Sum_probs=181.7

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      |.+++++|+|+||.||+|.++ +|+.+|+|.+..  +.+.+++.+|+.++++++.|++|++||.+-....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            567789999999999999874 699999998754  45668899999999999999999999999888899999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+..+.++.+.+.+.++++..+.+..+.|++||   |...-+|||||+.||+++.+|.+|++|||.|....+ ......+
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRNT  188 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRNT  188 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhCc
Confidence            999999999999999999999999999999999   666779999999999999999999999999976643 2234556


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE  834 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  834 (851)
                      ..|||.|||||++..-.|..++|+||+|+...||..|++||.++.+..
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR  236 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR  236 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence            789999999999999999999999999999999999999999876543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.98  E-value=2.9e-32  Score=293.76  Aligned_cols=194  Identities=26%  Similarity=0.348  Sum_probs=167.7

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||+||+|++. +++.||+|+++...   ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999874 68899999997643   223456778999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      +|..++.. ...+++..+..++.||+.|++||   |+ +||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT  155 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence            99887754 34688999999999999999999   75 7999999999999999999999999999875432221 2234


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            56899999999999999999999999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=5.6e-32  Score=291.53  Aligned_cols=193  Identities=26%  Similarity=0.365  Sum_probs=166.7

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +++.||+|+++...   ......+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999885 57889999997642   22345677888888776 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence            999887754 35688899999999999999999   889999999999999999999999999999875432221 2334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            5789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.98  E-value=1.1e-31  Score=289.79  Aligned_cols=198  Identities=25%  Similarity=0.385  Sum_probs=174.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||.||+|++. ++..||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999885 588899999876532 334678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+++++|.+++... ..+++..+..++.|++.|++||   |+ .+|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYL---REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            99999999988653 4578888999999999999999   55 46999999999999999999999999998765322  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       ......+++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence             22345689999999999999999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.98  E-value=5.5e-32  Score=290.61  Aligned_cols=194  Identities=25%  Similarity=0.369  Sum_probs=167.2

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +++.||+|+++...   ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999885 58899999987542   23345677888888876 699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST  155 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence            9999887543 5688899999999999999999   889999999999999999999999999999875432221 2334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  199 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE  199 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            57899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.98  E-value=3.8e-32  Score=292.29  Aligned_cols=194  Identities=25%  Similarity=0.365  Sum_probs=167.3

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|++. +++.||+|+++...   ....+.+..|.+++... +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999885 47899999997642   23345677888888866 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|...+... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT  155 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence            9998887543 4678888999999999999999   889999999999999999999999999999875432222 2334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~  199 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD  199 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence            57899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=7.8e-32  Score=295.79  Aligned_cols=192  Identities=26%  Similarity=0.322  Sum_probs=167.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+|++.+.||+|+||.||+|++. .++.||+|...      ...+.+|++++++++||||+++++++......++|||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999884 58889999643      245678999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      . +++..++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|+..........
T Consensus       166 ~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~  240 (391)
T PHA03212        166 K-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY  240 (391)
T ss_pred             C-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence            5 6787777543 4678889999999999999999   888999999999999999999999999999975433222233


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||-
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            34579999999999999999999999999999999999998864

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.98  E-value=7.6e-32  Score=289.89  Aligned_cols=199  Identities=24%  Similarity=0.326  Sum_probs=170.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +|++.+.||+|+||+||+|++. +|+.||+|+++...   ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3778899999999999999874 58899999997542   223456778888888885 577888999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            999999999887543 4588999999999999999999   889999999999999999999999999999875432221


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence             223456899999999999889999999999999999999999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.98  E-value=7.3e-32  Score=282.22  Aligned_cols=202  Identities=24%  Similarity=0.409  Sum_probs=172.7

Q ss_pred             cCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .+|++.+.||+|+||.||+|++.    .+..||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56899999999999999999763    356899999876532 3346788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++......+++..++.++.|++.|++||   |++|++||||||+||+++.++.++++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            999999999999876666789999999999999999999   88999999999999999999999999999876543222


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ........++..|+|||.+.+..++.++||||+||++||+++ |+.||...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            111122345678999999999999999999999999999875 99999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=1.1e-31  Score=287.64  Aligned_cols=194  Identities=26%  Similarity=0.394  Sum_probs=166.0

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +++.||+|+++...   +...+....|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999885 47889999997653   23345566778888764 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence            9999888543 4678888999999999999999   889999999999999999999999999999875322111 2234


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            56899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-32  Score=312.11  Aligned_cols=204  Identities=30%  Similarity=0.564  Sum_probs=177.5

Q ss_pred             cCCCccceeccccceEEEEEEEcC--Cc----EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD--GM----EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      +..+..+.||+|+||.||+|...+  |.    .||+|.++... .++..+|.+|+.+|+.++|||||+++|++-+.+..+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345667899999999999997743  43    38999887653 456788999999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcC------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          699 LVLDYMPKGSLEACLYSD------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      +++|||+||+|..++++.      ...+.......++.+||+|+.||   +++++|||||.++|+|+++...|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999886      67789999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCCccccc-cccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          773 AKLLSGDESMKHTQ-TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       773 a~~~~~~~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      |+.+.+...+.... ..-+.+|||||.+.+..++.|+|||||||++||++| |..||.....
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n  910 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN  910 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence            99544333333322 245789999999999999999999999999999999 9999977543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=9.8e-32  Score=303.49  Aligned_cols=201  Identities=24%  Similarity=0.360  Sum_probs=175.2

Q ss_pred             CCCccceeccccceEEEEEEEc-C-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-D-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999764 3 5778999876655555567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          705 PKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       705 ~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ++|+|.+++..   ....+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988754   244678888999999999999999   889999999999999999999999999999987643222


Q ss_pred             -ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 -MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence             1233457899999999999999999999999999999999999999753

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.98  E-value=9.3e-32  Score=288.28  Aligned_cols=194  Identities=23%  Similarity=0.387  Sum_probs=166.4

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|++. +|+.||+|+++...   ....+....|.+++... +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999885 58899999997643   22345567788887754 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++... ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence            9999887543 4678888999999999999999   8899999999999999999999999999998753221 122334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            67899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=1.2e-31  Score=308.87  Aligned_cols=202  Identities=26%  Similarity=0.362  Sum_probs=172.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||.||+|++. .|+.||+|+++...   ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999885 58899999987542   223467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcC----------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          702 DYMPKGSLEACLYSD----------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       702 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      ||++||+|.+++...          ....++..+..++.||++|++||   |++||+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999987531          12345567788999999999999   88899999999999999999999999999


Q ss_pred             CccccCCCCC-----------------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          772 IAKLLSGDES-----------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++........                 .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9976521110                 0111246899999999999999999999999999999999999999763

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.98  E-value=1.2e-31  Score=278.99  Aligned_cols=201  Identities=27%  Similarity=0.462  Sum_probs=174.5

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||.||+|++.++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4588899999999999999998888889999886432 234678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +|+|.+++......+++..+..++.|++.|++||   |++||+||||+|+||+++.++.+|++|||.++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999998876555688999999999999999999   8899999999999999999999999999998765433222222


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...++..|+|||+..+..++.++||||+|+++|||++ |+.||...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            2345678999999988889999999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.5e-32  Score=278.49  Aligned_cols=205  Identities=24%  Similarity=0.352  Sum_probs=181.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .-|.+.+.||+|.|++|-.|++. .|+.||||++.+..-  -....+.+|++.|+.++|||||++|++......+|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45888899999999999999874 799999999976542  244678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      .=++|+|.+|+.+....+.+....+++.||+.|+.|+   |+..+||||+||+||.+- .-|.||+.|||++-.+.+.  
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence            9999999999998888899999999999999999999   666799999999998875 5789999999999776543  


Q ss_pred             ccccccccCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCccCcCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQIS-TEGDVYSFGIMLMEIFTRKRPTDEIFSGEM  835 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~  835 (851)
                      ....+.+|+..|.|||++.+..|+ +++||||+|||+|.+++|+.||++-.+.|.
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET  227 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET  227 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence            355678999999999999998886 568999999999999999999988666553

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=1.2e-31  Score=289.04  Aligned_cols=194  Identities=26%  Similarity=0.378  Sum_probs=167.8

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|..++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999884 57889999998643   23345678899999888 699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST  155 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence            9998877543 4688999999999999999999   889999999999999999999999999999875322221 2334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            67899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=2.1e-31  Score=287.54  Aligned_cols=198  Identities=25%  Similarity=0.393  Sum_probs=173.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||.||+|++. ++..+|+|+++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999885 58889999887653 2334678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+++|+|.+++... ..+++..+..++.|++.|++||   |+ .+|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~l---H~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            99999999988653 4578888899999999999999   54 47999999999999999999999999998765322  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       ......+++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             12235689999999999988899999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-31  Score=282.54  Aligned_cols=199  Identities=27%  Similarity=0.392  Sum_probs=172.8

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .|++.+.||+|+||+||+|.+. +++.||+|++.....   .....+.+|++++++++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3788899999999999999874 588999999875321   223456789999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+++|+|.+.+... ...+++..+..++.|++.|++||   |+.||+||||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999887653 34688999999999999999999   88899999999999999999999999999997653222 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence             222346899999999999889999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=1.1e-31  Score=289.14  Aligned_cols=193  Identities=30%  Similarity=0.371  Sum_probs=163.8

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHH-HHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECE-VLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +|+.||+|++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999885 689999999975421   22234444544 56788999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|..++.. ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||++....... .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST  155 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence            999888754 34678888899999999999999   88999999999999999999999999999987542222 12334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            5789999999999999999999999999999999999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=1.6e-31  Score=281.75  Aligned_cols=193  Identities=27%  Similarity=0.379  Sum_probs=166.9

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||+|+||+||+|++. +++.||+|++.....   ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999874 688999999875422   2235677899999999999999999999999999999999999999


Q ss_pred             hHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          710 EACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       710 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      ...+..   ....+++..+..++.||+.|++||   |++||+||||||+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            887743   334688999999999999999999   889999999999999999999999999999976543222 2234


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            57899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6e-31  Score=266.68  Aligned_cols=211  Identities=30%  Similarity=0.490  Sum_probs=172.1

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc--CCCcccceeeeeecC----Cee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSCTND----DFK  697 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~  697 (851)
                      ...+..+.+.||+|.||.||+|+| .|+.||||+|....   .+.+.+|.+|++.+  +|+||+.+++.-..+    ...
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            345678899999999999999999 78999999997543   36788899998765  999999999865433    268


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF-----GHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~-----~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      ++|++|.+.|+|.+|+..  ..++.....+++..+|.||++||-     .-+..|.|||||++||++..++.+.|+|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999999965  568889999999999999999973     2356799999999999999999999999999


Q ss_pred             ccccCCCC---CccccccccCccccCccccccCC------CCcchhhHHHHHHHHHHHhC----------CCCCCccCcC
Q 046438          773 AKLLSGDE---SMKHTQTLATIGYMAPEYGREGQ------ISTEGDVYSFGIMLMEIFTR----------KRPTDEIFSG  833 (851)
Q Consensus       773 a~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g----------~~pf~~~~~~  833 (851)
                      |.....+.   +......+||.+|||||++....      ....+||||||.|+||+..+          +.||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            98765432   33445678999999999986532      22358999999999998643          3788777666


Q ss_pred             ccchhhh
Q 046438          834 EMSLKRW  840 (851)
Q Consensus       834 ~~~~~~~  840 (851)
                      +-.++++
T Consensus       443 DPs~eeM  449 (513)
T KOG2052|consen  443 DPSFEEM  449 (513)
T ss_pred             CCCHHHH
Confidence            6555544

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=255.18  Aligned_cols=208  Identities=25%  Similarity=0.328  Sum_probs=177.0

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----CeeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND-----DFKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  698 (851)
                      .++|.+.+.+|+|+|+-||.++. .+++.||+|++......+.+...+|++..++++|||+++++++...+     .+.|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            46899999999999999999986 46888999999877767778899999999999999999999876433     3589


Q ss_pred             EEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          699 LVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                      ++++|...|+|.+.+..   ++..+++.+.+.++.+|++|+++|   |...  +.||||||.||++.+++.+++.|||.+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            99999999999988754   456789999999999999999999   7766  999999999999999999999999998


Q ss_pred             cccCCCCC--------ccccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCcc
Q 046438          774 KLLSGDES--------MKHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM  835 (851)
Q Consensus       774 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~  835 (851)
                      +...-...        .......+|..|.|||.+.   +...++++|||||||++|+|+.|..||+.......
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            76532111        1222356899999999874   56788999999999999999999999997655443

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=1.2e-31  Score=288.90  Aligned_cols=194  Identities=28%  Similarity=0.328  Sum_probs=162.8

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHH-HHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAEC-EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +++.||+|++.....   .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999885 577899999975421   1223334443 456788999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|.+++... ..+.+..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~  155 (325)
T cd05602          81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST  155 (325)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence            9999888653 4567788888999999999999   88999999999999999999999999999987543222 12334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence            57899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=1.3e-31  Score=288.38  Aligned_cols=194  Identities=28%  Similarity=0.341  Sum_probs=163.5

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHH-HHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAEC-EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|++. +++.||+|++.....   .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999885 588999999875421   2223444454 467889999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|...+.. ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST  155 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence            999887754 35577888889999999999999   88999999999999999999999999999987532222 12334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            57899999999999889999999999999999999999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=9e-32  Score=289.93  Aligned_cols=194  Identities=29%  Similarity=0.370  Sum_probs=164.3

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHH-HHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECE-VLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999874 68899999997542   122334455544 56778999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|...+.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT  155 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence            999887754 45688899999999999999999   889999999999999999999999999999875422211 2334


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence            57899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=261.95  Aligned_cols=206  Identities=23%  Similarity=0.366  Sum_probs=174.0

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCC
Q 046438          618 YQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDD  695 (851)
Q Consensus       618 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  695 (851)
                      ++++...++     +.+|+|+|+.|--+.. .+|.+||||++.+...-...+..+|++++.+.+ |+||++++++|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            555555554     5799999999998865 679999999998876666788999999999995 999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccC
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGI  772 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~  772 (851)
                      ..|+|||-|.||++...+.+ .+.+++.++.++..+|+.||.+|   |.+||.|||+||+||+-..   -..+|||||.+
T Consensus       150 ~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999888854 46789999999999999999999   9999999999999999854   34689999999


Q ss_pred             ccccCCCC------CccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          773 AKLLSGDE------SMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       773 a~~~~~~~------~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      +.......      .....+.+|+..|||||+..     ...|+.++|.||+|||+|-|+.|.+||.+-..
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            87543222      22333568999999999763     24588899999999999999999999987543

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=289.07  Aligned_cols=204  Identities=30%  Similarity=0.481  Sum_probs=178.6

Q ss_pred             ceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChh
Q 046438          632 NLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE  710 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  710 (851)
                      -++|+|.||+||.|++.+ ...+|||-+..+.....+.+.+|+...++++|.|||+++|.+.+.++.-|.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            479999999999999865 5679999988777777788999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCc--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCcEEEeeccCccccCCCCCcccccc
Q 046438          711 ACLYSDNSNL--DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKHTQT  787 (851)
Q Consensus       711 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~  787 (851)
                      ++++..=+++  .+...-.+..||++|+.||   |...|||||||-+||+++ -.|.+||+|||-++...+-.. -..++
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF  736 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF  736 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence            9998765555  6677788999999999999   889999999999999996 589999999999988754433 33457


Q ss_pred             ccCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhh
Q 046438          788 LATIGYMAPEYGREG--QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR  839 (851)
Q Consensus       788 ~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  839 (851)
                      .||..|||||++..+  .|+.++|||||||.+.||.||++||-+.+...-.+-+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk  790 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK  790 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence            899999999999764  5889999999999999999999999887766654444

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=282.27  Aligned_cols=213  Identities=27%  Similarity=0.408  Sum_probs=183.8

Q ss_pred             ceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCC
Q 046438          632 NLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGS  708 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  708 (851)
                      +++|+|.||+||-|++ ++|+.||||++.+..  ......+++|+.|++.+.||.||.+...|+..+..++|||-+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            7999999999999988 469999999986542  2334679999999999999999999999999999999999997777


Q ss_pred             hhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---CcEEEeeccCccccCCCCCcccc
Q 046438          709 LEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       709 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      |+-.+.++.+.+++.....+..||+.|+.||   |-++|||.|+||+||++...   -.+||||||+|+++.  +.....
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksFRr  724 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSFRR  724 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeecc--hhhhhh
Confidence            7766777788898888888999999999999   88899999999999999654   479999999999884  334556


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcccccCccc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI  849 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  849 (851)
                      ..+|||.|.|||++..+.|...-|+||.|||+|--++|..||++.-+--+++..-.++.-|..|
T Consensus       725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW  788 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW  788 (888)
T ss_pred             hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch
Confidence            6799999999999999999999999999999999999999999865555566665565555554

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=2.4e-31  Score=285.49  Aligned_cols=194  Identities=25%  Similarity=0.358  Sum_probs=167.4

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|++. +++.||+|+++...   ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999885 47889999998643   23345677888898887 699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|...+... ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST  155 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence            9998877543 4688999999999999999999   899999999999999999999999999999875322221 2234


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            56899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=1.8e-31  Score=277.51  Aligned_cols=202  Identities=24%  Similarity=0.456  Sum_probs=174.8

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||+||.|++.++..||+|.++... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4588899999999999999988777789999887543 234678999999999999999999999998888999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +|+|.+++......+++..++.++.||+.|++||   |+.|++|+||+|+||+++.++.+||+|||.++....+......
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            9999999876555789999999999999999999   8899999999999999999999999999998765433222222


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ...++..|+|||+..+..++.++|||||||++|||++ |+.||....
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  206 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN  206 (256)
T ss_pred             CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            2345678999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=2.8e-31  Score=283.70  Aligned_cols=202  Identities=26%  Similarity=0.506  Sum_probs=168.9

Q ss_pred             cCCCccceeccccceEEEEEEEcC-----------------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccce
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-----------------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRI  687 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  687 (851)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|+++... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578999999999999999997532                 3369999987643 2334678899999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCChhHHhhcCC------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 046438          688 ISSCTNDDFKALVLDYMPKGSLEACLYSDN------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVH  749 (851)
Q Consensus       688 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH  749 (851)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.||+.|++||   |++||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCccc
Confidence            999999999999999999999998875421                  2356778889999999999999   8889999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCC
Q 046438          750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRP  826 (851)
Q Consensus       750 ~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p  826 (851)
                      |||||+||+++.++.+||+|||+++........ ......++..|+|||++....++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999765433221 1222345788999999988889999999999999999987  6678


Q ss_pred             CCcc
Q 046438          827 TDEI  830 (851)
Q Consensus       827 f~~~  830 (851)
                      |...
T Consensus       242 ~~~~  245 (304)
T cd05096         242 YGEL  245 (304)
T ss_pred             CCcC
Confidence            7653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=4.4e-32  Score=257.06  Aligned_cols=204  Identities=28%  Similarity=0.433  Sum_probs=175.6

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--------hhHHHHHHHHHHHhhc-CCCcccceee
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--------GALESFNAECEVLRSI-RHRNLVRIIS  689 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~  689 (851)
                      .-+..-..|.-.+.+|+|..++|.++.+ ..|+++|+|++.....        .-.+...+|++|++++ -||+|+++.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            3344556788889999999999998876 4688999999864331        1234567899999998 5999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEee
Q 046438          690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD  769 (851)
Q Consensus       690 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~D  769 (851)
                      +++.+...++|+|.|+.|.|.+++.+ ...+++.+..+|++|+.+|++||   |.+.|||||+||+||+++++..+||+|
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEec
Confidence            99999999999999999999999854 45688888999999999999999   999999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccCccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          770 FGIAKLLSGDESMKHTQTLATIGYMAPEYGR------EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||+|+...+..  .....+|||+|.|||.+.      ...|+..+|.||+|||+|.++.|.+||..
T Consensus       167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH  230 (411)
T KOG0599|consen  167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH  230 (411)
T ss_pred             cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence            99999886543  455679999999999874      34688899999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=2.1e-31  Score=292.05  Aligned_cols=203  Identities=26%  Similarity=0.435  Sum_probs=170.4

Q ss_pred             hcCCCccceeccccceEEEEEEE------cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF------LDGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||+||+|++      ..+..||+|+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35689999999999999999964      235679999987543 23446788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-----------------------------------------------------------
Q 046438          697 KALVLDYMPKGSLEACLYSDN-----------------------------------------------------------  717 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  717 (851)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999988875421                                                           


Q ss_pred             ---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          718 ---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       718 ---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                                     ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           2367788889999999999999   8889999999999999999999999999999866433221


Q ss_pred             c-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          783 K-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       783 ~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      . .....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            1 112334678999999999999999999999999999998 89999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=4.1e-31  Score=278.53  Aligned_cols=191  Identities=25%  Similarity=0.395  Sum_probs=165.5

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchhh---HHHHHHHHHHHhhcCCCcccceeeeeec----CCeeEEEEecc
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA---LESFNAECEVLRSIRHRNLVRIISSCTN----DDFKALVLDYM  704 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  704 (851)
                      ..||+|++|.||+|++ +|+.||+|.++......   .+.+.+|++++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 78999999987543322   4678899999999999999999999876    34678999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ..+++.....++.+++.|++||   |+ .+++||||||+||++++++.+||+|||+++......   
T Consensus       105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            999999998654 4678889999999999999999   65 488999999999999999999999999988654322   


Q ss_pred             ccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       ....+++.|+|||++.+  ..++.++|||||||++|||++|+.||+...
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence             23467899999999876  689999999999999999999999998643

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.2e-31  Score=289.45  Aligned_cols=198  Identities=27%  Similarity=0.396  Sum_probs=166.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----CeeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DFKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  698 (851)
                      +|++.+.||+|+||.||+|++. +++.||+|+++...  .....++.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999874 68999999987432  22345688999999999999999999987543     2579


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||++ ++|.+++.. ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 688887754 34688999999999999999999   889999999999999999999999999999975432


Q ss_pred             CCC--ccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          779 DES--MKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       779 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...  .......+++.|+|||++.+  ..++.++||||+||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            211  12234578999999999865  6789999999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=8.6e-32  Score=289.28  Aligned_cols=194  Identities=28%  Similarity=0.398  Sum_probs=168.6

Q ss_pred             ceeccccceEEEEEEE----cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          632 NLIGSGSFGSVYRGRF----LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999976    2578999999976432  233457789999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +|+|.+++.. ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||++........ ...
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~  156 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY  156 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence            9999988854 34688999999999999999999   889999999999999999999999999999876543221 233


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence            457899999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-31  Score=276.47  Aligned_cols=202  Identities=29%  Similarity=0.496  Sum_probs=173.4

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      .+|++.+.||+|+||.||+|++.++..+|+|++..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788999999999999999987777899999864422 33568889999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++......+++..+..++.|++.|++||   |++||+|||++|+||++++++.+||+|||.++...........
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            9999999876656789999999999999999999   8899999999999999999999999999998765432221111


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ...++..|+|||...+..++.++|||||||++|||++ |+.||+...
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence            2234457999999998899999999999999999999 899997543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=281.72  Aligned_cols=207  Identities=28%  Similarity=0.508  Sum_probs=181.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEEcC---Cc--EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFLD---GM--EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      ...+.....+.||.|.||.||+|.+.+   |+  .||||..+... ....+.|..|+-+|+.++||||++++|+|.+. .
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            334445666899999999999997643   33  48999888743 34568899999999999999999999999864 6


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++|||.++.|.|++|+......++......++.||+.|++||   |+...|||||..+||++.....||++|||+++.+
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            7899999999999999999888999999999999999999999   9999999999999999999999999999999999


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCcC
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSG  833 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~  833 (851)
                      .++..+..+...-+..|||||-+.-..++.++|||.|||++||++. |..||.+.-..
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs  599 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS  599 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence            8777666665566889999999999999999999999999999987 99999876443

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=3.4e-31  Score=288.86  Aligned_cols=195  Identities=29%  Similarity=0.451  Sum_probs=164.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|+..+.||+|+||+||+|++. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34667789999999999999875 589999999865432 3346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++|+|...     ....+..+..++.||+.|++||   |++||+||||||+||++++++.+||+|||+++....... .
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  224 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P  224 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence            999998643     2345667788999999999999   889999999999999999999999999999986543221 2


Q ss_pred             ccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....|+..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            234578999999998743     2345689999999999999999999973

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=3.7e-31  Score=280.90  Aligned_cols=199  Identities=31%  Similarity=0.471  Sum_probs=165.8

Q ss_pred             cCCCccceeccccceEEEEEEEc--CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhc---CCCcccceeeeeec-----
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL--DGMEVAIKVFHLQL--EGALESFNAECEVLRSI---RHRNLVRIISSCTN-----  693 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----  693 (851)
                      ++|++.+.||+|+||+||+|++.  +++.||+|+++...  ......+.+|+++++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36999999999999999999873  46789999987543  22234566677777665   69999999998752     


Q ss_pred             CCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          694 DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       694 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      ....++||||++ +++.+++... ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            346899999996 5888887653 34578899999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++.....  .......+++.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence            9865432  2233456899999999998889999999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=282.36  Aligned_cols=205  Identities=26%  Similarity=0.480  Sum_probs=176.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .+...+.++||+|.||.|-.+....+..||||+++..... ...+|.+|+++|.+++||||+.++++|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            4456788999999999999998867799999999877543 347899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCC-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-C
Q 046438          704 MPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-S  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  781 (851)
                      |++|+|..++.....+ .......+|+.||+.|++||   .+..+||||+.++|++++.++++||+|||+++..-..+ .
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999998664322 35566678999999999999   88999999999999999999999999999998543332 2


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCccCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRPTDEIFS  832 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~pf~~~~~  832 (851)
                      ......+-+.+|||||.+.-++++.++|||+||+.+||+++  ...||.+..+
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~  746 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD  746 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence            23334566889999999999999999999999999999865  8899976443

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-33  Score=288.72  Aligned_cols=203  Identities=26%  Similarity=0.417  Sum_probs=180.6

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +.|+|+..+|.|+||+||+|..++ +...|.|++......+.+++.-|++|+..+.||+||++++.|..++.++|..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            457788999999999999998764 4457889998888888999999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +||-.+..+-+-+..+++.++..+++|+++||.||   |++.|+|||+|+.||+++.+|.++++|||.+..... .-...
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR  187 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR  187 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence            99999998877788899999999999999999999   999999999999999999999999999998754332 22345


Q ss_pred             cccccCccccCcccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          785 TQTLATIGYMAPEYG-----REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      .++.|||+|||||+.     .+.+|++++||||||+.+.||..+.+|-.+..+
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp  240 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP  240 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence            578999999999976     457899999999999999999999999766443

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.9e-31  Score=274.23  Aligned_cols=202  Identities=27%  Similarity=0.479  Sum_probs=174.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            456899999999999999999987788899999875432 3466889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |++||+||||+|+||++++++.++|+|||++..........
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9999999986543 5688999999999999999999   88899999999999999999999999999998764322211


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ......+..|+|||+..+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  208 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM  208 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            122223468999999998899999999999999999999 99999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=294.43  Aligned_cols=206  Identities=26%  Similarity=0.388  Sum_probs=171.8

Q ss_pred             cCCCccceeccccceEEEEEEEcCC-cEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeee-eec------CCe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDG-MEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISS-CTN------DDF  696 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------~~~  696 (851)
                      .+++|.+.|.+|||+.||.|++..+ ..||+|++-...+...+.+.+|+++|++++ |+|||.+++. ...      ..+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4567889999999999999998765 999999988777778899999999999997 9999999993 221      125


Q ss_pred             eEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          697 KALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..+.||||.||.|-+++..+ ...+++.++++|+.++++|+++||+ .+..|+|||||.+|||+..++..||||||.|+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            67999999999999998753 3349999999999999999999955 334599999999999999999999999999875


Q ss_pred             cCCCC-Ccc-------ccccccCccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          776 LSGDE-SMK-------HTQTLATIGYMAPEYG---REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       776 ~~~~~-~~~-------~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ..... ...       .-....|+-|+|||++   .+.++++|+|||||||++|-|+....||++.+.
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            42221 100       0113579999999976   578899999999999999999999999987633

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=2.5e-31  Score=291.01  Aligned_cols=204  Identities=27%  Similarity=0.488  Sum_probs=170.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||.||+|++.      ++..||+|+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357899999999999999999752      23579999997543 23346688999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-----------------------------------------------------------
Q 046438          697 KALVLDYMPKGSLEACLYSDN-----------------------------------------------------------  717 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  717 (851)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875321                                                           


Q ss_pred             ----------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-cccc
Q 046438          718 ----------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-KHTQ  786 (851)
Q Consensus       718 ----------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  786 (851)
                                ..+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      2367778899999999999999   8899999999999999999999999999999765432221 1112


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ..+++.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            235678999999998899999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=285.02  Aligned_cols=191  Identities=32%  Similarity=0.431  Sum_probs=170.6

Q ss_pred             CCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |.-++.||+|+||.||.|++ .+.+.||+|++.-..   .....++.+|++++++++|||++.+-|+|..+.+.|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55568899999999999988 467889999986433   23457899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      | -|+-.+++....+++.+.++..|..+.++||+||   |+.+.+|||||+.||++++.|.||++|||.|..+.+.    
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            9 6788888887888999999999999999999999   8899999999999999999999999999999876543    


Q ss_pred             ccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          784 HTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                       .+++|||.|||||++.   .+.|+-|+||||+|+...|+...++|+
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence             3578999999999874   477999999999999999999999995

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=5e-31  Score=289.72  Aligned_cols=199  Identities=26%  Similarity=0.352  Sum_probs=169.0

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC-----eeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD-----FKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  698 (851)
                      +|++.+.||+|+||+||+|++ .+++.||+|++....  .....++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999987 468999999986432  223467889999999999999999999998776     789


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+. +++.+.+.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 577776643 45688999999999999999999   889999999999999999999999999999986543


Q ss_pred             CCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..........+++.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            333333345678999999998764 5789999999999999999999999754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=7.8e-31  Score=275.99  Aligned_cols=192  Identities=27%  Similarity=0.378  Sum_probs=165.2

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||+|+||+||+++.. +|+.||+|.+.....   .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999874 589999999864321   1234456799999999999999999999999999999999999999


Q ss_pred             hHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccc
Q 046438          710 EACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL  788 (851)
Q Consensus       710 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  788 (851)
                      .+.+... ....++..+..++.||+.|++||   |++||+||||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            8877543 34578888899999999999999   88999999999999999999999999999987654322  223346


Q ss_pred             cCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       789 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            899999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=5.8e-31  Score=281.87  Aligned_cols=200  Identities=25%  Similarity=0.394  Sum_probs=170.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56899999999999999999875 578899999875432 2334677899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++ ++.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            975 78777766666688889999999999999999   889999999999999999999999999999876432221 2


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            233467899999998765 46889999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.5e-31  Score=298.73  Aligned_cols=205  Identities=29%  Similarity=0.438  Sum_probs=174.0

Q ss_pred             HHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC----
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD----  695 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  695 (851)
                      ...++|++.+.||+|+||+||+|++ .+++.||+|++....  ......+.+|+.++..++|+|++++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457899999999999999999987 468999999987542  334567889999999999999999887764332    


Q ss_pred             ----eeEEEEeccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          696 ----FKALVLDYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       696 ----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                          ..++||||+++|+|.+++...   ...+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEEE
Confidence                368999999999999988643   34688889999999999999999   88999999999999999999999999


Q ss_pred             eccCccccCCCC-CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          769 DFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~  248 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE  248 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            999997654321 11223457899999999999999999999999999999999999999753

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=4.5e-31  Score=275.66  Aligned_cols=202  Identities=28%  Similarity=0.526  Sum_probs=175.0

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.++||+|++|.||+|...++..||+|.+.... ...+.+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35789999999999999999998788889999886543 23567899999999999999999999999989999999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++... ....++..+..++.|+++|++||   |+.+++||||+|+||+++.++.++|+|||.+..........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            999999988653 45678888899999999999999   88899999999999999999999999999998764322222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....++..|+|||+.....++.++||||+||++|||++ |+.||...
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            223345678999999988889999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2e-31  Score=282.19  Aligned_cols=199  Identities=27%  Similarity=0.436  Sum_probs=177.8

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..|.+.+.||+|.|++|..|++ .++..||+|++++..-.  ..+.+.+|+++++.++|||||+++.+.+....+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            5689999999999999999988 46999999999876533  23568999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+.+|.+.+++...++..+ ..+..++.|+.+|++||   |++.|||||||++|++++.+..+||+|||++..+..  ..
T Consensus       136 ya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~  209 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GL  209 (596)
T ss_pred             eccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeecc--cc
Confidence            9999999999987665555 77888999999999999   999999999999999999999999999999988753  22


Q ss_pred             cccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...+++|++.|+|||++.+..| ++++|+||+|+++|-|+.|..||++.
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence            4456799999999999998776 67899999999999999999999864

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=3.4e-31  Score=276.61  Aligned_cols=204  Identities=30%  Similarity=0.548  Sum_probs=179.1

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ...+|++.+.||+|+||.||+|++.++..+|+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34678999999999999999999988999999999876555567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ...+++..+..++.|++.|++||   |++||+||||+|+||++++++.+||+|||.+........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999998753 45678999999999999999999   889999999999999999999999999999977643322 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ......++..|+|||+..+..++.++||||||+++|+|++ |+.||....
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            1223346778999999988899999999999999999998 899997643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=9.2e-31  Score=281.15  Aligned_cols=201  Identities=30%  Similarity=0.487  Sum_probs=170.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCc----EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGM----EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|++.+.||+|+||+||+|++. ++.    .||+|+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 333    38999987543 23456788999999999999999999998764 5679


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+||+++|++.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999987666788899999999999999999   8899999999999999999999999999999876433


Q ss_pred             CCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ... ......++..|+|||++.+..++.++|||||||++|||++ |+.||++.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            221 1122234678999999999999999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-32  Score=272.69  Aligned_cols=201  Identities=26%  Similarity=0.385  Sum_probs=176.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +.|..-++||+|+||.||.++.+ +|+-||.|++.+..   .........|.+++++++.+.||.+-..|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777899999999999999764 68889999875432   222345778999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      ..|.||+|...++.- ...+++..+..++.+|+-||++|   |+.+||.||+||+||++|+.|+++|+|.|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            999999998888764 45689999999999999999999   99999999999999999999999999999999875433


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                        .....+||.+|||||++.+..|+...|.||+||++|||+.|+.||....
T Consensus       342 --~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  342 --PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             --ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence              3445589999999999999999999999999999999999999997643

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=1.6e-30  Score=272.60  Aligned_cols=201  Identities=24%  Similarity=0.411  Sum_probs=173.3

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||.||+|++ .+++.||+|+++.........+.+|+.++++++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999987 46888999999765444556788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++.. ...+++..+..++.|+++|++||   |++||+|||++|+||+++.++.++|+|||++....... ..
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06646          88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK  162 (267)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence            999999998754 34678899999999999999999   88899999999999999999999999999998653221 12


Q ss_pred             ccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||.+.   ...++.++||||+||++|||++|+.||...
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            23356889999999874   345788999999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=7.9e-31  Score=292.59  Aligned_cols=196  Identities=26%  Similarity=0.425  Sum_probs=162.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC--------C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND--------D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~  695 (851)
                      ..+|++.+.||+|+||+||+|++. +++.||+|++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999884 58899999885432    2345799999999999999998876432        2


Q ss_pred             eeEEEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeecc
Q 046438          696 FKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFG  771 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg  771 (851)
                      ..++||||+++ ++.+++..   ....+++..+..++.||+.|++||   |++||+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 56555532   355688899999999999999999   889999999999999998664 79999999


Q ss_pred             CccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +|+......  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            998664322  2234578999999998866 46899999999999999999999999764

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=1.7e-30  Score=274.62  Aligned_cols=198  Identities=26%  Similarity=0.378  Sum_probs=171.8

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |+..+.||+|+||+||+|++. +++.||+|++....   ......+.+|++++++++|++++++++.+.+++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999884 68899999986542   12234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+.+... ...+++..+..++.|++.|++||   |++||+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999998887653 34689999999999999999999   88999999999999999999999999999987653221  


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......++..|+|||++.+..++.++|+||+||++|||++|+.||...
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            223356899999999999889999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1e-30  Score=285.84  Aligned_cols=198  Identities=22%  Similarity=0.311  Sum_probs=167.0

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC-----
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD-----  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  695 (851)
                      ..++|++.+.||+|+||.||+|++. .|+.||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999874 58899999986542  233466789999999999999999999886543     


Q ss_pred             -eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          696 -FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       696 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                       ..++||||++++ +...+.   ..++...+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh---ccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             578999999764 544442   3477888889999999999999   88999999999999999999999999999997


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            54322  1233457899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=1.6e-30  Score=272.23  Aligned_cols=202  Identities=26%  Similarity=0.494  Sum_probs=174.1

Q ss_pred             cCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++..    ...||+|.++... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568999999999999999998742    4579999987543 33446788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++......+++..+..++.|++.|++||   |+++|+||||+|+||++++++.++++|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999877666789999999999999999999   88999999999999999999999999999998764221


Q ss_pred             -CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 -SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                       ........++..|+|||...+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~  212 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence             112222345678999999998899999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=2.5e-30  Score=274.72  Aligned_cols=202  Identities=27%  Similarity=0.436  Sum_probs=175.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .+.|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++|||++++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            367999999999999999999885 4889999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++++..++......+++..+..++.|++.|++||   |++||+|||++|+||+++.++.++|+|||.+...... ...
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence            999999888766666789999999999999999999   8899999999999999999999999999998754322 112


Q ss_pred             ccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++.     ...++.++||||+||++|||++|+.||...
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence            23456788999999874     345788999999999999999999998653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=1.4e-30  Score=285.81  Aligned_cols=203  Identities=27%  Similarity=0.489  Sum_probs=170.6

Q ss_pred             hcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||.||+|++..      +..||+|+++... ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5689999999999999999997631      3469999997543 233467899999999996 9999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-----------------------------------------------------------
Q 046438          697 KALVLDYMPKGSLEACLYSDN-----------------------------------------------------------  717 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  717 (851)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999988875421                                                           


Q ss_pred             ------------------------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC
Q 046438          718 ------------------------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE  761 (851)
Q Consensus       718 ------------------------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~  761 (851)
                                                          ..+++..+..++.||++|++||   |+++|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEeC
Confidence                                                2366777889999999999999   8899999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          762 DMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       762 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            99999999999976533221 12223456788999999998899999999999999999997 99998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=1.7e-30  Score=274.51  Aligned_cols=198  Identities=25%  Similarity=0.396  Sum_probs=171.4

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |++.+.||+|+||.||+|.+. +++.||+|.+....   ....+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677899999999999999884 58899999986542   12234567899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ...+++..+..++.|++.|++||   |++||+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            9999999887543 34588889999999999999999   88999999999999999999999999999987653322  


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            122346899999999999989999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=2.4e-30  Score=272.84  Aligned_cols=195  Identities=25%  Similarity=0.394  Sum_probs=170.0

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3688899999999999999987 468889999987543 22345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++++..+     ..+++..+..++.|++.|++||   |+.||+|+||||+||+++.++.++|+|||++......   .
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~  149 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I  149 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence            999998654     2467788889999999999999   8899999999999999999999999999998765322   2


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....++..|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  197 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ  197 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence            234578999999999999899999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=1.5e-30  Score=276.53  Aligned_cols=200  Identities=30%  Similarity=0.421  Sum_probs=175.7

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+|++.+.||+|++|.||+|++ .+++.||+|.+........+.+.+|+++++.++|||++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5789999999999999999987 468899999987665555677899999999999999999999999989999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++..  ..+++.++..++.|++.|++||   |++||+||||+|+||+++.++.++|+|||.+........ ..
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~  173 (296)
T cd06654         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (296)
T ss_pred             CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence            99999998854  3578889999999999999999   889999999999999999999999999999876533221 22


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....+++.|+|||...+..++.++|||||||++|||++|+.||....
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            33468899999999988889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=270.14  Aligned_cols=201  Identities=29%  Similarity=0.446  Sum_probs=173.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      +.|++.+.||+|++|.||+|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46899999999999999999874 58999999986542     1234568899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++++|.+.+... ..+++..+..++.|++.|++||   |+.||+||||+|+||++++++.++|+|||.++.....
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999888543 4578888899999999999999   8899999999999999999999999999998765332


Q ss_pred             CCccc--cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKH--TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....  ....++..|+|||+..+..++.++||||+|+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence            21111  2345788999999999988999999999999999999999999653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=1.2e-30  Score=275.65  Aligned_cols=202  Identities=32%  Similarity=0.549  Sum_probs=173.1

Q ss_pred             cCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      ++|.+.+.||+|+||.||+|++.+      ++.||+|+++..... ..+.+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            568889999999999999997643      478999998765444 4568999999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcCC-------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          699 LVLDYMPKGSLEACLYSDN-------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      +||||+++++|.+++...+             ..+++..+..++.|++.|++||   |++|++||||+|+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCeE
Confidence            9999999999999986532             3467888899999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          766 RLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+|||.++........ ......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999998765322211 1223345788999999999999999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=1.3e-30  Score=271.99  Aligned_cols=202  Identities=29%  Similarity=0.519  Sum_probs=172.1

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++.+.+ +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            356999999999999999999887777899999875332 23578899999999999999999998754 5678999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ...+++..+..++.|+++|++|+   |+.+|+||||+|+||++++++.++|+|||.++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999998653 34578889999999999999999   88999999999999999999999999999997664333222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .....++..|+|||+..+..++.++||||+||++|||++ |+.||....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~  208 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  208 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            223346678999999988899999999999999999999 888997643

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=269.98  Aligned_cols=203  Identities=29%  Similarity=0.454  Sum_probs=178.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.+|+|++|.||+|++. +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999874 5788999999876555667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++++.+++......+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+........ .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence            999999998876656789999999999999999999   889999999999999999999999999999876543221 2


Q ss_pred             ccccccCccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGREG---QISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....++..|+|||.....   .++.++||||+||++|||++|+.||....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            2335678899999998776   78899999999999999999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=275.23  Aligned_cols=202  Identities=26%  Similarity=0.455  Sum_probs=177.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||.||+|++. ++..||+|.++.......+.+.+|++++++++|||++++++++.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356899999999999999999884 5889999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++......+++..+..++.|++.|++||   |++||+|||++|+||+++.++.++|+|||.+........ .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence            999999999876666789999999999999999999   889999999999999999999999999998865432221 2


Q ss_pred             ccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++.     ...++.++|+||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            23456889999999874     345778999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=1.6e-30  Score=275.56  Aligned_cols=203  Identities=29%  Similarity=0.519  Sum_probs=173.7

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|.+.+.||+|+||+||+++..      ++..+|+|.++.........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56889999999999999999752      245689999876655556789999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCC------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEE
Q 046438          700 VLDYMPKGSLEACLYSDN------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL  767 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl  767 (851)
                      ||||+++++|.+++....            ..+++..+..++.|++.|++||   |++|++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999886432            2478899999999999999999   8899999999999999999999999


Q ss_pred             eeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          768 GDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999976533221 11222345778999999998899999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.8e-30  Score=274.46  Aligned_cols=200  Identities=26%  Similarity=0.432  Sum_probs=173.4

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      |++.+.||+|+||.||+|++. ++..+|+|.+........+.+.+|+++++.++|||++++++++..+...++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            678899999999999999885 4778899998766555667788999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      +++..++......+++..+..++.|+++|++||   |+.||+||||+|+||+++.++.+|++|||++....... .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  162 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS  162 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence            999988766566789999999999999999999   88899999999999999999999999999987543221 12234


Q ss_pred             cccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          787 TLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       787 ~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ..+++.|+|||++.     +..++.++||||+||++|||++|+.||....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence            56889999999873     4557889999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=2.2e-30  Score=270.64  Aligned_cols=200  Identities=28%  Similarity=0.518  Sum_probs=172.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+|.+.+.||+|++|.||+|.+. .++.||+|++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999875 4888999998754 333467889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++... ...+++..+..++.|+++|++||   |++|++||||||+||++++++.+||+|||.+..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999999988653 34578889999999999999999   88999999999999999999999999999998765432222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~  829 (851)
                      ......+..|+|||...+..++.++|||||||++|||++ |..||.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            222234668999999998899999999999999999998 9999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=3.5e-30  Score=268.12  Aligned_cols=201  Identities=29%  Similarity=0.418  Sum_probs=176.0

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|++. +++.||+|.+....  ....+++.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999884 58899999986532  33456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ...+++..++.++.|++.|++||   |++||+||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998764 46788899999999999999999   889999999999999999999999999999886643322 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......+++.|+|||+..+..++.++|+|||||++|||++|+.||....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            2233468899999999999899999999999999999999999997543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=5.8e-31  Score=273.92  Aligned_cols=198  Identities=37%  Similarity=0.648  Sum_probs=167.5

Q ss_pred             ccceeccccceEEEEEEEc-----CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          630 VNNLIGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.... ...+.+.+|++.+++++||||+++++++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999886     256799999965432 3467899999999999999999999999988889999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  781 (851)
                      +++|+|.+++... ...+++..+..++.||++|++||   |+++|+||||+++||++++++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999876 67789999999999999999999   778999999999999999999999999999987632222 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...........|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            12233457789999999998889999999999999999999 78998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=3.7e-30  Score=266.90  Aligned_cols=196  Identities=28%  Similarity=0.497  Sum_probs=169.0

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChh
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE  710 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  710 (851)
                      +.||+|+||.||+|...++..||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            468999999999999878899999998765432 3456889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccC
Q 046438          711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT  790 (851)
Q Consensus       711 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t  790 (851)
                      +++......+++..+..++.|++.|+.|+   |++|++|||++|+||+++.++.+|++|||++...............++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            98876666788999999999999999999   889999999999999999999999999999875432222111223446


Q ss_pred             ccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       791 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ..|+|||+..+..++.++|||||||++||+++ |..||...
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            77999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=267.13  Aligned_cols=200  Identities=26%  Similarity=0.345  Sum_probs=171.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  699 (851)
                      ..+|.++.+||+|+||+|..|.-+ +.+.||||++++..   +.+.+-...|-+++... +-|.++++...|+..+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356899999999999999999654 45669999998764   23344456777888776 45788999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+.||+|.-.+.+- +.+.+..+..+|.+|+-||-+|   |++||+.||+|.+|||++.+|++||+|||+++.--.+
T Consensus       428 VMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            99999999998777554 4456667788999999999999   9999999999999999999999999999999864433


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       .....+++|||.|+|||++...+|+..+|.||+||++|||+.|++||++
T Consensus       504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence             3355678999999999999999999999999999999999999999987

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=1.7e-30  Score=280.65  Aligned_cols=204  Identities=26%  Similarity=0.477  Sum_probs=169.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC-C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND-D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  695 (851)
                      .++|++.+.||+|+||.||+|+..      .++.||+|+++... ......+.+|+++++++ +|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999642      24789999987543 22345678899999999 799999999987654 5


Q ss_pred             eeEEEEeccCCCChhHHhhcCC----------------------------------------------------------
Q 046438          696 FKALVLDYMPKGSLEACLYSDN----------------------------------------------------------  717 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  717 (851)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999998875421                                                          


Q ss_pred             --CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCcccc
Q 046438          718 --SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYM  794 (851)
Q Consensus       718 --~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~  794 (851)
                        ..+++..+..++.||++|++||   |++||+||||||+||++++++.++|+|||+++.+..... .......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2568888999999999999999   889999999999999999999999999999987643222 1222334567899


Q ss_pred             CccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          795 APEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       795 aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      |||++.+..++.++||||+||++|||++ |+.||....
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.6e-30  Score=287.04  Aligned_cols=196  Identities=23%  Similarity=0.309  Sum_probs=169.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc---CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3577999987643     34568999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |++. +++.+++ .....+++..+..++.||+.|++||   |++||+||||||+||+++.++.++|+|||+++.......
T Consensus       166 e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 6777777 3456789999999999999999999   889999999999999999999999999999976543222


Q ss_pred             -ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 -MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .......||+.|+|||++....++.++||||+||++|||++|+.||.+.
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence             1223457899999999999999999999999999999999999999654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=2.5e-30  Score=269.82  Aligned_cols=202  Identities=28%  Similarity=0.508  Sum_probs=173.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ..+++.+|++++++++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467999999999999999999988899999999875432 3467899999999999999999999874 45689999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++... ...+++..+..++.|++.|++||   |+.|++||||+|+||++++++.++++|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            999999987653 45678889999999999999999   88999999999999999999999999999997664322222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .....++..|+|||+.....++.++|||||||++||+++ |+.||....
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            223345678999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=1.7e-30  Score=283.92  Aligned_cols=199  Identities=22%  Similarity=0.293  Sum_probs=167.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND-----  694 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  694 (851)
                      ...++|++.+.||+|+||.||+|++. .++.||+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999874 58899999987543  22346678899999999999999999987543     


Q ss_pred             -CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          695 -DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       695 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                       ...++||||+++ ++...+.   ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357899999975 4555443   3477888899999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +.....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            765322  2233457899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.5e-30  Score=271.56  Aligned_cols=198  Identities=36%  Similarity=0.574  Sum_probs=172.6

Q ss_pred             CCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhH--HHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      |++.+.||+|+||+||+|+... ++.||+|++........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999854 66899999987653322  23456999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++. ....+++..+..++.|+++|+++|   |++||+|+||||+||++++++.++|+|||.+.... ......
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF  155 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred             cccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999886 345678999999999999999999   77899999999999999999999999999987642 122234


Q ss_pred             cccccCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....++..|+|||+.. +..++.++||||+|+++|+|++|+.||...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4567899999999998 888999999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=2.4e-30  Score=269.98  Aligned_cols=201  Identities=27%  Similarity=0.524  Sum_probs=171.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|.+.++..||+|.++.... ..+.+.+|++++++++|++++++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            357899999999999999999988888899999876433 33678999999999999999999998854 5678999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++... ...+++..+..++.|++.|++||   |+.||+||||+|+||++++++.++|+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999988653 34578999999999999999999   88899999999999999999999999999997664332222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....++..|+|||+..+..++.++|+||||+++|||++ |+.||...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            222345678999999988889999999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=2.9e-30  Score=275.44  Aligned_cols=200  Identities=25%  Similarity=0.395  Sum_probs=171.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|.++... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57999999999999999999875 57889999987543 22335677899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++ +++.+++......+++..+..++.||++|++||   |+.||+||||||+||++++++.++|+|||++........ .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  160 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence            96 588888876666788999999999999999999   889999999999999999999999999999876432221 2


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            223457899999998765 45788999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-30  Score=269.99  Aligned_cols=202  Identities=30%  Similarity=0.567  Sum_probs=175.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.+..... ..+++.+|++++++++|||++++++++.+....++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            468999999999999999999987788899999875432 3467899999999999999999999999888999999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |++|++||||+|+||+++.++.++++|||.+..........
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence            9999999986643 5688999999999999999999   88899999999999999999999999999987664322222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ......+..|+|||...+..++.++|+||+||++||+++ |+.||...
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            222334678999999998889999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=2.7e-30  Score=273.24  Aligned_cols=203  Identities=30%  Similarity=0.566  Sum_probs=172.0

Q ss_pred             cCCCccceeccccceEEEEEEEcC-C-----cEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-G-----MEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      ++|++.+.||+|+||.||+|.... +     ..||+|.++.... .....+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468899999999999999998643 2     5699999875432 33466889999999999999999999999888999


Q ss_pred             EEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC
Q 046438          699 LVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM  763 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~  763 (851)
                      ++|||+++++|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence            9999999999999886532               4577888899999999999999   889999999999999999999


Q ss_pred             cEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          764 VARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999876533221 12223456788999999988899999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=3.8e-30  Score=273.61  Aligned_cols=200  Identities=30%  Similarity=0.423  Sum_probs=176.0

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36799999999999999999987 46899999999765555557788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++..  ..+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+........ .
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~  171 (297)
T cd06656          98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (297)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence            999999998854  3578888999999999999999   889999999999999999999999999999876543221 2


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||...+..++.++|+||+||++|+|++|+.||...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            23346889999999999888999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=4.5e-30  Score=266.61  Aligned_cols=196  Identities=29%  Similarity=0.501  Sum_probs=167.1

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      +.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999884 68899999876543 23346789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc-ccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTL  788 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~  788 (851)
                      .+++......+++..++.++.|+++|++||   |++||+||||+|+||+++.++.+|++|||.+.......... .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999876666788999999999999999999   89999999999999999999999999999987643221111 11122


Q ss_pred             cCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       789 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .+..|+|||.+.+..++.++||||+||++|||++ |..||+..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~  200 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL  200 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            3567999999988889999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.6e-31  Score=283.99  Aligned_cols=192  Identities=28%  Similarity=0.332  Sum_probs=160.8

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhc---CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSI---RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      ||+|+||+||+|++. +++.||+|++.....   ........|..++.+.   +||+|+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999885 589999999865321   2223445566676655   699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|.+++.. ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~  155 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT  155 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence            999888754 45688899999999999999999   889999999999999999999999999999875422221 2334


Q ss_pred             cccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~  200 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE  200 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence            5789999999998754 5899999999999999999999999653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=4.7e-30  Score=272.21  Aligned_cols=197  Identities=31%  Similarity=0.430  Sum_probs=174.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|++|.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36889999999999999999885 58899999987542   223467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++++|.+++... ..++...+..++.|+++|++||   |++||+||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999988654 5688889999999999999999   8899999999999999999999999999998875433  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  201 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD  201 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence              23346889999999998888899999999999999999999999653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.3e-31  Score=273.42  Aligned_cols=202  Identities=26%  Similarity=0.382  Sum_probs=171.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEee--cchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ...|++++.||+||.+.||++...+.+.||+|++..  ........+..|+..|.+++ |.+|+++++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            457999999999999999999987778888886643  23456778999999999995 899999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-  780 (851)
                      || ...+|..++.++....+...++.+..||+.|+.++   |.+||||.||||.|+++- .|.+||+|||.|.-+..+. 
T Consensus       440 E~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 EC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            96 46799999988766666557888999999999999   899999999999999984 5799999999998776554 


Q ss_pred             CccccccccCccccCccccccC-----------CCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGREG-----------QISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .......+||+.||+||.+...           ..++++||||+|||+|+|+.|+.||....
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            3445567999999999987432           25678999999999999999999997643

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=2.9e-30  Score=282.90  Aligned_cols=198  Identities=21%  Similarity=0.286  Sum_probs=167.5

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC------
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND------  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  694 (851)
                      ..++|++.+.||+|+||.||+|++. .++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999874 58889999987542  23346678899999999999999999887543      


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ...++||||+++ ++...+.   ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 5655553   3477888899999999999999   88999999999999999999999999999997


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            65322  2233457899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=2.7e-30  Score=270.73  Aligned_cols=200  Identities=26%  Similarity=0.419  Sum_probs=173.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++.........+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46888899999999999999874 58899999987665455567888999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++... ..+++..+..++.|++.|++||   |+.||+|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~  163 (267)
T cd06645          89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR  163 (267)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence            999999987543 4688999999999999999999   88899999999999999999999999999987653221 122


Q ss_pred             cccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....+++.|+|||++.   ...++.++||||+||++|||++|+.||...
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence            3457899999999874   456888999999999999999999998543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=4.4e-30  Score=267.18  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=174.8

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +|++.+.||+|+||.||++++. +++.||+|.++... ....+.+.+|+++++.++|||++++++.+.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999885 58899999986532 334567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++.+++.. ....++......++.|++.|++||   |++||+|+||+|+||++++++.++++|||.+........ .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            99999988765 344578889999999999999999   899999999999999999999999999999876643322 2


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||+..+..++.++|+||+|+++|+|++|+.||...
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  203 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN  203 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence            23456889999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=284.25  Aligned_cols=203  Identities=33%  Similarity=0.495  Sum_probs=176.4

Q ss_pred             CccceeccccceEEEEEEE-cCC----cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          629 NVNNLIGSGSFGSVYRGRF-LDG----MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      +-.++||+|+||+||+|.| .+|    .+||+|++.... .....++.+|+-+|.++.|||++++++++.... ..+|++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4457999999999999987 344    358999876543 334577999999999999999999999998765 789999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ||++|.|.++++..+..+..+..+.+..||++|+.||   |.+++|||||.++|||+.+-..+||.|||+|+....++..
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999999999999999999999999999   8999999999999999999999999999999988766543


Q ss_pred             ccc-ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCcCcc
Q 046438          783 KHT-QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM  835 (851)
Q Consensus       783 ~~~-~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~  835 (851)
                      ... .....+.|+|-|.+....|+.++|||||||.+||++| |..|++++...|+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI  909 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI  909 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence            222 2345778999999999999999999999999999999 9999998765543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=6.8e-30  Score=273.23  Aligned_cols=197  Identities=25%  Similarity=0.380  Sum_probs=171.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||.||+|++. ++..||+|.++.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36899999999999999999874 578899998875432 2345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ..+++..+..++.|+++|++||   |+ .+++||||+|+||+++.++.+||+|||.+......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999998654 5678888999999999999999   64 58999999999999999999999999998765322   


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......+++.|+|||+..+..++.++|+||+||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            12345688999999999888899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=4e-30  Score=271.89  Aligned_cols=202  Identities=27%  Similarity=0.481  Sum_probs=170.2

Q ss_pred             cCCCccceeccccceEEEEEEE-----cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|++.+.||+|+||+||+|++     ..+..||+|.++... ......+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4578889999999999999975     245789999987533 2334678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcC----------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC
Q 046438          700 VLDYMPKGSLEACLYSD----------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM  763 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~  763 (851)
                      ||||+++++|.+++...                ...+++.....++.|++.|++||   |++||+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCC
Confidence            99999999999987532                12467788889999999999999   888999999999999999999


Q ss_pred             cEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          764 VARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .+||+|||+++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999976533221 12223345678999999988889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.6e-30  Score=280.00  Aligned_cols=200  Identities=24%  Similarity=0.344  Sum_probs=169.3

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecC--
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTND--  694 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--  694 (851)
                      ...+..++|++.+.||+|+||+||+|++. +++.||+|++.....  ...+.+.+|++++++++||||+++++++...  
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            34455688999999999999999999874 678899999875432  2335677899999999999999999887543  


Q ss_pred             ----CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          695 ----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       695 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                          ...++++|++ ++++.+++.  ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCC
Confidence                3568999998 788887764  34688999999999999999999   8899999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          771 GIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       771 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+++.....    .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999865332    234578999999999876 5689999999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=4.1e-30  Score=270.92  Aligned_cols=201  Identities=28%  Similarity=0.471  Sum_probs=168.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCc----EEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGM----EVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|++.+.||+|+||+||+|++. +++    .+|+|.+..... ....++..|+.+++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888999999999999999874 344    477777754322 234567788889999999999999998764 45678


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ++||+++|+|.+++......+++..+..++.||+.|++||   |++|++||||||+||++++++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999977677789999999999999999999   8899999999999999999999999999999865432


Q ss_pred             CC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .. .......++..|+|||+..+..++.++|||||||++||+++ |+.||.+.
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            21 12223456778999999998899999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=5.4e-30  Score=266.72  Aligned_cols=199  Identities=31%  Similarity=0.472  Sum_probs=177.7

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||.||+|++.+ ++.||+|.+.....  .+.+.+|++++++++|||++++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578999999999999999999864 78999999876533  578999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++......+++..+..++.|++.|++||   |+.+|+|||++|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence            99999999877677889999999999999999999   888999999999999999999999999999887643321 22


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            3345788999999998889999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=3.4e-30  Score=271.50  Aligned_cols=204  Identities=27%  Similarity=0.479  Sum_probs=170.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      ..++|++.+.||+|+||+||+|++.      .+..||+|+++... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999763      24679999886432 2334568899999999999999999999998899


Q ss_pred             eEEEEeccCCCChhHHhhcCC---------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEE
Q 046438          697 KALVLDYMPKGSLEACLYSDN---------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL  767 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl  767 (851)
                      .++||||+++++|.+++....         ...++..+..++.|+++|++||   |+.|++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999886422         2356778889999999999999   8889999999999999999999999


Q ss_pred             eeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          768 GDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999998754322211 1112345788999999998899999999999999999999 78998764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=4.3e-30  Score=267.48  Aligned_cols=201  Identities=28%  Similarity=0.517  Sum_probs=173.6

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      .+|++.+.||+|+||.||+|.+.++..+|+|+++.... ....+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46888899999999999999887788999998875432 23568899999999999999999999999889999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++......+++..+..++.|++.|++||   |+.+++|||++|+||+++.++.++|+|||.+............
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999998876666788899999999999999999   8889999999999999999999999999998765332211122


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...++..|+|||+..+..++.++||||+||++|||++ |+.||...
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  205 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR  205 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            2335678999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=3.9e-31  Score=255.39  Aligned_cols=201  Identities=26%  Similarity=0.364  Sum_probs=168.8

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-----CcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeec-CCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTN-DDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  696 (851)
                      ...|+.++.||+|.||.||+|.-.+     ...+|+|+++...+  +.....-+|+..++.++|||++.+..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3569999999999999999994422     34699999986643  344667899999999999999999998877 778


Q ss_pred             eEEEEeccCCCChhHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC----CcEEEe
Q 046438          697 KALVLDYMPKGSLEACLYS----DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED----MVARLG  768 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~----~~~kl~  768 (851)
                      .++++||.+. +|...++.    +.+.++...+..|.+||+.|+.||   |+.-|.|||+||.||++..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999965 66666643    345688899999999999999999   99999999999999999877    899999


Q ss_pred             eccCccccCCCCCc--cccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          769 DFGIAKLLSGDESM--KHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       769 Dfg~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+|+|+.+..+-..  .....+.|.+|.|||.+.+. .|+++.||||.|||+.||++-++-|.+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            99999988654332  23345789999999998875 588889999999999999999988754

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=6.5e-30  Score=267.92  Aligned_cols=201  Identities=26%  Similarity=0.437  Sum_probs=173.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++...   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999874 68999999876422   233456889999999999999999999999989999999


Q ss_pred             eccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++++|.+++..   ....+++..+..++.|+++|++||   |++|++||||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   334578888999999999999999   889999999999999999999999999999887643


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ... ......+++.|+|||...+..++.++|+||+|+++|||++|+.||...
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            221 222346888999999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=5e-30  Score=268.67  Aligned_cols=202  Identities=27%  Similarity=0.502  Sum_probs=172.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-C---CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-D---GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .+|++.+.||+|+||.||+|++. +   +..+|+|.++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46889999999999999999874 2   3469999887543 23346789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++......+++.++..++.|++.|++||   |++|++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999977666789999999999999999999   88999999999999999999999999999998764332


Q ss_pred             Cccc--cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 SMKH--TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ....  ....++..|+|||++.+..++.++|+|||||++||+++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            2111  11223568999999998889999999999999999886 99999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=5.2e-30  Score=267.34  Aligned_cols=201  Identities=27%  Similarity=0.505  Sum_probs=170.9

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            5688999999999999999998777789999876543 234678899999999999999999998754 56789999999


Q ss_pred             CCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          706 KGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       706 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +++|.+++... ...+++..+..++.|++.|++||   |+.||+|+||+|+||++++++.++|+|||.+...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            99999998653 34578889999999999999999   889999999999999999999999999999976543322222


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ....++..|+|||...+..++.++||||+||++|||++ |+.||.+..
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  208 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV  208 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            23345678999999988889999999999999999999 999997643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=5.7e-30  Score=272.00  Aligned_cols=200  Identities=30%  Similarity=0.431  Sum_probs=176.1

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+|++.+.||.|++|.||+|.+ .+++.||+|.+........+.+.+|+++++.++|||++++++++.+.+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3589999999999999999987 468999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|..++..  ..+++..+..++.|++.|++||   |++|++||||+|+||+++.++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  172 (296)
T cd06655          99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR  172 (296)
T ss_pred             CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence            99999998754  3578999999999999999999   889999999999999999999999999999876543322 22


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            33468889999999998889999999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4e-30  Score=285.11  Aligned_cols=193  Identities=23%  Similarity=0.300  Sum_probs=167.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ...|.+.+.||+|+||.||+|++. .++.||+|....      ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346999999999999999999885 478899996432      3456899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  782 (851)
                      +. +++.+++......+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++........ 
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            94 688888766666789999999999999999999   8899999999999999999999999999999765432211 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            122356899999999999999999999999999999999987664

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=2.9e-30  Score=298.46  Aligned_cols=204  Identities=23%  Similarity=0.400  Sum_probs=168.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec--CCeeE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN--DDFKA  698 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  698 (851)
                      ..++|++.+.||+|+||+||+|++. .+..||+|++....  ......+..|+.++++++|||||+++++|.+  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4578999999999999999999885 47789999887542  3345678899999999999999999998854  35789


Q ss_pred             EEEeccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcC----CCCcEecCCCCCCEEECC----------
Q 046438          699 LVLDYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGH----PNPVVHCDIKPSNVLLDE----------  761 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h----~~~ivH~Dl~~~Nill~~----------  761 (851)
                      +||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    .++|+||||||+||+++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999988642   356899999999999999999995321    156999999999999964          


Q ss_pred             -------CCcEEEeeccCccccCCCCCccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          762 -------DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       762 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                             .+.+||+|||++.......  ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                   2358999999997653322  2234578999999998854  4588999999999999999999999975

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=6.4e-30  Score=275.08  Aligned_cols=194  Identities=24%  Similarity=0.327  Sum_probs=158.5

Q ss_pred             cceeccccceEEEEEEEc---CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec--CCeeEEEEeccC
Q 046438          631 NNLIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN--DDFKALVLDYMP  705 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  705 (851)
                      .++||+|+||+||+|+..   +++.||+|.++...  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999864   46789999986542  23457889999999999999999998854  456889999985


Q ss_pred             CCChhHHhhcC--------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE----CCCCcEEEeeccCc
Q 046438          706 KGSLEACLYSD--------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIA  773 (851)
Q Consensus       706 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill----~~~~~~kl~Dfg~a  773 (851)
                       +++.+++...        ...+++..+..++.||+.|++||   |++||+||||||+||++    +..+.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5777665421        23478888999999999999999   88999999999999999    45679999999999


Q ss_pred             cccCCCCC--ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDES--MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +.......  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87643221  12234578999999999876 45889999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=8.3e-30  Score=267.19  Aligned_cols=204  Identities=30%  Similarity=0.457  Sum_probs=172.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+++.+.....||+|+||.||+|++. ++..||+|.+........+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34555666689999999999999874 57789999987766556678999999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCc--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYSDNSNL--DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++++|.+++.......  ++..+..++.||+.|++||   |++||+||||+|+||+++. ++.++|+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999987654444  7788888999999999999   8899999999999999976 67999999999876532


Q ss_pred             CCCccccccccCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREG--QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ... ......+++.|+|||++...  .++.++||||+|+++|+|++|+.||...
T Consensus       162 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             CCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence            221 22234578999999998654  3788999999999999999999999754

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=274.57  Aligned_cols=207  Identities=28%  Similarity=0.501  Sum_probs=182.6

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      +++-...+..+.+++|.|.||.||.|.|+. .-.||||.++.. ..+.++|.+|+.+|+.++|||+|+++|+|..+-..|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            333344556777899999999999999964 677999998755 445688999999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          699 LVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ||+|||.+|+|.+|+++. +...+....+.|+.||..|++||   ..+.++||||.++|.++.++..||++|||+++.+.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            999999999999999875 44566677789999999999999   99999999999999999999999999999999998


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .+....+...-.+..|.|||-+....++.|+|||+|||++||+.| |-.||.++
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi  470 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI  470 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence            776655555566889999999999999999999999999999998 99999764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=5.8e-30  Score=271.70  Aligned_cols=202  Identities=30%  Similarity=0.527  Sum_probs=172.6

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|.+.+.||+|+||.||+|++.      ++..+|+|.++.......+.+.+|++++++++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999752      345689999876655555678999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc
Q 046438          700 VLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV  764 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~  764 (851)
                      ||||+++++|.+++....               ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence            999999999999986432               3478889999999999999999   8999999999999999999999


Q ss_pred             EEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          765 ARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       765 ~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ++|+|||++........ .......++..|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999976533221 11223456788999999999999999999999999999999 99998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=3.1e-30  Score=291.46  Aligned_cols=200  Identities=22%  Similarity=0.302  Sum_probs=163.9

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCC------cccceeeeeec
Q 046438          621 LLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR------NLVRIISSCTN  693 (851)
Q Consensus       621 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~  693 (851)
                      +....++|++.+.||+|+||+||+|++. .++.||||+++... ...+....|+++++.++|.      +++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999874 57889999996532 2234566788887777554      58888888876


Q ss_pred             C-CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCC--------
Q 046438          694 D-DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDM--------  763 (851)
Q Consensus       694 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~--------  763 (851)
                      + ++.++|||++ ++++.+++... ..+++..+..++.||+.|++||   |+ .||+||||||+||+++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            5 4789999998 67787777543 5688899999999999999999   65 6999999999999998765        


Q ss_pred             --------cEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          764 --------VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       764 --------~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                              .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                    49999999876432    1233467999999999999999999999999999999999999999753

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=8.2e-30  Score=267.55  Aligned_cols=202  Identities=28%  Similarity=0.490  Sum_probs=172.0

Q ss_pred             cCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|++++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            568889999999999999998743    2468999887654 3445678999999999999999999998875 456899


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++......+++..+..++.|++.|++||   |+.|++||||+|+||+++.++.++++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            999999999999976666789999999999999999999   88999999999999999999999999999998664432


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ........++..|+|||.+....++.++|||||||++||+++ |+.||....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            222223344568999999988889999999999999999986 999997654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=7.4e-30  Score=270.34  Aligned_cols=200  Identities=25%  Similarity=0.430  Sum_probs=170.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||.||+|++. ++..||+|.++... +.....+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999885 68999999887543 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSD--NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      +++++|..++...  ...+++..+..++.|++.|++|||  ++.||+||||+|+||+++.++.++|+|||.+......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999888653  336889999999999999999994  2469999999999999999999999999998765322  


Q ss_pred             ccccccccCccccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREG------QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+++.|+|||.+.+.      .++.++|+||+||++|||++|+.||...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence             12234578899999988543      3578999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=8.8e-30  Score=269.48  Aligned_cols=200  Identities=32%  Similarity=0.513  Sum_probs=170.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-----CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec--CCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN--DDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  698 (851)
                      .+|++.+.||+|+||+||+|+..     +++.||+|.++.......+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46889999999999999999742     478899999887665566789999999999999999999997644  34688


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+++++|.+++......+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999876666789999999999999999999   889999999999999999999999999999987643


Q ss_pred             CCCccc--cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          779 DESMKH--TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       779 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      ......  ....++..|+|||+..+..++.++||||+||++|||++|..|+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            322111  11223456999999988889999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.1e-29  Score=265.63  Aligned_cols=201  Identities=27%  Similarity=0.397  Sum_probs=170.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--Cee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFK  697 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  697 (851)
                      .+|++.+.||+|+||.||+|++. +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999874 58899999886432     22346788999999999999999999988764  467


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++... ..+++.....++.|++.|++||   |+++|+|+||+|+||+++.++.++|+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            8999999999999988644 4577888899999999999999   88999999999999999999999999999987653


Q ss_pred             CCCC--ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  .......++..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            2111  1122345888999999998888999999999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=1.2e-29  Score=265.57  Aligned_cols=199  Identities=30%  Similarity=0.456  Sum_probs=172.4

Q ss_pred             CCCccceeccccceEEEEEEEcCCcEEEEEEEeecc------hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL------EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      +|++.+.||+|+||.||+|...+++.+|+|.++...      ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            488899999999999999988889999999886432      22335688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|++.|++||   |+.+|+|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999999998653 4578888899999999999999   88899999999999999999999999999987542111


Q ss_pred             -----CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 -----SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                           ........++..|+|||+..+..++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence                 1112234688999999999988899999999999999999999999965

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=7.2e-30  Score=267.79  Aligned_cols=202  Identities=26%  Similarity=0.509  Sum_probs=171.6

Q ss_pred             cCCCccceeccccceEEEEEEEcC-C---cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-G---MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .+|++.+.||+|+||.||+|++.. +   ..||+|+++... ......+..|++++++++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357889999999999999998743 3   359999987543 33456799999999999999999999999998999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++......+++..+..++.|++.|++||   |++|++||||+|+||+++.++.+|++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999877667789999999999999999999   88999999999999999999999999999987654322


Q ss_pred             Ccc-ccc---cccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 SMK-HTQ---TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 ~~~-~~~---~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ... ...   ...+..|+|||+..+..++.++||||+||++||+++ |..||...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            111 111   112457999999998899999999999999999886 99999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=8.9e-30  Score=271.01  Aligned_cols=200  Identities=29%  Similarity=0.508  Sum_probs=167.0

Q ss_pred             cCCCccceeccccceEEEEEEEcC-Cc--EEEEEEEeec-chhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GM--EVAIKVFHLQ-LEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||.||+|+..+ +.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999998743 33  4788887642 233446788999999999 799999999999998899999


Q ss_pred             EeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          701 LDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      |||+++++|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeE
Confidence            99999999999886432               2477888999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          766 RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+|||++......  ........+..|+|||+..+..++.++|||||||++|||++ |+.||...
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999998643211  11112233567999999988889999999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.6e-30  Score=268.01  Aligned_cols=199  Identities=30%  Similarity=0.441  Sum_probs=175.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||.|++|.||+|++. +++.||+|++.... ......+.+|+++++.++|||++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888999999999999999875 58899999987653 33446788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++...  .+++..+..++.|++.|++||   |+++++|||++|+||++++++.++++|||.++...... ..
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence            9999999988653  788999999999999999999   88999999999999999999999999999998764332 12


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||+..+..++.++||||+||++|||++|+.||...
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~  201 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL  201 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            23456788999999999888999999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=5.8e-30  Score=270.05  Aligned_cols=202  Identities=31%  Similarity=0.521  Sum_probs=172.4

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|.+.+.||+|+||.||+|+..      ++..+|+|.+........+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788899999999999999642      356799998876656666789999999999999999999999999899999


Q ss_pred             EEeccCCCChhHHhhcCC--------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          700 VLDYMPKGSLEACLYSDN--------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      ||||+++++|.+++....              ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCE
Confidence            999999999999886532              3478888999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          766 RLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+|||++......... ......+++.|+|||+..+..++.++|||||||++|||++ |+.||...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            99999998755322211 1122345678999999998899999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=8.1e-30  Score=267.17  Aligned_cols=201  Identities=27%  Similarity=0.449  Sum_probs=174.3

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|++|.||+|++ .+++.||+|.+....   .....++.+|+++++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999987 478999999876532   223467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++++|.+++..   ....+++..++.++.||++|++||   |++|++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998753   244578899999999999999999   899999999999999999999999999999876543


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ... ......++..|+|||+..+..++.++|+||+|+++|||++|..||...
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            322 122346889999999998888999999999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=6.6e-30  Score=271.08  Aligned_cols=198  Identities=29%  Similarity=0.446  Sum_probs=164.3

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhc---CCCcccceeeeeec-----CC
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSI---RHRNLVRIISSCTN-----DD  695 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  695 (851)
                      +|++.+.||+|+||+||+|++. +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4889999999999999999885 588999999875432  2223456677777665   69999999998764     24


Q ss_pred             eeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          696 FKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ..++||||+++ ++.+++... ...+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999974 787777553 34588999999999999999999   88999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  ......+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            664322  223346789999999999889999999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=1e-29  Score=265.08  Aligned_cols=201  Identities=28%  Similarity=0.518  Sum_probs=172.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.++... ...+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46799999999999999999988777889999887542 334678899999999999999999999887 7789999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++... ....++..+..++.|++.|++||   |+.|++|+||+|+||+++.++.+||+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999998653 45578888899999999999999   88899999999999999999999999999987654322222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....++..|+|||++....++.++|+||+||++|++++ |+.||...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            222345678999999988889999999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=237.98  Aligned_cols=220  Identities=24%  Similarity=0.323  Sum_probs=182.8

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch-hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE-GALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+...-+..||+|+||.|-+-++ .+|...|+|.++.... +..++..+|+++..+. ..|.+|.+||....++..++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34455567899999999998888 4689999999976543 3345677788876655 6899999999998889999999


Q ss_pred             eccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      |.| ..+++.+..+   .+...++.-.-+|+..+.+|+.|||  .+..++|||+||+||+++.+|.+||||||.+-...+
T Consensus       125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            999 5677666433   5677888888999999999999996  456899999999999999999999999999877643


Q ss_pred             CCCccccccccCccccCccccc----cCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcccccCccc
Q 046438          779 DESMKHTQTLATIGYMAPEYGR----EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI  849 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  849 (851)
                        +...+-..|...|+|||.+.    ...|+-|+||||+|+.+.||.+++.||+.-+....++++-|.+.-|...
T Consensus       202 --SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  202 --SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             --hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence              33344456888999999874    3479999999999999999999999999988888999999988877644

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.7e-29  Score=263.00  Aligned_cols=200  Identities=26%  Similarity=0.383  Sum_probs=175.2

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||.|+||.||.++.. +++.+|+|.+....  ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4888999999999999999874 58889999887543  33456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ...+++..+..++.|+++|++||   |+.|++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999988664 45688899999999999999999   889999999999999999999999999999986643332 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+++.|.|||+..+..++.++||||+|+++|||++|+.||+..
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT  204 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence            223456899999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.7e-30  Score=279.13  Aligned_cols=191  Identities=22%  Similarity=0.314  Sum_probs=164.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ...|++.+.||+|+||.||+|+.. +++.||+|+...      .....|+.++++++||||+++++++.+....++|||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999885 467899997532      2345689999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +. +++.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||.++......  .
T Consensus       139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~  212 (357)
T PHA03209        139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A  212 (357)
T ss_pred             cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--c
Confidence            94 678888876667889999999999999999999   88999999999999999999999999999987542221  2


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      .....||+.|+|||++.+..++.++||||+||++|||+++..|+
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            23456899999999999999999999999999999999855443

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=1.1e-29  Score=267.86  Aligned_cols=202  Identities=29%  Similarity=0.478  Sum_probs=170.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCc----EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGM----EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      .++|++.+.||+|+||+||+|++. +++    .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            357889999999999999999863 444    48999987543 23346788999999999999999999998754 567


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ++|||+++|++.+++......+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999877666789999999999999999999   889999999999999999999999999999987643


Q ss_pred             CCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          779 DESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       779 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .... ......+++.|+|||...+..++.++|||||||++|||++ |..||+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  215 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI  215 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            2221 1112234678999999988899999999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1e-29  Score=264.34  Aligned_cols=195  Identities=27%  Similarity=0.510  Sum_probs=164.1

Q ss_pred             eeccccceEEEEEEEc---CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCC
Q 046438          633 LIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGS  708 (851)
Q Consensus       633 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  708 (851)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|++++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999764   355699999876532 234668899999999999999999998864 56789999999999


Q ss_pred             hhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc--cc
Q 046438          709 LEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQ  786 (851)
Q Consensus       709 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~  786 (851)
                      |.+++......+++..+..++.|+++|++||   |++|++||||||+||+++.++.+||+|||++.....+.....  ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999876667789999999999999999999   889999999999999999999999999999876543322111  11


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ..+++.|+|||+.....++.++|||||||++||+++ |+.||....
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  203 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK  203 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence            223578999999988889999999999999999996 999997643

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=6.1e-30  Score=268.93  Aligned_cols=202  Identities=28%  Similarity=0.435  Sum_probs=170.7

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecC------C
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTND------D  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~  695 (851)
                      +.+.|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+++++++ +|||++++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567899999999999999999874 58889999987553 2345688899999998 699999999988653      4


Q ss_pred             eeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          696 FKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ..++||||+++++|.+++... ...+++..+..++.|++.|++||   |+++|+|||++|+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            678999999999999988763 35678888999999999999999   78899999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...... .......+++.|+|||++.     +..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            653221 1233456899999999875     346888999999999999999999999653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=1.2e-29  Score=268.77  Aligned_cols=199  Identities=25%  Similarity=0.403  Sum_probs=174.0

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|++. +|..||+|++....  ......+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999884 68899999987654  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      + +++|.+++......+++..++.++.||++|++||   |++||+|+||+|+||+++.++.++++|||.+..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 9999999876667789999999999999999999   88899999999999999999999999999998765443222


Q ss_pred             ccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....++..|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            3345688999999988654 468999999999999999999888864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=231.60  Aligned_cols=207  Identities=26%  Similarity=0.376  Sum_probs=173.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|.-.++||+|.||+||+|+.. +++.||+|.++...  ++......+|+-+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3555688999999999999875 47789999988654  34456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      | ..+|..+..+-.+.++.+.+..++.|+++|+.++   |++.+.|||+||.|.+|+.+|+.|++|||+|+-..-+.. -
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipvr-c  157 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C  157 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence            9 5578888877788899999999999999999999   889999999999999999999999999999987644332 2


Q ss_pred             ccccccCccccCccccccCC-CCcchhhHHHHHHHHHHHh-CCCCCCccCcCccchhh
Q 046438          784 HTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMSLKR  839 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~  839 (851)
                      .+..+.|.+|.+|.++.+.. |+...|+||.|||+.|+.. |++.|.+ .+-++++++
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddqlkr  214 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKR  214 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHHHH
Confidence            23457899999999998865 7788899999999999998 5554543 333334443

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=6.6e-31  Score=278.41  Aligned_cols=198  Identities=27%  Similarity=0.465  Sum_probs=167.7

Q ss_pred             CccceeccccceEEEEEEEc-CCcEEEEEEEee----cchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--eeEEEE
Q 046438          629 NVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL----QLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD--FKALVL  701 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  701 (851)
                      +...+||+|+|-+||+|.+. +|.+||--.++.    +.+...+++..|+++++.++||||+++|++|.+..  ...+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45578999999999999874 577777543322    23455689999999999999999999999998865  478999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |.+..|+|+.|.++. +.........|++||++||.|||. |...|+|||||-+||+|+. -|.|||+|+|+|...... 
T Consensus       123 EL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            999999999998654 456777889999999999999987 6679999999999999974 689999999999987432 


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                        .....+|||.|||||+.. ..|.+.+||||||+++.||+|+.+||.+-..
T Consensus       200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n  248 (632)
T KOG0584|consen  200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN  248 (632)
T ss_pred             --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence              222368999999999998 7899999999999999999999999976433

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-30  Score=270.55  Aligned_cols=201  Identities=25%  Similarity=0.389  Sum_probs=171.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|++|+||+|+.. +++.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67999999999999999999885 6889999998754322 224567899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++ +|.+++......+++..+..++.|+++|++||   |++||+||||+|+||+++.++.+||+|||.++....... .
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  159 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T  159 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence            974 89888876666788999999999999999999   889999999999999999999999999999875432211 1


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....++..|+|||+..+ ..++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            223356889999998865 558899999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.5e-29  Score=267.56  Aligned_cols=200  Identities=27%  Similarity=0.473  Sum_probs=167.5

Q ss_pred             cCC-CccceeccccceEEEEEEE-----cCCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecC--Ce
Q 046438          626 DQF-NVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTND--DF  696 (851)
Q Consensus       626 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  696 (851)
                      ++| ++.+.||+|+||+||.++.     .++..||+|.++.... .....+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8899999999999988653     2577899999876532 2346788999999999999999999987654  36


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++++|.+++..  ..+++..+..++.|++.|++||   |++||+||||||+||++++++.++|+|||+++..
T Consensus        83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            7899999999999998854  3589999999999999999999   8889999999999999999999999999999866


Q ss_pred             CCCCCcc--ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMK--HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......  .....++..|+|||...+..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            4322111  11224566799999998888999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=1.9e-29  Score=264.50  Aligned_cols=200  Identities=26%  Similarity=0.447  Sum_probs=174.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|++|.||+|... +|+.||+|.++...   ....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999886 78999999886432   233567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++++|.+++..   ....+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999988753   244578899999999999999999   889999999999999999999999999999876543


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ... ......+++.|+|||...+..++.++||||+||++|+|++|+.||..
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            221 22334688899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=7.3e-30  Score=272.27  Aligned_cols=200  Identities=29%  Similarity=0.524  Sum_probs=166.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCc--EEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGM--EVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||.||+|++. ++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46888999999999999999874 344  35777765432 33446788999999999 899999999999999999999


Q ss_pred             EeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          701 LDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      |||+++++|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCcE
Confidence            99999999999886432               3578889999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          766 RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+|||++......  ........+..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            99999998643211  11112234667999999988889999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=1.2e-29  Score=269.47  Aligned_cols=203  Identities=23%  Similarity=0.382  Sum_probs=170.2

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999874 588999999865432 22346778999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++ +++.+++......+.+..+..++.|++.|++||   |+.||+|+||||+||+++.++.++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 677666655555677888889999999999999   888999999999999999999999999999875432211


Q ss_pred             ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||+...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence             2233457889999999875 457889999999999999999999997643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.6e-29  Score=263.61  Aligned_cols=191  Identities=23%  Similarity=0.398  Sum_probs=162.3

Q ss_pred             ceeccccceEEEEEEEcC-------------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          632 NLIGSGSFGSVYRGRFLD-------------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      +.||+|+||.||+|+...             ...||+|.+..........+.+|+.+++.++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358899887655555567889999999999999999999999888999


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc-------EEEeecc
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV-------ARLGDFG  771 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~-------~kl~Dfg  771 (851)
                      +||||+++|++..++......+++..+..++.||++|++||   |++||+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999988876666789999999999999999999   8999999999999999986654       8999999


Q ss_pred             CccccCCCCCccccccccCccccCccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCcc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIF-TRKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-~g~~pf~~~  830 (851)
                      .+......     ....++..|+|||++. +..++.++|||||||++|||+ +|+.||...
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            98654322     2245788899999886 467899999999999999997 589988653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=252.88  Aligned_cols=213  Identities=24%  Similarity=0.354  Sum_probs=182.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  699 (851)
                      ..+|.+.++||+|+|++|..++++ +.+.||+|++++..-   .+.+-.+.|..+..+. +||.+|-+..+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357899999999999999999885 477799999987542   2334466777777776 69999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |.||++||+|...+ +..+++++++++.+..+|+-|+.||   |++||+.||+|..||++|.+|++|+.|+|+++.--.+
T Consensus       329 vieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999997655 4556789999999999999999999   9999999999999999999999999999999876555


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC--cCccchhhhcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF--SGEMSLKRWVN  842 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~  842 (851)
                      ++ ..++++|||.|+|||++.+..|+..+|.|++||+++||+.|+.||+-..  ..+...+++..
T Consensus       405 gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf  468 (593)
T KOG0695|consen  405 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF  468 (593)
T ss_pred             Cc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence            44 4567899999999999999999999999999999999999999998543  34555555544

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.5e-29  Score=273.13  Aligned_cols=199  Identities=20%  Similarity=0.294  Sum_probs=166.1

Q ss_pred             ccceeccc--cceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          630 VNNLIGSG--SFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       630 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++++||+|  +|++||+++. .+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  6789999987 468999999987543  233456888999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-  782 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  782 (851)
                      ++|++.+++... ...+++..+..++.|++.|++||   |+++|+||||||+||+++.++.++++||+.+......+.. 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999988653 34588899999999999999999   8899999999999999999999999999875443211110 


Q ss_pred             -----cccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 -----KHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 -----~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                           ......++..|+|||++.+  ..++.++||||+||++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence                 0112346778999999876  468999999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=9.9e-30  Score=267.87  Aligned_cols=203  Identities=30%  Similarity=0.472  Sum_probs=169.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|++|.||+|.+.+      +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998853      5678999876443 22345688999999999999999999999988899


Q ss_pred             EEEEeccCCCChhHHhhcCC------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC---cEEEe
Q 046438          698 ALVLDYMPKGSLEACLYSDN------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM---VARLG  768 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~---~~kl~  768 (851)
                      ++||||+++++|.+++....      ..+++..+..++.||+.|++||   |+++++||||+|+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999886543      2578889999999999999999   888999999999999998654   69999


Q ss_pred             eccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          769 DFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999865322211 1112234568999999998899999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=1e-29  Score=269.32  Aligned_cols=204  Identities=25%  Similarity=0.471  Sum_probs=169.2

Q ss_pred             HhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.++.... .....+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3578999999999999999999753      245799998764432 233467889999999999999999999998889


Q ss_pred             eEEEEeccCCCChhHHhhcCC---------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEE
Q 046438          697 KALVLDYMPKGSLEACLYSDN---------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL  767 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl  767 (851)
                      .++||||+++|+|.+++....         ...+...+..++.|++.|++||   |+++|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986421         2345667888999999999999   8899999999999999999999999


Q ss_pred             eeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          768 GDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +|||+++........ ......++..|+|||...+..++.++|||||||++|||++ |+.||...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998765332211 1122345678999999998899999999999999999998 78898653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-29  Score=261.75  Aligned_cols=197  Identities=35%  Similarity=0.592  Sum_probs=173.3

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35788999999999999999987 588999999976644 4577899999999999999999999999888999999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |++||+||||+|+||+++.++.++|+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999986543 3689999999999999999999   88999999999999999999999999999998663221   


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                       .....+..|+|||+.....++.++||||+|+++||+++ |+.||...
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence             12334668999999988889999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=2e-29  Score=264.26  Aligned_cols=200  Identities=31%  Similarity=0.510  Sum_probs=171.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh---------hHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG---------ALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      +|.+...||+|++|.||+|.+. +++.||+|.+......         ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999874 5789999988654321         23568899999999999999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++++|.+++... ..+++..+..++.|++.|++||   |+.|++||||+|+||+++.++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999988653 5678888899999999999999   8889999999999999999999999999998866


Q ss_pred             CCCCC-----ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDES-----MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....     .......++..|+|||.+.+..++.++||||+||++|+|++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            42211     1112345788999999999888999999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=1.8e-29  Score=267.24  Aligned_cols=199  Identities=28%  Similarity=0.402  Sum_probs=168.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++....  .....+.+|++++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788999999999999999885 588999999865432  2345688899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSD--NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ++ +++.+++...  ...+++..+..++.|+++|++||   |++||+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 5787777543  25688999999999999999999   889999999999999999999999999999875532221


Q ss_pred             ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             2223457889999998765 45788999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=7.6e-30  Score=270.01  Aligned_cols=198  Identities=25%  Similarity=0.390  Sum_probs=168.3

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|++. +|+.||+|.++....  .....+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4888899999999999999885 588999999875422  2235677899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++ +++.+++......+++..+..++.||++|++||   |++||+||||+|+||+++.++.+||+|||.++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            96 577777766566789999999999999999999   888999999999999999999999999999876533221 2


Q ss_pred             ccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....+++.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            2334678899999988664 478999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=7e-30  Score=270.07  Aligned_cols=201  Identities=26%  Similarity=0.462  Sum_probs=169.3

Q ss_pred             CCCccceeccccceEEEEEEEcC------CcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      +|++.+.||+|+||+||+|++..      +..||+|+++..... ..+.+.+|+++++.++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            47788999999999999998632      477999998755432 34668899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcC---------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc
Q 046438          700 VLDYMPKGSLEACLYSD---------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV  764 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~  764 (851)
                      ++||+++++|.+++..+               ...+++..+..++.|++.|++|+   |++||+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCCc
Confidence            99999999999987432               23467788899999999999999   8899999999999999999999


Q ss_pred             EEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          765 ARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       765 ~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +||+|||+++....... .......+++.|+|||++.+..++.++||||+||++|||++ |..||.+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999876543221 11223345789999999988889999999999999999998 88898654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=3.3e-29  Score=262.22  Aligned_cols=200  Identities=28%  Similarity=0.420  Sum_probs=169.9

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  698 (851)
                      +|++.+.||+|+||.||+|.+. ++..||+|++....     ......+.+|++++++++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6889999999999999999874 58899999886432     22345688999999999999999999988653  5778


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ++|||+++++|.+++... ..+++.....++.|++.|++||   |+++|+|||++|+||+++.++.++|+|||++.....
T Consensus        83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            999999999999988643 3578888899999999999999   889999999999999999999999999999876532


Q ss_pred             CC--CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DE--SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..  ........++..|+|||++.+..++.++||||+||++||+++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            11  11112345788999999999888999999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.2e-29  Score=270.83  Aligned_cols=202  Identities=28%  Similarity=0.396  Sum_probs=174.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|++|+||+|+.. +++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999885 489999999876532   24567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      ||+.+++|.+++... ...+++..+..++.|+++|++||   |+.|++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999988653 35688899999999999999999   88999999999999999999999999999987543211


Q ss_pred             C----------------------------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 S----------------------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .                            .......|+..|+|||+..+..++.++||||+||++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1                            0111246788999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=1.8e-29  Score=276.93  Aligned_cols=204  Identities=27%  Similarity=0.476  Sum_probs=170.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIR-HRNLVRIISSCTNDD  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  695 (851)
                      ..++|.+.+.||+|+||.||+|++.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888999999999999999863      24679999997543 223456889999999997 999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCC----------------------------------------------------------
Q 046438          696 FKALVLDYMPKGSLEACLYSDN----------------------------------------------------------  717 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  717 (851)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999886421                                                          


Q ss_pred             ---------------------------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEE
Q 046438          718 ---------------------------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVL  758 (851)
Q Consensus       718 ---------------------------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nil  758 (851)
                                                             ..+++..+..++.||+.|++||   |+++|+||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceEE
Confidence                                                   1245667788999999999999   8899999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          759 LDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       759 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +++++.+|++|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999976532221 12223456788999999998889999999999999999998 89999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=1.6e-29  Score=269.30  Aligned_cols=204  Identities=25%  Similarity=0.434  Sum_probs=172.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||.||+|++.      .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356899999999999999999752      24579999987543 33446789999999999 79999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          697 KALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.|++||   |+++|+|+||||+||+++.++.++++|||.++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999986543 3478999999999999999999   889999999999999999999999999999976


Q ss_pred             cCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          776 LSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       776 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ....... ......++..|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            5433221 1122345778999999999999999999999999999998 999987543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=1.6e-29  Score=270.17  Aligned_cols=203  Identities=28%  Similarity=0.526  Sum_probs=171.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc--------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      .++|++.+.||+|+||.||+|++.        ++..||+|.++... ....+++.+|+++++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467899999999999999999752        24579999987543 33456789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 DFKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      ...++||||+++|+|.+++....               ..+++..+..++.||++|++||   |++||+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEEE
Confidence            99999999999999999986531               3467788899999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCcc-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          760 DEDMVARLGDFGIAKLLSGDESMK-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ++++.+||+|||.++......... .....+++.|+|||+..+..++.++||||||+++|||++ |..||...
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999998664322211 222345678999999988889999999999999999998 88888654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=2.1e-29  Score=266.98  Aligned_cols=201  Identities=26%  Similarity=0.358  Sum_probs=171.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|++|.||+|++. +++.||+|++.....  ...+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46899999999999999999885 588999998865432  223567899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++.+..+... ...+++..+..++.|++.|++||   |++||+||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            9999888776643 34688999999999999999999   889999999999999999999999999999987644322 


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            2233457889999999865 557899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=1.7e-29  Score=264.92  Aligned_cols=202  Identities=26%  Similarity=0.506  Sum_probs=171.8

Q ss_pred             cCCCccceeccccceEEEEEEEcC-C---cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-G---MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|.++... ....+.+.+|++++++++|||++++++++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467888999999999999998742 3   369999987553 33456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++......+++..+..++.|++.|++||   |+.|++|||+||+||+++.++.+|++|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999876667789999999999999999999   88899999999999999999999999999987654322


Q ss_pred             Ccccc--ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 SMKHT--QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....  ....+..|+|||+.....++.++||||+||++||+++ |+.||...
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            21111  1223457999999988889999999999999999997 99999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=2.1e-29  Score=273.40  Aligned_cols=203  Identities=25%  Similarity=0.457  Sum_probs=167.6

Q ss_pred             hcCCCccceeccccceEEEEEEE------cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC-C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF------LDGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND-D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  695 (851)
                      .++|++.+.||+|+||+||+|++      .+++.||||+++... ......+.+|++++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999974      246789999997543 22345688999999999 689999999988654 4


Q ss_pred             eeEEEEeccCCCChhHHhhcCC----------------------------------------------------------
Q 046438          696 FKALVLDYMPKGSLEACLYSDN----------------------------------------------------------  717 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  717 (851)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999998875421                                                          


Q ss_pred             --------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-ccccccc
Q 046438          718 --------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTL  788 (851)
Q Consensus       718 --------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~  788 (851)
                              ..+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    2356777788999999999999   889999999999999999999999999999876533222 1122234


Q ss_pred             cCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       789 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +++.|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            5678999999988899999999999999999997 99999754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=2.7e-29  Score=262.40  Aligned_cols=196  Identities=35%  Similarity=0.611  Sum_probs=172.2

Q ss_pred             ceeccccceEEEEEEEcC----CcEEEEEEEeecchhh-HHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQLEGA-LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|.+..    +..||+|+++...... .+.+.+|++.++.++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998854    7889999997654432 67889999999999999999999999998899999999999


Q ss_pred             CChhHHhhcC--------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          707 GSLEACLYSD--------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       707 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ++|.+++...        ...+++..++.++.|+++|++||   |++||+||||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998765        47789999999999999999999   889999999999999999999999999999987654


Q ss_pred             CCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          779 DES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       779 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ... .......++..|+|||......++.++||||+||++|||++ |+.||+..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            321 12233457889999999988889999999999999999999 69999765

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=1.1e-29  Score=269.38  Aligned_cols=196  Identities=28%  Similarity=0.397  Sum_probs=170.8

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      |.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|||++++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999874 5889999998765555567788999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      ++|.+++..  ..+++..+..++.||+.|++||   |++||+||||+|+||++++++.++|+|||++........ ....
T Consensus       104 ~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         104 GALTDIVTH--TRMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            999988743  3578889999999999999999   888999999999999999999999999999876533221 2233


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..++..|+|||...+..++.++||||+||++|||++|+.||..
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            5688999999999888899999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=1.9e-29  Score=262.68  Aligned_cols=195  Identities=29%  Similarity=0.498  Sum_probs=168.2

Q ss_pred             ceeccccceEEEEEEEcC--C--cEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFLD--G--MEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|++|+||+|.+.+  +  ..||+|.+..... ...+++.+|++++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  2  3699999987655 556789999999999999999999999988 889999999999


Q ss_pred             CChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc--c
Q 046438          707 GSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM--K  783 (851)
Q Consensus       707 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~  783 (851)
                      ++|.+++.... ..+++...+.++.|+++|++||   |++|++||||+|+||+++.++.+||+|||++.........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987654 5688999999999999999999   8899999999999999999999999999999876432211  1


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....++..|+|||+..+..++.++||||+||++|||++ |+.||...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            112456788999999998899999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-29  Score=264.53  Aligned_cols=201  Identities=26%  Similarity=0.521  Sum_probs=167.3

Q ss_pred             CCccceeccccceEEEEEEEcC----CcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe-----
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF-----  696 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  696 (851)
                      |++.+.||+|+||.||+|+...    +..||+|.++...  ......+.+|+++++.++||||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998742    3679999987542  2344678999999999999999999998765443     


Q ss_pred             -eEEEEeccCCCChhHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          697 -KALVLDYMPKGSLEACLYSD-----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       697 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                       .++||||+++|+|..++...     ...+++..+..++.|++.|++||   |+++|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887432     24578889999999999999999   8889999999999999999999999999


Q ss_pred             cCccccCCCCCcc-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          771 GIAKLLSGDESMK-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       771 g~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      |+++......... ......+..|+|||+..+..++.++||||+||++|||++ |..||.+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~  220 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE  220 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            9998664332211 112235678999999988899999999999999999999 999997643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=1.6e-29  Score=270.36  Aligned_cols=202  Identities=29%  Similarity=0.516  Sum_probs=169.4

Q ss_pred             cCCCccceeccccceEEEEEEEcC--------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      ++|.+.+.||+|+||.||+|++..        +..+|+|.++... ......+.+|+++++++ +||||+++++++.+.+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999997632        3469999987542 33446688899999999 7999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC
Q 046438          696 FKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD  760 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~  760 (851)
                      ..++||||+++|+|.+++....               ..+++..+..++.|++.|++||   |++|++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEEc
Confidence            9999999999999999986532               2477888999999999999999   888999999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCcc-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          761 EDMVARLGDFGIAKLLSGDESMK-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       761 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .++.+||+|||.++......... .....+++.|+|||+..+..++.++||||+||++|||++ |+.||...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            99999999999987653221111 112234568999999998889999999999999999998 89998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=3.9e-29  Score=260.44  Aligned_cols=200  Identities=27%  Similarity=0.422  Sum_probs=172.0

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec-CCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN-DDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  702 (851)
                      .|++.+.||+|++|.||+|++. +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999874 47889999986543  2345678899999999999999999988764 446789999


Q ss_pred             ccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |++++++.+++... ...+++..+..++.|++.|+++|   |+.||+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988663 44588999999999999999999   889999999999999999999999999999976643322


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+++.|+|||+..+..++.++||||+||++|||++|+.||+..
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence             223356889999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=2.6e-29  Score=261.52  Aligned_cols=194  Identities=36%  Similarity=0.551  Sum_probs=167.2

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeee-cCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT-NDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||.||+|.. .|..||+|.++...  ..+.+.+|+.++++++|++++++++++. +....++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4688999999999999999987 57889999986442  3467889999999999999999999754 456789999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |++||+||||+|+||++++++.+|++|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999987643 3478889999999999999999   88999999999999999999999999999987643221   


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~  829 (851)
                       ....++..|+|||+..+..++.++||||+||++|||++ |+.||..
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence             22345678999999988889999999999999999997 9999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=1.3e-29  Score=267.04  Aligned_cols=198  Identities=30%  Similarity=0.445  Sum_probs=171.9

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .|+..+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999874 57889999987543 334567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++..  ..+++..+..++.|+++|++||   |++|++|+||+|+||++++++.++++|||++....... ...
T Consensus        85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06642          85 GGGSALDLLKP--GPLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence            99999988743  4578889999999999999999   88999999999999999999999999999987654322 122


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence            3346788999999999888999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=1.4e-29  Score=269.08  Aligned_cols=196  Identities=29%  Similarity=0.399  Sum_probs=170.6

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      |+....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            444567999999999999874 6889999998765544556788999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      ++|..++..  ..+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||++....... .....
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  176 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS  176 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence            999987643  4578899999999999999999   88999999999999999999999999999987553322 12234


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  219 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS  219 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            5688999999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=2.9e-29  Score=266.28  Aligned_cols=199  Identities=31%  Similarity=0.439  Sum_probs=174.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||+||+|... +++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67999999999999999999874 57889999987655555577889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++..  ..+++..+..++.|++.|++||   |++|++|||++|+||+++.++.++|+|||++........ ..
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~  172 (293)
T cd06647          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (293)
T ss_pred             CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence            99999998854  3467888999999999999999   889999999999999999999999999998876543322 22


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....+++.|+|||......++.++|||||||++|++++|+.||...
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            3346888999999998888999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=1.9e-29  Score=267.68  Aligned_cols=201  Identities=25%  Similarity=0.457  Sum_probs=168.8

Q ss_pred             CCCccceeccccceEEEEEEEcC------CcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      +|++.+.||+|+||+||+|+...      ...+|+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47888999999999999997632      35688998865432 344678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcC-----------------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 046438          700 VLDYMPKGSLEACLYSD-----------------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSN  756 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~N  756 (851)
                      ||||+++++|.+++...                       ...+++..++.++.|++.|++||   |++||+||||+|+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhhe
Confidence            99999999999987532                       12467888899999999999999   88899999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          757 VLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       757 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |++++++.+||+|||+++........ ......++..|+|||...+..++.++||||||+++|||++ |+.||.+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999765332221 1222345678999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=2.8e-29  Score=270.21  Aligned_cols=193  Identities=24%  Similarity=0.334  Sum_probs=157.1

Q ss_pred             ceeccccceEEEEEEEc---CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec--CCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN--DDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  706 (851)
                      .+||+|+||+||+|+..   ++..||+|.++...  ....+.+|++++++++||||+++++++..  ....++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999874   35789999886542  23467889999999999999999998854  4578999999865


Q ss_pred             CChhHHhhc--------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE----CCCCcEEEeeccCcc
Q 046438          707 GSLEACLYS--------DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAK  774 (851)
Q Consensus       707 g~L~~~l~~--------~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill----~~~~~~kl~Dfg~a~  774 (851)
                       ++.+++..        ....+++..+..++.||+.|++||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             66666532        123478888899999999999999   88999999999999999    566799999999998


Q ss_pred             ccCCCCC--ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDES--MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            6543221  12233568999999999876 45789999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.6e-29  Score=265.06  Aligned_cols=202  Identities=30%  Similarity=0.477  Sum_probs=171.7

Q ss_pred             cCCCccceeccccceEEEEEEEcC-Cc----EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GM----EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|++.+.||+|+||+||+|.+.. |+    .+|+|...... ......+.+|++++++++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568899999999999999998743 33    58999876553 2344678899999999999999999999887 78899


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|.+++......+++..+..++.||+.|++||   |++||+||||+|+||+++.++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999999987666789999999999999999999   8899999999999999999999999999999876433


Q ss_pred             CCcc-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          780 ESMK-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       780 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .... .....++..|+|||......++.++|+||+||++||+++ |+.||+...
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence            2211 111223568999999988889999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.8e-29  Score=266.92  Aligned_cols=198  Identities=27%  Similarity=0.499  Sum_probs=168.8

Q ss_pred             CCCccceeccccceEEEEEEEc-----CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-----DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  698 (851)
                      -|++.+.||+|+||.||.|++.     ++..||+|.++... ....+.+.+|++++++++|||++++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4788999999999999999752     47789999987553 33346789999999999999999999988775  5688


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+++++|.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.++|+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            99999999999999866555689999999999999999999   889999999999999999999999999999986643


Q ss_pred             CCCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          779 DESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       779 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      ....  ......++..|+|||+..+..++.++||||+||++|||++++.|+
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            2221  112345677899999998888999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2e-29  Score=268.14  Aligned_cols=202  Identities=26%  Similarity=0.486  Sum_probs=168.7

Q ss_pred             cCCCccceeccccceEEEEEEEcC---------------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD---------------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIIS  689 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~  689 (851)
                      .+|++.+.||+|+||.||+|+..+               ...||+|.++... ....+.+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999987632               2348999987543 233467899999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhHHhhcCC-----------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEE
Q 046438          690 SCTNDDFKALVLDYMPKGSLEACLYSDN-----------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVL  758 (851)
Q Consensus       690 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nil  758 (851)
                      ++...+..++||||+++++|.+++....           ...++..+..++.|++.|++||   |++|++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhEE
Confidence            9999999999999999999999885421           2357788899999999999999   8899999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcc
Q 046438          759 LDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRPTDEI  830 (851)
Q Consensus       759 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~pf~~~  830 (851)
                      ++.++.+|++|||++......... ......++..|+|||+.....++.++|||||||++|||++  |..||...
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999998765332211 1122345678999999988889999999999999999998  67788654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=1.6e-29  Score=267.92  Aligned_cols=209  Identities=24%  Similarity=0.406  Sum_probs=173.4

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeee--
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCT--  692 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--  692 (851)
                      .++.+..+.++|++.+.||+|+||+||+|++. +++.+|+|+++... .....+.+|+.+++++ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34555567789999999999999999999884 57889999876532 2235678899999999 6999999999873  


Q ss_pred             ---cCCeeEEEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          693 ---NDDFKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       693 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                         ..+..++||||+++++|.+++..   ....+++..+..++.|+++|++||   |+++|+|||++|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCEE
Confidence               34578999999999999988753   345678888999999999999999   889999999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++|||++....... .......+++.|+|||++.     +..++.++||||+||++|||++|+.||...
T Consensus       165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999987654322 2223446899999999874     345788999999999999999999998754

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=3.8e-29  Score=267.30  Aligned_cols=201  Identities=25%  Similarity=0.340  Sum_probs=171.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||.||+|++. .++.||+|.+....   ....+.+.+|+++++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36889999999999999999885 47889999987543   233457889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-  780 (851)
                      ||++|++|.+++... ..+++..+..++.|++.|++||   |+.|++||||+|+||+++.++.++++|||.++...... 
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999998654 4678888899999999999999   88899999999999999999999999999886421100 


Q ss_pred             -------------CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 -------------SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                                   ........++..|+|||.+.+..++.++|+|||||++|||++|+.||.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                         00111235688999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=1.1e-29  Score=269.98  Aligned_cols=204  Identities=28%  Similarity=0.507  Sum_probs=172.0

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      ..++|++.+.||+|+||.||+|.+..      ...+|+|.++... ......+.+|+++++++ +||||+++++++.+.+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34578999999999999999998742      3679999987543 23445688999999999 7999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhc---------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC
Q 046438          696 FKALVLDYMPKGSLEACLYS---------------DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD  760 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~---------------~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~  760 (851)
                      ..++||||+++|+|.+++..               ....+++..+..++.|++.|++||   |++||+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEEEc
Confidence            99999999999999998853               234578889999999999999999   889999999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          761 EDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       761 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .++.+|++|||.++.+...... ......++..|+|||+..+..++.++|||||||++||+++ |..||...
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            9999999999999876433221 1122235678999999988899999999999999999997 99998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=250.08  Aligned_cols=196  Identities=24%  Similarity=0.341  Sum_probs=168.3

Q ss_pred             HhcCCCcc-ceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeec----CCe
Q 046438          624 ATDQFNVN-NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTN----DDF  696 (851)
Q Consensus       624 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  696 (851)
                      .+++|.+. ++||-|-.|+|..+.++ +|+.+|+|++...     ...++|++..-+. .|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677765 68999999999999874 6888999987533     5678888887666 59999999998865    347


Q ss_pred             eEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---CCCcEEEeeccC
Q 046438          697 KALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGI  772 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---~~~~~kl~Dfg~  772 (851)
                      +.+|||.|+||.|.+.+.++ ...+++.++..|+.||+.|+.||   |+..|.|||+||+|++..   .+..+|++|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            78999999999999888764 45699999999999999999999   999999999999999996   466899999999


Q ss_pred             ccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+.....  ....+.+.||.|.|||++....|+..+|+||+||++|-|++|.+||-.
T Consensus       211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence            9876432  344567889999999999999999999999999999999999999954

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.6e-29  Score=260.89  Aligned_cols=201  Identities=27%  Similarity=0.405  Sum_probs=170.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--Cee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFK  697 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  697 (851)
                      .+|++.+.||+|++|.||+|++. ++..||+|.+....     ......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46899999999999999999874 58899999875321     23446788999999999999999999998664  467


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++... ..+++.....++.|++.|++||   |++|++|+||+|+||+++.++.++|+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            8999999999999988643 3478888899999999999999   88999999999999999999999999999997653


Q ss_pred             CCC--CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDE--SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  ........++..|+|||+..+..++.++|+|||||++||+++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            211  11122356889999999999888999999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=2.5e-29  Score=264.03  Aligned_cols=191  Identities=24%  Similarity=0.417  Sum_probs=160.7

Q ss_pred             eeccccceEEEEEEEcC-------------------------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccce
Q 046438          633 LIGSGSFGSVYRGRFLD-------------------------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI  687 (851)
Q Consensus       633 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  687 (851)
                      .||+|+||.||+|....                         ...||+|++..........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997521                         13488998876555455678899999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC----
Q 046438          688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM----  763 (851)
Q Consensus       688 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~----  763 (851)
                      ++++.+....++||||+++|+|..++......+++..+..++.||++|++||   |++||+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999998876667788999999999999999999   889999999999999997543    


Q ss_pred             ---cEEEeeccCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCCccC
Q 046438          764 ---VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIF-TRKRPTDEIF  831 (851)
Q Consensus       764 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-~g~~pf~~~~  831 (851)
                         .+|++|||.+......     ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence               4899999987644221     12356788999998865 56899999999999999984 6999997643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=2.8e-29  Score=264.33  Aligned_cols=202  Identities=24%  Similarity=0.451  Sum_probs=172.6

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      ++|++.+.||+|+||+||+|+..      ..+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56889999999999999999864      2456999988654433 4567999999999999999999999999988999


Q ss_pred             EEEeccCCCChhHHhhcCC--------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          699 LVLDYMPKGSLEACLYSDN--------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++||   |+.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999986533        1578999999999999999999   8999999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          771 GIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       771 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |++...............++..|+|||...+..++.++||||+||++|++++ |..||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~  222 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL  222 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            9987543332223333456788999999988889999999999999999998 88898654

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.7e-29  Score=259.57  Aligned_cols=196  Identities=31%  Similarity=0.533  Sum_probs=168.7

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChh
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE  710 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  710 (851)
                      ++||+|++|.||+|.+.+++.||+|+++..... ....+.+|++++++++||||+++++++.+....++||||++++++.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999866999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc-ccccc
Q 046438          711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH-TQTLA  789 (851)
Q Consensus       711 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~  789 (851)
                      +++.......++..+..++.++++|++||   |+++++||||+|+||+++.++.++|+|||.+........... .....
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99876666788889999999999999999   889999999999999999999999999999876532211111 12234


Q ss_pred             CccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       790 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +..|+|||.+.+..++.++|+||+||++|||++ |..||...
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~  199 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM  199 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence            567999999988889999999999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=1.7e-29  Score=263.29  Aligned_cols=199  Identities=32%  Similarity=0.420  Sum_probs=175.5

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      +|++.+.||+|+||.||+|++. ++..||+|++....   ....+.+.+|++++++++||||+++++.+.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999885 58999999987543   2345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++++|..++... ..+++..+..++.|+++|++||   |.+|++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999988654 5788899999999999999999   88899999999999999999999999999987654332  


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......++..|+|||+..+..++.++|+||+|+++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            2234568889999999988889999999999999999999999998643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=4.7e-29  Score=260.93  Aligned_cols=201  Identities=28%  Similarity=0.396  Sum_probs=177.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|++|.||+|++. +++.||+|++..... ...+.+.+|++++.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36889999999999999999886 489999999876543 3457799999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ..+++..+..++.|+++|++||   |+ +|++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            9999999998654 5688999999999999999999   88 9999999999999999999999999999987643332 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......++..|+|||...+..++.++|+||||+++|||++|+.||....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            2223467889999999998899999999999999999999999997754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=3.7e-29  Score=266.70  Aligned_cols=198  Identities=26%  Similarity=0.391  Sum_probs=170.1

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-----hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-----ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      +|++.+.||+|++|.||+|.+. +++.||+|.++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999874 5899999999755322     234577899999999999999999999998999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+ +++|.+++......+++..+..++.||++|++||   |++||+||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8999999866545789999999999999999999   88999999999999999999999999999998764332


Q ss_pred             CccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      . ......+++.|+|||.+.+ ..++.++||||+||++|||++|..||..
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            2 2223456788999998754 4678899999999999999999888765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.3e-29  Score=265.37  Aligned_cols=203  Identities=28%  Similarity=0.483  Sum_probs=171.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||.||+|.+..      +..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578999999999999999997742      3679999986543 23345788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCC---------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          698 ALVLDYMPKGSLEACLYSDN---------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|++||   |+.+|+||||+|+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999886422         2367788899999999999999   88999999999999999999999999


Q ss_pred             eccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          769 DFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |||+++....... .......++..|+|||...+..++.++|||||||++||+++ |+.||...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  225 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL  225 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence            9999876543322 12223456788999999988889999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=2e-29  Score=263.89  Aligned_cols=199  Identities=26%  Similarity=0.398  Sum_probs=175.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999885 58899999987653 23446688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++......++......++.|+++|++||   |+ .|++||||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            999999999876557788899999999999999999   88 9999999999999999999999999999876532211 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        ....++..|+|||...+..++.++||||+|+++|+|++|+.||...
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence              1256888999999998889999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=4.2e-29  Score=263.08  Aligned_cols=199  Identities=29%  Similarity=0.458  Sum_probs=173.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ..|+..+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++++.||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34778899999999999999875 58899999987543 34457789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++..  ..+++..+..++.|++.|++||   |+.+++|+||+|+||+++.++.++++|||.+........ .
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            999999998853  4578888899999999999999   889999999999999999999999999999976543221 2


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....++..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            22346788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=5e-29  Score=259.78  Aligned_cols=199  Identities=31%  Similarity=0.626  Sum_probs=172.1

Q ss_pred             CCccceeccccceEEEEEEEcC-----CcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +++.+.||+|+||.||+|++.+     +..||+|+++..... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4577899999999999998853     378999999765433 4578999999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCC-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      ||++++++.+++...... +++..+..++.|++.|++||   |+.|++||||+|+||+++.++.++++|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998664444 89999999999999999999   89999999999999999999999999999998765432


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~  829 (851)
                      ........+++.|+|||...+..++.++||||+|+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            222212336789999999988889999999999999999998 8889865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=4.9e-29  Score=261.27  Aligned_cols=203  Identities=29%  Similarity=0.439  Sum_probs=175.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||.|++|+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..+...++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46899999999999999999874 57889999986543 23557789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC--CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSD--NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ++++++.+++...  ...+++..+..++.|++.|++||   |++||+|||++|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999998653  24688999999999999999999   889999999999999999999999999999876654322


Q ss_pred             c---cccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 M---KHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .   ......++..|+|||++... .++.++|+||+||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  211 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP  211 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence            2   12334688999999998776 78999999999999999999999997643

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=5.6e-29  Score=259.40  Aligned_cols=199  Identities=32%  Similarity=0.441  Sum_probs=172.9

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      +|+..+.||+|++|+||+|... +++.||+|.+....     ....+.+.+|+++++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999885 68999999986543     22446788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|+++|++||   |+.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999988654 4578888999999999999999   88999999999999999999999999999987654322


Q ss_pred             CccccccccCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                        ......++..|+|||...... ++.++|+||+||++|+|++|+.||....
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence              223456889999999987766 8999999999999999999999997643

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=4.1e-29  Score=262.63  Aligned_cols=200  Identities=26%  Similarity=0.484  Sum_probs=164.4

Q ss_pred             CCccceeccccceEEEEEEEcC-Cc--EEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC------Ce
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLD-GM--EVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND------DF  696 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  696 (851)
                      |.+.+.||+|+||.||+|++.+ +.  .||+|.++...  ....+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998754 32  58999886542  34457788999999999999999999976432      25


Q ss_pred             eEEEEeccCCCChhHHhhc-----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          697 KALVLDYMPKGSLEACLYS-----DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      .++||||+++|+|.+++..     ....+++.....++.|++.|++||   |++||+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999887642     223478888999999999999999   78899999999999999999999999999


Q ss_pred             CccccCCCCCcc-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          772 IAKLLSGDESMK-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +++......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            998764332211 122345778999999999999999999999999999999 89999753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=3e-29  Score=265.29  Aligned_cols=200  Identities=25%  Similarity=0.380  Sum_probs=172.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888999999999999999875 58889999887543 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++.. .+.+++..+..++.+++.|+.|||  +..+++||||+|+||+++.++.++|+|||++......   .
T Consensus        85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~  158 (284)
T cd06620          85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---I  158 (284)
T ss_pred             CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---c
Confidence            999999988754 346889999999999999999995  2358999999999999999999999999998654221   1


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....++..|+|||++.+..++.++|+||+||++||+++|+.||+...
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            223468999999999988889999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=6.5e-29  Score=259.91  Aligned_cols=200  Identities=32%  Similarity=0.505  Sum_probs=173.9

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|... +++.||+|.++.....  ..+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999874 6889999998765442  567899999999999999999999999988999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++... ...++..+..++.|+++|++||   |+.||+|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999988654 4478888999999999999999   88999999999999999999999999999988764432211


Q ss_pred             ---ccccccCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 ---HTQTLATIGYMAPEYGREGQ---ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ---~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                         .....+++.|+|||++.+..   ++.++||||||+++||+++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence               11346788999999988766   889999999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=4.2e-29  Score=263.95  Aligned_cols=209  Identities=28%  Similarity=0.434  Sum_probs=173.8

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeec-
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTN-  693 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  693 (851)
                      ++.+...+.+.|++.+.+|+|+||.||+|++. +++.||+|++.... .....+..|+.+++++ +|||++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            45555566788999999999999999999884 58889999986553 3345688899999998 69999999998853 


Q ss_pred             -----CCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEE
Q 046438          694 -----DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL  767 (851)
Q Consensus       694 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl  767 (851)
                           ....+++|||+++|+|.+++... ...+++..+..++.|++.|++||   |+.||+|||++|+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence                 45789999999999999988653 34577888889999999999999   8889999999999999999999999


Q ss_pred             eeccCccccCCCCCccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          768 GDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +|||++........ ......+++.|+|||++.     ...++.++||||+||++|||++|+.||...
T Consensus       163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            99999875432111 223356889999999875     356888999999999999999999999654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=243.61  Aligned_cols=210  Identities=27%  Similarity=0.328  Sum_probs=170.2

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEecc
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+++..+|+|+.|.|+++++. .|..+|||.+.... ..+..++.+.++++.+-+ .|.||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            455678999999999999985 48889999997654 334566777778776664 799999999999988889999998


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      . .-.+.+++.-..++++.-.-++...+..||.||.+.  +||+|||+||+||++|+.|.+|+||||.+-.+.+  +..+
T Consensus       174 s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAh  248 (391)
T KOG0983|consen  174 S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAH  248 (391)
T ss_pred             H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec--cccc
Confidence            4 455666666667788888888999999999999744  5799999999999999999999999999876643  3345


Q ss_pred             cccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcc
Q 046438          785 TQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN  842 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  842 (851)
                      +...|.+.|||||.+..   ..|+.++||||||+.++|+.||+.||.+...+.+.+....+
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln  309 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN  309 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence            55679999999999864   46889999999999999999999999874444444444333

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=3.8e-29  Score=268.36  Aligned_cols=202  Identities=28%  Similarity=0.516  Sum_probs=169.2

Q ss_pred             cCCCccceeccccceEEEEEEEc--------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      ++|.+.+.||+|+||.||+|++.        ....||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57889999999999999999752        24569999987543 23456788999999999 6999999999999888


Q ss_pred             eeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC
Q 046438          696 FKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD  760 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~  760 (851)
                      ..++||||+++|+|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEEEc
Confidence            9999999999999999986532               3478888899999999999999   889999999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          761 EDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       761 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +++.+||+|||.++........ ......++..|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999865432211 1112234567999999988899999999999999999999 89998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=5.4e-29  Score=261.13  Aligned_cols=197  Identities=27%  Similarity=0.450  Sum_probs=160.9

Q ss_pred             ceeccccceEEEEEEEcC---CcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFLD---GMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||.||+|++.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643   45799998875432 23356888999999999999999999999888999999999999


Q ss_pred             ChhHHhhcC----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-c
Q 046438          708 SLEACLYSD----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-M  782 (851)
Q Consensus       708 ~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~  782 (851)
                      +|.+++...    ....++..+..++.|++.|++||   |+.+++|+||||+||+++.++.+|++|||.+........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999988642    22456667788999999999999   889999999999999999999999999999875432221 1


Q ss_pred             cccccccCccccCccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREG-------QISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ......++..|+|||++.+.       .++.++|+|||||++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  214 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS  214 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            11234567889999987542       35789999999999999996 999997543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=1e-28  Score=258.20  Aligned_cols=202  Identities=25%  Similarity=0.318  Sum_probs=167.4

Q ss_pred             HHHHHHhcCCCcccee--ccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          619 QELLQATDQFNVNNLI--GSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      .+.....++|++.+.+  |+|+||.||+++.. ++..+|+|.+.......     .|......+ +|||++++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            4445556778888877  99999999999874 58889999986542211     122222222 699999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIA  773 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a  773 (851)
                      +..++||||+++++|.+++.... .+++..+..++.|+++|++||   |+.|++||||+|+||+++.++ .++|+|||.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999886543 789999999999999999999   889999999999999999988 9999999998


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE  834 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  834 (851)
                      ......     ....++..|+|||++.+..++.++||||+||++|||++|+.||....+.+
T Consensus       158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~  213 (267)
T PHA03390        158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE  213 (267)
T ss_pred             eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence            765322     23457899999999998899999999999999999999999998554433

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=6e-29  Score=258.81  Aligned_cols=199  Identities=27%  Similarity=0.422  Sum_probs=173.1

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|+||.||+++.. +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999874 58899999987532  33446789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++... ....++..+..++.|++.|++||   |++|++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            9999999988654 34578888999999999999999   889999999999999999999999999999976543221 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......+++.|+|||+..+..++.++|+|||||++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            12234578899999999888899999999999999999999999965

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=272.82  Aligned_cols=199  Identities=27%  Similarity=0.462  Sum_probs=173.1

Q ss_pred             CCccceeccccceEEEEEEEc--CCc--EEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL--DGM--EVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .+..+.||+|.||+|++|.|.  +|+  .||||+++..... ...+|.+|+.+|.+++|||++++||+..+ ....||||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345688999999999999885  344  4899999876654 67899999999999999999999999987 56789999


Q ss_pred             ccCCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      .++.|+|.+.++. ....+-......++.|||.|++||   ..++.||||+.++|+++-....|||+|||+.+.....+.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999987 455677788889999999999999   999999999999999999999999999999998765544


Q ss_pred             ccccc--cccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          782 MKHTQ--TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       782 ~~~~~--~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....  .-....|+|||.+....++.++|||+|||.+|||++ |+.||-+.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~  319 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC  319 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence            33322  234678999999999999999999999999999999 99999763

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=4.1e-29  Score=262.12  Aligned_cols=196  Identities=23%  Similarity=0.406  Sum_probs=158.8

Q ss_pred             ceeccccceEEEEEEEcC---CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFLD---GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||+||+|+...   ...+|+|.+.... ......+.+|+++++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   3468888775443 223456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCC----CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-
Q 046438          708 SLEACLYSDNS----NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-  782 (851)
Q Consensus       708 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  782 (851)
                      +|.+++.....    ..++.....++.||+.|++||   |++||+||||||+||++++++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865432    235677788999999999999   8899999999999999999999999999998654322211 


Q ss_pred             cccccccCccccCccccc-------cCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGR-------EGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ......+++.|+|||+..       ...++.++||||+||++|||++ |..||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            112234567899999864       3456889999999999999999 88898654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.96  E-value=4.9e-29  Score=259.51  Aligned_cols=193  Identities=27%  Similarity=0.485  Sum_probs=162.5

Q ss_pred             eeccccceEEEEEEEc---CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          633 LIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       633 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      .||+|+||.||+|.+.   ++..+|+|+++....  ...+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   478899999865432  234678899999999999999999998854 4678999999999


Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc--cc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK--HT  785 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~  785 (851)
                      +|.+++... ..+++..+..++.|++.|++||   |++||+||||||.||+++.++.+||+|||.++.........  ..
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999988543 4688899999999999999999   88999999999999999999999999999998664332211  11


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...++..|+|||......++.++|+|||||++|||++ |+.||...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2234578999999988889999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=4.2e-29  Score=263.70  Aligned_cols=203  Identities=26%  Similarity=0.428  Sum_probs=171.8

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeec-CCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTN-DDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  697 (851)
                      .++|++.+.||+|+||.||+|.+.+     +..||+|++.... ....+.+.+|++++++++||||+++++++.+ ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678999999999999999998865     6889999887543 3345678899999999999999999998766 4678


Q ss_pred             EEEEeccCCCChhHHhhcCC-------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          698 ALVLDYMPKGSLEACLYSDN-------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                      ++++||+++++|.+++....       ..+++..+..++.|++.|++||   |+++++||||+|+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999886532       4578999999999999999999   8899999999999999999999999999


Q ss_pred             cCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          771 GIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       771 g~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |+++.+...... ......++..|+|||+..+..++.++||||+||++||+++ |+.||...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            999765332211 1122345678999999998899999999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=2.5e-29  Score=266.42  Aligned_cols=199  Identities=27%  Similarity=0.394  Sum_probs=170.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++......  ..+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999985 5889999987643322  24567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++++..+... ...+++..+..++.||++|++||   |+.||+|||++|+||++++++.++|+|||++....... .
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~  155 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E  155 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence            9999988876643 34588999999999999999999   88899999999999999999999999999987654332 2


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......++..|+|||+..+ ..++.++|||||||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            2233567899999998865 4578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=4.4e-29  Score=265.90  Aligned_cols=203  Identities=28%  Similarity=0.461  Sum_probs=171.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-----------------CcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-----------------GMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVR  686 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  686 (851)
                      ..+|++.+.||+|+||.||+|++..                 +..||+|.+..... ...+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3579999999999999999997642                 24589999876532 34567889999999999999999


Q ss_pred             eeeeeecCCeeEEEEeccCCCChhHHhhcCC----------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 046438          687 IISSCTNDDFKALVLDYMPKGSLEACLYSDN----------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSN  756 (851)
Q Consensus       687 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~N  756 (851)
                      +++++..++..++||||+++++|.+++....          ..+++..++.++.|++.|++||   |++||+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhc
Confidence            9999999899999999999999999886533          2678899999999999999999   88899999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcc
Q 046438          757 VLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRPTDEI  830 (851)
Q Consensus       757 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~pf~~~  830 (851)
                      |+++.++.++|+|||+++........ ......+++.|+|||+..+..++.++|||||||++|||++  |..||...
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            99999999999999998765332211 1223456788999999988889999999999999999998  77888654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.96  E-value=3.7e-29  Score=266.23  Aligned_cols=202  Identities=23%  Similarity=0.459  Sum_probs=168.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-----------------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccce
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-----------------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRI  687 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  687 (851)
                      ++|++.+.||+|+||.||+|++.                 ++..||+|+++... .....++.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56999999999999999998642                 23468999987543 3344678999999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCChhHHhhcCC----------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCE
Q 046438          688 ISSCTNDDFKALVLDYMPKGSLEACLYSDN----------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNV  757 (851)
Q Consensus       688 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Ni  757 (851)
                      ++++.+.+..++||||+++++|.+++....          ..+++..+..++.|++.|++||   |++||+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChheE
Confidence            999999999999999999999999886532          2356778899999999999999   888999999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCCcc-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcc
Q 046438          758 LLDEDMVARLGDFGIAKLLSGDESMK-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT--RKRPTDEI  830 (851)
Q Consensus       758 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~pf~~~  830 (851)
                      +++.++.++++|||+++......... .....+++.|+|||+.....++.++|||||||++|||++  |..||...
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999987653322111 122334678999999888889999999999999999998  77888654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=3.7e-29  Score=265.63  Aligned_cols=209  Identities=27%  Similarity=0.381  Sum_probs=173.8

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      ..+++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34555566789999999999999999999884 58899999986542 2235677899999998 799999999988653


Q ss_pred             -----CeeEEEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          695 -----DFKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       695 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                           +..++||||+++++|.+++..   ....+++..++.++.|++.|++||   |++||+||||+|+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEE
Confidence                 358999999999999988753   345688899999999999999999   888999999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccCccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-----QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+|||++........ ......++..|+|||++...     .++.++||||+||++|||++|+.||...
T Consensus       169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            999999876543221 22334678999999987543     3688999999999999999999999764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=6.1e-29  Score=260.73  Aligned_cols=199  Identities=28%  Similarity=0.454  Sum_probs=171.2

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc------hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL------EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      +|+..+.||+|++|.||+|+. .+++.||+|++....      ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999987 468899999987543      1234678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCccccCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSG  778 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~  778 (851)
                      ||||+++++|.+++... ..+++..+..++.|++.|++||   |++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999988643 4678889999999999999999   889999999999999998775 699999999877643


Q ss_pred             CCC---ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          779 DES---MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       779 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...   .......++..|+|||+..+..++.++||||+||++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            321   111234678899999999888899999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.2e-30  Score=267.59  Aligned_cols=212  Identities=26%  Similarity=0.363  Sum_probs=177.9

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      -|..++.||-|+||.|..++- .+...||+|.+++..   ..+....+.|.+||..-..+.||++|..|++++.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            366778999999999999965 346679999987654   4556778899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc------
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL------  776 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~------  776 (851)
                      |++||++.+++... +-+.+..++.++.++..|+++.   |+.|++||||||+|||||.+|++||.|||+|.-.      
T Consensus       710 YIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            99999999988653 4567777778888999999999   9999999999999999999999999999998632      


Q ss_pred             ---CC-----CCC---------------------------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHH
Q 046438          777 ---SG-----DES---------------------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF  821 (851)
Q Consensus       777 ---~~-----~~~---------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~  821 (851)
                         ..     .+.                           ......+||+.|+|||++....|+..+|.||.|||+|||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence               10     000                           0011246999999999999999999999999999999999


Q ss_pred             hCCCCCCccCcCcc--chhhhcc
Q 046438          822 TRKRPTDEIFSGEM--SLKRWVN  842 (851)
Q Consensus       822 ~g~~pf~~~~~~~~--~~~~~~~  842 (851)
                      .|+.||-...+++.  .+..|..
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~  888 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRN  888 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhh
Confidence            99999988776665  4455654

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=5.8e-29  Score=259.48  Aligned_cols=189  Identities=25%  Similarity=0.484  Sum_probs=161.8

Q ss_pred             ceeccccceEEEEEEEcCCc-----------EEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          632 NLIGSGSFGSVYRGRFLDGM-----------EVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...+.+|++++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999885432           4788877654333 5778999999999999999999999887 778999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-------cEEEeeccCc
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-------VARLGDFGIA  773 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-------~~kl~Dfg~a  773 (851)
                      |||+++|+|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999877665788999999999999999999   889999999999999999887       7999999998


Q ss_pred             cccCCCCCccccccccCccccCccccccC--CCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREG--QISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....     .....++..|+|||++...  .++.++||||+||++||+++ |..||...
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            76532     1223467789999998776  78999999999999999999 68888665

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=4.1e-29  Score=265.03  Aligned_cols=200  Identities=28%  Similarity=0.398  Sum_probs=172.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.++...  ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999885 58899999886542  2234678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++.+..+.. ....+++..+..++.||+.|++||   |.+|++|||++|+||++++++.+||+|||.+.........
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            999877766553 345588999999999999999999   8889999999999999999999999999999876544332


Q ss_pred             cccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......++..|+|||+..+. .++.++||||+|+++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            33345678999999999887 889999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=7.5e-29  Score=262.60  Aligned_cols=202  Identities=30%  Similarity=0.432  Sum_probs=177.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..+.|++.+.+|+|++|.||+|.+. ++..||+|+++.... ..+.+.+|++.+++++|+|++++++.+...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566888899999999999999885 688999999986544 45678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++++|.+++......+++..+..++.|++.|++||   |+.||+|+|++|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            9999999999876555789999999999999999999   889999999999999999999999999999876543221 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+++.|+|||+..+..++.++|||||||++|+|++|+.||...
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            222345788999999998888999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=7.2e-29  Score=262.44  Aligned_cols=199  Identities=27%  Similarity=0.397  Sum_probs=163.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHH-HhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEV-LRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||.||+|++. +|+.||+|+++.... .....+..|.++ ++..+|||++++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999885 589999999876532 222344455554 666789999999999999999999999


Q ss_pred             ccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          703 YMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       703 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      |++ |+|.+++..   ....+++..+..++.||+.|++||   |++ +++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 677776643   335688999999999999999999   776 999999999999999999999999999876532


Q ss_pred             CCCccccccccCccccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGRE----GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..  ......++..|+|||++.+    ..++.++|+||+||++|||++|+.||...
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence            21  2223467889999998764    45688999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=1e-28  Score=257.04  Aligned_cols=199  Identities=30%  Similarity=0.505  Sum_probs=172.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4888999999999999999874 68889999987542  23456788999999999999999999999988999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~a~~~~~~~~  781 (851)
                      +++++|.+++... ...+++..+..++.|+++|++||   |++||+||||+|+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            9999999998764 34578899999999999999999   88999999999999999854 468999999998764322 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......++..|+|||...+..++.++||||+|+++|+|++|+.||+..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence             222346788999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=9.6e-29  Score=259.77  Aligned_cols=199  Identities=27%  Similarity=0.494  Sum_probs=169.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch----------hhHHHHHHHHHHHhhcCCCcccceeeeeecCC
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE----------GALESFNAECEVLRSIRHRNLVRIISSCTNDD  695 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  695 (851)
                      +|.+.+.||+|++|.||+|... +++.||+|.++....          ...+.+.+|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999774 588999998864311          12346788999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++||||+++++|.+++... ..+++..+..++.||+.|++||   |+++++||||+|+||+++.++.++++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999988654 5688888999999999999999   889999999999999999999999999999876


Q ss_pred             cCCCCC-ccccccccCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          776 LSGDES-MKHTQTLATIGYMAPEYGREGQ--ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       776 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...... .......++..|+|||+.....  ++.++||||+|+++||+++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            532211 1122346788999999987654  78999999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-31  Score=297.00  Aligned_cols=200  Identities=30%  Similarity=0.441  Sum_probs=170.5

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|+-...||.|.||.||.|.. .+|+-.|+|-++.....  ....+.+|..++..++|||+|++||+-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            467778999999999999987 45888999977654322  234578999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC---
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---  780 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~---  780 (851)
                      |++|+|.+.+.. ++-.++.....+..|++.|++||   |++|||||||||.||+++.+|.+|.+|||.|..+....   
T Consensus      1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            999999998854 34456666677899999999999   89999999999999999999999999999998876543   


Q ss_pred             CccccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ........||+-|||||++.+   .+...++||||+|||+.||+||+.||...
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence            122335689999999999975   35677899999999999999999999764

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=9.4e-29  Score=262.42  Aligned_cols=199  Identities=30%  Similarity=0.403  Sum_probs=169.8

Q ss_pred             CCCccceeccccceEEEEEEEc----CCcEEEEEEEeecch----hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCee
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQLE----GALESFNAECEVLRSI-RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  697 (851)
                      .|++.+.||+|+||.||+|+..    +|..||+|+++....    ...+.+.+|+++++++ +|++|+++++.++.+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999863    688899999875321    2346678899999999 589999999999998899


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++... ..+++..+..++.|+++|++||   |+.|++||||+|+||++++++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            9999999999999988654 4578888888999999999999   88999999999999999999999999999998764


Q ss_pred             CCCCccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...........++..|+|||....  ..++.++||||+|+++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            433223334568899999999865  3467899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=266.59  Aligned_cols=201  Identities=23%  Similarity=0.333  Sum_probs=176.7

Q ss_pred             cCCCccceeccccceEEEEEEEcCCc-EEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGM-EVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+++.+..+|-|+||.|-.++..+.. .+|+|++++..   ..+.+.+..|-++|...+.|.||++|..|.+.+..|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45677788999999999999875433 38999887543   345577889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |-|=||.++..+..+ +.++......++..+.+|++||   |++||+.||+||+|.+++.+|.+|+.|||+|+.+.... 
T Consensus       500 EaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             HhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            999999999998654 5677778888999999999999   99999999999999999999999999999999875432 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                       ...+++|||.|.|||++.++.++.++|.||+|+++||+++|.+||.+..+
T Consensus       575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence             45578999999999999999999999999999999999999999987443

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=6.2e-29  Score=265.27  Aligned_cols=201  Identities=31%  Similarity=0.525  Sum_probs=168.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCc----EEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGM----EVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56788899999999999999874 343    478888765432 2334688999999999999999999998754 4679


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ++||+++|++.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            9999999999999877666788899999999999999999   8899999999999999999999999999999866432


Q ss_pred             CCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ... ......++..|+|||+..+..++.++|||||||++|||++ |+.||.+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            221 1222345678999999998899999999999999999997 99999754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.2e-29  Score=261.06  Aligned_cols=198  Identities=28%  Similarity=0.483  Sum_probs=171.5

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcC---CCcccceeeeeecCCeeEEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIR---HRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .|++.+.||+|+||.||+|.+ .+++.||+|.++... ....+.+.+|++++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999987 468899999987543 334567889999999996   999999999999988999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++++|.+++..  ..+++..+..++.|+++|++||   |+.||+||||+|+||+++.++.++++|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            99999999998754  3688999999999999999999   88999999999999999999999999999998765433 


Q ss_pred             ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......++..|+|||...+ ..++.++||||+||++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  205 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV  205 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence            22334568899999998765 45788999999999999999999999754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=1.5e-28  Score=258.98  Aligned_cols=198  Identities=31%  Similarity=0.461  Sum_probs=172.2

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      -|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778899999999999999874 68899999986543 334467889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +++++.+++..  ..+++..+..++.|++.|++||   |+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06641          85 GGGSALDLLEP--GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence            99999988743  4578899999999999999999   89999999999999999999999999999987654322 122


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....++..|+|||...+..++.++|+||+||++|+|++|..||...
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            3356788999999998888899999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.3e-28  Score=260.30  Aligned_cols=197  Identities=27%  Similarity=0.390  Sum_probs=171.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      .|...+.||+|++|.||+|... +++.+|+|.++.......+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999874 688899999876544455678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++..  ..+++..+..++.|++.|++||   |++||+||||+|+||+++.++.++++|||.+........ ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            9999998865  4578889999999999999999   889999999999999999999999999998875543222 223


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...+++.|+|||...+..++.++||||+||++|||++|+.||..
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence            35688999999999888899999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1.6e-28  Score=254.98  Aligned_cols=199  Identities=33%  Similarity=0.507  Sum_probs=177.8

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      +|++.+.||+|++|.||+|.+. +++.+++|++..........+.+|++++++++||+++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999885 688999999987655456789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++......+++..+..++.|+++|+++|   |.+|++|||++|+||++++++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            9999998876556789999999999999999999   889999999999999999999999999999887654321  23


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...++..|+|||...+..++.++||||+|+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            456889999999998888999999999999999999999999764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=8.8e-29  Score=259.59  Aligned_cols=194  Identities=29%  Similarity=0.525  Sum_probs=161.3

Q ss_pred             ceeccccceEEEEEEEcC-Cc--EEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFLD-GM--EVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|++.+ +.  .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998854 43  46888876432 33446788999999999 799999999999999999999999999


Q ss_pred             CChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          707 GSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       707 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      |+|.+++....               ..+++..+..++.|++.|++||   |+.|++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999886432               2467888999999999999999   88999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ++.....  .........+..|+|||+.....++.++|||||||++|||++ |..||...
T Consensus       158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            9863321  111112234667999999988889999999999999999997 99999653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=5.6e-29  Score=263.83  Aligned_cols=203  Identities=26%  Similarity=0.469  Sum_probs=170.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||.||+|++.      ++..||+|+++.... .....+.+|++++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357899999999999999999863      467899999875532 3346688999999999999999999999998899


Q ss_pred             EEEEeccCCCChhHHhhcCC---------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 046438          698 ALVLDYMPKGSLEACLYSDN---------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSN  756 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~N  756 (851)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.|++||   |+++++||||+|+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhh
Confidence            99999999999999986421                     2467788899999999999999   88899999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          757 VLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       757 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |+++.++.++|+|||++......... .......+..|+|||...+..++.++|||||||++|||++ |..||.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999998765332211 1122345678999999988899999999999999999998 88898653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=6.3e-29  Score=269.05  Aligned_cols=202  Identities=28%  Similarity=0.514  Sum_probs=169.2

Q ss_pred             cCCCccceeccccceEEEEEEEcC--------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      .+|++.+.||+|+||.||+|++..        +..||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468999999999999999997521        2368999887543 23456788999999999 7999999999999988


Q ss_pred             eeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC
Q 046438          696 FKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD  760 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~  760 (851)
                      ..+++|||+++|+|.+++....               ..+++..+..++.|+++|++||   |++||+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEc
Confidence            9999999999999999986431               2467788889999999999999   889999999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          761 EDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       761 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .++.+||+|||+++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            9999999999999765432211 1122234568999999999999999999999999999998 88998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=7.6e-29  Score=257.64  Aligned_cols=194  Identities=29%  Similarity=0.579  Sum_probs=167.1

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||.||++.. .++.||+|+++...  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4589999999999999999975 77889999986543  336788999999999999999999998764 4789999999


Q ss_pred             CCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          706 KGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       706 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +++|.+++.... ..+++..+..++.|++.|++||   |+.|++|||++|+||+++.++.+||+|||.+......    .
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence            999999986543 4578889999999999999999   8899999999999999999999999999998754321    1


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....+..|+|||.+.+..++.++|+||+||++|||++ |+.||...
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence            12234678999999988899999999999999999997 99999754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.4e-28  Score=256.24  Aligned_cols=194  Identities=28%  Similarity=0.508  Sum_probs=163.2

Q ss_pred             ceeccccceEEEEEEEcC----CcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|++..    +..||+|.++.... ...+.+.+|+++++++.|||++++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            468999999999997632    26899999876543 244678899999999999999999998764 467999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      ++|.+++.... .+++..+..++.|++.|++||   |.++++||||+|+||+++.++.+||+|||.++............
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999986543 688999999999999999999   88899999999999999999999999999998664333221111


Q ss_pred             --cccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          787 --TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       787 --~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                        ..++..|+|||...+..++.++|||||||++|||++ |+.||+..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence              123467999999998899999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1.5e-28  Score=257.21  Aligned_cols=203  Identities=29%  Similarity=0.427  Sum_probs=172.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec--CCeeEEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN--DDFKALVL  701 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  701 (851)
                      +|++.+.+|+|+||.||+|.+. +++.||+|.++...  ....+.+..|++++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4888999999999999999874 67889999886432  3345678889999999999999999997754  34678999


Q ss_pred             eccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          702 DYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGH--PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       702 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h--~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ||+++++|.+++...   ...+++..++.++.||++|++|||..+  +.+|+||||+|+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999988653   456888999999999999999993221  889999999999999999999999999999876


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||+..
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            43322 123456899999999999888999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=8e-29  Score=262.24  Aligned_cols=202  Identities=29%  Similarity=0.525  Sum_probs=173.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-----CCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeec--CCee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTN--DDFK  697 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  697 (851)
                      +.|++.+.||+|+||.||+|++.     .+..||+|+++..... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999863     3678999999765443 45779999999999999999999999877  5578


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++......+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999977666789999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCCCcc--ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMK--HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  .....++..|+|||...+..++.++||||+|+++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            322211  11223456799999998888999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1e-28  Score=260.05  Aligned_cols=202  Identities=28%  Similarity=0.419  Sum_probs=171.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC------
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDD------  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------  695 (851)
                      +.++|++.+.||+|++|.||+|++. +++.+|+|++..... ..+.+.+|+++++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999884 578899999876543 346789999999999 6999999999986543      


Q ss_pred             eeEEEEeccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          696 FKALVLDYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      ..++||||+++++|.+++...   ...+++..+..++.|+++|++||   |++|++||||+|+||++++++.++++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            589999999999999887542   45788999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +....... .......++..|+|||++..     ..++.++||||+||++|+|++|+.||...
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            87653322 22334568899999998743     35778899999999999999999999753

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.3e-28  Score=257.36  Aligned_cols=195  Identities=29%  Similarity=0.542  Sum_probs=160.2

Q ss_pred             ceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeee-cCCeeEEEEeccC
Q 046438          632 NLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCT-NDDFKALVLDYMP  705 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  705 (851)
                      +.||+|+||.||+|++.+    ...||+|.+.... ....+.+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998632    3569999875432 334567889999999999999999999765 4556889999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC---c
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES---M  782 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~---~  782 (851)
                      +|+|.+++.......++..+..++.|+++|++||   |+.+|+||||+|+||++++++.+||+|||+++.......   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999876555667778888999999999999   889999999999999999999999999999976533221   1


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~  829 (851)
                      ......++..|+|||...+..++.++|||||||++|||++| ..||..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            11123456789999999888999999999999999999994 566654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.3e-29  Score=283.79  Aligned_cols=199  Identities=20%  Similarity=0.278  Sum_probs=158.7

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC--CcEEEEE------------------EEeecchhhHHHHHHHHHHHhhcCCCc
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIK------------------VFHLQLEGALESFNAECEVLRSIRHRN  683 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n  683 (851)
                      ..++|++++.||+|+||+||+|+.+.  +..++.|                  .++. .......+.+|++++++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999987532  2222222                  1111 1123456789999999999999


Q ss_pred             ccceeeeeecCCeeEEEEeccCCCChhHHhhcC----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSD----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       684 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      |+++++++.+.+..++|+|++. +++..++...    ...........++.||+.||+||   |++||+||||||+||++
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEE
Confidence            9999999999999999999995 4666655432    12233556778999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          760 DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      +.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999876543333333467999999999999999999999999999999999987543

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=4e-29  Score=260.28  Aligned_cols=190  Identities=27%  Similarity=0.432  Sum_probs=161.2

Q ss_pred             ceeccccceEEEEEEEcC--------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          632 NLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +.||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999997632        234888887655445557788999999999999999999999998899999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc--------EEEeeccCccc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV--------ARLGDFGIAKL  775 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~--------~kl~Dfg~a~~  775 (851)
                      +++|+|..++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999977666788999999999999999999   8899999999999999987664        69999998865


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCCc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRK-RPTDE  829 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~-~pf~~  829 (851)
                      ...     .....+++.|+|||++.+ ..++.++||||+||++|||++|. .||..
T Consensus       158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            432     123457889999999876 45789999999999999999984 66544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=1.3e-28  Score=259.27  Aligned_cols=192  Identities=27%  Similarity=0.374  Sum_probs=165.6

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||+|+||+||+|... +|+.||+|.+....   ......+.+|++++++++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999774 58899999986532   22234567899999999999999999999999999999999999999


Q ss_pred             hHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccc
Q 046438          710 EACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL  788 (851)
Q Consensus       710 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  788 (851)
                      .+++.... ..+++..+..++.|++.|+.||   |++|++||||+|+||++++++.++|+|||.+.......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            99886543 3688899999999999999999   88999999999999999999999999999987654321  222345


Q ss_pred             cCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       789 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++..|+|||+..+..++.++||||+||++|+|++|+.||...
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence            788999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=2.4e-28  Score=261.39  Aligned_cols=195  Identities=32%  Similarity=0.411  Sum_probs=167.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +.|++.+.||+|+||+||+|+.. +++.||+|++....   ....+++.+|+++++.++|||++++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888999999999999999874 68899999986432   223456889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++ |++.+++......+++..+..++.|++.|+.||   |+.||+||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 567676655556789999999999999999999   8899999999999999999999999999998765322  


Q ss_pred             ccccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                         ....+++.|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence               2346788999999874   45688899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=260.97  Aligned_cols=198  Identities=30%  Similarity=0.440  Sum_probs=170.4

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEEEe
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALVLD  702 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  702 (851)
                      |++.+.||+|++|.||+|++. +++.+|+|+++...  ......+.+|++++++++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999885 48899999998663  33345688899999999999999999999888  78999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++ ++.+++......+++..+..++.||++|++||   |++|++|+||+|+||++++++.++|+|||.+.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9974 88888766556789999999999999999999   7889999999999999999999999999999876544322


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2333456888999997764 4578999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=1.1e-28  Score=262.20  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=169.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  700 (851)
                      ++|++.+.||+|+||.||+|++. +++.+|+|.++.....  ....+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46889999999999999999885 5888999998754322  233567899999999999999999998777  789999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||++ ++|.+++......+++..+..++.|++.|++||   |++||+||||+|+||+++.++.++|+|||.+.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99996 588888866556789999999999999999999   88899999999999999999999999999988764432


Q ss_pred             CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||...
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            1 22334578899999988654 4688999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.3e-28  Score=263.64  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=168.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTND--DFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  699 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|.++.....  ......+|++++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367999999999999999999884 5899999998754322  223466899999999999999999998755  46899


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||++ +++.+++......+++..+..++.||+.|++||   |+.|++||||+|+||+++.++.+||+|||.+......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 478888766556789999999999999999999   8899999999999999999999999999999876433


Q ss_pred             CCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            21 2223345788999998865 56789999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=5.6e-30  Score=236.88  Aligned_cols=220  Identities=20%  Similarity=0.352  Sum_probs=178.6

Q ss_pred             cchhhccccHHHHHHHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccc
Q 046438          609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVR  686 (851)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~  686 (851)
                      |...|....+.......++|++.+++|+|.|+.||.|.. .+.+.+++|++++-   ..+.+.+|+.|++.++ ||||++
T Consensus        21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~   97 (338)
T KOG0668|consen   21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIK   97 (338)
T ss_pred             chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeee
Confidence            333444333333334567899999999999999999976 46888999999754   3477999999999997 999999


Q ss_pred             eeeeeecCC--eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CC
Q 046438          687 IISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DM  763 (851)
Q Consensus       687 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~  763 (851)
                      ++++..++.  ...+|+||+++.+...+.    ..++...+..++.+++.|+.|+   |++||.|||+||.|||||. ..
T Consensus        98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~r  170 (338)
T KOG0668|consen   98 LLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELR  170 (338)
T ss_pred             hhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhc
Confidence            999988764  678999999998887654    3466677888999999999999   9999999999999999985 56


Q ss_pred             cEEEeeccCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhh
Q 046438          764 VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW  840 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  840 (851)
                      .++++|+|+|.++.+...  ..-.+.+..|..||.+.+ ..|+..-|+|||||++..|+..+.||-...+.-+++.+.
T Consensus       171 kLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             eeeeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            799999999999865433  233467888999998866 567888899999999999999999997766555555554

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=1.6e-28  Score=257.23  Aligned_cols=196  Identities=21%  Similarity=0.424  Sum_probs=157.0

Q ss_pred             ceeccccceEEEEEEEcCCc---EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          632 NLIGSGSFGSVYRGRFLDGM---EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.||+|+||+||+|+..++.   .+++|.++... ....+.+.+|+++++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36899999999999764433   45666665432 234567899999999999999999999999988999999999999


Q ss_pred             ChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-Ccc
Q 046438          708 SLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK  783 (851)
Q Consensus       708 ~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~  783 (851)
                      +|.+++...   ....+...+..++.||++|++||   |+++|+||||||+||+++.++.++|+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999988653   23456667788999999999999   88899999999999999999999999999986432111 111


Q ss_pred             ccccccCccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-------GQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....++..|+|||+...       ..++.++|||||||++|||++ |..||...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            223467889999998743       345788999999999999997 67788653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=2.4e-28  Score=257.29  Aligned_cols=191  Identities=29%  Similarity=0.361  Sum_probs=157.8

Q ss_pred             eeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHh---hcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          633 LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLR---SIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       633 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      .||+|+||.||+|++. +++.||+|.+.....   .....+.+|..+++   ..+||+++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999884 588999998865421   11223344444433   3479999999999999899999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++... ..+++..+..++.|++.|++||   |+++|+||||||+||++++++.++++|||++......   ...
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~  153 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH  153 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Ccc
Confidence            99999887543 4589999999999999999999   8899999999999999999999999999998754322   122


Q ss_pred             ccccCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          786 QTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...++..|+|||... +..++.++||||+||++|||++|+.||...
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            346899999999886 456889999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=3e-28  Score=255.56  Aligned_cols=198  Identities=29%  Similarity=0.495  Sum_probs=169.1

Q ss_pred             CCCccceeccccceEEEEEEEcC--CcEEEEEEEeecc----------hhhHHHHHHHHHHHhh-cCCCcccceeeeeec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQL----------EGALESFNAECEVLRS-IRHRNLVRIISSCTN  693 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  693 (851)
                      .|++.+.||+|+||.||+|.+..  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37888999999999999998854  6889999875321          2234556778887765 799999999999999


Q ss_pred             CCeeEEEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEee
Q 046438          694 DDFKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGD  769 (851)
Q Consensus       694 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~D  769 (851)
                      .+..++||||++++++.+++..   ....+++..++.++.|++.|++||   |. .|++||||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL---HKEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh---ccCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999888643   345688899999999999999999   74 7899999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          770 FGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||.+.......  ......++..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            99998754332  23345688999999999988899999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2.7e-28  Score=258.37  Aligned_cols=199  Identities=26%  Similarity=0.355  Sum_probs=170.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  701 (851)
                      ++|++.+.||.|++|.||+|.+. +++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999984 588899999875432 3346788999999999999999999988653  4789999


Q ss_pred             eccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++++|.+++..   ....++...+..++.||++|++||   |+.|++|+|++|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643   345578888999999999999999   889999999999999999999999999999875432


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..   .....++..|+|||...+..++.++||||+||++|||++|+.||+..
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            21   12345788999999999889999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=247.32  Aligned_cols=213  Identities=27%  Similarity=0.291  Sum_probs=169.0

Q ss_pred             ccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCC
Q 046438          630 VNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      -...||.|+||+|+|-.++ .|+.+|||.++.... .+..++..|.+...+- +.||||++||.+-.++.-|+.||.| .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            3467999999999999874 699999999986543 4556788888876555 6899999999988888889999999 4


Q ss_pred             CChhHHhh---c-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          707 GSLEACLY---S-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       707 g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      .+++.+.+   . ....+++.-.-.|......||.||..  ...|+|||+||+||+++..|.+|+||||.+-...  ++.
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~Si  222 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DSI  222 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH--HHH
Confidence            56654432   1 35567888778888889999999974  4569999999999999999999999999987653  344


Q ss_pred             cccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcccccCc
Q 046438          783 KHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPI  847 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  847 (851)
                      ..+...|...|+|||.+..  ..|+-++||||+|+.+||+.||+.||+.-.+--+++.+-|...-|.
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~  289 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI  289 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence            5556678999999998854  4589999999999999999999999976444334444455544443

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=2e-28  Score=259.24  Aligned_cols=199  Identities=27%  Similarity=0.447  Sum_probs=168.9

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +|++.+.||+|++|.||+|++. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4888999999999999999985 588999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          705 PKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       705 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ++ ++.+++....  ..+++..+..++.|+++|++||   |++|++||||+|+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 7877765433  4578999999999999999999   888999999999999999999999999999875533211 


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......++..|++||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1223457889999998765 45788999999999999999999999764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-28  Score=263.71  Aligned_cols=201  Identities=26%  Similarity=0.412  Sum_probs=167.1

Q ss_pred             CCCccceeccccceEEEEEEEc---CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL---DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  698 (851)
                      +|++.+.||+|++|.||+|++.   .++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788999999999999999884   47899999998633   33346678899999999999999999999888  7899


Q ss_pred             EEEeccCCCChhHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC----CCcEEEeec
Q 046438          699 LVLDYMPKGSLEACLYS----DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE----DMVARLGDF  770 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~----~~~~kl~Df  770 (851)
                      +||||+++ ++.+.+..    ....+++..++.++.||+.|++||   |+++|+||||+|+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 56555432    123678889999999999999999   8899999999999999999    999999999


Q ss_pred             cCccccCCCCC--ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          771 GIAKLLSGDES--MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       771 g~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      |++........  .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99886543221  12223467889999998766 457899999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=2.2e-28  Score=266.87  Aligned_cols=197  Identities=23%  Similarity=0.301  Sum_probs=167.2

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC------
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND------  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  694 (851)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999874 68999999986432  22345677899999999999999999987643      


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ...++||||++ +++.+.+...   ++...+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||.++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 4777766432   78888899999999999999   88999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......  ......+++.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            654322  22334678999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.8e-28  Score=259.57  Aligned_cols=198  Identities=26%  Similarity=0.438  Sum_probs=167.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|++. +++.||+|.++...  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999884 58899999886543  22335688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ++ +++.+++... ...+++..+..++.|+++|++||   |++|++||||+|+||+++.++.+|++|||.+........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 5788777543 45678999999999999999999   888999999999999999999999999999876532211 


Q ss_pred             cccccccCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......+++.|+|||+..+.. ++.++||||+||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            223345688999999876644 68889999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9e-30  Score=256.32  Aligned_cols=205  Identities=25%  Similarity=0.391  Sum_probs=169.3

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchh-------hHHHHHHHHHHHhhcCCCcccceeeeeecC-C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG-------ALESFNAECEVLRSIRHRNLVRIISSCTND-D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~  695 (851)
                      .++|-+++.+|+|+|+.||+|.+ ...+.||||+-.....+       -.....+|.+|.+.+.||.||++|+++.-+ +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35688889999999999999976 46788999986544321       233467899999999999999999998754 5


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---CCCcEEEeeccC
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGI  772 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---~~~~~kl~Dfg~  772 (851)
                      ..|-|.|||+|.+|+.+++.. +..++.+++.|++||..||.||.+ -+..|+|-|+||.||++-   ..|.+||.|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            788999999999999999764 457788899999999999999976 456899999999999994   457999999999


Q ss_pred             ccccCCCCCc------cccccccCccccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          773 AKLLSGDESM------KHTQTLATIGYMAPEYGRE----GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       773 a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ++++.++...      -.+...||.+|++||.+.-    ...+.|+||||.|||+|+.+.|+.||....
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            9988654322      2234689999999997642    357889999999999999999999997643

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=2.6e-28  Score=260.81  Aligned_cols=203  Identities=32%  Similarity=0.443  Sum_probs=169.7

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCC----
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDD----  695 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  695 (851)
                      ...++|++.+.||+|++|.||+|.+. +++.||+|.++....  .....+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35578999999999999999999985 588999999875432  23356778999999999999999999887654    


Q ss_pred             ------eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEee
Q 046438          696 ------FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD  769 (851)
Q Consensus       696 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~D  769 (851)
                            ..++||||+++ ++...+......+++..+..++.||+.|++||   |+.||+||||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 66666665556789999999999999999999   888999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          770 FGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99998664333222223346788999998765 4578899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=2.1e-28  Score=259.24  Aligned_cols=193  Identities=27%  Similarity=0.382  Sum_probs=168.5

Q ss_pred             cceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          631 NNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ...||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            367999999999999874 6889999998765555556788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA  789 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  789 (851)
                      .+++..  ..+++.....++.|++.|++||   |+.|++||||+|+||++++++.++|+|||++........ ......+
T Consensus       105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  178 (292)
T cd06657         105 TDIVTH--TRMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG  178 (292)
T ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence            987643  3578888999999999999999   888999999999999999999999999999876543221 2233567


Q ss_pred             CccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       790 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ++.|+|||...+..++.++|+||+||++|||++|+.||..
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            8999999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=3.2e-29  Score=282.60  Aligned_cols=196  Identities=30%  Similarity=0.460  Sum_probs=160.8

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeee---------
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCT---------  692 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------  692 (851)
                      ...+|+.++.+|+|+||.||+++++ +|+.||||++.... +.....+.+|+..+++++|||||+++..|.         
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3456788899999999999999985 89999999997664 334567889999999999999999871100         


Q ss_pred             --------------------------------------------------------------------------------
Q 046438          693 --------------------------------------------------------------------------------  692 (851)
Q Consensus       693 --------------------------------------------------------------------------------  692 (851)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------cC-------CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc
Q 046438          693 -----------------------ND-------DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG  742 (851)
Q Consensus       693 -----------------------~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~  742 (851)
                                             +.       ...||-||||+..++++++......-.....++++++|++|++|+   
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI---  713 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI---  713 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH---
Confidence                                   00       235788999999888888865433325778899999999999999   


Q ss_pred             CCCCcEecCCCCCCEEECCCCcEEEeeccCccccC-----------------CCCCccccccccCccccCccccccCC--
Q 046438          743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-----------------GDESMKHTQTLATIGYMAPEYGREGQ--  803 (851)
Q Consensus       743 h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~-----------------~~~~~~~~~~~~t~~y~aPE~~~~~~--  803 (851)
                      |++|||||||||.||+++++..|||+|||+|....                 .......+..+||.-|+|||++.+..  
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999999999999999999998621                 11222455678999999999987654  


Q ss_pred             -CCcchhhHHHHHHHHHHHh
Q 046438          804 -ISTEGDVYSFGIMLMEIFT  822 (851)
Q Consensus       804 -~~~~~DvwslG~il~el~~  822 (851)
                       |+.|+|+||+|+|++||+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc
Confidence             9999999999999999985

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.4e-28  Score=250.78  Aligned_cols=199  Identities=33%  Similarity=0.502  Sum_probs=175.3

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|++. +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788999999999999999875 578999999876643  4557899999999999999999999999998999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++... ..+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-D  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-c
Confidence            9999999988654 5689999999999999999999   889999999999999999999999999999987654322 1


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....++..|+|||...+..++.++||||+|+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~  202 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL  202 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence            23356788999999988888899999999999999999999999653

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=3.1e-28  Score=259.03  Aligned_cols=199  Identities=27%  Similarity=0.412  Sum_probs=164.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|++|+||+|++. +++.||+|.++....  ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46899999999999999999885 688999998865432  233568889999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCccccCCCC
Q 046438          703 YMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |++ +++.+.+... ....++..+..++.||+.|++||   |++||+||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 4676666443 33357788889999999999999   8889999999999999985 5679999999997543221


Q ss_pred             CccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      . ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1 2223457889999998865 4578999999999999999999999964

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=2.4e-28  Score=255.65  Aligned_cols=193  Identities=28%  Similarity=0.406  Sum_probs=167.4

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||+|+||.||+|++. +|+.||+|++.....   ...+.+.+|++++++++|||++++++.+.+....++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999986 489999999875432   3456788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-------c
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-------M  782 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~  782 (851)
                      .+++.... .+++..+..++.|+++|++||   |++|++||||+|+||++++++.++|+|||++........       .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99886543 688999999999999999999   889999999999999999999999999999876432211       1


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......++..|+|||......++.++||||+|+++||+++|+.||...
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  204 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE  204 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            223346788999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=4.1e-28  Score=253.42  Aligned_cols=192  Identities=28%  Similarity=0.406  Sum_probs=167.8

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||.|++|.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999985 48899999987543   23346789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA  789 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  789 (851)
                      .+++... ..++...+..++.|++.|++||   |++|++|+||+|+||+++.++.++|+|||.+.......  ......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            9988653 4578888999999999999999   88999999999999999999999999999998764322  2223467


Q ss_pred             CccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       790 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            889999999988889999999999999999999999997644

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=2e-28  Score=265.31  Aligned_cols=199  Identities=25%  Similarity=0.352  Sum_probs=165.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----Cee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  697 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|+++... .....++.+|++++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            478999999999999999999874 68999999986432 23346678899999999999999999876543     357


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++|+||++ +++.+.+.  ...+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 47776663  34688899999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCCc--cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESM--KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....  ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            32211  1123467899999998654 5688999999999999999999999964

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=6.1e-28  Score=259.27  Aligned_cols=193  Identities=32%  Similarity=0.409  Sum_probs=166.4

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |+..+.||+|+||.||+|++. ++..||+|.+....   ......+.+|++++++++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677889999999999999874 58899999986432   22345688899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++ |++.+.+......+++..+..++.|++.|+.||   |++||+||||+|+||+++.++.++|+|||++.....     
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            96 477777766666789999999999999999999   889999999999999999999999999999875432     


Q ss_pred             ccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....+++.|+|||++.   ...++.++||||+||++|||++|+.||..
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            12346788999999873   45688999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=5.1e-28  Score=252.09  Aligned_cols=200  Identities=29%  Similarity=0.489  Sum_probs=176.5

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|.+. ++..||+|++.....  .....+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999885 588999999876532  4556788999999999999999999999998999999999


Q ss_pred             cCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          704 MPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       704 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      +++++|.+++...   ...+++..+..++.+++.|++||   |++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999988764   37789999999999999999999   88899999999999999999999999999998764432


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+++.|+|||...+..++.++||||+|+++|+|++|+.||+..
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence            1 223356889999999998888999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=5.7e-28  Score=254.38  Aligned_cols=191  Identities=29%  Similarity=0.376  Sum_probs=157.9

Q ss_pred             eeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHH---HHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          633 LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECE---VLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       633 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      .||+|+||.||+|++. +++.||+|++.....   .....+..|..   .++...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999874 588999999865421   11122333433   3444579999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      |++|..++.. ...+++..+..++.|++.|++||   |+++|+||||+|+||+++.++.++|+|||++......   ...
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  153 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH  153 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCc
Confidence            9999888754 45689999999999999999999   8899999999999999999999999999998755322   122


Q ss_pred             ccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...++..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            34689999999998754 6899999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=4.8e-28  Score=256.08  Aligned_cols=198  Identities=28%  Similarity=0.437  Sum_probs=167.7

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      |++.+.||+|++|.||+|++. +|..||+|++.....  ...+.+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999874 689999999875432  22356888999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      + +++.+++.... ..+++..+..++.|+++|++||   |+++++|||++|+||+++.++.++|+|||.+........ .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence            5 68888875543 4688999999999999999999   788999999999999999999999999999876532211 1


Q ss_pred             ccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2233568899999987654 5788999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=4.2e-28  Score=258.23  Aligned_cols=199  Identities=24%  Similarity=0.358  Sum_probs=165.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcC-CCcccceeeeeecCCe-----
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIR-HRNLVRIISSCTNDDF-----  696 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  696 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|.++.....  ....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999885 5889999988654322  2356888999999995 6999999998877655     


Q ss_pred             eEEEEeccCCCChhHHhhcC----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeecc
Q 046438          697 KALVLDYMPKGSLEACLYSD----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFG  771 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg  771 (851)
                      .++||||+++ ++.+++...    ...+++..+..++.||++|++||   |++||+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 787776543    24578999999999999999999   8899999999999999998 8999999999


Q ss_pred             CccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .+........ ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            9876533221 1222356888999998765 4578999999999999999999999965

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=4.9e-28  Score=257.59  Aligned_cols=199  Identities=27%  Similarity=0.370  Sum_probs=165.3

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL-EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|++|.||+|++.+ ++.||+|.++... ......+.+|++++.+.. ||||+++++++.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568899999999999999999864 8899999997543 223345666777666664 9999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |++ +.+.++.......+++..+..++.||+.|++||   |+ .||+||||+|+||++++++.+||+|||.+........
T Consensus        95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            984 577777655456788999999999999999999   65 5999999999999999999999999999876533221


Q ss_pred             ccccccccCccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQ----ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||...
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence              22335788999999986543    788999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=2.5e-28  Score=256.18  Aligned_cols=196  Identities=30%  Similarity=0.556  Sum_probs=163.9

Q ss_pred             ceeccccceEEEEEEEcC-------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          632 NLIGSGSFGSVYRGRFLD-------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +.||+|+||.||+|++.+       ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999876543 23456788999999999999999999999988899999999


Q ss_pred             cCCCChhHHhhcC------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-----cEEEeeccC
Q 046438          704 MPKGSLEACLYSD------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-----VARLGDFGI  772 (851)
Q Consensus       704 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-----~~kl~Dfg~  772 (851)
                      +++++|.+++...      ...+++..+..++.|++.|++||   |+++++|+|++|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      23467888899999999999999   889999999999999999877     899999999


Q ss_pred             ccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          773 AKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       773 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            875532221 11122345788999999999999999999999999999998 99998653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=3.1e-28  Score=258.17  Aligned_cols=199  Identities=27%  Similarity=0.338  Sum_probs=163.8

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|+..+.||+|+||.||++++. +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4566788999999999999884 58899999987543 234456888999999996 99999999999988889999999


Q ss_pred             cCCCChhHHh---hc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          704 MPKGSLEACL---YS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       704 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ++. ++.++.   .. ....+++..+..++.|++.|++|||  +..+|+||||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            854 554432   22 3456888999999999999999994  3459999999999999999999999999999765432


Q ss_pred             CCccccccccCccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREG---QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .  ......+++.|+|||++.+.   .++.++||||+||++|||++|+.||...
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            2  22234678899999998766   6899999999999999999999999653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=5.8e-28  Score=255.36  Aligned_cols=195  Identities=24%  Similarity=0.359  Sum_probs=163.3

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-hHHHHHHHHHHHhhcC-CCcccceeeeeecC--CeeEEEEe
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIR-HRNLVRIISSCTND--DFKALVLD  702 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  702 (851)
                      |++.+.||+|+||.||+|+.. ++..||+|+++..... ......+|+.+++++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999874 5889999998754322 2233457888888885 99999999999887  88999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++ +++.+.+......+++..+..++.|++.|++||   |+.||+||||+|+||+++. +.+||+|||.++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            996 577777766556789999999999999999999   8889999999999999999 9999999999986643322 


Q ss_pred             cccccccCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                       .....++..|+|||+.. +..++.++||||+||++|||++|+.||..
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence             22345789999999764 45678899999999999999999999965

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=5.1e-28  Score=259.65  Aligned_cols=200  Identities=25%  Similarity=0.418  Sum_probs=166.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCC-------
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDD-------  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  695 (851)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.....  .....+.+|++++++++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57999999999999999999884 588999998865432  22345678999999999999999999876643       


Q ss_pred             -eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          696 -FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       696 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                       ..++||||++ +++.+.+......+++..+..++.||+.|++||   |++|++|+||+|+||+++.++.+||+|||.+.
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             4599999996 578777766556789999999999999999999   78899999999999999999999999999997


Q ss_pred             ccCCCCCc---cccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          775 LLSGDESM---KHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       775 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ........   ......++..|+|||...+. .++.++||||+|+++|||++|+.||..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            65432211   11234578889999987654 478899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=4.7e-28  Score=252.29  Aligned_cols=200  Identities=28%  Similarity=0.445  Sum_probs=171.7

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+|++++++.+.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999885 58889999986542  12345788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~~~~  781 (851)
                      +++++|.+++... ...+++..+..++.|+++|++||   |+.+++|+|++|+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999988653 33578899999999999999999   888999999999999999875 569999999876643322


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+++.|+|||+..+..++.++||||+||++|||++|+.||...
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence             222346889999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=5.3e-28  Score=256.61  Aligned_cols=202  Identities=20%  Similarity=0.295  Sum_probs=153.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecchhhH-----------HHHHHHHHHHhhcCCCcccceee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQLEGAL-----------ESFNAECEVLRSIRHRNLVRIIS  689 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~  689 (851)
                      ..+|++.+.||+|+||+||+|++.+    +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999998754    34567775433221100           11122334456678999999998


Q ss_pred             eeecCC----eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          690 SCTNDD----FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       690 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      .+....    ..++++|++. .++.+.+.. ....++..+..++.|+++|++||   |+++|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcE
Confidence            765543    4467888774 455555533 23356778889999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCC------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          766 RLGDFGIAKLLSGDES------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      +|+|||+|+.......      .......||+.|+|||+..+..++.++||||+||++|||++|+.||....
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999976532211      11123468999999999999999999999999999999999999998763

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=9.6e-28  Score=250.21  Aligned_cols=201  Identities=34%  Similarity=0.455  Sum_probs=176.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALVL  701 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  701 (851)
                      +|+..+.||+|++|.||+|... +++.|++|+++....  ...+.+.+|++++++++||||+++++.+.+.  ...++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999885 688999999876542  3457889999999999999999999999888  8899999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++++|.+++.... .+++..+..++.|+++|++||   |+.|++|||++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999886544 789999999999999999999   789999999999999999999999999999987654322


Q ss_pred             c-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 M-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      . ......++..|+|||......++.++||||+|+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            1 1234568899999999988889999999999999999999999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.7e-28  Score=251.07  Aligned_cols=190  Identities=25%  Similarity=0.343  Sum_probs=160.4

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHH-hhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVL-RSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||.||+|.+. +++.||+|.++....   .....+..|..++ ...+|+|++++++++.+.+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999999874 588999999865431   1223344555444 445899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      ++|.+++... ..+++..+..++.|++.|++||   |+.+++||||+|+||++++++.++|+|||++.....     ...
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            9999988543 4678889999999999999999   889999999999999999999999999999875432     223


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..+++.|+|||...+..++.++||||+|+++|||++|..||...
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            46788999999998888899999999999999999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=6.3e-28  Score=251.17  Aligned_cols=198  Identities=28%  Similarity=0.450  Sum_probs=173.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|++.+.||+|++|.||+|++. +++.+|+|.+....  ......+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999874 67899999987543  23446678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          704 MPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       704 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      +++++|.+++...   ...+++..++.++.|++.|++||   |+.|++||||+|+||+++.++.+|++|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999987552   35678889999999999999999   8999999999999999999999999999999876443 


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        ......+++.|+|||...+..++.++|+||+|+++|||++|+.||+..
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  204 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR  204 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              222345788999999999888999999999999999999999999754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=4.5e-28  Score=255.92  Aligned_cols=201  Identities=30%  Similarity=0.510  Sum_probs=174.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++....   ....+.+.+|.+++++++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36899999999999999999885 68999999987532   233466888999999998 99999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|++.|++||   |+.|++|+|++|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            9999999999988654 4689999999999999999999   88899999999999999999999999999987654322


Q ss_pred             C-------------------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 S-------------------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~-------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .                   .......++..|+|||+.....++.++|+||+|++++++++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            1                   1223346788999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-29  Score=263.55  Aligned_cols=196  Identities=24%  Similarity=0.339  Sum_probs=167.8

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .+.|++...+|.|+|+.|-.+.+ .+++..++|++....    .+..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56788888999999999998877 468889999997652    3455677776666 69999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE-CCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL-DEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill-~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      .+.|+-+.+.+..... . ...+..|+.+|+.|+.||   |.+||||||+||+|||+ ++.++++|+|||.++...+.  
T Consensus       397 ~l~g~ell~ri~~~~~-~-~~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE-F-CSEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch-h-HHHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988776644322 2 266778999999999999   88999999999999999 69999999999999887543  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcC
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG  833 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  833 (851)
                        ..+.+-|..|.|||+.....|++++|+||+|+++|+|++|+.||..-..+
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence              44557789999999999999999999999999999999999999876555

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=3.7e-28  Score=263.02  Aligned_cols=200  Identities=29%  Similarity=0.384  Sum_probs=167.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeec----CCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTN----DDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  697 (851)
                      .++|++.+.||+|++|.||+|... +|+.||+|++.....  .....+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468999999999999999999874 589999999875432  234667889999999999999999988753    3468


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+. +++.+++.. ...+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 688887754 34589999999999999999999   88899999999999999999999999999997654


Q ss_pred             CCCCc---cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESM---KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            32211   1123468899999998765 4688999999999999999999999965

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=8.9e-28  Score=252.60  Aligned_cols=200  Identities=25%  Similarity=0.492  Sum_probs=164.6

Q ss_pred             CCccceeccccceEEEEEEEc----CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC------
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD------  695 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  695 (851)
                      |++.+.||+|+||.||+|.+.    .++.||+|++....  ....+.+.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999763    36789999987543  334567889999999999999999999876532      


Q ss_pred             eeEEEEeccCCCChhHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          696 FKALVLDYMPKGSLEACLYSD-----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                      ..++++||+.+|++..++...     ...+++.....++.||+.|++||   |+.||+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECcc
Confidence            347889999999998876432     22468888899999999999999   8889999999999999999999999999


Q ss_pred             cCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          771 GIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       771 g~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |+++........ ......+++.|++||......++.++||||+||++|||++ |+.||...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            999865432211 1223345678999999998889999999999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=6.9e-28  Score=255.47  Aligned_cols=199  Identities=30%  Similarity=0.433  Sum_probs=168.4

Q ss_pred             CCCccceeccccceEEEEEEEc----CCcEEEEEEEeecc----hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCee
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL----EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  697 (851)
                      +|++.+.||+|++|.||+|+..    ++..||+|+++...    ....+.+.+|+++++++ +||+|+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999999753    46789999987432    12335678899999999 599999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++... ..+++..+..++.|+++|++||   |..|++||||+|+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999887543 4578888899999999999999   88899999999999999999999999999987654


Q ss_pred             CCCCccccccccCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQ--ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...........++..|+|||...+..  .+.++||||+|+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            33322233356889999999987654  78899999999999999999999953

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=5.7e-28  Score=262.02  Aligned_cols=200  Identities=28%  Similarity=0.389  Sum_probs=166.9

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC--Cee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSI-RHRNLVRIISSCTND--DFK  697 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  697 (851)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++....  ......+.+|+++++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567999999999999999999875 58889999885432  22345677899999999 999999999988654  368


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||++ ++|..++...  .+++..+..++.||+.|++||   |++||+||||+|+||+++.++.+||+|||.+....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5888877543  678888889999999999999   88899999999999999999999999999998654


Q ss_pred             CCCC----ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDES----MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ....    .....+.++..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            3321    12234568899999998754 5678899999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5.3e-28  Score=261.76  Aligned_cols=199  Identities=27%  Similarity=0.358  Sum_probs=171.1

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC-----eeE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD-----FKA  698 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  698 (851)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999985 48899999987654  334467889999999999999999999987765     789


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||++ +++.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 5788877543 3788999999999999999999   889999999999999999999999999999987654


Q ss_pred             CCC--ccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DES--MKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  .......+++.|+|||++.+. .++.++|+||+|+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            321  122335678899999999887 7899999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=9.6e-28  Score=260.63  Aligned_cols=204  Identities=24%  Similarity=0.339  Sum_probs=170.6

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeee
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCT  692 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  692 (851)
                      ....++..+.++|++.+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|++++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34456677889999999999999999999987 468899999987542  222456788999999999999999999875


Q ss_pred             cC------CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          693 ND------DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       693 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                      ..      ...+++++++ ++++.+++..  ..+++..+..++.|+++|++||   |++||+||||+|+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 7888877643  3588899999999999999999   889999999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+|||++.....    ......++..|+|||...+ ..++.++||||+||++|||++|+.||..
T Consensus       161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999876432    1223467889999998766 5688899999999999999999999964

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=7.5e-29  Score=258.17  Aligned_cols=198  Identities=23%  Similarity=0.359  Sum_probs=168.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecc---hhh-----HHHHHHHHHHHhhcC---CCcccceeeeee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL---EGA-----LESFNAECEVLRSIR---HRNLVRIISSCT  692 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~  692 (851)
                      ..+|..++.+|.|+||.|+.|.++. ...|++|.+.+..   +.+     ....-.|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3569999999999999999998854 6779999886542   222     223567999999997   999999999999


Q ss_pred             cCCeeEEEEeccCC-CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          693 NDDFKALVLDYMPK-GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       693 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      +++.+|++||-... -+|.+++.. ...+++.+...|++||+.|+++|   |.+||||||||-+||.++.+|.+|++|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeecc
Confidence            99999999997653 477787743 45688889999999999999999   99999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS-TEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .|...+..   ....++||..|.|||++.+..|- ..-|+||+|+++|.++....||-.
T Consensus       716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99877543   33457899999999999998875 446999999999999999999843

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=8.7e-28  Score=254.19  Aligned_cols=198  Identities=25%  Similarity=0.397  Sum_probs=170.8

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      |++.+.||+|++|.||+|+.. +++.+|+|.++.....  ....+.+|++++++++|++|+++++++.+....++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            677899999999999999874 6888999998755322  3467888999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++ ++.+++......+++..+..++.|+++|++||   |+++|+||||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            75 78777766556789999999999999999999   88899999999999999999999999999987765433 122


Q ss_pred             cccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....++..|+|||...+. .++.++|+||+|+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  202 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK  202 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            334578899999998776 7899999999999999999999999653

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=2.6e-27  Score=253.76  Aligned_cols=193  Identities=31%  Similarity=0.382  Sum_probs=165.7

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |...+.||+|+||+||+|++. +++.||+|++....   ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999874 58899999986432   22345688899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +. |++.+++......+++..+..++.||+.|++||   |++||+||||+|+||+++.++.+||+|||.+.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 577777766666789999999999999999999   888999999999999999999999999998864321     


Q ss_pred             ccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....++..|+|||++.   ...++.++||||+||++|||++|+.||..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~  222 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  222 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22346888999999874   45688899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.1e-27  Score=260.00  Aligned_cols=199  Identities=25%  Similarity=0.365  Sum_probs=168.2

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--
Q 046438          621 LLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD--  695 (851)
Q Consensus       621 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  695 (851)
                      +....++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445788999999999999999999874 68899999986432  223356889999999999999999999886543  


Q ss_pred             ----eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          696 ----FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       696 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                          ..++||||+ ++++.+++..  ..+++..+..++.|+++|++||   |+.||+||||+|+||+++.++.++++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 7788887743  4688899999999999999999   88999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ++......    .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||..
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            98765322    223457889999998876 4588999999999999999999999975

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.8e-30  Score=240.99  Aligned_cols=199  Identities=24%  Similarity=0.367  Sum_probs=166.6

Q ss_pred             CCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCC-----eeEE
Q 046438          628 FNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDD-----FKAL  699 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  699 (851)
                      .+-.+.||-|+||+||.+.+ ++|+.||+|++..-..  ...+++.+|..++..++|.|+...++..+-..     ++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34558899999999999988 5799999998754322  24577889999999999999999888765543     5678


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ++|.| ..+|...+. ....++..++.-+.+||++|+.||   |+.+|.||||||.|.+++.+..+||||||+|+.-..+
T Consensus       135 ~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            89988 456666553 456788888999999999999999   9999999999999999999999999999999976655


Q ss_pred             CCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          780 ESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....+..+.|..|.|||++.+. .|+.+.||||.|||+.|++..+..|....
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~  262 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG  262 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence            55555556789999999999875 58899999999999999999999887643

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=8.9e-28  Score=257.88  Aligned_cols=201  Identities=26%  Similarity=0.432  Sum_probs=165.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCC------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDD------  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  695 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++......  ....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999875 5889999988654322  2345778999999999999999998775433      


Q ss_pred             --eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          696 --FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       696 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                        ..++||||+++ ++...+......+++..+..++.|+++|++||   |++||+|||++|+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46999999965 66666655556789999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCCc----------cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          774 KLLSGDESM----------KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       774 ~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      +........          ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            765432211          1122356788999998765 4588999999999999999999999965

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.7e-27  Score=258.53  Aligned_cols=195  Identities=26%  Similarity=0.379  Sum_probs=164.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC------C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND------D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  695 (851)
                      .++|.+.+.||+|+||.||+|++. +|+.||+|+++...  ......+.+|++++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999874 68999999987542  22335678999999999999999999988654      2


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++|+||+. .++..+.   ...+++..+..++.|++.|++||   |++||+||||+|+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4689999995 4666554   24578889999999999999999   889999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...    ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         167 ADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            432    1223467889999999876 46889999999999999999999999753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=1e-27  Score=259.81  Aligned_cols=199  Identities=26%  Similarity=0.328  Sum_probs=167.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----Ce
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  696 (851)
                      ..+|++.+.||+|+||+||+|++. +++.||+|.++...  ......+.+|+++++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999874 58899999987532  22345677899999999999999999987654     35


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||++ ++|.+++.. ...+++..+..++.|++.|++||   |+++++||||+|+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 678877754 35688999999999999999999   8889999999999999999999999999999866


Q ss_pred             CCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .... .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||..
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            4332 12233567889999998765 4688999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=1.4e-27  Score=256.45  Aligned_cols=199  Identities=20%  Similarity=0.256  Sum_probs=162.9

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeec--chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      .+.+.+|.|+++.||+++. +++.||+|+++..  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3444555555555555544 6899999998765  234557899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC----
Q 046438          707 GSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES----  781 (851)
Q Consensus       707 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  781 (851)
                      |++.+++... ...+++.....++.|+++|++||   |+++|+||||+|+||+++.++.+|++|||.+........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999988653 44578888899999999999999   888999999999999999999999999998865532211    


Q ss_pred             --ccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 --MKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 --~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                        .......++..|+|||++..  ..++.++||||+||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence              11123456788999999866  358899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=2.5e-27  Score=251.20  Aligned_cols=197  Identities=28%  Similarity=0.462  Sum_probs=165.2

Q ss_pred             CCccceeccccceEEEEEEEcC-CcEEEEEEEeecch--hhHHHHHHHHHHHhhc---CCCcccceeeeeecCCe-----
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLE--GALESFNAECEVLRSI---RHRNLVRIISSCTNDDF-----  696 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  696 (851)
                      |++.+.||+|+||.||+|++.. ++.||+|.++....  .....+.+|+++++++   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999864 89999999975432  2234566787777666   59999999999987766     


Q ss_pred             eEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          697 KALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      .+++|||++ +++.+++... ...+++..+..++.|+++|++||   |+.+++|+|++|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 4788877553 23588999999999999999999   888999999999999999999999999999977


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  .....++..|+|||+..+..++.++|+||+||++|||++|+.||+..
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~  209 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT  209 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence            643321  22335788999999999889999999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=1.9e-27  Score=256.69  Aligned_cols=197  Identities=24%  Similarity=0.357  Sum_probs=162.0

Q ss_pred             ceeccc--cceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSG--SFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      ..||+|  +||+||.|++. .|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  89999999884 68999999987543  23346788999999999999999999999999999999999999


Q ss_pred             CChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc--
Q 046438          707 GSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK--  783 (851)
Q Consensus       707 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  783 (851)
                      +++.+++... ...+++..+..++.|++.|++||   |++||+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999988653 34578888899999999999999   88999999999999999999999999998654332211110  


Q ss_pred             ----ccccccCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          784 ----HTQTLATIGYMAPEYGREG--QISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       784 ----~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                          .....++..|+|||++.+.  .++.++||||+||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence                0112345679999998763  47899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=2.4e-27  Score=253.51  Aligned_cols=194  Identities=31%  Similarity=0.435  Sum_probs=165.9

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeec---chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .|+..+.||+|++|.||+|++. ++..+|+|.+...   ......++.+|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4677789999999999999884 5788999988642   22334567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+. |++.+.+......+++..+..++.|++.|++||   |+++++||||+|+||+++.++.++++|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            996 577777665566788999999999999999999   8889999999999999999999999999998765322   


Q ss_pred             cccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                        ....+++.|+|||++.   ...++.++||||+||++|||++|+.||..
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence              2345788999999874   35678899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=2.1e-27  Score=255.93  Aligned_cols=198  Identities=26%  Similarity=0.355  Sum_probs=167.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec-CCee
Q 046438          622 LQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN-DDFK  697 (851)
Q Consensus       622 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  697 (851)
                      ...+++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++|||++++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446788999999999999999999875 68899999886432  2234668889999999999999999998865 4578


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+ ++++.+++..  ..++......++.|+++|++||   |++||+||||+|+||++++++.++|+|||.+....
T Consensus        86 ~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            8999998 5688877743  3567788888999999999999   88999999999999999999999999999987543


Q ss_pred             CCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .    ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       160 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         160 P----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             C----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2    1223457889999998765 5689999999999999999999999965

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=2.7e-27  Score=256.63  Aligned_cols=201  Identities=23%  Similarity=0.346  Sum_probs=165.5

Q ss_pred             hcCCCc-cceeccccceEEEEEEEc-CCcEEEEEEEeecchhh--------------HHHHHHHHHHHhhcCCCccccee
Q 046438          625 TDQFNV-NNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGA--------------LESFNAECEVLRSIRHRNLVRII  688 (851)
Q Consensus       625 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~  688 (851)
                      .++|.. .+.||+|+||+||+|++. +++.||+|+++......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            355654 577999999999999875 68999999986542211              12477899999999999999999


Q ss_pred             eeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       689 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                      +++...+..++||||++ |++.+++.. ...+++.....++.|++.|++||   |++||+||||+|+||+++.++.++++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 588887753 34588899999999999999999   88999999999999999999999999


Q ss_pred             eccCccccCCCC-------------CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          769 DFGIAKLLSGDE-------------SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |||.+.......             ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999987654111             1111223567889999988764 4688999999999999999999999753

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=2.6e-27  Score=250.44  Aligned_cols=197  Identities=28%  Similarity=0.421  Sum_probs=170.0

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      |++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999885 48999999998653  233466788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      + ++|.+++......+++..+..++.|++.|++||   |++||+||||+|+||++++++.++|+|||.+........ ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            7 589998876546789999999999999999999   888999999999999999999999999999876543221 22


Q ss_pred             cccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          785 TQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ....++..|+|||.+.+. .++.++||||+||++||+++|+.||..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            234567889999998766 789999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=2.1e-27  Score=257.70  Aligned_cols=199  Identities=24%  Similarity=0.353  Sum_probs=164.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC---------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND---------  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  694 (851)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            468999999999999999999884 5889999998766555567788999999999999999999776543         


Q ss_pred             -----CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCcEEEe
Q 046438          695 -----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLG  768 (851)
Q Consensus       695 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~~kl~  768 (851)
                           ...++||||++ +++.+++..  ..+++..+..++.||++|++||   |+.||+||||||+||+++ +++.++++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 588877743  3578889999999999999999   888999999999999997 45678999


Q ss_pred             eccCccccCCCCC--ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          769 DFGIAKLLSGDES--MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       769 Dfg~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |||.++.......  .......++..|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999876532211  11122357889999997654 5688899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=245.25  Aligned_cols=197  Identities=24%  Similarity=0.313  Sum_probs=169.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-C-Cc----ccceeeeeecCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-H-RN----LVRIISSCTNDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~~~~~~~~~~~  696 (851)
                      .+.+|++...+|+|.||.|.++.+. .+..||+|+++.- ..-.+...-|+++++++. + |+    +|++.+||.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3678999999999999999999874 4788999998743 334467788999999993 2 33    6788899999999


Q ss_pred             eEEEEeccCCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---------------
Q 046438          697 KALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---------------  760 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---------------  760 (851)
                      .++|+|.+ |-++.+++.. ...+++..++..|++|+++++++|   |+.+++|.|+||+||++-               
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 6788899876 456789999999999999999999   999999999999999993               


Q ss_pred             -----CCCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          761 -----EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       761 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                           .+..|+++|||.|+....    .++..+.|..|.|||++.+-+++.++||||+|||++|+.+|...|..
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             eeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                 134689999999986432    33567889999999999999999999999999999999999999865

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.3e-27  Score=248.79  Aligned_cols=197  Identities=26%  Similarity=0.387  Sum_probs=166.7

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-hHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEecc
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      |++.+.||+|++|+||+|+.. +++.||+|.+...... ......+|++.+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            678899999999999999985 4788999998654322 2234557899999998 999999999999999999999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                       +|++.+++.... ..+++..+..++.|++.+++||   |++|++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence             788888776543 5679999999999999999999   88899999999999999999999999999997664322  2


Q ss_pred             ccccccCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGR-EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....++..|+|||+.. ...++.++|+||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            23346788999999875 455789999999999999999999999643

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=8.1e-27  Score=237.52  Aligned_cols=214  Identities=28%  Similarity=0.413  Sum_probs=182.5

Q ss_pred             CCccceeccccceEEEEEEEcC-CcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      |.+.+.||+|++|.||+|+..+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999865 889999999876544 56789999999999999999999999998889999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++.......++.....++.++++++++|   |+++++|+|++|+||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9999998865443378889999999999999999   8889999999999999999999999999998876543211223


Q ss_pred             ccccCccccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCc-cCcCccchhhhcccc
Q 046438          786 QTLATIGYMAPEYG-REGQISTEGDVYSFGIMLMEIFTRKRPTDE-IFSGEMSLKRWVNDS  844 (851)
Q Consensus       786 ~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~  844 (851)
                      ...++..|++||.. ....++.++|||++|++++||++|+.||+. ..+.+.....|++..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            45678889999998 667788899999999999999999999977 445556666677655

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=260.48  Aligned_cols=213  Identities=27%  Similarity=0.411  Sum_probs=178.7

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeec-
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTN-  693 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  693 (851)
                      .++.....++.|++.+.||.|.+|.||+++.. +++.+|+|+.....+.+ ++++.|.++++.. .|||++.+++++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            33444445678999999999999999999874 68889999988765443 6788999999988 58999999998753 


Q ss_pred             ----CCeeEEEEeccCCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          694 ----DDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       694 ----~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                          ++.+|+|||||.||+.-++++. .+..+.+..+..|.+.++.|+.+|   |...++|||+|-.||+++.++.||++
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEe
Confidence                4689999999999999998864 356688888889999999999999   89999999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCccCcCc
Q 046438          769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE  834 (851)
Q Consensus       769 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  834 (851)
                      |||.+...... -....+.+|||.|||||++..     ..|+.++|+||+|++..||--|.+|+.+..+..
T Consensus       166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr  235 (953)
T KOG0587|consen  166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR  235 (953)
T ss_pred             eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence            99998766432 224556789999999998843     457778999999999999999999987654433

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.1e-27  Score=241.48  Aligned_cols=192  Identities=32%  Similarity=0.432  Sum_probs=167.6

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ||+|+||.||++.+. +++.||+|+++....   ...+.+..|++++++++|||++++++.++.+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999885 488999999876532   2446788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA  789 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  789 (851)
                      .+++... ..+++.....++.|+++|+.|+   |+.+++|+||+|+||+++.++.++|+|||.+....... .......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            9988654 3578899999999999999999   88999999999999999999999999999987654322 12334567


Q ss_pred             CccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       790 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +..|+|||...+..++.++|+||+|+++||+++|+.||...
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  196 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE  196 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            88999999998888899999999999999999999999653

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.3e-27  Score=257.57  Aligned_cols=197  Identities=26%  Similarity=0.359  Sum_probs=167.3

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe---
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF---  696 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  696 (851)
                      ...++|++.+.||+|++|.||+|++. +++.||+|++....  ......+.+|++++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999885 57889999986532  2233567789999999999999999988766544   


Q ss_pred             ---eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          697 ---KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       697 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                         .++|+||+ +++|.+++..  ..+++..+..++.|+++|++||   |+.||+||||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 6789888754  4688999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......    .....++..|+|||...+ ..++.++||||+||++||+++|+.||..
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            765322    233467889999998765 4678999999999999999999999964

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=5e-27  Score=244.95  Aligned_cols=198  Identities=24%  Similarity=0.403  Sum_probs=166.0

Q ss_pred             CCCccceeccccceEEEEEEEcC-CcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      +|.+.+.||+|+||+||+|++.. +..+++|+.+...     ......+.+|++++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999998743 4556666654321     22334577889999999999999999999988899999


Q ss_pred             EeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      |||++++++.+++..   ....+++..+..++.|+++|++||   |++|++|+|++|+||+++. +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988754   345688999999999999999999   8899999999999999975 569999999987664


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .... ......+++.|+|||...+..++.++|+||+|+++|+|++|..||..
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3322 22345678899999999888889999999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-27  Score=270.66  Aligned_cols=203  Identities=28%  Similarity=0.508  Sum_probs=174.1

Q ss_pred             cCCCccceeccccceEEEEEEEc----C----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL----D----GMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      ++.++.+.+|+|.||.|++|...    .    ...||||..+... ..+.+.+..|+++++.+ +|+||+.++|+|.+.+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            44466679999999999999642    1    3469999987554 34567899999999999 6999999999999988


Q ss_pred             eeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC
Q 046438          696 FKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD  760 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~  760 (851)
                      ..++|+||+..|+|.++++..+               ..++......++.|||.|++||   +++++||||+.++||+++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEEec
Confidence            9999999999999999998766               3488889999999999999999   888999999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCccccccc--cCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          761 EDMVARLGDFGIAKLLSGDESMKHTQTL--ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       761 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ++..+||+|||+|+.......+......  -+..|||||.+....|+.++|||||||++||+++ |..||.+..
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999976554443322222  3667999999999999999999999999999999 999997743

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=8.3e-27  Score=272.37  Aligned_cols=145  Identities=28%  Similarity=0.460  Sum_probs=130.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   ......+.+|+++++.++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57999999999999999999985 58899999987542   223467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ||+.+++|.+++... ..+++..++.++.||+.||+||   |.+||+||||||+||+++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999988543 4578888999999999999999   78899999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=8.4e-27  Score=252.20  Aligned_cols=198  Identities=26%  Similarity=0.326  Sum_probs=162.5

Q ss_pred             CCCccceeccccceEEEEEEEc-C--CcEEEEEEEeecchh--hHHHHHHHHHHHhhc-CCCcccceeeeeec----CCe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-D--GMEVAIKVFHLQLEG--ALESFNAECEVLRSI-RHRNLVRIISSCTN----DDF  696 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  696 (851)
                      +|++.+.||+|+||.||+|++. .  +..||+|++......  ..+.+.+|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999874 3  678999998643222  245678899999999 59999999986532    245


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++++||++ ++|.+.+.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||.+...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999985 688887743 45688999999999999999999   8899999999999999999999999999999765


Q ss_pred             CCCCC---ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDES---MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....   .......+++.|+|||+..+ ..++.++|+||+||++|+|++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            43221   11223468899999998765 5689999999999999999999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=8.1e-27  Score=239.31  Aligned_cols=181  Identities=21%  Similarity=0.192  Sum_probs=154.0

Q ss_pred             ccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChhHHhhc
Q 046438          637 GSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS  715 (851)
Q Consensus       637 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  715 (851)
                      |.+|+||+|++. +++.||+|.++...     ...+|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999884 68899999987643     233455555556799999999999999999999999999999988855


Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccC
Q 046438          716 DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA  795 (851)
Q Consensus       716 ~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~a  795 (851)
                      . ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.++++|||.+......    .....++..|+|
T Consensus        79 ~-~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a  150 (237)
T cd05576          79 F-LNIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA  150 (237)
T ss_pred             h-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence            3 3588899999999999999999   8899999999999999999999999999987655322    122345778999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       796 PE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ||......++.++||||+||++|||++|+.|++..
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence            99998888999999999999999999999887653

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=7.6e-29  Score=232.59  Aligned_cols=200  Identities=26%  Similarity=0.446  Sum_probs=164.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEee--cchhhHHHHHHHHHHHhhcCCCcccceeeeeec--------C
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHRNLVRIISSCTN--------D  694 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  694 (851)
                      ..|+-..+||+|.||.||+|+.. .|+.||+|++-.  ..++......+|+++++.++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666688999999999999875 477789986533  223444667899999999999999999987743        2


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ...|+||.+|+. +|..++......++..++.+++.++..|+.|+   |+..|+|||+|+.||+|+.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            358999999954 67666765667789999999999999999999   99999999999999999999999999999997


Q ss_pred             ccCCCC---CccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          775 LLSGDE---SMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       775 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......   ....+..+.|.+|.+||.+.+ ..|+++.|+|+.|||+.||++|.+-|.+
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence            654222   223445677999999998776 5799999999999999999999988865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=254.76  Aligned_cols=202  Identities=22%  Similarity=0.310  Sum_probs=151.5

Q ss_pred             hcCCCccceeccccceEEEEEEE-----------------cCCcEEEEEEEeecchhhHHH--------------HHHHH
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-----------------LDGMEVAIKVFHLQLEGALES--------------FNAEC  673 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e~  673 (851)
                      .++|++.++||+|+||+||+|..                 ..++.||||.++.......++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 235679999987543222222              33466


Q ss_pred             HHHhhcCCCcc-----cceeeeeec--------CCeeEEEEeccCCCChhHHhhcCC-----------------------
Q 046438          674 EVLRSIRHRNL-----VRIISSCTN--------DDFKALVLDYMPKGSLEACLYSDN-----------------------  717 (851)
Q Consensus       674 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~-----------------------  717 (851)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766544     567776643        346799999999999998876421                       


Q ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCcc
Q 046438          718 SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE  797 (851)
Q Consensus       718 ~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE  797 (851)
                      ...++..+..++.|++++++|+   |+++|+||||||+||+++.++.+||+|||++...............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            1235567788999999999999   8889999999999999999999999999999765432222222234588999999


Q ss_pred             ccccCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCc
Q 046438          798 YGREGQ--------------------I--STEGDVYSFGIMLMEIFTRKR-PTDE  829 (851)
Q Consensus       798 ~~~~~~--------------------~--~~~~DvwslG~il~el~~g~~-pf~~  829 (851)
                      .+....                    +  ..+.||||+||++|||++|.. ||..
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            875322                    1  234699999999999999885 7754

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-28  Score=245.84  Aligned_cols=417  Identities=25%  Similarity=0.294  Sum_probs=234.1

Q ss_pred             EEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccc-ccc
Q 046438           46 LDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE-NHL  124 (851)
Q Consensus        46 L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~-n~l  124 (851)
                      .+.++-.++ .+|-.-......++|..|+|+ .+|+..|+.+++|+.|||++|.|+.+-|++|.++.+|..|-+-+ |+|
T Consensus        51 VdCr~~GL~-eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI  128 (498)
T KOG4237|consen   51 VDCRGKGLT-EVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI  128 (498)
T ss_pred             EEccCCCcc-cCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence            334444444 344444556666667777776 66666666666666666666666666666666666666655444 666


Q ss_pred             ccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCcc
Q 046438          125 MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSF  204 (851)
Q Consensus       125 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  204 (851)
                      +....++|++|.+|+.|.+.-|++..+..+.|..+++|..|.+.+|.+. .++...|..+..++.+.++.|.+..     
T Consensus       129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic-----  202 (498)
T KOG4237|consen  129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC-----  202 (498)
T ss_pred             hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc-----
Confidence            6555556666666666666666666666666666666666666666665 5555555566666666666665321     


Q ss_pred             ccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccc
Q 046438          205 IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIG  284 (851)
Q Consensus       205 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~  284 (851)
                      ..+++.+..       +....|-.+++.+-..-..+.++++..+.... |...   +..+.. .++.+-..+...|.   
T Consensus       203 dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~k-f~c~---~esl~s-~~~~~d~~d~~cP~---  267 (498)
T KOG4237|consen  203 DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARK-FLCS---LESLPS-RLSSEDFPDSICPA---  267 (498)
T ss_pred             ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhh-hhhh---HHhHHH-hhccccCcCCcChH---
Confidence            111222211       11122334455555555556666665543321 1111   111100 11111111112222   


Q ss_pred             cccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCE
Q 046438          285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS  364 (851)
Q Consensus       285 ~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  364 (851)
                                           ..|..+++|+.|+|++|+|+.+-+.+|.++..+++|.|.+|+|..+....|.++..|+.
T Consensus       268 ---------------------~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~t  326 (498)
T KOG4237|consen  268 ---------------------KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKT  326 (498)
T ss_pred             ---------------------HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcccccee
Confidence                                 23555666666666666666555666666666666666666665555555556666666


Q ss_pred             EEccCcccCCCCCccccCCccccceecccCcCc------cCchhh-----------cccCcceEEEecCCCCCC---CCc
Q 046438          365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELT------FVPSTF-----------WNLTNILMVDLSSNPLSG---SLP  424 (851)
Q Consensus       365 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------~~p~~~-----------~~l~~L~~L~Ls~N~l~~---~~p  424 (851)
                      |+|.+|+|+..-|.+|..+.+|.+|+|-.|.+-      -+.+++           ..-..++.++++.+.+..   ..|
T Consensus       327 L~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~  406 (498)
T KOG4237|consen  327 LSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGP  406 (498)
T ss_pred             eeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCc
Confidence            666666666555666666666666665555442      011111           112245566666665432   123


Q ss_pred             cccc---------cchhhhh-hhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccccc
Q 046438          425 LEIG---------NLKVLVE-LYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI  494 (851)
Q Consensus       425 ~~~~---------~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  494 (851)
                      ++.+         .++-+.+ ...|++.++ .+|..+.  ..-..|++.+|.++ .+|.+  .+.+| .+|||+|+++..
T Consensus       407 ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~L  479 (498)
T KOG4237|consen  407 EELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSL  479 (498)
T ss_pred             cccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehh
Confidence            3222         2334443 345555555 6665543  34667889999998 77776  56778 889999999877


Q ss_pred             CCccccccccccceeccCc
Q 046438          495 IPSSLEKLLYLKYLNVSFN  513 (851)
Q Consensus       495 ~p~~l~~l~~L~~l~l~~N  513 (851)
                      --..|.++++|.+|-||+|
T Consensus       480 sn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  480 SNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcccccchhhhheeEEecC
Confidence            7777889999999988876

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=7.6e-26  Score=257.28  Aligned_cols=199  Identities=23%  Similarity=0.291  Sum_probs=142.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-C----CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeee------ee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-D----GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS------CT  692 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  692 (851)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++......  +....|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999885 3    688999987643221  111111  1111222222222211      23


Q ss_pred             cCCeeEEEEeccCCCChhHHhhcCCCCc-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 046438          693 NDDFKALVLDYMPKGSLEACLYSDNSNL-------------------DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIK  753 (851)
Q Consensus       693 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~  753 (851)
                      +....++||||+++++|.+++.......                   ....+..++.||+.|++||   |+++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCC
Confidence            4567899999999999998876432111                   1233557899999999999   88999999999


Q ss_pred             CCCEEECC-CCcEEEeeccCccccCCCCCccccccccCccccCccccccC----------------------CCCcchhh
Q 046438          754 PSNVLLDE-DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG----------------------QISTEGDV  810 (851)
Q Consensus       754 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Dv  810 (851)
                      |+||+++. ++.+||+|||+|+............+.+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57999999999986544333334456789999999965322                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCc
Q 046438          811 YSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       811 wslG~il~el~~g~~pf~~  829 (851)
                      ||+||++|||+++..|++.
T Consensus       363 wSlGviL~el~~~~~~~~~  381 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDS  381 (566)
T ss_pred             HHHHHHHHHHHhCcCCCch
Confidence            9999999999998877653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=226.23  Aligned_cols=203  Identities=23%  Similarity=0.328  Sum_probs=170.9

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecC------Ce
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTND------DF  696 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  696 (851)
                      .+|.-++.+|.|.- .|..|.+ ..+++||+|+...+..  ...++..+|...+..++|+||++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777888999998 6766655 4689999998765432  2356788999999999999999999988643      26


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .|+|||+| ..++...+.   ..++-.....+..|++.|+.||   |+.||+||||||+||++..++.+||.|||+|+..
T Consensus        96 ~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhccc
Confidence            78999999 557777765   3466678889999999999999   9999999999999999999999999999999865


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN  842 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  842 (851)
                      ..  ....+.++.|..|.|||++.+-.|.+.+||||.||++.||++|+.-|.    +++.+.+|-+
T Consensus       169 ~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~k  228 (369)
T KOG0665|consen  169 DT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNK  228 (369)
T ss_pred             Cc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHH
Confidence            43  356677899999999999999889999999999999999999998876    5777887754

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-28  Score=239.89  Aligned_cols=425  Identities=23%  Similarity=0.259  Sum_probs=268.3

Q ss_pred             eCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccc-cc
Q 046438           23 DLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAF-NQ   99 (851)
Q Consensus        23 ~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~-N~   99 (851)
                      |-+.-.++ .+|..+.  .+-..++|..|+|+.+++  |..+++|++||||+|.|+ .|.+..|++++.|..|-+.+ |+
T Consensus        52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~Nk  127 (498)
T KOG4237|consen   52 DCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNK  127 (498)
T ss_pred             EccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCc
Confidence            44455555 4553332  356789999999997766  999999999999999999 78888899999999988877 99


Q ss_pred             cccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchh
Q 046438          100 FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSS  179 (851)
Q Consensus       100 i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  179 (851)
                      |+....+.|++|..|+.|.+.-|++.-...++|..+++|..|.+.+|.+..+...+|..+..++.+++..|.+-.     
T Consensus       128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----  202 (498)
T KOG4237|consen  128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----  202 (498)
T ss_pred             hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence            998888899999999999999999998889999999999999999999997777799999999999999987421     


Q ss_pred             Hhhhccccccc--ccccccccccCCccccccCCCcEEecCCCCCccccCccccCC-CCcce-EeccCccccCCCCcchhh
Q 046438          180 IRLALPNLELF--SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM-RNLKE-LNLEYNYITSSNHELSFI  255 (851)
Q Consensus       180 ~~~~l~~L~~L--~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~-L~L~~N~i~~~~~~~~~~  255 (851)
                          .-+|+++  ++..|      |..++..+-..-..+.++++..+.+..|... .++.+ +...++.....|     .
T Consensus       203 ----dCnL~wla~~~a~~------~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP-----~  267 (498)
T KOG4237|consen  203 ----DCNLPWLADDLAMN------PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICP-----A  267 (498)
T ss_pred             ----ccccchhhhHHhhc------hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcCh-----H
Confidence                1111111  11111      1122222223333334444444433333211 11111 111111111111     2


Q ss_pred             hhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCC
Q 046438          256 SSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL  335 (851)
Q Consensus       256 ~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l  335 (851)
                      ..++.+++|++|+|++|+++.  +.+..+.-...+++|+|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+
T Consensus       268 ~cf~~L~~L~~lnlsnN~i~~--i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~  345 (498)
T KOG4237|consen  268 KCFKKLPNLRKLNLSNNKITR--IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTL  345 (498)
T ss_pred             HHHhhcccceEeccCCCccch--hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccc
Confidence            235555666666666665542  222222222356666777777766666677778888888888888887778888888


Q ss_pred             CCCcEEEccccccccc-ccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccC----chh--------
Q 046438          336 EKLQILGLENNQLEGR-ILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV----PST--------  402 (851)
Q Consensus       336 ~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----p~~--------  402 (851)
                      ..|.+|+|-.|.+.-- ...++..       .|..+.-.+. |.. +.-..++.+.++++.+...    |+.        
T Consensus       346 ~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~-~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~  416 (498)
T KOG4237|consen  346 FSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGN-PRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSP  416 (498)
T ss_pred             ceeeeeehccCcccCccchHHHHH-------HHhhCCCCCC-CCC-CCCchhccccchhccccccccCCccccCCCCCCC
Confidence            8888888877766521 1111111       0111111111 111 1112344445554443311    111        


Q ss_pred             -hcccCcceE-EEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCC
Q 046438          403 -FWNLTNILM-VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLIS  480 (851)
Q Consensus       403 -~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  480 (851)
                       -...+-+.+ ..-|++.++ .+|..+.  ...++|++.+|.++ .+|+.  .+..| .+|+++|++.-.-...|.++++
T Consensus       417 cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tq  489 (498)
T KOG4237|consen  417 CPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQ  489 (498)
T ss_pred             CCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhh
Confidence             011222222 223333333 5554432  35689999999998 67877  67778 8999999998666788999999


Q ss_pred             CCEEECCCC
Q 046438          481 LECLDLSNN  489 (851)
Q Consensus       481 L~~L~Ls~N  489 (851)
                      |.+|-||+|
T Consensus       490 l~tlilsyn  498 (498)
T KOG4237|consen  490 LSTLILSYN  498 (498)
T ss_pred             hheeEEecC
Confidence            999999887

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-26  Score=225.24  Aligned_cols=213  Identities=24%  Similarity=0.362  Sum_probs=173.9

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeee
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSC  691 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~  691 (851)
                      +++.....+++....+-+|.||.||.|.|.+      .+.|-+|.++... .-+...+..|.-.+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4455556678888899999999999997643      3456777765443 34567788888888889999999999987


Q ss_pred             ecC-CeeEEEEeccCCCChhHHhhc-------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC
Q 046438          692 TND-DFKALVLDYMPKGSLEACLYS-------DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM  763 (851)
Q Consensus       692 ~~~-~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~  763 (851)
                      .++ +..++++.++.-|+|..++..       ..+..+..+...++.|++.|++||   |++||+|.||.++|.+|++..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhe
Confidence            654 578899999999999999873       233466677888999999999999   999999999999999999999


Q ss_pred             cEEEeeccCccccCCCC-CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCcCc
Q 046438          764 VARLGDFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGE  834 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~  834 (851)
                      .+||+|=.+++..-+.+ ..-......+..||+||.+....|+.++|||||||++|||+| |+.|+.++.+-|
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence            99999999988654322 222233457889999999999999999999999999999999 999998875543

>PLN03210 Resistant to P

Probab=99.92  E-value=4e-24  Score=264.08  Aligned_cols=344  Identities=20%  Similarity=0.253  Sum_probs=176.7

Q ss_pred             CCccccCCCCCCEEEcCCCcccc------ccc--CCC-CCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccC
Q 046438           33 IPSSIFSINTLEILDLSNNQLSG------SFP--FFN-MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGH  103 (851)
Q Consensus        33 ~~~~~~~l~~L~~L~Ls~n~l~~------~~~--~~~-~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~  103 (851)
                      .+.+|..+++|+.|.+.++....      ..|  +.. ..+|+.|++.++.+. .+|..+  .+.+|++|+|++|++. .
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-c
Confidence            34456666666666665543211      111  222 245677777776665 666542  3566777777777665 4


Q ss_pred             CCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhh
Q 046438          104 LPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA  183 (851)
Q Consensus       104 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~  183 (851)
                      ++..+..+++|+.|+|++|.....+|. ++.+++|++|+|++|.....+|..+.++++|+.|++++|.....+|..+  .
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~  702 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--N  702 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--C
Confidence            555666677777777776654435553 6667777777777766555666667777777777777664333455433  4


Q ss_pred             cccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhcccccc
Q 046438          184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK  263 (851)
Q Consensus       184 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~  263 (851)
                      +++|+.|++++|.....+|..   ..+|+.|++++|.+..++ ..+ .+++|++|++.++....+..             
T Consensus       703 l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP-~~~-~l~~L~~L~l~~~~~~~l~~-------------  764 (1153)
T PLN03210        703 LKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFP-SNL-RLENLDELILCEMKSEKLWE-------------  764 (1153)
T ss_pred             CCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccccc-ccc-cccccccccccccchhhccc-------------
Confidence            566666666665443333321   234555555555554332 222 34555555554433211100             


Q ss_pred             ccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEc
Q 046438          264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGL  343 (851)
Q Consensus       264 L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  343 (851)
                               .+  ..++......+.+|+.|++++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|++
T Consensus       765 ---------~~--~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~L  832 (1153)
T PLN03210        765 ---------RV--QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDL  832 (1153)
T ss_pred             ---------cc--cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEEC
Confidence                     00  00111111122355555555555555556666666666666666654333444433 4555666666


Q ss_pred             ccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceeccc-CcCccCchhhcccCcceEEEecCC
Q 046438          344 ENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFAS-NELTFVPSTFWNLTNILMVDLSSN  417 (851)
Q Consensus       344 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~p~~~~~l~~L~~L~Ls~N  417 (851)
                      ++|..-..+|..   ..+|+.|+|++|.+. .+|..+..+++|+.|++++ |+++.+|..+..+++|+.+++++|
T Consensus       833 s~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        833 SGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence            555432222221   234444555555444 3344444444444444444 244444444444444444444444

syringae 6; Provisional

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=2.4e-26  Score=236.53  Aligned_cols=209  Identities=26%  Similarity=0.311  Sum_probs=175.9

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC------CCccccee
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR------HRNLVRII  688 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~  688 (851)
                      +.+.-.+....+|.+....|+|.|++|..|++. .|..||||+++.... ....=.+|++||++++      ..|++.++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            334444556688999999999999999999884 488999999986532 2344567999999995      34789999


Q ss_pred             eeeecCCeeEEEEeccCCCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcE
Q 046438          689 SSCTNDDFKALVLDYMPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVA  765 (851)
Q Consensus       689 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~  765 (851)
                      ..|....++|||||-+ .-+|.+.++..+  ..+....+..++.|+.-||..|   -..||+|.||||.|||+++. ..+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCccee
Confidence            9999999999999988 558888887643  3467788899999999999999   88999999999999999875 578


Q ss_pred             EEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          766 RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ||||||.|..+...   ..+.+..+..|.|||++.+.+|+...|+||.||++||+.||+..|.+...
T Consensus       577 KLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  577 KLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             eeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            99999999876433   44567788999999999999999999999999999999999999977543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.92  E-value=9e-25  Score=225.24  Aligned_cols=186  Identities=36%  Similarity=0.478  Sum_probs=164.0

Q ss_pred             cceEEEEEEEc-CCcEEEEEEEeecchhh-HHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChhHHhhc
Q 046438          638 SFGSVYRGRFL-DGMEVAIKVFHLQLEGA-LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS  715 (851)
Q Consensus       638 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  715 (851)
                      +||.||+|++. +++.+|+|++....... .+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48999999997665443 67899999999999999999999999998999999999999999998865


Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccC
Q 046438          716 DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA  795 (851)
Q Consensus       716 ~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~a  795 (851)
                      ... +++..+..++.++++++++|   |+.+++|+|++|+||+++.++.++++|||.+.......  ......++..|++
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            432 78899999999999999999   88899999999999999999999999999998764432  2334567889999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       796 PE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||......++.++||||+|+++|++++|..||..
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999888899999999999999999999999966

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=213.83  Aligned_cols=206  Identities=19%  Similarity=0.357  Sum_probs=162.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceee-eeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIIS-SCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~lv~  701 (851)
                      .+.|.|.+.+|+|.||.+-.++++ +...+|+|.+..+... .++|.+|..--=.+ .|.||+.-|+ .|+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            457999999999999999999995 4677999998766433 47788887654444 5899998886 477888999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC--CCCcEEEeeccCccccCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~--~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||++.|+|.+-+..  ..+.+.....++.|+++|+.|+   |++.+||||||.+||+|-  +..++|+||||..+....-
T Consensus       102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            99999999887643  5577888899999999999999   999999999999999993  3458999999998764321


Q ss_pred             CCccccccccCccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhh
Q 046438          780 ESMKHTQTLATIGYMAPEYGREG-----QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW  840 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  840 (851)
                          ......+..|.+||.....     ...+.+|+|.||+++|..+||+.||+...-.+....+|
T Consensus       177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~  238 (378)
T KOG1345|consen  177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW  238 (378)
T ss_pred             ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence                1112345678899976432     24566899999999999999999998655555444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=4.7e-26  Score=241.53  Aligned_cols=201  Identities=27%  Similarity=0.446  Sum_probs=177.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|+..+++|+|.||.||||++. +++..|+|+++.........+++|+-+++..+|||||.+++.+...+..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3578999999999999999999984 688999999998877777888999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ||.||+|++.. ...+.+++.++..+.+...+|++||   |++|-+|||||-.||++++.|.+|++|||.+..+..-. .
T Consensus        93 ycgggslQdiy-~~TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A  167 (829)
T ss_pred             ecCCCccccee-eecccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence            99999999864 4567888999999999999999999   99999999999999999999999999999886654322 2


Q ss_pred             cccccccCccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYG---REGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      +...+.||++|||||+.   ..+.|..++|+|+.|+...|+-.-+.|..+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd  217 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD  217 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence            44468999999999975   457899999999999999999888877443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=244.18  Aligned_cols=194  Identities=29%  Similarity=0.488  Sum_probs=159.6

Q ss_pred             ccceeccccceE-EEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEeccCCC
Q 046438          630 VNNLIGSGSFGS-VYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       630 ~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      -.+.+|.|+.|+ ||+|.. +|++||||.+-.   ...+.+.+|+..++.- +|||||++++.-.+..+.|+..|.| ..
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             cHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            346789999875 789988 889999998753   2345678999999988 6999999999999999999999999 67


Q ss_pred             ChhHHhhcCCCCc---CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---C--CcEEEeeccCccccCCC
Q 046438          708 SLEACLYSDNSNL---DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---D--MVARLGDFGIAKLLSGD  779 (851)
Q Consensus       708 ~L~~~l~~~~~~~---~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~--~~~kl~Dfg~a~~~~~~  779 (851)
                      +|+++++......   .....+.+..|+++|+++|   |+.+|||||+||.||+|..   +  .+++|+|||+++....+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            9999997631111   1134467899999999999   8899999999999999965   2  57999999999988654


Q ss_pred             CCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          780 ESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       780 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ...  ......||-+|+|||++....-+.++|++|+||++|..++ |.+||.+.-
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~  719 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL  719 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence            432  2345679999999999998888889999999999999988 599997643

>PLN03210 Resistant to P

Probab=99.91  E-value=1.6e-23  Score=258.63  Aligned_cols=335  Identities=24%  Similarity=0.303  Sum_probs=145.5

Q ss_pred             chhcCCccccccccccccc------ccCCCccccCCC-CccEEeccccccccccchhhcCcccccEEEccCccccCCCCc
Q 046438           82 NIFSYLPFVQFLSLAFNQF------AGHLPREIGNLT-SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPA  154 (851)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~i------~~~~~~~l~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  154 (851)
                      ..|.++++|+.|.+..+..      ...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|++.+|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            3455555555555544321      123344444432 3555555555444 344444 2445555555555544 2333


Q ss_pred             cccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCC
Q 046438          155 TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRN  234 (851)
Q Consensus       155 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~  234 (851)
                      .+..+++|+.|+|++|                         .....+|. +..+++|+.|+|++|......|..+..+++
T Consensus       629 ~~~~l~~Lk~L~Ls~~-------------------------~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~  682 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGS-------------------------KNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNK  682 (1153)
T ss_pred             ccccCCCCCEEECCCC-------------------------CCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCC
Confidence            4444445555555444                         32223332 444555555555555444445555666666


Q ss_pred             cceEeccCc-cccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccC
Q 046438          235 LKELNLEYN-YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLIN  313 (851)
Q Consensus       235 L~~L~L~~N-~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~  313 (851)
                      |+.|++++| .++.++..       .++++|+.|++++|...                          ..+|..   ..+
T Consensus       683 L~~L~L~~c~~L~~Lp~~-------i~l~sL~~L~Lsgc~~L--------------------------~~~p~~---~~n  726 (1153)
T PLN03210        683 LEDLDMSRCENLEILPTG-------INLKSLYRLNLSGCSRL--------------------------KSFPDI---STN  726 (1153)
T ss_pred             CCEEeCCCCCCcCccCCc-------CCCCCCCEEeCCCCCCc--------------------------cccccc---cCC
Confidence            666666654 33333211       13455555555554321                          111110   123


Q ss_pred             CcEEEecCCCCCCCcCccccCCCCCcEEEcccccccc-------cccccccccCCCCEEEccCcccCCCCCccccCCccc
Q 046438          314 LIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG-------RILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL  386 (851)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  386 (851)
                      |++|++++|.+. .+|..+ .+++|++|++.++....       ..+..+...++|+.|+|++|...+.+|..++++++|
T Consensus       727 L~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L  804 (1153)
T PLN03210        727 ISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL  804 (1153)
T ss_pred             cCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCC
Confidence            344444444443 223222 23444444444322110       011111123445555555554444455555555555


Q ss_pred             cceecccC-cCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          387 RKLSFASN-ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       387 ~~L~L~~N-~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      +.|++++| .++.+|..+ ++++|+.|++++|.....+|..   .++|++|+|++|.++ .+|.++..+++|+.|+|++|
T Consensus       805 ~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C  879 (1153)
T PLN03210        805 EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGC  879 (1153)
T ss_pred             CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCC
Confidence            55555554 344444433 4455555555554332223221   133444444444444 34444444444444444442


Q ss_pred             -ccCCCCcccccCCCCCCEEECCCC
Q 046438          466 -NLQGSIPNSIGDLISLECLDLSNN  489 (851)
Q Consensus       466 -~l~~~~~~~~~~l~~L~~L~Ls~N  489 (851)
                       ++. .+|..+..+++|+.|++++|
T Consensus       880 ~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        880 NNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCcC-ccCcccccccCCCeeecCCC
Confidence             222 33434444444444444444

syringae 6; Provisional

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.7e-24  Score=218.26  Aligned_cols=130  Identities=24%  Similarity=0.385  Sum_probs=108.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-----C---CcccceeeeeecC--
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-----H---RNLVRIISSCTND--  694 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~--  694 (851)
                      .+|.+.++||.|.|++||.|.+. ..+.||+|+.+... .-.+....|++++++++     |   .+||++++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68999999999999999999885 46779999998553 33466788999999984     2   3699999998764  


Q ss_pred             --CeeEEEEeccCCCChhHHhh-cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 --DFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 --~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                        .+.+||+|++ |..|..++. ...+.++...+.+|++||+.||.|||  ...||+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCCcceeee
Confidence              4899999999 556655554 45677899999999999999999997  55699999999999999

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=7.9e-24  Score=214.89  Aligned_cols=211  Identities=27%  Similarity=0.382  Sum_probs=171.8

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecC
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTND  694 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  694 (851)
                      .+....+.|..+++||+|+|++||+|.+.    .++.||+|.+....  ...++.+|++++..+. +.||+++.+++...
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34445667999999999999999999763    46779999887543  3367999999999995 89999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIA  773 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a  773 (851)
                      +...+|+||++.....++..    .++...+..+++.+..||+++   |..||||||+||.|++.+. .+.-.|+|||+|
T Consensus       108 d~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             CeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhH
Confidence            99999999999999888773    356788889999999999999   9999999999999999974 567889999999


Q ss_pred             cccCC---------------------------------CC----------CccccccccCccccCccccccC-CCCcchh
Q 046438          774 KLLSG---------------------------------DE----------SMKHTQTLATIGYMAPEYGREG-QISTEGD  809 (851)
Q Consensus       774 ~~~~~---------------------------------~~----------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~D  809 (851)
                      ..+..                                 +.          ........||++|.|||++... ..+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            72110                                 00          0111235799999999998764 4688899


Q ss_pred             hHHHHHHHHHHHhCCCCCCccCcCccchhh
Q 046438          810 VYSFGIMLMEIFTRKRPTDEIFSGEMSLKR  839 (851)
Q Consensus       810 vwslG~il~el~~g~~pf~~~~~~~~~~~~  839 (851)
                      |||.|||+..+++++.||-.-.++-+.+.+
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~e  290 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAE  290 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHH
Confidence            999999999999999999665555544444

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=1.5e-22  Score=203.75  Aligned_cols=183  Identities=36%  Similarity=0.603  Sum_probs=159.3

Q ss_pred             eccccceEEEEEEEcC-CcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChhH
Q 046438          634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA  711 (851)
Q Consensus       634 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  711 (851)
                      ||+|++|.||+++..+ ++++++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998854 899999999765432 34679999999999999999999999999899999999999999999


Q ss_pred             HhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCccccCCCCCccccccccC
Q 046438          712 CLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDESMKHTQTLAT  790 (851)
Q Consensus       712 ~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t  790 (851)
                      ++.......++..+..++.++++++++|   |++|++|+|++|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            9866545688899999999999999999   8889999999999999999 89999999999986643321 12335678


Q ss_pred             ccccCccccccC-CCCcchhhHHHHHHHHHH
Q 046438          791 IGYMAPEYGREG-QISTEGDVYSFGIMLMEI  820 (851)
Q Consensus       791 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el  820 (851)
                      ..|++||..... .++.++|+|++|++++++
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            899999998877 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=3.6e-23  Score=236.29  Aligned_cols=266  Identities=25%  Similarity=0.325  Sum_probs=169.0

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      .+-..||++.|.++ .+|..+.  .+|+.|++++|+++..+.  .+++|++|+|++|+|+ .+|..    .++|+.|+|+
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~--lp~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~Ls  270 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA--LPPELRTLEVSGNQLT-SLPVL----PPGLLELSIF  270 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC--CCCCCcEEEecCCccC-cccCc----ccccceeecc
Confidence            44678899999998 6777665  478999999999886443  3678888888888888 66642    4678888888


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI  176 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  176 (851)
                      +|.++ .+|..   .++|+.|+|++|+++ .+|.   ..++|+.|++++|+++++ |..   ..+|+.|++++|+|+ .+
T Consensus       271 ~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~-~L  337 (788)
T PRK15387        271 SNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLT-SL  337 (788)
T ss_pred             CCchh-hhhhc---hhhcCEEECcCCccc-cccc---cccccceeECCCCccccC-CCC---cccccccccccCccc-cc
Confidence            88877 34432   246778888888887 4454   246778888888877753 322   235667777777776 34


Q ss_pred             chhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhh
Q 046438          177 SSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFIS  256 (851)
Q Consensus       177 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~  256 (851)
                      |.    ..++|++|+|++|+|++ +|..   ..+|+.|++++|.++.+ |..   ..+|+.|++++|+++.++       
T Consensus       338 P~----lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP-------  398 (788)
T PRK15387        338 PT----LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSLP-------  398 (788)
T ss_pred             cc----cccccceEecCCCccCC-CCCC---CcccceehhhccccccC-ccc---ccccceEEecCCcccCCC-------
Confidence            42    11356666666666663 2321   23455555555555543 211   234555555555554433       


Q ss_pred             hccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCC
Q 046438          257 SLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLE  336 (851)
Q Consensus       257 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~  336 (851)
                                              ..    ..+|+.|++++|++++ +|...   .+|+.|++++|+++ .+|..+.+++
T Consensus       399 ------------------------~l----~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~  445 (788)
T PRK15387        399 ------------------------VL----PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLS  445 (788)
T ss_pred             ------------------------Cc----ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhcc
Confidence                                    11    1245555555555553 44322   35667778888877 5677777888


Q ss_pred             CCcEEEccccccccccccccc
Q 046438          337 KLQILGLENNQLEGRILDDIC  357 (851)
Q Consensus       337 ~L~~L~L~~n~l~~~~~~~~~  357 (851)
                      +|+.|+|++|++++..+..+.
T Consensus       446 ~L~~LdLs~N~Ls~~~~~~L~  466 (788)
T PRK15387        446 SETTVNLEGNPLSERTLQALR  466 (788)
T ss_pred             CCCeEECCCCCCCchHHHHHH
Confidence            888888888888876665553

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=2.7e-23  Score=237.34  Aligned_cols=201  Identities=25%  Similarity=0.302  Sum_probs=111.5

Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      +|+.|++++|+++ .+|..   .++|+.|++++|+++. +|..   .++|+.|++++|++++. |..   ...|+.|+++
T Consensus       263 sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls  330 (788)
T PRK15387        263 GLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PAL---PSELCKLWAY  330 (788)
T ss_pred             ccceeeccCCchh-hhhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCccccC-CCC---cccccccccc
Confidence            4455555555554 22322   1345555566665552 2321   24566666666666542 221   1245556666


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCC
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIP  448 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  448 (851)
                      +|++++ +|..   ..+|+.|+|++|+|+.+|..   ..+|+.|++++|+++ .+|..   ..+|+.|++++|+|+ .+|
T Consensus       331 ~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP  398 (788)
T PRK15387        331 NNQLTS-LPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLP  398 (788)
T ss_pred             cCcccc-cccc---ccccceEecCCCccCCCCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCC
Confidence            666653 3321   13566666666666666542   235566666666666 34432   235666667777666 344


Q ss_pred             cccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCC
Q 046438          449 TTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       449 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                      ...   ++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus       399 ~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        399 VLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             Ccc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            332   45667777777776 355432   35666777777776 5666677777777777777777766553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2e-22  Score=213.51  Aligned_cols=165  Identities=21%  Similarity=0.202  Sum_probs=129.0

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc--CCcEEEEEEEeec-----chhhHHHHHHHHHHHhhcCCCcccceeeeeecCC
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL--DGMEVAIKVFHLQ-----LEGALESFNAECEVLRSIRHRNLVRIISSCTNDD  695 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  695 (851)
                      ...++|.+.+.||+|+||+||+|++.  +++.||||+....     .....+.+.+|++++++++|+|+++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            45678999999999999999999874  4777899986533     122345689999999999999998644322   4


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCEEECCCCcEEEeeccCcc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI-KPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl-~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ..++||||++|++|... ..    ..   ...++.|+++|++||   |++||+|||| ||+||+++.++.+||+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            57999999999999632 11    11   145788999999999   8899999999 9999999999999999999998


Q ss_pred             ccCCCCCcc-------ccccccCccccCcccccc
Q 046438          775 LLSGDESMK-------HTQTLATIGYMAPEYGRE  801 (851)
Q Consensus       775 ~~~~~~~~~-------~~~~~~t~~y~aPE~~~~  801 (851)
                      .........       .....+++.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            765433211       134567888999998854

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.3e-23  Score=191.12  Aligned_cols=201  Identities=26%  Similarity=0.317  Sum_probs=171.7

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCC-CcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRH-RNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ...|+++++||+|+||.+|.|.. .+|++||+|+-+.....  ..+..|.++.+.+++ ..|..+..+..+..+-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            46799999999999999999977 57999999986544322  457789999999986 778888888888889999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---CcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---~~~kl~Dfg~a~~~~~~  779 (851)
                      .. |.+|+++..-..+.++..+++..+.|++.-++|+   |.++++||||||+|++++-+   ..+.++|||+|+.+.+.
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            98 8899998877788899999999999999999999   88999999999999999643   46899999999877543


Q ss_pred             CCc------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          780 ESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       780 ~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ...      ......||.+|++-....+...+.+.|+-|+|+++...--|..||++..
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            322      1223579999999988888888999999999999999999999998864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-21  Score=192.27  Aligned_cols=200  Identities=22%  Similarity=0.329  Sum_probs=174.0

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ...|++.++||+|+||+++.|+. -++++||+|.-...+  +.-.++.|.+..+.+. .++|..+|.+..+..+-.+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            35799999999999999999976 579999999754433  2356788899998885 5999999988888888899999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-----CCcEEEeeccCccccC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-----DMVARLGDFGIAKLLS  777 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-----~~~~kl~Dfg~a~~~~  777 (851)
                      .+ |-+|+++..-.++.++..++..+|.|++.-++|+   |.+..|.|||||+|+||..     ...+.|+|||+|+.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 8899999888899999999999999999999999   8889999999999999964     3468999999999887


Q ss_pred             CCCCcc------ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMK------HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++....      +....||.+||+-....+.+.+.+.|+-|+|-++...+-|..||.+.
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            655322      23457999999999999999999999999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-21  Score=207.12  Aligned_cols=201  Identities=24%  Similarity=0.335  Sum_probs=166.9

Q ss_pred             CCCccceeccccceEEEEEEEcCC--cEEEEEEEeecchhhHHHHHHHHHHHhhcCC----Ccccceeeee-ecCCeeEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLDG--MEVAIKVFHLQLEGALESFNAECEVLRSIRH----RNLVRIISSC-TNDDFKAL  699 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  699 (851)
                      +|++.+.||+|+||.||.|...+.  ..+|+|............+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999987553  4789998766533322368889999888863    6888999888 57778899


Q ss_pred             EEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-----CcEEEeeccCc
Q 046438          700 VLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-----MVARLGDFGIA  773 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-----~~~kl~Dfg~a  773 (851)
                      ||+.+ |.+|.++..... +.++..++.+++.|++.+++++   |+.|++||||||.|++++..     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999875543 7899999999999999999999   99999999999999999764     46999999999


Q ss_pred             c--ccCCCCC-----c-c-ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          774 K--LLSGDES-----M-K-HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       774 ~--~~~~~~~-----~-~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      +  .+.....     . . ...+.||..|+++.+..+...+++.|+||+++++.|+..|..||....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            8  3221111     1 1 234569999999999999999999999999999999999999996643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=3.4e-21  Score=188.88  Aligned_cols=171  Identities=13%  Similarity=0.128  Sum_probs=132.8

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHH---H------HHHHHHHHhhcCCCcccceeeeeecC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALE---S------FNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      ...+|++.+.+|.|+||.||.+.. ++..+|+|+++........   .      +.+|++.+.+++||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999766 6778999999755432222   2      67899999999999999998886543


Q ss_pred             --------CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          695 --------DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       695 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                              +..++||||++|.+|.++..     .+.    ....+++.++..+   |..|++|||++|+||+++.++ ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999977631     222    2456899999999   899999999999999999988 99


Q ss_pred             EeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHH
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF  821 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~  821 (851)
                      ++|||.......+..  ..           .+.....+..++|+|+|||.+....
T Consensus       175 liDfg~~~~~~e~~a--~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKA--KD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhh--HH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            999998765422111  10           1334445667899999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.7e-20  Score=182.98  Aligned_cols=140  Identities=18%  Similarity=0.187  Sum_probs=109.6

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchh--h-------H-----------------HHHHHHHHHHhhcCCCcc
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG--A-------L-----------------ESFNAECEVLRSIRHRNL  684 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni  684 (851)
                      .+.||+|++|.||+|...+|++||+|+++.....  .       .                 ....+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999764211  0       0                 122459999999988877


Q ss_pred             cceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc
Q 046438          685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV  764 (851)
Q Consensus       685 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~  764 (851)
                      .....+..  ...++||||++|+++..... ....++......++.|++.+++|+|  |+.||+|||+||+||+++ ++.
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence            54333222  22389999999887755432 2356788889999999999999996  678999999999999998 478


Q ss_pred             EEEeeccCcccc
Q 046438          765 ARLGDFGIAKLL  776 (851)
Q Consensus       765 ~kl~Dfg~a~~~  776 (851)
                      ++++|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.83  E-value=1.2e-20  Score=217.58  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=131.1

Q ss_pred             CCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccc
Q 046438          209 SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL  288 (851)
Q Consensus       209 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~  288 (851)
                      .+.+.|+++++.++.+ |..+.  ++|+.|+|++|+|+.++...        .++|++|++++|++..  +|..+   +.
T Consensus       178 ~~~~~L~L~~~~LtsL-P~~Ip--~~L~~L~Ls~N~LtsLP~~l--------~~nL~~L~Ls~N~Lts--LP~~l---~~  241 (754)
T PRK15370        178 NNKTELRLKILGLTTI-PACIP--EQITTLILDNNELKSLPENL--------QGNIKTLYANSNQLTS--IPATL---PD  241 (754)
T ss_pred             cCceEEEeCCCCcCcC-Ccccc--cCCcEEEecCCCCCcCChhh--------ccCCCEEECCCCcccc--CChhh---hc
Confidence            3456777777777754 33232  45777777777777655321        1356666666666642  33322   12


Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      +|+.|+|++|++. .+|..+.                          .+|+.|++++|+++. +|..+.  .+|+.|+++
T Consensus       242 ~L~~L~Ls~N~L~-~LP~~l~--------------------------s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls  291 (754)
T PRK15370        242 TIQEMELSINRIT-ELPERLP--------------------------SALQSLDLFHNKISC-LPENLP--EELRYLSVY  291 (754)
T ss_pred             cccEEECcCCccC-cCChhHh--------------------------CCCCEEECcCCccCc-cccccC--CCCcEEECC
Confidence            4455555555554 3333332                          244455555554442 233222  245555555


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCC
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIP  448 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  448 (851)
                      +|++++ +|..+.  ++|+.|++++|+++.+|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|
T Consensus       292 ~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP  362 (754)
T PRK15370        292 DNSIRT-LPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLP  362 (754)
T ss_pred             CCcccc-Ccccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCC
Confidence            555552 232221  245666666666665554332  456666666666653 444432  45666666666665 455


Q ss_pred             cccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccc----ccccccceeccCcccc
Q 046438          449 TTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLE----KLLYLKYLNVSFNRLE  516 (851)
Q Consensus       449 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----~l~~L~~l~l~~N~l~  516 (851)
                      ..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|++++|+|+ .+|..+.    .++.+..|++.+|+++
T Consensus       363 ~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        363 ETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            4442  45666666666666 4454443  25666666666666 3444332    3355666666666665

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.83  E-value=1.2e-20  Score=217.46  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=153.2

Q ss_pred             ccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccE
Q 046438          187 LELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV  266 (851)
Q Consensus       187 L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~  266 (851)
                      ...|++++++++. +|..+  .+.++.|+|++|+++.++...+   .+|++|++++|.++.++..      +  .+.|+.
T Consensus       180 ~~~L~L~~~~Lts-LP~~I--p~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsLP~~------l--~~~L~~  245 (754)
T PRK15370        180 KTELRLKILGLTT-IPACI--PEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSIPAT------L--PDTIQE  245 (754)
T ss_pred             ceEEEeCCCCcCc-CCccc--ccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccccCChh------h--hccccE
Confidence            3444555554442 23222  2345556666666554433222   3566666666666654421      1  135666


Q ss_pred             EeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccc
Q 046438          267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENN  346 (851)
Q Consensus       267 L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  346 (851)
                      |+|++|++.  .+|..+.   .+|+.|++++|+++ .+|..+.  ++|+.|++++|++++ +|..+.  ++|+.|++++|
T Consensus       246 L~Ls~N~L~--~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N  314 (754)
T PRK15370        246 MELSINRIT--ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSN  314 (754)
T ss_pred             EECcCCccC--cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCC
Confidence            666666664  3444432   35777777777776 4565543  478888888888874 444332  46778888888


Q ss_pred             cccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccc
Q 046438          347 QLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE  426 (851)
Q Consensus       347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  426 (851)
                      .++. +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+.+|..+.  ++|+.|+|++|+++ .+|..
T Consensus       315 ~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt-~LP~~  385 (754)
T PRK15370        315 SLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALT-NLPEN  385 (754)
T ss_pred             cccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCC-CCCHh
Confidence            8874 33333  2578888888888874 555443  578888888888888877653  57888888888888 45655


Q ss_pred             cccchhhhhhhccCCcccccCCccc----CCCCCccEEEccCcccC
Q 046438          427 IGNLKVLVELYLSRNNLSGDIPTTI----GGLKNLQNLSLGDNNLQ  468 (851)
Q Consensus       427 ~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~  468 (851)
                      +.  ..|+.|++++|+|+ .+|..+    ..++++..|++.+|.++
T Consensus       386 l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        386 LP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             HH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            43  46888888888887 455543    33466777777777776

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.82  E-value=8.7e-21  Score=227.85  Aligned_cols=148  Identities=20%  Similarity=0.324  Sum_probs=114.7

Q ss_pred             hcCC-Ccccceeeee-------ecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 046438          678 SIRH-RNLVRIISSC-------TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH  749 (851)
Q Consensus       678 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH  749 (851)
                      .++| +||+.+++++       .+....+.+|||+ +++|.+++......+++.++..++.||++|++||   |++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeee
Confidence            3455 5777788776       2234567788987 6699999976566789999999999999999999   8999999


Q ss_pred             cCCCCCCEEECCC-------------------CcEEEeeccCccccCCCC---------------CccccccccCccccC
Q 046438          750 CDIKPSNVLLDED-------------------MVARLGDFGIAKLLSGDE---------------SMKHTQTLATIGYMA  795 (851)
Q Consensus       750 ~Dl~~~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~~t~~y~a  795 (851)
                      |||||+|||++..                   +.+|++|||+++......               ........+|+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   455666666664321100               001112457899999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       796 PE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||++.+..|+.++|||||||++|||++|..|+..
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            9999999999999999999999999999998764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.82  E-value=5e-22  Score=176.16  Aligned_cols=181  Identities=31%  Similarity=0.492  Sum_probs=136.3

Q ss_pred             cCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEE
Q 046438          333 SRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV  412 (851)
Q Consensus       333 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L  412 (851)
                      ..+...+.|.|++|+++ ..|..++.+.+|+.|++++|+|. ..|..+..+++|+.|+++-|++..+|..|+.++.|+.|
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levl  107 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVL  107 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhh
Confidence            34556667777777777 55666777777777777777777 56777778888888888888888888888888888888


Q ss_pred             EecCCCCCC-CCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcc
Q 046438          413 DLSSNPLSG-SLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNIL  491 (851)
Q Consensus       413 ~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  491 (851)
                      ||.+|.+.. .+|..|-.++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.+++.+++|++|++++|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            888887753 46777878888888888888887 77888888888888888888887 7888888888888888888888


Q ss_pred             cccCCcccccccc---ccceeccCcccccc
Q 046438          492 SGIIPSSLEKLLY---LKYLNVSFNRLEGE  518 (851)
Q Consensus       492 ~~~~p~~l~~l~~---L~~l~l~~N~l~~~  518 (851)
                      + .+|.+++.+.-   =+.+.+.+|||-..
T Consensus       186 ~-vlppel~~l~l~~~k~v~r~E~NPwv~p  214 (264)
T KOG0617|consen  186 T-VLPPELANLDLVGNKQVMRMEENPWVNP  214 (264)
T ss_pred             e-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence            8 66666665433   24456666666433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.8e-19  Score=170.13  Aligned_cols=190  Identities=19%  Similarity=0.119  Sum_probs=140.7

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeecchh----hHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEec
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG----ALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .+...+++|+||+||.+.. .+.+++.+.+......    ....+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4568899999999998765 7788887777654321    1125889999999995 4889999886    346899999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI-KPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl-~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +.|.+|......        ....++.|++++++++   |++||+|||| ||.||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998654311        1234778999999999   8999999999 799999999999999999999865432210


Q ss_pred             ----c--------ccccccCccccCccccccC-CCC-cchhhHHHHHHHHHHHhCCCCCCccCcCc
Q 046438          783 ----K--------HTQTLATIGYMAPEYGREG-QIS-TEGDVYSFGIMLMEIFTRKRPTDEIFSGE  834 (851)
Q Consensus       783 ----~--------~~~~~~t~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~  834 (851)
                          .        ......++.|++|+...-- ..+ .+.+.++.|+-+|.++|+..|+-....+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~~  214 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEGQ  214 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCCC
Confidence                0        0112356777777743321 222 45689999999999999999976654443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-21  Score=174.11  Aligned_cols=180  Identities=27%  Similarity=0.439  Sum_probs=162.8

Q ss_pred             ccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhh
Q 046438          356 ICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVE  435 (851)
Q Consensus       356 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  435 (851)
                      +..+.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+.+|..++.++.|+.|+++-|++. .+|..|+.++.|+.
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            345677888999999999 6777899999999999999999999999999999999999999998 89999999999999


Q ss_pred             hhccCCcccc-cCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCcc
Q 046438          436 LYLSRNNLSG-DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNR  514 (851)
Q Consensus       436 L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~  514 (851)
                      |||++|++.. .+|+.|..+..|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- .+|.+++.+++|++|.+.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9999999974 47999999999999999999998 89999999999999999999998 799999999999999999999


Q ss_pred             ccccCCCCCcccccCc---ccccCCcCc
Q 046438          515 LEGEIPRGGTLANFTS---ESFMGNDLL  539 (851)
Q Consensus       515 l~~~~p~~~~~~~l~~---~~~~~n~~~  539 (851)
                      ++-.+|+.+++.....   ...+.|||.
T Consensus       185 l~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  185 LTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            9999998776654443   334666663

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.80  E-value=1.3e-18  Score=189.29  Aligned_cols=199  Identities=38%  Similarity=0.550  Sum_probs=169.9

Q ss_pred             CCccceeccccceEEEEEEEcCCcEEEEEEEeecchh---hHHHHHHHHHHHhhcCCC-cccceeeeeecCCeeEEEEec
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG---ALESFNAECEVLRSIRHR-NLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  703 (851)
                      |.+.+.+|.|+||.||++.+.  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++++.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999876  78999998765433   367799999999999988 799999999777778999999


Q ss_pred             cCCCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCccccCCCC
Q 046438          704 MPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDE  780 (851)
Q Consensus       704 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~~~  780 (851)
                      +.++++.+++....  ..........+..|++.+++|+   |+.+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997665443  2688889999999999999999   889999999999999999988 79999999998654333


Q ss_pred             Cc-----cccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SM-----KHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ..     ......++..|+|||...+   ..+....|+||+|++++++++|..||....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21     2356789999999999987   578889999999999999999999976543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=6.2e-19  Score=173.06  Aligned_cols=142  Identities=19%  Similarity=0.208  Sum_probs=110.9

Q ss_pred             ccceeccccceEEEEEEEcCCcEEEEEEEeecchh--------------------------hHHHHHHHHHHHhhcCCCc
Q 046438          630 VNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG--------------------------ALESFNAECEVLRSIRHRN  683 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~n  683 (851)
                      +.+.||+|++|.||+|++.+|+.||+|+++.....                          .......|.+.+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            35789999999999999878999999998764211                          0122467899999999998


Q ss_pred             ccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCC
Q 046438          684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDED  762 (851)
Q Consensus       684 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~  762 (851)
                      +.....+...  ..++||||++|+++..... .....+......++.|++.++.++   |. +||+|||+||+||+++ +
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~l---H~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRL---YQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCChhhEEEE-C
Confidence            7554443332  2489999999885533221 224567778889999999999999   66 8999999999999999 8


Q ss_pred             CcEEEeeccCccccCC
Q 046438          763 MVARLGDFGIAKLLSG  778 (851)
Q Consensus       763 ~~~kl~Dfg~a~~~~~  778 (851)
                      +.++|+|||+|.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.6e-19  Score=171.90  Aligned_cols=201  Identities=25%  Similarity=0.454  Sum_probs=160.5

Q ss_pred             CCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ..+..+|.+...|..|+|+| +|..+++|+++...  ....++|.+|.-.++-+.||||.++++.|..+....+|..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            45567889999999999999 56677788776442  2234679999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe--eccCccccCCCCCc
Q 046438          706 KGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG--DFGIAKLLSGDESM  782 (851)
Q Consensus       706 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~--Dfg~a~~~~~~~~~  782 (851)
                      .|+|+..+++.. .-.+..++.+++.+|++|++|||.... -|.---+.++.|+||++.+++|.  |--++        +
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfs--------f  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFS--------F  341 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceee--------e
Confidence            999999998753 346777889999999999999965332 24444689999999999988775  32222        1


Q ss_pred             cccccccCccccCccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCccCcCccchh
Q 046438          783 KHTQTLATIGYMAPEYGREGQIS---TEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK  838 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~---~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  838 (851)
                      ........|.|++||.+..++.+   .++|+|||++++||+.|.+.||.+..+.|..++
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk  400 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK  400 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence            22234567899999998776543   468999999999999999999999888777554

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=3.9e-20  Score=199.22  Aligned_cols=242  Identities=24%  Similarity=0.284  Sum_probs=119.4

Q ss_pred             ccCCCCccEEeccccccc------cccchhhcCcccccEEEccCccccCCCCccccCCCc---CcEEEeeccccccccch
Q 046438          108 IGNLTSLTSIDLSENHLM------GEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNIST---LKILQLTNNTLSGSISS  178 (851)
Q Consensus       108 l~~l~~L~~L~Ls~n~l~------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~---L~~L~L~~n~l~~~~~~  178 (851)
                      +...++|++|+++++.+.      ..++..+..+++|+.|++++|.+....+..+..+.+   |++|++++|++++....
T Consensus        47 l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~  126 (319)
T cd00116          47 LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR  126 (319)
T ss_pred             HhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH
Confidence            334444555555555443      112334445555555555555555444433333333   66666666655432111


Q ss_pred             hH---hhhc-cccccccccccccccc----CCccccccCCCcEEecCCCCCccc----cCccccCCCCcceEeccCcccc
Q 046438          179 SI---RLAL-PNLELFSLANNNFSGK----IPSFIFNASKLSICELPDNSFSGF----IPNRFHNMRNLKELNLEYNYIT  246 (851)
Q Consensus       179 ~~---~~~l-~~L~~L~L~~N~i~~~----~~~~~~~~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~  246 (851)
                      .+   ...+ ++|+.|++++|.+++.    .+..+..+++|+.|++++|.+++.    .+..+..+++|++|++++|.++
T Consensus       127 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  206 (319)
T cd00116         127 LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT  206 (319)
T ss_pred             HHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence            11   1123 5556666666665522    222334445666666666666532    1223444557777777777665


Q ss_pred             CCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCC
Q 046438          247 SSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG  326 (851)
Q Consensus       247 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~  326 (851)
                      ..... .+...+..+++|++|++++|++.+..+.......                     ....+.|+.|++++|.++.
T Consensus       207 ~~~~~-~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~---------------------~~~~~~L~~L~l~~n~i~~  264 (319)
T cd00116         207 DEGAS-ALAETLASLKSLEVLNLGDNNLTDAGAAALASAL---------------------LSPNISLLTLSLSCNDITD  264 (319)
T ss_pred             hHHHH-HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHH---------------------hccCCCceEEEccCCCCCc
Confidence            43211 1233455566677777777665431111000000                     0012456666666666542


Q ss_pred             ----CcCccccCCCCCcEEEccccccccc----cccccccc-CCCCEEEccCcc
Q 046438          327 ----SIPSTLSRLEKLQILGLENNQLEGR----ILDDICRL-ARLSSVYLDHNK  371 (851)
Q Consensus       327 ----~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l-~~L~~L~L~~N~  371 (851)
                          .....+..+++|+++++++|.++..    ....+... +.|+.+++.+|.
T Consensus       265 ~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         265 DGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence                1223344556777777777777644    22233333 567777776664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=1.9e-20  Score=201.58  Aligned_cols=209  Identities=25%  Similarity=0.277  Sum_probs=117.8

Q ss_pred             ccccccCCcEEEecCCCCCCCcCccccCCCC---CcEEEccccccccc----cccccccc-CCCCEEEccCcccCCC---
Q 046438          307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEK---LQILGLENNQLEGR----ILDDICRL-ARLSSVYLDHNKLSGS---  375 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~~----~~~~~~~l-~~L~~L~L~~N~l~~~---  375 (851)
                      .+..+++|+.|++++|.+.+..+..+..+..   |++|++++|.+++.    +...+..+ ++|+.|++++|.+++.   
T Consensus        76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  155 (319)
T cd00116          76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE  155 (319)
T ss_pred             HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence            3444555555555555554433333333333   55555555555521    12223334 5556666666665521   


Q ss_pred             -CCccccCCccccceecccCcCc-----cCchhhcccCcceEEEecCCCCCCCC----ccccccchhhhhhhccCCcccc
Q 046438          376 -IPACFGNLASLRKLSFASNELT-----FVPSTFWNLTNILMVDLSSNPLSGSL----PLEIGNLKVLVELYLSRNNLSG  445 (851)
Q Consensus       376 -~~~~~~~l~~L~~L~L~~N~l~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~  445 (851)
                       ++..+..+++|++|++++|.++     .++..+..+++|+.|++++|.+++..    +..+..+++|++|++++|++++
T Consensus       156 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence             2233444556666666666665     23334445556777777777665332    2334455667777777776664


Q ss_pred             cCCcccC-----CCCCccEEEccCcccCC----CCcccccCCCCCCEEECCCCccccc----CCcccccc-ccccceecc
Q 046438          446 DIPTTIG-----GLKNLQNLSLGDNNLQG----SIPNSIGDLISLECLDLSNNILSGI----IPSSLEKL-LYLKYLNVS  511 (851)
Q Consensus       446 ~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l-~~L~~l~l~  511 (851)
                      .....+.     ..+.|+.|++++|.++.    .+...+..+++|+.+++++|.++..    ....+... +.|+.+++.
T Consensus       236 ~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~  315 (319)
T cd00116         236 AGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK  315 (319)
T ss_pred             HHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence            2222221     24678888888888762    2344556667888888888888844    44445555 678888888


Q ss_pred             Cccc
Q 046438          512 FNRL  515 (851)
Q Consensus       512 ~N~l  515 (851)
                      +|+|
T Consensus       316 ~~~~  319 (319)
T cd00116         316 DDSF  319 (319)
T ss_pred             CCCC
Confidence            8875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.76  E-value=1.4e-18  Score=169.24  Aligned_cols=111  Identities=25%  Similarity=0.277  Sum_probs=96.4

Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |+|.+++......+++..++.++.||+.|++||   |+++      ||+||+++.++.+|+  ||.+.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            688898876667799999999999999999999   6666      999999999999999  99987654321      


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE  834 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  834 (851)
                      ..+++.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~  111 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS  111 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc
Confidence            258899999999999999999999999999999999999997644333

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=4.5e-18  Score=195.63  Aligned_cols=200  Identities=24%  Similarity=0.275  Sum_probs=160.3

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC---CCcccceeeeeecCCe
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR---HRNLVRIISSCTNDDF  696 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  696 (851)
                      +.+...+.|.|.+.+|+|+||+||.|...+|+.||+|+-+....++   |.--.+++.+++   -+.|..+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            3344567899999999999999999998889999999987765442   222334445554   2334555555555666


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-------CCCcEEEee
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-------EDMVARLGD  769 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-------~~~~~kl~D  769 (851)
                      -++|+||.+.|+|.+++. ..+..++.-++.++.|+++.+++|   |..+||||||||+|.++.       ...-++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            789999999999999986 566788899999999999999999   999999999999999994       234689999


Q ss_pred             ccCccccCCCC-CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 046438          770 FGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP  826 (851)
Q Consensus       770 fg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  826 (851)
                      ||.+..+.--. .......++|-.+-.+|+..++++++.+|.|.++-++|.|+.|+.-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99987654322 2244556789999999999999999999999999999999999854

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=3.8e-17  Score=160.52  Aligned_cols=137  Identities=17%  Similarity=0.294  Sum_probs=105.8

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-----CCCcccceeeeeecCC---e-eEE
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI-----RHRNLVRIISSCTNDD---F-KAL  699 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~l  699 (851)
                      .-.+.||+|+||.||.  +.+....+||++........+.+.+|+++++.+     .||||++++++++++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3357899999999995  544344479988765444557799999999999     5799999999998863   3 337


Q ss_pred             EEec--cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCCEEECC----CCcEEEee-cc
Q 046438          700 VLDY--MPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVHCDIKPSNVLLDE----DMVARLGD-FG  771 (851)
Q Consensus       700 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~L~~~h~~~ivH~Dl~~~Nill~~----~~~~kl~D-fg  771 (851)
                      |+||  +.+++|.+++.+.  .+++.  ..++.|++.++ +||   |+++|+||||||+||+++.    ++.++|+| ||
T Consensus        83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5579999999653  34444  34577777777 999   8899999999999999974    34799999 55


Q ss_pred             Ccc
Q 046438          772 IAK  774 (851)
Q Consensus       772 ~a~  774 (851)
                      ...
T Consensus       156 ~~~  158 (210)
T PRK10345        156 EST  158 (210)
T ss_pred             Ccc
Confidence            443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=3.5e-18  Score=193.62  Aligned_cols=199  Identities=22%  Similarity=0.291  Sum_probs=156.1

Q ss_pred             CccceeccccceEEEEEEEc-CCcEEEEEEEee---cc--hhh-HHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          629 NVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL---QL--EGA-LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~--~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ...+.+|.|++|.|+.+... .....+.|.++.   ..  +.. ...+..|..+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            44578999999988777543 344445554331   11  111 122556777778889999998888877766555569


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |||++ +|..++... ..+...++..++.|+..|+.|+   |..||.|||+|++|+++..+|.+||+|||.+....-+..
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 998887543 4677788888999999999999   999999999999999999999999999999876543322


Q ss_pred             ---ccccccccCccccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          782 ---MKHTQTLATIGYMAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       782 ---~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                         ......+|+..|+|||++.+..|.++ .||||.|+++..|.+|+.||..-..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~  530 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK  530 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence               34456789999999999999999876 6999999999999999999965433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.70  E-value=9.1e-17  Score=162.67  Aligned_cols=195  Identities=23%  Similarity=0.338  Sum_probs=128.3

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCC----------Ccccceeeeee-
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRH----------RNLVRIISSCT-  692 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~-  692 (851)
                      +...+.||.|+++.||.+++. +++++|+|++....   ....+.+++|.-....+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            455689999999999999995 48999999986544   2345667777665555332          12222222211 


Q ss_pred             -----------cCC-----eeEEEEeccCCCChhHHhhc---CCCC---cCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 046438          693 -----------NDD-----FKALVLDYMPKGSLEACLYS---DNSN---LDIFKRLNIVIDIALALEYLHFGHPNPVVHC  750 (851)
Q Consensus       693 -----------~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~---~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~  750 (851)
                                 +..     ..+++|+-+ .++|.+++..   ....   .....+..+..|+++.+++|   |..|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceEec
Confidence                       111     235788877 5678776432   2211   23334456678999999999   88999999


Q ss_pred             CCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCcccccc--------CCCCcchhhHHHHHHHHHHHh
Q 046438          751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE--------GQISTEGDVYSFGIMLMEIFT  822 (851)
Q Consensus       751 Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~  822 (851)
                      ||+|+|++++++|.++++||+.......  ....  ...+..|.+||....        ..++++.|.|++|+++|.+++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999998765432  1111  345678999997643        357888999999999999999


Q ss_pred             CCCCCCcc
Q 046438          823 RKRPTDEI  830 (851)
Q Consensus       823 g~~pf~~~  830 (851)
                      |+.||+..
T Consensus       246 ~~lPf~~~  253 (288)
T PF14531_consen  246 GRLPFGLS  253 (288)
T ss_dssp             SS-STCCC
T ss_pred             ccCCCCCC
Confidence            99999865

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=9.9e-17  Score=162.00  Aligned_cols=144  Identities=18%  Similarity=0.164  Sum_probs=111.6

Q ss_pred             hcCCCccceeccccceEEEEEE--EcCCcEEEEEEEeecchh------------------------hHHHHHHHHHHHhh
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGR--FLDGMEVAIKVFHLQLEG------------------------ALESFNAECEVLRS  678 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~  678 (851)
                      ..-|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+.+|++.+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458899999999999999998  457999999998754210                        11235789999999


Q ss_pred             cCCCc--ccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCC
Q 046438          679 IRHRN--LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP-VVHCDIKPS  755 (851)
Q Consensus       679 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~-ivH~Dl~~~  755 (851)
                      +.+..  +.+++++    ...++||||++|+++...... ...........++.||+.++++|   |.+| |+|||+||+
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~  178 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEY  178 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChh
Confidence            97533  3444442    234899999999887654422 23455556778999999999999   8889 999999999


Q ss_pred             CEEECCCCcEEEeeccCccccC
Q 046438          756 NVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       756 Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ||+++ ++.++++|||.|....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.69  E-value=4.1e-18  Score=182.62  Aligned_cols=185  Identities=28%  Similarity=0.333  Sum_probs=153.4

Q ss_pred             eccccceEEEEEEE----cCCcEEEEEEEeecchh--hHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEeccCC
Q 046438          634 IGSGSFGSVYRGRF----LDGMEVAIKVFHLQLEG--ALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       634 lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +|+|.||.|+.++-    ..|.-+|+|+.++....  .......|..++..++ ||.+|++...++.+...++++++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            68999999998743    24667899988765422  2225667888899887 99999999999999999999999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      |.+...+... ..++......+...++-+++++   |+.||+|||+|++||+++.+|++++.|||.++..-...     .
T Consensus        82 g~lft~l~~~-~~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~  152 (612)
T KOG0603|consen   82 GDLFTRLSKE-VMFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----I  152 (612)
T ss_pred             chhhhccccC-CchHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----h
Confidence            9987766443 3455566666777888889999   99999999999999999999999999999988653221     2


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .+||..|||||++.  .+..++|.||+|++++||++|..||..
T Consensus       153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            28999999999998  678889999999999999999999976

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.69  E-value=8.9e-18  Score=188.64  Aligned_cols=196  Identities=24%  Similarity=0.273  Sum_probs=150.4

Q ss_pred             CCCccceeccccceEEEEEEEcCCcEEEEEEEeecc-hhhHHHHHHHHHH--HhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL-EGALESFNAECEV--LRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +|...+.+|++.|=+|.+|++.+|. |+||++-++. .-..+.+.++++-  ....+|||.+++.-+...+...|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6778899999999999999998887 9999986654 2334444444333  4445899999988887777788899999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc--CCCCC
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~--~~~~~  781 (851)
                      + ..+|++.+. .+..+...+.+.|+.|++.|+..+   |..||+|||||.+||||+.=.-+.|+||..-+..  ..+..
T Consensus       103 v-khnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  103 V-KHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             H-hhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            8 557877763 344566677788999999999999   9999999999999999999999999999865432  22221


Q ss_pred             ----ccccccccCccccCccccccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCC
Q 046438          782 ----MKHTQTLATIGYMAPEYGREG----------Q-ISTEGDVYSFGIMLMEIFT-RKRPTD  828 (851)
Q Consensus       782 ----~~~~~~~~t~~y~aPE~~~~~----------~-~~~~~DvwslG~il~el~~-g~~pf~  828 (851)
                          +...+...-..|+|||.+...          . .+++=||||+||+++|+++ |++||+
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence                112223445689999976432          2 5667799999999999988 899986

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.7e-16  Score=155.87  Aligned_cols=143  Identities=20%  Similarity=0.196  Sum_probs=111.4

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchh----------------------hHHHHHHHHHHHh
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG----------------------ALESFNAECEVLR  677 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~  677 (851)
                      ++......|.+.+.||+|+||.||+|...+|+.||||+++.....                      .......|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444458888999999999999998888999999987643210                      1123677888899


Q ss_pred             hcCCCc--ccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 046438          678 SIRHRN--LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPS  755 (851)
Q Consensus       678 ~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~  755 (851)
                      ++.|++  +++.++.    ...++||||++|+++......       .....++.++++++.++   |+.||+|||++|+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCcc
Confidence            888774  4444432    345899999999998765321       23457889999999999   7799999999999


Q ss_pred             CEEECCCCcEEEeeccCcccc
Q 046438          756 NVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       756 Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ||++++++.++|+|||.+...
T Consensus       155 Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cEEEcCCCcEEEEECCccccC
Confidence            999999999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=2.9e-16  Score=157.86  Aligned_cols=135  Identities=22%  Similarity=0.317  Sum_probs=113.3

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecch--------hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--------GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +.||+|++|.||+|++ .|..|++|+......        .....+.+|++++..++|+++.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999988 778899998654321        1234578899999999999988777777677788999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ++|++|.+++....    . ....++.+++.+++++   |+.|++|||++|.||+++ ++.++++|||.+...
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999998875422    1 7788999999999999   889999999999999999 789999999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=3.5e-16  Score=155.58  Aligned_cols=131  Identities=25%  Similarity=0.357  Sum_probs=106.4

Q ss_pred             eeccccceEEEEEEEcCCcEEEEEEEeecc--------hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          633 LIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--------EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       633 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .||+|++|.||+|.+ ++..|++|+.....        .....++.+|+++++.++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 67889999865321        112356788999999999887665555555566678999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      +|+++.+.+.....        .++.+++.+++++   |+.|++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999887643211        7899999999999   899999999999999999 889999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=2e-16  Score=159.01  Aligned_cols=162  Identities=23%  Similarity=0.315  Sum_probs=117.6

Q ss_pred             CCCcccceeeeeec---------------------------CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHH
Q 046438          680 RHRNLVRIISSCTN---------------------------DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI  732 (851)
Q Consensus       680 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  732 (851)
                      +|||||.+.++|.+                           ....|+||..+ ..+|+.++...  ..+.....-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence            59999998765432                           23678999888 45888888653  45556677799999


Q ss_pred             HHHHHHHHhcCCCCcEecCCCCCCEEE--CCCC--cEEEeeccCccccCCCC-----CccccccccCccccCccccccCC
Q 046438          733 ALALEYLHFGHPNPVVHCDIKPSNVLL--DEDM--VARLGDFGIAKLLSGDE-----SMKHTQTLATIGYMAPEYGREGQ  803 (851)
Q Consensus       733 ~~~l~~L~~~h~~~ivH~Dl~~~Nill--~~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~  803 (851)
                      ++|+.||   |++||.|||+|++||++  ++|+  ...|+|||+|---+..+     .......-|...-||||+....+
T Consensus       351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999   99999999999999999  3443  56789999874222111     11112235677889999875422


Q ss_pred             ------CCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcccccCc
Q 046438          804 ------ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPI  847 (851)
Q Consensus       804 ------~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  847 (851)
                            -..|+|.|+.|.+.||+++...||-..+...-+...|..+.+|.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa  477 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA  477 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC
Confidence                  24579999999999999999999977544444555566666653

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.5e-15  Score=173.86  Aligned_cols=139  Identities=23%  Similarity=0.313  Sum_probs=112.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeec-c-------hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-L-------EGALESFNAECEVLRSIRHRNLVRIISSCTNDD  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  695 (851)
                      ....|...+.||+|+||+||+|.+... .+++|+.... .       ....+++.+|++++++++|++++....++.+..
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            344566789999999999999987443 4444432211 1       112356889999999999999988877777777


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++||||++|++|.+++.         ....++.++++++++|   |++|++|||+||+||++ .++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            7889999999999998774         3567899999999999   88999999999999999 678999999999976


Q ss_pred             c
Q 046438          776 L  776 (851)
Q Consensus       776 ~  776 (851)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=1.1e-14  Score=138.16  Aligned_cols=135  Identities=18%  Similarity=0.240  Sum_probs=114.3

Q ss_pred             ccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCC--CcccceeeeeecCCeeEEEEeccCCC
Q 046438          630 VNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRH--RNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      +.+.+|+|.++.||+++.. +..+++|.......  ...+.+|.++++.++|  ..+++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4578999999999999984 47899999865533  4678899999999976  58899998888778899999999988


Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      .+..+        +......++.+++++++++|..+..+++|||++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543        5566677899999999999665557899999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.59  E-value=1e-16  Score=168.42  Aligned_cols=172  Identities=31%  Similarity=0.535  Sum_probs=83.5

Q ss_pred             CCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecC
Q 046438          337 KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSS  416 (851)
Q Consensus       337 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~  416 (851)
                      --.+.+++.|++. .+|..++.+..|+.+.|.+|.+. .+|..++++..|+.|+|+.|++..+|..++.++ |+.|-+++
T Consensus        76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sN  152 (722)
T KOG0532|consen   76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSN  152 (722)
T ss_pred             chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEec
Confidence            3334444444444 33444444444444444444444 444444555555555555555555554444433 44455555


Q ss_pred             CCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCC
Q 046438          417 NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIP  496 (851)
Q Consensus       417 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  496 (851)
                      |+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.++..| .|..||+|.|+++ .+|
T Consensus       153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iP  227 (722)
T KOG0532|consen  153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLP  227 (722)
T ss_pred             Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecc
Confidence            5554 44444554445555555555554 34444555555555555555554 344444433 2445555555554 445


Q ss_pred             ccccccccccceeccCcccc
Q 046438          497 SSLEKLLYLKYLNVSFNRLE  516 (851)
Q Consensus       497 ~~l~~l~~L~~l~l~~N~l~  516 (851)
                      -.|.+|..|++|-|.+|||+
T Consensus       228 v~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  228 VDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             hhhhhhhhheeeeeccCCCC
Confidence            55555555555555555554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.58  E-value=9.6e-15  Score=143.69  Aligned_cols=136  Identities=21%  Similarity=0.211  Sum_probs=97.4

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchhh--HHH----------------------HHHHHHHHhhcCCCc--c
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA--LES----------------------FNAECEVLRSIRHRN--L  684 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i  684 (851)
                      .+.||+|+||+||+|++.++++||||+++......  ...                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46899999999999998789999999987542110  011                      134556666664432  3


Q ss_pred             cceeeeeecCCeeEEEEeccCCCChhHH-hhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCC
Q 046438          685 VRIISSCTNDDFKALVLDYMPKGSLEAC-LYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDED  762 (851)
Q Consensus       685 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~  762 (851)
                      .++++.    ...++||||++++.+... +....  .. .....++.+++.++.++   |. +||+|||++|+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhEEEE-C
Confidence            444433    235899999998543211 11110  11 55678999999999999   77 8999999999999999 8


Q ss_pred             CcEEEeeccCccccC
Q 046438          763 MVARLGDFGIAKLLS  777 (851)
Q Consensus       763 ~~~kl~Dfg~a~~~~  777 (851)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=4.3e-15  Score=167.42  Aligned_cols=164  Identities=29%  Similarity=0.388  Sum_probs=118.2

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+|+.++.|..|+||.||.++++. .+++|+|+-+...     -+++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee-------------------
Confidence            568999999999999999999854 6778886533210     0111   22222333333                   


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC------
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG------  778 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~------  778 (851)
                        |+=...++ ..+.++..        ++.+++|+   |+.||||||+||+|.+|+.-|++|+.|||+.+..-.      
T Consensus       136 --gDc~tllk-~~g~lPvd--------mvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 --GDCATLLK-NIGPLPVD--------MVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             --chhhhhcc-cCCCCcch--------hhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence              22222221 12233322        26789999   999999999999999999999999999999864310      


Q ss_pred             ---CC-----CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 ---DE-----SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ---~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                         ..     .+.-...+|||.|+|||++....|+..+|.|++|+|+||.+-|+.||.+.
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence               00     11112248999999999999999999999999999999999999999875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=7.7e-14  Score=141.35  Aligned_cols=135  Identities=20%  Similarity=0.202  Sum_probs=104.7

Q ss_pred             ceec-cccceEEEEEEEcCCcEEEEEEEeecc-------------hhhHHHHHHHHHHHhhcCCCcc--cceeeeeecCC
Q 046438          632 NLIG-SGSFGSVYRGRFLDGMEVAIKVFHLQL-------------EGALESFNAECEVLRSIRHRNL--VRIISSCTNDD  695 (851)
Q Consensus       632 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~  695 (851)
                      ..+| .|+.|+||.++. .+..+|+|.+....             .....++.+|++++..++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 899999999987 57889999885421             1223567889999999998875  66676643322


Q ss_pred             ----eeEEEEeccCC-CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          696 ----FKALVLDYMPK-GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       696 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                          ..++|||+++| .+|.+++..  ..++..    .+.+|++++++|   |++||+|||+||.||+++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 688887743  233333    357899999999   8999999999999999999999999999


Q ss_pred             cCcccc
Q 046438          771 GIAKLL  776 (851)
Q Consensus       771 g~a~~~  776 (851)
                      |.++..
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=7.1e-16  Score=162.09  Aligned_cols=194  Identities=29%  Similarity=0.448  Sum_probs=141.8

Q ss_pred             ccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccccee
Q 046438          311 LINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLS  390 (851)
Q Consensus       311 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  390 (851)
                      +..-...|++.|++. .+|..++.+-.|+.+.|..|.+. .+|..++.+..|++|||+.|+++ ..|..++.++ |+.|.
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            344455667777776 56666677777777777777776 56777777777777777777777 5666666665 77888


Q ss_pred             cccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCC
Q 046438          391 FASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS  470 (851)
Q Consensus       391 L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  470 (851)
                      +++|+++.+|..++....|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .
T Consensus       150 ~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~  225 (722)
T KOG0532|consen  150 VSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y  225 (722)
T ss_pred             EecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence            888888888887777777888888888887 67777888888888888888887 567777743 4777888888887 7


Q ss_pred             CcccccCCCCCCEEECCCCcccccCCcccccccc---ccceeccCc
Q 046438          471 IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY---LKYLNVSFN  513 (851)
Q Consensus       471 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~l~l~~N  513 (851)
                      +|-.|..|+.|++|-|.+|.|. ..|..+...-.   -++|+..-+
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            7888888888888888888887 66766554333   355555555

>PLN03150 hypothetical protein; Provisional

Probab=99.50  E-value=3e-14  Score=164.48  Aligned_cols=117  Identities=40%  Similarity=0.628  Sum_probs=92.9

Q ss_pred             hhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccC
Q 046438          433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSF  512 (851)
Q Consensus       433 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~  512 (851)
                      ++.|+|++|.+++.+|..++.+++|+.|+|++|++.|.+|..++.+++|+.|||++|++++.+|..+..+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            66778888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccccccCCCCC--cccccCcccccCCcCccCCCCCCCCCCC
Q 046438          513 NRLEGEIPRGG--TLANFTSESFMGNDLLCGSPHLQVPPCK  551 (851)
Q Consensus       513 N~l~~~~p~~~--~~~~l~~~~~~~n~~~c~~~~~~~~~c~  551 (851)
                      |+++|.+|..-  ....+...++.+|+.+|+.|.  .+.|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            88888887541  223445667889999999773  45664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=5e-15  Score=168.09  Aligned_cols=217  Identities=27%  Similarity=0.354  Sum_probs=176.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcC--CcEEEEEEEeecc--hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQL--EGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  699 (851)
                      ...|.+.+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-+.+. |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3568888999999999998886533  4456777665442  334455667888888886 9999999999999999999


Q ss_pred             EEeccCCCChhHHh-hcCCCCcCHHHHHHHHHHHHHHHHHHHhcC-CCCcEecCCCCCCEEECCCC-cEEEeeccCcccc
Q 046438          700 VLDYMPKGSLEACL-YSDNSNLDIFKRLNIVIDIALALEYLHFGH-PNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLL  776 (851)
Q Consensus       700 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h-~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~  776 (851)
                      ++||.+|+++.+.+ +......+......+..|+..++.|+   | ..+++|+|++|+|.+++..+ ..+++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999998877 44433556667778999999999999   8 89999999999999999999 9999999999877


Q ss_pred             CC--CCCcccccccc-CccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcccc
Q 046438          777 SG--DESMKHTQTLA-TIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDS  844 (851)
Q Consensus       777 ~~--~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  844 (851)
                      ..  .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence            55  33334445678 9999999999885 456778999999999999999999998777777777777654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.48  E-value=8.9e-15  Score=154.22  Aligned_cols=121  Identities=33%  Similarity=0.555  Sum_probs=107.3

Q ss_pred             eeEEEEeccCCCChhHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          696 FKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                      +.|+.|++|...+|.+++..  .....++.....++.|++.|++|      +|.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999953  35557778889999999999998      68999999999999999999999999998


Q ss_pred             cccCCCC-----CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh
Q 046438          774 KLLSGDE-----SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT  822 (851)
Q Consensus       774 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  822 (851)
                      .......     ...++...||..||+||.+.+..|+.|+|+||+|++++|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8765444     335566789999999999999999999999999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.46  E-value=1.2e-13  Score=149.19  Aligned_cols=158  Identities=34%  Similarity=0.508  Sum_probs=131.2

Q ss_pred             HhhcCCCcccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 046438          676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPS  755 (851)
Q Consensus       676 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~  755 (851)
                      ++.+.|.|+.+++|.+.++...+.|.+||+.|+|.+.+.......++.....+.++|+.|++|+|  ++..-+||.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeeccc
Confidence            35688999999999999999999999999999999999888888999999999999999999995  4444499999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCC-CCccccccccCccccCccccccCC-------CCcchhhHHHHHHHHHHHhCCCCC
Q 046438          756 NVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGREGQ-------ISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       756 Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      |.+++....+|+.|||+....... ............-|.|||.+....       .+.++|+||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998776421 111222223456799999887641       456789999999999999999999


Q ss_pred             CccCcCcc
Q 046438          828 DEIFSGEM  835 (851)
Q Consensus       828 ~~~~~~~~  835 (851)
                      +.....+.
T Consensus       159 ~~~~~~~~  166 (484)
T KOG1023|consen  159 DLRNLVED  166 (484)
T ss_pred             ccccccCC
Confidence            88654443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=1.3e-13  Score=152.81  Aligned_cols=199  Identities=40%  Similarity=0.537  Sum_probs=151.5

Q ss_pred             EEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccC-CCCEEEccCcccCCCCCccccCCccccceecccC
Q 046438          316 IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLA-RLSSVYLDHNKLSGSIPACFGNLASLRKLSFASN  394 (851)
Q Consensus       316 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  394 (851)
                      .++++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            4666666664 22334455577778888888777 3445555553 7888888888887 45567788888888888888


Q ss_pred             cCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCccc
Q 046438          395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS  474 (851)
Q Consensus       395 ~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  474 (851)
                      +++.+|......++|+.|++++|+++ .+|.....+..|++|++++|++. ..+..+..+.++..|.+++|++. ..+..
T Consensus       174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~  250 (394)
T COG4886         174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES  250 (394)
T ss_pred             hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence            88888887778888888888888888 66766666677888888888654 56777888888888888888887 45777


Q ss_pred             ccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCC
Q 046438          475 IGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       475 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      ++.+++++.|++++|+++ .++. +..+.+++.|++++|.+....|..
T Consensus       251 ~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         251 IGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence            888888999999999888 4444 888888899999998888776644

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=4.4e-13  Score=147.83  Aligned_cols=140  Identities=23%  Similarity=0.322  Sum_probs=98.3

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchhhH----------------------------------------HHHHH
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL----------------------------------------ESFNA  671 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  671 (851)
                      +.||+|++|.||+|+..+|+.||||+.++......                                        -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            68999999999999999999999999875421100                                        02445


Q ss_pred             HHHHHhhcC----CCcccceeeee-ecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 046438          672 ECEVLRSIR----HRNLVRIISSC-TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA-LEYLHFGHPN  745 (851)
Q Consensus       672 e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~L~~~h~~  745 (851)
                      |++.+.+++    |.+-+.+-.++ ......++||||++|+++.++........   ....++.+++.+ +..+   |..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql---~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV---LRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH---HhC
Confidence            555555552    32222222222 22345689999999999988764322222   234466666653 4555   888


Q ss_pred             CcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       746 ~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      |++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=3.1e-13  Score=149.68  Aligned_cols=202  Identities=34%  Similarity=0.494  Sum_probs=165.8

Q ss_pred             EEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCC-CCcEEEcccccccccccccccccCCCCEEEccCc
Q 046438          292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLE-KLQILGLENNQLEGRILDDICRLARLSSVYLDHN  370 (851)
Q Consensus       292 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  370 (851)
                      .+.+..|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .++..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            3555555553 22344556688999999999998 5566666664 8999999999998 44567888999999999999


Q ss_pred             ccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcc
Q 046438          371 KLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTT  450 (851)
Q Consensus       371 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  450 (851)
                      ++. .+|...+.+++|+.|++++|+++.+|........|++|++++|++. ..+..+.++.++..+.+.+|++. ..+..
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~  250 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES  250 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence            998 5566655789999999999999999998777788999999999755 57778889999999999999998 55888


Q ss_pred             cCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccc
Q 046438          451 IGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEK  501 (851)
Q Consensus       451 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  501 (851)
                      ++.++++++|++++|+++ .++. ++.+.+++.|++++|.++..+|.....
T Consensus       251 ~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         251 IGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             hccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhcc
Confidence            999999999999999998 4555 899999999999999999776655443

>PLN03150 hypothetical protein; Provisional

Probab=99.38  E-value=7.6e-13  Score=152.94  Aligned_cols=114  Identities=36%  Similarity=0.527  Sum_probs=106.7

Q ss_pred             cceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECC
Q 046438          408 NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLS  487 (851)
Q Consensus       408 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  487 (851)
                      .++.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCcccccc-ccccceeccCccccccCCC
Q 046438          488 NNILSGIIPSSLEKL-LYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       488 ~N~l~~~~p~~l~~l-~~L~~l~l~~N~l~~~~p~  521 (851)
                      +|+++|.+|..+..+ .++..+++++|+..|.+|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999999998764 4678899999998887663

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.35  E-value=1.1e-13  Score=141.75  Aligned_cols=161  Identities=20%  Similarity=0.242  Sum_probs=105.6

Q ss_pred             CCCCCCEEEcCCCcccccc---cCCCCCCCcEEeCCCCCCCCCCC-cchhcCCcccccccccccccccCCC-ccccCCCC
Q 046438           39 SINTLEILDLSNNQLSGSF---PFFNMSSLQVIDLSDNRLSGELP-ANIFSYLPFVQFLSLAFNQFAGHLP-REIGNLTS  113 (851)
Q Consensus        39 ~l~~L~~L~Ls~n~l~~~~---~~~~~~~L~~L~Ls~n~l~~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~-~~l~~l~~  113 (851)
                      ++..|+...|.+.......   ....|++++.||||+|-+...-+ ..+..++|+|+.|+|+.|++..-.. ..-..+++
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            5667777777777665322   24567777888888877763222 2456778888888888887762211 12235678


Q ss_pred             ccEEecccccccc-ccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccc
Q 046438          114 LTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL  192 (851)
Q Consensus       114 L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  192 (851)
                      |+.|.|+.|.++. .+......+++|+.|+|..|...........-++.|++|||++|.+-+.........+|.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            8888888888873 233445567888888888885443444445557788888888888764443444456777777777


Q ss_pred             ccccccc
Q 046438          193 ANNNFSG  199 (851)
Q Consensus       193 ~~N~i~~  199 (851)
                      +.+++..
T Consensus       279 s~tgi~s  285 (505)
T KOG3207|consen  279 SSTGIAS  285 (505)
T ss_pred             cccCcch
Confidence            7777764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=1e-11  Score=135.00  Aligned_cols=167  Identities=19%  Similarity=0.233  Sum_probs=128.7

Q ss_pred             EcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHH
Q 046438          647 FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL  726 (851)
Q Consensus       647 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  726 (851)
                      -.++.+|.|..++.......+...+.++.++.++||+|+++++.++.+++.|+|+|.+.  .|..++.+.+    ...+.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            35788999998887655445667888899999999999999999999999999999985  5666665433    55666


Q ss_pred             HHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCc
Q 046438          727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIST  806 (851)
Q Consensus       727 ~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  806 (851)
                      ..+.||+.||.+||  +..+++|+++.-..|++++.|..||++|.++.....-... .....---.|..|+.+....  -
T Consensus       108 ~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc--c
Confidence            78899999999997  6889999999999999999999999999988765332210 11111222355665443322  2


Q ss_pred             chhhHHHHHHHHHHHhCC
Q 046438          807 EGDVYSFGIMLMEIFTRK  824 (851)
Q Consensus       807 ~~DvwslG~il~el~~g~  824 (851)
                      ..|.|-|||+++|++.|.
T Consensus       183 s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             chhhhhHHHHHHHHhCcc
Confidence            359999999999999993

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.33  E-value=2.6e-13  Score=131.82  Aligned_cols=206  Identities=20%  Similarity=0.205  Sum_probs=147.0

Q ss_pred             CCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCc---ccCCCCCccc
Q 046438          304 IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHN---KLSGSIPACF  380 (851)
Q Consensus       304 ~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N---~l~~~~~~~~  380 (851)
                      +|-.+..+.+|..+.++.+.-. .+.+....-|.|+++......++.. + .+...+.+.  |.+.-   -..|......
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~--D~~~~E~~t~~G~~~~~~  280 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDV-P-SLLPETILA--DPSGSEPSTSNGSALVSA  280 (490)
T ss_pred             cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccccc-c-cccchhhhc--CccCCCCCccCCceEEec
Confidence            3445556667777777765533 1222222346777877766655521 1 111222222  22221   1223334445


Q ss_pred             cCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEE
Q 046438          381 GNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNL  460 (851)
Q Consensus       381 ~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  460 (851)
                      .....|+++|||+|.|+.+.++..-.+.++.|++|+|.|...  ..+..+++|+.||||+|.++ .+.++=.++.+.++|
T Consensus       281 dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             chHhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            556789999999999999988888899999999999999833  33888999999999999998 566777788999999


Q ss_pred             EccCcccCCCCcccccCCCCCCEEECCCCcccccC-CccccccccccceeccCccccccC
Q 046438          461 SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII-PSSLEKLLYLKYLNVSFNRLEGEI  519 (851)
Q Consensus       461 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~l~l~~N~l~~~~  519 (851)
                      .|++|.|. . -..++.+-+|+.||+++|+|.... -..++++|-|+.+.|.+||+.+.+
T Consensus       358 ~La~N~iE-~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  358 KLAQNKIE-T-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             ehhhhhHh-h-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            99999997 2 345788889999999999998532 356889999999999999998765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=2.3e-11  Score=117.09  Aligned_cols=138  Identities=20%  Similarity=0.196  Sum_probs=99.2

Q ss_pred             cceeccccceEEEEEEEcC-------CcEEEEEEEeecc------------h----------hhHHH----HHHHHHHHh
Q 046438          631 NNLIGSGSFGSVYRGRFLD-------GMEVAIKVFHLQL------------E----------GALES----FNAECEVLR  677 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~  677 (851)
                      ...||.|..+.||.|...+       +..+|||+++...            +          .....    .++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999997643       4789999986321            0          11122    338999999


Q ss_pred             hcCC--CcccceeeeeecCCeeEEEEeccCCCChhH-HhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 046438          678 SIRH--RNLVRIISSCTNDDFKALVLDYMPKGSLEA-CLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKP  754 (851)
Q Consensus       678 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~  754 (851)
                      ++..  -++.+++++    ...++||||++++.+.. .+.  ....+......+..+++.++..++  |+.||||||+++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCH
Confidence            9864  456666654    34579999997653321 121  123344456677899999999885  778999999999


Q ss_pred             CCEEECCCCcEEEeeccCccccC
Q 046438          755 SNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       755 ~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      .||+++ ++.+.++|||.|....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.32  E-value=1.1e-12  Score=123.71  Aligned_cols=108  Identities=30%  Similarity=0.383  Sum_probs=30.9

Q ss_pred             CCCCCCEEeCcCCCCccCCCcccc-CCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccc
Q 046438           15 SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFL   93 (851)
Q Consensus        15 ~l~~L~~L~ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L   93 (851)
                      +..++++|+|++|+|+. +. .+. .+.+|+.|+||+|+|+....+..+++|++|++++|+|+ .++..+...+|+|++|
T Consensus        17 n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             ccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            34456777777777763 32 244 46677777777777776656666677777777777776 4544333456666666


Q ss_pred             cccccccccCC-CccccCCCCccEEeccccccc
Q 046438           94 SLAFNQFAGHL-PREIGNLTSLTSIDLSENHLM  125 (851)
Q Consensus        94 ~L~~N~i~~~~-~~~l~~l~~L~~L~Ls~n~l~  125 (851)
                      +|++|+|.... -..+..+++|+.|+|.+|.++
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            66666665321 133445555555555555554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.31  E-value=5.8e-13  Score=136.44  Aligned_cols=191  Identities=23%  Similarity=0.210  Sum_probs=119.0

Q ss_pred             CCcccccccccccccccCCC--ccccCCCCccEEecccccccc--ccchhhcCcccccEEEccCccccCCCCccc-cCCC
Q 046438           86 YLPFVQFLSLAFNQFAGHLP--REIGNLTSLTSIDLSENHLMG--EIPHEIGNLRNLQALGLLSNNLVGVVPATL-FNIS  160 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~--~~l~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~  160 (851)
                      ++.+|+...|.+..+. ..+  .....|++++.||||.|-+..  .+.+....+++|+.|+|+.|++..-..... ..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            4555566666665554 222  345566777777777776652  223344567777777777777653322211 2467


Q ss_pred             cCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCcccc-CccccCCCCcceEe
Q 046438          161 TLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFI-PNRFHNMRNLKELN  239 (851)
Q Consensus       161 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~  239 (851)
                      .|+.|.|+.|.++..-...+...+|+|+.|+|..|............+..|+.|+|++|++-... -...+.++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            89999999999987777778889999999999999633333333444677788888887776543 13456677777777


Q ss_pred             ccCccccCCCCcch-hhhhccccccccEEeccCCCccCC
Q 046438          240 LEYNYITSSNHELS-FISSLANSKKLKVLSLTGNPLLDC  277 (851)
Q Consensus       240 L~~N~i~~~~~~~~-~~~~l~~l~~L~~L~Ls~N~l~~~  277 (851)
                      ++.+.|.++..... ........++|+.|++..|++.++
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w  316 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW  316 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccc
Confidence            77777776432110 111134455666666666666443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.30  E-value=1e-11  Score=120.01  Aligned_cols=128  Identities=21%  Similarity=0.231  Sum_probs=96.0

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCccc-ceeeeeecCCeeEEEEeccCCCCh
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV-RIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      ++.++.|.++.||+++. .++.|++|+...... ....+.+|+++++.+.+.+++ +++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            36789999999999987 478899999765432 123467899999998765554 4444432  345799999999887


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP-----VVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~-----ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ...     .    ......+.+++++++.|   |+.+     ++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~-----~----~~~~~~~~~l~~~l~~L---H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE-----D----FSDPENLEKIAKLLKKL---HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-----c----ccCHHHHHHHHHHHHHH---hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            542     0    11234567899999999   6655     59999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=2.5e-11  Score=135.15  Aligned_cols=146  Identities=18%  Similarity=0.232  Sum_probs=95.0

Q ss_pred             cCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhh----------------------------------HH---
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA----------------------------------LE---  667 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~---  667 (851)
                      ..|+. +.+|+|++|.||+|+..+ |+.||||+.++.....                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 799999999999999977 9999999997542110                                  01   


Q ss_pred             ---HHHHHHHHHhhcC----CCcccceeeeeec-CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHH
Q 046438          668 ---SFNAECEVLRSIR----HRNLVRIISSCTN-DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL  739 (851)
Q Consensus       668 ---~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L  739 (851)
                         ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.+...-.....+.   ..++...++.  |+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~--~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEV--FF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHH--HH
Confidence               1334444444442    3333333333332 34568999999999997743211122222   1233332222  22


Q ss_pred             HhcCCCCcEecCCCCCCEEECCCC----cEEEeeccCccccC
Q 046438          740 HFGHPNPVVHCDIKPSNVLLDEDM----VARLGDFGIAKLLS  777 (851)
Q Consensus       740 ~~~h~~~ivH~Dl~~~Nill~~~~----~~kl~Dfg~a~~~~  777 (851)
                      .+....|++|+|+||.||+++.++    .++++|||++....
T Consensus       274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            223567999999999999999888    99999999987664

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.28  E-value=2.5e-12  Score=121.26  Aligned_cols=138  Identities=25%  Similarity=0.358  Sum_probs=35.8

Q ss_pred             CCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccc
Q 046438           50 NNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIP  129 (851)
Q Consensus        50 ~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~  129 (851)
                      .+.|...+.+.++.++++|+|++|+|+ .+. ..-..+.+|+.|+|++|.|+..  +.+..+++|+.|++++|+|+. ++
T Consensus         6 ~~~i~~~~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~   80 (175)
T PF14580_consen    6 ANMIEQIAQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-IS   80 (175)
T ss_dssp             --------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--C
T ss_pred             ccccccccccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cc
Confidence            333443333444445555555555554 222 1111345555555555555532  235556666666666666663 33


Q ss_pred             hhh-cCcccccEEEccCccccCCCC-ccccCCCcCcEEEeeccccccc--cchhHhhhccccccccc
Q 046438          130 HEI-GNLRNLQALGLLSNNLVGVVP-ATLFNISTLKILQLTNNTLSGS--ISSSIRLALPNLELFSL  192 (851)
Q Consensus       130 ~~~-~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~~l~~L~~L~L  192 (851)
                      +.+ ..+++|++|++++|+|..... ..+..+++|+.|+|.+|.+...  ....+...+|+|+.||-
T Consensus        81 ~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   81 EGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             HHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             cchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            223 345666666666666654321 3445566677777777766532  12223345666666554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=5.1e-11  Score=109.76  Aligned_cols=132  Identities=22%  Similarity=0.326  Sum_probs=101.6

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeec-c-----hh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-L-----EG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~-----~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ..+++|+.+.+|.+.+ -|.++++|.=.++ .     +.  ...+..+|++++.+++-..|...+-+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4578999999999977 4445666642211 1     11  235678899999999877776666666677777899999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ++|..+.+++...        ...++..+-..+.-|   |..||+|||+.++||.+..+. +.++|||++..-
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999888654        244667777788889   999999999999999998665 999999998754

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.26  E-value=1.1e-12  Score=127.48  Aligned_cols=141  Identities=27%  Similarity=0.314  Sum_probs=114.5

Q ss_pred             cccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccc
Q 046438          349 EGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIG  428 (851)
Q Consensus       349 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  428 (851)
                      .|.....+..+..|+.+|||+|.|+ .+.++..-+|.++.|++|+|+|..+.. +..+++|+.||||+|.++ .+..+=.
T Consensus       273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~  349 (490)
T KOG1259|consen  273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHL  349 (490)
T ss_pred             CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHh
Confidence            3444445556778888999999888 567777778899999999999998855 888999999999999988 5555656


Q ss_pred             cchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCC-cccccCCCCCCEEECCCCccccc
Q 046438          429 NLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI-PNSIGDLISLECLDLSNNILSGI  494 (851)
Q Consensus       429 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~  494 (851)
                      .+.+++.|.|++|.|..  -..++++-+|..||+++|+|.... ...++++|.|+.|.|.+|.+.+.
T Consensus       350 KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  350 KLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            78889999999999863  345788889999999999997322 46789999999999999999953

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.25  E-value=9.4e-13  Score=131.46  Aligned_cols=242  Identities=22%  Similarity=0.252  Sum_probs=144.4

Q ss_pred             CCCCCCCCCEEeCcCCCCccC----CCccccCCCCCCEEEcCCC---ccccccc---------CCCCCCCcEEeCCCCCC
Q 046438           12 QLGSLSSLQYLDLSFNQLLGT----IPSSIFSINTLEILDLSNN---QLSGSFP---------FFNMSSLQVIDLSDNRL   75 (851)
Q Consensus        12 ~l~~l~~L~~L~ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n---~l~~~~~---------~~~~~~L~~L~Ls~n~l   75 (851)
                      .+..+..+++++||+|-+...    +...+.+.++|+.-++|+-   ++..-+|         +..+++|++||||.|.+
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            356678899999999998643    4456668889999998873   2222111         45677999999999998


Q ss_pred             CCCCCc---chhcCCcccccccccccccccCC-------------CccccCCCCccEEecccccccc----ccchhhcCc
Q 046438           76 SGELPA---NIFSYLPFVQFLSLAFNQFAGHL-------------PREIGNLTSLTSIDLSENHLMG----EIPHEIGNL  135 (851)
Q Consensus        76 ~~~~~~---~~~~~l~~L~~L~L~~N~i~~~~-------------~~~l~~l~~L~~L~Ls~n~l~~----~~~~~~~~l  135 (851)
                      .-.-+.   ..++.+..|++|+|.+|.+...-             ......-+.|+.+..++|++..    .+...|...
T Consensus       105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~  184 (382)
T KOG1909|consen  105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH  184 (382)
T ss_pred             CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence            743332   35667889999999999876211             1223445577777777777753    234456666


Q ss_pred             ccccEEEccCccccCCC----CccccCCCcCcEEEeeccccccccchhH---hhhcccccccccccccccccCCcccccc
Q 046438          136 RNLQALGLLSNNLVGVV----PATLFNISTLKILQLTNNTLSGSISSSI---RLALPNLELFSLANNNFSGKIPSFIFNA  208 (851)
Q Consensus       136 ~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~~---~~~l~~L~~L~L~~N~i~~~~~~~~~~~  208 (851)
                      +.|+++.+..|.|....    ...|..+++|+.|||.+|.++......+   +..+|+|++|+++++.+.......+.  
T Consensus       185 ~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~--  262 (382)
T KOG1909|consen  185 PTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV--  262 (382)
T ss_pred             cccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH--
Confidence            77777777777664322    2344566677777777776653222222   22344455555555544432222221  


Q ss_pred             CCCcEEecCCCCCccccCccc-cCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCc
Q 046438          209 SKLSICELPDNSFSGFIPNRF-HNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL  274 (851)
Q Consensus       209 ~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  274 (851)
                                        ++| ...++|+.|.+.+|.|+..... .....+...+.|+.|+|++|++
T Consensus       263 ------------------~al~~~~p~L~vl~l~gNeIt~da~~-~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  263 ------------------DALKESAPSLEVLELAGNEITRDAAL-ALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ------------------HHHhccCCCCceeccCcchhHHHHHH-HHHHHHhcchhhHHhcCCcccc
Confidence                              111 1245666666666666643221 1222344466777777777776

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.24  E-value=1.1e-10  Score=106.81  Aligned_cols=143  Identities=21%  Similarity=0.269  Sum_probs=107.9

Q ss_pred             ccceeccccceEEEEEEEcCCcEEEEEE-E----eecc-hh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          630 VNNLIGSGSFGSVYRGRFLDGMEVAIKV-F----HLQL-EG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~----~~~~-~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ....+.+|+.+.|+++.+ +|+.+.||. +    +.+. +.  ...+..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            568899999999999988 777777763 2    2111 22  3467889999999987666665555666666778999


Q ss_pred             eccCC-CChhHHhhcCCCCcCHHHH-HHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC---cEEEeeccCcccc
Q 046438          702 DYMPK-GSLEACLYSDNSNLDIFKR-LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM---VARLGDFGIAKLL  776 (851)
Q Consensus       702 e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~---~~kl~Dfg~a~~~  776 (851)
                      ||++| .++.+++.+.......... ..++.+|-+.+.-|   |..+|+||||.++||++..++   .+.++|||++..-
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99977 4777877664333333333 67899999999999   999999999999999996554   4589999998654

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.23  E-value=1.3e-12  Score=144.81  Aligned_cols=217  Identities=28%  Similarity=0.354  Sum_probs=143.6

Q ss_pred             CCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc-CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccc
Q 046438           15 SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFL   93 (851)
Q Consensus        15 ~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L   93 (851)
                      .+..++.+++..|.++ .+-..+..+++|+.|++.+|+|+.+.. +..+++|++||+++|.|+. +..  +..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~-i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITK-LEG--LSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcccchhhhhcchheecccccccc-ccc--hhhccchhhh
Confidence            4567777778888887 344557788888888888888887777 7778888888888888873 332  4556778888


Q ss_pred             cccccccccCCCccccCCCCccEEeccccccccccc-hhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccc
Q 046438           94 SLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIP-HEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL  172 (851)
Q Consensus        94 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l  172 (851)
                      ++++|.|+..  ..+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+...  ..+..+..+..+++..|.+
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccc
Confidence            8888888743  345567888888888888874333 2 46777888888888887643  3344455566667777777


Q ss_pred             ccccchhHhhhcc--cccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCcccc
Q 046438          173 SGSISSSIRLALP--NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYIT  246 (851)
Q Consensus       173 ~~~~~~~~~~~l~--~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  246 (851)
                      +..-+..   .++  .|+.+++++|++.. .+..+..+..+..|++.+|++...  ..+.....+..+....|.+.
T Consensus       221 ~~~~~l~---~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  221 SKLEGLN---ELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             eeccCcc---cchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence            5211111   122  26777777777763 224455566667777777766643  22344455556666666554

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.22  E-value=8e-13  Score=131.94  Aligned_cols=113  Identities=20%  Similarity=0.277  Sum_probs=59.6

Q ss_pred             ccccccCCcEEEecCCCCCCC----cCccccCCCCCcEEEccccccccc----ccccccccCCCCEEEccCcccCCCCCc
Q 046438          307 EMGNLINLIIIRLGYNKLNGS----IPSTLSRLEKLQILGLENNQLEGR----ILDDICRLARLSSVYLDHNKLSGSIPA  378 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~  378 (851)
                      .|...+.|+.+.+..|.|...    ....|..+++|+.|||++|-++..    ....++.+++|+.|++++|.+......
T Consensus       180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~  259 (382)
T KOG1909|consen  180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAI  259 (382)
T ss_pred             HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHH
Confidence            344455666666666666421    123455666777777777766532    234455566666666666666543333


Q ss_pred             ccc-----CCccccceecccCcCcc-----CchhhcccCcceEEEecCCCC
Q 046438          379 CFG-----NLASLRKLSFASNELTF-----VPSTFWNLTNILMVDLSSNPL  419 (851)
Q Consensus       379 ~~~-----~l~~L~~L~L~~N~l~~-----~p~~~~~l~~L~~L~Ls~N~l  419 (851)
                      +|.     ..|+|+.|.|.+|.++.     +...+...+.|+.|+|++|++
T Consensus       260 a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  260 AFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            221     24556666666666551     222333344555555555554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.12  E-value=8.7e-12  Score=138.11  Aligned_cols=231  Identities=27%  Similarity=0.302  Sum_probs=175.7

Q ss_pred             CcccccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcch
Q 046438            4 FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANI   83 (851)
Q Consensus         4 ~~~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~   83 (851)
                      +.-..+-..+..+++|++|++..|+|+. +...+..+++|++|+|++|+|+++.++..++.|+.|++++|.|+ .+..  
T Consensus        82 n~i~~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~-~~~~--  157 (414)
T KOG0531|consen   82 NLIAKILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLIS-DISG--  157 (414)
T ss_pred             hhhhhhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccchhhccchhhheeccCcch-hccC--
Confidence            3334444568899999999999999984 44448889999999999999999999999999999999999998 5554  


Q ss_pred             hcCCcccccccccccccccCCC-ccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCc-
Q 046438           84 FSYLPFVQFLSLAFNQFAGHLP-REIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNIST-  161 (851)
Q Consensus        84 ~~~l~~L~~L~L~~N~i~~~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-  161 (851)
                      |..++.|+.+++++|++....+ . ...+.+++.+++.+|.+.  ....+..+..+..+++..|.++...+  +..+.. 
T Consensus       158 ~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~  232 (414)
T KOG0531|consen  158 LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVML  232 (414)
T ss_pred             CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhH
Confidence            6669999999999999996544 2 578899999999999997  33446667777777999999885543  233333 


Q ss_pred             -CcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCcccc---Ccc-ccCCCCcc
Q 046438          162 -LKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFI---PNR-FHNMRNLK  236 (851)
Q Consensus       162 -L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~---~~~-~~~l~~L~  236 (851)
                       |+.+++++|.+.. .+ .....++++..|++.+|++...  ..+.....+..+.+.+|.+....   ... ....+.++
T Consensus       233 ~L~~l~l~~n~i~~-~~-~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (414)
T KOG0531|consen  233 HLRELYLSGNRISR-SP-EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLV  308 (414)
T ss_pred             HHHHHhcccCcccc-cc-ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccc
Confidence             8999999999873 22 2234678899999999998643  23445677777888888876321   111 44556677


Q ss_pred             eEeccCccccC
Q 046438          237 ELNLEYNYITS  247 (851)
Q Consensus       237 ~L~L~~N~i~~  247 (851)
                      ...+..|.+..
T Consensus       309 ~~~~~~~~~~~  319 (414)
T KOG0531|consen  309 TLTLELNPIRK  319 (414)
T ss_pred             ccccccCcccc
Confidence            77777776654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=7.6e-10  Score=112.20  Aligned_cols=142  Identities=19%  Similarity=0.206  Sum_probs=108.7

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCC--cccceeeeeecC---CeeEEEEeccC
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHR--NLVRIISSCTND---DFKALVLDYMP  705 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~  705 (851)
                      +.++.|..+.||+++..+|+.+++|+...... .....+..|+++++.+++.  .+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999886678999999765432 1345788999999999764  456777776654   26689999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG-------------------------------------------  742 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~-------------------------------------------  742 (851)
                      |.++.+.+..  ...+......++.++++++++||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888664421  3456666777888888888888631                                           


Q ss_pred             ----------CCCCcEecCCCCCCEEECC--CCcEEEeeccCccc
Q 046438          743 ----------HPNPVVHCDIKPSNVLLDE--DMVARLGDFGIAKL  775 (851)
Q Consensus       743 ----------h~~~ivH~Dl~~~Nill~~--~~~~kl~Dfg~a~~  775 (851)
                                -...++|||+++.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1356899999999999998  67789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=1.2e-10  Score=126.07  Aligned_cols=198  Identities=24%  Similarity=0.277  Sum_probs=157.5

Q ss_pred             cCCCccceecc--ccceEEEEEEE---cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCee
Q 046438          626 DQFNVNNLIGS--GSFGSVYRGRF---LDGMEVAIKVFHLQLE--GALESFNAECEVLRSI-RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       626 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  697 (851)
                      ..+.+.+.+|+  |.+|.||+++.   .++..+|+|.-+....  ....+=.+|+...+.+ .|++.++.+..+++.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34677889999  99999999976   3578899998554433  2223344566666666 499999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGI  772 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~  772 (851)
                      ++-+|++ +.++.++-+.....++....+....+..+    |++++   |...++|-|++|.||++..+ ...+++|||.
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCcce
Confidence            9999999 57887777666666777888888888888    99999   99999999999999999999 8899999999


Q ss_pred             ccccCCCCCccc----cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          773 AKLLSGDESMKH----TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       773 a~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      ............    ....+...|++||... ..++.++|+|++|.+..+...+-.+..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            887765432111    1125778899999875 467889999999999999988876643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=1.5e-09  Score=104.33  Aligned_cols=126  Identities=22%  Similarity=0.227  Sum_probs=83.5

Q ss_pred             EEEEEEEcCCcEEEEEEEeecc--------------------------hhhHHHHHHHHHHHhhcCCC--cccceeeeee
Q 046438          641 SVYRGRFLDGMEVAIKVFHLQL--------------------------EGALESFNAECEVLRSIRHR--NLVRIISSCT  692 (851)
Q Consensus       641 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  692 (851)
                      .||.|...+|..+|+|+.+...                          ........+|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999985421                          01123577899999999866  455666443 


Q ss_pred             cCCeeEEEEeccC--CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          693 NDDFKALVLDYMP--KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       693 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                         ..++||||++  |..+..+....   .+......++.+++..+..+.  |..||+|||+.+.||+++++ .+.|+||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence               2369999998  65554433211   112344567778887666543  78999999999999999987 9999999


Q ss_pred             cCcccc
Q 046438          771 GIAKLL  776 (851)
Q Consensus       771 g~a~~~  776 (851)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.04  E-value=1.9e-10  Score=135.60  Aligned_cols=206  Identities=24%  Similarity=0.349  Sum_probs=144.4

Q ss_pred             ccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCC--CCCCCCcchhcCCcccccccccccccccCCCccccCCCCc
Q 046438           37 IFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR--LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSL  114 (851)
Q Consensus        37 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~--l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L  114 (851)
                      ..+....+...+-+|++.....-..+++|++|-+..|.  +. .++..+|..+|.|+.|||++|.=-+.+|+.++.|-+|
T Consensus       519 ~~~~~~~rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  519 VKSWNSVRRMSLMNNKIEHIAGSSENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             ccchhheeEEEEeccchhhccCCCCCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            33447788888888888765556677789999999997  55 7888889999999999999987767999999999999


Q ss_pred             cEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccc-cccchhHhhhcccccccccc
Q 046438          115 TSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLS-GSISSSIRLALPNLELFSLA  193 (851)
Q Consensus       115 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~~l~~L~~L~L~  193 (851)
                      ++|+|++..+. .+|..+++++.|.+|++..+.-....|.....+++|++|.+...... +.....-...+.+|+.+...
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~  676 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT  676 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence            99999999998 89999999999999999998876666777778999999999876522 11111111344455555443


Q ss_pred             cccccccCCccccccCCCc----EEecCCCCCccccCccccCCCCcceEeccCccccC
Q 046438          194 NNNFSGKIPSFIFNASKLS----ICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS  247 (851)
Q Consensus       194 ~N~i~~~~~~~~~~~~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~  247 (851)
                      ....  .+-..+..+..|.    .+.+..+... ..+..+..+.+|+.|.+.++.+.+
T Consensus       677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e  731 (889)
T KOG4658|consen  677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE  731 (889)
T ss_pred             cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence            3222  0111112222222    2222222211 234456677788888888777764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=5e-09  Score=102.75  Aligned_cols=135  Identities=23%  Similarity=0.189  Sum_probs=99.2

Q ss_pred             CCccceeccccceEEEEEEEcCCcEEEEEEEeecc----------------------hhhHHHHHHHHHHHhhcCCC--c
Q 046438          628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL----------------------EGALESFNAECEVLRSIRHR--N  683 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n  683 (851)
                      +.+...||.|..+.||.|...+|.++|||.=+...                      .-.....++|.++|+++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999899999999743211                      01234578999999999754  6


Q ss_pred             ccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC
Q 046438          684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM  763 (851)
Q Consensus       684 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~  763 (851)
                      +.+.+++-    ..++|||+++|-.|...-      ++......++..|++-+...   -..||||||+++-||+++++|
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEecCC
Confidence            67776543    446999999997764321      12333344555555555555   456999999999999999999


Q ss_pred             cEEEeeccCccc
Q 046438          764 VARLGDFGIAKL  775 (851)
Q Consensus       764 ~~kl~Dfg~a~~  775 (851)
                      .+.++||.-+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999986644

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.93  E-value=2e-11  Score=132.32  Aligned_cols=181  Identities=29%  Similarity=0.319  Sum_probs=129.1

Q ss_pred             CccccCCCCCcEEEccccccccccccccccc-CCCCEEEccCcccC----------CCCCccccCCccccceecccCcCc
Q 046438          329 PSTLSRLEKLQILGLENNQLEGRILDDICRL-ARLSSVYLDHNKLS----------GSIPACFGNLASLRKLSFASNELT  397 (851)
Q Consensus       329 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~----------~~~~~~~~~l~~L~~L~L~~N~l~  397 (851)
                      |-.+..+.+|+.|.+.++.+..  ...+..+ ..|+.|... |.+.          |.+...+. ...|...+++.|+++
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence            4456667778888888877764  2222221 133433322 2221          11222222 235888899999999


Q ss_pred             cCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCc-ccCCCCCccEEEccCcccCCCCccccc
Q 046438          398 FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPT-TIGGLKNLQNLSLGDNNLQGSIPNSIG  476 (851)
Q Consensus       398 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~  476 (851)
                      .+..++.-++.|+.|||++|+++..  +.+..|+.|++|||++|.++ .+|. ...++. |+.|.|++|.++ .+ ..+.
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL-~gie  251 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TL-RGIE  251 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hh-hhHH
Confidence            9998998999999999999999844  37888999999999999998 4443 344555 999999999997 33 3478


Q ss_pred             CCCCCCEEECCCCcccccC-CccccccccccceeccCccccccC
Q 046438          477 DLISLECLDLSNNILSGII-PSSLEKLLYLKYLNVSFNRLEGEI  519 (851)
Q Consensus       477 ~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~l~l~~N~l~~~~  519 (851)
                      +|++|+.|||++|-|.+.- -..++.+..|+.|+|.|||+.|..
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            8999999999999888532 123667888999999999998754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.90  E-value=3e-09  Score=105.58  Aligned_cols=153  Identities=21%  Similarity=0.349  Sum_probs=115.9

Q ss_pred             HHHHhhcCCCcccceeeeeecCC-----eeEEEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCC
Q 046438          673 CEVLRSIRHRNLVRIISSCTNDD-----FKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHP  744 (851)
Q Consensus       673 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~  744 (851)
                      ..-+-++-|.|+|+++.||.+.+     ...+++|||+-|++..++++   ....+......++..||..|+.|||. ..
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            34455567999999999987643     56789999999999999875   24456667778899999999999976 45


Q ss_pred             CCcEecCCCCCCEEECCCCcEEEeeccCccccC---CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHH
Q 046438          745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF  821 (851)
Q Consensus       745 ~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~  821 (851)
                      ..|+|+++..+-|++..+|.+|++--.-.....   ...........+-++|.|||.-.....+.++|||+||.+..||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            689999999999999999999986322111110   00011112234678999999888878888999999999999998


Q ss_pred             hCCCC
Q 046438          822 TRKRP  826 (851)
Q Consensus       822 ~g~~p  826 (851)
                      -+..-
T Consensus       277 ilEiq  281 (458)
T KOG1266|consen  277 ILEIQ  281 (458)
T ss_pred             Hheec
Confidence            87754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=2e-08  Score=102.74  Aligned_cols=140  Identities=13%  Similarity=0.073  Sum_probs=100.4

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchh-----------hHHHHHHHHHHHhhcCCCcc--cceeeeeec-----
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG-----------ALESFNAECEVLRSIRHRNL--VRIISSCTN-----  693 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----  693 (851)
                      +.+-......|+++.+ +|+.|.||......-.           ....+.+|.+.+.++...+|  ++++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444445777766 7789999977433211           11147889999988864444  344555543     


Q ss_pred             CCeeEEEEeccCCC-ChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-------CCc
Q 046438          694 DDFKALVLDYMPKG-SLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-------DMV  764 (851)
Q Consensus       694 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-------~~~  764 (851)
                      ...-++|||++++. ++.+++... ....+......++.+++..++.|   |..||+|||++++||+++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCce
Confidence            23467999999886 788887532 23445566778999999999999   9999999999999999975       468


Q ss_pred             EEEeeccCccc
Q 046438          765 ARLGDFGIAKL  775 (851)
Q Consensus       765 ~kl~Dfg~a~~  775 (851)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=7.3e-10  Score=85.87  Aligned_cols=60  Identities=40%  Similarity=0.658  Sum_probs=35.0

Q ss_pred             CCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEecccccc
Q 046438           64 SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL  124 (851)
Q Consensus        64 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l  124 (851)
                      +|++|++++|+++ .+|...|.++++|++|++++|.++...++.|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4555566666555 55555556666666666666666555555555666666666655543

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.86  E-value=1.4e-09  Score=84.36  Aligned_cols=61  Identities=44%  Similarity=0.648  Sum_probs=40.1

Q ss_pred             CCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccc
Q 046438          455 KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL  515 (851)
Q Consensus       455 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l  515 (851)
                      ++|++|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566666666666655556666666666666666666666666666666777777766654

...

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.86  E-value=7.6e-10  Score=108.09  Aligned_cols=221  Identities=21%  Similarity=0.224  Sum_probs=136.8

Q ss_pred             CccCCCccccCCCCCCEEEcCCCccccccc---C-CCCCCCcEEeCCCCCCCCC-CCcchhcCCcccccccccccccccC
Q 046438           29 LLGTIPSSIFSINTLEILDLSNNQLSGSFP---F-FNMSSLQVIDLSDNRLSGE-LPANIFSYLPFVQFLSLAFNQFAGH  103 (851)
Q Consensus        29 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~-~~~~~L~~L~Ls~n~l~~~-~~~~~~~~l~~L~~L~L~~N~i~~~  103 (851)
                      .+|..+-.+.+++.++.|.|.++.|...-.   + ..++.+++|||.+|.|+.. --..++.++|+|+.|+|+.|.+...
T Consensus        33 ~~g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~  112 (418)
T KOG2982|consen   33 SAGLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSD  112 (418)
T ss_pred             ccccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCc
Confidence            344556666777788888888888764333   2 4578899999999999841 1125778999999999999988743


Q ss_pred             CCccccCCCCccEEecccccccc-ccchhhcCcccccEEEccCccccCC--CCccccC-CCcCcEEEeeccccccccchh
Q 046438          104 LPREIGNLTSLTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNLVGV--VPATLFN-ISTLKILQLTNNTLSGSISSS  179 (851)
Q Consensus       104 ~~~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~-l~~L~~L~L~~n~l~~~~~~~  179 (851)
                      +...=..+.+|+.|-|.+..+.- .....+..++.+++|+++.|++...  ..+.... -+.+++|++..|         
T Consensus       113 I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c---------  183 (418)
T KOG2982|consen  113 IKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPC---------  183 (418)
T ss_pred             cccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCc---------
Confidence            32221466799999999888762 3345567788888898888854321  1112221 124444444444         


Q ss_pred             HhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccc-cCccccCCCCcceEeccCccccCCCCcchhhhhc
Q 046438          180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGF-IPNRFHNMRNLKELNLEYNYITSSNHELSFISSL  258 (851)
Q Consensus       180 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l  258 (851)
                             +..+.++-|++...+|       ++..+.+.+|.+... ....+..++.+..|+|+.|+|.+    +..+..+
T Consensus       184 -------~~~~w~~~~~l~r~Fp-------nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~ids----wasvD~L  245 (418)
T KOG2982|consen  184 -------LEQLWLNKNKLSRIFP-------NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDS----WASVDAL  245 (418)
T ss_pred             -------HHHHHHHHHhHHhhcc-------cchheeeecCcccchhhcccCCCCCcchhhhhccccccc----HHHHHHH
Confidence                   2333333333332222       233333334433322 12345556667778888887765    3446677


Q ss_pred             cccccccEEeccCCCccC
Q 046438          259 ANSKKLKVLSLTGNPLLD  276 (851)
Q Consensus       259 ~~l~~L~~L~Ls~N~l~~  276 (851)
                      ..++.|.-|.+++|++.+
T Consensus       246 n~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  246 NGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             cCCchhheeeccCCcccc
Confidence            788888888888887753

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.84  E-value=9.2e-11  Score=127.23  Aligned_cols=179  Identities=27%  Similarity=0.306  Sum_probs=132.2

Q ss_pred             CCCCCCCCCCCEEeCcCCCCccCCCccccCC-CCCCEEEcCCCc--cccccc--------CCCCCCCcEEeCCCCCCCCC
Q 046438           10 PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSI-NTLEILDLSNNQ--LSGSFP--------FFNMSSLQVIDLSDNRLSGE   78 (851)
Q Consensus        10 p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l-~~L~~L~Ls~n~--l~~~~~--------~~~~~~L~~L~Ls~n~l~~~   78 (851)
                      |=+|..+..|++|.|.++.|..  ...+..+ ..|+.|..++--  +..++.        -...-+|.+.+.++|+++ .
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence            4557777788888888887763  2223333 346666544321  111111        123467889999999997 4


Q ss_pred             CCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccch-hhcCcccccEEEccCccccCCCCcccc
Q 046438           79 LPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH-EIGNLRNLQALGLLSNNLVGVVPATLF  157 (851)
Q Consensus        79 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~  157 (851)
                      +. ..+.-++.|+.|+|++|+++..  +.+..|++|++|||++|++.. +|. ....++ |+.|.+++|-++..  ..+.
T Consensus       179 mD-~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  179 MD-ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             HH-HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeeeecccHHHhh--hhHH
Confidence            43 3478899999999999999855  388999999999999999984 443 333444 99999999999865  4678


Q ss_pred             CCCcCcEEEeeccccccccchhHhhhccccccccccccccc
Q 046438          158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS  198 (851)
Q Consensus       158 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~  198 (851)
                      ++.+|+.||+++|-|.+--.-.....+..|+.|+|.+|.+-
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            89999999999999987666666678999999999999874

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.84  E-value=2.7e-09  Score=126.08  Aligned_cols=129  Identities=23%  Similarity=0.271  Sum_probs=58.9

Q ss_pred             cccccccccccccccCCCccccCCCCccEEeccccc--cccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEE
Q 046438           88 PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH--LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKIL  165 (851)
Q Consensus        88 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  165 (851)
                      ...+...+-+|.+. .++... .++.|++|-+..|.  +....++.|..++.|..|||++|.-.+.+|..++++-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            34444444444443 222221 22345555555553  332333334455555555555544444455555555555555


Q ss_pred             EeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCcc
Q 046438          166 QLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY  244 (851)
Q Consensus       166 ~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  244 (851)
                      +|++..++                          .+|..+.++++|.+|++..+.-...++.....|.+|++|.+..-.
T Consensus       601 ~L~~t~I~--------------------------~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  601 DLSDTGIS--------------------------HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccCCCcc--------------------------ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            55544444                          333444444444444444444333334445555666666554443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.83  E-value=1.6e-09  Score=117.33  Aligned_cols=196  Identities=23%  Similarity=0.221  Sum_probs=145.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEE--cCCcEEEEEEEeecchhhHHH--HHHHHHHHhhc-CCCcccceeeeeecCCee
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRF--LDGMEVAIKVFHLQLEGALES--FNAECEVLRSI-RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  697 (851)
                      ....+|..+..||.|.|+.|+++..  .++..|++|-..........+  -..|+.+...+ .|.+++..+..|......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788899999999999999854  357789999765443332222  23455555555 588889888888877788


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccCcccc
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLL  776 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~a~~~  776 (851)
                      |+--|||++++..... .-...+++..++++..|++.++.++   |++.++|+|++|+||++..+ +..++.|||.+..+
T Consensus       342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhcccccccccc
Confidence            8999999999886654 2234466777888899999999888   99999999999999999875 78899999998643


Q ss_pred             CCCCCccccccccCcccc--CccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 046438          777 SGDESMKHTQTLATIGYM--APEYGREGQISTEGDVYSFGIMLMEIFTRKRP  826 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  826 (851)
                      ..    ........-++.  +|+......+..+.|++|||.-+.|.+++..-
T Consensus       418 ~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  418 AF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ce----ecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            11    122222333344  55566677889999999999999999988744

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.81  E-value=5.7e-10  Score=96.40  Aligned_cols=136  Identities=23%  Similarity=0.316  Sum_probs=102.7

Q ss_pred             cccceecccCcCccCchh---hcccCcceEEEecCCCCCCCCccccc-cchhhhhhhccCCcccccCCcccCCCCCccEE
Q 046438          385 SLRKLSFASNELTFVPST---FWNLTNILMVDLSSNPLSGSLPLEIG-NLKVLVELYLSRNNLSGDIPTTIGGLKNLQNL  460 (851)
Q Consensus       385 ~L~~L~L~~N~l~~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  460 (851)
                      .+-.++|+++++-.+++.   +.....|+..+|++|.+. ..|+.|. ..+.++.|+|++|.|+ .+|..+..++.|+.|
T Consensus        28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            455677777777766554   445566777788888888 4454443 4457889999999998 788889999999999


Q ss_pred             EccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCc
Q 046438          461 SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGT  524 (851)
Q Consensus       461 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~  524 (851)
                      +++.|.+. ..|..+..|.+|-.||..+|.+. .+|..+-.-+......+.+++|.+.+|...+
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            99999998 77888888999999999999888 5555544444555666789999998887644

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.79  E-value=7.1e-08  Score=99.32  Aligned_cols=193  Identities=13%  Similarity=0.161  Sum_probs=131.6

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceee------eeecCC-eeEEE
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIIS------SCTNDD-FKALV  700 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~------~~~~~~-~~~lv  700 (851)
                      ...+.+|+|+.+-+|-.-  +-...+.|+++........   +..+.+... .||-+-.-+.      +..+.+ ...+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            445789999999999652  2234577888766433212   122233333 4554322111      111222 37889


Q ss_pred             EeccCCCC-hhHHhhc-----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          701 LDYMPKGS-LEACLYS-----DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       701 ~e~~~~g~-L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      |+.++|.. ...++..     ......|.-..++++.++.+.+.|   |..|.+-||+.++|+|+.+++.|.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCccceeeecCceEEEEccccee
Confidence            99988752 2222211     223468889999999999999999   88899999999999999999999999865433


Q ss_pred             ccCCCCCccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCccC
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTR-KRPTDEIF  831 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g-~~pf~~~~  831 (851)
                      ..  .........+|.+.|.+||...     +...+...|.|.+||++++++.| ++||.++.
T Consensus       166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            32  2222334467899999999764     34556778999999999999885 99998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.75  E-value=2.2e-09  Score=122.13  Aligned_cols=204  Identities=25%  Similarity=0.305  Sum_probs=146.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ..+.+.+.+.+.+|.++.++.++-. .|...+.|+.....   ..+.+....+-.+.-..++|-++.....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466788889999999999988543 34334444332221   1122333334344444456777766666556677899


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC-
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-  778 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~-  778 (851)
                      +++|..++++...++... ..+..........+..+.+||   |...+.|+|++|.+.++..++..++.|||....... 
T Consensus       882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            999999999988876543 344444455666778889999   888899999999999999999999999984332110 


Q ss_pred             -----------------------------CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          779 -----------------------------DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       779 -----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                                                   +.........+|+.|.+||...+......+|.|+.|++++|.++|..||+.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                         000112345789999999999999999999999999999999999999976


Q ss_pred             cC
Q 046438          830 IF  831 (851)
Q Consensus       830 ~~  831 (851)
                      ..
T Consensus      1038 ~t 1039 (1205)
T KOG0606|consen 1038 ET 1039 (1205)
T ss_pred             cc
Confidence            43

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=6.1e-08  Score=107.45  Aligned_cols=139  Identities=21%  Similarity=0.262  Sum_probs=94.7

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchhh------------------------------H----------HHHHH
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA------------------------------L----------ESFNA  671 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~----------~~~~~  671 (851)
                      +.|+.++-|.||+|+..+|+.||||+.++..+..                              .          =++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            7899999999999999999999999986542110                              0          02445


Q ss_pred             HHHHHhhcC-----CCcccceeeee-ecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHH-HHHHhcCC
Q 046438          672 ECEVLRSIR-----HRNLVRIISSC-TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHP  744 (851)
Q Consensus       672 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~L~~~h~  744 (851)
                      |+.-+.+++     .|.+ ++-.++ +-.+...++|||++|..+.+....+....+.   ..++..++++. ..+   -.
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~---~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQL---LR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHH---Hh
Confidence            555555552     2332 222222 2245668999999999988874333344443   33444444332 222   33


Q ss_pred             CCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       745 ~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      .|++|+|.+|.||+++.+|.+.+.|||+.....
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            689999999999999999999999999987654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.73  E-value=2.8e-09  Score=104.18  Aligned_cols=87  Identities=25%  Similarity=0.358  Sum_probs=61.8

Q ss_pred             CCCccEEecccccccc--ccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccc
Q 046438          111 LTSLTSIDLSENHLMG--EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE  188 (851)
Q Consensus       111 l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~  188 (851)
                      ++.++.|||.+|.|+.  .+...+.+|+.|+.|+|+.|++...+...-..+.+|+.|-|.+..+...-.......+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            5667777777777762  33444567777777777777776544322245678889989888887766777777888888


Q ss_pred             ccccccccc
Q 046438          189 LFSLANNNF  197 (851)
Q Consensus       189 ~L~L~~N~i  197 (851)
                      +|.++.|.+
T Consensus       150 elHmS~N~~  158 (418)
T KOG2982|consen  150 ELHMSDNSL  158 (418)
T ss_pred             hhhhccchh
Confidence            888888854

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.68  E-value=2.2e-07  Score=90.61  Aligned_cols=154  Identities=18%  Similarity=0.182  Sum_probs=100.5

Q ss_pred             ccHHHHHHHhcCCCcc---ceeccccceEEEEEEEcCCcEEEEEEEeecchhhH------------------------HH
Q 046438          616 FSYQELLQATDQFNVN---NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL------------------------ES  668 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~---~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~  668 (851)
                      .+++.+........+.   ..|++|..+.||+|...++..+|+|+++.......                        .=
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            4455566665555443   46778888899999887899999999975421100                        01


Q ss_pred             HHHHHHHHhhcC--CCcccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046438          669 FNAECEVLRSIR--HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP  746 (851)
Q Consensus       669 ~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~  746 (851)
                      ..+|..-|+++.  +-.+.+.+++..    -.+||||++..-. -.-.-............+..++++.+.-|-  +..+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~-pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~--~~a~  187 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGL-PAPRLKDVPLELEEAEGLYEDVVEYMRRLY--KEAG  187 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCC-CCCCcccCCcCchhHHHHHHHHHHHHHHHH--HhcC
Confidence            235666666663  333444454432    3699999965411 110001122222256667788888888874  5589


Q ss_pred             cEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       747 ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      +||+||+.-||+++ ++.+.|+|||-|....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999999999999 8899999999886553

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.62  E-value=3.6e-09  Score=91.56  Aligned_cols=83  Identities=23%  Similarity=0.250  Sum_probs=38.1

Q ss_pred             CCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          361 RLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       361 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      .|+..+|++|.+....+..-...+.++.|+|++|+|..+|..+..++.|+.|+++.|++. ..|..+..|.++-.|+..+
T Consensus        54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~  132 (177)
T KOG4579|consen   54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPE  132 (177)
T ss_pred             eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCC
Confidence            333444444444422222222223445555555555555555555555555555555554 4444444444555555555


Q ss_pred             Cccc
Q 046438          441 NNLS  444 (851)
Q Consensus       441 N~l~  444 (851)
                      |.+.
T Consensus       133 na~~  136 (177)
T KOG4579|consen  133 NARA  136 (177)
T ss_pred             Cccc
Confidence            5444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.59  E-value=5.5e-07  Score=95.52  Aligned_cols=168  Identities=19%  Similarity=0.253  Sum_probs=127.7

Q ss_pred             cceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec----CCeeEEEEeccCC-CChhH
Q 046438          638 SFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN----DDFKALVLDYMPK-GSLEA  711 (851)
Q Consensus       638 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~  711 (851)
                      ...+.|++.. .+|..|++|+++............-+++++++.|+|+|++.+++..    +..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4467889865 5899999999965544444445566889999999999999998863    3478899999986 46665


Q ss_pred             Hhhc--------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          712 CLYS--------------DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       712 ~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ....              .....++...|.++.|+..||.++   |+.|...+-+.+++|+++.+.+++|...|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5322              223457788999999999999999   88899999999999999999999999888765553


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP  826 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  826 (851)
                      .+.        +       |.+   .-..+-|.=.+|.++.-+.||..-
T Consensus       445 ~d~--------~-------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP--------T-------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC--------C-------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            322        0       001   112356899999999999999643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	851
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-41
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-35
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-32
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-26
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-24
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-23
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-22
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-15
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-10
3soa_A	444	Full-Length Human Camkii Length = 444		6e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-05
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-05
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-05
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-05
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		4e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-05
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		7e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-05
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		8e-05
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-04
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		1e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-04

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  168 bits (426), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 171/556 (30%), Positives = 250/556 (44%), Gaps = 56/556 (10%)
Query: 43  LEILDLSNNQLSGSFPFF-NMSSLQVIDLSDNRLSGELPANIFSY--------------- 86
           LE LD+S+N  S   PF  + S+LQ +D+S N+LSG+    I +                
Sbjct: 202 LEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 87  ----LPF--VQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEIGNLRNLQ 139
               LP   +Q+LSLA N+F G +P  + G   +LT +DLS NH  G +P   G+   L+
Sbjct: 262 PIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 140 AXXXXXXXXXXXXPA-TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS 198
           +            P  TL  +  LK+L L+ N  SG +  S+     +L    L++NNFS
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 199 GKIPSFIFNASKLSICEL--PDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFIS 256
           G I   +    K ++ EL   +N F+G IP    N   L  L+L +NY++ +       S
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT-----IPS 436
Query: 257 SLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXX 316
           SL +  KL+ L L  N +L+  +P  +  +  ++E   L   ++ G IP  +        
Sbjct: 437 SLGSLSKLRDLKLWLN-MLEGEIPQELMYVK-TLETLILDFNDLTGEIPSGLSNCTNLNW 494
Query: 317 XRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSI 376
             L  N+L G IP  + RLE L IL L NN   G I  ++     L  + L+ N  +G+I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 377 PACF----GNLAS----------------LRKLSFASNELTF--VPSTFWN-LTNILMVD 413
           PA      G +A+                 ++   A N L F  + S   N L+     +
Sbjct: 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 414 XXXXXXXXXXXXEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPN 473
                          N   ++ L +S N LSG IP  IG +  L  L+LG N++ GSIP+
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 474 SIGDLISLECLDLSNNILSGIIPXXXXXXXXXXXXNVSFNRLEGEIPRGGTLANFTSESF 533
            +GDL  L  LDLS+N L G IP            ++S N L G IP  G    F    F
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Query: 534 MGNDLLCGSPHLQVPP 549
           + N  LCG P  +  P
Sbjct: 735 LNNPGLCGYPLPRCDP 750

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/220 (39%), Positives = 126/220 (57%), Gaps = 6/220 (2%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-LEGALESFNAE 672
           +RFS +EL  A+D F+  N++G G FG VY+GR  DG  VA+K    +  +G    F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN---LDIFKRLNIV 729
            E++    HRNL+R+   C     + LV  YM  GS+ +CL     +   LD  KR  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 730 IDIALALEYLHFGHPNP-VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           +  A  L YLH  H +P ++H D+K +N+LLDE+  A +GDFG+AKL+   +        
Sbjct: 146 LGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
            TIG++APEY   G+ S + DV+ +G+ML+E+ T +R  D
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/220 (38%), Positives = 124/220 (56%), Gaps = 6/220 (2%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-LEGALESFNAE 672
           +RFS +EL  A+D F   N++G G FG VY+GR  DG  VA+K    +  +G    F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN---LDIFKRLNIV 729
            E++    HRNL+R+   C     + LV  YM  GS+ +CL     +   LD  KR  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 730 IDIALALEYLHFGHPNP-VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           +  A  L YLH  H +P ++H D+K +N+LLDE+  A +GDFG+AKL+   +        
Sbjct: 138 LGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
             IG++APEY   G+ S + DV+ +G+ML+E+ T +R  D
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 133/444 (29%), Positives = 208/444 (46%), Gaps = 43/444 (9%)
Query: 40  INTLEILDLSNNQLSGSFPFFNMSS-----LQVIDLSDNRLSGELPANIFSYLPFVQFLS 94
           +N+LE+LDLS N +SG+     + S     L+ + +S N++SG++     S    ++FL 
Sbjct: 147 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLD 203
Query: 95  LAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXXXXXXXXXXPA 154
           ++ N F+  +P  +G+ ++L  +D+S N L G+    I     L+             P 
Sbjct: 204 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 262
Query: 155 TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSIC 214
               + +L+ L L  N  +G I   +  A   L    L+ N+F G +P F  + S L   
Sbjct: 263 --LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 320
Query: 215 ELPDNSFSGFIP-NRFHNMRNLKELNLEYNYITSSNHELSFISSLAN-SKKLKVLSLTGN 272
            L  N+FSG +P +    MR LK L+L +N  +    E     SL N S  L  L L+ N
Sbjct: 321 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE-----SLTNLSASLLTLDLSSN 375
Query: 273 PLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYNKLNGSIPSTL 332
                +LP+   N   +++  YL N    G IP  +          L +N L+G+IPS+L
Sbjct: 376 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 435
Query: 333 SRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFA 392
             L KL+ L L  N LEG I  ++  +  L ++ LD N L+G IP+   N  +L  +S +
Sbjct: 436 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 495
Query: 393 SNELTF-VPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNNLSGDIPTTI 451
           +N LT  +P   W                      IG L+ L  L LS N+ SG+IP  +
Sbjct: 496 NNRLTGEIPK--W----------------------IGRLENLAILKLSNNSFSGNIPAEL 531
Query: 452 GGLKNLQNLSLGDNNLQGSIPNSI 475
           G  ++L  L L  N   G+IP ++
Sbjct: 532 GDCRSLIWLDLNTNLFNGTIPAAM 555

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 161/587 (27%), Positives = 235/587 (40%), Gaps = 107/587 (18%)
Query: 27  NQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSY 86
           N+L G    +I +   L++L++S+NQ  G  P   + SLQ + L++N+ +GE+P      
Sbjct: 230 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIP------ 283
Query: 87  LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQAXXXXXX 146
                FLS              G   +LT +DLS NH  G +P   G+   L++      
Sbjct: 284 ----DFLS--------------GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 325
Query: 147 XXXXXXPA-TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFI 205
                 P  TL  +  LK+L L+ N  SG +  S+     +L    L++NNFSG I   +
Sbjct: 326 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 385
Query: 206 FNASKLSICE--LPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK 263
               K ++ E  L +N F+G IP    N   L  L+L +NY++ +               
Sbjct: 386 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT--------------- 430
Query: 264 LKVLSLTGNPLLDCVLPSSIGNLS-LSMERFYLHNCNIRGSIPKEMGXXXXXXXXRLGYN 322
                          +PSS+G+LS L   + +L+   + G IP+E+          L +N
Sbjct: 431 ---------------IPSSLGSLSKLRDLKLWLN--MLEGEIPQELMYVKTLETLILDFN 473
Query: 323 KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
            L G IPS LS    L  + L NN+L G I   I RL  L+ + L +N  SG+IPA  G+
Sbjct: 474 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 533
Query: 383 LASLRKLSFASNELT-FVPSTFWNLT-----NILMVDXXXXXXXXXXXXEIGNLKVLVEL 436
             SL  L   +N     +P+  +  +     N +               E      L+E 
Sbjct: 534 CRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 593
Query: 437 YLSR----NNLSGDIPTTI-----GGLK--------NLQNLSLGDNNLQGSIPNSI---- 475
              R    N LS   P  I     GG          ++  L +  N L G IP  I    
Sbjct: 594 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 653
Query: 476 --------------------GDLISLECLDLSNNILSGIIPXXXXXXXXXXXXNVSFNRL 515
                               GDL  L  LDLS+N L G IP            ++S N L
Sbjct: 654 YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 713
Query: 516 EGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKSTKTRTNQKSR 562
            G IP  G    F    F+ N  LCG P  +  P  +     +Q+S 
Sbjct: 714 SGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSH 760

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  119 bits (297), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/235 (34%), Positives = 125/235 (53%), Gaps = 8/235 (3%)
Query: 615 RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECE 674
           R    +L +AT+ F+   LIG G FG VY+G   DG +VA+K    +    +E F  E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN---SNLDIFKRLNIVID 731
            L   RH +LV +I  C   +   L+  YM  G+L+  LY  +    ++   +RL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-DESMKHTQTLAT 790
            A  L YL   H   ++H D+K  N+LLDE+ V ++ DFGI+K  +  D++        T
Sbjct: 148 AARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM-SLKRWVNDS 844
           +GY+ PEY  +G+++ + DVYSFG++L E+   +    +    EM +L  W  +S
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/237 (35%), Positives = 125/237 (52%), Gaps = 12/237 (5%)
Query: 615 RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECE 674
           R    +L +AT+ F+   LIG G FG VY+G   DG +VA+K    +    +E F  E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN---SNLDIFKRLNIVID 731
            L   RH +LV +I  C   +   L+  YM  G+L+  LY  +    ++   +RL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMKHTQTL-- 788
            A  L YL   H   ++H D+K  N+LLDE+ V ++ DFGI+K   G E    H   +  
Sbjct: 148 AARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVK 202
Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM-SLKRWVNDS 844
            T+GY+ PEY  +G+++ + DVYSFG++L E+   +    +    EM +L  W  +S
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 116/206 (56%), Gaps = 13/206 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKV-----FHLQLEGALESFNAECEVLRSIRHR 682
            N+   IG+GSFG+V+R  +  G +VA+K+     FH +    +  F  E  +++ +RH 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAE---RVNEFLREVAIMKRLRHP 94
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLH 740
           N+V  + + T     ++V +Y+ +GSL   L+   +   LD  +RL++  D+A  + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
             +P P+VH D+K  N+L+D+    ++ DFG+++L      +       T  +MAPE  R
Sbjct: 155 NRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLR 212
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
           +   + + DVYSFG++L E+ T ++P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 116/206 (56%), Gaps = 13/206 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKV-----FHLQLEGALESFNAECEVLRSIRHR 682
            N+   IG+GSFG+V+R  +  G +VA+K+     FH +    +  F  E  +++ +RH 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAE---RVNEFLREVAIMKRLRHP 94
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLH 740
           N+V  + + T     ++V +Y+ +GSL   L+   +   LD  +RL++  D+A  + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
             +P P+VH ++K  N+L+D+    ++ DFG+++L      +       T  +MAPE  R
Sbjct: 155 NRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
           +   + + DVYSFG++L E+ T ++P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 121/231 (52%), Gaps = 20/231 (8%)
Query: 613 WRRFSYQELLQATDQFNVN------NLIGSGSFGSVYRGRFLDGMEVAIK----VFHLQL 662
           +  FS+ EL   T+ F+        N +G G FG VY+G +++   VA+K    +  +  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE---ACLYSDNSN 719
           E   + F+ E +V+   +H NLV ++   ++ D   LV  YMP GSL    +CL      
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 129
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L    R  I    A  + +LH  H    +H DIK +N+LLDE   A++ DFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
            +++  ++ + T  YMAPE  R G+I+ + D+YSFG++L+EI T     DE
Sbjct: 187 AQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 120/236 (50%), Gaps = 30/236 (12%)
Query: 613 WRRFSYQELLQATDQFNVN------NLIGSGSFGSVYRGRFLDGMEVAIK----VFHLQL 662
           +  FS+ EL   T+ F+        N +G G FG VY+G +++   VA+K    +  +  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE---ACLYSDNSN 719
           E   + F+ E +V+   +H NLV ++   ++ D   LV  YMP GSL    +CL      
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 129
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD 779
           L    R  I    A  + +LH  H    +H DIK +N+LLDE   A++ DFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA---- 182
Query: 780 ESMKHTQT------LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
            S K  QT      + T  YMAPE  R G+I+ + D+YSFG++L+EI T     DE
Sbjct: 183 -SEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 119/231 (51%), Gaps = 20/231 (8%)
Query: 613 WRRFSYQELLQATDQFNVN------NLIGSGSFGSVYRGRFLDGMEVAIK----VFHLQL 662
           +  FS+ EL   T+ F+        N +G G FG VY+G +++   VA+K    +  +  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 64
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE---ACLYSDNSN 719
           E   + F+ E +V+   +H NLV ++   ++ D   LV  YMP GSL    +CL      
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 123
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L    R  I    A  + +LH  H    +H DIK +N+LLDE   A++ DFG+A+     
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
            + +   + + T  YMAPE  R G+I+ + D+YSFG++L+EI T     DE
Sbjct: 181 AQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 125/275 (45%), Gaps = 33/275 (12%)
Query: 279 LPSSIGNLSLSMERFYLHNCN-IRGSIPKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEK 337
           +PSS+ NL   +   Y+   N + G IP  +          + +  ++G+IP  LS+++ 
Sbjct: 68  IPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 338 LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL-RKLSFASNEL 396
           L  L    N L G +   I  L  L  +  D N++SG+IP  +G+ + L   ++ + N L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 397 T-FVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNNLSGDIPTTIGGLK 455
           T  +P TF NL N+  VD                        LSRN L GD     G  K
Sbjct: 187 TGKIPPTFANL-NLAFVD------------------------LSRNMLEGDASVLFGSDK 221
Query: 456 NLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPXXXXXXXXXXXXNVSFNRL 515
           N Q + L  N+L   +   +G   +L  LDL NN + G +P            NVSFN L
Sbjct: 222 NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 516 EGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPC 550
            GEIP+GG L  F   ++  N  LCGSP   +P C
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH    
Sbjct: 69  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 124
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +I +MAPE  R   
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +   S + DVY+FGI+L E+ T + P   I
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH    
Sbjct: 72  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +I +MAPE  R   
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +   S + DVY+FGI+L E+ T + P   I
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH    
Sbjct: 67  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +I +MAPE  R   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +   S + DVY+FGI+L E+ T + P   I
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH    
Sbjct: 72  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +I +MAPE  R   
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +   S + DVY+FGI+L E+ T + P   I
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 116/223 (52%), Gaps = 12/223 (5%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNA 671
           RR S  +      Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  VLR  RH N++  +   T     A+V  +    SL   L+   +  ++ K ++I   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLAT 790
            A  ++YLH      ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 791 IGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           I +MAPE  R   +   S + DVY+FGI+L E+ T + P   I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 116/223 (52%), Gaps = 12/223 (5%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNA 671
           RR S  +      Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 80
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  VLR  RH N++  +   T     A+V  +    SL   L+   +  ++ K ++I   
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLAT 790
            A  ++YLH      ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +
Sbjct: 140 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 791 IGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           I +MAPE  R   +   S + DVY+FGI+L E+ T + P   I
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH    
Sbjct: 67  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED+  ++GDFG+A + S    S +  Q   +I +MAPE  R   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +   S + DVY+FGI+L E+ T + P   I
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNA 671
           RR S  +      Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 73
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  VLR  RH N++  +   T     A+V  +    SL   L+   +  ++ K ++I   
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLAT 790
            A  ++YLH      ++H D+K +N+ L ED+  ++GDFG+A   S    S +  Q   +
Sbjct: 133 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 791 IGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           I +MAPE  R   +   S + DVY+FGI+L E+ T + P   I
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L++  +  ++ K ++I    A  ++YLH    
Sbjct: 71  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 126
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED   ++GDFG+A + S    S +  Q   +I +MAPE  R   
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
               S + DVY+FGI+L E+ T + P   I
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNI 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNA 671
           RR S  +      Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  VLR  RH N++  +   T     A+V  +    SL   L+   +  ++ K ++I   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLAT 790
            A  ++YLH      ++H D+K +N+ L ED+  ++GDFG+A   S    S +  Q   +
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 791 IGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           I +MAPE  R   +   S + DVY+FGI+L E+ T + P   I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH    
Sbjct: 67  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED+  ++GDFG+A   S    S +  Q   +I +MAPE  R   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           +   S + DVY+FGI+L E+ T + P   I
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 122/226 (53%), Gaps = 19/226 (8%)
Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNA-- 671
           R  SY   ++A++   ++  IGSGSFG+VY+G++    +VA+K+  + ++   E F A  
Sbjct: 25  RDSSYYWEIEASEVM-LSTRIGSGSFGTVYKGKWHG--DVAVKILKV-VDPTPEQFQAFR 80
Query: 672 -ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI 730
            E  VLR  RH N++  +   T D+  A+V  +    SL   L+   +   +F+ ++I  
Sbjct: 81  NEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR 139
Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL---LSGDESMKHTQT 787
             A  ++YLH      ++H D+K +N+ L E +  ++GDFG+A +    SG + ++  Q 
Sbjct: 140 QTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE--QP 194
Query: 788 LATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
             ++ +MAPE  R       S + DVYS+GI+L E+ T + P   I
Sbjct: 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 613 WRRFSYQELLQATDQFNVN------NLIGSGSFGSVYRGRFLDGMEVAIK----VFHLQL 662
           +  FS+ EL   T+ F+        N  G G FG VY+G +++   VA+K    +  +  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 61
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE---ACLYSDNSN 719
           E   + F+ E +V    +H NLV ++   ++ D   LV  Y P GSL    +CL      
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPP 120
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L    R  I    A  + +LH  H    +H DIK +N+LLDE   A++ DFG+A+     
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
            + +  ++ + T  Y APE  R G+I+ + D+YSFG++L+EI T     DE
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L++  +  ++ K ++I    A  ++YLH    
Sbjct: 83  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED   ++GDFG+A   S    S +  Q   +I +MAPE  R   
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
               S + DVY+FGI+L E+ T + P   I
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 12/210 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNL 684
           Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +   T     A+V  +    SL   L++  +  ++ K ++I    A  ++YLH    
Sbjct: 83  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGR--- 800
             ++H D+K +N+ L ED   ++GDFG+A   S    S +  Q   +I +MAPE  R   
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
               S + DVY+FGI+L E+ T + P   I
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 133
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 193
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 194 SVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 213 SVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 213 SVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 193 SVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 225
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 226 SVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 138
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 198
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 199 SVASDVWSFGVVLYELFT 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 141
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 201
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 202 SVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 139
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 199
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 200 SVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 140
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 200
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 201 SVASDVWSFGVVLYELFT 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L +    +D  K L     I   +EYL       
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 72/196 (36%), Positives = 107/196 (54%), Gaps = 16/196 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           IG G FG V  G +  G +VA+K   ++ +   ++F AE  V+  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 694 DDFKA-LVLDYMPKGSLEACLYSDNSNL---DIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           +     +V +YM KGSL   L S   ++   D    L   +D+  A+EYL     N  VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 125
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            D+   NVL+ ED VA++ DFG+ K  S   S + T  L  + + APE  RE + ST+ D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLP-VKWTAPEALREKKFSTKSD 181
Query: 810 VYSFGIMLMEIFTRKR 825
           V+SFGI+L EI++  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 72/196 (36%), Positives = 107/196 (54%), Gaps = 16/196 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           IG G FG V  G +  G +VA+K   ++ +   ++F AE  V+  +RH NLV+++     
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 694 DDFKA-LVLDYMPKGSLEACLYSDNSNL---DIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           +     +V +YM KGSL   L S   ++   D    L   +D+  A+EYL     N  VH
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 140
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            D+   NVL+ ED VA++ DFG+ K  S   S + T  L  + + APE  RE + ST+ D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLP-VKWTAPEALREKKFSTKSD 196
Query: 810 VYSFGIMLMEIFTRKR 825
           V+SFGI+L EI++  R
Sbjct: 197 VWSFGILLWEIYSFGR 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++++P GSL   L      +D  K L     I   +EYL       
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 72/196 (36%), Positives = 106/196 (54%), Gaps = 16/196 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           IG G FG V  G +  G +VA+K   ++ +   ++F AE  V+  +RH NLV+++     
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 694 DDFKA-LVLDYMPKGSLEACLYSDNSNL---DIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           +     +V +YM KGSL   L S   ++   D    L   +D+  A+EYL     N  VH
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 131
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            D+   NVL+ ED VA++ DFG+ K  S   S + T  L  + + APE  RE   ST+ D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLP-VKWTAPEALREAAFSTKSD 187
Query: 810 VYSFGIMLMEIFTRKR 825
           V+SFGI+L EI++  R
Sbjct: 188 VWSFGILLWEIYSFGR 203

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 107/196 (54%), Gaps = 16/196 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           IG G FG V  G +  G +VA+K   ++ +   ++F AE  V+  +RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 694 DDFK-ALVLDYMPKGSLEACLYSDNSNL---DIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           +     +V +YM KGSL   L S   ++   D    L   +D+  A+EYL     N  VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 312
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            D+   NVL+ ED VA++ DFG+ K  S   S + T  L  + + APE  RE + ST+ D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLP-VKWTAPEALREKKFSTKSD 368
Query: 810 VYSFGIMLMEIFTRKR 825
           V+SFGI+L EI++  R
Sbjct: 369 VWSFGILLWEIYSFGR 384

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 689 SSCTNDDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 135
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            +H ++   N+L++ +   ++GDFG+ K+L  D+     +    + I + APE   E + 
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 195
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 196 SVASDVWSFGVVLYELFT 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V++YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 448 WSFGILLTELTTKGR 462

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ IRH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V++YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 249 SEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V++YM KG L   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 29  MERTD-ITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 86
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    +V +YMP G+L   L   N   +     L +   I+ A+EYL
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ V ++ DFG+++L++GD    H      I + APE  
Sbjct: 147 E---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 203
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
                S + DV++FG++L EI T
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 104/190 (54%), Gaps = 5/190 (2%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G + +  +VA+K        ++++F  E  ++++++H  LVR+ +  T 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALALEYLHFGHPNPVVHCDI 752
           ++   ++ +YM KGSL   L SD     +  +L +    IA  + Y+   +    +H D+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 136
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +NVL+ E ++ ++ DFG+A+++  +E          I + APE    G  + + DV+S
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 813 FGIMLMEIFT 822
           FGI+L EI T
Sbjct: 197 FGILLYEIVT 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 73  SEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 128
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 189 WSFGILLTELTTKGR 203

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D+  +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 115/227 (50%), Gaps = 13/227 (5%)
Query: 602 SNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ 661
           S++Q   P   W    ++      +   +   +G+G FG V+ G +    +VA+K     
Sbjct: 2   SHMQTQKPQKPWWEDEWE---VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-- 56
Query: 662 LEGAL--ESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS- 718
            +G++  ++F AE  +++ ++H+ LVR+ +  T +    ++ +YM  GSL   L + +  
Sbjct: 57  -QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI 114
Query: 719 NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
            L I K L++   IA   E + F      +H D++ +N+L+ + +  ++ DFG+A+L+  
Sbjct: 115 KLTINKLLDMAAQIA---EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 171
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKR 825
           +E          I + APE    G  + + DV+SFGI+L EI T  R
Sbjct: 172 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EGA+  E F  E EV+  + H  LV++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV ++M  G L   L +          L + +D+   + YL       V+H D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRD 128
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+F+  +
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KG L   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 83  SEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 76  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 131
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 192 WSFGILLTELTTKGR 206

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 250 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 305
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+ +L+  +E          I + APE    G+ + + DV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 366 WSFGILLTELTTKGR 380

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 120/242 (49%), Gaps = 14/242 (5%)
Query: 590 LISTCRKGDTKLSN-----IQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYR 644
           L+   +KG+  L         ++ P   W + +++      +   +   +G+G FG V+ 
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWM 206
Query: 645 GRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM 704
             +    +VA+K        ++E+F AE  V+++++H  LV++ +  T +    ++ ++M
Sbjct: 207 ATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFM 264
Query: 705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVHCDIKPSNVLLDEDM 763
            KGSL   L SD  +     +L   ID +  + E + F      +H D++ +N+L+   +
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 321
Query: 764 VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
           V ++ DFG+A+++  +E          I + APE    G  + + DV+SFGI+LMEI T 
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381
Query: 824 KR 825
            R
Sbjct: 382 GR 383

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 11  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 68
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    +++++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 129 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 185
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +  V  ++G G+FG V + ++    +VAIK   ++ E   ++F  E   L  + H N+V+
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVK 66
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +C N     LV++Y   GSL   L+             ++  +  +  + YLH   P
Sbjct: 67  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 745 NPVVHCDIKPSNVLL-DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
             ++H D+KP N+LL     V ++ DFG A     D     T    +  +MAPE      
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
            S + DV+S+GI+L E+ TR++P DEI
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +  V  ++G G+FG V + ++    +VAIK   ++ E   ++F  E   L  + H N+V+
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVK 65
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +C N     LV++Y   GSL   L+             ++  +  +  + YLH   P
Sbjct: 66  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 745 NPVVHCDIKPSNVLL-DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
             ++H D+KP N+LL     V ++ DFG A     D     T    +  +MAPE      
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
            S + DV+S+GI+L E+ TR++P DEI
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY-LHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +   +  + RL  ++D+A  +   + +      VH 
Sbjct: 72  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 188 WSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY-LHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +   +  + RL  ++D+A  +   + +      VH 
Sbjct: 74  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 190 WSFGILLTELTTKGR 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EGA+  E F  E EV+  + H  LV++   C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV ++M  G L   L +          L + +D+   + YL       V+H D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 126
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+F+  +
Sbjct: 187 SFGVLMWEVFSEGK 200

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EGA+  E F  E EV+  + H  LV++   C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV ++M  G L   L +          L + +D+   + YL       V+H D
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 131
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+F+  +
Sbjct: 192 SFGVLMWEVFSEGK 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EGA+  E F  E EV+  + H  LV++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV ++M  G L   L +          L + +D+   + YL       V+H D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 128
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+F+  +
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VA+K      +G++  ++F AE  +++ ++H+ LVR+ +  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           T +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H 
Sbjct: 87  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHR 142
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L EI T  R
Sbjct: 203 WSFGILLTEIVTHGR 217

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G FG VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 8   MERTD-ITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 65
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VA+K      +G++  ++F AE  +++ ++H+ LVR+ +  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           T +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H 
Sbjct: 86  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHR 141
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L EI T  R
Sbjct: 202 WSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VA+K      +G++  ++F AE  +++ ++H+ LVR+ +  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           T +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H 
Sbjct: 84  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHR 139
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L EI T  R
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 196 WSFGILLTELTTKGR 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+   +    +VA+K        ++E+F AE  V+++++H  LV++ +  T 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVHCDI 752
           +    ++ ++M KGSL   L SD  +     +L   ID +  + E + F      +H D+
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+   +V ++ DFG+A+++  +E          I + APE    G  + + DV+S
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197
Query: 813 FGIMLMEIFTRKR 825
           FGI+LMEI T  R
Sbjct: 198 FGILLMEIVTYGR 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 135
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 135
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 136
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 197 FGILLTEIVTHGR 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 10  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    +++++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 137
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 198 FGILLTEIVTHGR 210

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EGA+  E F  E EV+  + H  LV++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV ++M  G L   L +          L + +D+   + YL       V+H D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+F+  +
Sbjct: 190 SFGVLMWEVFSEGK 203

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 10  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    +++++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L  +    L + + +++   IA  + Y+   +    VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 196 WSFGILLTELTTKGR 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 141
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 202 FGILLTEIVTHGR 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 135
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 130
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 191 FGILLTEIVTHGR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 140
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 201 FGILLTEIVTHGR 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 23  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 80
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 140
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 141 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 197
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 198 AYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 12  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 130 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 15  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 133 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           IGSG FG V+ G +L+  +VAIK      EG++  + F  E EV+  + H  LV++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV ++M  G L   L +          L + +D+   + YL       V+H D
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 148
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S++ DV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 812 SFGIMLMEIFTRKR 825
           SFG+++ E+F+  +
Sbjct: 209 SFGVLMWEVFSEGK 222

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 12  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 130 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 15  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 133 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 10  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 10  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 53/190 (27%), Positives = 104/190 (54%), Gaps = 5/190 (2%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G + +  +VA+K        ++++F  E  ++++++H  LVR+ +  T 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALALEYLHFGHPNPVVHCDI 752
           ++   ++ ++M KGSL   L SD     +  +L +    IA  + Y+   +    +H D+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 135
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +NVL+ E ++ ++ DFG+A+++  +E          I + APE    G  + + +V+S
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 813 FGIMLMEIFT 822
           FGI+L EI T
Sbjct: 196 FGILLYEIVT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 15  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    +++++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 133 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 8   MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 65
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    +++++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 8   MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 65
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL 182
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 11/236 (4%)
Query: 589 GLISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL 648
           GLI+T      K      N P V     +Y +         + + +G G +G VY G + 
Sbjct: 227 GLITTLHYPAPK-----RNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK 281
Query: 649 D-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKG 707
              + VA+K    +    +E F  E  V++ I+H NLV+++  CT +    ++ ++M  G
Sbjct: 282 KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 340
Query: 708 SLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR 766
           +L   L   N   ++    L +   I+ A+EYL        +H ++   N L+ E+ + +
Sbjct: 341 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVK 397
Query: 767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + DFG+++L++GD    H      I + APE     + S + DV++FG++L EI T
Sbjct: 398 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 15  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 133 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 189
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 115/229 (50%), Gaps = 17/229 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL---QLEGALESFNAECEVLRSIRH 681
           +++ + + +G G   +VY     +  ++VAIK   +   + E  L+ F  E      + H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
           +N+V +I     DD   LV++Y+   +L   + S +  L +   +N    I   L+ +  
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQI---LDGIKH 126
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
            H   +VH DIKP N+L+D +   ++ DFGIAK LS     +    L T+ Y +PE  + 
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK- 185
Query: 802 GQISTE-GDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK---RWVNDSLP 846
           G+ + E  D+YS GI+L E+   + P    F+GE ++    + + DS+P
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVP 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 217 MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 274
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H ++   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G FG V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H ++
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRNL 131
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  + + DV+S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 192 FGILLTEIVTHGR 204

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 15  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 133 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 10  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 14  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 71
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 132 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 10  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE  
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 634 IGSGSFGSVYRGRF------LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D M VA+K      E A + F  E E+L  ++H+++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSN--------------LDIFKRLNIVIDIA 733
              CT      +V +YM  G L   L S   +              L + + L +   +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 734 LALEY---LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLA 789
             + Y   LHF      VH D+   N L+ + +V ++GDFG+++ + S D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            I +M PE     + +TE DV+SFG++L EIFT
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 634 IGSGSFGSVYRGRF------LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D M VA+K      E A + F  E E+L  ++H+++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSN--------------LDIFKRLNIVIDIA 733
              CT      +V +YM  G L   L S   +              L + + L +   +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 734 LALEY---LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLA 789
             + Y   LHF      VH D+   N L+ + +V ++GDFG+++ + S D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            I +M PE     + +TE DV+SFG++L EIFT
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 634 IGSGSFGSVYRGRF------LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D M VA+K      E A + F  E E+L  ++H+++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSN--------------LDIFKRLNIVIDIA 733
              CT      +V +YM  G L   L S   +              L + + L +   +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 734 LALEY---LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLA 789
             + Y   LHF      VH D+   N L+ + +V ++GDFG+++ + S D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            I +M PE     + +TE DV+SFG++L EIFT
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D + VA+K      + A + F+ E E+L +++H ++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 688 ISSCTNDDFKALVLDYMPKGSL---------EACLYSDN---SNLDIFKRLNIVIDIALA 735
              C   D   +V +YM  G L         +A L ++    + L   + L+I   IA  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           + YL   H    VH D+   N L+ E+++ ++GDFG+++ + S D       T+  I +M
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEIFSGEM 835
            PE     + +TE DV+S G++L EIFT  K+P  ++ + E+
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V+ G +    +VAIK       G +  ESF  E ++++ ++H  LV++ +  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 692 TNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
           + +    +V +YM KGSL   L   +   L +   +++   +A  + Y+   +    +H 
Sbjct: 74  SEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 129
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           D++ +N+L+   ++ ++ DFG+A+L+  +E          I + APE    G+ + + DV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 811 YSFGIMLMEIFTRKR 825
           +SFGI+L E+ T+ R
Sbjct: 190 WSFGILLTELVTKGR 204

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 6/192 (3%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRIISSC 691
           IG G+FG V+ GR   D   VA+K     L   L++ F  E  +L+   H N+VR+I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V++ +  G     L ++ + L +   L +V D A  +EYL        +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           +   N L+ E  V ++ DFG+++  + G  +         + + APE    G+ S+E DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 811 YSFGIMLMEIFT 822
           +SFGI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 6/192 (3%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRIISSC 691
           IG G+FG V+ GR   D   VA+K     L   L++ F  E  +L+   H N+VR+I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      +V++ +  G     L ++ + L +   L +V D A  +EYL        +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPEYGREGQISTEGDV 810
           +   N L+ E  V ++ DFG+++  + G  +         + + APE    G+ S+E DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 811 YSFGIMLMEIFT 822
           +SFGI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 133
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 134 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSV 190
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 33  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 92
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 93  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 152
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 153 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 209
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 210 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 34  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 93
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 94  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 153
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 154 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 210
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 211 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 11  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 68
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD           I + APE  
Sbjct: 129 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL 185
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 9/208 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +GSG FG V  G++    +VA+K+     EG++  + F  E + +  + H  LV+    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           + +    +V +Y+  G L   L S    L+  + L +  D+   + +L     +  +H D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+D D+  ++ DFG+ + +  D+ +    T   + + APE     + S++ DV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 812 SFGIMLMEIFTR-KRPTDEIFSGEMSLK 838
           +FGI++ E+F+  K P D   + E+ LK
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++ TD   + + +G G +G VY G +    + VA+K    +    +E F  E  V++ I+
Sbjct: 12  MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL 739
           H NLV+++  CT +    ++ ++M  G+L   L   N   ++    L +   I+ A+EYL
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
                   +H D+   N L+ E+ + ++ DFG+++L++GD           I + APE  
Sbjct: 130 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL 186
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + S + DV++FG++L EI T
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 135 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 7   ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 66
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 67  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 126
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 127 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 183
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 184 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 132
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 133 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 189
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 132 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 188
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 133
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 134 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 190
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           +G+G  G V+ G +    +VA+K    Q   + ++F AE  +++ ++H+ LVR+ +  T 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 694 DDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
           +    ++ +YM  GSL   L + +   L I K L++   IA   E + F      +H D+
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA---EGMAFIEERNYIHRDL 135
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           + +N+L+ + +  ++ DFG+A+L+   E          I + APE    G  + + DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 813 FGIMLMEIFTRKR 825
           FGI+L EI T  R
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 135 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK- 783
            +   + +A  ++YL        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 130 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+           D M VA+K        A + F  E E+L +++H ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 688 ISSCTNDDFKALVLDYMPKGSLEACLYSDNSN---------------LDIFKRLNIVIDI 732
              C + D   +V +YM  G L   L +   +               L + + L+I   I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATI 791
           A  + YL   H    VH D+   N L+  +++ ++GDFG+++ + S D       T+  I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            +M PE     + +TE DV+SFG++L EIFT
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG+A++L  D    +T      
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 135
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +L  +    
Sbjct: 136 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV 192
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 26  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 85  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 144
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 145 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 242

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 9   FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 127
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 128 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 20  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 79
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 80  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 139
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 140 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 196
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 197 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 135
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 136 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 192
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 114/232 (49%), Gaps = 22/232 (9%)
Query: 617 SYQELLQATDQF---------NVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QL 662
           +Y++  Q   +F         +++ ++G+G FG V  GR        + VAIK   +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDI 722
           E     F  E  ++    H N++R+    T      +V +YM  GSL++ L   ++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 723 FKRLNIVIDIALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
            + + ++  IA  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D  
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 782 MKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
             +T       I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 114/232 (49%), Gaps = 22/232 (9%)
Query: 617 SYQELLQATDQF---------NVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QL 662
           +Y++  Q   +F         +++ ++G+G FG V  GR        + VAIK   +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDI 722
           E     F  E  ++    H N++R+    T      +V +YM  GSL++ L   ++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 723 FKRLNIVIDIALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
            + + ++  IA  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D  
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 782 MKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
             +T       I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRI 687
           +G G FG V   R+       G +VA+K    +  G  +     E E+LR++ H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 688 ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              CT D      L+++++P GSL+  L  + + +++ ++L   + I   ++YL      
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQ 803
             VH D+   NVL++ +   ++GDFG+ K +  D+     +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 804 ISTEGDVYSFGIMLMEIFT 822
                DV+SFG+ L E+ T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ----LEGALESFNAECEVLRSIRHR 682
           +  +  +IG G FG VYR  F  G EVA+K         +   +E+   E ++   ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N++ +   C  +    LV+++   G L   L       DI   +N  + IA  + YLH  
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDE 124
Query: 743 HPNPVVHCDIKPSNVLLDEDM--------VARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
              P++H D+K SN+L+ + +        + ++ DFG+A+       M      A   +M
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA---WM 181
Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE  R    S   DV+S+G++L E+ T + P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRI 687
           +G G FG V   R+       G +VA+K    +  G  +     E E+LR++ H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 688 ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              CT D      L+++++P GSL+  L  + + +++ ++L   + I   ++YL      
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ--TLATIGYMAPEYGREGQ 803
             VH D+   NVL++ +   ++GDFG+ K +  D+     +    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 804 ISTEGDVYSFGIMLMEIFT 822
                DV+SFG+ L E+ T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 194 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 132
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 133 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 189
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 135 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GA 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 666 LESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACLYSDNSNLDIFK 724
           +  F  E  +++   H N++ ++  C   +   LV L YM  G L   + ++  N  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMK 783
            +   + +A  +++L        VH D+   N +LDE    ++ DFG+A+ +   E    
Sbjct: 135 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 784 HTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           H +T A   + +MA E  +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 114/232 (49%), Gaps = 22/232 (9%)
Query: 617 SYQELLQATDQF---------NVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QL 662
           +Y++  Q   +F         +++ ++G+G FG V  GR        + VAIK   +   
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDI 722
           E     F  E  ++    H N++R+    T      +V +YM  GSL++ L   ++   +
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
Query: 723 FKRLNIVIDIALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
            + + ++  IA  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D  
Sbjct: 145 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 200
Query: 782 MKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
             +T       I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 201 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 252

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG+ ++L  D    +T      
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 633 LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           ++G G++G VY GR L + + +AIK    +     +  + E  + + ++H+N+V+ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 692 TNDDFKALVLDYMPKGSLEACLYS------DNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           + + F  + ++ +P GSL A L S      DN     F    I       LE L + H N
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-------LEGLKYLHDN 127
Query: 746 PVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ- 803
            +VH DIK  NVL++    V ++ DFG +K L+G      T T  T+ YMAPE   +G  
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPR 186
Query: 804 -ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
                 D++S G  ++E+ T K P  E+
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 118/242 (48%), Gaps = 24/242 (9%)
Query: 590 LISTCRKGDTKLSN-----IQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYR 644
           L+   +KG+  L         ++ P   W + +++      +   +   +G+G FG V+ 
Sbjct: 144 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWM 200
Query: 645 GRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM 704
             +    +VA+K        ++E+F AE  V+++++H  LV++ +  T +    ++ ++M
Sbjct: 201 ATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFM 258
Query: 705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVHCDIKPSNVLLDEDM 763
            KGSL   L SD  +     +L   ID +  + E + F      +H D++ +N+L+   +
Sbjct: 259 AKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 315
Query: 764 VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
           V ++ DFG+A++ +             I + APE    G  + + DV+SFGI+LMEI T 
Sbjct: 316 VCKIADFGLARVGAK----------FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 365
Query: 824 KR 825
            R
Sbjct: 366 GR 367

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 22/229 (9%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL-QLEGALE------SFNAECEV 675
           A ++      IG G FG V++GR + D   VAIK   L   EG  E       F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           + ++ H N+V++     N     +V++++P G L   L      +    +L +++DIAL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLL---DED--MVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +EY+   +P P+VH D++  N+ L   DE+  + A++ DFG    LS       +  L  
Sbjct: 135 IEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLLGN 189
Query: 791 IGYMAPE-YGREGQISTE-GDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             +MAPE  G E +  TE  D YSF ++L  I T + P DE   G++  
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNA 671
           S+   ++A+ + ++  +IGSG  G V  GR        + VAIK       E     F +
Sbjct: 41  SFTREIEAS-RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS 99
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  ++    H N++R+    T      +V +YM  GSL+  L + +    I + + ++  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 732 IALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +   + YL   G+    VH D+   NVL+D ++V ++ DFG++++L  D    +T T   
Sbjct: 160 VGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 791 --IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
             I + APE       S+  DV+SFG+++ E+    +RP
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIK---VFHLQLEGALESFNAECEVLRSIRHRN 683
           F +   IG G F  VYR    LDG+ VA+K   +F L    A      E ++L+ + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALALEYLH 740
           +++  +S   D+   +VL+    G L   +        +     +    + +  ALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 V+H DIKP+NV +    V +LGD G+ +  S   +  H+  + T  YM+PE   
Sbjct: 154 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 209
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
           E   + + D++S G +L E+   + P
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V +YM  GSL++ L   ++   + + + ++  I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G     VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 157 ASGMKYLSDMG----FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 7/209 (3%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRH 681
           Q  + F+V   +G GS+GSVY+    + G  VAIK   + +E  L+    E  +++    
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDS 83
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            ++V+   S   +    +V++Y   GS+   +   N  L   +   I+      LEYLHF
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                 +H DIK  N+LL+ +  A+L DFG+A  L+ D   K    + T  +MAPE  +E
Sbjct: 144 MRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEVIQE 199
Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
              +   D++S GI  +E+   K P  +I
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADI 228

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAI+  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALEFLHSNQV 137
Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K ++ + T  +MAPE         +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL-EGALESFNA 671
           S+   ++A+ + ++  +IGSG  G V  GR        + VAIK       E     F +
Sbjct: 41  SFTREIEAS-RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS 99
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  ++    H N++R+    T      +V +YM  GSL+  L + +    I + + ++  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 732 IALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +   + YL   G+    VH D+   NVL+D ++V ++ DFG++++L  D     T T   
Sbjct: 160 VGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 791 --IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
             I + APE       S+  DV+SFG+++ E+    +RP
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 9/218 (4%)
Query: 620 ELLQATDQFNVNN---LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEV 675
           +LL+   +++ N    ++G G++G VY GR L + + +AIK    +     +  + E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
            + ++H+N+V+ + S + + F  + ++ +P GSL A L S    L   ++  I       
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQI 131
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE L + H N +VH DIK  NVL++    V ++ DFG +K L+G      T T  T+ YM
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYM 190
Query: 795 APEYGREGQ--ISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           APE   +G        D++S G  ++E+ T K P  E+
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 114/231 (49%), Gaps = 26/231 (11%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL-QLEGALE------SFNAECEV 675
           A ++      IG G FG V++GR + D   VAIK   L   EG  E       F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           + ++ H N+V++     N     +V++++P G L   L      +    +L +++DIAL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLL---DED--MVARLGDFGIAKLLSGDESMKHTQT--L 788
           +EY+   +P P+VH D++  N+ L   DE+  + A++ DFG +      +   H+ +  L
Sbjct: 135 IEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS------QQSVHSVSGLL 187
Query: 789 ATIGYMAPE-YGREGQISTE-GDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
               +MAPE  G E +  TE  D YSF ++L  I T + P DE   G++  
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 206 AFGVLMWEIYSL---------GKMPYERFTN 227

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 105/214 (49%), Gaps = 12/214 (5%)
Query: 631 NNLIGSGSFGSVYRGRFLDG-----MEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNL 684
             +IG+G FG VY+G          + VAIK       E     F  E  ++    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +R+    +      ++ +YM  G+L+  L   +    + + + ++  IA  ++YL   + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG--YMAPEYGREG 802
              VH D+   N+L++ ++V ++ DFG++++L  D    +T +   I   + APE     
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 803 QISTEGDVYSFGIMLMEIFTR-KRPTDEIFSGEM 835
           + ++  DV+SFGI++ E+ T  +RP  E+ + E+
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAI+  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALEFLHSNQV 137
Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAI+  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALEFLHSNQV 137
Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 116/239 (48%), Gaps = 24/239 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L D  +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 681 HRNLVRIISSCTNDD----FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V +  +   +        +V++Y+   +L   ++++   +   + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD---AC 126
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L+F H N ++H D+KP+N+++      ++ DFGIA+ ++ D     TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQY 185
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLPIS 848
           ++PE  R   +    DVYS G +L E+ T + P    F+G+    ++ +    D +P S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAI+  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALEFLHSNQV 138
Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 197 AFGVLMWEIYSL---------GKMPYERFTN 218

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 190 AFGVLMWEIYSL---------GKMPYERFTN 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 191 AFGVLMWEIYSL---------GKMPYERFTN 212

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 206 AFGVLMWEIYSL---------GKMPYERFTN 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 186 AFGVLMWEIYSL---------GKMPYERFTN 207

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 116/239 (48%), Gaps = 24/239 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L D  +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 681 HRNLVRIISSCTND----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V +  +   +        +V++Y+   +L   ++++   +   + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD---AC 126
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L+F H N ++H D+KP+N+++      ++ DFGIA+ ++ D     TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQY 185
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLPIS 848
           ++PE  R   +    DVYS G +L E+ T + P    F+G+    ++ +    D +P S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQHVREDPIPPS 240

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 22/229 (9%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL-QLEGALE------SFNAECEV 675
           A ++      IG G FG V++GR + D   VAIK   L   EG  E       F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           + ++ H N+V++     N     +V++++P G L   L      +    +L +++DIAL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLL---DED--MVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +EY+   +P P+VH D++  N+ L   DE+  + A++ DF     LS       +  L  
Sbjct: 135 IEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFS----LSQQSVHSVSGLLGN 189
Query: 791 IGYMAPE-YGREGQISTE-GDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             +MAPE  G E +  TE  D YSF ++L  I T + P DE   G++  
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 112/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 9   FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V + M  GSL++ L   ++   + + + ++  I
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGI 127
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 128 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 114/224 (50%), Gaps = 15/224 (6%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGME-----VAIKVFHLQLEG--ALESFNAEC 673
           +L+ T+   V  ++GSG+FG+VY+G ++   E     VAIK+ + +  G  A   F  E 
Sbjct: 34  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 91
Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            ++ S+ H +LVR++  C +   + LV   MP G L   ++    N+     LN  + IA
Sbjct: 92  LIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA 150
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIG 792
             + YL       +VH D+   NVL+      ++ DFG+A+LL GDE   +       I 
Sbjct: 151 KGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 207
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM 835
           +MA E     + + + DV+S+G+ + E+ T   +P D I + E+
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 113/232 (48%), Gaps = 22/232 (9%)
Query: 617 SYQELLQATDQF---------NVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QL 662
           +Y++  Q   +F         +++ ++G+G FG V  GR        + VAIK   +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDI 722
           E     F  E  ++    H N++R+    T      +V + M  GSL++ L   ++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 723 FKRLNIVIDIALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
            + + ++  IA  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D  
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 782 MKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
             +T       I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISSC 691
           +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  LV++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
           T      ++ +YM  G L   L          + L +  D+  A+EYL        +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVY 811
           +   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S++ D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 812 SFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           +FG+++ EI++          G+M  +R+ N
Sbjct: 191 AFGVLMWEIYSL---------GKMPYERFTN 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 113/232 (48%), Gaps = 22/232 (9%)
Query: 617 SYQELLQATDQF---------NVNNLIGSGSFGSVYRGRF-LDG---MEVAIKVFHL-QL 662
           +Y++  QA  +F          +  +IG+G FG V  GR  L G   + VAIK   +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDI 722
           E     F  E  ++    H N++ +    T      +V +YM  GSL+  L  ++    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 723 FKRLNIVIDIALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
            + + ++  I+  ++YL   G+    VH D+   N+L++ ++V ++ DFG++++L  D  
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 782 MKHTQTLATIG--YMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
             +T     I   + APE     + ++  DV+S+GI++ E+ +  +RP  E+
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 617 SYQELLQATDQF---------NVNNLIGSGSFGSVYRGRF-LDG---MEVAIKVFHLQL- 662
           +Y++  +A  QF          +  +IG+G FG V  GR  L G   + VAIK   +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 663 EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDI 722
           E     F  E  ++    H N+V +    T      +V+++M  G+L+A L   +    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 723 FKRLNIVIDIALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
            + + ++  IA  + YL   G+    VH D+   N+L++ ++V ++ DFG+++++  D  
Sbjct: 145 IQLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 782 MKHTQTLATI--GYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
             +T T   I   + APE  +  + ++  DV+S+GI++ E+ +  +RP
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 14/213 (6%)
Query: 632 NLIGSGSFGSVYRGRFLDGME-----VAIKVFHLQLEG--ALESFNAECEVLRSIRHRNL 684
            ++GSG+FG+VY+G ++   E     VAIK+ + +  G  A   F  E  ++ S+ H +L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 79
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           VR++  C +   + LV   MP G L   ++    N+     LN  + IA  + YL     
Sbjct: 80  VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---E 135
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYGREGQ 803
             +VH D+   NVL+      ++ DFG+A+LL GDE   +       I +MA E     +
Sbjct: 136 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 804 ISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM 835
            + + DV+S+G+ + E+ T   +P D I + E+
Sbjct: 196 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHL-QLEGALESFNAE 672
           + + L AT+  +++ ++G+G FG V  GR        + VAIK   +   E     F  E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
             ++    H N++R+    T      +V + M  GSL++ L   ++   + + + ++  I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 733 ALALEYL-HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT- 790
           A  ++YL   G     VH D+   N+L++ ++V ++ DFG++++L  D    +T      
Sbjct: 157 ASGMKYLSDMG----AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 791 -IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEI 830
            I + +PE     + ++  DV+S+GI+L E+ +  +RP  E+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRIIS 689
           IG GSFG+VY  R +   EV AIK      + + E +     E   L+ +RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPN 745
               +    LV++Y        CL S +  L++ K+    ++IA     AL+ L + H +
Sbjct: 122 CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY---GREG 802
            ++H D+K  N+LL E  + +LGDFG A +++          + T  +MAPE      EG
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDEG 228
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           Q   + DV+S GI  +E+  RK P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L D  +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 681 HRNLVRIISSCTND----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V +  +   +        +V++Y+   +L   ++++   +   + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD---AC 126
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L+F H N ++H D+KP+N+L+      ++ DFGIA+ ++ D      QT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIA-DSGNSVXQTAAVIGTAQY 185
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLPIS 848
           ++PE  R   +    DVYS G +L E+ T + P    F+G+    ++ +    D +P S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V  ++L  A      +    E  V+ S+ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 169 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P+G +   L    S  D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYC 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 183
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++  + H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHL--------QLEGALESFNAECEVLR 677
           +++  ++IG G    V R      G E A+K+  +        QLE   E+   E  +LR
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 678 SIR-HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVID 731
            +  H +++ +I S  +  F  LV D M KG L     E    S+     I + L     
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL----- 209
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
               LE + F H N +VH D+KP N+LLD++M  RL DFG +  L   E ++  +   T 
Sbjct: 210 ----LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR--ELCGTP 263
Query: 792 GYMAPE------------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           GY+APE            YG+      E D+++ G++L  +     P
Sbjct: 264 GYLAPEILKCSMDETHPGYGK------EVDLWACGVILFTLLAGSPP 304

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 631 NNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLV 685
           + +IG G FG VY G ++D     ++ AIK      E   +E+F  E  ++R + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 686 RIIS-SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
            +I      +    ++L YM  G L   + S   N  +   ++  + +A  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---E 142
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES---MKHTQTLATIGYMAPEYGRE 801
              VH D+   N +LDE    ++ DFG+A+ +   E     +H      + + A E  + 
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP 826
            + +T+ DV+SFG++L E+ TR  P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG G+ G+VY       G EVAI+  +LQ +   E    E  V+R  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 693 NDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPV 747
             D   +V++Y+  GSL     E C+  D   +    R          L+ L F H N V
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRE--------CLQALEFLHSNQV 138
Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           +H +IK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE         +
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D++S GIM +E+   + P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 634 IGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFN---AECEVLRSIRHRNLVRIIS 689
           IG GSFG+VY  R +   EV AIK      + + E +     E   L+ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYLHFGHPN 745
               +    LV++Y        CL S +  L++ K+    ++IA     AL+ L + H +
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY---GREG 802
            ++H D+K  N+LL E  + +LGDFG A +++          + T  +MAPE      EG
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDEG 189
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
           Q   + DV+S GI  +E+  RK P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++  + H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 116/239 (48%), Gaps = 24/239 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L    +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 681 HRNLVRIISSCTNDD----FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V + ++   +        +V++Y+   +L   ++++   +   + + ++ D   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD---AC 126
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L+F H N ++H D+KP+N+++      ++ DFGIA+ ++ D     TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQY 185
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLPIS 848
           ++PE  R   +    DVYS G +L E+ T + P    F+G+    ++ +    D +P S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 45  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 164 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 79  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 30  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 149 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 66
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 127 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 38  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 65  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 184 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 55  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 174 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L    +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 681 HRNLVRIISSCTND----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V +  +   +        +V++Y+   +L   ++++   +   + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD---AC 126
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L+F H N ++H D+KP+N+++      ++ DFGIA+ ++ D     TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQY 185
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLPIS 848
           ++PE  R   +    DVYS G +L E+ T + P    F+G+    ++ +    D +P S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVL 676
           QE     +Q  +  LIG G FG VY GR+    EVAI++  ++   E  L++F  E    
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAY 83
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           R  RH N+V  + +C +    A++       +L + +      LD+ K   I  +I   +
Sbjct: 84  RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI----AKLLSGDESMKHTQTLATIG 792
            YL   H   ++H D+K  NV  D   V  + DFG+      L +G    K       + 
Sbjct: 144 GYL---HAKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 793 YMAPEYGREGQISTE---------GDVYSFGIMLMEIFTRKRP 826
           ++APE  R+    TE          DV++ G +  E+  R+ P
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V R+ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 56  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++L+ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 175 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSD-----NSNLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 150
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE  
Sbjct: 151 HSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 204
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 205 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 75
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 136 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 82  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 141 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++++ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 634 IGSGSFGSVYRGRFLDGM-------EVAIKVF-HLQLEGALESFNAECEVLRSIRHRNLV 685
           +G G+FG VY G+ + GM       +VA+K    +  E     F  E  ++    H+N+V
Sbjct: 38  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYL 739
           R I        + ++++ M  G L++ L       S  S+L +   L++  DIA   +YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 740 HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
              H    +H DI   N LL       VA++GDFG+A+ +       K    +  + +M 
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFT 822
           PE   EG  +++ D +SFG++L EIF+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 616 FSYQELLQATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALE 667
           F   E   A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 668 SFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD------ 721
             N E  V++     ++VR++   +      ++++ M +G L++ L S    ++      
Sbjct: 66  FLN-EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 722 ---IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLS 777
              + K + +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +  
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            D   K  + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 160 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P+G +   L    S  D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYC 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMI 183
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 183
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 145 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALE---SFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L    +VA+KV    L         F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 681 HRNLVRIISSCTNDD----FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V +  +   +        +V++Y+   +L   ++++   +   + + ++ D   A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD---AC 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L+F H N ++H D+KP+N+++      ++ DFGIA+ ++ D     TQT A IG   Y
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQY 202
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLPIS 848
           ++PE  R   +    DVYS G +L E+ T + P    F+G+    ++ +    D +P S
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 257

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 129 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 141
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE  
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 195
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 196 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 22/233 (9%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 103
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 164 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T      +  S E  L+
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI 178
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKR 725
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         YS N + +  ++
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 726 LN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L+          +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 188 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 132 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 74
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 135 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG AKLL  +E   H +     I +MA E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQL--EGALESFNAECEVL 676
           L +A  Q+     IG G++G V++ R L   G  VA+K   +Q   EG   S   E  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 677 R---SIRHRNLVRIISSCT---NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI 730
           R   +  H N+VR+   CT    D    L L +            ++ + D+   L+ V 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF------------EHVDQDLTTYLDKVP 113
Query: 731 DIALALEY-----------LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD 779
           +  +  E            L F H + VVH D+KP N+L+      +L DFG+A++ S  
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
             M  T  + T+ Y APE   +   +T  D++S G +  E+F RK
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG AKLL  +E   H +     I +MA E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS +       + + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E   S   D+++ G ++ ++
Sbjct: 208 EKSASKSSDLWALGCIIYQL 227

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG AKLL  +E   H +     I +MA E  
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 81
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 142 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 75
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 136 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 74
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 135 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVR 686
           +G   FG VY+G             VAIK    + EG L E F  E  +   ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACL-----YSD----------NSNLDIFKRLNIVID 731
           ++   T D   +++  Y   G L   L     +SD           S L+    +++V  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLAT 790
           IA  +EYL   H   VVH D+   NVL+ + +  ++ D G+ + + + D       +L  
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           I +MAPE    G+ S + D++S+G++L E+F+
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 75
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKR 725
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         YS N + +  ++
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 726 LN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L+          +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 136 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L   + + +   +G G+FG VY+ +  + G   A KV   + E  LE +  E E+L +  
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 66
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H  +V+++ +  +D    +++++ P G+++A +   +  L       I +     LE L+
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLEALN 123
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI-AKLLSGDESMKHTQTLATIGYMAPEY- 798
           F H   ++H D+K  NVL+  +   RL DFG+ AK L   +  K    + T  +MAPE  
Sbjct: 124 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVV 181
Query: 799 ----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
                ++     + D++S GI L+E+   + P  E+
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKR 725
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         YS N + +  ++
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 726 LN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L+          +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKR 725
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         YS N + +  ++
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 726 LN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L+          +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 78
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKR 725
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         YS N + +  ++
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 726 LN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L+          +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 139 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH---LQLEGALESFNAECEVLRS 678
           +  + F V NL+G GSF  VYR   +  G+EVAIK+     +   G ++    E ++   
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           ++H +++ + +   + ++  LVL+    G +   L +        +  + +  I   + Y
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           LH    + ++H D+  SN+LL  +M  ++ DFG+A  L      KH     T  Y++PE 
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEI 183
Query: 799 GREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
                   E DV+S G M   +   + P D
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 79
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDNSNLDIFKR 725
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L         YS N + +  ++
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 726 LN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L+          +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 140 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXI 183
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG+   E  D++S G++  E    K P
Sbjct: 184 -EGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 21/223 (9%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFL--DG--MEVAIKVFHLQLEGA--LESFNAE 672
           +++L    QF +  ++G G FGSV   +    DG  ++VA+K+    +  +  +E F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKA------LVLDYMPKGSLEACLYSDNS-----NLD 721
              ++   H ++ +++        K       ++L +M  G L A L +        NL 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDE 780
           +   +  ++DIA  +EYL        +H D+   N +L EDM   + DFG++ K+ SGD 
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
             +   +   + ++A E   +   +   DV++FG+ + EI TR
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQL--EGALESFNAECEVL 676
           L +A  Q+     IG G++G V++ R L   G  VA+K   +Q   EG   S   E  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 677 R---SIRHRNLVRIISSCT---NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI 730
           R   +  H N+VR+   CT    D    L L +            ++ + D+   L+ V 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF------------EHVDQDLTTYLDKVP 113
Query: 731 DIALALEY-----------LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD 779
           +  +  E            L F H + VVH D+KP N+L+      +L DFG+A++ S  
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
             M  T  + T+ Y APE   +   +T  D++S G +  E+F RK
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L   + + +   +G G+FG VY+ +  + G   A KV   + E  LE +  E E+L +  
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 74
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H  +V+++ +  +D    +++++ P G+++A +   +  L       I +     LE L+
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLEALN 131
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI-AKLLSGDESMKHTQTLATIGYMAPEY- 798
           F H   ++H D+K  NVL+  +   RL DFG+ AK L   +  K    + T  +MAPE  
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVV 189
Query: 799 ----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
                ++     + D++S GI L+E+   + P  E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQL--EGALESFNAECEVL 676
           L +A  Q+     IG G++G V++ R L   G  VA+K   +Q   EG   S   E  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 677 R---SIRHRNLVRIISSCT---NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI 730
           R   +  H N+VR+   CT    D    L L +            ++ + D+   L+ V 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF------------EHVDQDLTTYLDKVP 113
Query: 731 DIALALEY-----------LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD 779
           +  +  E            L F H + VVH D+KP N+L+      +L DFG+A++ S  
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
             M  T  + T+ Y APE   +   +T  D++S G +  E+F RK
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 634 IGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGAL-ESFNAECEVLRSIRHRNLVR 686
           +G   FG VY+G             VAIK    + EG L E F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACL-----YSD----------NSNLDIFKRLNIVID 731
           ++   T D   +++  Y   G L   L     +SD           S L+    +++V  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLAT 790
           IA  +EYL   H   VVH D+   NVL+ + +  ++ D G+ + + + D       +L  
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           I +MAPE    G+ S + D++S+G++L E+F+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 622 LQATDQFNVNNLIGSGSFG-SVYRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRS 678
            Q+ +++     IG GSFG ++      DG +  IK  ++    + E   +  E  VL +
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL-------EACLYSDNSNLDIFKRLNIVID 731
           ++H N+V+   S   +    +V+DY   G L       +  L+ ++  LD F      + 
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------VQ 133
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           I LAL+++H      ++H DIK  N+ L +D   +LGDFGIA++L+    +     + T 
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTP 189
Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
            Y++PE       + + D+++ G +L E+ T K
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++ SG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L++  MP G L   +     N+     LN  + IA  + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           D F++   +G G FG+VY  R     F+  ++V  K   L+ EG       E E+   +R
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEKEGVEHQLRREIEIQSHLR 73
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++R+ +   +     L+L++ P+G L   L   +   D  +    + ++A AL   H
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADAL---H 129
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
           + H   V+H DIKP N+L+      ++ DFG +       S++      T+ Y+ PE   
Sbjct: 130 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMI- 185
Query: 801 EGQISTEG-DVYSFGIMLMEIFTRKRPTD 828
           EG+   E  D++  G++  E      P D
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------------YSDNSN 719
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L   L               ++    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L     ++    +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    ++         + K +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N  + ED   ++GDFG+ + +   D   K  
Sbjct: 129 QMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 123
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T+   T+ Y+ PE 
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEM 177
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG AKLL  +E   H +     I +MA E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      M VAIK   +   +   E F  E   +R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 129 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG AKLL  +E   H +     I +MA E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++GSG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG AKLL  +E   H +     I +MA E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE 780
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 781 SMKHTQT-LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             K+T      + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      M VAIK   +   +   E F  E   +R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 129 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R      + A+KV F  QLE  G       E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 150
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE  
Sbjct: 151 HSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMI 204
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 205 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    +++ Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 71
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNL---------DIFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    +          + K +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 132 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA-LESFNAECEVLRSIR 680
           Q    + +   +G+G FG V R    D G +VAIK    +L     E +  E ++++ + 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 681 HRNLVRI------ISSCTNDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDI 732
           H N+V        +     +D   L ++Y   G L   L  + +   L       ++ DI
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLA 789
           + AL YLH    N ++H D+KP N++L    + ++ ++ D G AK L  D+    T+ + 
Sbjct: 132 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVG 186
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T+ Y+APE   + + +   D +SFG +  E  T  RP
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRI 687
           +G G FG V    +       G  VA+K         L S +  E E+LR++ H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 688 ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              C +   K+  LV++Y+P GSL    Y     + + + L     I   + YLH  H  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH-- 132
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMK-HTQTLATIGYMAPEYGREGQ 803
             +H  +   NVLLD D + ++GDFG+AK +  G E  +      + + + APE  +E +
Sbjct: 133 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 804 ISTEGDVYSFGIMLMEIFT 822
                DV+SFG+ L E+ T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA-LESFNAECEVLRSIR 680
           Q    + +   +G+G FG V R    D G +VAIK    +L     E +  E ++++ + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 681 HRNLVRI------ISSCTNDDFKALVLDYMPKGSLEACL--YSDNSNLDIFKRLNIVIDI 732
           H N+V        +     +D   L ++Y   G L   L  + +   L       ++ DI
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLA 789
           + AL YLH    N ++H D+KP N++L    + ++ ++ D G AK L  D+    T+ + 
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVG 185
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T+ Y+APE   + + +   D +SFG +  E  T  RP
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS +       + + T  Y++PE   
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 205 EKSACKSSDLWALGCIIYQL 224

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL------------EACL---YSDNSN 719
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L            E C    ++    
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L     ++    +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVY--------RGRFLDGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V         + +  + + VA+K+      E  L    +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-----NLDI-------- 722
           + I +H+N++ ++ +CT D    +++ Y  KG+L   L +        + DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 723 -FKRL-NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG-D 779
            FK L +    +A  +EYL        +H D+   NVL+ E+ V ++ DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
              K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 127
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 128 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 186 EKSACKSSDLWALGCIIYQL 205

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS +       + + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 209 EKSACKSSDLWALGCIIYQL 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 124
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 183 EKSACKSSDLWALGCIIYQL 202

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 624 ATDQFNVNNLIGSGSFGSVY----RGRFLDGME--VAIKVFH--LQLEGALESFNAECEV 675
           A ++  ++  +G GSFG VY    +G   D  E  VAIK  +    +   +E  N E  V
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASV 81
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNL---------DIFKRL 726
           ++     ++VR++   +      ++++ M +G L++ L S    +          + K +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHT 785
            +  +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  
Sbjct: 142 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + L  + +M+PE  ++G  +T  DV+SFG++L EI T
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRI 687
           +G G FG V    +       G  VA+K         L S +  E E+LR++ H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 688 ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              C +   K+  LV++Y+P GSL    Y     + + + L     I   + YLH  H  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH-- 131
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMK-HTQTLATIGYMAPEYGREGQ 803
             +H  +   NVLLD D + ++GDFG+AK +  G E  +      + + + APE  +E +
Sbjct: 132 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 804 ISTEGDVYSFGIMLMEIFT 822
                DV+SFG+ L E+ T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 126
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 127 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 185 EKSACKSSDLWALGCIIYQL 204

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVFH---LQLEGALESFNAECEVLRSI 679
           QF +  ++G GSFG V+  + + G +     A+KV     L++   + +   E ++L  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALAL 736
            H  +V++  +   +    L+LD++  G L    ++  S   +F   ++   + ++ALAL
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           ++LH  G    +++ D+KP N+LLDE+   +L DFG++K  S D   K      T+ YMA
Sbjct: 140 DHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 796 PE-YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE   R G   +  D +SFG+++ E+ T   P
Sbjct: 195 PEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLP 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVFH---LQLEGALESFNAECEVLRSI 679
           QF +  ++G GSFG V+  + + G +     A+KV     L++   + +   E ++L  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALAL 736
            H  +V++  +   +    L+LD++  G L    ++  S   +F   ++   + ++ALAL
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           ++LH  G    +++ D+KP N+LLDE+   +L DFG++K  S D   K      T+ YMA
Sbjct: 140 DHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 796 PE-YGREGQISTEGDVYSFGIMLMEIFT 822
           PE   R G   +  D +SFG+++ E+ T
Sbjct: 195 PEVVNRRGHTQS-ADWWSFGVLMFEMLT 221

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 125
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 184 EKSACKSSDLWALGCIIYQL 203

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVFH---LQLEGALESFNAECEVLRSI 679
           QF +  ++G GSFG V+  + + G +     A+KV     L++   + +   E ++L  +
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 84
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALAL 736
            H  +V++  +   +    L+LD++  G L    ++  S   +F   ++   + ++ALAL
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           ++LH  G    +++ D+KP N+LLDE+   +L DFG++K  S D   K      T+ YMA
Sbjct: 141 DHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 195
Query: 796 PE-YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE   R G   +  D +SFG+++ E+ T   P
Sbjct: 196 PEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLP 226

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 128
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEM 182
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 123
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEM 177
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 65
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEM 178
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++ SG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           D F++   +G G FG+VY  R     F+  ++V  K   L+ EG       E E+   +R
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEKEGVEHQLRREIEIQSHLR 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++R+ +   +     L+L++ P+G L   L   +   D  +    + ++A AL   H
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADAL---H 128
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
           + H   V+H DIKP N+L+      ++ DFG +       S++      T+ Y+ PE   
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMI- 184
Query: 801 EGQISTEG-DVYSFGIMLMEIFTRKRPTD 828
           EG+   E  D++  G++  E      P D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGAL-----ESFNAECEVLRSIR 680
           +F    ++ SG+FG+VY+G ++ +G +V I V   +L  A      +    E  V+ S+ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGYMAPEYG 799
                 +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 800 REGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEMS 836
                + + DV+S+G+ + E+ T   +P D I + E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 616 FSYQELLQATDQF---------NVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-Q 661
           F++++  QA  +F          +  +IG G FG V  GR  + G     VAIK      
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 662 LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD 721
            +     F +E  ++    H N++ +    T      ++ +YM  GSL+A L  ++    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
           + + + ++  I   ++YL        VH D+   N+L++ ++V ++ DFG++++L  D  
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 782 MKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
             +T       I + APE     + ++  DV+S+GI++ E+ +  +RP
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-LATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS +         + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH- 131
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 190 EKSACKSSDLWALGCIIYQL 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 205 EKSACKSSDLWALGCIIYQL 224

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 123
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEM 177
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME---------VAIKVFHLQL-EGALESFNAECEV 675
           D+  +   +G G+FG V     + G++         VA+K+      E  L    +E E+
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAI-GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL------------EACL---YSDNSN 719
           ++ I +H+N++ ++ +CT D    ++++Y  KG+L            E C    ++    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG- 778
           L     ++    +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 211 EKSACKSSDLWALGCIIYQL 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 209 EKSACKSSDLWALGCIIYQL 228

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 68
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 127
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 181
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 180
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 63
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 122
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 123 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 176
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 177 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 61
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 120
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 174
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 175 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 180
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 123
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 177
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 208 EKSAXKSSDLWALGCIIYQL 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 632 NLIGSGSFGSVYRGRFLDGME-----VAIKVFHLQLEGALESFNAECE---VLRSIRHRN 683
            ++GSG FG+V++G ++   E     V IKV  ++ +   +SF A  +    + S+ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +VR++  C     + LV  Y+P GSL   +      L     LN  + IA  + YL    
Sbjct: 77  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLATIGYMAPEYGREG 802
            + +VH ++   NVLL      ++ DFG+A LL   D+ + +++    I +MA E    G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + + + DV+S+G+ + E+ T
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 8/207 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRS 678
           L + + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H N+V+++     ++   LV +++   S++   + D S L       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L F H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE 
Sbjct: 119 LAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEI 177
Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRK 824
               +  ST  D++S G +  E+ TR+
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 65
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ PE 
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEM 178
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 632 NLIGSGSFGSVYRGRFLDGME-----VAIKVFHLQLEGALESFNAECE---VLRSIRHRN 683
            ++GSG FG+V++G ++   E     V IKV  ++ +   +SF A  +    + S+ H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +VR++  C     + LV  Y+P GSL   +      L     LN  + IA  + YL    
Sbjct: 95  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 150
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLATIGYMAPEYGREG 802
            + +VH ++   NVLL      ++ DFG+A LL   D+ + +++    I +MA E    G
Sbjct: 151 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + + + DV+S+G+ + E+ T
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 634 IGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGALE---SFNAECEVLRSIRHRNLVRI 687
           +G G FG V    +    DG    + V  L+ +   +    +  E ++LR++ H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 688 ISSCTNDDFKAL--VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              C +    +L  V++Y+P GSL    Y    ++ + + L     I   + YLH  H  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 154
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMK-HTQTLATIGYMAPEYGREGQ 803
             +H D+   NVLLD D + ++GDFG+AK +  G E  +      + + + APE  +E +
Sbjct: 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 804 ISTEGDVYSFGIMLMEIFTR 823
                DV+SFG+ L E+ T 
Sbjct: 214 FYYASDVWSFGVTLYELLTH 233

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQLEGAL---ESFNAECEVLRS 678
           A +   +N ++G G FG VY G + +  G ++ + V   + +  L   E F +E  ++++
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H ++V++I     ++   ++++  P G L   L  + ++L +   +   + I  A+ Y
Sbjct: 82  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L   +    VH DI   N+L+      +LGDFG+++ +  ++  K + T   I +M+PE 
Sbjct: 141 LESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 799 GREGQISTEGDVYSFGIMLMEIFT 822
               + +T  DV+ F + + EI +
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILS 221

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRH 681
           TD++ +   +G G+F  V R  +   G E A K+ + +   A   +    E  + R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S + + F  LV D +  G     L+ D    + +   +    I   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H N +VH D+KP N+LL    +    +L DFG+A  + GD+         T GY++PE 
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG-FAGTPGYLSPEV 177
Query: 799 GREGQISTEGDVYSFGIML 817
            R+       D+++ G++L
Sbjct: 178 LRKDPYGKPVDMWACGVIL 196

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV-FHLQLE--GALESFNAECEVLRSI 679
           A + F +   +G G FG+VY  R  +   + A+KV F  QLE  G       E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE  
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEM- 177
Query: 800 REGQISTEG-DVYSFGIMLMEIFTRKRP 826
            EG++  E  D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 630 VNNLIGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +  ++G G FGSV  G  +  DG  + + V  ++L+ +    +E F +E   ++   H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 684 LVRIISSCTNDDFKAL-----VLDYMPKGSLEA-CLYSD----NSNLDIFKRLNIVIDIA 733
           ++R++  C     + +     +L +M  G L    LYS       ++ +   L  ++DIA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIG 792
           L +EYL   +    +H D+   N +L +DM   + DFG++ K+ SGD   +       + 
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
           ++A E   +   +++ DV++FG+ + EI TR
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGA--LESFNAECEVLRSIRH 681
           +D ++V   +G G+F  V R      G+E A K+ + +   A   +    E  + R ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S   + F  LV D +  G     L+ D    + +   +    I   LE + +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H N +VH ++KP N+LL    +    +L DFG+A  ++  E+        T GY++PE 
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFAGTPGYLSPEV 201
Query: 799 GREGQISTEGDVYSFGIML 817
            ++   S   D+++ G++L
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 8/207 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRS 678
           L + + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H N+V+++     ++   LV +++   S++   + D S L       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L F H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE 
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEI 177
Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRK 824
               +  ST  D++S G +  E+ TR+
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK   +   +   E F  E   +R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 129 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRI 687
           +G G FG V    +       G  VA+K           S +  E ++LR++ H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 688 ISSCTNDDFKAL--VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              C +   K+L  V++Y+P GSL    Y    ++ + + L     I   + YLH  H  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 137
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMK-HTQTLATIGYMAPEYGREGQ 803
             +H ++   NVLLD D + ++GDFG+AK +  G E  +      + + + APE  +E +
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 804 ISTEGDVYSFGIMLMEIFT 822
                DV+SFG+ L E+ T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK   +   +   E F  E   +R   
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 98  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 157 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 214 FRRFTSASDVWMFGVCMWEIL 234

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++   S++   + D S L       I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G++G VY+ +   G  VA+K   L  E  G   +   E  +L+ + H N+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            ++    LV ++M K  L+  L  + + L   +   I I +   L  +   H + ++H D
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY-GREGQISTEGDV 810
           +KP N+L++ D   +L DFG+A+   G     +T  + T+ Y AP+      + ST  D+
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203
Query: 811 YSFGIMLMEIFTRK 824
           +S G +  E+ T K
Sbjct: 204 WSIGCIFAEMITGK 217

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 8/207 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRS 678
           L + + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H N+V+++     ++   LV +++   S++   + D S L       I   +   L+ 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L F H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE 
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEI 176
Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRK 824
               +  ST  D++S G +  E+ TR+
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 112/230 (48%), Gaps = 22/230 (9%)
Query: 616 FSYQELLQATDQF---------NVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-Q 661
           F++++  +A  +F          +  +IG+G FG V  G   L G     VAIK      
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 662 LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD 721
            E     F +E  ++    H N++ +    T      ++ ++M  GSL++ L  ++    
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
           + + + ++  IA  ++YL   +    VH D+   N+L++ ++V ++ DFG+++ L  D S
Sbjct: 134 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 190
Query: 782 -MKHTQTLA---TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
              +T  L     I + APE  +  + ++  DV+S+GI++ E+ +  +RP
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      M VAIK   +   +   E F  E   +R   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 801 EGQISTEGDVYSFGIMLMEI 820
             + ++  DV+ FG+ + EI
Sbjct: 566 FRRFTSASDVWMFGVCMWEI 585

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVRI 687
           +G G FG V    +       G  VA+K           S +  E ++LR++ H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 688 ISSCTNDDFKAL--VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
              C +   K+L  V++Y+P GSL    Y    ++ + + L     I   + YLH  H  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHSQH-- 137
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMK-HTQTLATIGYMAPEYGREGQ 803
             +H ++   NVLLD D + ++GDFG+AK +  G E  +      + + + APE  +E +
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 804 ISTEGDVYSFGIMLMEIFT 822
                DV+SFG+ L E+ T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GR 800
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE   G 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 801 EGQISTEGDVYSFGIMLMEIFTRK 824
           +   ST  D++S G +  E+ TR+
Sbjct: 186 K-YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRH 681
           TD++ +   +G G+F  V R  +   G E A K+ + +   A   +    E  + R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S + + F  LV D +  G     L+ D    + +   +    I   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H N +VH D+KP N+LL    +    +L DFG+A  + GD+         T GY++PE 
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG-FAGTPGYLSPEV 177
Query: 799 GREGQISTEGDVYSFGIML 817
            R+       D+++ G++L
Sbjct: 178 LRKDPYGKPVDMWACGVIL 196

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GR 800
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE   G 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 801 EGQISTEGDVYSFGIMLMEIFTRK 824
           +   ST  D++S G +  E+ TR+
Sbjct: 179 K-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           +G G++G VY+ +   G  VA+K   L  + EG   +   E  +L+ + H N+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            ++    LV ++M K  L+  L  + + L   +   I I +   L  +   H + ++H D
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY-GREGQISTEGDV 810
           +KP N+L++ D   +L DFG+A+   G     +T  + T+ Y AP+      + ST  D+
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203
Query: 811 YSFGIMLMEIFTRK 824
           +S G +  E+ T K
Sbjct: 204 WSIGCIFAEMITGK 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/234 (33%), Positives = 116/234 (49%), Gaps = 40/234 (17%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESF-NAECEVLRSIRHRNLV 685
           +    +IG+GSFG VY+ +  D  E VAIK     L+G  ++F N E +++R + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 686 RI----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----- 734
           R+     SS    D  +  LVLDY+P     A +Y    +    K+   VI + L     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP-----ATVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 735 --ALEYLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLAT 790
             +L Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICS 185
Query: 791 IGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
             Y APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 186 RYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK   +   +   E F  E   +R   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 75  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 134 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG--------MEVAIKVFHLQLEGALESFNAECEVLR 677
           + F +  ++G+G++G V+  R + G        M+V  K   +Q     E    E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 678 SIRHRNLVRIISSCTNDDFK-ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIA 733
            IR    +  +      + K  L+LDY+  G L    ++  S  + F    + I   +I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIV 169
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           LALE+LH      +++ DIK  N+LLD +    L DFG++K    DE+ +      TI Y
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 794 MAPEYGREGQISTEG--DVYSFGIMLMEIFTRKRP 826
           MAP+  R G    +   D +S G+++ E+ T   P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++     +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 213 EKSACKSSDLWALGCIIYQL 232

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK   +   +   E F  E   +R   
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 73  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 132 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +    R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              V++  +  +D+     L Y   G L   +    S  +   R     +I  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLATIGYMAPEYGR 800
                ++H D+KP N+LL+EDM  ++ DFG AK+LS + +  +    + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 801 EGQISTEGDVYSFGIMLMEI 820
           E       D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRH 681
           TD++ +   IG G+F  V R  +   G E A K+ + +   A   +    E  + R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S + + F  LV D +  G     L+ D    + +   +    I   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 742 GHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H   VVH D+KP N+LL    +    +L DFG+A  + GD+         T GY++PE 
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG-FAGTPGYLSPEV 177
Query: 799 GREGQISTEGDVYSFGIML 817
            R+       D+++ G++L
Sbjct: 178 LRKEAYGKPVDIWACGVIL 196

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      M VAIK   +   +   E F  E   +R   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+      +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 509 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 801 EGQISTEGDVYSFGIMLMEI 820
             + ++  DV+ FG+ + EI
Sbjct: 566 FRRFTSASDVWMFGVCMWEI 585

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 179
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           + F++   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   +R
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHLR 70
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y H
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCH 129
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 V+H DIKP N+LL  +   ++ DFG +       S + T    T+ Y+ PE   
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM-I 182
Query: 801 EGQISTEG-DVYSFGIMLMEIFTRKRP 826
           EG++  E  D++S G++  E      P
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQ-LEGALESFNAECEVLRSI 679
           + ++ QF     +G+G++ +VY+G     G+ VA+K   L   EG   +   E  +++ +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALAL 736
           +H N+VR+      ++   LV ++M     +   Y D+  +    R   LN+V      L
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 737 -EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
            + L F H N ++H D+KP N+L+++    +LGDFG+A+   G      +  + T+ Y A
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVVTLWYRA 176
Query: 796 PEYGREGQI-STEGDVYSFGIMLMEIFTRK 824
           P+     +  ST  D++S G +L E+ T K
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV--R 686
           +G G+FGSV   R+       G  VA+K            F  E ++L+++    +V  R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
            +S         LV++Y+P G L   L    + LD  + L     I   +EYL       
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 131
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKL--LSGDESMKHTQTLATIGYMAPEYGREGQI 804
            VH D+   N+L++ +   ++ DFG+AKL  L  D  +      + I + APE   +   
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 805 STEGDVYSFGIMLMEIFT 822
           S + DV+SFG++L E+FT
Sbjct: 192 SRQSDVWSFGVVLYELFT 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 185
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRS--IRHRN 683
           D   +  LIG G +G+VY+G  LD   VA+KVF        ++F  E  + R   + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDN 68
Query: 684 LVRII---SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + R I      T D      LV++Y P GSL   L    S  D      +   +   L Y
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAY 126
Query: 739 LHF-----GHPNPVV-HCDIKPSNVLLDEDMVARLGDFGIAKLLS-------GDESMKHT 785
           LH       H  P + H D+   NVL+  D    + DFG++  L+       G+E     
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 786 QTLATIGYMAPEYGREGQIS--------TEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
             + TI YMAPE   EG ++         + D+Y+ G++  EIF R     ++F GE
Sbjct: 187 SEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 66
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 125
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ +FG +       S + T    T+ Y+ PE 
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEM 179
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 119/231 (51%), Gaps = 34/231 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESF-NAECEVLRSIRHRNLV 685
           +    +IG+GSFG VY+ +  D  E VAIK     L+G  ++F N E +++R + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 686 RI----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALAL 736
           R+     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRSL 135
Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGY 793
            Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYY 188
Query: 794 MAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
            APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 189 RAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ +FG +       S + T    T+ Y+ PE 
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEM 180
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME---VAIKVFHLQLEGALESF-NAEC 673
           Y + +   + F     IG GSFG V++G  +D      VAIK+  L+           E 
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEI 76
Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            VL       + +   S   D    ++++Y+  GS    L  +   LD  +   I+ +I 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 134
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             L+YLH       +H DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +
Sbjct: 135 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFW 190
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           MAPE  ++    ++ D++S GI  +E+   + P  E+
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE 
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEM 180
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 123
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE 
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEM 177
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV--R 686
           +G G+FGSV   R+       G  VA+K            F  E ++L+++    +V  R
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
            +S         LV++Y+P G L   L    + LD  + L     I   +EYL       
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            VH D+   N+L++ +   ++ DFG+AKLL  D+     +    + I + APE   +   
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 805 STEGDVYSFGIMLMEIFT 822
           S + DV+SFG++L E+FT
Sbjct: 195 SRQSDVWSFGVVLYELFT 212

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 66
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 125
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE 
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEM 179
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA--ECEVLRS 678
            Q+ +++    L+G GS+G V + R  D G  VAIK F    +  +    A  E ++L+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH NLV ++  C       LV +++           D++ LD  +     +D  +  +Y
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-----------DHTILDDLELFPNGLDYQVVQKY 129
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           L        F H + ++H DIKP N+L+ +  V +L DFG A+ L+    + +   +AT 
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YDDEVATR 188
Query: 792 GYMAPE-------YGREGQISTEGDVYSFGIMLMEIF 821
            Y APE       YG+        DV++ G ++ E+F
Sbjct: 189 WYRAPELLVGDVKYGK------AVDVWAIGCLVTEMF 219

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE 
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEM 180
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 123
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE 
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEM 177
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKV--FHLQLEGALESFNAECEVLRSIRHR 682
           + + V   IG+GS+G   +  R  DG  +  K   +    E   +   +E  +LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 683 NLVRIISSCTNDDFKAL--VLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALE 737
           N+VR      +     L  V++Y   G L + +     +   LD    L ++  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 738 YLHF----GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             H     GH   V+H D+KP+NV LD     +LGDFG+A++L+ D S   T  + T  Y
Sbjct: 126 ECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYY 182
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           M+PE       + + D++S G +L E+     P       E++ K
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 65
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +  +    S + T    T+ Y+ PE 
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT-LCGTLDYLPPEM 178
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGA--LESFNAECEVLRSIRH 681
           +D ++V   +G G+F  V R      G+E A K+ + +   A   +    E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S   + F  LV D +  G     L+ D    + +   +    I   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H N +VH ++KP N+LL    +    +L DFG+A  ++  E+        T GY++PE 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFAGTPGYLSPEV 178
Query: 799 GREGQISTEGDVYSFGIML 817
            ++   S   D+++ G++L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           A + F +   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +RH N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H      V+H DIKP N+LL      ++ DFG +       S +      T+ Y+ PE 
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEM 180
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRP 826
             EG++  E  D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKV--FHLQLEGALESFNAECEVLRSIRHR 682
           + + V   IG+GS+G   +  R  DG  +  K   +    E   +   +E  +LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 683 NLVRIISSCTNDDFKAL--VLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALE 737
           N+VR      +     L  V++Y   G L + +     +   LD    L ++  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 738 YLHF----GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             H     GH   V+H D+KP+NV LD     +LGDFG+A++L+ DE     + + T  Y
Sbjct: 126 ECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYY 182
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           M+PE       + + D++S G +L E+     P       E++ K
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 119/231 (51%), Gaps = 34/231 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESF-NAECEVLRSIRHRNLV 685
           +    +IG+GSFG VY+ +  D  E VAIK     L+G  ++F N E +++R + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 686 RI----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALAL 736
           R+     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRSL 135
Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGY 793
            Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYY 188
Query: 794 MAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
            APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 189 RAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL------ 736
           N+V+++     ++   LV +++            + +L  F   + +  I L L      
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV------------HQDLKTFMDASALTGIPLPLIKSYLF 109
Query: 737 ---EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
              + L F H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 168
Query: 794 MAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRK 824
            APE     +  ST  D++S G +  E+ TR+
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV--R 686
           +G G+FGSV   R+       G  VA+K            F  E ++L+++    +V  R
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
            +S         LV++Y+P G L   L    + LD  + L     I   +EYL       
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQI 804
            VH D+   N+L++ +   ++ DFG+AKLL  D+   +      + I + APE   +   
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 805 STEGDVYSFGIMLMEIFT 822
           S + DV+SFG++L E+FT
Sbjct: 196 SRQSDVWSFGVVLYELFT 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 18/233 (7%)
Query: 602 SNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME---VAIKVF 658
           S +Q+ +P +   +   +EL    ++      IG GSFG V++G  +D      VAIK+ 
Sbjct: 4   SPVQSGLPGMQNLKADPEELFTKLEK------IGKGSFGEVFKG--IDNRTQKVVAIKII 55
Query: 659 HLQLEGALESF-NAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN 717
            L+           E  VL       + +   S   D    ++++Y+  GS    L  + 
Sbjct: 56  DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EP 113
Query: 718 SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS 777
             LD  +   I+ +I   L+YLH       +H DIK +NVLL E    +L DFG+A  L+
Sbjct: 114 GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
            D  +K    + T  +MAPE  ++    ++ D++S GI  +E+   + P  E+
Sbjct: 171 -DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 634 IGSGSFGSVYRGRFLD-----GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV--R 686
           +G G+FGSV   R+       G  VA+K            F  E ++L+++    +V  R
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
            +S         LV++Y+P G L   L    + LD  + L     I   +EYL       
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGYMAPEYGREGQI 804
            VH D+   N+L++ +   ++ DFG+AKLL  D+     +    + I + APE   +   
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 805 STEGDVYSFGIMLMEIFT 822
           S + DV+SFG++L E+FT
Sbjct: 208 SRQSDVWSFGVVLYELFT 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLDGME---VAIKVFHLQLEGALESF-NAECEVLR 677
           L   + F     IG GSFG V++G  +D      VAIK+  L+           E  VL 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
                 + +   S   D    ++++Y+  GS    L  +   LD  +   I+ +I   L+
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLD 118
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           YLH       +H DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE
Sbjct: 119 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPE 174
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
             ++    ++ D++S GI  +E+   + P  E+
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-QLEGALESFNAECEVLRSIRHR 682
             +  +IG G FG V  GR  + G     VAIK       +     F +E  ++    H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N++ +    T      ++ +YM  GSL+A L  ++    + + + ++  I   ++YL   
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS-- 127
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGR 800
                VH D+   N+L++ ++V ++ DFG++++L  D    +T       I + APE   
Sbjct: 128 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
             + ++  DV+S+GI++ E+ +  +RP
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQLEGAL---ESFNAECEVLRS 678
           A +   +N ++G G FG VY G + +  G ++ + V   + +  L   E F +E  ++++
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H ++V++I     ++   ++++  P G L   L  + ++L +   +   + I  A+ Y
Sbjct: 66  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L   +    VH DI   N+L+      +LGDFG+++ +  ++  K + T   I +M+PE 
Sbjct: 125 LESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 799 GREGQISTEGDVYSFGIMLMEIFT 822
               + +T  DV+ F + + EI +
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFLD--GMEVAIKVFHLQLEGAL---ESFNAECEVLRS 678
           A +   +N ++G G FG VY G + +  G ++ + V   + +  L   E F +E  ++++
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H ++V++I     ++   ++++  P G L   L  + ++L +   +   + I  A+ Y
Sbjct: 70  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L   +    VH DI   N+L+      +LGDFG+++ +  ++  K + T   I +M+PE 
Sbjct: 129 LESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 799 GREGQISTEGDVYSFGIMLMEIFT 822
               + +T  DV+ F + + EI +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-QLEGALESFNAECEVLRSIRHR 682
             +  +IG G FG V  GR  + G     VAIK       +     F +E  ++    H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N++ +    T      ++ +YM  GSL+A L  ++    + + + ++  I   ++YL   
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS-- 133
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGR 800
                VH D+   N+L++ ++V ++ DFG++++L  D    +T       I + APE   
Sbjct: 134 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
             + ++  DV+S+GI++ E+ +  +RP
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLDGME---VAIKVFHLQLEGALESF-NAECEVLR 677
           L   + F     IG GSFG V++G  +D      VAIK+  L+           E  VL 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
                 + +   S   D    ++++Y+  GS    L  +   LD  +   I+ +I   L+
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLD 118
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           YLH       +H DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE
Sbjct: 119 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPE 174
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
             ++    ++ D++S GI  +E+   + P  E+
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 83
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH D+   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 83
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH D+   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 80
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH D+   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQ--LEGALESFNAECEVLR--- 677
           AT ++     IG G++G+VY+ R    G  VA+K   +    EG   S   E  +LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 678 SIRHRNLVRIISSC----TNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
           +  H N+VR++  C    T+ + K  LV +++ +   +   Y D +         I   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLM 118
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              L  L F H N +VH D+KP N+L+      +L DFG+A++ S    M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALAPVVVTLW 176
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
           Y APE   +   +T  D++S G +  E+F RK
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L   D + +   +G G+FG VY+ +  +  +  A KV   + E  LE +  E ++L S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N+V+++ +   ++   +++++   G+++A +      L       I +     L+ L+
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL---TESQIQVVCKQTLDALN 149
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-------LATIGY 793
           + H N ++H D+K  N+L   D   +L DFG+        S K+T+T       + T  +
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYW 201
Query: 794 MAPEY-----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           MAPE       ++     + DV+S GI L+E+   + P  E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 629 NVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
            +  +IG+G FG V RGR    G +   VAIK       E     F +E  ++    H N
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++R+    TN     ++ ++M  G+L++ L  ++    + + + ++  IA  + YL    
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---A 133
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLA---TIGYMAPEYG 799
               VH D+   N+L++ ++V ++ DFG+++ L  + S   +T +L     I + APE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + ++  D +S+GI++ E+ +
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGA--LESFNAECEVLRSIRH 681
           +D ++V   +G G+F  V R      G+E A K+ + +   A   +    E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S   + F  LV D +  G     L+ D    + +   +    I   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H N +VH ++KP N+LL    +    +L DFG+A  ++  E+        T GY++PE 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 799 GREGQISTEGDVYSFGIML 817
            ++   S   D+++ G++L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGA--LESFNAECEVLRSIRH 681
           +D ++V   +G G+F  V R      G+E A K+ + +   A   +    E  + R ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S   + F  LV D +  G     L+ D    + +   +    I   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H N +VH ++KP N+LL    +    +L DFG+A  ++  E+        T GY++PE 
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 177
Query: 799 GREGQISTEGDVYSFGIML 817
            ++   S   D+++ G++L
Sbjct: 178 LKKDPYSKPVDIWACGVIL 196

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 8/207 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRS 678
           L + + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L F H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE 
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEI 178
Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRK 824
               +  ST  D++S G +  E+ TR+
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 628 FNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           F    LIGSG FG V++ +  +DG    I+      E A      E + L  + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVH 69
Query: 687 IISSCTNDDFKALVLD-------YMPKGSLEA------CLY-----SDNSNLD--IFKRL 726
                   D+     D       Y P+ S  +      CL+      D   L+  I KR 
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 727 NIVIDIALALEYLH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD 779
              +D  LALE          + H   ++H D+KPSN+ L +    ++GDFG+   L  D
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 189
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEI 820
              K T++  T+ YM+PE         E D+Y+ G++L E+
Sbjct: 190 --GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DG--MEVAIK-VFHLQLEG 664
           P++ W    +Q            ++IG G+FG V + R   DG  M+ AIK +     + 
Sbjct: 20  PVLDWNDIKFQ------------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 67
Query: 665 ALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLE------------- 710
               F  E EVL  +  H N++ ++ +C +  +  L ++Y P G+L              
Sbjct: 68  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 127
Query: 711 --ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG 768
             A   S  S L   + L+   D+A  ++YL        +H D+   N+L+ E+ VA++ 
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 184
Query: 769 DFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           DFG+++   G E  +K T     + +MA E       +T  DV+S+G++L EI +
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DG--MEVAIK-VFHLQLEG 664
           P++ W    +Q            ++IG G+FG V + R   DG  M+ AIK +     + 
Sbjct: 10  PVLDWNDIKFQ------------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 57
Query: 665 ALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLE------------- 710
               F  E EVL  +  H N++ ++ +C +  +  L ++Y P G+L              
Sbjct: 58  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 117
Query: 711 --ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG 768
             A   S  S L   + L+   D+A  ++YL        +H D+   N+L+ E+ VA++ 
Sbjct: 118 AFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 174
Query: 769 DFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           DFG+++   G E  +K T     + +MA E       +T  DV+S+G++L EI +
Sbjct: 175 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 8/207 (3%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRS 678
           L + + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L F H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE 
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEI 177
Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRK 824
               +  ST  D++S G +  E+ TR+
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSV-YRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G +VA+K   L+ +   E    E  ++R   H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +      + + +  AL YLH      V+H DI
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLSVLRALSYLH---NQGVIHRDI 167
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  K    + T  +MAPE        TE D++S
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWS 226
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  L+  R + DSLP  + +
Sbjct: 227 LGIMVIEMIDGEPP----YFNEPPLQAMRRIRDSLPPRVKD 263

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
            ++G G FG   +    +  EV +    ++  E    +F  E +V+R + H N+++ I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              D     + +Y+  G+L   + S +S     +R++   DIA  + YLH  +   ++H 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHR 132
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESM-------------KHTQTLATIGYMAPE 797
           D+   N L+ E+    + DFG+A+L+  +++              K    +    +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTR 823
                    + DV+SFGI+L EI  R
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQ--LEGALESFNAECEVLR--- 677
           AT ++     IG G++G+VY+ R    G  VA+K   +    EG   S   E  +LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 678 SIRHRNLVRIISSC----TNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
           +  H N+VR++  C    T+ + K  LV +++ +   +   Y D +         I   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLM 118
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              L  L F H N +VH D+KP N+L+      +L DFG+A++ S    M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALDPVVVTLW 176
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
           Y APE   +   +T  D++S G +  E+F RK
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 629 NVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
            +  +IG+G FG V RGR    G +   VAIK       E     F +E  ++    H N
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++R+    TN     ++ ++M  G+L++ L  ++    + + + ++  IA  + YL    
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---A 135
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLA---TIGYMAPEYG 799
               VH D+   N+L++ ++V ++ DFG+++ L  + S    T +L     I + APE  
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
              + ++  D +S+GI++ E+ +
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 83
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH D+   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 82
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH D+   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK   +   +   E F  E   +R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 67  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK   +   +   E F  E   +R   
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 72  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 131 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQ--LEGALESFNAECEVLR--- 677
           AT ++     IG G++G+VY+ R    G  VA+K   +    EG   S   E  +LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 678 SIRHRNLVRIISSC----TNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDI 732
           +  H N+VR++  C    T+ + K  LV +++ +   +   Y D +         I   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLM 118
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              L  L F H N +VH D+KP N+L+      +L DFG+A++ S    M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALFPVVVTLW 176
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
           Y APE   +   +T  D++S G +  E+F RK
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALE---SFNAECEVLRSIRHR 682
            + + + +G G+FG V  G+  L G +VA+K+ + Q   +L+       E + L+  RH 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +++++    +      +V++Y+  G L   +   N  LD  +   +   I   ++Y H  
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHR- 134
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GR 800
             + VVH D+KP NVLLD  M A++ DFG++ ++S  E ++   +  +  Y APE   GR
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--XSCGSPNYAAPEVISGR 190
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
                 E D++S G++L  +     P D+
Sbjct: 191 -LYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVF-HLQLEGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      M VAIK   +   +   E F  E   +R   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T +    ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+      +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 129 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 801 EGQISTEGDVYSFGIMLMEIF 821
             + ++  DV+ FG+ + EI 
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           + F++   +G G FG+VY  R     F+  ++V  K   L+  G       E E+   +R
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHLR 70
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y H
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCH 129
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 V+H DIKP N+LL  +   ++ DFG +  +    S + T    T+ Y+ PE   
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT-LCGTLDYLPPEM-I 182
Query: 801 EGQISTEG-DVYSFGIMLMEIFTRKRP 826
           EG++  E  D++S G++  E      P
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 117/234 (50%), Gaps = 40/234 (17%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK   LQ +      N E +++R + H N+VR
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK---RFKNRELQIMRKLDHCNIVR 115
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL------ 734
           +     SS    D  +  LVLDY+P+      +Y    +    K+   VI + L      
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPE-----TVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 735 -ALEYLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLAT 790
            +L Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +
Sbjct: 171 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 223
Query: 791 IGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
             Y APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 224 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 272

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 32/230 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK   LQ +      N E +++R + H N+VR
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK---RFKNRELQIMRKLDHCNIVR 156
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 215
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y 
Sbjct: 216 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 268
Query: 795 APE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 269 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 313

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 115/230 (50%), Gaps = 32/230 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 82
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 141
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y 
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 194
Query: 795 APE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 195 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKV--FHLQLEGALESFNAECEVLRSIRHR 682
           + + V   IG+GS+G   +  R  DG  +  K   +    E   +   +E  +LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 683 NLVRIISSCTNDDFKAL--VLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALE 737
           N+VR      +     L  V++Y   G L + +     +   LD    L ++  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 738 YLHF----GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             H     GH   V+H D+KP+NV LD     +LGDFG+A++L+ D S      + T  Y
Sbjct: 126 ECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYY 182
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEI 820
           M+PE       + + D++S G +L E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 117/234 (50%), Gaps = 40/234 (17%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK   LQ +      N E +++R + H N+VR
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK---RFKNRELQIMRKLDHCNIVR 113
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL------ 734
           +     SS    D  +  LVLDY+P+      +Y    +    K+   VI + L      
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPE-----TVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 735 -ALEYLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLAT 790
            +L Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +
Sbjct: 169 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 221
Query: 791 IGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
             Y APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 222 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 270

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 115/230 (50%), Gaps = 32/230 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 105
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 164
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y 
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 217
Query: 795 APE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 218 APELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 262

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-----FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           D F +   +G G FG+VY  R     F+  ++V  K   ++ EG       E E+   + 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKS-QIEKEGVEHQLRREIEIQAHLH 81
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++R+ +   +     L+L+Y P+G L   L   +   D  +   I+ ++A AL Y H
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH 140
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 V+H DIKP N+LL      ++ DFG +       S++      T+ Y+ PE   
Sbjct: 141 G---KKVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMI- 193
Query: 801 EGQISTEG-DVYSFGIMLMEIFT 822
           EG++  E  D++  G++  E+  
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLV 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+    L  + EG   +   E  +L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+    L  + EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +T  + T+ Y APE     
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 115/230 (50%), Gaps = 32/230 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 111
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 223
Query: 795 APE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 268

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 629 NVNNLIGSGSFGSVYRGRF-LDGME---VAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
            +  +IG+G FG V  G   L G     VAIK       E     F +E  ++    H N
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++ +    T      ++ ++M  GSL++ L  ++    + + + ++  IA  ++YL   +
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLA---TIGYMAPEYG 799
               VH  +   N+L++ ++V ++ DFG+++ L  D S   +T  L     I + APE  
Sbjct: 130 ---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 800 REGQISTEGDVYSFGIMLMEIFTR-KRP 826
           +  + ++  DV+S+GI++ E+ +  +RP
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 115/230 (50%), Gaps = 32/230 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 90
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 149
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y 
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 202
Query: 795 APE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 203 APELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 247

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--------FNAE 672
           L    + ++V  +IG G+FG V   R     + + KV+ ++L    E         F  E
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRH----KASQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--IVI 730
            +++       +V++  +  +D +  +V++YMP G L   +    SN D+ ++       
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFYTA 181
Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQT-L 788
           ++ LAL+ +H      ++H D+KP N+LLD+    +L DFG    +  DE+ M H  T +
Sbjct: 182 EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAV 236
Query: 789 ATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            T  Y++PE     G +G    E D +S G+ L E+     P
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 115/230 (50%), Gaps = 32/230 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRSLA 136
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK-LLSGDESMKHTQTLATIGYM 794
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L+ G+ ++ +   + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 795 APE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           APE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 190 APELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 632 NLIGSGSFGSVYRGRFLDGME-VAIKVFHL-----QLEGALESFNAECEVLRSIRHRNLV 685
           + +G G F +VY+ R  +  + VAIK   L       +G   +   E ++L+ + H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            ++ +  +    +LV D+M +  LE  +  DNS   +    +I   + + L+ L + H +
Sbjct: 76  GLLDAFGHKSNISLVFDFM-ETDLEVII-KDNSL--VLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            ++H D+KP+N+LLDE+ V +L DFG+AK   G  +  +   + T  Y APE     ++ 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 806 TEG-DVYSFGIMLMEIFTR 823
             G D+++ G +L E+  R
Sbjct: 191 GVGVDMWAVGCILAELLLR 209

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 96
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 155
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 209
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 210 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 253

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 111
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 224
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 268

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRSLA 136
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 190
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 85
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 144
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 198
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 199 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 242

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 89
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 202
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 203 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 246

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 81
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRSLA 140
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 141 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 194
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 195 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 238

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 78
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLA 137
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 138 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 191
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 192 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 235

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL--QLEGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R  L G  VA+K   L  + EG   +   E  +L+ + H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +   + D S L       I   +   L+ L F 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H + V+H D+KP N+L++ +   +L DFG+A+   G     +   + T+ Y APE     
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 803 Q-ISTEGDVYSFGIMLMEIFTRK 824
           +  ST  D++S G +  E+ TR+
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L   D + +   +G G+FG VY+ +  +  +  A KV   + E  LE +  E ++L S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N+V+++ +   ++   +++++   G+++A +      L       I +     L+ L+
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL---TESQIQVVCKQTLDALN 149
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-------LATIGY 793
           + H N ++H D+K  N+L   D   +L DFG+        S K+T+        + T  +
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDSFIGTPYW 201
Query: 794 MAPEY-----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           MAPE       ++     + DV+S GI L+E+   + P  E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L   D + +   +G G+FG VY+ +  +  +  A KV   + E  LE +  E ++L S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N+V+++ +   ++   +++++   G+++A +      L       I +     L+ L+
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL---TESQIQVVCKQTLDALN 149
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT-------LATIGY 793
           + H N ++H D+K  N+L   D   +L DFG+        S K+T+        + T  +
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDXFIGTPYW 201
Query: 794 MAPEY-----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           MAPE       ++     + DV+S GI L+E+   + P  E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L 
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLA 136
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 190
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L +   +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRSLA 136
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 190
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 191 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           +    +IG+GSFG VY+ +  D  E VAIK    ++       N E +++R + H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 89
Query: 687 I----ISSCTNDD--FKALVLDYMPKGSLEACLYSDNSNLD---IFKRLNIVIDIALALE 737
           +     SS    D  +  LVLDY+P+       +   +      I+ +L  +  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 738 YLH-FGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E   +   + +  Y A
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 202
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           PE  +G     S+  DV+S G +L E+   +     IF G+  + + V 
Sbjct: 203 PELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 246

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALE---SFNAECEVLRSIRHR 682
            + + + +G G+FG V  G   L G +VA+K+ + Q   +L+       E + L+  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 683 NLVRI--ISSCTNDDFKALVLDYMPKGSL--EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +++++  + S   D F  +V++Y+  G L    C +     ++  +    ++    A++Y
Sbjct: 72  HIIKLYQVISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H    + VVH D+KP NVLLD  M A++ DFG++ ++S  E ++   +  +  Y APE 
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--DSCGSPNYAAPEV 181
Query: 799 --GREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
             GR      E D++S G++L  +     P D+
Sbjct: 182 ISGRL-YAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ------LEGALESFNAECEVLRSIR 680
           + +   +G GSFG V        G +VA+K+ + +      ++G +E    E   LR +R
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLR 71
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H +++++     + D   +V++Y      +  +  D  +    +R      I  A+EY H
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH 129
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
               + +VH D+KP N+LLDE +  ++ DFG++ +++    +K   +  +  Y APE   
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPEV-I 183
Query: 801 EGQIST--EGDVYSFGIMLMEIFTRKRPTDE 829
            G++    E DV+S G++L  +  R+ P D+
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 634 IGSGSFGSVYRGRFLDGME---VAIKVFHLQLEGALESF-NAECEVLRSIRHRNLVRIIS 689
           IG GSFG V++G  +D      VAIK+  L+           E  VL       + +   
Sbjct: 31  IGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
           S        ++++Y+  GS    L +     D F+   ++ +I   L+YLH       +H
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIH 143
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
            DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE  ++    ++ D
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 202
Query: 810 VYSFGIMLMEIFTRKRPTDEI 830
           ++S GI  +E+   + P  ++
Sbjct: 203 IWSLGITAIELAKGEPPNSDM 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DG--MEVAIK-VFHLQLEG 664
           P++ W    +Q            ++IG G+FG V + R   DG  M+ AIK +     + 
Sbjct: 17  PVLDWNDIKFQ------------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 64
Query: 665 ALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLE------------- 710
               F  E EVL  +  H N++ ++ +C +  +  L ++Y P G+L              
Sbjct: 65  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 124
Query: 711 --ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG 768
             A   S  S L   + L+   D+A  ++YL        +H ++   N+L+ E+ VA++ 
Sbjct: 125 AFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIA 181
Query: 769 DFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           DFG+++   G E  +K T     + +MA E       +T  DV+S+G++L EI +
Sbjct: 182 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 59/213 (27%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 627 QFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALE---SFNAECEVLRSIRHR 682
            + + + +G G+FG V  G   L G +VA+K+ + Q   +L+       E + L+  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 683 NLVRI--ISSCTNDDFKALVLDYMPKGSL--EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +++++  + S   D F  +V++Y+  G L    C +     ++  +    ++    A++Y
Sbjct: 72  HIIKLYQVISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDY 126
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H    + VVH D+KP NVLLD  M A++ DFG++ ++S  E ++   +  +  Y APE 
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--TSCGSPNYAAPEV 181
Query: 799 --GREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
             GR      E D++S G++L  +     P D+
Sbjct: 182 ISGRL-YAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ------LEGALESFNAECEVLRSIR 680
           + +   +G GSFG V        G +VA+K+ + +      ++G +E    E   LR +R
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLR 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H +++++     + D   +V++Y      +  +  D  +    +R      I  A+EY H
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH 130
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
               + +VH D+KP N+LLDE +  ++ DFG++ +++    +K   +  +  Y APE   
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPEV-I 184
Query: 801 EGQIST--EGDVYSFGIMLMEIFTRKRPTDE 829
            G++    E DV+S G++L  +  R+ P D+
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 628 FNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           F    LIGSG FG V++ +  +DG    IK      E A      E + L  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 687 IISSCTNDDFKALVLDYMPKGSLE-------ACLY-----SDNSNLD--IFKRLNIVIDI 732
             + C +        DY P+ S +        CL+      D   L+  I KR    +D 
Sbjct: 69  Y-NGCWDG------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 733 ALALEYLH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
            LALE          + H   +++ D+KPSN+ L +    ++GDFG+   L  D   K  
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRX 179
Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEI 820
           ++  T+ YM+PE         E D+Y+ G++L E+
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--------FN 670
           ++L    + + V  +IG G+FG V   R     +   KV+ ++L    E         F 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRH----KSTRKVYAMKLLSKFEMIKRSDSAFFW 122
Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--I 728
            E +++       +V++  +  +D +  +V++YMP G L   +    SN D+ ++     
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFY 178
Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             ++ LAL+ +H       +H D+KP N+LLD+    +L DFG    ++ +  ++    +
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 789 ATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            T  Y++PE     G +G    E D +S G+ L E+     P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 83
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH ++   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFH---LQLEGALESFNAECEVLRSI 679
            F +  ++G GSFG V+  R +     G   A+KV     L++   + +   E ++L  +
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADV 87
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALAL 736
            H  +V++  +   +    L+LD++  G L    ++  S   +F   ++   + ++AL L
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 737 EYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           ++LH  G    +++ D+KP N+LLDE+   +L DFG++K  + D   K      T+ YMA
Sbjct: 144 DHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMA 198
Query: 796 PE-YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE   R+G  S   D +S+G+++ E+ T   P
Sbjct: 199 PEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 624 ATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALE-----SFNAECEVLR 677
           AT ++     IG G++G+VY+ R    G  VA+K   +   G        S   E  +LR
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 678 ---SIRHRNLVRIISSC----TNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIV 729
              +  H N+VR++  C    T+ + K  LV +++ +   +   Y D +         I 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIK 123
Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA 789
             +   L  L F H N +VH D+KP N+L+      +L DFG+A++ S    M  T  + 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVV 181
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
           T+ Y APE   +   +T  D++S G +  E+F RK
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 84
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH ++   N ++  D   ++GDFG+ + +   D   K  + L  + +MA
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V   R    G +VA+K+  L+ +   E    E  ++R  +H N+V +  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             +   ++++++  G+L   +     N +      I       L+ L + H   V+H DI
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEE-----QIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S D   K    + T  +MAPE       +TE D++S
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKXLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 813 FGIMLMEIFTRKRPTDEIFSGE--MSLKRWVNDSLPISIMN 851
            GIM++E+   + P    FS     ++KR + DS P  + N
Sbjct: 227 LGIMVIEMVDGEPP---YFSDSPVQAMKR-LRDSPPPKLKN 263

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--------FN 670
           ++L    + + V  +IG G+FG V   R     +   KV+ ++L    E         F 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVR----HKSTRKVYAMKLLSKFEMIKRSDSAFFW 117
Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--I 728
            E +++       +V++  +  +D +  +V++YMP G L   +    SN D+ ++     
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFY 173
Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             ++ LAL+ +H       +H D+KP N+LLD+    +L DFG    ++ +  ++    +
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 789 ATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            T  Y++PE     G +G    E D +S G+ L E+     P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ------LEGALESFNAECEVLRSIR 680
           + +   +G GSFG V        G +VA+K+ + +      ++G +E    E   LR +R
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLR 62
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H +++++     + D   +V++Y      +  +  D  +    +R      I  A+EY H
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH 120
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
               + +VH D+KP N+LLDE +  ++ DFG++ +++    +K   +  +  Y APE   
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPEV-I 174
Query: 801 EGQIST--EGDVYSFGIMLMEIFTRKRPTDE 829
            G++    E DV+S G++L  +  R+ P D+
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ------LEGALESFNAECEVLRSIR 680
           + +   +G GSFG V        G +VA+K+ + +      ++G +E    E   LR +R
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLR 66
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H +++++     + D   +V++Y      +  +  D  +    +R      I  A+EY H
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH 124
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
               + +VH D+KP N+LLDE +  ++ DFG++ +++    +K   +  +  Y APE   
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPEV-I 178
Query: 801 EGQIST--EGDVYSFGIMLMEIFTRKRPTDE 829
            G++    E DV+S G++L  +  R+ P D+
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--------FN 670
           ++L    + + V  +IG G+FG V   R     +   KV+ ++L    E         F 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRH----KSTRKVYAMKLLSKFEMIKRSDSAFFW 122
Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--I 728
            E +++       +V++  +  +D +  +V++YMP G L   +    SN D+ ++     
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFY 178
Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             ++ LAL+ +H       +H D+KP N+LLD+    +L DFG    ++ +  ++    +
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 789 ATIGYMAPEY----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            T  Y++PE     G +G    E D +S G+ L E+     P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 634 IGSGSFGSVYRGR------FLDGMEVAIKVFHLQLEGALES-FNAECEVLRSIRHRNLVR 686
           IG G+FG V++ R      +     VA+K+   +    +++ F  E  ++    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACL------------YSDNSN-----------LDIF 723
           ++  C       L+ +YM  G L   L            +SD S            L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESM 782
           ++L I   +A  + YL        VH D+   N L+ E+MV ++ DFG+++ + S D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
                   I +M PE     + +TE DV+++G++L EIF+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 13/223 (5%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFL-DG----MEVAIKVFHLQLE-GALESFNAECE 674
           +L+ T+   V  ++GSG+FG+VY+G ++ DG    + VAIKV        A +    E  
Sbjct: 13  ILKETELRKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           V+  +    + R++  C     + LV   MP G L   +  +   L     LN  + IA 
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAK 130
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ-TLATIGY 793
            + YL       +VH D+   NVL+      ++ DFG+A+LL  DE+  H       I +
Sbjct: 131 GMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 187
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFSGEM 835
           MA E     + + + DV+S+G+ + E+ T   +P D I + E+
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 637 GSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRS--IRHRNLVRIISS---C 691
           G FG V++ + ++   VA+K+F LQ +   +S+ +E E+  +  ++H NL++ I++    
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 692 TNDDFK-ALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALALEYLHF-------- 741
           +N + +  L+  +  KGSL   L     N+  +  L ++   ++  L YLH         
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGR 800
           GH   + H D K  NVLL  D+ A L DFG+A +   G         + T  YMAPE   
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-L 197
Query: 801 EGQISTEG------DVYSFGIMLMEIFTRKRPTD 828
           EG I+ +       D+Y+ G++L E+ +R +  D
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 634 IGSGSFGSVYRGRFLDGME------VAIKVFH--LQLEGALESFNAECEVLRSIRHRNLV 685
           +G GSFG VY G   D ++      VA+K  +    L   +E  N E  V++     ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGFTCHHVV 83
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD---------IFKRLNIVIDIALAL 736
           R++   +      +V++ M  G L++ L S     +         + + + +  +IA  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLATIGYMA 795
            YL+       VH D+   N ++  D   ++GDFG+ + +       K  + L  + +MA
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           PE  ++G  +T  D++SFG++L EI +      +  S E  LK
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 637 GSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEV--LRSIRHRNLVRIISS---- 690
           G FG V++ + L+   VA+K+F +Q +   +S+  E EV  L  ++H N+++ I +    
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALALEYLHF-------G 742
            + D    L+  +  KGSL   L    +N+  +  L +I   +A  L YLH        G
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHTQTLATIGYMAPEYGRE 801
           H   + H DIK  NVLL  ++ A + DFG+A K  +G  +      + T  YMAPE   E
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LE 206
Query: 802 GQISTEG------DVYSFGIMLMEIFTRKRPTD 828
           G I+ +       D+Y+ G++L E+ +R    D
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNLV 685
           F     +G G FG V+  +  +D    AIK   L   E A E    E + L  + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 686 RIISSCTNDDFKALVLDYMPKGSL----EACLYSD-----NSNLDIFKR-----LNIVID 731
           R  ++    +    +    PK  L    + C   +     N    I +R     L+I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES---------- 781
           IA A+E+LH      ++H D+KPSN+    D V ++GDFG+   +  DE           
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 782 -MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
             +HT  + T  YM+PE       S + D++S G++L E+          FS +M   R 
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------PFSTQMERVRT 236
Query: 841 VND 843
           + D
Sbjct: 237 LTD 239

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 31/204 (15%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN---------AECEVLRSIRHRN 683
           IG GS+G V++ R  D G  VAIK F       LES +          E  +L+ ++H N
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIAL-ALEYL 739
           LV ++          LV +Y        C ++    LD ++R    ++V  I    L+ +
Sbjct: 64  LVNLLEVFRRKRRLHLVFEY--------CDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-Y 798
           +F H +  +H D+KP N+L+ +  V +L DFG A+LL+G  S  +   +AT  Y +PE  
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVATRWYRSPELL 174
Query: 799 GREGQISTEGDVYSFGIMLMEIFT 822
             + Q     DV++ G +  E+ +
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL   +    V
Sbjct: 437 GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 491
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 551
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 552 KSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL   +    V
Sbjct: 438 GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 492
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 552
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 553 KSDVWSFGVLMWEAFS 568

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--FNAECEVLRSIRHRNL 684
           Q N    +     G +++GR+  G ++ +KV  ++     +S  FN EC  LR   H N+
Sbjct: 11  QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 685 VRIISSCTNDD--FKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHF 741
           + ++ +C +       L+  +MP GSL   L+   N  +D  + +   +D+A  + +LH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
             P    H  +   +V++DEDM AR+       +     S +    +    ++APE  ++
Sbjct: 130 LEPLIPRHA-LNSRSVMIDEDMTARI------SMADVKFSFQSPGRMYAPAWVAPEALQK 182
Query: 802 GQIST---EGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
               T     D++SF ++L E+ TR+ P  ++ + E+ +K
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL   +    V
Sbjct: 93  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 147
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 207
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 208 KSDVWSFGVLMWEAFS 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGA-LESFNAECEVLRSIRHRNLVRIIS 689
           +G G+FGSV +G +      ++VAIKV     E A  E    E +++  + +  +VR+I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
            C  +    LV++    G L   L      + +     ++  +++ ++YL        VH
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQISTE 807
            D+   NVLL     A++ DFG++K L  D+S    ++     + + APE     + S+ 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 808 GDVYSFGIMLMEIFT 822
            DV+S+G+ + E  +
Sbjct: 194 SDVWSYGVTMWEALS 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL     +  V
Sbjct: 85  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 139
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 200 KSDVWSFGVLMWEAFS 215

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNL 684
           Q  +   +G G +G V+RG +  G  VA+K+F  + E   +S+  E E+  ++  RH N+
Sbjct: 38  QITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENI 93
Query: 685 VRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           +  I+S       +    L+  Y   GSL    Y   + LD    L IV+ IA  L +LH
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLH 151
Query: 741 F------GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATI 791
                  G P  + H D+K  N+L+ ++    + D G+A + S       + +   + T 
Sbjct: 152 IEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 210
Query: 792 GYMAPEYGREG-QIST-----EGDVYSFGIMLMEIFTR 823
            YMAPE   E  Q+         D+++FG++L E+  R
Sbjct: 211 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 628 FNVNNLIGSGSFGSVY--RGRFLDGMEVAIKVFHLQLEGAL---ESFNAECEVLRSIRHR 682
           F +   +G+GSFG V+  R R  +G   A+KV   ++   L   E  N E  +L  + H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            ++R+  +  +     +++DY+  G L + L       +   +     ++ LALEYLH  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH-- 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGRE 801
               +++ D+KP N+LLD++   ++ DFG AK +        T  L  T  Y+APE    
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVST 177
Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP 826
              +   D +SFGI++ E+     P
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL   +    V
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 149
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 209
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 210 KSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL   +    V
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 149
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 209
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 210 KSDVWSFGVLMWEAFS 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L+    F    ++G G+FG V + R  LD    AIK      E  L +  +E  +L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 681 H-------------RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN 727
           H             RN V+ +++        + ++Y   G+L   ++S+N N    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-------LLSGD- 779
           +   I  AL Y+H      ++H D+KP N+ +DE    ++GDFG+AK       +L  D 
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 780 -----ESMKHTQTLATIGYMAPEY-GREGQISTEGDVYSFGIMLMEI 820
                 S   T  + T  Y+A E     G  + + D+YS GI+  E+
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRH 681
           TD + +   +G G+F  V R  +     E A K+ + +   A   +    E  + R ++H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S + + F  LV D +  G     L+ D    + +   +    I   LE ++ 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIHQILESVNH 145
Query: 742 GHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H + +VH D+KP N+LL    +    +L DFG+A  + G E         T GY++PE 
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG-EQQAWFGFAGTPGYLSPEV 204
Query: 799 GREGQISTEGDVYSFGIML 817
            R+       D+++ G++L
Sbjct: 205 LRKDPYGKPVDIWACGVIL 223

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 8/205 (3%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESF-NAECEVLRSIRHRNLV 685
           F   + IG GSFG VY+G      EV AIK+  L+           E  VL       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R   S        ++++Y+  GS    L      L+      I+ +I   L+YLH     
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH---SE 135
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
             +H DIK +NVLL E    +L DFG+A  L+ D  +K    + T  +MAPE  ++    
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEI 830
            + D++S GI  +E+   + P  ++
Sbjct: 195 FKADIWSLGITAIELAKGEPPNSDL 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNL 684
           Q  +   +G G +G V+RG +  G  VA+K+F  + E   +S+  E E+  ++  RH N+
Sbjct: 9   QITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENI 64
Query: 685 VRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           +  I+S       +    L+  Y   GSL    Y   + LD    L IV+ IA  L +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 741 F------GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATI 791
                  G P  + H D+K  N+L+ ++    + D G+A + S       + +   + T 
Sbjct: 123 IEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 792 GYMAPEYGREG-QIS-----TEGDVYSFGIMLMEIFTR 823
            YMAPE   E  Q+         D+++FG++L E+  R
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL     +  V
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 133
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 194 KSDVWSFGVLMWEAFS 209

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 36/247 (14%)
Query: 598 DTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKV 657
           D   S   + +PL+  R  +   +LQ +        IG G FG V+RG++  G EVA+K+
Sbjct: 9   DMTTSGSGSGLPLLVQRTIARTIVLQES--------IGKGRFGEVWRGKW-RGEEVAVKI 59
Query: 658 FHLQLEGALESFNAECEVLRSI--RHRNLVRIISSCTNDDFKA----LVLDYMPKGSLEA 711
           F  + E    S+  E E+ +++  RH N++  I++   D+       LV DY   GSL  
Sbjct: 60  FSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 116
Query: 712 CLYSDNSNLDIFKRLNIVIDIALALEYLHF------GHPNPVVHCDIKPSNVLLDEDMVA 765
             Y +   + +   + + +  A  L +LH       G P  + H D+K  N+L+ ++   
Sbjct: 117 --YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTC 173
Query: 766 RLGDFGIA-KLLSGDESMKHT--QTLATIGYMAPEY------GREGQISTEGDVYSFGIM 816
            + D G+A +  S  +++       + T  YMAPE        +  +     D+Y+ G++
Sbjct: 174 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 233
Query: 817 LMEIFTR 823
             EI  R
Sbjct: 234 FWEIARR 240

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 36/247 (14%)
Query: 598 DTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKV 657
           D   S   + +PL+  R  +   +LQ +        IG G FG V+RG++  G EVA+K+
Sbjct: 22  DMTTSGSGSGLPLLVQRTIARTIVLQES--------IGKGRFGEVWRGKW-RGEEVAVKI 72
Query: 658 FHLQLEGALESFNAECEVLRSI--RHRNLVRIISSCTNDDFKA----LVLDYMPKGSLEA 711
           F  + E    S+  E E+ +++  RH N++  I++   D+       LV DY   GSL  
Sbjct: 73  FSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 129
Query: 712 CLYSDNSNLDIFKRLNIVIDIALALEYLHF------GHPNPVVHCDIKPSNVLLDEDMVA 765
             Y +   + +   + + +  A  L +LH       G P  + H D+K  N+L+ ++   
Sbjct: 130 --YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTC 186
Query: 766 RLGDFGIA-KLLSGDES--MKHTQTLATIGYMAPEY------GREGQISTEGDVYSFGIM 816
            + D G+A +  S  ++  +     + T  YMAPE        +  +     D+Y+ G++
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246
Query: 817 LMEIFTR 823
             EI  R
Sbjct: 247 FWEIARR 253

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL     +  V
Sbjct: 73  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 127
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 187
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 188 KSDVWSFGVLMWEAFS 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL     +  V
Sbjct: 75  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 190 KSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG---AL-ESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G + +  +   + V  L+ E    AL +   AE  V++ + +  +VR+I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL     +  V
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 133
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQIST 806
           H D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     + S+
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 807 EGDVYSFGIMLMEIFT 822
           + DV+SFG+++ E F+
Sbjct: 194 KSDVWSFGVLMWEAFS 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRF--LDGMEVAIKVFHLQLE-----GALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +    G  V++ V  L+ +      A++ F  E   + S+ HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF 201
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 202 SHASDTWMFGVTLWEMFT 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LQALSVLHAQGVIHRDI 142
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 202 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPRLKN 238

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 21/220 (9%)
Query: 632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIIS-- 689
            +IG+GSFG V++ + ++  EVAIK    ++       N E +++R ++H N+V + +  
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 690 ----SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
                  ++ F  LVL+Y+P+    A  +           L I + +   L  L + H  
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 746 PVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREG 802
            + H DIKP N+LLD    V +L DFG AK+L   E   +   + +  Y APE  +G   
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRYYRAPELIFG-AT 217
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
             +T  D++S G ++ E+   +     +F GE  + + V 
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQ----PLFPGESGIDQLVE 253

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSC 691
           +G G +G V+RG +  G  VA+K+F  + E   +S+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 692 TNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF------ 741
                 +    L+  Y   GSL    Y   + LD    L IV+ IA  L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATIGYMAPEY 798
           G P  + H D+K  N+L+ ++    + D G+A + S       + +   + T  YMAPE 
Sbjct: 130 GKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 799 GREG-QIS-----TEGDVYSFGIMLMEIFTR 823
             E  Q+         D+++FG++L E+  R
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRF--LDGMEVAIKVFHLQLE-----GALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +    G  V++ V  L+ +      A++ F  E   + S+ HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 135
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 195
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 196 SHASDTWMFGVTLWEMFT 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LQALSVLHAQGVIHRDI 151
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 210
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 211 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPRLKN 247

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVFHLQLEG-ALESFNAECE 674
           +F  NNL     +G+G+FG V        G+    ++VA+K+          E+  +E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           ++  + +H N+V ++ +CT+     ++ +Y   G L   L   +  L+      I    A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 734 LALEYLHFGHP----------NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-- 781
              + LHF                +H D+   NVLL    VA++GDFG+A+ +  D +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           +K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 222 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LQALSVLHAQGVIHRDI 153
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 212
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 213 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPRLKN 249

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 634 IGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGA-LESFNAECEVLRSIRHRNLVRIIS 689
           +G G+FGSV +G +      ++VAIKV     E A  E    E +++  + +  +VR+I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
            C  +    LV++    G L   L      + +     ++  +++ ++YL   +    VH
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQISTE 807
            ++   NVLL     A++ DFG++K L  D+S    ++     + + APE     + S+ 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 808 GDVYSFGIMLMEIFT 822
            DV+S+G+ + E  +
Sbjct: 520 SDVWSYGVTMWEALS 534

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LQALSVLHAQGVIHRDI 146
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 205
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 206 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPRLKN 242

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LQALSVLHAQGVIHRDI 196
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 255
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 256 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPRLKN 292

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRF--LDGMEVAIKVFHLQLE-----GALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +    G  V++ V  L+ +      A++ F  E   + S+ HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 202 SHASDTWMFGVTLWEMFT 219

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           +D++    ++G GSFG V   +  + G E A+KV     ++ +   ES   E ++L+ + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++++     +  +  LV +    G L    + +  +   F  ++    I   L  + 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGIT 146
Query: 741 FGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           + H N +VH D+KP N+LL+   +D   R+ DFG++      + MK    + T  Y+APE
Sbjct: 147 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK--DKIGTAYYIAPE 204
Query: 798 YGREGQISTEGDVYSFGIML 817
               G    + DV+S G++L
Sbjct: 205 V-LHGTYDEKCDVWSTGVIL 223

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 10/222 (4%)
Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
            +G G F   +     D  EV A K+    L       E  + E  + RS+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               ++DF  +VL+   + SL   L+     L   +    +  I L  +YLH    N V+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVI 139
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           H D+K  N+ L+ED+  ++GDFG+A  +  D   K T    T  Y+APE   +   S E 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEV 198
Query: 809 DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND-SLPISI 849
           DV+S G ++  +   K P +     E  L+   N+ S+P  I
Sbjct: 199 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 13/221 (5%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           IG GS G V        G  VA+K   L+ +   E    E  ++R  +H N+V + +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI 752
             D   +V++++  G+L   +     N +    + + +     L+ L   H   V+H DI
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV-----LQALSVLHAQGVIHRDI 273
Query: 753 KPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYS 812
           K  ++LL  D   +L DFG    +S  E  +    + T  +MAPE         E D++S
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 332
Query: 813 FGIMLMEIFTRKRPTDEIFSGEMSLK--RWVNDSLPISIMN 851
            GIM++E+   + P    +  E  LK  + + D+LP  + N
Sbjct: 333 LGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPRLKN 369

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRH 681
           D F +   IG GSFG V   +  D  ++ A+K  + Q       + +   E ++++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIALALEY 738
             LV +  S  +++   +V+D +  G L    Y    N+  FK   +   + ++ +AL+Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLR---YHLQQNVH-FKEETVKLFICELVMALDY 130
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           L       ++H D+KP N+LLDE     + DF IA +L  +  +  T    T  YMAPE 
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEM 185
Query: 799 --GREGQ-ISTEGDVYSFGIMLMEIFTRKRP 826
              R+G   S   D +S G+   E+   +RP
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 11/212 (5%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQ-LEGALESFNAECEVLRSIRHRN 683
           D + +  +IGSG+   V         E VAIK  +L+  + +++    E + +    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 684 LVRIISSCTNDDFKALVLDYMPKGS----LEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           +V   +S    D   LV+  +  GS    ++  +        +     I   +   LE L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS--GDESMKHTQT--LATIGYMA 795
            + H N  +H D+K  N+LL ED   ++ DFG++  L+  GD +    +   + T  +MA
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 796 PEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRP 826
           PE   + +    + D++SFGI  +E+ T   P
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 10/222 (4%)
Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
            +G G F   +     D  EV A K+    L       E  + E  + RS+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               ++DF  +VL+   + SL   L+     L   +    +  I L  +YLH    N V+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVI 139
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           H D+K  N+ L+ED+  ++GDFG+A  +  D   K T    T  Y+APE   +   S E 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEV 198
Query: 809 DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND-SLPISI 849
           DV+S G ++  +   K P +     E  L+   N+ S+P  I
Sbjct: 199 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 240

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 10/222 (4%)
Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
            +G G F   +     D  EV A K+    L       E  + E  + RS+ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               ++DF  +VL+   + SL   L+     L   +    +  I L  +YLH    N V+
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVI 143
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           H D+K  N+ L+ED+  ++GDFG+A  +  D   K T    T  Y+APE   +   S E 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEV 202
Query: 809 DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND-SLPISI 849
           DV+S G ++  +   K P +     E  L+   N+ S+P  I
Sbjct: 203 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 244

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 122/253 (48%), Gaps = 32/253 (12%)
Query: 599 TKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKV 657
           T  S    N+ L+  R F         D++ +   IG+G++G V   R  L G +VAIK 
Sbjct: 30  TAASVAAKNLALLKARSFDV--TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIK- 86
Query: 658 FHLQLEGALESF-NA-----ECEVLRSIRHRNLVRIIS----SCTNDDFKAL--VLDYMP 705
              ++  A +   NA     E ++L+  +H N++ I      +    +FK++  VLD M 
Sbjct: 87  ---KIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM- 142
Query: 706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA 765
           +  L   ++S +  L +      +  +   L+Y+H      V+H D+KPSN+L++E+   
Sbjct: 143 ESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCEL 198
Query: 766 RLGDFGIAKLL---SGDESMKHTQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIF 821
           ++GDFG+A+ L     +     T+ +AT  Y APE        T+  D++S G +  E+ 
Sbjct: 199 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 258
Query: 822 TRKRPTDEIFSGE 834
            R+    ++F G+
Sbjct: 259 ARR----QLFPGK 267

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVFHLQLEG-ALESFNAECE 674
           +F  NNL     +G+G+FG V        G+    ++VA+K+          E+  +E +
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL--------EACL-YSDNSNLDIFK 724
           ++  + +H N+V ++ +CT+     ++ +Y   G L        EA L   D   L++  
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--M 782
            L+    +A  + +L        +H D+   NVLL    VA++GDFG+A+ +  D +  +
Sbjct: 154 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 211 KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 11/212 (5%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQ-LEGALESFNAECEVLRSIRHRN 683
           D + +  +IGSG+   V         E VAIK  +L+  + +++    E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 684 LVRIISSCTNDDFKALVLDYMPKGS----LEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
           +V   +S    D   LV+  +  GS    ++  +        +     I   +   LE L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS--GDESMKHTQT--LATIGYMA 795
            + H N  +H D+K  N+LL ED   ++ DFG++  L+  GD +    +   + T  +MA
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 796 PEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRP 826
           PE   + +    + D++SFGI  +E+ T   P
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 122/255 (47%), Gaps = 32/255 (12%)
Query: 597 GDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAI 655
             T  S    N+ L+  R F         D++ +   IG+G++G V   R  L G +VAI
Sbjct: 27  AHTAASVAAKNLALLKARSFDVT--FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAI 84
Query: 656 KVFHLQLEGALESF-NA-----ECEVLRSIRHRNLVRIIS----SCTNDDFKAL--VLDY 703
           K    ++  A +   NA     E ++L+  +H N++ I      +    +FK++  VLD 
Sbjct: 85  K----KIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL 140
Query: 704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM 763
           M +  L   ++S +  L +      +  +   L+Y+H      V+H D+KPSN+L++E+ 
Sbjct: 141 M-ESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENC 195
Query: 764 VARLGDFGIAKLL---SGDESMKHTQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLME 819
             ++GDFG+A+ L     +     T+ +AT  Y APE        T+  D++S G +  E
Sbjct: 196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 255
Query: 820 IFTRKRPTDEIFSGE 834
           +  R+    ++F G+
Sbjct: 256 MLARR----QLFPGK 266

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSC 691
           IG G FG V+RG++  G EVA+K+F  + E    S+  E E+ +++  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 692 TNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF------ 741
             D+       LV DY   GSL    Y +   + +   + + +  A  L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHT--QTLATIGYMAPEY 798
           G P  + H D+K  N+L+ ++    + D G+A +  S  +++       + T  YMAPE 
Sbjct: 131 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 799 ------GREGQISTEGDVYSFGIMLMEIFTR 823
                  +  +     D+Y+ G++  EI  R
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSC 691
           IG G FG V+RG++  G EVA+K+F  + E    S+  E E+ +++  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 692 TNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF------ 741
             D+       LV DY   GSL    Y +   + +   + + +  A  L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHT--QTLATIGYMAPEY 798
           G P  + H D+K  N+L+ ++    + D G+A +  S  +++       + T  YMAPE 
Sbjct: 128 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 799 ------GREGQISTEGDVYSFGIMLMEIFTR 823
                  +  +     D+Y+ G++  EI  R
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSC 691
           IG G FG V+RG++  G EVA+K+F  + E    S+  E E+ +++  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 692 TNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF------ 741
             D+       LV DY   GSL    Y +   + +   + + +  A  L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHT--QTLATIGYMAPEY 798
           G P  + H D+K  N+L+ ++    + D G+A +  S  +++       + T  YMAPE 
Sbjct: 125 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 799 ------GREGQISTEGDVYSFGIMLMEIFTR 823
                  +  +     D+Y+ G++  EI  R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSC 691
           IG G FG V+RG++  G EVA+K+F  + E    S+  E E+ +++  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 692 TNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF------ 741
             D+       LV DY   GSL    Y +   + +   + + +  A  L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGDESMKHT--QTLATIGYMAPEY 798
           G P  + H D+K  N+L+ ++    + D G+A +  S  +++       + T  YMAPE 
Sbjct: 126 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 799 ------GREGQISTEGDVYSFGIMLMEIFTR 823
                  +  +     D+Y+ G++  EI  R
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           +D++    ++G GSFG V   +  + G E A+KV     ++ +   ES   E ++L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++++     +  +  LV +    G L   + S       F  ++    I   L  + 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 140
Query: 741 FGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           + H N +VH D+KP N+LL+   +D   R+ DFG++      + MK    + T  Y+APE
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK--DKIGTAYYIAPE 198
Query: 798 YGREGQISTEGDVYSFGIML 817
               G    + DV+S G++L
Sbjct: 199 V-LHGTYDEKCDVWSTGVIL 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 632 NLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGA-LESFNAECEVLRSI-RHRN 683
            ++GSG+FG V              ++VA+K+   + + +  E+  +E +++  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIV- 729
           +V ++ +CT      L+ +Y   G L             +   Y +   L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 730 --------IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDE 780
                     +A  +E+L F      VH D+   NVL+    V ++ DFG+A+ ++S   
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            +        + +MAPE   EG  + + DV+S+GI+L EIF+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 38/230 (16%)
Query: 621 LLQAT--DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
           L+Q T   Q  +   IG G +G V+ G++  G +VA+KVF    E    S+  E E+ ++
Sbjct: 30  LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETEIYQT 85
Query: 679 I--RHRNLVRIISSCTNDDFKA--------LVLDYMPKGSLEACLYSDNSNLDIFKRLNI 728
           +  RH N++  I++    D K         L+ DY   GSL    Y  ++ LD    L +
Sbjct: 86  VLMRHENILGFIAA----DIKGTGSWTQLYLITDYHENGSLYD--YLKSTTLDAKSMLKL 139
Query: 729 VIDIALALEYLHF------GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSG--D 779
                  L +LH       G P  + H D+K  N+L+ ++    + D G+A K +S   +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 780 ESMKHTQTLATIGYMAPEYGREG------QISTEGDVYSFGIMLMEIFTR 823
             +     + T  YM PE   E       Q     D+YSFG++L E+  R
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 626 DQFNVNNLIGSGSFGSVY-RGRFLDGMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
           D F     +GSG+FG V+       G+E  IK  +  + +  +E   AE EVL+S+ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +++I     +     +V++    G L   + S  +         +   +   +  L + H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 744 PNPVVHCDIKPSNVLLDE---DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
              VVH D+KP N+L  +       ++ DFG+A+L   DE    T    T  YMAPE  +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFK 199
Query: 801 EGQISTEGDVYSFGIMLMEIFT 822
              ++ + D++S G+++  + T
Sbjct: 200 R-DVTFKCDIWSAGVVMYFLLT 220

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVFHLQLEG-ALESFNAECE 674
           +F  NNL     +G+G+FG V        G+    ++VA+K+          E+  +E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL--------EACL-YSDNSNLDIFK 724
           ++  + +H N+V ++ +CT+     ++ +Y   G L        EA L   D   L++  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--M 782
            L+    +A  + +L        +H D+   NVLL    VA++GDFG+A+ +  D +  +
Sbjct: 162 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 219 KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRFL----DGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +       + VA+K      L    A++ F  E   + S+ HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF 191
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 192 SHASDTWMFGVTLWEMFT 209

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN----AECEVLRSIRHRNLVRII 688
           IG G+FG V++ R    G +VA+K   + +E   E F      E ++L+ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALA---------LEY 738
             C     KA   +   KGS+   L  D    D+   L N+++   L+         L  
Sbjct: 84  EICRT---KASPYNRC-KGSI--YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLATIGYMA 795
           L++ H N ++H D+K +NVL+  D V +L DFG+A+  S     +  ++   + T+ Y  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTR 823
           PE   G E       D++  G ++ E++TR
Sbjct: 198 PELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN----AECEVLRSIRHRNLVRII 688
           IG G+FG V++ R    G +VA+K   + +E   E F      E ++L+ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLY--SDNSNLDIFKRL-NIVIDIALA---------L 736
             C     KA      P    +A +Y   D    D+   L N+++   L+         L
Sbjct: 84  EICRT---KA-----SPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLATIGY 793
             L++ H N ++H D+K +NVL+  D V +L DFG+A+  S     +  ++   + T+ Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 794 MAPE--YGREGQISTEGDVYSFGIMLMEIFTR 823
             PE   G E       D++  G ++ E++TR
Sbjct: 196 RPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           +D++    ++G GSFG V   +  + G E A+KV     ++ +   ES   E ++L+ + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++++     +  +  LV +    G L   + S       F  ++    I   L  + 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 163
Query: 741 FGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           + H N +VH D+KP N+LL+   +D   R+ DFG++      + MK    + T  Y+APE
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK--DKIGTAYYIAPE 221
Query: 798 YGREGQISTEGDVYSFGIML 817
               G    + DV+S G++L
Sbjct: 222 V-LHGTYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           +D++    ++G GSFG V   +  + G E A+KV     ++ +   ES   E ++L+ + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N++++     +  +  LV +    G L   + S       F  ++    I   L  + 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 164
Query: 741 FGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           + H N +VH D+KP N+LL+   +D   R+ DFG++      + MK    + T  Y+APE
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK--DKIGTAYYIAPE 222
Query: 798 YGREGQISTEGDVYSFGIML 817
               G    + DV+S G++L
Sbjct: 223 V-LHGTYDEKCDVWSTGVIL 241

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     IG+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++YMP G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     IG+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++YMP G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 108/234 (46%), Gaps = 36/234 (15%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-LEGALESFNA--------ECEVLRS 678
           F +  ++G G +G V++ R + G     K+F ++ L+ A+   NA        E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVIDI 732
           ++H  +V +I +        L+L+Y+  G L      E     D +          + +I
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-------YLAEI 130
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
           ++AL +LH      +++ D+KP N++L+     +L DFG+ K    D ++ HT    TI 
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIE 186
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFT---------RKRPTDEIFSGEMSL 837
           YMAPE       +   D +S G ++ ++ T         RK+  D+I   +++L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 634 IGSGSFGSVYRGRFLDGME-VAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G++G+V++ +  +  E VA+K   L    EG   S   E  +L+ ++H+N+VR+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVH 749
             +D    LV ++  +  L+    S N +LD      IV      L + L F H   V+H
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP----EIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI-STEG 808
            D+KP N+L++ +   +L DFG+A+   G     ++  + T+ Y  P+     ++ ST  
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 809 DVYSFGIMLMEIFTRKRP 826
           D++S G +  E+    RP
Sbjct: 184 DMWSAGCIFAELANAARP 201

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRFL----DGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +       + VA+K      L    A++ F  E   + S+ HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 135
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 195
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 196 SHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRFL----DGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +       + VA+K      L    A++ F  E   + S+ HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 192 SHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 634 IGSGSFGSVYRGRFL----DGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVR 686
           +G GSFG V RG +       + VA+K      L    A++ F  E   + S+ HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           +         K +V +  P GSL   L     +  +       + +A  + YL       
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+LL    + ++GDFG+ + L  + D  +          + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 805 STEGDVYSFGIMLMEIFT 822
           S   D + FG+ L E+FT
Sbjct: 192 SHASDTWMFGVTLWEMFT 209

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 42/229 (18%)
Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVFHLQLEG-ALESFNAECE 674
           +F  NNL     +G+G+FG V        G+    ++VA+K+          E+  +E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           ++  + +H N+V ++ +CT+     ++ +Y        C Y D  N    K   +  D A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEY--------CCYGDLLNFLRRKSRVLETDPA 153
Query: 734 LAL--------EYLHFGHP----------NPVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
            A+        + LHF                +H D+   NVLL    VA++GDFG+A+ 
Sbjct: 154 FAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 776 LSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           +  D +  +K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 214 IMNDSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L+    F    ++G G+FG V + R  LD    AIK      E  L +  +E  +L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 681 H-------------RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN 727
           H             RN V+ +++        + ++Y    +L   ++S+N N    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-------LLSGD- 779
           +   I  AL Y+H      ++H D+KP N+ +DE    ++GDFG+AK       +L  D 
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 780 -----ESMKHTQTLATIGYMAPEY-GREGQISTEGDVYSFGIMLMEI 820
                 S   T  + T  Y+A E     G  + + D+YS GI+  E+
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+ N+   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 84
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +    +K    +    
Sbjct: 85  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 734 LALEYL-----------HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ES 781
           L LE+L            F      +H D+   N+LL E  V ++ DFG+A+ +  D + 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNL 684
           Q  +   +G G +G V+RG    G  VA+K+F  + E   +S+  E E+  ++  RH N+
Sbjct: 9   QVALVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNI 64
Query: 685 VRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           +  I+S       +    L+  Y   GSL   L      L+    L + +  A  L +LH
Sbjct: 65  LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFL--QRQTLEPHLALRLAVSAACGLAHLH 122
Query: 741 F------GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMK--HTQTLATI 791
                  G P  + H D K  NVL+  ++   + D G+A + S G + +   +   + T 
Sbjct: 123 VEIFGTQGKP-AIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTK 181
Query: 792 GYMAPEYGREGQISTE-------GDVYSFGIMLMEIFTR 823
            YMAPE   E QI T+        D+++FG++L EI  R
Sbjct: 182 RYMAPEVLDE-QIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALE--------SFNAECEVLR 677
           + F +  +IG G+FG V   +    ++ A KVF +++    E         F  E +VL 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVK----LKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           +   + +  +  +  +D+   LV+DY   G L   L      L        + ++ +A++
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
            +H  H    VH DIKP N+L+D +   RL DFG    L  D +++ +  + T  Y++PE
Sbjct: 190 SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 798 Y-----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
                 G +G+   E D +S G+ + E+   + P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN----AECEVLRSIRHRNLVRII 688
           IG G+FG V++ R    G +VA+K   + +E   E F      E ++L+ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALA---------LEY 738
             C     KA   +   KGS+   L  D    D+   L N+++   L+         L  
Sbjct: 84  EICRT---KASPYNRC-KGSIY--LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLATIGYMA 795
           L++ H N ++H D+K +NVL+  D V +L DFG+A+  S     +  ++   + T+ Y  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTR 823
           PE   G E       D++  G ++ E++TR
Sbjct: 198 PELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN----AECEVLRSIRHRNLVRII 688
           IG G+FG V++ R    G +VA+K   + +E   E F      E ++L+ ++H N+V +I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-NIVIDIALA---------LEY 738
             C     KA   +   KGS+   L  D    D+   L N+++   L+         L  
Sbjct: 83  EICRT---KASPYNRC-KGSI--YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQTLATIGYMA 795
           L++ H N ++H D+K +NVL+  D V +L DFG+A+  S     +  ++   + T+ Y  
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 796 PE--YGREGQISTEGDVYSFGIMLMEIFTR 823
           PE   G E       D++  G ++ E++TR
Sbjct: 197 PELLLG-ERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 627 QFNVNNLI-----GSGSFGSVYRGR--FLDGME----VAIKVFHL-----QLEGALESFN 670
           +F   NL+     G G FG V +     L G      VA+K+        +L   L  FN
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL----------------- 713
               VL+ + H +++++  +C+ D    L+++Y   GSL   L                 
Sbjct: 79  ----VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 714 ------YSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL 767
                 + D   L +   ++    I+  ++YL       +VH D+   N+L+ E    ++
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 768 GDFGIAK-LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            DFG+++ +   D  +K +Q    + +MA E   +   +T+ DV+SFG++L EI T
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           +D++    ++G GSFG V   +  + G E A+KV     ++ +   ES   E ++L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N+ ++     +  +  LV +    G L   + S       F  ++    I   L  + 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGIT 140
Query: 741 FGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           + H N +VH D+KP N+LL+   +D   R+ DFG++       S K    + T  Y+APE
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXKDKIGTAYYIAPE 198
Query: 798 YGREGQISTEGDVYSFGIML 817
               G    + DV+S G++L
Sbjct: 199 V-LHGTYDEKCDVWSTGVIL 217

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 627 QFNVNNLI-----GSGSFGSVYRGR--FLDGME----VAIKVFHL-----QLEGALESFN 670
           +F   NL+     G G FG V +     L G      VA+K+        +L   L  FN
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL----------------- 713
               VL+ + H +++++  +C+ D    L+++Y   GSL   L                 
Sbjct: 79  ----VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 714 ------YSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL 767
                 + D   L +   ++    I+  ++YL       +VH D+   N+L+ E    ++
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKI 191
Query: 768 GDFGIAK-LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            DFG+++ +   D  +K +Q    + +MA E   +   +T+ DV+SFG++L EI T
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 10/222 (4%)
Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
            +G G F   +     D  EV A K+    L       E  + E  + RS+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               ++DF  +VL+   + SL   L+     L   +    +  I L  +YLH    N V+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVI 163
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           H D+K  N+ L+ED+  ++GDFG+A  +  D   K      T  Y+APE   +   S E 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEV 222
Query: 809 DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND-SLPISI 849
           DV+S G ++  +   K P +     E  L+   N+ S+P  I
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 264

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 94/191 (49%), Gaps = 10/191 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G VY+ +   G   A+K   L+ E  G   +   E  +L+ ++H N+V++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV +++ +  L+  L      L+     + ++ +   + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GREGQISTEGD 809
           +KP N+L++ +   ++ DFG+A+   G    K+T  + T+ Y AP+   G + + ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTID 183
Query: 810 VYSFGIMLMEI 820
           ++S G +  E+
Sbjct: 184 IWSVGCIFAEM 194

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 627 QFNVNNLI-----GSGSFGSVYRGR--FLDGME----VAIKVFHL-----QLEGALESFN 670
           +F   NL+     G G FG V +     L G      VA+K+        +L   L  FN
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL----------------- 713
               VL+ + H +++++  +C+ D    L+++Y   GSL   L                 
Sbjct: 79  ----VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 714 ------YSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL 767
                 + D   L +   ++    I+  ++YL       +VH D+   N+L+ E    ++
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 768 GDFGIAK-LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            DFG+++ +   D  +K +Q    + +MA E   +   +T+ DV+SFG++L EI T
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 11/190 (5%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRNLVRIISS 690
           +G G+F  V R  + L G E A K+ + +   A   +    E  + R ++H N+VR+  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
            + +    L+ D +  G     L+ D    + +   +    I   LE +   H   VVH 
Sbjct: 90  ISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 751 DIKPSNVLLDEDM---VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
           D+KP N+LL   +     +L DFG+A  + G E         T GY++PE  R+      
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLRKDPYGKP 204
Query: 808 GDVYSFGIML 817
            D+++ G++L
Sbjct: 205 VDLWACGVIL 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 10/222 (4%)
Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
            +G G F   +     D  EV A K+    L       E  + E  + RS+ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               ++DF  +VL+   + SL   L+     L   +    +  I L  +YLH    N V+
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVI 161
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           H D+K  N+ L+ED+  ++GDFG+A  +  D   K      T  Y+APE   +   S E 
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEV 220
Query: 809 DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND-SLPISI 849
           DV+S G ++  +   K P +     E  L+   N+ S+P  I
Sbjct: 221 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 262

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 94/191 (49%), Gaps = 10/191 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G VY+ +   G   A+K   L+ E  G   +   E  +L+ ++H N+V++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV +++ +  L+  L      L+     + ++ +   + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GREGQISTEGD 809
           +KP N+L++ +   ++ DFG+A+   G    K+T  + T+ Y AP+   G + + ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDVLMGSK-KYSTTID 183
Query: 810 VYSFGIMLMEI 820
           ++S G +  E+
Sbjct: 184 IWSVGCIFAEM 194

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES------FNAECEVLRSIRH 681
           F+   +IG GSFG V   R     EV   V  LQ +  L+        +    +L++++H
Sbjct: 40  FHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV +  S    D    VLDY+  G L   L  +   L+   R     +IA AL YLH 
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS 157
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPE 797
            +   +V+ D+KP N+LLD      L DFG+ K     E+++H  T +T      Y+APE
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAPE 209
Query: 798 YGREGQISTEGDVYSFGIMLMEI 820
              +       D +  G +L E+
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEM 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKI 85
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +    +K  ++  D  
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF- 144
Query: 734 LALEYL-----------HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ES 781
           L LE+L            F      +H D+   N+LL E  V ++ DFG+A+ +  D + 
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 100/228 (43%), Gaps = 12/228 (5%)
Query: 596 KGDTKLSNIQANMPLVAWRRFSYQELL----QATDQFNVNNLIGSGSFGSVYR-GRFLDG 650
           +G   +S+   N     W+++  Q +        D ++++  +G+G+FG V+R      G
Sbjct: 17  RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 76
Query: 651 MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE 710
              A K      E   E+   E + +  +RH  LV +  +  +D+   ++ ++M  G L 
Sbjct: 77  NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 136
Query: 711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG-- 768
             +  +++ +   + +  +  +   L ++H    N  VH D+KP N++        L   
Sbjct: 137 EKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 193
Query: 769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIM 816
           DFG+   L   +S+K   T  T  + APE      +    D++S G++
Sbjct: 194 DFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 94/191 (49%), Gaps = 10/191 (5%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G VY+ +   G   A+K   L+ E  G   +   E  +L+ ++H N+V++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
                  LV +++ +  L+  L      L+     + ++ +   + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 752 IKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GREGQISTEGD 809
           +KP N+L++ +   ++ DFG+A+   G    K+T  + T+ Y AP+   G + + ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDVLMGSK-KYSTTID 183
Query: 810 VYSFGIMLMEI 820
           ++S G +  E+
Sbjct: 184 IWSVGCIFAEM 194

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLR------S 678
           + F ++ ++G GSFG V+   F    +  AIK   L+ +  L   + EC ++       +
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
             H  L  +  +    +    V++Y+  G L   + S +   D+ +      +I L L++
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQF 134
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPE 797
           LH      +V+ D+K  N+LLD+D   ++ DFG+ K  + GD   K  +   T  Y+APE
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNEFCGTPDYIAPE 189
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                + +   D +SFG++L E+   + P
Sbjct: 190 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 100/228 (43%), Gaps = 12/228 (5%)
Query: 596 KGDTKLSNIQANMPLVAWRRFSYQELL----QATDQFNVNNLIGSGSFGSVYR-GRFLDG 650
           +G   +S+   N     W+++  Q +        D ++++  +G+G+FG V+R      G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182
Query: 651 MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE 710
              A K      E   E+   E + +  +RH  LV +  +  +D+   ++ ++M  G L 
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 711 ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG-- 768
             +  +++ +   + +  +  +   L ++H    N  VH D+KP N++        L   
Sbjct: 243 EKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 299
Query: 769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIM 816
           DFG+   L   +S+K   T  T  + APE      +    D++S G++
Sbjct: 300 DFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     IG+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 10/222 (4%)
Query: 633 LIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRII 688
            +G G F   +     D  EV A K+    L       E  + E  + RS+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               ++DF  +VL+   + SL   L+     L   +    +  I L  +YLH    N V+
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVI 137
Query: 749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG 808
           H D+K  N+ L+ED+  ++GDFG+A  +  D   K      T  Y+APE   +   S E 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEV 196
Query: 809 DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND-SLPISI 849
           DV+S G ++  +   K P +     E  L+   N+ S+P  I
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 238

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V + +    G+ +A K+ HL+++ A+      E +VL       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L  +     +I  +++I +   LA  YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 133
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YMAPE  +  
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMAPERLQGT 188
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             S + D++S G+ L+E+   + P
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 185
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 240
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             S + D++S G+ L+E+   + P     + E+ L
Sbjct: 241 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 630 VNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRNLVRI 687
           +++++G G+  +V+RGR    G   AIKVF+ +     ++    E EVL+ + H+N+V++
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 688 --ISSCTNDDFKALVLDYMPKGSLEACLY--SDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             I   T    K L++++ P GSL   L   S+   L   + L ++ D+   + +L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---R 129
Query: 744 PNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-Y 798
            N +VH +IKP N++     D   V +L DFG A+ L  DE         T  Y+ P+ Y
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMY 187
Query: 799 GR-------EGQISTEGDVYSFGIMLMEIFTRKRP 826
            R       + +     D++S G+      T   P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLV 685
           F +  L+G+G++G VY+GR +  G   AIKV  +  +   E    E  +L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 686 RIISSCTN------DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
               +         DD   LV+++   GS+   +   N+  +  K   I       L  L
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 142
Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY- 798
              H + V+H DIK  NVLL E+   +L DFG++  L      ++T  + T  +MAPE  
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 201
Query: 799 ----GREGQISTEGDVYSFGIMLMEI 820
                 +     + D++S GI  +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGR 800
                +++ D+KP N+L+D+    ++ DFG AK + G      T TL  T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEIIL 212
Query: 801 EGQISTEGDVYSFGIMLMEI 820
               +   D ++ G+++ E+
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGR 800
                +++ D+KP N+L+D+    ++ DFG AK + G      T TL  T  Y+APE   
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEIIL 197
Query: 801 EGQISTEGDVYSFGIMLMEI 820
               +   D ++ G+++ E+
Sbjct: 198 SKGYNKAVDWWALGVLIYEM 217

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 30/221 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+ N+   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL----DIFKR---- 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +      D++K     
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 726 ---LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ES 781
              +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D + 
Sbjct: 144 EHLIXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 36/234 (15%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-LEGALESFNA--------ECEVLRS 678
           F +  ++G G +G V++ R + G     K+F ++ L+ A+   NA        E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVIDI 732
           ++H  +V +I +        L+L+Y+  G L      E     D +          + +I
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-------YLAEI 130
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
           ++AL +LH      +++ D+KP N++L+     +L DFG+ K    D ++ H     TI 
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX-FCGTIE 186
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFT---------RKRPTDEIFSGEMSL 837
           YMAPE       +   D +S G ++ ++ T         RK+  D+I   +++L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 21/168 (12%)
Query: 660 LQLEGALESFNAECEVLRSIRHRNLVRIISSCT--NDDFKALVLDYMPKGSLEAC----- 712
           +Q  G +E    E  +L+ + H N+V+++      N+D   +V + + +G +        
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 713 LYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
           L  D +    F+      D+   +EYLH+     ++H DIKPSN+L+ ED   ++ DFG+
Sbjct: 134 LSEDQARF-YFQ------DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG---DVYSFGIML 817
           +    G +++  + T+ T  +MAPE   E +    G   DV++ G+ L
Sbjct: 184 SNEFKGSDALL-SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 35/173 (20%)
Query: 672 ECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKR 725
           E ++LR +  H N++++  +   + F  LV D M KG L     E    S+     I + 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
           L   +++  AL  L+      +VH D+KP N+LLD+DM  +L DFG +  L   E ++  
Sbjct: 120 L---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-- 168
Query: 786 QTLATIGYMAPE------------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +   T  Y+APE            YG+      E D++S G+++  +     P
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGK------EVDMWSTGVIMYTLLAGSPP 215

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 38/243 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKV-----FHLQLEGALESFNAECEVLRSI 679
           D + +  +IG G+F  V R    + G + A+K+     F      + E    E  +   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--IVIDIALA-- 735
           +H ++V ++ + ++D    +V ++M    L  C        +I KR +   V   A+A  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL--CF-------EIVKRADAGFVYSEAVASH 134
Query: 736 -----LEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQT 787
                LE L + H N ++H D+KP NVLL   +     +LGDFG+A  L G+  +     
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGR 193
Query: 788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF--------TRKRPTDEIFSG--EMSL 837
           + T  +MAPE  +        DV+  G++L  +         T++R  + I  G  +M+ 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNP 253
Query: 838 KRW 840
           ++W
Sbjct: 254 RQW 256

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 630 VNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRNLVRI 687
           +++++G G+  +V+RGR    G   AIKVF+ +     ++    E EVL+ + H+N+V++
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 688 --ISSCTNDDFKALVLDYMPKGSLEACLY--SDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             I   T    K L++++ P GSL   L   S+   L   + L ++ D+   + +L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---R 129
Query: 744 PNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-Y 798
            N +VH +IKP N++     D   V +L DFG A+ L  DE         T  Y+ P+ Y
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VXLYGTEEYLHPDMY 187
Query: 799 GR-------EGQISTEGDVYSFGIMLMEIFTRKRP 826
            R       + +     D++S G+      T   P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRH 681
           T+++ +   +G G+F  V R  + L G E A  + + +   A   +    E  + R ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+VR+  S + +    L+ D +  G     L+ D    + +   +    I   LE +  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 742 GHPNPVVHCDIKPSNVLLDEDM---VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H   VVH ++KP N+LL   +     +L DFG+A  + G E         T GY++PE 
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEV 184
Query: 799 GREGQISTEGDVYSFGIML 817
            R+       D+++ G++L
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             S + D++S G+ L+E+   + P     + E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 634 IGSGSFGSVYRGRFLDGME-VAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G++G+V++ +  +  E VA+K   L    EG   S   E  +L+ ++H+N+VR+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL-EYLHFGHPNPVVH 749
             +D    LV ++  +  L+    S N +LD      IV      L + L F H   V+H
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP----EIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI-STEG 808
            D+KP N+L++ +   +L +FG+A+   G     ++  + T+ Y  P+     ++ ST  
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 809 DVYSFGIMLMEIFTRKRP 826
           D++S G +  E+    RP
Sbjct: 184 DMWSAGCIFAELANAGRP 201

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             S + D++S G+ L+E+   + P     + E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 30/239 (12%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRS 678
           +   ++     +G G F   Y    +D  EV A KV    +       E  + E  + +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID------I 732
           + + ++V       +DDF  +VL+   + SL          L++ KR   V +      +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL----------LELHKRRKAVTEPEARYFM 148
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              ++ + + H N V+H D+K  N+ L++DM  ++GDFG+A  +  D   K T    T  
Sbjct: 149 RQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPN 207
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD---------EIFSGEMSLKRWVN 842
           Y+APE   +   S E D++S G +L  +   K P +          I   E S+ R +N
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 266

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 126
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L  + +    + + T  YM+PE  +  
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA---NEFVGTRSYMSPERLQGT 181
Query: 803 QISTEGDVYSFGIMLMEIFTRK--RPTDEIFS 832
             S + D++S G+ L+E+   +  RP   IF 
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFE 213

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             S + D++S G+ L+E+   + P     + E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             S + D++S G+ L+E+   + P     + E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 150
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 205
Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
             S + D++S G+ L+E+   + P     + E+ L
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             S + D++S G+ L+E+   + P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
           +D F V + +G G+   VYR +     +  A+KV    ++  +     E  VL  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           ++++          +LVL+ +  G L     E   YS+    D  K++         LE 
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI---------LEA 160
Query: 739 LHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           + + H N +VH D+KP N+L      D   ++ DFG++K++     MK      T GY A
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK--TVCGTPGYCA 218
Query: 796 PEYGREGQISTEGDVYSFGIM 816
           PE  R      E D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGII 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 109/233 (46%), Gaps = 41/233 (17%)
Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVFHLQLEG-ALESFNAECE 674
           +F  NNL     +G+G+FG V        G+    ++VA+K+          E+  +E +
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL--------EACL------------ 713
           ++  + +H N+V ++ +CT+     ++ +Y   G L        EA L            
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 714 --YSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG 771
               D   L++   L+    +A  + +L   +    +H D+   NVLL    VA++GDFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 772 IAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           +A+ +  D +  +K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 204 LARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+ N+   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNLDIFKRLN------ 727
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +    +K L       
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 728 -----IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ES 781
                    +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D + 
Sbjct: 144 EHLICYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 626 DQFNVNNLIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALE-SFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL+++ A+      E +VL       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALEYLHFG 742
           +V    +  +D   ++ +++M  GSL+  L       + I  +++I +     L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 142
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           H   ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +  
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 197
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             S + D++S G+ L+E+   + P
Sbjct: 198 HYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           F+V+ +IG G FG VY  R  D      K++ ++          + E L ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 688 ISS-------CTNDDFK-----ALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDI 732
           +S+       C +  F      + +LD M  G L   L    S   +F   ++     +I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
            L LE++H      VV+ D+KP+N+LLDE    R+ D G+A   S     K   ++ T G
Sbjct: 302 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHG 355
Query: 793 YMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRP 826
           YMAPE  ++G    +  D +S G ML ++     P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           F+V+ +IG G FG VY  R  D      K++ ++          + E L ++  R ++ +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 244
Query: 688 ISS-------CTNDDFK-----ALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDI 732
           +S+       C +  F      + +LD M  G L   L    S   +F   ++     +I
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 300
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
            L LE++H      VV+ D+KP+N+LLDE    R+ D G+A   S     K   ++ T G
Sbjct: 301 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHG 354
Query: 793 YMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRP 826
           YMAPE  ++G    +  D +S G ML ++     P
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           F+V+ +IG G FG VY  R  D      K++ ++          + E L ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 688 ISS-------CTNDDFK-----ALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDI 732
           +S+       C +  F      + +LD M  G L   L    S   +F   ++     +I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
            L LE++H      VV+ D+KP+N+LLDE    R+ D G+A   S     K   ++ T G
Sbjct: 302 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHG 355
Query: 793 YMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRP 826
           YMAPE  ++G    +  D +S G ML ++     P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           F+V+ +IG G FG VY  R  D      K++ ++          + E L ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 688 ISS-------CTNDDFK-----ALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDI 732
           +S+       C +  F      + +LD M  G L   L    S   +F   ++     +I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
            L LE++H      VV+ D+KP+N+LLDE    R+ D G+A   S     K   ++ T G
Sbjct: 302 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHG 355
Query: 793 YMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRP 826
           YMAPE  ++G    +  D +S G ML ++     P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 624 ATDQ------FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF-HLQLE-GALESFNAECE 674
           ATD+      + +   IG G+F  V   R  L G EVA+K+    QL   +L+    E  
Sbjct: 7   ATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVR 66
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           +++ + H N+V++      +    LV++Y   G +   L +     +   R      I  
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 125
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           A++Y H  +   +VH D+K  N+LLD DM  ++ DFG +   +    +       +  Y 
Sbjct: 126 AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL--DTFCGSPPYA 180
Query: 795 APE-YGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
           APE +  +     E DV+S G++L  + +   P D
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAECEVLR------S 678
           + F ++ ++G GSFG V+   F    +  AIK   L+ +  L   + EC ++       +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
             H  L  +  +    +    V++Y+  G L   + S +   D+ +      +I L L++
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQF 133
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPE 797
           LH      +V+ D+K  N+LLD+D   ++ DFG+ K  + GD   K      T  Y+APE
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNXFCGTPDYIAPE 188
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                + +   D +SFG++L E+   + P
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 32/226 (14%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L+    F    ++G G+FG V + R  LD    AIK      E  L +  +E  +L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLN 60
Query: 681 H-------------RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN 727
           H             RN V+  ++        +  +Y    +L   ++S+N N    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-------LLSGD- 779
           +   I  AL Y+H      ++H ++KP N+ +DE    ++GDFG+AK       +L  D 
Sbjct: 121 LFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 780 -----ESMKHTQTLATIGYMAPEY-GREGQISTEGDVYSFGIMLME 819
                 S   T  + T  Y+A E     G  + + D YS GI+  E
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+K+    QL   +L+    E  +++ + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +    +       +  Y APE +  +     E D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+++    QL   +L+    E  +++ + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +    +   +   +  Y APE +  +     E D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DEFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+K+    QL   +L+    E  +++ + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +    +       +  Y APE +  +     E D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 628 FNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALE---SFNAECEVLRSIRHRN 683
           + +   +G GSFG V     +    +VA+K    QL    +       E   L+ +RH +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++++    T      +V++Y      +  +       D  +R      I  A+EY H   
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCH--- 125
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
            + +VH D+KP N+LLD+++  ++ DFG++ +++    +K   +  +  Y APE    G+
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPEVI-NGK 182
Query: 804 IST--EGDVYSFGIMLMEIFTRKRPTDEIF 831
           +    E DV+S GI+L  +   + P D+ F
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRS 678
           +   ++     +G G F   Y    +D  EV A KV    +       E  + E  + +S
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID------I 732
           + + ++V       +DDF  +VL+   + SL          L++ KR   V +      +
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL----------LELHKRRKAVTEPEARYFM 132
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              ++ + + H N V+H D+K  N+ L++DM  ++GDFG+A  +  D   K      T  
Sbjct: 133 RQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-KDLCGTPN 191
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD---------EIFSGEMSLKRWVN 842
           Y+APE   +   S E D++S G +L  +   K P +          I   E S+ R +N
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 250

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG+AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRS 678
           +   ++     +G G F   Y    +D  EV A KV    +       E  + E  + +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID------I 732
           + + ++V       +DDF  +VL+   + SL          L++ KR   V +      +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL----------LELHKRRKAVTEPEARYFM 148
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              ++ + + H N V+H D+K  N+ L++DM  ++GDFG+A  +  D   K      T  
Sbjct: 149 RQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-KDLCGTPN 207
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD---------EIFSGEMSLKRWVN 842
           Y+APE   +   S E D++S G +L  +   K P +          I   E S+ R +N
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 266

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV---FHLQLEGALESFNAECE 674
           +E+    + F +  +IG G+FG V   +  +   + A+K+   + +        F  E +
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           VL +   + +  +  +  +++   LV+DY   G L   L      L        + ++ L
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           A++ +H  H    VH DIKP NVLLD +   RL DFG    ++ D +++ +  + T  Y+
Sbjct: 203 AIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI 259
Query: 795 APEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRP 826
           +PE  +      G+   E D +S G+ + E+   + P
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+K+    QL   +L+    E  +++ + H N+V++   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 130
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +    +       +  Y APE +  +     E D
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 188
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 189 VWSLGVILYTLVSGSLPFD 207

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+K+    QL   +L+    E  +++ + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +    +          Y APE +  +     E D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 34/226 (15%)
Query: 627 QFNVNNL-----IGSGSFGSVYR------GRFLDGMEVAIKVFHLQLEG-ALESFNAECE 674
           +F  NNL     +G+G+FG V        G+    ++VA+K+          E+  +E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------YSDN------S 718
           ++  + +H N+V ++ +CT+     ++ +Y   G L   L         YS N       
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 719 NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
            L     L+    +A  + +L   +    +H D+   NVLL    VA++GDFG+A+ +  
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 779 DES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D +  +K    L  + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 219 DSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV---FHLQLEGALESFNAECE 674
           +E+    + F +  +IG G+FG V   +  +   + A+K+   + +        F  E +
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           VL +   + +  +  +  +++   LV+DY   G L   L      L        + ++ L
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           A++ +H  H    VH DIKP NVLLD +   RL DFG    ++ D +++ +  + T  Y+
Sbjct: 187 AIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI 243
Query: 795 APEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRP 826
           +PE  +      G+   E D +S G+ + E+   + P
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRS 678
           +   ++     +G G F   Y    +D  EV A KV    +       E  + E  + +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID------I 732
           + + ++V       +DDF  +VL+   + SL          L++ KR   V +      +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL----------LELHKRRKAVTEPEARYFM 148
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              ++ + + H N V+H D+K  N+ L++DM  ++GDFG+A  +  D   K      T  
Sbjct: 149 RQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-KXLCGTPN 207
Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD---------EIFSGEMSLKRWVN 842
           Y+APE   +   S E D++S G +L  +   K P +          I   E S+ R +N
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 266

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 12/194 (6%)
Query: 634 IGSGSFGSVYRGR--FLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISS 690
           +G G++ +VY+G+    D + VA+K   L+ E GA  +   E  +L+ ++H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV +Y+ K   +   Y D+   +I    N+ + +   L  L + H   V+H 
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQ---YLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREGQISTEG 808
           D+KP N+L++E    +L DFG+A+  S   +  +   + T+ Y  P+   G     ST+ 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLG-STDYSTQI 182
Query: 809 DVYSFGIMLMEIFT 822
           D++  G +  E+ T
Sbjct: 183 DMWGVGCIFYEMAT 196

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 14/223 (6%)
Query: 610 LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLEG 664
            + W+    Q + + T  F    ++G G FG V   +      +   +   K    + +G
Sbjct: 170 FLQWKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 665 ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIF 723
              + N E ++L  +  R +V +  +    D   LVL  M  G L+  +Y    +     
Sbjct: 228 EAMALN-EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286
Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK 783
           + +    +I   LE LH      +V+ D+KP N+LLD+    R+ D G+A  +   +++K
Sbjct: 287 RAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
               + T+GYMAPE  +  + +   D ++ G +L E+   + P
Sbjct: 344 G--RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 205
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 206 KGYNKAVDWWALGVLIYEM 224

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI---R 680
           T +F+    IGSG FGSV++  + LDG   AIK     L G+++  NA  EV       +
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALALE 737
           H ++VR  S+   DD   +  +Y   GSL   +  +   +  FK     ++++ +   L 
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 125
Query: 738 YLHFGHPNPVVHCDIKPSNVLL 759
           Y+H      +VH DIKPSN+ +
Sbjct: 126 YIH---SMSLVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI---R 680
           T +F+    IGSG FGSV++  + LDG   AIK     L G+++  NA  EV       +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALALE 737
           H ++VR  S+   DD   +  +Y   GSL   +  +   +  FK     ++++ +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 738 YLHFGHPNPVVHCDIKPSNVLL 759
           Y+H      +VH DIKPSN+ +
Sbjct: 130 YIH---SMSLVHMDIKPSNIFI 148

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI---R 680
           T +F+    IGSG FGSV++  + LDG   AIK     L G+++  NA  EV       +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALALE 737
           H ++VR  S+   DD   +  +Y   GSL   +  +   +  FK     ++++ +   L 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 738 YLHFGHPNPVVHCDIKPSNVLL 759
           Y+H      +VH DIKPSN+ +
Sbjct: 128 YIH---SMSLVHMDIKPSNIFI 146

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG+AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI---R 680
           T +F+    IGSG FGSV++  + LDG   AIK     L G+++  NA  EV       +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL---NIVIDIALALE 737
           H ++VR  S+   DD   +  +Y   GSL   +  +   +  FK     ++++ +   L 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 738 YLHFGHPNPVVHCDIKPSNVLL 759
           Y+H      +VH DIKPSN+ +
Sbjct: 128 YIH---SMSLVHMDIKPSNIFI 146

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 14/223 (6%)
Query: 610 LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLEG 664
            + W+    Q + + T  F    ++G G FG V   +      +   +   K    + +G
Sbjct: 170 FLQWKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 665 ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIF 723
              + N E ++L  +  R +V +  +    D   LVL  M  G L+  +Y    +     
Sbjct: 228 EAMALN-EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286
Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK 783
           + +    +I   LE LH      +V+ D+KP N+LLD+    R+ D G+A  +   +++K
Sbjct: 287 RAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
               + T+GYMAPE  +  + +   D ++ G +L E+   + P
Sbjct: 344 G--RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 16/220 (7%)
Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKV---FHLQLEGALESFNAECE 674
           +E+    D F +  +IG G+F  V   +    G   A+K+   + +   G +  F  E +
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 675 VLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           VL +   R + ++  +  ++++  LV++Y   G L   L      +        + +I +
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 735 ALEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           A++ +H  G+    VH DIKP N+LLD     RL DFG    L  D +++    + T  Y
Sbjct: 174 AIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 794 MAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           ++PE           G    E D ++ G+   E+F  + P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 35/178 (19%)
Query: 667 ESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNL 720
           E+   E ++LR +  H N++++  +   + F  LV D M KG L     E    S+    
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 721 DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE 780
            I + L   +++  AL  L+      +VH D+KP N+LLD+DM  +L DFG +  L   E
Sbjct: 128 KIMRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 781 SMKHTQTLATIGYMAPE------------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            ++  +   T  Y+APE            YG+      E D++S G+++  +     P
Sbjct: 179 KLR--EVCGTPSYLAPEIIECSMNDNHPGYGK------EVDMWSTGVIMYTLLAGSPP 228

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+++    QL   +L+    E  +++ + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +    +       +  Y APE +  +     E D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 205
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 206 KGYNKAVDWWALGVLIYEM 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNA---------ECEVLR 677
           F + +L+G G++G V         E VAIK         +E F+          E ++L+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILK 64
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
             +H N++ I +    D F+     Y+ +  ++  L+   S   +    +I   I   L 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH-----------TQ 786
            +   H + V+H D+KPSN+L++ +   ++ DFG+A+++  DES              T+
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGMTE 181
Query: 787 TLATIGYMAPEYG-REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG 833
            +AT  Y APE      + S   DV+S G +L E+F R RP   IF G
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP---IFPG 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLE------GALESFNAECEVLRSIRHRNLVRI 687
           IG GSF +VY+G  LD  E  ++V   +L+         + F  E E L+ ++H N+VR 
Sbjct: 34  IGRGSFKTVYKG--LD-TETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 688 I----SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI------DIALALE 737
                S+        LV +    G+L        + L  FK   I +       I   L+
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTL-------KTYLKRFKVXKIKVLRSWCRQILKGLQ 143
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
           +LH   P P++H D+K  N+ +       ++GD G+A L     +      + T  + AP
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFXAP 199
Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPIS 848
           E   E +     DVY+FG   +E  T + P  E  +     +R  +   P S
Sbjct: 200 EXYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPAS 250

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 233
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 234 KGYNKAVDWWALGVLIYEM 252

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 191
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 191
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 21/129 (16%)
Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-- 783
           L+I I IA A+E+LH      ++H D+KPSN+    D V ++GDFG+   +  DE  +  
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 784 ---------HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
                    H   + T  YM+PE       S + D++S G++L E+          FS +
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------FSTQ 276
Query: 835 MSLKRWVND 843
           M   R + D
Sbjct: 277 MERVRIITD 285

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             L ++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQLE-GALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVAIK+    QL   +L+    E  +++ + H N+V++   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    L+++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +     K      +  Y APE +  +     E D
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDTFCGSPPYAAPELFQGKKYDGPEVD 193
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 194 VWSLGVILYTLVSGSLPFD 212

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNA---------ECEVLR 677
           F + +L+G G++G V         E VAIK         +E F+          E ++L+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILK 64
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
             +H N++ I +    D F+     Y+ +  ++  L+   S   +    +I   I   L 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH-----------TQ 786
            +   H + V+H D+KPSN+L++ +   ++ DFG+A+++  DES              T+
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGMTE 181
Query: 787 TLATIGYMAPEYG-REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG 833
            +AT  Y APE      + S   DV+S G +L E+F R RP   IF G
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP---IFPG 225

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 85
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNLDIFKRL--NIVID 731
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +    +K    ++  D
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD 145
Query: 732 IALALEYL-----------HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD- 779
             L LE+L            F      +H D+   N+LL E  V ++ DFG+A+ +  D 
Sbjct: 146 F-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQLE-GALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVAIK+    QL   +L+    E  +++ + H N+V++   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    L+++Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD DM  ++ DFG +   +     K         Y APE +  +     E D
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 35/178 (19%)
Query: 667 ESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNL 720
           E+   E ++LR +  H N++++  +   + F  LV D M KG L     E    S+    
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 721 DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE 780
            I + L   +++  AL  L+      +VH D+KP N+LLD+DM  +L DFG +  L   E
Sbjct: 128 KIMRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 781 SMKHTQTLATIGYMAPE------------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            ++      T  Y+APE            YG+      E D++S G+++  +     P
Sbjct: 179 KLR--SVCGTPSYLAPEIIECSMNDNHPGYGK------EVDMWSTGVIMYTLLAGSPP 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 191
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 120
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 180
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 181 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 237
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             L ++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 191
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLV---RII 688
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++    II
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 689 SSCTNDDFK--ALVLDYMPKG--SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
            + T +  K   +V D M      L  C +  N ++  F     +  I   L+Y+H  + 
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----LYQILRGLKYIHSAN- 148
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEYGREG 802
             V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE     
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 803 QISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
           +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 207 KGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             L ++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIK-VFHLQLEGALESFNAECEV 675
           +++     D ++  +++G+G+F  V         + VAIK +    LEG   S   E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYS--DNSNLDIFKRLNI 728
           L  I+H N+V +     +     L++  +  G L     E   Y+  D S L IF+ L+ 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLD- 127
Query: 729 VIDIALALEYLH-FGHPNPVVHCDIKPSNVL---LDEDMVARLGDFGIAKLLSGDESMKH 784
                 A++YLH  G    +VH D+KP N+L   LDED    + DFG++K+   D     
Sbjct: 128 ------AVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVL 175
Query: 785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIM 816
           +    T GY+APE   +   S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 91  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 240

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRG------RFLDGMEVAIKVFHLQLEGALESFN----AECEV 675
           D+  +   +G G+FG V         +      VA+K+     EGA  S +    +E ++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 676 LRSIRHR-NLVRIISSCTNDDFKALVL-DYMPKGSLEACLYSDNSNL--------DIFKR 725
           L  I H  N+V ++ +CT      +V+ ++   G+L   L S  +          D++K 
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
                  +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 779 D-ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           D + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   +  + G   A+K+   Q    L+       E  + +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +VL+Y P G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 85  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 140 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 91  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 240

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 92  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 147 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 241

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 93  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 148 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 242

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 84  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 139 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 233

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 91  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 240

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAI-KVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAI K+   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 91  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 240

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPEYGR 800
                +++ D+KP N+L+D+    ++ DFG AK + G      T  LA T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPEIIL 211
Query: 801 EGQISTEGDVYSFGIMLMEI 820
               +   D ++ G+++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 621 LLQATDQFNVNNLIGSGSFG--SVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVL-- 676
           ++  +D+++    IGSG+FG   + R +    + VA+K       GA    N + E++  
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIE---RGAAIDENVQREIINH 70
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVID 731
           RS+RH N+VR           A++++Y   G L      A  +S++     F++L     
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL----- 125
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG--DFGIAKLLSGDESMKHTQTLA 789
               L  + + H   + H D+K  N LLD     RL   DFG +K      S+ H+Q  +
Sbjct: 126 ----LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKS 176
Query: 790 TIG---YMAPEY----GREGQISTEGDVYSFGIML 817
           T+G   Y+APE       +G+I+   DV+S G+ L
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIA---DVWSCGVTL 208

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L + RH N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 89  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 238

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 91  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT----QTLATIGYMAP 796
             +   V+H D+KPSN+LL+     ++ DFG+A++   D    HT    + +AT  Y AP
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAP 200
Query: 797 EYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
           E     +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 240

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 92  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT----QTLATIGYMAP 796
             +   V+H D+KPSN+LL+     ++ DFG+A++   D    HT    + +AT  Y AP
Sbjct: 147 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAP 201
Query: 797 EYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
           E     +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 241

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ------LEGALESFNAECEVLRSIRH 681
           F     +G+G+F  V     L   +   K+F ++      L+G   S   E  VLR I+H
Sbjct: 24  FEFKETLGTGAFSEV----VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALAL 736
            N+V +     + +   LV+  +  G L     E   Y++     + +++         L
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV---------L 130
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           + +++ H   +VH D+KP N+L    DE+    + DFG++K+    + M  +    T GY
Sbjct: 131 DAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM--STACGTPGY 188
Query: 794 MAPEYGREGQISTEGDVYSFGIM 816
           +APE   +   S   D +S G++
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+DE    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 199
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 200 KGYNKAVDWWALGVLIYEM 218

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 85  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 140 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 234

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGM-EVAIKVF-------------HLQLEGALESFNAEC 673
           F V  L GSG++G V   +  +G  E AIKV              +  +E   E    E 
Sbjct: 39  FKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            +L+S+ H N++++     +  +  LV ++   G L   + +     D     NI+  I 
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQIL 156
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDFGIAKLLSGDESMKHTQTLAT 790
             + YLH    + +VH DIKP N+LL+     +  ++ DFG++   S D  ++    L T
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR--DRLGT 211
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIML 817
             Y+APE  ++ + + + DV+S G+++
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIM 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQ-LEGALESFNAECEV 675
           +++     D ++  +++G+G+F  V         + VAIK    + LEG   S   E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYS--DNSNLDIFKRLNI 728
           L  I+H N+V +     +     L++  +  G L     E   Y+  D S L IF+ L+ 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLD- 127
Query: 729 VIDIALALEYLH-FGHPNPVVHCDIKPSNVL---LDEDMVARLGDFGIAKLLSGDESMKH 784
                 A++YLH  G    +VH D+KP N+L   LDED    + DFG++K+   D     
Sbjct: 128 ------AVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVL 175
Query: 785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIM 816
           +    T GY+APE   +   S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQ-LEGALESFNAECEV 675
           +++     D ++  +++G+G+F  V         + VAIK    + LEG   S   E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYS--DNSNLDIFKRLNI 728
           L  I+H N+V +     +     L++  +  G L     E   Y+  D S L IF+ L+ 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLD- 127
Query: 729 VIDIALALEYLH-FGHPNPVVHCDIKPSNVL---LDEDMVARLGDFGIAKLLSGDESMKH 784
                 A++YLH  G    +VH D+KP N+L   LDED    + DFG++K+   D     
Sbjct: 128 ------AVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVL 175
Query: 785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIM 816
           +    T GY+APE   +   S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 613 WRRFSYQ--ELLQAT--DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES 668
           W+++  Q  E+ Q +  D +++   +GSG+FG V+R        V +  F +     L+ 
Sbjct: 34  WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK 92
Query: 669 FNA--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL 726
           +    E  ++  + H  L+ +  +  +     L+L+++  G L   + +++  +   + +
Sbjct: 93  YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA--RLGDFGIAKLLSGDESMKH 784
           N    +  A E L   H + +VH DIKP N++ +    +  ++ DFG+A  L+ DE +K 
Sbjct: 153 NY---MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK- 208
Query: 785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIM 816
             T AT  + APE      +    D+++ G++
Sbjct: 209 -VTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQ-LEGALESFNAECEVLRSIRHRN 683
           D ++  +++G+G+F  V         + VAIK    + LEG   S   E  VL  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL-----EACLYS--DNSNLDIFKRLNIVIDIALAL 736
           +V +     +     L++  +  G L     E   Y+  D S L IF+ L+       A+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLD-------AV 129
Query: 737 EYLH-FGHPNPVVHCDIKPSNVL---LDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
           +YLH  G    +VH D+KP N+L   LDED    + DFG++K+   D     +    T G
Sbjct: 130 KYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 183
Query: 793 YMAPEYGREGQISTEGDVYSFGIM 816
           Y+APE   +   S   D +S G++
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGR 800
                +++ D+KP N+L+D+    ++ DFG AK + G      T TL  T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAPEIIL 232
Query: 801 EGQISTEGDVYSFGIMLMEI 820
               +   D ++ G+++ E+
Sbjct: 233 SKGYNKAVDWWALGVLIYEM 252

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 627 QFNVNNL-----IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRH 681
           Q  +N+L     +GSG+ G V++ RF     V I V  ++  G  E        L  +  
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHV-IAVKQMRRSGNKEENKRILMDLDVVLK 79
Query: 682 RNLVRIISSC-----TNDD-FKALVLDYMPKGSLEACLYSDNSNLD--IFKRL--NIVID 731
            +    I  C     TN D F A+ L       +  C       +   I +R+   + + 
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMEL-------MGTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           I  AL YL   H   V+H D+KPSN+LLDE    +L DFGI+  L  D++   +   A  
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA- 189
Query: 792 GYMAPEY-----GREGQISTEGDVYSFGIMLMEIFTRKRP 826
            YMAPE        +       DV+S GI L+E+ T + P
Sbjct: 190 -YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 610 LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-------- 661
            + W+    Q +    D F    ++G G FG V+  +    M+   K++  +        
Sbjct: 171 FLQWKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLK 224
Query: 662 ----LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY--- 714
                +GA+     E ++L  +  R +V +  +        LV+  M  G +   +Y   
Sbjct: 225 KRKGYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 715 SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
            DN      + +     I   LE+LH      +++ D+KP NVLLD+D   R+ D G+A 
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 775 LLSGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            L   ++ K      T G+MAPE   G E   S   D ++ G+ L E+   + P
Sbjct: 338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 610 LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-------- 661
            + W+    Q +    D F    ++G G FG V+  +    M+   K++  +        
Sbjct: 171 FLQWKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLK 224
Query: 662 ----LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY--- 714
                +GA+     E ++L  +  R +V +  +        LV+  M  G +   +Y   
Sbjct: 225 KRKGYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 715 SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
            DN      + +     I   LE+LH      +++ D+KP NVLLD+D   R+ D G+A 
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 775 LLSGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            L   ++ K      T G+MAPE   G E   S   D ++ G+ L E+   + P
Sbjct: 338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 610 LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-------- 661
            + W+    Q +    D F    ++G G FG V+  +    M+   K++  +        
Sbjct: 171 FLQWKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLK 224
Query: 662 ----LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY--- 714
                +GA+     E ++L  +  R +V +  +        LV+  M  G +   +Y   
Sbjct: 225 KRKGYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 715 SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
            DN      + +     I   LE+LH      +++ D+KP NVLLD+D   R+ D G+A 
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 775 LLSGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            L   ++ K      T G+MAPE   G E   S   D ++ G+ L E+   + P
Sbjct: 338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHR 682
           D++     +G G++G VY+    +    VAIK   L+ E  G   +   E  +L+ ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N++ + S   ++    L+ +Y  +  L+  +   + N D+  R+ I   +   +  ++F 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRV-IKSFLYQLINGVNFC 148
Query: 743 HPNPVVHCDIKPSNVLL-----DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           H    +H D+KP N+LL      E  V ++GDFG+A+   G    + T  + T+ Y  PE
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLWYRPPE 207
Query: 798 Y--GREGQISTEGDVYSFGIMLMEIFTR 823
              G     ST  D++S   +  E+  +
Sbjct: 208 ILLGSR-HYSTSVDIWSIACIWAEMLMK 234

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L + RH N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 89  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 238

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 87  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 236

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 610 LVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ-------- 661
            + W+    Q +    D F    ++G G FG V+  +    M+   K++  +        
Sbjct: 171 FLQWKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLK 224
Query: 662 ----LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY--- 714
                +GA+     E ++L  +  R +V +  +        LV+  M  G +   +Y   
Sbjct: 225 KRKGYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 715 SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
            DN      + +     I   LE+LH      +++ D+KP NVLLD+D   R+ D G+A 
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 775 LLSGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            L   ++ K      T G+MAPE   G E   S   D ++ G+ L E+   + P
Sbjct: 338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNA---------ECEVLR 677
           F + +L+G G++G V         E VAIK         +E F+          E ++L+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILK 64
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
             +H N++ I +    D F+     Y+ +  ++  L+   S   +    +I   I   L 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL---SGDESMKHTQT------L 788
            +   H + V+H D+KPSN+L++ +   ++ DFG+A+++   + D S    Q       +
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 789 ATIGYMAPEYG-REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG 833
           AT  Y APE      + S   DV+S G +L E+F R RP   IF G
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP---IFPG 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF     +G+GSFG V   + ++ G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 207
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 208 KGYNKAVDWWALGVLIYEM 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 87  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 236

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 87  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 236

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVL-RSI 679
           +Q TD + V   IG GS+    R       ME A+K+    ++ +      E E+L R  
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYG 73
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN---------IVI 730
           +H N++ +     +  +  +V + M  G L          LD   R           ++ 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSEREASAVLF 123
Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVL-LDED---MVARLGDFGIAKLLSGDESMKHTQ 786
            I   +EYLH      VVH D+KPSN+L +DE       R+ DFG AK L  +  +  T 
Sbjct: 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
              T  ++APE           D++S G++L  + T   P
Sbjct: 181 CY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 89  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 91/187 (48%), Gaps = 8/187 (4%)
Query: 633 LIGSGSFGSVYR-GRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           ++G G FG V++      G+++A K+   +     E    E  V+  + H NL+++  + 
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD 751
            + +   LV++Y+  G L   +  ++ NL     L+ ++ +    E +   H   ++H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 752 IKPSNVL-LDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGD 809
           +KP N+L ++ D    ++ DFG+A+     E +K      T  ++APE      +S   D
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLK--VNFGTPEFLAPEVVNYDFVSFPTD 270
Query: 810 VYSFGIM 816
           ++S G++
Sbjct: 271 MWSVGVI 277

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 233
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 234 KGYNKAVDWWALGVLIYEM 252

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 87  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 236

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 107 -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 162 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 256

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 95  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 150 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 244

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  +  D    D++K L             +  I   L+Y+H
Sbjct: 87  -NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 236

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVL--R 677
           ++  +D++ +   IGSG+FG     R     E VA+K       G   + N + E++  R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHR 70
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDI 732
           S+RH N+VR           A+V++Y   G L      A  +S++     F++L      
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ 124
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG--DFGIAKLLSGDESMKHTQTLAT 790
              +  + + H   V H D+K  N LLD     RL   DFG +K      S+ H+Q  +T
Sbjct: 125 ---ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKST 176
Query: 791 IG---YMAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRPTDE 829
           +G   Y+APE   + +   +  DV+S G+ L  +     P ++
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 42/237 (17%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRS--- 678
           +  D+F V  + G G+FG+V  G+    GM VAIK    ++       N E ++++    
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----KVIQDPRFRNRELQIMQDLAV 75
Query: 679 IRHRNLVRIIS-------SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL----N 727
           + H N+V++ S           D +  +V++Y+P      C        + ++R      
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC-------RNYYRRQVAPPP 128
Query: 728 IVIDIAL-----ALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDES 781
           I+I + L     ++  LH    N V H DIKP NVL++E D   +L DFG AK LS  E 
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 782 MKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMS 836
             +   + +  Y APE  +G +   +T  D++S G +  E+       + IF G+ S
Sbjct: 188 --NVAYICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMML----GEPIFRGDNS 237

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 16/220 (7%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALES--FNAECEVLRSIRHRNL 684
           Q N    +     G +++GR+  G ++ +KV  ++     +S  FN EC  LR   H N+
Sbjct: 11  QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 685 VRIISSCTND--DFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHF 741
           + ++ +C +       L+  + P GSL   L+   N  +D  + +   +D A    +LH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT 129
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
             P    H  +   +V +DED  AR+    +        S +         ++APE  ++
Sbjct: 130 LEPLIPRHA-LNSRSVXIDEDXTARISXADVKF------SFQSPGRXYAPAWVAPEALQK 182
Query: 802 GQIST---EGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
               T     D +SF ++L E+ TR+ P  ++ + E+  K
Sbjct: 183 KPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXK 222

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAIK+       +  A E+        E E+L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 69  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLLAV 126
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 127 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 181
Query: 794 MAPE----YGREGQISTEGDVYSFGIML 817
           +APE     G  G  +   D +S G++L
Sbjct: 182 LAPEVLVSVGTAG-YNRAVDCWSLGVIL 208

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAIK+       +  A E+        E E+L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 76  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLLAV 133
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 134 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 188
Query: 794 MAPE----YGREGQISTEGDVYSFGIML 817
           +APE     G  G  +   D +S G++L
Sbjct: 189 LAPEVLVSVGTAG-YNRAVDCWSLGVIL 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAIK+       +  A E+        E E+L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLLAV 127
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 182
Query: 794 MAPE----YGREGQISTEGDVYSFGIML 817
           +APE     G  G  +   D +S G++L
Sbjct: 183 LAPEVLVSVGTAG-YNRAVDCWSLGVIL 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLXGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAIK+       +  A E+        E E+L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLLAV 127
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 182
Query: 794 MAPE----YGREGQISTEGDVYSFGIML 817
           +APE     G  G  +   D +S G++L
Sbjct: 183 LAPEVLVSVGTAG-YNRAVDCWSLGVIL 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAIK+       +  A E+        E E+L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLLAV 127
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 182
Query: 794 MAPE----YGREGQISTEGDVYSFGIML 817
           +APE     G  G  +   D +S G++L
Sbjct: 183 LAPEVLVSVGTAG-YNRAVDCWSLGVIL 209

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 634 IGSGSFGSV---YRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +GSG++G+V     GR   G +VAIK  +   +  L +  A  E  +L+ +RH N++ ++
Sbjct: 33  VGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 689 SSCTND----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
              T D    DF    L  MP    +      +  L   +   +V  +   L Y+H    
Sbjct: 91  DVFTPDETLDDFTDFYL-VMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG- 148
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE----YGR 800
             ++H D+KP N+ ++ED   ++ DFG+A+    D  M     + T  Y APE    + R
Sbjct: 149 --IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEM--XGXVVTRWYRAPEVILNWMR 202
Query: 801 EGQISTEGDVYSFGIMLMEIFTRK 824
             Q     D++S G ++ E+ T K
Sbjct: 203 YTQTV---DIWSVGCIMAEMITGK 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 213
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN 180
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN 180
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 10/199 (5%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVF-HLQL-EGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVA+K+    QL   +L+    E  + + + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHC 750
              +    LV +Y   G +   L +     +   R      I  A++Y H      +VH 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 751 DIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQISTEGD 809
           D+K  N+LLD D   ++ DFG +   +    +          Y APE +  +     E D
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 810 VYSFGIMLMEIFTRKRPTD 828
           V+S G++L  + +   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++  +D++ +   IGSG+FG     R     E+    +  + E   E+   E    RS+R
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALA 735
           H N+VR           A+V++Y   G L      A  +S++     F++L         
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------- 123
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG--DFGIAKLLSGDESMKHTQTLATIG- 792
           +  + + H   V H D+K  N LLD     RL   DFG +K      S+ H+Q  +T+G 
Sbjct: 124 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGT 178
Query: 793 --YMAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRPTDE 829
             Y+APE   + +   +  DV+S G+ L  +     P ++
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 98/192 (51%), Gaps = 17/192 (8%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA----ECEVLRSIRHRNLVRII 688
           +GSG++G V   R  +  +E AIK+  ++      S N+    E  VL+ + H N++++ 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKI--IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
               +     LV++    G L    + +  +   F  ++  + I   L  + + H + +V
Sbjct: 103 DFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 749 HCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
           H D+KP N+LL   ++D + ++ DFG++ +    + MK  + L T  Y+APE  R+ +  
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK--ERLGTAYYIAPEVLRK-KYD 215
Query: 806 TEGDVYSFGIML 817
            + DV+S G++L
Sbjct: 216 EKCDVWSIGVIL 227

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 107/243 (44%), Gaps = 38/243 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKV-----FHLQLEGALESFNAECEVLRSI 679
           D + +  +IG G F  V R    + G + A+K+     F      + E    E  +   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--IVIDIALA-- 735
           +H ++V ++ + ++D    +V ++M    L  C        +I KR +   V   A+A  
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADL--CF-------EIVKRADAGFVYSEAVASH 136
Query: 736 -----LEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQT 787
                LE L + H N ++H D+KP  VLL   +     +LG FG+A  L G+  +     
Sbjct: 137 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGR 195
Query: 788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF--------TRKRPTDEIFSG--EMSL 837
           + T  +MAPE  +        DV+  G++L  +         T++R  + I  G  +M+ 
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNP 255
Query: 838 KRW 840
           ++W
Sbjct: 256 RQW 258

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 616 FSYQELLQ-ATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAE- 672
           + Y+E +  AT Q      +G GSFG V+R      G + A+K   L++      F AE 
Sbjct: 86  YEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV------FRAEE 135
Query: 673 ---CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIF 723
              C  L S R   +V +  +     +  + ++ +  GSL      + CL  D +     
Sbjct: 136 LMACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRA----- 187
Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV-ARLGDFGIAKLLSGDESM 782
                +  +  ALE L + H   ++H D+K  NVLL  D   A L DFG A  L  D   
Sbjct: 188 -----LYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 783 KHTQT----LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           K   T      T  +MAPE         + DV+S   M++ +     P  + F G + LK
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 125
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN 183
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVLEDN 180
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVLEDN 180
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 634 IGSGSFGSV---YRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +GSG++GSV   Y  R     +VA+K      +  + +     E  +L+ ++H N++ ++
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 689 SSCTN----DDFKALVLDYMPKGS----LEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
              T     +DF  + L     G+    +  C    + ++       +V  +   L+Y+H
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYIH 140
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 ++H D+KPSNV ++ED   R+ DFG+A+    DE M  T  +AT  Y APE   
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEM--TGYVATRWYRAPEIML 193
Query: 801 EG-QISTEGDVYSFGIMLMEIFTRK 824
                +   D++S G ++ E+   K
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 634 IGSGSFGSV---YRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +GSG++GSV   Y  R     +VA+K      +  + +     E  +L+ ++H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 689 SSCTN----DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALALEY 738
              T     +DF  + L       +   + +D +N+   + L+      +V  +   L+Y
Sbjct: 94  DVFTPATSIEDFSEVYL-------VTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 146
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           +H      ++H D+KPSNV ++ED   R+ DFG+A+    DE M  T  +AT  Y APE 
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEM--TGYVATRWYRAPEI 199
Query: 799 GREG-QISTEGDVYSFGIMLMEIFTRK 824
                  +   D++S G ++ E+   K
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 616 FSYQELLQ-ATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAE- 672
           + Y+E +  AT Q      +G GSFG V+R      G + A+K   L++      F AE 
Sbjct: 67  YEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV------FRAEE 116
Query: 673 ---CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIF 723
              C  L S R   +V +  +     +  + ++ +  GSL      + CL  D +     
Sbjct: 117 LMACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRA----- 168
Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV-ARLGDFGIAKLLSGDESM 782
                +  +  ALE L + H   ++H D+K  NVLL  D   A L DFG A  L  D   
Sbjct: 169 -----LYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 783 KHTQT----LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           K   T      T  +MAPE         + DV+S   M++ +     P  + F G + LK
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 632 NLIGSGSFGSVY-RGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
            ++GSG+F  V+   + L G   A+K           S   E  VL+ I+H N+V +   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 691 CTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIAL-ALEYLHFGHP 744
             +     LV+  +  G L     E  +Y++       K  ++VI   L A++YLH    
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTE-------KDASLVIQQVLSAVKYLH---E 124
Query: 745 NPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
           N +VH D+KP N+L    +E+    + DFG++K+   +++   +    T GY+APE   +
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 802 GQISTEGDVYSFGIM 816
              S   D +S G++
Sbjct: 182 KPYSKAVDCWSIGVI 196

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 634 IGSGSFGSV---YRGRFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRII 688
           +GSG++GSV   Y  R     +VA+K      +  + +     E  +L+ ++H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 689 SSCTN----DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALALEY 738
              T     +DF  + L       +   + +D +N+   + L+      +V  +   L+Y
Sbjct: 94  DVFTPATSIEDFSEVYL-------VTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKY 146
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           +H      ++H D+KPSNV ++ED   R+ DFG+A+    DE M  T  +AT  Y APE 
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEM--TGYVATRWYRAPEI 199
Query: 799 GREG-QISTEGDVYSFGIMLMEIFTRK 824
                  +   D++S G ++ E+   K
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVL--R 677
           ++  +D++ +   IG+G+FG     R     E VA+K       G     N + E++  R
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE---RGEKIDENVKREIINHR 70
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDI 732
           S+RH N+VR           A+V++Y   G L      A  +S++     F++L      
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ 124
Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL--GDFGIAKLLSGDESMKHTQTLAT 790
              +  + + H   V H D+K  N LLD     RL   DFG +K      S+ H+Q  + 
Sbjct: 125 ---ISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-----SVLHSQPKSA 176
Query: 791 IG---YMAPEYGREGQISTE-GDVYSFGIML 817
           +G   Y+APE   + +   +  DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 127
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVLEDN 185
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN--AECEVLRSIRH 681
            +++N+  ++G GSFG V + +  +   E A+KV +       ++     E E+L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N++++     +     +V +    G L    + +      F   +    I      + +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H + +VH D+KP N+LL   ++D   ++ DFG++     +  MK    + T  Y+APE 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--DRIGTAYYIAPEV 194
Query: 799 GREGQISTEGDVYSFGIML 817
            R G    + DV+S G++L
Sbjct: 195 LR-GTYDEKCDVWSAGVIL 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 634 IGSGSFGSVYRGR-FLDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      +    VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 692 TNDDFKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVH 749
                +A+   Y+ +  +E  LY    +  L        +  I   L+Y+H  +   V+H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH----TQTLATIGYMAPEYGREGQIS 805
            D+KPSN+L++     ++ DFG+A++   D    H    T+ +AT  Y APE     +  
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARI--ADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 806 TEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
           T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 226 TKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 256

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 107/243 (44%), Gaps = 38/243 (15%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKV-----FHLQLEGALESFNAECEVLRSI 679
           D + +  +IG G F  V R    + G + A+K+     F      + E    E  +   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN--IVIDIALA-- 735
           +H ++V ++ + ++D    +V ++M    L  C        +I KR +   V   A+A  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL--CF-------EIVKRADAGFVYSEAVASH 134
Query: 736 -----LEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQT 787
                LE L + H N ++H D+KP  VLL   +     +LG FG+A  L G+  +     
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGR 193
Query: 788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF--------TRKRPTDEIFSG--EMSL 837
           + T  +MAPE  +        DV+  G++L  +         T++R  + I  G  +M+ 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNP 253
Query: 838 KRW 840
           ++W
Sbjct: 254 RQW 256

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 634 IGSGSFGSVYRGRF-LDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC 691
           IG G++G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN-----------IVIDIALALEYLH 740
            ND  +A  ++ M     +  L +     D++K L             +  I   L+Y+H
Sbjct: 107 -NDIIRAPTIEQMK----DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGYMAPEY 798
             +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y APE 
Sbjct: 162 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 799 GREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
               +  T+  D++S G +L E+ +  RP   IF G+  L +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ 256

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN--AECEVLRSIRH 681
            +++N+  ++G GSFG V + +  +   E A+KV +       ++     E E+L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N++++     +     +V +    G L    + +      F   +    I      + +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H + +VH D+KP N+LL   ++D   ++ DFG++     +  MK    + T  Y+APE 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--DRIGTAYYIAPEV 194
Query: 799 GREGQISTEGDVYSFGIML 817
            R G    + DV+S G++L
Sbjct: 195 LR-GTYDEKCDVWSAGVIL 212

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN---AECEVLRSIRHRN 683
           F+   L+G G+FG V   R    G   A+K+   ++  A +       E  VL++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           L  +  +    D    V++Y   G L   L  +    +   R     +I  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKHTQTLATIGYMAPEYGREG 802
              VV+ DIK  N++LD+D   ++ DFG+ K  +S   +MK      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVLEDN 180
Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
                 D +  G+++ E+   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFN--AECEVLRSIRH 681
            +++N+  ++G GSFG V + +  +   E A+KV +       ++     E E+L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N++++     +     +V +    G L    + +      F   +    I      + +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            H + +VH D+KP N+LL   ++D   ++ DFG++     +  MK    + T  Y+APE 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--DRIGTAYYIAPEV 194
Query: 799 GREGQISTEGDVYSFGIML 817
            R G    + DV+S G++L
Sbjct: 195 LR-GTYDEKCDVWSAGVIL 212

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAI++       +  A E+        E E+L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLLAV 266
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 267 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 321
Query: 794 MAPE----YGREGQISTEGDVYSFGIMLM 818
           +APE     G  G  +   D +S G++L 
Sbjct: 322 LAPEVLVSVGTAG-YNRAVDCWSLGVILF 349

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ ++
Sbjct: 213 KGYNKAVDWWALGVLIYQM 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+++D+    ++ DFG AK + G    +      T  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIIIS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 33/236 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D + +   +GSG F  V + R    G E A K    +   +       E    E  +LR 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIA 733
           IRH N++ +     N     L+L+ +  G L     E    +++      K++       
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------- 124
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIA-KLLSGDESMKHTQTL 788
             L+ +H+ H   + H D+KP N++L +  V     +L DFGIA K+ +G+E        
Sbjct: 125 --LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIF 179
Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDS 844
            T  ++APE      +  E D++S G++   + +   P    F GE   +   N S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETKQETLTNIS 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVF---HLQLEGALES-----FNAECEVL 676
           D++ ++  +GSG+ G V          +VAI++       +  A E+        E E+L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           + + H  +++I +    +D+  +VL+ M  G L   +  +    +   +L     + LA+
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV 252
Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L G+ S+  T    T  Y
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-LCGTPTY 307
Query: 794 MAPE----YGREGQISTEGDVYSFGIMLM 818
           +APE     G  G  +   D +S G++L 
Sbjct: 308 LAPEVLVSVGTAG-YNRAVDCWSLGVILF 335

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 33/236 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D + +   +GSG F  V + R    G E A K    +   +       E    E  +LR 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIA 733
           IRH N++ +     N     L+L+ +  G L     E    +++      K++       
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------- 117
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIA-KLLSGDESMKHTQTL 788
             L+ +H+ H   + H D+KP N++L +  V     +L DFGIA K+ +G+E        
Sbjct: 118 --LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIF 172
Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDS 844
            T  ++APE      +  E D++S G++   + +   P    F GE   +   N S
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETKQETLTNIS 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EG-ALESFNAECEVLRS 678
           D + +   +GSG F  V + R    G E A K    +       G + E    E  +LR 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIA 733
           IRH N++ +     N     L+L+ +  G L     E    +++      K++       
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------- 138
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIA-KLLSGDESMKHTQTL 788
             L+ +H+ H   + H D+KP N++L +  V     +L DFGIA K+ +G+E        
Sbjct: 139 --LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIF 193
Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIM 816
            T  ++APE      +  E D++S G++
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 628 FNVNNLIGSGSFG----SVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
           + + N IG GS+G    +V +G  +      I  + ++    ++ F  E E+++S+ H N
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPN 84
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++R+  +  ++    LV++    G L    +    +  +F+  +    +   L  + + H
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCH 140
Query: 744 PNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
              V H D+KP N L      D   +L DFG+A      + M+    + T  Y++P+   
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR--TKVGTPYYVSPQV-L 197
Query: 801 EGQISTEGDVYSFGIML 817
           EG    E D +S G+M+
Sbjct: 198 EGLYGPECDEWSAGVMM 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA---ECEVLRSIR 680
           +D++     +GSG++G V   +  L G E AIK+          +  A   E  VL+ + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL--EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           H N++++     +     LV++    G L  E  L    S +D      I+  +     Y
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA---AVIMKQVLSGTTY 136
Query: 739 LHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           LH    + +VH D+KP N+LL+    D + ++ DFG++        MK  + L T  Y+A
Sbjct: 137 LH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK--ERLGTAYYIA 191
Query: 796 PEYGREGQISTEGDVYSFGIML 817
           PE  R+ +   + DV+S G++L
Sbjct: 192 PEVLRK-KYDEKCDVWSCGVIL 212

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 64/125 (51%), Gaps = 10/125 (8%)
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ 786
            I + I  ALE+LH      V+H D+KPSNVL++     ++ DFGI+  L   +S+  T 
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTI 212
Query: 787 TLATIGYMAPEY-----GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
                 YMAPE       ++G  S + D++S GI ++E+   + P D   +    LK+ V
Sbjct: 213 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 842 NDSLP 846
            +  P
Sbjct: 272 EEPSP 276

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV     +  G+++A+K      +  + +  
Sbjct: 37  FYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR 96
Query: 671 A--ECEVLRSIRHRNLVRIISSCTN----DDFKALVLDYMPKGSLEACLYSDNSNLDIFK 724
              E  +L+ ++H N++ ++   T     ++F  + L       +   + +D +N+   +
Sbjct: 97  TYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYL-------VTHLMGADLNNIVKCQ 149
Query: 725 RLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
           +L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    
Sbjct: 150 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HT 204
Query: 779 DESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 205 DDEM--TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 55/240 (22%)
Query: 634 IGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNAECEVLRSIR---------- 680
           +G G++G V++   +D   G  VA+K          ++F    +  R+ R          
Sbjct: 17  LGKGAYGIVWKS--IDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 681 HRNLVRIIS--SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           H N+V +++     ND    LV DYM +  L A + ++   L+   +  +V  +   ++Y
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI--LEPVHKQYVVYQLIKVIKY 124
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL------------LSGDESMKH-- 784
           LH G    ++H D+KPSN+LL+ +   ++ DFG+++             LS +E+ ++  
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 785 ------TQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
                 T  +AT  Y APE        T+G D++S G +L EI   K     IF G  ++
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK----PIFPGSSTM 237

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T  Y+AP     
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPAIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA---ECEVLRSIR 680
           +D++     +GSG++G V   +  L G E AIK+          +  A   E  VL+ + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL--EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           H N++++     +     LV++    G L  E  L    S +D      I+  +     Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA---AVIMKQVLSGTTY 119
Query: 739 LHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           LH    + +VH D+KP N+LL+    D + ++ DFG++        MK  + L T  Y+A
Sbjct: 120 LH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK--ERLGTAYYIA 174
Query: 796 PEYGREGQISTEGDVYSFGIML 817
           PE  R+ +   + DV+S G++L
Sbjct: 175 PEVLRK-KYDEKCDVWSCGVIL 195

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 111
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 232 KKIDSAPLALLH 243

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHR 682
            + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEY 738
           N+V+        + + L L+Y   G L             F R  I  DI +    A  +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRF 109
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTLAT 790
            H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +   +   T
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 791 IGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN- 842
           + Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N 
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 229
Query: 843 ----DSLPISIMN 851
               DS P+++++
Sbjct: 230 WKKIDSAPLALLH 242

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHR 682
            + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEY 738
           N+V+        + + L L+Y   G L             F R  I  DI +    A  +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRF 110
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTLAT 790
            H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +   +   T
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 791 IGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDE 829
           + Y+APE  +  +   E  DV+S GI+L  +   + P D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           IGSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 95  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM--TGYVATRWYRA 195
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGXVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVL-RSIRHR 682
           +D + V   IG GS+    R       ME A+KV    ++ +    + E E+L R  +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKV----IDKSKRDPSEEIEILLRYGQHP 81
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN---------IVIDIA 733
           N++ +     +     LV + M  G L          LD   R           ++  I 
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGEL----------LDKILRQKFFSEREASFVLHTIG 131
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVL-LDED---MVARLGDFGIAKLLSGDESMKHTQTLA 789
             +EYLH      VVH D+KPSN+L +DE       R+ DFG AK L  +  +  T    
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY- 187
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T  ++APE  +        D++S GI+L  +     P
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK-LLSGDESMKHTQTLAT 790
           +A  +E+L        +H D+   N+LL E+ V ++ DFG+A+ +    + ++   T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MAPE   +   ST+ DV+S+G++L EIF+
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVL-RSIRHR 682
           +D + V   IG GS+    R       ME A+KV    ++ +    + E E+L R  +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKV----IDKSKRDPSEEIEILLRYGQHP 81
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN---------IVIDIA 733
           N++ +     +     LV + M  G L          LD   R           ++  I 
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGEL----------LDKILRQKFFSEREASFVLHTIG 131
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVL-LDED---MVARLGDFGIAKLLSGDESMKHTQTLA 789
             +EYLH      VVH D+KPSN+L +DE       R+ DFG AK L  +  +  T    
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY- 187
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T  ++APE  +        D++S GI+L  +     P
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 14  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V++    G+++   +     ++D ++R +   ++   LE +H
Sbjct: 72  DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 125
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q + T+ YM PE 
Sbjct: 126 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGTVNYMPPEA 183
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 11  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V++    G+++   +     ++D ++R +   ++   LE +H
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 122
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q + T+ YM PE 
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGTVNYMPPEA 180
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 95  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM--TGYVATRWYRA 195
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 87  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 187
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 101 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM--TGYVATRWYRA 201
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 86  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 186
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHR 682
            + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEY 738
           N+V+        + + L L+Y   G L             F R  I  DI +    A  +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRF 110
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTLAT 790
            H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +   +   T
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 791 IGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN- 842
           + Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N 
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230
Query: 843 ----DSLPISIMN 851
               DS P+++++
Sbjct: 231 WKKIDSAPLALLH 243

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA---ECEVLRSIRH 681
           DQF+    +G+GSFG V   +  + G   A+K+   Q    L+       E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L       +   R      I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK + G    +      T   +APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEALAPEIILS 212
Query: 802 GQISTEGDVYSFGIMLMEI 820
              +   D ++ G+++ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEM 231

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHR 682
            + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEY 738
           N+V+        + + L L+Y   G L             F R  I  DI +    A  +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRF 110
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTLAT 790
            H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +   +   T
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 791 IGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN- 842
           + Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N 
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230
Query: 843 ----DSLPISIMN 851
               DS P+++++
Sbjct: 231 WKKIDSAPLALLH 243

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 625 TDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHR 682
            + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEY 738
           N+V+        + + L L+Y   G L             F R  I  DI +    A  +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRF 110
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK-HTQTLAT 790
            H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +   +   T
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 791 IGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN- 842
           + Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N 
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230
Query: 843 ----DSLPISIMN 851
               DS P+++++
Sbjct: 231 WKKIDSAPLALLH 243

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV        G+ VA+K      +  + +  
Sbjct: 6   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 65
Query: 671 A--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNSN 719
              E  +L+ ++H N++ ++   T            P  SLE           + +D +N
Sbjct: 66  TYRELRLLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNN 113
Query: 720 LDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           +   ++L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A
Sbjct: 114 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 170
Query: 774 KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           +    D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 171 R--HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 30  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V   M  G+++   +     ++D ++R +   ++   LE +H
Sbjct: 88  DKIIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q + T+ YM PE 
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGTVNYMPPEA 199
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 631 NNLIGSGSFGSVYRGRF--------LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR 682
           N  +G G+F  +++G          L   EV +KV         ESF     ++  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +LV     C   D   LV +++  GSL+  L  + + ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 743 HPNPVVHCDIKPSNVLL--DEDMVA------RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
             N ++H ++   N+LL  +ED         +L D GI+  +   + ++       I ++
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWV 184
Query: 795 APEYGREGQ-ISTEGDVYSFGIMLMEI 820
            PE     + ++   D +SFG  L EI
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 87  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 187
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 95  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 195
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 89  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 137 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 189
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 95  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 195
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 10  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V++    G+++   +     ++D ++R +   ++   LE +H
Sbjct: 68  DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 121
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q + T+ YM PE 
Sbjct: 122 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGTVNYMPPEA 179
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++  +D++ +   IGSG+FG     R     E+    +  + E   E+   E    RS+R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALA 735
           H N+VR           A+V++Y   G L      A  +S++     F++L         
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------- 124
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG--DFGIAKLLSGDESMKHTQTLATIG- 792
           +  + + H   V H D+K  N LLD     RL    FG +K      S+ H+Q  +T+G 
Sbjct: 125 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTVGT 179
Query: 793 --YMAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRPTDE 829
             Y+APE   + +   +  DV+S G+ L  +     P ++
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 92  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 192
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 92  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 192
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 92  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 192
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 96  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 196
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV        G+ VA+K      +  + +  
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 87
Query: 671 A--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNSN 719
              E  +L+ ++H N++ ++   T            P  SLE           + +D +N
Sbjct: 88  TYRELRLLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNN 135
Query: 720 LDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           +   ++L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A
Sbjct: 136 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 192
Query: 774 KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           +    D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 193 R--HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 97  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 197
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 30/230 (13%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
            Y+APE  +  +   E  DV+S GI+L  +   + P D+          W
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW 220

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 631 NNLIGSGSFGSVYRGRF--------LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR 682
           N  +G G+F  +++G          L   EV +KV         ESF     ++  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           +LV     C   D   LV +++  GSL+  L  + + ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 743 HPNPVVHCDIKPSNVLL--DEDMVA------RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
             N ++H ++   N+LL  +ED         +L D GI+  +   + ++       I ++
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWV 184
Query: 795 APEYGREGQ-ISTEGDVYSFGIMLMEI 820
            PE     + ++   D +SFG  L EI
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 102 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 202
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 102 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 202
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 102 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 202
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 109 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 209
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 101 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 201
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 58  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V++    G+++   +     ++D ++R +   ++   LE +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 169
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q + T+ YM PE 
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGTVNYMPPEA 227
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 92  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEM--TGYVATRWYRA 192
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV        G+ VA+K      +  + +  
Sbjct: 31  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 90
Query: 671 A--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNSN 719
              E  +L+ ++H N++ ++   T            P  SLE           + +D +N
Sbjct: 91  TYRELRLLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNN 138
Query: 720 LDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           +   ++L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A
Sbjct: 139 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 195
Query: 774 KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           +    D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 196 R--HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 96  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEM--TGYVATRWYRA 196
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 96  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 196
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEV 675
           +  D +++   +GSG F  V + R    G+E A K    +   A       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           LR + H N++ +     N     L+L+ +  G L   L +   +L   +  + +  I   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 736 LEYLHFGHPNPVVHCDIKPSNV-LLDEDMV---ARLGDFGIAKLLSGDESMKHTQTLATI 791
           + YLH      + H D+KP N+ LLD+++     +L DFG+A  +  ++ ++      T 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 792 GYMAPEYGREGQISTEGDVYSFGIM 816
            ++APE      +  E D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 109
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 230 KKIDSAPLALLH 241

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 111
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 232 KKIDSAPLALLH 243

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 110
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 231 KKIDSAPLALLH 242

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  + + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 111
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 232 KKIDSAPLALLH 243

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY-----GRE 801
           ++H DIKPSN+LLD     +L DFGI+  L   +S+  T+      YMAPE       R+
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP 826
           G      DV+S GI L E+ T + P
Sbjct: 205 G-YDVRSDVWSLGITLYELATGRFP 228

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVL-RSI 679
           +Q TD + V   IG GS+    R        E A+K+    ++ +      E E+L R  
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKI----IDKSKRDPTEEIEILLRYG 73
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGS------LEACLYSDNSNLDIFKRLNIVIDIA 733
           +H N++  +    +D     V+  + KG       L    +S+       +   ++  I 
Sbjct: 74  QHPNII-TLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSER------EASAVLFTIT 126
Query: 734 LALEYLHFGHPNPVVHCDIKPSNVL-LDED---MVARLGDFGIAKLLSGDESMKHTQTLA 789
             +EYLH      VVH D+KPSN+L +DE       R+ DFG AK L  +  +  T    
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY- 182
Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T  ++APE           D++S G++L    T   P
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 58  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V++    G+++   +     ++D ++R +   ++   LE +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 169
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q + T+ YM PE 
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGTVNYMPPEA 227
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 11/197 (5%)
Query: 628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEV---LRSIRHRN 683
           F   + +G GS+G V++ R   DG   A+K       G  +      EV    +  +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
            VR+  +        L  + +   SL+    +  ++L   +    + D  LAL +LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              +VH D+KP+N+ L      +LGDFG+   L G       Q      YMAPE   +G 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPEL-LQGS 231
Query: 804 ISTEGDVYSFGIMLMEI 820
             T  DV+S G+ ++E+
Sbjct: 232 YGTAADVFSLGLTILEV 248

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 626 DQFNVNNLIGSGSFGSV------YRGRFLDGMEVAIKVFHLQLEGALESFN---AECEVL 676
           ++F    L+G G+FG V        GR+      A+K+   ++  A +       E  VL
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVI 730
           ++ RH  L  +  S    D    V++Y   G L      E     D +            
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGA 255
Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +I  AL+YLH      VV+ D+K  N++LD+D   ++ DFG+ K     E +K   T+ T
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKT 308
Query: 791 I----GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                 Y+APE   +       D +  G+++ E+   + P
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 626 DQFNVNNLIGSGSFGSV------YRGRFLDGMEVAIKVFHLQLEGALESFN---AECEVL 676
           ++F    L+G G+FG V        GR+      A+K+   ++  A +       E  VL
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVI 730
           ++ RH  L  +  S    D    V++Y   G L      E     D +            
Sbjct: 206 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGA 258
Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           +I  AL+YLH      VV+ D+K  N++LD+D   ++ DFG+ K     E +K   T+ T
Sbjct: 259 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKT 311
Query: 791 I----GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                 Y+APE   +       D +  G+++ E+   + P
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEV 675
           +  D +++   +GSG F  V + R    G+E A K    +   A       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           LR + H N++ +     N     L+L+ +  G L   L +   +L   +  + +  I   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 736 LEYLHFGHPNPVVHCDIKPSNV-LLDEDMV---ARLGDFGIAKLLSGDESMKHTQTLATI 791
           + YLH      + H D+KP N+ LLD+++     +L DFG+A  +  ++ ++      T 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 792 GYMAPEYGREGQISTEGDVYSFGIM 816
            ++APE      +  E D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEV 675
           +  D +++   +GSG F  V + R    G+E A K    +   A       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           LR + H N++ +     N     L+L+ +  G L   L +   +L   +  + +  I   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 736 LEYLHFGHPNPVVHCDIKPSNV-LLDEDMV---ARLGDFGIAKLLSGDESMKHTQTLATI 791
           + YLH      + H D+KP N+ LLD+++     +L DFG+A  +  ++ ++      T 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 792 GYMAPEYGREGQISTEGDVYSFGIM 816
            ++APE      +  E D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 97  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+  + DE    T  +AT  Y A
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM---TGYVATRWYRA 197
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 97  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+  + DE    T  +AT  Y A
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM---TGYVATRWYRA 197
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 107/224 (47%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 30  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V   M  G+++   +     ++D ++R +   ++   LE +H
Sbjct: 88  DKIIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 141
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D    +K +Q + T+ YM PE 
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQ-VGTVNYMPPEA 199
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEV 675
           +  D +++   +GSG F  V + R    G+E A K    +   A       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           LR + H N++ +     N     L+L+ +  G L   L +   +L   +  + +  I   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 736 LEYLHFGHPNPVVHCDIKPSNV-LLDEDMV---ARLGDFGIAKLLSGDESMKHTQTLATI 791
           + YLH      + H D+KP N+ LLD+++     +L DFG+A  +  ++ ++      T 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 792 GYMAPEYGREGQISTEGDVYSFGIM 816
            ++APE      +  E D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEV 675
           +  D +++   +GSG F  V + R    G+E A K    +   A       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           LR + H N++ +     N     L+L+ +  G L   L +   +L   +  + +  I   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 736 LEYLHFGHPNPVVHCDIKPSNV-LLDEDMV---ARLGDFGIAKLLSGDESMKHTQTLATI 791
           + YLH      + H D+KP N+ LLD+++     +L DFG+A  +  ++ ++      T 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 792 GYMAPEYGREGQISTEGDVYSFGIM 816
            ++APE      +  E D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 97  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+  + DE    T  +AT  Y A
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM---TGYVATRWYRA 197
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 621 LLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           ++  +D++ +   IGSG+FG     R     E+    +  + E   E+   E    RS+R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALA 735
           H N+VR           A+V++Y   G L      A  +S++     F++L         
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------- 124
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG--DFGIAKLLSGDESMKHTQTLATIG- 792
           +  + + H   V H D+K  N LLD     RL    FG +K      S+ H+Q   T+G 
Sbjct: 125 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKDTVGT 179
Query: 793 --YMAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRPTDE 829
             Y+APE   + +   +  DV+S G+ L  +     P ++
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESF-NAECEVLRSIRHRNL 684
           +++ +   +G G FG V+R       +  +  F ++++G  +     E  +L   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNI 63
Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN----------IVIDIAL 734
           + +  S  + +   ++ +++             S LDIF+R+N          IV  +  
Sbjct: 64  LHLHESFESMEELVMIFEFI-------------SGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
             E L F H + + H DI+P N++         ++ +FG A+ L   ++ +   T     
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE-- 168
Query: 793 YMAPEYGREGQISTEGDVYSFGIML 817
           Y APE  +   +ST  D++S G ++
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 31/239 (12%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAEC-----EVLRSI 679
           D F    ++G GSFG V   R  + G   A+KV  L+ +  L+  + EC      +L   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 680 R-HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           R H  L ++       D    V++++  G L   +   +   D  +      +I  AL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMF 139
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYM 794
           LH      +++ D+K  NVLLD +   +L DFG+ K     E + +  T AT      Y+
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYI 191
Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIFSG----EMSLKRWVNDS 844
           APE  +E       D ++ G++L E+     P      D++F      E+    W+++ 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ D+G+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 86  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 186
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAE----CEVLRSIRHRNLVRII 688
           +G GSFG V+R +    G + A+K   L      E F  E    C  L S R   +V + 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPR---IVPLY 116
Query: 689 SSCTNDDFKALVLDYMPKGSLE------ACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +     +  + ++ +  GSL        CL  D +          +  +  ALE L + 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----------LYYLGQALEGLEYL 166
Query: 743 HPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQT----LATIGYMAPE 797
           H   ++H D+K  NVLL  D   A L DFG A  L  D   K   T      T  +MAPE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
                    + D++S   M++ +     P  + F G + LK
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 628 FNVNNLIGSGSFG----SVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
           + + N IG GS+G    +V +G  +      I  + ++    ++ F  E E+++S+ H N
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPN 67
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++R+  +  ++    LV++    G L    +    +  +F+  +    +   L  + + H
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 744 PNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
              V H D+KP N L      D   +L DFG+A      + M+    + T  Y++P+   
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR--TKVGTPYYVSPQV-L 180
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
           EG    E D +S G+M+  +     P       E+ LK
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLK 218

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 100 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 200
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 109 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 209
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 62/125 (49%), Gaps = 10/125 (8%)
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ 786
            I + I  ALE+LH      V+H D+KPSNVL++     ++ DFGI+  L  D  +    
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDI 168
Query: 787 TLATIGYMA-----PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
                 YMA     PE  ++G  S + D++S GI ++E+   + P D   +    LK+ V
Sbjct: 169 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 842 NDSLP 846
            +  P
Sbjct: 228 EEPSP 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 42/230 (18%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV        G  VA+K      +  + +  
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 87
Query: 671 A--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNSN 719
              E  +L+ ++H N++ ++   T            P  SLE           + +D +N
Sbjct: 88  TYRELRLLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNN 135
Query: 720 LDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           +   ++L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A
Sbjct: 136 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 192
Query: 774 KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           +    D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 193 R--HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 96  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M  T  +AT  Y A
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--TGYVATRWYRA 196
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAE----CEVLRSIRHRNLVRII 688
           +G GSFG V+R +    G + A+K   L      E F  E    C  L S R   +V + 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPR---IVPLY 132
Query: 689 SSCTNDDFKALVLDYMPKGSLE------ACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +     +  + ++ +  GSL        CL  D +          +  +  ALE L + 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----------LYYLGQALEGLEYL 182
Query: 743 HPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQT----LATIGYMAPE 797
           H   ++H D+K  NVLL  D   A L DFG A  L  D   K   T      T  +MAPE
Sbjct: 183 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
                    + D++S   M++ +     P  + F G + LK
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEV 675
           +  D +++   +GSG F  V + R    G+E A K    +   A       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           LR + H N++ +     N     L+L+ +  G L   L +   +L   +  + +  I   
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 736 LEYLHFGHPNPVVHCDIKPSNV-LLDEDMV---ARLGDFGIAKLLSGDESMKHTQTLATI 791
           + YLH      + H D+KP N+ LLD+++     +L DFG+A  +  ++ ++      T 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 792 GYMAPEYGREGQISTEGDVYSFGIM 816
            ++APE      +  E D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 667 ESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL 726
           E+   E  + + + H N+V+        + + L L+Y   G L             F R 
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR- 94
Query: 727 NIVIDIAL----ALEYLH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
            I  DI +    A  + H       + H   + H DIKP N+LLDE    ++ DFG+A +
Sbjct: 95  -IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 153
Query: 776 LSGDESMKHTQTL-ATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI--- 830
              +   +    +  T+ Y+APE  +  +   E  DV+S GI+L  +   + P D+    
Sbjct: 154 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213
Query: 831 ---FSGEMSLKRWVN-----DSLPISIMN 851
              +S     K ++N     DS P+++++
Sbjct: 214 CQEYSDWKEKKTYLNPWKKIDSAPLALLH 242

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAE----CEVLRSIRHRNLVRII 688
           +G GSFG V+R +    G + A+K   L      E F  E    C  L S R   +V + 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPR---IVPLY 130
Query: 689 SSCTNDDFKALVLDYMPKGSLE------ACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +     +  + ++ +  GSL        CL  D +          +  +  ALE L + 
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----------LYYLGQALEGLEYL 180
Query: 743 HPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQT----LATIGYMAPE 797
           H   ++H D+K  NVLL  D   A L DFG A  L  D   K   T      T  +MAPE
Sbjct: 181 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
                    + D++S   M++ +     P  + F G + LK
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 627 QFNVNNLIGSGSFGSV------YRGRFLDGMEVAIKVFHLQLEGALESFN---AECEVLR 677
           +F    L+G G+FG V        GR+      A+K+   ++  A +       E  VL+
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           + RH  L  +  S    D    V++Y   G L   L  +    +   R     +I  AL+
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD 122
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL----ATIGY 793
           YLH      VV+ D+K  N++LD+D   ++ DFG+ K     E +K   T+     T  Y
Sbjct: 123 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEY 175
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +APE   +       D +  G+++ E+   + P
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 627 QFNVNNLIGSGSFGSV------YRGRFLDGMEVAIKVFHLQLEGALESFN---AECEVLR 677
           +F    L+G G+FG V        GR+      A+K+   ++  A +       E  VL+
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           + RH  L  +  S    D    V++Y   G L   L  +    +   R     +I  AL+
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD 124
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL----ATIGY 793
           YLH      VV+ D+K  N++LD+D   ++ DFG+ K     E +K   T+     T  Y
Sbjct: 125 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEY 177
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +APE   +       D +  G+++ E+   + P
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 59/252 (23%), Positives = 108/252 (42%), Gaps = 41/252 (16%)
Query: 626 DQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V      +    VA+K+  ++      E+   E  +   + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL----ALEYL 739
           +V+        + + L L+Y   G L             F R  I  DI +    A  + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL-------------FDR--IEPDIGMPEPDAQRFF 111
Query: 740 H-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATI 791
           H       + H   + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEI------FSGEMSLKRWVN-- 842
            Y+APE  +  +   E  DV+S GI+L  +   + P D+       +S     K ++N  
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 843 ---DSLPISIMN 851
              DS P+++++
Sbjct: 232 KKIDSAPLALLH 243

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 38/219 (17%)
Query: 627 QFNVNNLIGSGSFGSV------YRGRFLDGMEVAIKVFHLQLEGALESFN---AECEVLR 677
           +F    L+G G+FG V        GR+      A+K+   ++  A +       E  VL+
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVID 731
           + RH  L  +  S    D    V++Y   G L      E     D +            +
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAE 117
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL--- 788
           I  AL+YLH      VV+ D+K  N++LD+D   ++ DFG+ K     E +K   T+   
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXF 170
Query: 789 -ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             T  Y+APE   +       D +  G+++ E+   + P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
           +++   IGSG    V++   L+  +    + ++ LE A    L+S+  E   L  ++  +
Sbjct: 58  YSILKQIGSGGSSKVFQ--VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 684 --LVRIISSCTNDDFKALVLDYMPKGSLEACLY-SDNSNLDIFKRLNIVIDIALALEYLH 740
             ++R+      D +  +V++    G+++   +     ++D ++R +   ++   LE +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVH 169
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEY 798
             H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +  +K +Q +  + YM PE 
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ-VGAVNYMPPEA 227
Query: 799 GREGQISTEG-----------DVYSFGIMLMEIFTRKRPTDEIF 831
            ++   S E            DV+S G +L  +   K P  +I 
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 113 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M     +AT  Y A
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--XGYVATRWYRA 213
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLAT 790
           +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D + ++       
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTN----DDFKALVL-DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            T     ++F  + L  ++    L   + S     D  + L  +  I   L+Y+H     
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIHSAD-- 145
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-QI 804
            ++H D+KPSN+ ++ED   ++ DFG+ +    D+ M  T  +AT  Y APE        
Sbjct: 146 -IIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEM--TGYVATRWYRAPEIMLNWMHY 200
Query: 805 STEGDVYSFGIMLMEIFT 822
           +   D++S G ++ E+ T
Sbjct: 201 NQTVDIWSVGCIMAELLT 218

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRN 683
           F++  +IG GS+  V   R      + A+KV   +L   +  ++    E  V     +  
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 684 LVRIISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +  + SC   + +   V++Y+  G L   +       +   R     +I+LAL YLH  
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH-- 123
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTLATIGYMAPEYGR 800
               +++ D+K  NVLLD +   +L D+G+ K  L  GD +   +    T  Y+APE  R
Sbjct: 124 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILR 179
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTD 828
                   D ++ G+++ E+   + P D
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 42/230 (18%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV        G  VA+K      +  + +  
Sbjct: 4   FYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 671 A--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNSN 719
              E  +L+ ++H N++ ++   T            P  SLE           + +D +N
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNN 111
Query: 720 LDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           +    +L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A
Sbjct: 112 IVKCAKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 774 KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           +    D+ M  T  +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 169 R--HTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 40/79 (50%)
Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTE 807
            H D+KP N+L+  D  A L DFGIA   + ++  +   T+ T+ Y APE   E   +  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 808 GDVYSFGIMLMEIFTRKRP 826
            D+Y+   +L E  T   P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLAT 790
           +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D + ++       
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLAT 790
           +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D + ++       
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRN 683
           F++  +IG GS+  V   R      + A+KV   +L   +  ++    E  V     +  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 684 LVRIISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +  + SC   + +   V++Y+  G L   +       +   R     +I+LAL YLH  
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH-- 127
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTLATIGYMAPEYGR 800
               +++ D+K  NVLLD +   +L D+G+ K  L  GD +   +    T  Y+APE  R
Sbjct: 128 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILR 183
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
                   D ++ G+++ E+   + P D + S +
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRN 683
           F++  +IG GS+  V   R      + A+KV   +L   +  ++    E  V     +  
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 684 LVRIISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +  + SC   + +   V++Y+  G L   +       +   R     +I+LAL YLH  
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH-- 138
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTLATIGYMAPEYGR 800
               +++ D+K  NVLLD +   +L D+G+ K  L  GD +   +    T  Y+APE  R
Sbjct: 139 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILR 194
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTD 828
                   D ++ G+++ E+   + P D
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD-ESMKHTQTLAT 790
           +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D + ++       
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 791 IGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 58/254 (22%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFL---------DGMEVAIKVFHLQLEGALESFNAE 672
            Q+ + FN   ++ S   G   RG+F           G E A K    +  G     +  
Sbjct: 20  FQSMENFNNFYILTSKELG---RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ----DCR 72
Query: 673 CEVLRSIRHRNLVRIISSC----------TNDDFKALVLDYMPKGSL-EACL------YS 715
            E+L  I    ++ +  SC           N     L+L+Y   G +   CL       S
Sbjct: 73  AEILHEIA---VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 716 DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-----DMVARLGDF 770
           +N  + + K++         LE +++ H N +VH D+KP N+LL       D+  ++ DF
Sbjct: 130 ENDVIRLIKQI---------LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI--KIVDF 178
Query: 771 GIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           G+++ +     ++  + + T  Y+APE      I+T  D+++ GI+   + T   P    
Sbjct: 179 GMSRKIGHACELR--EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP---- 232
Query: 831 FSGEMSLKRWVNDS 844
           F GE + + ++N S
Sbjct: 233 FVGEDNQETYLNIS 246

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 113/239 (47%), Gaps = 39/239 (16%)
Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIIS--- 689
           +G G  G V+     D    VAIK   L    +++    E +++R + H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 690 ---SCTNDDFKAL--------VLDYMPKGSL----EACLYSDNSNLDIFKRLNIVIDIAL 734
              S   DD  +L        V +YM         +  L  +++ L +++ L        
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR------- 131
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKH--TQTLATI 791
            L+Y+H  +   V+H D+KP+N+ ++ ED+V ++GDFG+A+++    S K   ++ L T 
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 792 GYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRKRPTDEIFSG--EMSLKRWVNDSLPI 847
            Y +P         T+  D+++ G +  E+ T K     +F+G  E+   + + +S+P+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----LFAGAHELEQMQLILESIPV 243

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 634 IGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNAECEVL--RSIRHRNLVRII 688
           +GSG++GSV     +D   G +VAIK      +  + +  A  E+L  + ++H N++ ++
Sbjct: 50  VGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 689 SSCTND-------DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              T         DF  LV+ +M +  L+  +  + S   I     +V  +   L+Y+H 
Sbjct: 108 DVFTPASSLRNFYDF-YLVMPFM-QTDLQKIMGMEFSEEKI---QYLVYQMLKGLKYIHS 162
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                VVH D+KP N+ ++ED   ++ DFG+A+    D  M  T  + T  Y APE    
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM--TGYVVTRWYRAPEVILS 215
Query: 802 G-QISTEGDVYSFGIMLMEIFTRK 824
               +   D++S G ++ E+ T K
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVF----HLQLEGALESFNAECEV 675
           ++ +    +G+G+FG V              M VA+K+     HL    AL S   E +V
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 102
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---- 730
           L  +  H N+V ++ +CT      ++ +Y        C Y D  N    KR + +     
Sbjct: 103 LSYLGNHMNIVNLLGACTIGGPTLVITEY--------CCYGDLLNFLRRKRDSFICSKTS 154
Query: 731 ---------------------DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
                                 +A  + +L   +    +H D+   N+LL    + ++ D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 211
Query: 770 FGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           FG+A+ +  D +  +K    L  + +MAPE       + E DV+S+GI L E+F+
Sbjct: 212 FGLARHIKNDSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL-------ESFNAECEVLRSI 679
           ++ + +L+G GS+G V     LD   +  +   +  +  L        +   E ++LR +
Sbjct: 6   KYLMGDLLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 680 RHRNLVRIISSCTNDDFKAL--VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           RH+N+++++    N++ + +  V++Y   G  E           + +       +   LE
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL---SGDESMKHTQTLATIGYM 794
           YLH      +VH DIKP N+LL      ++   G+A+ L   + D++ + +Q   +  + 
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQ 178
Query: 795 APEY--GREGQISTEGDVYSFGIMLMEIFT 822
            PE   G +     + D++S G+ L  I T
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVF----HLQLEGALESFNAECEV 675
           ++ +    +G+G+FG V              M VA+K+     HL    AL S   E +V
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 95
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---- 730
           L  +  H N+V ++ +CT      ++ +Y        C Y D  N    KR + +     
Sbjct: 96  LSYLGNHMNIVNLLGACTIGGPTLVITEY--------CCYGDLLNFLRRKRDSFICSKTS 147
Query: 731 ---------------------DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
                                 +A  + +L   +    +H D+   N+LL    + ++ D
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 204
Query: 770 FGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           FG+A+ +  D +  +K    L  + +MAPE       + E DV+S+GI L E+F+
Sbjct: 205 FGLARDIKNDSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVF----HLQLEGALESFNAECEV 675
           ++ +    +G+G+FG V              M VA+K+     HL    AL S   E +V
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 79
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID--- 731
           L  +  H N+V ++ +CT      ++ +Y        C Y D  N    KR + +     
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEY--------CCYGDLLNFLRRKRDSFICSKTS 131
Query: 732 --------------IALALEY-----LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
                           L+  Y     + F      +H D+   N+LL    + ++ DFG+
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 773 AKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           A+ +  D +  +K    L  + +MAPE       + E DV+S+GI L E+F+
Sbjct: 192 ARDIKNDSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 103/230 (44%), Gaps = 42/230 (18%)
Query: 616 FSYQEL----LQATDQFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFN 670
           F  QEL     +  +++   + +GSG++GSV        G  VA+K      +  + +  
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 87
Query: 671 A--ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEA---------CLYSDNSN 719
              E  +L+ ++H N++ ++   T            P  SLE           + +D +N
Sbjct: 88  TYRELRLLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNN 135
Query: 720 LDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA 773
           +   ++L       ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A
Sbjct: 136 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 192
Query: 774 KLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT 822
           +    D+ M     +AT  Y APE        +   D++S G ++ E+ T
Sbjct: 193 R--HTDDEM--XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++  FG+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVF----HLQLEGALESFNAECEV 675
           ++ +    +G+G+FG V              M VA+K+     HL    AL S   E +V
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 97
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---- 730
           L  +  H N+V ++ +CT      ++ +Y        C Y D  N    KR + +     
Sbjct: 98  LSYLGNHMNIVNLLGACTIGGPTLVITEY--------CCYGDLLNFLRRKRDSFICSKTS 149
Query: 731 ---------------------DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
                                 +A  + +L   +    +H D+   N+LL    + ++ D
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 206
Query: 770 FGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           FG+A+ +  D +  +K    L  + +MAPE       + E DV+S+GI L E+F+
Sbjct: 207 FGLARDIKNDSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ D G+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVF----HLQLEGALESFNAECEV 675
           ++ +    +G+G+FG V              M VA+K+     HL    AL S   E +V
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKV 102
Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---- 730
           L  +  H N+V ++ +CT      ++ +Y        C Y D  N    KR + +     
Sbjct: 103 LSYLGNHMNIVNLLGACTIGGPTLVITEY--------CCYGDLLNFLRRKRDSFICSKTS 154
Query: 731 ---------------------DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
                                 +A  + +L   +    +H D+   N+LL    + ++ D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 211
Query: 770 FGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           FG+A+ +  D +  +K    L  + +MAPE       + E DV+S+GI L E+F+
Sbjct: 212 FGLARDIKNDSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQL---EGALESFNAECEVLRSIRHRN 683
           F++  +IG GS+  V   R      + A++V   +L   +  ++    E  V     +  
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 684 LVRIISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
            +  + SC   + +   V++Y+  G L   +       +   R     +I+LAL YLH  
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH-- 170
Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK--LLSGDESMKHTQTLATIGYMAPEYGR 800
               +++ D+K  NVLLD +   +L D+G+ K  L  GD +   +    T  Y+APE  R
Sbjct: 171 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILR 226
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTD 828
                   D ++ G+++ E+   + P D
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M     +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--AGFVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 86  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M     +AT  Y A
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--AGFVATRWYRA 186
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ D G+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+    D+ M     +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM--AGFVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 40/234 (17%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDGME---VAIKVFHLQLEGALESFN--AECEVLR 677
           Q  D++ + +LIG+GS+G V      D +E   VAIK      E  ++      E  +L 
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEA--YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 678 SIRHRNLVRIISSCTNDD---FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
            + H ++V+++      D   F  L +      S    L+     L       ++ ++ +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-------------- 780
            ++Y+H      ++H D+KP+N L+++D   ++ DFG+A+ +   E              
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 781 ----SMKHTQTL--------ATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIF 821
               +  HT+ L         T  Y APE     +  TE  DV+S G +  E+ 
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G+ VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ D G+A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 660 LQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL---EACLYSD 716
           + ++   + F  E +++  I++   +      TN D   ++ +YM   S+   +   +  
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 717 NSNLDIFKRLNIVIDIALAL----EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI 772
           + N   F  + ++  I  ++     Y+H  +   + H D+KPSN+L+D++   +L DFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 773 AKLLSGDESMKHTQTLATIGYMAPEY--GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           ++ +  D+ +K ++   T  +M PE+          + D++S GI L  +F    P    
Sbjct: 199 SEYMV-DKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP---- 251
Query: 831 FSGEMSL 837
           FS ++SL
Sbjct: 252 FSLKISL 258

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 634 IGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNAECEVL--RSIRHRNLVRII 688
           +GSG++GSV     +D   G +VAIK      +  + +  A  E+L  + ++H N++ ++
Sbjct: 32  VGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 689 SSCTND-------DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              T         DF  LV+ +M +  L+  +    S   I     +V  +   L+Y+H 
Sbjct: 90  DVFTPASSLRNFYDF-YLVMPFM-QTDLQKIMGLKFSEEKI---QYLVYQMLKGLKYIHS 144
Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                VVH D+KP N+ ++ED   ++ DFG+A+    D  M  T  + T  Y APE    
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM--TGYVVTRWYRAPEVILS 197
Query: 802 G-QISTEGDVYSFGIMLMEIFTRK 824
               +   D++S G ++ E+ T K
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 95/344 (27%), Positives = 153/344 (44%), Gaps = 34/344 (9%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 42  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 98
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S    L 
Sbjct: 99  DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLT 151
Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           +L+  S ++N  +   P  + N + L   ++  N  S    +    + NL+ L       
Sbjct: 152 SLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESL------- 200
Query: 246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIP 305
            ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I    P
Sbjct: 201 IATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNLAP 256
Query: 306 KEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV 365
             +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+ +
Sbjct: 257 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL 310
Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
            L  N +S   P    +L  L++L F++N+++ V S+  NLTNI
Sbjct: 311 TLYFNNISDISPVS--SLTKLQRLFFSNNKVSDV-SSLANLTNI 351

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF 391
           L+ L  L  L L NNQ+    +D +  L  L+ + L  N +S  I A  G L SL++LSF
Sbjct: 103 LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS-DISALSG-LTSLQQLSF 158
Query: 392 ASNELTFVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELY-----LSRNNLSGD 446
           +SN++T +     NLT +  +D            ++ ++ VL +L      ++ NN   D
Sbjct: 159 SSNQVTDLKP-LANLTTLERLDISSN--------KVSDISVLAKLTNLESLIATNNQISD 209
Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIP 496
           I T +G L NL  LSL  N L+     ++  L +L  LDL+NN +S + P
Sbjct: 210 I-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 256

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIK-VFHLQLEGAL-----ESFNAEC 673
           EL      + V   I SGS+G+V  G   +G+ VAIK VF+   +G       +SF  + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK- 74
Query: 674 EVLRSIR------HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN 727
            VLR IR      H N++ +     + +  A+   Y+    +   + +D + +   +R+ 
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL----VTELMRTDLAQVIHDQRIV 130
Query: 728 IVIDIALALEY-----LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
           I         Y     LH  H   VVH D+ P N+LL ++    + DF +A+  + D + 
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 783 KHTQTLATIGYMAPEYGREGQISTE-GDVYSFGIMLMEIFTRK 824
            H  T     Y APE   + +  T+  D++S G ++ E+F RK
Sbjct: 191 THYVTHR--WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIK-VFHLQLEGAL-----ESFNAEC 673
           EL      + V   I SGS+G+V  G   +G+ VAIK VF+   +G       +SF  + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK- 74
Query: 674 EVLRSIR------HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN 727
            VLR IR      H N++ +     + +  A+   Y+    +   + +D + +   +R+ 
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL----VTELMRTDLAQVIHDQRIV 130
Query: 728 IVIDIALALEY-----LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
           I         Y     LH  H   VVH D+ P N+LL ++    + DF +A+  + D + 
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 783 KHTQTLATIGYMAPEYGREGQISTE-GDVYSFGIMLMEIFTRK 824
            H  T     Y APE   + +  T+  D++S G ++ E+F RK
Sbjct: 191 THYVTHR--WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           +GSG++GSV        G  VA+K      +  + +     E  +L+ ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 691 CTNDDFKALVLDYMPKGSLEA---------CLYSDNSNLDIFKRLN------IVIDIALA 735
            T            P  SLE           + +D +N+   ++L       ++  I   
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L+Y+H      ++H D+KPSN+ ++ED   ++ DF +A+    D+ M  T  +AT  Y A
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEM--TGYVATRWYRA 190
Query: 796 PEYGREG-QISTEGDVYSFGIMLMEIFT 822
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 59/123 (47%), Gaps = 6/123 (4%)
Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM---K 783
            I + I  ALE+LH      V+H D+KPSNVL++     +  DFGI+  L  D +     
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND 843
             +       + PE  ++G  S + D++S GI  +E+   + P D   +    LK+ V +
Sbjct: 198 GCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE 256
Query: 844 SLP 846
             P
Sbjct: 257 PSP 259

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 95/344 (27%), Positives = 152/344 (44%), Gaps = 34/344 (9%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 42  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 98
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S    L 
Sbjct: 99  DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLT 151
Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           +L+  S ++N  +   P  + N + L   ++  N  S    +    + NL+ L       
Sbjct: 152 SLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESL------- 200
Query: 246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIP 305
            ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I    P
Sbjct: 201 IATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNLAP 256
Query: 306 KEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV 365
             +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+ +
Sbjct: 257 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL 310
Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
            L  N +S   P    +L  L++L F +N+++ V S+  NLTNI
Sbjct: 311 TLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV-SSLANLTNI 351

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF 391
           L+ L  L  L L NNQ+    +D +  L  L+ + L  N +S  I A  G L SL++LSF
Sbjct: 103 LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS-DISALSG-LTSLQQLSF 158
Query: 392 ASNELTFVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELY-----LSRNNLSGD 446
           +SN++T +     NLT +  +D            ++ ++ VL +L      ++ NN   D
Sbjct: 159 SSNQVTDLKP-LANLTTLERLDISSN--------KVSDISVLAKLTNLESLIATNNQISD 209
Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIP 496
           I T +G L NL  LSL  N L+     ++  L +L  LDL+NN +S + P
Sbjct: 210 I-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 256

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDG-MEVAIKVFHLQLEGALE----------SFNA 671
           + + +++  + +GSG+FG V+     +   EV +K   ++ E  LE              
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK--FIKKEKVLEDCWIEDPKLGKVTL 78
Query: 672 ECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
           E  +L  + H N+++++    N  F  LV++    G         +  LD      I   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-AT 790
           +  A+ YL       ++H DIK  N+++ ED   +L DFG A  L   E  K   T   T
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGT 192
Query: 791 IGYMAPEY--GREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           I Y APE   G   +   E +++S G+ L  +   + P  E+
Sbjct: 193 IEYCAPEVLMGNPYR-GPELEMWSLGVTLYTLVFEENPFCEL 233

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 628 FNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAEC-----EVLRSIRH 681
           FN   ++G GSFG V         E+ AIK+  L+ +  ++  + EC      VL  +  
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 682 RNLVRIISSCTND-DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
              +  + SC    D    V++Y+  G L   +      +  FK    V   A     L 
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISIGLF 134
Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
           F H   +++ D+K  NV+LD +   ++ DFG+ K    D  +   +   T  Y+APE   
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD-GVTTREFCGTPDYIAPEIIA 193
Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTD 828
                   D +++G++L E+   + P D
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 97/345 (28%), Positives = 152/345 (44%), Gaps = 37/345 (10%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 46  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 102
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S    L 
Sbjct: 103 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLT 155
Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL-NLEYNY 244
           +L+  S  N     K  + +    +L I             N+  ++  L +L NLE   
Sbjct: 156 SLQQLSFGNQVTDLKPLANLTTLERLDISS-----------NKVSDISVLAKLTNLES-- 202
Query: 245 ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSI 304
           + ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I    
Sbjct: 203 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNLA 258
Query: 305 PKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS 364
           P  +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+ 
Sbjct: 259 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTY 312
Query: 365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
           + L  N +S   P    +L  L++L FA+N+++ V S+  NLTNI
Sbjct: 313 LTLYFNNISDISPVS--SLTKLQRLFFANNKVSDV-SSLANLTNI 354

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 22/233 (9%)
Query: 634 IGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           +G G F  V     L DG   A+K      +   E    E ++ R   H N++R+++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 693 ND----DFKALVLDYMPKGSL--EACLYSDNSN-LDIFKRLNIVIDIALALEYLHFGHPN 745
            +        L+L +  +G+L  E     D  N L   + L +++ I   LE +H     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFG-IAKLLSGDESMKHTQTL-------ATIGYMAPE 797
              H D+KP+N+LL ++    L D G + +     E  +   TL        TI Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 798 ---YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPI 847
                    I    DV+S G +L  +   + P D +F    S+   V + L I
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 79/171 (46%), Gaps = 17/171 (9%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFN--AECEVLRS 678
           ++  D + + +LIG GS+G VY     +  + VAIK  +   E  ++      E  +L  
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           ++   ++R+      +D   L  D      L   L   +S+L    +  I +        
Sbjct: 84  LKSDYIIRLHDLIIPEDL--LKFD-----ELYIVLEIADSDLKKLFKTPIFLTEQHVKTI 136
Query: 739 LH-------FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
           L+       F H + ++H D+KP+N LL++D   ++ DFG+A+ ++ D+ +
Sbjct: 137 LYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDI 187

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFH----LQLEGALESFNAECEVLRSIR- 680
           ++ +  L+G G FG+V+ G R  D ++VAIKV      L      +S     EV    + 
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 681 -----HRNLVRIISSCTNDDFKALVLDY-MPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
                H  ++R++      +   LVL+  +P   L   + ++   L           +  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVA 150
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           A+++ H      VVH DIK  N+L+D     A+L DFG   LL  DE   +T    T  Y
Sbjct: 151 AIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEP--YTDFDGTRVY 204
Query: 794 MAPEY-GREGQISTEGDVYSFGIMLMEIFTRKRPTD---EIFSGEM 835
             PE+  R    +    V+S GI+L ++     P +   EI   E+
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 150/346 (43%), Gaps = 39/346 (11%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 42  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 98
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S      
Sbjct: 99  DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS------ 148
Query: 186 NLELFSLANNNFSGKIPSF--IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
              L SL   NF  ++     + N + L   ++  N  S    +    + NL+ L     
Sbjct: 149 --GLTSLQQLNFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESL----- 199
Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
              ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I   
Sbjct: 200 --IATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNL 253
Query: 304 IPKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLS 363
            P  +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+
Sbjct: 254 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLT 307
Query: 364 SVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
            + L  N +S   P    +L  L++L F++N+++ V S+  NLTNI
Sbjct: 308 YLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSDV-SSLANLTNI 350

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 628 FNVNNLIGSGSFGS-VYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLR-SIRHRNLV 685
           F   +++G G+ G+ VYRG F D  +VA+K     L       + E ++LR S  H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R   +  +  F+ + ++       E     D ++L + + + ++      L +LH  +  
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL-EPITLLQQTTSGLAHLHSLN-- 138
Query: 746 PVVHCDIKPSNVLL-----DEDMVARLGDFGIAKLLS-GDESM-KHTQTLATIGYMAPE 797
            +VH D+KP N+L+        + A + DFG+ K L+ G  S  + +    T G++APE
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 94/344 (27%), Positives = 152/344 (44%), Gaps = 34/344 (9%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 42  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 98
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S    L 
Sbjct: 99  DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLT 151
Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           +L+  + ++N  +   P  + N + L   ++  N  S    +    + NL+ L       
Sbjct: 152 SLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESL------- 200
Query: 246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIP 305
            ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I    P
Sbjct: 201 IATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNLAP 256
Query: 306 KEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV 365
             +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+ +
Sbjct: 257 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL 310
Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
            L  N +S   P    +L  L++L F +N+++ V S+  NLTNI
Sbjct: 311 TLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV-SSLANLTNI 351

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF 391
           L+ L  L  L L NNQ+    +D +  L  L+ + L  N +S  I A  G L SL++L+F
Sbjct: 103 LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS-DISALSG-LTSLQQLNF 158
Query: 392 ASNELTFVPSTFWNLTNILMVDXXXXXXXXXXXXEIGNLKVLVELY-----LSRNNLSGD 446
           +SN++T +     NLT +  +D            ++ ++ VL +L      ++ NN   D
Sbjct: 159 SSNQVTDLKP-LANLTTLERLDISSN--------KVSDISVLAKLTNLESLIATNNQISD 209
Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIP 496
           I T +G L NL  LSL  N L+     ++  L +L  LDL+NN +S + P
Sbjct: 210 I-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 256

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 129 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 183
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVI 205

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 357 CRLARLSSV-----------YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP-STFW 404
           CR  R +SV           YL  N+++   P  F +L +L++L   SN+L  +P   F 
Sbjct: 26  CRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85
Query: 405 NLTNILMVDXXXXXXXXXXXXEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGD 464
           +LT + ++D                L  L EL++  N L+ ++P  I  L +L +L+L  
Sbjct: 86  SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144
Query: 465 NNLQGSIPNSIGDLIS 480
           N L+ SIP+   D +S
Sbjct: 145 NQLK-SIPHGAFDRLS 159

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 129 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 183
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVI 205

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 631 NNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRII 688
            +++G G+   V      +   E A+K+   Q          E E+L   + HRN++ +I
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
                +D   LV + M  GS+ + ++    + +  +   +V D+A AL++LH      + 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLH---NKGIA 133
Query: 749 HCDIKPSNVLLDE-DMVA--RLGDFGIAK--LLSGDESMKHTQTLAT----IGYMAPE-- 797
           H D+KP N+L +  + V+  ++ DFG+     L+GD S   T  L T      YMAPE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 798 --YGREGQI-STEGDVYSFGIML 817
             +  E  I     D++S G++L
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVIL 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 634 IGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIISS 690
           IGSG+ G V      + G+ VA+K      +    +  A  E  +L+ + H+N++ +++ 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 691 CTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
            T     ++F+   LV++ M     +      +  LD  +   ++  +   +++LH    
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVI----HMELDHERMSYLLYQMLCGIKHLHSAG- 144
Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI 804
             ++H D+KPSN+++  D   ++ DFG+A+  S +  M  T  + T  Y APE       
Sbjct: 145 --IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM--TPYVVTRYYRAPEVILGMGY 200
Query: 805 STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
               D++S G ++ E+         IF G   + +W
Sbjct: 201 KENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 49/236 (20%)
Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFN--AECEVLRS 678
           +   D + + +LIG GS+G VY     +  + VAIK  +   E  ++      E  +L  
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLNIVIDIALALE 737
           ++   ++R+      DD   L  D      L   L   +S+L  +FK       I L  E
Sbjct: 82  LKSDYIIRLYDLIIPDDL--LKFD-----ELYIVLEIADSDLKKLFK-----TPIFLTEE 129
Query: 738 YL-----------HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK------------ 774
           ++           +F H + ++H D+KP+N LL++D   ++ DFG+A+            
Sbjct: 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 775 -LLSGDESMKHTQTL--------ATIGYMAPEYGREGQISTEG-DVYSFGIMLMEI 820
            L   +E   H + L         T  Y APE     +  T+  D++S G +  E+
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 149/346 (43%), Gaps = 39/346 (11%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 42  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 98
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S      
Sbjct: 99  DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS------ 148
Query: 186 NLELFSLANNNFSGKIPSF--IFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
              L SL   NF  ++     + N + L   ++  N  S    +    + NL+ L     
Sbjct: 149 --GLTSLQQLNFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESL----- 199
Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
              ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I   
Sbjct: 200 --IATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNL 253
Query: 304 IPKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLS 363
            P  +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+
Sbjct: 254 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLT 307
Query: 364 SVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
            + L  N +S   P    +L  L++L F +N+++ V S+  NLTNI
Sbjct: 308 YLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV-SSLANLTNI 350

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKV------FHLQLEGALESFNAECEVLRSI 679
           ++ V  +IG GSFG V +         VA+K+      FH Q   A E      E LR  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AAEEIRI-LEHLRKQ 153
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALA-L 736
              N + +I    N  F+  +   M    L   LY     +    F  L +V   A + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYELIKKNKFQGFS-LPLVRKFAHSIL 210
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L   H N ++HCD+KP N+LL +      G  GI  +  G    +H +    I    Y
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQ-----GRSGIKVIDFGSSCYEHQRVYTXIQSRFY 265
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            APE     +     D++S G +L E+ T
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIM 816
           APE      +  E D++S G++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKV------FHLQLEGALESFNAECEVLRSI 679
           ++ V  +IG GSFG V +         VA+K+      FH Q   A E      E LR  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AAEEIRI-LEHLRKQ 153
Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALA-L 736
              N + +I    N  F+  +   M    L   LY     +    F  L +V   A + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYELIKKNKFQGFS-LPLVRKFAHSIL 210
Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---Y 793
           + L   H N ++HCD+KP N+LL +      G  GI  +  G    +H +    I    Y
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQ-----GRSGIKVIDFGSSCYEHQRVYTXIQSRFY 265
Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            APE     +     D++S G +L E+ T
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE      +  E D++S G++   + +   P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA------LESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +   +       E    E  +L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L   L ++  +L   +    +  I   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVA----RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LH      + H D+KP N++L +  V     ++ DFG+A  +      K+     T  ++
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE      +  E D++S G++   + +   P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 40/242 (16%)
Query: 632 NLIGSGSFGSV-YRGRFLDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIIS 689
            ++G GS G+V ++G F  G  VA+K   +   + AL       E   S  H N++R   
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVIRYYC 76
Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDN---SNLDIFKRLN---IVIDIALALEYLHFGH 743
           S T D F  + L+ +   +L+  + S N    NL + K  N   ++  IA  + +LH   
Sbjct: 77  SETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 744 PNPVVHCDIKPSNVLLD-------------EDMVARLGDFGIAKLLSGDESMKHT---QT 787
              ++H D+KP N+L+              E++   + DFG+ K L   +S   T     
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 788 LATIGYMAPEYGREG-------QISTEGDVYSFGIMLMEIFTR-KRPTDEIFSGEMSLKR 839
             T G+ APE   E        +++   D++S G +   I ++ K P  + +S E ++ R
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 840 WV 841
            +
Sbjct: 253 GI 254

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLE-----GALES---FNAECEVLR 677
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +     G L +      E  +L+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 678 SIRH--RNLVRIISSCTNDDFKALVLDYM-PKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
            +      ++R++      D   L+L+ M P   L   +    +  +   R         
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSF----FWQ 122
Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGY 793
            LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVY 179
Query: 794 MAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
             PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 232

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 627 QFNVNNLIGSGSFGSVYRG--RFLDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRN 683
           Q+ V   I  G  G +Y    R ++G  V +K + H     A     AE + L  + H +
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 684 LVRIISSCTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +V+I +   + D        +V++Y+   SL+    S    L + + +  +++I  AL Y
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYLLEILPALSY 197
Query: 739 LH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE 797
           LH  G    +V+ D+KP N++L E+ + +L D G    ++            T G+ APE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEEQL-KLIDLGAVSRIN-----SFGYLYGTPGFQAPE 247
Query: 798 YGREGQISTEGDVYSFGIMLMEI 820
             R G  +   D+Y+ G  L  +
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAAL 269

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 94
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 95  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 94
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 95  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRGR--FLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 25  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLXQVI----QMELDHERMSYLLYQMLXGIKHLHSAG 139
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 140 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 93
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 94  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 260

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 96/345 (27%), Positives = 151/345 (43%), Gaps = 37/345 (10%)
Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           QV  L  +RL G    +   YL  +  ++ + NQ     P  + NLT L  I ++ N + 
Sbjct: 47  QVTTLQADRL-GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 126 GEIPHEIGNLRNLQAXXXXXXXXXXXXPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P  + NL NL              P  L N++ L  L+L++NT+S   + S    L 
Sbjct: 104 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLT 156
Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL-NLEYNY 244
           +L+  S  N     K  + +    +L I             N+  ++  L +L NLE   
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISS-----------NKVSDISVLAKLTNLES-- 203
Query: 245 ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSI 304
           + ++N+++S I+ L     L  LSL GN L D    +S+ NL+       L N  I    
Sbjct: 204 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT----DLDLANNQISNLA 259
Query: 305 PKEMGXXXXXXXXRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS 364
           P  +         +LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+ 
Sbjct: 260 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTY 313
Query: 365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
           + L  N +S   P    +L  L++L F +N+++ V S+  NLTNI
Sbjct: 314 LTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV-SSLANLTNI 355

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 32  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVI----QMELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 94
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 95  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 93
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 94  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 25  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 93
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 94  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 260

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 94
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 95  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 108
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 109 KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 223
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 275

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 113
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 114 KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 171
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 172 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 228
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 229 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 280

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 32  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVI----QMELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 108
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 109 KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 223
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 275

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 26  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 84
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 141 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 70  IGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 128
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 32  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 93
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 94  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 70  IGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 128
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 31  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 89
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 90  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 145
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 146 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 233

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 32  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 66
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 67  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 181
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 26  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 84
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 141 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 32  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 81
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 82  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 196
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 248

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 80
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 81  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 195
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 247

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 81
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 82  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 196
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 248

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 33  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 91
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 148 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 33  IGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 91
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 148 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 100
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 101 KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 215
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 267

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 634 IGSGSFGSVYRG--RFLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHRNLVRIIS 689
           IGSG+ G V       LD   VAIK      +    +  A  E  +++ + H+N++ +++
Sbjct: 32  IGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 690 SCTN----DDFK--ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
             T     ++F+   LV++ M     +         LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y APE      
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                D++S G ++ E+   K     +F G   + +W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 61
Query: 686 RIISSCTNDDFKALV--LDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA--- 735
           + +SS     F  ++  LD+  +  S    L       D+F    +R  +  ++A +   
Sbjct: 62  KKVSS----GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 736 --LEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKHTQTLATIG 792
             LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  
Sbjct: 118 QVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 793 YMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
           Y  PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 80
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 81  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 195
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 247

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 81
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 82  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 196
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 248

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 39/239 (16%)
Query: 615 RFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVFHLQLEGALESFNAEC 673
            FS+++ +   + F V   +G G+FG V   + +D  +  A+KV    ++    S   E 
Sbjct: 24  HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEA 82
Query: 674 EVLRSIRHRNLVRIISSCTNDDF---KALVLDYMPKG-SLEACLYSDNSNLDIFKRLNI- 728
           ++L+ I++ ++        +  F     + L + P G SL   +  +N N    + + + 
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLY 142
Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA----------------------- 765
            I+I  AL YL       + H D+KP N+LLD+                           
Sbjct: 143 CIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 766 --RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             +L DFG A      +S  H   + T  Y APE           D++SFG +L E++T
Sbjct: 200 GIKLIDFGCATF----KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 627 QFNVNNLIGSGSFGSVYRG-RFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           Q+ V  L+GSG FGSVY G R  D + VAIK  H++ +  +  +       R      L+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVE-KDRISDWGELPNGTRVPMEVVLL 66
Query: 686 RIISSCTNDDFKALVLDYMPK-GSLEACLYSDNSNLDIF----KRLNIVIDIALA----- 735
           + +SS  +   +  +LD+  +  S    L       D+F    +R  +  ++A +     
Sbjct: 67  KKVSSGFSGVIR--LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-RLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           LE +   H   V+H DIK  N+L+D +    +L DFG   LL   +   +T    T  Y 
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 181
Query: 795 APEYGREGQI-STEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVN 842
            PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	851
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-166
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-131
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-131
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-122
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-101
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-62
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-50
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-93
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-86
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-76
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-64
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-61
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-36
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-91
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-88
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-85
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-63
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-50
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-90
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-87
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-59
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-50
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-42
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-32
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-85
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-58
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-55
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-55
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-49
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-82
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-68
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-65
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-56
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-52
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-79
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-69
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-78
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-66
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-54
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-43
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-75
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-73
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-66
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-63
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-60
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-47
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-47
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-16
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-54
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-11
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-37
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-37
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-19
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-54
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-46
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-42
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-42
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-43
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-40
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-38
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-42
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-39
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-39
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-38
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-37
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-21
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-05
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-10
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-05
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-09
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-22
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-22
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-18
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	7e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-05

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  501 bits (1292), Expect = e-166
 Identities = 177/565 (31%), Positives = 273/565 (48%), Gaps = 18/565 (3%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSS 64
            +  +P  LG  S+LQ+LD+S N+L G    +I +   L++L++S+NQ  G  P   + S
Sbjct: 212 FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS 270

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           LQ + L++N+ +GE+P  +      +  L L+ N F G +P   G+ + L S+ LS N+ 
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330

Query: 125 MGEIPHE-IGNLRNLQALGLLSNNLVGVVPATLFNIST-LKILQLTNNTLSGSISSSI-R 181
            GE+P + +  +R L+ L L  N   G +P +L N+S  L  L L++N  SG I  ++ +
Sbjct: 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390

Query: 182 LALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
                L+   L NN F+GKIP  + N S+L    L  N  SG IP+   ++  L++L L 
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450

Query: 242 YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR 301
            N +            L   K L+ L L  N  L   +PS + N + ++    L N  + 
Sbjct: 451 LNMLEGE-----IPQELMYVKTLETLILDFN-DLTGEIPSGLSNCT-NLNWISLSNNRLT 503

Query: 302 GSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR 361
           G IPK +G L NL I++L  N  +G+IP+ L     L  L L  N   G I   + + + 
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF---VPSTFWNLTNILMVDLSSNP 418
                +  N ++G       N    ++   A N L F          L+     +++S  
Sbjct: 564 K----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619

Query: 419 LSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDL 478
             G       N   ++ L +S N LSG IP  IG +  L  L+LG N++ GSIP+ +GDL
Sbjct: 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679

Query: 479 ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDL 538
             L  LDLS+N L G IP ++  L  L  +++S N L G IP  G    F    F+ N  
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPG 739

Query: 539 LCGSPHLQVPPCKSTKTRTNQKSRK 563
           LCG P  +  P  +     +Q+S  
Sbjct: 740 LCGYPLPRCDPSNADGYAHHQRSHH 764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  410 bits (1056), Expect = e-131
 Identities = 154/541 (28%), Positives = 253/541 (46%), Gaps = 31/541 (5%)

Query: 5   LTGTVPS--QLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP--- 58
           L+G V +   LGS S L++L++S N L      S    +N+LE+LDLS N +SG+     
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171

Query: 59  --FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTS 116
                   L+ + +S N++SG++     S    ++FL ++ N F+  +P  +G+ ++L  
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQH 227

Query: 117 IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI 176
           +D+S N L G+    I     L+ L + SN  VG +P     + +L+ L L  N  +G I
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEI 285

Query: 177 SSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIP-NRFHNMRNL 235
              +  A   L    L+ N+F G +P F  + S L    L  N+FSG +P +    MR L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345

Query: 236 KELNLEYNYITSSNHELSFISSLAN-SKKLKVLSLTGNPLLDCVLPSSIGNLSL-SMERF 293
           K L+L +N  +          SL N S  L  L L+ N      +  ++      +++  
Sbjct: 346 KVLDLSFNEFSG-----ELPESLTNLSASLLTLDLSSN-NFSGPILPNLCQNPKNTLQEL 399

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRIL 353
           YL N    G IP  + N   L+ + L +N L+G+IPS+L  L KL+ L L  N LEG I 
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

Query: 354 DDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMV 412
            ++  +  L ++ LD N L+G IP+   N  +L  +S ++N LT  +P     L N+ ++
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519

Query: 413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP 472
            LS+N  SG++P E+G+ + L+ L L+ N  +G IP  +          +  N + G   
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRY 575

Query: 473 NSIGDLISLECLDLSNNI--LSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG-GTLANFT 529
             I +    +    + N+    GI    L +L      N++     G          +  
Sbjct: 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635

Query: 530 S 530
            
Sbjct: 636 F 636

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  408 bits (1052), Expect = e-131
 Identities = 147/530 (27%), Positives = 243/530 (45%), Gaps = 29/530 (5%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---- 58
           +     V S L SL+ L+ L LS + + G++        +L  LDLS N LSG       
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121

Query: 59  FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI---GNLTSLT 115
             + S L+ +++S N L      +    L  ++ L L+ N  +G              L 
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181

Query: 116 SIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS 175
            + +S N + G++   +    NL+ L + SNN    +P  L + S L+ L ++ N LSG 
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238

Query: 176 ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR-FHNMRN 234
            S +I      L+L ++++N F G IP        L    L +N F+G IP+        
Sbjct: 239 FSRAIS-TCTELKLLNISSNQFVGPIPPLPL--KSLQYLSLAENKFTGEIPDFLSGACDT 295

Query: 235 LKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFY 294
           L  L+L  N+        +      +   L+ L+L+ N     +   ++  +   ++   
Sbjct: 296 LTGLDLSGNHFYG-----AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVLD 349

Query: 295 LHNCNIRGSIPKEMGNL-INLIIIRLGYNKLNGSIPSTLSR--LEKLQILGLENNQLEGR 351
           L      G +P+ + NL  +L+ + L  N  +G I   L +     LQ L L+NN   G+
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409

Query: 352 ILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNIL 410
           I   +   + L S++L  N LSG+IP+  G+L+ LR L    N L   +P     +  + 
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
            + L  N L+G +P  + N   L  + LS N L+G+IP  IG L+NL  L L +N+  G+
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529

Query: 471 IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
           IP  +GD  SL  LDL+ N+ +G IP+++ K        ++ N + G+  
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRY 575

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  385 bits (992), Expect = e-122
 Identities = 148/520 (28%), Positives = 236/520 (45%), Gaps = 23/520 (4%)

Query: 14  GSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-FFNMSSLQVIDLSD 72
             ++S+       N     + SS+ S+  LE L LSN+ ++GS   F   +SL  +DLS 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109

Query: 73  NRLSGELPANI-FSYLPFVQFLSLAFNQFAGHLPREIG-NLTSLTSIDLSENHLMGEIPH 130
           N LSG +           ++FL+++ N          G  L SL  +DLS N + G    
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169

Query: 131 EI---GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL 187
                     L+ L +  N + G V   +     L+ L +++N  S  I          L
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD--CSAL 225

Query: 188 ELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS 247
           +   ++ N  SG     I   ++L +  +  N F G IP     +++L+ L+L  N  T 
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTG 283

Query: 248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
              +            L  L L+GN      +P   G+ S  +E   L + N  G +P +
Sbjct: 284 EIPD----FLSGACDTLTGLDLSGN-HFYGAVPPFFGSCS-LLESLALSSNNFSGELPMD 337

Query: 308 M-GNLINLIIIRLGYNKLNGSIPSTLSRL-EKLQILGLENNQLEGRILDDICR--LARLS 363
               +  L ++ L +N+ +G +P +L+ L   L  L L +N   G IL ++C+     L 
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397

Query: 364 SVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGS 422
            +YL +N  +G IP    N + L  L  + N L+  +PS+  +L+ +  + L  N L G 
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457

Query: 423 LPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLE 482
           +P E+  +K L  L L  N+L+G+IP+ +    NL  +SL +N L G IP  IG L +L 
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517

Query: 483 CLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
            L LSNN  SG IP+ L     L +L+++ N   G IP  
Sbjct: 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  329 bits (846), Expect = e-101
 Identities = 132/448 (29%), Positives = 200/448 (44%), Gaps = 26/448 (5%)

Query: 94  SLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVP 153
           S   N     +   + +LT L S+ LS +H+ G +        +L +L L  N+L G V 
Sbjct: 59  SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVT 117

Query: 154 A--TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF---NA 208
              +L + S LK L +++NTL      S  L L +LE+  L+ N+ SG            
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177

Query: 209 SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLS 268
            +L    +  N  SG +        NL+ L++  N  ++       I  L +   L+ L 
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG------IPFLGDCSALQHLD 229

Query: 269 LTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSI 328
           ++GN  L      +I   +  ++   + +    G IP     L +L  + L  NK  G I
Sbjct: 230 ISGN-KLSGDFSRAISTCT-ELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285

Query: 329 PSTLS-RLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASL 386
           P  LS   + L  L L  N   G +       + L S+ L  N  SG +P      +  L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345

Query: 387 RKLSFASNELT-FVPSTFWNLT-NILMVDLSSNPLSGSLPLEIGN--LKVLVELYLSRNN 442
           + L  + NE +  +P +  NL+ ++L +DLSSN  SG +   +       L ELYL  N 
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405

Query: 443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL 502
            +G IP T+     L +L L  N L G+IP+S+G L  L  L L  N+L G IP  L  +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465

Query: 503 LYLKYLNVSFNRLEGEIPRGGTLANFTS 530
             L+ L + FN L GEIP    L+N T+
Sbjct: 466 KTLETLILDFNDLTGEIPS--GLSNCTN 491

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  223 bits (571), Expect = 3e-62
 Identities = 95/332 (28%), Positives = 143/332 (43%), Gaps = 41/332 (12%)

Query: 4   FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFN 61
           +L+GT+PS LGSLS L+ L L  N L G IP  +  + TLE L L  N L+G  P    N
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE 121
            ++L  I LS+NRL+GE+P  I   L  +  L L+ N F+G++P E+G+  SL  +DL+ 
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWI-GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547

Query: 122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT--LSGSISSS 179
           N   G IP  +          + +N + G     + N    K      N     G  S  
Sbjct: 548 NLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603

Query: 180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
           +   L      ++ +  + G       N   +   ++  N  SG+IP    +M  L  LN
Sbjct: 604 LN-RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCN 299
           L +N                         ++G+      +P  +G+L   +    L +  
Sbjct: 663 LGHN------------------------DISGS------IPDEVGDLR-GLNILDLSSNK 691

Query: 300 IRGSIPKEMGNLINLIIIRLGYNKLNGSIPST 331
           + G IP+ M  L  L  I L  N L+G IP  
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  188 bits (479), Expect = 5e-50
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 17/271 (6%)

Query: 260 NSKKLKVLSLTGNPLLDCV--LPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIII 317
              K+  + L+  PL      + SS+ +L+  +E  +L N +I GS+        +L  +
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLT-GLESLFLSNSHINGSVS-GFKCSASLTSL 105

Query: 318 RLGYNKLNGSIPS--TLSRLEKLQILGLENNQLEGRI-LDDICRLARLSSVYLDHNKLSG 374
            L  N L+G + +  +L     L+ L + +N L+    +    +L  L  + L  N +SG
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 375 SIP---ACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNL 430
           +             L+ L+ + N+++  V        N+  +D+SSN  S  +P  +G+ 
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDC 222

Query: 431 KVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNI 490
             L  L +S N LSGD    I     L+ L++  N   G IP     L SL+ L L+ N 
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENK 280

Query: 491 LSGIIPSSLEKLL-YLKYLNVSFNRLEGEIP 520
            +G IP  L      L  L++S N   G +P
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  123 bits (312), Expect = 3e-29
 Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 11/191 (5%)

Query: 357 CRLARLSSVYLDHNKLS---GSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVD 413
           CR  +++S+ L    L+    ++ +   +L  L  L  +++ +    S F    ++  +D
Sbjct: 47  CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106

Query: 414 LSSNPLSGSLP--LEIGNLKVLVELYLSRNNLSGDIPTTIG-GLKNLQNLSLGDNNLQGS 470
           LS N LSG +     +G+   L  L +S N L      + G  L +L+ L L  N++ G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 471 IPNSI---GDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLAN 527
                        L+ L +S N +SG +  S  + + L++L+VS N     IP  G  + 
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPFLGDCSA 224

Query: 528 FTSESFMGNDL 538
                  GN L
Sbjct: 225 LQHLDISGNKL 235

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  303 bits (779), Expect = 5e-93
 Identities = 115/537 (21%), Positives = 194/537 (36%), Gaps = 37/537 (6%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           L         S   LQ LDLS  ++      +  S++ L  L L+ N +       F  +
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSE 121
           SSLQ +   +  L+  L      +L  ++ L++A N      LP    NLT+L  +DLS 
Sbjct: 100 SSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 122 NHLMGEIPHEIGNLRNLQALGL---LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS 178
           N +      ++  L  +  L L   LS N +  +    F    L  L L NN  S ++  
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 179 SIRLALPNLELFSLANNNFSGK------IPSFIFNASKLSICELPDNSFSGF---IPNRF 229
           +    L  LE+  L    F  +        S +     L+I E        +   I + F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 230 HNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS 289
           + + N+   +L    I         +   + +   + L L                L L 
Sbjct: 279 NCLTNVSSFSLVSVTIER-------VKDFSYNFGWQHLELVNCKF------GQFPTLKLK 325

Query: 290 MERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLN--GSIPSTLSRLEKLQILGLENNQ 347
             +  L   + +G       +L +L  + L  N L+  G    +      L+ L L  N 
Sbjct: 326 SLK-RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 348 LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFV-PSTFWN 405
           +   +  +   L +L  +   H+ L        F +L +L  L  +           F  
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 406 LTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGD 464
           L+++ ++ ++ N    +   +I   L+ L  L LS+  L    PT    L +LQ L++  
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503

Query: 465 NNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY-LKYLNVSFNRLEGEIP 520
           NN           L SL+ LD S N +       L+     L +LN++ N       
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  285 bits (732), Expect = 4e-86
 Identities = 114/529 (21%), Positives = 196/529 (37%), Gaps = 32/529 (6%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQ 66
           +P  L    S + LDLSFN L      S FS   L++LDLS  ++       + ++S L 
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG 126
            + L+ N +   L    FS L  +Q L       A      IG+L +L  ++++ N +  
Sbjct: 80  TLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 127 -EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
            ++P    NL NL+ L L SN +  +    L  +  + +L L+ +     ++     A  
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198

Query: 186 NLEL--FSLANNNFSGKIPSFIFNA-SKLSICELPDNSFSGFI---PNRFHNMRNLKELN 239
            + L   +L NN  S  +        + L +  L    F             +  L  L 
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 240 LEYNYITSSNHELSFI-SSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS--LSMERFYLH 296
           +E   +   ++ L  I         +   SL    +        + + S     +   L 
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI------ERVKDFSYNFGWQHLELV 312

Query: 297 NCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL--EGRILD 354
           NC        ++ +L  L      +    G    +   L  L+ L L  N L  +G    
Sbjct: 313 NCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV--PSTFWNLTNILMV 412
                  L  + L  N +   + + F  L  L  L F  + L  +   S F +L N++ +
Sbjct: 368 SDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDI-PTTIGGLKNLQNLSLGDNNLQGSI 471
           D+S      +       L  L  L ++ N+   +  P     L+NL  L L    L+   
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
           P +   L SL+ L++S+N    +     + L  L+ L+ S N +     
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  258 bits (662), Expect = 3e-76
 Identities = 100/514 (19%), Positives = 182/514 (35%), Gaps = 33/514 (6%)

Query: 45  ILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHL 104
                        P     S + +DLS N L   L +  F   P +Q L L+  +     
Sbjct: 11  TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 105 PREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKI 164
                +L+ L+++ L+ N +          L +LQ L  +  NL  +    + ++ TLK 
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 165 LQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP----DNS 220
           L + +N +           L NLE   L++N       + +    ++ +  L      N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 221 FSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFIS-SLANSKKLKVLSLTGNPLLDCVL 279
            +   P  F  +  L +L L  N+ + +  +      +     +L +        L+   
Sbjct: 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 280 PSSIGNL-SLSMERFYL-HNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPST-LSRLE 336
            S++  L +L++E F L +       I      L N+    L    +      +     +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307

Query: 337 KLQILGLENNQLEGRILDDICRLA----------------RLSSVYLDHNKLS--GSIPA 378
            L+++  +  Q     L  + RL                  L  + L  N LS  G    
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 379 CFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELY 437
                 SL+ L  + N +  + S F  L  +  +D   + L       +  +L+ L+ L 
Sbjct: 368 SDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427

Query: 438 LSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI-PNSIGDLISLECLDLSNNILSGIIP 496
           +S  +          GL +L+ L +  N+ Q +  P+   +L +L  LDLS   L  + P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 497 SSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
           ++   L  L+ LN+S N                S
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNS 519

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  226 bits (579), Expect = 2e-64
 Identities = 105/533 (19%), Positives = 184/533 (34%), Gaps = 73/533 (13%)

Query: 4   FLTGTVPSQLGSLSSLQYLDLSFNQLLGT-IPSSIFSINTLEILDLSNNQLSGSFP--FF 60
            L       +G L +L+ L+++ N +    +P    ++  LE LDLS+N++   +     
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 61  NMSSLQV----IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE-IGNLTSLT 115
            +  + +    +DLS N ++  +    F  +     L+L  N  + ++ +  I  L  L 
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL-HKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 116 SIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS 175
              L                           NL     + L  +  L I +     L   
Sbjct: 229 VHRLVLGEF------------------RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 176 ISSSIRL--ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMR 233
           +   I L   L N+  FSL +      +  F +N       EL +  F  F   +  +++
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLK 328

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERF 293
            L   + +               S  +   L+ L L+ N L                   
Sbjct: 329 RLTFTSNKGGNAF----------SEVDLPSLEFLDLSRNGL------------------- 359

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI- 352
                + +G   +      +L  + L +N +   + S    LE+L+ L  +++ L+    
Sbjct: 360 -----SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 353 LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT--FVPSTFWNLTNIL 410
                 L  L  + + H     +    F  L+SL  L  A N     F+P  F  L N+ 
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
            +DLS   L    P    +L  L  L +S NN           L +LQ L    N++  S
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

Query: 471 IPNSIGDLI-SLECLDLSNNILSGIIPSS--LEKLLYLKYLNVSFNRLEGEIP 520
               +     SL  L+L+ N  +        L+ +   + L V   R+E   P
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  217 bits (555), Expect = 3e-61
 Identities = 85/481 (17%), Positives = 176/481 (36%), Gaps = 37/481 (7%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEI----LDLSNNQLSGSFP 58
              +  +P    +L++L++LDLS N++     + +  ++ + +    LDLS N ++   P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194

Query: 59  F-FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE---IGNLTSL 114
             F    L  + L +N  S  +       L  ++   L   +F      E      L  L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254

Query: 115 TSIDLSENHL------MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLT 168
            ++ + E  L      + +I      L N+ +  L+S  +  V           + L+L 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELV 312

Query: 169 NNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN--SFSGFIP 226
           N       +      L    L  L   +  G       +   L   +L  N  SF G   
Sbjct: 313 NCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366

Query: 227 NRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNL 286
                  +LK L+L +N +       +  S+    ++L+ L    + L      S   +L
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420

Query: 287 SLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSI-PSTLSRLEKLQILGLEN 345
             ++    + + + R +       L +L ++++  N    +  P   + L  L  L L  
Sbjct: 421 R-NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 346 NQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFW 404
            QLE         L+ L  + + HN         +  L SL+ L ++ N +         
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

Query: 405 NL-TNILMVDLSSNPLSGSLPLE--IGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS 461
           +  +++  ++L+ N  + +   +  +  +K   +L +    +    P+   G+  + +L+
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLN 598

Query: 462 L 462
           +
Sbjct: 599 I 599

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (413), Expect = 3e-42
 Identities = 70/422 (16%), Positives = 130/422 (30%), Gaps = 67/422 (15%)

Query: 1   LQSFLTGTVPSQLGSLSSLQYLDLSFNQL---LGTIPSSIFSINTLEILDLSNNQLSGSF 57
            +  L     S L  L +L   +     L   L  I      +  +    L +  +    
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298

Query: 58  PFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSI 117
            F      Q ++L + +         F  L       L F    G       +L SL  +
Sbjct: 299 DFSYNFGWQHLELVNCKFGQ------FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL 352

Query: 118 DLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSIS 177
           DLS N L                      +  G    + F  ++LK L L+ N +    S
Sbjct: 353 DLSRNGL----------------------SFKGCCSQSDFGTTSLKYLDLSFNGVITMSS 390

Query: 178 SSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKE 237
           +   L L  LE     ++N                              + F ++RNL  
Sbjct: 391 NF--LGLEQLEHLDFQHSNLKQMSE-----------------------FSVFLSLRNLIY 425

Query: 238 LNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHN 297
           L++ + +   + +             L+VL + GN   +  LP     L  ++    L  
Sbjct: 426 LDISHTHTRVAFNG-----IFNGLSSLEVLKMAGNSFQENFLPDIFTELR-NLTFLDLSQ 479

Query: 298 CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDIC 357
           C +    P    +L +L ++ + +N            L  LQ+L    N +      ++ 
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

Query: 358 RLAR-LSSVYLDHNKLSGSIPAC--FGNLASLRKLSFASNELT-FVPSTFWNLTNILMVD 413
                L+ + L  N  + +         +   R+L      +    PS    +  +L ++
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLN 598

Query: 414 LS 415
           ++
Sbjct: 599 IT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  145 bits (368), Expect = 1e-36
 Identities = 58/364 (15%), Positives = 120/364 (32%), Gaps = 34/364 (9%)

Query: 200 KIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLA 259
            +P+  +   +L+  ++PDN              + K L+L +N +           S  
Sbjct: 6   VVPNITYQCMELNFYKIPDNLPF-----------STKNLDLSFNPLRHLGS-----YSFF 49

Query: 260 NSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRL 319
           +  +L+VL L+   +   +   +  +LS  +    L    I+         L +L  +  
Sbjct: 50  SFPELQVLDLSRCEIQT-IEDGAYQSLS-HLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107

Query: 320 GYNKLNGSIPSTLSRLEKLQILGLENNQLEG-RILDDICRLARLSSVYLDHNKLSGSIPA 378
               L       +  L+ L+ L + +N ++  ++ +    L  L  + L  NK+      
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167

Query: 379 CFGNLASLR----KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLP-LEIGNLKVL 433
               L  +      L  + N + F+    +    +  + L +N  S ++    I  L  L
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227

Query: 434 VELYLSRNNLSGDI---PTTIGGLKNLQNLSLGDNNLQ------GSIPNSIGDLISLECL 484
               L       +          L+ L NL++ +  L         I +    L ++   
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287

Query: 485 DLSNNILSGIIPSS-LEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP 543
            L +  +  +   S      +L+ +N  F +      +      FTS            P
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347

Query: 544 HLQV 547
            L+ 
Sbjct: 348 SLEF 351

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  301 bits (773), Expect = 3e-91
 Identities = 115/568 (20%), Positives = 197/568 (34%), Gaps = 51/568 (8%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSG----SFPFF 60
           +     +      +L  LDLS N L  T   +   +  L+ L LSNN++          F
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIG---NLTSLTSI 117
             SSL+ ++LS N++        F  +  +  L L   Q    L  ++      TS+ ++
Sbjct: 169 ANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227

Query: 118 DLSENHLMGEIPHEIGNLR--NLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS 175
            LS + L          L+  NL  L L  NNL  V   +   +  L+   L  N +   
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287

Query: 176 ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNL 235
            S S+   L N+   +L  +                    +   S        F  ++ L
Sbjct: 288 FSHSLHG-LFNVRYLNLKRSFTKQ---------------SISLASLPKIDDFSFQWLKCL 331

Query: 236 KELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSI--GNLSLSMERF 293
           + LN+E N I          +       LK LSL+ +      L +          +   
Sbjct: 332 EHLNMEDNDIPGIKS-----NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIP-STLSRLEKLQILGLENNQLEGRI 352
            L    I          L +L ++ LG N++   +       LE +  + L  N+     
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446

Query: 353 LDDICRLARLSSVYLDHNKLSG--SIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNI 409
            +    +  L  + L    L    S P+ F  L +L  L  ++N +          L  +
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506

Query: 410 LMVDLSSNPLS--------GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS 461
            ++DL  N L+        G     +  L  L  L L  N            L  L+ + 
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY-LKYLNVSFNRLEGEIP 520
           LG NNL     +   + +SL+ L+L  N+++ +           L  L++ FN  +    
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

Query: 521 RGGTLANFTSES-----FMGNDLLCGSP 543
                 N+ +E+      + +  LC +P
Sbjct: 627 SIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  293 bits (753), Expect = 2e-88
 Identities = 123/546 (22%), Positives = 199/546 (36%), Gaps = 43/546 (7%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSL 65
            VP  L   +++  L+L+ NQL     ++    + L  LD+  N +S   P     +  L
Sbjct: 18  QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           +V++L  N LS  L    F++   +  L L  N              +L ++DLS N L 
Sbjct: 76  KVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGVVPATL--FNISTLKILQLTNNTLSGSISSSIRLA 183
                    L NLQ L L +N +  +    L  F  S+LK L+L++N +          A
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH-A 193

Query: 184 LPNLELFSLANNNFSGKIPSFIF---NASKLSICELPDNSFSGFIPNRFHNMR--NLKEL 238
           +  L    L N      +   +      + +    L ++  S      F  ++  NL  L
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253

Query: 239 NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL--------SM 290
           +L YN +    +      S A   +L+   L  N +   +   S+  L          S 
Sbjct: 254 DLSYNNLNVVGN-----DSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFNVRYLNLKRSF 307

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG 350
            +  +   ++          L  L  + +  N + G   +  + L  L+ L L N+    
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367

Query: 351 RILDDI----CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV--PSTFW 404
           R L +        + L  + L  NK+S      F  L  L  L    NE+        + 
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427

Query: 405 NLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG--DIPTTIGGLKNLQNLSL 462
            L NI  + LS N            +  L  L L R  L      P+    L+NL  L L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487

Query: 463 GDNNLQGSIPNSIGDLISLECLDLSNNILS--------GIIPSSLEKLLYLKYLNVSFNR 514
            +NN+     + +  L  LE LDL +N L+        G     L+ L +L  LN+  N 
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547

Query: 515 LEGEIP 520
            +    
Sbjct: 548 FDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  286 bits (734), Expect = 1e-85
 Identities = 119/522 (22%), Positives = 214/522 (40%), Gaps = 32/522 (6%)

Query: 18  SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRL 75
           S +  D S  + L  +P  + +   + +L+L++NQL       F   S L  +D+  N +
Sbjct: 5   SHEVADCSHLK-LTQVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 76  SGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNL 135
           S  L   +   LP ++ L+L  N+ +    +     T+LT + L  N +     +     
Sbjct: 62  SK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 136 RNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR-LALPNLELFSLAN 194
           +NL  L L  N L      T   +  L+ L L+NN +    S  +   A  +L+   L++
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRF---HNMRNLKELNLEYNYITSSNHE 251
           N      P       +L    L +      +  +        +++ L+L  + ++++++ 
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN- 239

Query: 252 LSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNL 311
            +    L  +  L +L L+ N L   V   S   L   +E F+L   NI+      +  L
Sbjct: 240 -TTFLGLKWT-NLTMLDLSYNNLNV-VGNDSFAWLP-QLEYFFLEYNNIQHLFSHSLHGL 295

Query: 312 INLIIIRLGYN---------KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
            N+  + L  +          L      +   L+ L+ L +E+N + G   +    L  L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355

Query: 363 SSVYLDHNKLSGS--IPACFGNLA--SLRKLSFASNELTFV-PSTFWNLTNILMVDLSSN 417
             + L ++  S        F +LA   L  L+   N+++ +    F  L ++ ++DL  N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415

Query: 418 PLSGSLP-LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG--SIPNS 474
            +   L   E   L+ + E+YLS N        +   + +LQ L L    L+   S P+ 
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475

Query: 475 IGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
              L +L  LDLSNN ++ I    LE L  L+ L++  N L 
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  224 bits (572), Expect = 6e-63
 Identities = 88/431 (20%), Positives = 156/431 (36%), Gaps = 30/431 (6%)

Query: 112 TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT 171
            S    D S   L  ++P ++    N+  L L  N L  +  A     S L  L +  NT
Sbjct: 4   VSHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 172 LSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHN 231
           +S       +  LP L++ +L +N  S          + L+   L  NS      N F  
Sbjct: 61  ISKLEPELCQ-KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 232 MRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSM- 290
            +NL  L+L +N ++S+      + +    + L+ L L+ N  +  +    +   + S  
Sbjct: 120 QKNLITLDLSHNGLSSTK-----LGTQVQLENLQELLLSNN-KIQALKSEELDIFANSSL 173

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLS---RLEKLQILGLENNQ 347
           ++  L +  I+   P     +  L  + L   +L  S+   L        ++ L L N+Q
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233

Query: 348 LEGRILDDI--CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFW 404
           L           +   L+ + L +N L+      F  L  L       N +  +   +  
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293

Query: 405 NLT---------NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK 455
            L          +     +S   L          LK L  L +  N++ G       GL 
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353

Query: 456 NLQNLSLGDNNLQGSIPNSIG----DLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
           NL+ LSL ++        +          L  L+L+ N +S I   +   L +L+ L++ 
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413

Query: 512 FNRLEGEIPRG 522
            N +  E+   
Sbjct: 414 LNEIGQELTGQ 424

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  188 bits (479), Expect = 1e-50
 Identities = 68/394 (17%), Positives = 136/394 (34%), Gaps = 44/394 (11%)

Query: 4   FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGS------- 56
            L          L  L+Y  L +N +      S+  +  +  L+L  +    S       
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318

Query: 57  ----FPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF-AGHLPREIG-- 109
               F F  +  L+ +++ DN + G + +N+F+ L  +++LSL+ +      L  E    
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377

Query: 110 -NLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQL 167
              + L  ++L++N +          L +L+ L L  N +   +    +  +  +  + L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437

Query: 168 TNNTLSGSISSSIRLALPNLELFSLANNNFSG--KIPSFIFNASKLSICELPDNSFSGFI 225
           + N       +S    +P+L+   L           PS       L+I +L +N+ +   
Sbjct: 438 SYNKYLQLTRNSFA-LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496

Query: 226 PNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGN 285
            +    +  L+ L+L++N +                                     +  
Sbjct: 497 DDMLEGLEKLEILDLQHNNLARLWKH----------------------ANPGGPIYFLKG 534

Query: 286 LSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLEN 345
           LS  +    L +        +   +L  L II LG N LN    S  +    L+ L L+ 
Sbjct: 535 LS-HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593

Query: 346 NQLEGRILDDICRLAR-LSSVYLDHNKLSGSIPA 378
           N +            R L+ + +  N    +  +
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  162 bits (411), Expect = 1e-41
 Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 15/275 (5%)

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNK 323
            +V   +   L    +P  +     ++    L +  +R            L  + +G+N 
Sbjct: 6   HEVADCSHLKLTQ--VPDDLPT---NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
           ++   P    +L  L++L L++N+L             L+ ++L  N +       F   
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 384 ASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLSGSLP--LEIGNLKVLVELYLSR 440
            +L  L  + N L+     T   L N+  + LS+N +       L+I     L +L LS 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD---LISLECLDLSNNILSGIIPS 497
           N +    P     +  L  L L +  L  S+   +       S+  L LSN+ LS    +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 498 SLEKLLY--LKYLNVSFNRLEGEIPRGGTLANFTS 530
           +   L +  L  L++S+N L        + A    
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGN--DSFAWLPQ 273

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (285), Expect = 5e-26
 Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 4/171 (2%)

Query: 361 RLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPL 419
                   H KL+  +P       ++  L+   N+L  +  + F   + +  +D+  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 420 SGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLI 479
           S   P     L +L  L L  N LS     T     NL  L L  N++Q    N      
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 480 SLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
           +L  LDLS+N LS     +  +L  L+ L +S N+++        +   +S
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (252), Expect = 4e-22
 Identities = 43/201 (21%), Positives = 75/201 (37%), Gaps = 17/201 (8%)

Query: 7   GTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-------- 58
            + PS    L +L  LDLS N +       +  +  LEILDL +N L+  +         
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529

Query: 59  --FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTS 116
                +S L +++L  N     +P  +F  L  ++ + L  N           N  SL S
Sbjct: 530 YFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588

Query: 117 IDLSENHLMGEIPHEIG-NLRNLQALGLLSNNLVGVVPATLF-----NISTLKILQLTNN 170
           ++L +N +        G   RNL  L +  N       +  +     N +   I +L+++
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648

Query: 171 TLSGSISSSIRLALPNLELFS 191
            L  +        +   +  S
Sbjct: 649 YLCNTPPHYHGFPVRLFDTSS 669

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  298 bits (765), Expect = 2e-90
 Identities = 89/552 (16%), Positives = 188/552 (34%), Gaps = 60/552 (10%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLG----TIPSSIFSINTLEILDLSNNQLSGSFPFF 60
            +G VP  +G L+ L+ L L  +          P  I +  + E           +F  +
Sbjct: 93  ASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDY 152

Query: 61  ----NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTS 116
               + S L    ++ +     +  +    L   Q +    N     + + +  LT L  
Sbjct: 153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ-IGQLSNNI-TFVSKAVMRLTKLRQ 210

Query: 117 IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI 176
             +  +  + E   E     N +                  N+  L  +++ N      +
Sbjct: 211 FYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265

Query: 177 SSSIRLALPNLELFSLANNNF--------SGKIPSFIFNASKLSICELPDNSF-SGFIPN 227
            + ++ ALP ++L ++A N            +  +      K+ I  +  N+  +  +  
Sbjct: 266 PTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324

Query: 228 RFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS 287
               M+ L  L   YN +         + +  +  KL  L+L  N + +  +P++    +
Sbjct: 325 SLQKMKKLGMLECLYNQLE------GKLPAFGSEIKLASLNLAYNQITE--IPANFCGFT 376

Query: 288 LSMERFYLHNCNIRG-SIPKEMGNLINLIIIRLGYNKLNG-------SIPSTLSRLEKLQ 339
             +E     +  ++      +  ++  +  I   YN++          +  T  +   + 
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436

Query: 340 ILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG-------SIPACFGNLASLRKLSFA 392
            + L NNQ+     +     + LSS+ L  N L+             F N   L  +   
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496

Query: 393 SNELTFVPS--TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYL------SRNNLS 444
            N+LT +        L  ++ +DLS N  S   P +  N   L    +        N   
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

Query: 445 GDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY 504
            + P  I    +L  L +G N+++  +   I    ++  LD+ +N    I  S +   + 
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612

Query: 505 LKYLNVSFNRLE 516
                + +++ +
Sbjct: 613 AGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  289 bits (741), Expect = 4e-87
 Identities = 77/561 (13%), Positives = 178/561 (31%), Gaps = 61/561 (10%)

Query: 12  QLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSL--QVID 69
            L S   +  L L      G +P +I  +  LE+L L ++    +   F    +   + D
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 70  LSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIP 129
               ++          Y P   F  L  +                    ++ +     I 
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKD-------------------CINSDPQQKSIK 176

Query: 130 HEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLEL 189
                      +G LSNN+   V   +  ++ L+   + N+                 E 
Sbjct: 177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA------WEN 229

Query: 190 FSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS-- 247
            +               N   L+  E+ +      +P     +  ++ +N+  N   S  
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 248 -SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPK 306
               +   ++     +K++++ +  N L    + +S+  +   +         + G +P 
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEGKLP- 347

Query: 307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG-RILDDICRLARLSSV 365
             G+ I L  + L YN++     +     E+++ L   +N+L+    + D   ++ +S++
Sbjct: 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAI 407

Query: 366 YLDHNKLSG-------SIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSN 417
              +N++          +        ++  ++ ++N+++ F    F   + +  ++L  N
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467

Query: 418 PLSG-------SLPLEIGNLKVLVELYLSRNNLSGDIPTTI--GGLKNLQNLSLGDNNLQ 468
            L+               N  +L  + L  N L+  +        L  L  + L  N+  
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS 526

Query: 469 GSIPNSIGDLISLECLDLSNNI------LSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
              P    +  +L+   + N             P  +     L  L +  N +   +   
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE- 583

Query: 523 GTLANFTSESFMGNDLLCGSP 543
               N +      N  +    
Sbjct: 584 KITPNISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  213 bits (544), Expect = 1e-59
 Identities = 60/439 (13%), Positives = 129/439 (29%), Gaps = 52/439 (11%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQL-------------------LGTIPSSIFSINTLEILDL 48
            V   +  L+ L+   +  +                       T      ++  L  +++
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 49  SNNQLSGSFP--FFNMSSLQVIDLSDNRLSG--ELPANI-----FSYLPFVQFLSLAFNQ 99
            N       P     +  +Q+I+++ NR     +L  +            +Q + + +N 
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316

Query: 100 FA-GHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN 158
                +   +  +  L  ++   N L G++P   G+   L +L L  N +  +       
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGF 375

Query: 159 ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSG-------KIPSFIFNASKL 211
              ++ L   +N L    +     ++  +     + N            +    F    +
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 212 SICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS--SNHELSFISSLANSKKLKVLSL 269
           S   L +N  S F    F     L  +NL  N +T    N       +  N+  L  + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 270 TGNPLLDCVLPSSIGNLSL-SMERFYLHNCNIRGSIPKEMGNLINLIIIRLG------YN 322
             N L    L       +L  +    L   +     P +  N   L    +        N
Sbjct: 496 RFNKLTK--LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN 552

Query: 323 KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
           +     P  ++    L  L + +N +   + + I     +S + +  N       +    
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCP 609

Query: 383 LASLRKLSFASNELTFVPS 401
                      ++   +  
Sbjct: 610 YIEAGMYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  186 bits (474), Expect = 4e-50
 Identities = 52/351 (14%), Positives = 127/351 (36%), Gaps = 19/351 (5%)

Query: 190 FSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN 249
           F+   + +  +    + +  +++   L     SG +P+    +  L+ L L  +     N
Sbjct: 62  FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VN 120

Query: 250 HELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMG 309
             L     ++ +   +             +          + +  +++   + SI K   
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
             +    I    N +   +   + RL KL+   + N+      + +            ++
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEY 234

Query: 370 NKLSGSIPACFGNLASLRKLSFAS-NELTFVPSTFWNLTNILMVDLSSN--------PLS 420
            +   +    + NL  L  +   +   LT +P+    L  + +++++ N           
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294

Query: 421 GSLPLEIGNLKVLVELYLSRNNL-SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLI 479
                +    + +  +Y+  NNL +  + T++  +K L  L    N L+G +P + G  I
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353

Query: 480 SLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
            L  L+L+ N ++ I  +       ++ L+ + N+L+  IP      + + 
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  163 bits (414), Expect = 2e-42
 Identities = 61/323 (18%), Positives = 111/323 (34%), Gaps = 33/323 (10%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FF 60
           +  T  V + L  +  L  L+  +NQL G +P +  S   L  L+L+ NQ++        
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCG 374

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG-------HLPREIGNLTS 113
               ++ +  + N+L           +  +  +  ++N+           L        +
Sbjct: 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434

Query: 114 LTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGV-------VPATLFNISTLKILQ 166
           ++SI+LS N +             L ++ L+ N L  +             N   L  + 
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494

Query: 167 LTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSI------CELPDNS 220
           L  N L+          LP L    L+ N+FS   P+   N+S L         +   N 
Sbjct: 495 LRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553

Query: 221 FSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLP 280
                P       +L +L +  N I   N ++        +  + VL +  NP +   L 
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--------TPNISVLDIKDNPNISIDLS 605

Query: 281 SSIGNLSLSMERFYL-HNCNIRG 302
                +   M   +     +IRG
Sbjct: 606 YVCPYIEAGMYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  131 bits (332), Expect = 6e-32
 Identities = 27/246 (10%), Positives = 68/246 (27%), Gaps = 13/246 (5%)

Query: 298 CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG----RIL 353
                     + +   +  + L     +G +P  + +L +L++L L ++  +        
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 354 DDICRLARLSSVYLDHNKLSGSIPACFGNLA--SLRKLSFASNELT-FVPSTFWNLTNIL 410
             I                  +            L K    S+     +  +        
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
            +   SN ++  +   +  L  L + Y+  +    +        +N +           +
Sbjct: 187 QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKT 240

Query: 471 IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
                 +L  L  +++ N      +P+ L+ L  ++ +NV+ NR                
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 531 ESFMGN 536
                 
Sbjct: 301 APVGEK 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  272 bits (698), Expect = 8e-85
 Identities = 93/334 (27%), Positives = 142/334 (42%), Gaps = 57/334 (17%)

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
           + ++ G + +       +  L+L    +                                
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP--------------------------- 67

Query: 278 VLPSSIGNLSLSMERFYLHNCN-IRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLE 336
            +PSS+ NL   +   Y+   N + G IP  +  L  L  + + +  ++G+IP  LS+++
Sbjct: 68  -IPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 337 KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL 396
            L  L    N L G +   I  L  L  +  D N++SG+IP  +G+ + L          
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL---------- 175

Query: 397 TFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
                          + +S N L+G +P    NL  L  + LSRN L GD     G  KN
Sbjct: 176 ------------FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKN 222

Query: 457 LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            Q + L  N+L   +   +G   +L  LDL NN + G +P  L +L +L  LNVSFN L 
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 517 GEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPC 550
           GEIP+GG L  F   ++  N  LCGSP   +P C
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  201 bits (514), Expect = 1e-58
 Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 16/276 (5%)

Query: 6   TGTVPSQLGSLSSLQYLDLSFNQLLGT--IPSSIFSINTLEILDLSN-NQLSGSFP--FF 60
            G +         +  LDLS   L     IPSS+ ++  L  L +   N L G  P    
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS 120
            ++ L  + ++   +SG +P  + S +  +  L  ++N  +G LP  I +L +L  I   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFL-SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157

Query: 121 ENHLMGEIPHEIGNLRNL-QALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSS 179
            N + G IP   G+   L  ++ +  N L G +P T  N++ L  + L+ N L G  S  
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVL 216

Query: 180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
              +  N +   LA N+ +  +   +  +  L+  +L +N   G +P     ++ L  LN
Sbjct: 217 F-GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLL 275
           + +N +         I    N ++  V +   N  L
Sbjct: 275 VSFNNLCGE------IPQGGNLQRFDVSAYANNKCL 304

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  191 bits (488), Expect = 6e-55
 Identities = 72/354 (20%), Positives = 123/354 (34%), Gaps = 69/354 (19%)

Query: 10  PSQLGSLSSLQ----YLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP----FFN 61
              LG+ ++L       D      LG +  +      +  LDLS   L   +P      N
Sbjct: 15  KKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE 121
           +  L  + +                           N   G +P  I  LT L  + ++ 
Sbjct: 75  LPYLNFLYIGGI------------------------NNLVGPIPPAIAKLTQLHYLYITH 110

Query: 122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
            ++ G IP  +  ++ L  L    N L G +P ++ ++  L  +    N +SG+I  S  
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 182 LALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
                    +++ N  +GKIP    N + L+  +L  N   G     F + +N ++++L 
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229

Query: 242 YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR 301
            N +         +  +  SK L  L L  N                           I 
Sbjct: 230 KNSLAFD------LGKVGLSKNLNGLDLRNN--------------------------RIY 257

Query: 302 GSIPKEMGNLINLIIIRLGYNKLNGSIPST--LSRLEKLQILGLENNQLEGRIL 353
           G++P+ +  L  L  + + +N L G IP    L R +        N  L G  L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN--NKCLCGSPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  191 bits (487), Expect = 9e-55
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 5/201 (2%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           L G +P  +  L+ L YL ++   + G IP  +  I TL  LD S N LSG+ P    ++
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
            +L  I    NR+SG +P +  S+      ++++ N+  G +P    NL +L  +DLS N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
            L G+     G+ +N Q + L  N+L   +   +     L  L L NN + G++   +  
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT- 265

Query: 183 ALPNLELFSLANNNFSGKIPS 203
            L  L   +++ NN  G+IP 
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQ 286

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  176 bits (448), Expect = 2e-49
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 8/195 (4%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           ++G +P  L  + +L  LD S+N L GT+P SI S+  L  +    N++SG+ P  + + 
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172

Query: 63  SSL-QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE 121
           S L   + +S NRL+G++P    + L    F+ L+ N   G      G+  +   I L++
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFAN-LNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

Query: 122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
           N L  ++  ++G  +NL  L L +N + G +P  L  +  L  L ++ N L G I     
Sbjct: 231 NSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-- 287

Query: 182 LALPNLELFSLANNN 196
             L   ++ + ANN 
Sbjct: 288 GNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  145 bits (368), Expect = 1e-38
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 5/164 (3%)

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT---FVPSTFWNLTNILMVDLSS-NP 418
            +    +    G +         +  L  +   L     +PS+  NL  +  + +   N 
Sbjct: 29  PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88

Query: 419 LSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDL 478
           L G +P  I  L  L  LY++  N+SG IP  +  +K L  L    N L G++P SI  L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 479 ISLECLDLSNNILSGIIPSSLEKLLYL-KYLNVSFNRLEGEIPR 521
            +L  +    N +SG IP S      L   + +S NRL G+IP 
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  116 bits (293), Expect = 9e-29
 Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 28/145 (19%)

Query: 4   FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-FFNM 62
            LTG +P    +L +L ++DLS N L G       S    + + L+ N L+         
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
            +L  +DL +NR+ G LP                           +  L  L S+++S N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQ-------------------------GLTQLKFLHSLNVSFN 278

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNN 147
           +L GEIP + GNL+        +N 
Sbjct: 279 NLCGEIP-QGGNLQRFDVSAYANNK 302

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  280 bits (718), Expect = 7e-82
 Identities = 87/582 (14%), Positives = 178/582 (30%), Gaps = 69/582 (11%)

Query: 12  QLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSL--QVID 69
            L +   +  L L+     G +P +I  +  L++L    +  + S   F    L   + +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 70  LSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG--- 126
              +R+          Y   +    L  +    +   E+  +   + I L +  +     
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTN 435

Query: 127 ---EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
               I   I  L  LQ +   ++       A        +           +   S    
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWS-N 489

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGF---------IPNRFHNMRN 234
           L +L    L N     ++P F+++  +L    +  N              + +       
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549

Query: 235 LKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFY 294
           ++   + YN +       S         KL +L    N +       + G     +    
Sbjct: 550 IQIFYMGYNNLEEFPASASL----QKMVKLGLLDCVHNKV---RHLEAFGTNV-KLTDLK 601

Query: 295 LHNCNIRGSIPKEMG-NLINLIIIRLGYNKLNGSIPST--LSRLEKLQILGLENNQLEGR 351
           L    I   IP++       +  +   +NKL   IP+      +  +  +    N++   
Sbjct: 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSE 659

Query: 352 ILD-----DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS----- 401
             +     D  +    S+V L +N++       F   + +  +  ++N +T +P      
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719

Query: 402 ---TFWNLTNILMVDLSSNPLSGSLPLEI--GNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
               + N   +  +DL  N L+ SL  +     L  L  + +S N  S   PT       
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777

Query: 457 LQ------NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNV 510
           L+            N +    P  I    SL  L + +N +  +      +   L  L++
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ---LYILDI 834

Query: 511 SFNRLEGEIPRGGTLANFTSESFM----GNDLLCGSPHLQVP 548
           + N     I          +  ++        + G   L + 
Sbjct: 835 ADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  243 bits (622), Expect = 1e-68
 Identities = 73/532 (13%), Positives = 175/532 (32%), Gaps = 46/532 (8%)

Query: 22  LDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGEL 79
            +   +         + +   +  L L+     G  P     ++ L+V+    +  +   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 80  PANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL-----MGEIPHEIGN 134
                  L               +    +     L   DL ++ +     M  I  +   
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 135 LRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN 194
                 +G L+N +   +   +  ++ L+I+   N+  +    +       + E  +   
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV------DWEDANSDY 476

Query: 195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSF 254
                       N   L+  EL +      +P+  +++  L+ LN+  N   S+    + 
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536

Query: 255 ISSLANS----KKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGN 310
            + LA+      K+++  +  N L +    +S+  +   +      +  +     +  G 
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV-KLGLLDCVHNKV--RHLEAFGT 593

Query: 311 LINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG-RILDDICRLARLSSVYLDH 369
            + L  ++L YN++        +  ++++ LG  +N+L+    + +   +  + SV   +
Sbjct: 594 NVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653

Query: 370 NKLSGSIPACFG-----NLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLS--- 420
           NK+                 +   ++ + NE+  F    F   + I  + LS+N ++   
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713

Query: 421 ----GSLPLEIGNLKVLVELYLSRNNLSGDIPTTI--GGLKNLQNLSLGDNNLQGSIPNS 474
                       N  +L  + L  N L+  +        L  L N+ +  N    S P  
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQ 771

Query: 475 IGDLISLECLDL------SNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
             +   L+   +        N +    P+ +     L  L +  N +  ++ 
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD 822

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  233 bits (597), Expect = 3e-65
 Identities = 72/469 (15%), Positives = 146/469 (31%), Gaps = 49/469 (10%)

Query: 93  LSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVV 152
            +   + +      ++ N   +T + L+     G +P  IG L  L+ L   +++     
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 153 PATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLS 212
                   T  + +   + +              L L  L  +  +      +    K S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDS 421

Query: 213 ICELPDNSFSG------FIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV 266
              L D           FI      +  L+ +    +  T  N  +            + 
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD----------WED 471

Query: 267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG 326
            +       +     S  NL   +    L+NC     +P  + +L  L  + +  N+   
Sbjct: 472 ANSDYAKQYE-NEELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529

Query: 327 ---------SIPSTLSRLEKLQILGLENNQLEG-RILDDICRLARLSSVYLDHNKLSGSI 376
                     +        K+QI  +  N LE       + ++ +L  +   HNK+   +
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HL 588

Query: 377 PACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV-DLSSNPLSGSLP--LEIGNLKVL 433
            A FG    L  L    N++  +P  F   T+ +     S N L   +P      ++ V+
Sbjct: 589 EA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646

Query: 434 VELYLSRNNLSGDIPTTIGGL-----KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSN 488
             +  S N +  +       +      N   ++L  N +Q            +  + LSN
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706

Query: 489 NILSGI-------IPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
           N+++ I          + +    L  +++ FN+L   +           
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPY 754

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  208 bits (531), Expect = 2e-56
 Identities = 72/541 (13%), Positives = 148/541 (27%), Gaps = 145/541 (26%)

Query: 7   GTVPSQLGSLSSLQYLDLSFNQL-------------------LGTIPSSIFSINTLEILD 47
             +   +  L+ LQ +  + +                           S  ++  L  ++
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497

Query: 48  LSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLP 105
           L N       P   +++  LQ ++++ NR                             L 
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW----------------TRLA 541

Query: 106 REIGNLTSLTSIDLSENHLMGEIPHE--IGNLRNLQALGLLSNNLVGVVPATLFNISTLK 163
            +      +    +  N+L  E P    +  +  L  L    +N V  + A       L 
Sbjct: 542 DDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLD-CVHNKVRHLEA-FGTNVKLT 598

Query: 164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG 223
            L+L  N +   I          +E    ++N                    +P+     
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK----------------YIPNIFN-- 639

Query: 224 FIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSI 283
                  ++  +  ++  YN I S                                  +I
Sbjct: 640 -----AKSVYVMGSVDFSYNKIGS-------------------------------EGRNI 663

Query: 284 GNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGL 343
                                  +    IN   + L YN++        +    +  + L
Sbjct: 664 S-------------------CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

Query: 344 ENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-- 401
            NN +   I ++                        + N   L  +    N+LT +    
Sbjct: 705 SNNLMT-SIPENSL----------------KPKDGNYKNTYLLTTIDLRFNKLTSLSDDF 747

Query: 402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR------NNLSGDIPTTIGGLK 455
               L  +  +D+S N  S S P +  N   L    +        N +    PT I    
Sbjct: 748 RATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806

Query: 456 NLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
           +L  L +G N+++  +   +     L  LD+++N    I  +S+   +      + +++ 
Sbjct: 807 SLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

Query: 516 E 516
           +
Sbjct: 864 Q 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  195 bits (497), Expect = 4e-52
 Identities = 63/403 (15%), Positives = 128/403 (31%), Gaps = 43/403 (10%)

Query: 1   LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-- 58
             +           +L  L  ++L     +  +P  ++ +  L+ L+++ N+   +    
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534

Query: 59  ---------FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIG 109
                          +Q+  +  N L     +     +  +  L    N+   HL    G
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFG 592

Query: 110 NLTSLTSIDLSENHLMGEIPHEIG-NLRNLQALGLLSNNLVGVVPATLF-NISTLKILQL 167
               LT + L  N +  EIP +       ++ LG   N L  +       ++  +  +  
Sbjct: 593 TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDF 651

Query: 168 TNNTLSG----SISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFS- 222
           + N +         S       N    +L+ N             S +S   L +N  + 
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711

Query: 223 ------GFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
                       + N   L  ++L +N +TS    LS          L  + ++ N    
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTS----LSDDFRATTLPYLSNMDVSYNCFSS 767

Query: 277 CVLPSSIGNLSLSMERFYL------HNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS 330
              P+   N S  ++ F +          I    P  +    +LI +++G N +   +  
Sbjct: 768 --FPTQPLNSS-QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE 823

Query: 331 TLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLS 373
            L    +L IL + +N      +  +C         L ++K  
Sbjct: 824 KL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (314), Expect = 2e-29
 Identities = 30/248 (12%), Positives = 70/248 (28%), Gaps = 13/248 (5%)

Query: 298 CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDIC 357
                    ++ N   +  + L      G +P  + +L +L++L    +           
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 358 RLARLSSVYLDHNKLSGSIPACFG-NLASLRKLSFASN------ELTFVPSTFWNLTNIL 410
                       +++       F      L       +      E+  +           
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
            +   +N ++  +   I  L  L  +Y + +  + D         + ++ +        +
Sbjct: 429 QIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482

Query: 471 IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
              S  +L  L  ++L N      +P  L  L  L+ LN++ NR                
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542

Query: 531 ESFMGNDL 538
           +   G  +
Sbjct: 543 DEDTGPKI 550

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  268 bits (687), Expect = 1e-79
 Identities = 108/548 (19%), Positives = 194/548 (35%), Gaps = 50/548 (9%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSL 65
            +P  L   +S + L+ SFN L     ++   +  L  LDL+  Q+       F +   L
Sbjct: 26  EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
             + L+ N L   +     S    ++ L       +      + N  +L S+ L  NH+ 
Sbjct: 84  DTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 126 GEIPHEIGNLRNLQALGL-------------------------LSNNLVGVVPATLFNIS 160
                +      L+ L                           L+ N +  +    F+ +
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA 202

Query: 161 TLKILQLTNNTLSGSISSSIR-LALPNLELFSLANNNFSGKIPSFIFNASKLSICELP-- 217
             + L          I   ++   + +L L +  + +     P+      ++S+  +   
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
            + F     N FH    L+EL+L   +++         S L     LK L L+ N   + 
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS------ELPSGLVGLSTLKKLVLSAN-KFEN 315

Query: 278 VLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGS--IPSTLSR 334
           +   S  N   S+    +     R  +      NL NL  + L ++ +  S      L  
Sbjct: 316 LCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 335 LEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIP-ACFGNLASLRKLSFAS 393
           L  LQ L L  N+      +      +L  + L   +L      + F NL  L+ L+ + 
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434

Query: 394 NELTFVP-STFWNLTNILMVDLSSNPLSGSLPLEIG---NLKVLVELYLSRNNLSGDIPT 449
           + L       F  L  +  ++L  N        +      L  L  L LS  +LS     
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494

Query: 450 TIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLN 509
               LK + ++ L  N L  S   ++  L  +  L+L++N +S I+PS L  L   + +N
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTIN 553

Query: 510 VSFNRLEG 517
           +  N L+ 
Sbjct: 554 LRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  238 bits (609), Expect = 9e-69
 Identities = 94/497 (18%), Positives = 167/497 (33%), Gaps = 20/497 (4%)

Query: 44  EILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGH 103
           +  +  N  L+   P    +S + ++ S N L   +    FS L  + FL L   Q    
Sbjct: 15  KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 104 LPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLK 163
                 +   L ++ L+ N L+      +   + L+ L  +   +  +    L N  TL+
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICEL--PDNSF 221
            L L +N +S             L++    NN         + +  + +   L    N  
Sbjct: 133 SLYLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPS 281
           +G  P  F +    + LN           +    S++ +   L + +       D     
Sbjct: 192 AGIEPGAFDSA-VFQSLNFGGTQNLLVIFKGLKNSTIQS---LWLGTFEDMDDEDISPAV 247

Query: 282 SIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQIL 341
             G   +S+E   L                  L  + L    L+  +PS L  L  L+ L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306

Query: 342 GLENNQLEGRILDDICRLARLSSVYLDHNKLSGSI-PACFGNLASLRKLSFASNELTFVP 400
            L  N+ E            L+ + +  N     +   C  NL +LR+L  + +++    
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 401 S---TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG-DIPTTIGGLKN 456
                  NL+++  ++LS N               L  L L+   L   D  +    L  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

Query: 457 LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII---PSSLEKLLYLKYLNVSFN 513
           L+ L+L  + L  S       L +L+ L+L  N          +SL+ L  L+ L +SF 
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486

Query: 514 RLEGEIPRGGTLANFTS 530
            L           +   
Sbjct: 487 DLSSIDQ--HAFTSLKM 501

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  122 bits (308), Expect = 5e-29
 Identities = 45/245 (18%), Positives = 93/245 (37%), Gaps = 27/245 (11%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQL--LGTIPSSIFSINTLEILDLSNNQLSGSFP-- 58
           +         L +L +L+ LDLS + +         + +++ L+ L+LS N+        
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395

Query: 59  FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSID 118
           F     L+++DL+  RL  +   + F  L  ++ L+L+ +       +    L +L  ++
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455

Query: 119 LSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS 178
           L  NH       +  +L+ L                       L+IL L+   LS     
Sbjct: 456 LQGNHFPKGNIQKTNSLQTL---------------------GRLEILVLSFCDLSSIDQH 494

Query: 179 SIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL 238
           +   +L  +    L++N  +      + +   + +  L  N  S  +P+    +   + +
Sbjct: 495 AFT-SLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTI 552

Query: 239 NLEYN 243
           NL  N
Sbjct: 553 NLRQN 557

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  112 bits (283), Expect = 5e-26
 Identities = 39/185 (21%), Positives = 67/185 (36%), Gaps = 3/185 (1%)

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLS 420
              +    N L       F  L +L  L     ++ ++   TF +   +  + L++NPL 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 421 GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLIS 480
                 +   K L  L+  +  +S      +   K L++L LG N++             
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

Query: 481 LECLDLSNNILSGIIPSSLEKL--LYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDL 538
           L+ LD  NN +  +    +  L       LN++ N + G  P     A F S +F G   
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214

Query: 539 LCGSP 543
           L    
Sbjct: 215 LLVIF 219

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  264 bits (677), Expect = 2e-78
 Identities = 114/530 (21%), Positives = 191/530 (36%), Gaps = 35/530 (6%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNM 62
           L         + S LQ+LDLS  ++      +   ++ L  L L+ N +    P  F  +
Sbjct: 44  LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSE 121
           +SL+ +   + +L+  L +     L  ++ L++A N      LP    NLT+L  +DLS 
Sbjct: 104 TSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162

Query: 122 NHLMGEIPHEIGNLRNLQALGL---LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS 178
           N++     +++  LR    + L   +S N +  +    F    L  L L  N  S +I  
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222

Query: 179 SIRLALPNLELFSLANNNFSGKIPSFIFNASKLS--------ICELPDNSFSGFIPNRFH 230
           +    L  L +  L    F  +    IF  S +            L   +       +FH
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282

Query: 231 NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSM 290
            + N+  ++L    I         +  +    K + LS+    L           L L  
Sbjct: 283 CLANVSAMSLAGVSIKY-------LEDVPKHFKWQSLSIIRCQL------KQFPTLDLPF 329

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLE--KLQILGLENNQL 348
            +  L     +GSI  +   L +L  + L  N L+ S   + S L    L+ L L  N  
Sbjct: 330 LK-SLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388

Query: 349 EGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVP-STFWNL 406
              +  +   L  L  +   H+ L        F +L  L  L  +           F  L
Sbjct: 389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447

Query: 407 TNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN 465
           T++  + ++ N    +    +  N   L  L LS+  L          L  LQ L++  N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507

Query: 466 NLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
           NL     +    L SL  LD S N +             L + N++ N +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  231 bits (592), Expect = 2e-66
 Identities = 109/515 (21%), Positives = 183/515 (35%), Gaps = 38/515 (7%)

Query: 46  LDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLP 105
               + +LS   P    SS + IDLS N L   L +  FS    +Q+L L+  +      
Sbjct: 16  YQCMDQKLS-KVPDDIPSSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIED 73

Query: 106 REIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKIL 165
           +    L  L+++ L+ N +    P     L +L+ L  +   L  +    +  + TLK L
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133

Query: 166 QLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICE----LPDNSF 221
            + +N +      +    L NL    L+ N       + +    +         +  N  
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193

Query: 222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSK--KLKVLSLTGNPLLDCVL 279
                  F  +  L EL L  N+ +S+  +     +LA     +L +        L+   
Sbjct: 194 DFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCL-QNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 280 PSSIGNL-SLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKL 338
           PS +  L  ++++ F L   N       +   L N+  + L    +       + +  K 
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKW 309

Query: 339 QILGLENNQLE-------------------GRILDDICRLARLSSVYLDHNKLSGSIPAC 379
           Q L +   QL+                   G I      L  LS + L  N LS S    
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCS 369

Query: 380 FGNLA--SLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE-IGNLKVLVEL 436
           + +L   SLR L  + N    + + F  L  +  +D   + L          +L+ L+ L
Sbjct: 370 YSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429

Query: 437 YLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP-NSIGDLISLECLDLSNNILSGII 495
            +S  N   D      GL +L  L +  N+ + +   N   +  +L  LDLS   L  I 
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 496 PSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
               + L  L+ LN+S N L              S
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDS--SHYNQLYS 522

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  197 bits (504), Expect = 3e-54
 Identities = 83/476 (17%), Positives = 165/476 (34%), Gaps = 45/476 (9%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFN 61
           +    P     L+SL+ L     +L       I  + TL+ L++++N +        F N
Sbjct: 92  IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQF----LSLAFNQFAGHLPREIGNLTSLTSI 117
           +++L  +DLS N +   +  N   +L         L ++ N     +  +      L  +
Sbjct: 152 LTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHEL 209

Query: 118 DLSENHLMGEIPHE-IGNLRNLQALGLLSNNLVGVVPATLFNIST---LKILQLTNNTLS 173
            L  N     I    + NL  L    L+           +F  S    L  + +    L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 174 GSISSSIRLA----LPNLELFSLANNNFSGKIPSFIF-------NASKLSICELPDNSFS 222
            +   S  +     L N+   SLA  +    +            +  +  + + P     
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTLDLP 328

Query: 223 -----------GFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTG 271
                      G I  +   + +L  L+L  N ++ S    S+  S   +  L+ L L+ 
Sbjct: 329 FLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFS-GCCSY--SDLGTNSLRHLDLSF 385

Query: 272 NPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPS 330
           N     ++ ++   L   ++     +  ++         +L  L+ + + Y         
Sbjct: 386 NGA--IIMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442

Query: 331 TLSRLEKLQILGLENNQLEGRILDDI-CRLARLSSVYLDHNKLSGSIPACFGNLASLRKL 389
               L  L  L +  N  +   L ++      L+ + L   +L       F  L  L+ L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502

Query: 390 SFASNELTFVP-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLS 444
           + + N L F+  S +  L ++  +D S N +  S  +     K L    L+ N+++
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  165 bits (421), Expect = 2e-43
 Identities = 79/439 (17%), Positives = 150/439 (34%), Gaps = 55/439 (12%)

Query: 9   VPSQLGSLSSLQYLDLSFNQL---------------------------LGTIPSSIFSIN 41
           +P+   +L++L ++DLS+N +                           +  I    F   
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204

Query: 42  TLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGE-----LPANIFSYLPFVQF- 92
            L  L L  N  S +       N++ L V  L       E        +I   L  V   
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 93  -LSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGV 151
              L +         +   L +++++ L+   +  +   ++      Q+L ++   L   
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF 322

Query: 152 VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKL 211
               L     LK L LT N  S S       ALP+L    L+ N  S        +    
Sbjct: 323 PTLDLPF---LKSLTLTMNKGSISFKKV---ALPSLSYLDLSRNALSFSGCCSYSDLGTN 376

Query: 212 SICELPDNSFSGF--IPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSL 269
           S+  L D SF+G   +   F  +  L+ L+ +++ +      ++  S+  + +KL  L +
Sbjct: 377 SLRHL-DLSFNGAIIMSANFMGLEELQHLDFQHSTLKR----VTEFSAFLSLEKLLYLDI 431

Query: 270 TGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSI 328
           +               L+ S+    +   + + +    +  N  NL  + L   +L    
Sbjct: 432 SYTNT-KIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 329 PSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK 388
                 L +LQ+L + +N L         +L  LS++    N++  S         SL  
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549

Query: 389 LSFASNELTFVPSTFWNLT 407
            +  +N +  +      L 
Sbjct: 550 FNLTNNSVACICEHQKFLQ 568

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  122 bits (308), Expect = 4e-29
 Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 33/290 (11%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQL--LGTIPSSIFSINTLEILDLSNNQLSG-SFPF 59
           +   G++  +  +L SL YLDLS N L   G    S    N+L  LDLS N     S  F
Sbjct: 336 TMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANF 395

Query: 60  FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDL 119
             +  LQ +D   + L      + F                         +L  L  +D+
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFL------------------------SLEKLLYLDI 431

Query: 120 SENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISS 178
           S  +   +       L +L  L +  N+      + +F N + L  L L+   L      
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491

Query: 179 SIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL 238
                L  L+L ++++NN      S       LS  +   N          H  ++L   
Sbjct: 492 VFD-TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550

Query: 239 NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL 288
           NL  N +        F+  +   +K  ++++     + C  P  +    +
Sbjct: 551 NLTNNSVACICEHQKFLQWV-KEQKQFLVNVEQ---MTCATPVEMNTSLV 596

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 97.8 bits (244), Expect = 3e-21
 Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 4/157 (2%)

Query: 374 GSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVL 433
           GS+  C   + ++        +L+ VP      ++   +DLS NPL         N   L
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSEL 58

Query: 434 VELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSG 493
             L LSR  +         GL +L NL L  N +Q   P S   L SLE L      L+ 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 494 IIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
           +    + +L+ LK LNV+ N +          +N T+
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTN 154

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  246 bits (631), Expect = 5e-75
 Identities = 87/228 (38%), Positives = 126/228 (55%), Gaps = 8/228 (3%)

Query: 607 NMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL 666
            + L   +RFS +EL  A+D F+  N++G G FG VY+GR  DG  VA+K    +     
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 667 ES-FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY---SDNSNLDI 722
           E  F  E E++    HRNL+R+   C     + LV  YM  GS+ +CL         LD 
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 723 FKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
            KR  I +  A  L YLH      ++H D+K +N+LLDE+  A +GDFG+AKL+   ++ 
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT- 189

Query: 783 KH--TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
            H  T    TIG++APEY   G+ S + DV+ +G+ML+E+ T +R  D
Sbjct: 190 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  242 bits (620), Expect = 2e-73
 Identities = 80/235 (34%), Positives = 122/235 (51%), Gaps = 12/235 (5%)

Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAEC 673
            R    +L +AT+ F+   LIG G FG VY+G   DG +VA+K    +    +E F  E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY---SDNSNLDIFKRLNIVI 730
           E L   RH +LV +I  C   +   L+  YM  G+L+  LY       ++   +RL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL-LSGDESMKH--TQT 787
             A  L YLH      ++H D+K  N+LLDE+ V ++ DFGI+K     D++  H  T  
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT--HLSTVV 201

Query: 788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS-GEMSLKRWV 841
             T+GY+ PEY  +G+++ + DVYSFG++L E+   +    +      ++L  W 
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  222 bits (568), Expect = 3e-66
 Identities = 77/243 (31%), Positives = 118/243 (48%), Gaps = 23/243 (9%)

Query: 614 RRFSYQELLQATDQFN------VNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALE 667
             FS+ EL   T+ F+        N +G G FG VY+G +++   VA+K   L     + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKK--LAAMVDIT 69

Query: 668 S------FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY--SDNSN 719
           +      F+ E +V+   +H NLV ++   ++ D   LV  YMP GSL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 720 LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SG 778
           L    R  I    A  + +LH    N  +H DIK +N+LLDE   A++ DFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
            +++  ++ + T  YMAPE  R G+I+ + D+YSFG++L+EI T     DE       L 
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLL 244

Query: 839 RWV 841
              
Sbjct: 245 DIK 247

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  223 bits (570), Expect = 1e-63
 Identities = 112/534 (20%), Positives = 192/534 (35%), Gaps = 42/534 (7%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQV 67
                S   LQ LDLS  ++      +  S++ L  L L+ N +       F  +SSLQ 
Sbjct: 45  SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFA-GHLPREIGNLTSLTSIDLSENHLMG 126
           +   +  L+  L      +L  ++ L++A N      LP    NLT+L  +DLS N +  
Sbjct: 105 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

Query: 127 EIPHEIGNLRNLQALGL---LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
               ++  L  +  L L   LS N +  +    F    L  L L NN  S ++  +    
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           L  LE+  L    F                    + +   F  +    + NL        
Sbjct: 224 LAGLEVHRLVLGEFRN------------------EGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
           Y+         I        +   SL    +    +     N     +   L NC     
Sbjct: 266 YLDYYL--DDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGW--QHLELVNCKFGQF 319

Query: 304 IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLE--GRILDDICRLAR 361
              ++ +L  L       NK   +   +   L  L+ L L  N L   G           
Sbjct: 320 PTLKLKSLKRL---TFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--STFWNLTNILMVDLSSNPL 419
           L  + L  N +  ++ + F  L  L  L F  + L  +   S F +L N++ +D+S    
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 420 SGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGDL 478
             +       L  L  L ++ N+   +    I   L+NL  L L    L+   P +   L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493

Query: 479 ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSES 532
            SL+ L++++N L  +     ++L  L+ + +  N  +   PR   L+ + +++
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  213 bits (543), Expect = 6e-60
 Identities = 107/507 (21%), Positives = 186/507 (36%), Gaps = 27/507 (5%)

Query: 23  DLSFNQLLGTIPSSIFSINTLEILDLSNNQLSG--SFPFFNMSSLQVIDLSDNRLSGELP 80
                     IP ++    + + LDLS N L    S+ FF+   LQV+DLS   +   + 
Sbjct: 13  QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68

Query: 81  ANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQA 140
              +  L  +  L L  N            L+SL  +   E +L       IG+L+ L+ 
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 141 LGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLA---NNN 196
           L +  N +        F N++ L+ L L++N +  SI  +    L  + L +L+   + N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 197 FSGKIPSFIFNASKLSICELPDNSFSGFIP-NRFHNMRNLKELNLEYNYITSSNHELSFI 255
               I    F   +L    L +N  S  +       +  L+   L      +  +   F 
Sbjct: 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 256 SSL---ANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI 312
            S      +  ++   L         +      L+ ++  F L +  I   +     N  
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF- 304

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKL 372
               + L   K        L  L++L      +N+           L  L  + L  N L
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGN--AFSEVDLPSLEFLDLSRNGL 359

Query: 373 S--GSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GN 429
           S  G          SL+ L  + N +  + S F  L  +  +D   + L       +  +
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 430 LKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI-GDLISLECLDLSN 488
           L+ L+ L +S  +          GL +L+ L +  N+ Q +    I  +L +L  LDLS 
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 489 NILSGIIPSSLEKLLYLKYLNVSFNRL 515
             L  + P++   L  L+ LN++ N+L
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQL 506

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  177 bits (452), Expect = 1e-47
 Identities = 90/464 (19%), Positives = 163/464 (35%), Gaps = 36/464 (7%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSG---SFPFFN 61
           +          LSSLQ L      L       I  + TL+ L++++N +        F N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQF----LSLAFNQFAGHLPREIGNLTSLTSI 117
           +++L+ +DLS N++   +       L  +      L L+ N     +         L  +
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205

Query: 118 DLSENHLMGEIPHE-IGNLRNLQALGLL------SNNLVGVVPATLFNISTLKILQLTNN 170
            L  N     +    I  L  L+   L+        NL     + L  +  L I +    
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 171 TLSGSISSSIRL--ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR 228
            L   +   I L   L N+  FSL +     ++  F +N       EL +  F  F    
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQF---P 320

Query: 229 FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL 288
              +++LK L    N   +         S  +   L+ L L+ N L      S     + 
Sbjct: 321 TLKLKSLKRLTFTSNKGGN-------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIP-STLSRLEKLQILGLENNQ 347
           S++   L    +  ++      L  L  +   ++ L      S    L  L  L + +  
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 348 LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVP-STFWN 405
                      L+ L  + +  N    +     F  L +L  L  +  +L  +  + F +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 406 LTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIP 448
           L+++ +++++SN L  S+P  I   L  L +++L  N      P
Sbjct: 493 LSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  177 bits (450), Expect = 2e-47
 Identities = 94/469 (20%), Positives = 163/469 (34%), Gaps = 28/469 (5%)

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG 126
                +     ++P N+       + L L+FN           +   L  +DLS   +  
Sbjct: 11  TYQCMELNFY-KIPDNLPFST---KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 127 EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPN 186
                  +L +L  L L  N +  +       +S+L+ L      L+   +  I   L  
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKT 125

Query: 187 LELFSLANNNF-SGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           L+  ++A+N   S K+P +  N + L   +L  N            +  +  LNL  +  
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL- 184

Query: 246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS------LSMERFYLHNCN 299
            S N             +L  L+L  N     V+ + I  L+      L +  F     N
Sbjct: 185 -SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG-N 242

Query: 300 IRGSIPKEMGNLINLIIIRLGYNKLNGS---IPSTLSRLEKLQILGLENNQLEGRILDDI 356
           +       +  L NL I       L+     I    + L  +    L +  +    + D 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDF 300

Query: 357 CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSS 416
                   + L + K           L SL++L+F SN+     S   +L ++  +DLS 
Sbjct: 301 SYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFS-EVDLPSLEFLDLSR 356

Query: 417 NPLS--GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS 474
           N LS  G           L  L LS N +   + +   GL+ L++L    +NL+     S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 415

Query: 475 I-GDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
           +   L +L  LD+S+             L  L+ L ++ N  +      
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  123 bits (310), Expect = 2e-29
 Identities = 54/277 (19%), Positives = 105/277 (37%), Gaps = 14/277 (5%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
           S       L+ ++  F Q           + +L+ L  ++N+   +F   ++ SL+ +DL
Sbjct: 301 SYNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 354

Query: 71  SDNRLSG-ELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIP 129
           S N LS     +        +++L L+FN     +      L  L  +D   ++L     
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 130 HEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE 188
             +  +LRNL  L +   +           +S+L++L++  N+   +    I   L NL 
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 189 LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
              L+        P+   + S L +  +  N         F  + +L+++ L  N    S
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533

Query: 249 NHELSFISSLANSKKLKVL-----SLTGNPLLDCVLP 280
              + ++S   N    K       S +G P+   + P
Sbjct: 534 CPRIDYLSRWLNKNSQKEQGSAKCSGSGKPVRSIICP 570

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  110 bits (276), Expect = 3e-25
 Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 18/271 (6%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
           NL  S +   L    +R        +   L ++ L   ++          L  L  L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV--PST 402
            N ++   L     L+ L  +      L+       G+L +L++L+ A N +     P  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVL----VELYLSRNNLSGDIPTTIGGLKNLQ 458
           F NLTN+  +DLSSN +      ++  L  +    + L LS N ++  I         L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203

Query: 459 NLSLGDNNLQGSIP-NSIGDLISLECLDL------SNNILSGIIPSSLEKL--LYLKYLN 509
            L+L +N    ++    I  L  LE   L      +   L     S+LE L  L ++   
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 510 VSFNRLEGEIPRG--GTLANFTSESFMGNDL 538
           +++     +        L N +S S +   +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 82.1 bits (203), Expect = 3e-16
 Identities = 34/138 (24%), Positives = 49/138 (35%), Gaps = 3/138 (2%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
                 +P      T  L  DLS NPL         +   L  L LSR  +         
Sbjct: 16  ELNFYKIPDNLPFSTKNL--DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSF 512
            L +L  L L  N +Q     +   L SL+ L      L+ +    +  L  LK LNV+ 
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 513 NRLEGEIPRGGTLANFTS 530
           N ++         +N T+
Sbjct: 134 NLIQ-SFKLPEYFSNLTN 150

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  202 bits (515), Expect = 1e-58
 Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 28/256 (10%)

Query: 616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEV 675
              + L   +    +  +   G FG V++ +      VA+K+F +Q +   +S+  E EV
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK---QSWQNEYEV 69

Query: 676 --LRSIRHRNLVRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIV 729
             L  ++H N+++ I +            L+  +  KGSL   L    + +   +  +I 
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIA 127

Query: 730 IDIALALEYLH------FGHPNP-VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
             +A  L YLH           P + H DIK  NVLL  ++ A + DFG+A      +S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 783 KHTQTLA-TIGYMAPEYGREGQISTEG------DVYSFGIMLMEIFTRKRPTDEIFSG-E 834
             T     T  YMAPE   EG I+ +       D+Y+ G++L E+ +R    D       
Sbjct: 188 GDTHGQVGTRRYMAPEVL-EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 835 MSLKRWVNDSLPISIM 850
           +  +  +     +  M
Sbjct: 247 LPFEEEIGQHPSLEDM 262

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  208 bits (532), Expect = 1e-58
 Identities = 100/517 (19%), Positives = 200/517 (38%), Gaps = 35/517 (6%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSL 65
           ++PS L   ++++ LDLSFN++       + +   L++L L +++++      F+++ SL
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSENHL 124
           + +DLSDN LS  L ++ F  L  +++L+L  N +    +     NLT+L ++ +     
Sbjct: 77  EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 125 MGEIPHE-IGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
             EI       L +L  L + + +L      +L +I  +  L L  +  +  +       
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADI 194

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           L ++    L + N +    S +      S  +      S      F+ +  L    LE +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
            +   +  L+ +     S+   V  L                  +++ R ++    +   
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVET-------------VTIRRLHIPQFYLFYD 301

Query: 304 IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDD---ICRLA 360
           +      L  +  I +  +K+     S    L+ L+ L L  N +    L +        
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361

Query: 361 RLSSVYLDHNKLS--GSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNP 418
            L ++ L  N L            L +L  L  + N    +P +      +  ++LSS  
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTG 421

Query: 419 LSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDL 478
           +   +   I   + L  L +S NNL          L  LQ L +  N L+ ++P++    
Sbjct: 422 IR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASL-F 472

Query: 479 ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
             L  + +S N L  +     ++L  L+ + +  N  
Sbjct: 473 PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  195 bits (497), Expect = 9e-54
 Identities = 99/515 (19%), Positives = 200/515 (38%), Gaps = 44/515 (8%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSD 72
           S  +    D        +IPS + +   ++ LDLS N+++  G       ++LQV+ L  
Sbjct: 3   SCDASGVCDGRSRSF-TSIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG-EIPHE 131
           +R++  +  + F  L  ++ L L+ N  +       G L+SL  ++L  N      +   
Sbjct: 60  SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 132 IGNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
             NL NLQ L + +      +    F  +++L  L++   +L  +  S    ++ ++   
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHL 177

Query: 191 SLANNNFSGKIPSFIFNA-SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS-S 248
           +L  +  +  +     +  S +   EL D + + F  +          +       +  +
Sbjct: 178 TLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

Query: 249 NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM 308
           +   + +  L       +L L+     DC L + +G+ + S          +        
Sbjct: 237 DESFNELLKLLRY----ILELSEVEFDDCTL-NGLGDFNPSESDVVSELGKV-------- 283

Query: 309 GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICR-LARLSSVYL 367
              + +  + +    L   + +  S LEK++ + +EN+++   +     + L  L  + L
Sbjct: 284 -ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341

Query: 368 DHNKLSGSI---PACFGNLASLRKLSFASNELTFVP---STFWNLTNILMVDLSSNPLSG 421
             N +        AC G   SL+ L  + N L  +         L N+  +D+S N    
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400

Query: 422 SLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL 481
            +P      + +  L LS   +   + T     + L+ L + +NNL  S       L  L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSL---FLPRL 453

Query: 482 ECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
           + L +S N L  +  +SL     L  + +S N+L+
Sbjct: 454 QELYISRNKLKTLPDASL--FPVLLVMKISRNQLK 486

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  185 bits (472), Expect = 2e-50
 Identities = 91/482 (18%), Positives = 179/482 (37%), Gaps = 37/482 (7%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSG--SFPFFNMSSLQ 66
              L + ++LQ L L  +++  TI    F     LE LDLS+N LS   S  F  +SSL+
Sbjct: 43  HGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK 101

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE-IGNLTSLTSIDLSENHLM 125
            ++L  N        ++F  L  +Q L +   +    + R     LTSL  +++    L 
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
                 + ++R++  L L  +    ++      +S+++ L+L +  L+    S + +   
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 186 NLELFSLANNNFS------GKIPSFIFNASKLSICELPDNSFSGF------IPNRFHNMR 233
           +  +  LA            ++   +    +LS  E  D + +G         +    + 
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL--LDCVLPSSIGNLSLSME 291
            ++ + +   +I          +  +  +K+K +++  + +  + C     + +L    E
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL----E 337

Query: 292 RFYLHNCNIRGSIPKEM---GNLINLIIIRLGYNKLN--GSIPSTLSRLEKLQILGLENN 346
              L    +     K     G   +L  + L  N L         L  L+ L  L +  N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397

Query: 347 QLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNL 406
                + D      ++  + L    +   +  C     +L  L  ++N L         L
Sbjct: 398 TFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTC--IPQTLEVLDVSNNNLDSFSL---FL 450

Query: 407 TNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN 466
             +  + +S N L  +LP +     VL+ + +SRN L          L +LQ + L  N 
Sbjct: 451 PRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508

Query: 467 LQ 468
             
Sbjct: 509 WD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  142 bits (360), Expect = 7e-36
 Identities = 69/391 (17%), Positives = 140/391 (35%), Gaps = 18/391 (4%)

Query: 144 LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPS 203
             +     +P+ L   + +K L L+ N ++  I      A  NL++  L ++  +  I  
Sbjct: 12  GRSRSFTSIPSGLT--AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRIN-TIEG 67

Query: 204 FIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSK 262
             F +   L   +L DN  S    + F  + +LK LNL  N   +    L   S   N  
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT----LGVTSLFPNLT 123

Query: 263 KLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYN 322
            L+ L +        +       L+ S+    +   ++R    + + ++ ++  + L  +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLT-SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 323 KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
           +    +      L  ++ L L +  L       +      S +     + S      F  
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242

Query: 383 LASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNN 442
           L  L +     +E+ F      + T   + D + +       L       +  L++ +  
Sbjct: 243 LLKLLRYILELSEVEF-----DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY 297

Query: 443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII---PSSL 499
           L  D+ T    L+ ++ +++ ++ +     +    L SLE LDLS N++        +  
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 500 EKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
                L+ L +S N L      G  L    +
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  141 bits (357), Expect = 2e-35
 Identities = 78/428 (18%), Positives = 163/428 (38%), Gaps = 26/428 (6%)

Query: 103 HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL 162
            +P  +    ++ S+DLS N +      ++    NLQ L L S+ +  +     +++ +L
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 163 KILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSG-KIPSFIFNASKLSICELPDNSF 221
           + L L++N LS S+SSS    L +L+  +L  N +    + S   N + L    + +   
Sbjct: 77  EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 222 SGFIPNR-FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLP 280
              I    F  + +L EL ++   + +   +     SL + + +  L+L  +      L 
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQ-----SLKSIRDIHHLTLHLSESAF--LL 188

Query: 281 SSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQI 340
               ++  S+    L + N+       +        ++    + +     + + L KL  
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248

Query: 341 LGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP 400
             LE +++E                  + ++             ++R+L      L +  
Sbjct: 249 YILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302

Query: 401 S-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTT---IGGLKN 456
           S  +  L  +  + + ++ +         +LK L  L LS N +  +        G   +
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362

Query: 457 LQNLSLGDNNLQ--GSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNR 514
           LQ L L  N+L+        +  L +L  LD+S N     +P S +    +++LN+S   
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 515 LEGEIPRG 522
           +   +   
Sbjct: 422 IR-VVKTC 428

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (276), Expect = 3e-25
 Identities = 53/285 (18%), Positives = 106/285 (37%), Gaps = 33/285 (11%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSIN--------TLEILDLSNNQLSGSFP- 58
            +   +  LS +++ D + N L    PS    ++        T+  L +    L      
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304

Query: 59  -FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF---AGHLPREIGNLTSL 114
            +  +  ++ I + ++++   +P +   +L  ++FL L+ N             G   SL
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 115 TSIDLSENHL--MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL 172
            ++ LS+NHL  M +    +  L+NL +L  +S N    +P +      ++ L L++  +
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLD-ISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422

Query: 173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
              + + I      LE+  ++NNN       F+    +L    +  N             
Sbjct: 423 R-VVKTCI---PQTLEVLDVSNNNLD-SFSLFLPRLQELY---ISRNKLKTLPDASL--F 472

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
             L  + +  N + S                L+ + L  NP  DC
Sbjct: 473 PVLLVMKISRNQLKSVPD-----GIFDRLTSLQKIWLHTNP-WDC 511

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  100 bits (250), Expect = 4e-22
 Identities = 60/290 (20%), Positives = 107/290 (36%), Gaps = 46/290 (15%)

Query: 2   QSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSG----- 55
           Q +L   + +    L  ++ + +  ++ +  +P S    + +LE LDLS N +       
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSK-VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353

Query: 56  SFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLT 115
           S       SLQ + LS N L               + +                 L +LT
Sbjct: 354 SACKGAWPSLQTLVLSQNHL---------------RSMQKTGEILL--------TLKNLT 390

Query: 116 SIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS 175
           S+D+S N     +P        ++ L L S  +  VV   +    TL++L ++NN L   
Sbjct: 391 SLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL--- 443

Query: 176 ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNL 235
              S  L LP L+   ++ N     +P        L + ++  N         F  + +L
Sbjct: 444 --DSFSLFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSL 499

Query: 236 KELNLEYNYITSSNHELSFISSLANSKKLKVL-----SLTGNPLLDCVLP 280
           +++ L  N    S   + ++S   N    K       S +G P+   + P
Sbjct: 500 QKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSGKPVRSIICP 549

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 99.8 bits (249), Expect = 5e-22
 Identities = 53/352 (15%), Positives = 123/352 (34%), Gaps = 30/352 (8%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFF 60
           S     +      LSS++YL+L    L     S +        +     + S      F 
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS 120
            +  L    L  + +        F             ++             ++  + + 
Sbjct: 242 ELLKLLRYILELSEVE-------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294

Query: 121 ENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLS--GSISS 178
           + +L  ++      L  ++ + + ++ +  V  +   ++ +L+ L L+ N +      +S
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354

Query: 179 SIRLALPNLELFSLANNNFS--GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLK 236
           + + A P+L+   L+ N+     K    +     L+  ++  N+F   +P+       ++
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR 413

Query: 237 ELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLH 296
            LNL    I      +         + L+VL ++ N L        +  L    +  Y+ 
Sbjct: 414 FLNLSSTGIRVVKTCI--------PQTLEVLDVSNNNLDS--FSLFLPRL----QELYIS 459

Query: 297 NCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL 348
              ++ ++P +      L+++++  N+L         RL  LQ + L  N  
Sbjct: 460 RNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 65.9 bits (161), Expect = 3e-11
 Identities = 34/119 (28%), Positives = 51/119 (42%), Gaps = 4/119 (3%)

Query: 412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI 471
            D  S   + S+P  +     +  L LS N ++      +    NLQ L L  + +    
Sbjct: 10  CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
            ++   L SLE LDLS+N LS +  S    L  LKYLN+  N  +  +       N T+
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  198 bits (506), Expect = 2e-57
 Identities = 64/209 (30%), Positives = 116/209 (55%), Gaps = 7/209 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRN 683
              N+   IG+GSFG+V+R  +  G +VA+K+   Q      +  F  E  +++ +RH N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN--LDIFKRLNIVIDIALALEYLHF 741
           +V  + + T     ++V +Y+ +GSL   L+   +   LD  +RL++  D+A  + YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
            +P P+VH ++K  N+L+D+    ++ DFG+++L +       +    T  +MAPE  R+
Sbjct: 156 RNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRD 213

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
              + + DVYSFG++L E+ T ++P   +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNL 242

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  210 bits (535), Expect = 4e-57
 Identities = 119/561 (21%), Positives = 216/561 (38%), Gaps = 58/561 (10%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP---FFNMSSLQVIDLS 71
           L++ + L LSFN  + T+ +S F  +  L++L+L +     +     F N+ +L+++DL 
Sbjct: 23  LNTTERLLLSFNY-IRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 72  DNRLSGELPANIFSYLPFVQFLSLAFNQFAGHL--PREIGNLTSLTSIDLSENHLMG-EI 128
            +++   L  + F  L  +  L L F   +  +       NL +LT +DLS+N +    +
Sbjct: 82  SSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNIS--TLKILQLTNNTLSGSISSSI-----R 181
               G L +L+++   SN +  V    L  +   TL    L  N+L   +S         
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200

Query: 182 LALPNLELFSLANNNFSGKIPSFIFNA------------SKLSICELPDNSFSGFIPNRF 229
                LE+  ++ N ++  I     NA              +       ++      N F
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260

Query: 230 HNMR--NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS 287
             +   +++ L+L + ++ S N            K LKVL+L  N  ++ +   +   L 
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLN-----SRVFETLKDLKVLNLAYN-KINKIADEAFYGLD 314

Query: 288 LSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQ 347
            +++   L    +          L  +  I L  N +      T   LEKLQ L L +N 
Sbjct: 315 -NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373

Query: 348 LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--STFWN 405
           L       I  +  +  ++L  NKL            +   +  + N L  +        
Sbjct: 374 LT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLR 424

Query: 406 LTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI-----GGLKNLQN 459
           + ++ ++ L+ N  S     +       L +L+L  N L     T +      GL +LQ 
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484

Query: 460 LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEI 519
           L L  N L    P     L +L  L L++N L+ +  + L     L+ L++S N+L    
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQL--LA 540

Query: 520 PRGGTLANFTSESFMGNDLLC 540
           P      + +      N  +C
Sbjct: 541 PNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  151 bits (382), Expect = 1e-37
 Identities = 86/458 (18%), Positives = 147/458 (32%), Gaps = 73/458 (15%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
              ++       L+      +   L   + L L+FN            L  L  ++L   
Sbjct: 4   FDGRIAFYRFCNLT-----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58

Query: 123 HLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
           +    I  E   NL NL+ L L S+ +  + P     +  L  L+L    LS ++     
Sbjct: 59  YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118

Query: 182 LA-LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL 240
              L  L    L+ N                          S ++   F  + +LK ++ 
Sbjct: 119 FRNLKALTRLDLSKNQIR-----------------------SLYLHPSFGKLNSLKSIDF 155

Query: 241 EYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNI 300
             N I         +  L   K L   SL  N L    +    G          L   ++
Sbjct: 156 SSNQIFLVCEHE--LEPLQG-KTLSFFSLAANSLY-SRVSVDWGKCMNPFRNMVLEILDV 211

Query: 301 RGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLA 360
            G       N   + I     N ++ S   +L     +   G   + ++    +    LA
Sbjct: 212 SG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264

Query: 361 RLSSVYLD--HNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSN 417
           R S  +LD  H  +       F  L  L+ L+ A N++  +    F+ L N         
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN--------- 315

Query: 418 PLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD 477
                          L  L LS N L     +   GL  +  + L  N++      +   
Sbjct: 316 ---------------LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 478 LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
           L  L+ LDL +N L     +++  +  +  + +S N+L
Sbjct: 361 LEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL 393

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  149 bits (379), Expect = 2e-37
 Identities = 78/371 (21%), Positives = 138/371 (37%), Gaps = 29/371 (7%)

Query: 158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF-NASKLSICEL 216
            ++T + L L+ N +  ++++S    L  L+L  L +      I    F N   L I +L
Sbjct: 22  VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 217 PDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
             +      P+ F  + +L EL L +  ++ +  +  +  +L     L  L L+ N +  
Sbjct: 81  GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA---LTRLDLSKNQIRS 137

Query: 277 CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNL--INLIIIRLGYNKLNGSIPSTLSR 334
             L  S G L+ S++     +  I      E+  L    L    L  N L   +     +
Sbjct: 138 LYLHPSFGKLN-SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196

Query: 335 LEK------LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK 388
                    L+IL +  N     I  +              N +S S          +  
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDITGNFS------------NAISKSQAFSLILAHHIMG 244

Query: 389 LSFASNELTFVP-STFWNL--TNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG 445
             F  + +     +TF  L  +++  +DLS   +          LK L  L L+ N ++ 
Sbjct: 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK 304

Query: 446 DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYL 505
                  GL NLQ L+L  N L     ++   L  +  +DL  N ++ I   + + L  L
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364

Query: 506 KYLNVSFNRLE 516
           + L++  N L 
Sbjct: 365 QTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  134 bits (338), Expect = 2e-32
 Identities = 70/349 (20%), Positives = 131/349 (37%), Gaps = 23/349 (6%)

Query: 1   LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS---INTLEILDLSNNQLS--G 55
             + ++ +    L     +      F+ +      + F+    +++  LDLS+  +    
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 56  SFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLT 115
           S  F  +  L+V++L+ N+++ ++    F  L  +Q L+L++N            L  + 
Sbjct: 283 SRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341

Query: 116 SIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS 175
            IDL +NH+          L  LQ L L  N L      T+  I ++  + L+ N L   
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL--- 393

Query: 176 ISSSIRLALPNLELFSLANNNFSG-KIPSFIFNASKLSICELPDNSFSGFIPNR-FHNMR 233
              ++        L  L+ N      I  F+     L I  L  N FS    ++      
Sbjct: 394 --VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERF 293
           +L++L L  N +  +               L+VL L  N  L+ + P    +L+ ++   
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN-YLNSLPPGVFSHLT-ALRGL 509

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILG 342
            L++  +   +        NL I+ +  N+L    P     L  L I  
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVFVSLSVLDITH 556

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 92.9 bits (231), Expect = 1e-19
 Identities = 51/240 (21%), Positives = 98/240 (40%), Gaps = 18/240 (7%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
           + +  + S+  + LS N+L+ T+P    + N + + +     L   +    +  LQ++ L
Sbjct: 375 TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-----GNLTSLTSIDLSENHLM 125
           + NR S        S  P ++ L L  N        E+       L+ L  + L+ N+L 
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
              P    +L  L+ L L SN L  +    L   + L+IL ++ N     + +       
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN----QLLAPNPDVFV 547

Query: 186 NLELFSLANNNFSGKIPSFIF----NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
           +L +  + +N F  +     F    N + ++I   P + +  + P+ F  +  L  L+ E
Sbjct: 548 SLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVY-PDSFSGVS-LFSLSTE 605

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.7 bits (168), Expect = 5e-12
 Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 5/120 (4%)

Query: 412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI 471
                  L+  +P  +   +    L LS N +     ++   L+ LQ L LG      +I
Sbjct: 9   AFYRFCNLT-QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64

Query: 472 -PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
              +  +L +L  LDL ++ +  + P + + L +L  L + F  L   + + G   N  +
Sbjct: 65  DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 57.5 bits (139), Expect = 2e-08
 Identities = 30/162 (18%), Positives = 56/162 (34%), Gaps = 16/162 (9%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFPFFNMSSLQVI 68
                 LS LQ L L+ N L  ++P  +FS +  L  L L++N+L+        ++L+++
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEIL 531

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAF-------------NQFAGHLPREIGNLTSLT 115
           D+S N+L      ++F  L  +      F             N     +     ++  + 
Sbjct: 532 DISRNQLL-APNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVY 590

Query: 116 SIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF 157
               S   L             L++L      +  V      
Sbjct: 591 PDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFL 632

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  195 bits (498), Expect = 2e-56
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 12/223 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
            +  V  ++G G+FG V + ++    +VAIK    + E   ++F  E   L  + H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGH 743
           ++  +C N     LV++Y   GSL   L+             ++  +  +  + YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 744 PNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           P  ++H D+KP N+LL     V ++ DFG A     D     T    +  +MAPE     
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 803 QISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSL 845
             S + DV+S+GI+L E+ TR++P DEI      +   V++  
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  199 bits (507), Expect = 6e-56
 Identities = 111/485 (22%), Positives = 188/485 (38%), Gaps = 67/485 (13%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
               +L+      L    +  T+      ++ +  L      +        +++L  I+ 
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINF 75

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           S+N+L+   P      L  +  + +  NQ A      + NLT+LT + L  N +    P 
Sbjct: 76  SNNQLTDITP---LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP- 129

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA-LPNLEL 189
            + NL NL  L L SN +  +    L  +++L+ L   N      ++    LA L  LE 
Sbjct: 130 -LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQ-----VTDLKPLANLTTLER 181

Query: 190 FSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN 249
             +++N  S                            +    + NL+ L    N I+   
Sbjct: 182 LDISSNKVSD--------------------------ISVLAKLTNLESLIATNNQISD-- 213

Query: 250 HELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMG 309
                I+ L     L  LSL GN L D     ++ +L+ ++    L N  I    P  + 
Sbjct: 214 -----ITPLGILTNLDELSLNGNQLKD---IGTLASLT-NLTDLDLANNQISNLAP--LS 262

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
            L  L  ++LG N+++   P  L+ L  L  L L  NQLE   +  I  L  L+ + L  
Sbjct: 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYF 318

Query: 370 NKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGN 429
           N +S   P    +L  L++L F +N+++ V S   NLTNI  +    N +S   P  + N
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSDVSS-LANLTNINWLSAGHNQISDLTP--LAN 373

Query: 430 LKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN 489
           L  + +L L+    + + P       ++ N            P +I D  S    D++ N
Sbjct: 374 LTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWN 431

Query: 490 ILSGI 494
           + S  
Sbjct: 432 LPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  194 bits (495), Expect = 3e-54
 Identities = 96/469 (20%), Positives = 180/469 (38%), Gaps = 43/469 (9%)

Query: 48  LSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE 107
             +  ++  F    ++      L    ++  +     + L  V  L              
Sbjct: 9   TQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS--IDG 63

Query: 108 IGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQL 167
           +  L +LT I+ S N L    P  + NL  L  + + +N +  + P  L N++ L  L L
Sbjct: 64  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119

Query: 168 TNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPN 227
            NN ++          L NL    L++N  S    S +   + L       N  +   P 
Sbjct: 120 FNNQITDIDPLK---NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP- 172

Query: 228 RFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS 287
              N+  L+ L++  N ++        IS LA    L+ L  T N + D    + +G L+
Sbjct: 173 -LANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISD---ITPLGILT 221

Query: 288 LSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQ 347
            +++   L+   ++      + +L NL  + L  N+++   P  LS L KL  L L  NQ
Sbjct: 222 -NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276

Query: 348 LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLT 407
           +    +  +  L  L+++ L+ N+L    P    NL +L  L+   N ++ +     +LT
Sbjct: 277 ISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLT 331

Query: 408 NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL 467
            +  +   +N +S      + NL  +  L    N +S   P  +  L  +  L L D   
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387

Query: 468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
             +  N   ++     +      L  I P+++         ++++N   
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  180 bits (458), Expect = 3e-49
 Identities = 96/468 (20%), Positives = 179/468 (38%), Gaps = 62/468 (13%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
                +  L++L  ++ S NQL  T  + + ++  L  + ++NNQ++   P  N+++L  
Sbjct: 59  KSIDGVEYLNNLTQINFSNNQL--TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTG 116

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE 127
           + L +N+++   P      L  +  L L+ N  +      +  LTSL  +    N +   
Sbjct: 117 LTLFNNQITDIDP---LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDL 170

Query: 128 IPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL 187
            P  + NL  L+ L + SN +  +    L  ++ L+ L  TNN +S          L NL
Sbjct: 171 KP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITPLG---ILTNL 223

Query: 188 ELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS 247
           +  SL  N     I +                           ++ NL +L+L  N I++
Sbjct: 224 DELSLNGNQLK-DIGT-------------------------LASLTNLTDLDLANNQISN 257

Query: 248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
                  ++ L+   KL  L L  N + +    S +  L+ ++    L+   +    P  
Sbjct: 258 -------LAPLSGLTKLTELKLGANQISN---ISPLAGLT-ALTNLELNENQLEDISP-- 304

Query: 308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYL 367
           + NL NL  + L +N ++   P  +S L KLQ L   NN++    +  +  L  ++ +  
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSA 360

Query: 368 DHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI 427
            HN++S   P    NL  + +L       T  P  +    +I     +        P  I
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATI 417

Query: 428 GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI 475
            +     E  ++ N  S               +  G     G++   +
Sbjct: 418 SDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (491), Expect = 1e-55
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 22/231 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ-------LEGALESFNAECEVLR 677
           ++      IG G FG V++GR + D   VAIK   L        +    + F  E  ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           ++ H N+V++     N     +V++++P G L   L      +    +L +++DIAL +E
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDE-----DMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
           Y+      P+VH D++  N+ L        + A++ DFG+++      S+  +  L    
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSV--SGLLGNFQ 191

Query: 793 YMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV 841
           +MAPE     E   + + D YSF ++L  I T + P DE   G++     +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (483), Expect = 7e-55
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 18/217 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQ----LEGALESFNAECEVLRSIRH 681
            +  +  +IG G FG VYR  +  G EVA+K         +   +E+   E ++   ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N++ +   C  +    LV+++   G L   L      +     +N  + IA  + YLH 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 742 GHPNPVVHCDIKPSNVLLDE--------DMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
               P++H D+K SN+L+ +        + + ++ DFG+A+       M          +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAW 180

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
           MAPE  R    S   DV+S+G++L E+ T + P   I
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 7e-54
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 12/207 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRN 683
            Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++  +   T     A+V  +    SL   L++  +  ++ K ++I    A  ++YLH   
Sbjct: 82  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS-GDESMKHTQTLATIGYMAPE---YG 799
              ++H D+K +N+ L ED   ++GDFG+A   S    S +  Q   +I +MAPE     
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRP 826
                S + DVY+FGI+L E+ T + P
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP 224

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (475), Expect = 1e-53
 Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 16/213 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRN 683
            Q N    +     G +++GR+  G ++ +KV  ++         FN EC  LR   H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 684 LVRIISSCTN--DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLH 740
           ++ ++ +C +       L+  +MP GSL   L+   N  +D  + +   +D+A  + +LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--Y 798
                 +    +   +V++DEDM AR+    +        S +    +    ++APE   
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQ 181

Query: 799 GREGQISTE-GDVYSFGIMLMEIFTRKRPTDEI 830
            +    +    D++SF ++L E+ TR+ P  ++
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  185 bits (470), Expect = 3e-52
 Identities = 65/247 (26%), Positives = 98/247 (39%), Gaps = 35/247 (14%)

Query: 616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEV 675
            +  E     D   +  LIG G +G+VY+G  LD   VA+KVF        ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFANR---QNFINEKNI 58

Query: 676 --LRSIRHRNLVRIISSCTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNI 728
             +  + H N+ R I               LV++Y P GSL   L       D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRL 116

Query: 729 VIDIALALEYLH-----FGHPNP-VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
              +   L YLH       H  P + H D+   NVL+  D    + DFG++  L+G+  +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 783 KHTQTLA-------TIGYMAPEYGRE-------GQISTEGDVYSFGIMLMEIFTRKRPTD 828
           +  +          TI YMAPE                + D+Y+ G++  EIF R   TD
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234

Query: 829 EIFSGEM 835
                 +
Sbjct: 235 LFPGESV 241

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  183 bits (467), Expect = 5e-52
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRN 683
           +Q  +  LIG G FG VY GR+    EVAI++  ++   E  L++F  E    R  RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +V  + +C +    A++       +L + +      LD+ K   I  +I   + YL   H
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---H 147

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS----GDESMKHTQTLATIGYMAPEYG 799
              ++H D+K  NV  D   V  + DFG+  +      G    K       + ++APE  
Sbjct: 148 AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 800 REGQISTEG---------DVYSFGIMLMEIFTRKRP 826
           R+    TE          DV++ G +  E+  R+ P
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (455), Expect = 1e-50
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 26/229 (11%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEV--LRSIRHRNL 684
              +   +G G +G V+RG +  G  VA+K+F  + E   +S+  E E+     +RH N+
Sbjct: 9   DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENI 64

Query: 685 VRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           +  I+S       +    L+  Y   GSL   L    + LD    L IV+ IA  L +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLH 122

Query: 741 -----FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG--- 792
                      + H D+K  N+L+ ++    + D G+A + S   +         +G   
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 793 YMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM 835
           YMAPE                 D+++FG++L E+  R      +   + 
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 2e-49
 Identities = 63/253 (24%), Positives = 100/253 (39%), Gaps = 28/253 (11%)

Query: 620 ELLQATD--QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEV-- 675
            L+Q T   Q  +   IG G +G V+ G++  G +VA+KVF    E    S+  E E+  
Sbjct: 29  LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQ 84

Query: 676 LRSIRHRNLVRIISSCTNDDFK----ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
              +RH N++  I++            L+ DY   GSL   L   ++ LD    L +   
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYS 142

Query: 732 IALALEYLH-----FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ 786
               L +LH           + H D+K  N+L+ ++    + D G+A     D +     
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 787 TLATIG---YMAPE-----YGREGQISTE-GDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
               +G   YM PE       R    S    D+YSFG++L E+  R      +   ++  
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 838 KRWVNDSLPISIM 850
              V        M
Sbjct: 263 HDLVPSDPSYEDM 275

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  175 bits (447), Expect = 2e-49
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 17/215 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
                  ++G G FG   +    + G  + +K      E    +F  E +V+R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           ++ I     D     + +Y+  G+L   + S +S     +R++   DIA  + YLH    
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS--- 126

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-------------TI 791
             ++H D+   N L+ E+    + DFG+A+L+  +++                       
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            +MAPE         + DV+SFGI+L EI  R   
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  176 bits (448), Expect = 2e-49
 Identities = 60/323 (18%), Positives = 112/323 (34%), Gaps = 25/323 (7%)

Query: 204 FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK 263
              ++S         ++      +     +     +                   ANS  
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW---------HSAWRQANSNN 57

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSL-SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYN 322
            ++ + TG  L        + + +        L +  +    P +   L +L  + +   
Sbjct: 58  PQIETRTGRALKA--TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 323 KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
            L   +P T+ +   L+ L L  N L   +   I  L RL  + +        +P    +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 383 ---------LASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVL 433
                    L +L+ L      +  +P++  NL N+  + + ++PLS +L   I +L  L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231

Query: 434 VELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSG 493
            EL L       + P   GG   L+ L L D +   ++P  I  L  LE LDL   +   
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 494 IIPSSLEKLLYLKYLNVSFNRLE 516
            +PS + +L     + V  +   
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  167 bits (426), Expect = 3e-46
 Identities = 53/322 (16%), Positives = 104/322 (32%), Gaps = 23/322 (7%)

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
               E      +         +    +    +            R  N  N +       
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
            + ++   L      A       L L   PL     P     LS  ++   +    +   
Sbjct: 67  ALKATADLLED----ATQPGRVALELRSVPLP--QFPDQAFRLS-HLQHMTIDAAGLM-E 118

Query: 304 IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGL-ENNQLE--------GRILD 354
           +P  M     L  + L  N L  ++P++++ L +L+ L +    +L              
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177

Query: 355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDL 414
           +   L  L S+ L+   +  S+PA   NL +L+ L   ++ L+ +     +L  +  +DL
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDL 236

Query: 415 SSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS 474
                  + P   G    L  L L   +    +P  I  L  L+ L L        +P+ 
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 475 IGDLISLECLDLSNNILSGIIP 496
           I  L +   + +  ++ + +  
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  146 bits (371), Expect = 6e-39
 Identities = 56/338 (16%), Positives = 114/338 (33%), Gaps = 32/338 (9%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSD 72
               S  + L    +  L      +         D +    +      N ++ Q+   + 
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA--NSNNPQIETRTG 65

Query: 73  NRLSGELPANI-FSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHE 131
             L       +  +  P    L L         P +   L+ L  + +    LM E+P  
Sbjct: 66  RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122

Query: 132 IGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFS 191
           +     L+ L L  N L   +PA++ +++ L+ L +        +   +     + E   
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

Query: 192 LANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHE 251
           L N                L    L        +P    N++NLK L +  + ++     
Sbjct: 182 LVN----------------LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS----- 219

Query: 252 LSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNL 311
            +   ++ +  KL+ L L G   L    P   G  +  ++R  L +C+   ++P ++  L
Sbjct: 220 -ALGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRL 276

Query: 312 INLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLE 349
             L  + L        +PS +++L    I+ +  +   
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  125 bits (316), Expect = 1e-31
 Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 15/231 (6%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSL 65
             P Q   LS LQ++ +     L  +P ++     LE L L+ N L  + P    +++ L
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAG-LMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152

Query: 66  QVIDLSDNRLSGELPANI--------FSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSI 117
           + + +       ELP  +           L  +Q L L +      LP  I NL +L S+
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211

Query: 118 DLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSIS 177
            +  + L   +   I +L  L+ L L     +   P      + LK L L + +   ++ 
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270

Query: 178 SSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR 228
             I   L  LE   L       ++PS I       I  +P +  +    +R
Sbjct: 271 LDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 6/148 (4%)

Query: 375 SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKV-- 432
           ++      L+  ++   A            N  N  +   +   L  +    + +     
Sbjct: 24  ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPG 82

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS 492
            V L L    L    P     L +LQ++++    L   +P+++     LE L L+ N L 
Sbjct: 83  RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140

Query: 493 GIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
             +P+S+  L  L+ L++       E+P
Sbjct: 141 -ALPASIASLNRLRELSIRACPELTELP 167

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 16/121 (13%), Positives = 34/121 (28%), Gaps = 23/121 (19%)

Query: 421 GSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK-----------------NLQNLSLG 463
           GS      +      LY   +         +   +                 N  N  + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 464 DNNLQG--SIPNSIGDLIS--LECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEI 519
               +   +  + + D        L+L +  L    P    +L +L+++ +    L  E+
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 520 P 520
           P
Sbjct: 120 P 120

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  170 bits (434), Expect = 3e-47
 Identities = 78/379 (20%), Positives = 146/379 (38%), Gaps = 34/379 (8%)

Query: 138 LQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNF 197
              L  L   +  + P    +++      L   +++  ++      L ++    +A    
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56

Query: 198 SGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISS 257
           +      I   + L    L  N  +   P    N+  L  L +  N IT        IS+
Sbjct: 57  AS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISA 105

Query: 258 LANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIII 317
           L N   L+ L L  + + D    S + NL+  M    L   +   S    + N+  L  +
Sbjct: 106 LQNLTNLRELYLNEDNISD---ISPLANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYL 160

Query: 318 RLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIP 377
            +  +K+    P  ++ L  L  L L  NQ+E   +  +  L  L       N+++   P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP 216

Query: 378 ACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELY 437
               N+  L  L   +N++T +     NL+ +  +++ +N +S  +   + +L  L  L 
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLN 271

Query: 438 LSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPS 497
           +  N +S    + +  L  L +L L +N L       IG L +L  L LS N ++ I P 
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328

Query: 498 SLEKLLYLKYLNVSFNRLE 516
            L  L  +   + +   ++
Sbjct: 329 -LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  165 bits (421), Expect = 2e-45
 Identities = 89/450 (19%), Positives = 160/450 (35%), Gaps = 105/450 (23%)

Query: 43  LEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG 102
              L      ++  FP  +++      L    ++  +                       
Sbjct: 2   AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT---------------------- 39

Query: 103 HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL 162
                   L S+T + ++   +   I   I  L NL+ L L  N +  + P  L N+  L
Sbjct: 40  -----QEELESITKLVVAGEKV-ASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKL 90

Query: 163 KILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFS 222
             L +  N ++   +      L NL    L  +N S   P                    
Sbjct: 91  TNLYIGTNKITDISALQ---NLTNLRELYLNEDNISDISP-------------------- 127

Query: 223 GFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSS 282
                   N+  +  LNL  N+  S       +S L+N   L  L               
Sbjct: 128 ------LANLTKMYSLNLGANHNLSD------LSPLSNMTGLNYL--------------- 160

Query: 283 IGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILG 342
                       +    ++   P  + NL +L  + L YN++    P  L+ L  L    
Sbjct: 161 -----------TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT 205

Query: 343 LENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPST 402
              NQ+    +  +  + RL+S+ + +NK++   P    NL+ L  L   +N+++ + + 
Sbjct: 206 AYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA- 260

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSL 462
             +LT + M+++ SN +S      + NL  L  L+L+ N L  +    IGGL NL  L L
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318

Query: 463 GDNNLQGSIPNSIGDLISLECLDLSNNILS 492
             N++    P  +  L  ++  D +N ++ 
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  162 bits (413), Expect = 2e-44
 Identities = 74/342 (21%), Positives = 149/342 (43%), Gaps = 30/342 (8%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
           T       L S+  L ++  ++       I  +  LE L+L+ NQ++   P  N+  L  
Sbjct: 35  TDVVTQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTN 92

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE 127
           + +  N+++ ++ A     L  ++ L L  +  +      + NLT + S++L  NH + +
Sbjct: 93  LYIGTNKIT-DISA--LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD 147

Query: 128 IPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL 187
           +   + N+  L  L +  + +  V P  + N++ L  L L  N +      +   +L +L
Sbjct: 148 LS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA---SLTSL 201

Query: 188 ELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS 247
             F+   N  +   P  + N ++L+  ++ +N  +   P    N+  L  L +  N I+ 
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

Query: 248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
                  I+++ +  KLK+L++  N + D    S + NLS  +   +L+N  +     + 
Sbjct: 258 -------INAVKDLTKLKMLNVGSNQISD---ISVLNNLS-QLNSLFLNNNQLGNEDMEV 306

Query: 308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLE 349
           +G L NL  + L  N +    P  L+ L K+      N  ++
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  161 bits (410), Expect = 6e-44
 Identities = 68/363 (18%), Positives = 142/363 (39%), Gaps = 32/363 (8%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
                L+      L    +   +        ++  L ++  +++       +++L+ ++L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVTQEELE--SITKLVVAGEKVASIQGIEYLTNLEYLNL 73

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           + N+++   P    S L  +  L +  N+        + NLT+L  + L+E+++    P 
Sbjct: 74  NGNQITDISP---LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
            + NL  + +L L +N+ +    + L N++ L  L +T + +      +    L +L   
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIA---NLTDLYSL 182

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
           SL  N      P  + + + L       N  +   P    NM  L  L +  N IT    
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--- 235

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGN 310
               +S LAN  +L  L +  N + D    +++ +L+  ++   + +  I  S    + N
Sbjct: 236 ----LSPLANLSQLTWLEIGTNQISD---INAVKDLT-KLKMLNVGSNQI--SDISVLNN 285

Query: 311 LINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHN 370
           L  L  + L  N+L       +  L  L  L L  N +    +  +  L+++ S    + 
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQ 343

Query: 371 KLS 373
            + 
Sbjct: 344 VIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  157 bits (399), Expect = 2e-42
 Identities = 83/360 (23%), Positives = 143/360 (39%), Gaps = 34/360 (9%)

Query: 162 LKILQLTNNTLSGSISSSIRLA-LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNS 220
              L          I+     A L       L   + +  +         ++   +    
Sbjct: 2   AATLATLPA----PINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK 55

Query: 221 FSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLP 280
            +         + NL+ LNL  N IT        IS L+N  KL  L +  N + D    
Sbjct: 56  VASIQG--IEYLTNLEYLNLNGNQITD-------ISPLSNLVKLTNLYIGTNKITD---I 103

Query: 281 SSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQI 340
           S++ NL+ ++   YL+  NI    P  + NL  +  + LG N    S  S LS +  L  
Sbjct: 104 SALQNLT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNY 159

Query: 341 LGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP 400
           L +  ++++   +  I  L  L S+ L++N++    P    +L SL   +   N++T + 
Sbjct: 160 LTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215

Query: 401 STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNL 460
               N+T +  + + +N ++   PL   NL  L  L +  N +S      +  L  L+ L
Sbjct: 216 P-VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270

Query: 461 SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
           ++G N +  S  + + +L  L  L L+NN L       +  L  L  L +S N +    P
Sbjct: 271 NVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (431), Expect = 7e-47
 Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 34/253 (13%)

Query: 598 DTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKV 657
           D   S   + +PL+  R  +            +   IG G FG V+RG++  G EVA+K+
Sbjct: 22  DMTTSGSGSGLPLLVQRTIA--------RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKI 72

Query: 658 FHLQLEGALESFNAECEV--LRSIRHRNLVRIISSCTNDDFKA----LVLDYMPKGSLEA 711
           F  + E    S+  E E+     +RH N++  I++   D+       LV DY   GSL  
Sbjct: 73  FSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 129

Query: 712 CLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN-----PVVHCDIKPSNVLLDEDMVAR 766
            L  +   + +   + + +  A  L +LH           + H D+K  N+L+ ++    
Sbjct: 130 YL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187

Query: 767 LGDFGIAKLLSGDESMKHTQTLATIG---YMAPE-----YGREGQISTE-GDVYSFGIML 817
           + D G+A                 +G   YMAPE        +   S +  D+Y+ G++ 
Sbjct: 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247

Query: 818 MEIFTRKRPTDEI 830
            EI  R       
Sbjct: 248 WEIARRCSIGGIH 260

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  166 bits (423), Expect = 1e-44
 Identities = 87/525 (16%), Positives = 175/525 (33%), Gaps = 81/525 (15%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR 74
           S + LQ      + L   +P    ++ +      + ++   + P     + +  +++ +R
Sbjct: 9   SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAP---PGNGEQREMAVSR 64

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGN 134
           L   L             L L        LP    +L SL     S N L  E+P    +
Sbjct: 65  LRDCLDRQA-------HELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQS 112

Query: 135 LRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN 194
           L++L         L  +          L+ L ++NN L   +          L++  + N
Sbjct: 113 LKSLLVDNNNLKALSDL-------PPLLEYLGVSNNQLE-KLPELQN--SSFLKIIDVDN 162

Query: 195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSF 254
           N+   K+P    +   ++     +N     +P    N+  L  +  + N +         
Sbjct: 163 NSLK-KLPDLPPSLEFIA---AGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPDLPL- 215

Query: 255 ISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL 314
                    L+ +    N L        + NL   +   Y  N  ++ ++P    +L  L
Sbjct: 216 --------SLESIVAGNNIL---EELPELQNLP-FLTTIYADNNLLK-TLPDLPPSLEAL 262

Query: 315 IIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG 374
               +  N L   +P     L  L +     + L             L  +    N++  
Sbjct: 263 ---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR- 310

Query: 375 SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV 434
           S+        SL +L+ ++N+L  +P+    L  +     S N L+  +P    NLK   
Sbjct: 311 SLC---DLPPSLEELNVSNNKLIELPALPPRLERL---IASFNHLA-EVPELPQNLK--- 360

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
           +L++  N L  + P     +++L+      N+    +P       +L+ L +  N L   
Sbjct: 361 QLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQ---NLKQLHVETNPLR-E 410

Query: 495 IPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLL 539
            P   E    ++ L ++  R+           +   +    +   
Sbjct: 411 FPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  159 bits (404), Expect = 4e-42
 Identities = 89/498 (17%), Positives = 166/498 (33%), Gaps = 82/498 (16%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
            +P +  ++ S      ++++     P        + +  L +                 
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR---------QAHE 75

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE 127
           ++L++  LS  LP         ++ L  + N     LP    +L SL   + +       
Sbjct: 76  LELNNLGLS-SLPELPPH----LESLVASCNSLT-ELPELPQSLKSLLVDNNNLK----A 125

Query: 128 IPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL 187
           +      L  L     +SNN +  +P  L N S LKI+ + NN+L            P+L
Sbjct: 126 LSDLPPLLEYLG----VSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDL-----PPSL 175

Query: 188 ELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS 247
           E  +  NN    ++P    N   L+     +NS             +L+ +    N +  
Sbjct: 176 EFIAAGNNQLE-ELPELQ-NLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNILEE 229

Query: 248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
                  +  L N   L  +    N L    LP    +L    E   + +  +   +P+ 
Sbjct: 230 -------LPELQNLPFLTTIYADNNLLKT--LPDLPPSL----EALNVRDNYLT-DLPEL 275

Query: 308 MGNLINLIIIRLGYNKLNGSIPS----TLSR---------LEKLQILGLENNQLEGRILD 354
             +L  L +    ++ L+   P+      S             L+ L + NN+L   +  
Sbjct: 276 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 334

Query: 355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDL 414
              RL RL       N L+  +P    NL   ++L    N L   P    ++ +     L
Sbjct: 335 LPPRLERL---IASFNHLA-EVPELPQNL---KQLHVEYNPLREFPDIPESVED-----L 382

Query: 415 SSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS 474
             N     +P    NLK   +L++  N L  + P       ++++L +    +      +
Sbjct: 383 RMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFA 435

Query: 475 IGDLISLECLDLSNNILS 492
                 LE     ++   
Sbjct: 436 HETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  157 bits (400), Expect = 1e-41
 Identities = 101/437 (23%), Positives = 160/437 (36%), Gaps = 71/437 (16%)

Query: 80  PANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQ 139
           P N+     F+Q      +     +P E  N+ S T    + +      P   G  R + 
Sbjct: 5   PRNVS--NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 140 ALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSG 199
              L                     L+L N  L     SS+    P+LE    + N+ + 
Sbjct: 62  VSRLRDCLD-----------RQAHELELNNLGL-----SSLPELPPHLESLVASCNSLT- 104

Query: 200 KIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLA 259
           ++P    +   L +      + S   P        L+ L +  N +         +  L 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-------LPELQ 150

Query: 260 NSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRL 319
           NS  LK++ +  N L    LP    +L    E     N  +   +P E+ NL  L  I  
Sbjct: 151 NSSFLKIIDVDNNSL--KKLPDLPPSL----EFIAAGNNQLE-ELP-ELQNLPFLTAIYA 202

Query: 320 GYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPAC 379
             N L   +P     LE +      NN LE   L ++  L  L+++Y D+N L  ++P  
Sbjct: 203 DNNSLK-KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL 255

Query: 380 FGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLS 439
             +   L  L+   N LT +P    +LT +   D+S N  S  L     NL     L  S
Sbjct: 256 PPS---LEALNVRDNYLTDLPELPQSLTFL---DVSENIFS-GLSELPPNLY---YLNAS 305

Query: 440 RNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSL 499
            N +   +        +L+ L++ +N L   +P        LE L  S N L+  +P   
Sbjct: 306 SNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELP 356

Query: 500 EKLLYLKYLNVSFNRLE 516
           +    LK L+V +N L 
Sbjct: 357 QN---LKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  115 bits (289), Expect = 3e-27
 Identities = 58/302 (19%), Positives = 102/302 (33%), Gaps = 31/302 (10%)

Query: 224 FIPNRFHNMRNLKELNLEYNYITSSNHELSFISSL-----ANSKKLKVLSLTGNPLLDCV 278
           FI  R  +   L+E     + +T    E   + S      A S+  +          +  
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 279 LPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKL 338
           +      L        L+N  +  S+P+   +L +L       N L   +P     L+ L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 116

Query: 339 QILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF 398
            +       L             L  + + +N+L   +P    N + L+ +   +N L  
Sbjct: 117 LVDNNNLKALSDLP-------PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK 167

Query: 399 VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQ 458
           +P    +L  I      +N L   LP E+ NL  L  +Y   N+L            +L+
Sbjct: 168 LPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK----KLPDLPLSLE 218

Query: 459 NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGE 518
           ++  G+N L       + +L  L  +   NN+L   +P     L  L   +     L   
Sbjct: 219 SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPEL 275

Query: 519 IP 520
             
Sbjct: 276 PQ 277

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  163 bits (413), Expect = 6e-43
 Identities = 90/512 (17%), Positives = 175/512 (34%), Gaps = 55/512 (10%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQ 66
           VP  L        L++S N +     S I S++ L IL +S+N++       F     L+
Sbjct: 15  VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSENHLM 125
            +DLS N+L  ++  +    L   + L L+FN F    + +E GN++ L  + LS  HL 
Sbjct: 73  YLDLSHNKLV-KISCHPTVNL---KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
                 I +L   + L +L                  + L +                  
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF--------------PT 174

Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           N E   + + +        + N   +          S           N K  NL  N I
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL----AKLQTNPKLSNLTLNNI 230

Query: 246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIP 305
            ++ +    I  L     +   S++   L   +          S++   +H         
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ-------- 282

Query: 306 KEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV 365
                        +  +               + I     +      +    +++    +
Sbjct: 283 -------------VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPST---FWNLTNILMVDLSSNPLSGS 422
              +N L+ ++    G+L  L  L    N+L  +         + ++  +D+S N +S  
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389

Query: 423 LPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL 481
                    K L+ L +S N L+  I   +     ++ L L  N ++ SIP  +  L +L
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEAL 446

Query: 482 ECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
           + L++++N L  +     ++L  L+ + +  N
Sbjct: 447 QELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  154 bits (391), Expect = 5e-40
 Identities = 91/515 (17%), Positives = 189/515 (36%), Gaps = 71/515 (13%)

Query: 22  LDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGEL 79
           +D S N L+  +P  +       IL++S N +S  +     ++S L+++ +S NR+   L
Sbjct: 5   VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60

Query: 80  PANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH--EIGNLRN 137
             ++F +   +++L L+ N+    +        +L  +DLS N     +P   E GN+  
Sbjct: 61  DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAF-DALPICKEFGNMSQ 116

Query: 138 LQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNF 197
           L+ LGL + +L       + +++  K+L +   T            L +           
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE---GLQDFNT-------- 165

Query: 198 SGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN-YITSSNHELSFIS 256
                        L I    +  F   +      + NL+  N++        ++ LS ++
Sbjct: 166 -----------ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214

Query: 257 SLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS-MERFYLHNCNIRGSIPKEMGNLIN-- 313
            L  + KL  L+L             +  +  + +  F + N  ++G +     +     
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274

Query: 314 ---LIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHN 370
              L I ++  +               + I     +      +    +++    +   +N
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334

Query: 371 KLSGSIPACFGNLASLRKLSFASNELTFVPST---FWNLTNILMVDLSSNPLSGSLPLEI 427
            L+ ++    G+L  L  L    N+L  +         + ++  +D+S N +S       
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK--- 391

Query: 428 GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLS 487
                                      K+L +L++  N L  +I   +     ++ LDL 
Sbjct: 392 --------------------KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429

Query: 488 NNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
           +N +  I P  + KL  L+ LNV+ N+L+  +P G
Sbjct: 430 SNKIKSI-PKQVVKLEALQELNVASNQLK-SVPDG 462

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  149 bits (377), Expect = 3e-38
 Identities = 87/464 (18%), Positives = 163/464 (35%), Gaps = 25/464 (5%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSGSFPFFNMSSLQVI 68
            S + SLS L+ L +S N++   +  S+F  N  LE LDLS+N+L          +L+ +
Sbjct: 38  TSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHL 95

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI 128
           DLS N          F  +  ++FL L+           I +L     + +       + 
Sbjct: 96  DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE 188
             +   L++     L            + ++S   +  L  + +           +    
Sbjct: 156 --DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC---------VLEDN 204

Query: 189 LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
             S   +  +    +   +   L+  E   NSF   +   +H    +   ++    +   
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT--TVWYFSISNVKLQGQ 262

Query: 249 NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM 308
                F  S  + K L +  +  +        S I  +  +M          R       
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFG--FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 309 GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLE--GRILDDICRLARLSSVY 366
             +   + +    N L  ++      L +L+ L L+ NQL+   +I +   ++  L  + 
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 367 LDHNKLSGSIPAC-FGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLP 424
           +  N +S            SL  L+ +SN LT  +         +L  DL SN +  S+P
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVL--DLHSNKIK-SIP 437

Query: 425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ 468
            ++  L+ L EL ++ N L          L +LQ + L  N   
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.4 bits (201), Expect = 3e-16
 Identities = 48/288 (16%), Positives = 102/288 (35%), Gaps = 25/288 (8%)

Query: 1   LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF 60
             S L     +   S  +L  ++ ++N  +      +    T+    +SN +L G   F 
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDFR 266

Query: 61  -------NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTS 113
                  ++ +L +  +  +       + I+     +   +   +            ++ 
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325

Query: 114 LTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNL--VGVVPATLFNISTLKILQLTNNT 171
              +D S N L   +    G+L  L+ L L  N L  +  +      + +L+ L ++ N+
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385

Query: 172 LSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNA--SKLSICELPDNSFSGFIPNRF 229
           +S            +L   ++++N     +   IF     ++ + +L  N     IP + 
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSN----ILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQV 440

Query: 230 HNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
             +  L+ELN+  N + S                L+ + L  NP  DC
Sbjct: 441 VKLEALQELNVASNQLKSVPD-----GIFDRLTSLQKIWLHTNP-WDC 482

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 36/161 (22%), Positives = 60/161 (37%), Gaps = 11/161 (6%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
            N L  VP      T IL  ++S N +S     +I +L  L  L +S N +     +   
Sbjct: 9   KNGLIHVPKDLSQKTTIL--NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI-IPSSLEKLLYLKYLNVS 511
             + L+ L L  N L   I       ++L+ LDLS N    + I      +  LK+L +S
Sbjct: 67  FNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123

Query: 512 FNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPCKS 552
              L        ++      +     L+ G  + +    + 
Sbjct: 124 TTHL-----EKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  159 bits (403), Expect = 4e-42
 Identities = 80/401 (19%), Positives = 157/401 (39%), Gaps = 47/401 (11%)

Query: 42  TLEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQ 99
            +  +DLS N ++      F  +  LQ + +        +  N F  L  +  L L +NQ
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 100 FAGHLPREI-GNLTSLTSIDLSENHLMG-EIPHEI-GNLRNLQALGLLSNNLVGVVPATL 156
           F   L       L +L  + L++ +L G  +       L +L+ L L  NN+  + PA+ 
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 157 F-NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICE 215
           F N+    +L LT N +          ++   +L +    +F+      +   S +++ +
Sbjct: 150 FLNMRRFHVLDLTFNKVK---------SICEEDLLNFQGKHFT------LLRLSSITLQD 194

Query: 216 LPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLL 275
           + +               ++  L+L  N    S  +  F        K++ L L+ +  +
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF--DAIAGTKIQSLILSNSYNM 252

Query: 276 DCVLPSSI----------GNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKL 324
                 +           G  +  ++   L    I  ++ K +  +  +L  + L  N++
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311

Query: 325 NGSIPS-TLSRLEKLQILGLENNQL---EGRILDDICRLARLSSVYLDHNKLSGSIPAC- 379
           N  I       L  L  L L  N L   + R+ +    L +L  + L +N +  ++    
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE---NLDKLEVLDLSYNHIR-ALGDQS 366

Query: 380 FGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPL 419
           F  L +L++L+  +N+L  VP   F  LT++  + L +NP 
Sbjct: 367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 49/299 (16%), Positives = 87/299 (29%), Gaps = 61/299 (20%)

Query: 281 SSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQ 339
             +  L   +    L   +I          L +L  +++        I + T   L  L 
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 340 ILGLENNQ---LEGRILDDICRLARLSSVYLDHNKL-SGSIPA-CFGNLASLRKLSFASN 394
           IL L+ NQ   LE    +    LA L  + L    L    +    F  L SL  L    N
Sbjct: 83  ILKLDYNQFLQLETGAFN---GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139

Query: 395 ELTFVP--STFWNLTNILMVDLSSNPLS----------GSLPLEIGNLKVLVELYLSRNN 442
            +  +   S F N+    ++DL+ N +                 +  L  +    ++   
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199

Query: 443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLEC------------------- 483
           L  +         ++  L L  N  + S+     D I+                      
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259

Query: 484 --------------------LDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
                                DLS + +  ++ S       L+ L ++ N +  +I   
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDN 317

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 56/278 (20%), Positives = 98/278 (35%), Gaps = 35/278 (12%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF---SINTLEILDLSNNQLSGSFP----------FFN 61
           ++     LDL+FN+ + +I              +L LS+  L                F 
Sbjct: 152 NMRRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE 121
            +S+  +DLS N     +    F  +   +  SL  +    +      +       D   
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS----NSYNMGSSFGHTNFKDPDN 266

Query: 122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSI 180
               G    E   ++       LS + +  +  ++F + + L+ L L  N ++  I  + 
Sbjct: 267 FTFKG---LEASGVKTCD----LSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA 318

Query: 181 RLALPNLELFSLANNNFSGKIPSFIFNA-SKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
              L +L   +L+ N     I S +F    KL + +L  N         F  + NLKEL 
Sbjct: 319 FWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
           L+ N + S    +           L+ + L  NP  DC
Sbjct: 378 LDTNQLKSVPDGI-----FDRLTSLQKIWLHTNP-WDC 409

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 1/99 (1%)

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNIL 491
           +  + LS N+++    T+   L++LQ L +        I N+    L SL  L L  N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 492 SGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
             +   +   L  L+ L ++   L+G +  G      TS
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  151 bits (383), Expect = 3e-39
 Identities = 59/461 (12%), Positives = 135/461 (29%), Gaps = 30/461 (6%)

Query: 14  GSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLS 71
            + +  +   ++ + L   + S   S   ++ LDLS N LS          + L++++LS
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 72  DNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHE 131
            N L  E        L  ++ L L  N       +E+    S+ ++  + N++   +   
Sbjct: 67  SNVLY-ETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVS-- 115

Query: 132 IGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFS 191
               +  + + L +N +  +        S ++ L L  N +     + +  +   LE  +
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 192 LANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHE 251
           L  N     +   +   +KL   +L  N  + F+   F +   +  ++L  N +      
Sbjct: 176 LQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV----- 227

Query: 252 LSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNL 311
                +L  S+ L+   L GN      L               +    ++    +     
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ---TVAKQTVKKLTGQNEEEC 283

Query: 312 INLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI----CRLARLSSVYL 367
               +   G             RL  L+         +G   + +       AR   +  
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343

Query: 368 DHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLE 426
              +    I        +   L      L    S        +      +          
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403

Query: 427 IGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL 467
                + +   + +      +         +++  +  +  
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  150 bits (381), Expect = 6e-39
 Identities = 70/503 (13%), Positives = 153/503 (30%), Gaps = 57/503 (11%)

Query: 33  IPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFV 90
           I     + N  +I  ++++ L  +      +  +++ +DLS N LS ++ A   +    +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 91  QFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVG 150
           + L+L+ N        ++ +L++L ++DL+ N++      E+    +++ L   +NN + 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETL-HAANNNIS 112

Query: 151 VVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASK 210
            V  +       K + L NN ++             ++   L  N               
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEG-CRSRVQYLDLKLNE-------------- 155

Query: 211 LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT 270
             I  +              +   L+ LNL+YN+I         +       KLK L L+
Sbjct: 156 --IDTVNFAEL-------AASSDTLEHLNLQYNFIYD-------VKGQVVFAKLKTLDLS 199

Query: 271 GNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS 330
            N L    +     + +  +    L N  +   I K +    NL    L  N  +     
Sbjct: 200 SNKLAF--MGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255

Query: 331 TLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK-- 388
                +  ++  +    ++     +       +  +                L +L++  
Sbjct: 256 DF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKE 314

Query: 389 ---LSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG 445
              LS   +E   +     N      +D         +       +  + L   +  L  
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDE 374

Query: 446 DIPTTIGGLKNLQNL---SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL 502
            +         L      ++G   LQ +        +    +     +           +
Sbjct: 375 QVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAI 434

Query: 503 LYLKYLNVSFNRLEGEIPRGGTL 525
                      +L  E  R   L
Sbjct: 435 RDWDMYQHKETQLAEENARLKKL 457

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  133 bits (337), Expect = 3e-33
 Identities = 62/478 (12%), Positives = 138/478 (28%), Gaps = 52/478 (10%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVID 69
            + L   + L+ L+LS N L       + S++TL  LDL+NN +          S++ + 
Sbjct: 51  AADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQE---LLVGPSIETLH 105

Query: 70  LSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG-EI 128
            ++N +S  +  +        + + LA N+       + G  + +  +DL  N +     
Sbjct: 106 AANNNIS-RVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE 188
                +   L+ L  L  N +  V   +   + LK L L++N L+  +    + +   + 
Sbjct: 162 AELAASSDTLEHL-NLQYNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVT 217

Query: 189 LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
             SL NN                             I       +NL+  +L  N     
Sbjct: 218 WISLRNNKLV-------------------------LIEKALRFSQNLEHFDLRGNGFHCG 252

Query: 249 NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM 308
                F    + +++++ ++      L           +L     +              
Sbjct: 253 TLRDFF----SKNQRVQTVAKQTVKKLTGQNEEECTVPTL----GHYGAYCCEDLPAPFA 304

Query: 309 GNLINLIIIRLGYNKLNGS----IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS 364
             LI L           GS    +        + + +     Q    I     R     +
Sbjct: 305 DRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364

Query: 365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLS-GSL 423
           +      L   +       A L      +     +       + + ++           +
Sbjct: 365 LEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYV 424

Query: 424 PLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL 481
             +      + +  + ++  +          K      L   +   ++   +    +L
Sbjct: 425 EQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  113 bits (284), Expect = 2e-26
 Identities = 48/263 (18%), Positives = 95/263 (36%), Gaps = 31/263 (11%)

Query: 303 SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
           +I +   N     I ++  + L  ++ S       ++ L L  N L      D+    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--------------------ST 402
             + L  N L  ++     +L++LR L   +N +  +                     S 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR 118

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG-DIPTTIGGLKNLQNLS 461
                NI    L++N ++    L+ G    +  L L  N +   +          L++L+
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR 521
           L  N +   +   +     L+ LDLS+N L+  +    +    + ++++  N+L   I +
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 522 G-GTLANFTSESFMGNDLLCGSP 543
                 N       GN   CG+ 
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTL 254

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 31/268 (11%), Positives = 73/268 (27%), Gaps = 8/268 (2%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS-GSFPFFNMSSLQ 66
            +  +  S + + ++ L  N+ L  I  ++     LE  DL  N    G+   F   + +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNK-LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL-- 124
           V  ++   +  +L                               L +L   + +      
Sbjct: 264 VQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 125 --MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
                +  E  N    + +  L      V+            L+     L     S+ R 
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD-EQVSNGRR 381

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
           A   L+              +    +    +  +       ++  +      +++ ++  
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQ 441

Query: 243 NYITSSNHELSFISSLANSKKLKVLSLT 270
           +  T    E + +  L     L + S  
Sbjct: 442 HKETQLAEENARLKKLNGEADLALASAN 469

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  149 bits (377), Expect = 4e-39
 Identities = 80/474 (16%), Positives = 162/474 (34%), Gaps = 106/474 (22%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSG--SFPFFNMSSL 65
            + S L        + +              ++N  +I+   N+ +    +    +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHL 124
           ++++L+D ++  E+    F+Y   +Q L + FN    +LP  +  N+  LT + L  N L
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129

Query: 125 MGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
              +P  I  N   L  L + +NNL  +   T    ++L+ LQL++N L+  +  S    
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---L 184

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           +P+L   +++ N  S                                    ++EL+  +N
Sbjct: 185 IPSLFHANVSYNLLS-----------------------------TLAIPIAVEELDASHN 215

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
            I         +    N  +L +L L  N L      +    L                 
Sbjct: 216 SINV-------VRGPVNV-ELTILKLQHNNL------TDTAWLL---------------- 245

Query: 304 IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLS 363
                 N   L+ + L YN+L   +     ++++L+ L + NN+L               
Sbjct: 246 ------NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-------------- 285

Query: 364 SVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSL 423
                      ++      + +L+ L  + N L  V         +  + L  N +    
Sbjct: 286 -----------ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV--- 331

Query: 424 PLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD 477
            L++     L  L LS N+   +    +   +N+   ++ D +    I   +  
Sbjct: 332 TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  146 bits (370), Expect = 3e-38
 Identities = 74/442 (16%), Positives = 148/442 (33%), Gaps = 102/442 (23%)

Query: 30  LGTIPSSIFSINTLE--ILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYL 87
              I S++          +D+    +   F    +++ +++   ++ +  +LPA +    
Sbjct: 10  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLD-- 66

Query: 88  PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI-GNLRNLQALGLLSN 146
                                 +   +  ++L++  +  EI          +Q L +  N
Sbjct: 67  ----------------------SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 103

Query: 147 NLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF 206
            +  + P    N+  L +L L  N LS S+   I    P L   S++NNN          
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN---------- 152

Query: 207 NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV 266
                 +  + D++F            +L+ L L  N +T           L+    L  
Sbjct: 153 ------LERIEDDTFQA--------TTSLQNLQLSSNRLTHV--------DLSLIPSLFH 190

Query: 267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG 326
            +++ N L                                 +   I +  +   +N +N 
Sbjct: 191 ANVSYNLL-------------------------------STLAIPIAVEELDASHNSIN- 218

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL 386
            +   +    +L IL L++N L       +     L  V L +N+L   +   F  +  L
Sbjct: 219 VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274

Query: 387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGD 446
            +L  ++N L  +      +  + ++DLS N L   +         L  LYL  N++   
Sbjct: 275 ERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332

Query: 447 IPTTIGGLKNLQNLSLGDNNLQ 468
           +   +     L+NL+L  N+  
Sbjct: 333 LK--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  135 bits (341), Expect = 2e-34
 Identities = 72/392 (18%), Positives = 136/392 (34%), Gaps = 54/392 (13%)

Query: 152 VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF-NASK 210
           + + L        + +   T          + L N ++ +  N+    K+P+ +  +  +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFE-DITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 211 LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT 270
           + +  L D          F     +++L + +N I      +       N   L VL L 
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLE 125

Query: 271 GNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIP 329
            N L                            S+P+ +  N   L  + +  N L     
Sbjct: 126 RNDL---------------------------SSLPRGIFHNTPKLTTLSMSNNNLERIED 158

Query: 330 STLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKL 389
            T      LQ L L +N+L   +  D+  +  L    + +N LS           ++ +L
Sbjct: 159 DTFQATTSLQNLQLSSNRLT-HV--DLSLIPSLFHANVSYNLLST-----LAIPIAVEEL 210

Query: 390 SFASNELTFVP-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIP 448
             + N +  V       LT +    L  N L+      + N   LVE+ LS N L   + 
Sbjct: 211 DASHNSINVVRGPVNVELTIL---KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMY 265

Query: 449 TTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYL 508
                ++ L+ L + +N L  ++      + +L+ LDLS+N L   +  +  +   L+ L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323

Query: 509 NVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
            +  N +   +    T     + +   ND  C
Sbjct: 324 YLDHNSIV-TLKL-STHHTLKNLTLSHNDWDC 353

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 90.1 bits (224), Expect = 3e-19
 Identities = 40/192 (20%), Positives = 74/192 (38%), Gaps = 6/192 (3%)

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL 386
            I S L        + ++    +     +   L     V   ++ +     A   +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 387 RKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLS 444
             L+    ++  + +  F     I  + +  N +   LP  +  N+ +L  L L RN+LS
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 445 GDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY 504
                       L  LS+ +NNL+    ++     SL+ L LS+N L+ +  S +     
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS--- 187

Query: 505 LKYLNVSFNRLE 516
           L + NVS+N L 
Sbjct: 188 LFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 18/128 (14%), Positives = 41/128 (32%), Gaps = 1/128 (0%)

Query: 395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGL 454
           E   + S          V +           E   L     +    + +       +   
Sbjct: 9   EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68

Query: 455 KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNR 514
           + ++ L+L D  ++     +     +++ L +  N +  + P   + +  L  L +  N 
Sbjct: 69  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

Query: 515 LEGEIPRG 522
           L   +PRG
Sbjct: 129 LS-SLPRG 135

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 11/101 (10%), Positives = 35/101 (34%)

Query: 416 SNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI 475
             P    +   +    V  ++++               L N + ++  ++ ++      +
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 476 GDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
                +E L+L++  +  I   +      ++ L + FN + 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (382), Expect = 2e-38
 Identities = 71/453 (15%), Positives = 153/453 (33%), Gaps = 80/453 (17%)

Query: 30  LGTIPSSIFSINTLE--ILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYL 87
              I S++          +D+    +   F    +++ +++   ++ +  +LPA +    
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74

Query: 88  PFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSN 146
             V+ L+L   Q    +         ++  + +  N +    PH   N+  L  L L  N
Sbjct: 75  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133

Query: 147 NLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF 206
           +L  +      N   L  L ++NN L   I      A  +L+   L++N           
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR---------- 182

Query: 207 NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV 266
                 +  +  +              +L   N+ YN ++          +LA    ++ 
Sbjct: 183 ------LTHVDLSLIP-----------SLFHANVSYNLLS----------TLAIPIAVEE 215

Query: 267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG 326
           L  + N +                             +       + L I++L +N L  
Sbjct: 216 LDASHNSI---------------------------NVVRG--PVNVELTILKLQHNNL-- 244

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL 386
           +  + L     L  + L  N+LE  +     ++ RL  +Y+ +N+L  ++      + +L
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303

Query: 387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGD 446
           + L  + N L  V         +  + L  N +     L++     L  L LS N+   +
Sbjct: 304 KVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCN 360

Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLI 479
               +   +N+   ++ D +    I   +   +
Sbjct: 361 SLRAL--FRNVARPAVDDADQHCKIDYQLEHGL 391

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  130 bits (329), Expect = 1e-31
 Identities = 72/392 (18%), Positives = 135/392 (34%), Gaps = 54/392 (13%)

Query: 152 VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF-NASK 210
           + + L        + +   T          + L N ++ +  N+    K+P+ +  +  +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFE-DITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 211 LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT 270
           + +  L D          F     +++L + +N I      +       N   L VL L 
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLE 131

Query: 271 GNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIP 329
            N L                            S+P+ +  N   L  + +  N L     
Sbjct: 132 RNDL---------------------------SSLPRGIFHNTPKLTTLSMSNNNLERIED 164

Query: 330 STLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKL 389
            T      LQ L L +N+L      D+  +  L    + +N LS           ++ +L
Sbjct: 165 DTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLST-----LAIPIAVEEL 216

Query: 390 SFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIP 448
             + N +  V       LT +    L  N L+      + N   LVE+ LS N L   + 
Sbjct: 217 DASHNSINVVRGPVNVELTIL---KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMY 271

Query: 449 TTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYL 508
                ++ L+ L + +N L  ++      + +L+ LDLS+N L   +  +  +   L+ L
Sbjct: 272 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329

Query: 509 NVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
            +  N +   +    T     + +   ND  C
Sbjct: 330 YLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  117 bits (294), Expect = 2e-27
 Identities = 68/337 (20%), Positives = 130/337 (38%), Gaps = 31/337 (9%)

Query: 194 NNNFSGKIPSFIFNASKLS-ICELPDNSFSGFIPNRFH-----NMRNLKELNLEYNYITS 247
             N   + P +    S L   C   D        + +       + N K +  + + +  
Sbjct: 6   RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65

Query: 248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
               L     L + +++++L+L    + +  + +     + ++++ Y+    IR  +P  
Sbjct: 66  LPAAL-----LDSFRQVELLNLNDLQIEE--IDTYAFAYAHTIQKLYMGFNAIR-YLPPH 117

Query: 308 M-GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI-CRLARLSSV 365
           +  N+  L ++ L  N L+           KL  L + NN LE RI DD       L ++
Sbjct: 118 VFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL 425
            L  N+L+  +      + SL   + + N L+ +         +  +D S N ++    +
Sbjct: 177 QLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLA----IPIAVEELDASHNSINV---V 226

Query: 426 EIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLD 485
                  L  L L  NNL+ D    +     L  + L  N L+  + +    +  LE L 
Sbjct: 227 RGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284

Query: 486 LSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
           +SNN L   +    + +  LK L++S N L   + R 
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 319

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  111 bits (279), Expect = 1e-25
 Identities = 70/385 (18%), Positives = 144/385 (37%), Gaps = 19/385 (4%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
           S L    +++ LD S N +   +   +     L IL L +N L+ +    N   L  +DL
Sbjct: 205 STLAIPIAVEELDASHNSI-NVVRGPVNV--ELTILKLQHNNLTDTAWLLNYPGLVEVDL 261

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           S N L  ++  + F  +  ++ L ++ N+    L      + +L  +DLS NHL+  +  
Sbjct: 262 SYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 318

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
                  L+ L L  N++V +  +T      LK L L++N       +S+R    N+   
Sbjct: 319 NQPQFDRLENLYLDHNSIVTLKLSTHHT---LKNLTLSHNDWD---CNSLRALFRNVARP 372

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
           ++ + +   KI    +       C+  D  +   +         ++++       ++++ 
Sbjct: 373 AVDDADQHCKID---YQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDT 429

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLD-CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMG 309
             S  S      +   + L GN  L+  V         L+ E+       ++G   +   
Sbjct: 430 INSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQ-LLQGLHAEIDT 488

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
           NL    + + G  + + ++    + L++ Q   L   Q      D   +      +  ++
Sbjct: 489 NLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEAD--AKQKETEDLEQEN 546

Query: 370 NKLSGSIPACFGNLASLRKLSFASN 394
             L   +       A LR+ +    
Sbjct: 547 IALEKQLDNKRAKQAELRQETSLKR 571

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  149 bits (377), Expect = 5e-38
 Identities = 95/491 (19%), Positives = 176/491 (35%), Gaps = 63/491 (12%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSGSFPFFNMSSLQVI 68
              +  LS L+ L LS N++  ++   +F  N  LE LD+S+N+L  +     M+SL+ +
Sbjct: 69  MPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHL 126

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI 128
           DLS N     LP                       + +E GNLT LT + LS        
Sbjct: 127 DLSFNDFD-VLP-----------------------VCKEFGNLTKLTFLGLSAAKFRQLD 162

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE 188
              + +L     L  L +  +         I    +L L  +  S   S  + +++  L 
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS-LFSVQVNMSVNALG 221

Query: 189 LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
              L+N   +                   D +    +       R    LN+   +I ++
Sbjct: 222 HLQLSNIKLN-------------------DENCQRLMTFLSELTRGPTLLNVTLQHIETT 262

Query: 249 NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM 308
                 +      + ++ L++    + + +          +++   + +   +  +  + 
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322

Query: 309 G---NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV 365
                   + I  L  +                  L    N     +      L RL ++
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-----TFWNLTNILMVDLSSNPLS 420
            L  N L  +         ++  L      L  + S     T     +IL+++LSSN L+
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 421 GSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-L 478
           GS+   +   +KV   L L  N +   IP  +  L+ LQ L++  N L+ S+P+ + D L
Sbjct: 442 GSVFRCLPPKVKV---LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRL 496

Query: 479 ISLECLDLSNN 489
            SL+ + L +N
Sbjct: 497 TSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  146 bits (371), Expect = 3e-37
 Identities = 103/526 (19%), Positives = 185/526 (35%), Gaps = 66/526 (12%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSD 72
           S      +D S   L   +P  +      + L LS N +S         +S L+V+ LS 
Sbjct: 29  SNELESMVDYSNRNL-THVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSH 85

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH-- 130
           NR+   L  ++F +   +++L ++ N+   ++      + SL  +DLS N     +P   
Sbjct: 86  NRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCK 140

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
           E GNL  L  LGL +     +    + +   L +  +  + +S  I      +L      
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAH---LHLSCILLDLVSYHIKGGETESLQIP--- 194

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
                           N + L +   P++ FS  +    + + +L+  N++ N   +   
Sbjct: 195 ----------------NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE-NCQR 237

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS-MERFYLHNCNIRGSIPKEMG 309
            ++F+S L     L  ++L                     +E   ++N  I   I +E  
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
                                    L+ L I  ++N              A ++   L  
Sbjct: 298 TYSETA-------------------LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338

Query: 370 NKLSGSIPACFGNLASLRKLSFASNELTFVPST-FWNLTNILMVDLSSNPLSGSLPLEIG 428
           +        C  + +S   L+F  N  T         L  +  + L  N L  +      
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVAL 397

Query: 429 NLKVLVELYLSRNNL----SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECL 484
             K +  L     +L    S     T    +++  L+L  N L GS+   +     ++ L
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVL 455

Query: 485 DLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTS 530
           DL NN +   IP  +  L  L+ LNV+ N+L+  +P  G     TS
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLTS 498

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.4 bits (206), Expect = 9e-17
 Identities = 49/277 (17%), Positives = 92/277 (33%), Gaps = 47/277 (16%)

Query: 12  QLGSLSSLQYLDLSFNQLLGTIPSSIF-----SINTLEILDLSNNQLSGSFP--FFNMSS 64
           Q      ++YL++    +   I    F     ++ +L I  + N     S    +   + 
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           + +  LS +     +            FL+   N F   + +    L  L ++ L  N L
Sbjct: 331 MNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389

Query: 125 MGEIPHEIGNLRNLQALGLLSNNLV----GVVPATLFNISTLKILQLTNNTLSGSISSSI 180
                      +N+ +L  L  +L          T     ++ +L L++N L+GS+   +
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448

Query: 181 RLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL 240
               P +++  L NN                             IP    +++ L+ELN+
Sbjct: 449 ---PPKVKVLDLHNNRIMS-------------------------IPKDVTHLQALQELNV 480

Query: 241 EYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
             N + S                L+ + L  NP  DC
Sbjct: 481 ASNQLKSVPD-----GVFDRLTSLQYIWLHDNP-WDC 511

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 65/450 (14%), Positives = 138/450 (30%), Gaps = 53/450 (11%)

Query: 113 SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL 172
             + +D S  +L   +P ++      +AL L  N++  +    +  +S L++L+L++N +
Sbjct: 32  LESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88

Query: 173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
             S+   + L   +LE   +++N     I                              M
Sbjct: 89  R-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--------------------------CCPM 120

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
            +L+ L+L +N        L       N  KL  L L+       +    + +L LS   
Sbjct: 121 ASLRHLDLSFNDFDV----LPVCKEFGNLTKLTFLGLSAAKFRQ-LDLLPVAHLHLSCIL 175

Query: 293 FYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
             L + +I+G   + +    N  ++ L ++  +         +  L  L L N +L    
Sbjct: 176 LDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234

Query: 353 LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLT----N 408
              +       +       ++            L+ +         +   FW       N
Sbjct: 235 CQRLMTFLSELTRGPTLLNVT------------LQHIETTWKCSVKLFQFFWPRPVEYLN 282

Query: 409 ILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ 468
           I  + ++              LK L+  ++                  +    L  ++  
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342

Query: 469 GSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANF 528
                      S   L+ + N+ +  +      L  L+ L +  N L+          N 
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM 402

Query: 529 TSESFMGNDLLCGSPHLQVPPCKSTKTRTN 558
           +S   +   L   + H     C   ++   
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILV 432

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 6/102 (5%)

Query: 1   LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-- 58
           L S  +           S+  L+LS N L G++   +     +++LDL NN++  S P  
Sbjct: 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKD 468

Query: 59  FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF 100
             ++ +LQ ++++ N+L   +P  +F  L  +Q++ L  N +
Sbjct: 469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 1e-37
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIK---VFHLQLEGALESFNAECEVLRSIRH 681
             F +   IG G F  VYR   L DG+ VA+K   +F L    A      E ++L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALEY 738
            N+++  +S   D+   +VL+    G L   +        +          + +  ALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           +H      V+H DIKP+NV +    V +LGD G+ +  S   +  H+    T  YM+PE 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 799 GREGQISTEGDVYSFGIMLMEIFTRKRP 826
             E   + + D++S G +L E+   + P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  144 bits (365), Expect = 1e-37
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 6/200 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRN 683
           +   +   IG G+FG V+ GR   D   VA+K     L       F  E  +L+   H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +VR+I  CT      +V++ +  G     L ++ + L +   L +V D A  +EYL    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---E 230

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREG 802
               +H D+   N L+ E  V ++ DFG+++  +    +         + + APE    G
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290

Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + S+E DV+SFGI+L E F+
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (356), Expect = 1e-37
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRN 683
            +      IGSG FG V+ G +L+  +VAIK      EGA+  E F  E EV+  + H  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 64

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---H 740
           LV++   C       LV ++M  G L   L +          L + +D+   + YL    
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  +H D+   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE   
Sbjct: 125 V------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
             + S++ DV+SFG+++ E+F+  K P
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  146 bits (369), Expect = 2e-37
 Identities = 69/323 (21%), Positives = 139/323 (43%), Gaps = 19/323 (5%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLS--GSFPFFNMSS 64
            VP  +   +  + LDL  N++  T+    F+    LE L+L+ N +S      F N+ +
Sbjct: 25  AVPEGI--PTETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           L+ + L  NRL   +P  +F+ L  +  L ++ N+    L     +L +L S+++ +N L
Sbjct: 82  LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140

Query: 125 MGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
           +  I H     L +L+ L L   NL  +    L ++  L +L+L +  ++ +I       
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           L  L++  +++  +   +         L+   +   + +        ++  L+ LNL YN
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
            I++        S L    +L+ + L G   L  V P +   L+  +    +    +  +
Sbjct: 259 PISTIEG-----SMLHELLRLQEIQLVGGQ-LAVVEPYAFRGLN-YLRVLNVSGNQLT-T 310

Query: 304 IPKEM-GNLINLIIIRLGYNKLN 325
           + + +  ++ NL  + L  N L 
Sbjct: 311 LEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  137 bits (347), Expect = 1e-34
 Identities = 68/313 (21%), Positives = 124/313 (39%), Gaps = 15/313 (4%)

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
              + L+L  N I + N         A+   L+ L L  N +   V P +  NL  ++  
Sbjct: 32  TETRLLDLGKNRIKTLNQ-----DEFASFPHLEELELNENIVSA-VEPGAFNNLF-NLRT 84

Query: 293 FYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGR 351
             L +  ++  IP  +   L NL  + +  NK+   +      L  L+ L + +N L   
Sbjct: 85  LGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143

Query: 352 ILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNI 409
                  L  L  + L+   L+ SIP     +L  L  L      +  +   +F  L  +
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202

Query: 410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG 469
            ++++S  P   ++         L  L ++  NL+      +  L  L+ L+L  N +  
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262

Query: 470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG--GTLAN 527
              + + +L+ L+ + L    L+ + P +   L YL+ LNVS N+L   +      ++ N
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGN 321

Query: 528 FTSESFMGNDLLC 540
             +     N L C
Sbjct: 322 LETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 7/124 (5%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLS--GSFPFFN 61
              T+        +L  L ++    L  +P      +  L  L+LS N +S         
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCN-LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE 270

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLS 120
           +  LQ I L   +L+  +    F  L +++ L+++ NQ    L   +  ++ +L ++ L 
Sbjct: 271 LLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILD 328

Query: 121 ENHL 124
            N L
Sbjct: 329 SNPL 332

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  140 bits (354), Expect = 3e-37
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 15/207 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRN 683
           ++  +   +GSG FG V  G++    +VA+K+     EG++  + F  E + +  + H  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPK 64

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---H 740
           LV+    C+ +    +V +Y+  G L   L S    L+  + L +  D+   + +L    
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
           F      +H D+   N L+D D+  ++ DFG+ + +  D+ +    T   + + APE   
Sbjct: 125 F------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
             + S++ DV++FGI++ E+F+  K P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP 205

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (359), Expect = 4e-37
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 14/208 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
           +++     IG GSFG     +   DG +  IK  ++        E    E  VL +++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNL----DIFKRLNIVIDIALALEY 738
           N+V+   S   +    +V+DY   G L   + +    L     I   L+  + I LAL++
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI---LDWFVQICLALKH 140

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           +H      ++H DIK  N+ L +D   +LGDFGIA++L+    +       T  Y++PE 
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196

Query: 799 GREGQISTEGDVYSFGIMLMEIFTRKRP 826
                 + + D+++ G +L E+ T K  
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (355), Expect = 4e-37
 Identities = 63/242 (26%), Positives = 109/242 (45%), Gaps = 25/242 (10%)

Query: 591 ISTCRKGDTKLSNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLD- 649
           + +  +GD +   ++ +                         ++G G++G VY GR L  
Sbjct: 2   MRSTEEGDCESDLLEYDYEYDENGDRV---------------VLGKGTYGIVYAGRDLSN 46

Query: 650 GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL 709
            + +AIK    +     +  + E  + + ++H+N+V+ + S + + F  + ++ +P GSL
Sbjct: 47  QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106

Query: 710 EACLYSDNSNLDIFKRL--NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VAR 766
            A L S    L   ++        I   L+YL   H N +VH DIK  NVL++    V +
Sbjct: 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLK 163

Query: 767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
           + DFG +K L+G      T T  T+ YMAPE             D++S G  ++E+ T K
Sbjct: 164 ISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

Query: 825 RP 826
            P
Sbjct: 223 PP 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (353), Expect = 5e-37
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 11/211 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
           + + V   IG+GS+G   + R   DG  +  K        E   +   +E  +LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 683 NLVRIISSCTNDDFKAL--VLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALE 737
           N+VR      +     L  V++Y   G L + +               L ++  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 738 YLHFGH--PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
             H      + V+H D+KP+NV LD     +LGDFG+A++L+ D S   T  + T  YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMS 184

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           PE       + + D++S G +L E+     P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (353), Expect = 5e-37
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 20/230 (8%)

Query: 631 NNLIGSGSFGSVYRGRFLD---GMEVAIKVFHL--QLEGALESFNAECEVLRSIRHRNLV 685
           +  IG GSF +VY+G  LD    +EVA          +   + F  E E+L+ ++H N+V
Sbjct: 31  DIEIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 686 RIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
           R   S  +         LV + M  G+L          + I    +    I   L++LH 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH- 146

Query: 742 GHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPEYG 799
               P++H D+K  N+ +       ++GD G+A L          + +  T  +MAPE  
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMY 202

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
            E       DVY+FG+ ++E+ T + P  E  +     +R  +   P S 
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (349), Expect = 2e-36
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 15/207 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRN 683
                   +G+G FG V  G++    +VAIK+     EG++  + F  E +V+ ++ H  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK 80

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---H 740
           LV++   CT      ++ +YM  G L   L          + L +  D+  A+EYL    
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
           F      +H D+   N L+++  V ++ DFG+++ +  DE      +   + +  PE   
Sbjct: 141 F------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194

Query: 801 EGQISTEGDVYSFGIMLMEIFTR-KRP 826
             + S++ D+++FG+++ EI++  K P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (360), Expect = 2e-36
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 10/200 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRN 683
           +   +   +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK 240

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFG 742
           LV++ +  + +    +V +YM KGSL   L       L + + +++   IA  + Y+   
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           +    VH D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + + + DV+SFGI+L E+ T
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 2e-36
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 10/201 (4%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA--LESFNAECEVLRSIRHR 682
               + + +G G +G VY G +    + VA+K      E    +E F  E  V++ I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHF 741
           NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
            +    +H ++   N L+ E+ + ++ DFG+++L++GD    H      I + APE    
Sbjct: 337 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 802 GQISTEGDVYSFGIMLMEIFT 822
            + S + DV++FG++L EI T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (348), Expect = 2e-36
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 27/219 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
             F    LIGSG FG V++ +  +DG    IK      E A      E + L  + H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66

Query: 685 VRIISSCTNDDFKA----------------LVLDYMPKGSLEACLYSDNSN-LDIFKRLN 727
           V         D+                  + +++  KG+LE  +       LD    L 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
           +   I   ++Y+H      +++ D+KPSN+ L +    ++GDFG+   L  D   K T++
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRTRS 181

Query: 788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             T+ YM+PE         E D+Y+ G++L E+      
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (361), Expect = 4e-36
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 10/200 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRN 683
           +   +   +G G FG V+ G +     VAIK       G +  E+F  E +V++ +RH  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK 323

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFG 742
           LV++ +  + +    +V +YM KGSL   L       L + + +++   IA  + Y+   
Sbjct: 324 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           +    VH D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 803 QISTEGDVYSFGIMLMEIFT 822
           + + + DV+SFGI+L E+ T
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (356), Expect = 6e-36
 Identities = 55/200 (27%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA--LESFNAECEVLRSIRHRN 683
           +   +   +G+G FG V+   +    +VA+K       G+  +E+F AE  V+++++H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDK 244

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFG 742
           LV++ +  T +    ++ ++M KGSL   L S + S   + K ++    IA  + ++   
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           +    +H D++ +N+L+   +V ++ DFG+A+++  +E          I + APE    G
Sbjct: 304 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 803 QISTEGDVYSFGIMLMEIFT 822
             + + DV+SFGI+LMEI T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  144 bits (364), Expect = 6e-36
 Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 31/220 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR--FLDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHR 682
            Q+ V   I  G  G +Y      ++G  V +K         A     AE + L  + H 
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 683 NLVRIISSCTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           ++V+I +   + D        +V++Y+   SL+         L + + +  +++I  AL 
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALS 196

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT---LATIGYM 794
           YLH      +V+ D+KP N++L E+ + +L D G    +                T G+ 
Sbjct: 197 YLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRI--------NSFGYLYGTPGFQ 244

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
           APE  R    +   D+Y+ G  L  +           +G 
Sbjct: 245 APEIVR-TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (344), Expect = 8e-36
 Identities = 56/205 (27%), Positives = 108/205 (52%), Gaps = 11/205 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHRN 683
           +   +   +G+G FG V+ G +    +VA+K      +G++  ++F AE  +++ ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQR 69

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFG 742
           LVR+ +  T +    ++ +YM  GSL   L +     L I K L++   IA  + ++   
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           +    +H D++ +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 803 QISTEGDVYSFGIMLMEIFTR-KRP 826
             + + DV+SFGI+L EI T  + P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  135 bits (343), Expect = 1e-35
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 17/209 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG-MEVAIKVFHLQLEGAL--ESFNAECEVLRSIRHR 682
               + + +G G +G VY G +    + VA+K      E  +  E F  E  V++ I+H 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYL-- 739
           NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   I+ A+EYL  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 740 -HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
            +F      +H D+   N L+ E+ + ++ DFG+++L++GD    H      I + APE 
Sbjct: 130 KNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183

Query: 799 GREGQISTEGDVYSFGIMLMEIFTR-KRP 826
               + S + DV++FG++L EI T    P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  135 bits (342), Expect = 2e-35
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 689 SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+     +      I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194

Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  135 bits (343), Expect = 3e-35
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K      E  L  F  E E+L+S++H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 689 SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
             C +   +   L+++Y+P GSL   L      +D  K L     I   +EYL       
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGREGQI 804
            +H D+   N+L++ +   ++GDFG+ K+L  D+          + I + APE   E + 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225

Query: 805 STEGDVYSFGIMLMEIFT 822
           S   DV+SFG++L E+FT
Sbjct: 226 SVASDVWSFGVVLYELFT 243

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (341), Expect = 3e-35
 Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 25/229 (10%)

Query: 630 VNNLIGSGSFGSVYRGR--FLDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNL 684
           + + +G G   +VY      L+ ++VAIK   +     E  L+ F  E      + H+N+
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           V +I     DD   LV++Y+   +L   +   +  L +   +N    I   +++    H 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKH---AHD 129

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPEYGRE 801
             +VH DIKP N+L+D +   ++ DFGIAK LS + S+  TQT   +G   Y +PE  + 
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSL--TQTNHVLGTVQYFSPEQAKG 186

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE----MSLKRWVNDSLP 846
                  D+YS GI+L E+   + P    F+GE    +++K  + DS+P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVP 230

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (342), Expect = 3e-35
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 13/206 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSI-RH 681
             F   + +G GS+G V++ R   DG   A+K       G  +      E      + +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
              VR+  +        L  +     SL+    +  ++L   +    + D  LAL +LH 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH- 174

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPEYGR 800
                +VH D+KP+N+ L      +LGDFG+   L    +    +       YMAPE   
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPEL-L 228

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
           +G   T  DV+S G+ ++E+      
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMEL 254

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (341), Expect = 5e-35
 Identities = 54/245 (22%), Positives = 90/245 (36%), Gaps = 32/245 (13%)

Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
            +     +G G F  V       DG   A+K      +   E    E ++ R   H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 686 RIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALEY 738
           R+++ C  +        L+L +  +G+L   +       +       L +++ I   LE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS------------GDESMKHTQ 786
           +H        H D+KP+N+LL ++    L D G                   D + +   
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC- 205

Query: 787 TLATIGYMAPE----YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
              TI Y APE          I    DV+S G +L  +   + P D +F    S+   V 
Sbjct: 206 ---TISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

Query: 843 DSLPI 847
           + L I
Sbjct: 262 NQLSI 266

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (342), Expect = 5e-35
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-----VAIKVFHL-QLEGALESFNAECEVLRSI 679
            +F    ++GSG+FG+VY+G ++   E     VAIK         A +    E  V+ S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
            + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 740 ---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT-IGYMA 795
                      VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA
Sbjct: 134 EDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            E       + + DV+S+G+ + E+ T   +P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  133 bits (338), Expect = 6e-35
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 20/214 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVF---HLQLEGALESFNAECEVLRS 678
               +   +G GSFG V RG +       + VA+K      L    A++ F  E   + S
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + HRNL+R+         K +V +  P GSL   L     +  +       + +A  + Y
Sbjct: 78  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 739 L---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGY 793
           L    F      +H D+   N+LL    + ++GDFG+ + L  ++     Q        +
Sbjct: 137 LESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            APE  +    S   D + FG+ L E+FT  + P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (337), Expect = 7e-35
 Identities = 50/213 (23%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEGALES----FNAECEVLR 677
           +   +N ++G G FG VY G + +     + VA+K      +         F +E  +++
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMK 68

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           ++ H ++V++I     +    ++++  P G L   L  + ++L +   +   + I  A+ 
Sbjct: 69  NLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 738 YL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           YL   +       VH DI   N+L+      +LGDFG+++ +  ++  K + T   I +M
Sbjct: 128 YLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
           +PE     + +T  DV+ F + + EI +  K+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  133 bits (336), Expect = 2e-34
 Identities = 58/211 (27%), Positives = 83/211 (39%), Gaps = 22/211 (10%)

Query: 633 LIGSGSFGSVYRGRFLD---GMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVR 686
           L+G G  G VY     D      VA+K+    L            E      ++  ++V 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           I      D    + +  +    L A L      L   + + IV  I  AL+  H      
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAG--- 154

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPEYGREGQ 803
             H D+KP N+L+  D  A L DFGIA   + DE +  TQ   T+G   YMAPE   E  
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKL--TQLGNTVGTLYYMAPERFSESH 211

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
            +   D+Y+   +L E  T   P    + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (335), Expect = 2e-34
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLV 685
           +G G FG V   R+       G +VA+K   L+       +     E E+LR++ H N+V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 686 RIISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +    CT D      L+++++P GSL+  L  + + +++ ++L   + I   ++YL    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGRE 801
               VH D+   NVL++ +   ++GDFG+ K +  D+     +      + + APE   +
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 802 GQISTEGDVYSFGIMLMEIFT 822
            +     DV+SFG+ L E+ T
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (336), Expect = 2e-34
 Identities = 51/323 (15%), Positives = 106/323 (32%), Gaps = 24/323 (7%)

Query: 225 IPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIG 284
           I     N    K   +  + +  +       S   ++  +K L L+GN  L  +  + + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQAL-----ASLRQSAWNVKELDLSGN-PLSQISAADLA 55

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
             +  +E   L +  +      ++ +L  L  + L  N +       L     ++ L   
Sbjct: 56  PFT-KLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAA 107

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--ST 402
           NN +  R+           ++YL +NK++       G  + ++ L    NE+  V     
Sbjct: 108 NNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSL 462
             +   +  ++L  N +   +  ++     L  L LS N L+  +         +  +SL
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 463 GDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
            +N L   I  ++    +LE  DL  N                +   V+   ++    + 
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQN 279

Query: 523 GTLANFTSESFMGNDLLCGSPHL 545
                  +    G       P  
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAP 302

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  131 bits (331), Expect = 9e-34
 Identities = 57/333 (17%), Positives = 120/333 (36%), Gaps = 28/333 (8%)

Query: 158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP 217
           N +  KI ++T+++L     +S+R +  N++   L+ N  S    + +   +KL +  L 
Sbjct: 8   NGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
            N     +     ++  L+ L+L  NY+            L     ++ L    N +   
Sbjct: 67  SNVLYETLD--LESLSTLRTLDLNNNYVQE----------LLVGPSIETLHAANNNISR- 113

Query: 278 VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG-SIPSTLSRLE 336
            +  S G      +  YL N  I      + G    +  + L  N+++  +     +  +
Sbjct: 114 -VSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 337 KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL 396
            L+ L L+ N +    +      A+L ++ L  NKL+  +   F + A +  +S  +N+L
Sbjct: 170 TLEHLNLQYNFIY--DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 397 TFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN 456
             +        N+   DL  N       L     K      +++  +   +         
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECT 284

Query: 457 LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN 489
           +  L          +P    D +    + L ++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRL----IALGHH 313

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  129 bits (327), Expect = 4e-33
 Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 17/280 (6%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSS 64
           L   + S   S  +++ LDLS N L     + +     LE+L+LS+N L  +    ++S+
Sbjct: 22  LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLST 81

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           L+ +DL++N +  EL        P ++ L  A N  +  +           +I L+ N +
Sbjct: 82  LRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKI 132

Query: 125 MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSIRLA 183
                 + G    +Q L L  N +  V  A L  +  TL+ L L  N +   +   +   
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--V 189

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
              L+   L++N  +  +     +A+ ++   L +N     I       +NL+  +L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 244 YITSSNHELSFIS--SLANSKKLKVLSLTGNPLLDCVLPS 281
                     F     +    K  V  LTG    +C +P+
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (320), Expect = 3e-32
 Identities = 58/335 (17%), Positives = 126/335 (37%), Gaps = 49/335 (14%)

Query: 33  IPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFV 90
           I     + N  +I  ++++ L  +      +  +++ +DLS N LS ++ A   +    +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 91  QFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVG 150
           + L+L+ N        ++ +L++L ++DL+ N++      E+    +++ L   +NN + 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETL-HAANNNIS 112

Query: 151 VVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASK 210
            V  +       K + L NN ++  +          ++   L  N               
Sbjct: 113 RVSCSRG--QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNE-------------- 155

Query: 211 LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT 270
             I  +              +   L+ LNL+YN+I         +       KLK L L+
Sbjct: 156 --IDTVNFAEL-------AASSDTLEHLNLQYNFIYD-------VKGQVVFAKLKTLDLS 199

Query: 271 GNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLN-GSIP 329
            N L    +     + +  +    L N  +   I K +    NL    L  N  + G++ 
Sbjct: 200 SNKLAF--MGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255

Query: 330 STLSRLEKLQILGLENNQLEGRILDDICRLARLSS 364
              S+ +++Q +  +  +      ++ C +  L  
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  123 bits (311), Expect = 4e-31
 Identities = 48/274 (17%), Positives = 100/274 (36%), Gaps = 22/274 (8%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSD 72
           + +  +   ++ + L   + S   S   ++ LDLS N LS          + L++++LS 
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI 132
           N L  E        L  ++ L L  N       +E+    S+ ++  + N++   +    
Sbjct: 68  NVLY-ETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVS--C 116

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL 192
              +  + + L +N +  +        S ++ L L  N +     + +  +   LE  +L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 193 ANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHEL 252
             N     +   +   +KL   +L  N  + F+   F +   +  ++L  N +       
Sbjct: 177 QYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV------ 227

Query: 253 SFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNL 286
               +L  S+ L+   L GN      L       
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (299), Expect = 1e-29
 Identities = 63/334 (18%), Positives = 117/334 (35%), Gaps = 47/334 (14%)

Query: 59  FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSID 118
             N +  ++  ++D+ L  +  A++                          +  ++  +D
Sbjct: 6   KQNGNRYKIEKVTDSSLK-QALASLRQ------------------------SAWNVKELD 40

Query: 119 LSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS 178
           LS N L      ++     L+ L L SN L   +   L ++STL+ L L NN +   +  
Sbjct: 41  LSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV 97

Query: 179 SIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL 238
                 P++E    ANNN S ++              L +N  +            ++ L
Sbjct: 98  -----GPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 239 NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNC 298
           +L+ N I +    ++F    A+S  L+ L+L  N + D  +   +    L  +   L + 
Sbjct: 150 DLKLNEIDT----VNFAELAASSDTLEHLNLQYNFIYD--VKGQVVFAKL--KTLDLSSN 201

Query: 299 NIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDD-IC 357
            +   +  E  +   +  I L  NKL   I   L   + L+   L  N      L D   
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259

Query: 358 RLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF 391
           +  R+ +V     K           + +L     
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (297), Expect = 3e-29
 Identities = 48/263 (18%), Positives = 93/263 (35%), Gaps = 31/263 (11%)

Query: 303 SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
           +I +   N     I ++  + L  ++ S       ++ L L  N L      D+    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--------------------ST 402
             + L  N L         +L++LR L   +N +  +                     S 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR 118

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG-DIPTTIGGLKNLQNLS 461
                NI    L++N ++    L+ G    +  L L  N +   +          L++L+
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR 521
           L  N +   +   +     L+ LDLS+N L+  +    +    + ++++  N+L   I +
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 522 G-GTLANFTSESFMGNDLLCGSP 543
                 N       GN   CG+ 
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTL 254

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (336), Expect = 2e-34
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 26/232 (11%)

Query: 609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEG 664
           P  A R F+  E+     + ++  +IGSG  G V  GR        + VAIK       G
Sbjct: 35  PGRAGRSFTR-EI--EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AG 88

Query: 665 ALES----FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNL 720
             E     F +E  ++    H N++R+    T      +V +YM  GSL+  L + +   
Sbjct: 89  YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF 148

Query: 721 DIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS 777
            I + + ++  +   + YL    +      VH D+   NVL+D ++V ++ DFG++++L 
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202

Query: 778 GDESMKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            D    +T T     I + APE       S+  DV+SFG+++ E+    +RP
Sbjct: 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (334), Expect = 2e-34
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 632 NLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
            +IG G FG VY G ++D     ++ AIK             +E+F  E  ++R + H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83

Query: 684 LVRIISSCTNDD-FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL--- 739
           ++ +I      +    ++L YM  G L   + S   N  +   ++  + +A  +EYL   
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATIGYMAP 796
            F      VH D+   N +LDE    ++ DFG+A+ +   E     +H      + + A 
Sbjct: 144 KF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTR 823
           E  +  + +T+ DV+SFG++L E+ TR
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTR 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  133 bits (336), Expect = 3e-34
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 634 IGSGSFGSVYRGRFL-----DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +G G+FGSV   R+       G  VA+K            F  E ++L+++    +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 689 SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFGH 743
                   ++  LV++Y+P G L   L    + LD  + L     I   +EYL       
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC-- 148

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGRE 801
               VH D+   N+L++ +   ++ DFG+AKLL  D+   +      + I + APE   +
Sbjct: 149 ----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204

Query: 802 GQISTEGDVYSFGIMLMEIFT 822
              S + DV+SFG++L E+FT
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (333), Expect = 3e-34
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 634 IGSGSFGSVYRGRFLDG---MEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G G+FGSV +G +      ++VAIKV      +   E    E +++  + +  +VR+I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPNP 746
            C  +    LV++    G L   L      + +     ++  +++ ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQI 804
            VH D+   NVLL     A++ DFG++K L  D+S    ++     + + APE     + 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 805 STEGDVYSFGIMLMEIFTR-KRP 826
           S+  DV+S+G+ + E  +  ++P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (333), Expect = 3e-34
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)

Query: 634 IGSGSFGSVYRGRFLDG---MEVAIKVFH--LQLEGALESFNAECEVLRSIRHRNLVRII 688
           +GSG+FG+V +G +        VA+K+           +   AE  V++ + +  +VR+I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPN 745
             C  + +  LV++    G L   L   N ++     + +V  +++ ++YL   +F    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQ 803
             VH D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196

Query: 804 ISTEGDVYSFGIMLMEIFTR-KRP 826
            S++ DV+SFG+++ E F+  ++P
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  138 bits (348), Expect = 5e-34
 Identities = 79/427 (18%), Positives = 143/427 (33%), Gaps = 105/427 (24%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           +   V+++ ++ L+  LP  + +++     L +  N     LP     L +L   ++S N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCLPAHI---TTLVIPDNNLT-SLPALPPELRTL---EVSGN 91

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
            L   +P     L  L        +L  +        S L  L +  N L+     S+ +
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-----SLPV 138

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
             P L+  S+++N  +  +P+                               L +L    
Sbjct: 139 LPPGLQELSVSDNQLA-SLPALPSE---------------------------LCKLWAYN 170

Query: 243 NYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRG 302
           N +TS     S          L+ LS++ N L    LP+    L     + + +N  +  
Sbjct: 171 NQLTSLPMLPS---------GLQELSVSDNQL--ASLPTLPSEL----YKLWAYNNRLT- 214

Query: 303 SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
           S+P     L  LI   +  N+L  S+P   S L++L                        
Sbjct: 215 SLPALPSGLKELI---VSGNRLT-SLPVLPSELKEL------------------------ 246

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGS 422
               +  N+L+ S+P     L     LS   N+LT +P +  +L++   V+L  NPLS  
Sbjct: 247 ---MVSGNRLT-SLPMLPSGL---LSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS-E 298

Query: 423 LPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLE 482
             L+          Y            +        +L+  D  +    P   G+    +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLV----PAREGEPAPAD 354

Query: 483 CLDLSNN 489
              +   
Sbjct: 355 RWHMFGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  132 bits (334), Expect = 3e-32
 Identities = 84/423 (19%), Positives = 144/423 (34%), Gaps = 101/423 (23%)

Query: 111 LTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNN 170
                 +++ E+ L   +P  +    ++  L +  NNL   +PA       L+ L+++ N
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPA---LPPELRTLEVSGN 91

Query: 171 TLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFH 230
            L+ S+       L  L +FS    +                   LP             
Sbjct: 92  QLT-SLPVLPP-GLLELSIFSNPLTHLP----------------ALPSG----------- 122

Query: 231 NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSM 290
               L +L +  N +TS                L+ LS++ N L    LP+    L    
Sbjct: 123 ----LCKLWIFGNQLTSLPVLPP---------GLQELSVSDNQLAS--LPALPSEL---- 163

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG 350
            + + +N  +  S+P     L  L    +  N+L  S+P+  S L KL      NN+L  
Sbjct: 164 CKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAY---NNRLT- 214

Query: 351 RILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNIL 410
                                   S+PA     + L++L  + N LT +P     L  + 
Sbjct: 215 ------------------------SLPA---LPSGLKELIVSGNRLTSLPVLPSELKEL- 246

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
              +S N L+ SLP+    L     L + RN L+  +P ++  L +   ++L  N L   
Sbjct: 247 --MVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299

Query: 471 IPNSIGDLISLECLDLSNNILSGIIPS--SLEKLLYLKYLNVSFNRLEGEIPRGGTLANF 528
              ++ ++ S                S     + L+L   +      EGE         F
Sbjct: 300 TLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMF 359

Query: 529 TSE 531
             E
Sbjct: 360 GQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (332), Expect = 4e-32
 Identities = 85/495 (17%), Positives = 155/495 (31%), Gaps = 84/495 (16%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRL 75
            +    L++  + L  T+P  +     +  L + +N L+ S P      L+ +++S N+L
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPA-LPPELRTLEVSGNQL 93

Query: 76  SGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNL 135
           +                           LP     L  L+       HL    P     L
Sbjct: 94  T--------------------------SLPVLPPGLLELSIFSNPLTHL----PALPSGL 123

Query: 136 RNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANN 195
             L     +  N +  +P        L+ L +++N L     +S+      L      NN
Sbjct: 124 CKLW----IFGNQLTSLPVLPPG---LQELSVSDNQL-----ASLPALPSELCKLWAYNN 171

Query: 196 NFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFI 255
             +  +P       +LS   + DN  +  +P     +  L   N   N +TS     S  
Sbjct: 172 QLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSELYKLWAYN---NRLTSLPALPS-- 221

Query: 256 SSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLI 315
                   LK L ++GN L    LP     L    +   +    +  S+P     L++L 
Sbjct: 222 -------GLKELIVSGNRL--TSLPVLPSEL----KELMVSGNRLT-SLPMLPSGLLSL- 266

Query: 316 IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGS 375
              +  N+L   +P +L  L     + LE N L  R L  +     ++S       +   
Sbjct: 267 --SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR---EITSAPGYSGPIIRF 320

Query: 376 IPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVE 435
             A        R L  A+ +                        + +  L +  L     
Sbjct: 321 DMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETEN 380

Query: 436 LYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL-----ECLDLSNNI 490
            ++        I + +  L   + L      +     +S  D ++      + + L +N 
Sbjct: 381 -FIKDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNA 439

Query: 491 LSGIIPSSLEKLLYL 505
             G   + L  L+  
Sbjct: 440 EKGQYDNDLAALVAT 454

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  114 bits (287), Expect = 1e-26
 Identities = 70/382 (18%), Positives = 122/382 (31%), Gaps = 56/382 (14%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR 74
               L+ L++S NQ L ++P     +  L I       L         S L  + +  N+
Sbjct: 79  LPPELRTLEVSGNQ-LTSLPVLPPGLLELSIFSNPLTHLPALP-----SGLCKLWIFGNQ 132

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGN 134
           L+  LP         +Q LS++ NQ A  LP     L  L       N L   +P     
Sbjct: 133 LT-SLPVLPPG----LQELSVSDNQLA-SLPALPSELCKL---WAYNNQL-TSLPMLPSG 182

Query: 135 LRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN 194
           L+ L     +S+N +  +P     +  L        +L    S         L+   ++ 
Sbjct: 183 LQELS----VSDNQLASLPTLPSELYKLWAYNNRLTSLPALPS--------GLKELIVSG 230

Query: 195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSF 254
           N  +  +P      S+L    +  N  +  +P        L  L++  N +T        
Sbjct: 231 NRLTS-LPVLP---SELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT------RL 276

Query: 255 ISSLANSKKLKVLSLTGNPL--LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI 312
             SL +      ++L GNPL          I +           +     S P+E   L 
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG-ASAPRETRALH 335

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKL 372
                    + L  +     +  ++  + G E+N                +  ++     
Sbjct: 336 LAA-----ADWLVPAREGEPAPADRWHMFGQEDNADA---FSLFLDRLSETENFIKDAGF 387

Query: 373 SGSIPACFGNLA---SLRKLSF 391
              I +    LA   +LR  +F
Sbjct: 388 KAQISSWLAQLAEDEALRANTF 409

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 92.3 bits (229), Expect = 2e-19
 Identities = 47/228 (20%), Positives = 79/228 (34%), Gaps = 23/228 (10%)

Query: 14  GSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDN 73
              S L  L    NQ L ++P        L+ L +S+NQL+ S P    S L  +   +N
Sbjct: 158 ALPSELCKLWAYNNQ-LTSLPMLPSG---LQELSVSDNQLA-SLP-TLPSELYKLWAYNN 211

Query: 74  RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIG 133
           RL+  LPA        ++ L ++ N+    LP     L  L    +S N L   +P    
Sbjct: 212 RLT-SLPALPSG----LKELIVSGNRL-TSLPVLPSELKEL---MVSGNRLT-SLPMLPS 261

Query: 134 NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLA 193
            L +L     +  N +  +P +L ++S+   + L  N LS   +      + +   +S  
Sbjct: 262 GLLSLS----VYRNQLTRLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGP 316

Query: 194 NNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
              F     S        ++     +                     E
Sbjct: 317 IIRFDMAGAS--APRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 91.1 bits (226), Expect = 4e-19
 Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 22/161 (13%)

Query: 356 ICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLS 415
            C     + + +  + L+ ++P C      +  L    N LT +P+    L  +   ++S
Sbjct: 36  ACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTSLPALPPELRTL---EVS 89

Query: 416 SNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI 475
            N L+ SLP+    L  L        +L             L  L +  N L  S+P   
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLP 140

Query: 476 GDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
                L+ L +S+N L+  +P+   +   L  L    N+L 
Sbjct: 141 P---GLQELSVSDNQLAS-LPALPSE---LCKLWAYNNQLT 174

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (334), Expect = 5e-34
 Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 27/207 (13%)

Query: 632 NLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISS 690
             +G GSFG V+R +    G + A+K   ++LE        E      +    +V +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVK--KVRLEVFRVE---ELVACAGLSSPRIVPLYGA 118

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------NIVIDIALALEYLHFGHP 744
                +  + ++ +  GSL   +            L        +      LEYLH    
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQ-------MGCLPEDRALYYLGQALEGLEYLHT--- 168

Query: 745 NPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLAT-IG---YMAPEYG 799
             ++H D+K  NVLL  D   A L DFG A  L  D   K   T     G   +MAPE  
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRP 826
                  + D++S   M++ +     P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (333), Expect = 5e-34
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 30/220 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEGA----LESFNAECEVLR 677
           +   +  ++G G FGSV  G         ++VA+K   ++L+ +    +E F +E   ++
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMK 91

Query: 678 SIRHRNLVRIISSCTNDDFKA-----LVLDYMPKGSL-----EACLYSDNSNLDIFKRLN 727
              H N++R++  C     +      ++L +M  G L      + L +   ++ +   L 
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151

Query: 728 IVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMK 783
            ++DIAL +EYL   +F      +H D+   N +L +DM   + DFG++K + SGD   +
Sbjct: 152 FMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205

Query: 784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
                  + ++A E   +   +++ DV++FG+ + EI TR
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (329), Expect = 8e-34
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 634 IGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRNLV 685
           IG G FG V++G ++      + VAIK              E F  E   +R   H ++V
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFG 742
           ++I   T +    ++++    G L + L     +LD+   +     ++ AL YL    F 
Sbjct: 80  KLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF- 137

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
                VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE     
Sbjct: 138 -----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 803 QISTEGDVYSFGIMLMEIFTR-KRP 826
           + ++  DV+ FG+ + EI     +P
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  131 bits (332), Expect = 8e-34
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-----VAIKVFHLQL-EGALESFNAECEVLRSI 679
            +     ++GSG FG+V++G ++   E     V IKV   +    + ++       + S+
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
            H ++VR++  C     + LV  Y+P GSL   +      L     LN  + IA  + YL
Sbjct: 73  DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 740 ---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMA 795
                      VH ++   NVLL      ++ DFG+A LL  D+  + +++    I +MA
Sbjct: 132 EEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            E    G+ + + DV+S+G+ + E+ T    P
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (330), Expect = 1e-33
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 30/224 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
             F     +G G FG V+  +  +D    AIK   L   E A E    E + L  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 684 LVRIISSCTNDDFKA------------LVLDYMPKGSLEACLYSDNSNLDIFKR--LNIV 729
           +VR  ++    +               + +    K +L+  +    +  +  +   L+I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA 789
           + IA A+E+LH      ++H D+KPSN+    D V ++GDFG+   +  DE  +   T  
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 790 TIG-----------YMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
                         YM+PE       S + D++S G++L E+  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  130 bits (329), Expect = 2e-33
 Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 22/239 (9%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNL 684
            +++   IGSG    V++         AIK  +L+      L+S+  E   L  ++  + 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 685 --VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
             +R+      D +  +V++      L + L     ++D ++R +   ++  A+  +H  
Sbjct: 89  KIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ- 145

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPE---- 797
             + +VH D+KP+N L+ + M+ +L DFGIA  +  D +     +   T+ YM PE    
Sbjct: 146 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 798 -------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
                     + +IS + DV+S G +L  +   K P  +I +    L   ++ +  I  
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  130 bits (329), Expect = 2e-33
 Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 27/219 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFH--LQLEGALESFNAECEVLRSI 679
            QF +  ++G G FGSV   +        ++VA+K+    +     +E F  E   ++  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 680 RHRNLVRIISSCTNDDFKA------LVLDYMPKGSL-----EACLYSDNSNLDIFKRLNI 728
            H ++ +++        K       ++L +M  G L      + +  +  NL +   +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 729 VIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKH 784
           ++DIA  +EYL   +F      +H D+   N +L EDM   + DFG+++ + SGD   + 
Sbjct: 143 MVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196

Query: 785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
             +   + ++A E   +   +   DV++FG+ + EI TR
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  129 bits (327), Expect = 2e-33
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 34/232 (14%)

Query: 620 ELLQATDQF---------NVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEGA- 665
           EL+QA             + N +IG G FG VY G  LD     +  A+K  +       
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITD 66

Query: 666 ---LESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLD 721
              +  F  E  +++   H N++ ++  C   +   L VL YM  G L   + ++  N  
Sbjct: 67  IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 126

Query: 722 IFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG 778
           +   +   + +A  ++YL    F      VH D+   N +LDE    ++ DFG+A+ +  
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYD 180

Query: 779 DE---SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            E       T     + +MA E  +  + +T+ DV+SFG++L E+ TR   P
Sbjct: 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (328), Expect = 3e-33
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGME-----VAIKVFHL-QLEGALESFNAECEVLRSI 679
            +F    ++GSG+FG+VY+G ++   E     VAIK         A +    E  V+ S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
            + ++ R++  C     + L+   MP G L   +     N+     LN  + IA  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 740 ---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT-IGYMA 795
                      VH D+   NVL+      ++ DFG+AKLL  +E   H +     I +MA
Sbjct: 134 EDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
            E       + + DV+S+G+ + E+ T   +P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (329), Expect = 3e-33
 Identities = 58/233 (24%), Positives = 109/233 (46%), Gaps = 27/233 (11%)

Query: 609 PLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDG-----MEVAIKVFHLQLE 663
           P  A  +F+  E+           +IG+G FG VY+G          + VAIK       
Sbjct: 30  PNQAVLKFTT-EI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---A 83

Query: 664 GALES----FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN 719
           G  E     F  E  ++    H N++R+    +      ++ +YM  G+L+  L   +  
Sbjct: 84  GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 143

Query: 720 LDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL 776
             + + + ++  IA  ++YL   ++      VH D+   N+L++ ++V ++ DFG++++L
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVL 197

Query: 777 SGDESMKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
             D    +T +     I + APE     + ++  DV+SFGI++ E+ T  +RP
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (341), Expect = 3e-33
 Identities = 50/203 (24%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 634 IGSGSFGSVYRGRFLDG---MEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNLVRIIS 689
           +G G+FGSV +G +      ++VAIKV      +   E    E +++  + +  +VR+I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPNP 746
            C  +    LV++    G L   L      + +     ++  +++ ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT--IGYMAPEYGREGQI 804
            VH ++   NVLL     A++ DFG++K L  D+S    ++     + + APE     + 
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 805 STEGDVYSFGIMLMEIFTR-KRP 826
           S+  DV+S+G+ + E  +  ++P
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (329), Expect = 3e-33
 Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 22/239 (9%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNL 684
            +++   IGSG    V++         AIK  +L+      L+S+  E   L  ++  + 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 685 --VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
             +R+      D +  +V++      L + L     ++D ++R +   ++  A+  +H  
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ- 126

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPE---- 797
             + +VH D+KP+N L+ + M+ +L DFGIA  +  D +     +   T+ YM PE    
Sbjct: 127 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 798 -------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
                     + +IS + DV+S G +L  +   K P  +I +    L   ++ +  I  
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (334), Expect = 5e-33
 Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
            +  +   IG G FG V  G +  G +VA+K   ++ +   ++F AE  V+  +RH NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 249

Query: 686 RIISSCTNDDFKA-LVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGH 743
           +++     +     +V +YM KGSL   L S   S L     L   +D+  A+EYL   +
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
               VH D+   NVL+ ED VA++ DFG    L+ + S         + + APE  RE +
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKK 362

Query: 804 ISTEGDVYSFGIMLMEIFT 822
            ST+ DV+SFGI+L EI++
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  131 bits (330), Expect = 6e-33
 Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 22/239 (9%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNL 684
            +++   IGSG    V++         AIK  +L+      L+S+  E   L  ++  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 685 --VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
             +R+      D +  +V++      L + L    S +D ++R +   ++  A+  +   
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI--- 171

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPE---- 797
           H + +VH D+KP+N L+ + M+ +L DFGIA  +  D +     +    + YM PE    
Sbjct: 172 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 798 -------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
                     + +IS + DV+S G +L  +   K P  +I +    L   ++ +  I  
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  130 bits (328), Expect = 8e-33
 Identities = 58/233 (24%), Positives = 109/233 (46%), Gaps = 26/233 (11%)

Query: 608 MPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQLE 663
            P      F+ +EL       +++ ++G+G FG V  GR        + VAIK       
Sbjct: 30  DPTQTVHEFA-KEL--DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---V 83

Query: 664 GALES----FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN 719
           G  E     F  E  ++    H N++R+    T      +V +YM  GSL++ L   ++ 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 720 LDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL 776
             + + + ++  IA  ++YL    +      VH D+   N+L++ ++V ++ DFG+ ++L
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVL 197

Query: 777 SGDESMKHTQTLAT--IGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
             D    +T       I + +PE     + ++  DV+S+GI+L E+ +  +RP
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (322), Expect = 1e-32
 Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 39/255 (15%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
              F    ++G G+FG V + R  LD    AIK      E  L +  +E  +L S+ H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63

Query: 684 LVRIISSCTNDDFKA-------------LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI 730
           +VR  ++                     + ++Y   G+L   ++S+N N    +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
            I  AL Y+H      ++H D+KP N+ +DE    ++GDFG+AK +     +    +   
Sbjct: 124 QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 791 IG-------------YMAPE-YGREGQISTEGDVYSFGIMLMEI-------FTRKRPTDE 829
            G             Y+A E     G  + + D+YS GI+  E+         R     +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240

Query: 830 IFSGEMSLKRWVNDS 844
           + S  +      +D+
Sbjct: 241 LRSVSIEFPPDFDDN 255

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 1e-32
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 19/201 (9%)

Query: 634 IGSGSFGSVYRGRFLD-----GMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLV 685
           +G G FG V    +       G  VA+K   L+          +  E ++LR++ H +++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 686 RIISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +    C +    +  LV++Y+P GSL   L     ++ + + L     I   + YLH  H
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQH 154

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGRE 801
               +H D+   NVLLD D + ++GDFG+AK +              + + + APE  +E
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 802 GQISTEGDVYSFGIMLMEIFT 822
            +     DV+SFG+ L E+ T
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (322), Expect = 1e-32
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 22/217 (10%)

Query: 630 VNNLIGSGSFGSVYRGR--FLDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNL 684
           +  ++G G    V+  R       +VA+KV    L         F  E +   ++ H  +
Sbjct: 16  LGEILGFGGMSEVHLARDLRDH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 685 VRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           V +  +   +        +V++Y+   +L   +      +   + + ++ D   AL +  
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNF-- 131

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG---YMAPE 797
             H N ++H D+KP+N+++      ++ DFGIA+ ++ D     TQT A IG   Y++PE
Sbjct: 132 -SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPE 189

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
             R   +    DVYS G +L E+ T + P    F+G+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  127 bits (322), Expect = 2e-32
 Identities = 64/289 (22%), Positives = 119/289 (41%), Gaps = 33/289 (11%)

Query: 216 LPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL- 274
           L +N  +      F N++NL  L L  N I+  +       + A   KL+ L L+ N L 
Sbjct: 59  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----AFAPLVKLERLYLSKNQLK 113

Query: 275 -LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSI--PS 330
            L   +P ++  L        +H   I   + K +   L  +I++ LG N L  S     
Sbjct: 114 ELPEKMPKTLQEL-------RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 331 TLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKL 389
               ++KL  + + +  +   I   +     L+ ++LD NK++  + A     L +L KL
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221

Query: 390 SFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG--- 445
             + N ++ V + +  N  ++  + L++N L   +P  + + K +  +YL  NN+S    
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280

Query: 446 ---DIPTTIGGLKNLQNLSLGDNNLQGSI--PNSIGDLISLECLDLSNN 489
                P       +   +SL  N +Q     P++   +     + L N 
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  120 bits (304), Expect = 4e-30
 Identities = 58/274 (21%), Positives = 105/274 (38%), Gaps = 18/274 (6%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDN 73
                LDL  N+ +  I    F  +  L  L L NN++S   P  F  +  L+ + LS N
Sbjct: 52  PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110

Query: 74  RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL-MGEIPHEI 132
           +L  ELP  +   L   Q L +  N+           L  +  ++L  N L    I +  
Sbjct: 111 QLK-ELPEKMPKTL---QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166

Query: 133 -GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFS 191
              ++ L  + +   N+   +P  L    +L  L L  N ++  + ++    L NL    
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLG 222

Query: 192 LANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS-SN 249
           L+ N+ S  + +    N   L    L +N     +P    + + ++ + L  N I++  +
Sbjct: 223 LSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280

Query: 250 HELSFISSLANSKKLKVLSLTGNPLLDCVLPSSI 283
           ++               +SL  NP+    +  S 
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  119 bits (301), Expect = 1e-29
 Identities = 71/361 (19%), Positives = 117/361 (32%), Gaps = 71/361 (19%)

Query: 113 SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL 172
            L  +  S+  L  ++P ++    +   L L +N +  +      N+  L  L L NN +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
           S  IS      L  LE   L+ N                   ELP+              
Sbjct: 89  S-KISPGAFAPLVKLERLYLSKNQLK----------------ELPEKMP----------- 120

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
           + L+EL +  N IT         S      ++ V+ L  NPL    + +           
Sbjct: 121 KTLQELRVHENEITKVRK-----SVFNGLNQMIVVELGTNPLKSSGIENGA--------- 166

Query: 293 FYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
                             +  L  IR+    +  +IP  L     L  L L+ N++    
Sbjct: 167 ---------------FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 208

Query: 353 LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV 412
              +  L  L+ + L  N +S        N   LR+L   +N+L  VP    +   I +V
Sbjct: 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 268

Query: 413 DLSSNPLSG------SLPLEIGNLKVLVELYLSRNNLSGDI--PTTIGGLKNLQNLSLGD 464
            L +N +S         P           + L  N +      P+T   +     + LG+
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328

Query: 465 N 465
            
Sbjct: 329 Y 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  115 bits (290), Expect = 3e-28
 Identities = 73/364 (20%), Positives = 128/364 (35%), Gaps = 76/364 (20%)

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH 123
            L+V+  SD  L  ++P ++    P    L L  N+       +  NL +L ++ L  N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87

Query: 124 LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
           +    P     L  L+ L  LS N +  +P  +    TL+ L++  N ++  +  S+   
Sbjct: 88  ISKISPGAFAPLVKLERL-YLSKNQLKELPEKMP--KTLQELRVHENEIT-KVRKSVFNG 143

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           L  + +  L  N               L    + + +F G        M+ L  + +   
Sbjct: 144 LNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSYIRIADT 181

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
            IT+                           +   LP S+  L       +L    I   
Sbjct: 182 NITT---------------------------IPQGLPPSLTEL-------HLDGNKIT-K 206

Query: 304 IPKEM-GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
           +       L NL  + L +N ++     +L+    L+ L L NN+L  ++   +     +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 363 SSVYLDHNKLSG------SIPACFGNLASLRKLSFASNELTFV---PSTFWNLTNILMVD 413
             VYL +N +S         P      AS   +S  SN + +    PSTF  +     V 
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325

Query: 414 LSSN 417
           L + 
Sbjct: 326 LGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (286), Expect = 1e-27
 Identities = 54/266 (20%), Positives = 99/266 (37%), Gaps = 20/266 (7%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
           +L        L N  I      +  NL NL  + L  NK++   P   + L KL+ L L 
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV---PS 401
            NQL+  + + +     L  + +  N+++    + F  L  +  +   +N L        
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS 461
            F  +  +  + ++   ++ ++P   G    L EL+L  N ++     ++ GL NL  L 
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR 521
           L  N++      S+ +   L  L L+NN L   +P  L    Y++ + +  N +      
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS----- 276

Query: 522 GGTLANFTSESFMGNDLLCGSPHLQV 547
                   S  F              
Sbjct: 277 -----AIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  109 bits (275), Expect = 3e-26
 Identities = 58/271 (21%), Positives = 105/271 (38%), Gaps = 23/271 (8%)

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNK 323
             +L L  N  +  +      NL  ++    L N  I    P     L+ L  + L  N+
Sbjct: 54  TALLDLQNN-KITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDI-CRLARLSSVYLDHNKLSGSI--PACF 380
           L   +P  +   + LQ L +  N++  ++   +   L ++  V L  N L  S      F
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 381 GNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYL 438
             +  L  +  A   +T +P     +LT +    L  N ++  +       L  L +L L
Sbjct: 168 QGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKIT-KVDAASLKGLNNLAKLGL 223

Query: 439 SRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI---- 494
           S N++S     ++    +L+ L L +N L   +P  + D   ++ + L NN +S I    
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282

Query: 495 --IPSSLEKLLYLKYLNVSFNRLE-GEIPRG 522
              P    K      +++  N ++  EI   
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 36/195 (18%), Positives = 78/195 (40%), Gaps = 12/195 (6%)

Query: 10  PSQLGSLSSLQYLDLSFNQL-LGTIPSSIFS-INTLEILDLSNNQLSGSFPFFNMSSLQV 67
            S    L+ +  ++L  N L    I +  F  +  L  + +++  ++ + P     SL  
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTE 196

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE 127
           + L  N+++ ++ A     L  +  L L+FN  +      + N   L  + L+ N L+ +
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 254

Query: 128 IPHEIGNLRNLQALGLLSNNLVGV------VPATLFNISTLKILQLTNNTLS-GSISSSI 180
           +P  + + + +Q + L +NN+  +       P      ++   + L +N +    I  S 
Sbjct: 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314

Query: 181 RLALPNLELFSLANN 195
              +       L N 
Sbjct: 315 FRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 32/146 (21%), Positives = 56/146 (38%), Gaps = 5/146 (3%)

Query: 385 SLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLS 444
            LR +  +   L  VP       +  ++DL +N ++     +  NLK L  L L  N +S
Sbjct: 32  HLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 445 GDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY 504
              P     L  L+ L L  N L+  +P  +    +L+ L +  N ++ +  S    L  
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146

Query: 505 LKYLNVSFNRLEGEIPRGGTLANFTS 530
           +  + +  N L+      G       
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKK 172

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 13/78 (16%), Positives = 24/78 (30%), Gaps = 12/78 (15%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-------LEILDLSNNQLSGSF--- 57
            VP  L     +Q + L  N  +  I S+ F              + L +N +       
Sbjct: 254 KVPGGLADHKYIQVVYLHNNN-ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312

Query: 58  -PFFNMSSLQVIDLSDNR 74
             F  +     + L + +
Sbjct: 313 STFRCVYVRAAVQLGNYK 330

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (324), Expect = 2e-32
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 632 NLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQLEGA----LESFNAECEVLRSIRHRN 683
            +IG G FG VY G  LD     +  A+K  +          +  F  E  +++   H N
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 684 LVRIISSCTNDDFKAL-VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL--- 739
           ++ ++  C   +   L VL YM  G L   + ++  N  +   +   + +A  +++L   
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM---KHTQTLATIGYMAP 796
            F      VH D+   N +LDE    ++ DFG+A+ +   E       T     + +MA 
Sbjct: 212 KF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
           E  +  + +T+ DV+SFG++L E+ TR   P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (317), Expect = 3e-32
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA-LESFNAECEVLRSIRHRNL 684
            +  +   IG G FG V  G    G +VA+K        A  ++F AE  V+  +RH NL
Sbjct: 21  KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNL 76

Query: 685 VRIISSCTNDDFKA-LVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYL--- 739
           V+++     +     +V +YM KGSL   L S   S L     L   +D+  A+EYL   
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
           +F      VH D+   NVL+ ED VA++ DFG    L+ + S         + + APE  
Sbjct: 137 NF------VHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL 186

Query: 800 REGQISTEGDVYSFGIMLMEIFT 822
           RE + ST+ DV+SFGI+L EI++
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYS 209

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (317), Expect = 4e-32
 Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 36/224 (16%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF--------LDGMEVAIKVFHLQLEGALESFNAECEVLR 677
           +    N  +G G+F  +++G          L   EV +KV         ESF     ++ 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
            + H++LV     C   D   LV +++  GSL+  L  + + ++I  +L +   +A A+ 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 738 YL---HFGHPNPVVHCDIKPSNVLLD--------EDMVARLGDFGIAKLLSGDESMKHTQ 786
           +L           +H ++   N+LL              +L D GI+  +   + ++   
Sbjct: 128 FLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ--- 178

Query: 787 TLATIGYMAPE---YGREGQISTEGDVYSFGIMLMEIFTR-KRP 826
               I ++ PE     +   ++   D +SFG  L EI +   +P
Sbjct: 179 --ERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  131 bits (332), Expect = 6e-32
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 15/197 (7%)

Query: 634 IGSGSFGSVYRGRFLDG----MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRII 688
           IG G FG V++G ++      M VAIK       +   E F  E   +R   H ++V++I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 689 SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPN 745
              T +    ++++    G L + L     +LD+   +     ++ AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
             VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE     + +
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 806 TEGDVYSFGIMLMEIFT 822
           +  DV+ FG+ + EI  
Sbjct: 571 SASDVWMFGVCMWEILM 587

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (311), Expect = 2e-31
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALESFNA--ECEVLRSI-R 680
           T +F+    IGSG FGSV++    LDG   AIK     L G+++  NA  E      + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALE 737
           H ++VR  S+   DD   +  +Y   GSL   +  +   +  FK     ++++ +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDED-------------------MVARLGDFGIAKLLSG 778
           Y+H      +VH DIKPSN+ +                      ++ ++GD G    +S 
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 779 DESMKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRP 826
            +  +         ++A E  +E      + D+++  + ++     +  
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  122 bits (309), Expect = 1e-30
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 32/221 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALES----FNAECEV 675
           ++  ++  +G GSFG VY G             VAIK  +   E A       F  E  V
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 81

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL---------EACLYSDNSNLDIFKRL 726
           ++     ++VR++   +      ++++ M +G L                 +   + K +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 727 NIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESM 782
            +  +IA  + YL    F      VH D+   N ++ ED   ++GDFG+ + +   D   
Sbjct: 142 QMAGEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195

Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR 823
           K  + L  + +M+PE  ++G  +T  DV+SFG++L EI T 
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  123 bits (310), Expect = 1e-30
 Identities = 59/284 (20%), Positives = 114/284 (40%), Gaps = 27/284 (9%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMS 63
           ++PS  G   +++ LDLS N+ +  I +S       L+ L L++N ++ +     F ++ 
Sbjct: 45  SIPS--GLTEAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
           SL+ +DLS N LS  L ++ F  L  + FL+L  N +       +  +LT L  + +   
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159

Query: 123 HLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
               +I  +    L  L+ L + +++L    P +L +I  +  L L        +     
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFV 218

Query: 182 LALPNLELFSLANNNFSG----KIPSFIFNA----SKLSICELPDNSFSGFIPNRFHNMR 233
               ++E   L + +       ++ +   N+          ++ D S    +    + + 
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQIS 277

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
            L EL    N + S    +           L+ + L  NP  DC
Sbjct: 278 GLLELEFSRNQLKSVPDGI-----FDRLTSLQKIWLHTNP-WDC 315

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  105 bits (265), Expect = 7e-25
 Identities = 57/289 (19%), Positives = 109/289 (37%), Gaps = 17/289 (5%)

Query: 45  ILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHL 104
           I   S+  L+ S P     +++ +DLS+NR++  +  +       +Q L L  N     +
Sbjct: 35  ICKGSSGSLN-SIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TI 91

Query: 105 PREI-GNLTSLTSIDLSENHLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLF-NIST 161
             +   +L SL  +DLS N+L   +       L +L  L LL N    +   +LF +++ 
Sbjct: 92  EEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150

Query: 162 LKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF-NASKLSICELPDNS 220
           L+IL++ N      I       L  LE   +  ++           +   +S   L    
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQ 209

Query: 221 FSGFIPNRFHNMRNLKELNLEYNYITSSNH-ELSFIS--SLANSKKLKVLSLTGNPLLDC 277
               +        +++ L L    + + +  ELS     SL      + + +T   L   
Sbjct: 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ- 268

Query: 278 VLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLN 325
            +   +  +S  +         ++ S+P  +   L +L  I L  N  +
Sbjct: 269 -VMKLLNQIS-GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 53/293 (18%), Positives = 102/293 (34%), Gaps = 47/293 (16%)

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERF 293
            +K L+L  N IT  ++     S L     L+ L LT N +      ++I   S S    
Sbjct: 53  AVKSLDLSNNRITYISN-----SDLQRCVNLQALVLTSNGI------NTIEEDSFS---- 97

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQLEGRI 352
                           +L +L  + L YN L  ++ S     L  L  L L  N  +  +
Sbjct: 98  ----------------SLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TL 139

Query: 353 LDDIC--RLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTN 408
            +      L +L  + + +      I    F  L  L +L   +++L      +  ++ N
Sbjct: 140 GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199

Query: 409 ILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI--------GGLKNLQNL 460
           +  + L        L + +     +  L L   +L     + +              +N+
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259

Query: 461 SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
            + D +L   +   +  +  L  L+ S N L  +     ++L  L+ + +  N
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.5 bits (243), Expect = 6e-22
 Identities = 55/360 (15%), Positives = 116/360 (32%), Gaps = 55/360 (15%)

Query: 87  LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSN 146
                   +          +   +         S   L   IP  +     +++L L +N
Sbjct: 6   WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSL-NSIPSGL--TEAVKSLDLSNN 62

Query: 147 NLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF 206
            +  +  + L     L+ L LT+N ++ +I      +L +LE   L+ N           
Sbjct: 63  RITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY---------- 111

Query: 207 NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV 266
                 +  L  + F          + +L  LNL  N   +    L   S  ++  KL++
Sbjct: 112 ------LSNLSSSWF--------KPLSSLTFLNLLGNPYKT----LGETSLFSHLTKLQI 153

Query: 267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLN 325
           L +        +       L+  +E   +   +++ S   +   ++ N+  + L   +  
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLT-FLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI 211

Query: 326 GSIPS-TLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLA 384
             +    +     ++ L L +  L+                    ++LS           
Sbjct: 212 -LLLEIFVDVTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKF 254

Query: 385 SLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNL 443
           + R +      L  V      ++ +L ++ S N L  S+P  I   L  L +++L  N  
Sbjct: 255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.1 bits (242), Expect = 6e-22
 Identities = 59/301 (19%), Positives = 108/301 (35%), Gaps = 28/301 (9%)

Query: 182 LALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
           L+     +   ++ + +  IPS +     +   +L +N  +    +      NL+ L L 
Sbjct: 28  LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84

Query: 242 YNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSI-GNLSLSMERFYLHNCNI 300
            N I +   E SF SSL +   L+ L L+ N L    L SS    LS S+    L     
Sbjct: 85  SNGINTI-EEDSF-SSLGS---LEHLDLSYNYL--SNLSSSWFKPLS-SLTFLNLLGNPY 136

Query: 301 RGSIPKEM--GNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQLEGRILDDIC 357
           + ++ +     +L  L I+R+G       I     + L  L+ L ++ + L+      + 
Sbjct: 137 K-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLK 195

Query: 358 RLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPST---------FWNLT 407
            +  +S + L   +    +        +S+  L     +L     +              
Sbjct: 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254

Query: 408 NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL 467
               V ++   L   +   +  +  L+EL  SRN L          L +LQ + L  N  
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

Query: 468 Q 468
            
Sbjct: 314 D 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 21/219 (9%)

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL---EGRILDDICRLARLSSVYLDH 369
            +  + L  N++     S L R   LQ L L +N +   E      +  L  L    L +
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL---DLSY 109

Query: 370 NKLSGSIPA-CFGNLASLRKLSFASNELTFVP--STFWNLTNILMVDLSSNPLSGSLPLE 426
           N LS ++ +  F  L+SL  L+   N    +   S F +LT + ++ + +      +  +
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 427 I-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECL 484
               L  L EL +  ++L    P ++  ++N+ +L L        +     D   S+ECL
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227

Query: 485 DLSNNILSG--------IIPSSLEKLLYLKYLNVSFNRL 515
           +L +  L             +SL K    + + ++   L
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 45/195 (23%), Positives = 85/195 (43%), Gaps = 7/195 (3%)

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLAS 385
           SIPS L+  E ++ L L NN++      D+ R   L ++ L  N ++ +I    F +L S
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 386 LRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNL 443
           L  L  + N L+ + S  F  L+++  ++L  NP        +  +L  L  L +   + 
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161

Query: 444 SGDIPT-TIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL 502
              I      GL  L+ L +  ++LQ   P S+  + ++  L L       ++   ++  
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221

Query: 503 LYLKYLNVSFNRLEG 517
             ++ L +    L+ 
Sbjct: 222 SSVECLELRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.3 bits (227), Expect = 7e-20
 Identities = 47/275 (17%), Positives = 104/275 (37%), Gaps = 28/275 (10%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
           SL SL++LDLS+N L   + SS F   + L  L+L  N          F +++ LQ++ +
Sbjct: 98  SLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
            +     ++    F+ L F++ L +  +    + P+ + ++ +++ + L     +  +  
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI 216

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
            +    +++ L L   +L     + L    T  +++                        
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK-----------------KFTFRNV 259

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
            + + +   ++   +   S L   E   N         F  + +L+++ L  N    S  
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318

Query: 251 ELSFISSLANSKKLKVL-----SLTGNPLLDCVLP 280
            + ++S   N    K       S +G P+   + P
Sbjct: 319 RIDYLSRWLNKNSQKEQGSAKCSGSGKPVRSIICP 353

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  121 bits (305), Expect = 2e-30
 Identities = 55/268 (20%), Positives = 106/268 (39%), Gaps = 15/268 (5%)

Query: 18  SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNRL 75
           S   +  +   L  ++P+ I S  +   L+L +N+L       F  ++ L  + LS N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 76  S-GELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI-G 133
           S     +        +++L L+FN     +      L  L  +D   ++L       +  
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 134 NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLA 193
           +LRNL  L +   +           +S+L++L++  N+   +    I   L NL    L+
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183

Query: 194 NNNFSGKIPSFIFNA-SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHEL 252
                 ++    FN+ S L +  +  N+F       +  + +L+ L+   N+I +S  + 
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242

Query: 253 SFISSLANSKKLKVLSLTGNPLL-DCVL 279
                 ++   L  L+LT N     C  
Sbjct: 243 -LQHFPSS---LAFLNLTQNDFACTCEH 266

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  117 bits (294), Expect = 6e-29
 Identities = 57/255 (22%), Positives = 98/255 (38%), Gaps = 16/255 (6%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
            CN +G  S+P  +    +   + L  NKL         +L +L  L L +N L  +   
Sbjct: 13  RCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70

Query: 355 DIC--RLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--STFWNLTNIL 410
                    L  + L  N +  ++ + F  L  L  L F  + L  +   S F +L N++
Sbjct: 71  SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129

Query: 411 MVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQ 468
            +D+S           I   L  L  L ++ N+   +    I   L+NL  L L    L+
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188

Query: 469 GSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG---GTL 525
              P +   L SL+ L++S+N    +     + L  L+ L+ S N +     +       
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFP 247

Query: 526 ANFTSESFMGNDLLC 540
           ++    +   ND  C
Sbjct: 248 SSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  116 bits (293), Expect = 8e-29
 Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 9/238 (3%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLN--GSIPSTLSRLEKLQILG 342
            +  S  R  L +  ++         L  L  + L  N L+  G    +      L+ L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 343 LENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPAC--FGNLASLRKLSFASNELTFVP 400
           L  N +   +  +   L +L  +   H+ L   +     F +L +L  L  +        
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 142

Query: 401 S-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQ 458
           +  F  L+++ ++ ++ N    +   +I   L+ L  L LS+  L    PT    L +LQ
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202

Query: 459 NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY-LKYLNVSFNRL 515
            L++  NN           L SL+ LD S N +       L+     L +LN++ N  
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (259), Expect = 2e-24
 Identities = 50/239 (20%), Positives = 86/239 (35%), Gaps = 30/239 (12%)

Query: 10  PSQLGSLSSLQYLDLSFNQL-LGTIPSSIFS-INTLEILDLSNNQLSG-SFPFFNMSSLQ 66
                 L+ L  L LS N L      S       +L+ LDLS N +   S  F  +  L+
Sbjct: 45  HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLE 104

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLM 125
            +D   + L      ++F  L  + +L ++           I   L+SL  + ++ N   
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQ 163

Query: 126 GEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLAL 184
                +I   LRNL  L L    L  + P    ++S+L++L +++N    S+ +     L
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCL 222

Query: 185 PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
            +L++   + N+                           F         +L  LNL  N
Sbjct: 223 NSLQVLDYSLNHIM----------------TSKKQELQHF-------PSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 6/168 (3%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP--FFNMSS 64
           T+ S    L  L++LD   + L      S+F  +  L  LD+S+     +F   F  +SS
Sbjct: 92  TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENH 123
           L+V+ ++ N        +IF+ L  + FL L+  Q    L      +L+SL  +++S N+
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN 210

Query: 124 LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNIST-LKILQLTNN 170
                      L +LQ L    N+++      L +  + L  L LT N
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 6/103 (5%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSG--SFPF 59
           SF    +P     L +L +LDLS  Q L  +  + F+ +++L++L++S+N      +FP+
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219

Query: 60  FNMSSLQVIDLSDNRLSGELPANIFSYLP-FVQFLSLAFNQFA 101
             ++SLQV+D S N +          + P  + FL+L  N FA
Sbjct: 220 KCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  123 bits (311), Expect = 3e-30
 Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 18/211 (8%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLR-SIRHRNLV 685
            F   +++G G+ G++      D  +VA+K    +     +    E ++LR S  H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R   +  +  F+ + ++     +L+  +   +      + + ++      L +LH     
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---L 137

Query: 746 PVVHCDIKPSNVLLDE-----DMVARLGDFGIAKLLSGDESM--KHTQTLATIGYMAPEY 798
            +VH D+KP N+L+        + A + DFG+ K L+       + +    T G++APE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 799 ---GREGQISTEGDVYSFGIMLMEIFTRKRP 826
                +   +   D++S G +   + +    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (307), Expect = 6e-30
 Identities = 28/244 (11%), Positives = 71/244 (29%), Gaps = 50/244 (20%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALES----------------------- 668
           ++G     +         G    + V +        +                       
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 669 -----FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM-PKGSLE------ACLYSD 716
                F    ++++  + + ++R+     +    +    Y   + +L+          S 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 717 NSNLDIFKRLNIVIDIALALEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
           + +L    RL + + +   L  LH +G    +VH  ++P +++LD+     L  F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 776 LSGDESMKHTQTLATIGYMAPE-----YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
                     +  A     A             ++   D ++ G+ +  I+    P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 831 FSGE 834
            + +
Sbjct: 317 NTDD 320

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  119 bits (301), Expect = 6e-30
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 36/221 (16%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
            + + +   +G G+FG VY+ +  + G   A KV   + E  LE +  E E+L +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID---IA------- 733
           +V+++ +  +D    +++++ P G++            I   L+  +    I        
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAV----------DAIMLELDRGLTEPQIQVVCRQML 127

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG- 792
            AL +LH      ++H D+K  NVL+  +   RL DFG++         + +     IG 
Sbjct: 128 EALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS----FIGT 180

Query: 793 --YMAPE-----YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             +MAPE       ++     + D++S GI L+E+   + P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (301), Expect = 7e-30
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 30/215 (13%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHR 682
            + F     IG GSFG V++G        VAIK+  L + E  +E    E  VL      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK--RLN------IVIDIAL 734
            + +   S   D    ++++Y+  GS           LD+ +   L+      I+ +I  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILK 130

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG-- 792
            L+YLH       +H DIK +NVLL E    +L DFG+A  L+  +  ++T     +G  
Sbjct: 131 GLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT----FVGTP 183

Query: 793 -YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            +MAPE  ++    ++ D++S GI  +E+   + P
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 7e-30
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 29/207 (14%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
             ++     IG G+ G+VY    +  G EVAI+  +LQ +   E    E  V+R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK--RLN------IVIDIALA 735
           +V  + S    D   +V++Y+  GSL           D+     ++      +  +   A
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQA 128

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG--- 792
           LE+LH      V+H DIK  N+LL  D   +L DFG    ++ ++S + T     +G   
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPY 181

Query: 793 YMAPEYGREGQISTEGDVYSFGIMLME 819
           +MAPE         + D++S GIM +E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIE 208

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 1e-29
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
               +    IG GS G V   R    G +VA+K+  L+ +   E    E  ++R  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK--RLN------IVIDIALA 735
           +V +  S    +   ++++++  G+L           DI    RLN      +   +  A
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQA 153

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG--- 792
           L YLH      V+H DIK  ++LL  D   +L DFG    +S D   + +     +G   
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS----LVGTPY 206

Query: 793 YMAPEYGREGQISTEGDVYSFGIMLME 819
           +MAPE       +TE D++S GIM++E
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIE 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  118 bits (299), Expect = 1e-29
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 634 IGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+     +       M VA+K        A + F  E E+L +++H ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 688 ISSCTNDDFKALVLDYMPKGSL---------------EACLYSDNSNLDIFKRLNIVIDI 732
              C + D   +V +YM  G L               +         L + + L+I   I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 733 ALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTL 788
           A  + YL   HF      VH D+   N L+  +++ ++GDFG+++ + S D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             I +M PE     + +TE DV+SFG++L EIFT
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  119 bits (300), Expect = 1e-29
 Identities = 72/320 (22%), Positives = 131/320 (40%), Gaps = 39/320 (12%)

Query: 186 NLELFSLANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY 244
           +L +   ++      +P  I  + + L    L +N  S    + F  +++L  L L  N 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPDTTLLD---LQNNDISELRKDDFKGLQHLYALVLVNNK 89

Query: 245 ITSSNHELSFISSLANSKKLKVLSLTGNPL--LDCVLPSSIGNLSLSMERFYLHNCNIRG 302
           I+   HE +F    +  +KL+ L ++ N L  +   LPSS+  L        +H+  IR 
Sbjct: 90  ISK-IHEKAF----SPLRKLQKLYISKNHLVEIPPNLPSSLVEL-------RIHDNRIR- 136

Query: 303 SIPKEM-GNLINLIIIRLGYNKL-NGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLA 360
            +PK +   L N+  I +G N L N           KL  L +   +L   I  D+    
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PE 193

Query: 361 RLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNP 418
            L+ ++LDHNK+  +I        + L +L    N++  + + +   L  +  + L +N 
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252

Query: 419 LSGSLPLEIGNLKVLVELYLSRNNLSGDIP-------TTIGGLKNLQNLSLGDNNLQGSI 471
           LS  +P  + +LK+L  +YL  NN++  +                   +SL +N +    
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310

Query: 472 --PNSIGDLISLECLDLSNN 489
             P +   +     +   N 
Sbjct: 311 VQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (284), Expect = 2e-27
 Identities = 59/272 (21%), Positives = 97/272 (35%), Gaps = 17/272 (6%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDN 73
                LDL  N  +  +    F  +  L  L L NN++S      F  +  LQ + +S N
Sbjct: 54  PDTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112

Query: 74  RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL-MGEIPHEI 132
            L  E+P N+ S L     L +  N+           L ++  I++  N L         
Sbjct: 113 HLV-EIPPNLPSSL---VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL 192
            +   L  L +    L G +P  L    TL  L L +N +  +I     L    L    L
Sbjct: 169 FDGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224

Query: 193 ANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS-SNH 250
            +N     I +        L    L +N  S  +P    +++ L+ + L  N IT    +
Sbjct: 225 GHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLDCVLPSS 282
           +   +           +SL  NP+    +  +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  111 bits (280), Expect = 7e-27
 Identities = 67/361 (18%), Positives = 125/361 (34%), Gaps = 72/361 (19%)

Query: 113 SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL 172
            L  +  S+  L   +P EI    +   L L +N++  +       +  L  L L NN +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
           S  I       L  L+   ++ N+                + E+P N             
Sbjct: 91  S-KIHEKAFSPLRKLQKLYISKNH----------------LVEIPPNLP----------- 122

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
            +L EL +  N I             +  + +  + + GNPL +                
Sbjct: 123 SSLVELRIHDNRIRKVPK-----GVFSGLRNMNCIEMGGNPLEN---------------- 161

Query: 293 FYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
                            + + L  +R+   KL   IP  L   E L  L L++N+++   
Sbjct: 162 ---------SGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIE 209

Query: 353 LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV 412
           L+D+ R ++L  + L HN++          L +LR+L   +N+L+ VP+   +L  + +V
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVV 269

Query: 413 DLSSNPLSG------SLPLEIGNLKVLVELYLSRNNLSGDI--PTTIGGLKNLQNLSLGD 464
            L +N ++                     + L  N +      P T   + +   +  G+
Sbjct: 270 YLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329

Query: 465 N 465
            
Sbjct: 330 Y 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (264), Expect = 7e-25
 Identities = 55/242 (22%), Positives = 94/242 (38%), Gaps = 14/242 (5%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
            +S       L N +I      +   L +L  + L  NK++       S L KLQ L + 
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV---PS 401
            N L   I  ++   + L  + +  N++       F  L ++  +    N L      P 
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPT-TIGGLKNLQNL 460
            F  L  +  + +S   L+  +P      + L EL+L  N +   I    +     L  L
Sbjct: 168 AFDGL-KLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222

Query: 461 SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
            LG N ++     S+  L +L  L L NN LS  +P+ L  L  L+ + +  N +  ++ 
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVG 280

Query: 521 RG 522
             
Sbjct: 281 VN 282

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  103 bits (259), Expect = 3e-24
 Identities = 51/242 (21%), Positives = 94/242 (38%), Gaps = 24/242 (9%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSD 72
            L  LQ L +S N  L  IP ++ S  +L  L + +N++       F  + ++  I++  
Sbjct: 100 PLRKLQKLYISKNH-LVEIPPNLPS--SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156

Query: 73  NRL-SGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHE 131
           N L +       F  L  + +L ++  +    +P+      +L  + L  N +   I  E
Sbjct: 157 NPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELE 211

Query: 132 I-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
                  L  LGL  N +  +   +L  + TL+ L L NN LS  + + +   L  L++ 
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP-DLKLLQVV 269

Query: 191 SLANNNFSGKIPSFIF-------NASKLSICELPDN--SFSGFIPNRFHNMRNLKELNLE 241
            L  NN + K+    F         +  +   L +N   +    P  F  + +   +   
Sbjct: 270 YLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328

Query: 242 YN 243
             
Sbjct: 329 NY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 34/196 (17%), Positives = 65/196 (33%), Gaps = 15/196 (7%)

Query: 10  PSQLGSLSSLQYLDLSFNQL-LGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVI 68
                 L ++  +++  N L         F    L  L +S  +L+   P     +L  +
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLNEL 198

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGE 127
            L  N++   +          +  L L  NQ    +       L +L  + L  N L   
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-R 255

Query: 128 IPHEIGNLRNLQALGLLSNNLVGVVPATLF-------NISTLKILQLTNNTLS-GSISSS 179
           +P  + +L+ LQ + L +NN+   V    F         +    + L NN +    +  +
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

Query: 180 IRLALPNLELFSLANN 195
               + +       N 
Sbjct: 315 TFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 16/94 (17%), Positives = 35/94 (37%), Gaps = 10/94 (10%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS----GSF----PFFNMSSLQ 66
            L +L+ L L  N+L   +P+ +  +  L+++ L  N ++      F         +   
Sbjct: 239 FLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297

Query: 67  VIDLSDNRLS-GELPANIFSYLPFVQFLSLAFNQ 99
            I L +N +   E+    F  +     +     +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 25/90 (27%), Positives = 36/90 (40%), Gaps = 4/90 (4%)

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS 492
           L  +  S   L   +P  I    +   L L +N++     +    L  L  L L NN +S
Sbjct: 35  LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 493 GIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
            I   +   L  L+ L +S N L  EIP  
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPN 120

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 7/111 (6%)

Query: 412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI 471
           V  S   L  ++P EI        L L  N++S        GL++L  L L +N +    
Sbjct: 38  VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94

Query: 472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
             +   L  L+ L +S N L  I P+       L  L +  NR+  ++P+G
Sbjct: 95  EKAFSPLRKLQKLYISKNHLVEIPPNLPSS---LVELRIHDNRIR-KVPKG 141

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 14/78 (17%), Positives = 25/78 (32%), Gaps = 12/78 (15%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-------INTLEILDLSNNQLS----GS 56
            VP+ L  L  LQ + L  N  +  +  + F              + L NN +       
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNN-ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

Query: 57  FPFFNMSSLQVIDLSDNR 74
             F  ++    I   + +
Sbjct: 314 ATFRCVTDRLAIQFGNYK 331

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (299), Expect = 2e-29
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 32/220 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALES----FNAECEV 675
               +   +G G+FG VY G+          ++VA+K      E   E     F  E  +
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 86

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL------YSDNSNLDIFKRLNIV 729
           +    H+N+VR I        + ++++ M  G L++ L       S  S+L +   L++ 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 730 IDIALALEYL---HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLL-SGDESM 782
            DIA   +YL   HF      +H DI   N LL       VA++GDFG+A+ +       
Sbjct: 147 RDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200

Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           K    +  + +M PE   EG  +++ D +SFG++L EIF+
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 3e-29
 Identities = 33/244 (13%), Positives = 63/244 (25%), Gaps = 44/244 (18%)

Query: 620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH---LQLEGALESFNAECEV 675
            L Q   +  +   +  G    V+  R ++   + A+KVF          LE  +     
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 676 LRSIRHRNLVRI-----------------------ISSCTNDDFKALVLDYMPK------ 706
              +   +                           +S   +D   A  L  MP       
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 707 --GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV 764
              S    +Y    +  I     +   +      L       +VH    P N+ +  D  
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232

Query: 765 ARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY--GREGQISTEGDVYSFGIMLMEIFT 822
             LGD      +              + Y   E+        +   + +  G+ +  ++ 
Sbjct: 233 LMLGDVSALWKVGTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 823 RKRP 826
              P
Sbjct: 289 LFLP 292

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  117 bits (296), Expect = 3e-29
 Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 46/234 (19%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALES----FNAECEV 675
               +   +G G FG V +              VA+K+     E A  S      +E  V
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----------------------EAC 712
           L+ + H +++++  +C+ D    L+++Y   GSL                        + 
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 713 LYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
            + D   L +   ++    I+  ++YL           VH D+   N+L+ E    ++ D
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISD 193

Query: 770 FGIA-KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           FG++  +   D  +K +Q    + +MA E   +   +T+ DV+SFG++L EI T
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (296), Expect = 4e-29
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRN 683
             + +++++G G+  +V+RGR    G   AIKVF+ +     ++    E EVL+ + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 684 LVR---IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALE 737
           +V+   I    T      L++++ P GSL   L  + SN         L ++ D+   + 
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 738 YLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIG 792
           +L     N +VH +IKP N++     D   V +L DFG A+ L  DE      +L  T  
Sbjct: 127 HL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEE 180

Query: 793 YMAPE-YGREGQISTEG-------DVYSFGIMLMEIFTRKRP 826
           Y+ P+ Y R               D++S G+      T   P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 8e-29
 Identities = 52/248 (20%), Positives = 91/248 (36%), Gaps = 52/248 (20%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNL 684
           +  V  ++  G F  VY  + +  G E A+K      E    +   E   ++ +  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACL---YSDNSNLDIFKR------------LNIV 729
           V+  S+ +         +    G  E  L         ++  K+            L I 
Sbjct: 89  VQFCSAASIGK------EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG----------- 778
                A++++H   P P++H D+K  N+LL      +L DFG A  +S            
Sbjct: 143 YQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 779 ----DESMKHTQTLATIGYMAPE----YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI 830
               +E  ++T    T  Y  PE    Y     I  + D+++ G +L  +  R+ P    
Sbjct: 202 ALVEEEITRNT----TPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP---- 252

Query: 831 FSGEMSLK 838
           F     L+
Sbjct: 253 FEDGAKLR 260

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  115 bits (291), Expect = 1e-28
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 38/218 (17%)

Query: 634 IGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALES----FNAECEVLRSIRHRN 683
           +G   FG VY+G             VAIK      + A       F  E  +   ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL---------------EACLYSDNSNLDIFKRLNI 728
           +V ++   T D   +++  Y   G L                    +  S L+    +++
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 729 VIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKH 784
           V  IA  +EYL   H       VH D+   NVL+ + +  ++ D G+ + + + D     
Sbjct: 134 VAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187

Query: 785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             +L  I +MAPE    G+ S + D++S+G++L E+F+
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  116 bits (294), Expect = 1e-28
 Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 37/225 (16%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGA----LESFNAECEV 675
           +       +G+G+FG V              ++VA+K+       A     E+  +E ++
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102

Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLD 721
           +  + +H N+V ++ +CT+     ++ +Y   G L             +      NS   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 722 IFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLS 777
               L+    +A  + +L   +       +H D+   NVLL    VA++GDFG+A  +++
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216

Query: 778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
               +        + +MAPE   +   + + DV+S+GI+L EIF+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  116 bits (292), Expect = 1e-28
 Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGA----LESFNAECEV 675
           ++ +    +G+G+FG V              M VA+K+       A     E+  +E +V
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79

Query: 676 LRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL-----------------EACLYSDN 717
           L  +  H N+V ++ +CT      ++ +Y   G L                  A +  D 
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 718 SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL- 776
             LD+   L+    +A  + +L   +    +H D+   N+LL    + ++ DFG+A+ + 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           +    +        + +MAPE       + E DV+S+GI L E+F+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (294), Expect = 1e-28
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 41/229 (17%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLEGA----LESFNAEC 673
           D+  +   +G G+FG V     +          + VA+K+     + A    L    +E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91

Query: 674 EVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL---------------EACLYSDN 717
           E+++ I +H+N++ ++ +CT D    ++++Y  KG+L                       
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 718 SNLDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
             +     ++    +A  +EYL           +H D+   NVL+ E+ V ++ DFG+A+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR 205

Query: 775 LL-SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            + + D   K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (295), Expect = 1e-28
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 32/220 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALES----FNAECEV 675
               +   +G G+FG VY G+          ++VA+K      E   E     F  E  +
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 127

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL------YSDNSNLDIFKRLNIV 729
           +    H+N+VR I        + ++L+ M  G L++ L       S  S+L +   L++ 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 730 IDIALALEYL---HFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLL-SGDESM 782
            DIA   +YL   HF      +H DI   N LL       VA++GDFG+A+ +       
Sbjct: 188 RDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241

Query: 783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           K    +  + +M PE   EG  +++ D +SFG++L EIF+
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  116 bits (292), Expect = 2e-28
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)

Query: 634 IGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI 687
           +G G+FG V+     +       M VA+K      E A + F  E E+L  ++H+++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 688 ISSCTNDDFKALVLDYMPKGSL--------------EACLYSDNSNLDIFKRLNIVIDIA 733
              CT      +V +YM  G L                        L + + L +   +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 734 LALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTLA 789
             + YL   HF      VH D+   N L+ + +V ++GDFG+++ + S D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            I +M PE     + +TE DV+SFG++L EIFT
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (290), Expect = 2e-28
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 33/209 (15%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
            + F+V   +G GS+GSVY+    + G  VAIK   + +E  L+    E  +++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ--VPVESDLQEIIKEISIMQQCDSPH 85

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID---IA------- 733
           +V+   S   +    +V++Y   GS+           DI +  N  +    IA       
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSV----------SDIIRLRNKTLTEDEIATILQSTL 135

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG- 792
             LEYLHF      +H DIK  N+LL+ +  A+L DFG+A  L+   + ++T     IG 
Sbjct: 136 KGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT----VIGT 188

Query: 793 --YMAPEYGREGQISTEGDVYSFGIMLME 819
             +MAPE  +E   +   D++S GI  +E
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIE 217

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  116 bits (293), Expect = 3e-28
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 41/229 (17%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLEGA----LESFNAEC 673
           D+  +   +G G FG V     +          + VA+K+     + A    L    +E 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137

Query: 674 EVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL---------------EACLYSDN 717
           E+++ I +H+N++ ++ +CT D    ++++Y  KG+L                       
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 718 SNLDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
             +     ++    +A  +EYL           +H D+   NVL+ E+ V ++ DFG+A+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR 251

Query: 775 LL-SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            + + D   K T     + +MAPE   +   + + DV+SFG+++ EIFT
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (290), Expect = 4e-28
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 46/234 (19%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGALES----FNAECEV 675
           +       IG G+FG V++ R            VA+K+     E A       F  E  +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----------------------EAC 712
           +    + N+V+++  C       L+ +YM  G L                          
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 713 LYSDNSNLDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGD 769
                  L   ++L I   +A  + YL    F      VH D+   N L+ E+MV ++ D
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIAD 217

Query: 770 FGIA-KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           FG++  + S D           I +M PE     + +TE DV+++G++L EIF+
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (286), Expect = 4e-28
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 32/235 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH---LQLEGALESFNAECEVLRSIRH 681
           + F +   +G G FG+VY  R       +A+KV     L+  G       E E+   +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALA 735
            N++R+     +     L+L+Y P G++          L    + +       + ++A A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITELANA 121

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           L Y H      V+H DIKP N+LL      ++ DFG +       S + T    T+ Y+ 
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLP 175

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKRWV 841
           PE         + D++S G++  E    K P +          I   E +   +V
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  116 bits (292), Expect = 4e-28
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 41/229 (17%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLEGA----LESFNAEC 673
           D+  +   +G G+FG V     +           +VA+K+       A    L    +E 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125

Query: 674 EVLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSL---------------EACLYSDN 717
           E+++ I +H+N++ ++ +CT D    ++++Y  KG+L                   ++  
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 718 SNLDIFKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK 774
             L     ++    +A  +EYL           +H D+   NVL+ ED V ++ DFG+A+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLAR 239

Query: 775 LL-SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
            +   D   K T     + +MAPE   +   + + DV+SFG++L EIFT
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  114 bits (287), Expect = 4e-28
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
           D + +  +IGSG+   V          +VAIK  +L + + +++    E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACL-YSDNSNLDIFKRLN------IVIDIALAL 736
           +V   +S    D   LV+  +  GS+   + +           L+      I+ ++   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT-IG--- 792
           EYLH    N  +H D+K  N+LL ED   ++ DFG++  L+    +   +   T +G   
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 793 YMAPE-YGREGQISTEGDVYSFGIMLMEI 820
           +MAPE   +      + D++SFGI  +E+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (295), Expect = 4e-28
 Identities = 75/507 (14%), Positives = 152/507 (29%), Gaps = 102/507 (20%)

Query: 19  LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGE 78
                 +  ++  T   S   + TL  LD  N+ ++       ++ L  +  + N ++  
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-T 78

Query: 79  LPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNL 138
           L     S    + +L+   N+   +L   +  LT LT ++   N L      ++     L
Sbjct: 79  LD---LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPLL 129

Query: 139 QALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS 198
             L    N L  +    + + + L  L    N     +  +       L     + N   
Sbjct: 130 TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKI- 182

Query: 199 GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSL 258
                     ++L + +                   L  LN + N IT  +        L
Sbjct: 183 ----------TELDVSQNK----------------LLNRLNCDTNNITKLD--------L 208

Query: 259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIR 318
             + +L  L  + N L      + I                       ++  L  L    
Sbjct: 209 NQNIQLTFLDCSSNKL------TEI-----------------------DVTPLTQLTYFD 239

Query: 319 LGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA 378
              N L   +   +S L KL  L      L      D+    +L     +  +    +  
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD- 292

Query: 379 CFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYL 438
              +   L  L   +  +T +         ++ + L++  L+  L   + +   L  L  
Sbjct: 293 -VTHNTQLYLLDCQAAGITELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346

Query: 439 SRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP-----NSIGDLISLECLDLSNNILSG 493
              ++  D   ++G +  L N    +             NS+   +S + LD   N ++ 
Sbjct: 347 VNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN- 403

Query: 494 IIPSSLEKLLYLKYLNVSFNRLEGEIP 520
            I      +       +++  L  + P
Sbjct: 404 -IEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  112 bits (282), Expect = 2e-26
 Identities = 53/382 (13%), Positives = 124/382 (32%), Gaps = 50/382 (13%)

Query: 137 NLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN 196
           N  +    +  +      +   ++TL  L   N++++          L  L      +NN
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE---KLTGLTKLICTSNN 75

Query: 197 FSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFIS 256
            +  +   +   + L+      N  +         +  L  LN + N +T  +       
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLTKLD------- 122

Query: 257 SLANSKKLKVLSLTGNPL--LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL 314
            ++ +  L  L+   N L  +D    + +  L              +     ++     L
Sbjct: 123 -VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCH---------LNKKITKLDVTPQTQL 172

Query: 315 IIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG 374
             +   +NK+   +   +S+ + L  L  + N +  ++  D+ +  +L+ +    NKL+ 
Sbjct: 173 TTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLT- 225

Query: 375 SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV 434
            I      L  L     + N LT +      L+ +  +      L     +++ +   L+
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLI 278

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
                      ++   +     L  L      +   +   +     L  L L+N  L+ +
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTEL 333

Query: 495 IPSSLEKLLYLKYLNVSFNRLE 516
               +     LK L+     ++
Sbjct: 334 ---DVSHNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  107 bits (268), Expect = 1e-24
 Identities = 70/471 (14%), Positives = 152/471 (32%), Gaps = 78/471 (16%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
           + +  L+ L  L  + N  + T+   +     L  L   +N+L+ +     ++ L  ++ 
Sbjct: 58  TGIEKLTGLTKLICTSNN-ITTLD--LSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNC 113

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
             N+L+ +L  +    L    +L+ A N        ++ + T LT +D   N  + ++  
Sbjct: 114 DTNKLT-KLDVSQNPLL---TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD- 165

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
            +     L  L    N +  +    +     L  L    N ++  +  +       L   
Sbjct: 166 -VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFL 217

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
             ++N  +                E+               +  L   +   N +T  + 
Sbjct: 218 DCSSNKLT----------------EID-----------VTPLTQLTYFDCSVNPLTELD- 249

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGN 310
                  ++   KL  L      LL+  L       +  +  F    C     +  ++ +
Sbjct: 250 -------VSTLSKLTTLHCIQTDLLEIDLTH-----NTQLIYFQAEGCRKIKEL--DVTH 295

Query: 311 LINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHN 370
              L ++      +   +   LS+  KL  L L N +L   +  D+    +L S+   + 
Sbjct: 296 NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNA 349

Query: 371 KLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNIL------MVDLSSNPLSGSLP 424
            +     +  G + +L     A  +   +P       ++       ++D   NP+  ++ 
Sbjct: 350 HIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIE 405

Query: 425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI 475
              G +       ++  NLS D P       +     +G        P  I
Sbjct: 406 PGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQPI 456

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  101 bits (254), Expect = 8e-23
 Identities = 56/344 (16%), Positives = 109/344 (31%), Gaps = 44/344 (12%)

Query: 185 PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY 244
            N      A               + L+  +  ++S +         +  L +L    N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNN 75

Query: 245 IT----SSNHELSFIS---------SLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSME 291
           IT    S N  L++++          +    KL  L+   N L        +      + 
Sbjct: 76  ITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTK----LDVSQNP-LLT 130

Query: 292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGR 351
                   +   I   + +   L  +    NK    +   ++   +L  L    N++   
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE- 184

Query: 352 ILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILM 411
              D+ +   L+ +  D N ++  +         L  L  +SN+LT +      LT +  
Sbjct: 185 --LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTY 237

Query: 412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI 471
            D S NPL+    L++  L  L  L+  + +L  +I   +     L             +
Sbjct: 238 FDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL 291

Query: 472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
              +     L  LD     ++ +    L +   L YL ++   L
Sbjct: 292 D--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 45/287 (15%), Positives = 93/287 (32%), Gaps = 27/287 (9%)

Query: 3   SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNM 62
                     +   + L  LD SFN++       +     L  L+   N ++        
Sbjct: 156 HLNKKITKLDVTPQTQLTTLDCSFNKI---TELDVSQNKLLNRLNCDTNNIT-KLDLNQN 211

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
             L  +D S N+L+ E+     + L  + +   + N     L   +  L+ LT++   + 
Sbjct: 212 IQLTFLDCSSNKLT-EID---VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQT 264

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
            L+ EI   + +   L          +  +   + + + L +L      ++  +  S   
Sbjct: 265 DLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDLS--- 315

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
             P L    L N   + ++   + + +KL      +     F       +  L       
Sbjct: 316 QNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAE 370

Query: 243 NYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS 289
               +   E    +SL  +    +L   GNP+   + P   G    +
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQA 415

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 5e-28
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRN 683
             + +++++G G+  +V+RGR    G   AIKVF+ +     ++    E EVL+ + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 684 LVRI--ISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR---LNIVIDIALALEY 738
           +V++  I   T    K L++++ P GSL   L  + SN         L ++ D+   + +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 739 LHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGY 793
           L     N +VH +IKP N++     D   V +L DFG A+ L  DE      +L  T  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEY 181

Query: 794 MAPE-YGREGQISTEG-------DVYSFGIMLMEIFTRKRP 826
           + P+ Y R               D++S G+      T   P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  113 bits (286), Expect = 7e-28
 Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 34/225 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGALES----FNAECEV 675
           D+  +   +G G+FG V                VA+K+     EGA  S      +E ++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83

Query: 676 LRSI-RHRNLVRIISSCTNDDFKALV-LDYMPKGSL---------------EACLYSDNS 718
           L  I  H N+V ++ +CT      +V +++   G+L                A       
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 719 NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-S 777
            L +   +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             + ++       + +MAPE   +   + + DV+SFG++L EIF+
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  114 bits (287), Expect = 9e-28
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 40/223 (17%)

Query: 634 IGSGSFGSVYRGRFLDG------MEVAIKVFHLQLEGA----LESFNAECEVLRSI-RHR 682
           +GSG+FG V              ++VA+K+     E A     E+  +E +++  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSL----------------------EACLYSDNSNL 720
           N+V ++ +CT      L+ +Y   G L                            D + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 721 DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA-KLLSGD 779
                L     +A  +E+L F      VH D+   NVL+    V ++ DFG+A  ++S  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             +        + +MAPE   EG  + + DV+S+GI+L EIF+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  119 bits (298), Expect = 9e-28
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 30/223 (13%)

Query: 623 QATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQL-EGALESFNAECEVLRSIR 680
           Q    + +   +G+G FG V R      G +VAIK    +L     E +  E ++++ + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 681 HRNLVRII------SSCTNDDFKALVLDYMPKGSL--------EACLYSDNSNLDIFKRL 726
           H N+V              +D   L ++Y   G L          C   +     +    
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-- 128

Query: 727 NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMK 783
               DI+ AL YLH    N ++H D+KP N++L    + ++ ++ D G AK L   E   
Sbjct: 129 ----DISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181

Query: 784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
             + + T+ Y+APE   + + +   D +SFG +  E  T  RP
Sbjct: 182 --EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  113 bits (286), Expect = 1e-27
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 37/223 (16%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG---MEVAIKVFHLQLEGALES----FNAECEVLRS 678
           +     ++IG G+FG V + R       M+ AIK      E A +     F  E EVL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCK 81

Query: 679 I-RHRNLVRIISSCTNDDFKALVLDYMPKGSL---------------EACLYSDNSNLDI 722
           +  H N++ ++ +C +  +  L ++Y P G+L                A   S  S L  
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 723 FKRLNIVIDIALALEYL---HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD 779
            + L+   D+A  ++YL    F      +H D+   N+L+ E+ VA++ DFG+++    +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR--GQE 193

Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
             +K T     + +MA E       +T  DV+S+G++L EI +
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  116 bits (292), Expect = 1e-27
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 6/232 (2%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
            +  +     L   NI+        +L +L +++LG N +        + L  L  L L 
Sbjct: 72  GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFAS-NELTFVPS- 401
           +N L          L++L  ++L +N +  SIP+  F  + SL +L      +L ++   
Sbjct: 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190

Query: 402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS 461
            F  L N+  ++L    +   +P  +  L  L EL +S N+     P +  GL +L+ L 
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
           + ++ +     N+   L SL  L+L++N LS +       L YL  L++  N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  114 bits (286), Expect = 6e-27
 Identities = 63/252 (25%), Positives = 104/252 (41%), Gaps = 15/252 (5%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
            C  RG   +P+ +    N   + L  N +      T   L  L++L L  N +  +I  
Sbjct: 60  VCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV 116

Query: 355 DI-CRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILM 411
                LA L+++ L  N L+  IP+  F  L+ LR+L   +N +  +PS  F  + +++ 
Sbjct: 117 GAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMR 175

Query: 412 VDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
           +DL        +       L  L  L L   N+  D+P  +  L  L+ L +  N+    
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEI 233

Query: 471 IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG--GTLANF 528
            P S   L SL+ L + N+ +S I  ++ + L  L  LN++ N L   +P      L   
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYL 292

Query: 529 TSESFMGNDLLC 540
                  N   C
Sbjct: 293 VELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (279), Expect = 5e-26
 Identities = 54/287 (18%), Positives = 97/287 (33%), Gaps = 56/287 (19%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNR 74
           +    +  +   L   +P  I S      L+L  N +    +  F ++  L+V+ L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI- 132
           +  ++    F+ L  +  L L  N     +P      L+ L  + L  N +   IP    
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAF 167

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL 192
             + +L  L L                   K+  ++     G         L NL+  +L
Sbjct: 168 NRVPSLMRLDLGELK---------------KLEYISEGAFEG---------LFNLKYLNL 203

Query: 193 ANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS----- 247
              N    +P+       L   E+  N F    P  FH + +LK+L +  + ++      
Sbjct: 204 GMCNIK-DMPNLT-PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261

Query: 248 ------------SNHELSFISS--LANSKKLKVLSLTGNPLL-DCVL 279
                       +++ LS +        + L  L L  NP   DC +
Sbjct: 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 33/142 (23%), Positives = 57/142 (40%), Gaps = 4/142 (2%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFPFFNMSSLQVI 68
                 + SL  LDL   + L  I    F  +  L+ L+L    +        +  L+ +
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEEL 223

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI 128
           ++S N    E+    F  L  ++ L +  +Q +         L SL  ++L+ N+L   +
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SL 281

Query: 129 PHEI-GNLRNLQALGLLSNNLV 149
           PH++   LR L  L L  N   
Sbjct: 282 PHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 4/115 (3%)

Query: 408 NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL 467
               V  +   LS  +P  I        L L  NN+      T   L +L+ L LG N++
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
           +     +   L SL  L+L +N L+ I   + E L  L+ L +  N +E  IP  
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (290), Expect = 2e-27
 Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 45/251 (17%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLR-SIRHRNL 684
           +      ++G GS G+V       G  VA+K   +      +    E ++L  S  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLE------ACLYSDNSNLDIFKRLNIVIDIALALEY 738
           +R   S T D F  + L+     +L+           +      +  ++++  IA  + +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 739 LHFGHPNPVVHCDIKPSNVLLD-------------EDMVARLGDFGIAKLLSGDESMKHT 785
           LH      ++H D+KP N+L+              E++   + DFG+ K L   +S   T
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 786 QTLA---TIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRP--------T 827
                  T G+ APE          + +++   D++S G +   I ++ +          
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 828 DEIFSGEMSLK 838
             I  G  SL 
Sbjct: 248 SNIIRGIFSLD 258

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (281), Expect = 2e-27
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 29/238 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH---LQLEGALESFNAECEVLRSIRH 681
           + F V NL+G GSF  VYR   +  G+EVAIK+     +   G ++    E ++   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            +++ + +   + ++  LVL+    G +   L +        +  + +  I   + YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE---- 797
                ++H D+  SN+LL  +M  ++ DFG+A  L       +T    T  Y++PE    
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATR 186

Query: 798 --YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKRWVNDS 844
             +G       E DV+S G M   +   + P D          +   +  +  +++  
Sbjct: 187 SAHG------LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  115 bits (289), Expect = 2e-27
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 11/234 (4%)

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI-CRLARLSSVYLDHNK 371
           N  ++ L  N++     ++   L  L+IL L  N +   I       LA L+++ L  N+
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123

Query: 372 LSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-G 428
           L+ +IP   F  L+ L++L   +N +  +PS  F  + ++  +DL        +      
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 429 NLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSN 488
            L  L  L L+  NL  +IP  +  L  L  L L  N+L    P S   L+ L+ L +  
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 489 NILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG--GTLANFTSESFMGNDLLC 540
           + +  I  ++ + L  L  +N++ N L   +P      L +        N   C
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (277), Expect = 7e-26
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 6/232 (2%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
            +S +     LH   I+        +L +L I++L  N +        + L  L  L L 
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFAS-NELTFVPS- 401
           +N+L          L++L  ++L +N +  SIP+  F  + SLR+L       L+++   
Sbjct: 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS 461
            F  L+N+  ++L+   L   +P  +  L  L EL LS N+LS   P +  GL +LQ L 
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
           +  + +Q    N+  +L SL  ++L++N L+ +       L +L+ +++  N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (274), Expect = 2e-25
 Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 56/287 (19%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNR 74
           +    +      L   +P  I +     +L+L  NQ+       F ++  L+++ LS N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI- 132
           +   +    F+ L  +  L L  N+    +P      L+ L  + L  N +   IP    
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAF 156

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL 192
             + +L+ L L                   ++  ++     G         L NL   +L
Sbjct: 157 NRIPSLRRLDLGELK---------------RLSYISEGAFEG---------LSNLRYLNL 192

Query: 193 ANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITS----- 247
           A  N   +IP+      KL   +L  N  S   P  F  + +L++L +  + I       
Sbjct: 193 AMCNLR-EIPNLT-PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250

Query: 248 ------------SNHELSFISS--LANSKKLKVLSLTGNPLL-DCVL 279
                       +++ L+ +          L+ + L  NP   +C +
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 4/142 (2%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFPFFNMSSLQVI 68
                 + SL+ LDL   + L  I    F  ++ L  L+L+   L        +  L  +
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDEL 212

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI 128
           DLS N LS  +    F  L  +Q L +  +Q          NL SL  I+L+ N+L   +
Sbjct: 213 DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LL 270

Query: 129 PHEI-GNLRNLQALGLLSNNLV 149
           PH++   L +L+ + L  N   
Sbjct: 271 PHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 29/123 (23%), Positives = 46/123 (37%), Gaps = 4/123 (3%)

Query: 400 PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQN 459
           PS          V      L   +P  I        L L  N +      +   L++L+ 
Sbjct: 36  PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEI 92

Query: 460 LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEI 519
           L L  N+++     +   L +L  L+L +N L+ I   +   L  LK L +  N +E  I
Sbjct: 93  LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151

Query: 520 PRG 522
           P  
Sbjct: 152 PSY 154

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.8 bits (114), Expect = 9e-06
 Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 6/73 (8%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP---FF 60
           L+   P     L  LQ L +  +Q +  I  + F  + +L  ++L++N L+   P   F 
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQ-IQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276

Query: 61  NMSSLQVIDLSDN 73
            +  L+ I L  N
Sbjct: 277 PLHHLERIHLHHN 289

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (293), Expect = 2e-27
 Identities = 73/485 (15%), Positives = 140/485 (28%), Gaps = 99/485 (20%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSN---NQLSGSFPFFNMSS 64
           ++   + +  SL   +  +N + GT      + +  E   L     N+         ++ 
Sbjct: 2   SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
              + L+   LS  LP N+   +     L +  N     LP    +L  L   D  +N L
Sbjct: 61  FSELQLNRLNLS-SLPDNLPPQI---TVLEITQNAL-ISLPELPASLEYL---DACDNRL 112

Query: 125 MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLAL 184
              +P    +L++L     + NN + ++P      + L+ +   NN L     + +    
Sbjct: 113 S-TLPELPASLKHLD----VDNNQLTMLPEL---PALLEYINADNNQL-----TMLPELP 159

Query: 185 PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY 244
            +LE+ S+ NN                 +  LP+               +L+ L++  N 
Sbjct: 160 TSLEVLSVRNNQ----------------LTFLPE------------LPESLEALDVSTNL 191

Query: 245 ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIG---NLSLSMERFYLHNCNIR 301
           + S                               LP+      +   +   F      I 
Sbjct: 192 LES-------------------------------LPAVPVRNHHSEETEIFFRCRENRIT 220

Query: 302 GSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLAR 361
             IP+ + +L     I L  N L+  I  +LS+                           
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLH 277

Query: 362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSG 421
                        +  +    +    +    +N  +       +  +          ++ 
Sbjct: 278 RPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAA 337

Query: 422 SLPLEIGNLKVLVELYLSRNNLSGDIPTTIG-----GLKNLQNLSLGDNNLQGSIPNSIG 476
            L      L    EL      ++ D   +          NL+   L     +G   N  G
Sbjct: 338 WLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTG 393

Query: 477 DLISL 481
            L+SL
Sbjct: 394 ALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  115 bits (290), Expect = 5e-27
 Identities = 56/292 (19%), Positives = 107/292 (36%), Gaps = 34/292 (11%)

Query: 237 ELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLH 296
             N  YN I+ +  +    S+    +K  +     N  +  +    I           L+
Sbjct: 14  SQNSFYNTISGTYADY--FSAWDKWEKQALPGENRNEAVSLLKECLINQF----SELQLN 67

Query: 297 NCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI 356
             N+  S+P  +     + ++ +  N L  S+P   + LE L      +N+L   + +  
Sbjct: 68  RLNLS-SLPDNLPP--QITVLEITQNAL-ISLPELPASLEYLD---ACDNRLS-TLPELP 119

Query: 357 CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSS 416
             L  L    +D+N+L+  +P     L     ++  +N+LT +P    +L  +    + +
Sbjct: 120 ASLKHL---DVDNNQLT-MLPELPALL---EYINADNNQLTMLPELPTSLEVL---SVRN 169

Query: 417 NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQN----LSLGDNNLQGSIP 472
           N L+  LP    +L+    L +S N L   +P       + +         +N +   IP
Sbjct: 170 NQLT-FLPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIP 223

Query: 473 NSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGT 524
            +I  L     + L +N LS  I  SL +       +           +  T
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  113 bits (283), Expect = 3e-26
 Identities = 64/317 (20%), Positives = 113/317 (35%), Gaps = 54/317 (17%)

Query: 180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
           + + LP    FSL+ N+F   I                 + FS +           ++  
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISG------------TYADYFSAW--------DKWEKQA 40

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCN 299
           L       + +E   +       +   L L    L    LP ++      +    +    
Sbjct: 41  LPGE----NRNEAVSLLKECLINQFSELQLNRLNL--SSLPDNLPP---QITVLEITQNA 91

Query: 300 IRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRL 359
           +  S+P+   +L  L       N+L+ ++P   + L+ L    ++NNQL   + +    L
Sbjct: 92  LI-SLPELPASLEYLD---ACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALL 142

Query: 360 ARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPL 419
             +     D+N+L+  +P       SL  LS  +N+LTF+P    +L  +   D+S+N L
Sbjct: 143 EYI---NADNNQLT-MLPE---LPTSLEVLSVRNNQLTFLPELPESLEAL---DVSTNLL 192

Query: 420 SGSLPLEIGNL----KVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI 475
             SLP          +  +      N ++  IP  I  L     + L DN L   I  S+
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250

Query: 476 GDLISLECLDLSNNILS 492
               +           S
Sbjct: 251 SQQTAQPDYHGPRIYFS 267

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 5e-27
 Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 8/203 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRN 683
           D F   + +G+G+ G V++      G+ +A K+ HL++          E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +V    +  +D   ++ +++M  GSL+  +      +       + I +   L YL   H
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              ++H D+KPSN+L++     +L DFG++  L   +SM ++  + T  YM+PE  +   
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGTH 206

Query: 804 ISTEGDVYSFGIMLMEIFTRKRP 826
            S + D++S G+ L+E+   + P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYP 229

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (279), Expect = 1e-26
 Identities = 29/241 (12%), Positives = 72/241 (29%), Gaps = 55/241 (22%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEGALES----------------------- 668
           ++G     +         G    + V +        +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 669 -----FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM-PKGSLEACL------YSD 716
                F    ++++  + + ++R+     +    +    Y   + +L+          S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 717 NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL 776
           + +L    RL + + +   L  LH      +VH  ++P +++LD+     L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 777 SGDESMKHTQTLATIGYMAPEY-----------GREGQISTEGDVYSFGIMLMEIFTRKR 825
                     +  + G+  PE             R   ++   D ++ G+++  I+    
Sbjct: 257 G-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 826 P 826
           P
Sbjct: 312 P 312

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (277), Expect = 2e-26
 Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 34/240 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH---LQLEGALESFNAECEVLRSIRH 681
            ++     +G G F   +     D     A K+     L      E  + E  + RS+ H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALA 735
           +++V       ++DF  +VL+   + SL              K L        +  I L 
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSL-------LELHKRRKALTEPEARYYLRQIVLG 153

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ--TLATIGY 793
            +YLH      V+H D+K  N+ L+ED+  ++GDFG+A  +  D   K     T     Y
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---Y 207

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKRWVNDS 844
           +APE   +   S E DV+S G ++  +   K P +          I   E S+ + +N  
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 34/240 (14%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
            ++     +G G F   +     D     A K+     L      E  + E  + RS+ H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALA 735
           +++V       ++DF  +VL+   + SL              K L        +  I L 
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSL-------LELHKRRKALTEPEARYYLRQIVLG 127

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQ--TLATIGY 793
            +YLH    N V+H D+K  N+ L+ED+  ++GDFG+A  +  D   K     T     Y
Sbjct: 128 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---Y 181

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKRWVNDS 844
           +APE   +   S E DV+S G ++  +   K P +          I   E S+ + +N  
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 2e-26
 Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 46/242 (19%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           D F++   +G G FG+VY  R       +A+KV     L+ EG       E E+   +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALA 735
            N++R+ +   +     L+L++ P+G L          L    R +       + ++A A
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGEL-------YKELQKHGRFDEQRSATFMEELADA 126

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYM 794
           L Y H      V+H DIKP N+L+      ++ DFG +            +T+  T+ Y+
Sbjct: 127 LHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYL 179

Query: 795 APE------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKR 839
            PE      +        + D++  G++  E      P D          I + ++    
Sbjct: 180 PPEMIEGKTHDE------KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233

Query: 840 WV 841
           ++
Sbjct: 234 FL 235

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (271), Expect = 6e-26
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 47/222 (21%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF---------HLQLEGALESFNAECE 674
            + +    ++G G    V R        E A+K+            +++   E+   E +
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 675 VLRSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------- 726
           +LR +  H N++++  +   + F  LV D M KG L             F  L       
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLS 122

Query: 727 -----NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
                 I+  +   +  LH      +VH D+KP N+LLD+DM  +L DFG +  L   E 
Sbjct: 123 EKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179

Query: 782 MKHTQTLATIGYMAPE------YGREGQISTEGDVYSFGIML 817
           ++  +   T  Y+APE               E D++S G+++
Sbjct: 180 LR--EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 6e-26
 Identities = 41/226 (18%), Positives = 78/226 (34%), Gaps = 37/226 (16%)

Query: 625 TDQFNVNNLIGSG--SFGSVYRGRFLD-GMEVAIKVFHL--QLEGALESFNAECEVLRSI 679
              + +  +IG G     +V   R+   G  V ++  +L       +     E  V +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-----------NI 728
            H N+V   ++   D+   +V  +M  GS            D+                I
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSA----------KDLICTHFMDGMNELAIAYI 133

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK---HT 785
           +  +  AL+Y+H       VH  +K S++L+  D    L        +      +   H 
Sbjct: 134 LQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 786 QTLATIG---YMAPEYGREGQI--STEGDVYSFGIMLMEIFTRKRP 826
               ++    +++PE  ++       + D+YS GI   E+     P
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (273), Expect = 7e-26
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 42/222 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA---LESFNAECEVLRSIR 680
              F+    IG GSFG+VY  R +     VAIK      + +    +    E   L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID---IA---- 733
           H N ++       +    LV++Y   GS            D+ +     +    IA    
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSA----------SDLLEVHKKPLQEVEIAAVTH 161

Query: 734 ---LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
                L YLH  +   ++H D+K  N+LL E  + +LGDFG A +++   S         
Sbjct: 162 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-------- 210

Query: 791 IG---YMAPE---YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +G   +MAPE      EGQ   + DV+S GI  +E+  RK P
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (271), Expect = 7e-26
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 35/246 (14%)

Query: 603 NIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQ 661
           ++ ++ P  +        L      F +  L+G+G++G VY+GR +  G   AIKV  + 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 662 LEGALESFNAECEVLRSI-RHRNLVRIISS------CTNDDFKALVLDYMPKGSLEACLY 714
                E    E  +L+    HRN+     +         DD   LV+++   GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 715 SDNSNLDIFKRLN------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG 768
           +D         L       I  +I   L +LH      V+H DIK  NVLL E+   +L 
Sbjct: 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171

Query: 769 DFGIAKLLSGDESMKHTQTLATIG---YMAPEYGREGQISTEG-----DVYSFGIMLMEI 820
           DFG++  L      ++T     IG   +MAPE     +          D++S GI  +E+
Sbjct: 172 DFGVSAQLDRTVGRRNT----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

Query: 821 FTRKRP 826
                P
Sbjct: 228 AEGAPP 233

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (272), Expect = 8e-26
 Identities = 46/240 (19%), Positives = 92/240 (38%), Gaps = 38/240 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFH-----------------LQLEGALES 668
           + + +   +  G F  +      D    A+K +                  + ++   + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 669 FNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-------EACLYSDNSNLD 721
           F  E +++  I++   +      TN D   ++ +YM   S+            +    + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
           I     I+  +  +  Y+H  +   + H D+KPSN+L+D++   +L DFG ++ +     
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--- 204

Query: 782 MKHTQTLA-TIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK 838
            K  +    T  +M PE           + D++S GI L  +F    P    FS ++SL 
Sbjct: 205 -KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (269), Expect = 2e-25
 Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 20/208 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEV-LRSIRHR 682
           +       IG G++GSV +      G  +A+K     + E   +    + +V +RS    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALAL 736
            +V+   +   +    + ++ M   S +       S LD    +       I +    AL
Sbjct: 82  YIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKAL 138

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
            +L       ++H DIKPSN+LLD     +L DFGI+  L   +S+  T+      YMAP
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 194

Query: 797 E----YGREGQISTEGDVYSFGIMLMEI 820
           E               DV+S GI L E+
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (267), Expect = 4e-25
 Identities = 37/238 (15%), Positives = 73/238 (30%), Gaps = 27/238 (11%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGALESFNAECEVLRS 678
           +    V++L+G G+F  VY     D        +  +KV                E L+ 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL----EACLYSDNSNLDIFKRLNIVIDIAL 734
                 ++  S+    +   LV +    G+L         +    +     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLL-----------DEDMVARLGDFGIAKLLSG-DESM 782
            +E +H      ++H DIKP N +L           D      L D G +  +    +  
Sbjct: 184 MIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 783 KHTQTLATIGYMAPEYGREGQIST-EGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
             T    T G+   E     +    + D +     +  +        +   GE   + 
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  105 bits (263), Expect = 4e-25
 Identities = 56/258 (21%), Positives = 95/258 (36%), Gaps = 39/258 (15%)

Query: 27  NQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNRLSGELPANIF 84
            Q L  +P  I +    + + L  N++S   +  F    +L ++ L  N L+  + A  F
Sbjct: 20  QQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAF 76

Query: 85  SYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI-GNLRNLQALG 142
           + L  ++ L L+ N     +       L  L ++ L    L  E+   +   L  LQ L 
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135

Query: 143 LLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIP 202
           L  N L  +   T  ++  L  L L  N +S S+       L +L+   L  N  +    
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA---- 190

Query: 203 SFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSK 262
                        +  ++F          +  L  L L  N +++   E      LA  +
Sbjct: 191 ------------HVHPHAFRD--------LGRLMTLYLFANNLSALPTEA-----LAPLR 225

Query: 263 KLKVLSLTGNPLL-DCVL 279
            L+ L L  NP + DC  
Sbjct: 226 ALQYLRLNDNPWVCDCRA 243

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  104 bits (261), Expect = 9e-25
 Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 13/220 (5%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLS--GSFPFFNMSS 64
            VP  +   ++ Q + L  N++   +P++ F     L IL L +N L+   +  F  ++ 
Sbjct: 25  AVPVGI--PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENH 123
           L+ +DLSDN     +    F  L  +  L L        L   +   L +L  + L +N 
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140

Query: 124 LMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
           L   +P +   +L NL  L L  N +  V       + +L  L L  N ++  +      
Sbjct: 141 L-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNA-SKLSICELPDNSF 221
            L  L    L  NN S  +P+        L    L DN +
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (253), Expect = 1e-23
 Identities = 57/222 (25%), Positives = 87/222 (39%), Gaps = 8/222 (3%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
           +C  +G  ++P  +        I L  N+++    ++      L IL L +N L      
Sbjct: 17  SCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 355 DICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMV 412
               LA L  + L  N    S+    F  L  L  L      L  +    F  L  +  +
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 413 DLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI 471
            L  N L  +LP +   +L  L  L+L  N +S        GL +L  L L  N +    
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
           P++  DL  L  L L  N LS +   +L  L  L+YL ++ N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (250), Expect = 2e-23
 Identities = 53/220 (24%), Positives = 80/220 (36%), Gaps = 11/220 (5%)

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL 386
           ++P  +      Q + L  N++             L+ ++L  N L+    A F  LA L
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 387 RKLSFASNE-LTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNL 443
            +L  + N  L  V   TF  L  +  + L    L   L   +   L  L  LYL  N L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 444 SGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL 502
              +P      L NL +L L  N +      +   L SL+ L L  N ++ + P +   L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 503 LYLKYLNVSFNRLEGEIPRG--GTLANFTSESFMGNDLLC 540
             L  L +  N L   +P      L          N  +C
Sbjct: 201 GRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 11/213 (5%)

Query: 112 TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT 171
            +   I L  N +           RNL  L L SN L  +  A    ++ L+ L L++N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 172 LSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFH 230
              S+  +    L  L    L       ++   +F   + L    L DN+      + F 
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 231 NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSM 290
           ++ NL  L L  N I+S         +      L  L L  N  +  V P +  +L   +
Sbjct: 151 DLGNLTHLFLHGNRISSVPER-----AFRGLHSLDRLLLHQNR-VAHVHPHAFRDLG-RL 203

Query: 291 ERFYLHNCNIRGSIPKE-MGNLINLIIIRLGYN 322
              YL   N+  ++P E +  L  L  +RL  N
Sbjct: 204 MTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  105 bits (264), Expect = 5e-25
 Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 37/210 (17%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
              F    ++GSG+F  V+  +    G   A+K           S   E  VL+ I+H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------------NIVID 731
           +V +     +     LV+  +  G L             F R+             ++  
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQ 114

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           +  A++YLH    N +VH D+KP N+L    +E+    + DFG++K+   +  M    T 
Sbjct: 115 VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMS---TA 167

Query: 789 A-TIGYMAPEYGREGQISTEGDVYSFGIML 817
             T GY+APE   +   S   D +S G++ 
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  105 bits (263), Expect = 7e-25
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 47/218 (21%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNI 728
              V++  +  +D+     L Y   G L                 Y+             
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------------- 136

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             +I  ALEYLH      ++H D+KP N+LL+EDM  ++ DFG AK+LS +       + 
Sbjct: 137 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192

Query: 789 -ATIGYMAPE------YGREGQISTEGDVYSFGIMLME 819
             T  Y++PE        +        D+++ G ++ +
Sbjct: 193 VGTAQYVSPELLTEKSACK------SSDLWALGCIIYQ 224

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (264), Expect = 1e-24
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 48/222 (21%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF--------HLQLEGALESFNAECEV 675
             +++  ++IG G    V R      G E A+K+           QLE   E+   E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 676 LRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL-------- 726
           LR +  H +++ +I S  +  F  LV D M KG L             F  L        
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVALSE 199

Query: 727 ----NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
               +I+  +  A+ +LH    N +VH D+KP N+LLD++M  RL DFG +  L   E +
Sbjct: 200 KETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256

Query: 783 KHTQTLA-TIGYMAPE------YGREGQISTEGDVYSFGIML 817
           +    L  T GY+APE               E D+++ G++L
Sbjct: 257 R---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  103 bits (259), Expect = 3e-24
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 17/205 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNA---ECEVL-RSIR 680
           +       +GSG+ G V++ RF   G  +A+K   ++  G  E       + +V+ +S  
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ--MRRSGNKEENKRILMDLDVVLKSHD 82

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
              +V+   +   +    + ++ M     E         +       + + I  AL YL 
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--- 797
             H   V+H D+KPSN+LLDE    +L DFGI+  L   +     ++     YMAPE   
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMAPERID 197

Query: 798 --YGREGQISTEGDVYSFGIMLMEI 820
                +       DV+S GI L+E+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVEL 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 3e-24
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGA-LESFNAECEVLRSIRH 681
           +D ++V   +G G+F  V R      G+E A K+ +  +L     +    E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALAL 736
            N+VR+  S   + F  LV D +  G L         YS+       +       I  ++
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESI 118

Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
            Y H    N +VH ++KP N+LL    +    +L DFG+A  ++  E+        T GY
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFAGTPGY 173

Query: 794 MAPEYGREGQISTEGDVYSFGIML 817
           ++PE  ++   S   D+++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  102 bits (256), Expect = 5e-24
 Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 21/208 (10%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGA-LESFNAECEV-LRSIRHR 682
           D       +G G++G V + R +  G  +A+K     +     +    + ++ +R++   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLN------IVIDIALAL 736
             V    +   +    + ++ M   SL+         +D  + +       I + I  AL
Sbjct: 67  FTVTFYGALFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
           E+LH      V+H D+KPSNVL++     ++ DFGI+  L   + +          YMAP
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAP 178

Query: 797 E----YGREGQISTEGDVYSFGIMLMEI 820
           E       +   S + D++S GI ++E+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIEL 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (254), Expect = 6e-24
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 33/209 (15%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH-LQLEGA-LESFNAECEVLRSIRH 681
            +++N+  ++G GSFG V + +      E A+KV +    +     +   E E+L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALAL 736
            N++++     +     +V +    G L     +   +S++    I K       +   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGI 134

Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
            Y+H    + +VH D+KP N+LL   ++D   ++ DFG++     +  M     + T  Y
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYY 189

Query: 794 MAPE-----YGREGQISTEGDVYSFGIML 817
           +APE     Y        + DV+S G++L
Sbjct: 190 IAPEVLRGTYD------EKCDVWSAGVIL 212

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (258), Expect = 7e-24
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 28/211 (13%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKV-----FHLQLEGALESFNAECEVLRS 678
            D + +  +IG G F  V R    + G + A+K+     F      + E    E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL---------EACLYSDNSNLDIFKRLNIV 729
           ++H ++V ++ + ++D    +V ++M    L            +YS+       +     
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----- 137

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQ 786
             I  AL Y H    N ++H D+KP  VLL   +     +LG FG+A  L G+  +    
Sbjct: 138 -QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGG 192

Query: 787 TLATIGYMAPEYGREGQISTEGDVYSFGIML 817
            + T  +MAPE  +        DV+  G++L
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (254), Expect = 1e-23
 Identities = 53/273 (19%), Positives = 87/273 (31%), Gaps = 69/273 (25%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK-VFHLQLEGALESFNAECEVLRSIRHRN 683
             F     +G G FG V+  +  +D    AIK +     E A E    E + L  + H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 684 LVRIISSCTNDDFKALVLDY-------------------MPKGSLEACLYSDNSNLDI-- 722
           +VR  ++      +    +                    M   S++       S  +   
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 723 -------FKRLNIV---------------------IDIALALEY-------LHFGHPNPV 747
                     L I                       +  + L         + F H   +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-----------TIGYMAP 796
           +H D+KPSN+    D V ++GDFG+   +  DE  +   T             T  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE 829
           E       S + D++S G++L E+        E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (257), Expect = 1e-23
 Identities = 44/202 (21%), Positives = 87/202 (43%), Gaps = 20/202 (9%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
            D +++   +GSG+FG V+R      G     K  +        +   E  ++  + H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVIDIALALE 737
           L+ +  +  +     L+L+++  G L      E    S+   ++  +           L+
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR------QACEGLK 163

Query: 738 YLHFGHPNPVVHCDIKPSNVLL--DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           ++H    + +VH DIKP N++    +    ++ DFG+A  L+ DE +K   T AT  + A
Sbjct: 164 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--VTTATAEFAA 218

Query: 796 PEYGREGQISTEGDVYSFGIML 817
           PE      +    D+++ G++ 
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  104 bits (261), Expect = 2e-23
 Identities = 57/313 (18%), Positives = 112/313 (35%), Gaps = 30/313 (9%)

Query: 231 NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL-- 288
                 + NL+   +T          +      +  +    + +       S+  +    
Sbjct: 19  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI------KSVQGIQYLP 65

Query: 289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL 348
           ++ + +L+   +   I K + NL NL  + L  NK+   + S+L  L+KL+ L LE+N +
Sbjct: 66  NVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI 121

Query: 349 EGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTN 408
               ++ +  L +L S+YL +NK++  I      L  L  LS   N+++ +      LT 
Sbjct: 122 --SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVP-LAGLTK 176

Query: 409 ILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ 468
           +  + LS N +S    L    LK L  L L               L     +   D +L 
Sbjct: 177 LQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

Query: 469 GSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKY--LNVSFNRLEGEIPRGGTLA 526
              P  I D    E  ++  ++       S      +        F+    +  +     
Sbjct: 235 --TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTV 292

Query: 527 NFTSESFMGNDLL 539
           ++  +  +    +
Sbjct: 293 SYDVDGTVIKTKV 305

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.0 bits (220), Expect = 2e-18
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 13/187 (6%)

Query: 330 STLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKL 389
                  +     L+   +          L  +  +  +++ +  S+      L ++ KL
Sbjct: 15  FPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 70

Query: 390 SFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPT 449
               N+LT +     NL N+  + L  N +     L+  +LK L  L L  N +S DI  
Sbjct: 71  FLNGNKLTDI-KPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS-DI-N 125

Query: 450 TIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLN 509
            +  L  L++L LG+N +  +    +  L  L+ L L +N +S I    L  L  L+ L 
Sbjct: 126 GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLY 181

Query: 510 VSFNRLE 516
           +S N + 
Sbjct: 182 LSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.9 bits (217), Expect = 4e-18
 Identities = 46/267 (17%), Positives = 98/267 (36%), Gaps = 71/267 (26%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
               + +     +L    +  T   +   +N+++ +  +N+ +        + ++  + L
Sbjct: 15  FPDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFL 72

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           + N+L+     +I                        + NL +L  + L EN +  ++  
Sbjct: 73  NGNKLT-----DIKP----------------------LTNLKNLGWLFLDENKIK-DLS- 103

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA-LPNLEL 189
            + +L+ L++L L  N +  +    L ++  L+ L L NN ++  I+    L+ L  L+ 
Sbjct: 104 SLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITV---LSRLTKLDT 157

Query: 190 FSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN 249
            SL +N                 I ++               +  L+ L L  N+I+   
Sbjct: 158 LSLEDNQ----------------ISDIVP----------LAGLTKLQNLYLSKNHISD-- 189

Query: 250 HELSFISSLANSKKLKVLSLTGNPLLD 276
                + +LA  K L VL L     L+
Sbjct: 190 -----LRALAGLKNLDVLELFSQECLN 211

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.9 bits (217), Expect = 4e-18
 Identities = 51/247 (20%), Positives = 101/247 (40%), Gaps = 30/247 (12%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT---LEILDLSNNQLSGSFPFFNMSSLQV 67
                L+S+  +  + + +      S+  I     +  L L+ N+L+   P  N+ +L  
Sbjct: 37  VTQNELNSIDQIIANNSDI-----KSVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGW 91

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI---GNLTSLTSIDLSENHL 124
           + L +N++  +L +     L  ++ LSL  N        +I    +L  L S+ L  N +
Sbjct: 92  LFLDENKIK-DLSS--LKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKI 143

Query: 125 MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA- 183
                  +  L  L  L L  N +  +VP  L  ++ L+ L L+ N +S  + +   LA 
Sbjct: 144 --TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRA---LAG 195

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           L NL++  L +     K  +   N    +  +  D S     P    +  + ++ N++++
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

Query: 244 YITSSNH 250
               +N 
Sbjct: 254 LPEFTNE 260

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 50.9 bits (121), Expect = 2e-06
 Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 5/117 (4%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
           T  + L  L+ L  L L  NQ+  +    +  +  L+ L LS N +S       + +L V
Sbjct: 144 TDITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDV 201

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           ++L         P N  S L     +           P  I +       ++  +  
Sbjct: 202 LELFSQECL-NKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP 255

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (254), Expect = 3e-23
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH-LQLEGA-LESFNAECEVLRSIRH 681
           +D ++V   +G G+F  V R      G+E A K+ +  +L     +    E  + R ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALAL 736
            N+VR+  S   + F  LV D +  G L         YS+       +       I  ++
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESI 141

Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
            Y H    N +VH ++KP N+LL    +    +L DFG+A  ++  E+        T GY
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGY 196

Query: 794 MAPEYGREGQISTEGDVYSFGIML 817
           ++PE  ++   S   D+++ G++L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  100 bits (251), Expect = 3e-23
 Identities = 50/255 (19%), Positives = 99/255 (38%), Gaps = 19/255 (7%)

Query: 255 ISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL 314
           I           ++   + + D V  + +  +             +  +I   +  L NL
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVTQADLDGI----TTLSAFGTGVT-TIE-GVQYLNNL 65

Query: 315 IIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG 374
           I + L  N++  +  + L  L K+  L L  N L  + +  I  L  + ++ L   +++ 
Sbjct: 66  IGLELKDNQI--TDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121

Query: 375 SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV 434
             P     L++L+ L    N++T +      LTN+  + + +  +S   PL   NL  L 
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLT 176

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
            L    N +S DI   +  L NL  + L +N +    P  + +  +L  + L+N  ++  
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232

Query: 495 IPSSLEKLLYLKYLN 509
                  L+    + 
Sbjct: 233 PVFYNNNLVVPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 50/266 (18%), Positives = 101/266 (37%), Gaps = 24/266 (9%)

Query: 229 FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL 288
             ++  +  L+     +T+       I  +     L  L L  N + D    + + NL+ 
Sbjct: 37  QADLDGITTLSAFGTGVTT-------IEGVQYLNNLIGLELKDNQITD---LAPLKNLT- 85

Query: 289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL 348
            +    L    +       +  L ++  + L   ++    P  L+ L  LQ+L L+ NQ+
Sbjct: 86  KITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI 141

Query: 349 EGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTN 408
               +  +  L  L  + + + ++S   P    NL+ L  L    N+++ +     +L N
Sbjct: 142 TN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP-LASLPN 196

Query: 409 ILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ 468
           ++ V L +N +S   PL   N   L  + L+   ++         L     +     +  
Sbjct: 197 LIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK--GPSGA 252

Query: 469 GSIPNSIGDLISLECLDLSNNILSGI 494
              P +I D  +    +L+ N+ S I
Sbjct: 253 PIAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 54/274 (19%), Positives = 102/274 (37%), Gaps = 28/274 (10%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSD 72
             +L++   +    + +  T   +   ++ +  L      ++       +++L  ++L D
Sbjct: 15  DPALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKD 72

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI 132
           N+++   P      L  +  L L+ N         I  L S+ ++DL+   +    P  +
Sbjct: 73  NQITDLAP---LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--L 125

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA-LPNLELFS 191
             L NLQ L L  N +  + P  L  ++ L+ L + N      +S    LA L  L    
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNA----QVSDLTPLANLSKLTTLK 179

Query: 192 LANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHE 251
             +N  S  I     +   L    L +N  S   P    N  NL  + L    IT+    
Sbjct: 180 ADDNKIS-DISPLA-SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN---- 231

Query: 252 LSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGN 285
                 +  +  L V ++   P    + P++I +
Sbjct: 232 ----QPVFYNNNLVVPNVVKGPSGAPIAPATISD 261

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 51/277 (18%), Positives = 101/277 (36%), Gaps = 27/277 (9%)

Query: 48  LSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE 107
                ++  FP   +++   I    + ++  +     + L  +  LS         +   
Sbjct: 4   TQPTAINVIFPDPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TIE-G 58

Query: 108 IGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQL 167
           +  L +L  ++L +N +  ++   + NL  +  L L  N L  V    +  + ++K L L
Sbjct: 59  VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDL 114

Query: 168 TNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPN 227
           T+  ++     +    L NL++  L  N  +  I   +   + L    + +   S   P 
Sbjct: 115 TSTQITDVTPLA---GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP- 168

Query: 228 RFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS 287
              N+  L  L  + N I+        IS LA+   L  + L  N + D    S + N S
Sbjct: 169 -LANLSKLTTLKADDNKISD-------ISPLASLPNLIEVHLKNNQISD---VSPLANTS 217

Query: 288 LSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKL 324
            ++    L N  I         NL+   +++      
Sbjct: 218 -NLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 16/239 (6%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
             +  L++L  L+L  NQ+  T  + + ++  +  L+LS N L        + S++ +DL
Sbjct: 57  EGVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDL 114

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           +  +++   P    + L  +Q L L  NQ   ++   +  LT+L  + +    +    P 
Sbjct: 115 TSTQITDVTP---LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP- 168

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
            + NL  L  L    N +  + P  L ++  L  + L NN +S     S      NL + 
Sbjct: 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS---DVSPLANTSNLFIV 222

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN 249
           +L N   + +   +  N    ++  +   S +   P    +       NL +N  +  N
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNV--VKGPSGAPIAPATISDNGTYASPNLTWNLTSFIN 279

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 3e-23
 Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 64/236 (27%)

Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF--------------------------H 659
           Q+ + + IG GS+G V       D    A+KV                            
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 660 LQLEGALESFNAECEVLRSIRHRNLVR---IISSCTNDDFKALVLDYMPKGSL------- 709
           +Q  G +E    E  +L+ + H N+V+   ++     D    +V + + +G +       
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132

Query: 710 -----EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV 764
                +A  Y        F+      D+   +EYLH+     ++H DIKPSN+L+ ED  
Sbjct: 133 PLSEDQARFY--------FQ------DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGH 175

Query: 765 ARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE---YGREGQISTEGDVYSFGIML 817
            ++ DFG++    G +++    T+ T  +MAPE     R+       DV++ G+ L
Sbjct: 176 IKIADFGVSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 28/203 (13%), Positives = 56/203 (27%), Gaps = 42/203 (20%)

Query: 633 LIGSGSFGSVYRGRFLD---GMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVR 686
             G       ++    D     +VA+     Q    +  L+   +    L  I    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           ++          +V +++  GSL+      +++      +  +  +A A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIST 806
           V      PS V +  D    L                          M          + 
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181

Query: 807 EGDVYSFGIMLMEIFTRKRPTDE 829
           + D+   G  L  +   + P  E
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPE 204

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  103 bits (258), Expect = 3e-23
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 38/212 (17%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVF---HLQLEGALESFNAECEVLRSIR 680
           +D++    ++G GSFG V   +  + G E A+KV     ++ +   ES   E ++L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------------NI 728
           H N++++     +  +  LV +    G L             F  +             I
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARI 131

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHT 785
           +  +   + Y+H    N +VH D+KP N+LL    +D   R+ DFG++      + M   
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--K 186

Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
             + T  Y+APE    G    + DV+S G++L
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVIL 217

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  101 bits (254), Expect = 4e-23
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 41/222 (18%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
           D F +   IG GSFG V   +  D  ++ A+K            + +   E ++++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNI 728
             LV +  S  +++   +V+D +  G L                L+              
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-------------- 120

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           + ++ +AL+YL       ++H D+KP N+LLDE     + DF IA +L  +       T+
Sbjct: 121 ICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTM 174

Query: 789 A-TIGYMAPE-YGREGQI--STEGDVYSFGIMLMEIFTRKRP 826
           A T  YMAPE +        S   D +S G+   E+   +RP
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (257), Expect = 4e-23
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRH 681
           ++ +     +GSG++G V   R     +E AIK+         +      E  VL+ + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKR--------LNIVIDI 732
            N++++     +     LV++    G L           D I  R          I+  +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----------FDEIIHRMKFNEVDAAVIIKQV 145

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLA 789
              + YLH    + +VH D+KP N+LL   ++D + ++ DFG++ +    + M   + L 
Sbjct: 146 LSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLG 200

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
           T  Y+APE  R  +   + DV+S G++L  +     P       EI 
Sbjct: 201 TAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =   99 bits (249), Expect = 8e-23
 Identities = 49/270 (18%), Positives = 91/270 (33%), Gaps = 22/270 (8%)

Query: 18  SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDLSDNRL 75
           S +      +++   IPS +        L     +L       F     L+ I++S N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 76  SGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI-G 133
              + A++FS LP +  + +       ++  E   NL +L  + +S   +   +P     
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKI 125

Query: 134 NLRNLQALGLLSNNLVGVVPATLFN--ISTLKILQLTNNTLSGSISSSIRLALPNLELFS 191
           +      L +  N  +  +    F        IL L  N +   I +S        EL  
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184

Query: 192 LANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
             NNN   ++P+ +F  AS   I ++              N++ L+  +          +
Sbjct: 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST---------Y 234

Query: 251 ELSFISSLANSKKLKVLSLTGNPLLDCVLP 280
            L  + +L     L   SLT          
Sbjct: 235 NLKKLPTLEKLVALMEASLTYPSHCCAFAN 264

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 92.6 bits (230), Expect = 2e-20
 Identities = 48/316 (15%), Positives = 92/316 (29%), Gaps = 29/316 (9%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSGSFP---FFNMS 63
            +PS L    +   L     + L  I    FS    LE +++S N +        F N+ 
Sbjct: 23  EIPSDL--PRNAIELRFVLTK-LRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79

Query: 64  SLQVIDLSD-NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
            L  I +   N L   +    F  LP +Q+L ++             +      +D+ +N
Sbjct: 80  KLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138

Query: 123 HLMGEIPHEI--GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
             +  I      G       L L  N +  +  +        ++    NN L   + + +
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDV 197

Query: 181 RLALPNLELFSLANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
                   +  ++       +PS+   N  KL        +           +  L E +
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRA--RSTYNLKKLPT--LEKLVALMEAS 252

Query: 240 LEYNY-----------ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL 288
           L Y             I+  +   +          +       + L +    S      +
Sbjct: 253 LTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDM 312

Query: 289 SMERFYLHNCNIRGSI 304
           +   F    CN    +
Sbjct: 313 TYTEFDYDLCNEVVDV 328

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 37/204 (18%), Positives = 75/204 (36%), Gaps = 9/204 (4%)

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQ----LEGRILDDICRLARLSSVYLD 368
           N I +R    KL        S    L+ + +  N     +E  +  ++ +L  +      
Sbjct: 31  NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR--IEK 88

Query: 369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI 427
            N L    P  F NL +L+ L  ++  +  +P     +    +++D+  N    ++    
Sbjct: 89  ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 428 --GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLD 485
             G     V L+L++N +     +   G +  +     +NNL+    +          LD
Sbjct: 149 FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208

Query: 486 LSNNILSGIIPSSLEKLLYLKYLN 509
           +S   +  +    LE L  L+  +
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARS 232

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 51/307 (16%), Positives = 95/307 (30%), Gaps = 62/307 (20%)

Query: 113 SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL 172
           S       E+ +  EIP ++   RN   L  +   L  +          L+ ++++ N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
              I + +   LP L    +   N               ++  +         P  F N+
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKAN---------------NLLYIN--------PEAFQNL 103

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
            NL+ L +    I     ++  I SL    +  +L +  N  +  +  +S   LS     
Sbjct: 104 PNLQYLLISNTGIKHL-PDVHKIHSL----QKVLLDIQDNINIHTIERNSFVGLSFESVI 158

Query: 293 FYLHNCNIRGSIPKEMGNLINLI-IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGR 351
            +L+   I+  I     N   L  +     N L               IL +   ++   
Sbjct: 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-- 215

Query: 352 ILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPSTFWNLTNIL 410
                                  S+P+    NL  LR  S  +  L  +P+    L  ++
Sbjct: 216 -----------------------SLPSYGLENLKKLRARS--TYNLKKLPT-LEKLVALM 249

Query: 411 MVDLSSN 417
              L+  
Sbjct: 250 EASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.8 bits (202), Expect = 8e-17
 Identities = 45/261 (17%), Positives = 88/261 (33%), Gaps = 38/261 (14%)

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
           RN  EL      +           + +    L+ + ++ N +L+ +      NL   +  
Sbjct: 30  RNAIELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEADVFSNLP-KLHE 83

Query: 293 FYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
             +   N    I                        P     L  LQ L + N  ++  +
Sbjct: 84  IRIEKANNLLYIN-----------------------PEAFQNLPNLQYLLISNTGIK-HL 119

Query: 353 LDDI-CRLARLSSVYLDHNKLSGSIPA-CFGNLAS-LRKLSFASNELTFVPSTFWNLTNI 409
            D       +   + +  N    +I    F  L+     L    N +  + ++ +N T +
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQL 179

Query: 410 LMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ 468
             ++LS N     LP ++       V L +SR  +   +P+   GL+NL+ L        
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNL 236

Query: 469 GSIPNSIGDLISLECLDLSNN 489
             +P ++  L++L    L+  
Sbjct: 237 KKLP-TLEKLVALMEASLTYP 256

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 8e-23
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 31/207 (14%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
              + + N IG GS+G V         +  A K         ++ F  E E+++S+ H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVIDIALALEY 738
           ++R+  +  ++    LV++    G L        ++ ++    I K      D+  A+ Y
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 121

Query: 739 LHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
            H      V H D+KP N L      D   +L DFG+A      + M+    + T  Y++
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR--TKVGTPYYVS 176

Query: 796 PE-----YGREGQISTEGDVYSFGIML 817
           P+     YG       E D +S G+M+
Sbjct: 177 PQVLEGLYG------PECDEWSAGVMM 197

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 38/210 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
           +D F V + +G G+   VYR +        A+KV    ++   +    E  VL  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------------NIVID 731
           ++++          +LVL+ +  G L             F R+            + V  
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQ 156

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTL 788
           I  A+ YLH    N +VH D+KP N+L      D   ++ DFG++K++     MK   T+
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TV 210

Query: 789 A-TIGYMAPEYGREGQISTEGDVYSFGIML 817
             T GY APE  R      E D++S GI+ 
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 55/195 (28%), Positives = 80/195 (41%), Gaps = 14/195 (7%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSGSFP---FFNMSSL 65
                S   LQ LDLS  + + TI    +   + L  L L+ N +  S     F  +SSL
Sbjct: 45  SYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF-AGHLPREIGNLTSLTSIDLSENHL 124
           Q +   +  L+  L      +L  ++ L++A N   +  LP    NLT+L  +DLS N +
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 125 MGEIPHEI-GNLRNLQALGL---LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
              I       L  +  L L   LS N +  +    F    LK L L  N L  S+   I
Sbjct: 162 -QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGI 219

Query: 181 RLALPNLELFSLANN 195
              L +L+   L  N
Sbjct: 220 FDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 30/232 (12%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSD 72
            S + LDLSFN L   + S  F S   L++LDLS  ++  +     + ++S L  + L+ 
Sbjct: 28  FSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI 132
           N +   L    FS L  +Q L       A      IG+L +L  ++++ N +      E 
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 133 -GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFS 191
             NL NL+ L L SN +   +  T      L  + L N +L                   
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDL--RVLHQMPLLNLSL------------------D 183

Query: 192 LANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
           L+ N  +  I    F   +L    L  N         F  + +L+++ L  N
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 19/213 (8%)

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL---EGRILDDICRLARLSSVYLDH 369
           +   + L +N L      +     +LQ+L L   ++   E         L+ LS++ L  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ---SLSHLSTLILTG 85

Query: 370 NKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLE- 426
           N +  S+    F  L+SL+KL      L  + +    +L  +  ++++ N +  S  L  
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143

Query: 427 -IGNLKVLVELYLSRNNLSGDIPT-TIGGLKNLQ----NLSLGDNNLQGSIPNSIGDLIS 480
              NL  L  L LS N +   I    +  L  +     +L L  N +   I       I 
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201

Query: 481 LECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
           L+ L L  N L  +     ++L  L+ + +  N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 16/205 (7%)

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLAS 385
            IP  L      + L L  N L             L  + L   ++  +I    + +L+ 
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 386 LRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNL 443
           L  L    N +  +    F  L+++  +      L+ SL     G+LK L EL ++ N +
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 444 -SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLEC----LDLSNNILSGIIPS 497
            S  +P     L NL++L L  N +Q SI  +    L  +      LDLS N ++ I   
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QP 194

Query: 498 SLEKLLYLKYLNVSFNRLEGEIPRG 522
              K + LK L +  N+L+  +P G
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 22/214 (10%)

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLA--NSKKLKVLSLTGN 272
           +L  N         F +   L+ L+L    I +       I   A  +   L  L LTGN
Sbjct: 34  DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-------IEDGAYQSLSHLSTLILTGN 86

Query: 273 PLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPS- 330
           P+    L     +   S+++      N+  S+     G+L  L  + + +N +  S    
Sbjct: 87  PIQS--LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP 142

Query: 331 -TLSRLEKLQILGLENNQL---EGRILDDICRLARLS-SVYLDHNKLSGSIPACFGNLAS 385
              S L  L+ L L +N++       L  + ++  L+ S+ L  N ++   P  F  +  
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-R 201

Query: 386 LRKLSFASNELTFVPS-TFWNLTNILMVDLSSNP 418
           L++L+  +N+L  VP   F  LT++  + L +NP
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 36/181 (19%), Positives = 66/181 (36%), Gaps = 42/181 (23%)

Query: 357 CRLARLSSV-----------YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFW 404
           C       +            L  N L       F +   L+ L  +  E+  +    + 
Sbjct: 14  CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73

Query: 405 NLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLG 463
           +L++                        L  L L+ N +   +      GL +LQ L   
Sbjct: 74  SLSH------------------------LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108

Query: 464 DNNLQGSIPNSI-GDLISLECLDLSNN-ILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR 521
           + NL  S+ N   G L +L+ L++++N I S  +P     L  L++L++S N+++  I  
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166

Query: 522 G 522
            
Sbjct: 167 T 167

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 36/140 (25%), Positives = 51/140 (36%), Gaps = 7/140 (5%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI- 451
                 +P      T  L  DLS NPL         +   L  L LSR  +   I     
Sbjct: 16  ELNFYKIPDNLPFSTKNL--DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAY 72

Query: 452 GGLKNLQNLSLGDNNLQGSIPNSI-GDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNV 510
             L +L  L L  N +Q S+       L SL+ L      L+ +    +  L  LK LNV
Sbjct: 73  QSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 511 SFNRLEGEIPRGGTLANFTS 530
           + N ++         +N T+
Sbjct: 132 AHNLIQ-SFKLPEYFSNLTN 150

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 51/216 (23%), Positives = 80/216 (37%), Gaps = 41/216 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH------LQLEGALESFNAECEVLR 677
            D + +   +GSG F  V + R    G E A K          +   + E    E  +LR
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL----------- 726
            IRH N++ +     N     L+L+ +  G L             F  L           
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEA 110

Query: 727 -NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDES 781
              +  I   + YLH      + H D+KP N++L      +   +L DFGIA  +     
Sbjct: 111 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
            K      T  ++APE      +  E D++S G++ 
Sbjct: 168 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (251), Expect = 1e-22
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 34/214 (15%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFH--------LQLEGALESFNAECEV 675
            D++ ++  +GSG+ G V          +VAI++           +      +   E E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVI 730
           L+ + H  +++I +    +D+  +VL+ M  G L           + +    F       
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------ 246

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQT 787
            + LA++YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L     M+   T
Sbjct: 247 QMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---T 300

Query: 788 LA-TIGYMAPE---YGREGQISTEGDVYSFGIML 817
           L  T  Y+APE          +   D +S G++L
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 46/220 (20%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH--------LQLEGALESFNAECEV 675
            D++ ++  +GSG+ G V          +VAIK+           +      +   E E+
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-----EACLYSDNSNLDIFKRLNIVI 730
           L+ + H  +++I +    +D+  +VL+ M  G L           + +    F       
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------ 121

Query: 731 DIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQT 787
            + LA++YLH    N ++H D+KP NVLL   +ED + ++ DFG +K+L     M+   T
Sbjct: 122 QMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---T 175

Query: 788 LA-TIGYMAPE---------YGREGQISTEGDVYSFGIML 817
           L  T  Y+APE         Y R        D +S G++L
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNR------AVDCWSLGVIL 209

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  100 bits (252), Expect = 1e-22
 Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 35/211 (16%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF--HLQLEGALESFNAECEVLRSIRH 681
           T+++ +   +G G+F  V R   +  G E A  +           +    E  + R ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL------------NIV 729
            N+VR+  S + +    L+ D +  G L             F+ +            + +
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCI 116

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQ 786
             I  A+ + H      VVH ++KP N+LL    +    +L DFG+A  + G++      
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172

Query: 787 TLATIGYMAPEYGREGQISTEGDVYSFGIML 817
              T GY++PE  R+       D+++ G++L
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 26/207 (12%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFH-LQLEGALESFNAECEVLRSIRHR 682
            D F     +GSG+FG V+       G+E  IK  +  + +  +E   AE EVL+S+ H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSL---------EACLYSDNSNLDIFKRLNIVIDIA 733
           N+++I     +     +V++    G L              S+    ++ K       + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK------QMM 134

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
            AL Y H      VVH D+KP N+L          ++ DFG+A+L   DE         T
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST--NAAGT 189

Query: 791 IGYMAPEYGREGQISTEGDVYSFGIML 817
             YMAPE  +   ++ + D++S G+++
Sbjct: 190 ALYMAPEVFK-RDVTFKCDIWSAGVVM 215

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (251), Expect = 2e-22
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL-QLEGA-LESFNAECEVLRSIRH 681
            +++N+  ++G GSFG V + +      E A+KV +    +     +   E E+L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKR--------LNIVIDI 732
            N++++     +     +V +    G L           D I KR          I+  +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----------FDEIIKRKRFSEHDAARIIKQV 130

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLA 789
              + Y+H    + +VH D+KP N+LL   ++D   ++ DFG++     +  M     + 
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG 185

Query: 790 TIGYMAPEYGREGQISTEGDVYSFGIML 817
           T  Y+APE  R G    + DV+S G++L
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVIL 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  100 bits (251), Expect = 2e-22
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 47/238 (19%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKV-------------FHLQLEGALESFN 670
            + +     +GSG++G V   +      E AIKV              +  +E   E   
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 671 AECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKR---- 725
            E  +L+S+ H N++++     +  +  LV ++   G L           + I  R    
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----------FEQIINRHKFD 144

Query: 726 ----LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSG 778
                NI+  I   + YLH    + +VH DIKP N+LL   +  +  ++ DFG++   S 
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
           D  +     L T  Y+APE  +  + + + DV+S G+++  +     P       +I 
Sbjct: 202 DYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 3e-22
 Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
            D ++++  +G+G+FG V+R      G   A K      E   E+   E + +  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVIDIALALE 737
           LV +  +  +D+   ++ ++M  G L      E    S++  ++  +       +   L 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR------QVCKGLC 269

Query: 738 YLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           ++H    N  VH D+KP N++      + + +L DFG+   L   +S+K   T  T  + 
Sbjct: 270 HMHE---NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVK--VTTGTAEFA 323

Query: 795 APEYGREGQISTEGDVYSFGIML 817
           APE      +    D++S G++ 
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLS 346

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 16/195 (8%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMS 63
            +PS     +  + LDL  N+L  ++PS  F  +  L +L L++N+L  + P   F  + 
Sbjct: 30  AIPS--NIPADTKKLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
           +L+ + ++DN+L   LP  +F  L  +  L L  NQ    LP  +  +LT LT + L  N
Sbjct: 86  NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143

Query: 123 HLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSI 180
            L   +P  +   L +L+ L L +N L   VP   F  ++ LK L+L NN L   +    
Sbjct: 144 EL-QSLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

Query: 181 RLALPNLELFSLANN 195
             +L  L++  L  N
Sbjct: 201 FDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 58/161 (36%), Positives = 80/161 (49%), Gaps = 8/161 (4%)

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLP 424
            L  NKLS      F  L  LR L    N+L  +P+  F  L N+  + ++ N L  +LP
Sbjct: 43  DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALP 101

Query: 425 LEI-GNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISL 481
           + +   L  L EL L RN L   +P  +   L  L  LSLG N LQ S+P  + D L SL
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159

Query: 482 ECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
           + L L NN L  +   + +KL  LK L +  N+L+  +P G
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 15/191 (7%)

Query: 328 IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASL 386
           IP+   +L+      L++N+L         RL +L  +YL+ NKL  ++PA  F  L +L
Sbjct: 35  IPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87

Query: 387 RKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLS 444
             L    N+L  +P   F  L N+  + L  N L  SLP  +  +L  L  L L  N L 
Sbjct: 88  ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146

Query: 445 GDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKL 502
             +P  +   L +L+ L L +N L+  +P    D L  L+ L L NN L  +   + + L
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204

Query: 503 LYLKYLNVSFN 513
             LK L +  N
Sbjct: 205 EKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 24/194 (12%)

Query: 234 NLKELNLEYNYITSSNHELSFISSLA--NSKKLKVLSLTGNPLLDCVLPSSIGNLSLSME 291
           + K+L+L+ N ++S       + S A     KL++L L  N L    LP+ I     ++E
Sbjct: 38  DTKKLDLQSNKLSS-------LPSKAFHRLTKLRLLYLNDNKLQT--LPAGIFKELKNLE 88

Query: 292 RFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPSTL-SRLEKLQILGLENNQLE 349
             ++ +  ++ ++P  +   L+NL  +RL  N+L  S+P  +   L KL  L L  N+L+
Sbjct: 89  TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146

Query: 350 ---GRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVP-STFW 404
                + D   +L  L  + L +N+L   +P   F  L  L+ L   +N+L  VP   F 
Sbjct: 147 SLPKGVFD---KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

Query: 405 NLTNILMVDLSSNP 418
           +L  + M+ L  NP
Sbjct: 203 SLEKLKMLQLQENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 48/132 (36%), Positives = 67/132 (50%), Gaps = 7/132 (5%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI- 451
           S +LT +PS     T  L  DL SN LS         L  L  LYL+ N L   +P  I 
Sbjct: 25  SKKLTAIPSNIPADTKKL--DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF 81

Query: 452 GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNV 510
             LKNL+ L + DN LQ ++P  + D L++L  L L  N L  + P   + L  L YL++
Sbjct: 82  KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140

Query: 511 SFNRLEGEIPRG 522
            +N L+  +P+G
Sbjct: 141 GYNELQ-SLPKG 151

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 19/191 (9%)

Query: 186 NLELFSLANNNFSGKIPSFIFNA-SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY 244
           + +   L +N  S  +PS  F+  +KL +  L DN         F  ++NL+ L +  N 
Sbjct: 38  DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96

Query: 245 ITSSNHELSFISS--LANSKKLKVLSLTGNPLLDCVLPSSI-GNLSLSMERFYLHNCNIR 301
           + +       +          L  L L  N L    LP  +  +L+  +    L    ++
Sbjct: 97  LQA-------LPIGVFDQLVNLAELRLDRNQLKS--LPPRVFDSLT-KLTYLSLGYNELQ 146

Query: 302 GSIPKEM-GNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQLEGRILDDICRL 359
            S+PK +   L +L  +RL  N+L   +P     +L +L+ L L+NNQL+         L
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204

Query: 360 ARLSSVYLDHN 370
            +L  + L  N
Sbjct: 205 EKLKMLQLQEN 215

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 37/202 (18%), Positives = 81/202 (40%), Gaps = 21/202 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
            +++ +   +G G FG V+R            K   ++          E  +L   RHRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRN 62

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVIDIALALE 737
           ++ +  S  + +   ++ +++    +       A   ++   +           +  AL+
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------QVCEALQ 116

Query: 738 YLHFGHPNPVVHCDIKPSNVLL--DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
           +LH    + + H DI+P N++         ++ +FG A+ L   ++ +         Y A
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR--LLFTAPEYYA 171

Query: 796 PEYGREGQISTEGDVYSFGIML 817
           PE  +   +ST  D++S G ++
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 5e-22
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 22/223 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
           D F    ++G G FG V+  +     ++ A K      L+     +    E ++L  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALEY 738
           R +V +  +        LV+  M  G +   +Y+ + +   F+    +     I   LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPE 797
           LH      +++ D+KP NVLLD+D   R+ D G+A  L   ++   T+  A T G+MAPE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359

Query: 798 YGREGQISTEGDVYSFGIMLMEIFT---------RKRPTDEIF 831
                +     D ++ G+ L E+            K    E+ 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 97.2 bits (242), Expect = 6e-22
 Identities = 50/245 (20%), Positives = 83/245 (33%), Gaps = 55/245 (22%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVF-----HLQLEGALESFNAECEVLRS 678
             ++++   IG GS+G V            AIK+             +E    E  +++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL---------------------------EA 711
           + H N+ R+     ++ +  LV++    G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 712 CLYSDNSNLDIFKRL------------NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL 759
           C     +      R             NI+  I  AL YLH      + H DIKP N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 760 --DEDMVARLGDFGIAKLL---SGDESMKHTQTLATIGYMAPE--YGREGQISTEGDVYS 812
             ++    +L DFG++K     +  E    T    T  ++APE           + D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 813 FGIML 817
            G++L
Sbjct: 262 AGVLL 266

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 97.4 bits (243), Expect = 7e-22
 Identities = 48/216 (22%), Positives = 80/216 (37%), Gaps = 41/216 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH------LQLEGALESFNAECEVLR 677
            D +++   +GSG F  V + R    G+E A K          +     E    E  +LR
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL----------- 726
            + H N++ +     N     L+L+ +  G L             F  L           
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117

Query: 727 -NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDES 781
            + +  I   + YLH      + H D+KP N++L          +L DFG+A  +     
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
            K      T  ++APE      +  E D++S G++ 
Sbjct: 175 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 56/247 (22%), Positives = 105/247 (42%), Gaps = 34/247 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNA----ECEVLRSIRH 681
           +++     +G G++G VY+ +   G  VA+K   L  E   E   +    E  +L+ + H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHH 78

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+V +I    ++    LV ++M K  L+  L  + + L   +    +  +   + + H 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH- 136

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YG 799
              + ++H D+KP N+L++ D   +L DFG+A+   G     +T  + T+ Y AP+   G
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMG 193

Query: 800 REGQISTEGDVYSFGIMLMEIFTRK--------------------RPTDEIFSGEMSLKR 839
            + + ST  D++S G +  E+ T K                     P    +     L  
Sbjct: 194 SK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252

Query: 840 WVNDSLP 846
           W   +  
Sbjct: 253 WKQRTFQ 259

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 45/214 (21%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVL-RSIRHR 682
           TD + V   IG GS+    R       ME A+K+         E    E E+L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLN--------IVIDIA 733
           N++ +     +  +  +V + M  G L          LD I ++          ++  I 
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSEREASAVLFTIT 126

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDESMKHTQTLA 789
             +EYLH      VVH D+KPSN+L           R+ DFG AK L  +  +  T    
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCY 182

Query: 790 TIGYMAPE------YGREGQISTEGDVYSFGIML 817
           T  ++APE      Y          D++S G++L
Sbjct: 183 TANFVAPEVLERQGYDA------ACDIWSLGVLL 210

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 48/216 (22%), Positives = 81/216 (37%), Gaps = 41/216 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH------LQLEGALESFNAECEVLR 677
            D +++   +GSG F  V + R    G+E A K          +   + E    E  +LR
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL----------- 726
            + H N++ +     N     L+L+ +  G L             F  L           
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117

Query: 727 -NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDES 781
            + +  I   + YLH      + H D+KP N++L          +L DFG+A  +     
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
            K      T  ++APE      +  E D++S G++ 
Sbjct: 175 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 22/194 (11%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT 692
           +G G FG V++      G+++A K+   +     E    E  V+  + H NL+++  +  
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156

Query: 693 NDDFKALVLDYMPKGSL------EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP 746
           + +   LV++Y+  G L      E+   ++   +   K       I   + ++H      
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK------QICEGIRHMHQ---MY 207

Query: 747 VVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
           ++H D+KP N+L    D   + ++ DFG+A+     E +K      T  ++APE      
Sbjct: 208 ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLK--VNFGTPEFLAPEVVNYDF 264

Query: 804 ISTEGDVYSFGIML 817
           +S   D++S G++ 
Sbjct: 265 VSFPTDMWSVGVIA 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 46/216 (21%), Positives = 80/216 (37%), Gaps = 41/216 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFH------LQLEGALESFNAECEVLR 677
            D ++    +GSG F  V + R    G++ A K          +   + E    E  +L+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRL----------- 726
            I+H N++ +     N     L+L+ +  G L             F  L           
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL-------------FDFLAEKESLTEEEA 116

Query: 727 -NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAKLLSGDES 781
              +  I   + YLH      + H D+KP N++L          ++ DFG+A  +     
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
            K      T  ++APE      +  E D++S G++ 
Sbjct: 174 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 45/198 (22%), Positives = 83/198 (41%), Gaps = 31/198 (15%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSC 691
           +G GSF    +          A+K+   ++E   +    E   L+    H N+V++    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 692 TNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLN--------IVIDIALALEYLHFG 742
            +     LV++ +  G L           + I K+ +        I+  +  A+ ++H  
Sbjct: 76  HDQLHTFLVMELLNGGEL----------FERIKKKKHFSETEASYIMRKLVSAVSHMHD- 124

Query: 743 HPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
               VVH D+KP N+L    ++++  ++ DFG A+L   D     T    T+ Y APE  
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELL 181

Query: 800 REGQISTEGDVYSFGIML 817
            +       D++S G++L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.9 bits (237), Expect = 2e-21
 Identities = 52/216 (24%), Positives = 103/216 (47%), Gaps = 18/216 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA----ECEVLRSIR 680
            ++     IG G++G+V++ +  +    VA+K   L  +   E   +    E  +L+ ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H+N+VR+     +D    LV ++  +  L+    S N +LD     + +  +   L + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--Y 798
                 V+H D+KP N+L++ +   +L +FG+A+   G     ++  + T+ Y  P+  +
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 799 GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
           G +   ST  D++S G +  E+    RP   +F G 
Sbjct: 175 GAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 50/158 (31%), Positives = 68/158 (43%), Gaps = 5/158 (3%)

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL 425
           +L  N L     A       L +L+    ELT +      L  +  +DLS N L  SLPL
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-VDGTLPVLGTLDLSHNQLQ-SLPL 94

Query: 426 EIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECL 484
               L  L  L +S N L+      + GL  LQ L L  N L+ ++P  +      LE L
Sbjct: 95  LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153

Query: 485 DLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
            L+NN L+ +    L  L  L  L +  N L   IP+G
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 9/179 (5%)

Query: 338 LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT 397
             IL L  N L    L  +    RL+ + LD  +L+  +    G L  L  L  + N+L 
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ 90

Query: 398 FVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI-GGLK 455
            +P     L  + ++D+S N L+ SLPL     L  L ELYL  N L   +P  +     
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148

Query: 456 NLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN 513
            L+ LSL +NNL   +P  + + L +L+ L L  N L   IP        L +  +  N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 50/192 (26%), Positives = 72/192 (37%), Gaps = 14/192 (7%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFPFFNMSSLQ 66
            +P           L LS N L  T   +       L  L+L   +L+       +  L 
Sbjct: 24  ALPP--DLPKDTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLG 80

Query: 67  VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLM 125
            +DLS N+L   LP  +   LP +  L ++FN+    LP      L  L  + L  N L 
Sbjct: 81  TLDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137

Query: 126 GEIPHEI-GNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSIRLA 183
             +P  +      L+ L L +NNL   +PA L   +  L  L L  N+L  +I       
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGF-FG 193

Query: 184 LPNLELFSLANN 195
              L    L  N
Sbjct: 194 SHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 44/166 (26%), Positives = 65/166 (39%), Gaps = 10/166 (6%)

Query: 359 LARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPST-FWNLTNILMVDLSSN 417
           +A    V  D   L+ ++P           L  + N L           T +  ++L   
Sbjct: 9   VASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 418 PLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD 477
            L+  L ++ G L VL  L LS N L   +P     L  L  L +  N L  S+P     
Sbjct: 66  ELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121

Query: 478 -LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
            L  L+ L L  N L  + P  L     L+ L+++ N L  E+P G
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAG 166

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 20/190 (10%)

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERF 293
           +   L+L  N + + +      ++L    +L  L+L    L    L        L     
Sbjct: 32  DTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL--GTL 82

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQL---E 349
            L +  ++ S+P     L  L ++ + +N+L  S+P   L  L +LQ L L+ N+L    
Sbjct: 83  DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLP 140

Query: 350 GRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPSTFWNLTN 408
             +L       +L  + L +N L+  +PA     L +L  L    N L  +P  F+    
Sbjct: 141 PGLLT---PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL 196

Query: 409 ILMVDLSSNP 418
           +    L  NP
Sbjct: 197 LPFAFLHGNP 206

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 9/148 (6%)

Query: 377 PAC-FGNLASLRKLSFASNELTFVPSTFWNL-TNILMVDLSSNPLSGSLPLEIGNLKVLV 434
           P C    +AS  +++     LT +P    +L  +  ++ LS N L       +     L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
           +L L R  L+  +    G L  L  L L  N LQ S+P     L +L  LD+S N L+ +
Sbjct: 59  QLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 495 IPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
              +L  L  L+ L +  N L+  +P G
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPG 142

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 36/241 (14%)

Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNA-----ECEVLR 677
           +++  + +GSG+FG V+         EV +K      +  +  +E         E  +L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY---SDNSNLD------IFKRLNI 728
            + H N+++++    N  F  LV++    G L+  L+     +  LD      IF++   
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQ--- 138

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
              +  A+ YL       ++H DIK  N+++ ED   +L DFG A  L   +   +T   
Sbjct: 139 ---LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF-YT-FC 190

Query: 789 ATIGYMAPE-YGREGQISTEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVNDS 844
            TI Y APE          E +++S G+ L  +   + P    +E     +     V+  
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250

Query: 845 L 845
           L
Sbjct: 251 L 251

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 94.7 bits (236), Expect = 8e-21
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 53/237 (22%)

Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR 682
           Q    +    +IG+GSFG V++ + ++  EVAIK             N E +++R ++H 
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK----NRELQIMRIVKHP 92

Query: 683 NLVR----IISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL-- 734
           N+V       S+    D     LVL+Y+P+      +Y        + +L   + + L  
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-----TVYRA---SRHYAKLKQTMPMLLIK 144

Query: 735 --------ALEYLH-FGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKH 784
                   +L Y+H  G    + H DIKP N+LLD    V +L DFG AK+L   E    
Sbjct: 145 LYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-- 198

Query: 785 TQTLATIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
              + +  Y APE       Y      +T  D++S G ++ E+   + P   +F GE
Sbjct: 199 VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ-P---LFPGE 245

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 38/210 (18%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISS 690
           ++G G+   V     L    E A+K+   Q          E E+L   + HRN++ +I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLN--------IVIDIALALEYLHF 741
              +D   LV + M  GS+          L  I KR +        +V D+A AL++LH 
Sbjct: 80  FEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 742 GHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLS--GDESMKHTQTLATI----G 792
                + H D+KP N+L    ++    ++ DF +   +   GD S   T  L T      
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 793 YMAPEYGREGQISTEG-----DVYSFGIML 817
           YMAPE                D++S G++L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 49/205 (23%), Positives = 98/205 (47%), Gaps = 14/205 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNA----ECEVLRSIRH 681
           ++++    IG G++G VY+ +   G   A+K   L+ E   E   +    E  +L+ ++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N+V++           LV +++ +  L+  L      L+     + ++ +   + Y H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YG 799
                V+H D+KP N+L++ +   ++ DFG+A+   G    K+T  + T+ Y AP+   G
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 800 REGQISTEGDVYSFGIMLMEIFTRK 824
            + + ST  D++S G +  E+    
Sbjct: 175 SK-KYSTTIDIWSVGCIFAEMVNGT 198

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.1 bits (232), Expect = 2e-20
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 25/218 (11%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIK--VFHLQLEGALESFNA---------EC 673
              + V   I SGS+G+V  G   +G+ VAIK     +     +   +          E 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 674 EVLRSIRHRNLVR---IISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNL-DIFKRLN 727
            +L    H N++    I             LV + M    L   ++     +     +  
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
            +  I L L  LH      VVH D+ P N+LL ++    + DF +A+  + D +   T  
Sbjct: 139 FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THY 193

Query: 788 LATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
           +    Y APE   + +  T+  D++S G ++ E+F RK
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.2 bits (237), Expect = 2e-20
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 25/223 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F    ++G G FG V   +     ++ A K      ++          E ++L  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALALEY 738
           R +V +  +    D   LVL  M  G L+  +Y  +     F     V    +I   LE 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPE 797
           LH      +V+ D+KP N+LLD+    R+ D G+A  +   ++    +    T+GYMAPE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355

Query: 798 YGREGQISTEGDVYSFGIMLMEIFT---------RKRPTDEIF 831
             +  + +   D ++ G +L E+           +K   +E+ 
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 65/262 (24%), Positives = 118/262 (45%), Gaps = 19/262 (7%)

Query: 255 ISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL 314
           I S     +    +L    + D V  + + ++    ++   +N +I+ S+ + +  L N+
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNELNSI----DQIIANNSDIK-SV-QGIQYLPNV 70

Query: 315 IIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG 374
             + L  NKL   I   L+ L+ L  L L+ N++  + L  +  L +L S+ L+HN +S 
Sbjct: 71  TKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGIS- 125

Query: 375 SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV 434
            I     +L  L  L   +N++T + +    LT +  + L  N +S  +PL    L  L 
Sbjct: 126 DING-LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQ 181

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
            LYLS+N++S D+   + GLKNL  L L          N   +L+    +  ++  L  +
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 237

Query: 495 IPSSLEKLLYLKYLNVSFNRLE 516
            P  +      +  NV ++  E
Sbjct: 238 TPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 51/248 (20%), Positives = 104/248 (41%), Gaps = 17/248 (6%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
                L+S+  +  + + +       I  +  +  L L+ N+L+   P  N+ +L  + L
Sbjct: 40  VTQNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFL 97

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
            +N++  +L +     L  ++ LSL  N  +  +   + +L  L S+ L  N +      
Sbjct: 98  DENKVK-DLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI--TDIT 150

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
            +  L  L  L L  N +  +VP  L  ++ L+ L L+ N +S  + +     L NL++ 
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRALAG--LKNLDVL 205

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
            L +     K  +   N    +  +  D S     P    +  + ++ N++++    +N 
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTN- 262

Query: 251 ELSFISSL 258
           E+SFI   
Sbjct: 263 EVSFIFYQ 270

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 46/260 (17%), Positives = 103/260 (39%), Gaps = 24/260 (9%)

Query: 209 SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLS 268
           ++     L   S +  +    + + ++ ++    + I S       +  +     +  L 
Sbjct: 24  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 74

Query: 269 LTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSI 328
           L GN L D      + NL  ++   +L    ++  +   + +L  L  + L +N +  S 
Sbjct: 75  LNGNKLTDI---KPLANLK-NLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SD 126

Query: 329 PSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK 388
            + L  L +L+ L L NN++    +  + RL +L ++ L+ N++S  I      L  L+ 
Sbjct: 127 INGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 182

Query: 389 LSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIP 448
           L  + N ++ +      L N+ +++L S            NL V   +  +  +L    P
Sbjct: 183 LYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--P 239

Query: 449 TTIGGLKNLQNLSLGDNNLQ 468
             I    + +  ++  +  +
Sbjct: 240 EIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 44/256 (17%), Positives = 95/256 (37%), Gaps = 20/256 (7%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
               + +     +L    +  T   +   +N+++ +  +N+ +        + ++  + L
Sbjct: 18  FSDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFL 75

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           + N+L+   P    + L  + +L L  N+        + +L  L S+ L  N +  +I  
Sbjct: 76  NGNKLTDIKP---LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING 129

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELF 190
            + +L  L++L L +N +  +    L  ++ L  L L +N +S  I       L  L+  
Sbjct: 130 -LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPLA--GLTKLQNL 183

Query: 191 SLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH 250
            L+ N+ S      +     L + EL          N   N+     +      + +   
Sbjct: 184 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--- 238

Query: 251 ELSFISSLANSKKLKV 266
               IS   + +K  V
Sbjct: 239 -PEIISDDGDYEKPNV 253

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 49/235 (20%), Positives = 93/235 (39%), Gaps = 47/235 (20%)

Query: 43  LEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG 102
               +L    ++ +     ++S+  I  +++ +   +      YLP V  L L  N+   
Sbjct: 26  TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTD 82

Query: 103 HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL 162
             P  + NL +L  + L EN +  ++   + +L+ L++L L  N +  +    L ++  L
Sbjct: 83  IKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDING--LVHLPQL 136

Query: 163 KILQLTNNTLSGSISSSIRLA-LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSF 221
           + L L NN ++  I+    L+ L  L+  SL +N                 I ++     
Sbjct: 137 ESLYLGNNKIT-DITV---LSRLTKLDTLSLEDNQ----------------ISDIVP--- 173

Query: 222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
                     +  L+ L L  N+I+        + +LA  K L VL L     L+
Sbjct: 174 -------LAGLTKLQNLYLSKNHISD-------LRALAGLKNLDVLELFSQECLN 214

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 34/189 (17%), Positives = 73/189 (38%), Gaps = 11/189 (5%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSD 72
           L  L  L+ L L  N +  +  + +  +  LE L L NN+++       ++ L  + L D
Sbjct: 108 LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI 132
           N++S ++     + L  +Q L L+ N  +    R +  L +L  ++L     + +  +  
Sbjct: 166 NQIS-DIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQ 220

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL 192
            NL     +     +L  V P  + +    +   +  +      ++ +            
Sbjct: 221 SNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP--EFTNEVSFIFYQPVTIGK 276

Query: 193 ANNNFSGKI 201
           A   F G++
Sbjct: 277 AKARFHGRV 285

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 42/221 (19%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV---FHLQLEGALESFNAECEVLRSIRH 681
           + F +  +IG G+FG V   +  +  +V A+K+   + +        F  E +VL +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL--------------EACLYSDNSNLDIFKRLN 727
           + +  +  +  +D+   LV+DY   G L               A  Y             
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY------------- 180

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
            + ++ +A++ +H       VH DIKP N+L+D +   RL DFG    L  D +++ +  
Sbjct: 181 -LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSV 235

Query: 788 L-ATIGYMAPE-----YGREGQISTEGDVYSFGIMLMEIFT 822
              T  Y++PE      G +G+   E D +S G+ + E+  
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 52/240 (21%)

Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIK-VFH--------LQLEGALESFNAE 672
           +  D+F V  + G G+FG+V  G+    GM VAIK V          LQ           
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----------I 69

Query: 673 CEVLRSIRHRNLVRII-------SSCTNDDFKALVLDYMP---KGSLEACLYSDNSNLDI 722
            + L  + H N+V++             D +  +V++Y+P               +   I
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129

Query: 723 FKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDES 781
             ++  +  +  ++  LH    N V H DIKP NVL++  D   +L DFG AK LS  E 
Sbjct: 130 LIKV-FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 782 MKHTQTLATIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
                 + +  Y APE       Y      +T  D++S G +  E+   + P   IF G+
Sbjct: 188 N--VAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE-P---IFRGD 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.5 bits (230), Expect = 5e-20
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV---FHLQLEGALESFNAECEVLRSIRH 681
           D F +  +IG G+F  V   +     +V A+K+   + +   G +  F  E +VL +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI-DIALALEYLH 740
           R + ++  +  ++++  LV++Y   G L   L      +   +     + +I +A++ + 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-EMARFYLAEIVMAIDSV- 178

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--- 797
             H    VH DIKP N+LLD     RL DFG    L  D +++    + T  Y++PE   
Sbjct: 179 --HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 798 ----YGREGQISTEGDVYSFGIMLMEIFT 822
                   G    E D ++ G+   E+F 
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 13/192 (6%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGA--LESFNAECEVLRSIRHR-NLVRIIS 689
           +G G F  V +      G E A K    +  G         E  VL   +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 690 SCTNDDFKALVLDYMPKGSL-EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV 748
              N     L+L+Y   G +   CL      +     + ++  I   + YLH    N +V
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIV 153

Query: 749 HCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
           H D+KP N+LL         ++ DFG+++ +     ++  + + T  Y+APE      I+
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR--EIMGTPEYLAPEILNYDPIT 211

Query: 806 TEGDVYSFGIML 817
           T  D+++ GI+ 
Sbjct: 212 TATDMWNIGIIA 223

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.8 bits (233), Expect = 6e-20
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 27/226 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL---RS 678
           + F+V+ +IG G FG VY  R  D  ++ A+K      ++++        E  +L    +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVI---DIALA 735
                +V +  +    D  + +LD M  G L   L        +F   ++     +I L 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 304

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYM 794
           LE++H      VV+ D+KP+N+LLDE    R+ D G+A   S  +          T GYM
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357

Query: 795 APE-YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
           APE   +     +  D +S G ML ++     P    F    +  +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK 399

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 7e-20
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 39/218 (17%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKV---FHLQLEGALESFNAECEVLRSIRH 681
           + + V  +IG G+FG V   R     +V A+K+   F +        F  E +++     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL------------EACLYSDNSNLDIFKRLNIV 729
             +V++  +  +D +  +V++YMP G L             A  Y+              
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT-------------- 174

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL- 788
            ++ LAL+ +   H    +H D+KP N+LLD+    +L DFG    ++ +  ++   T  
Sbjct: 175 AEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAV 230

Query: 789 ATIGYMAPE----YGREGQISTEGDVYSFGIMLMEIFT 822
            T  Y++PE     G +G    E D +S G+ L E+  
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 50/236 (21%), Positives = 88/236 (37%), Gaps = 30/236 (12%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFH----LQLEGALESFNAECEVLRSIRHRNLVR- 686
           L+G GS+G V            A+K+       ++     +   E ++LR +RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 687 --IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
             ++ +        +V++Y   G  E           + +       +   LEYLH    
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GYMAPE--Y 798
             +VH DIKP N+LL      ++   G+A+ L          T  T      +  PE   
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 799 GREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKRWVNDSL 845
           G +     + D++S G+ L  I T   P +          I  G  ++       L
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 8e-20
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 31/246 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHR 682
           +++    L+G GS+G V + R  D G  VAIK F    +  +    A  E ++L+ +RH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           NLV ++  C       LV +++   ++   L    + LD       +  I   + + H  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--YGR 800
             + ++H DIKP N+L+ +  V +L DFG A+ L       +   +AT  Y APE   G 
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVG- 198

Query: 801 EGQISTEGDVYSFGIMLMEIFTRK--------------------RPTDEIFSGEMSLKRW 840
           + +     DV++ G ++ E+F  +                                   +
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258

Query: 841 VNDSLP 846
               LP
Sbjct: 259 AGVRLP 264

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 33/186 (17%), Positives = 70/186 (37%), Gaps = 11/186 (5%)

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
                +   LG +        T +++  L  + L N  +    L  I     +  + +++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINN 75

Query: 370 NKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEIG 428
              +   P     L++L +L     ++T         LT++ ++D+S +    S+  +I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 429 NLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSN 488
            L  +  + LS N    DI   +  L  L++L++  + +       I D   L  L   +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 489 NILSGI 494
             + G 
Sbjct: 191 QTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 33/157 (21%), Positives = 63/157 (40%), Gaps = 7/157 (4%)

Query: 359 LARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNP 418
                +  L  +  +    A    + SL  ++ A+  +T + +      NI  + +++  
Sbjct: 22  FKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIH 77

Query: 419 LSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDL 478
            +   P+    L  L  L +   +++ D    + GL +L  L +  +    SI   I  L
Sbjct: 78  ATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 479 ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
             +  +DLS N     I   L+ L  LK LN+ F+ +
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 31/159 (19%), Positives = 71/159 (44%), Gaps = 6/159 (3%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRL 75
           ++SL Y+ L+   +  T  + I   + ++ L ++N   +   P   +S+L+ + +    +
Sbjct: 43  MNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDV 100

Query: 76  SGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNL 135
           + +   N+ S L  +  L ++ +     +  +I  L  + SIDLS N  + +I   +  L
Sbjct: 101 TSDKIPNL-SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158

Query: 136 RNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSG 174
             L++L +  + +       + +   L  L   + T+ G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 24/187 (12%), Positives = 62/187 (33%), Gaps = 11/187 (5%)

Query: 259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIR 318
           +  K      L  +   + +  + + +L        L N N+   +   +    N+  + 
Sbjct: 20  STFKAYLNGLLGQSSTAN-ITEAQMNSL----TYITLANINVT-DL-TGIEYAHNIKDLT 72

Query: 319 LGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA 378
           +          + +S L  L+ L +    +    + ++  L  L+ + + H+    SI  
Sbjct: 73  INNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 379 CFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYL 438
               L  +  +  + N           L  +  +++  + +     +E  +   L +LY 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYA 188

Query: 439 SRNNLSG 445
               + G
Sbjct: 189 FSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 23/138 (16%), Positives = 55/138 (39%), Gaps = 8/138 (5%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF--PFFNMSSLQVIDL 70
           +    +++ L ++      T  + I  ++ LE L +    ++         ++SL ++D+
Sbjct: 62  IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH 130
           S +     +   I + LP V  + L++N     +   +  L  L S+++  + +      
Sbjct: 120 SHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG- 176

Query: 131 EIGNLRNLQALGLLSNNL 148
            I +   L  L   S  +
Sbjct: 177 -IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 21/209 (10%), Positives = 60/209 (28%), Gaps = 57/209 (27%)

Query: 40  INTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQ 99
           +N+L  + L+N  ++         +++ + +++   +   P                   
Sbjct: 43  MNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP------------------- 83

Query: 100 FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
                   I  L++L  + +    +  +    +  L +L  L +  +     +   +  +
Sbjct: 84  --------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 160 STLKILQLTNNTLSGSISSSIRLA-LPNLELFSLANNNFSGKIPSFIFNASKLSICELPD 218
             +  + L+ N     I     L  LP L+  ++  +         + +   +       
Sbjct: 136 PKVNSIDLSYNGAITDIMP---LKTLPELKSLNIQFDG--------VHDYRGIE------ 178

Query: 219 NSFSGFIPNRFHNMRNLKELNLEYNYITS 247
                       +   L +L      I  
Sbjct: 179 ------------DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 29/195 (14%), Positives = 68/195 (34%), Gaps = 41/195 (21%)

Query: 107 EIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQ 166
               + SLT I L+             N+ +L  +    N               +K L 
Sbjct: 39  TEAQMNSLTYITLANI-----------NVTDLTGIEYAHN---------------IKDLT 72

Query: 167 LTNNTLSGSISSSIRLA-LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFI 225
           + N       ++   ++ L NLE   +   + +      +   + L++ ++  ++    I
Sbjct: 73  INNI----HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 226 PNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGN 285
             + + +  +  ++L      S N  ++ I  L    +LK L++  + + D      I +
Sbjct: 129 LTKINTLPKVNSIDL------SYNGAITDIMPLKTLPELKSLNIQFDGVHDY---RGIED 179

Query: 286 LSLSMERFYLHNCNI 300
               + + Y  +  I
Sbjct: 180 FP-KLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 32/241 (13%), Positives = 74/241 (30%), Gaps = 66/241 (27%)

Query: 134 NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLA 193
             +      L  ++   +  A    +++L  + L N     +++      L  +E     
Sbjct: 21  TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANI----NVTD-----LTGIE----- 63

Query: 194 NNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELS 253
                                                   N+K+L +   + T+      
Sbjct: 64  -------------------------------------YAHNIKDLTINNIHATN------ 80

Query: 254 FISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLIN 313
             + ++    L+ L + G  +       ++  L+ S+    + +     SI  ++  L  
Sbjct: 81  -YNPISGLSNLERLRIMGKDVTS-DKIPNLSGLT-SLTLLDISHSAHDDSILTKINTLPK 137

Query: 314 LIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLS 373
           +  I L YN     I   L  L +L+ L ++ + +       I    +L+ +Y     + 
Sbjct: 138 VNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIG 194

Query: 374 G 374
           G
Sbjct: 195 G 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 20/116 (17%), Positives = 47/116 (40%), Gaps = 6/116 (5%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF--PFFNMSSLQVI 68
           + +  LS+L+ L +    +      ++  + +L +LD+S++    S       +  +  I
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           DLS N    ++       LP ++ L++ F+    +    I +   L  +      +
Sbjct: 142 DLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 4/99 (4%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLS-NNQLSGSFPFFNMS 63
           +T      L  L+SL  LD+S +    +I + I ++  +  +DLS N  ++   P   + 
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG 102
            L+ +++  + +            P +  L        G
Sbjct: 160 ELKSLNIQFDGVHDYRG---IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 10/74 (13%), Positives = 32/74 (43%), Gaps = 1/74 (1%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSS 64
              ++ +++ +L  +  +DLS+N  +  I   + ++  L+ L++  + +       +   
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPK 182

Query: 65  LQVIDLSDNRLSGE 78
           L  +      + G+
Sbjct: 183 LNQLYAFSQTIGGK 196

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.5 bits (223), Expect = 2e-19
 Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 41/251 (16%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA--ECEVLRSIRHR 682
           +++     IG GS+G V++ R  D G  VAIK F    +  +    A  E  +L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           NLV ++          LV +Y    ++   L      +      +I      A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE----- 797
             +  +H D+KP N+L+ +  V +L DFG A+LL    S  +   +AT  Y +PE     
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGD 177

Query: 798 --YGREGQISTEGDVYSFGIMLMEIFTRK--------------------RPTDEIFSGEM 835
             Y          DV++ G +  E+ +                                 
Sbjct: 178 TQY------GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231

Query: 836 SLKRWVNDSLP 846
           + + +    +P
Sbjct: 232 TNQYFSGVKIP 242

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 16/206 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNA----ECEVLRSIR 680
           + +   + +G G++ +VY+G+  L    VA+K   L+ E   E        E  +L+ ++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N+V +      +    LV +Y+ K  L+  L    + +++      +  +   L Y H
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE--Y 798
                 V+H D+KP N+L++E    +L DFG+A+      +  +   + T+ Y  P+   
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVVTLWYRPPDILL 173

Query: 799 GREGQISTEGDVYSFGIMLMEIFTRK 824
           G     ST+ D++  G +  E+ T +
Sbjct: 174 GST-DYSTQIDMWGVGCIFYEMATGR 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 19/214 (8%)

Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA----ECEVL 676
           + ++ QF     +G+G++ +VY+G     G+ VA+K   L  E   E   +    E  ++
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLM 57

Query: 677 RSIRHRNLVRIISSCTNDDFKALVLDYMP---KGSLEACLYSDN-SNLDIFKRLNIVIDI 732
           + ++H N+VR+      ++   LV ++M    K  +++    +    L++         +
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
              L + H    N ++H D+KP N+L+++    +LGDFG+A+   G      +  + T+ 
Sbjct: 118 LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVVTLW 173

Query: 793 YMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
           Y AP+   G     ST  D++S G +L E+ T K
Sbjct: 174 YRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 89.8 bits (223), Expect = 4e-19
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 40/229 (17%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
              +    +IG+GSFG VY+ +  D G  VAIK             N E +++R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK----NRELQIMRKLDHCN 108

Query: 684 LVRII------SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNI---VIDIAL 734
           +VR+           ++ +  LVLDY+P+ ++       +        + +   +  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 735 ALEYLH-FGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKHTQTLATIG 792
           +L Y+H FG    + H DIKP N+LLD D  V +L DFG AK L   E       + +  
Sbjct: 168 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 221

Query: 793 YMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
           Y APE       Y      ++  DV+S G +L E+    +P   IF G+
Sbjct: 222 YRAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.4 bits (220), Expect = 5e-19
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLEG-ALESFNA----ECEVLRSI 679
            ++   + +G G F +VY+ R       VAIK   L     A +  N     E ++L+ +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
            H N++ ++ +  +    +LV D+M    LE  +  ++  L        ++     LEYL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-- 797
           H    + ++H D+KP+N+LLDE+ V +L DFG+AK   G  +  +T  + T  Y APE  
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELL 184

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRK 824
           +G         D+++ G +L E+  R 
Sbjct: 185 FGAR-MYGVGVDMWAVGCILAELLLRV 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.8 bits (223), Expect = 5e-19
 Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 53/235 (22%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
           ++F    L+G G+FG V   +        A+K+     +  +  +     E  VL++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNI 728
             L  +  S    D    V++Y   G L              A  Y              
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG------------- 254

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             +I  AL+YLH      VV+ D+K  N++LD+D   ++ DFG+ K    D +    +T 
Sbjct: 255 -AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTF 309

Query: 789 -ATIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
             T  Y+APE      YGR        D +  G+++ E+   + P      +++F
Sbjct: 310 CGTPEYLAPEVLEDNDYGR------AVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 88.0 bits (218), Expect = 9e-19
 Identities = 46/165 (27%), Positives = 66/165 (40%), Gaps = 15/165 (9%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSD 72
           S    LDLS N L         + +  L  L LS+N L+       F  + +L+ +DLS 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHE 131
           N L   L   +FS L  ++ L L  N     + R    ++  L  + LS+N +    P E
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154

Query: 132 I----GNLRNLQALGLLSNNLVGVVPATLFNISTLK--ILQLTNN 170
           +      L  L  L L SN L  +    L  +       L L NN
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 41/168 (24%), Positives = 74/168 (44%), Gaps = 15/168 (8%)

Query: 363 SSVYLDHNKLSGSIPACFGNL-ASLRKLSFASNELTFVPS--TFWNLTNILMVDLSSNPL 419
           + +     +L  ++P    +L +    L  + N L+ + +  T   LTN+  + LS N L
Sbjct: 21  NILSCSKQQLP-NVPQ---SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL 76

Query: 420 SGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI-GD 477
           +  +  E    +  L  L LS N+L          L+ L+ L L +N++   +  +   D
Sbjct: 77  N-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134

Query: 478 LISLECLDLSNNILSGIIP---SSLEKLLYLKYLNVSFNRLEGEIPRG 522
           +  L+ L LS N +S           KL  L  L++S N+L+ ++P  
Sbjct: 135 MAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 12/118 (10%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSGSFP---FFNMSSLQVIDLS 71
           + +L+YLDLS N  L T+   +FS    LE+L L NN +        F +M+ LQ + LS
Sbjct: 87  VPNLRYLDLSSNH-LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144

Query: 72  DNRLSGELPANIF---SYLPFVQFLSLAFNQFAGHLPREIGNLTSLT--SIDLSENHL 124
            N++S   P  +    + LP +  L L+ N+       ++  L +     + L  N L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 44/249 (17%), Positives = 87/249 (34%), Gaps = 22/249 (8%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSE 121
           S   ++DLS N LS        + L  +  L L+ N     +  E    + +L  +DLS 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 122 NHLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
           NHL   +   +  +L+ L+ L L +N++V V      +++ L+ L L+ N +S      +
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 181 ---RLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFH---NMRN 234
                 LP L L  L++N       + +          L  ++      N       +  
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN------NPLECDCKLYQ 209

Query: 235 LKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFY 294
           L          +  + +      L      K+ ++      +C         +   +   
Sbjct: 210 LFSHWQYRQLSSVMDFQ----EDLYCMHSKKLHNIFSLDFFNCSEYKESAWEAHLGDTLT 265

Query: 295 LHNCNIRGS 303
           +  C+ +  
Sbjct: 266 IR-CDTKQQ 273

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 30/164 (18%), Positives = 61/164 (37%), Gaps = 15/164 (9%)

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSI-GNLSLSME 291
                L+L +N ++    E +          L  L L+ N L    + S     +  ++ 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTP----TRLTNLHSLLLSHNHLN--FISSEAFVPVP-NLR 91

Query: 292 RFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQL- 348
              L + ++  ++ + +  +L  L ++ L  N +   +       + +LQ L L  NQ+ 
Sbjct: 92  YLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149

Query: 349 --EGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLS 390
                ++ D  +L +L  + L  NKL          L +  K  
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 87.2 bits (217), Expect = 9e-19
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 50/217 (23%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
             F +   +G+GSFG V+  R        A+KV     +     +E  N E  +L  + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNI 728
             ++R+  +  +     +++DY+  G L              A  Y+             
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA------------- 112

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
             ++ LALEYLH      +++ D+KP N+LLD++   ++ DFG AK          T TL
Sbjct: 113 -AEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 163

Query: 789 -ATIGYMAPEYGREGQISTEG-----DVYSFGIMLME 819
             T  Y+APE      +ST+      D +SFGI++ E
Sbjct: 164 CGTPDYIAPEV-----VSTKPYNKSIDWWSFGILIYE 195

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 53/301 (17%), Positives = 94/301 (31%), Gaps = 41/301 (13%)

Query: 229 FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL 288
           +   R+L+ L    +           I SL     LK L++    +   +L  ++  L +
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSL----SLKRLTVRAARIPSRILFGALRVLGI 94

Query: 289 S-MERFYLHNCNIRGSIPKEMGNLI--NLIIIRLGYNKLNGSIPSTLS----RLEKLQIL 341
           S ++   L N  + G+ P  +      +L I+ L                      L++L
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154

Query: 342 GLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIP----ACFGNLASLRKLSFASNELT 397
            +          + +     LS++ L  N   G        C     +L+ L+  +  + 
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM- 213

Query: 398 FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI-GGLKN 456
                                 SG           L  L LS N+L              
Sbjct: 214 -------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 457 LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
           L +L+L    L+  +P  +     L  LDLS N L      S ++L  +  L++  N   
Sbjct: 255 LNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFL 309

Query: 517 G 517
            
Sbjct: 310 D 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 54/276 (19%), Positives = 96/276 (34%), Gaps = 48/276 (17%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPF----FNMSSLQVIDL 70
           SL  L          +      +  I+ L+ L L N +++G+ P          L +++L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 71  SDNRLSGELP--ANIFSYL-PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE 127
            +   +      A +  +L P ++ LS+A          ++    +L+++DLS+N  +GE
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 128 IPHEI----GNLRNLQALGLLSNN---LVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
                         LQ L L +       GV  A       L+ L L++N+L  +  +  
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 181 RLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL 240
                 L   +L+                     ++P    +            L  L+L
Sbjct: 249 CDWPSQLNSLNLSFTGLK----------------QVPKGLPA-----------KLSVLDL 281

Query: 241 EYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
            YN +           S     ++  LSL GNP LD
Sbjct: 282 SYNRLDR-------NPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 81.9 bits (202), Expect = 6e-17
 Identities = 44/254 (17%), Positives = 72/254 (28%), Gaps = 47/254 (18%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSI--NTLEILDLSNNQLSGSFPFFN------M 62
            ++  +S LQ L L   ++ GT P  +       L IL+L N   +    +         
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI----GNLTSLTSID 118
             L+V+ ++                P +  L L+ N   G              +L  + 
Sbjct: 149 PGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 119 LSENH---LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI-STLKILQLTNNTLSG 174
           L         G           LQ L L  N+L     A   +  S L  L L+   L  
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266

Query: 175 SISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRN 234
            +   +      L +  L+ N      PS                            +  
Sbjct: 267 QVPKGL---PAKLSVLDLSYNRLDR-NPSPDE-------------------------LPQ 297

Query: 235 LKELNLEYNYITSS 248
           +  L+L+ N    S
Sbjct: 298 VGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 49/211 (23%), Positives = 69/211 (32%), Gaps = 23/211 (10%)

Query: 5   LTGTVPSQLGSLS--SLQYLDLSFNQLLGTIPS----SIFSINTLEILDLSNNQLSGSFP 58
           +TGT P  L   +   L  L+L                 +    L++L ++      +F 
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFS 165

Query: 59  ---FFNMSSLQVIDLSDNRLSGELP---ANIFSYLPFVQFLSLAFNQFA---GHLPREIG 109
                   +L  +DLSDN   GE     A      P +Q L+L         G       
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225

Query: 110 NLTSLTSIDLSENHLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLT 168
               L  +DLS N L              L +L L    L   VP  L   + L +L L+
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLS 282

Query: 169 NNTLSGSISSSIRLALPNLELFSLANNNFSG 199
            N L     +     LP +   SL  N F  
Sbjct: 283 YNRLD---RNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 43/250 (17%), Positives = 87/250 (34%), Gaps = 15/250 (6%)

Query: 134 NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI-RLALPNLELFSL 192
           +L+ L        + +      +  IS L+ L L N  ++G+    +     P+L + +L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 193 ANNNFSGKIPS----FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
            N +++ +         +    L +  +       F   +      L  L+L  N     
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 249 NHELSFISSLANSKKLKVLSLTGNPL--LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPK 306
              +S +  L     L+VL+L    +     V  +        ++   L + ++R +   
Sbjct: 189 RGLISALCPLKFPT-LQVLALRNAGMETPSGVCSALAAARV-QLQGLDLSHNSLRDAAGA 246

Query: 307 EM-GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV 365
                   L  + L +  L   +P  L    KL +L L  N+L+         L ++ ++
Sbjct: 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR--NPSPDELPQVGNL 301

Query: 366 YLDHNKLSGS 375
            L  N    S
Sbjct: 302 SLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 57/296 (19%), Positives = 98/296 (33%), Gaps = 30/296 (10%)

Query: 133 GNLRNLQALGLLSNNLVGVVP-ATLFNISTLKILQLTNNTLSGSISSSI--RLALPNLEL 189
           G  R+L+ L    +    +     +    +LK L +    +   I       L +  L+ 
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 190 FSLANNNFSGKIPSFIFNASKLSICEL--PDNSFSGFIPNRFHNMRNLKELNLEYNYITS 247
            +L N   +G  P  +  A+   +  L   + S++         ++   +  L+   I  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQ 158

Query: 248 SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
           ++        +     L  L L+ NP L        G   L           I    P +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPEL--------GERGL-----------ISALCPLK 199

Query: 308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICR-LARLSSVY 366
              L  L +   G    +G   +  +   +LQ L L +N L        C   ++L+S+ 
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 367 LDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGS 422
           L    L   +P      A L  L  + N L   PS    L  +  + L  NP   S
Sbjct: 260 LSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 37/243 (15%), Positives = 76/243 (31%), Gaps = 26/243 (10%)

Query: 298 CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDIC 357
           CN     P        L    +       S+   L R+         + + +     DI 
Sbjct: 15  CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRV---------DTEADLGQFTDII 65

Query: 358 RLARLSSVYLDHNKLSGSIPAC---FGNLASLRKLSFASNELT---FVPSTFWNLTNILM 411
           +   L  + +   ++   I         ++ L++L+  + E+T     P       ++ +
Sbjct: 66  KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 412 VDLSSNPLSGSLP----LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL 467
           ++L +   +        L+      L  L +++ +        +     L  L L DN  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 468 QGSIPNSI----GDLISLECLDLSNN---ILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
            G              +L+ L L N      SG+  +     + L+ L++S N L     
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 521 RGG 523
              
Sbjct: 246 APS 248

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 45/237 (18%)

Query: 626 DQFNVNNL-IGSGSFGSVYRGRFLD---GMEVAIKVFHLQLEGALESFNAECEVLRSIRH 681
           D F      +G G++G VY+ +  D     + A+K       G   S   E  +LR ++H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKH 77

Query: 682 RNLVR---IISSCTNDDFKALVLDYMP---KGSLEACLYSDNSNLDIFKRLNIVIDIAL- 734
            N++    +  S  +     L+ DY        ++    S  +   +     +V  +   
Sbjct: 78  PNVISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 735 ---ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR----LGDFGIAKLLSGDESMKHTQT 787
               + YLH    N V+H D+KP+N+L+  +   R    + D G A+L            
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADL 192

Query: 788 LA---TIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
                T  Y APE       Y      +   D+++ G +  E+ T + P   IF   
Sbjct: 193 DPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE-P---IFHCR 239

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 35/230 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA----ECEVLRSIR 680
            ++     IG G+FG V++ R    G +VA+K   + +E   E F      E ++L+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLK 74

Query: 681 HRNLVRIISSCTNDDFKA--------LVLDYMP---KGSLEACLYSDNSNLDIFKRLNIV 729
           H N+V +I  C               LV D+      G L            + +   ++
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVM 130

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS---GDESMKHTQ 786
             +   L Y+H    N ++H D+K +NVL+  D V +L DFG+A+  S     +  ++T 
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 787 TLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
            + T+ Y  PE   G E       D++  G ++ E++TR  P   I  G 
Sbjct: 188 RVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS-P---IMQGN 232

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 87.7 bits (218), Expect = 2e-18
 Identities = 99/537 (18%), Positives = 178/537 (33%), Gaps = 122/537 (22%)

Query: 17  SSLQYLDLSFNQL-LGTIPSSIFSINTLEILDLSNNQLSG------SFPFFNMSSLQVID 69
             +Q LD+   +L        +  +   +++ L +  L+       S       +L  ++
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 70  LSDNRLSGELPANIFSYLPF----VQFLSLAFNQF----AGHLPREIGNLTSLTSIDLSE 121
           L  N L       +   L      +Q LSL          G L   +  L +L  + LS+
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
           N L          L+ L   GLL                 L+ LQL   +LS +    + 
Sbjct: 123 NLLGDA------GLQLL-CEGLLDPQ------------CRLEKLQLEYCSLSAASCEPLA 163

Query: 182 LAL---PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL 238
             L   P+ +  +++NN+ +      +    K                    +   L+ L
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLK-------------------DSPCQLEAL 204

Query: 239 NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD---CVLPSSIGNLSLSMERFYL 295
            LE   +TS N        +A+   L+ L+L  N L D     L   + + S  +   ++
Sbjct: 205 KLESCGVTSDNCR-DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 296 HNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDD 355
             C I                      K  G +   L   E L+ L L  N+L       
Sbjct: 264 WECGIT--------------------AKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 356 ICRLAR-----LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNIL 410
           +C         L S+++     +    AC  + +S+                      +L
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFT---AACCSHFSSVLA----------------QNRFLL 344

Query: 411 MVDLSSNPL--SGSLPLEIG---NLKVLVELYLSRNNLS----GDIPTTIGGLKNLQNLS 461
            + +S+N L  +G   L  G      VL  L+L+  ++S      +  T+    +L+ L 
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404

Query: 462 LGDNNLQGSIPNSIGDLI-----SLECLDLSNNILSGIIPSSLEKLL----YLKYLN 509
           L +N L  +    + + +      LE L L +   S  +   L+ L      L+ ++
Sbjct: 405 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 66/389 (16%), Positives = 124/389 (31%), Gaps = 54/389 (13%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSI-----NTLEILDLSNNQLSG------SFPFFN 61
           L    +L  L+L  N+L       +          ++ L L N  L+G      S     
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYL----PFVQFLSLAFNQF----AGHLPREIGNLTS 113
           + +LQ + LSDN L       +   L      ++ L L +          L   +     
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171

Query: 114 LTSIDLSENHLMGEIPHEIG-----NLRNLQALGLLSNNL----VGVVPATLFNISTLKI 164
              + +S N +       +      +   L+AL L S  +       +   + + ++L+ 
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231

Query: 165 LQLTNNTLSGS----ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASK---------L 211
           L L +N L       +   +      L    +     + K    +    +         L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291

Query: 212 SICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTG 271
           +  EL D                L+ L ++    T++     F S LA ++ L  L ++ 
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS-HFSSVLAQNRFLLELQISN 350

Query: 272 NPLLD---CVLPSSIGNLSLSMERFYLHNCNIR----GSIPKEMGNLINLIIIRLGYNKL 324
           N L D     L   +G     +   +L +C++      S+   +    +L  + L  N L
Sbjct: 351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

Query: 325 NGSIPSTLSRL-----EKLQILGLENNQL 348
             +    L          L+ L L +   
Sbjct: 411 GDAGILQLVESVRQPGCLLEQLVLYDIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 53.0 bits (128), Expect = 3e-07
 Identities = 43/239 (17%), Positives = 89/239 (37%), Gaps = 33/239 (13%)

Query: 313 NLIIIRLGYNKLN-GSIPSTLSRLEKLQILGLENNQLEGRILDDICRL----ARLSSVYL 367
           ++  + +   +L+       L  L++ Q++ L++  L      DI         L+ + L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 368 DHNKLSGS-----IPACFGNLASLRKLSFASNELT-----FVPSTFWNLTNILMVDLSSN 417
             N+L        +         ++KLS  +  LT      + ST   L  +  + LS N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 418 PL--SGSLPLEIGNLKV---LVELYLSRNNLS----GDIPTTIGGLKNLQNLSLGDNNLQ 468
            L  +G   L  G L     L +L L   +LS      + + +    + + L++ +N++ 
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 469 GSIPNSIGDLI-----SLECLDLSNNILS----GIIPSSLEKLLYLKYLNVSFNRLEGE 518
            +    +   +      LE L L +  ++      +   +     L+ L +  N+L   
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 50/217 (23%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
           DQF+    +G+GSFG V   +  +     A+K+     +     +E    E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNI 728
             LV++  S  ++    +V++Y+  G +              A  Y+             
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA------------- 147

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL 788
              I L  EYLH      +++ D+KP N+L+D+    ++ DFG AK          T TL
Sbjct: 148 -AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTL 198

Query: 789 -ATIGYMAPEYGREGQISTEG-----DVYSFGIMLME 819
             T   +APE      I ++G     D ++ G+++ E
Sbjct: 199 CGTPEALAPEI-----ILSKGYNKAVDWWALGVLIYE 230

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 34/202 (16%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNLVRIISS 690
            +G G++G V           VA+K+  + +     E+   E  + + + H N+V+    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 691 CTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVIDIALALE 737
               + + L L+Y   G L             +A  +        F +L   +     + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQL---MA---GVV 119

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAP 796
           YLH      + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 797 E-YGREGQISTEGDVYSFGIML 817
           E   R    +   DV+S GI+L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 40/204 (19%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVL-RSIRHRNLVRII--- 688
           +G G  G V +        + A+K+              E E+  R+ +  ++VRI+   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 124

Query: 689 -SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLN----------IVIDIALAL 736
            +         +V++ +  G L             I  R +          I+  I  A+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
           +YLH      + H D+KP N+L      + + +L DFG AK  +   S+       T  Y
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYY 229

Query: 794 MAPEYGREGQISTEGDVYSFGIML 817
           +APE     +     D++S G+++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 27/214 (12%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNA----ECEVLRSIR 680
           D++     +G G++G VY+         VAIK   L+ E   E        E  +L+ ++
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQ 91

Query: 681 HRNLVRIISSCTNDDFKALVLDYMP---KGSLEACLYSDNSNLDIFKRLNIVIDIALALE 737
           HRN++ + S   ++    L+ +Y     K  ++         +  F     +  +   + 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSF-----LYQLINGVN 146

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVAR-----LGDFGIAKLLSGDESMKHTQTLATIG 792
           + H       +H D+KP N+LL     +      +GDFG+A+   G    + T  + T+ 
Sbjct: 147 FCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLW 202

Query: 793 YMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
           Y  PE   G     ST  D++S   +  E+  + 
Sbjct: 203 YRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.2 bits (211), Expect = 9e-18
 Identities = 50/259 (19%), Positives = 93/259 (35%), Gaps = 68/259 (26%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
           + ++++   +G+GSFG V     ++ G   A+K               E ++++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 684 LVRII---------SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID--- 731
           +++++                             +     S   N    K LN++++   
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 732 ----------------------------IALALEYLHFGHPNPVVHCDIKPSNVLLD-ED 762
                                       +  A+ ++H      + H DIKP N+L++ +D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKD 178

Query: 763 MVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-------YGREGQISTEGDVYSFGI 815
              +L DFG AK L   E       + +  Y APE       Y      +   D++S G 
Sbjct: 179 NTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGC 230

Query: 816 MLMEIFTRKRPTDEIFSGE 834
           +  E+   K P   +FSGE
Sbjct: 231 VFGELILGK-P---LFSGE 245

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 38/239 (15%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNA---ECEVLRS 678
            Q+ V  L+GSG FGSVY G    D + VAIK      +   G L +      E  +L+ 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 679 IRHR--NLVRIISSCTNDDFKALVLDYMPKGSLEACLY---SDNSNLD------IFKRLN 727
           +      ++R++      D   L+L+  P+   +  L+   ++   L        F +  
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQ-- 157

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQ 786
               +  A+ + H      V+H DIK  N+L+D +    +L DFG   LL    ++    
Sbjct: 158 ----VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTD- 207

Query: 787 TLATIGYMAPEY-GREGQISTEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWV 841
              T  Y  PE+            V+S GI+L ++     P    +EI  G++  ++ V
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 9/145 (6%)

Query: 30  LGTIPSSIFSINTLEILDLSNNQLSG--SFPFFNMSSLQVIDLSDNRLSGELPANIFSYL 87
           L  IP+++    T+  + L  N +       F     L+ IDLS+N++S EL  + F  L
Sbjct: 23  LTEIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL 79

Query: 88  PFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI-GNLRNLQALGLLS 145
             +  L L  N+    LP+ +   L SL  + L+ N +   +  +   +L NL  L L  
Sbjct: 80  RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYD 137

Query: 146 NNLVGVVPATLFNISTLKILQLTNN 170
           N L  +   T   +  ++ + L  N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 11/136 (8%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSD 72
            ++  + L  N  +  IP   F     L  +DLSNNQ+S       F  + SL  + L  
Sbjct: 32  ETITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHE 131
           N+++ ELP ++F  L  +Q L L  N+    L  +   +L +L  + L +N L   I   
Sbjct: 90  NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKG 146

Query: 132 I-GNLRNLQALGLLSN 146
               LR +Q + L  N
Sbjct: 147 TFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.1 bits (180), Expect = 9e-15
 Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 357 CRLARLSSV-----------YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFW 404
           CR   L+ +            L+ N +    P  F     LR++  ++N+++ +    F 
Sbjct: 18  CRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ 77

Query: 405 NLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLG 463
            L ++  + L  N ++  LP  +   L  L  L L+ N ++         L NL  LSL 
Sbjct: 78  GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY 136

Query: 464 DNNLQGSIPNSIGD-LISLECLDLSNN 489
           DN LQ +I       L +++ + L+ N
Sbjct: 137 DNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 28/113 (24%), Positives = 55/113 (48%), Gaps = 9/113 (7%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
               L+ +DLS NQ +  +    F  + +L  L L  N+++   P   F  + SLQ++ L
Sbjct: 54  PYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
           + N+++  L  + F  L  +  LSL  N+    + +     L ++ ++ L++N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 33/141 (23%), Positives = 55/141 (39%), Gaps = 11/141 (7%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGL 343
           NL  ++    L    I+   P        L  I L  N+++  +       L  L  L L
Sbjct: 29  NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87

Query: 344 ENNQLE---GRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFV 399
             N++      + +    L  L  + L+ NK++  +    F +L +L  LS   N+L  +
Sbjct: 88  YGNKITELPKSLFE---GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTI 143

Query: 400 P-STFWNLTNILMVDLSSNPL 419
              TF  L  I  + L+ NP 
Sbjct: 144 AKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 13/145 (8%)

Query: 327 SIPSTLSRLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGN 382
            IP+ L   E +  + LE N    +            +L  + L +N++S  +    F  
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIKVIPPGAFS---PYKKLRRIDLSNNQIS-ELAPDAFQG 78

Query: 383 LASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSR 440
           L SL  L    N++T +P   F  L ++ ++ L++N ++  L ++   +L  L  L L  
Sbjct: 79  LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD 137

Query: 441 NNLSGDIPTTIGGLKNLQNLSLGDN 465
           N L      T   L+ +Q + L  N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 5/131 (3%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
              LT +P+        +   L  N +    P      K L  + LS N +S   P    
Sbjct: 20  GKGLTEIPTNLPETITEI--RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ 77

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
           GL++L +L L  N +   +P S+ + L SL+ L L+ N ++ +   + + L  L  L++ 
Sbjct: 78  GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY 136

Query: 512 FNRLEGEIPRG 522
            N+L+  I +G
Sbjct: 137 DNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 11/161 (6%)

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH 123
           S  ++D     L+ E+P N+      +  + L  N      P        L  IDLS N 
Sbjct: 12  SNNIVDCRGKGLT-EIPTNLPET---ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ 67

Query: 124 LMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSIR 181
           +  E+  +    LR+L +L L  N +   +P +LF  + +L++L L  N ++  +     
Sbjct: 68  IS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124

Query: 182 LALPNLELFSLANNNFSGKIPSFIFNA-SKLSICELPDNSF 221
             L NL L SL +N     I    F+    +    L  N F
Sbjct: 125 QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 32/159 (20%), Positives = 57/159 (35%), Gaps = 37/159 (23%)

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISS--LANSKKLKVLSLTGN 272
            L  N+     P  F   + L+ ++L  N I+        ++       + L  L L GN
Sbjct: 38  RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-------LAPDAFQGLRSLNSLVLYGN 90

Query: 273 PLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-T 331
            + +  LP S+         F                 L +L ++ L  NK+N  +    
Sbjct: 91  KITE--LPKSL---------FE---------------GLFSLQLLLLNANKIN-CLRVDA 123

Query: 332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHN 370
              L  L +L L +N+L+         L  + +++L  N
Sbjct: 124 FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 11/199 (5%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLS-NNQLS--GSFPFFNMSSLQVIDLS 71
             S Q L L    L  TIPS  FS +  +  + +S +  L    S  F+N+S +  I++ 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 72  DNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLP--REIGNLTSLTSIDLSENHLMGEIP 129
           + R    +  +    LP ++FL +         P   ++ +      +++++N  M  IP
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 130 HEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPN-L 187
                 L N      L NN    V    FN + L  + L  N     I       + +  
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207

Query: 188 ELFSLANNNFSGKIPSFIF 206
            L  ++  + +  +PS   
Sbjct: 208 SLLDVSQTSVT-ALPSKGL 225

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 37/207 (17%), Positives = 79/207 (38%), Gaps = 13/207 (6%)

Query: 313 NLIIIRLGYNKLNGSIPS-TLSRLEKLQILGL-ENNQLEGRILDDI-CRLARLSSVYLDH 369
           +   ++L    L  +IPS   S L  +  + +  +  L+ ++       L++++ + + +
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRN 89

Query: 370 NKLSGSIPA-CFGNLASLRKLSFASNELTFVP--STFWNLTNILMVDLSSNPLSGSLPLE 426
            +    I       L  L+ L   +  L   P  +  ++     +++++ NP   S+P+ 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 427 I--GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP-NSIGDLIS-LE 482
              G     + L L  N  +  +         L  + L  N     I  ++ G + S   
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 483 CLDLSNNILSGIIPSSLEKLLYLKYLN 509
            LD+S   ++ +    LE L  L   N
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 30/240 (12%), Positives = 68/240 (28%), Gaps = 34/240 (14%)

Query: 112 TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT 171
                  ++   +   IP       + Q L L+  +L  +      N+  +  + ++ + 
Sbjct: 11  HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66

Query: 172 LSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHN 231
               + S     L  +    + N      I                        P+    
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYID-----------------------PDALKE 103

Query: 232 MRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSME 291
           +  LK L +    +         ++ + ++    +L +T NP +  +  ++   L     
Sbjct: 104 LPLLKFLGIFNTGLKM----FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159

Query: 292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLSRL-EKLQILGLENNQLE 349
              L+N     S+     N   L  + L  NK    I       +     +L +    + 
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 17/86 (19%), Positives = 36/86 (41%), Gaps = 2/86 (2%)

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP-NSIGDLISLECLDLSNN-I 490
              L L   +L          L N+  + +  +     +  +S  +L  +  +++ N   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 491 LSGIIPSSLEKLLYLKYLNVSFNRLE 516
           L+ I P +L++L  LK+L +    L+
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK 118

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 45/214 (21%), Positives = 87/214 (40%), Gaps = 42/214 (19%)

Query: 625 TDQFNVNN-LIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVL-RSIRH 681
           TD + ++  ++G G  G V        G + A+K+ +            E +   ++   
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81

Query: 682 RNLVRII----SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLN--------- 727
            ++V I+    +         ++++ M  G L             I +R +         
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAA 131

Query: 728 -IVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMK 783
            I+ DI  A+++LH    + + H D+KP N+L    ++D V +L DFG AK  + +    
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ- 187

Query: 784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIML 817
                 T  Y+APE     +     D++S G+++
Sbjct: 188 --TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 60/238 (25%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVLRSIRH 681
           + F+   L+G G+FG V   R        A+K+     +  +  +     E  VL++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNI 728
             L  +  +    D    V++Y   G L              A  Y              
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG------------- 111

Query: 729 VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH---T 785
             +I  ALEYLH      VV+ DIK  N++LD+D   ++ DFG+ K     E +      
Sbjct: 112 -AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATM 162

Query: 786 QTL-ATIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
           +T   T  Y+APE      YGR        D +  G+++ E+   + P      + +F
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGR------AVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 34/227 (14%)

Query: 633 LIGSGSFGSVYRGRFLD-GMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRNLVRIISS 690
            +G G++G V           VA+K+  + +     E+   E  + + + H N+V+    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 691 CTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVIDIALALE 737
               + + L L+Y   G L             +A  +        F +L   +     + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQL---MA---GVV 119

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTL-ATIGYMAP 796
           YLH      + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 797 E-YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN 842
           E   R    +   DV+S GI+L  +   + P D+          W  
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 52/242 (21%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVF---HLQLEGALESFNAECEVLRSIRHRNLVR-- 686
            +G G+FG V  G   L G +VA+K+     ++    +     E + L+  RH ++++  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 687 -IISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVIDI 732
            +IS+   D F  +V++Y+  G L             EA           F++      I
Sbjct: 78  QVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRL--------FQQ------I 120

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIG 792
             A++Y H    + VVH D+KP NVLLD  M A++ DFG++ ++S  E    T +  +  
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPN 175

Query: 793 YMAPE-YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKRWVN 842
           Y APE          E D++S G++L  +     P D+         I  G   +  ++N
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

Query: 843 DS 844
            S
Sbjct: 236 RS 237

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 44/211 (20%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK----VFHLQLEGALESFNAECEVLRSI 679
             ++     IGSG+ G V      +    VAIK     F  Q   A  ++  E  +++ +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYR-ELVLMKCV 81

Query: 680 RHRNLVRI----ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            H+N++ +        + ++F+   +V++ M   +L   +  +           ++  + 
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD--HERMSY-LLYQML 137

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             +++LH      ++H D+KPSN+++  D   ++ DFG+A+       M  T  + T  Y
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 192

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
            APE           D++S G ++ E+    
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 37/225 (16%)

Query: 623 QATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVFHLQLE-GALESFNAEC--EV--- 675
            AT ++     IG G++G+VY+ R    G  VA+K   +    G           EV   
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 676 --LRSIRHRNLVRIISSCTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNI 728
             L +  H N+VR++  C            LV +++ +  L   L  D +         I
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETI 122

Query: 729 ---VIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
              +      L++LH    N +VH D+KP N+L+      +L DFG+A++ S    M  T
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALT 177

Query: 786 QTLATIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRK 824
             + T+ Y APE      Y      +T  D++S G +  E+F RK
Sbjct: 178 PVVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 7e-17
 Identities = 47/211 (22%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK----VFHLQLEGALESFNAECEVLRSI 679
             ++     IGSG+ G V      +    VAIK     F  Q   A  ++  E  +++ +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYR-ELVLMKCV 118

Query: 680 RHRNLVRII----SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            H+N++ ++       T ++F+   LV++ M   +L   +  +           ++  + 
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELD--HERMSY-LLYQML 174

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             +++LH      ++H D+KPSN+++  D   ++ DFG+A+       M  T  + T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 229

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRK 824
            APE           D++S G ++ E+   K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 40/241 (16%)

Query: 626 DQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK------VFHLQLEGALESFNAECEVLRS 678
            ++ +  L+G G FG+V+ G    D ++VAIK      V          +   E  +L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 679 IR----HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY---SDNSNLD------IFKR 725
           +     H  ++R++      +   LVL+       +  L+   ++   L        F +
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDYITEKGPLGEGPSRCFFGQ 147

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESMKH 784
                 +  A+++ H      VVH DIK  N+L+D     A+L DFG   LL        
Sbjct: 148 ------VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYT 196

Query: 785 TQTLATIGYMAPEY-GREGQISTEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRW 840
                T  Y  PE+  R    +    V+S GI+L ++     P     EI   E+     
Sbjct: 197 D-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH 255

Query: 841 V 841
           V
Sbjct: 256 V 256

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 44/205 (21%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRIISS 690
           IG G+F  V   R  L G EVAIK+         +L+    E  +++ + H N+V++   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 691 CTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVIDIALALE 737
              +    L+++Y   G +             EA           F+       I  A++
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--------FR------QIVSAVQ 128

Query: 738 YLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI----GY 793
           Y H      +VH D+K  N+LLD DM  ++ DFG +              L        Y
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE------FTVGGKLDAFCGAPPY 179

Query: 794 MAPE-YGREGQISTEGDVYSFGIML 817
            APE +  +     E DV+S G++L
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVIL 204

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 82.5 bits (203), Expect = 2e-16
 Identities = 49/346 (14%), Positives = 97/346 (28%), Gaps = 16/346 (4%)

Query: 139 QALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS 198
           Q+       L+G               +    ++  S   ++   +  L L         
Sbjct: 226 QSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSV 285

Query: 199 GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSL 258
                   N            +       +          + +   +   +    +    
Sbjct: 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS 345

Query: 259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLS--LSMERFYLHNCNIRGSIPKEMGNLINLII 316
           A  ++L    L+       VL S + +      +E            + + +  L+    
Sbjct: 346 ATDEQLFRCELSVEKS--TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKE 403

Query: 317 IRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSI 376
               ++ L    P   + L+ L+   L  N +      D+  L      +L H  L+  +
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL------HLAHKDLT-VL 456

Query: 377 PACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVEL 436
                 L  +  L  + N L  +P     L  + ++  S N L  ++   + NL  L EL
Sbjct: 457 CH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQEL 513

Query: 437 YLSRNNLSG-DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL 481
            L  N L        +     L  L+L  N+L          L  +
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.8 bits (170), Expect = 2e-12
 Identities = 30/196 (15%), Positives = 65/196 (33%), Gaps = 8/196 (4%)

Query: 321 YNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACF 380
                       +  E+L    L   +    +  ++     L  +  ++     +I    
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM 392

Query: 381 GNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR 440
             L  L          +       +      +D   +       +       +  L+L+ 
Sbjct: 393 RALDPLLYEKETLQYFS--TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450

Query: 441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLE 500
            +L+  +   +  L  + +L L  N L+ ++P ++  L  LE L  S+N L  +    + 
Sbjct: 451 KDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVA 505

Query: 501 KLLYLKYLNVSFNRLE 516
            L  L+ L +  NRL+
Sbjct: 506 NLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 3e-12
 Identities = 33/186 (17%), Positives = 71/186 (38%), Gaps = 6/186 (3%)

Query: 226 PNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGN 285
           P     +  +  L    + +      L + S+L     ++   L        +  S +  
Sbjct: 379 PENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKM 438

Query: 286 LSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLEN 345
               +   +L + ++  ++   +  L+ +  + L +N+L  ++P  L+ L  L++L   +
Sbjct: 439 EYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495

Query: 346 NQLEGRILDDICRLARLSSVYLDHNKLSG-SIPACFGNLASLRKLSFASNELTFVPSTFW 404
           N LE   +D +  L RL  + L +N+L   +      +   L  L+   N L        
Sbjct: 496 NALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553

Query: 405 NLTNIL 410
            L  +L
Sbjct: 554 RLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 1e-10
 Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 26/131 (19%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
           TV   L  L  + +LDLS N+L   +P ++ ++  LE+L  S+N L       N+  LQ 
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALENVDGVANLPRLQE 512

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE 127
           + L +NRL  +  A                        + + +   L  ++L  N L  +
Sbjct: 513 LLLCNNRLQ-QSAA-----------------------IQPLVSCPRLVLLNLQGNSLC-Q 547

Query: 128 IPHEIGNLRNL 138
                  L  +
Sbjct: 548 EEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.5 bits (151), Expect = 4e-10
 Identities = 41/260 (15%), Positives = 80/260 (30%), Gaps = 36/260 (13%)

Query: 1   LQSFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF 60
           L             +   L   +LS  +    + S + S   L+ L+  N     +    
Sbjct: 333 LLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI-IL 390

Query: 61  NMSSLQVIDLSDNRLSG--ELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSID 118
            M +L  +      L     L A       ++  L    ++F             +  + 
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR---SKFLLENSVLKMEYADVRVLH 447

Query: 119 LSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISS 178
           L+   L   +   +  L  +  L  LS+N +  +P  L  +  L++LQ ++N L  ++  
Sbjct: 448 LAHKDL--TVLCHLEQLLLVTHLD-LSHNRLRALPPALAALRCLEVLQASDNALE-NVDG 503

Query: 179 SIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL 238
                LP L+   L NN                 + +               +   L  L
Sbjct: 504 VAN--LPRLQELLLCNNR----------------LQQSAA-------IQPLVSCPRLVLL 538

Query: 239 NLEYNYITSSNHELSFISSL 258
           NL+ N +         ++ +
Sbjct: 539 NLQGNSLCQEEGIQERLAEM 558

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 41/218 (18%)

Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKVF--HLQLEGALESFNAECEV 675
             ++  +D+++    IGSG+FG     R  L    VA+K       ++  ++    E   
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIIN 69

Query: 676 LRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDI 722
            RS+RH N+VR           A++++Y   G L             EA  +        
Sbjct: 70  HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF-------- 121

Query: 723 FKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL--GDFGIAKLLSGDE 780
           F++L   +     + Y H      + H D+K  N LLD     RL   DFG +K  S   
Sbjct: 122 FQQL---LS---GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLH 171

Query: 781 SMKHTQTLATIGYMAPE-YGREGQISTEGDVYSFGIML 817
           S   + T+ T  Y+APE   R+       DV+S G+ L
Sbjct: 172 SQPKS-TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 31/221 (14%)

Query: 623 QATDQFNVNNLIGSGSFGSVYRGR--FLDGMEVAIKVFHLQLEGALESFNA----ECEVL 676
           +A  Q+     IG G++G V++ R     G  VA+K   +Q     E        E  VL
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVL 65

Query: 677 RSIR---HRNLVRIISSCTNDDFKA-----LVLDYMP---KGSLEACLYSDNSNLDIFKR 725
           R +    H N+VR+   CT           LV +++       L+         +     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETI 122

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
            +++  +   L++LH    + VVH D+KP N+L+      +L DFG+A++ S    M  T
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALT 177

Query: 786 QTLATIGYMAPE--YGREGQISTEGDVYSFGIMLMEIFTRK 824
             + T+ Y APE         +T  D++S G +  E+F RK
Sbjct: 178 SVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.5 bits (197), Expect = 4e-16
 Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 64/242 (26%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVFH----LQLEGALESFNAECEVLR 677
           + F +  ++G G +G V++ R + G       A+KV      ++         AE  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFK 724
            ++H  +V +I +        L+L+Y+  G L              AC Y          
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL--------- 127

Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH 784
                 +I++AL +LH      +++ D+KP N++L+     +L DFG+ K     ES+  
Sbjct: 128 -----AEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHD 174

Query: 785 TQTLA----TIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDE 829
                    TI YMAPE      + R        D +S G ++ ++ T   P       +
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNR------AVDWWSLGALMYDMLTGAPPFTGENRKK 228

Query: 830 IF 831
             
Sbjct: 229 TI 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.1 bits (196), Expect = 5e-16
 Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 64/241 (26%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVF---HLQLEGALESFNAECEVLRS 678
            QF +  ++G GSFG V+  + + G +     A+KV     L++   + +   E ++L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK-MERDILVE 82

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKR 725
           + H  +V++  +   +    L+LD++  G L             +   Y           
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------- 132

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
                ++ALAL++LH      +++ D+KP N+LLDE+   +L DFG++K     ES+ H 
Sbjct: 133 ----AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHE 180

Query: 786 QTLA----TIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEI 830
           +       T+ YMAPE      + +        D +SFG+++ E+ T   P       E 
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQ------SADWWSFGVLMFEMLTGTLPFQGKDRKET 234

Query: 831 F 831
            
Sbjct: 235 M 235

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 34/149 (22%), Positives = 63/149 (42%), Gaps = 10/149 (6%)

Query: 27  NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANI 83
           NQ L  IP  I        L L+NN+ +       F  +  L+ I+ S+N+++ ++    
Sbjct: 20  NQKLNKIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGA 76

Query: 84  FSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI-GNLRNLQAL 141
           F     V  + L  N+    +  ++   L SL ++ L  N +   + ++    L +++ L
Sbjct: 77  FEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLL 134

Query: 142 GLLSNNLVGVVPATLFNISTLKILQLTNN 170
            L  N +  V P     + +L  L L  N
Sbjct: 135 SLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 31/136 (22%), Positives = 57/136 (41%), Gaps = 10/136 (7%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSD 72
                L L+ N+      + IF  +  L  ++ SNN+++       F   S +  I L+ 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHE 131
           NRL   +   +F  L  ++ L L  N+    +  +    L+S+  + L +N +   +   
Sbjct: 91  NRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPG 147

Query: 132 I-GNLRNLQALGLLSN 146
               L +L  L LL+N
Sbjct: 148 AFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 28/113 (24%), Positives = 53/113 (46%), Gaps = 9/113 (7%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
            L  L+ ++ S N+ +  I    F   + +  + L++N+L  +     F  + SL+ + L
Sbjct: 55  KLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
             NR++  +  + F  L  V+ LSL  NQ    +       L SL++++L  N
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 29/141 (20%), Positives = 55/141 (39%), Gaps = 10/141 (7%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGL 343
           ++        L+N          +   L  L  I    NK+             +  + L
Sbjct: 29  HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88

Query: 344 ENNQLE---GRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFV 399
            +N+LE    ++      L  L ++ L  N+++  +    F  L+S+R LS   N++T V
Sbjct: 89  TSNRLENVQHKMFK---GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTV 144

Query: 400 P-STFWNLTNILMVDLSSNPL 419
               F  L ++  ++L +NP 
Sbjct: 145 APGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 33/137 (24%), Positives = 63/137 (45%), Gaps = 12/137 (8%)

Query: 384 ASLRKLSFASNELTFVPST--FWNLTNILMVDLSSNPLSGSLPLEIG---NLKVLVELYL 438
               +L   +NE T + +T  F  L  +  ++ S+N ++    +E G       + E+ L
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEEGAFEGASGVNEILL 88

Query: 439 SRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIP 496
           + N L  ++   +  GL++L+ L L  N +   + N     L S+  L L +N ++ + P
Sbjct: 89  TSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAP 146

Query: 497 SSLEKLLYLKYLNVSFN 513
            + + L  L  LN+  N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 26/132 (19%), Positives = 55/132 (41%), Gaps = 6/132 (4%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI 451
           + +L  +P      T  L   L++N  +      I   L  L ++  S N ++       
Sbjct: 20  NQKLNKIPEHIPQYTAEL--RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF 77

Query: 452 GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNV 510
            G   +  + L  N L+ ++ + +   L SL+ L L +N ++ +   S   L  ++ L++
Sbjct: 78  EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136

Query: 511 SFNRLEGEIPRG 522
             N++   +  G
Sbjct: 137 YDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 28/137 (20%), Positives = 62/137 (45%), Gaps = 5/137 (3%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSE 121
                + L++N  +      IF  LP ++ ++ + N+    +        + +  I L+ 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 122 NHLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
           N L   + H++   L +L+ L L SN +  V   +   +S++++L L +N ++ +++   
Sbjct: 91  NRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148

Query: 181 RLALPNLELFSLANNNF 197
              L +L   +L  N F
Sbjct: 149 FDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 21/90 (23%), Positives = 45/90 (50%), Gaps = 7/90 (7%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
             S +  + L+ N+ L  +   +F  + +L+ L L +N+++       F  +SS++++ L
Sbjct: 79  GASGVNEILLTSNR-LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQF 100
            DN+++  +    F  L  +  L+L  N F
Sbjct: 137 YDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 35/223 (15%), Positives = 68/223 (30%), Gaps = 67/223 (30%)

Query: 160 STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
                L+L NN  +   ++ I   LP L   + +NN                 I ++ + 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK----------------ITDIEEG 75

Query: 220 SFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVL 279
           +F G           + E+ L  N + +                               +
Sbjct: 76  AFEG--------ASGVNEILLTSNRLEN-------------------------------V 96

Query: 280 PSSI-GNLSLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIP-STLSRLE 336
              +   L  S++   L +  I   +  +    L ++ ++ L  N++  ++       L 
Sbjct: 97  QHKMFKGLE-SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153

Query: 337 KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPAC 379
            L  L L  N       +  C LA L   +L   ++    P C
Sbjct: 154 SLSTLNLLANP-----FNCNCYLAWLGE-WLRKKRIVTGNPRC 190

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 57/234 (24%), Positives = 106/234 (45%), Gaps = 29/234 (12%)

Query: 607 NMPLVAWRRFSYQELLQA----TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIK----V 657
           ++ L+  + F  Q++ +        +     +GSG++GSV        G +VAIK     
Sbjct: 1   SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP 60

Query: 658 FHLQLEGALESFNAECEVLRSIRHRNLVRI----ISSCTNDDFKA--LVLDYMPKGSLEA 711
           F  ++  A  ++  E  +L+ ++H N++ +      + +  +F    LV+ +M    L+ 
Sbjct: 61  FQSEIF-AKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQK 117

Query: 712 CLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG 771
            +          K   +V  +   L+Y+H      VVH D+KP N+ ++ED   ++ DFG
Sbjct: 118 IM---GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171

Query: 772 IAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
           +A+    D  M  T  + T  Y APE         +  D++S G ++ E+ T K
Sbjct: 172 LAR--HADAEM--TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.2 bits (195), Expect = 8e-16
 Identities = 50/269 (18%), Positives = 94/269 (34%), Gaps = 72/269 (26%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF--LDGMEVAIKVFHLQL-EGA----LESFNAECEVLRS 678
           D+  +   +G G+FG V       +D       V    L EGA      +  +E ++L  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 679 I-RHRNLVRIISSCTNDDFKALV-LDYMPKGSLEACL----------------------Y 714
           I  H N+V ++ +CT      +V +++   G+L   L                      Y
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 715 SDNSNLDIFKRLNIVI-----DIALALEYLHFGHPNPVVHCDIKPSNVL----------- 758
                +D+ +RL+ +        +  +E             +    + L           
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 759 ------------------------LDEDMVARLGDFGIAKLL-SGDESMKHTQTLATIGY 793
                                   L E  V ++ DFG+A+ +    + ++       + +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           MAPE   +   + + DV+SFG++L EIF+
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.9 bits (195), Expect = 9e-16
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 45/220 (20%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV----AIKVFH----LQLEGALESFNAECEVLR 677
           + F +  ++G+G++G V+  R + G +     A+KV      +Q     E    E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 678 SIRHRN-LVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIF 723
            IR    LV +  +   +    L+LDY+  G L             E  +Y         
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV-------- 165

Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK 783
                  +I LALE+LH      +++ DIK  N+LLD +    L DFG++K    DE+ +
Sbjct: 166 ------GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 784 HTQTLA-TIGYMAPE---YGREGQISTEGDVYSFGIMLME 819
                  TI YMAP+    G  G      D +S G+++ E
Sbjct: 217 -AYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYE 254

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.5 bits (198), Expect = 9e-16
 Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 61/239 (25%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
             FN   ++G GSFG V         E+ A+K+     +  +  +E    E  VL    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
              L ++ S     D    V++Y+  G L              A  Y+            
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA------------ 448

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--- 784
              +IA+ L +L       +++ D+K  NV+LD +   ++ DFG+ K     E++     
Sbjct: 449 --AEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVT 498

Query: 785 TQTLA-TIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
           T+T   T  Y+APE      YG+        D ++FG++L E+   + P      DE+F
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.8 bits (197), Expect = 1e-15
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 51/210 (24%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVR-- 686
            +G G+FG V  G+  L G +VA+K+ +   ++    +     E + L+  RH ++++  
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 687 -IISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLNIVIDI 732
            +IS+  +D F  +V++Y+  G L             E+           F++      I
Sbjct: 83  QVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQ------I 125

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI- 791
              ++Y H    + VVH D+KP NVLLD  M A++ DFG++ +      M   + L T  
Sbjct: 126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSC 176

Query: 792 ---GYMAPE-YGREGQISTEGDVYSFGIML 817
               Y APE          E D++S G++L
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 49/233 (21%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
           + F ++ ++G GSFG V+   F    +  AIK      + ++  +E    E  VL  +  
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
           H  L  +  +    +    V++Y+  G L              A  Y+            
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA------------ 124

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
              +I L L++LH      +V+ D+K  N+LLD+D   ++ DFG+ K     E+M     
Sbjct: 125 --AEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAK 174

Query: 788 LA----TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
                 T  Y+APE     + +   D +SFG++L E+   + P      +E+F
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 68/253 (26%), Positives = 100/253 (39%), Gaps = 65/253 (25%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
             F+   +IG GSFG V   R        A+KV     +  +   +   +E  VL ++++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
           H  LV +  S    D    VLDY+  G L              A  Y+            
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA------------ 145

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--- 784
              +IA AL YLH      +V+ D+KP N+LLD      L DFG+ K     E+++H   
Sbjct: 146 --AEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNST 195

Query: 785 TQTL-ATIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF- 831
           T T   T  Y+APE      Y R        D +  G +L E+     P     T E++ 
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDR------TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

Query: 832 ---SGEMSLKRWV 841
              +  + LK  +
Sbjct: 250 NILNKPLQLKPNI 262

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 61/239 (25%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
           D F    ++G GSFG V   R  +  ++ A+KV     +  +  +E    E  +L  +  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
           H  L ++       D    V++++  G L              A  Y+            
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA------------ 130

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
              +I  AL +LH      +++ D+K  NVLLD +   +L DFG+ K     E + +  T
Sbjct: 131 --AEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVT 180

Query: 788 LA----TIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
            A    T  Y+APE      YG         D ++ G++L E+     P      D++F
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGP------AVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 20/212 (9%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK---VFHLQLEGALESFNAECEVLRSIR 680
             ++   + IG G++G V      L+ + VAIK    F  Q      +   E ++L   R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFR 83

Query: 681 HRNLVR---IISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALA 735
           H N++    II + T +  K   +V D M    L   L +     +       +  I   
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICY-FLYQILRG 140

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH--TQTLATIGY 793
           L+Y+H  +   V+H D+KPSN+LL+     ++ DFG+A++   D       T+ +AT  Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 794 MAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
            APE     +  T+  D++S G +L E+ + +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 55/245 (22%), Positives = 101/245 (41%), Gaps = 59/245 (24%)

Query: 633 LIGSGSFGSVYRGR-FLDGMEVAIKVFH---LQLEGALESFNAECEVLRSIRHRNLVR-- 686
            +G GSFG V     +    +VA+K      L+          E   L+ +RH ++++  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 687 -IISSCTNDDFKALVLDY---------MPKGSL---EACLYSDNSNLDIFKRLNIVIDIA 733
            +I++   D    +V++Y         + K  +   E   +        F++      I 
Sbjct: 76  DVITT-PTDIV--MVIEYAGGELFDYIVEKKRMTEDEGRRF--------FQQ------II 118

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI-- 791
            A+EY H    + +VH D+KP N+LLD+++  ++ DFG++ +      M     L T   
Sbjct: 119 CAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------MTDGNFLKTSCG 169

Query: 792 --GYMAPE-YGREGQISTEGDVYSFGIMLMEIFTRKRPTDE---------IFSGEMSLKR 839
              Y APE    +     E DV+S GI+L  +   + P D+         + S    +  
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD 229

Query: 840 WVNDS 844
           +++  
Sbjct: 230 FLSPG 234

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 11/168 (6%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSS 64
           +VPS  G  +  + LDL    L     ++   +  L  L+L  NQL  +     F +++ 
Sbjct: 28  SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENH 123
           L  + L++N+L+  LP  +F +L  +  L L  NQ    LP  +   LT L  + L+ N 
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQ 142

Query: 124 LMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNN 170
           L   IP      L NLQ L L +N L  V       +  L+ + L  N
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)

Query: 357 CRLARLSSV-----------YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFW 404
           C+   L SV            L    L+    A F  L  L  L+   N+L  + +  F 
Sbjct: 21  CQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD 80

Query: 405 NLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSL 462
           +LT +  + L++N L+ SLPL +  +L  L +LYL  N L   +P+ +   L  L+ L L
Sbjct: 81  DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRL 138

Query: 463 GDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYL 508
             N LQ SIP    D L +L+ L LS N L  +   + ++L  L+ +
Sbjct: 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 55/167 (32%), Positives = 80/167 (47%), Gaps = 15/167 (8%)

Query: 328 IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASL 386
           IP+   +L+      L++  L          L +L+ + LD+N+L  ++ A  F +L  L
Sbjct: 33  IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 387 RKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLS 444
             L  A+N+L  +P   F +LT +  + L  N L  SLP  +   L  L EL L+ N L 
Sbjct: 86  GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 445 GDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNN 489
             IP      L NLQ LSL  N LQ S+P+   D L  L+ + L  N
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 11/148 (7%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FF 60
           L     +    L+ L +L+L +NQ L T+ + +F  +  L  L L+NNQL+ S P   F 
Sbjct: 47  LATLSDATFRGLTKLTWLNLDYNQ-LQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFD 104

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDL 119
           +++ L  + L  N+L   LP+ +F  L  ++ L L  NQ    +P      LT+L ++ L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162

Query: 120 SENHLMGEIPHEI-GNLRNLQALGLLSN 146
           S N L   +PH     L  LQ + L  N
Sbjct: 163 STNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 11/157 (7%)

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQL- 348
           E+  L +  +          L  L  + L YN+L  ++ +     L +L  LGL NNQL 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96

Query: 349 --EGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFW 404
                + D    L +L  +YL  N+L  S+P+  F  L  L++L   +N+L  +P+  F 
Sbjct: 97  SLPLGVFD---HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD 152

Query: 405 NLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRN 441
            LTN+  + LS+N L          L  L  + L  N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 46/210 (21%), Positives = 72/210 (34%), Gaps = 66/210 (31%)

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
           +L     +      F  +  L  LNL+YN + +                           
Sbjct: 41  DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--------------------------- 73

Query: 275 LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTL-S 333
               L + + +    +    L N                        N+L  S+P  +  
Sbjct: 74  ----LSAGVFDDLTELGTLGLAN------------------------NQLA-SLPLGVFD 104

Query: 334 RLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKL 389
            L +L  L L  NQ   L   + D   RL +L  + L+ N+L  SIPA  F  L +L+ L
Sbjct: 105 HLTQLDKLYLGGNQLKSLPSGVFD---RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTL 160

Query: 390 SFASNELTFVP-STFWNLTNILMVDLSSNP 418
           S ++N+L  VP   F  L  +  + L  N 
Sbjct: 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 40/131 (30%), Positives = 52/131 (39%), Gaps = 5/131 (3%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
              L  VPS     T  L  DL S  L+         L  L  L L  N L         
Sbjct: 23  GKSLDSVPSGIPADTEKL--DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD 80

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
            L  L  L L +N L  S+P  + D L  L+ L L  N L  +     ++L  LK L ++
Sbjct: 81  DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN 139

Query: 512 FNRLEGEIPRG 522
            N+L+  IP G
Sbjct: 140 TNQLQ-SIPAG 149

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 44/168 (26%), Positives = 65/168 (38%), Gaps = 11/168 (6%)

Query: 112 TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN-ISTLKILQLTNN 170
                +DL    L          L  L  L L  N L   + A +F+ ++ L  L L NN
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 171 TLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRF 229
            L+ S+   +   L  L+   L  N     +PS +F   +KL    L  N         F
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151

Query: 230 HNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
             + NL+ L+L  N + S  H      +     KL+ ++L GN   DC
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPH-----GAFDRLGKLQTITLFGNQ-FDC 193

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.1 bits (188), Expect = 6e-15
 Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 49/233 (21%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
             FN   ++G GSFG V         E+ A+K+     +  +  +E    E  VL    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
              L ++ S     D    V++Y+  G L              A  Y+            
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA------------ 127

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
              +IA+ L +L       +++ D+K  NV+LD +   ++ DFG+ K     E++    T
Sbjct: 128 --AEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVT 177

Query: 788 LA----TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP-----TDEIF 831
                 T  Y+APE           D ++FG++L E+   + P      DE+F
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 45/228 (19%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIK---VFHLQLEGALESFNAECEVLRSIR 680
           +  F + +L+G G++G V        G  VAIK    F   L  AL +   E ++L+  +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLR-EIKILKHFK 67

Query: 681 HRNLVR---IISSCTNDDFKA--LVLDYMPKGSLEACLY---SDNSNLDIFKRLNIVIDI 732
           H N++    I    + ++F    ++ + M     +  L+   S     D   +   +   
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY-FIYQT 121

Query: 733 ALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH-------- 784
             A++ LH  +   V+H D+KPSN+L++ +   ++ DFG+A+++    +           
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 785 -TQTLATIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRK 824
             + +AT  Y APE       Y      S   DV+S G +L E+F R+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIK----VFHLQLEGALESFNAECEVLRSI 679
            +++   + +GSG++GSV        G+ VA+K     F   +  A  ++  E  +L+ +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYR-ELRLLKHM 85

Query: 680 RHRNLVRI----ISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           +H N++ +      + + ++F    LV   M    L   +       D  +   ++  I 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQIL 142

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGY 793
             L+Y+H      ++H D+KPSN+ ++ED   ++ DFG+A+     + M  T  +AT  Y
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEM--TGYVATRWY 195

Query: 794 MAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
            APE         +  D++S G ++ E+ T +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 29/221 (13%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK--VFHLQLEGALESFNAECEVLRSIRH 681
             ++     +G G  G V+          VAIK  V          +   E +++R + H
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKHALR-EIKIIRRLDH 67

Query: 682 RNLVRII------------SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLN 727
            N+V++                +  +  +  +V +YM    L   L      L+   RL 
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARL- 124

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKH-- 784
            +  +   L+Y+H  +   V+H D+KP+N+ ++ ED+V ++GDFG+A+++    S K   
Sbjct: 125 FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 785 TQTLATIGYMAPEYGREGQISTEG-DVYSFGIMLMEIFTRK 824
           ++ L T  Y +P         T+  D+++ G +  E+ T K
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 50/226 (22%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
             F++  +IG GS+  V   R      + A++V     +  +  ++    E  V  ++  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
           H  LV + S    +     V++Y+  G L              A  YS            
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------------ 159

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
              +I+LAL YLH      +++ D+K  NVLLD +   +L D+G+ K          T T
Sbjct: 160 --AEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST 212

Query: 788 L-ATIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
              T  Y+APE      YG         D ++ G+++ E+   + P
Sbjct: 213 FCGTPNYIAPEILRGEDYGF------SVDWWALGVLMFEMMAGRSP 252

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 13/185 (7%)

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
            L ++  I    + +  S+   +  L  ++ L L  N+L          L  L+ + L  
Sbjct: 39  ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHDISALK--ELTNLTYLILTG 94

Query: 370 NKLSGSIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI 427
           N+L  S+P   F  L +L++L    N+L  +P   F  LTN+  ++L+ N L  SLP  +
Sbjct: 95  NQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV 152

Query: 428 -GNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECL 484
              L  L EL LS N L   +P  +   L  L++L L  N L+ S+P+ + D L SL+ +
Sbjct: 153 FDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYI 210

Query: 485 DLSNN 489
            L +N
Sbjct: 211 WLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 34/208 (16%)

Query: 317 IRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSI 376
             L    +     +  + L  +  +   N+ ++   +  I  L  +  + L  NKL   I
Sbjct: 24  ANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-DI 78

Query: 377 PACFGNLASLRKLSFASNELTFVPST-FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVE 435
            A    L +L  L    N+L  +P+  F  LTN+  + L  N L  SLP  + +      
Sbjct: 79  SA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD------ 130

Query: 436 LYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGI 494
                             L NL  L+L  N LQ S+P  + D L +L  LDLS N L  +
Sbjct: 131 -----------------KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSL 172

Query: 495 IPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
                +KL  LK L +  N+L+  +P G
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR 74
            L+S+  +  + + +       I  +  +  L L  N+L        +++L  + L+ N+
Sbjct: 39  ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQ 96

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGN-LTSLTSIDLSENHLMGEIPHEI- 132
           L   LP  +F  L  ++ L L  NQ    LP  + + LT+LT ++L+ N L   +P  + 
Sbjct: 97  LQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVF 153

Query: 133 GNLRNLQALGLLSNNLVGVVPATLFNIST-LKILQLTNNTL 172
             L NL  L L  N L   +P  +F+  T LK L+L  N L
Sbjct: 154 DKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 10/161 (6%)

Query: 364 SVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSL 423
              L    ++         L S+ ++   ++++  V      L N+  + L  N L   +
Sbjct: 23  KANLKKKSVT-DAVT-QNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLH-DI 78

Query: 424 PLEIGNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISL 481
              +  L  L  L L+ N L   +P  +   L NL+ L L +N LQ S+P+ + D L +L
Sbjct: 79  SA-LKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNL 135

Query: 482 ECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
             L+L++N L  +     +KL  L  L++S+N+L+  +P G
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEG 175

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 54/251 (21%), Positives = 96/251 (38%), Gaps = 44/251 (17%)

Query: 30  LGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPF 89
               P   F+       +L    ++ +     ++S+  I  +++ +   +      YLP 
Sbjct: 10  KQIFPDDAFA--ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG--IQYLPN 64

Query: 90  VQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLV 149
           V++L+L  N+           L  ++++                 L NL  L L  N L 
Sbjct: 65  VRYLALGGNK-----------LHDISALK---------------ELTNLTYLILTGNQLQ 98

Query: 150 GVVPATLFN-ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNA 208
             +P  +F+ ++ LK L L  N L  S+   +   L NL   +LA+N     +P  +F+ 
Sbjct: 99  S-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDK 155

Query: 209 -SKLSICELPDNSFSGFIPNR-FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV 266
            + L+  +L  N     +P   F  +  LK+L L  N + S                L+ 
Sbjct: 156 LTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSVPDG-----VFDRLTSLQY 209

Query: 267 LSLTGNPLLDC 277
           + L  NP  DC
Sbjct: 210 IWLHDNP-WDC 219

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 52/232 (22%), Positives = 77/232 (33%), Gaps = 47/232 (20%)

Query: 144 LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPS 203
           L    V         ++++  +   N+ +           +  L L      N    I +
Sbjct: 26  LKKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQGIQYLPNVRYLAL----GGNKLHDISA 80

Query: 204 FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK 263
                + L+   L  N         F  + NLKEL L  N + S          L N   
Sbjct: 81  L-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSL--PDGVFDKLTN--- 134

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNK 323
           L  L+L  N L    LP  +         F                 L NL  + L YN+
Sbjct: 135 LTYLNLAHNQLQ--SLPKGV---------F---------------DKLTNLTELDLSYNQ 168

Query: 324 LNGSIPS-TLSRLEKLQILGLENNQL----EGRILDDICRLARLSSVYLDHN 370
           L  S+P     +L +L+ L L  NQL    +G + D   RL  L  ++L  N
Sbjct: 169 LQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDG-VFD---RLTSLQYIWLHDN 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 50/226 (22%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEV-AIKVF---HLQLEGALESFNAECEVL-RSIR 680
             F++  +IG GS+  V   R      + A+KV     +  +  ++    E  V  ++  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSL-------------EACLYSDNSNLDIFKRLN 727
           H  LV + S    +     V++Y+  G L              A  YS            
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------------ 116

Query: 728 IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT 787
              +I+LAL YLH      +++ D+K  NVLLD +   +L D+G+ K          T T
Sbjct: 117 --AEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST 169

Query: 788 L-ATIGYMAPE------YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
              T  Y+APE      YG         D ++ G+++ E+   + P
Sbjct: 170 FCGTPNYIAPEILRGEDYGF------SVDWWALGVLMFEMMAGRSP 209

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.0 bits (182), Expect = 6e-14
 Identities = 40/193 (20%), Positives = 79/193 (40%), Gaps = 17/193 (8%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK----VFHLQLEGALESFNAECEVLRSI 679
            D + + +LIG GS+G VY          VAIK    +F   ++        E  +L  +
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID-CKRILR-EITILNRL 82

Query: 680 RHRNLVR---IISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           +   ++R   +I       F    +VL+      L+    +     +   +  I+ ++ L
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLL 140

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
              ++H      ++H D+KP+N LL++D   ++ DFG+A+ ++ ++       L      
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 795 APEYGREGQISTE 807
            P      +  T 
Sbjct: 198 GPHNKNLKKQLTS 210

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 47/250 (18%), Positives = 92/250 (36%), Gaps = 22/250 (8%)

Query: 247 SSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPK 306
                ++ +            +L    + D     S   LS  ++ F   N NI+ S+  
Sbjct: 4   QRPTPINQVFPDPGLANAVKQNLGKQSVTDL---VSQKELS-GVQNFNGDNSNIQ-SL-A 57

Query: 307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLS--S 364
            M    NL  + L +N++  S  S L  L KL+ L +  N+L+     ++  +       
Sbjct: 58  GMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSR 110

Query: 365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLP 424
           ++LD+N+L  +      +L +L  LS  +N+L  +      L+ + ++DL  N ++ +  
Sbjct: 111 LFLDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVM-LGFLSKLEVLDLHGNEITNTGG 167

Query: 425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECL 484
           L    LK +  + L+      +       L     +   D       P  I +  S    
Sbjct: 168 LT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDG 223

Query: 485 DLSNNILSGI 494
            +   +    
Sbjct: 224 CVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 18/176 (10%)

Query: 343 LENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPST 402
                +    +     LA      L    ++  +      L+ ++  +  ++ +  + + 
Sbjct: 4   QRPTPINQ--VFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL-AG 58

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK--NLQNL 460
               TN+  + LS N +S   PL+  +L  L EL ++RN L       + G+    L  L
Sbjct: 59  MQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRL-----KNLNGIPSACLSRL 111

Query: 461 SLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            L +N L     +S+  L +LE L + NN L  I    L  L  L+ L++  N + 
Sbjct: 112 FLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 44/230 (19%), Positives = 79/230 (34%), Gaps = 48/230 (20%)

Query: 48  LSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE 107
                ++  FP   +++    +L    ++  +       L  VQ  +   +     L   
Sbjct: 4   QRPTPINQVFPDPGLANAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQ-SLA-G 58

Query: 108 IGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQL 167
           +   T+L  + LS N +  ++   + +L  L+ L +  N L  +        + L  L L
Sbjct: 59  MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFL 113

Query: 168 TNNTLSGSISSSIRLA-LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIP 226
            NN L     S   L  L NLE+ S+ NN                 +  +          
Sbjct: 114 DNNELR-DTDS---LIHLKNLEILSIRNNK----------------LKSIVM-------- 145

Query: 227 NRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
                +  L+ L+L  N IT+          L   KK+  + LTG   ++
Sbjct: 146 --LGFLSKLEVLDLHGNEITN-------TGGLTRLKKVNWIDLTGQKCVN 186

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 38/241 (15%), Positives = 90/241 (37%), Gaps = 21/241 (8%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
                L++    +L    +  T   S   ++ ++  +  N+ +         ++L+ + L
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHL 70

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNL--TSLTSIDLSENHLMGEI 128
           S N++S +L       L  ++ LS+  N+      + +  +    L+ + L  N L    
Sbjct: 71  SHNQIS-DLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNEL--RD 120

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE 188
              + +L+NL+ L + +N L  +V   L  +S L++L L  N ++ +        L  + 
Sbjct: 121 TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NTGGL--TRLKKVN 175

Query: 189 LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
              L       +   +       +  + PD  +    P    N  +  +  + +     +
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPVYT 233

Query: 249 N 249
           +
Sbjct: 234 D 234

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 31/193 (16%), Positives = 66/193 (34%), Gaps = 16/193 (8%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSIN--TLEILDLSNNQLSGSFPFFNMSSLQVI 68
           S L  L+ L+ L ++ N+L      ++  I    L  L L NN+L  +    ++ +L+++
Sbjct: 79  SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEIL 133

Query: 69  DLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI 128
            + +N+L   +      +L  ++ L L  N+        +  L  +  IDL+    + E 
Sbjct: 134 SIRNNKLK-SIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEP 188

Query: 129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLE 188
                 L     +         + P  + N  +     +         +  +        
Sbjct: 189 VKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPVY--TDEVSYKFSEYI 244

Query: 189 LFSLANNNFSGKI 201
                   F G +
Sbjct: 245 NVGETEAIFDGTV 257

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 24/203 (11%)

Query: 634 IGSGSFGSVYRGR-FLDGMEVAIK----VFHLQLEGALESFNAECEVLRSIRHRNLVRII 688
           +GSG++G+V        G +VAIK     F  +L  A  ++  E  +L+ +RH N++ ++
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAYR-ELRLLKHMRHENVIGLL 90

Query: 689 ----SSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
                  T DDF    LV+ +M    L   +  +    D  +   +V  +   L Y+H  
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF--LVYQMLKGLRYIHAA 147

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
               ++H D+KP N+ ++ED   ++ DFG+A+    D  M  T  + T  Y APE     
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEM--TGYVVTRWYRAPEVILNW 200

Query: 803 QISTEG-DVYSFGIMLMEIFTRK 824
              T+  D++S G ++ E+ T K
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 46/227 (20%), Positives = 92/227 (40%), Gaps = 43/227 (18%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR-HR 682
            D + +   +G G +  V+    +    +V +K+  L+     +    E ++L ++R   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIKR-EIKILENLRGGP 91

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNL-DIFKRLN------IVIDIALA 735
           N++ +     +   +   L +          + +N++   +++ L        + +I  A
Sbjct: 92  NIITLADIVKDPVSRTPALVFE---------HVNNTDFKQLYQTLTDYDIRFYMYEILKA 142

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
           L+Y H      ++H D+KP NV++D E    RL D+G+A+     +       +A+  + 
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFK 197

Query: 795 APE-------YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
            PE       Y          D++S G ML  +  RK P    F G 
Sbjct: 198 GPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 38/161 (23%)

Query: 634 IGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVL-RSIRHRNLVRII--- 688
           +G G  G V +        + A+K+              E E+  R+ +  ++VRI+   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 689 -SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD-IFKRLN----------IVIDIALAL 736
            +         +V++ +  G L             I  R +          I+  I  A+
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 737 EYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAK 774
           +YLH      + H D+KP N+L      + + +L DFG AK
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 37/194 (19%), Positives = 85/194 (43%), Gaps = 17/194 (8%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK----VFHLQLEGALESFNAECEVLRSI 679
            D++ + +LIG+GS+G V      L+   VAIK    VF   ++        E  +L  +
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-CKRILR-EIAILNRL 109

Query: 680 RHRNLVR---IISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
            H ++V+   I+     + F    +VL+       +    +     ++  +  ++ ++ +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLV 167

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
            ++Y+H      ++H D+KP+N L+++D   ++ DFG+A+ +   E+      ++     
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 795 APEYGREGQISTEG 808
                     + + 
Sbjct: 225 MNLVTFPHTKNLKR 238

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 6/143 (4%)

Query: 30  LGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYL 87
             ++P+ I +    +IL L +NQ++   P  F ++ +L+ + L  N+L   LP  +F  L
Sbjct: 31  HASVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSL 87

Query: 88  PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNN 147
             +  L L  NQ           L  L  + +  N L  E+P  I  L +L  L L  N 
Sbjct: 88  TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQ 146

Query: 148 LVGVVPATLFNISTLKILQLTNN 170
           L  +       +S+L    L  N
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 48/142 (33%), Positives = 71/142 (50%), Gaps = 10/142 (7%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSL 65
           VP+  G  ++ Q L L  NQ+    P    S+  L+ L L +NQL  + P   F +++ L
Sbjct: 34  VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
            V+DL  N+L+  LP+ +F  L  ++ L +  N+    LPR I  LT LT + L +N L 
Sbjct: 91  TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148

Query: 126 GEIPHEI-GNLRNLQALGLLSN 146
             IPH     L +L    L  N
Sbjct: 149 S-IPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 10/133 (7%)

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTL-SRLEKLQILGLENNQ-- 347
           +  YLH+  I    P    +LINL  + LG N+L  ++P  +   L +L +L L  NQ  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 348 -LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWN 405
            L   + D   RL  L  +++  NKL+  +P     L  L  L+   N+L  +P   F  
Sbjct: 102 VLPSAVFD---RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157

Query: 406 LTNILMVDLSSNP 418
           L+++    L  NP
Sbjct: 158 LSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 14/152 (9%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQL---EGR 351
           +C  +   S+P   G   N  I+ L  N++    P     L  L+ L L +NQL      
Sbjct: 25  DCRSKRHASVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG 82

Query: 352 ILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVPSTFWNLTNIL 410
           + D    L +L+ + L  N+L+  +P+  F  L  L++L    N+LT +P     LT++ 
Sbjct: 83  VFD---SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLT 138

Query: 411 MVDLSSNPLSGSLPLEI-GNLKVLVELYLSRN 441
            + L  N L  S+P      L  L   YL  N
Sbjct: 139 HLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 6/142 (4%)

Query: 369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPST-FWNLTNILMVDLSSNPLSGSLPLEI 427
            +K   S+PA  G   + + L    N++T +    F +L N+  + L SN L  +LP+ +
Sbjct: 27  RSKRHASVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV 83

Query: 428 -GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDL 486
             +L  L  L L  N L+         L +L+ L +  N L   +P  I  L  L  L L
Sbjct: 84  FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142

Query: 487 SNNILSGIIPSSLEKLLYLKYL 508
             N L  I   + ++L  L + 
Sbjct: 143 DQNQLKSIPHGAFDRLSSLTHA 164

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 3/89 (3%)

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSG 493
            LYL  N ++   P     L NL+ L LG N L  ++P  + D L  L  LDL  N L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 494 IIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
           +  +  ++L++LK L +  N+L  E+PRG
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRG 130

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 56/235 (23%), Positives = 102/235 (43%), Gaps = 49/235 (20%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIK----VFHLQLEGALESFNAECEVLRSI 679
             ++ +   +G G++G V++      G  VA+K     F    + A  +F  E  +L  +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-AQRTFR-EIMILTEL 65

Query: 680 R-HRNLVRIISSCTNDDFKA--LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
             H N+V +++    D+ +   LV DYM    L A + ++   L+   +  +V  +   +
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI--LEPVHKQYVVYQLIKVI 122

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH------------ 784
           +YLH G    ++H D+KPSN+LL+ +   ++ DFG+++       + +            
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 785 --------TQTLATIGYMAPE-------YGREGQISTEGDVYSFGIMLMEIFTRK 824
                   T  +AT  Y APE       Y      +   D++S G +L EI   K
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCGK 228

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 13/165 (7%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRH-RNL 684
            F V   IG G+FG +  G+ L     VAIK+  ++        + E    + +     +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
            ++        + A+VL+ +   SLE      +    +   L I I +   +EY+H  + 
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125

Query: 745 NPVVHCDIKPSNVLLDEDMVAR-----LGDFGIAKLLSGDESMKH 784
             +++ D+KP N L+            + DF +AK     E+ KH
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 41/255 (16%), Positives = 92/255 (36%), Gaps = 65/255 (25%)

Query: 627 QFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKV------FHLQLEGALESFNAECEVLRSI 679
           ++ +   +G G F +V+  +  ++   VA+K+      +      A +    E ++L+ +
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AED----EIKLLQRV 72

Query: 680 R-----------HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSD--NSNLDIFKRL 726
                         ++++++     D F     ++     +   +  +    NL    + 
Sbjct: 73  NDADNTKEDSMGANHILKLL-----DHF-----NHKGPNGVHVVMVFEVLGENLLALIKK 122

Query: 727 N------------IVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE------DMVARLG 768
                        I   + L L+Y+H      ++H DIKP NVL++        +  ++ 
Sbjct: 123 YEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180

Query: 769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
           D G A          +T ++ T  Y +PE           D++S   ++ E+ T      
Sbjct: 181 DLGNA----CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF--- 233

Query: 829 EIFSGEMSLKRWVND 843
            +F  +       +D
Sbjct: 234 -LFEPDEGHSYTKDD 247

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 38/164 (23%), Positives = 76/164 (46%), Gaps = 11/164 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRH-RN 683
           +++ +   IGSGSFG +Y G  +  G EVAIK+  ++ +      + E ++ + ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +  I       D+  +V++ +   SLE      +    +   L +   +   +EY+H  +
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 744 PNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGDESMKH 784
               +H D+KP N L+    +  +  + DFG+AK      + +H
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 13/166 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRH-RN 683
             + V   IG GSFG ++ G  L +  +VAIK    + +        E    + +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +  +           LV+D +   SLE  L        +         +   ++ +H   
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 744 PNPVVHCDIKPSNVLLDEDMVAR-----LGDFGIAKLLSGDESMKH 784
              +V+ DIKP N L+            + DFG+ K      + +H
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 68.3 bits (166), Expect = 8e-12
 Identities = 99/755 (13%), Positives = 204/755 (27%), Gaps = 280/755 (37%)

Query: 104 LPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLK 163
           +P+ I     L+  ++  +H++      +     L     L +         +      +
Sbjct: 41  MPKSI-----LSKEEI--DHIIMS-KDAVSGTLRL--FWTLLSK-----QEEMVQKFVEE 85

Query: 164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG 223
           +L++    L   I +  R       ++    +        F    +K ++          
Sbjct: 86  VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF----AKYNVS--------- 132

Query: 224 FIPNRFHNMRN-LKELNLEYNYITSSNHELSFI--------SSLANSKKLKVLSLTGNPL 274
                +  +R  L EL      +         I        + +A      V     +  
Sbjct: 133 -RLQPYLKLRQALLELRPA-KNVL--------IDGVLGSGKTWVALD----VCL---SYK 175

Query: 275 LDCVLPSSIGNLSLSMERFYLH--NCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTL 332
           + C +   I         F+L+  NCN   ++ + +  L  L  I   +   +    +  
Sbjct: 176 VQCKMDFKI---------FWLNLKNCNSPETVLEMLQKL--LYQIDPNWTSRSDHSSNIK 224

Query: 333 SRLE----KLQILGLENNQLEGR---ILDDICRLARLSSVYLDHNKLSGSIPACFGNLAS 385
            R+     +L+ L L++   E     +L ++                             
Sbjct: 225 LRIHSIQAELRRL-LKSKPYE-NCLLVLLNV----------------------------- 253

Query: 386 LRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG 445
                              N       +LS               K+L+           
Sbjct: 254 ------------------QNAKAWNAFNLSC--------------KILL----------- 270

Query: 446 DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYL 505
              TT       +   + D      +  +    ISL+      +    + P  ++ LL L
Sbjct: 271 ---TT-------RFKQVTD-----FLSAATTTHISLD------HHSMTLTPDEVKSLL-L 308

Query: 506 KYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCG--SPHLQVPPCKSTKTRTNQKSRK 563
           KYL+     L    PR         E    N       +  ++         +     + 
Sbjct: 309 KYLDCRPQDL----PR---------EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355

Query: 564 VVIL---LGVALP--LSAAFIIISILAFKFGLISTCRKGDTKLSNIQANMPLVAWRRFSY 618
             I+   L V  P      F  +S+                  ++I   +  + W     
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVF----------PPS----AHIPTILLSLIWFDVIK 401

Query: 619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRS 678
            +++   ++ +  +L+      S               +  + LE        + E   +
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTIS------------IPSIYLE-----LKVKLENEYA 444

Query: 679 IRHRNLV---RIISSCTNDDFKALVLD--------YMPKGSLEACLYSDNSNLDIFKRLN 727
           + HR++V    I  +  +DD     LD        +     L+   + +   L  F+ + 
Sbjct: 445 L-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH----HLKNIEHPERMTL--FRMV- 496

Query: 728 IVIDIALALEYLHFG-------HPNPVVHCDIKPSNVLLD---------------EDMVA 765
                     +L F        H +   +      N L                 E +V 
Sbjct: 497 ----------FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546

Query: 766 RLGDFGIAKLLSGDESM---KHTQTLATIGYMAPE 797
            + DF    L   +E++   K+T  L  I  MA +
Sbjct: 547 AILDF----LPKIEENLICSKYTD-LLRIALMAED 576

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.0 bits (147), Expect = 1e-09
 Identities = 65/442 (14%), Positives = 127/442 (28%), Gaps = 110/442 (24%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNL-TSLTSIDLSE 121
           + + +      ++  ++   IF       +L+L        +   +  L   +     S 
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIF-------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216

Query: 122 NHLMGEIPHEIGN----LRNLQALGLLSNNLV--------GVVPATLFNISTLKILQLTN 169
           +     I   I +    LR L       N L+            A  FN+S  KIL  T 
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--FNLSC-KILLTTR 273

Query: 170 NT-----LSGSISSSIRLALPN--------LELFSLANNNFSGKIPSFIFNASKLSIC-- 214
                  LS + ++ I L   +          L     +     +P  +   +   +   
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333

Query: 215 --ELPDNSFSGFIPNRFHNMR--NLKELN--LE--YNYITSSNHELSFISSLA----NSK 262
              + D          + N +  N  +L   +E   N +  + +   F   L+    ++ 
Sbjct: 334 AESIRDG------LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-RLSVFPPSAH 386

Query: 263 -KLKVLS-LTGNPLLDCV--LPSSIGNLSL-----SMERFYLHNCNIRGSIP-KEMGNLI 312
               +LS +  + +   V  + + +   SL           + +  +   +  +    L 
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEK----LQILG--LENNQLEGRILDDICRLARLSSVY 366
             I+    YN         L            +G  L+N +   R+            V+
Sbjct: 447 RSIVDH--YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM-------TLFRMVF 497

Query: 367 LD----HNKLSGSIPACFGN------LASLRKLS--FASNE----------LTFVPSTFW 404
           LD      K+     A   +      L  L+        N+          L F+P    
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE 557

Query: 405 NL-----TNILMVDLSSNPLSG 421
           NL     T++L + L       
Sbjct: 558 NLICSKYTDLLRIAL-MAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 5e-08
 Identities = 67/451 (14%), Positives = 126/451 (27%), Gaps = 128/451 (28%)

Query: 467 LQGSIPNSIGDLISLECLDLSNNILSG-----II--PSSLEKLLYLKYLNVSFNRLEGEI 519
           L       + +    +  D+  +ILS      II    ++   L L      F  L  + 
Sbjct: 22  LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL------FWTLLSK- 74

Query: 520 PRGGTLANFTSESFMGN-DLL-------CGSPHLQVPPCKSTKTR---TNQK------SR 562
            +   +  F  E    N   L          P +        + R    NQ       SR
Sbjct: 75  -QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133

Query: 563 --KVVILLGVALPL-SAAFIII--------SILAFKFGLISTCRKGDTKLSNIQANMPL- 610
               + L    L L  A  ++I        + +A     +  C     K   +Q  M   
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA-----LDVCL--SYK---VQCKMDFK 183

Query: 611 VAWRRFSYQ-------ELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHL-QL 662
           + W             E+LQ        N        S  + R         ++      
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243

Query: 663 EGAL------------ESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLE 710
           E  L             +FN  C++L + R + +   +S+ T      + LD+       
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT---THISLDHHSMT--- 297

Query: 711 ACLYSDNSNLDIF-KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNV----LLDEDMVA 765
             L  D     +  K L+      L           P       P  +        D +A
Sbjct: 298 --LTPDEV-KSLLLKYLDCRPQ-DL-----------PREVLTTNPRRLSIIAESIRDGLA 342

Query: 766 RLGDFGIAKLLSGDESMKHTQTL-ATIGYMAPEYGREGQISTEGDVY-SFGI-------- 815
              ++   K ++ D   K T  + +++  + P   R+        ++    +        
Sbjct: 343 TWDNW---KHVNCD---KLTTIIESSLNVLEPAEYRK--------MFDRLSVFPPSAHIP 388

Query: 816 -MLMEIFTRKRPTDEIFSGEMSLKRWVNDSL 845
            +L+ +        ++    + + +    SL
Sbjct: 389 TILLSLIWFDVIKSDV---MVVVNKLHKYSL 416

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.3 bits (164), Expect = 8e-12
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 11/164 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           ++F +   IGSGSFG +Y G  +    EVAIK+ +++ +        E ++ R ++    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64

Query: 685 V-RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +  +       D+  LV+D +   SLE      +  L +   L +   +   +E++H   
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 744 PNPVVHCDIKPSNVLLDEDMVAR---LGDFGIAKLLSGDESMKH 784
               +H DIKP N L+     A    + DFG+AK      + +H
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 19/101 (18%), Positives = 34/101 (33%), Gaps = 5/101 (4%)

Query: 27  NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANI 83
                     +     L  L + N Q            +  L+ + +  + L   +  + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 84  FSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
           F + P +  L+L+FN     L  +     SL  + LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 20/95 (21%), Positives = 33/95 (34%), Gaps = 2/95 (2%)

Query: 396 LTFVPSTFWNLTNILMVDLSSNPLSGSLPLE-IGNLKVLVELYLSRNNLSGDIPTTIGGL 454
                       N+  + + +      L L  +  L  L  L + ++ L    P      
Sbjct: 20  ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79

Query: 455 KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN 489
             L  L+L  N L+ S+       +SL+ L LS N
Sbjct: 80  PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 4e-09
 Identities = 22/100 (22%), Positives = 37/100 (37%), Gaps = 3/100 (3%)

Query: 322 NKLNGSIPSTLSRLEKLQILGLENNQLEGRI-LDDICRLARLSSVYLDHNKLSGSIPA-C 379
                     L   E L  L +EN Q    + L D+  L  L ++ +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 380 FGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPL 419
           F     L +L+ + N L  +        ++  + LS NPL
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.8 bits (139), Expect = 5e-09
 Identities = 23/101 (22%), Positives = 44/101 (43%), Gaps = 2/101 (1%)

Query: 416 SNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPT-TIGGLKNLQNLSLGDNNLQGSIPNS 474
           +   +      +   + L ELY+        +    + GL  L+NL++  + L+   P++
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 475 IGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
                 L  L+LS N L  +   +++  L L+ L +S N L
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQ-GLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 7e-08
 Identities = 14/108 (12%), Positives = 34/108 (31%), Gaps = 4/108 (3%)

Query: 115 TSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLS 173
           + +  + +  + +  H +    NL  L + +   +  +       +  L+ L +  + L 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 174 GSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSF 221
             ++       P L   +L+ N     +         L    L  N  
Sbjct: 70  -FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 22/98 (22%), Positives = 34/98 (34%), Gaps = 8/98 (8%)

Query: 184 LPNLELFSLANNNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
             NL    + N      +         +L    +  +      P+ FH    L  LNL +
Sbjct: 30  AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89

Query: 243 NYITSSNHELSFISSLANSKKLKVLSLTGNPL-LDCVL 279
           N + S + +            L+ L L+GNPL   C L
Sbjct: 90  NALESLSWK------TVQGLSLQELVLSGNPLHCSCAL 121

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 3e-06
 Identities = 20/68 (29%), Positives = 27/68 (39%), Gaps = 3/68 (4%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINT-LEILDLSNNQLSG-SFPFFNMSSLQV 67
              L  L  L+ L +  +  L  +    F     L  L+LS N L   S+      SLQ 
Sbjct: 49  LRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQE 107

Query: 68  IDLSDNRL 75
           + LS N L
Sbjct: 108 LVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 5e-06
 Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 3/94 (3%)

Query: 105 PREIGNLTSLTSIDLSENHLMGEIPHE-IGNLRNLQALGLLSNNLVGVVPATLFNISTLK 163
              +    +LT + +     +  +    +  L  L+ L ++ + L  V P        L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNF 197
            L L+ N L  S+S    +   +L+   L+ N  
Sbjct: 84  RLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPL 115

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 49/223 (21%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKV------FHLQLEGALESFNAECEVLR 677
             ++ V  +IG GSFG V +         VA+K+      FH Q   A E    E  +L 
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AAE----EIRILE 148

Query: 678 SIRHR------NLVRIISSCTNDDFKA---LVLDYMPKGSLEACLYS---DNS----NLD 721
            +R +      N++ ++ +     F+    +  +      L   LY     N     +L 
Sbjct: 149 HLRKQDKDNTMNVIHMLEN---FTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLP 200

Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE--DMVARLGDFGIAKLLSGD 779
           + ++      I   L+ LH    N ++HCD+KP N+LL +      ++ DFG     S  
Sbjct: 201 LVRK--FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG----SSCY 251

Query: 780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
           E  +    + +  Y APE     +     D++S G +L E+ T
Sbjct: 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 27/181 (14%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFLDG------MEVAIKVFH-----LQLEGALESFNAECEV 675
            + V   IG G FG +Y                 +KV       L  E       A+ E 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 676 LRSIRHRNLVRII----------SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR 725
           ++       ++ +                 ++ +++D      L+    ++         
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTV 154

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR--LGDFGIAKLLSGDESMK 783
           L + + I   LEY+H    +  VH DIK SN+LL+     +  L D+G+A     +   K
Sbjct: 155 LQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

Query: 784 H 784
            
Sbjct: 212 A 212

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.9 bits (151), Expect = 4e-11
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 8/107 (7%)

Query: 20  QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLS 76
             L L  NQ    +P  + +   L ++DLSNN++S +     F NM+ L  + LS NRL 
Sbjct: 34  TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 77  GELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
             +P   F  L  ++ LSL  N  +  +P     +L++L+ + +  N
Sbjct: 92  -CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 8/124 (6%)

Query: 369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI- 427
            NK    +P   G    + +L    N+ T VP    N  ++ ++DLS+N +S +L  +  
Sbjct: 18  SNKGLKVLPK--GIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSF 74

Query: 428 GNLKVLVELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLD 485
            N+  L+ L LS N L   IP     GLK+L+ LSL  N++   +P    + L +L  L 
Sbjct: 75  SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA 132

Query: 486 LSNN 489
           +  N
Sbjct: 133 IGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 28/131 (21%)

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG 350
              YL   N    +PKE+ N  +L +I L  N+++     + S + +L  L L  N+L  
Sbjct: 34  TELYLDG-NQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 351 RILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELTFVP-STFWNLTN 408
                                    IP   F  L SLR LS   N+++ VP   F +L+ 
Sbjct: 92  ------------------------CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSA 127

Query: 409 ILMVDLSSNPL 419
           +  + + +NPL
Sbjct: 128 LSHLAIGANPL 138

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 6/63 (9%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
           +++ L  L LS+N+ L  IP   F  + +L +L L  N +S   P   F ++S+L  + +
Sbjct: 76  NMTQLLTLILSYNR-LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI 133

Query: 71  SDN 73
             N
Sbjct: 134 GAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 29/103 (28%), Positives = 41/103 (39%), Gaps = 5/103 (4%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
           +  L  +P         L   L  N  +  +P E+ N K L  + LS N +S     +  
Sbjct: 19  NKGLKVLPKGIPRDVTEL--YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFS 75

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGI 494
            +  L  L L  N L+  IP    D L SL  L L  N +S +
Sbjct: 76  NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVV 117

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 39/132 (29%), Positives = 56/132 (42%), Gaps = 10/132 (7%)

Query: 66  QVIDLSDNRLSGELPANIFSYLPF-VQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
            V+  S+  L   LP  I    P  V  L L  NQF   +P+E+ N   LT IDLS N +
Sbjct: 13  TVVRCSNKGLK-VLPKGI----PRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRI 66

Query: 125 MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN-ISTLKILQLTNNTLSGSISSSIRLA 183
                    N+  L  L L  N L   +P   F+ + +L++L L  N +S  +       
Sbjct: 67  STLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFND 124

Query: 184 LPNLELFSLANN 195
           L  L   ++  N
Sbjct: 125 LSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 10/94 (10%)

Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLK 506
           IP  +        L L  N     +P  + +   L  +DLSNN +S +   S   +  L 
Sbjct: 29  IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 507 YLNVSFNRLEGEIPRG--GTLANFTSESFMGNDL 538
            L +S+NRL   IP      L +    S  GND+
Sbjct: 82  TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 49/224 (21%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKV------FHLQLEGALESFNAECEVLR 677
            D++ +++LIG GSFG V +     +   VAIK+      F  Q   A      E  +L 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQI----EVRLLE 105

Query: 678 SIRHR------NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR------ 725
            +          +V +       +   LV +      L   LY      D+ +       
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLY------DLLRNTNFRGV 154

Query: 726 -LNIVIDIA----LALEYLHFGHPNPVVHCDIKPSNVLL--DEDMVARLGDFGIAKLLSG 778
            LN+    A     AL +L     + ++HCD+KP N+LL   +    ++ DFG +     
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS----C 209

Query: 779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT 822
               +  Q + +  Y +PE           D++S G +L+E+ T
Sbjct: 210 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 36/188 (19%), Positives = 66/188 (35%), Gaps = 44/188 (23%)

Query: 627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF--------HLQLEGALESFNAECEVLR 677
           Q+ +   IGSG FG +Y         + A  V          L  E       A+ + ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 678 SIRHRNLVRII----------SSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR-- 725
               R  +  +          +      ++ +V++ +    L+           I  +  
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ----------KISGQNG 146

Query: 726 -------LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR--LGDFGIAKLL 776
                  L + I +   LEY+H    N  VH DIK +N+LL      +  L D+G++   
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 777 SGDESMKH 784
             + + K 
Sbjct: 204 CPNGNHKQ 211

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 9/123 (7%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FF 60
           L          L+SL  L L  N+ L ++P+ +F  + +L  L+LS NQL  S P   F 
Sbjct: 40  LKSLPNGVFDELTSLTQLYLGGNK-LQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFD 97

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDL 119
            ++ L+ + L+ N+L   LP  +F  L  ++ L L  NQ    +P  +   LTSL  I L
Sbjct: 98  KLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWL 155

Query: 120 SEN 122
            +N
Sbjct: 156 HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 11/143 (7%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSL 65
           VP+  G  +   YLDL  N L          + +L  L L  N+L  S P   F  ++SL
Sbjct: 22  VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHL 124
             ++LS N+L   LP  +F  L  ++ L+L  NQ    LP  +   LT L  + L +N L
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL 136

Query: 125 MGEIPHEI-GNLRNLQALGLLSN 146
              +P  +   L +LQ + L  N
Sbjct: 137 KS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 35/130 (26%), Positives = 55/130 (42%), Gaps = 11/130 (8%)

Query: 318 RLGYNKLNGSIPSTLSRLEKLQILGLENNQL---EGRILDDICRLARLSSVYLDHNKLSG 374
            L  N L          L  L  L L  N+L      + +   +L  L+ + L  N+L  
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN---KLTSLTYLNLSTNQLQ- 89

Query: 375 SIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLK 431
           S+P   F  L  L++L+  +N+L  +P   F  LT +  + L  N L  S+P  +   L 
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148

Query: 432 VLVELYLSRN 441
            L  ++L  N
Sbjct: 149 SLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 43/131 (32%), Positives = 58/131 (44%), Gaps = 5/131 (3%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
           S   T VP+     T  L  DL +N L          L  L +LYL  N L         
Sbjct: 16  SQGRTSVPTGIPAQTTYL--DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
            L +L  L+L  N LQ S+PN + D L  L+ L L+ N L  +     +KL  LK L + 
Sbjct: 74  KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLY 132

Query: 512 FNRLEGEIPRG 522
            N+L+  +P G
Sbjct: 133 QNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 31/155 (20%)

Query: 339 QILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNELT 397
             L LE N L+         L  L+ +YL  NKL  S+P   F  L SL  L+ ++N+L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 398 FVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI-GGLK 455
            +P+  F  LT                         L EL L+ N L   +P  +   L 
Sbjct: 90  SLPNGVFDKLTQ------------------------LKELALNTNQLQS-LPDGVFDKLT 124

Query: 456 NLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNN 489
            L++L L  N L+ S+P+ + D L SL+ + L +N
Sbjct: 125 QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 35/158 (22%)

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
           +L  NS        F  + +L +L L  N + S        + L +   L  L+L+ N L
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL--PNGVFNKLTS---LTYLNLSTNQL 88

Query: 275 LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS-TLS 333
               LP+ +         F                 L  L  + L  N+L  S+P     
Sbjct: 89  Q--SLPNGV---------F---------------DKLTQLKELALNTNQLQ-SLPDGVFD 121

Query: 334 RLEKLQILGLENNQLEGRILDDIC-RLARLSSVYLDHN 370
           +L +L+ L L  NQL+  + D +  RL  L  ++L  N
Sbjct: 122 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 64/384 (16%), Positives = 121/384 (31%), Gaps = 102/384 (26%)

Query: 18  SLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNM----SSLQV 67
           S++   L  + +      ++ + +   ++++ + LS N +    +            L++
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 68  IDLSDN---RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
            + SD    R+  E+P                       L + +     L ++ LS+N  
Sbjct: 65  AEFSDIFTGRVKDEIPEA------------------LRLLLQALLKCPKLHTVRLSDN-- 104

Query: 125 MGEIPHEIGNLRNLQALG-LLSNNLVGVVPATLFNISTLKILQLTNN------------T 171
                   G     + L   LS +            + L+ L L NN             
Sbjct: 105 ------AFGP-TAQEPLIDFLSKH------------TPLEHLYLHNNGLGPQAGAKIARA 145

Query: 172 LSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHN 231
           L     +      P L       N         + N S     +             F +
Sbjct: 146 LQELAVNKKAKNAPPLRSIICGRNR--------LENGSMKEWAKT------------FQS 185

Query: 232 MRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD---CVLPSSIGNLSL 288
            R L  + +  N I     E   +  LA  ++LKVL L  N         L  ++ +   
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP- 244

Query: 289 SMERFYLHNCNIRG----SIPKEMGNLIN--LIIIRLGYNKLNGSIPSTLSR-----LEK 337
           ++    L++C +      ++      L N  L  +RL YN++      TL       +  
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304

Query: 338 LQILGLENNQL--EGRILDDICRL 359
           L  L L  N+   E  ++D+I  +
Sbjct: 305 LLFLELNGNRFSEEDDVVDEIREV 328

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 62/307 (20%), Positives = 100/307 (32%), Gaps = 64/307 (20%)

Query: 13  LGSLSSLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNNQLSGSFPFF-------- 60
           L    S++ + LS N +       +  +I S   LEI + S+                  
Sbjct: 28  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87

Query: 61  ----NMSSLQVIDLSDNRLSGELPANIFSYL---PFVQFLSLAFNQF------------- 100
                   L  + LSDN         +  +L     ++ L L  N               
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147

Query: 101 AGHLPREIGNLTSLTSIDLSENHL----MGEIPHEIGNLRNLQALGLLSNNL--VGVVPA 154
              + ++  N   L SI    N L    M E      + R L  + ++ N +   G+   
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207

Query: 155 ---TLFNISTLKILQLTNNTLSGSISSSIRLAL---PNLELFSLANNNFSGKIPSFIFNA 208
               L     LK+L L +NT +   SS++ +AL   PNL    L +   S +  + + +A
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267

Query: 209 SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLA-NSKKLKVL 267
              S  E                   L+ L L+YN I       +  + +      L  L
Sbjct: 268 --FSKLENI----------------GLQTLRLQYNEIELDA-VRTLKTVIDEKMPDLLFL 308

Query: 268 SLTGNPL 274
            L GN  
Sbjct: 309 ELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 45/228 (19%), Positives = 72/228 (31%), Gaps = 43/228 (18%)

Query: 13  LGSLSSLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNNQLS-------------- 54
           L     L  + LS N         +   +     LE L L NN L               
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149

Query: 55  -GSFPFFNMSSLQVIDLSDNRL---SGELPANIFSYLPFVQFLSLAFNQF-----AGHLP 105
             +    N   L+ I    NRL   S +  A  F     +  + +  N          L 
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209

Query: 106 REIGNLTSLTSIDLSENHL----MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF---- 157
             +     L  +DL +N         +   + +  NL+ LG L++ L+    A       
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG-LNDCLLSARGAAAVVDAF 268

Query: 158 ---NISTLKILQLTNNTLSG----SISSSIRLALPNLELFSLANNNFS 198
                  L+ L+L  N +      ++ + I   +P+L    L  N FS
Sbjct: 269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 39/270 (14%), Positives = 81/270 (30%), Gaps = 45/270 (16%)

Query: 283 IGNLSLSMERFYLHNCNIRG--SIPKEMGNLINLIIIRLGYNKLNG----SIPSTLSRLE 336
           +   S+  +   L         S+   +    ++  I L  N +       +   ++  +
Sbjct: 1   MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 337 KLQILGLENNQLEGRILDDI-----------CRLARLSSVYLDHNKLSG----SIPACFG 381
            L+I    +    GR+ D+I            +  +L +V L  N         +     
Sbjct: 61  DLEIAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 382 NLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRN 441
               L  L   +N L   P     +   L     +     + PL          +   RN
Sbjct: 120 KHTPLEHLYLHNNGLG--PQAGAKIARALQELAVNKKAKNAPPLR--------SIICGRN 169

Query: 442 NLSGD----IPTTIGGLKNLQNLSLGDNNL-----QGSIPNSIGDLISLECLDLSNNILS 492
            L          T    + L  + +  N +     +  +   +     L+ LDL +N  +
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

Query: 493 GI----IPSSLEKLLYLKYLNVSFNRLEGE 518
            +    +  +L+    L+ L ++   L   
Sbjct: 230 HLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 60/361 (16%), Positives = 108/361 (29%), Gaps = 78/361 (21%)

Query: 136 RNLQALGLLSNNL----VGVVPATLFNISTLKILQLTNNTLSGSISSSIRLAL---PNLE 188
            +++   L  + +       V A L    ++K + L+ NT+    +  +   +    +LE
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 189 LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
           +   ++  F+G++   I  A +L +  L                  L  + L  N    +
Sbjct: 64  IAEFSDI-FTGRVKDEIPEALRLLLQALLKCP-------------KLHTVRLSDNAFGPT 109

Query: 249 NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM 308
             E   I  L+    L+ L L  N          +G  + +     L    +     K+ 
Sbjct: 110 AQE-PLIDFLSKHTPLEHLYLHNN---------GLGPQAGAKIARALQELAVN----KKA 155

Query: 309 GNLINLIIIRLGYNKLNG----SIPSTLSRLEKLQILGLENNQL--EGRILDDICRLARL 362
            N   L  I  G N+L          T      L  + +  N +  EG I   +      
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG-IEHLLLEG--- 211

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-----FVPSTFWNLTNILMVDLSSN 417
               L + +              L+ L    N  T      +     +  N+  + L+  
Sbjct: 212 ----LAYCQ-------------ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 254

Query: 418 PLSG------SLPLEIGNLKVLVELYLSRNNLSGDIPTTIG-----GLKNLQNLSLGDNN 466
            LS                  L  L L  N +  D   T+       + +L  L L  N 
Sbjct: 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314

Query: 467 L 467
            
Sbjct: 315 F 315

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 31/171 (18%), Positives = 61/171 (35%), Gaps = 27/171 (15%)

Query: 627 QFNVNNLIGSGSFGSVYRGR---------FLDGMEVAIKV--FHLQLEGALESFNAECEV 675
           Q+ + +     + G +Y                 + ++K+     +L      F    + 
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 676 --------LRSIRHRNLVRIISS-CTNDDFKALVLDYMPKGSLEACL-YSDNSNLDIFKR 725
                   L S     +   +      D ++ LVL  + + SL++ L  S    L     
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSV 161

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR--LGDFGIAK 774
           L +   +  ALE+LH    N  VH ++   N+ +D +  ++  L  +G A 
Sbjct: 162 LQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 12/111 (10%)

Query: 316 IIRLGYNKLNGSIPST--LSRLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHN 370
            + L  N+L   I S     RL  L  L L+ NQ   +E    +     + +  + L  N
Sbjct: 33  ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE---GASHIQELQLGEN 88

Query: 371 KLSGSIPA-CFGNLASLRKLSFASNELTFVP-STFWNLTNILMVDLSSNPL 419
           K+   I    F  L  L+ L+   N+++ V   +F +L ++  ++L+SNP 
Sbjct: 89  KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 29/125 (23%), Positives = 53/125 (42%), Gaps = 10/125 (8%)

Query: 27  NQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANI 83
            + L  IP  I        L L++N+L        F  +  L  ++L  N+L+  +  N 
Sbjct: 17  GRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNA 73

Query: 84  FSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEI-GNLRNLQAL 141
           F     +Q L L  N+    +  ++   L  L +++L +N +   +      +L +L +L
Sbjct: 74  FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131

Query: 142 GLLSN 146
            L SN
Sbjct: 132 NLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 2/106 (1%)

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
             + L+DN L       +F  LP +  L L  NQ  G  P      + +  + L EN + 
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI- 90

Query: 126 GEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNN 170
            EI +++   L  L+ L L  N +  V+P +  ++++L  L L +N
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 5/123 (4%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI 451
              L  +P      T  L   L+ N L       + G L  LV+L L RN L+G  P   
Sbjct: 17  GRGLKEIPRDIPLHTTEL--LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74

Query: 452 GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLYLKYLNV 510
            G  ++Q L LG+N ++  I N +   L  L+ L+L +N +S ++P S E L  L  LN+
Sbjct: 75  EGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133

Query: 511 SFN 513
           + N
Sbjct: 134 ASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 27/110 (24%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDN 73
            L  L  L+L  NQ L  I  + F   + ++ L L  N++                    
Sbjct: 52  RLPHLVKLELKRNQ-LTGIEPNAFEGASHIQELQLGENKIK------------------- 91

Query: 74  RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
               E+   +F  L  ++ L+L  NQ +  +      +L SLTS++L+ N
Sbjct: 92  ----EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 24/90 (26%), Positives = 36/90 (40%), Gaps = 4/90 (4%)

Query: 435 ELYLSRNNLSGDIPTTI-GGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILS 492
           EL L+ N L       + G L +L  L L  N L   I  +  +    ++ L L  N + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 493 GIIPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
            I       L  LK LN+  N++   +  G
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 6/107 (5%)

Query: 339 QILGLENNQLEGRILDDI-CRLARLSSVYLDHNKLSGSIPA-CFGNLASLRKLSFASNEL 396
             L L +N+L     D +  RL  L  + L  N+L+  I    F   + +++L    N++
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 397 TFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRN 441
             + +  F  L  +  ++L  N +S  +      +L  L  L L+ N
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 8/78 (10%)

Query: 446 DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGIIPSSLEKLLY 504
           DIP           L L DN L     + +   L  L  L+L  N L+GI P++ E   +
Sbjct: 26  DIPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 505 LKYLNVSFNRLEGEIPRG 522
           ++ L +  N+++ EI   
Sbjct: 80  IQELQLGENKIK-EISNK 96

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 58.4 bits (142), Expect = 4e-10
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 9/106 (8%)

Query: 318 RLGYNKLNGSIPSTLSRLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHNKLSG 374
            L  NKL         +L +L  L L  NQ   L   + D   +L +L+ +YL  NKL  
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD---KLTKLTILYLHENKLQ- 89

Query: 375 SIPA-CFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNP 418
           S+P   F  L  L++L+  +N+L  VP   F  LT++  + L +NP
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 11/119 (9%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSS 64
           VP+  G  SS   L+L  N+ L ++P  +F  +  L  L LS NQ+  S P   F  ++ 
Sbjct: 22  VPT--GIPSSATRLELESNK-LQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
           L ++ L +N+L   LP  +F  L  ++ L+L  NQ    +P  I   LTSL  I L  N
Sbjct: 78  LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 3/109 (2%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
           SS   ++L  N+L   LP  +F  L  +  LSL+ NQ           LT LT + L EN
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86

Query: 123 HLMGEIPHEI-GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNN 170
            L   +P+ +   L  L+ L L +N L  V       +++L+ + L  N
Sbjct: 87  KLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 29/88 (32%), Positives = 39/88 (44%), Gaps = 3/88 (3%)

Query: 436 LYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD-LISLECLDLSNNILSGI 494
           L L  N L          L  L  LSL  N +Q S+P+ + D L  L  L L  N L  +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSL 91

Query: 495 IPSSLEKLLYLKYLNVSFNRLEGEIPRG 522
                +KL  LK L +  N+L+  +P G
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 17/120 (14%)

Query: 328 IPSTLSRLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNL 383
           IPS+         L LE+N+   L   + D   +L +L+ + L  N++  S+P   F  L
Sbjct: 26  IPSSA------TRLELESNKLQSLPHGVFD---KLTQLTKLSLSQNQIQ-SLPDGVFDKL 75

Query: 384 ASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRN 441
             L  L    N+L  +P+  F  LT +  + L +N L  S+P  I   L  L +++L  N
Sbjct: 76  TKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 26/131 (19%), Positives = 46/131 (35%), Gaps = 9/131 (6%)

Query: 144 LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPS 203
           L+  L+        N    + L L    +   I + +   L   +    ++N    K+  
Sbjct: 4   LTAELIEQAA-QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLDG 59

Query: 204 FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK 263
           F     +L    + +N            + +L EL L  N +     EL  +  LA+ K 
Sbjct: 60  FPLL-RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKS 114

Query: 264 LKVLSLTGNPL 274
           L  L +  NP+
Sbjct: 115 LTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 26/128 (20%), Positives = 47/128 (36%), Gaps = 7/128 (5%)

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
           MV L++  +  +      N     EL L    +   I      L     +   DN ++  
Sbjct: 1   MVKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56

Query: 471 IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE--GEIPRGGTLANF 528
           +      L  L+ L ++NN +  I     + L  L  L ++ N L   G++    +L + 
Sbjct: 57  LDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115

Query: 529 TSESFMGN 536
           T    + N
Sbjct: 116 TYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 23/110 (20%), Positives = 41/110 (37%), Gaps = 5/110 (4%)

Query: 382 NLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE-IGNLKVLVELYLSR 440
           N    R+L     ++  + +    L     +D S N +     L+    L+ L  L ++ 
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNN 73

Query: 441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQG-SIPNSIGDLISLECLDLSNN 489
           N +          L +L  L L +N+L      + +  L SL  L +  N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 24/114 (21%), Positives = 52/114 (45%), Gaps = 5/114 (4%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
           +Q  +    + LDL   + +  I +   +++  + +D S+N++     F  +  L+ + +
Sbjct: 13  AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 71

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFA--GHLPREIGNLTSLTSIDLSEN 122
           ++NR+   +   +   LP +  L L  N     G L   + +L SLT + +  N
Sbjct: 72  NNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 12/116 (10%)

Query: 403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKV----LVELYLSRNNLSGDIPTTIGGLKNLQ 458
           + N      +DL    +       I NL         +  S N +   +      L+ L+
Sbjct: 15  YTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLK 67

Query: 459 NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI-IPSSLEKLLYLKYLNVSFN 513
            L + +N +          L  L  L L+NN L  +     L  L  L YL +  N
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 26/141 (18%), Positives = 48/141 (34%), Gaps = 27/141 (19%)

Query: 110 NLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTN 169
           N      +DL    +   I +    L    A+    N +  +       +  LK L + N
Sbjct: 17  NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNN 73

Query: 170 NTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRF 229
           N +   I   +  ALP+L    L NN+                + +L          +  
Sbjct: 74  NRIC-RIGEGLDQALPDLTELILTNNSLV-------------ELGDL----------DPL 109

Query: 230 HNMRNLKELNLEYNYITSSNH 250
            ++++L  L +  N +T+  H
Sbjct: 110 ASLKSLTYLCILRNPVTNKKH 130

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 25/152 (16%), Positives = 52/152 (34%), Gaps = 30/152 (19%)

Query: 45  ILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHL 104
           ++ L+   +  +  + N    + +DL   ++   +  N+ + L     +  + N+     
Sbjct: 1   MVKLTAELIEQAAQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNE----- 53

Query: 105 PREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKI 164
                 +  L                    LR L+ L + +N +  +       +  L  
Sbjct: 54  ------IRKLDGFP---------------LLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92

Query: 165 LQLTNNTLSGSISSSIRLA-LPNLELFSLANN 195
           L LTNN+L   +     LA L +L    +  N
Sbjct: 93  LILTNNSLV-ELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 21/116 (18%), Positives = 50/116 (43%), Gaps = 5/116 (4%)

Query: 307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVY 366
           +  N +    + L   K+   I +  + L++   +   +N++  R LD    L RL ++ 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 70

Query: 367 LDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--STFWNLTNILMVDLSSNPLS 420
           +++N++          L  L +L   +N L  +       +L ++  + +  NP++
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 8/125 (6%)

Query: 22  LDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF-NMSSLQVIDLSDNRLSGELP 80
           + L+   L+        +      LDL   ++         +     ID SDN +     
Sbjct: 2   VKLTAE-LIEQAAQ-YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR---K 56

Query: 81  ANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQA 140
            + F  L  ++ L +  N+           L  LT + L+ N L      ++  L +L++
Sbjct: 57  LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKS 114

Query: 141 LGLLS 145
           L  L 
Sbjct: 115 LTYLC 119

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 21/123 (17%), Positives = 41/123 (33%), Gaps = 17/123 (13%)

Query: 228 RFHNMRNLKELNLEYNYITSSNHELSFISSLANS-KKLKVLSLTGNPLLDCVLPSSIGNL 286
           ++ N    +EL+L    I         I +L  +  +   +  + N +        +   
Sbjct: 14  QYTNAVRDRELDLRGYKIPV-------IENLGATLDQFDAIDFSDNEI------RKLDGF 60

Query: 287 SL--SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG-SIPSTLSRLEKLQILGL 343
            L   ++   ++N  I          L +L  + L  N L        L+ L+ L  L +
Sbjct: 61  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 120

Query: 344 ENN 346
             N
Sbjct: 121 LRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 20/111 (18%), Positives = 43/111 (38%), Gaps = 11/111 (9%)

Query: 15  SLSSLQYLDLSFNQL--LGTIPSSIFSINTLEILDLSNNQLS--GSFPFFNMSSLQVIDL 70
           +L     +D S N++  L   P     +  L+ L ++NN++   G      +  L  + L
Sbjct: 40  TLDQFDAIDFSDNEIRKLDGFPL----LRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFN---QFAGHLPREIGNLTSLTSID 118
           ++N L      +  + L  + +L +  N       +    I  +  +  +D
Sbjct: 96  TNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 7/116 (6%)

Query: 423 LPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLE 482
           +   +  LK    L LS NN+   I +++ G++NL+ LSLG N ++  I N      +LE
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 483 CLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE--GEIPRGGTLANFTSESFMGN 536
            L +S N ++ +  S +EKL+ L+ L +S N++   GEI +   L         GN
Sbjct: 97  ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 25/116 (21%), Positives = 50/116 (43%), Gaps = 11/116 (9%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSD 72
           L  + +L+ L L  N  +  I +     +TLE L +S NQ++       + +L+V+ +S+
Sbjct: 66  LSGMENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSN 124

Query: 73  NRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE----------IGNLTSLTSID 118
           N+++     +  + L  ++ L LA N                   +  L +L  +D
Sbjct: 125 NKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 28/144 (19%), Positives = 60/144 (41%), Gaps = 6/144 (4%)

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL 425
           +     +   + A    L + + L+ ++N +  + S+   + N+ ++ L  N +     L
Sbjct: 31  HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIENL 88

Query: 426 EIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG-SIPNSIGDLISLECL 484
           +      L EL++S N ++  + + I  L NL+ L + +N +      + +  L  LE L
Sbjct: 89  D-AVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145

Query: 485 DLSNNILSGIIPSSLEKLLYLKYL 508
            L+ N L      +     Y   +
Sbjct: 146 LLAGNPLYNDYKENNATSEYRIEV 169

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 35/184 (19%), Positives = 71/184 (38%), Gaps = 18/184 (9%)

Query: 290 MERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG--SIPSTLSRLEKLQILGLENNQ 347
           M +       IR    ++         + L +  +     + +TLS L+  + L L  N 
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNN 59

Query: 348 LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLT 407
           +E   +  +  +  L  + L  N +   I        +L +L  + N++  + S    L 
Sbjct: 60  IE--KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLV 115

Query: 408 NILMVDLSSNPLSGSLPLE-IGNLKVLVELYLSRNNLSGDI----------PTTIGGLKN 456
           N+ ++ +S+N ++    ++ +  L  L +L L+ N L  D              +  L N
Sbjct: 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175

Query: 457 LQNL 460
           L+ L
Sbjct: 176 LKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 39/183 (21%), Positives = 67/183 (36%), Gaps = 40/183 (21%)

Query: 106 REIGNLTSLTSIDLSENHLMG------EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
           R      S+ + +  +  L G      ++   +  L+  + L  LS N +  + ++L  +
Sbjct: 12  RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHL-ALSTNNIEKI-SSLSGM 69

Query: 160 STLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDN 219
             L+IL L  N +   I +   +    LE   ++ N  +                     
Sbjct: 70  ENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIA--------------------- 106

Query: 220 SFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVL 279
           S SG        + NL+ L +  N IT        I  LA   KL+ L L GNPL +   
Sbjct: 107 SLSG-----IEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157

Query: 280 PSS 282
            ++
Sbjct: 158 ENN 160

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 28/135 (20%), Positives = 59/135 (43%), Gaps = 8/135 (5%)

Query: 15  SLSSLQYLDLSFN-QLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDN 73
             +  + ++L      +  + +++ ++   + L LS N +        M +L+++ L  N
Sbjct: 21  VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRN 80

Query: 74  RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL--MGEIPHE 131
            +      N+ +    ++ L +++NQ A  L   I  L +L  + +S N +   GEI   
Sbjct: 81  LIKK--IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK- 135

Query: 132 IGNLRNLQALGLLSN 146
           +  L  L+ L L  N
Sbjct: 136 LAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 13/57 (22%), Positives = 27/57 (47%), Gaps = 3/57 (5%)

Query: 460 LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
           L      ++  +  ++  L + + L LS N +  I  SSL  +  L+ L++  N ++
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK 83

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.6 bits (139), Expect = 8e-09
 Identities = 55/272 (20%), Positives = 93/272 (34%), Gaps = 85/272 (31%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFLDGME-VAIKVFHLQLEGALESFNAECEVLRSIRH-- 681
             +++V   +G G F +V+    + G + VA+KV     E   E+   E  +L+S+R+  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSD 94

Query: 682 -----RNLVRIISSCTNDDFK---------ALVLDYMPKG-SLEACLYSDNSN---LDIF 723
                R +V  +     DDFK          +V + +  G  L   +   N     L   
Sbjct: 95  PNDPNREMVVQL----LDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCV 148

Query: 724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL------------------------ 759
           K+  I+  +   L+YLH      ++H DIKP N+LL                        
Sbjct: 149 KK--IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 760 -------------------------DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
                                     E +  ++ D G A  +        T+ + T  Y 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYR 260

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           + E       +T  D++S   M  E+ T    
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYL 292

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 33/117 (28%), Positives = 45/117 (38%), Gaps = 6/117 (5%)

Query: 158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP 217
             S +K L L N+  +      +      LE  S  N   +  I + +   +KL   EL 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
           DN  SG +        NL  LNL  N I     +LS I  L   + LK L L    +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 429 NLKVLVELYLS-RNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLS 487
               + EL L    +  G +       + L+ LS  +  L  SI N +  L  L+ L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 488 NNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
           +N +SG +    EK   L +LN+S N+++
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 6e-06
 Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 27/134 (20%)

Query: 358 RLARLSSVYLDHNKLS-GSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSS 416
             + +  + LD+++ + G +         L  LS  +  LT + +               
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN--------------- 59

Query: 417 NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG-SIPNSI 475
                     +  L  L +L LS N +SG +        NL +L+L  N ++  S    +
Sbjct: 60  ----------LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109

Query: 476 GDLISLECLDLSNN 489
             L +L+ LDL N 
Sbjct: 110 KKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 8e-06
 Identities = 28/116 (24%), Positives = 48/116 (41%), Gaps = 13/116 (11%)

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL--SME 291
           ++KEL L+ +     ++E          ++L+ LS     L      +SI NL     ++
Sbjct: 18  DVKELVLDNS----RSNEGKLEGLTDEFEELEFLSTINVGL------TSIANLPKLNKLK 67

Query: 292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG-SIPSTLSRLEKLQILGLENN 346
           +  L +  + G +        NL  + L  NK+   S    L +LE L+ L L N 
Sbjct: 68  KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 24/127 (18%), Positives = 52/127 (40%), Gaps = 15/127 (11%)

Query: 307 EMGNLINLIIIRLGYNKL-----------NGSIPSTLSRLEKLQILGLENNQLEGRILDD 355
           EMG  I+L +     + +            G +       E+L+ L   N  L    + +
Sbjct: 2   EMGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIAN 59

Query: 356 ICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS--TFWNLTNILMVD 413
           + +L +L  + L  N++SG +        +L  L+ + N++  + +      L N+  +D
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 414 LSSNPLS 420
           L +  ++
Sbjct: 120 LFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 4/88 (4%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF--NMSSLQVIDL 70
                 L++L      L  T  +++  +N L+ L+LS+N++SG          +L  ++L
Sbjct: 38  TDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFN 98
           S N++           L  ++ L L   
Sbjct: 96  SGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 4/109 (3%)

Query: 39  SINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFN 98
            +  L + +  +N+            L+ +   +  L+          L  ++ L L+ N
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELSDN 74

Query: 99  QFAGHLPREIGNLTSLTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSN 146
           + +G L        +LT ++LS N +        +  L NL++L L + 
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 25/142 (17%), Positives = 50/142 (35%), Gaps = 27/142 (19%)

Query: 110 NLTSLTSIDLSENHL-MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLT 168
             + +  + L  +    G++         L+ L  ++  L  +  A L  ++ LK L+L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 169 NNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR 228
           +N +S      +    PNL   +L+ N                 +  +            
Sbjct: 73  DNRVS-GGLEVLAEKCPNLTHLNLSGNKIK-------------DLSTI----------EP 108

Query: 229 FHNMRNLKELNLEYNYITSSNH 250
              + NLK L+L    +T+ N 
Sbjct: 109 LKKLENLKSLDLFNCEVTNLND 130

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 7/89 (7%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQ---LSGSFPFFNMSSLQV 67
           + L  L+ L+ L+LS N++ G +         L  L+LS N+   LS   P   + +L+ 
Sbjct: 58  ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117

Query: 68  IDLSDNRLSGELP---ANIFSYLPFVQFL 93
           +DL +  ++  L     N+F  LP + +L
Sbjct: 118 LDLFNCEVT-NLNDYRENVFKLLPQLTYL 145

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 49/310 (15%), Positives = 98/310 (31%), Gaps = 54/310 (17%)

Query: 17  SSLQYLDLSFNQL----LGTIPSSIFSIN-TLEILDLSNNQLS-------GSFPFFNMSS 64
           +S+  L+LS N L       +   + +I   +  L+LS N LS                +
Sbjct: 51  ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110

Query: 65  LQVIDLSDNRLSGELPANIFSYLPFV----QFLSLAFNQF----AGHLPREIGNL-TSLT 115
           + V+DL  N  S +  +        +      L+L  N      +  L + +  +  ++ 
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVN 170

Query: 116 SIDLSENHLMGE--------IPHEIGNLRNLQALGLLSNNLVGVVPATLF------NIST 161
           S++L  N+L  +        +     ++ +L     LS NL+G+              + 
Sbjct: 171 SLNLRGNNLASKNCAELAKFLASIPASVTSLD----LSANLLGLKSYAELAYIFSSIPNH 226

Query: 162 LKILQLTNNTLSGSISSSIRLAL---PNLELFSLANNNFSGKIPSFIFNASK-------- 210
           +  L L  N L G    +++L      +L+   L  +                       
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286

Query: 211 ----LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV 266
                +  E+  +                   +L    +  +    + I  L    +L+ 
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRE 346

Query: 267 LSLTGNPLLD 276
              T  PLL+
Sbjct: 347 SIQTCKPLLE 356

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 49/328 (14%), Positives = 105/328 (32%), Gaps = 60/328 (18%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSI-----NTLEILDLSNNQLS-------GSFPFF 60
                 +  LDLS N L       +         ++  L+LS N L              
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS 120
             +++  ++LS N LS +              L                   ++T +DL 
Sbjct: 78  IPANVTSLNLSGNFLSYK----------SSDELVKTL----------AAIPFTITVLDLG 117

Query: 121 ENHLMGEIPHEIGNL-----RNLQALGLLSNNL-----VGVVPATLFNISTLKILQLTNN 170
            N    +   E          ++ +L L  N+L       ++       + +  L L  N
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN 177

Query: 171 TLS----GSISSSIRLALPNLELFSLANNNFSGK-----IPSFIFNASKLSICELPDNSF 221
            L+      ++  +     ++    L+ N    K        F    + +    L  N  
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237

Query: 222 SG----FIPNRFHNMRNLKELNLEYNYITSSNHEL--SFISSLANSKKLKVLSLTGNPLL 275
            G     +     ++++L+ + L+Y+ + + + E   +  ++  N +K+ ++   G  + 
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

Query: 276 D---CVLPSSIGNLSLSMERFYLHNCNI 300
                 + + I  LS   +   L N  +
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCL 325

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 52/327 (15%), Positives = 102/327 (31%), Gaps = 59/327 (18%)

Query: 230 HNMRNLKELNLEYNYITSSNHELSFISSLA-NSKKLKVLSLTGNPLLD---CVLPSSIGN 285
           +   ++  LNL  N +    +    +  LA     +  L+L+GN L       L  ++  
Sbjct: 48  NTPASVTSLNLSGNSLGFK-NSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAA 106

Query: 286 LSLSMERFYLHNCNIRGSIPKEMGNLI-----NLIIIRLGYNKLNGSIPSTLSRL----- 335
           +  ++    L   +       E          ++  + L  N L       L ++     
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166

Query: 336 EKLQILGLENNQLEGRILDDICRL-----ARLSSVYLDHNKLSGSIPACFGNLASLRKLS 390
             +  L L  N L  +   ++ +      A ++S+ L  N L            S  +L+
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL---------KSYAELA 217

Query: 391 FASNELTFVPSTFWNLTNILMVDLSSNPLSGS----LPLEIGNLKVLVELYLSRNNLSG- 445
           +     + +P+   +L      +L  N L G     L L   +LK L  +YL  + +   
Sbjct: 218 YI---FSSIPNHVVSL------NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM 268

Query: 446 ------DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLI-----SLECLDLSNNILSGI 494
                  +      ++ +  +      +  S    I +LI       +   L N  L   
Sbjct: 269 SKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFA 328

Query: 495 -----IPSSLEKLLYLKYLNVSFNRLE 516
                    L     L+    +   L 
Sbjct: 329 QKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 43/320 (13%), Positives = 95/320 (29%), Gaps = 62/320 (19%)

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD---CVLPSSIGNLSLSMERFYLH 296
           + Y                +    +  L L+ N L       L  +  N   S+    L 
Sbjct: 1   MNYKLTLHPGSNP-VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLS 59

Query: 297 NCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI 356
             ++                     ++L   + +  + +  L    L  N L  +  D++
Sbjct: 60  GNSLGFK----------------NSDELVQILAAIPANVTSLN---LSGNFLSYKSSDEL 100

Query: 357 CRL-----ARLSSVYLDHNKLSGS-----IPACFGNLASLRKLSFASNELT------FVP 400
            +        ++ + L  N  S         A     AS+  L+   N+L        + 
Sbjct: 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160

Query: 401 STFWNLTNILMVDLSSNPLSG------SLPLEIGNLKVLVELYLSRNNLSGDIPTTIG-G 453
                  N+  ++L  N L+       +  L       +  L LS N L       +   
Sbjct: 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP-ASVTSLDLSANLLGLKSYAELAYI 219

Query: 454 LKN----LQNLSLGDNNLQGSIPNSIGDLI----SLECLDLSNNILSGI-------IPSS 498
             +    + +L+L  N L G    ++  L      L+ + L  +I+  +       + ++
Sbjct: 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA 279

Query: 499 LEKLLYLKYLNVSFNRLEGE 518
              +  +  ++ +   +   
Sbjct: 280 FPNIQKIILVDKNGKEIHPS 299

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 46/245 (18%), Positives = 81/245 (33%), Gaps = 75/245 (30%)

Query: 625 TDQFNVNNLIGSGSFGSVYRG--RFLDGMEVAIKV------FHLQLEGALESFNAECEVL 676
            +++ +   +G G+FG V           +VA+K+      +      A      E  VL
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---ARL----EINVL 70

Query: 677 RSIRHR------NLVRIISSCTNDDFKA---LVLDYMPKGSLEACLYS---DNSNLDIFK 724
           + I+ +        V +       +F     +  +      L    +    +N+      
Sbjct: 71  KKIKEKDKENKFLCVLMSDWF---NFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPL 122

Query: 725 RL--NIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA----------------- 765
               ++   +  AL +L   H N + H D+KP N+L                        
Sbjct: 123 PHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

Query: 766 --RLGDFGIAKLLSGDESMKHTQTLATIGYMAPE------YGREGQISTEGDVYSFGIML 817
             R+ DFG A      +   HT  +AT  Y  PE      +      +   DV+S G +L
Sbjct: 180 SIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCIL 229

Query: 818 MEIFT 822
            E + 
Sbjct: 230 FEYYR 234

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 27/117 (23%), Positives = 43/117 (36%), Gaps = 6/117 (5%)

Query: 158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP 217
             + ++ L L N   +      +     NLE  SL N      + +      KL   EL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKL-PKLKKLELS 79

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
           +N   G +      + NL  LNL  N +     ++S +  L   + LK L L    +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK----DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 429 NLKVLVELYLS-RNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLS 487
               + EL L    +  G I        NL+ LSL +  L  S+ N +  L  L+ L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 488 NNILSGIIPSSLEKLLYLKYLNVSFNRLE 516
            N + G +    EKL  L +LN+S N+L+
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 5/111 (4%)

Query: 15  SLSSLQYLDLSFNQL-LGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDN 73
           + ++++ L L   +   G I         LE L L N  L        +  L+ ++LS+N
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSEN 81

Query: 74  RLSGELPANIFSYLPFVQFLSLAFNQFA--GHLPREIGNLTSLTSIDLSEN 122
           R+ G L   +   LP +  L+L+ N+      L   +  L  L S+DL   
Sbjct: 82  RIFGGLD-MLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 23/115 (20%), Positives = 43/115 (37%), Gaps = 7/115 (6%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF--NMSSLQVIDL 70
                +L++L L    L     S++  +  L+ L+LS N++ G        + +L  ++L
Sbjct: 45  TAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFN---QFAGHLPREIGNLTSLTSIDLSEN 122
           S N+L           L  ++ L L          +       L  LT +D  + 
Sbjct: 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 40/174 (22%), Positives = 64/174 (36%), Gaps = 32/174 (18%)

Query: 342 GLENNQLEGRILDDI--CRLARLSSVYLDHNKLS-GSIPACFGNLASLRKLSFASNELTF 398
           G     ++ RI  ++     A +  + LD+ K + G I        +L  LS  +  L  
Sbjct: 4   GSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS 63

Query: 399 VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQ 458
           V +                         +  L  L +L LS N + G +      L NL 
Sbjct: 64  VSN-------------------------LPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98

Query: 459 NLSLGDNNLQG-SIPNSIGDLISLECLDLSNNILSGII---PSSLEKLLYLKYL 508
           +L+L  N L+  S    +  L  L+ LDL N  ++ +     S  + L  L YL
Sbjct: 99  HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 9e-05
 Identities = 31/159 (19%), Positives = 53/159 (33%), Gaps = 29/159 (18%)

Query: 110 NLTSLTSIDLSENHL-MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLT 168
              ++  + L       G+I        NL+ L L++  L+ V  + L  +  LK L+L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 169 NNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR 228
            N +       +   LPNL   +L+ N                 I  L            
Sbjct: 80  ENRIF-GGLDMLAEKLPNLTHLNLSGNKLK-------------DISTL----------EP 115

Query: 229 FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVL 267
              +  LK L+L    +T+ N     +       +L  L
Sbjct: 116 LKKLECLKSLDLFNCEVTNLNDYRESV--FKLLPQLTYL 152

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 53/255 (20%), Positives = 86/255 (33%), Gaps = 91/255 (35%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGR-FLDGMEVAIKV------FHLQLEGALESFNAECEVLR 677
            + F V   +G G+FG V   +   +    A+KV      +      A      E ++L+
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS---AKI----EADILK 86

Query: 678 SIRHR-----NLVRIISSCTNDDFKA---LVLDYMPKGSLEACLYSDNSNLDIFKR---- 725
            I++      N+V+         +     L+ +      L   LY      +I  R    
Sbjct: 87  KIQNDDINNNNIVKYHGKF---MYYDHMCLIFE-----PLGPSLY------EIITRNNYN 132

Query: 726 ---LNIVIDIA----LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA------------- 765
              +  +         AL YL       + H D+KP N+LLD+                 
Sbjct: 133 GFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189

Query: 766 ------------RLGDFGIAKLLSGDESMKHTQTLATIGYMAPE------YGREGQISTE 807
                       +L DFG A      +S  H   + T  Y APE      +         
Sbjct: 190 KIQIYRTKSTGIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGW------DVS 239

Query: 808 GDVYSFGIMLMEIFT 822
            D++SFG +L E++T
Sbjct: 240 SDMWSFGCVLAELYT 254

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 53.0 bits (128), Expect = 2e-07
 Identities = 47/248 (18%), Positives = 86/248 (34%), Gaps = 81/248 (32%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL--DGMEVAIKV------FHLQLEGALESFNAECEVL 676
           + ++ + + +G G+FG V         G  VA+K+      +      A      E +VL
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---ARS----EIQVL 65

Query: 677 RSIRHR------NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKR----- 725
             +           V+++    +     +V +      L    Y      D  K      
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTY------DFIKENGFLP 114

Query: 726 --LNIVIDIA----LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA-------------- 765
             L+ +  +A     ++ +L   H N + H D+KP N+L  +                  
Sbjct: 115 FRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171

Query: 766 -----RLGDFGIAKLLSGDESMKHTQTLATIGYMAPE------YGREGQISTEGDVYSFG 814
                ++ DFG A      +   H+  ++T  Y APE      +      S   DV+S G
Sbjct: 172 INPDIKVVDFGSA----TYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIG 221

Query: 815 IMLMEIFT 822
            +L+E + 
Sbjct: 222 CILIEYYL 229

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.0 bits (126), Expect = 2e-07
 Identities = 31/200 (15%), Positives = 55/200 (27%), Gaps = 52/200 (26%)

Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHL--------QLEGALESFNAEC 673
              T++      IG G FG V++    D   VAIK+  +          +   E    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 674 EVLRSI---------RHRNLVRIISSC------------------------------TND 694
            + + +         R    + + S                                  D
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKP 754
           D   +VL++   G              +    +I+  +  +L            H D+  
Sbjct: 135 DQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHW 190

Query: 755 SNVLLDEDMVARLGDFGIAK 774
            NVLL +  + +L      K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 30  LGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANIFSY 86
           L ++P+ I +  T ++L L +NQ++       F  ++ L  +DL +N+L+  LPA +F  
Sbjct: 21  LASVPTGIPT--TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDK 76

Query: 87  LPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
           L  +  LSL  NQ    +PR    NL SLT I L  N
Sbjct: 77  LTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 48.8 bits (117), Expect = 8e-07
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 15/96 (15%)

Query: 328 IPSTLSRLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNL 383
           IP+T       Q+L L +NQ   LE  + D   RL +L+ + LD+N+L+  +PA  F  L
Sbjct: 28  IPTTT------QVLYLYDNQITKLEPGVFD---RLTQLTRLDLDNNQLT-VLPAGVFDKL 77

Query: 384 ASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNP 418
             L +LS   N+L  +P   F NL ++  + L +NP
Sbjct: 78  TQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNP 113

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 25/63 (39%), Positives = 34/63 (53%), Gaps = 6/63 (9%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
            L+ L  LDL  NQ L  +P+ +F  +  L  L L++NQL  S P   F N+ SL  I L
Sbjct: 52  RLTQLTRLDLDNNQ-LTVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWL 109

Query: 71  SDN 73
            +N
Sbjct: 110 LNN 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 9/97 (9%)

Query: 30  LGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANIFSY 86
           L ++P+ I +    + L L+NNQ++       F ++ +LQ +  + N+L+  +P  +F  
Sbjct: 24  LASVPAGIPT--DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDK 79

Query: 87  LPFVQFLSLAFNQFAGHLPREI-GNLTSLTSIDLSEN 122
           L  +  L L  N     +PR    NL SLT I L  N
Sbjct: 80  LTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.8 bits (117), Expect = 8e-07
 Identities = 32/96 (33%), Positives = 44/96 (45%), Gaps = 15/96 (15%)

Query: 328 IPSTLSRLEKLQILGLENNQ---LEGRILDDICRLARLSSVYLDHNKLSGSIPA-CFGNL 383
           IP+        Q L L NNQ   LE  + D    L  L  +Y + NKL+ +IP   F  L
Sbjct: 31  IPTDK------QRLWLNNNQITKLEPGVFD---HLVNLQQLYFNSNKLT-AIPTGVFDKL 80

Query: 384 ASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNP 418
             L +L    N L  +P   F NL ++  + L +NP
Sbjct: 81  TQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNP 116

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 6/63 (9%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIF-SINTLEILDLSNNQLSGSFP---FFNMSSLQVIDL 70
            L +LQ L  + N+ L  IP+ +F  +  L  LDL++N L  S P   F N+ SL  I L
Sbjct: 55  HLVNLQQLYFNSNK-LTAIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYL 112

Query: 71  SDN 73
            +N
Sbjct: 113 YNN 115

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 47/289 (16%), Positives = 94/289 (32%), Gaps = 36/289 (12%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFSI-----NTLEILDLSNNQLS--GSFPFFNM-SSLQV 67
           LSSL+ L+L+  ++     + + ++     + L+ ++L++ QL   G      +    + 
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 68  IDLSDNRLSGE----LPANIFSYLPFVQFLSLAFNQF----AGHLPREIGNLTSLTSIDL 119
           + L  N L  E    L   +      +  L L+ N         L   +   TS+T + L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190

Query: 120 SENHL----MGEIPHEIGNLRNLQALGLLSNNL----VGVVPATLFNISTLKILQLTNNT 171
               L    +  +  ++   R LQ L +  N         +        +L++L L  N 
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250

Query: 172 LSGS----ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPN 227
           LS      +      A     +             + +     + + E+  N  S +   
Sbjct: 251 LSSEGRQVLRDLGGAAEGGARVVVSLTEG------TAVSEYWSVILSEVQRNLNS-WDRA 303

Query: 228 RFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
           R      L   +LE +   + N        L    +++ L         
Sbjct: 304 RVQRHLELLLRDLEDSRGATLN-PWRKAQLLRVEGEVRALLEQLGSSGS 351

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 69/522 (13%), Positives = 154/522 (29%), Gaps = 83/522 (15%)

Query: 70  LSDNRLSGELPANIFSYLPFV-----------QFLSLA---------FNQFAGHLPREIG 109
           LS      ++   + +Y+              ++  +             +     R   
Sbjct: 11  LSCVATVDDVIEQVMTYITDPKDRDSASLVCRRWFKIDSETREHVTMALCYTATPDRLSR 70

Query: 110 NLTSLTSIDLSE---------------NHLMGEIPHEIGNLRNLQALGLLSNNL--VGVV 152
              +L S+ L                  ++   +     NLR L+++      +  + + 
Sbjct: 71  RFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLD 130

Query: 153 PATLFNISTLKILQLTNNTLSGSIS-SSIRLALPNLELFSLANNNFSGKIPSFIFNASK- 210
                    L+ L+L   +   +    SI      ++   +  ++FS K   ++   ++ 
Sbjct: 131 RLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH 190

Query: 211 --------LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSK 262
                     + E    S    +     N R+L  + +    I      + F  + AN +
Sbjct: 191 NTSLEVLNFYMTEFAKISPKD-LETIARNCRSLVSVKVGDFEILEL---VGFFKAAANLE 246

Query: 263 KLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYN 322
           +    SL  +  +     + +    L          N    +P        +  + L Y 
Sbjct: 247 EFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN---EMPILFPFAAQIRKLDLLYA 303

Query: 323 KLNG-SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFG 381
            L      + + +   L++L   N   +  +        +L  + ++       +    G
Sbjct: 304 LLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG 363

Query: 382 ------------NLASLRKLSFASNELT-----FVPSTFWNLTNILMVDLSSNPLSGSLP 424
                           L  ++   +++T      + +   NL +  +V L        LP
Sbjct: 364 LVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP 423

Query: 425 LEIG------NLKVLVELYLSRN--NLSGDIPTTIG-GLKNLQNLSLGDNNLQ-GSIPNS 474
           L+ G        K L           L+    + IG    N++ + LG        +   
Sbjct: 424 LDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483

Query: 475 IGDLISLECLDLSN-NILSGIIPSSLEKLLYLKYLNVSFNRL 515
                +L+ L++         I +++ KL  L+YL V   R 
Sbjct: 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.9 bits (110), Expect = 2e-05
 Identities = 23/160 (14%), Positives = 58/160 (36%), Gaps = 16/160 (10%)

Query: 102 GHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNL--QALGLLSNNLVGVVPATLFNI 159
             L   +  +  L ++ +   + +        NL++L   + GL  + +  ++ + L N+
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221

Query: 160 STLKILQLTNNTLSGSISSSIRLAL-----PNLELFSLANNNFSGKIPSFIFNASK---- 210
             L +     +       +  R        PNL+   + +      +      +      
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281

Query: 211 ----LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYIT 246
               +S   L D      + +    +++LK +N++YNY++
Sbjct: 282 ETMDISAGVLTDEGARL-LLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 2e-05
 Identities = 47/289 (16%), Positives = 98/289 (33%), Gaps = 31/289 (10%)

Query: 253 SFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI 312
           +F S+    K    L               +        + Y  + +        M  ++
Sbjct: 42  NFSSAGEAEKAAGKLIAEKTKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKIL 101

Query: 313 NLI----IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD 368
                  + ++                + +     +    EG    DI    +  S +++
Sbjct: 102 KDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEIS-WIE 160

Query: 369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIG 428
              LS  +      L +L+     +N L+       NL ++   ++ S  L  S+  +I 
Sbjct: 161 QVDLS-PVLDAMPLLNNLK--IKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDIL 214

Query: 429 -----NLKVLVELYLSRNNLSGDIPTTI-------GGLKNLQNLSLGDNNLQGSIPNSIG 476
                NL+ L  LY+   +   D    +           NL+ L + D   Q  +     
Sbjct: 215 GSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273

Query: 477 D---LISLECLDLSNNILSG----IIPSSLEKLLYLKYLNVSFNRLEGE 518
           +   L  LE +D+S  +L+     ++   ++K+ +LK++N+ +N L  E
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 2e-04
 Identities = 17/92 (18%), Positives = 35/92 (38%), Gaps = 9/92 (9%)

Query: 12  QLGSLSSLQYLDLSFNQLLGTIPSSIFS---INTLEILDLSNNQLS--GSFPFF----NM 62
                 +L++L +   +    +         +  LE +D+S   L+  G+         +
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI 306

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLS 94
             L+ I++  N LS E+   +   LP    +S
Sbjct: 307 KHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 2e-04
 Identities = 25/182 (13%), Positives = 55/182 (30%), Gaps = 22/182 (12%)

Query: 343 LENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLAS--LRKLSFASNELT--- 397
            E  ++      D+  +   +   L++ K+ G+     G      L+ L   S  L    
Sbjct: 151 FEEQEISWIEQVDLSPVLD-AMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSV 209

Query: 398 ---FVPSTFWNLTNILMVDLSSNPLSGSLP------LEIGNLKVLVELYLSRNNLSGDIP 448
               + S   NL  +++     +                     L  L +        + 
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269

Query: 449 TTIGG---LKNLQNLSLGDNNLQGS----IPNSIGDLISLECLDLSNNILSGIIPSSLEK 501
                   L  L+ + +    L       + + +  +  L+ +++  N LS  +   L+K
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

Query: 502 LL 503
            L
Sbjct: 330 SL 331

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.4 bits (101), Expect = 2e-04
 Identities = 23/175 (13%), Positives = 57/175 (32%), Gaps = 18/175 (10%)

Query: 30  LGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIF-SYLP 88
              +   + ++  L  L +     + S       +L+ +++    L   +  +I  S LP
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTN-NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP 219

Query: 89  FVQFLSLAF---NQFAGHLPREI------GNLTSLTSIDLSENHLMGEIPHEIGN---LR 136
            ++ L L     +                    +L  + + +      +         L 
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279

Query: 137 NLQALGLLSNNL----VGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL 187
            L+ + + +  L      ++   +  I  LK + +  N LS  +   ++ +LP  
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 4e-04
 Identities = 21/161 (13%), Positives = 52/161 (32%), Gaps = 14/161 (8%)

Query: 199 GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSL 258
             +   +     L+  ++   +          N   LK L +    +  S  E    S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPN---LKSLEIISGGLPDSVVEDILGSDL 218

Query: 259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLSL----SMERFYLHNCNIRGSIPK---EMGNL 311
            N +KL +     +   D  +       S     +++   + +   +  + +   E   L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 312 INLIIIRLGYNKLNGS----IPSTLSRLEKLQILGLENNQL 348
             L  + +    L       +   + +++ L+ + ++ N L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 65/490 (13%), Positives = 146/490 (29%), Gaps = 81/490 (16%)

Query: 73  NRLSGELPANIFSYLPFV-----------QFLSLA---------FNQFAGHLPREIGNLT 112
                E+  ++FS++               +  +           N +A      I    
Sbjct: 7   LSFPEEVLEHVFSFIQLDKDRNSVSLVCKSWYEIERWCRRKVFIGNCYAVSPATVIRRFP 66

Query: 113 SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNIST----LKILQLT 168
            + S++L                 +     L+ +   G V   +  +S+    L+ ++L 
Sbjct: 67  KVRSVELKGK-------------PHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLK 113

Query: 169 NNTLSGSISSSIRLALPNLELFSLAN-NNFSGKIPSFIFNASK------LSICELPDNSF 221
              ++      I  +  N ++  L++   FS    + I    +      L   ++ D S 
Sbjct: 114 RMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG 173

Query: 222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPS 281
              + +      +L  LN+       S   L  +  +     LK L L     L+ +  +
Sbjct: 174 HW-LSHFPDTYTSLVSLNISCLASEVSFSALERL--VTRCPNLKSLKLNRAVPLEKL--A 228

Query: 282 SIGNLSLSMERFYLHNCN------IRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL 335
           ++   +  +E              +   +   +     L  +   ++ +   +P+  S  
Sbjct: 229 TLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288

Query: 336 EKLQILGLENNQLEGR-ILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASN 394
            +L  L L    ++   ++  +C+  +L  +++        +         LR+L    +
Sbjct: 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPS 348

Query: 395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG-G 453
           E  FV      LT   +V +S                 L  +      ++     TI   
Sbjct: 349 E-PFVMEPNVALTEQGLVSVSMG------------CPKLESVLYFCRQMTNAALITIARN 395

Query: 454 LKNLQNLSLGDNNLQGS--IPNSIGD---------LISLECLDLSNNILSGIIPSSLEKL 502
             N+    L     +    +     D            L  L LS  +   +        
Sbjct: 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYA 455

Query: 503 LYLKYLNVSF 512
             ++ L+V+F
Sbjct: 456 KKMEMLSVAF 465

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	851
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.98
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.98
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.98
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.98
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.98
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.98
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.98
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.98
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.98
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.98
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.98
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.98
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.98
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.98
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.98
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.98
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.98
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.79
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.71
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.63
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.62
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.4
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.4
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.39
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.34
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.06
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.02
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.92
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.92
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.52
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.5
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.5
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.43
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.39
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.22
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.11
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.92
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.89
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.85
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.74
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.62
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.6
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.42
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.36
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.35
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.26
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.15
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.98
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.52
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.12
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.49
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	93.58
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.48

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1e-69  Score=651.67  Aligned_cols=543  Identities=33%  Similarity=0.536  Sum_probs=446.7

Q ss_pred             CCCcccccCC--CCCCCCCCCEEeCcCCCCccCCCccc-cCCCCCCEEEcCCCccccccc-----CCCCCCCcEEeCCCC
Q 046438            2 QSFLTGTVPS--QLGSLSSLQYLDLSFNQLLGTIPSSI-FSINTLEILDLSNNQLSGSFP-----FFNMSSLQVIDLSDN   73 (851)
Q Consensus         2 ~~~~~~~~p~--~l~~l~~L~~L~ls~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~-----~~~~~~L~~L~Ls~n   73 (851)
                      ++.++|.+|.  .++++++|++|+|++|.+++.+|..+ ..+++|++|+|++|++++..+     +..+++|++|++++|
T Consensus       109 ~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n  188 (768)
T 3rgz_A          109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN  188 (768)
T ss_dssp             SSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSS
T ss_pred             CCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCC
Confidence            3567888888  89999999999999999988877766 788888888888888887554     567888888888888


Q ss_pred             CCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCC
Q 046438           74 RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVP  153 (851)
Q Consensus        74 ~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  153 (851)
                      .+++..+   +..+++|++|+|++|.+++.+|. ++++++|++|+|++|.+++.+|..|+.+++|++|++++|++.+..|
T Consensus       189 ~l~~~~~---~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~  264 (768)
T 3rgz_A          189 KISGDVD---VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP  264 (768)
T ss_dssp             EEESCCB---CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCC
T ss_pred             cccccCC---cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccC
Confidence            8875544   36678888888888888776666 7888888888888888887778888888888888888888776666


Q ss_pred             ccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCcc-ccCC
Q 046438          154 ATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNR-FHNM  232 (851)
Q Consensus       154 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-~~~l  232 (851)
                      ..  .+++|++|++++|++++.+|..++..+++|++|+|++|++++..|..+.++++|+.|+|++|.+++..|.. |.++
T Consensus       265 ~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l  342 (768)
T 3rgz_A          265 PL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM  342 (768)
T ss_dssp             CC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTC
T ss_pred             cc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcC
Confidence            54  67777777777777777777766655577777777777777777777777777777777777777555543 7777


Q ss_pred             CCcceEeccCcccc-CCCCcchh-------------------hhhccc--cccccEEeccCCCccCCCCCCccccccccc
Q 046438          233 RNLKELNLEYNYIT-SSNHELSF-------------------ISSLAN--SKKLKVLSLTGNPLLDCVLPSSIGNLSLSM  290 (851)
Q Consensus       233 ~~L~~L~L~~N~i~-~~~~~~~~-------------------~~~l~~--l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L  290 (851)
                      ++|++|++++|+++ .++.....                   ...+..  +++|++|++++|++. ..+|..+..+. +|
T Consensus       343 ~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~p~~l~~l~-~L  420 (768)
T 3rgz_A          343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT-GKIPPTLSNCS-EL  420 (768)
T ss_dssp             TTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEE-EECCGGGGGCT-TC
T ss_pred             CCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccc-cccCHHHhcCC-CC
Confidence            77777777777776 22222110                   011111  456777777777664 24566666665 78


Q ss_pred             cEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCc
Q 046438          291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHN  370 (851)
Q Consensus       291 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  370 (851)
                      +.|++++|++++.+|..++.+++|++|++++|.+.+.+|..+..+++|++|++++|++++..|..+..+++|+.|+|++|
T Consensus       421 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  500 (768)
T 3rgz_A          421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN  500 (768)
T ss_dssp             CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             CEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCC
Confidence            89999999998888999999999999999999999888999999999999999999999888999999999999999999


Q ss_pred             ccCCCCCccccCCccccceecccCcCc-cCchhhcccCcceEEEecCCCCCCCCcccc----------------------
Q 046438          371 KLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEI----------------------  427 (851)
Q Consensus       371 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------------------  427 (851)
                      ++.+.+|..++.+++|++|++++|+++ .+|..+..+++|+.|++++|+++|.+|..+                      
T Consensus       501 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~  580 (768)
T 3rgz_A          501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN  580 (768)
T ss_dssp             CCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEEC
T ss_pred             ccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccc
Confidence            999999999999999999999999998 788899999999999999999887777543                      


Q ss_pred             ------------------------------------------------ccchhhhhhhccCCcccccCCcccCCCCCccE
Q 046438          428 ------------------------------------------------GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQN  459 (851)
Q Consensus       428 ------------------------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  459 (851)
                                                                      +.+++|+.|+|++|+++|.+|..|+.+++|+.
T Consensus       581 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~  660 (768)
T 3rgz_A          581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI  660 (768)
T ss_dssp             CSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCE
T ss_pred             ccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCE
Confidence                                                            33567889999999999999999999999999


Q ss_pred             EEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCc
Q 046438          460 LSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLL  539 (851)
Q Consensus       460 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~  539 (851)
                      |+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..+++|++|++++|+++|.+|..+++.++...+|.||+.+
T Consensus       661 L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~L  740 (768)
T 3rgz_A          661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL  740 (768)
T ss_dssp             EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEE
T ss_pred             EeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCC
Q 046438          540 CGSPHLQVPPCKSTKT  555 (851)
Q Consensus       540 c~~~~~~~~~c~~~~~  555 (851)
                      ||.|   .++|.....
T Consensus       741 cg~~---l~~C~~~~~  753 (768)
T 3rgz_A          741 CGYP---LPRCDPSNA  753 (768)
T ss_dssp             ESTT---SCCCCSCC-
T ss_pred             cCCC---CcCCCCCcc
Confidence            9998   457866554

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2e-65  Score=614.47  Aligned_cols=519  Identities=33%  Similarity=0.490  Sum_probs=460.4

Q ss_pred             cCCCCCCCCCCCEEeCcCCCCccCCCc--cccCCCCCCEEEcCCCcccccccC---CCCCCCcEEeCCCCCCCCCCCcch
Q 046438            9 VPSQLGSLSSLQYLDLSFNQLLGTIPS--SIFSINTLEILDLSNNQLSGSFPF---FNMSSLQVIDLSDNRLSGELPANI   83 (851)
Q Consensus         9 ~p~~l~~l~~L~~L~ls~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~---~~~~~L~~L~Ls~n~l~~~~~~~~   83 (851)
                      +|+.++++++|++|||++|.+++.+|.  .++.+++|++|+|++|.+++..+.   ..+++|++|||++|++++..|...
T Consensus        92 l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  171 (768)
T 3rgz_A           92 SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW  171 (768)
T ss_dssp             CCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHH
T ss_pred             CchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhh
Confidence            448999999999999999999998998  999999999999999999986662   689999999999999996555432


Q ss_pred             --hcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCc
Q 046438           84 --FSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNIST  161 (851)
Q Consensus        84 --~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  161 (851)
                        +..+++|++|+|++|.+++..|.  ..+++|++|+|++|.+++.+|. ++++++|++|++++|++++..|..+.++++
T Consensus       172 ~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~  248 (768)
T 3rgz_A          172 VLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTE  248 (768)
T ss_dssp             HHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSS
T ss_pred             hhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCC
Confidence              78999999999999999976654  8899999999999999987877 999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccchhHhhhcccccccccccccccccCCcccccc-CCCcEEecCCCCCccccCccccCCCCcceEec
Q 046438          162 LKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNA-SKLSICELPDNSFSGFIPNRFHNMRNLKELNL  240 (851)
Q Consensus       162 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  240 (851)
                      |++|++++|++++.++..   .+++|++|++++|.+++.+|..+... ++|+.|+|++|.+++..|..|+++++|++|+|
T Consensus       249 L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  325 (768)
T 3rgz_A          249 LKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL  325 (768)
T ss_dssp             CCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEEC
T ss_pred             CCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEEC
Confidence            999999999999777764   78999999999999999999998876 99999999999999999999999999999999


Q ss_pred             cCcccc-CCCCcchhhhhccccccccEEeccCCCccCCCCCCccccc--------------------------cccccEE
Q 046438          241 EYNYIT-SSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNL--------------------------SLSMERF  293 (851)
Q Consensus       241 ~~N~i~-~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~--------------------------~~~L~~L  293 (851)
                      ++|.++ .++.     ..+..+++|++|++++|++. ..+|..+..+                          ..+|+.|
T Consensus       326 ~~n~l~~~ip~-----~~l~~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  399 (768)
T 3rgz_A          326 SSNNFSGELPM-----DTLLKMRGLKVLDLSFNEFS-GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL  399 (768)
T ss_dssp             CSSEEEEECCH-----HHHTTCTTCCEEECCSSEEE-ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred             CCCcccCcCCH-----HHHhcCCCCCEEeCcCCccC-ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence            999997 4332     23667777777777777764 2344444333                          2357788


Q ss_pred             EeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccC
Q 046438          294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLS  373 (851)
Q Consensus       294 ~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  373 (851)
                      ++++|++++.+|..+.++++|++|++++|.+++..|..+..+++|++|++++|.+.+.+|..+..+++|+.|++++|++.
T Consensus       400 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  479 (768)
T 3rgz_A          400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT  479 (768)
T ss_dssp             ECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             ECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCccc
Confidence            88888888888889999999999999999999899999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCccccceecccCcCc-cCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCccc-
Q 046438          374 GSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI-  451 (851)
Q Consensus       374 ~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-  451 (851)
                      +.+|..+..+++|++|++++|+++ .+|..++.+++|++|+|++|++++.+|..++.+++|+.|++++|++++.+|..+ 
T Consensus       480 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~  559 (768)
T 3rgz_A          480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF  559 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGG
T ss_pred             CcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHh
Confidence            999999999999999999999998 788899999999999999999999999999999999999999999987776543 


Q ss_pred             ---------------------------------------------------------------------CCCCCccEEEc
Q 046438          452 ---------------------------------------------------------------------GGLKNLQNLSL  462 (851)
Q Consensus       452 ---------------------------------------------------------------------~~l~~L~~L~L  462 (851)
                                                                                           +.+++|+.|||
T Consensus       560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdL  639 (768)
T 3rgz_A          560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM  639 (768)
T ss_dssp             TTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEEC
T ss_pred             cccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEEC
Confidence                                                                                 34577999999


Q ss_pred             cCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCC-CcccccCcccccCCcCc
Q 046438          463 GDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG-GTLANFTSESFMGNDLL  539 (851)
Q Consensus       463 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~  539 (851)
                      ++|+++|.+|.+++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+...++.+|+..
T Consensus       640 s~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~  717 (768)
T 3rgz_A          640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS  717 (768)
T ss_dssp             CSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred             cCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence            999999999999999999999999999999999999999999999999999999999865 45777888888888643

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.3e-58  Score=548.73  Aligned_cols=530  Identities=25%  Similarity=0.267  Sum_probs=332.8

Q ss_pred             cCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcC
Q 046438            9 VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSY   86 (851)
Q Consensus         9 ~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~   86 (851)
                      +|..+.  +++++|+|++|++++..+.+|..+++|++|+|++|++++..+  +..+++|++|+|++|+++ .+|...|+.
T Consensus        19 ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~   95 (680)
T 1ziw_A           19 VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAF   95 (680)
T ss_dssp             CCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTT
T ss_pred             cccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhcc
Confidence            444443  445555555555554444445555555555555555554333  344555555555555554 444444455


Q ss_pred             CcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCcccc--CCCcCcE
Q 046438           87 LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLF--NISTLKI  164 (851)
Q Consensus        87 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~--~l~~L~~  164 (851)
                      +++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|++++..+..+.  .+++|+.
T Consensus        96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~  175 (680)
T 1ziw_A           96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK  175 (680)
T ss_dssp             CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE
T ss_pred             CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccE
Confidence            55555555555555544444455555555555555555544444455555555555555555444443332  2344555


Q ss_pred             EEeeccccccccchhHhh--------------------------hcccccccccccccccccCCccccccCC--CcEEec
Q 046438          165 LQLTNNTLSGSISSSIRL--------------------------ALPNLELFSLANNNFSGKIPSFIFNASK--LSICEL  216 (851)
Q Consensus       165 L~L~~n~l~~~~~~~~~~--------------------------~l~~L~~L~L~~N~i~~~~~~~~~~~~~--L~~L~L  216 (851)
                      |++++|.+++..+..+..                          ..++|+.|++++|.+++..|..+.+++.  |+.|+|
T Consensus       176 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~L  255 (680)
T 1ziw_A          176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL  255 (680)
T ss_dssp             EECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEEC
T ss_pred             EECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEEC
Confidence            555555444322221110                          1134555555555555555555555433  566666


Q ss_pred             CCCCCccccCccccCCCCcceEeccCccccCCCCcc------------------------hh----hhhccccccccEEe
Q 046438          217 PDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHEL------------------------SF----ISSLANSKKLKVLS  268 (851)
Q Consensus       217 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~------------------------~~----~~~l~~l~~L~~L~  268 (851)
                      ++|.++++.+..|+.+++|++|++++|+++......                        ..    ...+..+++|++|+
T Consensus       256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~  335 (680)
T 1ziw_A          256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN  335 (680)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEE
T ss_pred             CCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEE
Confidence            666555555555555555666666555555432110                        00    00234455555555


Q ss_pred             ccCCCccCCCCCCccccccccccEEEeecCcccc--CCCcccccc--cCCcEEEecCCCCCCCcCccccCCCCCcEEEcc
Q 046438          269 LTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRG--SIPKEMGNL--INLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE  344 (851)
Q Consensus       269 Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~--~~p~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  344 (851)
                      +++|++.. ..+..+..+ .+|+.|++++|.+..  ..+..+..+  ++|+.|++++|++.+..|.+|..+++|+.|+++
T Consensus       336 l~~n~l~~-~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  413 (680)
T 1ziw_A          336 MEDNDIPG-IKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG  413 (680)
T ss_dssp             CCSCCBCC-CCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCCccCC-CChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCC
Confidence            55555532 112222222 245555555554321  111222222  356666666677776777788888888888888


Q ss_pred             ccccccccc-ccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCc---cCchhhcccCcceEEEecCCCCC
Q 046438          345 NNQLEGRIL-DDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT---FVPSTFWNLTNILMVDLSSNPLS  420 (851)
Q Consensus       345 ~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~p~~~~~l~~L~~L~Ls~N~l~  420 (851)
                      +|.+.+.++ ..+..+++|+.|++++|++.+..+..|..+++|+.|++++|.++   .+|..+.++++|+.|+|++|+++
T Consensus       414 ~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~  493 (680)
T 1ziw_A          414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA  493 (680)
T ss_dssp             SSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCC
T ss_pred             CCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCC
Confidence            888876554 67788888888888888888778888888888999999888875   56788899999999999999999


Q ss_pred             CCCccccccchhhhhhhccCCcccccCC--------cccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc
Q 046438          421 GSLPLEIGNLKVLVELYLSRNNLSGDIP--------TTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       421 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +..+..|.++++|++|++++|++++..+        ..|.++++|+.|+|++|+++...+..|.++++|+.|+|++|+++
T Consensus       494 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~  573 (680)
T 1ziw_A          494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN  573 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCC
Confidence            8888889999999999999999985422        23788999999999999998555567899999999999999999


Q ss_pred             ccCCccccccccccceeccCccccccCCCCC--cccccCcccccCCcCccCCC
Q 046438          493 GIIPSSLEKLLYLKYLNVSFNRLEGEIPRGG--TLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       493 ~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~--~~~~l~~~~~~~n~~~c~~~  543 (851)
                      +..+..|..+++|+.|++++|++++..|..-  .+..+..+.+.+||+.|+++
T Consensus       574 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             cCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            7777778899999999999999998776432  46788888999999999876

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9e-58  Score=543.61  Aligned_cols=516  Identities=22%  Similarity=0.247  Sum_probs=430.1

Q ss_pred             CCcccccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCC
Q 046438            3 SFLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELP   80 (851)
Q Consensus         3 ~~~~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~   80 (851)
                      +.+++..|..+.++++|++|+|++|++++..|.++..+++|++|+|++|++++.++  +..+++|++|++++|+++ .++
T Consensus        35 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~  113 (680)
T 1ziw_A           35 NQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ-KIK  113 (680)
T ss_dssp             SCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCC
T ss_pred             CCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccC-ccC
Confidence            55677555679999999999999999999899999999999999999999998765  789999999999999998 677


Q ss_pred             cchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhc--CcccccEEEccCccccCCCCccccC
Q 046438           81 ANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIG--NLRNLQALGLLSNNLVGVVPATLFN  158 (851)
Q Consensus        81 ~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~  158 (851)
                      +..|+.+++|++|+|++|.+++..|..++++++|++|++++|.+++..+..+.  .+++|++|++++|++.+..|..+..
T Consensus       114 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~  193 (680)
T 1ziw_A          114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA  193 (680)
T ss_dssp             SCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGG
T ss_pred             hhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhh
Confidence            77789999999999999999988899999999999999999999977777665  4589999999999998887776654


Q ss_pred             C---------------------------CcCcEEEeeccccccccchhHhhhccc--ccccccccccccccCCccccccC
Q 046438          159 I---------------------------STLKILQLTNNTLSGSISSSIRLALPN--LELFSLANNNFSGKIPSFIFNAS  209 (851)
Q Consensus       159 l---------------------------~~L~~L~L~~n~l~~~~~~~~~~~l~~--L~~L~L~~N~i~~~~~~~~~~~~  209 (851)
                      +                           ++|+.|++++|.+++..+.. +..++.  |++|+|++|++++..|..+.+++
T Consensus       194 l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~-~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~  272 (680)
T 1ziw_A          194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT-FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP  272 (680)
T ss_dssp             SSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT-TGGGGGSCCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH-hhccCcCCCCEEECCCCCcCccCcccccCcc
Confidence            4                           34566666666666444433 334433  77777777777776677777777


Q ss_pred             CCcEEecCCCCCccccCcc---------------------------------ccCCCCcceEeccCccccCCCCcchhhh
Q 046438          210 KLSICELPDNSFSGFIPNR---------------------------------FHNMRNLKELNLEYNYITSSNHELSFIS  256 (851)
Q Consensus       210 ~L~~L~L~~n~l~~~~~~~---------------------------------~~~l~~L~~L~L~~N~i~~~~~~~~~~~  256 (851)
                      +|+.|++++|.+++..+..                                 |..+++|++|++++|.++.++.     .
T Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~-----~  347 (680)
T 1ziw_A          273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS-----N  347 (680)
T ss_dssp             TCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCT-----T
T ss_pred             cccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCCh-----h
Confidence            7777777777776665544                                 4455666666666676665432     3


Q ss_pred             hccccccccEEeccCCCccCCCCCCccc-cc-cccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcC-cccc
Q 046438          257 SLANSKKLKVLSLTGNPLLDCVLPSSIG-NL-SLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIP-STLS  333 (851)
Q Consensus       257 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~-~~-~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~~~~  333 (851)
                      .+..+++|++|++++|.+....++.... .. ..+|+.|++++|++++..|..+..+++|++|++++|.+.+.+| ..|.
T Consensus       348 ~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  427 (680)
T 1ziw_A          348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR  427 (680)
T ss_dssp             TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGT
T ss_pred             HhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCccccc
Confidence            4778999999999999865444443322 22 1479999999999999999999999999999999999987555 6899


Q ss_pred             CCCCCcEEEcccccccccccccccccCCCCEEEccCcccC--CCCCccccCCccccceecccCcCccCch-hhcccCcce
Q 046438          334 RLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLS--GSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNIL  410 (851)
Q Consensus       334 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~  410 (851)
                      .+++|++|++++|.+.+..+..+..+++|+.|++++|.+.  +..|..|..+++|+.|++++|+++.+|. .+.++++|+
T Consensus       428 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~  507 (680)
T 1ziw_A          428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE  507 (680)
T ss_dssp             TCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             CcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccC
Confidence            9999999999999999998999999999999999999987  5788999999999999999999998875 588999999


Q ss_pred             EEEecCCCCCCCCc--------cccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCC
Q 046438          411 MVDLSSNPLSGSLP--------LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLE  482 (851)
Q Consensus       411 ~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  482 (851)
                      +|+|++|++++..+        ..|.++++|++|+|++|+++...+..|.++++|+.|+|++|++++..+..|.++++|+
T Consensus       508 ~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~  587 (680)
T 1ziw_A          508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK  587 (680)
T ss_dssp             EEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             EEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCC
Confidence            99999999985422        2378899999999999999955456799999999999999999977777889999999


Q ss_pred             EEECCCCcccccCCcccc-ccccccceeccCccccccCCCCCcc
Q 046438          483 CLDLSNNILSGIIPSSLE-KLLYLKYLNVSFNRLEGEIPRGGTL  525 (851)
Q Consensus       483 ~L~Ls~N~l~~~~p~~l~-~l~~L~~l~l~~N~l~~~~p~~~~~  525 (851)
                      .|+|++|+|++..|..+. .+++|+.|++++|+|.|+|+...+|
T Consensus       588 ~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~  631 (680)
T 1ziw_A          588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF  631 (680)
T ss_dssp             EEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSE
T ss_pred             EEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHH
Confidence            999999999988888887 8999999999999999999863333

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.4e-57  Score=534.71  Aligned_cols=503  Identities=21%  Similarity=0.212  Sum_probs=420.4

Q ss_pred             ccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            8 TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         8 ~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      ++|..+.  +++++|||++|+++++.|.+|..+++|++|+|++|++++..|  +..+++|++|+|++|+++ .+++..|+
T Consensus        26 ~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~  102 (606)
T 3t6q_A           26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALS  102 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCS-EECTTTTS
T ss_pred             cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccc-ccChhhhc
Confidence            5777775  478999999999998889999999999999999999987655  789999999999999998 55555689


Q ss_pred             CCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCc--
Q 046438           86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLK--  163 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~--  163 (851)
                      .+++|++|+|++|.+++..+..++++++|++|+|++|.+++..+..+..+++|++|++++|++.+..|..+..+++|+  
T Consensus       103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l  182 (606)
T 3t6q_A          103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL  182 (606)
T ss_dssp             SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSE
T ss_pred             ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhccccee
Confidence            999999999999999987788899999999999999999875444555599999999999999988888899999999  


Q ss_pred             EEEeeccccccccchhHhhhccccccccccccccc--------------------------ccCCccccccC--CCcEEe
Q 046438          164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS--------------------------GKIPSFIFNAS--KLSICE  215 (851)
Q Consensus       164 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~--------------------------~~~~~~~~~~~--~L~~L~  215 (851)
                      .|++++|.+++..+.. + ..++|++|++++|...                          ...+..+..+.  +|+.|+
T Consensus       183 ~L~l~~n~l~~~~~~~-~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~  260 (606)
T 3t6q_A          183 SLNLNGNDIAGIEPGA-F-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN  260 (606)
T ss_dssp             EEECTTCCCCEECTTT-T-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEE
T ss_pred             EEecCCCccCccChhH-h-hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEE
Confidence            8999999998554443 3 4468888888877511                          11122222222  788999


Q ss_pred             cCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEe
Q 046438          216 LPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYL  295 (851)
Q Consensus       216 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L  295 (851)
                      +++|.++++.+..|+.+++|++|++++|.++.++.      .+..+++|++|++++|++.. ..|..+..+. +|+.|++
T Consensus       261 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~------~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~-~L~~L~l  332 (606)
T 3t6q_A          261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS------GLVGLSTLKKLVLSANKFEN-LCQISASNFP-SLTHLSI  332 (606)
T ss_dssp             CTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS------SCCSCTTCCEEECTTCCCSB-GGGGCGGGCT-TCSEEEC
T ss_pred             eecCccCccCHHHhccccCCCEEeccCCccCCCCh------hhcccccCCEEECccCCcCc-CchhhhhccC-cCCEEEC
Confidence            99999999888889999999999999999987653      36778899999999998863 2344555554 8999999


Q ss_pred             ecCccccCCCc-ccccccCCcEEEecCCCCCCCc--CccccCCCCCcEEEcccccccccccccccccCCCCEEEccCccc
Q 046438          296 HNCNIRGSIPK-EMGNLINLIIIRLGYNKLNGSI--PSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKL  372 (851)
Q Consensus       296 ~~n~i~~~~p~-~l~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  372 (851)
                      ++|++.+.+|. .+..+++|++|++++|.+.+..  +..+..+++|++|++++|.+.+..+..+..+++|+.|++++|++
T Consensus       333 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  412 (606)
T 3t6q_A          333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL  412 (606)
T ss_dssp             CSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCE
T ss_pred             CCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcC
Confidence            99998866654 4888999999999999998765  77888999999999999999988888899999999999999999


Q ss_pred             CCCCCc-cccCCccccceecccCcCccC-chhhcccCcceEEEecCCCCCCC---CccccccchhhhhhhccCCcccccC
Q 046438          373 SGSIPA-CFGNLASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLSGS---LPLEIGNLKVLVELYLSRNNLSGDI  447 (851)
Q Consensus       373 ~~~~~~-~~~~l~~L~~L~L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~  447 (851)
                      .+..+. .+..+++|++|++++|.++.. |..+..+++|++|++++|++.+.   .+..+..+++|++|++++|++++..
T Consensus       413 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  492 (606)
T 3t6q_A          413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID  492 (606)
T ss_dssp             ECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEEC
T ss_pred             CCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccC
Confidence            876654 488899999999999999865 56788899999999999998762   3356888999999999999999888


Q ss_pred             CcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCc
Q 046438          448 PTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGT  524 (851)
Q Consensus       448 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~  524 (851)
                      |..|+.+++|+.|+|++|++++..|..+..+++| .|+|++|++++.+|..+..+++|+.|++++|+|+|+|+..+.
T Consensus       493 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~  568 (606)
T 3t6q_A          493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF  568 (606)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHH
T ss_pred             hhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHH
Confidence            8899999999999999999998889999999999 999999999988888899999999999999999999885433

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=6.1e-57  Score=529.21  Aligned_cols=499  Identities=22%  Similarity=0.218  Sum_probs=414.3

Q ss_pred             ccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            8 TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         8 ~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      .+|..+.  +++++|+|++|++++..+.+|..+++|++|+|++|++++..|  +..+++|++|+|++|+++ .+++..|+
T Consensus        25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~~~  101 (606)
T 3vq2_A           25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ-SFSPGSFS  101 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-CCCTTSST
T ss_pred             cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc-ccChhhcC
Confidence            4777665  789999999999998888889999999999999999987655  788999999999999998 55445588


Q ss_pred             CCcccccccccccccccCCCccccCCCCccEEecccccccc-ccchhhcCcccccEEEccCccccCCCCccccCCCcCc-
Q 046438           86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLK-  163 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~-  163 (851)
                      ++++|++|+|++|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..+..+++|+ 
T Consensus       102 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  181 (606)
T 3vq2_A          102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ  181 (606)
T ss_dssp             TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTT
T ss_pred             CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhcccc
Confidence            89999999999999987777889999999999999999985 5688999999999999999999988888887776655 


Q ss_pred             ---EEEeeccccccccchhHhhhccccccccccccccc-ccCCccccccCCCcEEec-----------------------
Q 046438          164 ---ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS-GKIPSFIFNASKLSICEL-----------------------  216 (851)
Q Consensus       164 ---~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~L~~L~L-----------------------  216 (851)
                         .|++++|.++ .++...+... +|++|++++|.++ +..|..+.+++.|+.+++                       
T Consensus       182 ~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~  259 (606)
T 3vq2_A          182 VNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC  259 (606)
T ss_dssp             CCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGG
T ss_pred             ccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhh
Confidence               7999999988 5555555443 8999999999886 455666667777766665                       


Q ss_pred             ----------CCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccc
Q 046438          217 ----------PDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNL  286 (851)
Q Consensus       217 ----------~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~  286 (851)
                                ..|.+.+..|. +..+++|++|++++|.++.++       .+..+++|++|++++|++  ..+|. +  .
T Consensus       260 ~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-------~l~~~~~L~~L~l~~n~l--~~lp~-~--~  326 (606)
T 3vq2_A          260 DVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-------DVPKHFKWQSLSIIRCQL--KQFPT-L--D  326 (606)
T ss_dssp             GSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-------CCCTTCCCSEEEEESCCC--SSCCC-C--C
T ss_pred             hccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh-------hccccccCCEEEcccccC--ccccc-C--C
Confidence                      66677777666 888899999999999887654       467788999999999998  45663 3  3


Q ss_pred             cccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCC--cCccccCCCCCcEEEcccccccccccccccccCCCCE
Q 046438          287 SLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGS--IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS  364 (851)
Q Consensus       287 ~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  364 (851)
                      ..+|+.|++++|+..+..  .+..+++|++|++++|.+++.  .|..+..+++|++|++++|.+++ .+..+..+++|+.
T Consensus       327 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~  403 (606)
T 3vq2_A          327 LPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH  403 (606)
T ss_dssp             CSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCE
T ss_pred             CCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCe
Confidence            348999999999655433  677889999999999998865  37788889999999999999885 4578888999999


Q ss_pred             EEccCcccCCCCC-ccccCCccccceecccCcCcc-CchhhcccCcceEEEecCCCCCC-CCccccccchhhhhhhccCC
Q 046438          365 VYLDHNKLSGSIP-ACFGNLASLRKLSFASNELTF-VPSTFWNLTNILMVDLSSNPLSG-SLPLEIGNLKVLVELYLSRN  441 (851)
Q Consensus       365 L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N  441 (851)
                      |++++|++.+..+ ..|..+++|++|++++|+++. .|..+.++++|++|++++|++++ .+|..|+.+++|++|++++|
T Consensus       404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n  483 (606)
T 3vq2_A          404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC  483 (606)
T ss_dssp             EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             eECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC
Confidence            9999999987777 688889999999999999885 56778889999999999999987 47888899999999999999


Q ss_pred             cccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccc-cccceeccCccccccCC
Q 046438          442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLL-YLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       442 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~l~l~~N~l~~~~p  520 (851)
                      ++++..|..|+.+++|++|+|++|++++..|..+.++++|++|+|++|+++ .+|..+..++ +|+.|++++|+|.|.|+
T Consensus       484 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             cCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            999888888999999999999999999888899999999999999999998 6777788887 59999999999999988


Q ss_pred             CCCccccc
Q 046438          521 RGGTLANF  528 (851)
Q Consensus       521 ~~~~~~~l  528 (851)
                      ..+...++
T Consensus       563 ~~~~~~~l  570 (606)
T 3vq2_A          563 HQKFLQWV  570 (606)
T ss_dssp             THHHHTTT
T ss_pred             cHHHHHHH
Confidence            65433333

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5e-56  Score=521.42  Aligned_cols=510  Identities=21%  Similarity=0.228  Sum_probs=450.2

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      -+.++.++..++ .+|..+..  ++++|+|++|++++..+  +..+++|++|||++|+++ .+++..|+.+++|++|+|+
T Consensus        14 ~~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls   89 (606)
T 3t6q_A           14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLT   89 (606)
T ss_dssp             TTEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECT
T ss_pred             CceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccc-eeChhhccCccccCeeeCC
Confidence            457899999998 67876654  79999999999998755  889999999999999998 5655669999999999999


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI  176 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  176 (851)
                      +|++++..|..|+++++|++|+|++|.+++..+..|+++++|++|++++|++.+..+..+..+++|++|++++|.++ .+
T Consensus        90 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~  168 (606)
T 3t6q_A           90 ANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YL  168 (606)
T ss_dssp             TCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC-EE
T ss_pred             CCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc-cc
Confidence            99999999999999999999999999999777888999999999999999999866566667999999999999998 45


Q ss_pred             chhHhhhccccc--ccccccccccccCCccccccCCCcEEecCCCCC--------------------------ccccCcc
Q 046438          177 SSSIRLALPNLE--LFSLANNNFSGKIPSFIFNASKLSICELPDNSF--------------------------SGFIPNR  228 (851)
Q Consensus       177 ~~~~~~~l~~L~--~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l--------------------------~~~~~~~  228 (851)
                      +...+..+++|+  .|++++|.+++..|..+. ..+|+.|++++|..                          ..+.+..
T Consensus       169 ~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~  247 (606)
T 3t6q_A          169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV  247 (606)
T ss_dssp             CHHHHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGG
T ss_pred             ChhhhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhH
Confidence            555566899999  899999999988777654 46889999888751                          1222344


Q ss_pred             ccCCC--CcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCc
Q 046438          229 FHNMR--NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPK  306 (851)
Q Consensus       229 ~~~l~--~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~  306 (851)
                      |.++.  +|++|++++|.++.++.     ..+..+++|++|++++|++.  .+|..+..+. +|+.|++++|++.+..|.
T Consensus       248 ~~~l~~~~L~~L~l~~n~l~~~~~-----~~~~~l~~L~~L~l~~n~l~--~lp~~l~~l~-~L~~L~l~~n~l~~~~~~  319 (606)
T 3t6q_A          248 FEGLCEMSVESINLQKHYFFNISS-----NTFHCFSGLQELDLTATHLS--ELPSGLVGLS-TLKKLVLSANKFENLCQI  319 (606)
T ss_dssp             GGGGGGSEEEEEECTTCCCSSCCT-----TTTTTCTTCSEEECTTSCCS--CCCSSCCSCT-TCCEEECTTCCCSBGGGG
T ss_pred             hchhhcCceeEEEeecCccCccCH-----HHhccccCCCEEeccCCccC--CCChhhcccc-cCCEEECccCCcCcCchh
Confidence            44443  79999999999988764     34788999999999999996  5788877765 899999999999988899


Q ss_pred             ccccccCCcEEEecCCCCCCCcCc-cccCCCCCcEEEcccccccccc--cccccccCCCCEEEccCcccCCCCCccccCC
Q 046438          307 EMGNLINLIIIRLGYNKLNGSIPS-TLSRLEKLQILGLENNQLEGRI--LDDICRLARLSSVYLDHNKLSGSIPACFGNL  383 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  383 (851)
                      .+..+++|++|++++|.+.+..|. .+..+++|++|++++|.+++..  +..+..+++|+.|++++|++.+..|..|..+
T Consensus       320 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  399 (606)
T 3t6q_A          320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC  399 (606)
T ss_dssp             CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred             hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence            999999999999999999865554 5899999999999999999876  7789999999999999999998889999999


Q ss_pred             ccccceecccCcCccC-c-hhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCccccc---CCcccCCCCCcc
Q 046438          384 ASLRKLSFASNELTFV-P-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGD---IPTTIGGLKNLQ  458 (851)
Q Consensus       384 ~~L~~L~L~~N~l~~~-p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~  458 (851)
                      ++|++|++++|+++.. | ..+..+++|+.|++++|.+.+..|..++.+++|++|++++|++++.   .+..+..+++|+
T Consensus       400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~  479 (606)
T 3t6q_A          400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE  479 (606)
T ss_dssp             TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred             ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence            9999999999999865 3 3488999999999999999988999999999999999999999863   336799999999


Q ss_pred             EEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCC-CcccccCcccccCCc
Q 046438          459 NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG-GTLANFTSESFMGND  537 (851)
Q Consensus       459 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~  537 (851)
                      +|++++|++++..|..|+.+++|++|+|++|++++..|..+..++.| .|++++|++++.+|.. ..+..+..+.+.+||
T Consensus       480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  558 (606)
T 3t6q_A          480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP  558 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred             EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence            99999999998889999999999999999999999999999999999 9999999999887764 457888999999999


Q ss_pred             CccCCC
Q 046438          538 LLCGSP  543 (851)
Q Consensus       538 ~~c~~~  543 (851)
                      +.|+++
T Consensus       559 ~~c~c~  564 (606)
T 3t6q_A          559 LDCTCS  564 (606)
T ss_dssp             EECSGG
T ss_pred             ccccCC
Confidence            999876

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2e-55  Score=533.15  Aligned_cols=488  Identities=24%  Similarity=0.266  Sum_probs=324.8

Q ss_pred             cCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccc-c--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            9 VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF-P--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         9 ~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      +|.   -.++|++|||++|+|++..|..|..+++|++|+|++|...+.+ +  +.++++|++|+|++|.++ .+++..|.
T Consensus        19 vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~-~~~p~~~~   94 (844)
T 3j0a_A           19 VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQ   94 (844)
T ss_dssp             CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCC-EECTTSSC
T ss_pred             CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCc-ccCHhHcc
Confidence            776   3578999999999999888999999999999999999655433 3  788999999999999998 55455688


Q ss_pred             CCcccccccccccccccCCCcc--ccCCCCccEEeccccccccccc-hhhcCcccccEEEccCccccCCCCccccCC--C
Q 046438           86 YLPFVQFLSLAFNQFAGHLPRE--IGNLTSLTSIDLSENHLMGEIP-HEIGNLRNLQALGLLSNNLVGVVPATLFNI--S  160 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l--~  160 (851)
                      .+++|++|+|++|.+++..|..  |+++++|++|+|++|.+++..+ ..|+++++|++|++++|++++..+..+..+  +
T Consensus        95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~  174 (844)
T 3j0a_A           95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK  174 (844)
T ss_dssp             SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHC
T ss_pred             CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCC
Confidence            9999999999999998766654  8999999999999999987654 678999999999999999998888888877  8


Q ss_pred             cCcEEEeeccccccccchhHhhhcc------cccccccccccccccCCcccccc--------------------------
Q 046438          161 TLKILQLTNNTLSGSISSSIRLALP------NLELFSLANNNFSGKIPSFIFNA--------------------------  208 (851)
Q Consensus       161 ~L~~L~L~~n~l~~~~~~~~~~~l~------~L~~L~L~~N~i~~~~~~~~~~~--------------------------  208 (851)
                      +|+.|++++|.+.+..+..+. .++      .|++|++++|.+++..+..+...                          
T Consensus       175 ~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~  253 (844)
T 3j0a_A          175 TLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK  253 (844)
T ss_dssp             SSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSST
T ss_pred             ccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccC
Confidence            899999999998876655432 223      48999999998877666655432                          


Q ss_pred             ------------CCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccC
Q 046438          209 ------------SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD  276 (851)
Q Consensus       209 ------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  276 (851)
                                  ++|+.|+|++|.+.+..+..|..+++|++|+|++|.++....     ..+..+++|++|++++|++..
T Consensus       254 ~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-----~~~~~l~~L~~L~Ls~N~l~~  328 (844)
T 3j0a_A          254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD-----EAFYGLDNLQVLNLSYNLLGE  328 (844)
T ss_dssp             TGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT-----TTTTTCSSCCEEEEESCCCSC
T ss_pred             CCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh-----HHhcCCCCCCEEECCCCCCCc
Confidence                        345555555555555555555555555555555555554321     234455555555555555532


Q ss_pred             CCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccc
Q 046438          277 CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDI  356 (851)
Q Consensus       277 ~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  356 (851)
                       ..|..+..+. +|+.|++++|++.+..+..|..+++|++|++++|.+++.     ..+++|+.|++++|+++.. |.. 
T Consensus       329 -~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~l-~~~-  399 (844)
T 3j0a_A          329 -LYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVTL-PKI-  399 (844)
T ss_dssp             -CCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCCC-CCC-
T ss_pred             -cCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcccc-ccc-
Confidence             1233333332 555555555555555555555555555555555555422     1245555555555555522 211 


Q ss_pred             cccCCCCEEEccCcccCCCC-CccccCCccccceecccCcCccCch--hhcccCcceEEEecCCCCC-----CCCccccc
Q 046438          357 CRLARLSSVYLDHNKLSGSI-PACFGNLASLRKLSFASNELTFVPS--TFWNLTNILMVDLSSNPLS-----GSLPLEIG  428 (851)
Q Consensus       357 ~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~p~--~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~  428 (851)
                        ...++.|++++|++.+.. +..+..+++|+.|+|++|+++.++.  .+..+++|+.|+|++|.++     +..+..|.
T Consensus       400 --~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~  477 (844)
T 3j0a_A          400 --NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE  477 (844)
T ss_dssp             --CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSS
T ss_pred             --ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhc
Confidence              344556666666665432 1223456666666666666665433  2445666666677766665     23344566


Q ss_pred             cchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccce
Q 046438          429 NLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYL  508 (851)
Q Consensus       429 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l  508 (851)
                      ++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..+   ++|+.|
T Consensus       478 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l  552 (844)
T 3j0a_A          478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVL  552 (844)
T ss_dssp             CBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEE
T ss_pred             CcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEE
Confidence            666677777777777666666666677777777777777655555444  567777777777776666554   356666


Q ss_pred             eccCccccccCCCC
Q 046438          509 NVSFNRLEGEIPRG  522 (851)
Q Consensus       509 ~l~~N~l~~~~p~~  522 (851)
                      ++++|+|.|+|+..
T Consensus       553 ~l~~Np~~C~c~~~  566 (844)
T 3j0a_A          553 DITHNKFICECELS  566 (844)
T ss_dssp             EEEEECCCCSSSCC
T ss_pred             EecCCCcccccccH
Confidence            77777777766644

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=5.7e-55  Score=512.48  Aligned_cols=510  Identities=22%  Similarity=0.200  Sum_probs=438.9

Q ss_pred             CCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccc
Q 046438           18 SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSL   95 (851)
Q Consensus        18 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L   95 (851)
                      ..+.++.++++++ .+|..+.  ++|++|+|++|++++..+  +..+++|++||+++|+++ .+++..|.++++|++|+|
T Consensus        12 ~~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~L   87 (606)
T 3vq2_A           12 PNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLIL   87 (606)
T ss_dssp             TTTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CCCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccc-ccCHHHhhchhhcCEeEC
Confidence            3568999999998 6776554  899999999999998765  889999999999999998 666667999999999999


Q ss_pred             cccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccC-CCCccccCCCcCcEEEeecccccc
Q 046438           96 AFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVG-VVPATLFNISTLKILQLTNNTLSG  174 (851)
Q Consensus        96 ~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~  174 (851)
                      ++|.+++..|+.|+++++|++|+|++|.+++..+..|+++++|++|++++|++.+ .+|..+.++++|++|++++|++++
T Consensus        88 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~  167 (606)
T 3vq2_A           88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT  167 (606)
T ss_dssp             TTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred             CCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence            9999998889999999999999999999998777889999999999999999987 469999999999999999999985


Q ss_pred             ccchhHhhhccccc----ccccccccccccCCccccccCCCcEEecCCCCCc-cccCccccCCCCcceEeccCccccCC-
Q 046438          175 SISSSIRLALPNLE----LFSLANNNFSGKIPSFIFNASKLSICELPDNSFS-GFIPNRFHNMRNLKELNLEYNYITSS-  248 (851)
Q Consensus       175 ~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~-  248 (851)
                      ..+ ..+..+++|+    +|++++|.+++..+..+... +|+.|++++|.++ +..+..+.++++|+.+++..+.+... 
T Consensus       168 ~~~-~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~  245 (606)
T 3vq2_A          168 ITV-NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER  245 (606)
T ss_dssp             ECT-TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC
T ss_pred             cCh-hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC
Confidence            444 3444666665    79999999997776666554 8999999999987 45677788888888877744332211 


Q ss_pred             --------------------------CCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCcccc
Q 046438          249 --------------------------NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRG  302 (851)
Q Consensus       249 --------------------------~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~  302 (851)
                                                ..-......+..+++|+.|++++|.+..  +| .+.... +|+.|++++|++ +
T Consensus       246 ~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~--l~-~l~~~~-~L~~L~l~~n~l-~  320 (606)
T 3vq2_A          246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LE-DVPKHF-KWQSLSIIRCQL-K  320 (606)
T ss_dssp             CCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCC--CC-CCCTTC-CCSEEEEESCCC-S
T ss_pred             cccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchh--hh-hccccc-cCCEEEcccccC-c
Confidence                                      0000112236788999999999999954  44 555544 899999999999 5


Q ss_pred             CCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccc--cccccccCCCCEEEccCcccCCCCCccc
Q 046438          303 SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI--LDDICRLARLSSVYLDHNKLSGSIPACF  380 (851)
Q Consensus       303 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~  380 (851)
                      .+| .+ .+++|+.|++++|...+..  .+..+++|++|++++|.+++..  +..+..+++|+.|++++|.+.+ +|..|
T Consensus       321 ~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~  395 (606)
T 3vq2_A          321 QFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANF  395 (606)
T ss_dssp             SCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCC
T ss_pred             ccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhc
Confidence            778 45 9999999999999654333  6779999999999999999763  7888999999999999999985 66889


Q ss_pred             cCCccccceecccCcCccCch--hhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccc-cCCcccCCCCCc
Q 046438          381 GNLASLRKLSFASNELTFVPS--TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG-DIPTTIGGLKNL  457 (851)
Q Consensus       381 ~~l~~L~~L~L~~N~l~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L  457 (851)
                      ..+++|++|++++|+++.++.  .+..+++|+.|++++|++.+..|..++.+++|++|++++|++++ ..|..|+.+++|
T Consensus       396 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  475 (606)
T 3vq2_A          396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL  475 (606)
T ss_dssp             TTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             cCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC
Confidence            999999999999999997754  78899999999999999999899999999999999999999997 479999999999


Q ss_pred             cEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCccc-ccCcccccCC
Q 046438          458 QNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLA-NFTSESFMGN  536 (851)
Q Consensus       458 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~-~l~~~~~~~n  536 (851)
                      +.|+|++|++++..|..++.+++|++|+|++|++++.+|..+..+++|+.|++++|+++..++....++ .+..+.+.+|
T Consensus       476 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N  555 (606)
T 3vq2_A          476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN  555 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSC
T ss_pred             CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCC
Confidence            999999999999899999999999999999999999999999999999999999999995554434454 4888999999


Q ss_pred             cCccCCC
Q 046438          537 DLLCGSP  543 (851)
Q Consensus       537 ~~~c~~~  543 (851)
                      ++.|+++
T Consensus       556 ~~~c~c~  562 (606)
T 3vq2_A          556 SVACICE  562 (606)
T ss_dssp             CCCCSST
T ss_pred             CcccCCc
Confidence            9999887

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=8e-54  Score=519.19  Aligned_cols=499  Identities=22%  Similarity=0.278  Sum_probs=377.1

Q ss_pred             CEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccc
Q 046438           20 QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAF   97 (851)
Q Consensus        20 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~   97 (851)
                      +..|.++++++ .+|.   -.++|++|||++|++++..+  +..+++|++|||++|...+.+++..|+.+++|++|+|++
T Consensus         7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            46788999998 5776   56899999999999998654  889999999999999777788778899999999999999


Q ss_pred             cccccCCCccccCCCCccEEeccccccccccchh--hcCcccccEEEccCccccCCCC-ccccCCCcCcEEEeecccccc
Q 046438           98 NQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHE--IGNLRNLQALGLLSNNLVGVVP-ATLFNISTLKILQLTNNTLSG  174 (851)
Q Consensus        98 N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~  174 (851)
                      |.|++..|+.|+++++|++|+|++|.+++.+|..  |+++++|++|+|++|++.+..+ ..|.++++|++|+|++|.+++
T Consensus        83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A           83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            9999999999999999999999999999766665  9999999999999999988765 578999999999999999986


Q ss_pred             ccchhHhhhc--ccccccccccccccccCCccccccCC------CcEEecCCCCCccccCccccCC--------------
Q 046438          175 SISSSIRLAL--PNLELFSLANNNFSGKIPSFIFNASK------LSICELPDNSFSGFIPNRFHNM--------------  232 (851)
Q Consensus       175 ~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~~~~------L~~L~L~~n~l~~~~~~~~~~l--------------  232 (851)
                      ..+..+. .+  ++|+.|++++|.+.+..|..+..+.+      |+.|++++|.+++..+..+...              
T Consensus       163 ~~~~~l~-~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~  241 (844)
T 3j0a_A          163 VCEHELE-PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH  241 (844)
T ss_dssp             CCSGGGH-HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred             eCHHHcc-cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence            6665543 55  89999999999999988887766655      9999999998887666555432              


Q ss_pred             ------------------------CCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccc
Q 046438          233 ------------------------RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL  288 (851)
Q Consensus       233 ------------------------~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~  288 (851)
                                              ++|++|+|++|.+.....     ..+..+++|+.|++++|++.. ..|..+..+. 
T Consensus       242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~-----~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~-  314 (844)
T 3j0a_A          242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----RVFETLKDLKVLNLAYNKINK-IADEAFYGLD-  314 (844)
T ss_dssp             CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS-----CCSSSCCCCCEEEEESCCCCE-ECTTTTTTCS-
T ss_pred             cccccccccccCCCChhhhhccccCCccEEECCCCcccccCh-----hhhhcCCCCCEEECCCCcCCC-CChHHhcCCC-
Confidence                                    345555555555543321     224445555555555555432 1122333322 


Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      +|+.|++++|++++..|..+..+++|+.|++++|.+.+..+..|..+++|++|+|++|.+++.     ..+++|+.|+++
T Consensus       315 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~  389 (844)
T 3j0a_A          315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLS  389 (844)
T ss_dssp             SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEE
T ss_pred             CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccC
Confidence            455555555555544455555555555555555555544444555555555555555555422     114455555555


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCch--hhcccCcceEEEecCCCCCCCCcc-ccccchhhhhhhccCCccc-
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPS--TFWNLTNILMVDLSSNPLSGSLPL-EIGNLKVLVELYLSRNNLS-  444 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-  444 (851)
                      +|++. .+|..   ..+++.|++++|+++.++.  .+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ 
T Consensus       390 ~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~  465 (844)
T 3j0a_A          390 GNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL  465 (844)
T ss_dssp             SCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSS
T ss_pred             CCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccc
Confidence            55554 22222   3456666667776665543  356899999999999999865443 4567899999999999997 


Q ss_pred             ----ccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          445 ----GDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       445 ----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                          +..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|+|++|++++.+|
T Consensus       466 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~  543 (844)
T 3j0a_A          466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNP  543 (844)
T ss_dssp             SCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCS
T ss_pred             ccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCCh
Confidence                34456789999999999999999998999999999999999999999987777776  899999999999999988


Q ss_pred             CCCcccccCcccccCCcCccCCC
Q 046438          521 RGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       521 ~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ..  +..+..+++.+||+.|+++
T Consensus       544 ~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          544 DV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             CC--CSSCCEEEEEEECCCCSSS
T ss_pred             hH--hCCcCEEEecCCCcccccc
Confidence            54  6788899999999999775

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-52  Score=484.83  Aligned_cols=515  Identities=23%  Similarity=0.285  Sum_probs=418.1

Q ss_pred             ccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            8 TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         8 ~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      ++|..+.  +++++|+|++|++++..+.+|..+++|++|+|++|++++..+  +..+++|++|+|++|+++ .+++..|.
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~   97 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFS   97 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC-ccCHhhhc
Confidence            4676653  578899999999988778888889999999999998887654  778889999999999887 66666788


Q ss_pred             CCcccccccccccccccCCCccccCCCCccEEecccccccc-ccchhhcCcccccEEEccCccccCCCCccccCCCcC--
Q 046438           86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL--  162 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--  162 (851)
                      ++++|++|+|++|.+++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..+..+++|  
T Consensus        98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  177 (570)
T 2z63_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  177 (570)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTT
T ss_pred             CccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccch
Confidence            88999999999998887666678888899999999998886 368888888999999999898888777788877777  


Q ss_pred             --cEEEeeccccccccchhHhhhcccccccccccccccc-cCCccccccCCCcEEecCCC------CCccccCccccCCC
Q 046438          163 --KILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSG-KIPSFIFNASKLSICELPDN------SFSGFIPNRFHNMR  233 (851)
Q Consensus       163 --~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L~L~~n------~l~~~~~~~~~~l~  233 (851)
                        +.|++++|.+++..+ ..+... +|+.|++++|.... ..+..+..++.++.+.+.-.      .+..+....|.+++
T Consensus       178 ~~~~L~l~~n~l~~~~~-~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~  255 (570)
T 2z63_A          178 LNLSLDLSLNPMNFIQP-GAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC  255 (570)
T ss_dssp             CCCEEECTTCCCCEECT-TTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGG
T ss_pred             hhhhcccCCCCceecCH-HHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccc
Confidence              788888888884443 344333 78888888875432 23445556666666554322      23334444555554


Q ss_pred             C--cceEeccCc-cccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCccccc
Q 046438          234 N--LKELNLEYN-YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGN  310 (851)
Q Consensus       234 ~--L~~L~L~~N-~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~  310 (851)
                      +  ++.+++++| .+....     ...+..+++|++|++++|.+.  .+|..+...  +|+.|++++|++. .+|.  ..
T Consensus       256 ~l~l~~l~l~~~~~~~~~~-----~~~~~~l~~L~~L~l~~~~l~--~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~  323 (570)
T 2z63_A          256 NLTIEEFRLAYLDYYLDDI-----IDLFNCLTNVSSFSLVSVTIE--RVKDFSYNF--GWQHLELVNCKFG-QFPT--LK  323 (570)
T ss_dssp             GSEEEEEEEEETTEEESCS-----TTTTGGGTTCSEEEEESCEEC--SCCBCCSCC--CCSEEEEESCBCS-SCCB--CB
T ss_pred             ccchhhhhhhcchhhhhhc-----hhhhcCcCcccEEEecCccch--hhhhhhccC--CccEEeeccCccc-ccCc--cc
Confidence            3  456677666 444322     345778899999999999985  478777776  8999999999998 5555  57


Q ss_pred             ccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccc--cccccccCCCCEEEccCcccCCCCCccccCCccccc
Q 046438          311 LINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI--LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK  388 (851)
Q Consensus       311 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  388 (851)
                      +++|+.|++++|.+.+..+.  ..+++|++|++++|.+++..  +..+..+++|+.|++++|++.+..+. +..+++|++
T Consensus       324 l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~  400 (570)
T 2z63_A          324 LKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEH  400 (570)
T ss_dssp             CSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCE
T ss_pred             ccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCE
Confidence            89999999999998866554  78999999999999998765  67888999999999999999965544 999999999


Q ss_pred             eecccCcCccCch--hhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCccc-ccCCcccCCCCCccEEEccCc
Q 046438          389 LSFASNELTFVPS--TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLS-GDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       389 L~L~~N~l~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      |++++|+++..+.  .+..+++|++|++++|.+.+..|..+.++++|++|++++|+++ +.+|..|..+++|+.|++++|
T Consensus       401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n  480 (570)
T 2z63_A          401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC  480 (570)
T ss_dssp             EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence            9999999997643  6889999999999999999889999999999999999999998 578999999999999999999


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcc-cccCc--ccccCCcCccCC
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTL-ANFTS--ESFMGNDLLCGS  542 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~-~~l~~--~~~~~n~~~c~~  542 (851)
                      ++++..|..|..+++|++|+|++|++++.+|..+..+++|+.|++++|+|+|.||....+ .++..  ..+.+.+ .|..
T Consensus       481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~  559 (570)
T 2z63_A          481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSG  559 (570)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTT
T ss_pred             ccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCC
Confidence            999888999999999999999999999988888999999999999999999999987655 33333  2344554 7766


Q ss_pred             C
Q 046438          543 P  543 (851)
Q Consensus       543 ~  543 (851)
                      |
T Consensus       560 ~  560 (570)
T 2z63_A          560 S  560 (570)
T ss_dssp             T
T ss_pred             C
Confidence            5

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.2e-51  Score=478.41  Aligned_cols=483  Identities=20%  Similarity=0.240  Sum_probs=376.3

Q ss_pred             ccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            8 TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         8 ~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      ++|+.+.  ++|++|+|++|++++..|.++..+++|++|+|++|++++..+  +..+++|++|||++|+++ .+++..|+
T Consensus        19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~   95 (549)
T 2z81_A           19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFG   95 (549)
T ss_dssp             SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-SCCHHHHT
T ss_pred             cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccC-ccCHHHhc
Confidence            5888775  789999999999998888999999999999999999998765  889999999999999998 67777789


Q ss_pred             CCccccccccccccccc-CCCccccCCCCccEEecccccccccc-chhhcCcccccEEEccCccccCCCCccccCCCcCc
Q 046438           86 YLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSENHLMGEI-PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLK  163 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~-~~~~~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  163 (851)
                      .+++|++|+|++|.+++ ..|..++++++|++|++++|.+.+.+ +..|+++++|++|++++|++.+..|..+..+++|+
T Consensus        96 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  175 (549)
T 2z81_A           96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH  175 (549)
T ss_dssp             TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEE
T ss_pred             cCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCc
Confidence            99999999999999986 35678999999999999999844444 46899999999999999999988999999999999


Q ss_pred             EEEeeccccccccchhHhhhcccccccccccccccccC---CccccccCCCcEEecCCCCCccccCc----cccCCCCcc
Q 046438          164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKI---PSFIFNASKLSICELPDNSFSGFIPN----RFHNMRNLK  236 (851)
Q Consensus       164 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~~~~L~~L~L~~n~l~~~~~~----~~~~l~~L~  236 (851)
                      +|+++.|.+. .++..++..+++|++|++++|++++..   ......+++|+.|++++|.+++..+.    .+..+++|+
T Consensus       176 ~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~  254 (549)
T 2z81_A          176 HLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS  254 (549)
T ss_dssp             EEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCC
T ss_pred             eEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccc
Confidence            9999999886 666666667899999999999988642   12233467888888888887764433    345667788


Q ss_pred             eEeccCccccCCCCcc-hhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCc
Q 046438          237 ELNLEYNYITSSNHEL-SFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLI  315 (851)
Q Consensus       237 ~L~L~~N~i~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~  315 (851)
                      .|++++|.+...+... .....+..+++|+.|++.++.+.....                     ...++..+....+|+
T Consensus       255 ~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~---------------------~~~l~~~~~~~~~L~  313 (549)
T 2z81_A          255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL---------------------FYDLSTVYSLLEKVK  313 (549)
T ss_dssp             EEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG---------------------SCCCCHHHHHSTTCC
T ss_pred             ccccccccccccccccccchhhhhhhcccccccccccccchhhh---------------------cccchhhhhhcccce
Confidence            8888888776543210 011223445555556555554421100                     001222334456778


Q ss_pred             EEEecCCCCCCCcCccc-cCCCCCcEEEcccccccccccc---cccccCCCCEEEccCcccCCCCC--ccccCCccccce
Q 046438          316 IIRLGYNKLNGSIPSTL-SRLEKLQILGLENNQLEGRILD---DICRLARLSSVYLDHNKLSGSIP--ACFGNLASLRKL  389 (851)
Q Consensus       316 ~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L  389 (851)
                      .|++++|.+. .+|..+ ..+++|++|++++|++++..+.   .+..+++|+.|++++|++++..+  ..+..+++|++|
T Consensus       314 ~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L  392 (549)
T 2z81_A          314 RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL  392 (549)
T ss_dssp             EEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEE
T ss_pred             EEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEE
Confidence            8888888876 455544 5678888888888888765543   36677888888888888875432  457788888888


Q ss_pred             ecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCC
Q 046438          390 SFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG  469 (851)
Q Consensus       390 ~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  469 (851)
                      ++++|+++.+|..+..+++|++|++++|+++ .+|..+  .++|++|++++|++++.    +..+++|++|+|++|+|+ 
T Consensus       393 ~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-  464 (549)
T 2z81_A          393 DISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-  464 (549)
T ss_dssp             ECTTCCCCCCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-
T ss_pred             ECCCCCCccCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhh----cccCChhcEEECCCCccC-
Confidence            8888888888888888888889999988887 444443  25889999999999853    257899999999999998 


Q ss_pred             CCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcc
Q 046438          470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTL  525 (851)
Q Consensus       470 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~  525 (851)
                      .+|. ...+++|++|+|++|++++.+|..+..+++|+.|++++|+|+|.||...++
T Consensus       465 ~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l  519 (549)
T 2z81_A          465 TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL  519 (549)
T ss_dssp             SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHH
T ss_pred             cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHH
Confidence            6776 567999999999999999999999999999999999999999999965444

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.1e-51  Score=483.87  Aligned_cols=470  Identities=18%  Similarity=0.203  Sum_probs=286.0

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccc------------ccCCCCCCCcEEeCCCCCCCCCCCcchh
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGS------------FPFFNMSSLQVIDLSDNRLSGELPANIF   84 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~------------~~~~~~~~L~~L~Ls~n~l~~~~~~~~~   84 (851)
                      .+++.|+|++|+++|.+|.+++.+++|++|+|++|.+...            .|...+..|+ +++++|.+.+.+|..+.
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~  159 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFS  159 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSC
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHH
Confidence            4799999999999999999999999999999999987311            1111144566 77777777766665543


Q ss_pred             cCCccccccccc--------------------ccccccCCCccccCCCCccEEeccccccccc-----------------
Q 046438           85 SYLPFVQFLSLA--------------------FNQFAGHLPREIGNLTSLTSIDLSENHLMGE-----------------  127 (851)
Q Consensus        85 ~~l~~L~~L~L~--------------------~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~-----------------  127 (851)
                      ..+..+..+++.                    +|++++ +|..|+++++|++|+|++|.+++.                 
T Consensus       160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~  238 (636)
T 4eco_A          160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY  238 (636)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence            333333343433                    567776 677777788888888888877764                 


Q ss_pred             cchhhc--CcccccEEEccCccccCCCCccccCCCcCcEEEeeccc-ccc-ccchhHhh-----hccccccccccccccc
Q 046438          128 IPHEIG--NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT-LSG-SISSSIRL-----ALPNLELFSLANNNFS  198 (851)
Q Consensus       128 ~~~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~-----~l~~L~~L~L~~N~i~  198 (851)
                      +|..++  ++++|++|++++|++.+.+|..+.++++|++|++++|+ +++ .+|..+..     .+++|++|++++|+++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            777777  77777777777777777777777777777777777777 776 56655542     1266667777666666


Q ss_pred             ccCCc--cccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccC
Q 046438          199 GKIPS--FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD  276 (851)
Q Consensus       199 ~~~~~--~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  276 (851)
                       .+|.  .+.++++|+.|++++|.+++.+| .|..+++|++|+|++|+++.++.      .+..+++             
T Consensus       319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~------~l~~l~~-------------  377 (636)
T 4eco_A          319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA------NFCGFTE-------------  377 (636)
T ss_dssp             -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCT------TSEEECT-------------
T ss_pred             -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccH------hhhhhcc-------------
Confidence             5555  56666666666666666665555 55556666666666665553221      1223333             


Q ss_pred             CCCCCccccccccccEEEeecCccccCCCccccccc--CCcEEEecCCCCCCCcCcccc-------CCCCCcEEEccccc
Q 046438          277 CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI--NLIIIRLGYNKLNGSIPSTLS-------RLEKLQILGLENNQ  347 (851)
Q Consensus       277 ~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~n~  347 (851)
                                  +|+.|++++|+++ .+|..+..++  +|++|++++|.+.+..|..+.       .+++|++|++++|.
T Consensus       378 ------------~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~  444 (636)
T 4eco_A          378 ------------QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ  444 (636)
T ss_dssp             ------------TCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSC
T ss_pred             ------------cCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCc
Confidence                        1333333333333 3344444332  566666666666666666555       45555566666555


Q ss_pred             ccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCcccc
Q 046438          348 LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI  427 (851)
Q Consensus       348 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  427 (851)
                      +++..+..+..+++|+.|+|++|+++...+..+....                ..+.++++|+.|+|++|+++ .+|..+
T Consensus       445 l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~----------------~~~~~l~~L~~L~Ls~N~l~-~lp~~~  507 (636)
T 4eco_A          445 ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN----------------ENFKNTYLLTSIDLRFNKLT-KLSDDF  507 (636)
T ss_dssp             CCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETT----------------EECTTGGGCCEEECCSSCCC-BCCGGG
T ss_pred             cCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccc----------------ccccccCCccEEECcCCcCC-ccChhh
Confidence            5533333334455555555555555522222222111                00011125555555555555 444444


Q ss_pred             c--cchhhhhhhccCCcccccCCcccCCCCCccEEEc------cCcccCCCCcccccCCCCCCEEECCCCcccccCCccc
Q 046438          428 G--NLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSL------GDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSL  499 (851)
Q Consensus       428 ~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  499 (851)
                      .  .+++|++|+|++|++++ +|..+..+++|+.|+|      ++|++.+.+|..++.+++|++|+|++|+++ .+|..+
T Consensus       508 ~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~  585 (636)
T 4eco_A          508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI  585 (636)
T ss_dssp             STTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCC
T ss_pred             hhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhH
Confidence            4  55555555555555554 5555555555555555      567778888888888888888888888884 677766


Q ss_pred             cccccccceeccCccccccCCCCC---cccccCcccccCCcCccCCC
Q 046438          500 EKLLYLKYLNVSFNRLEGEIPRGG---TLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       500 ~~l~~L~~l~l~~N~l~~~~p~~~---~~~~l~~~~~~~n~~~c~~~  543 (851)
                      .  ++|+.|++++|++.+.-+...   .........+......||+|
T Consensus       586 ~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~C~  630 (636)
T 4eco_A          586 T--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCD  630 (636)
T ss_dssp             C--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEECCTTSEEESCG
T ss_pred             h--CcCCEEECcCCCCccccHHhcchhhhcccceeecCCccccCCCc
Confidence            5  788888888888876443221   11222233344444555655

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=465.80  Aligned_cols=510  Identities=21%  Similarity=0.231  Sum_probs=426.5

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      .+..+.++.+++ .+|..+.  +++++|+|++|++++..+  +..+++|++|||++|+++ .+++..|+.+++|++|+|+
T Consensus         9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~   84 (570)
T 2z63_A            9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT   84 (570)
T ss_dssp             TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECT
T ss_pred             CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCc
Confidence            466788888887 6776553  579999999999997654  789999999999999998 6777779999999999999


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCC-CCccccCCCcCcEEEeeccccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGV-VPATLFNISTLKILQLTNNTLSGS  175 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~  175 (851)
                      +|++++..|..|+++++|++|++++|.+++..+..|+++++|++|++++|.+.+. .|..+.++++|++|++++|++++ 
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~-  163 (570)
T 2z63_A           85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-  163 (570)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE-
T ss_pred             CCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce-
Confidence            9999988889999999999999999999866666799999999999999999874 68899999999999999999984 


Q ss_pred             cchhHhhhcccc----cccccccccccccCCccccccCCCcEEecCCCCCcc-ccCccccCCCCcceEeccCccccCCCC
Q 046438          176 ISSSIRLALPNL----ELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG-FIPNRFHNMRNLKELNLEYNYITSSNH  250 (851)
Q Consensus       176 ~~~~~~~~l~~L----~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~  250 (851)
                      ++...+..+++|    +.|++++|.+++..+..+... +|+.|++++|.... ..+..+.++++++.+.+..+.+.....
T Consensus       164 ~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~  242 (570)
T 2z63_A          164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN  242 (570)
T ss_dssp             ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred             ecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchh
Confidence            444445577888    889999999998877777655 79999998885432 334566777777777665443322110


Q ss_pred             ----cchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCC
Q 046438          251 ----ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG  326 (851)
Q Consensus       251 ----~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~  326 (851)
                          ....+..+..+ .++.++++++.-.....|..+..+. +|+.|++++|++. .+|..+..+ +|+.|++++|.+. 
T Consensus       243 l~~~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-  317 (570)
T 2z63_A          243 LEKFDKSALEGLCNL-TIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-  317 (570)
T ss_dssp             CEECCTTTTGGGGGS-EEEEEEEEETTEEESCSTTTTGGGT-TCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-
T ss_pred             hhhcchhhhcccccc-chhhhhhhcchhhhhhchhhhcCcC-cccEEEecCccch-hhhhhhccC-CccEEeeccCccc-
Confidence                00111222222 3677888877333345666666654 8999999999998 688889888 9999999999998 


Q ss_pred             CcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCC--CccccCCccccceecccCcCccCchhhc
Q 046438          327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSI--PACFGNLASLRKLSFASNELTFVPSTFW  404 (851)
Q Consensus       327 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~p~~~~  404 (851)
                      .+|.  ..+++|++|++++|.+.+..+.  ..+++|+.|++++|++++..  +..+..+++|++|++++|+++.+|..+.
T Consensus       318 ~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~  393 (570)
T 2z63_A          318 QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL  393 (570)
T ss_dssp             SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEE
T ss_pred             ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccccc
Confidence            4554  4789999999999999876554  78999999999999998654  6788999999999999999999988899


Q ss_pred             ccCcceEEEecCCCCCCCCc-cccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccC-CCCcccccCCCCCC
Q 046438          405 NLTNILMVDLSSNPLSGSLP-LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ-GSIPNSIGDLISLE  482 (851)
Q Consensus       405 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~  482 (851)
                      .+++|+.|++++|.+.+..| ..+..+++|++|++++|++++..|..|.++++|+.|++++|+++ +.+|..+..+++|+
T Consensus       394 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~  473 (570)
T 2z63_A          394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT  473 (570)
T ss_dssp             TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred             ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence            99999999999999997766 57899999999999999999889999999999999999999997 57899999999999


Q ss_pred             EEECCCCcccccCCccccccccccceeccCccccccCCCC-CcccccCcccccCCcCccCCC
Q 046438          483 CLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG-GTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       483 ~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      +|+|++|++++..|..+..+++|+.|++++|++++.+|.. ..+..+..+.+.+|++.|.+|
T Consensus       474 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            9999999999988999999999999999999999987754 567889999999999999877

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=463.09  Aligned_cols=459  Identities=20%  Similarity=0.227  Sum_probs=329.4

Q ss_pred             CCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEE
Q 046438           63 SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALG  142 (851)
Q Consensus        63 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  142 (851)
                      ++|++|||++|+++ .+++..|..+++|++|+|++|+|++..|+.|+++++|++|+|++|+++ .+|..  .+++|++|+
T Consensus        21 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~   96 (520)
T 2z7x_B           21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD   96 (520)
T ss_dssp             TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred             ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence            44444444444444 344344555555555555555555555556666666666666666665 34433  566666666


Q ss_pred             ccCccccCC-CCccccCCCcCcEEEeeccccccccchhHhhhcccc--cccccccccc--cccCCccccccC-CCcEEec
Q 046438          143 LLSNNLVGV-VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL--ELFSLANNNF--SGKIPSFIFNAS-KLSICEL  216 (851)
Q Consensus       143 L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~~~-~L~~L~L  216 (851)
                      +++|++++. .|..|.++++|++|++++|.+++    ..+..+++|  ++|++++|.+  ++..|..+..+. +...+++
T Consensus        97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l  172 (520)
T 2z7x_B           97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF  172 (520)
T ss_dssp             CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred             ccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence            666666552 45566666666666666666553    123345555  6666666666  555555555543 3345667


Q ss_pred             CCCCCcccc-CccccCCCCcceEeccCcc-------ccCCCCcchhhhhccccccccEEeccCCCccCCCCCCcccc-cc
Q 046438          217 PDNSFSGFI-PNRFHNMRNLKELNLEYNY-------ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGN-LS  287 (851)
Q Consensus       217 ~~n~l~~~~-~~~~~~l~~L~~L~L~~N~-------i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~-~~  287 (851)
                      ++|.+.+.. +..+..+++|+.|++++|.       +.      ..+..+..+++|+.|++++|.+....+...... ..
T Consensus       173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~------~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~  246 (520)
T 2z7x_B          173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL------SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH  246 (520)
T ss_dssp             CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH------HHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHT
T ss_pred             ccCcchhhhhhhhhhcccceeeccccccccccccceee------cchhhhccccchhhccccccccCHHHHHHHHHHhhh
Confidence            777765543 3467778888888888875       22      123457778888888888887653221111111 11


Q ss_pred             ccccEEEeecCccccCCCccc-----ccccCCcEEEecCCCCCCCcC-ccccCC---CCCcEEEcccccccccccccccc
Q 046438          288 LSMERFYLHNCNIRGSIPKEM-----GNLINLIIIRLGYNKLNGSIP-STLSRL---EKLQILGLENNQLEGRILDDICR  358 (851)
Q Consensus       288 ~~L~~L~L~~n~i~~~~p~~l-----~~l~~L~~L~L~~n~l~~~~~-~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~  358 (851)
                      .+|+.|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..+   ++|+.|++++|.+.+..  .+..
T Consensus       247 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~  322 (520)
T 2z7x_B          247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSK  322 (520)
T ss_dssp             SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSS
T ss_pred             CcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhh
Confidence            379999999999999999998     9999999999999999  444 555554   78999999999987543  1268


Q ss_pred             cCCCCEEEccCcccCCCCCccccCCccccceecccCcCcc---CchhhcccCcceEEEecCCCCCCCCcc-ccccchhhh
Q 046438          359 LARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF---VPSTFWNLTNILMVDLSSNPLSGSLPL-EIGNLKVLV  434 (851)
Q Consensus       359 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~  434 (851)
                      +++|++|++++|++++..|..+..+++|++|++++|+++.   +|..+..+++|++|++++|++++.+|. .+..+++|+
T Consensus       323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~  402 (520)
T 2z7x_B          323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL  402 (520)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred             CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence            8999999999999999899999999999999999999995   456789999999999999999985665 488999999


Q ss_pred             hhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcc-ccccccccceeccCc
Q 046438          435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSS-LEKLLYLKYLNVSFN  513 (851)
Q Consensus       435 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~l~l~~N  513 (851)
                      +|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++ +|.. +..+++|+.|++++|
T Consensus       403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N  478 (520)
T 2z7x_B          403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTN  478 (520)
T ss_dssp             EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCC
Confidence            999999999988887765  79999999999999 888888899999999999999995 5554 999999999999999


Q ss_pred             cccccCCCCCc-ccccCccc-ccCCcCccCCC
Q 046438          514 RLEGEIPRGGT-LANFTSES-FMGNDLLCGSP  543 (851)
Q Consensus       514 ~l~~~~p~~~~-~~~l~~~~-~~~n~~~c~~~  543 (851)
                      +|+|+|+.... ..++.... .......|+.|
T Consensus       479 ~~~c~c~~~~~~~~~~~~~~~~~~~~~~C~~p  510 (520)
T 2z7x_B          479 PWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGS  510 (520)
T ss_dssp             CBCCCHHHHHHHHHHHHHTTTTEESCCBBTTT
T ss_pred             CCcccCCchHHHHHHHHhccccCCCCCCcCCc
Confidence            99999985433 12222111 13344577766

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.9e-49  Score=458.36  Aligned_cols=484  Identities=20%  Similarity=0.232  Sum_probs=327.2

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccc
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLS   94 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~   94 (851)
                      +.....|.++|+++ .+|..+.  ++|++|+|++|++++..+  +..+++|++|++++|+++ .+++..|..+++|++|+
T Consensus         5 ~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             CTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEE
T ss_pred             CCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC-ccChhhccccccCCEEE
Confidence            34445677777777 5665443  677777777777776543  566666666666666666 44444456666666666


Q ss_pred             ccccccccCCCccccCCCCccEEecccccccc-ccchhhcCcccccEEEccCccc-cCCCCccccCCCcCcEEEeecccc
Q 046438           95 LAFNQFAGHLPREIGNLTSLTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNL-VGVVPATLFNISTLKILQLTNNTL  172 (851)
Q Consensus        95 L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l-~~~~~~~l~~l~~L~~L~L~~n~l  172 (851)
                      |++|++++..|..|+++++|++|+|++|.+++ ..|..|+++++|++|++++|++ ....+..+.++++|++|++++|.+
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            66666665555556666666666666666654 2345566666666666666652 323334555666666666666666


Q ss_pred             ccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCcccc---CccccCCCCcceEeccCccccCCC
Q 046438          173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFI---PNRFHNMRNLKELNLEYNYITSSN  249 (851)
Q Consensus       173 ~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~L~~N~i~~~~  249 (851)
                      ++..+..+ ..+++|++|+++.|.+.......+..+++|+.|++++|++++..   ......+++|+.|++++|.+++..
T Consensus       161 ~~~~~~~l-~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  239 (549)
T 2z81_A          161 RNYQSQSL-KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES  239 (549)
T ss_dssp             CEECTTTT-TTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred             cccChhhh-hccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence            54444332 24555555665555554322222234555555555555555431   112223445555555555544311


Q ss_pred             CcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccC------CCcccccccCCcEEEecCCC
Q 046438          250 HELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS------IPKEMGNLINLIIIRLGYNK  323 (851)
Q Consensus       250 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~------~p~~l~~l~~L~~L~L~~n~  323 (851)
                      .. .....+..+++                          ++.+++++|.+.+.      ....+..+.+|+.|++.++.
T Consensus       240 ~~-~l~~~~~~~~~--------------------------L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~  292 (549)
T 2z81_A          240 FN-ELLKLLRYILE--------------------------LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH  292 (549)
T ss_dssp             HH-HHHGGGGGCTT--------------------------CCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCB
T ss_pred             HH-HHHHHhhhhcc--------------------------ccccccccccccccccccccchhhhhhhcccccccccccc
Confidence            10 11112233344                          45555555554432      12345667888899998887


Q ss_pred             CCCC-----cCccccCCCCCcEEEcccccccccccccc-cccCCCCEEEccCcccCCCCC---ccccCCccccceecccC
Q 046438          324 LNGS-----IPSTLSRLEKLQILGLENNQLEGRILDDI-CRLARLSSVYLDHNKLSGSIP---ACFGNLASLRKLSFASN  394 (851)
Q Consensus       324 l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N  394 (851)
                      +...     .+..+...++|++|++++|.++. +|..+ ..+++|+.|++++|++.+..|   ..++.+++|++|++++|
T Consensus       293 i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N  371 (549)
T 2z81_A          293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN  371 (549)
T ss_dssp             CSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTS
T ss_pred             cchhhhcccchhhhhhcccceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCC
Confidence            7532     12223446789999999999985 45444 689999999999999987654   34788999999999999


Q ss_pred             cCccCc---hhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCC
Q 046438          395 ELTFVP---STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI  471 (851)
Q Consensus       395 ~l~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  471 (851)
                      +++.++   ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+.  ++|++|+|++|+|++.+
T Consensus       372 ~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~  447 (549)
T 2z81_A          372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS  447 (549)
T ss_dssp             CCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC
T ss_pred             cccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc
Confidence            999886   35889999999999999999 78889999999999999999998 4555442  68999999999999643


Q ss_pred             cccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCC-CCcccccCcccccCCcCccCCC
Q 046438          472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR-GGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       472 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                          ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|. ...+..+..+.+.+|++.|++|
T Consensus       448 ----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          448 ----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             ----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             ----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence                57899999999999999 6776 56899999999999999998876 3567888999999999999876

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.9e-48  Score=458.75  Aligned_cols=516  Identities=22%  Similarity=0.231  Sum_probs=392.2

Q ss_pred             ccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            8 TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         8 ~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      ++|+.+-  +++++|||++|+|+++.|.+|.++++|++|+|++|+|+++.+  |..+++|++|+|++|+|+ .+|...|.
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~  121 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFS  121 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhc
Confidence            4676663  478999999999987777889999999999999999987665  788999999999999998 78888889


Q ss_pred             CCcccccccccccccccCCCccccCCCCccEEecccccccc-ccchhhcCcccccEEEccCccccCCCCccccCCCcC--
Q 046438           86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMG-EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL--  162 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--  162 (851)
                      ++++|++|+|++|++++..+..|+++++|++|+|++|.+++ ..|..++.+++|++|++++|++++..+..+..+.++  
T Consensus       122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~  201 (635)
T 4g8a_A          122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  201 (635)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred             CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhh
Confidence            99999999999999988777788999999999999999875 357888889999999999999988877777655443  


Q ss_pred             --cEEEeeccccccccchhHhhhcccccccccccccccc-cCCccccccCCCcEE-------------------------
Q 046438          163 --KILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSG-KIPSFIFNASKLSIC-------------------------  214 (851)
Q Consensus       163 --~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L-------------------------  214 (851)
                        ..++++.|.++ .++...+ ....++.+++.+|.... ..+..+..+..++..                         
T Consensus       202 ~~~~~~ls~n~l~-~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~  279 (635)
T 4g8a_A          202 LNLSLDLSLNPMN-FIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC  279 (635)
T ss_dssp             CCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGG
T ss_pred             hhhhhhcccCccc-ccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccccccc
Confidence              36777777776 3333333 23345556666554331 112222333333332                         


Q ss_pred             -----ecCCCCCc---cccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccc
Q 046438          215 -----ELPDNSFS---GFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNL  286 (851)
Q Consensus       215 -----~L~~n~l~---~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~  286 (851)
                           .+..+...   ......+..+.+++.+++.+|.+...       ..+.....|+.|++++|.+....  .   ..
T Consensus       280 ~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~-------~~~~~~~~L~~L~l~~~~~~~~~--~---~~  347 (635)
T 4g8a_A          280 NLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV-------KDFSYNFGWQHLELVNCKFGQFP--T---LK  347 (635)
T ss_dssp             GSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC-------GGGGSCCCCSEEEEESCEESSCC--C---CB
T ss_pred             chhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc-------cccccchhhhhhhcccccccCcC--c---cc
Confidence                 22222111   11223445566777777777766643       23455677888888888774322  1   12


Q ss_pred             cccccEEEeecCccccCCCcccccccCCcEEEecCCCCCC--CcCccccCCCCCcEEEcccccccccccccccccCCCCE
Q 046438          287 SLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG--SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS  364 (851)
Q Consensus       287 ~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  364 (851)
                      ...++.+++.+|.+...  .....+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.
T Consensus       348 l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~  424 (635)
T 4g8a_A          348 LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEH  424 (635)
T ss_dssp             CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCE
T ss_pred             chhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccc
Confidence            23678888888887643  345678999999999998853  345567788899999999998874 4567788999999


Q ss_pred             EEccCcccCCCC-CccccCCccccceecccCcCccC-chhhcccCcceEEEecCCCCC-CCCccccccchhhhhhhccCC
Q 046438          365 VYLDHNKLSGSI-PACFGNLASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLS-GSLPLEIGNLKVLVELYLSRN  441 (851)
Q Consensus       365 L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N  441 (851)
                      ++++.|...... +..|..+++++.++++.|.+..+ +..+..+++|+.|+|++|.+. +..|..|..+++|++|+|++|
T Consensus       425 l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N  504 (635)
T 4g8a_A          425 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC  504 (635)
T ss_dssp             EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             hhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCC
Confidence            999988776544 45788899999999999999865 556788999999999999854 457889999999999999999


Q ss_pred             cccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccccc-ccccceeccCccccccCC
Q 046438          442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL-LYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       442 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~l~l~~N~l~~~~p  520 (851)
                      +|++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|++..|..+..+ ++|+.|+|++|||+|+|.
T Consensus       505 ~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          505 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             ccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            9998889999999999999999999998889999999999999999999999999999988 689999999999999997


Q ss_pred             CCCcccccCcc---cccCCcCccCCC
Q 046438          521 RGGTLANFTSE---SFMGNDLLCGSP  543 (851)
Q Consensus       521 ~~~~~~~l~~~---~~~~n~~~c~~~  543 (851)
                      ..+...++...   ........|..|
T Consensus       585 ~~~~~~wl~~~~~~~~~~~~~~C~~P  610 (635)
T 4g8a_A          585 HQSFLQWIKDQRQLLVEVERMECATP  610 (635)
T ss_dssp             GHHHHHHHHHTTTTBSCGGGCBBCSS
T ss_pred             cHHHHHHHHhCCCccCCCCCceeCCc
Confidence            54333333221   122334578877

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.1e-48  Score=460.76  Aligned_cols=459  Identities=19%  Similarity=0.251  Sum_probs=306.4

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEc-CCCcccccccCCCCCCCcEEeCCC--------------------CCC
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDL-SNNQLSGSFPFFNMSSLQVIDLSD--------------------NRL   75 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L-s~n~l~~~~~~~~~~~L~~L~Ls~--------------------n~l   75 (851)
                      .+++.|+|++|+++|.+|.+++.+++|++|+| ++|.+.|..++.....  .++++.                    ..+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~--~~~l~~~~l~~lr~~~~~~~l~~~~~~~~  400 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL--TPDMSEERKHRIRMHYKKMFLDYDQRLNL  400 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCC--CSSCCHHHHHHHHTHHHHHHTCCCGGGGS
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeeccccccccccccccccc--ccccchhHHHHHHHhhhhhhhccCcchhh
Confidence            47999999999999999999999999999999 9999988755542211  000000                    000


Q ss_pred             CC----------CCCcchhcCCcccccccccc--cccccCCCccccCCCCccEEecccccccc-----------------
Q 046438           76 SG----------ELPANIFSYLPFVQFLSLAF--NQFAGHLPREIGNLTSLTSIDLSENHLMG-----------------  126 (851)
Q Consensus        76 ~~----------~~~~~~~~~l~~L~~L~L~~--N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~-----------------  126 (851)
                      ++          ............++.+.+..  |.+++ +|..|+++++|++|+|++|.+++                 
T Consensus       401 s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g  479 (876)
T 4ecn_A          401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ  479 (876)
T ss_dssp             CHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred             hHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccc
Confidence            00          00000012334555566654  88887 78889999999999999999987                 


Q ss_pred             ccchhhc--CcccccEEEccCccccCCCCccccCCCcCcEEEeeccc-ccc-ccchhHhhhc-------ccccccccccc
Q 046438          127 EIPHEIG--NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT-LSG-SISSSIRLAL-------PNLELFSLANN  195 (851)
Q Consensus       127 ~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~~l-------~~L~~L~L~~N  195 (851)
                      .+|..++  ++++|++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+. .+       ++|++|+|++|
T Consensus       480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~-~L~~~~~~l~~L~~L~Ls~N  558 (876)
T 4ecn_A          480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYN  558 (876)
T ss_dssp             HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHH-HHHHCTTTTTTCCEEECCSS
T ss_pred             cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHH-hhhhcccccCCccEEEeeCC
Confidence            3788877  88899999998888888888888888899999999887 876 6666553 34       37777777777


Q ss_pred             cccccCCc--cccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhcccccc-ccEEeccCC
Q 046438          196 NFSGKIPS--FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK-LKVLSLTGN  272 (851)
Q Consensus       196 ~i~~~~~~--~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~-L~~L~Ls~N  272 (851)
                      +++ .+|.  .+.++++|+.|+|++|.++ .+| .|+.+++|++|+|++|+++.++      ..+..+++ |+.|++++|
T Consensus       559 ~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp------~~l~~l~~~L~~L~Ls~N  629 (876)
T 4ecn_A          559 NLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIP------EDFCAFTDQVEGLGFSHN  629 (876)
T ss_dssp             CCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCC------TTSCEECTTCCEEECCSS
T ss_pred             cCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccch------HHHhhccccCCEEECcCC
Confidence            777 5666  6777777777777777777 344 6777777777777777766433      23455555 666666666


Q ss_pred             CccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccc---c--CCCCCcEEEccccc
Q 046438          273 PLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTL---S--RLEKLQILGLENNQ  347 (851)
Q Consensus       273 ~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~L~~n~  347 (851)
                      ++.  .+|..+....                       .++|+.|++++|.+.+.+|...   .  .+++|+.|+|++|.
T Consensus       630 ~L~--~lp~~~~~~~-----------------------~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~  684 (876)
T 4ecn_A          630 KLK--YIPNIFNAKS-----------------------VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE  684 (876)
T ss_dssp             CCC--SCCSCCCTTC-----------------------SSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSC
T ss_pred             CCC--cCchhhhccc-----------------------cCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCc
Confidence            654  3444333322                       1125555555555544333211   1  22355555555555


Q ss_pred             ccccccccccccCCCCEEEccCcccCCCCCccccC-------CccccceecccCcCccCchhhc--ccCcceEEEecCCC
Q 046438          348 LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN-------LASLRKLSFASNELTFVPSTFW--NLTNILMVDLSSNP  418 (851)
Q Consensus       348 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------l~~L~~L~L~~N~l~~~p~~~~--~l~~L~~L~Ls~N~  418 (851)
                      ++......+..+++|+.|+|++|++....+..+..       +++|+.|+|++|+++.+|..+.  .+++|+.|+|++|+
T Consensus       685 L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~  764 (876)
T 4ecn_A          685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNC  764 (876)
T ss_dssp             CCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSC
T ss_pred             CCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCC
Confidence            55333333335555666666666555222222221       2266666666666666666665  66666666666666


Q ss_pred             CCCCCccccccchhhhhhhccC------CcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc
Q 046438          419 LSGSLPLEIGNLKVLVELYLSR------NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       419 l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +++ +|..+..+++|+.|+|++      |++.+.+|..|..+++|+.|+|++|+| +.+|..+.  ++|+.|||++|++.
T Consensus       765 L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~  840 (876)
T 4ecn_A          765 FSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNI  840 (876)
T ss_dssp             CSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTC
T ss_pred             CCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCC
Confidence            664 566666666666666654      778888888888888888999998888 57887765  58888899888888


Q ss_pred             ccCCccccccccccceeccCccccc
Q 046438          493 GIIPSSLEKLLYLKYLNVSFNRLEG  517 (851)
Q Consensus       493 ~~~p~~l~~l~~L~~l~l~~N~l~~  517 (851)
                      ...+..+.....+..+.|++|++..
T Consensus       841 ~i~~~~~~~~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          841 SIDVTSVCPYIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             EEECGGGHHHHHTTCCEEECCTTSE
T ss_pred             ccChHHccccccchheeecCCCccc
Confidence            7777777777777888888887764

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.6e-49  Score=465.50  Aligned_cols=434  Identities=18%  Similarity=0.233  Sum_probs=338.7

Q ss_pred             CCcccccCCCCCCCCCCCEEeCcCCCCc------c------CCCccccCCCCCCEEEcCCCccccccc--CC--------
Q 046438            3 SFLTGTVPSQLGSLSSLQYLDLSFNQLL------G------TIPSSIFSINTLEILDLSNNQLSGSFP--FF--------   60 (851)
Q Consensus         3 ~~~~~~~p~~l~~l~~L~~L~ls~n~l~------~------~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~--------   60 (851)
                      +.++|.+|+++++|++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+.+.++  +.        
T Consensus        91 ~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~  167 (636)
T 4eco_A           91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCIN  167 (636)
T ss_dssp             SCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred             cccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhh
Confidence            5689999999999999999999999772      2      233322  44555 6666666654333  11        


Q ss_pred             -----------CCCCCcEEeCC--CCCCCCCCCcchhcCCcccccccccccccccC-----------------CCcccc-
Q 046438           61 -----------NMSSLQVIDLS--DNRLSGELPANIFSYLPFVQFLSLAFNQFAGH-----------------LPREIG-  109 (851)
Q Consensus        61 -----------~~~~L~~L~Ls--~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~-----------------~~~~l~-  109 (851)
                                 ....++.+.+.  .|++++ +|.. |+.+++|++|+|++|.+++.                 +|..++ 
T Consensus       168 ~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~  245 (636)
T 4eco_A          168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA-VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW  245 (636)
T ss_dssp             HCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCG
T ss_pred             cCccccccccccccchhhhhhccccCCCcc-CCHH-HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhh
Confidence                       11223333333  578886 7775 78899999999999999875                 888888 


Q ss_pred             -CCCCccEEeccccccccccchhhcCcccccEEEccCcc-ccC-CCCccccCC------CcCcEEEeeccccccccch-h
Q 046438          110 -NLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNN-LVG-VVPATLFNI------STLKILQLTNNTLSGSISS-S  179 (851)
Q Consensus       110 -~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~l~~l------~~L~~L~L~~n~l~~~~~~-~  179 (851)
                       ++++|++|+|++|.+.+.+|..|+++++|++|++++|+ +++ .+|..+..+      ++|++|++++|+++ .+|. .
T Consensus       246 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~  324 (636)
T 4eco_A          246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVET  324 (636)
T ss_dssp             GGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHH
T ss_pred             cccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchh
Confidence             99999999999999988899999999999999999998 887 778777766      89999999999998 7776 3


Q ss_pred             HhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCC-cceEeccCccccCCCCcchhhhhc
Q 046438          180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRN-LKELNLEYNYITSSNHELSFISSL  258 (851)
Q Consensus       180 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~~~l  258 (851)
                      .+..+++|++|++++|++++.+| .+.++++|+.|+|++|.++ ..|..|.++++ |++|++++|+++.++..      +
T Consensus       325 ~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~------~  396 (636)
T 4eco_A          325 SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNI------F  396 (636)
T ss_dssp             HHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSC------C
T ss_pred             hhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchh------h
Confidence            45688999999999999998888 8888999999999999999 56777999999 99999999998865432      1


Q ss_pred             cccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccc-------cccCCcEEEecCCCCCCCcCcc
Q 046438          259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMG-------NLINLIIIRLGYNKLNGSIPST  331 (851)
Q Consensus       259 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~-------~l~~L~~L~L~~n~l~~~~~~~  331 (851)
                      ..++                        ..+|+.|++++|++++..|..+.       .+++|++|++++|.++...+..
T Consensus       397 ~~~~------------------------l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~  452 (636)
T 4eco_A          397 DAKS------------------------VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL  452 (636)
T ss_dssp             CTTC------------------------SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHH
T ss_pred             hhcc------------------------cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHH
Confidence            1111                        01345555555556666677776       7889999999999999665556


Q ss_pred             ccCCCCCcEEEcccccccccccccccccC-------CCCEEEccCcccCCCCCcccc--CCccccceecccCcCccCchh
Q 046438          332 LSRLEKLQILGLENNQLEGRILDDICRLA-------RLSSVYLDHNKLSGSIPACFG--NLASLRKLSFASNELTFVPST  402 (851)
Q Consensus       332 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~p~~  402 (851)
                      +..+++|++|+|++|.++...+..+....       +|+.|+|++|+++ .+|..+.  .+++|++|+|++|+++.+|..
T Consensus       453 ~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~  531 (636)
T 4eco_A          453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQ  531 (636)
T ss_dssp             HHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCG
T ss_pred             HccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChh
Confidence            77899999999999999954444444332       7888888888887 5666665  778888888888888888877


Q ss_pred             hcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCC
Q 046438          403 FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLE  482 (851)
Q Consensus       403 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  482 (851)
                      +..+++|+.|+|++|+                  ++++|++.+.+|..++.+++|+.|+|++|++ +.+|..+.  ++|+
T Consensus       532 ~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~  590 (636)
T 4eco_A          532 PLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNIS  590 (636)
T ss_dssp             GGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCC
T ss_pred             hhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCC
Confidence            8888888888887775                  5678899889999999999999999999999 47888766  7999


Q ss_pred             EEECCCCcccccCC
Q 046438          483 CLDLSNNILSGIIP  496 (851)
Q Consensus       483 ~L~Ls~N~l~~~~p  496 (851)
                      .|||++|++....+
T Consensus       591 ~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          591 VLDIKDNPNISIDL  604 (636)
T ss_dssp             EEECCSCTTCEEEC
T ss_pred             EEECcCCCCccccH
Confidence            99999998875443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=438.19  Aligned_cols=443  Identities=21%  Similarity=0.268  Sum_probs=286.4

Q ss_pred             ccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            8 TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         8 ~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      .+|..+.  ++|++|+|++|++++..|.++..+++|++|+|++|++++..|  +..+++|++|||++|+++ .+|..   
T Consensus        14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---   87 (520)
T 2z7x_B           14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH---   87 (520)
T ss_dssp             SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC---
T ss_pred             ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc---
Confidence            3565554  566666666666665555566666666666666666665433  556666666666666665 45543   


Q ss_pred             CCccccccccccccccc-CCCccccCCCCccEEeccccccccccchhhcCcccc--cEEEccCccc--cCCCCccccCCC
Q 046438           86 YLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNL--QALGLLSNNL--VGVVPATLFNIS  160 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~-~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~l~~l~  160 (851)
                      .+++|++|+|++|.+++ .+|..|+++++|++|+|++|.+++   ..+..+++|  ++|++++|++  .+..|..+..+.
T Consensus        88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~  164 (520)
T 2z7x_B           88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN  164 (520)
T ss_dssp             CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred             ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccc
Confidence            46666666666666654 345566666666666666666553   334555555  6666666666  555555555444


Q ss_pred             -cCcEEEeeccccccccchhHhhhccccccccccccc-------ccccCCccccccCCCcEEecCCCCCccccCccccCC
Q 046438          161 -TLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN-------FSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM  232 (851)
Q Consensus       161 -~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~-------i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l  232 (851)
                       +...+++++|.+.+.++...+..+++|+.|++++|.       +.+.++                         .|+.+
T Consensus       165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-------------------------~l~~l  219 (520)
T 2z7x_B          165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-------------------------KLQTN  219 (520)
T ss_dssp             EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-------------------------GGGGC
T ss_pred             cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-------------------------hhccc
Confidence             233445555555555555555555566666666554       333333                         34444


Q ss_pred             CCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCcc-----ccccccccEEEeecCccccCCC-c
Q 046438          233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSI-----GNLSLSMERFYLHNCNIRGSIP-K  306 (851)
Q Consensus       233 ~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~-----~~~~~~L~~L~L~~n~i~~~~p-~  306 (851)
                      ++|+.|++++|.++..... ... .....++|++|++++|++. ..+|..+     ..+. .|+.+++++|.+  .+| .
T Consensus       220 ~~L~~L~l~~~~l~~~~~~-~~~-~~~~~~~L~~L~l~~n~l~-~~~p~~~~~~~~~~l~-~L~~l~l~~n~~--~~p~~  293 (520)
T 2z7x_B          220 PKLSNLTLNNIETTWNSFI-RIL-QLVWHTTVWYFSISNVKLQ-GQLDFRDFDYSGTSLK-ALSIHQVVSDVF--GFPQS  293 (520)
T ss_dssp             TTCCEEEEEEEEEEHHHHH-HHH-HHHHTSSCSEEEEEEEEEE-SCCCCCCCCCCSCCCC-EEEEEEEEECCC--CSCTH
T ss_pred             cchhhccccccccCHHHHH-HHH-HHhhhCcccEEEeeccccc-CccccchhhcccccCc-eeEeccccccce--ecchh
Confidence            5555555555444321100 000 0011235555555555543 2344444     3332 566666666666  334 4


Q ss_pred             ccccc---cCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCC--CCCcccc
Q 046438          307 EMGNL---INLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG--SIPACFG  381 (851)
Q Consensus       307 ~l~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~  381 (851)
                      .+..+   .+|+.|++++|.+....  .+..+++|++|++++|.+++..|..+..+++|+.|++++|++.+  .+|..+.
T Consensus       294 ~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~  371 (520)
T 2z7x_B          294 YIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT  371 (520)
T ss_dssp             HHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHT
T ss_pred             hhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHh
Confidence            45444   56788888888775332  12567788888888888887777788888888888888888875  4456788


Q ss_pred             CCccccceecccCcCcc-Cchh-hcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccE
Q 046438          382 NLASLRKLSFASNELTF-VPST-FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQN  459 (851)
Q Consensus       382 ~l~~L~~L~L~~N~l~~-~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  459 (851)
                      .+++|++|++++|+++. +|.. +..+++|+.|++++|++++..|..+.  ++|+.|++++|+|+ .+|..+..+++|+.
T Consensus       372 ~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~  448 (520)
T 2z7x_B          372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQE  448 (520)
T ss_dssp             TCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCE
T ss_pred             hCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCE
Confidence            88888888888888886 7764 77788999999999999877777664  78999999999999 78888889999999


Q ss_pred             EEccCcccCCCCccc-ccCCCCCCEEECCCCcccccCC
Q 046438          460 LSLGDNNLQGSIPNS-IGDLISLECLDLSNNILSGIIP  496 (851)
Q Consensus       460 L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p  496 (851)
                      |+|++|+|+ .+|.. +..+++|++|+|++|++++..+
T Consensus       449 L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          449 LNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             EECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             EECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            999999999 56654 8999999999999999997544

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=8.4e-47  Score=437.92  Aligned_cols=463  Identities=19%  Similarity=0.197  Sum_probs=345.3

Q ss_pred             CCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccc
Q 046438           42 TLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE  121 (851)
Q Consensus        42 ~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~  121 (851)
                      ..+++++++|++++ +|..-.++|++||+++|.++ .+++..|..+++|++|+|++|+|++..|+.|.++++|++|+|++
T Consensus        32 ~~~~l~ls~~~L~~-ip~~~~~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           32 LESMVDYSNRNLTH-VPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             -CCEEECTTSCCCS-CCTTSCTTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCcEEEcCCCCCcc-CCCCCCCCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence            33666666666664 33223366777777777776 55555567777777777777777766677777777777777777


Q ss_pred             cccccccchhhcCcccccEEEccCccccCC-CCccccCCCcCcEEEeeccccccccchhHhhhcccc--cccccccccc-
Q 046438          122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGV-VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNL--ELFSLANNNF-  197 (851)
Q Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L--~~L~L~~N~i-  197 (851)
                      |.++ .+|..  .+++|++|++++|++.+. .|..|.++++|++|++++|++++.    .+..+++|  ++|++++|.+ 
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~L~~n~l~  182 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL----DLLPVAHLHLSCILLDLVSYH  182 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT----TTGGGTTSCEEEEEEEESSCC
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC----chhhhhhceeeEEEeeccccc
Confidence            7776 45544  677777777777777653 346777777777777777777642    12344455  7777777777 


Q ss_pred             -cccCCccccccC-CCcEEecCCCCCccccC-ccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCc
Q 046438          198 -SGKIPSFIFNAS-KLSICELPDNSFSGFIP-NRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL  274 (851)
Q Consensus       198 -~~~~~~~~~~~~-~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  274 (851)
                       ++..|..+..+. +...+++++|.+.+..+ ..+..+++|+.|++++|+.... .-...+..+..+++|+.++++++.+
T Consensus       183 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-~l~~~~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-RLMTFLSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-HHHHHHHHHHSCSSCEEEEEEEEEE
T ss_pred             ccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-hHHHHHHHHhccCcceEEEecCCcC
Confidence             666676666543 12245777887766444 3567788899999988852110 0012344577788888888888776


Q ss_pred             cCCCC---CCccccccccccEEEeecCccccCCCccc-----ccccCCcEEEecCCCCCCCcC-ccccC---CCCCcEEE
Q 046438          275 LDCVL---PSSIGNLSLSMERFYLHNCNIRGSIPKEM-----GNLINLIIIRLGYNKLNGSIP-STLSR---LEKLQILG  342 (851)
Q Consensus       275 ~~~~~---p~~~~~~~~~L~~L~L~~n~i~~~~p~~l-----~~l~~L~~L~L~~n~l~~~~~-~~~~~---l~~L~~L~  342 (851)
                      ....+   +....  ..+|+.|++++|++++.+|..+     .+++.|+.++++.|.+  .+| ..+..   ..+|++|+
T Consensus       262 ~~~~~~~~~~~~~--~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~  337 (562)
T 3a79_B          262 TWKCSVKLFQFFW--PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLS  337 (562)
T ss_dssp             CHHHHHHHHHHHT--TSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEE
T ss_pred             cHHHHHHHHHhhh--cccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEE
Confidence            43221   11111  1379999999999998899888     7888888888888887  344 33333   36899999


Q ss_pred             cccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCc---hhhcccCcceEEEecCCCC
Q 046438          343 LENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP---STFWNLTNILMVDLSSNPL  419 (851)
Q Consensus       343 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p---~~~~~l~~L~~L~Ls~N~l  419 (851)
                      +++|.+....  ....+++|+.|++++|++++..|..+..+++|++|++++|+++.++   ..+.++++|+.|++++|++
T Consensus       338 l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l  415 (562)
T 3a79_B          338 ISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL  415 (562)
T ss_dssp             EESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCC
T ss_pred             ccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcC
Confidence            9999987432  1267899999999999999989999999999999999999999764   5688999999999999999


Q ss_pred             CCCCcc-ccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcc
Q 046438          420 SGSLPL-EIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSS  498 (851)
Q Consensus       420 ~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  498 (851)
                      ++.+|. .+..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|..
T Consensus       416 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~  491 (562)
T 3a79_B          416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDG  491 (562)
T ss_dssp             BSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTT
T ss_pred             CCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHH
Confidence            984554 588999999999999999987777665  79999999999999 788888899999999999999995 5555


Q ss_pred             -ccccccccceeccCccccccCCCCCc
Q 046438          499 -LEKLLYLKYLNVSFNRLEGEIPRGGT  524 (851)
Q Consensus       499 -l~~l~~L~~l~l~~N~l~~~~p~~~~  524 (851)
                       +..+++|+.|++++|+|+|+||....
T Consensus       492 ~~~~l~~L~~L~l~~N~~~c~c~~~~~  518 (562)
T 3a79_B          492 VFDRLTSLQYIWLHDNPWDCTCPGIRY  518 (562)
T ss_dssp             STTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred             HHhcCCCCCEEEecCCCcCCCcchHHH
Confidence             99999999999999999999986533

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.8e-47  Score=448.77  Aligned_cols=470  Identities=17%  Similarity=0.172  Sum_probs=308.2

Q ss_pred             CCCCEEEcCCCccccccc--CCCCCCCcEEeC-CCCCCCCCCCcchhcC---Ccccccccccc------------cccc-
Q 046438           41 NTLEILDLSNNQLSGSFP--FFNMSSLQVIDL-SDNRLSGELPANIFSY---LPFVQFLSLAF------------NQFA-  101 (851)
Q Consensus        41 ~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~L-s~n~l~~~~~~~~~~~---l~~L~~L~L~~------------N~i~-  101 (851)
                      .+++.|+|++|++.|.+|  +..+++|++||| ++|.++|..|......   ++..+...+..            ..+. 
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            567777777777776554  677777777777 7777665433221110   00000000000            0000 


Q ss_pred             ----------cCCCccccCCCCccEEeccc--cccccccchhhcCcccccEEEccCccccCC-----------------C
Q 046438          102 ----------GHLPREIGNLTSLTSIDLSE--NHLMGEIPHEIGNLRNLQALGLLSNNLVGV-----------------V  152 (851)
Q Consensus       102 ----------~~~~~~l~~l~~L~~L~Ls~--n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~  152 (851)
                                ...+-.......++.+.+..  |.+++ +|..|+++++|++|+|++|++++.                 +
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                      00000111222344444433  66665 677777777777777777777662                 4


Q ss_pred             Ccccc--CCCcCcEEEeeccccccccchhHhhhccccccccccccc-ccc-cCCccccccCCCcEEecCCCCCccccCcc
Q 046438          153 PATLF--NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN-FSG-KIPSFIFNASKLSICELPDNSFSGFIPNR  228 (851)
Q Consensus       153 ~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~  228 (851)
                      |..+.  ++++|+.|+|++|.+.+.+|..+ ..+++|++|+|++|+ +++ .+|..+.+++                 ..
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l-~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~-----------------~~  543 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFL-YDLPELQSLNIACNRGISAAQLKADWTRLA-----------------DD  543 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGG-GGCSSCCEEECTTCTTSCHHHHHHHHHHHH-----------------HC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHH-hCCCCCCEEECcCCCCcccccchHHHHhhh-----------------hc
Confidence            55544  56666666666665555555332 255555555555555 554 4454444333                 01


Q ss_pred             ccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCccc
Q 046438          229 FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM  308 (851)
Q Consensus       229 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l  308 (851)
                      +..+++|++|+|++|.++.++.    ...+..+++|+.|++++|++.  .+| .+..+. +|+.|++++|+++ .+|..+
T Consensus       544 ~~~l~~L~~L~Ls~N~L~~ip~----~~~l~~L~~L~~L~Ls~N~l~--~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l  614 (876)
T 4ecn_A          544 EDTGPKIQIFYMGYNNLEEFPA----SASLQKMVKLGLLDCVHNKVR--HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDF  614 (876)
T ss_dssp             TTTTTTCCEEECCSSCCCBCCC----HHHHTTCTTCCEEECTTSCCC--BCC-CCCTTS-EESEEECCSSCCS-CCCTTS
T ss_pred             ccccCCccEEEeeCCcCCccCC----hhhhhcCCCCCEEECCCCCcc--cch-hhcCCC-cceEEECcCCccc-cchHHH
Confidence            1112245555555554443221    012344445555555555543  333 333332 5666666666666 678889


Q ss_pred             ccccC-CcEEEecCCCCCCCcCccccCCCC--CcEEEcccccccccccccc---c--ccCCCCEEEccCcccCCCCCccc
Q 046438          309 GNLIN-LIIIRLGYNKLNGSIPSTLSRLEK--LQILGLENNQLEGRILDDI---C--RLARLSSVYLDHNKLSGSIPACF  380 (851)
Q Consensus       309 ~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~  380 (851)
                      ..+++ |+.|++++|.++ .+|..+..++.  |+.|++++|.+.+.+|...   .  .+++|+.|+|++|++....+..+
T Consensus       615 ~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~  693 (876)
T 4ecn_A          615 CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF  693 (876)
T ss_dssp             CEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHH
T ss_pred             hhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHH
Confidence            99999 999999999998 77888877654  9999999999998665332   2  34589999999999995544555


Q ss_pred             cCCccccceecccCcCccCchhhccc--------CcceEEEecCCCCCCCCccccc--cchhhhhhhccCCcccccCCcc
Q 046438          381 GNLASLRKLSFASNELTFVPSTFWNL--------TNILMVDLSSNPLSGSLPLEIG--NLKVLVELYLSRNNLSGDIPTT  450 (851)
Q Consensus       381 ~~l~~L~~L~L~~N~l~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~  450 (851)
                      ..+++|+.|+|++|+++.+|..+...        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..
T Consensus       694 ~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~  771 (876)
T 4ecn_A          694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ  771 (876)
T ss_dssp             HTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred             ccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchh
Confidence            68999999999999999998865543        39999999999999 7888887  99999999999999996 7999


Q ss_pred             cCCCCCccEEEccC------cccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCc
Q 046438          451 IGGLKNLQNLSLGD------NNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGT  524 (851)
Q Consensus       451 ~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~  524 (851)
                      +..+++|+.|+|++      |++.+.+|..+..+++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++....+..-.
T Consensus       772 l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~  848 (876)
T 4ecn_A          772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVC  848 (876)
T ss_dssp             GGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGH
T ss_pred             hhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHcc
Confidence            99999999999977      888899999999999999999999999 58888876  6999999999999765442211


Q ss_pred             -ccccCcccccCCcC--ccCCCC
Q 046438          525 -LANFTSESFMGNDL--LCGSPH  544 (851)
Q Consensus       525 -~~~l~~~~~~~n~~--~c~~~~  544 (851)
                       ........+.+|+.  .||||.
T Consensus       849 ~~~~~~~~~L~~n~~~~I~gC~~  871 (876)
T 4ecn_A          849 PYIEAGMYVLLYDKTQDIRGCDA  871 (876)
T ss_dssp             HHHHTTCCEEECCTTSEEESCGG
T ss_pred             ccccchheeecCCCccccCCCCC
Confidence             11223334445544  346663

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.1e-45  Score=432.85  Aligned_cols=524  Identities=20%  Similarity=0.228  Sum_probs=406.6

Q ss_pred             CcccccCCCCCCCCC---CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCC
Q 046438            4 FLTGTVPSQLGSLSS---LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGE   78 (851)
Q Consensus         4 ~~~~~~p~~l~~l~~---L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~   78 (851)
                      ..+..+|++...|..   -...+-++-+++ .+|..+.  +++++|||++|+|+++.+  |..+++|++|||++|+|+ .
T Consensus        15 ~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~   90 (635)
T 4g8a_A           15 AANSSIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-T   90 (635)
T ss_dssp             ----------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-E
T ss_pred             cccCCCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-C
Confidence            456677877665532   345577777888 6776553  589999999999998765  889999999999999998 7


Q ss_pred             CCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCC-CCcccc
Q 046438           79 LPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGV-VPATLF  157 (851)
Q Consensus        79 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~  157 (851)
                      +++..|+++++|++|+|++|+|++..++.|.++++|++|+|++|++++..+..|+++++|++|++++|++++. .|..+.
T Consensus        91 i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~  170 (635)
T 4g8a_A           91 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS  170 (635)
T ss_dssp             ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGG
T ss_pred             cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhc
Confidence            8888899999999999999999988888999999999999999999987778899999999999999999864 577888


Q ss_pred             CCCcCcEEEeeccccccccchhHhhhccccc----ccccccccccccCCccccccCCCcEEecCCCCCcc-ccCccccCC
Q 046438          158 NISTLKILQLTNNTLSGSISSSIRLALPNLE----LFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG-FIPNRFHNM  232 (851)
Q Consensus       158 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l  232 (851)
                      .+++|++|+|++|++++..+. .+..+.+++    .++++.|.++...+..+ ....+..+++.+|.... ..+..+..+
T Consensus       171 ~l~~L~~L~L~~N~l~~~~~~-~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l  248 (635)
T 4g8a_A          171 NLTNLEHLDLSSNKIQSIYCT-DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGL  248 (635)
T ss_dssp             GCTTCCEEECCSSCCCEECGG-GGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTT
T ss_pred             cchhhhhhcccCccccccccc-cccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCC
Confidence            999999999999999854444 444566554    57889999986555444 44567788888886652 334455666


Q ss_pred             CCcceEeccCccccCCCC----------------------------cchhhhhccccccccEEeccCCCccCCCCCCccc
Q 046438          233 RNLKELNLEYNYITSSNH----------------------------ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIG  284 (851)
Q Consensus       233 ~~L~~L~L~~N~i~~~~~----------------------------~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~  284 (851)
                      ..++...+..+.......                            .......+....+++.+++.++.+...  + .+.
T Consensus       249 ~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~-~~~  325 (635)
T 4g8a_A          249 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--K-DFS  325 (635)
T ss_dssp             TTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--G-GGG
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--c-ccc
Confidence            666655543332211000                            000112234455667777777665321  1 111


Q ss_pred             cccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccc--cccccccccCCC
Q 046438          285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG--RILDDICRLARL  362 (851)
Q Consensus       285 ~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L  362 (851)
                       ...+++.|++.+|.+....+   ..+..|+.+++..|.+...  .....+++|+.|++++|.+..  ..+..+..+.+|
T Consensus       326 -~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L  399 (635)
T 4g8a_A          326 -YNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISL  399 (635)
T ss_dssp             -SCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCC
T ss_pred             -cchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhh
Confidence             22368888888888875443   3466788888888887632  334578999999999999864  345566778899


Q ss_pred             CEEEccCcccCCCCCccccCCccccceecccCcCccCc--hhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       363 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      +.++++.|.+. ..+..+..+++|+.+++++|+....+  ..+..+.+++.++++.|.+.+..+..+..++.|+.|++++
T Consensus       400 ~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~  478 (635)
T 4g8a_A          400 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG  478 (635)
T ss_dssp             CEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred             hhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence            99999999887 45667888999999999999877543  4678899999999999999989999999999999999999


Q ss_pred             Cccc-ccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccC
Q 046438          441 NNLS-GDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEI  519 (851)
Q Consensus       441 N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~  519 (851)
                      |++. +..|+.|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.+
T Consensus       479 N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~  558 (635)
T 4g8a_A          479 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK  558 (635)
T ss_dssp             CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCC
T ss_pred             cccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCC
Confidence            9854 457889999999999999999999989999999999999999999999999999999999999999999999998


Q ss_pred             CCCC-cc-cccCcccccCCcCccCCC
Q 046438          520 PRGG-TL-ANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       520 p~~~-~~-~~l~~~~~~~n~~~c~~~  543 (851)
                      |..- .+ ..+..+.+.+||+.|++.
T Consensus       559 ~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          559 KQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             SSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             HHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            8652 23 578889999999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=8.4e-45  Score=421.11  Aligned_cols=463  Identities=20%  Similarity=0.166  Sum_probs=369.6

Q ss_pred             CCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCccccc
Q 046438           60 FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQ  139 (851)
Q Consensus        60 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  139 (851)
                      ..+...+++|+++|+++ .+|..++   ++|++|+|++|.|++..|..|.++++|++|+|++|.+++..|+.|+++++|+
T Consensus        28 ~~~~~~~~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  103 (562)
T 3a79_B           28 FSNELESMVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE  103 (562)
T ss_dssp             -----CCEEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred             cccCCCcEEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCC
Confidence            44556699999999999 7998653   8999999999999988889999999999999999999988899999999999


Q ss_pred             EEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCC--cEEecC
Q 046438          140 ALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKL--SICELP  217 (851)
Q Consensus       140 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L--~~L~L~  217 (851)
                      +|++++|+++. +|..  .+++|++|+|++|++++......+..+++|++|++++|++++.   .+..+++|  +.|+++
T Consensus       104 ~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~  177 (562)
T 3a79_B          104 YLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLD  177 (562)
T ss_dssp             EEECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEE
T ss_pred             EEECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEee
Confidence            99999999995 4544  8999999999999998533334566899999999999999864   34555666  999999


Q ss_pred             CCCC--ccccCccccCCC-CcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCC---Ccccccccccc
Q 046438          218 DNSF--SGFIPNRFHNMR-NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLP---SSIGNLSLSME  291 (851)
Q Consensus       218 ~n~l--~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p---~~~~~~~~~L~  291 (851)
                      +|.+  ++..|..|..+. ..-.+++++|.+.....    ...+..+++|+.+++++|+.....++   ..+... ..++
T Consensus       178 ~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~----~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l-~~L~  252 (562)
T 3a79_B          178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV----NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG-PTLL  252 (562)
T ss_dssp             ESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCC----EEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSC-SSCE
T ss_pred             cccccccccCcccccccCcceEEEEecCccchhhhh----hhcccccceEEEecccccccccchHHHHHHHHhcc-Ccce
Confidence            9999  888888888765 22366888888775322    22466789999999999963111111   122222 3677


Q ss_pred             EEEeecCccccCCCcc---cccccCCcEEEecCCCCCCCcCccc-----cCCCCCcEEEcccccccccccccccc---cC
Q 046438          292 RFYLHNCNIRGSIPKE---MGNLINLIIIRLGYNKLNGSIPSTL-----SRLEKLQILGLENNQLEGRILDDICR---LA  360 (851)
Q Consensus       292 ~L~L~~n~i~~~~p~~---l~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~~~~~~---l~  360 (851)
                      .++++++.+.+.....   ....++|++|++++|.+.+.+|..+     ..++.|+.++++.|.+ ......+..   ..
T Consensus       253 ~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~  331 (562)
T 3a79_B          253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEM  331 (562)
T ss_dssp             EEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTC
T ss_pred             EEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhhccC
Confidence            7888877765422111   1223599999999999998888887     7777888888888877 222233333   36


Q ss_pred             CCCEEEccCcccCCCCCccccCCccccceecccCcCcc-CchhhcccCcceEEEecCCCCCCC--Cccccccchhhhhhh
Q 046438          361 RLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF-VPSTFWNLTNILMVDLSSNPLSGS--LPLEIGNLKVLVELY  437 (851)
Q Consensus       361 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~  437 (851)
                      +|+.|++++|.+....  ....+++|++|++++|+++. +|..+.++++|++|+|++|++++.  .|..++.+++|++|+
T Consensus       332 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~  409 (562)
T 3a79_B          332 NIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD  409 (562)
T ss_dssp             CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEE
T ss_pred             cceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEE
Confidence            7999999999986332  23688999999999999996 688899999999999999999963  356799999999999


Q ss_pred             ccCCcccccCCc-ccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCcccc
Q 046438          438 LSRNNLSGDIPT-TIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE  516 (851)
Q Consensus       438 L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  516 (851)
                      +++|++++.+|. .+..+++|+.|++++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++
T Consensus       410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  486 (562)
T 3a79_B          410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK  486 (562)
T ss_dssp             CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred             CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence            999999974554 589999999999999999987776654  79999999999999 68877779999999999999999


Q ss_pred             ccCCC-CCcccccCcccccCCcCccCCC
Q 046438          517 GEIPR-GGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       517 ~~~p~-~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ..++. ...+..+..+.+.+|++.|+++
T Consensus       487 ~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          487 SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            65444 4567888889999999999876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.4e-45  Score=385.47  Aligned_cols=199  Identities=26%  Similarity=0.368  Sum_probs=181.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999985 68999999998765555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +||+|.+++..  ..+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus       154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  227 (346)
T 4fih_A          154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  227 (346)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred             CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence            99999998865  4589999999999999999999   889999999999999999999999999999987754332 34


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  273 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  273 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            5678999999999999999999999999999999999999999763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.6e-45  Score=380.10  Aligned_cols=201  Identities=27%  Similarity=0.445  Sum_probs=181.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++++..   ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999984 68999999997542   334577999999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-  780 (851)
                      |||+||+|.+++... +.+++..+..++.||+.|++||   |++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus       112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999998654 5689999999999999999999   88999999999999999999999999999998775433 


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            22345678999999999999999999999999999999999999999763

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.6e-45  Score=386.67  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=174.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++|||||++++++++++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999984 58999999997653  3345789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+||+|.+++... ...+++..++.++.||+.||+||   |++||+||||||+|||+++++.+||+|||+|+...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999754 44578889999999999999999   88999999999999999999999999999998764321 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1234568999999999999999999999999999999999999999764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-44  Score=377.94  Aligned_cols=203  Identities=29%  Similarity=0.520  Sum_probs=178.3

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|++++++++|||||++++++.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888899999999999999874      367899999987766667889999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEE
Q 046438          700 VLDYMPKGSLEACLYSD------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL  767 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl  767 (851)
                      |||||++|+|.++++..            ...+++..+..++.||++|++||   |+++|+||||||+||++++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999653            34689999999999999999999   7889999999999999999999999


Q ss_pred             eeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          768 GDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~  235 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  235 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999876433322 2223468999999999999999999999999999999999 999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=387.45  Aligned_cols=199  Identities=26%  Similarity=0.368  Sum_probs=181.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999985 58999999998766555677999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +||+|.+++..  ..+++..+..++.||+.||+||   |++||+||||||+|||++.+|.+||+|||+|+.+..... ..
T Consensus       231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  304 (423)
T 4fie_A          231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  304 (423)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred             CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence            99999998865  3589999999999999999999   889999999999999999999999999999987654332 34


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  350 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  350 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            5678999999999999999999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8e-44  Score=372.12  Aligned_cols=201  Identities=32%  Similarity=0.556  Sum_probs=170.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .+++++.+.||+|+||+||+|++.  ..||||+++...  ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            367888999999999999999864  369999987542  3445789999999999999999999998865 56899999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-C
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-S  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  781 (851)
                      ||++|+|.+++......+++..+..|+.||++||+||   |+++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999987777899999999999999999999   78899999999999999999999999999998764322 2


Q ss_pred             ccccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 MKHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......+||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+..
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~  241 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN  241 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence            23345689999999999853   468999999999999999999999997643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=376.35  Aligned_cols=203  Identities=31%  Similarity=0.504  Sum_probs=172.4

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45777899999999999999874      478899999987766677889999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          700 VLDYMPKGSLEACLYSD--------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      |||||++|+|.++++..              ...+++.++..++.||++|++||   |+++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHhhEEECCCCcE
Confidence            99999999999998653              24589999999999999999999   78899999999999999999999


Q ss_pred             EEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          766 RLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ||+|||+|+....... .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            9999999987643322 22334679999999999999999999999999999999999 999997643

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.1e-43  Score=397.66  Aligned_cols=393  Identities=19%  Similarity=0.217  Sum_probs=250.7

Q ss_pred             EEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEecccccccccc-chhhcCcccccEEEccC
Q 046438           67 VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEI-PHEIGNLRNLQALGLLS  145 (851)
Q Consensus        67 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~  145 (851)
                      .++.+++.++ .+|.    -.++|++|+|++|.|++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|++++
T Consensus        14 ~~~c~~~~l~-~lp~----l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLH-QVPE----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCS-SCCC----CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCcc-cCCC----CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            4555555554 4554    1255566666666665555566666666666666666655332 44566666666666666


Q ss_pred             ccccCCCCccccCCCcCcEEEeeccccccccch-hHhhhcccccccccccccccccCCcc-ccccCCCcEEecCCCCCcc
Q 046438          146 NNLVGVVPATLFNISTLKILQLTNNTLSGSISS-SIRLALPNLELFSLANNNFSGKIPSF-IFNASKLSICELPDNSFSG  223 (851)
Q Consensus       146 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~~~~L~~L~L~~n~l~~  223 (851)
                      |++.+..|..|.++++|++|+|++|.+++..+. ..+..+++|++|+|++|.+++..|.. +.++++|+.|++++|.+++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            666655566666666666666666666543222 22335555666666666655554443 5556666666666666666


Q ss_pred             ccCccccCC--CCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccc
Q 046438          224 FIPNRFHNM--RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR  301 (851)
Q Consensus       224 ~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~  301 (851)
                      ..+..+..+  .+|+.|++++|.+...+......                                              
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------------------------------------  202 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------------------------------------  202 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------------------------------------
T ss_pred             cChhhhhccccccccccccccCcccccchhhccc----------------------------------------------
Confidence            655555554  45666666666665433211000                                              


Q ss_pred             cCCCcccccccCCcEEEecCCCCCCCcCccccCC---CCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCc
Q 046438          302 GSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL---EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPA  378 (851)
Q Consensus       302 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  378 (851)
                       .....+..+++|++|++++|.+.+..|..+...   ++|+.|++++|.+.+..              +..+.+....+.
T Consensus       203 -~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~  267 (455)
T 3v47_A          203 -EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNF  267 (455)
T ss_dssp             -HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTT
T ss_pred             -cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCccc
Confidence             000112223344444444444443333333222   45555555555443211              111122222222


Q ss_pred             cccC--CccccceecccCcCccC-chhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCC
Q 046438          379 CFGN--LASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK  455 (851)
Q Consensus       379 ~~~~--l~~L~~L~L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  455 (851)
                      .+..  .++|+.|++++|+++.+ |..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|..++
T Consensus       268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (455)
T 3v47_A          268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD  347 (455)
T ss_dssp             TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred             ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence            2222  25677888888877754 55677888888888888888877788888899999999999999887888999999


Q ss_pred             CccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcc
Q 046438          456 NLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTL  525 (851)
Q Consensus       456 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~  525 (851)
                      +|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|+|+|.||...++
T Consensus       348 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l  417 (455)
T 3v47_A          348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL  417 (455)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred             cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHH
Confidence            9999999999999888999999999999999999999877778899999999999999999999976554

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.3e-44  Score=375.04  Aligned_cols=199  Identities=25%  Similarity=0.305  Sum_probs=173.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +.|++.++||+|+||+||+|++. +|+.||||+++....     ..+|++++++++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45788899999999999999985 589999999975422     246999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCccccCCCCCc-
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDESM-  782 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~-  782 (851)
                      +||+|.+++... ..+++..+..++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+|+........ 
T Consensus       133 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            999999999654 4689999999999999999999   889999999999999999987 6999999999876543221 


Q ss_pred             ---cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcC
Q 046438          783 ---KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSG  833 (851)
Q Consensus       783 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  833 (851)
                         .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~  262 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG  262 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence               123357999999999999999999999999999999999999999875443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-43  Score=363.81  Aligned_cols=196  Identities=28%  Similarity=0.439  Sum_probs=169.5

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec----CCeeEEE
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN----DDFKALV  700 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  700 (851)
                      |++.++||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ++..++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367788999999999999985 58899999997543  3345779999999999999999999999865    3468999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEEC-CCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLD-EDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~~~  777 (851)
                      ||||+||+|.+++... ..+++..+..++.||+.||+||   |+++  |+||||||+|||++ .++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999998653 5689999999999999999999   6666  99999999999997 47999999999998643


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ..   ...+.+||+.|+|||++.+ .|+.++||||+||++|||+||+.||.+..
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~  233 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ  233 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            22   3345689999999998865 69999999999999999999999997643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.7e-43  Score=362.02  Aligned_cols=198  Identities=25%  Similarity=0.455  Sum_probs=162.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999884 68999999997543   233467899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+ +|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||++++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 67898888654 5699999999999999999999   88999999999999999999999999999998764322 


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ...+.+||+.|+|||++.+..| +.++||||+||++|||++|+.||.+.
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence             3345789999999999998876 57999999999999999999999763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-44  Score=373.63  Aligned_cols=200  Identities=28%  Similarity=0.398  Sum_probs=170.6

Q ss_pred             cCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|++.+.||+|+||+||+|+..    .++.||+|+++...  .....++.+|++++++++|||||++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999873    36789999997543  2233468899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |||||+||+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+|||+++++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999999999998654 4689999999999999999999   8899999999999999999999999999999865433


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ....+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~  229 (304)
T 3ubd_A          180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK  229 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence            2 2344578999999999999999999999999999999999999999763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-43  Score=370.91  Aligned_cols=203  Identities=27%  Similarity=0.454  Sum_probs=176.0

Q ss_pred             cCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      .++++.+.||+|+||+||+|++.      +++.||||+++.... ...+.|.+|++++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            35677899999999999999863      467899999975543 33578999999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcC---------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC
Q 046438          699 LVLDYMPKGSLEACLYSD---------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM  763 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~  763 (851)
                      +|||||++|+|.+++...               ...+++..+..++.||++|++||   |+++|+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCccccceEECCCC
Confidence            999999999999998643               23588999999999999999999   888999999999999999999


Q ss_pred             cEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          764 VARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .+||+|||+|+....... .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            999999999987643322 22344679999999999999999999999999999999998 899998743

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.2e-41  Score=384.72  Aligned_cols=393  Identities=22%  Similarity=0.262  Sum_probs=254.7

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      -+..+.++++++ .+|. +  .++|++|+|++|++++..+  +..+++|++|++++|.+.+.++...|..+++|++|+|+
T Consensus        12 ~~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            456788888887 5665 2  2778888888888887544  67788888888888888767777777888888888888


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchh--hcCcccccEEEccCccccCCCCcc-ccCCCcCcEEEeeccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHE--IGNLRNLQALGLLSNNLVGVVPAT-LFNISTLKILQLTNNTLS  173 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~  173 (851)
                      +|++++..|..|+++++|++|+|++|.+++..+..  |+.+++|++|++++|++.+..|.. +.++++|++|++++|+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            88887777777888888888888888877644444  777777777777777777666655 566777777777777776


Q ss_pred             cccchhHhhhc--ccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCc
Q 046438          174 GSISSSIRLAL--PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHE  251 (851)
Q Consensus       174 ~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~  251 (851)
                      +..+..+. .+  ++|+.|++++|.+.+..+..+.                ......+..+++|++|++++|+++.....
T Consensus       168 ~~~~~~l~-~l~~~~L~~L~l~~n~l~~~~~~~~~----------------~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~  230 (455)
T 3v47_A          168 SICEEDLL-NFQGKHFTLLRLSSITLQDMNEYWLG----------------WEKCGNPFKNTSITTLDLSGNGFKESMAK  230 (455)
T ss_dssp             CCCTTTSG-GGTTCEEEEEECTTCBCTTCSTTCTT----------------HHHHCCTTTTCEEEEEECTTSCCCHHHHH
T ss_pred             ccChhhhh-ccccccccccccccCcccccchhhcc----------------ccccccccccceeeeEecCCCcccccchh
Confidence            44333322 22  3444455554444432222110                00001122345555666655555431100


Q ss_pred             chhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCcc
Q 046438          252 LSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPST  331 (851)
Q Consensus       252 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~  331 (851)
                        .+......++|+.|++++|....                          ..              +..+.+.+..+..
T Consensus       231 --~~~~~~~~~~L~~L~l~~~~~~~--------------------------~~--------------~~~~~~~~~~~~~  268 (455)
T 3v47_A          231 --RFFDAIAGTKIQSLILSNSYNMG--------------------------SS--------------FGHTNFKDPDNFT  268 (455)
T ss_dssp             --HHHHHTTTCCEEEEECTTCTTTS--------------------------CC--------------TTCCSSCCCCTTT
T ss_pred             --hhhccccccceeeEeeccccccc--------------------------cc--------------cchhhhccCcccc
Confidence              00011112344444444433211                          00              0011111111111


Q ss_pred             ccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccC-chhhcccCcce
Q 046438          332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFWNLTNIL  410 (851)
Q Consensus       332 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-p~~~~~l~~L~  410 (851)
                      +..+                      ..++|+.|++++|++.+..|..|..+++|++|++++|+++.+ |..+.++++|+
T Consensus       269 ~~~~----------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  326 (455)
T 3v47_A          269 FKGL----------------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL  326 (455)
T ss_dssp             TGGG----------------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             cccc----------------------cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCC
Confidence            1111                      124556666666666655666666666777777777777655 44677777888


Q ss_pred             EEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCc
Q 046438          411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNI  490 (851)
Q Consensus       411 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  490 (851)
                      +|+|++|++++..|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|+|++|+
T Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  406 (455)
T 3v47_A          327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  406 (455)
T ss_dssp             EEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence            88888888877778888888899999999999988888899999999999999999997777788999999999999999


Q ss_pred             ccccCC
Q 046438          491 LSGIIP  496 (851)
Q Consensus       491 l~~~~p  496 (851)
                      +++..|
T Consensus       407 l~~~~~  412 (455)
T 3v47_A          407 WDCSCP  412 (455)
T ss_dssp             BCCCTT
T ss_pred             cccCCC
Confidence            998766

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.3e-41  Score=377.42  Aligned_cols=410  Identities=23%  Similarity=0.252  Sum_probs=207.1

Q ss_pred             CCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCC-------------CcEEeCCCCCC
Q 046438           11 SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSS-------------LQVIDLSDNRL   75 (851)
Q Consensus        11 ~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~-------------L~~L~Ls~n~l   75 (851)
                      +.-.+.++|++|++++|.+ +.+|.+++.+++|++|++++|++++..|  +..+.+             +++|++++|.+
T Consensus         5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l   83 (454)
T 1jl5_A            5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL   83 (454)
T ss_dssp             ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCC
T ss_pred             ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcc
Confidence            3333568899999999999 5889889999999999999999887655  556655             48888888888


Q ss_pred             CCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCcc
Q 046438           76 SGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPAT  155 (851)
Q Consensus        76 ~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  155 (851)
                      + .+|..    .++|++|++++|.+++ +|..   +++|++|++++|.+++ +|..   .++|++|++++|++++ +| .
T Consensus        84 ~-~lp~~----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~  148 (454)
T 1jl5_A           84 S-SLPEL----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-E  148 (454)
T ss_dssp             S-CCCSC----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-C
T ss_pred             c-cCCCC----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-c
Confidence            7 55542    4678888888888876 5543   3678888888888874 3321   1678888888888875 45 4


Q ss_pred             ccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCc
Q 046438          156 LFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNL  235 (851)
Q Consensus       156 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L  235 (851)
                      +.++++|++|++++|++++ ++..    .++|++|++++|++++ +| .+.++++|+.|++++|.++++.. .   .++|
T Consensus       149 ~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~---~~~L  217 (454)
T 1jl5_A          149 LQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L---PLSL  217 (454)
T ss_dssp             CTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C---CTTC
T ss_pred             cCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C---cCcc
Confidence            7788888888888888773 4432    3467777777777765 33 46666667777777776665321 1   1466


Q ss_pred             ceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCc
Q 046438          236 KELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLI  315 (851)
Q Consensus       236 ~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~  315 (851)
                      ++|++++|.++.++       .+..+++|++|++++|++..  +|.                         .   .++|+
T Consensus       218 ~~L~l~~n~l~~lp-------~~~~l~~L~~L~l~~N~l~~--l~~-------------------------~---~~~L~  260 (454)
T 1jl5_A          218 ESIVAGNNILEELP-------ELQNLPFLTTIYADNNLLKT--LPD-------------------------L---PPSLE  260 (454)
T ss_dssp             CEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSS--CCS-------------------------C---CTTCC
T ss_pred             cEEECcCCcCCccc-------ccCCCCCCCEEECCCCcCCc--ccc-------------------------c---ccccC
Confidence            66666666666433       14455666666666665532  221                         1   24455


Q ss_pred             EEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCC-ccccceecccC
Q 046438          316 IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL-ASLRKLSFASN  394 (851)
Q Consensus       316 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N  394 (851)
                      .|++++|++.+ +|..   .++|++|++++|.+++.. . +  .++|+.|++++|++.+. +    .+ ++|++|++++|
T Consensus       261 ~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~-~-~--~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N  327 (454)
T 1jl5_A          261 ALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS-E-L--PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNN  327 (454)
T ss_dssp             EEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES-C-C--CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSS
T ss_pred             EEECCCCcccc-cCcc---cCcCCEEECcCCccCccc-C-c--CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCC
Confidence            55555555553 2322   245566666666555421 1 0  14566666666666531 1    12 36666777777


Q ss_pred             cCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccc--cCCcccCCCCCccEEEccCcccCCCCc
Q 046438          395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSG--DIPTTIGGLKNLQNLSLGDNNLQGSIP  472 (851)
Q Consensus       395 ~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~  472 (851)
                      +++.+|..   +++|+.|++++|+++ .+|.   .+++|++|++++|++++  .+|.+++.        |+.|.+.+.+|
T Consensus       328 ~l~~lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~  392 (454)
T 1jl5_A          328 KLIELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVP  392 (454)
T ss_dssp             CCSCCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC------
T ss_pred             cccccccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccc
Confidence            66666553   466777777777776 3444   35667777777777775  45554432        23456666666


Q ss_pred             ccccCCCCCCEEECCCCcccc--cCCccccccccccceeccCccccccCCC
Q 046438          473 NSIGDLISLECLDLSNNILSG--IIPSSLEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       473 ~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                      ..   +++|+.|++++|++++  .+|.+      ++.|.+++|.+.+..|.
T Consensus       393 ~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          393 EL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF  434 (454)
T ss_dssp             ---------------------------------------------------
T ss_pred             cc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence            53   4678888888888886  55533      45667788888777664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.2e-42  Score=357.71  Aligned_cols=198  Identities=28%  Similarity=0.475  Sum_probs=160.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCC--------
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDD--------  695 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  695 (851)
                      .+|++++.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45899999999999999999984 689999999976543 34567899999999999999999999987544        


Q ss_pred             ----eeEEEEeccCCCChhHHhhcCCC--CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEee
Q 046438          696 ----FKALVLDYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD  769 (851)
Q Consensus       696 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~D  769 (851)
                          ..|+|||||++|+|.+++.....  ..++..++.++.||++|++||   |++||+||||||+||+++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999865432  345566788999999999999   889999999999999999999999999


Q ss_pred             ccCccccCCCCC-----------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          770 FGIAKLLSGDES-----------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       770 fg~a~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||+|+.......           ......+||+.|+|||++.+..|+.++||||+||++|||++   ||..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            999987643221           12234579999999999999999999999999999999996   7764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=8.8e-41  Score=374.00  Aligned_cols=404  Identities=25%  Similarity=0.301  Sum_probs=210.9

Q ss_pred             CCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCc-------------cEEecccccccccc
Q 046438           62 MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSL-------------TSIDLSENHLMGEI  128 (851)
Q Consensus        62 ~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L-------------~~L~Ls~n~l~~~~  128 (851)
                      .+.|++|++++|.+ +.+|+. ++.+++|++|++++|.+.+.+|..++.+++|             ++|++++|.+++ +
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~-i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l   86 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L   86 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred             cccchhhhcccCch-hhCChh-HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence            45566666666666 466665 5667777777777777777777777766654             778888888774 3


Q ss_pred             chhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCcccccc
Q 046438          129 PHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNA  208 (851)
Q Consensus       129 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~  208 (851)
                      |..   .++|++|++++|++++ +|..   +++|+.|++++|++++ ++.    ..++|++|++++|++++ +| .+.++
T Consensus        87 p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~----~~~~L~~L~L~~n~l~~-lp-~~~~l  152 (454)
T 1jl5_A           87 PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSD----LPPLLEYLGVSNNQLEK-LP-ELQNS  152 (454)
T ss_dssp             CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCS----CCTTCCEEECCSSCCSS-CC-CCTTC
T ss_pred             CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccC----CCCCCCEEECcCCCCCC-Cc-ccCCC
Confidence            432   3677888888888776 4433   3677888888887763 221    12577777888777775 45 47777


Q ss_pred             CCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccc
Q 046438          209 SKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSL  288 (851)
Q Consensus       209 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~  288 (851)
                      ++|+.|++++|+++++ |..   ..+|++|++++|+++.++       .+..+++|++|++++|++..  +|..    ..
T Consensus       153 ~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l~-------~~~~l~~L~~L~l~~N~l~~--l~~~----~~  215 (454)
T 1jl5_A          153 SFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEELP-------ELQNLPFLTAIYADNNSLKK--LPDL----PL  215 (454)
T ss_dssp             TTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSS--CCCC----CT
T ss_pred             CCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcCc-------cccCCCCCCEEECCCCcCCc--CCCC----cC
Confidence            7777777777777763 322   247777777777777643       35667777777777777743  3322    23


Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      +|+.|++++|+++ .+| .++.+++|++|++++|++++ +|..   .++|++|++++|++++ +|..   .++|+.|+++
T Consensus       216 ~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls  285 (454)
T 1jl5_A          216 SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVS  285 (454)
T ss_dssp             TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             cccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECc
Confidence            6677777777776 455 36677777777777777764 3332   3567777777777665 2222   3566677777


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCC
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIP  448 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  448 (851)
                      +|++++. +..   .++|++|++++|+++.++..   .++|+.|++++|++++ +|..   +++|++|++++|+++ .+|
T Consensus       286 ~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp  353 (454)
T 1jl5_A          286 ENIFSGL-SEL---PPNLYYLNASSNEIRSLCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVP  353 (454)
T ss_dssp             SSCCSEE-SCC---CTTCCEEECCSSCCSEECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCC
T ss_pred             CCccCcc-cCc---CCcCCEEECcCCcCCcccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-ccc
Confidence            7766642 111   14666667777666654421   1356666666666664 4433   356666666666666 344


Q ss_pred             cccCCCCCccEEEccCcccCC--CCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccc--cCCCCCc
Q 046438          449 TTIGGLKNLQNLSLGDNNLQG--SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEG--EIPRGGT  524 (851)
Q Consensus       449 ~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~--~~p~~~~  524 (851)
                      .   .+++|++|++++|++++  .+|.+++.        |+.|.+.+.+|..   +++|+.|++++|++++  .+|..  
T Consensus       354 ~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s--  417 (454)
T 1jl5_A          354 E---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES--  417 (454)
T ss_dssp             C---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC------------------------------------
T ss_pred             c---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh--
Confidence            4   35666666666666665  44443332        2335555555543   3889999999999998  66642  


Q ss_pred             ccccCcccccCCcCcc
Q 046438          525 LANFTSESFMGNDLLC  540 (851)
Q Consensus       525 ~~~l~~~~~~~n~~~c  540 (851)
                         +....+.+|...|
T Consensus       418 ---l~~L~~~~~~~~~  430 (454)
T 1jl5_A          418 ---VEDLRMNSERVVD  430 (454)
T ss_dssp             ----------------
T ss_pred             ---HhheeCcCcccCC
Confidence               4444455554444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-41  Score=364.24  Aligned_cols=214  Identities=24%  Similarity=0.418  Sum_probs=182.0

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCC-Cccccee
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRH-RNLVRII  688 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~  688 (851)
                      ..++++...++|++.+.||+|+||+||+|++..      ++.||||+++... ....+.+.+|++++.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            334455567889999999999999999998743      3579999997653 3345679999999999965 8999999


Q ss_pred             eeeecC-CeeEEEEeccCCCChhHHhhcC---------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 046438          689 SSCTND-DFKALVLDYMPKGSLEACLYSD---------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI  752 (851)
Q Consensus       689 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl  752 (851)
                      ++|.++ +..++|||||++|+|.++++..               ...+++..+..++.||++|++||   |+++|+||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhCCeecCcc
Confidence            998764 5789999999999999998653               23478999999999999999999   8889999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          753 KPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       753 ~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+||++++++.+||+|||+|+....... .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654333 23345678999999999999999999999999999999998 99999875


Q ss_pred             CcC
Q 046438          831 FSG  833 (851)
Q Consensus       831 ~~~  833 (851)
                      ...
T Consensus       292 ~~~  294 (353)
T 4ase_A          292 KID  294 (353)
T ss_dssp             CCS
T ss_pred             CHH
Confidence            433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.2e-41  Score=354.16  Aligned_cols=200  Identities=27%  Similarity=0.398  Sum_probs=162.9

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC----eeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD----FKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  701 (851)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++|||||++++++.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4578889999999999999998 7899999999754322 122344555667889999999999997654    579999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG-----HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~-----h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      |||++|+|.++++.  ..+++..+.+++.|+++|++|||..     |..+|+||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            99999999999965  3588999999999999999999642     3459999999999999999999999999999876


Q ss_pred             CCCCCc---cccccccCccccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESM---KHTQTLATIGYMAPEYGREG------QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......   .....+||+.|+|||++.+.      .++.++|||||||++|||+||+.||..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            433221   22345799999999998754      367899999999999999999887654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-40  Score=355.19  Aligned_cols=202  Identities=23%  Similarity=0.329  Sum_probs=172.1

Q ss_pred             HHHhcCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          622 LQATDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       622 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      ....++|++.+.||+|+||+||+|+++    .++.||+|++....  ...++.+|+++++.+ +|||||++++++.+.++
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            345678999999999999999999873    36789999986543  335688999999998 69999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccCccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKL  775 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~a~~  775 (851)
                      .|+||||+++|+|.+++.    .+++..+..++.||+.|++||   |++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999999883    488999999999999999999   88999999999999999876 7999999999976


Q ss_pred             cCCCCC---------------------------ccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          776 LSGDES---------------------------MKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       776 ~~~~~~---------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      ......                           ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            532211                           112345799999999998775 5899999999999999999999999


Q ss_pred             CccCc
Q 046438          828 DEIFS  832 (851)
Q Consensus       828 ~~~~~  832 (851)
                      ....+
T Consensus       248 ~~~~~  252 (361)
T 4f9c_A          248 YKASD  252 (361)
T ss_dssp             SCCSS
T ss_pred             CCCCC
Confidence            65443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2e-39  Score=363.38  Aligned_cols=217  Identities=16%  Similarity=0.169  Sum_probs=155.4

Q ss_pred             ccccCCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhc
Q 046438            6 TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFS   85 (851)
Q Consensus         6 ~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~   85 (851)
                      ++.-|.+++++++|++|++++|++++. | .+..+++|++|+|++|++++. ++..+++|++|++++|++++ ++   ++
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~L~~L~Ls~N~l~~-~~---~~  103 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-DLSQNTNLTYLACDSNKLTN-LD---VT  103 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC---CT
T ss_pred             CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-ccccCCCCCEEECcCCCCce-ee---cC
Confidence            344555677888899999999988864 5 688888999999999988875 58888888888888888884 44   67


Q ss_pred             CCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEE
Q 046438           86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKIL  165 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  165 (851)
                      .+++|++|+|++|++++. |  ++.+++|++|++++|.+++. +  ++.+++|++|++++|+..+.+  .+..+++|+.|
T Consensus       104 ~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L  175 (457)
T 3bz5_A          104 PLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL  175 (457)
T ss_dssp             TCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred             CCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence            788888888888888864 3  77888888888888888853 3  777888888888888554444  46677788888


Q ss_pred             EeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccc
Q 046438          166 QLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI  245 (851)
Q Consensus       166 ~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i  245 (851)
                      ++++|++++ ++   +..+++|++|++++|++++.   .+..+++|+.|++++|+++++ |  +..+++|++|++++|++
T Consensus       176 ~ls~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l  245 (457)
T 3bz5_A          176 DCSFNKITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPL  245 (457)
T ss_dssp             ECCSSCCCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCC
T ss_pred             ECCCCccce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcC
Confidence            888887774 33   34566666666666666643   245555666666666666553 2  55555555555555555


Q ss_pred             cC
Q 046438          246 TS  247 (851)
Q Consensus       246 ~~  247 (851)
                      +.
T Consensus       246 ~~  247 (457)
T 3bz5_A          246 TE  247 (457)
T ss_dssp             SC
T ss_pred             CC
Confidence            54

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2e-38  Score=358.48  Aligned_cols=151  Identities=27%  Similarity=0.433  Sum_probs=79.5

Q ss_pred             ccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceE
Q 046438          332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILM  411 (851)
Q Consensus       332 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~  411 (851)
                      +..+++|+.|++++|.+++..+  +..+++|+.|++++|++.+..+  +..+++|+.|++++|+++.++. +..+++|+.
T Consensus       239 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~  313 (466)
T 1o6v_A          239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTY  313 (466)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSE
T ss_pred             hhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCE
Confidence            3334444444444444443222  3444444444444444443222  4445555555555555554443 455555555


Q ss_pred             EEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcc
Q 046438          412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNIL  491 (851)
Q Consensus       412 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  491 (851)
                      |++++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++
T Consensus       314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~  387 (466)
T 1o6v_A          314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW  387 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred             EECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence            5555555554433  45555666666666666532  345666666666666666665444  56666666666666666


Q ss_pred             cc
Q 046438          492 SG  493 (851)
Q Consensus       492 ~~  493 (851)
                      ++
T Consensus       388 ~~  389 (466)
T 1o6v_A          388 TN  389 (466)
T ss_dssp             EC
T ss_pred             cC
Confidence            64

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-40  Score=355.64  Aligned_cols=201  Identities=27%  Similarity=0.389  Sum_probs=172.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec------CC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN------DD  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~  695 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++++.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999984 69999999997543  2345678899999999999999999998754      35


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..|+|||||+ |+|.+++.. ...+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 678888854 45799999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCC---CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDE---SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....   .....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            64321   2234457899999999998775 5689999999999999999999999753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-39  Score=368.42  Aligned_cols=198  Identities=28%  Similarity=0.378  Sum_probs=172.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHH---HHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESF---NAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++++..   .......   +.++++++.++|||||++++++++++..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999985 58999999997542   1122223   34466677789999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +|||||+||+|.+++... ..+++..+..++.||+.||+||   |++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       269 lVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            999999999999998654 4689999999999999999999   899999999999999999999999999999987643


Q ss_pred             CCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .   ...+.+||+.|+|||++.. ..|+.++|+||+||++|||++|+.||.+.
T Consensus       345 ~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          345 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             C---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             C---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3   2345789999999999964 57999999999999999999999999764

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3e-38  Score=357.09  Aligned_cols=344  Identities=29%  Similarity=0.399  Sum_probs=161.2

Q ss_pred             CCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccc
Q 046438           16 LSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSL   95 (851)
Q Consensus        16 l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L   95 (851)
                      +++++.|++++|.++. +|. +..+++|++|+|++|++++..++..+++|++|++++|+++ .+++  +..+++|++|+|
T Consensus        45 l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~L  119 (466)
T 1o6v_A           45 LDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIA-DITP--LANLTNLTGLTL  119 (466)
T ss_dssp             HHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEEC
T ss_pred             hccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchhhhccccCCEEECCCCccc-cChh--hcCCCCCCEEEC
Confidence            4556666666666652 332 5556666666666666665555555666666666666655 2332  455555555555


Q ss_pred             cccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccc
Q 046438           96 AFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS  175 (851)
Q Consensus        96 ~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  175 (851)
                      ++|.+++..+  +.++++|++|++++|.+.+ ++ .++.+++|++|+++ |.+.+..  .+.++++|+.|++++|.+++ 
T Consensus       120 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~-  191 (466)
T 1o6v_A          120 FNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD-  191 (466)
T ss_dssp             CSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC-
T ss_pred             CCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC-
Confidence            5555553321  5555555555555555542 22 24555555555553 3333221  14444445555544444432 


Q ss_pred             cchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhh
Q 046438          176 ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFI  255 (851)
Q Consensus       176 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  255 (851)
                                              .  ..+..+++|+.|++++|.+++..+  ++.+++|++|++++|+++.+       
T Consensus       192 ------------------------~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-------  236 (466)
T 1o6v_A          192 ------------------------I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-------  236 (466)
T ss_dssp             ------------------------C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-------
T ss_pred             ------------------------C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-------
Confidence                                    1  112333344444444444443322  33444445555544444432       


Q ss_pred             hhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCC
Q 046438          256 SSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRL  335 (851)
Q Consensus       256 ~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l  335 (851)
                      ..+..+++|++|++++|++                          .+..+  +..+++|+.|++++|.+.+..+  +..+
T Consensus       237 ~~l~~l~~L~~L~l~~n~l--------------------------~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l  286 (466)
T 1o6v_A          237 GTLASLTNLTDLDLANNQI--------------------------SNLAP--LSGLTKLTELKLGANQISNISP--LAGL  286 (466)
T ss_dssp             GGGGGCTTCSEEECCSSCC--------------------------CCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred             hhhhcCCCCCEEECCCCcc--------------------------ccchh--hhcCCCCCEEECCCCccCcccc--ccCC
Confidence            1223333333333333333                          11111  3444455555555555543322  4445


Q ss_pred             CCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEec
Q 046438          336 EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLS  415 (851)
Q Consensus       336 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls  415 (851)
                      ++|+.|++++|++++..+  +..+++|+.|++++|++.+..|  +..+++|++|++++|+++.++ .+..+++|+.|+++
T Consensus       287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~  361 (466)
T 1o6v_A          287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAG  361 (466)
T ss_dssp             TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECC
T ss_pred             CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCch-hhccCCCCCEEeCC
Confidence            555555555555544322  4444555555555555544333  344444555555555444442 34444445555555


Q ss_pred             CCCCCCCCccccccchhhhhhhccCCccc
Q 046438          416 SNPLSGSLPLEIGNLKVLVELYLSRNNLS  444 (851)
Q Consensus       416 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  444 (851)
                      +|++++..|  +..+++|+.|++++|+++
T Consensus       362 ~n~l~~~~~--~~~l~~L~~L~l~~n~~~  388 (466)
T 1o6v_A          362 HNQISDLTP--LANLTRITQLGLNDQAWT  388 (466)
T ss_dssp             SSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred             CCccCccch--hhcCCCCCEEeccCCccc
Confidence            554444333  444444444444444444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=365.64  Aligned_cols=327  Identities=21%  Similarity=0.195  Sum_probs=241.3

Q ss_pred             cccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhcccccccc
Q 046438          186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLK  265 (851)
Q Consensus       186 ~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~  265 (851)
                      ++++|+|++|++++..+..|.++++|+.|+|++|.++++.|..|.++++|++|+|++|+++.++..     .+..+++|+
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~  107 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG-----VFTGLSNLT  107 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT-----SSTTCTTCC
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc-----cccCCCCCC
Confidence            344444445555444455555556666666666666666566666666666666666666554321     233444444


Q ss_pred             EEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEccc
Q 046438          266 VLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLEN  345 (851)
Q Consensus       266 ~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  345 (851)
                      +|++++|++                          .+..|..|..+++|+.|++++|.+.+..+..|..+++|++|++++
T Consensus       108 ~L~Ls~n~i--------------------------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  161 (477)
T 2id5_A          108 KLDISENKI--------------------------VILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK  161 (477)
T ss_dssp             EEECTTSCC--------------------------CEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEES
T ss_pred             EEECCCCcc--------------------------ccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCC
Confidence            444444443                          334455666777777777777777766677777777777777777


Q ss_pred             ccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcC-ccCchhhcccCcceEEEecCCCCCCCCc
Q 046438          346 NQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNEL-TFVPSTFWNLTNILMVDLSSNPLSGSLP  424 (851)
Q Consensus       346 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  424 (851)
                      |.+++..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+ ..+|.......+|+.|+|++|++++..+
T Consensus       162 n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  241 (477)
T 2id5_A          162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY  241 (477)
T ss_dssp             CCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCH
T ss_pred             CcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCH
Confidence            777776666777777888888888877777777778888888888887754 3666666666688889999998886555


Q ss_pred             cccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccccccc
Q 046438          425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY  504 (851)
Q Consensus       425 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  504 (851)
                      ..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++
T Consensus       242 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  321 (477)
T 2id5_A          242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN  321 (477)
T ss_dssp             HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGG
T ss_pred             HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcc
Confidence            67888899999999999998777888999999999999999999888999999999999999999999877888899999


Q ss_pred             ccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          505 LKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       505 L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      |+.|+|++|+|+|+|+..+.+.+.....+.++...|+.|
T Consensus       322 L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          322 LETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             CCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             cCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            999999999999999765545555556778888888877

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.2e-38  Score=356.91  Aligned_cols=365  Identities=21%  Similarity=0.205  Sum_probs=239.0

Q ss_pred             CCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCc
Q 046438           27 NQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPR  106 (851)
Q Consensus        27 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~  106 (851)
                      ....+..+..++.+++|++|+|++|++++.+.+..+++|++|++++|+++ .+|   ++.+++|++|+|++|++++. + 
T Consensus        28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~n~l~-~~~---~~~l~~L~~L~Ls~N~l~~~-~-  101 (457)
T 3bz5_A           28 FEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-TLD---LSQNTNLTYLACDSNKLTNL-D-  101 (457)
T ss_dssp             TTCCTTSEEEHHHHTTCCEEECCSSCCCCCTTGGGCTTCSEEECCSSCCS-CCC---CTTCTTCSEEECCSSCCSCC-C-
T ss_pred             cCcCcccccChhHcCCCCEEEccCCCcccChhhcccCCCCEEEccCCcCC-eEc---cccCCCCCEEECcCCCCcee-e-
Confidence            33444555667778888888888888887655777788888888888877 344   66677777777777777754 2 


Q ss_pred             cccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccc
Q 046438          107 EIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPN  186 (851)
Q Consensus       107 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~  186 (851)
                       ++++++|++|++++|++++ +|  ++.+++|++|++++|++++.   .+..+++|+.|++++|+..+.+          
T Consensus       102 -~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~----------  164 (457)
T 3bz5_A          102 -VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL----------  164 (457)
T ss_dssp             -CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC----------
T ss_pred             -cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc----------
Confidence             6777777777777777774 33  66777777777777777654   2556666666666666433232          


Q ss_pred             ccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccE
Q 046438          187 LELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV  266 (851)
Q Consensus       187 L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~  266 (851)
                                       .+..+++|+.|++++|+++++.   ++.+++|++|++++|+++.++        +..+++|+.
T Consensus       165 -----------------~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~~--------l~~l~~L~~  216 (457)
T 3bz5_A          165 -----------------DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLD--------LNQNIQLTF  216 (457)
T ss_dssp             -----------------CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCCC--------CTTCTTCSE
T ss_pred             -----------------ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCCeec--------cccCCCCCE
Confidence                             1334455555555555555432   555666666666666665431        334445555


Q ss_pred             EeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccc
Q 046438          267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENN  346 (851)
Q Consensus       267 L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  346 (851)
                      |++++|++.                          + +|  ++.+++|+.|++++|++++..   +..+++|+.|++++|
T Consensus       217 L~Ls~N~l~--------------------------~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n  264 (457)
T 3bz5_A          217 LDCSSNKLT--------------------------E-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT  264 (457)
T ss_dssp             EECCSSCCS--------------------------C-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC
T ss_pred             EECcCCccc--------------------------c-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC
Confidence            555444442                          2 22  455666666677766666543   344566777776655


Q ss_pred             cccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCc-cCchhhcccCcceEEEecCCCCCCCCcc
Q 046438          347 QLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNILMVDLSSNPLSGSLPL  425 (851)
Q Consensus       347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  425 (851)
                      .              |+.|++++|.+.+.+|  ++.+++|+.|++++|... .+|.   ...+|+.|++++|        
T Consensus       265 ~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~--------  317 (457)
T 3bz5_A          265 D--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN--------  317 (457)
T ss_dssp             C--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC--------
T ss_pred             C--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc--------
Confidence            3              3456677777665555  456677777777777543 4443   2344555544444        


Q ss_pred             ccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccc
Q 046438          426 EIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYL  505 (851)
Q Consensus       426 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  505 (851)
                           ++|++|++++|++++. +  ++.+++|+.|++++|+|++        ++.|+.|++++|.++|.     ..+..|
T Consensus       318 -----~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l  376 (457)
T 3bz5_A          318 -----PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITM  376 (457)
T ss_dssp             -----TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEEC
T ss_pred             -----ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeec
Confidence                 5778888888888863 3  8888889999999998885        24677778889988875     356678


Q ss_pred             cceeccCccccccCCCC
Q 046438          506 KYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       506 ~~l~l~~N~l~~~~p~~  522 (851)
                      ..+++++|+++|.+|..
T Consensus       377 ~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          377 PKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             CCBCCBTTBEEEECCTT
T ss_pred             CccccccCcEEEEcChh
Confidence            88899999999998853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.5e-39  Score=366.94  Aligned_cols=200  Identities=22%  Similarity=0.371  Sum_probs=182.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++.......+.+.+|+++++.++|||||++++++.+.+..++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999985 68999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC--CcEEEeeccCccccCCCCCc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED--MVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~--~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +||+|.+++......+++..+..++.||++||+||   |++||+||||||+||+++.+  +.+||+|||+|+......  
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            99999999977667899999999999999999999   88999999999999999854  899999999999875432  


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~  359 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  359 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            334568999999999999999999999999999999999999999764

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=351.54  Aligned_cols=348  Identities=23%  Similarity=0.225  Sum_probs=229.8

Q ss_pred             ccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecc
Q 046438           91 QFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNN  170 (851)
Q Consensus        91 ~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n  170 (851)
                      +.++.+++.++ .+|..+.  ++++.|+|++|.+++..+..|.++++|++|+|++|++.+..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            35566666665 4444442  46677777777776666666667777777777777666666666666666666666666


Q ss_pred             ccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCC
Q 046438          171 TLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNH  250 (851)
Q Consensus       171 ~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  250 (851)
                      +++ .++...+..+++|++                        |+|++|.++++.+..|.++++|++|+|++|.++.   
T Consensus        91 ~l~-~~~~~~~~~l~~L~~------------------------L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~---  142 (477)
T 2id5_A           91 RLK-LIPLGVFTGLSNLTK------------------------LDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY---  142 (477)
T ss_dssp             CCC-SCCTTSSTTCTTCCE------------------------EECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE---
T ss_pred             cCC-ccCcccccCCCCCCE------------------------EECCCCccccCChhHccccccCCEEECCCCccce---
Confidence            665 333333333334444                        4444444443444444444444444444443332   


Q ss_pred             cchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCc
Q 046438          251 ELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPS  330 (851)
Q Consensus       251 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~  330 (851)
                                                                          ..+..|.++++|+.|++++|.+++..+.
T Consensus       143 ----------------------------------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A          143 ----------------------------------------------------ISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             ----------------------------------------------------ECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             ----------------------------------------------------eChhhccCCCCCCEEECCCCcCcccChh
Confidence                                                                2223344444455555555555444444


Q ss_pred             cccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCch-hhcccCcc
Q 046438          331 TLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNI  409 (851)
Q Consensus       331 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L  409 (851)
                      .+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+.+.++.......+|++|++++|+++.+|. .+..+++|
T Consensus       171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  250 (477)
T 2id5_A          171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL  250 (477)
T ss_dssp             HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred             HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence            45555555555555555555555555566666666666665555555555555688888888888888874 67888999


Q ss_pred             eEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCC
Q 046438          410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN  489 (851)
Q Consensus       410 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  489 (851)
                      +.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  330 (477)
T 2id5_A          251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN  330 (477)
T ss_dssp             CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred             CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence            99999999998877888999999999999999999888999999999999999999999877788899999999999999


Q ss_pred             cccccCCccccccccccceeccCccccccCCCC
Q 046438          490 ILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       490 ~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      .+...-+ ...-...+..+.+.++...|..|..
T Consensus       331 ~l~c~c~-~~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          331 PLACDCR-LLWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             CEECSGG-GHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             CccCccc-hHhHHhhhhccccCccCceeCCchH
Confidence            9985432 2222334455778888888887753

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.3e-36  Score=335.78  Aligned_cols=335  Identities=22%  Similarity=0.225  Sum_probs=268.5

Q ss_pred             CCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceE
Q 046438          159 ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL  238 (851)
Q Consensus       159 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  238 (851)
                      +++++.|++++|.++ .+|..++..+++|++|+|++|.+++..+..+.++++|+.|+|++|.++++.|..|+++++|++|
T Consensus        44 l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            567788888888876 6777777778888888888888877777777888888888888888888777778888888888


Q ss_pred             eccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEE
Q 046438          239 NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIR  318 (851)
Q Consensus       239 ~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~  318 (851)
                      +|++|+++.++..     .+..+++|++|++++|++                          ++..|..+..+++|++|+
T Consensus       123 ~L~~n~l~~l~~~-----~~~~l~~L~~L~L~~n~l--------------------------~~~~~~~~~~l~~L~~L~  171 (390)
T 3o6n_A          123 VLERNDLSSLPRG-----IFHNTPKLTTLSMSNNNL--------------------------ERIEDDTFQATTSLQNLQ  171 (390)
T ss_dssp             ECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCC--------------------------CBCCTTTTSSCTTCCEEE
T ss_pred             ECCCCccCcCCHH-----HhcCCCCCcEEECCCCcc--------------------------CccChhhccCCCCCCEEE
Confidence            8888887765432     134455555555555544                          445566778888888888


Q ss_pred             ecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCcc
Q 046438          319 LGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF  398 (851)
Q Consensus       319 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  398 (851)
                      +++|.+++.   .+..+++|+.|++++|.+++.     ....+|+.|++++|.+... |..  ..++|+.|++++|+++.
T Consensus       172 l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~  240 (390)
T 3o6n_A          172 LSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTD  240 (390)
T ss_dssp             CCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcc
Confidence            888888754   255678888888888888743     3346788999999988854 332  24789999999999998


Q ss_pred             CchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCC
Q 046438          399 VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDL  478 (851)
Q Consensus       399 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  478 (851)
                      . ..+..+++|++|+|++|.+++..|..|..+++|++|++++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+
T Consensus       241 ~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l  317 (390)
T 3o6n_A          241 T-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF  317 (390)
T ss_dssp             C-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred             c-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcccccc
Confidence            7 468899999999999999998889999999999999999999994 6777889999999999999998 678889999


Q ss_pred             CCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          479 ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       479 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ++|+.|+|++|++++. |  +..+++|+.|++++|+|+|.+.. ..+..+....+.+++..|..+
T Consensus       318 ~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          318 DRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             TTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             CcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            9999999999999954 4  77889999999999999998743 356777778888888888866

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.6e-37  Score=342.37  Aligned_cols=210  Identities=24%  Similarity=0.363  Sum_probs=184.2

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeec
Q 046438          618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTN  693 (851)
Q Consensus       618 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  693 (851)
                      +.++....++|++.+.||+|+||+||+|++.. ++.||+|+++....   ...+.+.+|.+++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44555567899999999999999999999864 78899999975321   223348899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       694 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                      .+..++||||+++|+|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999977667799999999999999999999   8889999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +.............+||+.|+|||++.     ...++.++||||+||++|||++|+.||...
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            876554444445568999999999986     567899999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.8e-36  Score=316.92  Aligned_cols=200  Identities=30%  Similarity=0.423  Sum_probs=180.5

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999987 46899999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++|+|.+++...  .+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence            9999999998654  588899999999999999999   888999999999999999999999999999987654332 3


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            44567999999999999999999999999999999999999999653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=335.17  Aligned_cols=211  Identities=26%  Similarity=0.389  Sum_probs=184.6

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeee
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCT  692 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  692 (851)
                      .+++.....++|++.+.||+|+||+||+|++. +|+.||+|+++...   ....+.+.+|.+++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556788999999999999999999985 68999999997532   223345889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          693 NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       693 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      +.+..|+||||++||+|.+++...+..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999999977666789999999999999999999   888999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCccccCccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGR-------EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+.............+||+.|+|||++.       ...++.++||||+||++|||++|+.||...
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            9877554443344568999999999987       356899999999999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.9e-36  Score=323.46  Aligned_cols=217  Identities=39%  Similarity=0.636  Sum_probs=189.6

Q ss_pred             hccccHHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeee
Q 046438          613 WRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSC  691 (851)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~  691 (851)
                      ...++++++....++|++.+.||+|+||+||+|++.+++.||+|+++..... ....+.+|++++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            3567889999999999999999999999999999878999999998754322 223689999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          692 TNDDFKALVLDYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       692 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                      .+.+..++||||+++|+|.+++...   ...+++..+..++.|++.|++|||..+..||+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            9999999999999999999998763   3348999999999999999999954444499999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       769 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |||+++..............||+.|+|||++.+..++.++||||+||++|||++|+.||+.
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence            9999987754444444556799999999999888899999999999999999999999963

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-36  Score=320.68  Aligned_cols=200  Identities=27%  Similarity=0.367  Sum_probs=177.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57999999999999999999985 58999999997642   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++||+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.......
T Consensus        85 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999999888643 4688999999999999999999   888999999999999999999999999999986433222


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence             334568999999999999999999999999999999999999999753

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-35  Score=345.48  Aligned_cols=335  Identities=22%  Similarity=0.226  Sum_probs=272.8

Q ss_pred             CCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceE
Q 046438          159 ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKEL  238 (851)
Q Consensus       159 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  238 (851)
                      +++++.|++++|.+. .+|..++..+++|++|+|++|.+++..|..+.++++|+.|+|++|.+++++|..|+++++|++|
T Consensus        50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            467778888888776 6677777778888888888888887777778888888888888888888888888888888888


Q ss_pred             eccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEE
Q 046438          239 NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIR  318 (851)
Q Consensus       239 ~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~  318 (851)
                      +|++|.++.++..     .+..+++|++|++++|                          ++++..|..|+.+++|++|+
T Consensus       129 ~L~~n~l~~l~~~-----~~~~l~~L~~L~Ls~N--------------------------~l~~~~~~~~~~l~~L~~L~  177 (597)
T 3oja_B          129 VLERNDLSSLPRG-----IFHNTPKLTTLSMSNN--------------------------NLERIEDDTFQATTSLQNLQ  177 (597)
T ss_dssp             ECCSSCCCCCCTT-----TTTTCTTCCEEECCSS--------------------------CCCBCCTTTTTTCTTCCEEE
T ss_pred             EeeCCCCCCCCHH-----HhccCCCCCEEEeeCC--------------------------cCCCCChhhhhcCCcCcEEE
Confidence            8888887765432     2344555555555544                          44556677788899999999


Q ss_pred             ecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCcc
Q 046438          319 LGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF  398 (851)
Q Consensus       319 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  398 (851)
                      +++|.+++..   +..+++|+.|++++|.+++.     ....+|+.|++++|.+....+..   .++|+.|+|++|.++.
T Consensus       178 L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~  246 (597)
T 3oja_B          178 LSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD  246 (597)
T ss_dssp             CTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC
T ss_pred             CcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC
Confidence            9999988653   55678899999999988753     34568999999999988443322   3689999999999997


Q ss_pred             CchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCC
Q 046438          399 VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDL  478 (851)
Q Consensus       399 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  478 (851)
                      . ..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+
T Consensus       247 ~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l  323 (597)
T 3oja_B          247 T-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF  323 (597)
T ss_dssp             C-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred             C-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccC
Confidence            5 678899999999999999999999999999999999999999995 6778888999999999999999 788889999


Q ss_pred             CCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          479 ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       479 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ++|+.|+|++|++++. |  +..+++|+.|++++|+|+|.++. .++..+....+.+++..|+.+
T Consensus       324 ~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          324 DRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             TTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            9999999999999964 3  67789999999999999998743 457777788889999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-36  Score=333.14  Aligned_cols=207  Identities=23%  Similarity=0.371  Sum_probs=180.5

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecC
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      .++....++|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344445678999999999999999999985 58899999997532   12234578999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      +..++||||++||+|.+++..  ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            999999999999999998865  3588899999999999999999   88899999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQ----ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .............+||+.|+|||++.+..    ++.++||||+||++|||++|+.||...
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            76554433445678999999999987665    789999999999999999999999753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9e-36  Score=319.17  Aligned_cols=200  Identities=26%  Similarity=0.430  Sum_probs=178.1

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .++|++.+.||+|+||.||+|++ .+|+.||+|++....  ....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999998 579999999997653  334567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            999999999988654 4588999999999999999999   88899999999999999999999999999998764332 


Q ss_pred             ccccccccCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQIS-TEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..+. .++||||+||++|||++|+.||++.
T Consensus       169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  217 (328)
T 3fe3_A          169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ  217 (328)
T ss_dssp             -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence             34456899999999999887765 7899999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=316.24  Aligned_cols=204  Identities=25%  Similarity=0.431  Sum_probs=181.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            57899999999999999999985 58899999987666666788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc--
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM--  782 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  782 (851)
                      ++|+|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++........  
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            99999999988777899999999999999999999   8889999999999999999999999999999876432211  


Q ss_pred             -----------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          783 -----------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       783 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                                 ......||+.|+|||++.+..++.++||||+||++|||++|..||.....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence                       11145799999999999999999999999999999999999999876443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=9.6e-36  Score=317.30  Aligned_cols=257  Identities=34%  Similarity=0.591  Sum_probs=243.3

Q ss_pred             cccEEEeecCcccc--CCCcccccccCCcEEEecC-CCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEE
Q 046438          289 SMERFYLHNCNIRG--SIPKEMGNLINLIIIRLGY-NKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV  365 (851)
Q Consensus       289 ~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  365 (851)
                      .++.|++++|++++  .+|..+.++++|++|++++ |.+.+.+|..|.++++|++|++++|.+++..|..+..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            67888888888888  8899999999999999995 99999999999999999999999999999999999999999999


Q ss_pred             EccCcccCCCCCccccCCccccceecccCcCc-cCchhhcccC-cceEEEecCCCCCCCCccccccchhhhhhhccCCcc
Q 046438          366 YLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLT-NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNL  443 (851)
Q Consensus       366 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  443 (851)
                      ++++|++.+.+|..|..+++|++|++++|+++ .+|..+..++ +|+.|++++|++++..|..+..++ |++|++++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            99999999999999999999999999999999 8899999998 999999999999999999999998 99999999999


Q ss_pred             cccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCC
Q 046438          444 SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGG  523 (851)
Q Consensus       444 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~  523 (851)
                      ++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|...
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            999999999999999999999999976665 8899999999999999999999999999999999999999999999998


Q ss_pred             cccccCcccccCCcCccCCCCCCCCCC
Q 046438          524 TLANFTSESFMGNDLLCGSPHLQVPPC  550 (851)
Q Consensus       524 ~~~~l~~~~~~~n~~~c~~~~~~~~~c  550 (851)
                      .+..+....+.+|+++||.|   .++|
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p---~~~C  312 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred             cccccChHHhcCCCCccCCC---CCCC
Confidence            99999999999999999987   4456

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-36  Score=323.56  Aligned_cols=201  Identities=25%  Similarity=0.374  Sum_probs=173.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|.++++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999985 58899999997642   33456688999999988 69999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||++||+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999988654 5689999999999999999999   8889999999999999999999999999999864322


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       178 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          178 G-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            2 2344568999999999999989999999999999999999999999763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-35  Score=314.19  Aligned_cols=203  Identities=28%  Similarity=0.465  Sum_probs=173.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999984 58899999986533   33456789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999998654 4689999999999999999999   88899999999999999999999999999998765443


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            333444679999999999999999999999999999999999999997643

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=3.6e-35  Score=324.10  Aligned_cols=153  Identities=22%  Similarity=0.198  Sum_probs=79.2

Q ss_pred             CCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEec
Q 046438          336 EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLS  415 (851)
Q Consensus       336 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls  415 (851)
                      ++|+.|++++|.+++.  ..+..+++|+.|++++|++.+..|..|..+++|++|++++|+++.+|..+..+++|+.|+|+
T Consensus       226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~  303 (390)
T 3o6n_A          226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLS  303 (390)
T ss_dssp             SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECC
T ss_pred             ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECC
Confidence            3455555555555432  34444555555555555555444555555555555555555555554444444444444444


Q ss_pred             CCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccC
Q 046438          416 SNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII  495 (851)
Q Consensus       416 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  495 (851)
                      +|+++                         .+|..+..+++|+.|+|++|+++. ++  +..+++|+.|++++|++++.-
T Consensus       304 ~n~l~-------------------------~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~  355 (390)
T 3o6n_A          304 HNHLL-------------------------HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNS  355 (390)
T ss_dssp             SSCCC-------------------------CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHH
T ss_pred             CCcce-------------------------ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchh
Confidence            44444                         233344445556666666666653 22  555667777777777776532


Q ss_pred             CccccccccccceeccCccccccCC
Q 046438          496 PSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       496 p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      ...  -+..+....+..+...|..|
T Consensus       356 ~~~--~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          356 LRA--LFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             HHH--HTTTCCTTTBCCCCSCCCTT
T ss_pred             HHH--HHHHHHhhcccccCceeccc
Confidence            211  12334444455666555544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.6e-35  Score=314.38  Aligned_cols=211  Identities=27%  Similarity=0.366  Sum_probs=186.1

Q ss_pred             ccccHHHHHHHhcC----------CCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCC
Q 046438          614 RRFSYQELLQATDQ----------FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR  682 (851)
Q Consensus       614 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  682 (851)
                      ..++++++..+.+.          |+..+.||+|+||.||+|++. +|+.||||+++.......+.+.+|++++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677887777654          677789999999999999986 6999999999876666667899999999999999


Q ss_pred             cccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC
Q 046438          683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED  762 (851)
Q Consensus       683 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~  762 (851)
                      ||+++++++...+..++||||+++++|.+++..  ..+++..+..++.|+++|++||   |++||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCC
Confidence            999999999999999999999999999998853  4689999999999999999999   78899999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          763 MVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       763 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +.+||+|||++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999987654322 234567999999999999999999999999999999999999999653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-35  Score=324.53  Aligned_cols=201  Identities=25%  Similarity=0.365  Sum_probs=176.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999985 57889999998653   22334578899999887 89999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|..++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999888653 4689999999999999999999   8889999999999999999999999999999864322


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            2 2344578999999999999999999999999999999999999999653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-36  Score=320.63  Aligned_cols=214  Identities=35%  Similarity=0.611  Sum_probs=186.9

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD  695 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  695 (851)
                      +++.++..+.++|++.+.||+|+||+||+|++.+++.||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44445556778999999999999999999998889999999988766666788999999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCC---CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          696 FKALVLDYMPKGSLEACLYSDN---SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                      ..++||||+++|+|.+++....   ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999886532   3588999999999999999999   788999999999999999999999999999


Q ss_pred             ccccCCCC-CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          773 AKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       773 a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~  246 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP  246 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence            98654322 1222345689999999999888999999999999999999999999976543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-35  Score=313.67  Aligned_cols=197  Identities=27%  Similarity=0.418  Sum_probs=177.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57999999999999999999985 68999999997643   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....   
T Consensus        86 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            999999999998654 4688999999999999999999   889999999999999999999999999999987543   


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence             223467999999999999999999999999999999999999999653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-35  Score=317.97  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=177.9

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCee
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  697 (851)
                      ...++|++.+.||+|+||+||+|++. +|+.||+|+++...   ....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999985 58899999997643   23456688899999887 899999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||++||+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            9999999999999988653 4688999999999999999999   88899999999999999999999999999998643


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence            222 2344568999999999999999999999999999999999999999753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.4e-35  Score=317.50  Aligned_cols=200  Identities=24%  Similarity=0.389  Sum_probs=178.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh------hHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG------ALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .+.|++.+.||+|+||+||+|++. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999985 5899999999765322      246789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC----cEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM----VARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~----~~kl~Dfg~a  773 (851)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999854 45689999999999999999999   888999999999999998776    7999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            8765432  234567999999999999999999999999999999999999999763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.1e-35  Score=319.37  Aligned_cols=199  Identities=28%  Similarity=0.400  Sum_probs=176.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67999999999999999999985 58889999997543   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++||+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|......  
T Consensus        95 e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             CCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence            99999999998864 45689999999999999999999   8889999999999999999999999999999876432  


Q ss_pred             ccccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......||+.|+|||++..   ..++.++||||+||++|||++|+.||...
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            23445689999999999864   46899999999999999999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-35  Score=314.43  Aligned_cols=200  Identities=20%  Similarity=0.326  Sum_probs=179.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999985 58889999987553 3446788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC--CCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE--DMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      +++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.  ++.+||+|||+++...... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            999999999977666799999999999999999999   8889999999999999987  7899999999998765432 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  206 (321)
T 1tki_A          159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence             234457899999999999888999999999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.9e-35  Score=312.83  Aligned_cols=204  Identities=25%  Similarity=0.408  Sum_probs=175.7

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||+||+|++.+|+.||+|+++....  .....+.+|++++++++||||+++++++.+++..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            3578999999999999999999998899999999875432  23467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++ ++.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            99975 78787777667799999999999999999999   888999999999999999999999999999987643222


Q ss_pred             ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          782 MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                       ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....+
T Consensus       175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  225 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD  225 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred             -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence             2334578999999999876 5689999999999999999999999976443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.8e-35  Score=316.71  Aligned_cols=199  Identities=26%  Similarity=0.372  Sum_probs=176.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|.++++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999985 58899999998653   23456688999999988 899999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus        89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            9999999999988653 4688999999999999999999   88899999999999999999999999999998643222


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      . .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       165 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          165 D-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            2 33456899999999999999999999999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-35  Score=309.03  Aligned_cols=201  Identities=28%  Similarity=0.482  Sum_probs=180.5

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||+||+|++.+++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57899999999999999999998899999999976533 34678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++......+++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|||++............
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence            9999999987777799999999999999999999   8889999999999999999999999999999876543333333


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            4567888999999998999999999999999999999 99999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.6e-35  Score=316.30  Aligned_cols=201  Identities=23%  Similarity=0.320  Sum_probs=177.6

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||+||+|++.. ++.||+|+++...   ....+.+.+|.+++..+ +||+|+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4689999999999999999999854 7889999997653   23456788999999988 79999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||++||+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999988653 4588999999999999999999   8889999999999999999999999999999864322


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence            2 2344568999999999999999999999999999999999999999753

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.6e-34  Score=310.20  Aligned_cols=307  Identities=25%  Similarity=0.395  Sum_probs=177.0

Q ss_pred             CCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccc
Q 046438           13 LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQF   92 (851)
Q Consensus        13 l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~   92 (851)
                      +..+++|++|++++|.++. +| .+..+++|++|+|++|++++..++..+++|++|++++|.++ .++  .|..+++|++
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~~~~l~~L~~L~L~~n~i~-~~~--~~~~l~~L~~  114 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT-DIS--ALQNLTNLRE  114 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCG--GGTTCTTCSE
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchhhhcCCcCCEEEccCCccc-Cch--HHcCCCcCCE
Confidence            3456667777777777663 33 26666777777777776666555666666666666666665 333  2556666666


Q ss_pred             ccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccc
Q 046438           93 LSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL  172 (851)
Q Consensus        93 L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l  172 (851)
                      |+|++|.+++..+  +..+++|++|++++|.....++ .+..+++|++|++++|++.+..+  +..+++|+.|++++|.+
T Consensus       115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred             EECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence            6666666653322  5566666666666664442222 25555666666666555554322  44555555555555555


Q ss_pred             ccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcc
Q 046438          173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHEL  252 (851)
Q Consensus       173 ~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  252 (851)
                      .                         +..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|.++..+   
T Consensus       190 ~-------------------------~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~---  237 (347)
T 4fmz_A          190 E-------------------------DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS---  237 (347)
T ss_dssp             C-------------------------CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG---
T ss_pred             c-------------------------cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc---
Confidence            4                         2222  4444555555555555554433  555566666666666665432   


Q ss_pred             hhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccc
Q 046438          253 SFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTL  332 (851)
Q Consensus       253 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~  332 (851)
                          .+..+++|++|++++|++.+                          .  ..+..+++|++|++++|.+++.  ..+
T Consensus       238 ----~~~~l~~L~~L~l~~n~l~~--------------------------~--~~~~~l~~L~~L~l~~n~l~~~--~~~  283 (347)
T 4fmz_A          238 ----PLANLSQLTWLEIGTNQISD--------------------------I--NAVKDLTKLKMLNVGSNQISDI--SVL  283 (347)
T ss_dssp             ----GGTTCTTCCEEECCSSCCCC--------------------------C--GGGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred             ----chhcCCCCCEEECCCCccCC--------------------------C--hhHhcCCCcCEEEccCCccCCC--hhh
Confidence                14455555555555554421                          0  2344555666666666666543  346


Q ss_pred             cCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCc
Q 046438          333 SRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT  397 (851)
Q Consensus       333 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  397 (851)
                      ..+++|++|++++|.+++..+..+..+++|+.|++++|++++..|  +..+++|++|++++|.|+
T Consensus       284 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             cCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            666677777777777766666666777777777777777765544  666777777777777664

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-35  Score=318.24  Aligned_cols=201  Identities=21%  Similarity=0.341  Sum_probs=180.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999885 5889999999876555567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC--CCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE--DMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      +++|+|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.  ++.+||+|||+++...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            999999999877666799999999999999999999   8889999999999999974  5789999999998765432 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  253 (387)
T 1kob_A          206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE  253 (387)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence             223457999999999999999999999999999999999999999763

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-35  Score=320.73  Aligned_cols=203  Identities=16%  Similarity=0.189  Sum_probs=174.8

Q ss_pred             HhcCCCccceeccccceEEEEEE------EcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC---CCcccceeeeeecC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGR------FLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR---HRNLVRIISSCTND  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  694 (851)
                      ..++|++.+.||+|+||+||+|+      ...++.||+|+++...   ...+.+|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34679999999999999999994      3468899999997553   345777788877776   99999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---------
Q 046438          695 DFKALVLDYMPKGSLEACLYS----DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---------  761 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---------  761 (851)
                      +..++||||+++|+|.+++..    ....+++..++.++.||++|++||   |++||+||||||+||+++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999864    356799999999999999999999   8899999999999999998         


Q ss_pred             --CCcEEEeeccCccccCC-CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          762 --DMVARLGDFGIAKLLSG-DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       762 --~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                        ++.+||+|||+|+.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence              89999999999976432 122234456799999999999999999999999999999999999999965443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-35  Score=306.36  Aligned_cols=203  Identities=25%  Similarity=0.464  Sum_probs=181.4

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||+||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467999999999999999999998888999999976533 3467899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++......+++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|||.+...........
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            99999999977666789999999999999999999   888999999999999999999999999999987655444344


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||+...
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT  210 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence            44556788999999998899999999999999999999 999997543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-35  Score=314.07  Aligned_cols=213  Identities=23%  Similarity=0.382  Sum_probs=179.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999985 688999999875432 233568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-C
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-S  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  781 (851)
                      |+++|+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++...... .
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999998854 45689999999999999999999   88999999999999999999999999999997653222 1


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWV  841 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  841 (851)
                      .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|.
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  222 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK  222 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence            22334679999999999987775 7789999999999999999999987655444444443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.2e-34  Score=309.17  Aligned_cols=308  Identities=25%  Similarity=0.343  Sum_probs=235.3

Q ss_pred             cccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCC
Q 046438          155 TLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRN  234 (851)
Q Consensus       155 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~  234 (851)
                      .+..+++|+.|++++|.+. .++.  +..+++|++|++++|++++..+  +.++++|++|++++|.++.+  ..|.++++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             cchhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence            3456778888888888886 3332  4467788888888887775444  67777777777777777764  35777777


Q ss_pred             cceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCC
Q 046438          235 LKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL  314 (851)
Q Consensus       235 L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L  314 (851)
                      |++|++++|.++..+       .+..+++|+.|++++|...                          .. +..+..+++|
T Consensus       112 L~~L~l~~n~i~~~~-------~~~~l~~L~~L~l~~n~~~--------------------------~~-~~~~~~l~~L  157 (347)
T 4fmz_A          112 LRELYLNEDNISDIS-------PLANLTKMYSLNLGANHNL--------------------------SD-LSPLSNMTGL  157 (347)
T ss_dssp             CSEEECTTSCCCCCG-------GGTTCTTCCEEECTTCTTC--------------------------CC-CGGGTTCTTC
T ss_pred             CCEEECcCCcccCch-------hhccCCceeEEECCCCCCc--------------------------cc-ccchhhCCCC
Confidence            777777777776532       2556666666666666432                          12 2337778888


Q ss_pred             cEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccC
Q 046438          315 IIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASN  394 (851)
Q Consensus       315 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  394 (851)
                      ++|++++|.+.+..+  +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|
T Consensus       158 ~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n  231 (347)
T 4fmz_A          158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN  231 (347)
T ss_dssp             CEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             cEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence            888888888875544  7788888888888888876443  7788888888888888885544  778888889999999


Q ss_pred             cCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCccc
Q 046438          395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS  474 (851)
Q Consensus       395 ~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  474 (851)
                      +++.++. +..+++|+.|++++|.+++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..
T Consensus       232 ~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~  306 (347)
T 4fmz_A          232 KITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEV  306 (347)
T ss_dssp             CCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred             ccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhH
Confidence            8888876 78888999999999988853  4678888999999999988853  45888899999999999998888888


Q ss_pred             ccCCCCCCEEECCCCcccccCCccccccccccceeccCcccc
Q 046438          475 IGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE  516 (851)
Q Consensus       475 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  516 (851)
                      ++.+++|++|+|++|++++..|  +..+++|+.|++++|+++
T Consensus       307 l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            9999999999999999997666  888999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.3e-35  Score=310.09  Aligned_cols=203  Identities=31%  Similarity=0.545  Sum_probs=169.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||+||+|++ .|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356799999999999999999987 78899999987553  334567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCC--CcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          702 DYMPKGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ||+++|+|.+++.....  .+++..++.++.||++|++||   |++|  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999865432  388999999999999999999   8888  9999999999999999999999999997643


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~  243 (309)
T 3p86_A          191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN  243 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             cc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32 222334678999999999999999999999999999999999999997643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.1e-35  Score=314.54  Aligned_cols=197  Identities=25%  Similarity=0.338  Sum_probs=177.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57999999999999999999985 68999999997543   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999998654 4588999999999999999999   8899999999999999999999999999999876432  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  241 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence              23467999999999999999999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.2e-35  Score=317.32  Aligned_cols=204  Identities=27%  Similarity=0.513  Sum_probs=176.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc--------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      .++|++.+.||+|+||+||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467999999999999999999873        34579999997553 33456799999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 DFKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      +..++||||+++|+|.+++....               ..+++..+..++.||+.|++||   |++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchhhEEE
Confidence            99999999999999999987643               3478899999999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          760 DEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999986644322 12233467889999999999999999999999999999999 999997643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-34  Score=314.60  Aligned_cols=201  Identities=25%  Similarity=0.437  Sum_probs=176.9

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..++|++.+.||+|+||.||+|++. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999985 58999999997543  33456789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---CcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---~~~kl~Dfg~a~~~~  777 (851)
                      |||+++|+|.+.+.. ...+++..+..++.||++|++||   |++||+||||||+||+++.+   +.+||+|||++....
T Consensus       107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999988854 35688999999999999999999   88899999999999999765   459999999998765


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            332  233467999999999999999999999999999999999999999653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-34  Score=313.92  Aligned_cols=201  Identities=23%  Similarity=0.359  Sum_probs=175.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-----hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-----GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++....     ...+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999884 589999999975321     13567899999999999999999999999999999


Q ss_pred             EEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc---EEEeeccC
Q 046438          699 LVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV---ARLGDFGI  772 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~---~kl~Dfg~  772 (851)
                      +||||+++++|.+.+..   ....+++..+..++.||++|++||   |++||+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999887754   234588999999999999999999   8889999999999999976554   99999999


Q ss_pred             ccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      +........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            987654322 23346799999999999999999999999999999999999999976

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.5e-35  Score=307.35  Aligned_cols=200  Identities=24%  Similarity=0.402  Sum_probs=172.5

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||+||+|++.+|+.||+|+++....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999997899999999975432  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++ ++.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence            975 88888877667789999999999999999999   888999999999999999999999999999986643221 2


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            334578999999999876 45899999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-34  Score=311.33  Aligned_cols=198  Identities=25%  Similarity=0.427  Sum_probs=174.2

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999998 568999999997543   122357899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+ +|++.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        89 E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-  162 (336)
T ss_dssp             CCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred             ECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence            999 67888877553 4688999999999999999999   78899999999999999999999999999998764332 


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .....+||+.|+|||++.+..+ ++++||||+||++|||++|+.||++.
T Consensus       163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence             2344679999999999988776 78999999999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=320.85  Aligned_cols=202  Identities=23%  Similarity=0.367  Sum_probs=176.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4568999999999999999999884 68899999997643  23456789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---CCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---~~~~~kl~Dfg~a~~~~  777 (851)
                      |||+++|+|.+.+... ..+++..+..++.||++|++||   |++||+||||||+||+++   .++.+||+|||++....
T Consensus        89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999888654 5689999999999999999999   888999999999999998   56889999999998765


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~  216 (444)
T 3soa_A          165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE  216 (444)
T ss_dssp             TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence            4322 234567999999999999999999999999999999999999999653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.4e-35  Score=312.43  Aligned_cols=201  Identities=25%  Similarity=0.372  Sum_probs=167.3

Q ss_pred             hcCCCccceeccccceEEEEEEE----cCCcEEEEEEEeecc----hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF----LDGMEVAIKVFHLQL----EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|++++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36799999999999999999988    368899999997642    2234567889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++++|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999988653 4578889999999999999999   8889999999999999999999999999999764


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  224 (327)
T 3a62_A          172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE  224 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence            32222 233457999999999999999999999999999999999999999763

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.3e-35  Score=311.79  Aligned_cols=202  Identities=28%  Similarity=0.513  Sum_probs=175.1

Q ss_pred             cCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++.    .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56899999999999999999984    34569999997643 33456799999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            999999999999977777899999999999999999999   88899999999999999999999999999998765432


Q ss_pred             Cc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 SM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ..  ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  258 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM  258 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence            21  2223346778999999998899999999999999999999 99999664

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=308.95  Aligned_cols=200  Identities=23%  Similarity=0.367  Sum_probs=177.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh------hHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG------ALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .+.|++.+.||+|+||.||+|++. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356999999999999999999985 5899999999764321      356799999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC----cEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM----VARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~----~~kl~Dfg~a  773 (851)
                      ++||||+++++|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999854 45689999999999999999999   888999999999999999887    8999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  220 (326)
T 2y0a_A          166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  220 (326)
T ss_dssp             EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            8764332  233457999999999999999999999999999999999999999753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.5e-35  Score=306.69  Aligned_cols=202  Identities=24%  Similarity=0.472  Sum_probs=177.3

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||+||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            467999999999999999999998888999999976532 3367899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++..........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence            99999999977666799999999999999999999   888999999999999999999999999999987654333333


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            34456788999999998899999999999999999998 99999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.8e-35  Score=316.77  Aligned_cols=200  Identities=29%  Similarity=0.345  Sum_probs=167.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHH-HhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEV-LRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++....   .....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57999999999999999999985 588899999976532   233456667766 5778999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||++||+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       118 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            9999999999988653 4678889999999999999999   88899999999999999999999999999998643222


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+||+.|+|||++.+..++.++|+||+||++|||++|+.||...
T Consensus       194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  242 (373)
T 2r5t_A          194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  242 (373)
T ss_dssp             -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence             2344568999999999999999999999999999999999999999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-34  Score=326.52  Aligned_cols=202  Identities=25%  Similarity=0.384  Sum_probs=179.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            357999999999999999999985 68999999997542   22346688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          701 LDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |||++||+|.+++.... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999886543 4589999999999999999999   8889999999999999999999999999999876433


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            2  2334589999999999999899999999999999999999999998643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-34  Score=304.33  Aligned_cols=199  Identities=25%  Similarity=0.387  Sum_probs=172.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999985 58899999997543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++ ++.+.+......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            9976 55556656667799999999999999999999   888999999999999999999999999999987643322 


Q ss_pred             cccccccCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......+|+.|+|||++.+.. ++.++||||+||++|||++|..||..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            334457899999999987765 89999999999999999998888643

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.6e-34  Score=331.94  Aligned_cols=311  Identities=20%  Similarity=0.206  Sum_probs=164.5

Q ss_pred             CcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEE
Q 046438           87 LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQ  166 (851)
Q Consensus        87 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~  166 (851)
                      +++++.|++++|.++...+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+..|..|.++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            34555566666655554444555556666666666666555555555666666666666665555555555555555555


Q ss_pred             eeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCcccc
Q 046438          167 LTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYIT  246 (851)
Q Consensus       167 L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  246 (851)
                      |++|.++ .++.                        ..|.++++|+.|+|++|.++++.|..|+++++|++|+|++|.++
T Consensus       130 L~~n~l~-~l~~------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  184 (597)
T 3oja_B          130 LERNDLS-SLPR------------------------GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT  184 (597)
T ss_dssp             CCSSCCC-CCCT------------------------TTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             eeCCCCC-CCCH------------------------HHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence            5555554 3333                        33444555555555555555555555666666666666666655


Q ss_pred             CCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCC
Q 046438          247 SSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG  326 (851)
Q Consensus       247 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~  326 (851)
                      ..+        +..+++|+.|++++|.+...                               ...++|+.|++++|.+..
T Consensus       185 ~~~--------~~~l~~L~~L~l~~n~l~~l-------------------------------~~~~~L~~L~ls~n~l~~  225 (597)
T 3oja_B          185 HVD--------LSLIPSLFHANVSYNLLSTL-------------------------------AIPIAVEELDASHNSINV  225 (597)
T ss_dssp             BCC--------GGGCTTCSEEECCSSCCSEE-------------------------------ECCTTCSEEECCSSCCCE
T ss_pred             CcC--------hhhhhhhhhhhcccCccccc-------------------------------cCCchhheeeccCCcccc
Confidence            432        23344555555555544211                               111234444444444432


Q ss_pred             CcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhccc
Q 046438          327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNL  406 (851)
Q Consensus       327 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l  406 (851)
                      ..+..   .++|+.|+|++|.+++  +..+..+++|+.|+|++|.+.+..|..|..+++|+.|+|++|+++.+|..+..+
T Consensus       226 ~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l  300 (597)
T 3oja_B          226 VRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPI  300 (597)
T ss_dssp             EECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCC
T ss_pred             ccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccC
Confidence            21111   1345555555555553  234455555555555555555555555555555555555555555544444444


Q ss_pred             CcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEEC
Q 046438          407 TNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDL  486 (851)
Q Consensus       407 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  486 (851)
                      ++|+.|+|++|                        .++ .+|..+..+++|+.|+|++|++++. |  +..+++|+.|+|
T Consensus       301 ~~L~~L~Ls~N------------------------~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l  352 (597)
T 3oja_B          301 PTLKVLDLSHN------------------------HLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTL  352 (597)
T ss_dssp             TTCCEEECCSS------------------------CCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEEC
T ss_pred             CCCcEEECCCC------------------------CCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEe
Confidence            44444444444                        444 3444455556666666666666532 2  556677777777


Q ss_pred             CCCccccc
Q 046438          487 SNNILSGI  494 (851)
Q Consensus       487 s~N~l~~~  494 (851)
                      ++|++++.
T Consensus       353 ~~N~~~~~  360 (597)
T 3oja_B          353 SHNDWDCN  360 (597)
T ss_dssp             CSSCEEHH
T ss_pred             eCCCCCCh
Confidence            77777754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-34  Score=311.70  Aligned_cols=201  Identities=22%  Similarity=0.321  Sum_probs=177.4

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.....  .+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999998 4689999999875432  24688999999999 99999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc-----EEEeeccCccccC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV-----ARLGDFGIAKLLS  777 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~-----~kl~Dfg~a~~~~  777 (851)
                      |+ +++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.     +||+|||+|+...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 9999999987667899999999999999999999   7889999999999999998887     9999999998764


Q ss_pred             CCCCc------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          778 GDESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       778 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            33221      1235679999999999999999999999999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.2e-34  Score=324.26  Aligned_cols=201  Identities=25%  Similarity=0.373  Sum_probs=178.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++....   ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57899999999999999999985 589999999975432   23467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||++||+|.+++...   ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999988653   34689999999999999999999   888999999999999999999999999999987654


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            322 233458999999999999999999999999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=312.09  Aligned_cols=201  Identities=26%  Similarity=0.368  Sum_probs=161.9

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567999999999999999999985 47889999997653  33668899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+++|+|.+++.. ...+++..+..++.||++|++||   |++||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999999998864 35688999999999999999999   8889999999999999975   889999999999865432


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  255 (349)
T 2w4o_A          205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG  255 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred             c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence            2  22345789999999999999999999999999999999999999976443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=308.06  Aligned_cols=201  Identities=27%  Similarity=0.440  Sum_probs=174.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--eeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDD--FKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367999999999999999999985 48999999997543 234567889999999999999999999987755  77999


Q ss_pred             EeccCCCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE----CCCCcEEEeeccCcc
Q 046438          701 LDYMPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAK  774 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill----~~~~~~kl~Dfg~a~  774 (851)
                      |||+++++|.+++....  ..+++..++.++.||++|++||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999987643  3389999999999999999999   88899999999999999    788889999999998


Q ss_pred             ccCCCCCccccccccCccccCccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGR--------EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  ......+|+.|+|||++.        +..++.++||||+||++|||++|+.||...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            765433  233457999999999876        578899999999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=314.33  Aligned_cols=195  Identities=23%  Similarity=0.380  Sum_probs=170.3

Q ss_pred             cceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          631 NNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      .+.||+|+||.||+|++. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999884 5899999999876656667899999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE--CCCCcEEEeeccCccccCCCCCcccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL--DEDMVARLGDFGIAKLLSGDESMKHTQT  787 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  787 (851)
                      .+++......+++..+..++.||++|++||   |++||+||||||+||++  +.++.+||+|||+++......  .....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~  248 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN  248 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence            998877666789999999999999999999   88899999999999999  667899999999998765432  22345


Q ss_pred             ccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       788 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            6999999999999889999999999999999999999999764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-34  Score=309.07  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=170.8

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC----eeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD----FKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++ .++.||||+++.... ......+|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            36799999999999999999988 478999999975532 3345667889999999999999999998754    46999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC----------CcEecCCCCCCEEECCCCcEEEeec
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN----------PVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~----------~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                      |||+++|+|.+++...  .+++..+..++.|+++|++||   |+.          ||+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999998653  489999999999999999999   777          9999999999999999999999999


Q ss_pred             cCccccCCCCCc-cccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          771 GIAKLLSGDESM-KHTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       771 g~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      |+|+........ ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||....
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            999876543321 2333578999999999876     355678899999999999999999997643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.8e-34  Score=315.16  Aligned_cols=202  Identities=26%  Similarity=0.524  Sum_probs=165.9

Q ss_pred             cCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||.||+|++.    ++..||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999875    46779999997643 33456799999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            999999999999987777899999999999999999999   78899999999999999999999999999998764332


Q ss_pred             Cc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          781 SM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       781 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ..  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~  254 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM  254 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            21  1112245678999999999999999999999999999998 99999654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.1e-34  Score=306.86  Aligned_cols=201  Identities=26%  Similarity=0.436  Sum_probs=160.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999874 589999999976532 234678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          703 YMPKGSLEACLYSD-----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      |++ |+|.+++...     ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 5888887542     24588899999999999999999   88899999999999999999999999999998764


Q ss_pred             CCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3222 2334578999999999876 46899999999999999999999999754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-34  Score=302.84  Aligned_cols=199  Identities=27%  Similarity=0.428  Sum_probs=168.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--------------------------hhHHHHHHHHHHHh
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--------------------------GALESFNAECEVLR  677 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  677 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999884 588999999875421                          11356889999999


Q ss_pred             hcCCCcccceeeeeec--CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 046438          678 SIRHRNLVRIISSCTN--DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPS  755 (851)
Q Consensus       678 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~  755 (851)
                      +++||||+++++++.+  .+..++||||+++++|.++.  ....+++..+..++.||++|++||   |++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHH
Confidence            9999999999999986  56889999999999998765  345689999999999999999999   8889999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCccccccccCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          756 NVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ---ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       756 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||+++.++.+||+|||+++....... ......||+.|+|||++.+..   ++.++||||+||++|||++|+.||..
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999987654322 233457999999999997765   47789999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.7e-35  Score=310.85  Aligned_cols=203  Identities=23%  Similarity=0.454  Sum_probs=168.7

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe----
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF----  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  696 (851)
                      .++|++.+.||+|+||.||+|++ .+++.||+|+++...   ......+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999998 568899999997643   2334578899999999999999999999876543    


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++++|.+++... ..+++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            49999999999999998654 4688999999999999999999   8889999999999999999999999999999866


Q ss_pred             CCCCC--ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          777 SGDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       777 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            43221  12233568999999999999999999999999999999999999997643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-34  Score=305.50  Aligned_cols=202  Identities=31%  Similarity=0.530  Sum_probs=173.6

Q ss_pred             hcCCCccceeccccceEEEEEEE-----cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC--Cee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND--DFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  697 (851)
                      .++|++.+.||+|+||+||+|++     .+++.||+|+++.......+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46799999999999999999985     25889999999877666667899999999999999999999998653  468


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++|+|.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999987766799999999999999999999   78899999999999999999999999999998764


Q ss_pred             CCCC--ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ....  .......+++.|+|||++.+..++.++||||+||++|||++|..||..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            3322  122234577889999999999999999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-34  Score=299.84  Aligned_cols=201  Identities=28%  Similarity=0.476  Sum_probs=179.6

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||.||+|++.+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57899999999999999999998888999999976533 33678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++............
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  163 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence            9999999987777789999999999999999999   8889999999999999999999999999999876433222233


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...+++.|+|||+..+..++.++||||+|+++|||++ |+.||...
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (267)
T 3t9t_A          164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  209 (267)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence            4457889999999998899999999999999999999 99999764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-33  Score=312.20  Aligned_cols=205  Identities=19%  Similarity=0.293  Sum_probs=178.1

Q ss_pred             hcCCCccceeccc--cceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSG--SFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|  +||+||+|++. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999985 68999999997654  3345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          700 VLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||||+++|+|.+++... ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999998764 35689999999999999999999   888999999999999999999999999998865422


Q ss_pred             CCC------ccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          779 DES------MKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       779 ~~~------~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ...      .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+...
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            111      11223478999999999987  6799999999999999999999999976443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-34  Score=318.07  Aligned_cols=199  Identities=27%  Similarity=0.464  Sum_probs=177.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999985 699999999975432   23467899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        96 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-  170 (476)
T 2y94_A           96 EYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  170 (476)
T ss_dssp             ECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence            99999999998854 45689999999999999999999   88999999999999999999999999999998764332 


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||++.
T Consensus       171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence             2345679999999999988776 68999999999999999999999763

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9e-34  Score=297.58  Aligned_cols=202  Identities=27%  Similarity=0.483  Sum_probs=158.8

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....   ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35799999999999999999998 4689999999975432   2346789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++......+++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999987667889999999999999999999   88899999999999999999999999999998764322


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  215 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD  215 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence            2 223457899999999999989999999999999999999999999753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.5e-34  Score=301.14  Aligned_cols=203  Identities=26%  Similarity=0.462  Sum_probs=164.8

Q ss_pred             hcCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||.||+|++..    +..||+|+++... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4679999999999999999998743    4569999986543 334567899999999999999999999985 457889


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            9999999999999987767799999999999999999999   7889999999999999999999999999999876544


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .........+++.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~  222 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  222 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence            3333334457889999999998899999999999999999996 999997643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-34  Score=317.29  Aligned_cols=203  Identities=29%  Similarity=0.493  Sum_probs=176.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467899999999999999999985 689999999875432 234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            9999999999977666789999999999999999999   8889999999999999999999999999999865332211


Q ss_pred             cc-cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          783 KH-TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       783 ~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .. ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            11 12235778999999998889999999999999999998 99999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.7e-34  Score=322.36  Aligned_cols=201  Identities=25%  Similarity=0.347  Sum_probs=167.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|+++...   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999984 58899999997542   23345678899999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |||+++|+|.+++... ..+++..+..++.||+.||+||   |+ +||+||||||+||+++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999888653 4688999999999999999999   76 89999999999999999999999999999764332


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            2 2334568999999999999999999999999999999999999999653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-33  Score=303.36  Aligned_cols=191  Identities=22%  Similarity=0.345  Sum_probs=151.2

Q ss_pred             ceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEeccCCCCh
Q 046438          632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGSL  709 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L  709 (851)
                      +.||+|+||+||+|++. +++.||+|++...   ....+.+|+++++.++ ||||+++++++.+....++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            78999999999999985 5899999999754   3356788999999997 99999999999999999999999999999


Q ss_pred             hHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC---cEEEeeccCccccCCCCCccccc
Q 046438          710 EACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM---VARLGDFGIAKLLSGDESMKHTQ  786 (851)
Q Consensus       710 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~  786 (851)
                      .+++... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++   .+||+|||+++....... ....
T Consensus        94 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~  168 (325)
T 3kn6_A           94 FERIKKK-KHFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT  168 (325)
T ss_dssp             HHHHHHC-SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence            9998654 5689999999999999999999   888999999999999997665   899999999986543322 3344


Q ss_pred             cccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          787 TLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       787 ~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence            57899999999999999999999999999999999999999763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-33  Score=299.11  Aligned_cols=201  Identities=20%  Similarity=0.269  Sum_probs=177.5

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++....  ..+.+.+|+++++++ +|++++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999997 568999999986543  235688899999999 79999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc-----EEEeeccCccccC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV-----ARLGDFGIAKLLS  777 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~-----~kl~Dfg~a~~~~  777 (851)
                      |+ +++|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 9999999987777799999999999999999999   8899999999999999987776     9999999998765


Q ss_pred             CCCCc------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          778 GDESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       778 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .....      ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            43221      2334579999999999999999999999999999999999999998743

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.2e-34  Score=305.90  Aligned_cols=202  Identities=29%  Similarity=0.442  Sum_probs=170.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC-------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDD-------  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  695 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999985 78999999997543 335577999999999999999999999885543       


Q ss_pred             --------------------------------------------------eeEEEEeccCCCChhHHhhcCC--CCcCHH
Q 046438          696 --------------------------------------------------FKALVLDYMPKGSLEACLYSDN--SNLDIF  723 (851)
Q Consensus       696 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~  723 (851)
                                                                        ..++||||+++++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3799999999999999987643  234556


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC-----------ccccccccCcc
Q 046438          724 KRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES-----------MKHTQTLATIG  792 (851)
Q Consensus       724 ~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~t~~  792 (851)
                      .++.++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            6889999999999999   888999999999999999999999999999987654321           12234579999


Q ss_pred             ccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       793 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+|||++.+..++.++||||+||++|||++|..|+..
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~  278 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME  278 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence            9999999999999999999999999999999888643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.7e-34  Score=309.93  Aligned_cols=200  Identities=25%  Similarity=0.317  Sum_probs=165.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999985 688999999976432 336788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc--EEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV--ARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~--~kl~Dfg~a~~~~~~~~  781 (851)
                      +++|+|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.  +||+|||+++...... 
T Consensus        98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            9999999988553 4689999999999999999999   8889999999999999987765  9999999997543221 


Q ss_pred             ccccccccCccccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....
T Consensus       173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence             2334579999999999988887666 899999999999999999997643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-33  Score=296.15  Aligned_cols=200  Identities=24%  Similarity=0.337  Sum_probs=177.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||.||+|++. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467999999999999999999985 477899999987665667889999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+++++|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            99999999887653 4588999999999999999999   88899999999999999   78899999999999876533


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .  ......+|+.|+|||++.+. ++.++||||+|+++|||++|+.||...
T Consensus       163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          163 K--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             S--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             c--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence            2  23345799999999988654 899999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-34  Score=313.08  Aligned_cols=214  Identities=24%  Similarity=0.428  Sum_probs=180.8

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccce
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRI  687 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~  687 (851)
                      +...++....++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            445566667789999999999999999999852      35789999997643 33456799999999999 78999999


Q ss_pred             eeeeecCC-eeEEEEeccCCCChhHHhhcCCC------------------------------------------------
Q 046438          688 ISSCTNDD-FKALVLDYMPKGSLEACLYSDNS------------------------------------------------  718 (851)
Q Consensus       688 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  718 (851)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988765 58999999999999999875432                                                


Q ss_pred             -----------------CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          719 -----------------NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       719 -----------------~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                                       .+++..++.++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             188899999999999999999   888999999999999999999999999999986543322


Q ss_pred             -ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          782 -MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       782 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                       .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  301 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  301 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence             23334568899999999999999999999999999999998 9999976443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-34  Score=319.23  Aligned_cols=197  Identities=22%  Similarity=0.295  Sum_probs=165.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC------C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND------D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  695 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  ....+++.+|+++++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999885 58899999997642  33456788999999999999999999998654      3


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++||||++++ +.+.+.   ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            579999999765 545443   3488899999999999999999   888999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            6432  2334568999999999999999999999999999999999999999763

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=301.06  Aligned_cols=198  Identities=25%  Similarity=0.316  Sum_probs=166.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +++.||||++.....  ........|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999986 689999999865432  2233444555555555 899999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+ +++|.+++......+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 6788888877677799999999999999999999   78899999999999999999999999999998764322


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                        ......||+.|+|||++.+ .++.++||||+||++|||++|..|+..
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence              2334568999999998876 789999999999999999999766643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.3e-33  Score=297.02  Aligned_cols=213  Identities=35%  Similarity=0.567  Sum_probs=185.1

Q ss_pred             ccccHHHHHHHhcCCCcc------ceeccccceEEEEEEEcCCcEEEEEEEeecc----hhhHHHHHHHHHHHhhcCCCc
Q 046438          614 RRFSYQELLQATDQFNVN------NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL----EGALESFNAECEVLRSIRHRN  683 (851)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~n  683 (851)
                      ..++++++..+++.|...      +.||+|+||+||+|++ +++.||+|++....    ....+.+.+|++++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            568899999999888766      8999999999999987 78899999987532    234577999999999999999


Q ss_pred             ccceeeeeecCCeeEEEEeccCCCChhHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC
Q 046438          684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE  761 (851)
Q Consensus       684 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~  761 (851)
                      |+++++++.+.+..++||||+++++|.+++..  ....+++..++.++.||++|++||   |++||+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEcC
Confidence            99999999999999999999999999998864  245689999999999999999999   7889999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          762 DMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       762 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ++.+||+|||++........ .......|++.|+|||++.+ .++.++||||+|+++|||++|+.||+...
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~  238 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR  238 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence            99999999999987643222 12234578999999998865 48899999999999999999999998643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=299.49  Aligned_cols=197  Identities=30%  Similarity=0.516  Sum_probs=165.5

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||+||+|++ .++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            5789999999999999999998 5788999998643  345778999999999999999999998874  4789999999


Q ss_pred             CCChhHHhhcCCC--CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc-EEEeeccCccccCCCCCc
Q 046438          706 KGSLEACLYSDNS--NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV-ARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       706 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~  782 (851)
                      +|+|.+++.....  .++...++.++.|+++|++|||..|.+||+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999875432  4678889999999999999997655589999999999999998886 799999999765322   


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence             223468999999999999999999999999999999999999997643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-33  Score=311.27  Aligned_cols=201  Identities=25%  Similarity=0.387  Sum_probs=162.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcC-CCcccceeeeeecCC--ee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIR-HRNLVRIISSCTNDD--FK  697 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~  697 (851)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|++....  .....++.+|+.+++++. ||||+++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999884 68999999986432  334567889999999997 999999999987544  78


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||++ ++|..++..  ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+...
T Consensus        87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 588888865  4688899999999999999999   88899999999999999999999999999998653


Q ss_pred             CC--------------------CCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GD--------------------ESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~--------------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..                    ........+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            21                    1112334689999999999876 67899999999999999999999999763

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-33  Score=301.67  Aligned_cols=200  Identities=24%  Similarity=0.391  Sum_probs=177.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh------hHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG------ALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457999999999999999999985 5899999999765321      356799999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC----cEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM----VARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~----~~kl~Dfg~a  773 (851)
                      ++||||+++++|.+++.. ...+++..+..++.|+++|++||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999864 45688999999999999999999   788999999999999999887    7999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  221 (321)
T 2a2a_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (321)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence            8765432  233457899999999999999999999999999999999999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.5e-34  Score=309.28  Aligned_cols=208  Identities=27%  Similarity=0.364  Sum_probs=180.7

Q ss_pred             ccccHHHHHHHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-----CCcccce
Q 046438          614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-----HRNLVRI  687 (851)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~  687 (851)
                      ..+++++.....++|++.+.||+|+||+||+|++ .+++.||+|+++.. ....+.+..|+++++.++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3445555556678999999999999999999998 46889999999753 334466788999999996     9999999


Q ss_pred             eeeeecCCeeEEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-----
Q 046438          688 ISSCTNDDFKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-----  761 (851)
Q Consensus       688 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-----  761 (851)
                      ++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.|++||   |++||+||||||+||+++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 999999987643 4588999999999999999999   8889999999999999975     


Q ss_pred             --------------------CCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHH
Q 046438          762 --------------------DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIF  821 (851)
Q Consensus       762 --------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~  821 (851)
                                          ++.+||+|||+|+.....    .....||+.|+|||++.+..++.++||||+||++|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                789999999999865332    23457899999999999999999999999999999999


Q ss_pred             hCCCCCCcc
Q 046438          822 TRKRPTDEI  830 (851)
Q Consensus       822 ~g~~pf~~~  830 (851)
                      +|+.||...
T Consensus       254 ~g~~pf~~~  262 (360)
T 3llt_A          254 TGSLLFRTH  262 (360)
T ss_dssp             HSSCSCCCS
T ss_pred             HCCCCCCCC
Confidence            999999753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-33  Score=299.85  Aligned_cols=204  Identities=29%  Similarity=0.477  Sum_probs=168.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhh--cCCCcccceeeeeec----CCeeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRS--IRHRNLVRIISSCTN----DDFKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~  698 (851)
                      .++|++.+.||+|+||+||+|++ +++.||||++...   ....+.+|.+++..  ++||||+++++++.+    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 7899999998754   23456667777766  789999999998654    34689


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG-----HPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~-----h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                      +||||+++|+|.+++.  ...+++..+..++.||++|++|||..     +++||+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999999999984  35689999999999999999999411     1899999999999999999999999999999


Q ss_pred             cccCCCCCc---cccccccCccccCccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCccCcCc
Q 046438          774 KLLSGDESM---KHTQTLATIGYMAPEYGREG------QISTEGDVYSFGIMLMEIFTR----------KRPTDEIFSGE  834 (851)
Q Consensus       774 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g----------~~pf~~~~~~~  834 (851)
                      +........   ......||+.|+|||++.+.      .++.++||||+||++|||++|          +.||......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            765433221   12234799999999998876      455789999999999999999          88887654433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-33  Score=309.86  Aligned_cols=196  Identities=23%  Similarity=0.331  Sum_probs=162.7

Q ss_pred             cCCCcc-ceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhh-cCCCcccceeeeeec----CCeeE
Q 046438          626 DQFNVN-NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRS-IRHRNLVRIISSCTN----DDFKA  698 (851)
Q Consensus       626 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~  698 (851)
                      ++|.+. +.||+|+||+||+|++. +++.||+|+++..     ..+.+|++++.+ .+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            567776 68999999999999985 5889999998643     456788888744 589999999998865    56789


Q ss_pred             EEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCcc
Q 046438          699 LVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIAK  774 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a~  774 (851)
                      +||||+++|+|.+++.... ..+++..+..++.||+.|++||   |++||+||||||+||+++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999987643 4689999999999999999999   7889999999999999987   7899999999998


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            764322  2345678999999999999999999999999999999999999997643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-34  Score=308.11  Aligned_cols=208  Identities=25%  Similarity=0.336  Sum_probs=172.5

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-----hhhHHHHHHHHHHHhhcCCCcccceeeeeecC
Q 046438          621 LLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       621 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      +....++|++.+.||+|+||+||+|++. +++.||+|++....     ....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4556788999999999999999999884 58889999987542     33457799999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcC---------------------------------------CCCcCHHHHHHHHHHHHHH
Q 046438          695 DFKALVLDYMPKGSLEACLYSD---------------------------------------NSNLDIFKRLNIVIDIALA  735 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  735 (851)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999987421                                       1123566778899999999


Q ss_pred             HHHHHhcCCCCcEecCCCCCCEEECCCC--cEEEeeccCccccCCC---CCccccccccCccccCcccccc--CCCCcch
Q 046438          736 LEYLHFGHPNPVVHCDIKPSNVLLDEDM--VARLGDFGIAKLLSGD---ESMKHTQTLATIGYMAPEYGRE--GQISTEG  808 (851)
Q Consensus       736 l~~L~~~h~~~ivH~Dl~~~Nill~~~~--~~kl~Dfg~a~~~~~~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~  808 (851)
                      ++||   |++||+||||||+||+++.++  .+||+|||+++.....   .........+|+.|+|||++.+  ..++.++
T Consensus       181 l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999   888999999999999998776  8999999999865321   1122345679999999999865  6789999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCccC
Q 046438          809 DVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       809 DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ||||+||++|||++|+.||....
T Consensus       258 DiwslG~il~el~~g~~pf~~~~  280 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVN  280 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999997643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-33  Score=304.81  Aligned_cols=196  Identities=31%  Similarity=0.425  Sum_probs=172.6

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      +.|++.+.||+|+||+||+|++ .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588999999999999999998 468899999997542   233467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++ |++.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 578777766667789999999999999999999   8889999999999999999999999999999765422  


Q ss_pred             ccccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                         ....||+.|+|||++.   ...++.++|||||||++|||++|+.||...
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  256 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  256 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence               2457899999999874   567899999999999999999999999653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.9e-34  Score=320.59  Aligned_cols=201  Identities=28%  Similarity=0.517  Sum_probs=175.6

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||+||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            46788999999999999999999888999999997643 34578999999999999999999999986 56789999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.........
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence            999999998653 23578889999999999999999   88899999999999999999999999999998764332222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....+++.|+|||++....++.++|||||||++|||++ |+.||.+.
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~  389 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  389 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            233456789999999998999999999999999999999 99999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=308.98  Aligned_cols=203  Identities=29%  Similarity=0.507  Sum_probs=176.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc--------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      .++|++.+.||+|+||+||+|++.        .+..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999873        23579999997653 33457789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 DFKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      +..++||||+++|+|.+++....               ..+++..++.++.||+.|++||   |++||+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCcceEEE
Confidence            99999999999999999987643               3589999999999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          760 DEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +.++.+||+|||+|+....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999987643322 22233467889999999999999999999999999999999 99999764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-34  Score=306.54  Aligned_cols=202  Identities=26%  Similarity=0.419  Sum_probs=169.1

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCC--CcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRH--RNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|.+.+++.||+|++....  ....+.+.+|++++++++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999998889999999997543  3345678999999999986  9999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      || +.+++|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++ ++.+||+|||+++......
T Consensus        88 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 4588999998654 5688999999999999999999   888999999999999997 6789999999998764332


Q ss_pred             Cc-cccccccCccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          781 SM-KHTQTLATIGYMAPEYGRE-----------GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       781 ~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      .. ......||+.|+|||++.+           ..++.++||||+||++|||++|+.||....+
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  225 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  225 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence            21 2334579999999999864           6789999999999999999999999976443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.6e-33  Score=293.75  Aligned_cols=214  Identities=22%  Similarity=0.378  Sum_probs=182.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999985 68999999997543 2345778999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-C
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-S  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  781 (851)
                      |+++++|.+++.. ...+++..+..++.|+++|++||   |++||+||||+|+||+++.++.+||+|||.+....... .
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999999998753 45688999999999999999999   78899999999999999999999999999997653222 1


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCccCcCccchhhhcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVN  842 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  842 (851)
                      .......+++.|+|||++.+..+ +.++||||+|+++|||++|+.||+...........|..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  223 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE  223 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh
Confidence            12334578999999999987765 77899999999999999999999876554444444443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-34  Score=307.27  Aligned_cols=204  Identities=26%  Similarity=0.460  Sum_probs=176.8

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      ..++|++.+.||+|+||.||+|++..      ++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            45789999999999999999998853      4789999997653 3345679999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-----------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 046438          697 KALVLDYMPKGSLEACLYSDN-----------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIK  753 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~  753 (851)
                      .++||||+++|+|.+++....                       ..+++..++.++.||++|++||   |++||+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCC
Confidence            999999999999999987632                       5688999999999999999999   88899999999


Q ss_pred             CCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          754 PSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       754 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999976543221 12234567899999999998899999999999999999999 99999764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=299.74  Aligned_cols=201  Identities=29%  Similarity=0.435  Sum_probs=169.5

Q ss_pred             HhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch-----hhHHHHHHHHHHHhhcC---CCcccceeeeeecC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE-----GALESFNAECEVLRSIR---HRNLVRIISSCTND  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  694 (851)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|+++....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999997 4688999999875431     11245667777777664   99999999998775


Q ss_pred             C-----eeEEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          695 D-----FKALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       695 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                      .     ..++||||++ ++|.+++.... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5789999996 59998886643 3489999999999999999999   88899999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |||+++......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999998764322  234567899999999999999999999999999999999999999653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-34  Score=305.98  Aligned_cols=200  Identities=24%  Similarity=0.371  Sum_probs=167.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++..... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999985 6889999998754322 112455799999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++ |++.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence            97 588888877777899999999999999999999   888999999999999999999999999999976543222 2


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            334578999999999876 56899999999999999999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.4e-34  Score=309.81  Aligned_cols=202  Identities=20%  Similarity=0.265  Sum_probs=169.1

Q ss_pred             hcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecchhh-----------HHHHHHHHHHHhhcCCCcccce
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQLEGA-----------LESFNAECEVLRSIRHRNLVRI  687 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~  687 (851)
                      .++|++.+.||+|+||+||+|++..      ++.||+|++.......           ......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998854      4789999987543211           1123345566777889999999


Q ss_pred             eeeeecC----CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC--C
Q 046438          688 ISSCTND----DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD--E  761 (851)
Q Consensus       688 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~--~  761 (851)
                      ++++.+.    ...++||||+ +++|.+++......+++..+..++.||+.||+||   |++||+||||||+||+++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 9999999987777899999999999999999999   788999999999999998  8


Q ss_pred             CCcEEEeeccCccccCCCCCc------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          762 DMVARLGDFGIAKLLSGDESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       762 ~~~~kl~Dfg~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++.+||+|||+|+.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            899999999999766432211      113345999999999999999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.1e-34  Score=305.97  Aligned_cols=200  Identities=26%  Similarity=0.383  Sum_probs=174.9

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--------hhHHHHHHHHHHHhhcCCCcccceeeeeecC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--------GALESFNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++....        ...+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4568999999999999999999874 688999999976531        1234577899999999999999999999999


Q ss_pred             CeeEEEEeccCCC-ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          695 DFKALVLDYMPKG-SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       695 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                      +..++||||+.+| +|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 99888854 44689999999999999999999   8889999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      +......  ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..
T Consensus       178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            8765432  2334679999999999988877 7889999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-34  Score=308.56  Aligned_cols=201  Identities=29%  Similarity=0.395  Sum_probs=173.4

Q ss_pred             cCCCccceeccccceEEEEEEE----cCCcEEEEEEEeecc----hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF----LDGMEVAIKVFHLQL----EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      ++|++.+.||+|+||+||+|+.    .+++.||+|+++...    ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999988    368999999986532    22345677899999999 69999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++|+|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999998654 4688999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCCccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ............||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            4433334445679999999999875  45789999999999999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.7e-33  Score=293.15  Aligned_cols=201  Identities=25%  Similarity=0.433  Sum_probs=176.5

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999885 58899999997643  33456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc---EEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV---ARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~---~kl~Dfg~a~~~~  777 (851)
                      |||+++++|.+.+... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.   +||+|||.+....
T Consensus        84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999998887554 5688999999999999999999   8889999999999999976655   9999999998764


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  ......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus       160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  210 (284)
T 3kk8_A          160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  210 (284)
T ss_dssp             SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence            332  233467999999999999999999999999999999999999999653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-33  Score=308.84  Aligned_cols=200  Identities=26%  Similarity=0.423  Sum_probs=169.1

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcC--CCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIR--HRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+|++.+.||+|+||+||+|++.+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998789999999997543  334577899999999996  599999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      | +.+++|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++ ++.+||+|||+++.......
T Consensus       136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 5688999988654 4678889999999999999999   889999999999999995 58999999999987643322


Q ss_pred             -ccccccccCccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 -MKHTQTLATIGYMAPEYGRE-----------GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 -~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence             12334679999999999864           468899999999999999999999997643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=299.99  Aligned_cols=201  Identities=25%  Similarity=0.347  Sum_probs=170.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999985 489999999865432  234668899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++++.+++.. ...+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||.+........ 
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            9999999887754 45688999999999999999999   888999999999999999999999999999987653322 


Q ss_pred             cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            2334578999999999876 678999999999999999999999997643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-34  Score=310.59  Aligned_cols=203  Identities=30%  Similarity=0.463  Sum_probs=173.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++... ......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357899999999999999999853      46789999986542 33446788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCC------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC---cEEEe
Q 046438          698 ALVLDYMPKGSLEACLYSDN------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM---VARLG  768 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~---~~kl~  768 (851)
                      ++||||+++|+|.+++....      ..+++..++.++.||++|++||   |++||+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999987532      4588999999999999999999   888999999999999999555   59999


Q ss_pred             eccCccccCCCC-CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          769 DFGIAKLLSGDE-SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |||+|+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~  290 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  290 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999997542221 122234567999999999999999999999999999999998 99999764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-33  Score=293.69  Aligned_cols=199  Identities=27%  Similarity=0.457  Sum_probs=172.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999885 47789999986543   22346688999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            9999999999988653 4588999999999999999999   8899999999999999999999999999998654322 


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  210 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  210 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence              233457899999999999999999999999999999999999999753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-33  Score=328.37  Aligned_cols=202  Identities=23%  Similarity=0.318  Sum_probs=178.2

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  698 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++...   ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999985 57889999998542   33456788899999987 7999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+++|+|.+++... ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999988654 4688999999999999999999   888999999999999999999999999999986433


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .. .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            32 2344578999999999999999999999999999999999999999763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.7e-34  Score=305.63  Aligned_cols=198  Identities=26%  Similarity=0.400  Sum_probs=171.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4567999999999999999999985 588999999975432    245688888888 7999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC----CcEEEeeccCccccC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED----MVARLGDFGIAKLLS  777 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~----~~~kl~Dfg~a~~~~  777 (851)
                      ||+++|+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||++..+    +.+||+|||++....
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999998854 35689999999999999999999   88899999999999998433    359999999998764


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            4322 234567899999999998888999999999999999999999999753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-33  Score=298.54  Aligned_cols=202  Identities=26%  Similarity=0.328  Sum_probs=166.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++....   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999985 688999999875432   2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|+++|++||   |++||+||||+|+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999999988653 4688999999999999999999   88899999999999999999999999999998765433


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ........+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence            33334567899999999999999999999999999999999999999753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.8e-34  Score=321.51  Aligned_cols=203  Identities=28%  Similarity=0.506  Sum_probs=178.8

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3568899999999999999999864 8899999997653 2457899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++|+|.+++... ...+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++........
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            9999999999763 45688999999999999999999   8889999999999999999999999999999876544333


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ......+++.|+|||++....++.++|||||||++|||++ |+.||....
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence            3334456789999999998899999999999999999999 999997643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.2e-33  Score=294.83  Aligned_cols=201  Identities=29%  Similarity=0.512  Sum_probs=173.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-------hHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-------ALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367999999999999999999984 6889999998654321       1267899999999999999999999997665 


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEECCCCc-----EEEee
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLDEDMV-----ARLGD  769 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~~~~~-----~kl~D  769 (851)
                       ++||||+++|+|.+++......+++..+..++.|++.|++||   |++|  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999998887777899999999999999999999   7788  999999999999988776     99999


Q ss_pred             ccCccccCCCCCccccccccCccccCcccc--ccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCc
Q 046438          770 FGIAKLLSGDESMKHTQTLATIGYMAPEYG--REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE  834 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  834 (851)
                      ||+++....    ......+|+.|+|||++  ....++.++||||+||++|||++|+.||......+
T Consensus       173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            999975432    23346789999999998  44567899999999999999999999998654433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-33  Score=303.60  Aligned_cols=202  Identities=29%  Similarity=0.481  Sum_probs=168.3

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcE----EEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGME----VAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|.++... ....+.+.+|++++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57999999999999999999874 3443    5788775432 234567999999999999999999999998754 678


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+||+++|+|.+++......+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            9999999999999988778899999999999999999999   7889999999999999999999999999999876433


Q ss_pred             CCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          780 ESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       780 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||+...
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  224 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence            321 2223456889999999999999999999999999999999 999997643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-33  Score=297.53  Aligned_cols=203  Identities=33%  Similarity=0.546  Sum_probs=163.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||+||+|++.  ..||+|+++...  ....+.+.+|++++++++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3568999999999999999999753  369999987543  34457799999999999999999999965 455689999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-  780 (851)
                      ||+++++|.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999977777899999999999999999999   88899999999999999999999999999997654321 


Q ss_pred             CccccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          781 SMKHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ........||+.|+|||++.   +..++.++||||+||++|||++|+.||.....
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  230 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  230 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence            22233457899999999986   56788999999999999999999999976433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.1e-33  Score=295.28  Aligned_cols=202  Identities=25%  Similarity=0.475  Sum_probs=172.0

Q ss_pred             hcCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||+||+|++..    +..||+|+++... ....+.+.+|++++++++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4679999999999999999998743    3359999987653 33457799999999999999999999998754 5689


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||.+......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999999999977667789999999999999999999   8889999999999999999999999999999876544


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .........+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            3333344567889999999998899999999999999999998 99999753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-33  Score=297.82  Aligned_cols=203  Identities=28%  Similarity=0.519  Sum_probs=180.5

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||+||+|++.. +..||+|+++.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            45679999999999999999999854 888999999754 3345778999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+++++|.+++... ...+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||.+........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999998763 45689999999999999999999   788999999999999999999999999999987765444


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||...
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            44444567889999999998999999999999999999999 99999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-33  Score=305.43  Aligned_cols=209  Identities=25%  Similarity=0.308  Sum_probs=173.4

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch-----------hhHHHHHHHHHHHhhcCCCcc
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE-----------GALESFNAECEVLRSIRHRNL  684 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni  684 (851)
                      ...+++....++|++.+.||+|+||.||+|++.+|+.||+|++.....           ...+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            456778888999999999999999999999988899999999865322           123678999999999999999


Q ss_pred             cceeeeeec-----CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          685 VRIISSCTN-----DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       685 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      +++++++..     ....++||||++ |++.+.+......+++..+..++.||+.|++||   |++||+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEEE
Confidence            999999843     346899999997 678888777667799999999999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          760 DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +.++.+||+|||+++......  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999999999997543322  2334578999999999876 67899999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-33  Score=304.55  Aligned_cols=205  Identities=27%  Similarity=0.464  Sum_probs=175.0

Q ss_pred             HhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      ..++|++.+.||+|+||.||+|++.      .+..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3578999999999999999999872      35679999997543 23456799999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcCCC----------------------CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 046438          696 FKALVLDYMPKGSLEACLYSDNS----------------------NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIK  753 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~  753 (851)
                      ..++||||+++|+|.+++.....                      .+++..++.++.||++|++||   |++||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCC
Confidence            99999999999999999876433                      368889999999999999999   88899999999


Q ss_pred             CCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          754 PSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       754 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      |+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999986643322 12334567889999999998999999999999999999998 999997754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-33  Score=298.85  Aligned_cols=195  Identities=25%  Similarity=0.420  Sum_probs=172.0

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-C-------cEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-G-------MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||+||+|++.. +       ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578999999999999999998743 3       4699999987666667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc--------EEEe
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV--------ARLG  768 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~--------~kl~  768 (851)
                      .++||||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999987766689999999999999999999   8889999999999999988876        9999


Q ss_pred             eccCccccCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          769 DFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       769 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      |||.+.....     .....+++.|+|||++.+ ..++.++||||+||++|||++|..|+
T Consensus       164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            9999875532     123457889999999987 77899999999999999999955444

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-33  Score=310.45  Aligned_cols=203  Identities=25%  Similarity=0.358  Sum_probs=164.7

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--------hhHHHHHHHHHHHhhcCCCcccceeeeeec
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--------GALESFNAECEVLRSIRHRNLVRIISSCTN  693 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  693 (851)
                      ...++|++.+.||+|+||+||+|++. +++.||+|++.....        .....+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999885 588999999975421        112347899999999999999999999864


Q ss_pred             CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---CcEEEeec
Q 046438          694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDF  770 (851)
Q Consensus       694 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---~~~kl~Df  770 (851)
                       +..++||||+++|+|.+++.. ...+++..+..++.|+++|++||   |++||+||||||+||+++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCCcceEEEeec
Confidence             457899999999999988754 45689999999999999999999   78899999999999999654   45999999


Q ss_pred             cCccccCCCCCccccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          771 GIAKLLSGDESMKHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       771 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      |+|+......  ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.....
T Consensus       287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  349 (419)
T 3i6u_A          287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  349 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred             ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence            9998764322  2334679999999999853   6688899999999999999999999976433

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.2e-33  Score=300.40  Aligned_cols=204  Identities=25%  Similarity=0.447  Sum_probs=177.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||.||+|++.      +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467999999999999999999872      34789999997543 33457789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCC-----------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 046438          698 ALVLDYMPKGSLEACLYSDN-----------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKP  754 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~  754 (851)
                      ++||||+++++|.+++....                       ..+++..++.++.||++|++||   |++||+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH---HHTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH---HHCCCcccccch
Confidence            99999999999999987543                       2478899999999999999999   788999999999


Q ss_pred             CCEEECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          755 SNVLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       755 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999876433221 2233457889999999998899999999999999999999 999997643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-33  Score=299.99  Aligned_cols=203  Identities=23%  Similarity=0.352  Sum_probs=170.3

Q ss_pred             hcCCCcc-ceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVN-NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+.|++. +.||+|+||+||+|++. +++.||+|+++.......+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678885 78999999999999874 6899999999876555567899999999985 7999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc---EEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV---ARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~---~kl~Dfg~a~~~~~  778 (851)
                      ||+++|+|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999998654 4688999999999999999999   7889999999999999988765   99999999876532


Q ss_pred             CCC------ccccccccCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          779 DES------MKHTQTLATIGYMAPEYGRE-----GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       779 ~~~------~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ...      .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||....
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            211      11223468999999999865     568899999999999999999999997654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-33  Score=302.35  Aligned_cols=205  Identities=25%  Similarity=0.481  Sum_probs=160.7

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCC----cEEEEEEEeec--chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQ--LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      ..++|++.+.||+|+||+||+|++...    ..||+|+++..  .....+.+.+|++++++++||||+++++++.+....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            346799999999999999999987542    27999998764  234567899999999999999999999999876654


Q ss_pred             ------EEEEeccCCCChhHHhhcC-----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          698 ------ALVLDYMPKGSLEACLYSD-----NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       698 ------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                            ++||||+++|+|.+++...     ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCcceEEEcCCCCEE
Confidence                  8999999999999988542     22588999999999999999999   888999999999999999999999


Q ss_pred             EeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          767 LGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      |+|||+++....... .......+++.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            999999986643322 12223456889999999999999999999999999999999 999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-33  Score=294.28  Aligned_cols=200  Identities=29%  Similarity=0.423  Sum_probs=170.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            357999999999999999999984 588999999876542 345789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCcccc
Q 046438          703 YMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLL  776 (851)
Q Consensus       703 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~  776 (851)
                      |+++|+|.+++..   ....+++..+..++.|+++|++||   |++||+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999988754   246789999999999999999999   88899999999999999   45688999999999765


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  ......+|+.|+|||++. ..++.++||||+||++|||++|+.||...
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence            4322  233457899999999875 56899999999999999999999999764

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=9.7e-33  Score=297.41  Aligned_cols=136  Identities=21%  Similarity=0.234  Sum_probs=73.3

Q ss_pred             CCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecC
Q 046438          337 KLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSS  416 (851)
Q Consensus       337 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~  416 (851)
                      +|++|++++|.+++..+..+..+++|+.|++++|++.+..+..|..+++|++|++++|+++.+|..+..+++|+.|++++
T Consensus       194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~  273 (332)
T 2ft3_A          194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHT  273 (332)
T ss_dssp             SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCS
T ss_pred             CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCC
Confidence            44444455555544444444455555555555555554445555555566666666666666665555666666666666


Q ss_pred             CCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccC--CCCcccccCCCCCCEEECCCCc
Q 046438          417 NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ--GSIPNSIGDLISLECLDLSNNI  490 (851)
Q Consensus       417 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~  490 (851)
                      |++++..+..|..+.                +  -.....|+.|++++|.+.  +..|..|..+++|+.|+|++|+
T Consensus       274 N~l~~~~~~~~~~~~----------------~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          274 NNITKVGVNDFCPVG----------------F--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCCCBCCTTSSSCSS----------------C--CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             CCCCccChhHccccc----------------c--ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            666544333332210                0  011345677777777765  4566677777777777777764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-33  Score=295.50  Aligned_cols=201  Identities=27%  Similarity=0.511  Sum_probs=175.3

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|++.++..||+|+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            46799999999999999999999888899999997543 234778999999999999999999999864 4688999999


Q ss_pred             CCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++|.+++.... ..+++..+..++.|+++|++||   |++||+||||||+||++++++.+||+|||.+..........
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence            9999999986432 3688999999999999999999   88899999999999999999999999999998765443333


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence            334456889999999988889999999999999999999 99999764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-33  Score=312.92  Aligned_cols=197  Identities=36%  Similarity=0.538  Sum_probs=172.1

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC-eeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD-FKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  703 (851)
                      .++|++.+.||+|+||.||+|++ .++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            45788999999999999999998 57899999997653  4478999999999999999999999987655 78999999


Q ss_pred             cCCCChhHHhhcCCC-CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++|+|.+++..... .+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999976543 468899999999999999999   8889999999999999999999999999999864322   


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                       .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  391 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  391 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred             -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence             122357889999999999999999999999999999998 999997653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.9e-33  Score=293.39  Aligned_cols=201  Identities=26%  Similarity=0.369  Sum_probs=177.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999985 47889999987543   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            9999999999987543 4688999999999999999999   88899999999999999999999999999998764332


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            2 233457899999999999999999999999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-33  Score=304.01  Aligned_cols=203  Identities=27%  Similarity=0.387  Sum_probs=169.2

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-----hHHHHHHHHHHHhhcCCCcccceeeeeecCCe
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-----ALESFNAECEVLRSIRHRNLVRIISSCTNDDF  696 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  696 (851)
                      ...++|++.+.||+|+||.||+|++. +|+.||+|+++.....     ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999885 5899999998754321     12467899999999999999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++ ++.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999976 88888877666788899999999999999999   8889999999999999999999999999999876


Q ss_pred             CCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..... ......+|+.|+|||++.+ ..++.++||||+||++|||++|..||.+.
T Consensus       163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            43322 2334578999999999865 45899999999999999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.5e-33  Score=309.96  Aligned_cols=200  Identities=24%  Similarity=0.363  Sum_probs=168.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----Ce
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  696 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...  ....+++.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999985 58889999997543  23456789999999999999999999998766     57


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .|+||||++ |+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 589888854 45689999999999999999999   8889999999999999999999999999999876


Q ss_pred             CCCCC---------------------ccccccccCccccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDES---------------------MKHTQTLATIGYMAPEYG-REGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~---------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....                     ......+||++|+|||++ ....++.++||||+||++|||++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            43221                     123457899999999985 566799999999999999999997766653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-33  Score=316.85  Aligned_cols=201  Identities=29%  Similarity=0.519  Sum_probs=170.1

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            35688999999999999999999888889999997643 234679999999999999999999999876 6789999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.........
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence            999999998653 35688999999999999999999   88899999999999999999999999999998765433222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus       338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence            333456889999999998999999999999999999999 99999764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=312.33  Aligned_cols=201  Identities=27%  Similarity=0.438  Sum_probs=173.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--eeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDD--FKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999985 48999999997543 234567889999999999999999999988765  77999


Q ss_pred             EeccCCCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE----CCCCcEEEeeccCcc
Q 046438          701 LDYMPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARLGDFGIAK  774 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill----~~~~~~kl~Dfg~a~  774 (851)
                      |||+++|+|.+++....  ..+++..++.++.||+.|++||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999986532  3389999999999999999999   88899999999999999    778889999999998


Q ss_pred             ccCCCCCccccccccCccccCcccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGRE--------GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~  226 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            764432  2334579999999998865        56788999999999999999999999753

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=5.3e-36  Score=339.05  Aligned_cols=383  Identities=19%  Similarity=0.178  Sum_probs=179.0

Q ss_pred             cccccccccccccccCCCc-cccCCCCccEEecccccccc----ccchhhcCcccccEEEccCccccCCCCccccCCCcC
Q 046438           88 PFVQFLSLAFNQFAGHLPR-EIGNLTSLTSIDLSENHLMG----EIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL  162 (851)
Q Consensus        88 ~~L~~L~L~~N~i~~~~~~-~l~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  162 (851)
                      ++|++|+|++|.++..... .+..+++|++|+|++|.++.    .++..+..+++|++|++++|++.+            
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~------------   70 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD------------   70 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHH------------
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCCh------------
Confidence            4556666666665532222 24555566666666666552    234444455555555555555543            


Q ss_pred             cEEEeeccccccccchhHhhhcc----cccccccccccccc----cCCccccccCCCcEEecCCCCCccccCcccc----
Q 046438          163 KILQLTNNTLSGSISSSIRLALP----NLELFSLANNNFSG----KIPSFIFNASKLSICELPDNSFSGFIPNRFH----  230 (851)
Q Consensus       163 ~~L~L~~n~l~~~~~~~~~~~l~----~L~~L~L~~N~i~~----~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~----  230 (851)
                                  ..+..++..++    +|++|+|++|+++.    .++..+..+++|+.|+|++|.+++..+..+.    
T Consensus        71 ------------~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~  138 (461)
T 1z7x_W           71 ------------VGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL  138 (461)
T ss_dssp             ------------HHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred             ------------HHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHh
Confidence                        22333333333    34444444444432    2234444445555555555554433222222    


Q ss_pred             -CCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCccc-
Q 046438          231 -NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM-  308 (851)
Q Consensus       231 -~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l-  308 (851)
                       ..++|++|++++|+++..... .+...+..+++|++|++++|++.+... ..+.                     ..+ 
T Consensus       139 ~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~-~~l~---------------------~~l~  195 (461)
T 1z7x_W          139 DPQCRLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGV-RVLC---------------------QGLK  195 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHH-HHHHHHHHCTTCCEEECCSSBCHHHHH-HHHH---------------------HHHH
T ss_pred             cCCCcceEEECCCCCCCHHHHH-HHHHHHhhCCCCCEEECcCCCcchHHH-HHHH---------------------HHHh
Confidence             134456666666555532211 122334445555555555555432100 0000                     000 


Q ss_pred             ccccCCcEEEecCCCCCCC----cCccccCCCCCcEEEcccccccccccccc-----cccCCCCEEEccCcccCCC----
Q 046438          309 GNLINLIIIRLGYNKLNGS----IPSTLSRLEKLQILGLENNQLEGRILDDI-----CRLARLSSVYLDHNKLSGS----  375 (851)
Q Consensus       309 ~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----  375 (851)
                      ...++|++|++++|.+++.    ++..+..+++|++|++++|.+++.....+     ..+++|+.|++++|++++.    
T Consensus       196 ~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~  275 (461)
T 1z7x_W          196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD  275 (461)
T ss_dssp             HSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH
T ss_pred             cCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHH
Confidence            0123444444444444432    23334444555555555555443221111     1244555555555555432    


Q ss_pred             CCccccCCccccceecccCcCccCc-hhhc-----ccCcceEEEecCCCCCCC----CccccccchhhhhhhccCCcccc
Q 046438          376 IPACFGNLASLRKLSFASNELTFVP-STFW-----NLTNILMVDLSSNPLSGS----LPLEIGNLKVLVELYLSRNNLSG  445 (851)
Q Consensus       376 ~~~~~~~l~~L~~L~L~~N~l~~~p-~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  445 (851)
                      ++..+..+++|++|++++|+++..+ ..+.     ..++|++|++++|.+++.    ++..+..+++|++|++++|++++
T Consensus       276 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~  355 (461)
T 1z7x_W          276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED  355 (461)
T ss_dssp             HHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred             HHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccc
Confidence            3344444555555555555554211 1111     124566666666665543    23444455666666666666654


Q ss_pred             cCCcccCC-----CCCccEEEccCcccCC----CCcccccCCCCCCEEECCCCcccccCCcccc-----ccccccceecc
Q 046438          446 DIPTTIGG-----LKNLQNLSLGDNNLQG----SIPNSIGDLISLECLDLSNNILSGIIPSSLE-----KLLYLKYLNVS  511 (851)
Q Consensus       446 ~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~l~l~  511 (851)
                      ..+..+..     .++|++|+|++|++++    .+|..+..+++|++|+|++|++++.....+.     ...+|+.|++.
T Consensus       356 ~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~  435 (461)
T 1z7x_W          356 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY  435 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             ccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeec
Confidence            43333321     4567777777777764    5566666677777777777777643221111     12245555555


Q ss_pred             Cccccc
Q 046438          512 FNRLEG  517 (851)
Q Consensus       512 ~N~l~~  517 (851)
                      ++.+..
T Consensus       436 ~~~~~~  441 (461)
T 1z7x_W          436 DIYWSE  441 (461)
T ss_dssp             TCCCCH
T ss_pred             ccccCH
Confidence            555543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.6e-33  Score=302.21  Aligned_cols=207  Identities=29%  Similarity=0.465  Sum_probs=179.2

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--------hhHHHHHHHHHHHhhc-CCCcccc
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--------GALESFNAECEVLRSI-RHRNLVR  686 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~  686 (851)
                      .+.......++|++.+.||+|+||.||+|++. +|+.||||+++....        ...+.+.+|+++++++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34445556678999999999999999999985 699999999975431        1245688999999999 7999999


Q ss_pred             eeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          687 IISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       687 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                      +++++...+..++||||+++++|.+++... ..+++..+..++.||+.|++||   |+.||+||||||+||+++.++.+|
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999988643 4688999999999999999999   788999999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccCccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE------GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |+|||++.......  ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||..
T Consensus       241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            99999998765332  2344679999999998853      3688999999999999999999999965

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3.7e-33  Score=297.33  Aligned_cols=255  Identities=31%  Similarity=0.488  Sum_probs=228.9

Q ss_pred             ccccEEeccCCCccCC-CCCCccccccccccEEEeec-CccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCc
Q 046438          262 KKLKVLSLTGNPLLDC-VLPSSIGNLSLSMERFYLHN-CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQ  339 (851)
Q Consensus       262 ~~L~~L~Ls~N~l~~~-~~p~~~~~~~~~L~~L~L~~-n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  339 (851)
                      .+++.|++++|.+... .+|..+..+. .|+.|++++ |++.+.+|..++++++|++|++++|.+++..|..|.++++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            3566666666666421 4566666654 788888884 888889999999999999999999999989999999999999


Q ss_pred             EEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCc-cccceecccCcCc-cCchhhcccCcceEEEecCC
Q 046438          340 ILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLA-SLRKLSFASNELT-FVPSTFWNLTNILMVDLSSN  417 (851)
Q Consensus       340 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~-~~p~~~~~l~~L~~L~Ls~N  417 (851)
                      +|++++|.+++..|..+..+++|++|++++|++++.+|..+..++ +|++|++++|+++ .+|..+..+. |+.|++++|
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N  207 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN  207 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence            999999999999999999999999999999999988999999998 9999999999998 7888888887 999999999


Q ss_pred             CCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCc
Q 046438          418 PLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPS  497 (851)
Q Consensus       418 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  497 (851)
                      ++++..|..|+.+++|+.|++++|++++..|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.
T Consensus       208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  286 (313)
T 1ogq_A          208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence            99999999999999999999999999976665 88999999999999999999999999999999999999999999998


Q ss_pred             cccccccccceeccCccccccCC
Q 046438          498 SLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       498 ~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      . ..+++|+.+++++|+.-|..|
T Consensus       287 ~-~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          287 G-GNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             S-TTGGGSCGGGTCSSSEEESTT
T ss_pred             C-ccccccChHHhcCCCCccCCC
Confidence            7 899999999999999666555

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-33  Score=314.65  Aligned_cols=194  Identities=23%  Similarity=0.379  Sum_probs=154.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec-----CCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN-----DDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  696 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  ....+++.+|+++++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999885 68899999986543  2345678999999999999999999999843     357


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .|+||||+ +++|.+++.. ...+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 5688888754 45689999999999999999999   8889999999999999999999999999999876


Q ss_pred             CCCCC--------------------------ccccccccCccccCcccc-ccCCCCcchhhHHHHHHHHHHHhC
Q 046438          777 SGDES--------------------------MKHTQTLATIGYMAPEYG-REGQISTEGDVYSFGIMLMEIFTR  823 (851)
Q Consensus       777 ~~~~~--------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g  823 (851)
                      .....                          ......+||++|+|||++ ....++.++||||+||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            42211                          123446789999999976 566799999999999999999993

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.4e-33  Score=291.18  Aligned_cols=196  Identities=24%  Similarity=0.475  Sum_probs=171.4

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--CeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++ +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            5799999999999999999998 58899999997653  33456799999999999999999999999887  6889999


Q ss_pred             eccCCCChhHHhhcCCC-CcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++|+|.+++..... .+++..+..++.|+++|++||   |++|  |+||||||+||+++.++.++++|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999976543 589999999999999999999   8888  99999999999999999999999998764322


Q ss_pred             CCCccccccccCccccCccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCccC
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQIST---EGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                            ....+|+.|+|||++.+..++.   ++||||+||++|||++|+.||....
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  215 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS  215 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence                  2346899999999988765444   7999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.2e-33  Score=299.23  Aligned_cols=201  Identities=26%  Similarity=0.369  Sum_probs=177.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999985 47889999987543   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..++.++.||++|++||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999987543 5688999999999999999999   78899999999999999999999999999998764332


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      . ......+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence            2 233457899999999999999999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.4e-33  Score=296.70  Aligned_cols=201  Identities=29%  Similarity=0.416  Sum_probs=174.2

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|++....  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999985 48999999997543  34678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++++|.+++......+++..+..++.|++.|++||   |++||+||||+|+||+++.++.+||+|||.+........ 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            9999999999876667789999999999999999999   888999999999999999999999999999987643322 


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  228 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI  228 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            233457899999999999999999999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.4e-33  Score=298.69  Aligned_cols=204  Identities=25%  Similarity=0.438  Sum_probs=177.5

Q ss_pred             hcCCCccceeccccceEEEEEEE------cCCcEEEEEEEeecch-hhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF------LDGMEVAIKVFHLQLE-GALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||.||+|++      .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46799999999999999999986      2467899999975542 3457799999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCC-----------------CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          697 KALVLDYMPKGSLEACLYSDNS-----------------NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      .++||||+++|+|.+++.....                 .+++..++.++.||++|++||   |++||+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEE
Confidence            9999999999999999876432                 488999999999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          760 DEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999999999999876543321 2233457889999999999999999999999999999999 999997644

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.7e-33  Score=298.96  Aligned_cols=203  Identities=24%  Similarity=0.319  Sum_probs=172.7

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec----CCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN----DDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  699 (851)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+++++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            36799999999999999999998 5689999999977666667889999999999999999999999863    347899


Q ss_pred             EEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          700 VLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ||||+++|+|.+++..   ....+++..++.++.||++|++||   |++||+||||||+||+++.++.+||+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999998865   456789999999999999999999   7889999999999999999999999999998765


Q ss_pred             CCCCCc--------cccccccCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESM--------KHTQTLATIGYMAPEYGREGQ---ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......        ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  249 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV  249 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence            321110        112345799999999987554   688999999999999999999999754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-33  Score=298.81  Aligned_cols=201  Identities=26%  Similarity=0.495  Sum_probs=173.7

Q ss_pred             cCCCccceeccccceEEEEEEE-----cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--Cee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTND--DFK  697 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  697 (851)
                      ..|++.+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5689999999999999999984     358899999997543 23457789999999999999999999999876  568


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++|+|.+++......+++..++.++.|++.|++||   |++||+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            999999999999999977677799999999999999999999   88899999999999999999999999999998765


Q ss_pred             CCCC--ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.|+..
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  231 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS  231 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence            4332  123345678889999999998999999999999999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.5e-33  Score=296.28  Aligned_cols=200  Identities=25%  Similarity=0.359  Sum_probs=174.1

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467999999999999999999985 689999999986654455678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+++++|.+++... ..+++..+..++.|++.|++||   |++||+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            99999999888553 4588999999999999999999   88899999999999999   78899999999998764322


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                         ......+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence               223456899999999999999999999999999999999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.4e-33  Score=292.06  Aligned_cols=197  Identities=27%  Similarity=0.515  Sum_probs=162.4

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch----hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE----GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++ .++.||+|+++....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35789999999999999999998 588999999875432    2346789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC---cEecCCCCCCEEECC--------CCcEEEee
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP---VVHCDIKPSNVLLDE--------DMVARLGD  769 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~---ivH~Dl~~~Nill~~--------~~~~kl~D  769 (851)
                      |||+++++|.+++.  ...+++..++.++.|+++|++||   |++|   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~l---H~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYL---HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHH---HHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHH---HhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999999999884  45688999999999999999999   6666   999999999999986        77899999


Q ss_pred             ccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          770 FGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ||.+.......   .....+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  217 (271)
T 3dtc_A          160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI  217 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99998654322   22457899999999999999999999999999999999999999764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-33  Score=293.56  Aligned_cols=202  Identities=25%  Similarity=0.487  Sum_probs=174.9

Q ss_pred             cCCCccc-eeccccceEEEEEEEc---CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNN-LIGSGSFGSVYRGRFL---DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|.+.+ .||+|+||.||+|++.   ++..||+|+++... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            5677776 9999999999999863   57789999998643 33457799999999999999999999999 45568999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            999999999999977777799999999999999999999   88899999999999999999999999999998764333


Q ss_pred             Cc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          781 SM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       781 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ..  ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  218 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  218 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            21  1223456889999999988889999999999999999998 999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9e-33  Score=290.90  Aligned_cols=198  Identities=26%  Similarity=0.444  Sum_probs=175.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67999999999999999999985 57889999987542   223467899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++++|.+++... ..+++..+..++.|+++|++||   |++||+||||+|+||+++.++.+||+|||++......  
T Consensus        94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            999999999988654 4588999999999999999999   8899999999999999999999999999998765332  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence             233457899999999999999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.1e-33  Score=291.61  Aligned_cols=200  Identities=26%  Similarity=0.403  Sum_probs=173.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh------hHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG------ALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999985 5899999998764311      357799999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC----cEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM----VARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~----~~kl~Dfg~a  773 (851)
                      ++||||+++++|.+++.. ...+++..+..++.||++|++||   |++||+||||+|+||+++.++    .+||+|||.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999864 34688999999999999999999   888999999999999998877    8999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......  ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence            8764322  223456899999999999999999999999999999999999999764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-33  Score=303.95  Aligned_cols=196  Identities=26%  Similarity=0.354  Sum_probs=165.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD------  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  695 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999984 68999999986543  234567889999999999999999999987653      


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++||||+ +++|.+++..  ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 8899998865  4688999999999999999999   888999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            5432    334678999999999877 67999999999999999999999999753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-33  Score=301.82  Aligned_cols=202  Identities=28%  Similarity=0.469  Sum_probs=170.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcE----EEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGME----VAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57899999999999999999874 3444    7777775432 223356778999999999999999999986 456889


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            9999999999999977666788999999999999999999   8889999999999999999999999999999876543


Q ss_pred             CC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          780 ES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       780 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .. .......+++.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            32 22334567889999999999999999999999999999999 999997643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.5e-33  Score=299.70  Aligned_cols=203  Identities=28%  Similarity=0.525  Sum_probs=175.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc--------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      .++|++.+.||+|+||+||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999873        46789999997543 33456789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 DFKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      +..++||||+++|+|.+++....               ..+++..++.++.||++|++||   |++||+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCccceEEE
Confidence            99999999999999999987543               2478899999999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          760 DEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      +.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            99999999999999876543321 2223456889999999988889999999999999999999 99999764

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.4e-32  Score=292.12  Aligned_cols=277  Identities=21%  Similarity=0.253  Sum_probs=147.1

Q ss_pred             CCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccc
Q 046438          112 TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFS  191 (851)
Q Consensus       112 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~  191 (851)
                      ++|++|+|++|.+++..+..|+++++|++|++++|++++..|..|.++++|++|++++|+++ .++..++          
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~----------  120 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP----------  120 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC----------
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc----------
Confidence            34555555555555444445555555555555555555555555555666666666655554 2222111          


Q ss_pred             cccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccC
Q 046438          192 LANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTG  271 (851)
Q Consensus       192 L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~  271 (851)
                                       ++|+.|++++|.++++.+..|.++++|++|++++|.++..+                      
T Consensus       121 -----------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~----------------------  161 (330)
T 1xku_A          121 -----------------KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG----------------------  161 (330)
T ss_dssp             -----------------TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG----------------------
T ss_pred             -----------------ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC----------------------
Confidence                             23444444444444444444555555555555555543211                      


Q ss_pred             CCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEccccccccc
Q 046438          272 NPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGR  351 (851)
Q Consensus       272 N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  351 (851)
                                                     ..+..+..+++|++|++++|.++. +|..+.  ++|++|++++|.+++.
T Consensus       162 -------------------------------~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~  207 (330)
T 1xku_A          162 -------------------------------IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKV  207 (330)
T ss_dssp             -------------------------------BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEE
T ss_pred             -------------------------------cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCcc
Confidence                                           122334444444444444444442 222221  4566666666666655


Q ss_pred             ccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccch
Q 046438          352 ILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLK  431 (851)
Q Consensus       352 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  431 (851)
                      .+..+..+++|+.|++++|++++..+..|..+++|++|++++|+++.+|..+..+++|++|++++|++++..+..|....
T Consensus       208 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~  287 (330)
T 1xku_A          208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG  287 (330)
T ss_dssp             CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred             CHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccChhhcCCcc
Confidence            55556666666666666666665555566666667777777777766666666667777777777776654444443210


Q ss_pred             hhhhhhccCCcccccCCcccCCCCCccEEEccCcccCC--CCcccccCCCCCCEEECCCCc
Q 046438          432 VLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG--SIPNSIGDLISLECLDLSNNI  490 (851)
Q Consensus       432 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~  490 (851)
                                        .......|+.|++++|.+..  ..|..|..+.+++.++|++|+
T Consensus       288 ------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          288 ------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             ------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ------------------cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                              01123455566666666542  445566666666666666663

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.8e-32  Score=293.77  Aligned_cols=287  Identities=21%  Similarity=0.269  Sum_probs=176.9

Q ss_pred             cCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEec
Q 046438          161 TLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL  240 (851)
Q Consensus       161 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  240 (851)
                      +++.++++++.++ .+|..+   .++|++|++++|.+++..+..+.++++|+.|+|++|.++++.|..|+++++|++|++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCcc-ccCCCC---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            4555666555554 334332   244555555555555555555566666666666666666665666666666666666


Q ss_pred             cCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEec
Q 046438          241 EYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLG  320 (851)
Q Consensus       241 ~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~  320 (851)
                      ++|+++.++..                               +.                           ++|++|+++
T Consensus       110 ~~n~l~~l~~~-------------------------------~~---------------------------~~L~~L~l~  131 (332)
T 2ft3_A          110 SKNHLVEIPPN-------------------------------LP---------------------------SSLVELRIH  131 (332)
T ss_dssp             CSSCCCSCCSS-------------------------------CC---------------------------TTCCEEECC
T ss_pred             CCCcCCccCcc-------------------------------cc---------------------------ccCCEEECC
Confidence            66655543211                               11                           234444444


Q ss_pred             CCCCCCCcCccccCCCCCcEEEcccccccc--cccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCcc
Q 046438          321 YNKLNGSIPSTLSRLEKLQILGLENNQLEG--RILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF  398 (851)
Q Consensus       321 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  398 (851)
                      +|.+.+..+..|.++++|++|++++|.++.  ..+..+..+ +|+.|++++|++++ +|..+.  ++|++|++++|+++.
T Consensus       132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~  207 (332)
T 2ft3_A          132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQA  207 (332)
T ss_dssp             SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCC
T ss_pred             CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCc
Confidence            444443333344444555555555555432  334444444 55555566665553 333322  466777777777765


Q ss_pred             Cc-hhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccC
Q 046438          399 VP-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGD  477 (851)
Q Consensus       399 ~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  477 (851)
                      ++ ..+..+++|+.|+|++|++++..+..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+|++..+..|..
T Consensus       208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~  286 (332)
T 2ft3_A          208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP  286 (332)
T ss_dssp             CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred             cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc
Confidence            54 45666777777777777777666667777777888888888877 67777888888888888888888666666655


Q ss_pred             ------CCCCCEEECCCCccc--ccCCccccccccccceeccCcc
Q 046438          478 ------LISLECLDLSNNILS--GIIPSSLEKLLYLKYLNVSFNR  514 (851)
Q Consensus       478 ------l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~l~l~~N~  514 (851)
                            ..+|+.|++++|.+.  +..|..+..+++|+.+++++|+
T Consensus       287 ~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          287 VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                  367899999999987  6788889999999999999885

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-32  Score=292.55  Aligned_cols=200  Identities=31%  Similarity=0.460  Sum_probs=177.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .+.|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356999999999999999999884 58899999997553 3345789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |+++++|.+++..  ..+++..+..++.|++.|++||   |++||+||||+|+||+++.++.+||+|||++....... .
T Consensus       101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  174 (303)
T 3a7i_A          101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  174 (303)
T ss_dssp             CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence            9999999998853  5688999999999999999999   88899999999999999999999999999998764332 2


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence            334467899999999999999999999999999999999999999764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.7e-33  Score=293.01  Aligned_cols=202  Identities=23%  Similarity=0.366  Sum_probs=170.8

Q ss_pred             HhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeee-ecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC-TNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|++.....  ...+.+|+++++.++|++++..++.+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999998 5688999998765432  24588899999999988877776655 5667889999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+ +++|.+++......+++..+..++.||+.|++||   |++||+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 9999999987677899999999999999999999   88899999999999999   7889999999999987654


Q ss_pred             CCC------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          779 DES------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       779 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ...      .......+|+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            322      12234578999999999999999999999999999999999999998643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.4e-33  Score=301.71  Aligned_cols=201  Identities=28%  Similarity=0.442  Sum_probs=177.3

Q ss_pred             cCCCccceeccccceEEEEEEE-----cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeee--cCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT--NDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  698 (851)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5799999999999999999985     357889999998776666678999999999999999999999876  445789


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+++++|.+++......+++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            99999999999999977566789999999999999999999   788999999999999999999999999999987643


Q ss_pred             CCCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          779 DESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       779 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ....  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            3321  22334678889999999988899999999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.1e-33  Score=301.68  Aligned_cols=201  Identities=26%  Similarity=0.418  Sum_probs=172.4

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecC--------
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTND--------  694 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  694 (851)
                      ++|++.+.||+|+||+||+|++ .+|+.||+|++.....  .....+.+|++++++++||||+++++++.+.        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            6799999999999999999998 4689999999865432  2345678999999999999999999998773        


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      +..++||||+++ ++.+.+......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999975 77777766667799999999999999999999   88899999999999999999999999999998


Q ss_pred             ccCCCC---CccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDE---SMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......   ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            764222   122344578999999998876 56899999999999999999999999764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.2e-33  Score=301.43  Aligned_cols=201  Identities=22%  Similarity=0.365  Sum_probs=176.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhh-----------------HHHHHHHHHHHhhcCCCcccce
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGA-----------------LESFNAECEVLRSIRHRNLVRI  687 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~  687 (851)
                      .++|++.+.||+|+||.||+|++ +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999999 99999999997543221                 1789999999999999999999


Q ss_pred             eeeeecCCeeEEEEeccCCCChhHH------hhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEE
Q 046438          688 ISSCTNDDFKALVLDYMPKGSLEAC------LYSD-NSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLL  759 (851)
Q Consensus       688 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill  759 (851)
                      ++++.+.+..++||||+++++|.++      +... ...+++..++.++.|++.|++||   |+ +||+||||+|+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHhEEE
Confidence            9999999999999999999999988      5432 56789999999999999999999   76 899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCccccccccCccccCccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          760 DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-QIST-EGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      +.++.+||+|||.+......   ......+++.|+|||++.+. .++. ++||||+||++|||++|+.||.....
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            99999999999999876432   33446789999999999877 6666 89999999999999999999976544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.5e-33  Score=297.95  Aligned_cols=209  Identities=22%  Similarity=0.324  Sum_probs=177.2

Q ss_pred             cHHHHHHHhcCCCcc-ceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcC-CCcccceeeee
Q 046438          617 SYQELLQATDQFNVN-NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIR-HRNLVRIISSC  691 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~  691 (851)
                      .++......++|.+. +.||+|+||+||+|++. +++.||+|+++....  .....+.+|+.++++++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344455567788887 89999999999999985 589999999976432  23567899999999995 69999999999


Q ss_pred             ecCCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEE
Q 046438          692 TNDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARL  767 (851)
Q Consensus       692 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl  767 (851)
                      .+.+..++||||+++|+|.+++... ...+++..++.++.|++.|++||   |++||+||||||+||+++.   ++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999999999999987543 46689999999999999999999   8889999999999999987   789999


Q ss_pred             eeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          768 GDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +|||+++......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999998764322  233457999999999999999999999999999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.2e-33  Score=313.89  Aligned_cols=200  Identities=24%  Similarity=0.405  Sum_probs=173.7

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999985 68999999997543  23456789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---CCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---~~~~~kl~Dfg~a~~~~  777 (851)
                      |||+++|+|.+.+... ..+++..+..++.||+.|++||   |++||+||||||+||+++   .++.+||+|||+++...
T Consensus       100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999998887554 4688999999999999999999   888999999999999995   56689999999998764


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.
T Consensus       176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            332  2344579999999999875 5899999999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-32  Score=288.36  Aligned_cols=199  Identities=27%  Similarity=0.421  Sum_probs=170.7

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec----CCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN----DDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  698 (851)
                      ..|++.+.||+|+||+||+|++. ++..||+|++....  ....+.+.+|++++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34788899999999999999884 57889999987543  3345778999999999999999999998765    35689


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEEC-CCCcEEEeeccCccc
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLD-EDMVARLGDFGIAKL  775 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~  775 (851)
                      +||||+++++|.+++... ..+++..+..++.||+.|++||   |++|  |+||||||+||+++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999998653 5688899999999999999999   7777  99999999999997 789999999999976


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ....   ......+|+.|+|||++. ..++.++||||+||++|+|++|+.||.....
T Consensus       182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  234 (290)
T 1t4h_A          182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence            5332   233457899999999886 4589999999999999999999999976443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-33  Score=298.93  Aligned_cols=213  Identities=24%  Similarity=0.428  Sum_probs=180.0

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecch-hhHHHHHHHHHHHhhc-CCCccccee
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLE-GALESFNAECEVLRSI-RHRNLVRII  688 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~  688 (851)
                      ...+.....++|++.+.||+|+||+||+|++.      +++.||+|+++.... ...+.+.+|+++++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            34445555788999999999999999999852      467899999976532 3456789999999999 789999999


Q ss_pred             eeeecCC-eeEEEEeccCCCChhHHhhcCCCC---------------cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 046438          689 SSCTNDD-FKALVLDYMPKGSLEACLYSDNSN---------------LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDI  752 (851)
Q Consensus       689 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl  752 (851)
                      +++.+.+ ..++||||+++|+|.+++......               +++..+..++.||++|++||   |++||+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---HhCCcccccC
Confidence            9987754 589999999999999998764332               78899999999999999999   8889999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          753 KPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       753 ~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999986643322 22334567889999999999999999999999999999998 99999765


Q ss_pred             Cc
Q 046438          831 FS  832 (851)
Q Consensus       831 ~~  832 (851)
                      ..
T Consensus       255 ~~  256 (316)
T 2xir_A          255 KI  256 (316)
T ss_dssp             CC
T ss_pred             ch
Confidence            43

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.4e-33  Score=298.25  Aligned_cols=202  Identities=26%  Similarity=0.445  Sum_probs=172.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999985 5889999999876666668899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +++++|.+++......+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||++...... ...
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  173 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK  173 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence            999999998877667799999999999999999999   7889999999999999999999999999987543211 111


Q ss_pred             ccccccCccccCcccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYG-----REGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||++     .+..++.++||||+||++|||++|+.||...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  225 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  225 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            2335689999999988     4677899999999999999999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.7e-33  Score=300.13  Aligned_cols=201  Identities=23%  Similarity=0.392  Sum_probs=164.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh--hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG--ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++.....  ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4578999999999999999999884 6889999999754322  245678999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE-----CCCCcEEEeeccCccc
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL-----DEDMVARLGDFGIAKL  775 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill-----~~~~~~kl~Dfg~a~~  775 (851)
                      |||++ |+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+||++     ++++.+||+|||+++.
T Consensus       112 ~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99997 4898888654 4588999999999999999999   88899999999999999     4556699999999987


Q ss_pred             cCCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            643222 23345689999999998774 5899999999999999999999999753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-33  Score=297.80  Aligned_cols=202  Identities=26%  Similarity=0.503  Sum_probs=169.3

Q ss_pred             cCCCccceeccccceEEEEEEEcC-----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|++.+.||+|+||+||+|++..     +..||+|+++... ......+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467888999999999999998743     2359999997543 2345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999999999987777899999999999999999999   8889999999999999999999999999999876433


Q ss_pred             CCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ...  ......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  254 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL  254 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence            221  1222346788999999998999999999999999999999 99999754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.1e-33  Score=298.01  Aligned_cols=200  Identities=27%  Similarity=0.391  Sum_probs=169.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||.||+|++. +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            67999999999999999999985 489999999865432  234567899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++++..+.. ....+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++....... 
T Consensus       105 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          105 FVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             CCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence            999998888754 345689999999999999999999   888999999999999999999999999999976543322 


Q ss_pred             cccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......+++.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            23345789999999998775 7899999999999999999999999764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=304.84  Aligned_cols=201  Identities=20%  Similarity=0.241  Sum_probs=165.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecchh-----------hHHHHHHHHHHHhhcCCCcccceee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQLEG-----------ALESFNAECEVLRSIRHRNLVRIIS  689 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~  689 (851)
                      .++|++.+.||+|+||+||+|++.    .+..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999985    5778999998754321           1234667888899999999999999


Q ss_pred             eeec----CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC--
Q 046438          690 SCTN----DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM--  763 (851)
Q Consensus       690 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~--  763 (851)
                      ++.+    ....++||||+ +++|.+++.... .+++..++.++.||+.|++||   |++||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEEccCCCC
Confidence            9887    67899999999 999999986544 789999999999999999999   788999999999999998877  


Q ss_pred             cEEEeeccCccccCCCCC------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          764 VARLGDFGIAKLLSGDES------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .+||+|||+|+.+.....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            999999999987643221      1123457999999999999999999999999999999999999999654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.6e-33  Score=292.99  Aligned_cols=207  Identities=24%  Similarity=0.300  Sum_probs=161.2

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .++|++.+.||+|+||+||+|++ .+++.||+|+++....  ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46799999999999999999998 4688999999976432  22334555566688889999999999999999999999


Q ss_pred             eccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          702 DYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       702 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ||+++ ++.+++..   ....+++..+..++.|++.|++||   |++ ||+||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99974 77776643   466799999999999999999999   776 99999999999999999999999999998764


Q ss_pred             CCCCccccccccCccccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccch
Q 046438          778 GDESMKHTQTLATIGYMAPEYG----REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL  837 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  837 (851)
                      ...  ......+|+.|+|||++    .+..++.++||||+||++|||++|+.||+........+
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  223 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL  223 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence            332  22334689999999995    56678999999999999999999999997644333333

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-32  Score=291.02  Aligned_cols=200  Identities=24%  Similarity=0.376  Sum_probs=173.6

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeee-ecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSC-TNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....  .+.+.+|+++++.++|+++++.+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56899999999999999999998 5689999999875433  25688999999999998877766655 55668899999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+ +++|.+++......+++..+..++.||++|++||   |++||+||||||+||++   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 9999999976677899999999999999999999   88899999999999999   48899999999999876543


Q ss_pred             CCc------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...      ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            221      123457999999999999999999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-32  Score=292.15  Aligned_cols=202  Identities=27%  Similarity=0.515  Sum_probs=170.2

Q ss_pred             cCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeee-ecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSC-TNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l  699 (851)
                      .+|++.+.||+|+||+||+|++.+    ...||+|.++... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468899999999999999998643    2358999887543 33457789999999999999999999985 44568899


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            9999999999999987777889999999999999999999   8889999999999999999999999999999866433


Q ss_pred             CC---ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ES---MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ..   .......+|+.|+|||++.+..++.++||||+|+++|||++ |..||...
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence            21   12233467889999999999999999999999999999999 56666543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-32  Score=293.79  Aligned_cols=202  Identities=27%  Similarity=0.444  Sum_probs=165.2

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeec---chhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQ---LEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++ .+|+.||+|+++..   .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999988 46899999999753   233456788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      |||+++++|.+++..   ....+++..++.++.|+++|++||   |++||+||||+|+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999998864   456689999999999999999999   88899999999999999999999999999987654


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            3322 223456899999999999999999999999999999999999999754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9e-33  Score=314.03  Aligned_cols=200  Identities=25%  Similarity=0.410  Sum_probs=170.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .++|++.+.||+|+||+||+|++. ++..||+|+++...  ......+.+|+++++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456999999999999999999985 68899999997643  233567899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCccccCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIAKLLSG  778 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a~~~~~  778 (851)
                      ||+++|+|.+.+... ..+++..+..++.||++|++||   |++||+||||||+||+++.   ++.+||+|||+|+....
T Consensus       116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            999999998887554 4688999999999999999999   8889999999999999976   45699999999987653


Q ss_pred             CCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          779 DESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ..  ......||+.|+|||++. ..++.++||||+||++|+|++|+.||....
T Consensus       192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  241 (494)
T 3lij_A          192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT  241 (494)
T ss_dssp             TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32  234467999999999886 569999999999999999999999997643

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=1.2e-35  Score=336.02  Aligned_cols=384  Identities=21%  Similarity=0.196  Sum_probs=184.9

Q ss_pred             CCcEEeCCCCCCCCCCCcchhcCCccccccccccccccc----CCCccccCCCCccEEeccccccccccchhh-cCcc--
Q 046438           64 SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG----HLPREIGNLTSLTSIDLSENHLMGEIPHEI-GNLR--  136 (851)
Q Consensus        64 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~----~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~--  136 (851)
                      +|++|||++|+++......+|..+++|++|+|++|.+++    .++..+..+++|++|+|++|.+++..+..+ ..++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            445555555555422222335555555666666555542    234455556666666666666654333222 2333  


Q ss_pred             --cccEEEccCccccC----CCCccccCCCcCcEEEeeccccccccchhHhhh----cccccccccccccccccC----C
Q 046438          137 --NLQALGLLSNNLVG----VVPATLFNISTLKILQLTNNTLSGSISSSIRLA----LPNLELFSLANNNFSGKI----P  202 (851)
Q Consensus       137 --~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~----l~~L~~L~L~~N~i~~~~----~  202 (851)
                        +|++|++++|++..    .++..+..+++|++|+|++|.+++..+..+...    .++|++|++++|++++..    +
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence              46666666666653    235555666666666666666654333333322    334666666666665432    3


Q ss_pred             ccccccCCCcEEecCCCCCccccCcccc-----CCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCC
Q 046438          203 SFIFNASKLSICELPDNSFSGFIPNRFH-----NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC  277 (851)
Q Consensus       203 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  277 (851)
                      ..+..+++|+.|++++|.++...+..+.     .+++|++|++++|.++..+.. .+...+..+++|++|++++|++.+.
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR-DLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH-HHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH-HHHHHHHhCCCccEEeccCCcCChH
Confidence            3444456666666666666554433332     244666666666666542211 1233455566666666666655321


Q ss_pred             CCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCC----cCccccCCCCCcEEEccccccccccc
Q 046438          278 VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGS----IPSTLSRLEKLQILGLENNQLEGRIL  353 (851)
Q Consensus       278 ~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~  353 (851)
                      .... +                    .+..+..+++|++|++++|.++..    ++..+..+++|++|++++|.+++..+
T Consensus       243 ~~~~-l--------------------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~  301 (461)
T 1z7x_W          243 GMAE-L--------------------CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA  301 (461)
T ss_dssp             HHHH-H--------------------HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred             HHHH-H--------------------HHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence            1000 0                    001111234444444444444322    23333344444444444444443333


Q ss_pred             cccccc-----CCCCEEEccCcccCCC----CCccccCCccccceecccCcCccC-chhhcc-----cCcceEEEecCCC
Q 046438          354 DDICRL-----ARLSSVYLDHNKLSGS----IPACFGNLASLRKLSFASNELTFV-PSTFWN-----LTNILMVDLSSNP  418 (851)
Q Consensus       354 ~~~~~l-----~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-p~~~~~-----l~~L~~L~Ls~N~  418 (851)
                      ..+...     ++|+.|++++|.+++.    ++..+..+++|++|++++|+++.. +..+..     .++|++|+|++|.
T Consensus       302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            222221     3455555555544432    233344445555555555555422 111211     3455555555555


Q ss_pred             CCC----CCccccccchhhhhhhccCCcccccCCcc----c-CCCCCccEEEccCcccCC
Q 046438          419 LSG----SLPLEIGNLKVLVELYLSRNNLSGDIPTT----I-GGLKNLQNLSLGDNNLQG  469 (851)
Q Consensus       419 l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~  469 (851)
                      +++    .+|..+..+++|++|++++|++++.....    + ....+|+.|++.++.+..
T Consensus       382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~  441 (461)
T 1z7x_W          382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  441 (461)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence            553    44555555555555555555555321111    1 123456677777666653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-33  Score=297.52  Aligned_cols=203  Identities=29%  Similarity=0.481  Sum_probs=167.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcE----EEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGME----VAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.++... ....+.+.+|++++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999874 3544    4667664332 334577999999999999999999999998765 78


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +|+||+++|+|.+++......+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            89999999999999988777899999999999999999999   888999999999999999999999999999987643


Q ss_pred             CCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          779 DES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       779 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ... .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||+...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  224 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            322 12223456889999999999999999999999999999999 999997643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-32  Score=300.89  Aligned_cols=197  Identities=21%  Similarity=0.286  Sum_probs=162.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD------  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  695 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999884 58899999997643  334567889999999999999999999987654      


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++||||+++ ++.+.+.   ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 6777664   3478899999999999999999   888999999999999999999999999999986


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            5432  1233467899999999999999999999999999999999999999763

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.7e-33  Score=314.80  Aligned_cols=199  Identities=26%  Similarity=0.437  Sum_probs=175.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457999999999999999999985 68999999986542   33457799999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~~  777 (851)
                      |||+++|+|.+.+... ..+++..+..++.||+.|++||   |++||+||||||+||++   +.++.+||+|||+++...
T Consensus       105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999888643 5688999999999999999999   88899999999999999   567899999999998764


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...
T Consensus       181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  230 (484)
T 3nyv_A          181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA  230 (484)
T ss_dssp             CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence            432  2344579999999999865 6899999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-32  Score=295.70  Aligned_cols=194  Identities=22%  Similarity=0.367  Sum_probs=170.3

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeec--CCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTN--DDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++ .+++.||+|+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6799999999999999999988 46889999998743   2367899999999997 9999999999987  56789999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~~~  780 (851)
                      ||+++++|.+++.    .+++..+..++.||++|++||   |++||+||||||+||+++.++ .+||+|||+|+......
T Consensus       113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            9999999998874    378889999999999999999   888999999999999999776 89999999998764332


Q ss_pred             CccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                        ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~  235 (330)
T 3nsz_A          186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  235 (330)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence              2334578999999999877 678999999999999999999999996543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.4e-31  Score=288.12  Aligned_cols=197  Identities=23%  Similarity=0.349  Sum_probs=93.6

Q ss_pred             CCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccc
Q 046438           42 TLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE  121 (851)
Q Consensus        42 ~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~  121 (851)
                      +++.++++++.++. +|..-.+++++|++++|+++ .++...|..+++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus        32 ~l~~l~~~~~~l~~-lp~~~~~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           32 HLRVVQCSDLGLEK-VPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             ETTEEECTTSCCCS-CCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCeEEEecCCCccc-cCccCCCCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            44555555555542 22222345555555555555 34444455555555555555555555555555555555555555


Q ss_pred             cccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccc-ccchhHhhhccccccccccccccccc
Q 046438          122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSG-SISSSIRLALPNLELFSLANNNFSGK  200 (851)
Q Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~N~i~~~  200 (851)
                      |.++ .+|..+.  ++|++|++++|++.+..+..+.++++|+.|++++|.+.. ......+..+++|++|++++|.++. 
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-  185 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-  185 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-
Confidence            5555 3333322  455555555555554444445555555555555555532 1222223344444444444444442 


Q ss_pred             CCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCcccc
Q 046438          201 IPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYIT  246 (851)
Q Consensus       201 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  246 (851)
                      +|..+.  ++|+.|++++|.++++.+..|.++++|++|+|++|+++
T Consensus       186 l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  229 (330)
T 1xku_A          186 IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS  229 (330)
T ss_dssp             CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred             CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence            222211  34444444444444444444444444444444444443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-33  Score=309.85  Aligned_cols=197  Identities=15%  Similarity=0.218  Sum_probs=161.7

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeec---chhhHHHHHHHHH---HHhhcCCCccccee-------ee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQ---LEGALESFNAECE---VLRSIRHRNLVRII-------SS  690 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~~  690 (851)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++..   .....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46789999999999999999987 46899999999743   2345577899995   55555799999998       55


Q ss_pred             eecCC-----------------eeEEEEeccCCCChhHHhhcCC------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 046438          691 CTNDD-----------------FKALVLDYMPKGSLEACLYSDN------SNLDIFKRLNIVIDIALALEYLHFGHPNPV  747 (851)
Q Consensus       691 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~i  747 (851)
                      +.+.+                 ..++||||+ +|+|.+++....      ..+++..++.++.||++||+||   |++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH---HhCCe
Confidence            55443                 278999999 689999986532      1233577888999999999999   88899


Q ss_pred             EecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCccccccC-----------CCCcchhhHHHHHH
Q 046438          748 VHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-----------QISTEGDVYSFGIM  816 (851)
Q Consensus       748 vH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~DvwslG~i  816 (851)
                      +||||||+||+++.++.+||+|||+|+....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986422    2334567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCcc
Q 046438          817 LMEIFTRKRPTDEI  830 (851)
Q Consensus       817 l~el~~g~~pf~~~  830 (851)
                      +|||++|+.||...
T Consensus       303 l~elltg~~Pf~~~  316 (377)
T 3byv_A          303 IYWIWCADLPITKD  316 (377)
T ss_dssp             HHHHHHSSCCC---
T ss_pred             HHHHHHCCCCCccc
Confidence            99999999999764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-32  Score=302.46  Aligned_cols=198  Identities=23%  Similarity=0.374  Sum_probs=166.3

Q ss_pred             HHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec--------
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN--------  693 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  693 (851)
                      ...++|++.+.||+|+||+||+|++ .+|+.||+|++.....    ...+|+++++.++||||+++++++..        
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999988 4689999999875432    23479999999999999999998843        


Q ss_pred             ------------------------------CCeeEEEEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHH
Q 046438          694 ------------------------------DDFKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLH  740 (851)
Q Consensus       694 ------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~  740 (851)
                                                    ....++||||++ |+|.+.+..   ....+++..+..++.||++|++|| 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-  157 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI-  157 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH-
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-
Confidence                                          334889999997 477666543   456789999999999999999999 


Q ss_pred             hcCCCCcEecCCCCCCEEEC-CCCcEEEeeccCccccCCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHH
Q 046438          741 FGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLM  818 (851)
Q Consensus       741 ~~h~~~ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~  818 (851)
                        |++||+||||||+||+++ .++.+||+|||+|+......  ......+|+.|+|||++.+. .++.++||||+||++|
T Consensus       158 --H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          158 --HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             --HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             --HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence              889999999999999997 68999999999998764332  23345789999999998765 4899999999999999


Q ss_pred             HHHhCCCCCCcc
Q 046438          819 EIFTRKRPTDEI  830 (851)
Q Consensus       819 el~~g~~pf~~~  830 (851)
                      ||++|+.||.+.
T Consensus       234 ell~g~~pf~~~  245 (383)
T 3eb0_A          234 ELILGKPLFSGE  245 (383)
T ss_dssp             HHHHSSCSSCCS
T ss_pred             HHHhCCCCCCCC
Confidence            999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-33  Score=303.25  Aligned_cols=199  Identities=25%  Similarity=0.389  Sum_probs=174.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999985 68899999997653 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+++++|.+++... ..+++..+..++.|++.|++||   |++ ||+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            99999999998654 4588899999999999999999   654 8999999999999999999999999998754221  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence             223457899999999999999999999999999999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-33  Score=303.15  Aligned_cols=202  Identities=27%  Similarity=0.521  Sum_probs=163.0

Q ss_pred             CCCccceeccccceEEEEEEEcC--C--cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeec-CCeeEEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLD--G--MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTN-DDFKALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  700 (851)
                      .|++.+.||+|+||+||+|++.+  +  ..||+|.++... ....+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46778999999999999998742  2  358999886543 3455789999999999999999999998654 5578999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            999999999999987777789999999999999999999   88899999999999999999999999999998654322


Q ss_pred             C---ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          781 S---MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       781 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .   .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence            1   11223457889999999999999999999999999999999 778886643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-32  Score=291.10  Aligned_cols=201  Identities=30%  Similarity=0.447  Sum_probs=170.6

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      +|.....||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555669999999999999984 588999999987655556789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCccccCCCCCc
Q 046438          706 KGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       706 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++|.+++....  ...++..+..++.|+++|++||   |++||+||||+|+||+++. ++.+||+|||.+........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            999999987643  3456888889999999999999   7889999999999999987 89999999999987643222 


Q ss_pred             cccccccCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          783 KHTQTLATIGYMAPEYGREGQ--ISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ......+++.|+|||++.+..  ++.++||||+|+++|||++|+.||....
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            233457899999999987643  8899999999999999999999997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-33  Score=299.95  Aligned_cols=210  Identities=28%  Similarity=0.442  Sum_probs=171.0

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeec
Q 046438          616 FSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTN  693 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  693 (851)
                      +.+.++....++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+++++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            333444456788999999999999999999984 689999999976533 346789999999999 79999999999876


Q ss_pred             ------CCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEE
Q 046438          694 ------DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVAR  766 (851)
Q Consensus       694 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~k  766 (851)
                            .+..++||||+++++|.+++... ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHEEEcCCCCEE
Confidence                  45789999999999999998764 35688899999999999999999   888999999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+|||++........ ......+++.|+|||++.     +..++.++||||+||++|||++|+.||...
T Consensus       170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876543221 233457899999999986     567899999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.98  E-value=2.7e-33  Score=300.77  Aligned_cols=208  Identities=27%  Similarity=0.462  Sum_probs=177.5

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeee
Q 046438          620 ELLQATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCT  692 (851)
Q Consensus       620 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  692 (851)
                      ++....++|++.+.||+|+||.||+|++.      .++.||+|+++... ......+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999764      36789999987543 234456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhHHhhcC---------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC
Q 046438          693 NDDFKALVLDYMPKGSLEACLYSD---------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM  763 (851)
Q Consensus       693 ~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~  763 (851)
                      +.+..++||||+++|+|.+++...         ...+++..+..++.||++|++||   |++||+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCccceEEEcCCC
Confidence            999999999999999999988642         14568899999999999999999   888999999999999999999


Q ss_pred             cEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          764 VARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .+||+|||+++....... .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            999999999976543222 12223456889999999999999999999999999999999 89999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.2e-32  Score=290.23  Aligned_cols=200  Identities=28%  Similarity=0.477  Sum_probs=170.3

Q ss_pred             CCCccceeccccceEEEEEEEcC-C---cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee-EEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLD-G---MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK-ALV  700 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  700 (851)
                      .|++.+.||+|+||+||+|++.+ +   ..||+|+++... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667999999999999998743 2   369999987543 33457789999999999999999999999876654 899


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+.+|+|.+++......+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999987777889999999999999999999   88899999999999999999999999999997654322


Q ss_pred             ---CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          781 ---SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       781 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                         ........+++.|+|||...+..++.++||||+||++|||++|..|+..
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~  230 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR  230 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc
Confidence               1122345678999999999999999999999999999999996655433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.98  E-value=1.9e-32  Score=287.26  Aligned_cols=200  Identities=26%  Similarity=0.460  Sum_probs=167.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999985 68999999997543   22346788999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++... ..+++..+..++.||++|++||   |++||+||||+|+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999998654 4588999999999999999999   78899999999999999999999999999998764332


Q ss_pred             CccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        ......+++.|+|||++.+..+ +.++||||+|+++|||++|+.||+..
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence              2234568999999999988765 58899999999999999999999753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.98  E-value=2.3e-32  Score=311.43  Aligned_cols=200  Identities=27%  Similarity=0.409  Sum_probs=172.5

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-------------hhHHHHHHHHHHHhhcCCCcccceee
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-------------GALESFNAECEVLRSIRHRNLVRIIS  689 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~  689 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999985 578999999875431             23467889999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC---cEE
Q 046438          690 SCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM---VAR  766 (851)
Q Consensus       690 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~---~~k  766 (851)
                      ++.+....++||||+++|+|.+.+... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            999999999999999999999888653 4689999999999999999999   888999999999999998775   699


Q ss_pred             EeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+|||+++......  ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.
T Consensus       190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999998765432  334567999999999987 46899999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.98  E-value=6.4e-33  Score=301.94  Aligned_cols=196  Identities=24%  Similarity=0.358  Sum_probs=154.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC------C
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND------D  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  695 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+++.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999874 68899999986542  23456788999999999999999999998654      5


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..++|||++ +++|.+++..  ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7889888754  5689999999999999999999   888999999999999999999999999999986


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...    ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          182 TAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            532    2334678999999999877 67899999999999999999999999764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=5.1e-32  Score=292.86  Aligned_cols=204  Identities=28%  Similarity=0.452  Sum_probs=167.5

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc--CCCcccceeeeeecC--
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI--RHRNLVRIISSCTND--  694 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--  694 (851)
                      .......++|++.+.||+|+||.||+|++ .++.||+|++....   .....+|.+++...  +||||+++++++.+.  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            33344567899999999999999999998 48999999986442   24455566666655  899999999998876  


Q ss_pred             --CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC--------CcEecCCCCCCEEECCCCc
Q 046438          695 --DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN--------PVVHCDIKPSNVLLDEDMV  764 (851)
Q Consensus       695 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~--------~ivH~Dl~~~Nill~~~~~  764 (851)
                        ...++||||+++|+|.+++...  .+++..++.++.|++.|++||   |++        ||+||||||+||+++.++.
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHL---HTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH---HSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH---HHhhhhhccCCCEEecccchHHEEECCCCC
Confidence              6889999999999999998653  588999999999999999999   555        9999999999999999999


Q ss_pred             EEEeeccCccccCCCCCc---cccccccCccccCccccccCCCCcc------hhhHHHHHHHHHHHhC----------CC
Q 046438          765 ARLGDFGIAKLLSGDESM---KHTQTLATIGYMAPEYGREGQISTE------GDVYSFGIMLMEIFTR----------KR  825 (851)
Q Consensus       765 ~kl~Dfg~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~------~DvwslG~il~el~~g----------~~  825 (851)
                      +||+|||+++........   ......||+.|+|||++.+..++.+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999999999766433221   1224579999999999987766665      9999999999999999          67


Q ss_pred             CCCccC
Q 046438          826 PTDEIF  831 (851)
Q Consensus       826 pf~~~~  831 (851)
                      ||....
T Consensus       261 p~~~~~  266 (337)
T 3mdy_A          261 PYHDLV  266 (337)
T ss_dssp             TTTTTS
T ss_pred             cHhhhc
Confidence            776543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.98  E-value=3.4e-33  Score=303.60  Aligned_cols=199  Identities=17%  Similarity=0.229  Sum_probs=170.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcC---------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccc---------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD---------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR---------  686 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  686 (851)
                      .++|++.+.||+|+||.||+|++..         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999998863         788999998754     46789999999999999988         


Q ss_pred             ------eeeeeec-CCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEE
Q 046438          687 ------IISSCTN-DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVL  758 (851)
Q Consensus       687 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nil  758 (851)
                            +++++.. .+..++||||+ +++|.+++... ...+++..+..++.||++|++||   |++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL---HENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEE
Confidence                  5566655 67889999999 99999999764 46789999999999999999999   8889999999999999


Q ss_pred             ECCCC--cEEEeeccCccccCCCCC------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          759 LDEDM--VARLGDFGIAKLLSGDES------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       759 l~~~~--~~kl~Dfg~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++.++  .+||+|||+++.......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  999999999976643221      1123357999999999999999999999999999999999999999876


Q ss_pred             Cc
Q 046438          831 FS  832 (851)
Q Consensus       831 ~~  832 (851)
                      ..
T Consensus       272 ~~  273 (352)
T 2jii_A          272 LP  273 (352)
T ss_dssp             TT
T ss_pred             Cc
Confidence            43

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.98  E-value=3.7e-33  Score=319.24  Aligned_cols=201  Identities=29%  Similarity=0.521  Sum_probs=175.4

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||.||+|++.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            457889999999999999999998888899999976432 34679999999999999999999999876 6789999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ...+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++.........
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence            999999998653 35588999999999999999999   88899999999999999999999999999998764322222


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....++..|+|||++....++.++|||||||++|||++ |+.||.+.
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            223456789999999998999999999999999999999 99999764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.98  E-value=8.3e-33  Score=297.23  Aligned_cols=202  Identities=31%  Similarity=0.533  Sum_probs=176.5

Q ss_pred             hcCCCccceeccccceEEEEEEE-----cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--ee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-----LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD--FK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~  697 (851)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35689999999999999999985     358899999998766666678999999999999999999999887654  78


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++......+++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999987777799999999999999999999   78899999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          778 GDESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       778 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....  ......++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            43321  12234567889999999888899999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.98  E-value=1.7e-32  Score=294.41  Aligned_cols=202  Identities=26%  Similarity=0.368  Sum_probs=169.0

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--------hhHHHHHHHHHHHhhcCCCcccceeeeeecC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--------GALESFNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.....        .....+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3567999999999999999999985 578999999865321        1234578999999999999999999998765


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc---EEEeecc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV---ARLGDFG  771 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~---~kl~Dfg  771 (851)
                      + .++||||+++++|.+++.. ...+++..+..++.||++|++||   |++||+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 7999999999999988854 45688999999999999999999   8889999999999999987654   9999999


Q ss_pred             CccccCCCCCccccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      +++......  ......+|+.|+|||++.   ...++.++||||+||++|||++|+.||.....
T Consensus       163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            998764322  223456899999999863   56789999999999999999999999976433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.98  E-value=1.8e-32  Score=293.35  Aligned_cols=200  Identities=27%  Similarity=0.466  Sum_probs=172.2

Q ss_pred             cCC-CccceeccccceEEEEEEEc-----CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecC--Ce
Q 046438          626 DQF-NVNNLIGSGSFGSVYRGRFL-----DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTND--DF  696 (851)
Q Consensus       626 ~~~-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  696 (851)
                      ++| ++.+.||+|+||+||+|.+.     +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            344 99999999999999998653     57889999997653 23456789999999999999999999999874  57


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+++|+|.+++...  .+++..++.++.|++.|++||   |++||+||||||+||+++.++.+||+|||.+...
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            89999999999999998654  488999999999999999999   8889999999999999999999999999999876


Q ss_pred             CCCCCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            543321  223356788899999999889999999999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.98  E-value=4.6e-33  Score=304.77  Aligned_cols=198  Identities=14%  Similarity=0.145  Sum_probs=154.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhc--CCCccccee-------eeee
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSI--RHRNLVRII-------SSCT  692 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~  692 (851)
                      .+|++.+.||+|+||+||+|++. +++.||+|+++....   ...+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45889999999999999999985 688999999987542   3456678886555555  699988755       3333


Q ss_pred             cC-----------------CeeEEEEeccCCCChhHHhhcCCCCcCHHHH------HHHHHHHHHHHHHHHhcCCCCcEe
Q 046438          693 ND-----------------DFKALVLDYMPKGSLEACLYSDNSNLDIFKR------LNIVIDIALALEYLHFGHPNPVVH  749 (851)
Q Consensus       693 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~L~~~h~~~ivH  749 (851)
                      ..                 ...++||||++ |+|.+++........+..+      ..++.||++|++||   |++||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L---H~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH---HHTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH---HHCCCcc
Confidence            22                 34799999998 8999998764444455555      67889999999999   8889999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 046438          750 CDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPT  827 (851)
Q Consensus       750 ~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf  827 (851)
                      |||||+||+++.++.+||+|||+|+.....    .....+|+.|+|||++.+  ..++.++||||+||++|||++|+.||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999875322    213457799999999987  77999999999999999999999999


Q ss_pred             CccC
Q 046438          828 DEIF  831 (851)
Q Consensus       828 ~~~~  831 (851)
                      ....
T Consensus       294 ~~~~  297 (371)
T 3q60_A          294 GLVT  297 (371)
T ss_dssp             TBCC
T ss_pred             CCcC
Confidence            8753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.98  E-value=2.5e-32  Score=288.28  Aligned_cols=197  Identities=24%  Similarity=0.364  Sum_probs=170.1

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...  ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999985 68999999997643  23456788899999999 999999999999999999999


Q ss_pred             EeccCCCChhHHhhcC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---------------
Q 046438          701 LDYMPKGSLEACLYSD---NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---------------  762 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---------------  762 (851)
                      |||+++++|.+++...   ...+++..++.++.||++|++||   |++||+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999998653   25689999999999999999999   88899999999999999844               


Q ss_pred             ----CcEEEeeccCccccCCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          763 ----MVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       763 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                          ..+||+|||.+.......     ...+|+.|+|||++.+. .+++++||||+||++|||++|..|+..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                479999999998764322     23589999999998765 566899999999999999999987643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.98  E-value=1.5e-32  Score=295.47  Aligned_cols=200  Identities=29%  Similarity=0.522  Sum_probs=169.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcE--EEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGME--VAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||.||+|++. ++..  ||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999874 4554  4999887532 23446788999999999 899999999999999999999


Q ss_pred             EeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          701 LDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      |||+++|+|.+++....               ..+++..++.++.||++|++||   |++||+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCccceEEEcCCCeE
Confidence            99999999999986543               4689999999999999999999   88899999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          766 RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ||+|||+++....  ........+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence            9999999874322  112233456889999999988889999999999999999998 99999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.98  E-value=1.3e-32  Score=288.93  Aligned_cols=202  Identities=29%  Similarity=0.460  Sum_probs=172.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeee--cCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCT--NDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  699 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367999999999999999999985 68999999997543  334567899999999999999999999874  4568899


Q ss_pred             EEeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEecCCCCCCEEECCCCcEEEeecc
Q 046438          700 VLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGHPNP-----VVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~-----ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      ||||+++++|.+++..   ....+++..++.++.|+++|++||   |++|     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999865   234589999999999999999999   6666     9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .++....... ......+++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            9987643321 223457899999999999889999999999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.98  E-value=2.6e-32  Score=291.72  Aligned_cols=205  Identities=25%  Similarity=0.485  Sum_probs=164.5

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD--  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  695 (851)
                      ..++|++.+.||+|+||.||+|++..    ++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45679999999999999999998742    4579999987542  334567899999999999999999999987754  


Q ss_pred             ---eeEEEEeccCCCChhHHhhc-----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEE
Q 046438          696 ---FKALVLDYMPKGSLEACLYS-----DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARL  767 (851)
Q Consensus       696 ---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl  767 (851)
                         ..++||||+++|+|.+++..     ....+++..++.++.||++|++||   |++||+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEE
Confidence               35899999999999998843     345689999999999999999999   8899999999999999999999999


Q ss_pred             eeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          768 GDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            99999986643322 12233457889999999999999999999999999999999 999997643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.98  E-value=1.2e-32  Score=319.52  Aligned_cols=201  Identities=24%  Similarity=0.477  Sum_probs=168.9

Q ss_pred             CCCccc-eeccccceEEEEEEEc---CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          627 QFNVNN-LIGSGSFGSVYRGRFL---DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       627 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++|||||++++++.+ +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999874   45679999997653 2356789999999999999999999999976 5689999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999977777799999999999999999999   888999999999999999999999999999987643322


Q ss_pred             c--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          782 M--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       782 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  544 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  544 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            1  1122345689999999999999999999999999999998 999997643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=1.3e-32  Score=289.66  Aligned_cols=197  Identities=28%  Similarity=0.480  Sum_probs=172.9

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec---------
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN---------  693 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  693 (851)
                      ...+|++.+.||+|+||.||+|++. +++.||+|+++...    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999985 68999999997653    346789999999999999999998754         


Q ss_pred             -------CCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          694 -------DDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       694 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                             ....++||||+++++|.+++... ...+++..++.++.||++|++||   |++||+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHEEEcCCCCE
Confidence                   34579999999999999998653 45688999999999999999999   78899999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          766 RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||+|||++.......  ......+++.|+|||++.+..++.++||||+|+++|||++|..||..
T Consensus       162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            999999998765432  23345689999999999999999999999999999999999998753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.98  E-value=5.7e-33  Score=295.53  Aligned_cols=205  Identities=27%  Similarity=0.396  Sum_probs=158.9

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999874 68899999886543 233467889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhc-------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          702 DYMPKGSLEACLYS-------DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       702 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      ||+++++|.+++..       ....+++..+..++.||++|++||   |++||+||||+|+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999998864       345689999999999999999999   78899999999999999999999999999987


Q ss_pred             ccCCCCC----ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          775 LLSGDES----MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       775 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .......    .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  231 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP  231 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence            6543221    11234578999999999876 568999999999999999999999997643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.98  E-value=3.8e-32  Score=296.68  Aligned_cols=200  Identities=26%  Similarity=0.311  Sum_probs=171.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----Cee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  697 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999985 58889999997543 33446788999999999999999999998654     368


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||++ |+|.+++..  ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999996 588888754  3588999999999999999999   88899999999999999999999999999998764


Q ss_pred             CCCCc--cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESM--KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            33221  1234579999999998654 55899999999999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=3.2e-32  Score=303.01  Aligned_cols=197  Identities=21%  Similarity=0.306  Sum_probs=171.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhc------CCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSI------RHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  697 (851)
                      ..+|++.+.||+|+||+||+|++. +++.||||+++... ...+.+.+|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999885 48899999997542 3345677888888877      567999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc--EEEeeccCcc
Q 046438          698 ALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV--ARLGDFGIAK  774 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~--~kl~Dfg~a~  774 (851)
                      ++||||++ ++|.+++.... ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 68888876543 4589999999999999999999   7889999999999999999887  9999999997


Q ss_pred             ccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....    ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            6532    233467899999999999999999999999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.98  E-value=1.9e-32  Score=301.76  Aligned_cols=196  Identities=28%  Similarity=0.413  Sum_probs=164.7

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC------eeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD------FKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  699 (851)
                      .+|++.+.||+|+||+||+|++..+..||+|++.....    ...+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            56999999999999999999998777799998865432    2347999999999999999999985433      3789


Q ss_pred             EEeccCCCChhHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCcEEEeeccCcccc
Q 046438          700 VLDYMPKGSLEACLY--SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLL  776 (851)
Q Consensus       700 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~~  776 (851)
                      ||||++++.+.....  .....+++..+..++.||++|++||   |++||+||||||+||+++ .++.+||+|||+|+..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998765443322  2356789999999999999999999   888999999999999998 7999999999999876


Q ss_pred             CCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.
T Consensus       193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4332  23346789999999998764 5899999999999999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.98  E-value=5.7e-32  Score=286.99  Aligned_cols=202  Identities=27%  Similarity=0.384  Sum_probs=175.6

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---------hhhHHHHHHHHHHHhhcC-CCcccceeeee
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---------EGALESFNAECEVLRSIR-HRNLVRIISSC  691 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  691 (851)
                      ...++|++.+.||+|+||.||+|++. +++.||+|+++...         ....+.+.+|++++++++ ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999985 58899999997542         123456889999999996 99999999999


Q ss_pred             ecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          692 TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       692 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      .+.+..++||||+++++|.+++... ..+++..+..++.||+.|++||   |++||+||||+|+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999998653 5688999999999999999999   88899999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGR------EGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .+.......  ......+++.|+|||++.      ...++.++||||+|+++|||++|+.||...
T Consensus       170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  232 (298)
T 1phk_A          170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  232 (298)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence            998764332  233457899999999874      456889999999999999999999999653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=3.9e-32  Score=293.79  Aligned_cols=202  Identities=23%  Similarity=0.321  Sum_probs=158.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeee--------cC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCT--------ND  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~  694 (851)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357999999999999999999984 68999999997766666678999999999996 999999999883        34


Q ss_pred             CeeEEEEeccCCCChhHHhhc--CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEECCCCcEEEeec
Q 046438          695 DFKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                      ...++||||++ |+|.+++..  ....+++..++.++.||+.|++||   |++|  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            46899999995 688888754  456689999999999999999999   7778  999999999999999999999999


Q ss_pred             cCccccCCCCCc-----------cccccccCccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          771 GIAKLLSGDESM-----------KHTQTLATIGYMAPEYG---REGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       771 g~a~~~~~~~~~-----------~~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+++........           ......+|+.|+|||++   .+..++.++||||+||++|||++|+.||...
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999876433221           11134689999999998   5677899999999999999999999999753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.98  E-value=5e-32  Score=293.55  Aligned_cols=211  Identities=26%  Similarity=0.434  Sum_probs=175.4

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhh--cCCCcccceeeeeecC
Q 046438          617 SYQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRS--IRHRNLVRIISSCTND  694 (851)
Q Consensus       617 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~  694 (851)
                      +........++|++.+.||+|+||+||+|++ +++.||+|+++..   ..+.+.+|.++++.  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3444455678899999999999999999998 6899999999744   33567788999887  6899999999999877


Q ss_pred             C----eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEecCCCCCCEEECCCCcE
Q 046438          695 D----FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF-----GHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       695 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~-----~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      .    ..++||||+++|+|.+++..  ..+++..++.++.|++.|++|||.     .|++||+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    78999999999999999865  358899999999999999999941     118899999999999999999999


Q ss_pred             EEeeccCccccCCCCCc---cccccccCccccCccccccCC------CCcchhhHHHHHHHHHHHhC----------CCC
Q 046438          766 RLGDFGIAKLLSGDESM---KHTQTLATIGYMAPEYGREGQ------ISTEGDVYSFGIMLMEIFTR----------KRP  826 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g----------~~p  826 (851)
                      ||+|||++.........   ......+|+.|+|||++.+..      ++.++|||||||++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999776443321   223457899999999987652      33689999999999999999          788


Q ss_pred             CCccCcC
Q 046438          827 TDEIFSG  833 (851)
Q Consensus       827 f~~~~~~  833 (851)
                      |......
T Consensus       267 ~~~~~~~  273 (342)
T 1b6c_B          267 YYDLVPS  273 (342)
T ss_dssp             TTTTSCS
T ss_pred             ccccCcC
Confidence            8765443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=2.7e-32  Score=302.30  Aligned_cols=199  Identities=24%  Similarity=0.323  Sum_probs=168.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC--------CCcccceeeeee---
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR--------HRNLVRIISSCT---  692 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~---  692 (851)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++.. ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999999884 5888999999754 334567889999999985        788999999987   


Q ss_pred             -cCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCC-------
Q 046438          693 -NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDM-------  763 (851)
Q Consensus       693 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~-------  763 (851)
                       +....++||||++++.+..+.......+++..++.++.||+.||+||   |++ ||+||||||+||+++.++       
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence             45688999999954444444434446789999999999999999999   777 999999999999998775       


Q ss_pred             ------------------------------------------cEEEeeccCccccCCCCCccccccccCccccCcccccc
Q 046438          764 ------------------------------------------VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE  801 (851)
Q Consensus       764 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~  801 (851)
                                                                .+||+|||.++.....    .....||+.|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999876422    234578999999999999


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          802 GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       802 ~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ..++.++||||+||++|||++|+.||....
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            999999999999999999999999997643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=5.2e-32  Score=303.54  Aligned_cols=202  Identities=24%  Similarity=0.347  Sum_probs=173.7

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCC-CcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIRH-RNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||.||+|++ .+++.||||++......  ..+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999998 46899999988754332  457889999999987 555566666677788999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE---CCCCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL---DEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill---~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+ +++|.+++......+++..++.++.||+.||+||   |++||+||||||+||++   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999987677899999999999999999999   88899999999999999   58899999999999876543


Q ss_pred             CCc------cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          780 ESM------KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       780 ~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ...      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            321      12246799999999999999999999999999999999999999987543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=3.2e-32  Score=302.41  Aligned_cols=195  Identities=30%  Similarity=0.419  Sum_probs=163.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC------CeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND------DFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  698 (851)
                      .+|++.+.||+|+||+||+|++. +|+.||||++....    +...+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46899999999999999999985 58999999986542    2245799999999999999999987432      2467


Q ss_pred             EEEeccCCCChhHHhh---cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-CcEEEeeccCcc
Q 046438          699 LVLDYMPKGSLEACLY---SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAK  774 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-~~~kl~Dfg~a~  774 (851)
                      +||||+++ ++.+.+.   .....+++..+..++.||++||+||   |++||+||||||+||+++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 5554443   2456789999999999999999999   88999999999999999965 678999999998


Q ss_pred             ccCCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          775 LLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       775 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.
T Consensus       206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            764332  23346789999999998764 7899999999999999999999999764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=295.51  Aligned_cols=196  Identities=30%  Similarity=0.504  Sum_probs=159.4

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHH--HhhcCCCcccceeeeee-----cCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEV--LRSIRHRNLVRIISSCT-----NDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~~~  697 (851)
                      .++|++.+.||+|+||+||+|++ +++.||+|+++....   ..+..|.++  +..++||||+++++.+.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36799999999999999999987 789999999975432   334445454  44589999999997543     23367


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC---------CcEecCCCCCCEEECCCCcEEEe
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN---------PVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~---------~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                      ++||||+++|+|.+++...  ..++..+..++.||++|++||   |++         ||+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHH---HhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            8999999999999998654  347888999999999999999   666         99999999999999999999999


Q ss_pred             eccCccccCCCC-------CccccccccCccccCcccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          769 DFGIAKLLSGDE-------SMKHTQTLATIGYMAPEYGRE-------GQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       769 Dfg~a~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      |||+++......       ........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999998764322       112224579999999999876       4567789999999999999999877644

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=1.7e-32  Score=295.97  Aligned_cols=205  Identities=26%  Similarity=0.493  Sum_probs=175.7

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC-C-----cEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCC
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD-G-----MEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDD  695 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  695 (851)
                      ..++|++.+.||+|+||.||+|++.. +     ..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999998743 2     479999997653 23456789999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhHHhhcC-------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC
Q 046438          696 FKALVLDYMPKGSLEACLYSD-------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED  762 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~  762 (851)
                      ..++||||+++|+|.+++...             ...+++..++.++.||+.|++||   |++||+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCcccceEEECCC
Confidence            999999999999999988642             34578899999999999999999   78899999999999999999


Q ss_pred             CcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          763 MVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       763 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            9999999999986543222 12233456889999999999999999999999999999998 999997643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=7.5e-32  Score=287.10  Aligned_cols=203  Identities=22%  Similarity=0.349  Sum_probs=169.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc----hhhHHHHHHHHHHHhhcCCCcccceeeeee--cCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL----EGALESFNAECEVLRSIRHRNLVRIISSCT--NDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  696 (851)
                      ..++|++.+.||+|+||.||+|++. +++.||+|+++...    ....+.+.+|++++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999884 58899999997543    234577999999999999999999999984  4558


Q ss_pred             eEEEEeccCCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          697 KALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      .++||||++++ +.+++.. ....+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999877 6666544 356789999999999999999999   888999999999999999999999999999987


Q ss_pred             cCCCC-CccccccccCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDE-SMKHTQTLATIGYMAPEYGREGQ--ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..... ........+++.|+|||+..+..  ++.++||||+||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD  216 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            64322 22233457899999999987644  477999999999999999999999763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=4e-32  Score=288.91  Aligned_cols=195  Identities=28%  Similarity=0.433  Sum_probs=164.0

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec---------
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN---------  693 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  693 (851)
                      ..++|++.+.||+|+||.||+|++. +++.||+|+++.. ....+.+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3567999999999999999999984 6899999999754 3445778999999999999999999998754         


Q ss_pred             ----CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEee
Q 046438          694 ----DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGD  769 (851)
Q Consensus       694 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~D  769 (851)
                          .+..++||||+++|+|.+++.......++..++.++.|+++|++||   |++||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH---HhCCeecccCCHHhEEEcCCCCEEEee
Confidence                3578999999999999999987777788899999999999999999   888999999999999999999999999


Q ss_pred             ccCccccCCCC-------------CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHh
Q 046438          770 FGIAKLLSGDE-------------SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFT  822 (851)
Q Consensus       770 fg~a~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~  822 (851)
                      ||++.......             ........+++.|+|||++.+. .++.++||||+||++|||++
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            99997654221             1122345689999999998764 68999999999999999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=1.3e-32  Score=288.69  Aligned_cols=196  Identities=36%  Similarity=0.547  Sum_probs=164.4

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC-CeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND-DFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++ +|+.||+|+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            36799999999999999999988 58899999987543  447789999999999999999999986554 478999999


Q ss_pred             cCCCChhHHhhcCCC-CcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          704 MPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      +++++|.+++..... .+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999865422 378888999999999999999   8889999999999999999999999999998765332   


Q ss_pred             cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                       .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence             223357889999999998999999999999999999998 99999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=5.6e-32  Score=291.03  Aligned_cols=201  Identities=30%  Similarity=0.445  Sum_probs=171.0

Q ss_pred             HhcCCCccceeccccceEEEEEEEc--CCcEEEEEEEeecchh--hHHHHHHHHHHHhhc---CCCcccceeeeee----
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL--DGMEVAIKVFHLQLEG--ALESFNAECEVLRSI---RHRNLVRIISSCT----  692 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  692 (851)
                      +.++|++.+.||+|+||.||+|++.  +++.||+|+++.....  ....+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999983  5788999998754321  223566777777766   8999999999987    


Q ss_pred             -cCCeeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          693 -NDDFKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       693 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                       .....++||||++ |+|.+++... ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHHeEEcCCCCEEEecC
Confidence             4567899999997 6999888764 34589999999999999999999   8889999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          771 GIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       771 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |.++......  ......+++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9997654222  234467899999999999999999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=5.6e-32  Score=290.28  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=165.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeee-----------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT-----------  692 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----------  692 (851)
                      .++|++.+.||+|+||.||+|++.. ++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4689999999999999999999864 8999999998766666788999999999999999999998873           


Q ss_pred             ---cCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCcEEEe
Q 046438          693 ---NDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLG  768 (851)
Q Consensus       693 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~~kl~  768 (851)
                         +....++||||++ |+|.+++..  ..+++..++.++.|+++|++||   |++||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 689988853  5688999999999999999999   888999999999999997 56799999


Q ss_pred             eccCccccCCCCC--ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          769 DFGIAKLLSGDES--MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       769 Dfg~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      |||+++.......  .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            9999987643211  12233467999999998765 678999999999999999999999997643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=3e-32  Score=293.10  Aligned_cols=203  Identities=29%  Similarity=0.467  Sum_probs=170.1

Q ss_pred             hcCCCccceeccccceEEEEEEE------cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF------LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999983      347789999986442 34456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCC------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEe
Q 046438          698 ALVLDYMPKGSLEACLYSDN------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLG  768 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~  768 (851)
                      ++||||+++++|.+++....      ..+++..++.++.||++|++||   |++||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999987643      4488899999999999999999   8889999999999999984   4569999


Q ss_pred             eccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          769 DFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       769 Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      |||++........ .......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            9999975532221 12234567899999999998999999999999999999998 99999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=3.1e-32  Score=301.82  Aligned_cols=199  Identities=24%  Similarity=0.339  Sum_probs=153.4

Q ss_pred             cCCCc-cceeccccceEEEEEEEc---CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeee--cCCeeEE
Q 046438          626 DQFNV-NNLIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCT--NDDFKAL  699 (851)
Q Consensus       626 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  699 (851)
                      +.|++ .++||+|+||+||+|++.   +++.||+|++....  ....+.+|++++++++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44666 458999999999999975   47889999987542  2356889999999999999999999994  4668999


Q ss_pred             EEeccCCCChhHHhhc--------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE----CCCCcEEE
Q 046438          700 VLDYMPKGSLEACLYS--------DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----DEDMVARL  767 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~--------~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill----~~~~~~kl  767 (851)
                      ||||+++ ++.+++..        ....+++..++.++.||+.|++||   |++||+||||||+||++    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999965 67666542        122488999999999999999999   88899999999999999    67889999


Q ss_pred             eeccCccccCCCCC--ccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          768 GDFGIAKLLSGDES--MKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       768 ~Dfg~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +|||+|+.......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999987643221  223346789999999998874 5899999999999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=2e-32  Score=289.26  Aligned_cols=201  Identities=26%  Similarity=0.481  Sum_probs=169.8

Q ss_pred             hcCCCccc-eeccccceEEEEEEEc---CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          625 TDQFNVNN-LIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       625 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      .++|++.+ .||+|+||+||+|.+.   .++.||+|+++....  ...+.+.+|+++++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45788888 9999999999999653   367899999976532  2356799999999999999999999999 556789


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+++++|.+++... ..+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            999999999999998654 4688999999999999999999   888999999999999999999999999999987654


Q ss_pred             CCCcc--ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          779 DESMK--HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       779 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....  .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  224 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  224 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            33221  222346788999999988889999999999999999999 99999764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=1.1e-31  Score=292.96  Aligned_cols=207  Identities=27%  Similarity=0.357  Sum_probs=159.8

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC--
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD--  695 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  695 (851)
                      +......++|++.+.||+|+||+||+|++. +++.||||++.... .......+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            344556789999999999999999999984 58999999986543 22345677888889999999999999986533  


Q ss_pred             -----eeEEEEeccCCCChhHHhh---cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEE
Q 046438          696 -----FKALVLDYMPKGSLEACLY---SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVAR  766 (851)
Q Consensus       696 -----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~k  766 (851)
                           ..++||||++++ +...+.   .....+++..+..++.|++.|++|||. |++||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 378999999765 433332   245678889999999999999999931 2999999999999999996 89999


Q ss_pred             EeeccCccccCCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          767 LGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       767 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      |+|||+++......  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            99999998765332  23345789999999998654 4899999999999999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=8.1e-32  Score=294.63  Aligned_cols=195  Identities=26%  Similarity=0.361  Sum_probs=166.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee----
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK----  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  697 (851)
                      .++|.+.+.||+|+||+||+|++. +|+.||+|++....  ....+.+.+|+++++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999985 58999999997643  23356788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          698 --ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       698 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                        ++||||++ ++|.+.+   ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 5777766   34489999999999999999999   888999999999999999999999999999986


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...    ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            532    2334578999999999877 78899999999999999999999999763

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=1.3e-31  Score=288.20  Aligned_cols=201  Identities=25%  Similarity=0.318  Sum_probs=150.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHH-HHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECE-VLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|+++.... .....+..|.. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367999999999999999999984 689999999976532 23344555555 777789999999999999999999999


Q ss_pred             eccCCCChhHHhhc----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          702 DYMPKGSLEACLYS----DNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       702 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ||+++ ++.+++..    ....+++..+..++.|++.|++||   |++ ||+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 77666542    356788999999999999999999   777 9999999999999999999999999999766


Q ss_pred             CCCCCccccccccCccccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          777 SGDESMKHTQTLATIGYMAPEYG----REGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....  ......||+.|+|||++    .+..++.++|||||||++|||++|+.||....
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            4322  22334689999999998    45678999999999999999999999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=1.3e-31  Score=289.85  Aligned_cols=197  Identities=22%  Similarity=0.324  Sum_probs=172.1

Q ss_pred             hcCCCccceeccccceEEEEEEE-c-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCc------ccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-L-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN------LVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||+||+|.+ . +++.||+|+++.. ....+.+.+|+++++.++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999987 3 5889999999754 334567889999999987664      9999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC--------------
Q 046438          697 KALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE--------------  761 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~--------------  761 (851)
                      .++||||+ ++++.+++.... ..+++..+..++.||++|++||   |++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889988886643 4688999999999999999999   8889999999999999987              


Q ss_pred             -----CCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          762 -----DMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       762 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                           ++.+||+|||.++.....    .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                 668999999999865322    23457899999999999999999999999999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=3e-32  Score=288.08  Aligned_cols=202  Identities=26%  Similarity=0.463  Sum_probs=164.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc--CCc--EEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL--DGM--EVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||+||+|++.  +++  .||+|+++...   ....+.+.+|++++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357999999999999999999863  233  68999987542   334577899999999999999999999998765 7


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||+++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            899999999999999877666789999999999999999999   78899999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          778 GDESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       778 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....  ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  228 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL  228 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence            43321  1223457888999999988889999999999999999999 99999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=1.4e-31  Score=291.34  Aligned_cols=200  Identities=25%  Similarity=0.347  Sum_probs=169.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----Cee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  697 (851)
                      .++|++.+.||+|+||.||+|++. +|+.||+|+++... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999985 58899999997543 23446788999999999999999999987654     678


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccC
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLS  777 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~  777 (851)
                      ++||||++ ++|.+++..  ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 588888765  4688999999999999999999   78899999999999999999999999999998764


Q ss_pred             CCCCc---------cccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          778 GDESM---------KHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       778 ~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....         ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            32211         1223478999999998754 67899999999999999999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=2.5e-31  Score=292.07  Aligned_cols=200  Identities=24%  Similarity=0.334  Sum_probs=171.4

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CC-----cccceeeeeecCCe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HR-----NLVRIISSCTNDDF  696 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~  696 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++.. ......+.+|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999985 5788999999754 233466788888888885 44     49999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC--CCCcEEEeeccCc
Q 046438          697 KALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD--EDMVARLGDFGIA  773 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~--~~~~~kl~Dfg~a  773 (851)
                      .++||||++ ++|.+++.... ..+++..+..++.|++.|++|||. |+.||+||||||+||+++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 58988887643 568999999999999999999942 368999999999999995  4788999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +.....    .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876432    23467899999999999999999999999999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.1e-31  Score=286.75  Aligned_cols=203  Identities=26%  Similarity=0.419  Sum_probs=168.6

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcC--CCcccceeeeeecCCeeEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIR--HRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l  699 (851)
                      ..++|++.+.||+|+||.||+|++.+++.||+|++....  ....+.+.+|++++++++  ||||+++++++.+.+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            456799999999999999999998889999999997543  334577899999999997  5999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||| +.+++|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++ ++.+||+|||+++.....
T Consensus       106 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            999 5688999998654 4688899999999999999999   888999999999999996 489999999999876433


Q ss_pred             CC-ccccccccCccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          780 ES-MKHTQTLATIGYMAPEYGRE-----------GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       780 ~~-~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      .. .......+++.|+|||++.+           ..++.++||||+||++|||++|+.||.....
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            22 12234578999999999865           4788899999999999999999999976543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=8e-32  Score=314.42  Aligned_cols=202  Identities=27%  Similarity=0.468  Sum_probs=171.6

Q ss_pred             hcCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||+||+|++..    +..||+|+++... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            4678999999999999999998843    4569999987543 3344678999999999999999999999854 56899


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|+|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            9999999999999987766789999999999999999999   7889999999999999999999999999999876544


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .........+|+.|+|||++.+..++.++||||+||++|||++ |+.||.+.
T Consensus       545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  596 (656)
T 2j0j_A          545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  596 (656)
T ss_dssp             ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            3333334567889999999998899999999999999999997 99999764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.8e-31  Score=281.28  Aligned_cols=201  Identities=23%  Similarity=0.393  Sum_probs=173.9

Q ss_pred             HHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999985 689999999975432  345778999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC---CcEEEeeccCcccc
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED---MVARLGDFGIAKLL  776 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~---~~~kl~Dfg~a~~~  776 (851)
                      ||||+++++|.+++... ..+++..++.++.||+.|++||   |++||+||||+|+||+++.+   +.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999998887543 4688999999999999999999   88899999999999999754   47999999999866


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  ......+++.|+|||++.+ .++.++||||+|+++|+|++|+.||...
T Consensus       175 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             CCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence            4332  2233468999999998875 4899999999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=290.06  Aligned_cols=195  Identities=26%  Similarity=0.352  Sum_probs=165.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe-----
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF-----  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  696 (851)
                      .++|.+.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999984 58999999997543  2335678899999999999999999999987653     


Q ss_pred             -eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          697 -KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       697 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                       .++||||++ ++|.+++.   ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 57877663   3488999999999999999999   788999999999999999999999999999976


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            5322    234578999999999876 67899999999999999999999999763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=8.7e-32  Score=312.92  Aligned_cols=195  Identities=28%  Similarity=0.485  Sum_probs=164.4

Q ss_pred             ceeccccceEEEEEEEc---CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFL---DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|.+.   .++.||||+++....  ...+.+.+|++++++++|||||++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999763   367899999976532  335789999999999999999999999965 457899999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc--cc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM--KH  784 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~  784 (851)
                      |+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+........  ..
T Consensus       454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999864 45688999999999999999999   7889999999999999999999999999999876543321  22


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  577 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  577 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            23456789999999999999999999999999999998 999997643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=3e-31  Score=289.10  Aligned_cols=197  Identities=23%  Similarity=0.333  Sum_probs=169.3

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CC-cEEEEEEEeecchhhHHHHHHHHHHHhhcCCCc------ccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DG-MEVAIKVFHLQLEGALESFNAECEVLRSIRHRN------LVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||+||+|++. ++ +.||+|+++.. ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999884 34 68999999754 334567889999999998766      8899999999999


Q ss_pred             eEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE----------------
Q 046438          697 KALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL----------------  759 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill----------------  759 (851)
                      .++||||+ ++++.+++... ...+++..+..++.||+.|++||   |++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 55565555443 45789999999999999999999   88999999999999999                


Q ss_pred             ---CCCCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          760 ---DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       760 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                         +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence               56789999999999864322    23457899999999999999999999999999999999999999764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=1.4e-31  Score=305.68  Aligned_cols=200  Identities=29%  Similarity=0.434  Sum_probs=171.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeec------CCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTN------DDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  696 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999874 58899999987543 3345678999999999999999999998765      667


Q ss_pred             eEEEEeccCCCChhHHhhcCC--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCc---EEEeecc
Q 046438          697 KALVLDYMPKGSLEACLYSDN--SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMV---ARLGDFG  771 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~---~kl~Dfg  771 (851)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.|++||   |++||+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999987633  3588889999999999999999   7889999999999999987664   9999999


Q ss_pred             CccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          772 IAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       772 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .+.......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            998764332  23446799999999999999999999999999999999999999965

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=2.5e-31  Score=284.95  Aligned_cols=200  Identities=27%  Similarity=0.337  Sum_probs=153.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++.+.||+|+||.||+|++. +|+.||+|+++....  ...+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            57899999999999999999985 689999999976532  223345555667888899999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+ ++.+..+.......+++..+..++.|+++|++||   |++ ||+||||||+||+++.++.+||+|||++....... 
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            99 5666666554466789999999999999999999   664 99999999999999999999999999997654322 


Q ss_pred             ccccccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 MKHTQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                       ......+++.|+|||++.     ...++.++||||+||++|||++|+.||....
T Consensus       180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (318)
T 2dyl_A          180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK  233 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence             223456899999999984     5578899999999999999999999997643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=3.1e-31  Score=285.73  Aligned_cols=198  Identities=22%  Similarity=0.327  Sum_probs=146.8

Q ss_pred             HhcCCCccc-eeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec----CCee
Q 046438          624 ATDQFNVNN-LIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN----DDFK  697 (851)
Q Consensus       624 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  697 (851)
                      ..++|++.+ .||+|+||+||+|++. +++.||+|++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356798865 6999999999999985 68999999987532    222233344666799999999999876    4468


Q ss_pred             EEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a  773 (851)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.|++||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999987643 4689999999999999999999   8889999999999999976   456999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      +.....   ......+|+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            865432   2234568999999999988889999999999999999999999996543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=9.4e-32  Score=287.27  Aligned_cols=205  Identities=26%  Similarity=0.352  Sum_probs=164.0

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchh------hHHHHHHHHHHHhhc----CCCcccc
Q 046438          618 YQELLQATDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEG------ALESFNAECEVLRSI----RHRNLVR  686 (851)
Q Consensus       618 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~  686 (851)
                      ..+.....++|++.+.||+|+||.||+|++ .+++.||+|+++.....      ....+.+|++++.++    +||||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            344555678899999999999999999987 46889999998754321      223456789999888    8999999


Q ss_pred             eeeeeecCCeeEEEEec-cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCc
Q 046438          687 IISSCTNDDFKALVLDY-MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMV  764 (851)
Q Consensus       687 ~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~  764 (851)
                      +++++.+.+..++|||+ +++++|.+++... ..+++..++.++.||++|++||   |++||+||||||+||+++ .++.
T Consensus       103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          103 LLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEETTTTE
T ss_pred             EEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEeCCCCe
Confidence            99999999999999999 7899999998653 4688999999999999999999   788999999999999999 8899


Q ss_pred             EEEeeccCccccCCCCCccccccccCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCc
Q 046438          765 ARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS-TEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       765 ~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      +||+|||+++.....   ......+++.|+|||++.+..+. .++||||+||++|||++|+.||..
T Consensus       179 ~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            999999999876433   23345689999999998877664 589999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=7.2e-32  Score=289.25  Aligned_cols=201  Identities=28%  Similarity=0.459  Sum_probs=168.1

Q ss_pred             HhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ..++|++.+.||+|+||.||+|++.+  .||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35789999999999999999998743  59999987543  223356778999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC--
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD--  779 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~--  779 (851)
                      ||+++++|.+++......+++..+..++.||++|++||   |++||+||||||+||+++ ++.+||+|||+++.....  
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999999999977666789999999999999999999   788999999999999998 679999999998754321  


Q ss_pred             --CCccccccccCccccCcccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 --ESMKHTQTLATIGYMAPEYGRE---------GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 --~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .........|++.|+|||++.+         ..++.++|||||||++|||++|+.||...
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              1112233468999999998864         45788999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1e-31  Score=287.74  Aligned_cols=202  Identities=26%  Similarity=0.334  Sum_probs=172.4

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchh------hHHHHHHHHHHHhhcC--CCcccceeeee
Q 046438          621 LLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG------ALESFNAECEVLRSIR--HRNLVRIISSC  691 (851)
Q Consensus       621 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~  691 (851)
                      .....++|++.+.||+|+||.||+|++. +++.||+|+++.....      ..+.+.+|++++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3345678999999999999999999874 6889999999765321      2245678999999996  59999999999


Q ss_pred             ecCCeeEEEEeccCC-CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC-CCCcEEEee
Q 046438          692 TNDDFKALVLDYMPK-GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGD  769 (851)
Q Consensus       692 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~-~~~~~kl~D  769 (851)
                      .+.+..++|||++.+ ++|.+++.. ...+++..++.++.||++|++||   |++||+||||||+||+++ +++.+||+|
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999999976 899998865 35688999999999999999999   888999999999999999 789999999


Q ss_pred             ccCccccCCCCCccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          770 FGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       770 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ||+++.....   ......+|+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus       194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            9999876432   2234568999999999887766 6788999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=3.9e-31  Score=294.99  Aligned_cols=199  Identities=25%  Similarity=0.404  Sum_probs=157.6

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   .+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3455668899999999987766789999999987542   35678899999886 8999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCC------cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCC-------------CcE
Q 046438          705 PKGSLEACLYSDNSN------LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDED-------------MVA  765 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~-------------~~~  765 (851)
                      + |+|.+++......      ..+..++.++.||+.|++||   |++||+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999998654321      12334577999999999999   78899999999999999654             489


Q ss_pred             EEeeccCccccCCCCCc---cccccccCccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          766 RLGDFGIAKLLSGDESM---KHTQTLATIGYMAPEYGRE-------GQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ||+|||+|+........   ......||+.|+|||++.+       ..++.++||||+||++|||++ |+.||....
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            99999999876543221   1234579999999999865       678999999999999999999 999997643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=4.3e-32  Score=292.99  Aligned_cols=192  Identities=18%  Similarity=0.193  Sum_probs=160.1

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch--------hhHHHHHHHHHHHhhcC----------------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--------GALESFNAECEVLRSIR----------------  680 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~----------------  680 (851)
                      .++|++.+.||+|+||+||+|++ +|+.||+|+++....        ...+.+.+|+++++.++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35689999999999999999998 789999999986531        23367889999998886                


Q ss_pred             ----------CCcccceeeeeec-------------CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHH
Q 046438          681 ----------HRNLVRIISSCTN-------------DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALE  737 (851)
Q Consensus       681 ----------h~niv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  737 (851)
                                ||||+++++++.+             .+..++||||+++|++.+.+..  ..+++..+..++.||+.|++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence                      5555555555554             6789999999999976655533  56789999999999999999


Q ss_pred             HHHhcC-CCCcEecCCCCCCEEECCCC--------------------cEEEeeccCccccCCCCCccccccccCccccCc
Q 046438          738 YLHFGH-PNPVVHCDIKPSNVLLDEDM--------------------VARLGDFGIAKLLSGDESMKHTQTLATIGYMAP  796 (851)
Q Consensus       738 ~L~~~h-~~~ivH~Dl~~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aP  796 (851)
                      ||   | ++||+||||||+||+++.++                    .+||+|||+|+.....      ...||+.|+||
T Consensus       176 ~l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VA---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HH---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HH---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            99   7 88999999999999999887                    9999999999876422      34799999999


Q ss_pred             cccccCCCCcchhhHHHHHH-HHHHHhCCCCCCc
Q 046438          797 EYGREGQISTEGDVYSFGIM-LMEIFTRKRPTDE  829 (851)
Q Consensus       797 E~~~~~~~~~~~DvwslG~i-l~el~~g~~pf~~  829 (851)
                      |++.+.. +.++||||+|++ .+++++|..||..
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            9998766 889999998777 7888999999854

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=3.6e-31  Score=290.51  Aligned_cols=197  Identities=19%  Similarity=0.338  Sum_probs=167.9

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-----------CCcccceeeeee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-----------HRNLVRIISSCT  692 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  692 (851)
                      .++|++.+.||+|+||+||+|++ .+++.||+|+++... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999998 468899999997542 33467888999998886           889999999987


Q ss_pred             cCC----eeEEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCEEEC------
Q 046438          693 NDD----FKALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPN-PVVHCDIKPSNVLLD------  760 (851)
Q Consensus       693 ~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~-~ivH~Dl~~~Nill~------  760 (851)
                      ..+    ..++||||+ +++|.+++... ...+++..+..++.||+.|++||   |++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 88999988763 45589999999999999999999   777 999999999999994      


Q ss_pred             CCCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          761 EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       761 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ..+.+||+|||+++.....    .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            4458999999999875422    23457899999999999999999999999999999999999999754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.9e-31  Score=293.88  Aligned_cols=198  Identities=21%  Similarity=0.357  Sum_probs=160.4

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .+|++.+.||+|+||+||.....+++.||||++.....   ..+.+|+++++.+ +||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            46888999999999997665556899999999865322   2356899999999 7999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-----CCcEEEeeccCccccCCC
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-----DMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-----~~~~kl~Dfg~a~~~~~~  779 (851)
                      + |+|.+++...........+..++.||+.|++||   |++||+||||||+||+++.     ...+||+|||+|+.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            6 599999877665566666788999999999999   8889999999999999953     336889999999876432


Q ss_pred             CC--ccccccccCccccCccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          780 ES--MKHTQTLATIGYMAPEYGR---EGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       780 ~~--~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ..  .......||+.|+|||++.   ...++.++||||+||++|||++ |+.||...
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            21  2233467999999999987   4567889999999999999999 99999653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=8.9e-31  Score=309.09  Aligned_cols=193  Identities=25%  Similarity=0.354  Sum_probs=166.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc--CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCe-----
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL--DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDF-----  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  696 (851)
                      .++|++.+.||+|+||+||+|++.  +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999985  58999999986543 3344678899999999999999999999987654     


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .|+||||++|++|.+++..   .+++..+..++.||++||+||   |++||+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999887643   689999999999999999999   88899999999999999886 8999999999876


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...     ....||+.|+|||++.+. ++.++|||||||++|||++|..||...
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence            432     345799999999998765 488999999999999999999998754

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2e-30  Score=275.98  Aligned_cols=272  Identities=21%  Similarity=0.225  Sum_probs=224.9

Q ss_pred             EEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCC--cCccccCCCCCcEEEc
Q 046438          266 VLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGS--IPSTLSRLEKLQILGL  343 (851)
Q Consensus       266 ~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L  343 (851)
                      .++++++.+..  +|..+   +.++++|++++|+++...+..|.++++|++|++++|.++..  .+..+..+++|++|++
T Consensus        11 ~l~c~~~~l~~--ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A           11 EIRCNSKGLTS--VPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             EEECCSSCCSS--CCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             EEEcCCCCccc--CCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            44555555432  33322   23677788888888755555688999999999999998733  2567778999999999


Q ss_pred             ccccccccccccccccCCCCEEEccCcccCCCCC-ccccCCccccceecccCcCccC-chhhcccCcceEEEecCCCCCC
Q 046438          344 ENNQLEGRILDDICRLARLSSVYLDHNKLSGSIP-ACFGNLASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLSG  421 (851)
Q Consensus       344 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~~  421 (851)
                      ++|.++. .+..+..+++|++|++++|++.+..+ ..+..+++|++|++++|+++.+ +..+..+++|++|++++|.+++
T Consensus        86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A           86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence            9999984 56678899999999999999987655 6889999999999999999854 5678889999999999999986


Q ss_pred             -CCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccc
Q 046438          422 -SLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLE  500 (851)
Q Consensus       422 -~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  500 (851)
                       ..|..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+.
T Consensus       165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  244 (306)
T 2z66_A          165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ  244 (306)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred             ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence             5788999999999999999999988899999999999999999999987788899999999999999999999999999


Q ss_pred             ccc-cccceeccCccccccCCCCC---cccccCcccccCCcCccCCC
Q 046438          501 KLL-YLKYLNVSFNRLEGEIPRGG---TLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       501 ~l~-~L~~l~l~~N~l~~~~p~~~---~~~~l~~~~~~~n~~~c~~~  543 (851)
                      .++ +|+.|++++|+|+|+++...   ++..........+...|..|
T Consensus       245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence            995 99999999999999987542   33334444456677788776

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=4.4e-30  Score=287.88  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=223.1

Q ss_pred             ccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEc
Q 046438          264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGL  343 (851)
Q Consensus       264 L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  343 (851)
                      .+.++.+++.+.  .+|..+.   .+++.|+|++|+|++..+..|.++++|++|+|++|.+.+..+..|.++++|++|+|
T Consensus        45 ~~~v~c~~~~l~--~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           45 FSKVICVRKNLR--EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             SCEEECCSCCCS--SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCEEEeCCCCcC--cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            345555555553  3444333   46788888888888888889999999999999999999888889999999999999


Q ss_pred             ccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceeccc-CcCccCch-hhcccCcceEEEecCCCCCC
Q 046438          344 ENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFAS-NELTFVPS-TFWNLTNILMVDLSSNPLSG  421 (851)
Q Consensus       344 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~  421 (851)
                      ++|++++..+..|..+++|+.|+|++|++.+..+..|..+++|++|++++ |.+..++. .|.++++|++|+|++|.++ 
T Consensus       120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-  198 (440)
T 3zyj_A          120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-  198 (440)
T ss_dssp             CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred             CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence            99999988888899999999999999999988888999999999999998 56777765 6889999999999999998 


Q ss_pred             CCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccc
Q 046438          422 SLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEK  501 (851)
Q Consensus       422 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  501 (851)
                      .+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..
T Consensus       199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  277 (440)
T 3zyj_A          199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP  277 (440)
T ss_dssp             SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred             ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence            555 4888999999999999999888999999999999999999999888999999999999999999999888888999


Q ss_pred             cccccceeccCccccccCCCC
Q 046438          502 LLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       502 l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      +++|+.|+|++|+|.|+|...
T Consensus       278 l~~L~~L~L~~Np~~CdC~l~  298 (440)
T 3zyj_A          278 LHHLERIHLHHNPWNCNCDIL  298 (440)
T ss_dssp             CTTCCEEECCSSCEECSSTTH
T ss_pred             ccCCCEEEcCCCCccCCCCch
Confidence            999999999999999999754

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=4.3e-30  Score=270.37  Aligned_cols=232  Identities=25%  Similarity=0.252  Sum_probs=175.7

Q ss_pred             cCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcc-cCCCCCccccCCcccccee
Q 046438          312 INLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNK-LSGSIPACFGNLASLRKLS  390 (851)
Q Consensus       312 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~  390 (851)
                      ++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|++|++++|+ +....+..|..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            466666777766665555666677777777777777776666667777777777777775 6655566777777777777


Q ss_pred             cccCcCccC-chhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCC
Q 046438          391 FASNELTFV-PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG  469 (851)
Q Consensus       391 L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  469 (851)
                      +++|+++.+ |..+..+++|++|++++|++++..+..|+.+++|++|++++|++++..+..|..+++|+.|++++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            777777766 4456777778888888888876666667788888888888888886656678888888888888888887


Q ss_pred             CCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       470 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ..|..|+.+++|+.|+|++|++++..+..+..+++|+.|++++|+|+|+++....+.++.......+...|..|
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence            77888888888888888888888766677888888888888888888888766556666666666777777766

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.1e-30  Score=280.38  Aligned_cols=261  Identities=19%  Similarity=0.208  Sum_probs=169.6

Q ss_pred             CCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCcccccccc
Q 046438          210 KLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS  289 (851)
Q Consensus       210 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~  289 (851)
                      +|+.|++++|.++++.+..|.++++|++|++++|.++.+..     ..+..+++|++|++++|++               
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L~~L~Ls~n~l---------------  112 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE-----DSFSSLGSLEHLDLSYNYL---------------  112 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT-----TTTTTCTTCCEEECCSSCC---------------
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH-----hhcCCCCCCCEEECCCCcC---------------
Confidence            45555555555555544455555555555555555543221     1233333333333333332               


Q ss_pred             ccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcC-ccccCCCCCcEEEcccc-cccccccccccccCCCCEEEc
Q 046438          290 MERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIP-STLSRLEKLQILGLENN-QLEGRILDDICRLARLSSVYL  367 (851)
Q Consensus       290 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L  367 (851)
                                 ++..+..+..+++|++|++++|++++..+ ..+..+++|++|++++| .+++..+..+..+++|+.|++
T Consensus       113 -----------~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l  181 (353)
T 2z80_A          113 -----------SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI  181 (353)
T ss_dssp             -----------SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred             -----------CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEEC
Confidence                       22233446777888888888888875444 46778888888888887 466666667777778888888


Q ss_pred             cCcccCCCCCccccCCccccceecccCcCccCchhh-cccCcceEEEecCCCCCCCCccccccchhhhhhhccCCccccc
Q 046438          368 DHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTF-WNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGD  446 (851)
Q Consensus       368 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  446 (851)
                      ++|++.+..|..|..+++|++|++++|+++.+|..+ ..+++|+.|++++|++++..+..+..                 
T Consensus       182 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~-----------------  244 (353)
T 2z80_A          182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-----------------  244 (353)
T ss_dssp             EETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------
T ss_pred             CCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-----------------
Confidence            888877777777777777777777777777776643 34677777777777776543332211                 


Q ss_pred             CCcccCCCCCccEEEccCcccCC----CCcccccCCCCCCEEECCCCcccccCCcc-ccccccccceeccCccccccCCC
Q 046438          447 IPTTIGGLKNLQNLSLGDNNLQG----SIPNSIGDLISLECLDLSNNILSGIIPSS-LEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       447 ~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                          ......++.++|++|.+++    .+|..+..+++|+.|+|++|+++. +|.. |..+++|+.|++++|+|+|++|.
T Consensus       245 ----~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          245 ----GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             ------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ----ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence                1223456666666666654    467788889999999999999984 5544 68899999999999999999884


Q ss_pred             CC
Q 046438          522 GG  523 (851)
Q Consensus       522 ~~  523 (851)
                      ..
T Consensus       320 l~  321 (353)
T 2z80_A          320 ID  321 (353)
T ss_dssp             HH
T ss_pred             cH
Confidence            43

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=8.9e-30  Score=267.28  Aligned_cols=174  Identities=16%  Similarity=0.135  Sum_probs=151.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999985 48999999997653   23346789999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||++|++|.+++...   ....++..++.|+++|++||   |++||+||||||+||+++.++.+||+++|.        
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~kl~~~~~--------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------  175 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence            9999999999998432   35567888999999999999   888999999999999999999999985542        


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                                   ++       .++.++|||||||++|||++|+.||.+...
T Consensus       176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                         22       368899999999999999999999987543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=6.7e-32  Score=315.64  Aligned_cols=408  Identities=16%  Similarity=0.117  Sum_probs=197.0

Q ss_pred             CCcchhcCCcccccccccccccc---cCCCcccc------------CCCCccEEeccccccccccchhhcCc--ccccEE
Q 046438           79 LPANIFSYLPFVQFLSLAFNQFA---GHLPREIG------------NLTSLTSIDLSENHLMGEIPHEIGNL--RNLQAL  141 (851)
Q Consensus        79 ~~~~~~~~l~~L~~L~L~~N~i~---~~~~~~l~------------~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L  141 (851)
                      .|..++..+++|++|+|+++...   +.+|..++            .+++|++|+|++|.+++..+..+...  .+|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            34445556666666666554321   12222222            56777777777777765555555553  347777


Q ss_pred             EccCccc-cC-CCCccccCCCcCcEEEeecccccccc---chhHhhhccccccccccccccc----ccCCccccccCCCc
Q 046438          142 GLLSNNL-VG-VVPATLFNISTLKILQLTNNTLSGSI---SSSIRLALPNLELFSLANNNFS----GKIPSFIFNASKLS  212 (851)
Q Consensus       142 ~L~~n~l-~~-~~~~~l~~l~~L~~L~L~~n~l~~~~---~~~~~~~l~~L~~L~L~~N~i~----~~~~~~~~~~~~L~  212 (851)
                      ++++|.- .. ..+....++++|++|+|++|.+++..   ...+...+++|++|++++|.++    +.++..+.++++|+
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            7776651 11 01112235677777777777765442   2224446677777777777765    23334445667777


Q ss_pred             EEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccE
Q 046438          213 ICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER  292 (851)
Q Consensus       213 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~  292 (851)
                      .|++++|.+.++ +..+..+++|++|+++.+.....  .......+..+++|+.|+++++..  ..+|..+... .+|++
T Consensus       224 ~L~L~~~~~~~l-~~~~~~~~~L~~L~l~~~~~~~~--~~~~~~~l~~~~~L~~L~l~~~~~--~~l~~~~~~~-~~L~~  297 (592)
T 3ogk_B          224 SVKVGDFEILEL-VGFFKAAANLEEFCGGSLNEDIG--MPEKYMNLVFPRKLCRLGLSYMGP--NEMPILFPFA-AQIRK  297 (592)
T ss_dssp             EEECSSCBGGGG-HHHHHHCTTCCEEEECBCCCCTT--CTTSSSCCCCCTTCCEEEETTCCT--TTGGGGGGGG-GGCCE
T ss_pred             EEeccCccHHHH-HHHHhhhhHHHhhcccccccccc--hHHHHHHhhccccccccCccccch--hHHHHHHhhc-CCCcE
Confidence            777777776653 35666777777777764322110  011223455556666666665422  2233333222 24555


Q ss_pred             EEeecCccccCCC-cccccccCCcEEEecCCCCC-CCcCccccCCCCCcEEEccc-----------cccccccccc-ccc
Q 046438          293 FYLHNCNIRGSIP-KEMGNLINLIIIRLGYNKLN-GSIPSTLSRLEKLQILGLEN-----------NQLEGRILDD-ICR  358 (851)
Q Consensus       293 L~L~~n~i~~~~p-~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~-----------n~l~~~~~~~-~~~  358 (851)
                      |++++|.+++... ..+..+++|+.|+++ +.+. +.++..+..+++|++|++++           |.+++..... ...
T Consensus       298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~  376 (592)
T 3ogk_B          298 LDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG  376 (592)
T ss_dssp             EEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred             EecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence            5555555432222 223445555555555 2222 11222223445555555552           3333222211 223


Q ss_pred             cCCCCEEEccCcccCCCCCccccC-Cccccceecc----cCcCccCc------hhhcccCcceEEEecCCC--CCCCCcc
Q 046438          359 LARLSSVYLDHNKLSGSIPACFGN-LASLRKLSFA----SNELTFVP------STFWNLTNILMVDLSSNP--LSGSLPL  425 (851)
Q Consensus       359 l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~p------~~~~~l~~L~~L~Ls~N~--l~~~~p~  425 (851)
                      +++|+.|+++.|++++..+..+.. +++|+.|+++    .|+++..|      ..+.++++|++|++++|.  +++..+.
T Consensus       377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~  456 (592)
T 3ogk_B          377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS  456 (592)
T ss_dssp             CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred             CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence            455555555555554433333333 4455555553    34444321      223445555555554322  3333222


Q ss_pred             cccc-chhhhhhhccCCccccc-CCcccCCCCCccEEEccCcccCCC-CcccccCCCCCCEEECCCCcccc
Q 046438          426 EIGN-LKVLVELYLSRNNLSGD-IPTTIGGLKNLQNLSLGDNNLQGS-IPNSIGDLISLECLDLSNNILSG  493 (851)
Q Consensus       426 ~~~~-l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~  493 (851)
                      .+.. +++|++|++++|++++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|++++
T Consensus       457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence            2222 44455555555555431 233334455555555555554322 22223344555555555555543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.2e-29  Score=283.15  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=225.3

Q ss_pred             ccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEc
Q 046438          264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGL  343 (851)
Q Consensus       264 L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  343 (851)
                      ...++.+++.+..  +|..+   +.+++.|+|++|+|++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus        56 ~~~v~c~~~~l~~--iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           56 FSKVVCTRRGLSE--VPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SCEEECCSSCCSS--CCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CcEEEECCCCcCc--cCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence            3455566655532  44433   247888999999998888999999999999999999999888899999999999999


Q ss_pred             ccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceeccc-CcCccCch-hhcccCcceEEEecCCCCCC
Q 046438          344 ENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFAS-NELTFVPS-TFWNLTNILMVDLSSNPLSG  421 (851)
Q Consensus       344 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~  421 (851)
                      ++|.+++..+..|..+++|+.|+|++|++.+..+..|..+++|++|++++ |.++.++. .+.++++|++|+|++|++++
T Consensus       131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            99999988888899999999999999999988888999999999999998 67777765 68899999999999999995


Q ss_pred             CCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccc
Q 046438          422 SLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEK  501 (851)
Q Consensus       422 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  501 (851)
                       +| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..
T Consensus       211 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  288 (452)
T 3zyi_A          211 -MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP  288 (452)
T ss_dssp             -CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred             -cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence             44 5889999999999999999888999999999999999999999888999999999999999999999888888999


Q ss_pred             cccccceeccCccccccCCCC
Q 046438          502 LLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       502 l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      +++|+.|+|++|+|.|+|...
T Consensus       289 l~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          289 LRYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             CTTCCEEECCSSCEECSTTTH
T ss_pred             ccCCCEEEccCCCcCCCCCch
Confidence            999999999999999999754

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=276.12  Aligned_cols=280  Identities=19%  Similarity=0.193  Sum_probs=167.0

Q ss_pred             CCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEecc
Q 046438           41 NTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS  120 (851)
Q Consensus        41 ~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls  120 (851)
                      +.....++++|+++.+ |..-.++|++|++++|+++ .++...|..+++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        31 ~~~~~c~~~~~~l~~i-P~~~~~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           31 DRNGICKGSSGSLNSI-PSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS  108 (353)
T ss_dssp             CTTSEEECCSTTCSSC-CTTCCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCeEeeCCCCCcccc-cccccccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence            3334455555555532 2233345666666666665 4555556666777777777777666666667777777777777


Q ss_pred             ccccccccchhhcCcccccEEEccCccccCCCC-ccccCCCcCcEEEeeccc-cccccchhHhhhccccccccccccccc
Q 046438          121 ENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVP-ATLFNISTLKILQLTNNT-LSGSISSSIRLALPNLELFSLANNNFS  198 (851)
Q Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~~l~~L~~L~L~~N~i~  198 (851)
                      +|.+++..+..|+++++|++|++++|++.+..+ ..+.++++|++|++++|. +. .++...+..+++|++|++++|+++
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l~  187 (353)
T 2z80_A          109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQ  187 (353)
T ss_dssp             SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCCCcC
Confidence            777775545557777777777777777775444 466677777777777774 43 444444456666666777666666


Q ss_pred             ccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCC
Q 046438          199 GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCV  278 (851)
Q Consensus       199 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  278 (851)
                      +..|..+.++++|+.|++++|.++.+.+..+..+++|++|++++|.++..+...  +........               
T Consensus       188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~--l~~~~~~~~---------------  250 (353)
T 2z80_A          188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE--LSTGETNSL---------------  250 (353)
T ss_dssp             EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--------CCCC---------------
T ss_pred             ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc--cccccccch---------------
Confidence            666666666666666666666666555445555666777777777666543211  111112222               


Q ss_pred             CCCccccccccccEEEeecCcccc----CCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEccccccccc
Q 046438          279 LPSSIGNLSLSMERFYLHNCNIRG----SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGR  351 (851)
Q Consensus       279 ~p~~~~~~~~~L~~L~L~~n~i~~----~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  351 (851)
                                 ++.++++++.+.+    .+|..+..+++|+.|++++|+++...+..|..+++|++|++++|++.+.
T Consensus       251 -----------l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          251 -----------IKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             -----------CCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             -----------hhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence                       3334444444332    3455666677777777777777643333356667777777777766643

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=4.3e-29  Score=267.47  Aligned_cols=224  Identities=24%  Similarity=0.292  Sum_probs=183.7

Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      .++.|++++|+++ .+|..+..+++|++|++++|.+. .+|..+..+++|++|+|++|.++ .+|..+..+++|+.|+++
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            4455555555555 45556666667777777777666 56666666777777777777766 456666667777777777


Q ss_pred             CcccCCCCCcccc---------CCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhcc
Q 046438          369 HNKLSGSIPACFG---------NLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLS  439 (851)
Q Consensus       369 ~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  439 (851)
                      +|++.+.+|..+.         .+++|++|++++|+++.+|..+..+++|++|+|++|+++ .+|..++.+++|++|+|+
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls  237 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR  237 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECT
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECc
Confidence            7666666666554         489999999999999999999999999999999999999 466789999999999999


Q ss_pred             CCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCcccc
Q 046438          440 RNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLE  516 (851)
Q Consensus       440 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  516 (851)
                      +|++.+.+|..|+.+++|+.|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988665

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.3e-29  Score=269.82  Aligned_cols=212  Identities=25%  Similarity=0.285  Sum_probs=151.1

Q ss_pred             cccCCcEEEecCCCCCCCcCccccCCCCCcEEEccccccccccc-ccccccCCCCEEEccCcccCCCCCccccCCccccc
Q 046438          310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRIL-DDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK  388 (851)
Q Consensus       310 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  388 (851)
                      .+++|++|++++|.+. .+|..+..+++|++|++++|.+++..+ ..+..+++|+.|++++|.+.+..+..|..+++|++
T Consensus        76 ~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  154 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  154 (306)
T ss_dssp             SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred             cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE
Confidence            3444444444444444 233345555555555555555554433 34555666666666666666566666667777777


Q ss_pred             eecccCcCcc--CchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcc
Q 046438          389 LSFASNELTF--VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN  466 (851)
Q Consensus       389 L~L~~N~l~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  466 (851)
                      |++++|+++.  +|..+..+++|++|+|++|++++..|..|..+++|++|++++|++++..+..+..+++|+.|+|++|+
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            7777777764  56777778888888888888887778888888888888888888887667788899999999999999


Q ss_pred             cCCCCcccccCCC-CCCEEECCCCcccccCC--ccccccccccceeccCccccccCCCC
Q 046438          467 LQGSIPNSIGDLI-SLECLDLSNNILSGIIP--SSLEKLLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       467 l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      +++..|..+..++ +|++|+|++|++++.-+  .....+...+.+.++.+.+.|..|..
T Consensus       235 l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~  293 (306)
T 2z66_A          235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD  293 (306)
T ss_dssp             CCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred             CcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence            9988899999884 99999999999986432  22333556667788889999988853

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=5.3e-29  Score=263.97  Aligned_cols=175  Identities=23%  Similarity=0.362  Sum_probs=151.1

Q ss_pred             hcCCCcc-ceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHH-hhcCCCcccceeeeeec----CCee
Q 046438          625 TDQFNVN-NLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVL-RSIRHRNLVRIISSCTN----DDFK  697 (851)
Q Consensus       625 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~  697 (851)
                      .++|.+. +.||+|+||.||+|++ .+++.||+|+++..     ..+.+|++++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567777 7899999999999998 46889999998643     4567888887 55689999999999876    6688


Q ss_pred             EEEEeccCCCChhHHhhcCC-CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDN-SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a  773 (851)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.|++||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999987643 4689999999999999999999   8889999999999999998   789999999998


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....                       +..++.++||||+||++|||++|+.||...
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            6542                       134678899999999999999999999654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.1e-29  Score=281.44  Aligned_cols=197  Identities=16%  Similarity=0.196  Sum_probs=154.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch---hhHHHHHHHHHHHhhcCC-Cccccee------------
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE---GALESFNAECEVLRSIRH-RNLVRII------------  688 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~~~------------  688 (851)
                      ..|...+.||+|+||+||+|++. +|+.||||+++....   ...+.+.+|+.+++.++| ++...+.            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34777899999999999999974 689999999874322   235779999999999987 3221111            


Q ss_pred             ---------eeeec-----CCeeEEEEeccCCCChhHHhh------cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 046438          689 ---------SSCTN-----DDFKALVLDYMPKGSLEACLY------SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVV  748 (851)
Q Consensus       689 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~iv  748 (851)
                               .++..     ....+++|+++ +++|.+++.      .....+++..+..++.||++|++||   |++||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcc
Confidence                     11111     12456777766 688988873      2344577788899999999999999   888999


Q ss_pred             ecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCcccc----------ccCCCCcchhhHHHHHHHH
Q 046438          749 HCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG----------REGQISTEGDVYSFGIMLM  818 (851)
Q Consensus       749 H~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~DvwslG~il~  818 (851)
                      ||||||+||+++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999998765322    334567 999999998          5566889999999999999


Q ss_pred             HHHhCCCCCCccC
Q 046438          819 EIFTRKRPTDEIF  831 (851)
Q Consensus       819 el~~g~~pf~~~~  831 (851)
                      ||++|+.||....
T Consensus       309 elltg~~Pf~~~~  321 (413)
T 3dzo_A          309 WIWCADLPNTDDA  321 (413)
T ss_dssp             HHHHSSCCCCTTG
T ss_pred             HHHHCCCCCCCcc
Confidence            9999999997643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=6.3e-31  Score=307.37  Aligned_cols=407  Identities=15%  Similarity=0.099  Sum_probs=303.2

Q ss_pred             CCCccccCCCCccEEeccccccc---cccchh------------hcCcccccEEEccCccccCCCCccccC-CC-cCcEE
Q 046438          103 HLPREIGNLTSLTSIDLSENHLM---GEIPHE------------IGNLRNLQALGLLSNNLVGVVPATLFN-IS-TLKIL  165 (851)
Q Consensus       103 ~~~~~l~~l~~L~~L~Ls~n~l~---~~~~~~------------~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~-~L~~L  165 (851)
                      ..+..+..+++|++|+|++|...   +.+|..            +..+++|++|+|++|.+++..+..+.. ++ +|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            33455677899999999886431   122322            237899999999999887666666655 34 49999


Q ss_pred             Eeeccc-cccccchhHhhhccccccccccccccccc----CCccccccCCCcEEecCCCCCcc----ccCccccCCCCcc
Q 046438          166 QLTNNT-LSGSISSSIRLALPNLELFSLANNNFSGK----IPSFIFNASKLSICELPDNSFSG----FIPNRFHNMRNLK  236 (851)
Q Consensus       166 ~L~~n~-l~~~~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~  236 (851)
                      +|++|. ++......+...+++|++|+|++|.+++.    ++..+.++++|+.|++++|.+++    ..+..+.++++|+
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            999987 33223334445789999999999998776    33455678999999999999973    3344567889999


Q ss_pred             eEeccCccccCCCCcchhhhhccccccccEEeccCCCcc--CCCCCCccccccccccEEEeecCccccCCCcccccccCC
Q 046438          237 ELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLL--DCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL  314 (851)
Q Consensus       237 ~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L  314 (851)
                      +|++++|.+..+      ...+..+++|+.|+++.+...  ....+..+... .+|+.+.++++.. ..+|..+..+++|
T Consensus       224 ~L~L~~~~~~~l------~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~-~~L~~L~l~~~~~-~~l~~~~~~~~~L  295 (592)
T 3ogk_B          224 SVKVGDFEILEL------VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP-RKLCRLGLSYMGP-NEMPILFPFAAQI  295 (592)
T ss_dssp             EEECSSCBGGGG------HHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCC-TTCCEEEETTCCT-TTGGGGGGGGGGC
T ss_pred             EEeccCccHHHH------HHHHhhhhHHHhhcccccccccchHHHHHHhhcc-ccccccCccccch-hHHHHHHhhcCCC
Confidence            999999988753      345778899999999853321  12233344444 4899999988644 3678888999999


Q ss_pred             cEEEecCCCCCCCcC-ccccCCCCCcEEEccccccccc-ccccccccCCCCEEEccC-----------cccCCC-CCccc
Q 046438          315 IIIRLGYNKLNGSIP-STLSRLEKLQILGLENNQLEGR-ILDDICRLARLSSVYLDH-----------NKLSGS-IPACF  380 (851)
Q Consensus       315 ~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~-----------N~l~~~-~~~~~  380 (851)
                      ++|++++|.+++... ..+..+++|++|+++ +.+.+. .+.....+++|+.|++++           |.+++. ++..+
T Consensus       296 ~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~  374 (592)
T 3ogk_B          296 RKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA  374 (592)
T ss_dssp             CEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHH
T ss_pred             cEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHH
Confidence            999999999765443 346889999999999 445433 333446789999999993           566533 22334


Q ss_pred             cCCccccceecccCcCcc-Cchhhcc-cCcceEEEec----CCCCCCC-----CccccccchhhhhhhccCCc--ccccC
Q 046438          381 GNLASLRKLSFASNELTF-VPSTFWN-LTNILMVDLS----SNPLSGS-----LPLEIGNLKVLVELYLSRNN--LSGDI  447 (851)
Q Consensus       381 ~~l~~L~~L~L~~N~l~~-~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N~--l~~~~  447 (851)
                      ..+++|++|+++.|+++. .+..+.. +++|+.|+++    .|.+++.     ++..+.++++|+.|++++|.  +++..
T Consensus       375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~  454 (592)
T 3ogk_B          375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG  454 (592)
T ss_dssp             HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred             hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence            568999999999999983 3445554 8999999996    7788853     33446778999999998543  66655


Q ss_pred             CcccC-CCCCccEEEccCcccCC-CCcccccCCCCCCEEECCCCccccc-CCccccccccccceeccCcccccc
Q 046438          448 PTTIG-GLKNLQNLSLGDNNLQG-SIPNSIGDLISLECLDLSNNILSGI-IPSSLEKLLYLKYLNVSFNRLEGE  518 (851)
Q Consensus       448 ~~~~~-~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~l~l~~N~l~~~  518 (851)
                      +..+. .+++|+.|+|++|++++ .++..+..+++|++|+|++|.+++. ++.....+++|+.|++++|+++..
T Consensus       455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            55554 48899999999999986 3456678899999999999998754 455567899999999999998764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=4e-28  Score=259.95  Aligned_cols=225  Identities=20%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             ccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEE
Q 046438          262 KKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQIL  341 (851)
Q Consensus       262 ~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  341 (851)
                      ++++.|++++|.+.  .+|..++.+. .|+.|++++|+++ .+|..++.+++|++|++++|.++ .+|..+..+++|++|
T Consensus        81 ~~l~~L~L~~n~l~--~lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L  155 (328)
T 4fcg_A           81 PGRVALELRSVPLP--QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL  155 (328)
T ss_dssp             TTCCEEEEESSCCS--SCCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred             cceeEEEccCCCch--hcChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence            45566666666663  4566666543 6777777777777 67788888888888888888888 668888888888888


Q ss_pred             Ecccccccccccccccc---------cCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEE
Q 046438          342 GLENNQLEGRILDDICR---------LARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV  412 (851)
Q Consensus       342 ~L~~n~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L  412 (851)
                      ++++|++.+..|..+..         +++|+.|+|++|+++ .+|..+..+++|++|++++|+++.+|..+..+++|++|
T Consensus       156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L  234 (328)
T 4fcg_A          156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL  234 (328)
T ss_dssp             EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEE
T ss_pred             ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEE
Confidence            88888887777776654         999999999999999 78888999999999999999999999999999999999


Q ss_pred             EecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc
Q 046438          413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       413 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +|++|.+.+.+|..++.+++|++|++++|++.+.+|..++.+++|+.|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus       235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988776

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.8e-28  Score=256.50  Aligned_cols=252  Identities=25%  Similarity=0.276  Sum_probs=216.8

Q ss_pred             cEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcc
Q 046438          265 KVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE  344 (851)
Q Consensus       265 ~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  344 (851)
                      ++++.+++.+..  +|..+   +.++++|++++|++++..+..|..+++|++|++++|.+++..|..|..+++|++|+++
T Consensus        14 ~~~~c~~~~l~~--ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   88 (285)
T 1ozn_A           14 VTTSCPQQGLQA--VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS   88 (285)
T ss_dssp             CEEECCSSCCSS--CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             eEEEcCcCCccc--CCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCC
Confidence            445555555532  33322   3467888888888887777889999999999999999998888999999999999999


Q ss_pred             ccc-ccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCch-hhcccCcceEEEecCCCCCCC
Q 046438          345 NNQ-LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGS  422 (851)
Q Consensus       345 ~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~  422 (851)
                      +|. ++...+..+..+++|++|++++|++.+..+..|..+++|++|++++|+++.++. .+..+++|+.|+|++|++++.
T Consensus        89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  168 (285)
T 1ozn_A           89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (285)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence            997 887778899999999999999999998889999999999999999999998876 478899999999999999977


Q ss_pred             CccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccccc
Q 046438          423 LPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL  502 (851)
Q Consensus       423 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  502 (851)
                      .+..|..+++|++|++++|++++..|..|..+++|+.|++++|++++..+..+..+++|+.|+|++|++....+.. ...
T Consensus       169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~  247 (285)
T 1ozn_A          169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW  247 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred             CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHH
Confidence            7778999999999999999999888999999999999999999999877788999999999999999998644322 334


Q ss_pred             ccccceeccCccccccCCCC
Q 046438          503 LYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       503 ~~L~~l~l~~N~l~~~~p~~  522 (851)
                      ..++.+..+.|.+.|..|..
T Consensus       248 ~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          248 AWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHHHHCCSEECCCBEEESGG
T ss_pred             HHHHhcccccCccccCCchH
Confidence            56777888999999999864

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=271.41  Aligned_cols=250  Identities=23%  Similarity=0.281  Sum_probs=226.4

Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      ....++..+++++ .+|..+.  ++++.|+|++|.+.+..+..|.++++|++|+|++|.+++..+..|..+++|+.|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            4567888999998 6676665  689999999999998888999999999999999999999888999999999999999


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCch-hhcccCcceEEEecCC-CCCCCCccccccchhhhhhhccCCccccc
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSN-PLSGSLPLEIGNLKVLVELYLSRNNLSGD  446 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  446 (851)
                      +|++++..+..|..+++|++|+|++|+++.+|. .+..+++|+.|+|++| .+....+..|.++++|++|+|++|+++ .
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~  199 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E  199 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence            999998888899999999999999999998876 7889999999999994 555445557999999999999999999 5


Q ss_pred             CCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCC-Ccc
Q 046438          447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG-GTL  525 (851)
Q Consensus       447 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~~  525 (851)
                      +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+.. ..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            66 4899999999999999999888999999999999999999999999999999999999999999999777654 457


Q ss_pred             cccCcccccCCcCccCCC
Q 046438          526 ANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       526 ~~l~~~~~~~n~~~c~~~  543 (851)
                      ..+..+.+.+||+.|++.
T Consensus       279 ~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          279 HHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             TTCCEEECCSSCEECSST
T ss_pred             cCCCEEEcCCCCccCCCC
Confidence            888899999999999875

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=2.4e-29  Score=284.16  Aligned_cols=217  Identities=18%  Similarity=0.178  Sum_probs=183.5

Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      +|+.|+|++|++++..|..|..+++|++|+|++|.+++..|  +..+++|++|+|++|.+++..+     .++|+.|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            68888888888888778889999999999999999986655  8889999999999999986443     3889999999


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccC-chhhcccCcceEEEecCCCCCCCCccccc-cchhhhhhhccCCccccc
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLSGSLPLEIG-NLKVLVELYLSRNNLSGD  446 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~  446 (851)
                      +|.+.+..+.   .+++|+.|+|++|+++.+ |..+..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++.
T Consensus       108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            9999876554   357899999999999976 45788899999999999999988888876 789999999999999865


Q ss_pred             CCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccC
Q 046438          447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEI  519 (851)
Q Consensus       447 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~  519 (851)
                       |. +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.|..
T Consensus       185 -~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~  253 (487)
T 3oja_A          185 -KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT  253 (487)
T ss_dssp             -EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred             -cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence             33 4468999999999999986 44458899999999999999995 7778889999999999999998543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.4e-29  Score=269.78  Aligned_cols=202  Identities=20%  Similarity=0.200  Sum_probs=158.8

Q ss_pred             cccCCcEEEecCCCCCCCcCccc--cCCCCCcEEEccccccccccccccccc-----CCCCEEEccCcccCCCCCccccC
Q 046438          310 NLINLIIIRLGYNKLNGSIPSTL--SRLEKLQILGLENNQLEGRILDDICRL-----ARLSSVYLDHNKLSGSIPACFGN  382 (851)
Q Consensus       310 ~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~  382 (851)
                      ++++|++|++++|.+++..|..+  ..+++|++|++++|.+++. |..+..+     ++|++|+|++|++.+..+..|+.
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            57778888888888877777765  7788888888888888866 6666666     78888888888888777788888


Q ss_pred             CccccceecccCcCcc---Cchhh--cccCcceEEEecCCCCCCC--Cc-cccccchhhhhhhccCCcccccCC-cccCC
Q 046438          383 LASLRKLSFASNELTF---VPSTF--WNLTNILMVDLSSNPLSGS--LP-LEIGNLKVLVELYLSRNNLSGDIP-TTIGG  453 (851)
Q Consensus       383 l~~L~~L~L~~N~l~~---~p~~~--~~l~~L~~L~Ls~N~l~~~--~p-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~  453 (851)
                      +++|++|++++|++..   +|..+  ..+++|++|+|++|++++.  .+ ..+..+++|++|++++|++++..| ..+..
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            8888888888888653   34444  7788888888888888731  12 334567888888888888887664 45677


Q ss_pred             CCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccc
Q 046438          454 LKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEG  517 (851)
Q Consensus       454 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~  517 (851)
                      +++|++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+++|+.|++++|++++
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            889999999999998 7777776  8899999999999865 65 8889999999999999875

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=1.3e-27  Score=268.72  Aligned_cols=245  Identities=21%  Similarity=0.228  Sum_probs=160.0

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      ...++.+++.++ .+|..+.  ++|++|+|++|++++..+  +..+++|++|+|++|+++ .++...|.++++|++|+|+
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECC
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEECC
Confidence            456666666666 4554443  566777777777665433  566677777777777766 4555556667777777777


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccC-ccccCCCCccccCCCcCcEEEeeccccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLS-NNLVGVVPATLFNISTLKILQLTNNTLSGS  175 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  175 (851)
                      +|++++..+..|.++++|++|+|++|.++...+..|.++++|++|++++ |.+....+..|.++++|+.|+|++|++++ 
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-  210 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-  210 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence            7777666566666677777777777777655555666777777777766 34444444456667777777777777663 


Q ss_pred             cchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhh
Q 046438          176 ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFI  255 (851)
Q Consensus       176 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  255 (851)
                      ++.  +..+++|++|+|++|.+++..|..+.++++|+.|+|++|.++++.+..|.++++|++|+|++|+++.++.+    
T Consensus       211 ~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----  284 (452)
T 3zyi_A          211 MPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD----  284 (452)
T ss_dssp             CCC--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT----
T ss_pred             ccc--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChH----
Confidence            332  33566777777777777766666777777777777777777777677777777777777777777665432    


Q ss_pred             hhccccccccEEeccCCCcc
Q 046438          256 SSLANSKKLKVLSLTGNPLL  275 (851)
Q Consensus       256 ~~l~~l~~L~~L~Ls~N~l~  275 (851)
                       .+..+++|+.|+|++|++.
T Consensus       285 -~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          285 -LFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             -SSTTCTTCCEEECCSSCEE
T ss_pred             -HhccccCCCEEEccCCCcC
Confidence             3455667777777777664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.3e-28  Score=263.01  Aligned_cols=267  Identities=20%  Similarity=0.226  Sum_probs=186.5

Q ss_pred             cCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEec
Q 046438          161 TLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL  240 (851)
Q Consensus       161 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  240 (851)
                      +++.++++.+.+. ..+..++..+++|++|+|++|++++..|..+.++++|+.|+|++|.+++..+  |..+++|++|++
T Consensus        11 ~l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             EEEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             ceeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            4556667777665 4555566677788888888888887777788888888888888888887654  888888999999


Q ss_pred             cCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEec
Q 046438          241 EYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLG  320 (851)
Q Consensus       241 ~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~  320 (851)
                      ++|+++.++          ..++|++|++++|++.....  .   ...+|+.|++++|++++..+..+..+++|++|+++
T Consensus        88 s~n~l~~l~----------~~~~L~~L~l~~n~l~~~~~--~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls  152 (317)
T 3o53_A           88 NNNYVQELL----------VGPSIETLHAANNNISRVSC--S---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK  152 (317)
T ss_dssp             CSSEEEEEE----------ECTTCCEEECCSSCCSEEEE--C---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred             cCCcccccc----------CCCCcCEEECCCCccCCcCc--c---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence            998887532          34788888888888754221  1   12357777777777776666677777777777777


Q ss_pred             CCCCCCCcCcccc-CCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccC
Q 046438          321 YNKLNGSIPSTLS-RLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV  399 (851)
Q Consensus       321 ~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  399 (851)
                      +|.+.+..+..+. .+++|++|++++|.+++..  ....+++|+.|+|++|++++. |..+..+++|++|++++|+++.+
T Consensus       153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~l  229 (317)
T 3o53_A          153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLI  229 (317)
T ss_dssp             TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEE
T ss_pred             CCCCCcccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccch
Confidence            7777766665553 5677777777777777542  223467777777777777743 33466777777777777777777


Q ss_pred             chhhcccCcceEEEecCCCCC-CCCccccccchhhhhhhccC-CcccccCC
Q 046438          400 PSTFWNLTNILMVDLSSNPLS-GSLPLEIGNLKVLVELYLSR-NNLSGDIP  448 (851)
Q Consensus       400 p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~-N~l~~~~~  448 (851)
                      |..+..+++|+.|++++|++. +.+|..+..+++|+.|++++ +.+++..|
T Consensus       230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            777777777777777777776 55666667777777777773 33444333

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.95  E-value=1.3e-30  Score=304.91  Aligned_cols=406  Identities=16%  Similarity=0.122  Sum_probs=202.1

Q ss_pred             hcCCcccccccccccccccCCCcccc-CCCCccEEecccc-ccccc-cchhhcCcccccEEEccCccccCCCCcccc---
Q 046438           84 FSYLPFVQFLSLAFNQFAGHLPREIG-NLTSLTSIDLSEN-HLMGE-IPHEIGNLRNLQALGLLSNNLVGVVPATLF---  157 (851)
Q Consensus        84 ~~~l~~L~~L~L~~N~i~~~~~~~l~-~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~---  157 (851)
                      +..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|++++|.+++..+..+.   
T Consensus       101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~  180 (594)
T 2p1m_B          101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP  180 (594)
T ss_dssp             HHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred             HHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence            34556666666666666654444443 4667777777776 34322 344445667777777777776655444333   


Q ss_pred             -CCCcCcEEEeeccc--cccccchhHhhhcccccccccccc-cccccCCccccccCCCcEEecCCC-------CCccccC
Q 046438          158 -NISTLKILQLTNNT--LSGSISSSIRLALPNLELFSLANN-NFSGKIPSFIFNASKLSICELPDN-------SFSGFIP  226 (851)
Q Consensus       158 -~l~~L~~L~L~~n~--l~~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~L~~L~L~~n-------~l~~~~~  226 (851)
                       .+++|+.|++++|.  ++......+...+++|++|++++| .+++ ++..+..+++|+.|++..+       .+.++. 
T Consensus       181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~-  258 (594)
T 2p1m_B          181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLS-  258 (594)
T ss_dssp             TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHH-
T ss_pred             hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHH-
Confidence             45577777777775  322222233334577777777776 3333 5555666677777764433       233322 


Q ss_pred             ccccCCCCcceE-eccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccC-C
Q 046438          227 NRFHNMRNLKEL-NLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS-I  304 (851)
Q Consensus       227 ~~~~~l~~L~~L-~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~-~  304 (851)
                      ..+.++++|+.| .+.+.....      +...+..+++|++|++++|.+.+..++..+... ++|++|++++| +... +
T Consensus       259 ~~l~~~~~L~~Ls~~~~~~~~~------l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~-~~L~~L~l~~~-~~~~~l  330 (594)
T 2p1m_B          259 VALSGCKELRCLSGFWDAVPAY------LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC-PKLQRLWVLDY-IEDAGL  330 (594)
T ss_dssp             HHHHTCTTCCEEECCBTCCGGG------GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTC-TTCCEEEEEGG-GHHHHH
T ss_pred             HHHhcCCCcccccCCcccchhh------HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcC-CCcCEEeCcCc-cCHHHH
Confidence            255666666666 333322111      112233456666666666664322111111111 24555555544 2211 1


Q ss_pred             CcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEccccccccccccccc-ccCCCCEEEccCcccCCCCCcccc-C
Q 046438          305 PKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDIC-RLARLSSVYLDHNKLSGSIPACFG-N  382 (851)
Q Consensus       305 p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~  382 (851)
                      +.....+++|+.|++.++.-.|               ..+.+.+++.....+. .+++|+.|+++.|.+++.....+. .
T Consensus       331 ~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~  395 (594)
T 2p1m_B          331 EVLASTCKDLRELRVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARN  395 (594)
T ss_dssp             HHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHH
T ss_pred             HHHHHhCCCCCEEEEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhh
Confidence            1111234555555552210000               0011222222222222 234444444444444332222222 2


Q ss_pred             Cccccceecc--c----CcCccCc------hhhcccCcceEEEecCCCCCCCCcccccc-chhhhhhhccCCcccccCCc
Q 046438          383 LASLRKLSFA--S----NELTFVP------STFWNLTNILMVDLSSNPLSGSLPLEIGN-LKVLVELYLSRNNLSGDIPT  449 (851)
Q Consensus       383 l~~L~~L~L~--~----N~l~~~p------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~~~  449 (851)
                      +++|+.|+++  +    |.++..|      ..+..+++|+.|+|++ .+++..+..++. +++|++|+|++|.+++..+.
T Consensus       396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~  474 (594)
T 2p1m_B          396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH  474 (594)
T ss_dssp             CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred             CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence            4444455444  2    3333222      2244566667777755 454444444443 56667777777766544443


Q ss_pred             cc-CCCCCccEEEccCcccCCCCcc-cccCCCCCCEEECCCCcccccCCccc-cccccccceeccCccc
Q 046438          450 TI-GGLKNLQNLSLGDNNLQGSIPN-SIGDLISLECLDLSNNILSGIIPSSL-EKLLYLKYLNVSFNRL  515 (851)
Q Consensus       450 ~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~l~l~~N~l  515 (851)
                      .+ ..+++|+.|+|++|++++.... ....+++|+.|++++|+++......+ ..+|+|+...+..+.-
T Consensus       475 ~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            33 5567777777777777543332 33446777777777777754333333 4456666655555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=7e-29  Score=264.38  Aligned_cols=249  Identities=20%  Similarity=0.225  Sum_probs=196.6

Q ss_pred             ccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccc-------cccccccEEEeecCccc
Q 046438          229 FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIG-------NLSLSMERFYLHNCNIR  301 (851)
Q Consensus       229 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~-------~~~~~L~~L~L~~n~i~  301 (851)
                      ++..++|++|++++|.+ .++..      +..  .|+.|++++|++....+|..+.       .+ .+|++|++++|+++
T Consensus        39 ~~~~~~L~~l~l~~n~l-~~p~~------~~~--~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~n~l~  108 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE-ADLGQ------FTD--IIKSLSLKRLTVRAARIPSRILFGALRVLGI-SGLQELTLENLEVT  108 (312)
T ss_dssp             EEEEEECTTHHHHCCTT-CCCHH------HHH--HHHHCCCCEEEEEEEECBHHHHHHHHHHHTT-SCCCEEEEEEEBCB
T ss_pred             EccCCCceeEeeccccc-ccHHH------HHH--HHhhcccccccccCCCcCHHHHHHHHHhcCc-CCccEEEccCCccc
Confidence            44455666666666666 33321      111  1566666666665455555443       23 37888888888888


Q ss_pred             cCCCccc--ccccCCcEEEecCCCCCCCcCccccCC-----CCCcEEEcccccccccccccccccCCCCEEEccCcccCC
Q 046438          302 GSIPKEM--GNLINLIIIRLGYNKLNGSIPSTLSRL-----EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG  374 (851)
Q Consensus       302 ~~~p~~l--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  374 (851)
                      +.+|..+  ..+++|++|++++|++++. |..+..+     ++|++|++++|++++..+..+..+++|+.|++++|++.+
T Consensus       109 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  187 (312)
T 1wwl_A          109 GTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG  187 (312)
T ss_dssp             SCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred             chhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence            8888876  8899999999999999877 7777776     899999999999998888899999999999999999765


Q ss_pred             C--CCccc--cCCccccceecccCcCccCch----hhcccCcceEEEecCCCCCCCCc-cccccchhhhhhhccCCcccc
Q 046438          375 S--IPACF--GNLASLRKLSFASNELTFVPS----TFWNLTNILMVDLSSNPLSGSLP-LEIGNLKVLVELYLSRNNLSG  445 (851)
Q Consensus       375 ~--~~~~~--~~l~~L~~L~L~~N~l~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~  445 (851)
                      .  .+..+  ..+++|++|++++|+++.++.    .+..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ 
T Consensus       188 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-  266 (312)
T 1wwl_A          188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-  266 (312)
T ss_dssp             HHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-
T ss_pred             chHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-
Confidence            4  23333  889999999999999995542    34578999999999999998775 45677899999999999999 


Q ss_pred             cCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccc
Q 046438          446 DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSG  493 (851)
Q Consensus       446 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  493 (851)
                      .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus       267 ~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          267 QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            7888776  8999999999999965 66 9999999999999999985

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=9.9e-27  Score=267.75  Aligned_cols=268  Identities=24%  Similarity=0.308  Sum_probs=142.4

Q ss_pred             CCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEc
Q 046438           64 SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGL  143 (851)
Q Consensus        64 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  143 (851)
                      ++++|++++|.++ .+|..++   ++|++|+|++|.|+ .+|.   .+++|++|+|++|.++ .+|.   .+++|++|++
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L  108 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI  108 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred             CCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence            4556666666665 5555432   55566666666555 2333   3456666666666665 3333   4556666666


Q ss_pred             cCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCcc
Q 046438          144 LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG  223 (851)
Q Consensus       144 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~  223 (851)
                      ++|++++..+    .+++|+.|++++|++++ ++.    .+++|++|+|++|++++. |.                    
T Consensus       109 s~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~----~l~~L~~L~Ls~N~l~~l-~~--------------------  158 (622)
T 3g06_A          109 FSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPV----LPPGLQELSVSDNQLASL-PA--------------------  158 (622)
T ss_dssp             CSCCCCCCCC----CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSCC-CC--------------------
T ss_pred             cCCcCCCCCC----CCCCcCEEECCCCCCCc-CCC----CCCCCCEEECcCCcCCCc-CC--------------------
Confidence            6666554322    34555666666665552 222    124444444444444321 11                    


Q ss_pred             ccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccC
Q 046438          224 FIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS  303 (851)
Q Consensus       224 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~  303 (851)
                             .+.+|+.|++++|.++.++         ..+++|+.|++++|++..                           
T Consensus       159 -------~~~~L~~L~L~~N~l~~l~---------~~~~~L~~L~Ls~N~l~~---------------------------  195 (622)
T 3g06_A          159 -------LPSELCKLWAYNNQLTSLP---------MLPSGLQELSVSDNQLAS---------------------------  195 (622)
T ss_dssp             -------CCTTCCEEECCSSCCSCCC---------CCCTTCCEEECCSSCCSC---------------------------
T ss_pred             -------ccCCCCEEECCCCCCCCCc---------ccCCCCcEEECCCCCCCC---------------------------
Confidence                   1233444444444444322         112333334433333321                           


Q ss_pred             CCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCC
Q 046438          304 IPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL  383 (851)
Q Consensus       304 ~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  383 (851)
                      +|..   +++|+.|++++|.++. +|..   +++|++|++++|.+++. |   ..+++|+.|+|++|+|++ +|.   .+
T Consensus       196 l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~~-lp~---~~  260 (622)
T 3g06_A          196 LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLTS-LPM---LP  260 (622)
T ss_dssp             CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCC---CC
T ss_pred             CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCCc-CCc---cc
Confidence            1111   1344444555554442 2221   25566666666666642 2   334667777777777763 343   45


Q ss_pred             ccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccch
Q 046438          384 ASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLK  431 (851)
Q Consensus       384 ~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  431 (851)
                      ++|+.|+|++|+|+.+|..+.++++|+.|+|++|++++..|..+..++
T Consensus       261 ~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          261 SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            678888888888888888888888888888888888876666554443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=8.9e-27  Score=268.16  Aligned_cols=266  Identities=25%  Similarity=0.310  Sum_probs=122.4

Q ss_pred             ccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccE
Q 046438          187 LELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV  266 (851)
Q Consensus       187 L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~  266 (851)
                      ++.|++++|.++ .+|..+.  ++|+.|+|++|.++.+.+    .+++|++|+|++|+|+.++.         .+++|++
T Consensus        42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~---------~l~~L~~  105 (622)
T 3g06_A           42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV---------LPPGLLE  105 (622)
T ss_dssp             CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC---------CCTTCCE
T ss_pred             CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC---------CCCCCCE
Confidence            444444444444 2233222  445555555555543322    23455555555555544331         2344555


Q ss_pred             EeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccc
Q 046438          267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENN  346 (851)
Q Consensus       267 L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  346 (851)
                      |++++|++..  +|.    ...+|+.|++++|++++ +|..   +++|++|++++|.+++. |.   .+++|+.|++++|
T Consensus       106 L~Ls~N~l~~--l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N  171 (622)
T 3g06_A          106 LSIFSNPLTH--LPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNN  171 (622)
T ss_dssp             EEECSCCCCC--CCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSS
T ss_pred             EECcCCcCCC--CCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCC
Confidence            5555554432  222    12244444444444442 2322   24555555555555532 22   1244555555555


Q ss_pred             cccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccc
Q 046438          347 QLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE  426 (851)
Q Consensus       347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  426 (851)
                      .+++. |   ..+++|+.|++++|++++ +|..   +++|+.|++++|.++.+|..   +++|+.|+|++|.+++ +|  
T Consensus       172 ~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp--  237 (622)
T 3g06_A          172 QLTSL-P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP--  237 (622)
T ss_dssp             CCSCC-C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC--
T ss_pred             CCCCC-c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC--
Confidence            55532 2   234455555555555553 2221   24455555555555555432   2445555555555553 33  


Q ss_pred             cccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccccc
Q 046438          427 IGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL  502 (851)
Q Consensus       427 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  502 (851)
                       ..+++|+.|++++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.+|..+..+
T Consensus       238 -~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          238 -VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             -CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             -CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence             23344555555555554 2333   3344555555555554 444445555555555555555555444444433

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=5.2e-29  Score=266.02  Aligned_cols=267  Identities=18%  Similarity=0.181  Sum_probs=172.8

Q ss_pred             ccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccE
Q 046438          187 LELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKV  266 (851)
Q Consensus       187 L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~  266 (851)
                      ++..+++.+.+.......+..+++|+.|+|++|.++++.+..|+++++|++|+|++|.++...       .+..+++|++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~   84 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRT   84 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCE
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCE
Confidence            344455666665444444445556666666666666666666666666666666666655321       1333444444


Q ss_pred             EeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccc
Q 046438          267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENN  346 (851)
Q Consensus       267 L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  346 (851)
                      |++++                                                  |.+++..     ..++|++|++++|
T Consensus        85 L~Ls~--------------------------------------------------n~l~~l~-----~~~~L~~L~l~~n  109 (317)
T 3o53_A           85 LDLNN--------------------------------------------------NYVQELL-----VGPSIETLHAANN  109 (317)
T ss_dssp             EECCS--------------------------------------------------SEEEEEE-----ECTTCCEEECCSS
T ss_pred             EECcC--------------------------------------------------Ccccccc-----CCCCcCEEECCCC
Confidence            44444                                                  4333111     1245555555555


Q ss_pred             cccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCc-hhh-cccCcceEEEecCCCCCCCCc
Q 046438          347 QLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP-STF-WNLTNILMVDLSSNPLSGSLP  424 (851)
Q Consensus       347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p-~~~-~~l~~L~~L~Ls~N~l~~~~p  424 (851)
                      .+++..+..   +++|+.|++++|++++..+..+..+++|++|++++|+++.++ ..+ ..+++|++|+|++|.+++. +
T Consensus       110 ~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~  185 (317)
T 3o53_A          110 NISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K  185 (317)
T ss_dssp             CCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred             ccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c
Confidence            555433322   345666666666666555556666666666666666666543 333 3567777777777777643 3


Q ss_pred             cccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc-ccCCccccccc
Q 046438          425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS-GIIPSSLEKLL  503 (851)
Q Consensus       425 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~  503 (851)
                      . ...+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..++
T Consensus       186 ~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~  262 (317)
T 3o53_A          186 G-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ  262 (317)
T ss_dssp             C-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH
T ss_pred             c-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccc
Confidence            2 2347788888888888884 4555888899999999999998 57888999999999999999998 78889999999


Q ss_pred             cccceecc-CccccccCCCC
Q 046438          504 YLKYLNVS-FNRLEGEIPRG  522 (851)
Q Consensus       504 ~L~~l~l~-~N~l~~~~p~~  522 (851)
                      +|+.++++ .+.++|..|..
T Consensus       263 ~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          263 RVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             HHHHHHHHHHHHHHSSSSCC
T ss_pred             cceEEECCCchhccCCchhc
Confidence            99999999 45577666543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=2.4e-27  Score=248.02  Aligned_cols=212  Identities=23%  Similarity=0.254  Sum_probs=127.1

Q ss_pred             CCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecc
Q 046438          313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFA  392 (851)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  392 (851)
                      +|++|++++|.+++..+..|.++++|++|++++|.+++..+..+..+++|++|++++|++.+..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34444444444443333344444444444444444444444444444455555555555444444445555555555555


Q ss_pred             cCcCccCch-hhcccCcceEEEecCCCCCCC-CccccccchhhhhhhccCCcccccCCcccCCCCCcc----EEEccCcc
Q 046438          393 SNELTFVPS-TFWNLTNILMVDLSSNPLSGS-LPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQ----NLSLGDNN  466 (851)
Q Consensus       393 ~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~  466 (851)
                      +|+++.++. .+..+++|++|++++|++++. +|..++.+++|++|++++|++++..+..|..+.+|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            555554433 345555555555555555532 355555555566666666666554445555555554    78899999


Q ss_pred             cCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcc
Q 046438          467 LQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTL  525 (851)
Q Consensus       467 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~  525 (851)
                      +++..+..+. ..+|+.|+|++|++++..+..+..+++|+.|++++|+|+|.||...++
T Consensus       189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~~l  246 (276)
T 2z62_A          189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL  246 (276)
T ss_dssp             CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTHHH
T ss_pred             ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchHHH
Confidence            8855555444 458999999999999777777889999999999999999999876554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=6.2e-28  Score=276.17  Aligned_cols=184  Identities=21%  Similarity=0.146  Sum_probs=129.6

Q ss_pred             eccccceEEEEEEE-cCCcEEEEEEEeecc----------hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEEE
Q 046438          634 IGSGSFGSVYRGRF-LDGMEVAIKVFHLQL----------EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       634 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      .+.|+.|.+..++. --|+.||+|++....          +...+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45666666655432 247889999997542          23446799999999999 6999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++|++|.+.+... ..++..   +|+.||++||+|+   |++|||||||||+|||++.+|.+||+|||+|+....+..
T Consensus       322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            999999999999654 445543   5899999999999   899999999999999999999999999999987654332


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP  826 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  826 (851)
                       ...+.+||+.|+|||++.+ .+..++|+||+|++.+++.++..|
T Consensus       395 -~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 -WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             -cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence             3345689999999999875 467789999999998877655443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4.7e-29  Score=291.67  Aligned_cols=399  Identities=16%  Similarity=0.144  Sum_probs=172.7

Q ss_pred             CCCCcEEeCCCCCCCCCCCcchhcCCccccccccccc-ccccC-CCccccCCCCccEEeccccccccccchhhc----Cc
Q 046438           62 MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFN-QFAGH-LPREIGNLTSLTSIDLSENHLMGEIPHEIG----NL  135 (851)
Q Consensus        62 ~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~----~l  135 (851)
                      +++|++|+|++|.+++..+..+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+
T Consensus       104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~  183 (594)
T 2p1m_B          104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY  183 (594)
T ss_dssp             CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred             CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence            3445555555544443222222223445555555544 23211 222233445555555555554433222222    33


Q ss_pred             ccccEEEccCccccCCCCccc----cCCCcCcEEEeecc-ccccccchhHhhhcccccccccc-------cccccccCCc
Q 046438          136 RNLQALGLLSNNLVGVVPATL----FNISTLKILQLTNN-TLSGSISSSIRLALPNLELFSLA-------NNNFSGKIPS  203 (851)
Q Consensus       136 ~~L~~L~L~~n~l~~~~~~~l----~~l~~L~~L~L~~n-~l~~~~~~~~~~~l~~L~~L~L~-------~N~i~~~~~~  203 (851)
                      ++|++|++++|. .......+    .++++|+.|++++| .+. . ....+..+++|++|+++       .|.+.+ ++.
T Consensus       184 ~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~  259 (594)
T 2p1m_B          184 TSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLE-K-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSV  259 (594)
T ss_dssp             CCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHH-H-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHH
T ss_pred             CcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHH-H-HHHHHhcCCcceEcccccccCccchhhHHH-HHH
Confidence            455555555444 11111111    22355555555554 222 1 22223345555555522       223332 222


Q ss_pred             cccccCCCcEE-ecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCc
Q 046438          204 FIFNASKLSIC-ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSS  282 (851)
Q Consensus       204 ~~~~~~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~  282 (851)
                      .+.++++|+.| .+.+... ...+..+..+++|++|+|++|.++..    .+...+..+++|++|++++| +.+..++. 
T Consensus       260 ~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~----~l~~~~~~~~~L~~L~l~~~-~~~~~l~~-  332 (594)
T 2p1m_B          260 ALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSY----DLVKLLCQCPKLQRLWVLDY-IEDAGLEV-  332 (594)
T ss_dssp             HHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHH----HHHHHHTTCTTCCEEEEEGG-GHHHHHHH-
T ss_pred             HHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHH----HHHHHHhcCCCcCEEeCcCc-cCHHHHHH-
Confidence            44555555555 2332221 12223333455666666666654321    11222445566666666655 32211111 


Q ss_pred             cccccccccEEEeec---------CccccCCCcccc-cccCCcEEEecCCCCCCCcCcccc-CCCCCcEEEcc--c----
Q 046438          283 IGNLSLSMERFYLHN---------CNIRGSIPKEMG-NLINLIIIRLGYNKLNGSIPSTLS-RLEKLQILGLE--N----  345 (851)
Q Consensus       283 ~~~~~~~L~~L~L~~---------n~i~~~~p~~l~-~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~----  345 (851)
                      +.....+|++|++.+         +.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++  +    
T Consensus       333 l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~  412 (594)
T 2p1m_B          333 LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP  412 (594)
T ss_dssp             HHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCC
T ss_pred             HHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCc
Confidence            111123566666633         233322222222 255566665555555543333332 35555555555  2    


Q ss_pred             ccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCc-cCchhhcc-cCcceEEEecCCCCCCCC
Q 046438          346 NQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWN-LTNILMVDLSSNPLSGSL  423 (851)
Q Consensus       346 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~-l~~L~~L~Ls~N~l~~~~  423 (851)
                      +.+++...+.                   .++..+..+++|++|++++ .++ ..+..+.. +++|+.|+|++|.+++..
T Consensus       413 ~~l~~~~~~~-------------------~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~  472 (594)
T 2p1m_B          413 DYLTLEPLDI-------------------GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG  472 (594)
T ss_dssp             CTTTCCCTHH-------------------HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred             ccccCCchhh-------------------HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence            2333111000                   0111133444555555544 333 11222332 555666666666655443


Q ss_pred             cccc-ccchhhhhhhccCCcccccCCc-ccCCCCCccEEEccCcccCCCCcccc-cCCCCCCEEECCCCcc
Q 046438          424 PLEI-GNLKVLVELYLSRNNLSGDIPT-TIGGLKNLQNLSLGDNNLQGSIPNSI-GDLISLECLDLSNNIL  491 (851)
Q Consensus       424 p~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l  491 (851)
                      +..+ .++++|++|+|++|.+++..+. .+..+++|+.|++++|+++......+ ..+++|+...+..+.-
T Consensus       473 ~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          473 MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            3333 4456666666666666433322 33446677777777777643333333 3456666666655543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=3.8e-26  Score=239.81  Aligned_cols=207  Identities=25%  Similarity=0.281  Sum_probs=185.1

Q ss_pred             cccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccc
Q 046438          308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR  387 (851)
Q Consensus       308 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  387 (851)
                      +.++++++++++++|.++ .+|..+.  +.++.|++++|.+++..+..+..+++|+.|+|++|.+++..+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            567788999999999988 4454443  6889999999999988888899999999999999999854332  7889999


Q ss_pred             ceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCccc
Q 046438          388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL  467 (851)
Q Consensus       388 ~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  467 (851)
                      +|++++|+++.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus        81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G           81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            99999999999999999999999999999999987788999999999999999999977777889999999999999999


Q ss_pred             CCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       468 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      ++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.++|++|+|.|.|.
T Consensus       161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            9766677889999999999999999 788888899999999999999999884

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=2.7e-27  Score=267.49  Aligned_cols=148  Identities=19%  Similarity=0.147  Sum_probs=103.8

Q ss_pred             CCCCEEEccCcccCCCCCccccCCccccceecccCcCcc-Cchhhc-ccCcceEEEecCCCCCCCCccccccchhhhhhh
Q 046438          360 ARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF-VPSTFW-NLTNILMVDLSSNPLSGSLPLEIGNLKVLVELY  437 (851)
Q Consensus       360 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  437 (851)
                      ++|+.|+|++|.+++..|..|+.+++|+.|+|++|.++. .|..+. .+++|+.|+|++|.+++. | .+..+++|+.|+
T Consensus       120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~  197 (487)
T 3oja_A          120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLD  197 (487)
T ss_dssp             SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEE
Confidence            344555555555554445555555555555555555553 233443 466666666666666644 2 233477788888


Q ss_pred             ccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc-ccCCccccccccccceecc
Q 046438          438 LSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS-GIIPSSLEKLLYLKYLNVS  511 (851)
Q Consensus       438 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~l~l~  511 (851)
                      |++|+|++ +|..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       198 Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            88888875 4445888889999999999998 47778889999999999999998 6788889999999999887

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=1.8e-25  Score=232.71  Aligned_cols=207  Identities=27%  Similarity=0.323  Sum_probs=168.3

Q ss_pred             CCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecc
Q 046438          313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFA  392 (851)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  392 (851)
                      +.+.++++++.++ .+|..+.  +++++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            3556666666666 3444333  467777777777776666677777777777777777776666667778888888888


Q ss_pred             cCcCccCch-hhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCC
Q 046438          393 SNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI  471 (851)
Q Consensus       393 ~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  471 (851)
                      +|+++.+|. .+..+++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            888887765 4577888888888888888777778888999999999999998666667899999999999999999777


Q ss_pred             cccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCC
Q 046438          472 PNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       472 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      +..|..+++|++|+|++|++++..+..+..+++|+.|++++|+|.|.|+..
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  224 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGI  224 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSSS
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCccH
Confidence            778999999999999999999877778999999999999999999998743

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=3.2e-25  Score=231.93  Aligned_cols=207  Identities=23%  Similarity=0.221  Sum_probs=187.2

Q ss_pred             ccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEc
Q 046438          288 LSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYL  367 (851)
Q Consensus       288 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  367 (851)
                      .+++.|++++|++++..+..+.++++|++|++++|.+.+..+..|..+++|++|++++|.+++..+..+..+++|+.|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            47888888889888777778999999999999999999888889999999999999999999888899999999999999


Q ss_pred             cCcccCCCCCccccCCccccceecccCcCcc--CchhhcccCcceEEEecCCCCCCCCccccccchhhh----hhhccCC
Q 046438          368 DHNKLSGSIPACFGNLASLRKLSFASNELTF--VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV----ELYLSRN  441 (851)
Q Consensus       368 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N  441 (851)
                      ++|++.+..+..+..+++|++|++++|+++.  +|..+..+++|+.|+|++|++++..+..+..+++|+    +|++++|
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            9999998888789999999999999999996  688999999999999999999988888888888888    8999999


Q ss_pred             cccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccC
Q 046438          442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII  495 (851)
Q Consensus       442 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  495 (851)
                      ++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus       188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence            99965555554 458999999999999777777899999999999999999643

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=1.1e-24  Score=228.64  Aligned_cols=208  Identities=26%  Similarity=0.201  Sum_probs=186.5

Q ss_pred             cccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcce
Q 046438          331 TLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNIL  410 (851)
Q Consensus       331 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~  410 (851)
                      .+.++++++++++++|.++.. |..+.  +.++.|+|++|++.+..+..|..+++|++|+|++|+++.++.. ..+++|+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~   80 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG   80 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred             cccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence            367889999999999999954 44443  6899999999999988889999999999999999999988765 7899999


Q ss_pred             EEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCc
Q 046438          411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNI  490 (851)
Q Consensus       411 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  490 (851)
                      +|+|++|+++ .+|..+..+++|++|++++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            9999999998 788899999999999999999997777899999999999999999998778888999999999999999


Q ss_pred             ccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          491 LSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       491 l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      |++..+..+..+++|+.|+|++|+++..++.......+..+.+.+||+.|++.
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence            99777777899999999999999999655555556778888999999999754

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=4.5e-24  Score=222.18  Aligned_cols=203  Identities=26%  Similarity=0.334  Sum_probs=109.5

Q ss_pred             CCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccc
Q 046438           18 SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSL   95 (851)
Q Consensus        18 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L   95 (851)
                      +.+.+++++++++ .+|..+.  ++|++|+|++|++++..+  +..+++|++|++++|+++ .++..+|..+++|++|+|
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEEC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEEC
Confidence            3555666666665 3444332  445555555555554332  444555555555555554 444444444455555555


Q ss_pred             cccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccc
Q 046438           96 AFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS  175 (851)
Q Consensus        96 ~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  175 (851)
                      ++|.+++..+..|.++++|++|+|++|.++                        +..+..|..+++|++|+|++|.++ .
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~Ls~n~l~-~  147 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLK------------------------SLPPRVFDSLTKLTYLSLGYNELQ-S  147 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccC------------------------eeCHHHhCcCcCCCEEECCCCcCC-c
Confidence            555444444444444444444444444444                        444444444444444444444444 2


Q ss_pred             cchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCC
Q 046438          176 ISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN  249 (851)
Q Consensus       176 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  249 (851)
                      ++...+..+++|++|+|++|++++..+..+.++++|+.|+|++|.++++.+..|..+++|+.|+|++|++....
T Consensus       148 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  221 (270)
T 2o6q_A          148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC  221 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred             cCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence            33333334445555555555555444555566667777777777777666677777788888888888776543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=4e-24  Score=222.73  Aligned_cols=205  Identities=24%  Similarity=0.292  Sum_probs=176.0

Q ss_pred             ccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccc
Q 046438          307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL  386 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  386 (851)
                      .+..+++|+.|++++|.+...  ..+..+++|++|++++|.+++.  ..+..+++|++|++++|++++..+..|..+++|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            356778888888888888632  3477888899999999988863  477888899999999999988888888889999


Q ss_pred             cceecccCcCccCchh-hcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          387 RKLSFASNELTFVPST-FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       387 ~~L~L~~N~l~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      ++|++++|+++.++.. +..+++|++|++++|++++..+..|+.+++|++|++++|++++..+..|+.+++|+.|++++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            9999999999877654 688999999999999999777777889999999999999999777777899999999999999


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCC
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      ++++..|..+..+++|+.|+|++|.+.+.       +++|+.++++.|.++|.+|..
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            99988888899999999999999998854       557899999999999999864

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.9e-24  Score=225.15  Aligned_cols=209  Identities=22%  Similarity=0.272  Sum_probs=126.2

Q ss_pred             CCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccc
Q 046438           13 LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQF   92 (851)
Q Consensus        13 l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~   92 (851)
                      +..+++|++|++++|.++. + ..+..+++|++|+|++|++++...+..+++|++|++++|.++ .++...|..+++|++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~  113 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKE  113 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCE
T ss_pred             cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccC-ccChhHhcCCcCCCE
Confidence            4455666666666666652 2 236666666666666666666555666666666666666666 455555666666666


Q ss_pred             ccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccc
Q 046438           93 LSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL  172 (851)
Q Consensus        93 L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l  172 (851)
                      |+|++|++++..+..|+++++|++|+|++|.+++..+..|+.+++|++|++++|++++..+..+..+++|++|++++|++
T Consensus       114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  193 (272)
T 3rfs_A          114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL  193 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence            66666666655555566666666666666666655555566666666666666666665555566666666666666666


Q ss_pred             ccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCC
Q 046438          173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM  232 (851)
Q Consensus       173 ~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l  232 (851)
                      ++ ++...+..+++|++|++++|.+.+.       +++|+.+++..|.+++.+|..++.+
T Consensus       194 ~~-~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          194 KS-VPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             SC-CCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             Cc-cCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            63 3333444566666666666655432       2345555555555555555555443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=3.7e-25  Score=251.87  Aligned_cols=185  Identities=21%  Similarity=0.200  Sum_probs=146.5

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeecc--------hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--------EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ...+.||+|+||+||+|+. .++.+|+|+.....        ....+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 67889999864432        11235689999999999999999666666667778999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++++|.+++..         +..++.|+++|++||   |++||+||||||+||+++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999998854         457999999999999   8889999999999999998  99999999999875432


Q ss_pred             Ccc------ccccccCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          781 SMK------HTQTLATIGYMAPEYGRE--GQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       781 ~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      ...      .....||+.|+|||++..  ..|+..+|+|+...-..+.+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            211      235689999999999987  668888999999999999998888774

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=4.8e-24  Score=226.82  Aligned_cols=201  Identities=18%  Similarity=0.222  Sum_probs=103.8

Q ss_pred             ccEEEeecCccccCCCccc--ccccCCcEEEecCCCCCCCcC----ccccCCCCCcEEEcccccccccccccccccCCCC
Q 046438          290 MERFYLHNCNIRGSIPKEM--GNLINLIIIRLGYNKLNGSIP----STLSRLEKLQILGLENNQLEGRILDDICRLARLS  363 (851)
Q Consensus       290 L~~L~L~~n~i~~~~p~~l--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  363 (851)
                      |++|++++|++.+..|..+  ..+++|++|++++|.+.+..+    ..+..+++|++|++++|.+.+..+..+..+++|+
T Consensus        93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  172 (310)
T 4glp_A           93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT  172 (310)
T ss_dssp             CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred             eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence            4445555555554555554  555555555555555554333    2233455555555555555554445555555555


Q ss_pred             EEEccCcccCCC--C--CccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCcc-ccccchhhhhhhc
Q 046438          364 SVYLDHNKLSGS--I--PACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL-EIGNLKVLVELYL  438 (851)
Q Consensus       364 ~L~L~~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L  438 (851)
                      +|+|++|++.+.  .  +..+..+++|++|+|++|+++.++..                     +. .++.+++|++|+|
T Consensus       173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~---------------------~~~l~~~l~~L~~L~L  231 (310)
T 4glp_A          173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGV---------------------CAALAAAGVQPHSLDL  231 (310)
T ss_dssp             EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHH---------------------HHHHHHHTCCCSSEEC
T ss_pred             EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHH---------------------HHHHHhcCCCCCEEEC
Confidence            555555554321  1  12223445555555555555444331                     00 1234445555555


Q ss_pred             cCCcccccCCcccCCC---CCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccc
Q 046438          439 SRNNLSGDIPTTIGGL---KNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL  515 (851)
Q Consensus       439 ~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l  515 (851)
                      ++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|++++|+|
T Consensus       232 s~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l  306 (310)
T 4glp_A          232 SHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPF  306 (310)
T ss_dssp             TTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTT
T ss_pred             CCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCC
Confidence            5555554444444444   46666666666666 4555543  5666667766666643 32 45666677777777766


Q ss_pred             c
Q 046438          516 E  516 (851)
Q Consensus       516 ~  516 (851)
                      +
T Consensus       307 ~  307 (310)
T 4glp_A          307 L  307 (310)
T ss_dssp             S
T ss_pred             C
Confidence            5

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=2.6e-24  Score=228.93  Aligned_cols=204  Identities=23%  Similarity=0.211  Sum_probs=139.9

Q ss_pred             ccCCcEEEecCCCCCCCcCccc--cCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccc
Q 046438          311 LINLIIIRLGYNKLNGSIPSTL--SRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK  388 (851)
Q Consensus       311 l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  388 (851)
                      +++|++|++++|.+.+..|..+  ..+++|++|++++|.+++..+..                    ....+..+++|++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~--------------------~~~~~~~~~~L~~  149 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWL--------------------AELQQWLKPGLKV  149 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSH--------------------HHHHTTBCSCCCE
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhh--------------------HHHHhhhccCCCE
Confidence            4456666666666666666555  55666666666666665432200                    0022234455555


Q ss_pred             eecccCcCccCc-hhhcccCcceEEEecCCCCCCC--C--ccccccchhhhhhhccCCcccccCCc----ccCCCCCccE
Q 046438          389 LSFASNELTFVP-STFWNLTNILMVDLSSNPLSGS--L--PLEIGNLKVLVELYLSRNNLSGDIPT----TIGGLKNLQN  459 (851)
Q Consensus       389 L~L~~N~l~~~p-~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~  459 (851)
                      |+|++|+++.++ ..+..+++|++|+|++|++.+.  +  +..++.+++|++|+|++|+++. ++.    .++.+++|++
T Consensus       150 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~  228 (310)
T 4glp_A          150 LSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHS  228 (310)
T ss_dssp             EEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSS
T ss_pred             EEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCE
Confidence            555555555443 3455566666666666665431  1  2234667888888888888873 333    3578899999


Q ss_pred             EEccCcccCCCCcccccCC---CCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCC
Q 046438          460 LSLGDNNLQGSIPNSIGDL---ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGN  536 (851)
Q Consensus       460 L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n  536 (851)
                      |+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|++++. |....++.+..+.+.+|
T Consensus       229 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N  304 (310)
T 4glp_A          229 LDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGN  304 (310)
T ss_dssp             EECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSST
T ss_pred             EECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCC
Confidence            9999999998878888777   69999999999999 6787774  8999999999999975 44567889999999999


Q ss_pred             cCc
Q 046438          537 DLL  539 (851)
Q Consensus       537 ~~~  539 (851)
                      +..
T Consensus       305 ~l~  307 (310)
T 4glp_A          305 PFL  307 (310)
T ss_dssp             TTS
T ss_pred             CCC
Confidence            764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=4.2e-25  Score=240.43  Aligned_cols=99  Identities=20%  Similarity=0.219  Sum_probs=56.9

Q ss_pred             CCcEEEccccccccc----ccccccc-cCCCCEEEccCcccCCCCC----ccccCCccccceecccCcCc--------cC
Q 046438          337 KLQILGLENNQLEGR----ILDDICR-LARLSSVYLDHNKLSGSIP----ACFGNLASLRKLSFASNELT--------FV  399 (851)
Q Consensus       337 ~L~~L~L~~n~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~--------~~  399 (851)
                      +|++|+|++|.+++.    ++..+.. .++|+.|+|++|++++..+    ..+..+++|+.|++++|++.        .+
T Consensus       197 ~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l  276 (362)
T 3goz_A          197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL  276 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHH
T ss_pred             CCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHH
Confidence            555555555555542    2223333 2356666666666654433    23455667777777777743        33


Q ss_pred             chhhcccCcceEEEecCCCCCCCCccccccchhhhhhh
Q 046438          400 PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELY  437 (851)
Q Consensus       400 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  437 (851)
                      +..+..+++|+.||+++|++.+..+..+.  ..++.+.
T Consensus       277 ~~~~~~l~~L~~LdL~~N~l~~~~~~~~~--~~l~~~~  312 (362)
T 3goz_A          277 GAAFPNIQKIILVDKNGKEIHPSHSIPIS--NLIRELS  312 (362)
T ss_dssp             HTTSTTCCEEEEECTTSCBCCGGGCHHHH--HHHHHHH
T ss_pred             HHHhccCCceEEEecCCCcCCCcchHHHH--HHHHHCC
Confidence            44567788888999999988765444332  3344443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=7.7e-24  Score=216.17  Aligned_cols=196  Identities=17%  Similarity=0.193  Sum_probs=130.7

Q ss_pred             CCcEEEecCCCCCCCcCccccCCCCCcEEEccccc-ccccccccccccCCCCEEEccC-cccCCCCCccccCCcccccee
Q 046438          313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQ-LEGRILDDICRLARLSSVYLDH-NKLSGSIPACFGNLASLRKLS  390 (851)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  390 (851)
                      +|++|++++|++++..+..|..+++|++|++++|. +++..+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            55556666666555545556666666666666664 5555555566666666666666 666655556666666777777


Q ss_pred             cccCcCccCchhhcccCcce---EEEecCC-CCCCCCccccccchhhh-hhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          391 FASNELTFVPSTFWNLTNIL---MVDLSSN-PLSGSLPLEIGNLKVLV-ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       391 L~~N~l~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      +++|+++.+|. +..+++|+   +|++++| .+++..+..|.++++|+ +|++++|+++...+..|.. ++|+.|+|++|
T Consensus       112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n  189 (239)
T 2xwt_C          112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN  189 (239)
T ss_dssp             EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred             CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence            77777766665 56666666   7777777 77765566677777787 8888888877333333444 77888888888


Q ss_pred             c-cCCCCcccccCC-CCCCEEECCCCcccccCCccccccccccceeccCc
Q 046438          466 N-LQGSIPNSIGDL-ISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFN  513 (851)
Q Consensus       466 ~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N  513 (851)
                      + +++..+..|.++ ++|+.|+|++|++++ +|..  .+++|+.|+++++
T Consensus       190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             TTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             CCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            4 876666777888 888888888888874 4433  5667777777765

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=1.8e-25  Score=246.00  Aligned_cols=187  Identities=24%  Similarity=0.276  Sum_probs=98.9

Q ss_pred             cccccCCcEEEecCCCCCC----CcCccccCCCCCcEEEcccccccccccccccc----c---------CCCCEEEccCc
Q 046438          308 MGNLINLIIIRLGYNKLNG----SIPSTLSRLEKLQILGLENNQLEGRILDDICR----L---------ARLSSVYLDHN  370 (851)
Q Consensus       308 l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----l---------~~L~~L~L~~N  370 (851)
                      +..+++|++|+|++|.+++    .+|..+..+++|++|+|++|.+++..+..+..    +         ++|++|+|++|
T Consensus        90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n  169 (386)
T 2ca6_A           90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN  169 (386)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred             HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCC
Confidence            4566777777777777765    35556677777777777777776444433333    2         56666666666


Q ss_pred             ccC-CCCC---ccccCCccccceecccCcCc------cCchhhcccCcceEEEecCCCCC----CCCccccccchhhhhh
Q 046438          371 KLS-GSIP---ACFGNLASLRKLSFASNELT------FVPSTFWNLTNILMVDLSSNPLS----GSLPLEIGNLKVLVEL  436 (851)
Q Consensus       371 ~l~-~~~~---~~~~~l~~L~~L~L~~N~l~------~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L  436 (851)
                      +++ +..+   ..+..+++|++|++++|+++      .+|..+..+++|+.|+|++|.++    +.+|..+..+++|++|
T Consensus       170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L  249 (386)
T 2ca6_A          170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL  249 (386)
T ss_dssp             CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred             CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence            665 2222   23445555555555555555      12224455555555555555553    2344444444445555


Q ss_pred             hccCCccccc----CCccc--CCCCCccEEEccCcccCC----CCcccc-cCCCCCCEEECCCCccccc
Q 046438          437 YLSRNNLSGD----IPTTI--GGLKNLQNLSLGDNNLQG----SIPNSI-GDLISLECLDLSNNILSGI  494 (851)
Q Consensus       437 ~L~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~  494 (851)
                      +|++|++++.    +|..+  +.+++|+.|+|++|++++    .+|..+ .++++|++|+|++|++++.
T Consensus       250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~  318 (386)
T 2ca6_A          250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  318 (386)
T ss_dssp             ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence            5555544432    23333  224555555555555543    244444 3345555555555555543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=1.5e-23  Score=214.11  Aligned_cols=194  Identities=18%  Similarity=0.205  Sum_probs=108.8

Q ss_pred             CCCEEEcCCCccccccc--CCCCCCCcEEeCCCCC-CCCCCCcchhcCCcccccccccc-cccccCCCccccCCCCccEE
Q 046438           42 TLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNR-LSGELPANIFSYLPFVQFLSLAF-NQFAGHLPREIGNLTSLTSI  117 (851)
Q Consensus        42 ~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~-l~~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~l~~l~~L~~L  117 (851)
                      +|++|+|++|++++..+  +..+++|++|++++|+ ++ .+++..|..+++|++|+|++ |.+++..+..|.++++|++|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            56666666666665443  4556666666666664 54 55555566666666666665 66665555566666666666


Q ss_pred             eccccccccccchhhcCccccc---EEEccCc-cccCCCCccccCCCcCc-EEEeeccccccccchhHhhhccccccccc
Q 046438          118 DLSENHLMGEIPHEIGNLRNLQ---ALGLLSN-NLVGVVPATLFNISTLK-ILQLTNNTLSGSISSSIRLALPNLELFSL  192 (851)
Q Consensus       118 ~Ls~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  192 (851)
                      ++++|.+++ +|. |..+++|+   +|++++| ++++..+..|.++++|+ .|++++|+++ .++...+.. +       
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~-------  179 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-T-------  179 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-C-------
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-C-------
Confidence            666666653 443 55555555   6666666 55555555555555565 6666555555 444433322 4       


Q ss_pred             ccccccccCCccccccCCCcEEecCCCC-CccccCccccCC-CCcceEeccCccccCCCCcchhhhhccccccccEEecc
Q 046438          193 ANNNFSGKIPSFIFNASKLSICELPDNS-FSGFIPNRFHNM-RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT  270 (851)
Q Consensus       193 ~~N~i~~~~~~~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls  270 (851)
                                       +|+.|++++|+ ++.+.+..|.++ ++|++|++++|+++.++..        .+++|+.|+++
T Consensus       180 -----------------~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--------~~~~L~~L~l~  234 (239)
T 2xwt_C          180 -----------------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--------GLEHLKELIAR  234 (239)
T ss_dssp             -----------------EEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--------TCTTCSEEECT
T ss_pred             -----------------CCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--------HhccCceeecc
Confidence                             44455555552 554545555555 5555666655555544321        34455555555


Q ss_pred             CC
Q 046438          271 GN  272 (851)
Q Consensus       271 ~N  272 (851)
                      ++
T Consensus       235 ~~  236 (239)
T 2xwt_C          235 NT  236 (239)
T ss_dssp             TC
T ss_pred             Cc
Confidence            54

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=1e-24  Score=237.40  Aligned_cols=231  Identities=18%  Similarity=0.202  Sum_probs=149.5

Q ss_pred             ccEEEeecCccccCCC----ccccccc-CCcEEEecCCCCCCCcCccccCC-----CCCcEEEccccccccccccccccc
Q 046438          290 MERFYLHNCNIRGSIP----KEMGNLI-NLIIIRLGYNKLNGSIPSTLSRL-----EKLQILGLENNQLEGRILDDICRL  359 (851)
Q Consensus       290 L~~L~L~~n~i~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l  359 (851)
                      |++|++++|++++..+    ..+..++ +|++|+|++|.+++..+..+..+     ++|++|+|++|.+++..+..++..
T Consensus        24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~  103 (362)
T 3goz_A           24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT  103 (362)
T ss_dssp             CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred             ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence            4444444444443333    4555566 67777777777766555555553     677777777777776555544433


Q ss_pred             -----CCCCEEEccCcccCCCCCcccc----C-CccccceecccCcCc-----cCchhhcccC-cceEEEecCCCCCCCC
Q 046438          360 -----ARLSSVYLDHNKLSGSIPACFG----N-LASLRKLSFASNELT-----FVPSTFWNLT-NILMVDLSSNPLSGSL  423 (851)
Q Consensus       360 -----~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~-----~~p~~~~~l~-~L~~L~Ls~N~l~~~~  423 (851)
                           ++|+.|+|++|++++..+..+.    . .++|++|+|++|+++     .++..+..++ +|++|+|++|++++..
T Consensus       104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~  183 (362)
T 3goz_A          104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN  183 (362)
T ss_dssp             HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred             HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence                 6777777777777655554433    2 247777777777777     3344455555 7888888888887666


Q ss_pred             ccccccc-----hhhhhhhccCCccccc----CCcccCC-CCCccEEEccCcccCCCCc----ccccCCCCCCEEECCCC
Q 046438          424 PLEIGNL-----KVLVELYLSRNNLSGD----IPTTIGG-LKNLQNLSLGDNNLQGSIP----NSIGDLISLECLDLSNN  489 (851)
Q Consensus       424 p~~~~~l-----~~L~~L~L~~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N  489 (851)
                      +..+...     ++|++|+|++|+|++.    ++..+.. .++|++|+|++|++++..+    ..+..+++|++|+|++|
T Consensus       184 ~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n  263 (362)
T 3goz_A          184 CAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD  263 (362)
T ss_dssp             HHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHH
T ss_pred             HHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccC
Confidence            6544433     5788888888888752    4445554 3578888888888876544    33466788888888888


Q ss_pred             ccccc-------CCccccccccccceeccCccccccCC
Q 046438          490 ILSGI-------IPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       490 ~l~~~-------~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      .+.+.       ++..+..+++|+.|++++|++.+..+
T Consensus       264 ~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             CccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            85543       33456677888888888888876633

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=4e-23  Score=219.02  Aligned_cols=196  Identities=21%  Similarity=0.302  Sum_probs=156.7

Q ss_pred             cccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccc
Q 046438          308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR  387 (851)
Q Consensus       308 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  387 (851)
                      +..+++|+.|++++|.+.. ++ .+..+++|++|++++|.+++..+  +..+++|+.|++++|++.+.  ..+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence            4567788888888888774 33 57778888888888888876544  77888888888888888753  3578888888


Q ss_pred             ceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCccc
Q 046438          388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL  467 (851)
Q Consensus       388 ~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  467 (851)
                      +|++++|+++.++. +..+++|+.|++++|++++..+  ++.+++|++|++++|++++ ++. +..+++|+.|++++|++
T Consensus       111 ~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          111 TLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred             EEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCcc
Confidence            88888888888765 7888888888998888885443  7888889999999998885 343 88889999999999999


Q ss_pred             CCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCcccccc
Q 046438          468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGE  518 (851)
Q Consensus       468 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~  518 (851)
                      ++. +. +..+++|++|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       186 ~~~-~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          186 SDI-SP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CCC-GG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             CcC-hh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            854 33 8888999999999999986543  78899999999999999764

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=7.8e-23  Score=210.25  Aligned_cols=182  Identities=24%  Similarity=0.260  Sum_probs=115.3

Q ss_pred             CCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecc
Q 046438          313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFA  392 (851)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  392 (851)
                      +.++++++++.++ .+|..+.  +.++.|+|++|.+++..+..+..+++|++|+|++|++.+..+..|            
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~------------   79 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF------------   79 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT------------
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh------------
Confidence            4556666666666 3343333  355555555555555444445555555555555555544444444            


Q ss_pred             cCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCc
Q 046438          393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP  472 (851)
Q Consensus       393 ~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  472 (851)
                                 ..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus        80 -----------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A           80 -----------DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             -----------TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             -----------ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence                       445555555555555554445555666666666666666665555556777777888888887776666


Q ss_pred             ccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          473 NSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       473 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      ..|+.+++|++|+|++|++++..+..+..+++|+.|++++|+|+|.+.
T Consensus       149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred             HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence            677777888888888888887666677778888888888888877743

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=7.8e-23  Score=216.84  Aligned_cols=195  Identities=23%  Similarity=0.332  Sum_probs=100.5

Q ss_pred             CCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEe
Q 046438           39 SINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSID  118 (851)
Q Consensus        39 ~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~  118 (851)
                      .+++|++|++++|+++....+..+++|++|++++|.++ .++.  +..+++|++|+|++|++++.  ..+..+++|++|+
T Consensus        39 ~l~~L~~L~l~~~~i~~l~~~~~l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~  113 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD  113 (308)
T ss_dssp             HHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred             HcCCcCEEEeeCCCccCchhhhccCCCCEEEccCCcCC-CChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence            34444455555544444333444444555555555444 2332  44445555555555554432  2345555555555


Q ss_pred             ccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccccccccc
Q 046438          119 LSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS  198 (851)
Q Consensus       119 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~  198 (851)
                      |++|.+++ ++. +..+++|++|++++|++++..+  +..+++|+.|++++|++++ ++.  +..+++|++|++++|+++
T Consensus       114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~  186 (308)
T 1h6u_A          114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP--LANLSKLTTLKADDNKIS  186 (308)
T ss_dssp             CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh--hcCCCCCCEEECCCCccC
Confidence            55555543 222 5555555555555555554322  4455555555555555542 222  334555555555555555


Q ss_pred             ccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCC
Q 046438          199 GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN  249 (851)
Q Consensus       199 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  249 (851)
                      +..+  +..+++|+.|+|++|.+++..+  +..+++|++|++++|+++..+
T Consensus       187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~  233 (308)
T 1h6u_A          187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP  233 (308)
T ss_dssp             CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred             cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence            4332  4556666666666666665542  666777777777777776543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=5.4e-25  Score=242.14  Aligned_cols=244  Identities=22%  Similarity=0.276  Sum_probs=191.6

Q ss_pred             hhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCC---CCCcCcc
Q 046438          255 ISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKL---NGSIPST  331 (851)
Q Consensus       255 ~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l---~~~~~~~  331 (851)
                      ...+..+++|++|+|++|++.+...                      ..++..+..+++|++|+|++|.+   .+.+|..
T Consensus        25 ~~~l~~~~~L~~L~L~~n~i~~~~~----------------------~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~   82 (386)
T 2ca6_A           25 FAVLLEDDSVKEIVLSGNTIGTEAA----------------------RWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA   82 (386)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHH----------------------HHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH
T ss_pred             HHHHhcCCCccEEECCCCCCCHHHH----------------------HHHHHHHHhCCCccEEeCcccccCccccchhHH
Confidence            3455666677777777766532100                      01234466788899999988644   3444544


Q ss_pred             c-------cCCCCCcEEEcccccccc----cccccccccCCCCEEEccCcccCCCCCccccC----C---------cccc
Q 046438          332 L-------SRLEKLQILGLENNQLEG----RILDDICRLARLSSVYLDHNKLSGSIPACFGN----L---------ASLR  387 (851)
Q Consensus       332 ~-------~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~  387 (851)
                      +       ..+++|++|+|++|.+++    .++..+..+++|+.|+|++|.++...+..+..    +         ++|+
T Consensus        83 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~  162 (386)
T 2ca6_A           83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  162 (386)
T ss_dssp             HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence            4       788999999999999997    46778889999999999999997544444443    3         8999


Q ss_pred             ceecccCcCc--cCc---hhhcccCcceEEEecCCCCCC-----CCccccccchhhhhhhccCCccc----ccCCcccCC
Q 046438          388 KLSFASNELT--FVP---STFWNLTNILMVDLSSNPLSG-----SLPLEIGNLKVLVELYLSRNNLS----GDIPTTIGG  453 (851)
Q Consensus       388 ~L~L~~N~l~--~~p---~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~  453 (851)
                      +|++++|+++  .+|   ..+..+++|+.|+|++|+++.     ..|..+..+++|+.|+|++|.++    +.+|..+..
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~  242 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  242 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence            9999999997  445   467789999999999999973     34447889999999999999996    567888999


Q ss_pred             CCCccEEEccCcccCCC----Ccccc--cCCCCCCEEECCCCcccc----cCCccc-cccccccceeccCccccccCC
Q 046438          454 LKNLQNLSLGDNNLQGS----IPNSI--GDLISLECLDLSNNILSG----IIPSSL-EKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       454 l~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      +++|+.|+|++|++++.    +|..+  +.+++|++|+|++|++++    .+|..+ .++++|+.|++++|++++..|
T Consensus       243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            99999999999999865    56666  448999999999999997    488777 668999999999999987654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=8.3e-23  Score=221.06  Aligned_cols=248  Identities=18%  Similarity=0.158  Sum_probs=183.7

Q ss_pred             CCCCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCC
Q 046438           10 PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYL   87 (851)
Q Consensus        10 p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l   87 (851)
                      |+.+..|.. +.++.++++++ .+|..+  .+++++|+|++|+|+.+.+  |.++++|++|||++|++.+.+|...|.++
T Consensus         3 p~~~C~C~~-~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L   78 (350)
T 4ay9_X            3 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL   78 (350)
T ss_dssp             CCSSSEEET-TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSC
T ss_pred             CCCccEeeC-CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcc
Confidence            444444543 67788899998 677666  3688999999999987654  78889999999999998767888888888


Q ss_pred             ccccc-ccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccC-ccccCCCCccccCCC-cCcE
Q 046438           88 PFVQF-LSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLS-NNLVGVVPATLFNIS-TLKI  164 (851)
Q Consensus        88 ~~L~~-L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~-~L~~  164 (851)
                      +++++ +.+++|+++.+.|+.|.++++|++|++++|.++...+..+....++..|++.+ +++..+.+..|..+. .++.
T Consensus        79 ~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~  158 (350)
T 4ay9_X           79 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI  158 (350)
T ss_dssp             TTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEE
T ss_pred             hhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhh
Confidence            88775 66677888888888889999999999999998876666777778888888865 567766666777664 6888


Q ss_pred             EEeeccccccccchhHhhhccccccccccc-ccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCc
Q 046438          165 LQLTNNTLSGSISSSIRLALPNLELFSLAN-NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN  243 (851)
Q Consensus       165 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  243 (851)
                      |+|++|+|+ .++...+ ..++|++|++++ |.++...+..|.++++|+.|+|++|+|+.+++..|.++++|+.+++  +
T Consensus       159 L~L~~N~i~-~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~  234 (350)
T 4ay9_X          159 LWLNKNGIQ-EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--Y  234 (350)
T ss_dssp             EECCSSCCC-EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--T
T ss_pred             hcccccccc-CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--C
Confidence            888888887 5666665 456788888864 6666555566777888888888888888777766666555555444  2


Q ss_pred             cccCCCCcchhhhhccccccccEEeccCC
Q 046438          244 YITSSNHELSFISSLANSKKLKVLSLTGN  272 (851)
Q Consensus       244 ~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N  272 (851)
                      .++.+|       .+..+++|+.++++++
T Consensus       235 ~l~~lP-------~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          235 NLKKLP-------TLEKLVALMEASLTYP  256 (350)
T ss_dssp             TCCCCC-------CTTTCCSCCEEECSCH
T ss_pred             CcCcCC-------CchhCcChhhCcCCCC
Confidence            344332       3566677777776643

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=2.3e-22  Score=206.78  Aligned_cols=183  Identities=22%  Similarity=0.247  Sum_probs=125.7

Q ss_pred             CCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEc
Q 046438           64 SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGL  143 (851)
Q Consensus        64 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  143 (851)
                      +.+++|++++.++ .+|..+.   +++++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|++
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            3455666666665 5555432   45666666666666665666666666666666666666666666666666666666


Q ss_pred             cCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCcc
Q 046438          144 LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG  223 (851)
Q Consensus       144 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~  223 (851)
                      ++|++++..+..|..+++|++|+|++|+++ .++...+..+++|++|+|++|++++..+..+.++++|+.|+|++|++++
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  169 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS  169 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence            666666666666666667777777777666 4444555566777777777777776666677778888888888888888


Q ss_pred             ccCccccCCCCcceEeccCccccCCCCc
Q 046438          224 FIPNRFHNMRNLKELNLEYNYITSSNHE  251 (851)
Q Consensus       224 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~  251 (851)
                      +.+..|..+++|++|+|++|+++....+
T Consensus       170 ~~~~~~~~l~~L~~L~l~~N~~~c~~~~  197 (251)
T 3m19_A          170 VPHGAFDRLGKLQTITLFGNQFDCSRCE  197 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred             cCHHHHhCCCCCCEEEeeCCceeCCccc
Confidence            8888888888999999999988875333

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=7.7e-24  Score=228.41  Aligned_cols=222  Identities=17%  Similarity=0.184  Sum_probs=144.0

Q ss_pred             CCEEEcCCCcccccccCCCC--CCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccC-CCccccCCCCccEEec
Q 046438           43 LEILDLSNNQLSGSFPFFNM--SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGH-LPREIGNLTSLTSIDL  119 (851)
Q Consensus        43 L~~L~Ls~n~l~~~~~~~~~--~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~l~~l~~L~~L~L  119 (851)
                      ++.+++++|++.+ ..+..+  ++++.|++++|.+.+..+.  +..+++|++|+|++|.+++. ++..+..+++|++|+|
T Consensus        49 ~~~l~l~~~~~~~-~~~~~~~~~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L  125 (336)
T 2ast_B           49 WQTLDLTGKNLHP-DVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL  125 (336)
T ss_dssp             SSEEECTTCBCCH-HHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred             heeeccccccCCH-HHHHhhhhccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeC
Confidence            5566666666552 112233  5666666666666643333  23467777777777766643 5566677777777777


Q ss_pred             cccccccccchhhcCcccccEEEccCc-cccCC-CCccccCCCcCcEEEeecc-ccccccchhHhhhcc-cccccccccc
Q 046438          120 SENHLMGEIPHEIGNLRNLQALGLLSN-NLVGV-VPATLFNISTLKILQLTNN-TLSGSISSSIRLALP-NLELFSLANN  195 (851)
Q Consensus       120 s~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~~l~-~L~~L~L~~N  195 (851)
                      ++|.+++..+..++.+++|++|++++| .+++. .+..+.++++|++|++++| .+++......+..++ +|++|++++|
T Consensus       126 ~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          126 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             cCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            777776666667777777777777777 45532 4445666777777777777 776543344455677 7777777777


Q ss_pred             --ccc-ccCCccccccCCCcEEecCCCC-CccccCccccCCCCcceEeccCcc-ccCCCCcchhhhhccccccccEEecc
Q 046438          196 --NFS-GKIPSFIFNASKLSICELPDNS-FSGFIPNRFHNMRNLKELNLEYNY-ITSSNHELSFISSLANSKKLKVLSLT  270 (851)
Q Consensus       196 --~i~-~~~~~~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~~~l~~l~~L~~L~Ls  270 (851)
                        .++ +.++..+.++++|+.|++++|. +++..+..+..+++|++|++++|. +..     ..+..+..+++|+.|+++
T Consensus       206 ~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~-----~~~~~l~~~~~L~~L~l~  280 (336)
T 2ast_B          206 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP-----ETLLELGEIPTLKTLQVF  280 (336)
T ss_dssp             GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG-----GGGGGGGGCTTCCEEECT
T ss_pred             cccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCH-----HHHHHHhcCCCCCEEecc
Confidence              344 3455566677888888888887 666666778888888888888885 221     122356677788888887


Q ss_pred             CC
Q 046438          271 GN  272 (851)
Q Consensus       271 ~N  272 (851)
                      +|
T Consensus       281 ~~  282 (336)
T 2ast_B          281 GI  282 (336)
T ss_dssp             TS
T ss_pred             Cc
Confidence            77

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=1.3e-23  Score=226.58  Aligned_cols=228  Identities=20%  Similarity=0.211  Sum_probs=175.5

Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCC-cCccccCCCCCcEEEcccccccccccccccccCCCCEEEc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGS-IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYL  367 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  367 (851)
                      .++.|++++|.+.+..+. +..+++|++|++++|.+++. .+..+..+++|++|++++|.+++..+..+..+++|++|++
T Consensus        71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  149 (336)
T 2ast_B           71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  149 (336)
T ss_dssp             TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence            455556666666555444 55678888888888887754 6677888888888888888888777888888888888888


Q ss_pred             cCc-ccCC-CCCccccCCccccceecccC-cCcc--CchhhcccC-cceEEEecCC--CCC-CCCccccccchhhhhhhc
Q 046438          368 DHN-KLSG-SIPACFGNLASLRKLSFASN-ELTF--VPSTFWNLT-NILMVDLSSN--PLS-GSLPLEIGNLKVLVELYL  438 (851)
Q Consensus       368 ~~N-~l~~-~~~~~~~~l~~L~~L~L~~N-~l~~--~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~L  438 (851)
                      ++| .+++ .++..+..+++|++|++++| .++.  ++..+..++ +|++|++++|  .++ +.+|..+..+++|++|++
T Consensus       150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l  229 (336)
T 2ast_B          150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL  229 (336)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence            888 5664 25666778888999999999 8874  677788888 9999999999  454 356777788899999999


Q ss_pred             cCCc-ccccCCcccCCCCCccEEEccCcc-cCCCCcccccCCCCCCEEECCCCcccccCCccccccc-cccceeccCccc
Q 046438          439 SRNN-LSGDIPTTIGGLKNLQNLSLGDNN-LQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLL-YLKYLNVSFNRL  515 (851)
Q Consensus       439 ~~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~l~l~~N~l  515 (851)
                      ++|. +++..+..+..+++|+.|++++|. +.......++.+++|+.|++++| ++   ...+..+. .++.|++++|++
T Consensus       230 ~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l  305 (336)
T 2ast_B          230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHF  305 (336)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCS
T ss_pred             CCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccC
Confidence            9998 776777888999999999999995 32222236788999999999999 33   23455553 488888999999


Q ss_pred             cccCCC
Q 046438          516 EGEIPR  521 (851)
Q Consensus       516 ~~~~p~  521 (851)
                      ++..|.
T Consensus       306 ~~~~~~  311 (336)
T 2ast_B          306 TTIARP  311 (336)
T ss_dssp             CCTTCS
T ss_pred             ccccCC
Confidence            988774

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=2.1e-22  Score=202.04  Aligned_cols=178  Identities=21%  Similarity=0.260  Sum_probs=146.4

Q ss_pred             CEEEccCcccCCCCCccccCCccccceecccCcCccCc--hhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP--STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       363 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      +.+++++|.++. +|..+.  +.+++|+|++|+++.++  ..|..+++|+.|+|++|++++..+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            467777777774 454443  35678888888888774  3478899999999999999977777899999999999999


Q ss_pred             CcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       441 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      |+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+|+|+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            99998778889999999999999999998889999999999999999999999889999999999999999999999998


Q ss_pred             CCCcccccCcccccCCcCccCCC
Q 046438          521 RGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       521 ~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ......++.......+...|+.|
T Consensus       171 l~~l~~~~~~~~~~~~~~~C~~P  193 (220)
T 2v70_A          171 LAWLGEWLRKKRIVTGNPRCQKP  193 (220)
T ss_dssp             GHHHHHHHHHSCCBCCCCEEEES
T ss_pred             hHHHHHHHHhcCccccCCccCCC
Confidence            65433334333333333478766

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=4.4e-22  Score=215.35  Aligned_cols=125  Identities=18%  Similarity=0.072  Sum_probs=58.1

Q ss_pred             cCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccC-cccCCCCCccccCCc-cccceecccCcCc
Q 046438          320 GYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH-NKLSGSIPACFGNLA-SLRKLSFASNELT  397 (851)
Q Consensus       320 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  397 (851)
                      ++|++....|..|..+++|++|++++|.++...+..+....++..+++.+ |++....+..|..+. .++.|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            33444444444444455555555555554444333344444444444433 334433333444443 3555555555555


Q ss_pred             cCchhhcccCcceEEEecC-CCCCCCCccccccchhhhhhhccCCccc
Q 046438          398 FVPSTFWNLTNILMVDLSS-NPLSGSLPLEIGNLKVLVELYLSRNNLS  444 (851)
Q Consensus       398 ~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~  444 (851)
                      .+|.......+|+.|++++ |.++...++.|.++++|++|+|++|+|+
T Consensus       168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence            5555444445555555543 3444222233444455555555555544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=3.4e-22  Score=208.17  Aligned_cols=153  Identities=15%  Similarity=0.107  Sum_probs=121.2

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch------------------hhHHHHHHHHHHHhhc
Q 046438          618 YQELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE------------------GALESFNAECEVLRSI  679 (851)
Q Consensus       618 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l  679 (851)
                      ...+......|++.+.||+|+||.||+|++.+|+.||+|+++....                  .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444445566788899999999999999997799999999964321                  1345688999999999


Q ss_pred             CCCcccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       680 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      +  | +++++++.. +..++||||++|++|.+ +..       .....++.|+++|++||   |++||+||||||+||++
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEE
Confidence            9  4 666665543 55699999999999987 421       23456999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCccccccccCccccCccccc
Q 046438          760 DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR  800 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~  800 (851)
                      + ++.+||+|||+|+..              ..+.|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEV--------------GEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence            9 999999999998643              3457777664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=4.4e-22  Score=199.77  Aligned_cols=178  Identities=21%  Similarity=0.278  Sum_probs=142.7

Q ss_pred             CEEEccCcccCCCCCccccCCccccceecccCcCccCch-hhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCC
Q 046438          363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRN  441 (851)
Q Consensus       363 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  441 (851)
                      +.+++++|.++ .+|..+.  ++|++|++++|+|+.++. .|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            45677777776 3444433  578888888888887765 6788888999999999998777888999999999999999


Q ss_pred             cccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCC
Q 046438          442 NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       442 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                      +|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|+|+.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l  170 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL  170 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence            99866566789999999999999999988899999999999999999999988888899999999999999999999875


Q ss_pred             CCcccccCcccccCCcCccCCC
Q 046438          522 GGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       522 ~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      .+...++...........|..|
T Consensus       171 ~~l~~~l~~~~~~~~~~~C~~P  192 (220)
T 2v9t_B          171 KWLADYLHTNPIETSGARCTSP  192 (220)
T ss_dssp             HHHHHHHHHCCCBCSCCBEEES
T ss_pred             HHHHHHHHhCCCCccCCCcCCc
Confidence            4332233333333444567665

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=1e-20  Score=188.47  Aligned_cols=179  Identities=23%  Similarity=0.295  Sum_probs=151.0

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      -+.++.+++.++ .+|..+  .++|++|+|++|++++..+  +..+++|++|++++|+++ .++...|..+++|++|+|+
T Consensus         9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence            367888888887 566444  4689999999999987665  678899999999999998 7777778899999999999


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI  176 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  176 (851)
                      +|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|.+.+  
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--  162 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--  162 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec--
Confidence            999997777778899999999999999997777778999999999999999998877778889999999999998764  


Q ss_pred             chhHhhhcccccccccccccccccCCccccccC
Q 046438          177 SSSIRLALPNLELFSLANNNFSGKIPSFIFNAS  209 (851)
Q Consensus       177 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~  209 (851)
                            .+++|++|+++.|++++.+|..+..+.
T Consensus       163 ------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          163 ------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             ------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             ------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence                  457889999999999988887766544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=3.7e-21  Score=218.59  Aligned_cols=169  Identities=25%  Similarity=0.308  Sum_probs=104.1

Q ss_pred             cCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceec
Q 046438          312 INLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF  391 (851)
Q Consensus       312 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  391 (851)
                      ++|++|++++|.|+ .+|   ..+++|++|++++|.|++ +|. +..  +|+.|+|++|++++ +|.   .+++|+.|++
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  147 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA  147 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence            44555555555555 333   234555566666665554 333 333  56666666666654 333   4556666666


Q ss_pred             ccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCc-------cEEEccC
Q 046438          392 ASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNL-------QNLSLGD  464 (851)
Q Consensus       392 ~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~L~~  464 (851)
                      ++|+|+.+|.   .+++|+.|+|++|++++ +|. |.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++
T Consensus       148 s~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~  216 (571)
T 3cvr_A          148 DNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE  216 (571)
T ss_dssp             CSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred             CCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence            6666666655   45566666666666664 444 44  66666667766666 4555 443  55       8888888


Q ss_pred             cccCCCCcccccCCCCCCEEECCCCcccccCCcccccccc
Q 046438          465 NNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY  504 (851)
Q Consensus       465 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  504 (851)
                      |+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus       217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            8887 57777777888888888888888877777776654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=5e-21  Score=217.49  Aligned_cols=182  Identities=23%  Similarity=0.296  Sum_probs=158.6

Q ss_pred             CCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecc
Q 046438          313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFA  392 (851)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  392 (851)
                      +++.|++++|.+++ +|..+  .++|++|+|++|.|+. +|   ..+++|+.|+|++|+|++ +|. +..  +|+.|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999986 56555  3789999999999994 45   457999999999999997 666 665  99999999


Q ss_pred             cCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCc
Q 046438          393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP  472 (851)
Q Consensus       393 ~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  472 (851)
                      +|+|+.+|.   .+++|+.|+|++|++++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|
T Consensus       129 ~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp  196 (571)
T 3cvr_A          129 NNQLTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP  196 (571)
T ss_dssp             SSCCSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred             CCcCCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence            999999988   68999999999999996 665   57899999999999996 777 66  89999999999999 677


Q ss_pred             ccccCCCCC-------CEEECCCCcccccCCccccccccccceeccCccccccCCC
Q 046438          473 NSIGDLISL-------ECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       473 ~~~~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                      . +..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus       197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            7 665  77       99999999999 6888888899999999999999998774

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=8.6e-21  Score=206.08  Aligned_cols=161  Identities=28%  Similarity=0.270  Sum_probs=118.4

Q ss_pred             CCEEEccCcccCCCCCcccc-CCccccceecccCcCccCc-hhhcccCcceEEEecCCCCCCCCccccccchhhhhhhcc
Q 046438          362 LSSVYLDHNKLSGSIPACFG-NLASLRKLSFASNELTFVP-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLS  439 (851)
Q Consensus       362 L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  439 (851)
                      ++.|+|++|+|++..+..|. .+++|+.|+|++|+|+.++ ..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44455555555544444454 5666666666666666554 346667777777777777776666677778888888888


Q ss_pred             CCcccccCCcccCCCCCccEEEccCcccCCCCcccc---cCCCCCCEEECCCCcccccCCcccccccc--ccceeccCcc
Q 046438          440 RNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI---GDLISLECLDLSNNILSGIIPSSLEKLLY--LKYLNVSFNR  514 (851)
Q Consensus       440 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~l~l~~N~  514 (851)
                      +|+|++..|..|..+++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|++..+..+..++.  ++.|+|++|+
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~  200 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP  200 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence            888887778888999999999999999985444445   57899999999999999777678888887  4889999999


Q ss_pred             ccccCCCC
Q 046438          515 LEGEIPRG  522 (851)
Q Consensus       515 l~~~~p~~  522 (851)
                      |.|+|...
T Consensus       201 ~~C~C~l~  208 (361)
T 2xot_A          201 LECDCKLY  208 (361)
T ss_dssp             EECCHHHH
T ss_pred             ccCCcCcH
Confidence            99998643

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=6.6e-20  Score=182.56  Aligned_cols=161  Identities=24%  Similarity=0.282  Sum_probs=113.4

Q ss_pred             cccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc
Q 046438          289 SMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD  368 (851)
Q Consensus       289 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  368 (851)
                      +++.|++++|++++..+..+..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            56666666666665555667777777777777777776666667777777777777777776666666777777777777


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCchh-hcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccC
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPST-FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDI  447 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  447 (851)
                      +|++++..+..|..+++|+.|++++|+++.+|.. +..+++|+.|++++|.+.+       .+++|++|+++.|+++|.+
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i  181 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV  181 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence            7777766666677777777777777777766553 5667777777777776653       2446777777777777777


Q ss_pred             CcccCCCCC
Q 046438          448 PTTIGGLKN  456 (851)
Q Consensus       448 ~~~~~~l~~  456 (851)
                      |..++.++.
T Consensus       182 p~~~~~l~~  190 (208)
T 2o6s_A          182 RNSAGSVAP  190 (208)
T ss_dssp             BCTTSSBCT
T ss_pred             eccCccccC
Confidence            776665544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=2.8e-20  Score=195.26  Aligned_cols=173  Identities=25%  Similarity=0.321  Sum_probs=93.6

Q ss_pred             cccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccc
Q 046438          308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR  387 (851)
Q Consensus       308 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  387 (851)
                      +..+++|+.|++++|.+... + .+..+++|++|++++|.+++..+  +..+++|+.|++++|+++              
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~--------------  103 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--------------  103 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC--------------
T ss_pred             hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC--------------
Confidence            34556666666666665533 2 25555555555555555554332  445555555555555554              


Q ss_pred             ceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCccc
Q 046438          388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL  467 (851)
Q Consensus       388 ~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  467 (851)
                                .+|. +..+++|++|++++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++
T Consensus       104 ----------~~~~-l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l  168 (291)
T 1h6t_A          104 ----------DLSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI  168 (291)
T ss_dssp             ----------CGGG-GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             ----------CChh-hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence                      4332 44445555555555555432  2344555555555555555532  3455566666666666666


Q ss_pred             CCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccc
Q 046438          468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEG  517 (851)
Q Consensus       468 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~  517 (851)
                      ++..|  +..+++|+.|+|++|++++ +| .+..+++|+.|++++|++++
T Consensus       169 ~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            54333  6666666666666666663 33 25666666666666666654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=6.5e-20  Score=192.50  Aligned_cols=169  Identities=28%  Similarity=0.398  Sum_probs=119.1

Q ss_pred             ccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEc
Q 046438          288 LSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYL  367 (851)
Q Consensus       288 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  367 (851)
                      .+|+.|++++|.+... + .+..+++|++|++++|++++..+  +..+++|++|++++|.+++.  ..+..+++|+.|++
T Consensus        46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L  119 (291)
T 1h6t_A           46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSL  119 (291)
T ss_dssp             HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEEC
T ss_pred             CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEEC
Confidence            4799999999999854 3 58999999999999999997655  99999999999999999863  34777777777777


Q ss_pred             cCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccC
Q 046438          368 DHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDI  447 (851)
Q Consensus       368 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  447 (851)
                      ++|++.+.  ..+..+++|+.|++++|+++.+                         ..++.+++|++|++++|++++..
T Consensus       120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-------------------------~~l~~l~~L~~L~L~~N~l~~~~  172 (291)
T 1h6t_A          120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI-------------------------TVLSRLTKLDTLSLEDNQISDIV  172 (291)
T ss_dssp             TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-------------------------GGGGGCTTCSEEECCSSCCCCCG
T ss_pred             CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-------------------------hhhccCCCCCEEEccCCccccch
Confidence            77777642  3445555555555555555544                         23444555555555555555332


Q ss_pred             CcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccc
Q 046438          448 PTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSG  493 (851)
Q Consensus       448 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  493 (851)
                      |  +..+++|+.|++++|++++ ++ .+..+++|+.|++++|+++.
T Consensus       173 ~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          173 P--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             G--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             h--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            2  5666677777777777763 34 36777777777777777764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.81  E-value=1e-20  Score=185.49  Aligned_cols=155  Identities=26%  Similarity=0.341  Sum_probs=118.3

Q ss_pred             cceecccCcCccCchhhcccCcceEEEecCCCCCCCCcc-ccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL-EIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       387 ~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      +.+++++|+++.+|..+..  +|+.|++++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            5667777777777765543  777788888887755553 3777888888888888888777888888888888888888


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      +|++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|+|+|+++......++....+.++...|+.|
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            888777777888888888888888888888888888888888888888888888754444445555556666777766

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=8.4e-20  Score=184.43  Aligned_cols=157  Identities=25%  Similarity=0.238  Sum_probs=120.2

Q ss_pred             CCEEEccCcccCCCCCccccCCccccceecccCcCccC-chhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          362 LSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       362 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      .+.++++++++. .+|..+.  ++|+.|+|++|+++.+ |..+..+++|+.|+|++|+++...+..|..+++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            344666666665 3343332  5677777777777755 44566777777777777777755556677788888888888


Q ss_pred             CcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       441 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      |+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|+|+|.|+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            8888666667888899999999999998 788888999999999999999997777788889999999999999999887


Q ss_pred             CC
Q 046438          521 RG  522 (851)
Q Consensus       521 ~~  522 (851)
                      ..
T Consensus       177 ~~  178 (229)
T 3e6j_A          177 DI  178 (229)
T ss_dssp             GG
T ss_pred             hh
Confidence            43

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=1.8e-19  Score=207.21  Aligned_cols=186  Identities=22%  Similarity=0.310  Sum_probs=138.8

Q ss_pred             cccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccc
Q 046438          308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR  387 (851)
Q Consensus       308 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  387 (851)
                      +..+++|+.|++++|.+... + .+..+++|+.|+|++|.+++..+  +..+++|+.|+|++|++.+ ++ .+..+++|+
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~  112 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK  112 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred             hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence            56677788888888887743 3 47778888888888888886554  7788888888888888875 23 677788888


Q ss_pred             ceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCccc
Q 046438          388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL  467 (851)
Q Consensus       388 ~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  467 (851)
                      .|+|++|+++.++ .+..+++|+.|+|++|++++.  ..++.+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|
T Consensus       113 ~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          113 SLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             EEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEEecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence            8888888888764 477788888888888888754  567778888888888888876544  77888888888888888


Q ss_pred             CCCCcccccCCCCCCEEECCCCcccccCCcccccccccc
Q 046438          468 QGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLK  506 (851)
Q Consensus       468 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  506 (851)
                      ++ +| .+..+++|+.|+|++|++++.....+..+..+.
T Consensus       188 ~~-l~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~  224 (605)
T 1m9s_A          188 SD-LR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPN  224 (605)
T ss_dssp             CB-CG-GGTTCTTCSEEECCSEEEECCCCCCCSSCEEEC
T ss_pred             CC-Ch-HHccCCCCCEEEccCCcCcCCcccccccEEecc
Confidence            74 33 577888888888888888765444444444333

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=3.9e-19  Score=178.24  Aligned_cols=155  Identities=22%  Similarity=0.267  Sum_probs=132.3

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc---CCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP---FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSL   95 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L   95 (851)
                      -+.+++++|.++ .+|..+.  ..+++|+|++|++++..+   +..+++|++|+|++|+|+ .++...|..+++|++|+|
T Consensus        13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~L   88 (220)
T 2v70_A           13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILL   88 (220)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEEEC
Confidence            468999999998 5676553  456899999999987644   678899999999999998 677767889999999999


Q ss_pred             cccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccc
Q 046438           96 AFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGS  175 (851)
Q Consensus        96 ~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  175 (851)
                      ++|+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+...
T Consensus        89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A           89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            99999988888899999999999999999988888899999999999999999988888899999999999999988755


Q ss_pred             cc
Q 046438          176 IS  177 (851)
Q Consensus       176 ~~  177 (851)
                      .+
T Consensus       169 c~  170 (220)
T 2v70_A          169 CY  170 (220)
T ss_dssp             GG
T ss_pred             Cc
Confidence            44

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=1.7e-19  Score=207.47  Aligned_cols=144  Identities=19%  Similarity=0.291  Sum_probs=72.2

Q ss_pred             CCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccccc
Q 046438           19 LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFN   98 (851)
Q Consensus        19 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N   98 (851)
                      +..++++.+.+++..+  +..+.+|+.|+|++|.+.+..++..+++|++|+|++|+++ .+++  +..+++|++|+|++|
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~~l~~l~~L~~L~Ls~N~l~-~~~~--l~~l~~L~~L~Ls~N   97 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIKP--LTNLKNLGWLFLDEN   97 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCTTGGGCTTCCEEECTTSCCC-CCGG--GGGCTTCCEEECCSS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCChHHccCCCCCEEEeeCCCCC-CChh--hccCCCCCEEECcCC
Confidence            4444555555543333  4455555555555555554444555555555555555555 2332  445555555555555


Q ss_pred             ccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccc
Q 046438           99 QFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLS  173 (851)
Q Consensus        99 ~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  173 (851)
                      .|++. | .+..+++|++|+|++|.+.+ + ..+..+++|+.|+|++|++.+.  ..+..+++|+.|+|++|.++
T Consensus        98 ~l~~l-~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           98 KIKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             CCCCC-T-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred             CCCCC-h-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence            55431 2 45555555555555555543 2 2344555555555555555443  34444455555555555444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=2.4e-19  Score=179.72  Aligned_cols=156  Identities=22%  Similarity=0.256  Sum_probs=142.4

Q ss_pred             ccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          386 LRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       386 L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      -+.+++++|+++.+|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|+.|.++++|++|+|++|
T Consensus        13 ~~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           13 NNIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TTEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CCEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            3678999999999998765  78999999999999888889999999999999999999888999999999999999999


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCC-CCcccccCcccccCCcCccCCC
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR-GGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      +|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+. ...+..+..+.+.+|++.|++.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            99976667789999999999999999999999999999999999999999988774 3457888889999999999765

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.79  E-value=1.8e-19  Score=195.64  Aligned_cols=126  Identities=26%  Similarity=0.308  Sum_probs=55.5

Q ss_pred             CEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CC-CCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           20 QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FF-NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        20 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~-~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      +.+++++++++ .+|..+.  ..+++|+|++|+|++..+  +. .+++|++|+|++|+|+ .+++..|..+++|++|+|+
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECC
Confidence            45555555555 3443332  234555555555544332  22 4444444444444444 3333334444444444444


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCcccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLV  149 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  149 (851)
                      +|+|+...+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  149 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS  149 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence            44444333334444444444444444444333444444444444444444444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.78  E-value=1.5e-19  Score=176.93  Aligned_cols=154  Identities=23%  Similarity=0.226  Sum_probs=122.2

Q ss_pred             cceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcc
Q 046438          387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN  466 (851)
Q Consensus       387 ~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  466 (851)
                      +.+++++|+++.+|..+.  ++|+.|+|++|.++ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            457777777777776543  57888888888887 667788888888888888888887777889999999999999999


Q ss_pred             cCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcccccCCcCccCCC
Q 046438          467 LQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       467 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      |++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|+|.......++.......+...|..|
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P  166 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGP  166 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEES
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCc
Confidence            99888888999999999999999999777778999999999999999999998754333333332233444567666

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=4.2e-19  Score=174.89  Aligned_cols=154  Identities=16%  Similarity=0.217  Sum_probs=118.6

Q ss_pred             cccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhh
Q 046438          357 CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVEL  436 (851)
Q Consensus       357 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  436 (851)
                      ..+++|+.|++++|.+. .+| .+..+++|++|++++|.++.++ .+..+++|++|++++|++++..|..++.+++|++|
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            34455566666666665 333 4666677777777777666554 57778888888888888887778888888999999


Q ss_pred             hccCCcccccCCcccCCCCCccEEEccCcc-cCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccc
Q 046438          437 YLSRNNLSGDIPTTIGGLKNLQNLSLGDNN-LQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL  515 (851)
Q Consensus       437 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l  515 (851)
                      ++++|++++..|..++.+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred             EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence            999999987778888999999999999998 65 566 68889999999999999985 44 788899999999999987


Q ss_pred             cc
Q 046438          516 EG  517 (851)
Q Consensus       516 ~~  517 (851)
                      .+
T Consensus       194 ~~  195 (197)
T 4ezg_A          194 GG  195 (197)
T ss_dssp             --
T ss_pred             CC
Confidence            54

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=1.3e-19  Score=194.22  Aligned_cols=233  Identities=13%  Similarity=0.087  Sum_probs=155.7

Q ss_pred             ccccCCCCCC--CCCCCEEeCcCCCCccCCCccccC-CCCCCEEEcCCCcccccc-cCCCCCCCcEEeCCCCCCCCCCCc
Q 046438            6 TGTVPSQLGS--LSSLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSF-PFFNMSSLQVIDLSDNRLSGELPA   81 (851)
Q Consensus         6 ~~~~p~~l~~--l~~L~~L~ls~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~   81 (851)
                      .|+++..+..  +.+++.|.++++ +....-..+.. +++|++|||++|++.... ....++.++.+++..|    .+|.
T Consensus        12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~----~I~~   86 (329)
T 3sb4_A           12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMAN----FVPA   86 (329)
T ss_dssp             TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTT----EECT
T ss_pred             CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccccccccccccc----ccCH
Confidence            4566666654  778999999876 22222223444 888999999999998211 1223333566666666    4677


Q ss_pred             chhcC--------CcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCc----ccc
Q 046438           82 NIFSY--------LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSN----NLV  149 (851)
Q Consensus        82 ~~~~~--------l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n----~l~  149 (851)
                      ..|.+        +++|+.|+|.+ .++.+.+.+|.+|++|+.|+++.|.+....+.+|.++.++..+.+..+    ...
T Consensus        87 ~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~  165 (329)
T 3sb4_A           87 YAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN  165 (329)
T ss_dssp             TTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST
T ss_pred             HHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc
Confidence            78888        99999999999 888788889999999999999999998788889999888888877653    234


Q ss_pred             CCCCccccCCCcCc-EEEeeccccccccchhHhhh---cccccccccccccccccCCccccccCCCcEEecCCCCCcccc
Q 046438          150 GVVPATLFNISTLK-ILQLTNNTLSGSISSSIRLA---LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFI  225 (851)
Q Consensus       150 ~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~~~~---l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~  225 (851)
                      ......|.++..|+ .+++....   .++..++..   ..+++.+.+.++-...........+++|+.++|++|+++.+.
T Consensus       166 ~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~  242 (329)
T 3sb4_A          166 RWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIP  242 (329)
T ss_dssp             TTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEEC
T ss_pred             cccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceec
Confidence            44556777888887 56665432   344444332   455566655554221111111123577777777777777777


Q ss_pred             CccccCCCCcceEeccCccccCC
Q 046438          226 PNRFHNMRNLKELNLEYNYITSS  248 (851)
Q Consensus       226 ~~~~~~l~~L~~L~L~~N~i~~~  248 (851)
                      +.+|.++.+|++|+|.+| ++.+
T Consensus       243 ~~aF~~~~~L~~l~l~~n-i~~I  264 (329)
T 3sb4_A          243 DFTFAQKKYLLKIKLPHN-LKTI  264 (329)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEE
T ss_pred             HhhhhCCCCCCEEECCcc-ccee
Confidence            777777777777777766 5443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=8.8e-22  Score=225.14  Aligned_cols=154  Identities=23%  Similarity=0.229  Sum_probs=111.2

Q ss_pred             ccccccccccccCCCCEEE-ccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccc
Q 046438          348 LEGRILDDICRLARLSSVY-LDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE  426 (851)
Q Consensus       348 l~~~~~~~~~~l~~L~~L~-L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  426 (851)
                      +.+..|..+..+++|+.|+ ++.|.+           ..|+.+.+++|.++.+|..     .|+.|+|++|.+++ +|. 
T Consensus       397 ~~~~~~~~l~~l~~L~~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~-----~L~~L~Ls~n~l~~-lp~-  458 (567)
T 1dce_A          397 PLLYEKETLQYFSTLKAVDPMRAAYL-----------DDLRSKFLLENSVLKMEYA-----DVRVLHLAHKDLTV-LCH-  458 (567)
T ss_dssp             TGGGHHHHHHHHHHHHHHCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT-----TCSEEECTTSCCSS-CCC-
T ss_pred             cccCCHHHHHHHHhcccCcchhhccc-----------chhhhhhhhcccccccCcc-----CceEEEecCCCCCC-CcC-
Confidence            4445566666667777666 555543           2455666666666655432     47778888888874 565 


Q ss_pred             cccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccC-Cccccccccc
Q 046438          427 IGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGII-PSSLEKLLYL  505 (851)
Q Consensus       427 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L  505 (851)
                      |+.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|
T Consensus       459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L  535 (567)
T 1dce_A          459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL  535 (567)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence            777888888888888887 677788888888888888888874 56 6788888888888888888665 7788888888


Q ss_pred             cceeccCccccccCCCC
Q 046438          506 KYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       506 ~~l~l~~N~l~~~~p~~  522 (851)
                      +.|+|++|++++.+|..
T Consensus       536 ~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          536 VLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             CEEECTTSGGGGSSSCT
T ss_pred             CEEEecCCcCCCCccHH
Confidence            88888888888777644

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=1.2e-19  Score=187.17  Aligned_cols=171  Identities=25%  Similarity=0.336  Sum_probs=90.0

Q ss_pred             cccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccce
Q 046438          310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKL  389 (851)
Q Consensus       310 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  389 (851)
                      .+.++..+++++|.+++..  .+..+++|++|++++|.++.. + .+..+++|+.|+|++|++++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3455555666666665322  355566666666666666532 2 44555555555555555553332  5555555555


Q ss_pred             ecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCC
Q 046438          390 SFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG  469 (851)
Q Consensus       390 ~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  469 (851)
                      ++++|+++.+|....  ++|+.|+|++|+                        +++ ++ .+..+++|+.|+|++|++++
T Consensus        91 ~L~~N~l~~l~~~~~--~~L~~L~L~~N~------------------------l~~-~~-~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           91 SVNRNRLKNLNGIPS--ACLSRLFLDNNE------------------------LRD-TD-SLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             ECCSSCCSCCTTCCC--SSCCEEECCSSC------------------------CSB-SG-GGTTCTTCCEEECTTSCCCB
T ss_pred             ECCCCccCCcCcccc--CcccEEEccCCc------------------------cCC-Ch-hhcCcccccEEECCCCcCCC
Confidence            555555554443211  444444444444                        442 22 35555555555555555553


Q ss_pred             CCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCcccccc
Q 046438          470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGE  518 (851)
Q Consensus       470 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~  518 (851)
                       ++ .++.+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.
T Consensus       143 -~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          143 -IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence             22 455555666666666666543  4455566666666666666554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=3.6e-18  Score=172.42  Aligned_cols=155  Identities=24%  Similarity=0.221  Sum_probs=99.8

Q ss_pred             CcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEcc
Q 046438           65 LQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLL  144 (851)
Q Consensus        65 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  144 (851)
                      -+.+++++++++ .+|..+   .++|++|+|++|.|++..|..|.++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus        21 ~~~v~c~~~~l~-~ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEeEccCCCcC-ccCCCC---CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            345677777766 666543   2566666666666666666666667777777777777665555556666666666666


Q ss_pred             CccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccc
Q 046438          145 SNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGF  224 (851)
Q Consensus       145 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~  224 (851)
                      +|++++..+..|..+++|+.|+|++|+|+ .                         +|..+.++++|+.|+|++|+++++
T Consensus        97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~-------------------------lp~~~~~l~~L~~L~L~~N~l~~~  150 (229)
T 3e6j_A           97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-E-------------------------LPRGIERLTHLTHLALDQNQLKSI  150 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCC-S-------------------------CCTTGGGCTTCSEEECCSSCCCCC
T ss_pred             CCcCCccChhHhCcchhhCeEeccCCccc-c-------------------------cCcccccCCCCCEEECCCCcCCcc
Confidence            66666655555666666666666666655 3                         333444555666666666666666


Q ss_pred             cCccccCCCCcceEeccCccccCCC
Q 046438          225 IPNRFHNMRNLKELNLEYNYITSSN  249 (851)
Q Consensus       225 ~~~~~~~l~~L~~L~L~~N~i~~~~  249 (851)
                      .+..|..+++|++|+|++|++....
T Consensus       151 ~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          151 PHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             CHHHHhCCCCCCEEEeeCCCccCCc
Confidence            6666777777777888777776543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=5.8e-19  Score=173.91  Aligned_cols=153  Identities=16%  Similarity=0.194  Sum_probs=85.1

Q ss_pred             cCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEE
Q 046438           38 FSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSI  117 (851)
Q Consensus        38 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L  117 (851)
                      ..+++|++|++++|++++...+..+++|++|++++|.++ .++  .+..+++|++|+|++|++++..+..++.+++|++|
T Consensus        41 ~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHHHTCCEEEEESSCCSCCTTGGGCTTCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             hhcCCccEEeccCCCccChHHHhcCCCCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            344455555555555554334445555555555555443 222  24555666666666666655555556666666666


Q ss_pred             eccccccccccchhhcCcccccEEEccCcc-ccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccccccc
Q 046438          118 DLSENHLMGEIPHEIGNLRNLQALGLLSNN-LVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN  196 (851)
Q Consensus       118 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~  196 (851)
                      +|++|.+++..|..++.+++|++|++++|+ +.. +| .+..+++|+.|++++|++++ ++  .+..+++|++|++++|+
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT--TGGGCSSCCEEEECBC-
T ss_pred             EecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH--HhccCCCCCEEEeeCcc
Confidence            666666665556666666666666666665 443 23 45666666666666666653 22  23456666666666666


Q ss_pred             cc
Q 046438          197 FS  198 (851)
Q Consensus       197 i~  198 (851)
                      |.
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=5.7e-19  Score=182.20  Aligned_cols=152  Identities=19%  Similarity=0.243  Sum_probs=119.0

Q ss_pred             ccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccc
Q 046438          307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL  386 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  386 (851)
                      .+..+++|+.|++++|.++. ++ .+..+++|++|++++|++++..+  +..+++|+.|++++|++++..+ . .. ++|
T Consensus        36 ~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~-~-~~-~~L  108 (263)
T 1xeu_A           36 SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG-I-PS-ACL  108 (263)
T ss_dssp             CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT-C-CC-SSC
T ss_pred             chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc-c-cc-Ccc
Confidence            46778888888888888874 34 67888889999999998887655  8888889999999998886433 2 22 889


Q ss_pred             cceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcc
Q 046438          387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN  466 (851)
Q Consensus       387 ~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  466 (851)
                      ++|++++|+++.++ .+..+++|+.|+|++|++++. + .++.+++|++|++++|++++.  ..+..+++|+.|++++|+
T Consensus       109 ~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~  183 (263)
T 1xeu_A          109 SRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK  183 (263)
T ss_dssp             CEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred             cEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence            99999999999876 488888999999999988854 3 577777788888888887754  567777777778887777


Q ss_pred             cCCC
Q 046438          467 LQGS  470 (851)
Q Consensus       467 l~~~  470 (851)
                      +.+.
T Consensus       184 ~~~~  187 (263)
T 1xeu_A          184 CVNE  187 (263)
T ss_dssp             EECC
T ss_pred             ccCC
Confidence            7643

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.75  E-value=2.8e-20  Score=212.73  Aligned_cols=100  Identities=24%  Similarity=0.306  Sum_probs=58.1

Q ss_pred             hhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccC
Q 046438          433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSF  512 (851)
Q Consensus       433 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~  512 (851)
                      |+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .+..+++|+.|+|++
T Consensus       443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence            5556666666653 444 666666666666666665 555566666666666666666664 44 556666666666666


Q ss_pred             ccccccC-C-CCCcccccCcccccCCc
Q 046438          513 NRLEGEI-P-RGGTLANFTSESFMGND  537 (851)
Q Consensus       513 N~l~~~~-p-~~~~~~~l~~~~~~~n~  537 (851)
                      |++++.. | ....+..+..+.+.+|+
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~  544 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNS  544 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence            6666553 3 22345555555555554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=5.3e-19  Score=208.74  Aligned_cols=196  Identities=20%  Similarity=0.221  Sum_probs=117.9

Q ss_pred             CCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCccccccc
Q 046438          233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI  312 (851)
Q Consensus       233 ~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~  312 (851)
                      +.++.|+|.+|.+...+           ...|+.++|+.|.+                ..+++..|++. ..|..+..++
T Consensus       173 ~~~~~l~L~~n~~~~~~-----------~~~l~~l~Ls~~~i----------------~~~~~~~n~~~-~~~~~~~~l~  224 (727)
T 4b8c_D          173 PLTPKIELFANGKDEAN-----------QALLQHKKLSQYSI----------------DEDDDIENRMV-MPKDSKYDDQ  224 (727)
T ss_dssp             -----------------------------------------------------------------------------CCC
T ss_pred             CccceEEeeCCCCCcch-----------hhHhhcCccCcccc----------------cCcccccccee-cChhhhccCC
Confidence            34566666666655422           12345555555543                23445556655 5677888899


Q ss_pred             CCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecc
Q 046438          313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFA  392 (851)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  392 (851)
                      +|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..+..+++|+.|+|++|+|+ .+|..|+.+++|++|+|+
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            9999999999988 56666778999999999999998 67788889999999999999998 678889999999999999


Q ss_pred             cCcCccCchhhcccCcceEEEecCCCCCCCCccccccchh-hhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKV-LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       393 ~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      +|.|+.+|..|+.+++|+.|+|++|++++.+|..+..+.. +..|+|++|.+++.+|..      |+.|++++|
T Consensus       302 ~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          302 DNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD  369 (727)
T ss_dssp             SSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred             CCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence            9999999988999999999999999999888888766543 345788999988777754      455667666

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=8.4e-19  Score=180.37  Aligned_cols=137  Identities=17%  Similarity=0.231  Sum_probs=107.3

Q ss_pred             CCCccceeccccceEEEEEEE-cCCcE--EEEEEEeecchh------------------------hHHHHHHHHHHHhhc
Q 046438          627 QFNVNNLIGSGSFGSVYRGRF-LDGME--VAIKVFHLQLEG------------------------ALESFNAECEVLRSI  679 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  679 (851)
                      -|++.+.||+|+||.||+|++ .+|+.  ||||+++.....                        ....+.+|+++++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            467889999999999999998 68888  999997643211                        113678999999999


Q ss_pred             CCCcc--cceeeeeecCCeeEEEEeccCC-C----ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcC-CCCcEecC
Q 046438          680 RHRNL--VRIISSCTNDDFKALVLDYMPK-G----SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH-PNPVVHCD  751 (851)
Q Consensus       680 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h-~~~ivH~D  751 (851)
                      +|+++  +.+++.    +..++||||+++ |    +|.+....    .++..+..++.|++.|++||   | ++||+|||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l---H~~~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL---YQEAELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH---HHTSCEECSS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH---HHHCCEEeCC
Confidence            88864  334432    356899999943 3    66655422    22446678999999999999   7 88999999


Q ss_pred             CCCCCEEECCCCcEEEeeccCcccc
Q 046438          752 IKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       752 l~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      |||+||+++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=3.7e-18  Score=167.17  Aligned_cols=175  Identities=22%  Similarity=0.271  Sum_probs=137.9

Q ss_pred             CEEEccCcccCCCCCccccCCccccceecccCcCccCchh--hcccCcceEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPST--FWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       363 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      +.+++++|++. .+|..+..  +|++|++++|+++.++..  +..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56777777776 45554432  788899999999888753  88899999999999999988899999999999999999


Q ss_pred             CcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       441 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      |+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+.. .-...++...+.++...|.-|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch-HHHHHHHHcCCCCCCCCCCCC
Confidence            9999888888999999999999999999988999999999999999999999765521 111234445667777777766


Q ss_pred             CCCcccccCcccccCCcCccCCC
Q 046438          521 RGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       521 ~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      ..  +....-.++..+...|..+
T Consensus       167 ~~--l~~~~l~~l~~~~~~C~~~  187 (192)
T 1w8a_A          167 SK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             TT--TTTSBGGGSCTTTCCCCCC
T ss_pred             hH--HcCCChhhCcHhhcCcCCC
Confidence            53  3444444556666677654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=5.2e-19  Score=208.74  Aligned_cols=150  Identities=25%  Similarity=0.275  Sum_probs=80.2

Q ss_pred             cCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccC
Q 046438          320 GYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV  399 (851)
Q Consensus       320 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  399 (851)
                      +.|.+. ..+..+..++.|+.|+|++|.+. .++..+..+++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+.+
T Consensus       209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l  285 (727)
T 4b8c_D          209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSL  285 (727)
T ss_dssp             --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSC
T ss_pred             ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCcc
Confidence            334443 44555666666666666666666 34444445666666666666666 4555566666666666666666666


Q ss_pred             chhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCC-ccEEEccCcccCCCCcc
Q 046438          400 PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN-LQNLSLGDNNLQGSIPN  473 (851)
Q Consensus       400 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~  473 (851)
                      |..++.+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus       286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~  359 (727)
T 4b8c_D          286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH  359 (727)
T ss_dssp             CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred             ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence            666666666666666666665 45555666666666666666666555555543322 12355666666655554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.71  E-value=1.2e-17  Score=178.81  Aligned_cols=224  Identities=13%  Similarity=0.093  Sum_probs=110.6

Q ss_pred             cccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhcccccc
Q 046438          184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK  263 (851)
Q Consensus       184 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~  263 (851)
                      +++|+.|+|.+ .++.+.+.+|.++++|+.+++++|.+..+.+.+|.++.++..+.+..+........+ .-..+..+..
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i-~~~~f~~~~~  177 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRW-EHFAFIEGEP  177 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTT-TTSCEEESCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccc-cccccccccc
Confidence            66677777766 666666666777777777777777777777777777777776666553221000000 0112344445


Q ss_pred             cc-EEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCcccc-CCCCCcEE
Q 046438          264 LK-VLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLS-RLEKLQIL  341 (851)
Q Consensus       264 L~-~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L  341 (851)
                      |+ .+++.....    ++..+...                     -....++..+.+.++-.. .....+. .+++|+.|
T Consensus       178 L~~~i~~~~~~~----l~~~~~~~---------------------~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l  231 (329)
T 3sb4_A          178 LETTIQVGAMGK----LEDEIMKA---------------------GLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSL  231 (329)
T ss_dssp             CEEEEEECTTCC----HHHHHHHT---------------------TCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEE
T ss_pred             cceeEEecCCCc----HHHHHhhc---------------------ccCccccceEEEeeeecH-HHHHHHHHhcCCCeEE
Confidence            55 344333211    11111110                     011223333333322111 1111111 14455555


Q ss_pred             EcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccc-ceecccCcCccCc-hhhcccCcceEEEecCCCC
Q 046438          342 GLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR-KLSFASNELTFVP-STFWNLTNILMVDLSSNPL  419 (851)
Q Consensus       342 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~p-~~~~~l~~L~~L~Ls~N~l  419 (851)
                      +|++|.++.+....|..+.+|+.++|.+| +..+.+.+|.++++|+ .+++.+ .++.++ .+|.++++|+.+++++|.+
T Consensus       232 ~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i  309 (329)
T 3sb4_A          232 DISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI  309 (329)
T ss_dssp             ECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred             ECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence            55555555444444555555555555554 4444455555555555 555555 455443 3555566666666666666


Q ss_pred             CCCCccccccchhhhhhh
Q 046438          420 SGSLPLEIGNLKVLVELY  437 (851)
Q Consensus       420 ~~~~p~~~~~l~~L~~L~  437 (851)
                      +...+.+|.++++|+.|+
T Consensus       310 ~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          310 TTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CEECTTTTCTTCCCCEEE
T ss_pred             CccchhhhcCCcchhhhc
Confidence            555555666666665554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.70  E-value=2.9e-17  Score=158.72  Aligned_cols=137  Identities=24%  Similarity=0.230  Sum_probs=115.9

Q ss_pred             ccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          386 LRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       386 L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      .+.+++++|+++.+|..+.  ++|+.|++++|++++..+..|+.+++|++|++++|++++..+..|..+++|+.|++++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            4677788888888876543  68888999999988777777888899999999999998666677899999999999999


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCc
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGT  524 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~  524 (851)
                      +|++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|+|+|.+|...+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~~  145 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  145 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCccHHH
Confidence            99977777789999999999999999977776778899999999999999999884433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=9.4e-17  Score=153.64  Aligned_cols=132  Identities=25%  Similarity=0.227  Sum_probs=55.8

Q ss_pred             CCCCEEEccCcccC-CCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhc
Q 046438          360 ARLSSVYLDHNKLS-GSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYL  438 (851)
Q Consensus       360 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  438 (851)
                      ++|+.|++++|++. +.+|..+..+++|+.|++++|.++.+ ..+..+++|++|+|++|++++.+|..+..+++|++|++
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            33444444444443 33344444444444444444444444 33444444444444444444333333333444444444


Q ss_pred             cCCcccccC-CcccCCCCCccEEEccCcccCCCCc---ccccCCCCCCEEECCCCccc
Q 046438          439 SRNNLSGDI-PTTIGGLKNLQNLSLGDNNLQGSIP---NSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       439 ~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      ++|++++.. +..+..+++|+.|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            444443211 1334444444444444444442222   23444444444444444443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=8.4e-17  Score=153.97  Aligned_cols=134  Identities=23%  Similarity=0.239  Sum_probs=120.9

Q ss_pred             CccccceecccCcCc--cCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEE
Q 046438          383 LASLRKLSFASNELT--FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNL  460 (851)
Q Consensus       383 l~~L~~L~L~~N~l~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  460 (851)
                      .++|++|++++|+++  .+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            478999999999999  8999899999999999999999965  789999999999999999997788888889999999


Q ss_pred             EccCcccCCCC-cccccCCCCCCEEECCCCcccccCC---ccccccccccceeccCcccccc
Q 046438          461 SLGDNNLQGSI-PNSIGDLISLECLDLSNNILSGIIP---SSLEKLLYLKYLNVSFNRLEGE  518 (851)
Q Consensus       461 ~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~l~l~~N~l~~~  518 (851)
                      +|++|++++.. +..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|++...
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            99999998542 2789999999999999999996555   4899999999999999998744

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=3.3e-16  Score=153.09  Aligned_cols=129  Identities=29%  Similarity=0.368  Sum_probs=113.8

Q ss_pred             CEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCc
Q 046438          363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNN  442 (851)
Q Consensus       363 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  442 (851)
                      +.+++++|++. .+|..+.  ++|++|++++|+|+.+|..+.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            56788888877 4454443  57999999999999999999999999999999999998888889999999999999999


Q ss_pred             ccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccccc
Q 046438          443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI  494 (851)
Q Consensus       443 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  494 (851)
                      |++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            9988888999999999999999999976677899999999999999999753

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.64  E-value=2.8e-15  Score=163.77  Aligned_cols=264  Identities=16%  Similarity=0.175  Sum_probs=124.7

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccc--cCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccc
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF--PFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLS   94 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~   94 (851)
                      ..++...+..+ ++.+...+|.+. +|+.+++..+ ++.+.  .|.++ +|+.+++.. .++ .++...|.++++|+.++
T Consensus       113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCeee
Confidence            33444444332 333344444442 4555555443 33211  13332 355555543 333 44444455555555555


Q ss_pred             ccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccc
Q 046438           95 LAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSG  174 (851)
Q Consensus        95 L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~  174 (851)
                      |++|.++.+...+|. +++|+.+.|..+ ++.....+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. +.++ 
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~-  260 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVT-  260 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCC-
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCcc-
Confidence            555555444444444 345555555432 33334444555555555555432 33344444444 445555552 2233 


Q ss_pred             ccchhHhhhccccccccccccccc-----ccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCC
Q 046438          175 SISSSIRLALPNLELFSLANNNFS-----GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSN  249 (851)
Q Consensus       175 ~~~~~~~~~l~~L~~L~L~~N~i~-----~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  249 (851)
                      .+....|..+++|+.+++.+|.+.     ...+..|.++++|+.+.|. +.++.+...+|.++++|+.++|..| ++.++
T Consensus       261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~  338 (401)
T 4fdw_A          261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN  338 (401)
T ss_dssp             EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred             EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence            344444445555555555544433     3444555556666666665 3355555666666666666666443 44333


Q ss_pred             CcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccc
Q 046438          250 HELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIR  301 (851)
Q Consensus       250 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~  301 (851)
                      .     .+|.++ +|+.+++++|.+... .+..+...+..+..+++..+.+.
T Consensus       339 ~-----~aF~~~-~L~~l~l~~n~~~~l-~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          339 F-----SAFNNT-GIKEVKVEGTTPPQV-FEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             T-----TSSSSS-CCCEEEECCSSCCBC-CCSSCCCSCTTCCEEEECGGGHH
T ss_pred             H-----HhCCCC-CCCEEEEcCCCCccc-ccccccCCCCCccEEEeCHHHHH
Confidence            2     235555 666666666655321 12233334345667777666544

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=9.6e-17  Score=150.17  Aligned_cols=126  Identities=20%  Similarity=0.250  Sum_probs=72.1

Q ss_pred             ccccceecccCcCc--cCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEE
Q 046438          384 ASLRKLSFASNELT--FVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS  461 (851)
Q Consensus       384 ~~L~~L~L~~N~l~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  461 (851)
                      ++|++|++++|+++  .+|..+..+++|+.|++++|.+++.  ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34444455555444  4444444555555555555555533  4455555555555555555544555555566666666


Q ss_pred             ccCcccCCC-CcccccCCCCCCEEECCCCcccccCC---ccccccccccceecc
Q 046438          462 LGDNNLQGS-IPNSIGDLISLECLDLSNNILSGIIP---SSLEKLLYLKYLNVS  511 (851)
Q Consensus       462 L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~l~l~  511 (851)
                      +++|++++. .+..++.+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666642 23566666667777777776665444   356666777766665

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=1.2e-16  Score=169.80  Aligned_cols=137  Identities=14%  Similarity=0.170  Sum_probs=100.5

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecch--------------hhHH--------HHHHHHHHHhhcCCCc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE--------------GALE--------SFNAECEVLRSIRHRN  683 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~n  683 (851)
                      .-|++.+.||+|++|.||+|.+.+|+.||||+++....              ....        ...+|...+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34999999999999999999998999999999763210              0011        1235666666665444


Q ss_pred             cc--ceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC
Q 046438          684 LV--RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE  761 (851)
Q Consensus       684 iv--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~  761 (851)
                      +.  ..++.    ...++||||++|+++..+...       .....++.|++.++.||   |++|||||||||.|||+++
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRL---AKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeC
Confidence            32  22221    123799999999888654321       23456889999999999   7889999999999999987


Q ss_pred             CC----------cEEEeeccCcccc
Q 046438          762 DM----------VARLGDFGIAKLL  776 (851)
Q Consensus       762 ~~----------~~kl~Dfg~a~~~  776 (851)
                      ++          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999977654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=3.4e-16  Score=146.45  Aligned_cols=128  Identities=23%  Similarity=0.225  Sum_probs=90.2

Q ss_pred             CCCCCEEeCcCCCCc-cCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccc
Q 046438           16 LSSLQYLDLSFNQLL-GTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLS   94 (851)
Q Consensus        16 l~~L~~L~ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~   94 (851)
                      .++|++|++++|+++ +.+|..+..+++|++|+|++|++++...+..+++|++|++++|.+++.+| ..+..+++|++|+
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~   94 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLE-VLAEKCPNLTHLN   94 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTH-HHHHHCTTCCEEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCchhhhcCCCCCEEECCCCcccchHH-HHhhhCCCCCEEE
Confidence            467889999999887 67888888888888888888888876556777788888888888774333 3455567777777


Q ss_pred             ccccccccC-CCccccCCCCccEEeccccccccccc---hhhcCcccccEEEcc
Q 046438           95 LAFNQFAGH-LPREIGNLTSLTSIDLSENHLMGEIP---HEIGNLRNLQALGLL  144 (851)
Q Consensus        95 L~~N~i~~~-~~~~l~~l~~L~~L~Ls~n~l~~~~~---~~~~~l~~L~~L~L~  144 (851)
                      +++|.+++. .+..++.+++|++|++++|.+++..+   ..+..+++|++|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            777776643 23566666667777777776664443   356666666666654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.63  E-value=5.3e-15  Score=161.53  Aligned_cols=273  Identities=13%  Similarity=0.109  Sum_probs=163.1

Q ss_pred             CCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEE
Q 046438           86 YLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKIL  165 (851)
Q Consensus        86 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  165 (851)
                      .+..++.+.+.++ ++.+...+|.++ +|+.+++..+ ++.....+|.++ +|+.+.+.. .+..+.+.+|.+|++|+.+
T Consensus       111 ~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l  185 (401)
T 4fdw_A          111 ILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA  185 (401)
T ss_dssp             ECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred             ecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence            3444444444432 333444455554 4555555554 443444455553 456655543 4544555555666666666


Q ss_pred             EeeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccc
Q 046438          166 QLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI  245 (851)
Q Consensus       166 ~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i  245 (851)
                      ++++|.++ .++...|. ..+|+.+.|..+ ++.....+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+. +.+
T Consensus       186 ~l~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i  259 (401)
T 4fdw_A          186 DLSKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGV  259 (401)
T ss_dssp             ECTTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTC
T ss_pred             ecCCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCc
Confidence            66655555 44444443 355666666533 55455556666666666666653 55566666666 567777773 334


Q ss_pred             cCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCC
Q 046438          246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLN  325 (851)
Q Consensus       246 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~  325 (851)
                      +.++.     .++..+++|+.+++.+|.+.                     .+.+..+.+.+|.++++|+.+++. +.+.
T Consensus       260 ~~I~~-----~aF~~c~~L~~l~l~~~~~~---------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~  312 (401)
T 4fdw_A          260 TNIAS-----RAFYYCPELAEVTTYGSTFN---------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIR  312 (401)
T ss_dssp             CEECT-----TTTTTCTTCCEEEEESSCCC---------------------CCTTCEECTTTTTTCTTCCEECCC-TTCC
T ss_pred             cEECh-----hHhhCCCCCCEEEeCCcccc---------------------CCcccEECHHHhhCCccCCeEEeC-CceE
Confidence            44432     24666777777777666542                     111122335567777778887777 4466


Q ss_pred             CCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCc-cccceecccCcCcc
Q 046438          326 GSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLA-SLRKLSFASNELTF  398 (851)
Q Consensus       326 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~  398 (851)
                      .....+|.++++|+.+.|..| ++.+...+|..+ +|+.+++++|.+....+..|.+++ +++.|.+..+.+..
T Consensus       313 ~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~  384 (401)
T 4fdw_A          313 ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK  384 (401)
T ss_dssp             EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred             EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence            566677888888888888544 665667777777 888888888877766677777774 67788887776653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.62  E-value=3.3e-15  Score=164.11  Aligned_cols=80  Identities=18%  Similarity=0.171  Sum_probs=39.3

Q ss_pred             ccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccc
Q 046438          424 PLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLL  503 (851)
Q Consensus       424 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  503 (851)
                      ..+|.++++|+.+++..+ ++......|.++.+|+.+++..| ++.....+|.++++|+.+++..+ ++ .+...|..++
T Consensus       313 ~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~  388 (394)
T 4fs7_A          313 EEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTT  388 (394)
T ss_dssp             TTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTC
T ss_pred             hhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCC
Confidence            334444444554444322 33333445555555555555544 44344455556666666655443 22 2334455555


Q ss_pred             cccc
Q 046438          504 YLKY  507 (851)
Q Consensus       504 ~L~~  507 (851)
                      +|+.
T Consensus       389 ~L~~  392 (394)
T 4fs7_A          389 KFKW  392 (394)
T ss_dssp             EEEE
T ss_pred             CCcE
Confidence            5554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.62  E-value=1.2e-14  Score=159.57  Aligned_cols=155  Identities=14%  Similarity=0.094  Sum_probs=66.3

Q ss_pred             CCCccccCCCCCCEEEcCCCcccc--cccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCcccc
Q 046438           32 TIPSSIFSINTLEILDLSNNQLSG--SFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIG  109 (851)
Q Consensus        32 ~~~~~~~~l~~L~~L~Ls~n~l~~--~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~  109 (851)
                      +-..+|.++.+|+.+.|..+ ++.  ...|.+|++|+.+++..+ ++ .++...|.+++.|+.+.+..+ +..+...+|.
T Consensus        62 Ig~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~  137 (394)
T 4fs7_A           62 IGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFK  137 (394)
T ss_dssp             ECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred             hHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeee
Confidence            33444555555555555432 332  223455555555555433 33 444445555555555544433 2223334444


Q ss_pred             CCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccc
Q 046438          110 NLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLEL  189 (851)
Q Consensus       110 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~  189 (851)
                      ++..++.........  ....+|.++++|+.+.+.++ +..+....|.++.+|+.+++..+ ++ .+....|...+.|+.
T Consensus       138 ~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~  212 (394)
T 4fs7_A          138 GCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLEN  212 (394)
T ss_dssp             TCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCB
T ss_pred             cccccccccCccccc--cchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ce-EeCchhhccccccce
Confidence            443333222222211  22334555555555555332 22233444445555555554433 22 333344444444444


Q ss_pred             cccccc
Q 046438          190 FSLANN  195 (851)
Q Consensus       190 L~L~~N  195 (851)
                      +.+..+
T Consensus       213 i~~~~~  218 (394)
T 4fs7_A          213 MEFPNS  218 (394)
T ss_dssp             CCCCTT
T ss_pred             eecCCC
Confidence            444433

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=2.9e-15  Score=144.52  Aligned_cols=131  Identities=27%  Similarity=0.282  Sum_probs=93.6

Q ss_pred             CEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccc
Q 046438           44 EILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH  123 (851)
Q Consensus        44 ~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~  123 (851)
                      +.+++++|+++. +|....++|++|++++|+++ .++...|..+++|++|+|++|.+++..+..|..+++|++|+|++|.
T Consensus        10 ~~l~~~~~~l~~-~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A           10 TEIRCNSKGLTS-VPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             TEEECCSSCCSS-CCTTCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEecCCCCcc-CCCCCCCCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            455556665553 23333456677777777766 5666667777777777777777776666667778888888888888


Q ss_pred             cccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccccc
Q 046438          124 LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI  176 (851)
Q Consensus       124 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  176 (851)
                      +++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|.+.+..
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            88666667778888888888888888766666777888888888888877544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=9e-16  Score=147.93  Aligned_cols=110  Identities=20%  Similarity=0.224  Sum_probs=68.8

Q ss_pred             CCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccc
Q 046438           13 LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQF   92 (851)
Q Consensus        13 l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~   92 (851)
                      +..+.+|++|++++|+++. +|......++|++|+|++|++++...+..+++|++|++++|+++ .+|+.+|..+++|++
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTE   92 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCE
T ss_pred             cCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcccccccCCCCCEEECCCCccc-ccCcchhhcCCCCCE
Confidence            5567778888888888874 45433333477778877777776655666777777777777776 555555555666666


Q ss_pred             ccccccccccCCCc--cccCCCCccEEeccccccc
Q 046438           93 LSLAFNQFAGHLPR--EIGNLTSLTSIDLSENHLM  125 (851)
Q Consensus        93 L~L~~N~i~~~~~~--~l~~l~~L~~L~Ls~n~l~  125 (851)
                      |+|++|+|+ .+|.  .+..+++|++|++++|.++
T Consensus        93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence            666666554 2333  4555555555555555554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=8.8e-18  Score=165.54  Aligned_cols=153  Identities=21%  Similarity=0.280  Sum_probs=98.2

Q ss_pred             cCCCCEEEccCcccCCCCCc------cccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchh
Q 046438          359 LARLSSVYLDHNKLSGSIPA------CFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKV  432 (851)
Q Consensus       359 l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  432 (851)
                      ...++.++++.+.+.+..|.      .+..+++|++|++++|+++.+| .+..+++|+.|++++|+++ .+|..+..+++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            34444444444444444443      5666666666666666666666 6666666777777777666 45556666667


Q ss_pred             hhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCc-ccccCCCCCCEEECCCCcccccCCcc----------ccc
Q 046438          433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP-NSIGDLISLECLDLSNNILSGIIPSS----------LEK  501 (851)
Q Consensus       433 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~  501 (851)
                      |++|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|++++.+|..          +..
T Consensus        95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~  172 (198)
T 1ds9_A           95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR  172 (198)
T ss_dssp             CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred             CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence            7777777777764 34 46667777777777777763222 36777777888888888777665543          677


Q ss_pred             cccccceeccCccccc
Q 046438          502 LLYLKYLNVSFNRLEG  517 (851)
Q Consensus       502 l~~L~~l~l~~N~l~~  517 (851)
                      +++|+.|+  +|+++.
T Consensus       173 l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          173 LPNLKKLD--GMPVDV  186 (198)
T ss_dssp             CSSCSEEC--CGGGTT
T ss_pred             CCCcEEEC--CcccCH
Confidence            78888775  676653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=5.5e-16  Score=149.46  Aligned_cols=134  Identities=18%  Similarity=0.185  Sum_probs=103.1

Q ss_pred             cccCCccccceecccCcCccCchhhcccC-cceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCc
Q 046438          379 CFGNLASLRKLSFASNELTFVPSTFWNLT-NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNL  457 (851)
Q Consensus       379 ~~~~l~~L~~L~L~~N~l~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  457 (851)
                      .+..+++|++|++++|+++.+|. +..+. +|+.|++++|.+++.  ..|+.+++|++|++++|+|++..+..|..+++|
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hcCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            34556677777777777777754 44444 788888888888754  577788888888888888885544556888889


Q ss_pred             cEEEccCcccCCCCcc--cccCCCCCCEEECCCCcccccCCcc----ccccccccceeccCccccc
Q 046438          458 QNLSLGDNNLQGSIPN--SIGDLISLECLDLSNNILSGIIPSS----LEKLLYLKYLNVSFNRLEG  517 (851)
Q Consensus       458 ~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~l~l~~N~l~~  517 (851)
                      ++|+|++|+|+ .+|.  .+..+++|+.|++++|.++ .+|..    +..+++|+.|++++|+...
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            99999999986 5665  7888899999999999998 45664    8889999999999988764

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=3.5e-15  Score=142.58  Aligned_cols=110  Identities=25%  Similarity=0.273  Sum_probs=81.2

Q ss_pred             eEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCC
Q 046438          410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN  489 (851)
Q Consensus       410 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  489 (851)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            45555555555 3444432  56677777777777666777788888888888888888666667788888888888888


Q ss_pred             cccccCCccccccccccceeccCccccccCCCC
Q 046438          490 ILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       490 ~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~  522 (851)
                      +|++..+..|..+++|+.|+|++|+|+|.++..
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l  121 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI  121 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence            888766667888888888888888888888743

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=2.9e-17  Score=161.78  Aligned_cols=133  Identities=22%  Similarity=0.252  Sum_probs=92.1

Q ss_pred             cccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhh
Q 046438          355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV  434 (851)
Q Consensus       355 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  434 (851)
                      .+..+++|+.|++++|++.+ +| .+..+++|+.|++++|+++.+|..+..+++|+.|++++|++++ +| .+..+++|+
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~  118 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLR  118 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCC
Confidence            55666666666666666664 44 6666677777777777777777666666777777777777774 44 566777777


Q ss_pred             hhhccCCcccccCC-cccCCCCCccEEEccCcccCCCCcc----------cccCCCCCCEEECCCCcccc
Q 046438          435 ELYLSRNNLSGDIP-TTIGGLKNLQNLSLGDNNLQGSIPN----------SIGDLISLECLDLSNNILSG  493 (851)
Q Consensus       435 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----------~~~~l~~L~~L~Ls~N~l~~  493 (851)
                      +|++++|++++..+ ..+..+++|++|++++|++.+.+|.          .+..+++|+.||  +|.++.
T Consensus       119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            77777777774322 4677788888888888888765554          277788888887  777763

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1e-14  Score=139.73  Aligned_cols=109  Identities=26%  Similarity=0.300  Sum_probs=71.1

Q ss_pred             eEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCC
Q 046438          410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN  489 (851)
Q Consensus       410 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  489 (851)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            34455555554 3444332  45566666666666555666777777777777777777555555677777777777777


Q ss_pred             cccccCCccccccccccceeccCccccccCCC
Q 046438          490 ILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       490 ~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                      +|++..+..|..+++|+.|+|++|+|.|.++.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            77765555577777777777777777777653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=4e-14  Score=135.23  Aligned_cols=109  Identities=26%  Similarity=0.227  Sum_probs=96.2

Q ss_pred             cccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccC
Q 046438          385 SLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGD  464 (851)
Q Consensus       385 ~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  464 (851)
                      +.+.+++++|+++.+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        10 ~~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           10 SGTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            35678888888888887663  7899999999999988888999999999999999999977777889999999999999


Q ss_pred             cccCCCCcccccCCCCCCEEECCCCcccccC
Q 046438          465 NNLQGSIPNSIGDLISLECLDLSNNILSGII  495 (851)
Q Consensus       465 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  495 (851)
                      |+|++..+..|..+++|++|+|++|.++...
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            9999777778999999999999999998543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=4.3e-14  Score=135.43  Aligned_cols=107  Identities=24%  Similarity=0.241  Sum_probs=93.8

Q ss_pred             ccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          386 LRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       386 L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      -+.+++++|+++.+|..+.  ++|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            3678888888888887664  78999999999999888889999999999999999999766667899999999999999


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCccccc
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILSGI  494 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  494 (851)
                      +|++..+..|..+++|+.|+|++|++...
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            99976666799999999999999999843

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.40  E-value=3.5e-12  Score=139.96  Aligned_cols=32  Identities=16%  Similarity=0.242  Sum_probs=13.6

Q ss_pred             CCcEEecCCCCCccccCccccCCCCcceEeccC
Q 046438          210 KLSICELPDNSFSGFIPNRFHNMRNLKELNLEY  242 (851)
Q Consensus       210 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  242 (851)
                      +|+.+.+..+ +..+...+|.++.+++......
T Consensus       183 ~l~~i~ip~~-~~~i~~~af~~c~~l~~~~~~~  214 (394)
T 4gt6_A          183 ALTQIHIPAK-VTRIGTNAFSECFALSTITSDS  214 (394)
T ss_dssp             CCSEEEECTT-CCEECTTTTTTCTTCCEEEECC
T ss_pred             ceeEEEECCc-ccccccchhhhccccceecccc
Confidence            3444444432 2223344455555554444433

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.40  E-value=1.6e-13  Score=148.10  Aligned_cols=103  Identities=20%  Similarity=0.152  Sum_probs=60.6

Q ss_pred             ceecccC-cCccCchhhcccCcceEEEecC-CCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCc
Q 046438          388 KLSFASN-ELTFVPSTFWNLTNILMVDLSS-NPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDN  465 (851)
Q Consensus       388 ~L~L~~N-~l~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  465 (851)
                      .++++++ +|+.+|. +..+++|+.|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            4566666 6666666 66666666666664 6666555555666666666666666665555555555666666666666


Q ss_pred             ccCCCCcccccCCCCCCEEECCCCccc
Q 046438          466 NLQGSIPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       466 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +|++..+..|..++ |+.|+|++|.+.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            66544444444443 555555555555

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.39  E-value=1.8e-14  Score=155.72  Aligned_cols=159  Identities=19%  Similarity=0.232  Sum_probs=89.4

Q ss_pred             CCCCEEEcCCCccccccc------C-CCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccc-----
Q 046438           41 NTLEILDLSNNQLSGSFP------F-FNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREI-----  108 (851)
Q Consensus        41 ~~L~~L~Ls~n~l~~~~~------~-~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l-----  108 (851)
                      +.|+.|+|++|.+++...      + ...++|++|||++|.+++.....++..+++|++|+|++|.|++.....+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            567777777777764221      1 2346777777777777633333344456667777777777664333333     


Q ss_pred             cCCCCccEEeccccccccc----cchhhcCcccccEEEccCccccCCC----CccccCCCcCcEEEeeccccccccchhH
Q 046438          109 GNLTSLTSIDLSENHLMGE----IPHEIGNLRNLQALGLLSNNLVGVV----PATLFNISTLKILQLTNNTLSGSISSSI  180 (851)
Q Consensus       109 ~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~~  180 (851)
                      ...++|++|+|++|.++..    ++..+..+++|++|+|++|++.+..    +..+...++|+.|+|++|.|++.....+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            2356677777777776532    3444456666777777777665432    3344555666666666666654332222


Q ss_pred             hh---hcccccccccccccccc
Q 046438          181 RL---ALPNLELFSLANNNFSG  199 (851)
Q Consensus       181 ~~---~l~~L~~L~L~~N~i~~  199 (851)
                      ..   ..++|++|+|++|.|++
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCCH
T ss_pred             HHHHHhCCCCCEEeccCCCCCH
Confidence            22   22445555555554443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.39  E-value=4e-13  Score=144.95  Aligned_cols=131  Identities=22%  Similarity=0.196  Sum_probs=103.6

Q ss_pred             eEEEecCC-CCCCCCccccccchhhhhhhccC-CcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECC
Q 046438          410 LMVDLSSN-PLSGSLPLEIGNLKVLVELYLSR-NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLS  487 (851)
Q Consensus       410 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  487 (851)
                      ..++++++ .++ .+|. +..+++|++|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688888 888 5777 98999999999996 99997777889999999999999999998888899999999999999


Q ss_pred             CCcccccCCccccccccccceeccCccccccCCCCCc--ccccCcccccCCcCccCCC
Q 046438          488 NNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGT--LANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       488 ~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~--~~~l~~~~~~~n~~~c~~~  543 (851)
                      +|+|++..+..+..++ |+.|+|++|+|.|+|+....  +.......+..+...|..|
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~  145 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ  145 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence            9999976666676666 99999999999998864322  1112223344566777766

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=7.9e-12  Score=137.10  Aligned_cols=133  Identities=11%  Similarity=0.162  Sum_probs=77.0

Q ss_pred             CccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCC
Q 046438          377 PACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKN  456 (851)
Q Consensus       377 ~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  456 (851)
                      ..+|.++.+|+.+.+.++..+.-..+|.++++|+.+.+. +.++.....+|.++.+|+++++..+ ++.+....|.++.+
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~  335 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ  335 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             cceeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence            445666666666666544333223456666666666665 3344345556777777777777654 55455667777788


Q ss_pred             ccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccc
Q 046438          457 LQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRL  515 (851)
Q Consensus       457 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l  515 (851)
                      |+.+.+..+ ++.....+|.++++|+.+++.+|....   ..+.....|+.+.+..|.+
T Consensus       336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            888877644 554556777788888888887775441   3455666777777665543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.34  E-value=1.3e-14  Score=156.83  Aligned_cols=186  Identities=17%  Similarity=0.109  Sum_probs=92.6

Q ss_pred             cCCcEEEecCCCCCCCcCccccC-----CCCCcEEEccccccccccccccc-ccCCCCEEEccCcccCCCCCccc-----
Q 046438          312 INLIIIRLGYNKLNGSIPSTLSR-----LEKLQILGLENNQLEGRILDDIC-RLARLSSVYLDHNKLSGSIPACF-----  380 (851)
Q Consensus       312 ~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~-----  380 (851)
                      +.|+.|++++|.++......+..     .++|++|+|++|.++......+. .+++|+.|+|++|.++......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            44555555555554332222221     14566666666666543333322 24455555555555543222222     


Q ss_pred             cCCccccceecccCcCcc-----CchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCC
Q 046438          381 GNLASLRKLSFASNELTF-----VPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLK  455 (851)
Q Consensus       381 ~~l~~L~~L~L~~N~l~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  455 (851)
                      ...++|++|+|++|.|+.     ++..+...++|++|+|++|.+++....                    .++..+...+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~~  211 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRNR  211 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGCS
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcCC
Confidence            123445555555555542     233334444555555555544321100                    1234455566


Q ss_pred             CccEEEccCcccCCC----CcccccCCCCCCEEECCCCcccccCCcccccccc-----cccee--ccCccccc
Q 046438          456 NLQNLSLGDNNLQGS----IPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY-----LKYLN--VSFNRLEG  517 (851)
Q Consensus       456 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-----L~~l~--l~~N~l~~  517 (851)
                      +|+.|+|++|.|+..    ++..+...++|++|||++|.|+......+..+..     |+.+.  +.+|.++.
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~  284 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE  284 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CHH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCH
Confidence            788888888887643    3344455678888888888887655444444321     55565  66666543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.25  E-value=1.4e-11  Score=127.10  Aligned_cols=146  Identities=13%  Similarity=0.112  Sum_probs=114.9

Q ss_pred             HHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEE
Q 046438          623 QATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       623 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ...+.|++....+.|+.+.||++.. +++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..++||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            3446788888899999999999975 47899999987533233356889999999985 677888999998888999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG---------------------------------------  742 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~---------------------------------------  742 (851)
                      ||++|.++.+...      +......++.+++++++.||..                                       
T Consensus        90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999876531      1123346888999999999761                                       


Q ss_pred             -----------------CCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          743 -----------------HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       743 -----------------h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                                       +...++|||+++.||+++++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             115699999999999998766677999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.10  E-value=1.3e-10  Score=119.79  Aligned_cols=138  Identities=19%  Similarity=0.109  Sum_probs=100.7

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCc--ccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN--LVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~  703 (851)
                      ..|.+....+.|..+.||++...+|..+++|+....   ....+.+|+++++.+++.+  +.+++++..+.+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            345543333456679999998767888999997643   2245788999999986544  45688888877788999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH----------------------------------------  743 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h----------------------------------------  743 (851)
                      ++|.++.  . ..   .+   ...++.+++++++.||...                                        
T Consensus        97 i~G~~l~--~-~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--S-SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--T-SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--c-Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998884  2 11   11   2356778888888885321                                        


Q ss_pred             ---------------CCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          744 ---------------PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       744 ---------------~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                                     ..+++|||++|.||+++.++.+.|+|||.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                           12399999999999998776677999998764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.06  E-value=3.3e-09  Score=115.53  Aligned_cols=59  Identities=5%  Similarity=0.064  Sum_probs=35.3

Q ss_pred             cccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEee
Q 046438          107 EIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLT  168 (851)
Q Consensus       107 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~  168 (851)
                      ++....+|+.+.+... ++..-..+|.++.+|+.+.+.. .++.+...+|.++ +|+.+.+.
T Consensus        41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~   99 (379)
T 4h09_A           41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGM   99 (379)
T ss_dssp             TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEEC
T ss_pred             ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECC
Confidence            3445566777776543 4445556677777777777743 3555555666665 46665554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.02  E-value=9.2e-09  Score=112.02  Aligned_cols=83  Identities=5%  Similarity=0.009  Sum_probs=58.9

Q ss_pred             hhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcC
Q 046438           83 IFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTL  162 (851)
Q Consensus        83 ~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  162 (851)
                      .|....+|+.+.+..+ ++.+...+|.+|++|+.++|..+ ++..-..+|.++ +|+.+.+.. ++..+...+|..+ +|
T Consensus        41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DL  115 (379)
T ss_dssp             TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CC
T ss_pred             ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-Cc
Confidence            3666778888888753 66566778999999999999765 665666788887 688777753 4554555566554 68


Q ss_pred             cEEEeecc
Q 046438          163 KILQLTNN  170 (851)
Q Consensus       163 ~~L~L~~n  170 (851)
                      +.+.+..+
T Consensus       116 ~~i~lp~~  123 (379)
T 4h09_A          116 DDFEFPGA  123 (379)
T ss_dssp             SEEECCTT
T ss_pred             ccccCCCc
Confidence            88877654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.98  E-value=1.2e-10  Score=124.65  Aligned_cols=83  Identities=17%  Similarity=0.213  Sum_probs=52.6

Q ss_pred             chhhhhhhccCCcccccCCccc---CCCCCccEEEccCcccCCC----CcccccCCCCCCEEECCCCcccccCCccccc-
Q 046438          430 LKVLVELYLSRNNLSGDIPTTI---GGLKNLQNLSLGDNNLQGS----IPNSIGDLISLECLDLSNNILSGIIPSSLEK-  501 (851)
Q Consensus       430 l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-  501 (851)
                      +++|+.|+|++|.+++..+..+   ..+++|++|+|+.|.|.+.    ++..+..+++|+.|+|++|.++...-..+.. 
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            5666666666666653322222   2467888888888888753    2333455788899999888887543333333 


Q ss_pred             cccccceeccCcc
Q 046438          502 LLYLKYLNVSFNR  514 (851)
Q Consensus       502 l~~L~~l~l~~N~  514 (851)
                      +  ...+++++|+
T Consensus       331 l--g~~~~~~~~~  341 (362)
T 2ra8_A          331 L--PMKIDVSDSQ  341 (362)
T ss_dssp             C--CSEEECCSBC
T ss_pred             c--CCEEEecCCc
Confidence            2  2457888887

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.92  E-value=1.9e-09  Score=116.51  Aligned_cols=143  Identities=10%  Similarity=0.150  Sum_probs=106.7

Q ss_pred             ccceeccccceEEEEEEEcCCcEEEEEEEe--ecc-hhhHHHHHHHHHHHhhcCC--CcccceeeeeecC---CeeEEEE
Q 046438          630 VNNLIGSGSFGSVYRGRFLDGMEVAIKVFH--LQL-EGALESFNAECEVLRSIRH--RNLVRIISSCTND---DFKALVL  701 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~  701 (851)
                      .++.++.|.++.||+++.. +..+++|+..  ... ......+.+|+++++.+..  ..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4578899999999999864 5678898875  321 1223568889999999974  5578888888766   4588999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH--------------------------------------  743 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h--------------------------------------  743 (851)
                      ||++|..+.+..   ...++......++.+++++++.||...                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998774321   233567778889999999999998521                                      


Q ss_pred             -----------------CCCcEecCCCCCCEEECCCCc--EEEeeccCcccc
Q 046438          744 -----------------PNPVVHCDIKPSNVLLDEDMV--ARLGDFGIAKLL  776 (851)
Q Consensus       744 -----------------~~~ivH~Dl~~~Nill~~~~~--~kl~Dfg~a~~~  776 (851)
                                       ...++|||+++.||+++.++.  +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             357999999999999987753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.92  E-value=8.6e-10  Score=116.16  Aligned_cols=187  Identities=16%  Similarity=0.138  Sum_probs=121.6

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCc--ccceeeeeecCC---eeEEEEecc
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRN--LVRIISSCTNDD---FKALVLDYM  704 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  704 (851)
                      ++.++.|....||++.    ..+++|+....  .....+.+|+++++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4678999999999863    56899986533  33467899999998884 333  344555443333   457899999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG------------------------------------------  742 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~------------------------------------------  742 (851)
                      +|.++.....   ..++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988865332   2355666677788888888888641                                          


Q ss_pred             -------------CCCCcEecCCCCCCEEECC--CCcEEEeeccCccccCCCCCccccccc---cCc--------cc--c
Q 046438          743 -------------HPNPVVHCDIKPSNVLLDE--DMVARLGDFGIAKLLSGDESMKHTQTL---ATI--------GY--M  794 (851)
Q Consensus       743 -------------h~~~ivH~Dl~~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~t~--------~y--~  794 (851)
                                   ....++|||+++.||++++  +..+.++||+.+....+..+.......   ..+        .|  .
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         1245899999999999998  556889999998754221111000000   000        01  1


Q ss_pred             C-ccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046438          795 A-PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD  828 (851)
Q Consensus       795 a-PE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  828 (851)
                      . |+....  .....+.|+++.++|++.+|+.+|-
T Consensus       256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1 111110  1122589999999999999998874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.90  E-value=1e-09  Score=117.27  Aligned_cols=115  Identities=16%  Similarity=0.202  Sum_probs=67.5

Q ss_pred             chhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhc--CcccccEEEccC--ccccCC-----C
Q 046438           82 NIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIG--NLRNLQALGLLS--NNLVGV-----V  152 (851)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~L~~--n~l~~~-----~  152 (851)
                      .++..+|+|+.|+|++|.-. .++. +. +++|++|+|+.|.+.......+.  .+++|++|+|+.  |...+.     +
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l  242 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF  242 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred             HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence            34566778888888776311 1222 33 67888888888877644444443  678888888753  221111     0


Q ss_pred             Cccc--cCCCcCcEEEeeccccccccchhHhh--hcccccccccccccccc
Q 046438          153 PATL--FNISTLKILQLTNNTLSGSISSSIRL--ALPNLELFSLANNNFSG  199 (851)
Q Consensus       153 ~~~l--~~l~~L~~L~L~~n~l~~~~~~~~~~--~l~~L~~L~L~~N~i~~  199 (851)
                      ...+  ..+++|+.|+|.+|.+.+..+..++.  .+|+|++|+|+.|.+++
T Consensus       243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            1122  24678888888888776544444432  35566666666666654

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.52  E-value=1.4e-08  Score=102.75  Aligned_cols=106  Identities=26%  Similarity=0.321  Sum_probs=64.2

Q ss_pred             hcCCccccc--ccccccccc---cCCCccccCCCCccEEecccccccc--ccchhhcCcccccEEEccCccccCCCCccc
Q 046438           84 FSYLPFVQF--LSLAFNQFA---GHLPREIGNLTSLTSIDLSENHLMG--EIPHEIGNLRNLQALGLLSNNLVGVVPATL  156 (851)
Q Consensus        84 ~~~l~~L~~--L~L~~N~i~---~~~~~~l~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l  156 (851)
                      |...+.|+.  ++++.|+..   ..++....++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|++.+.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            455566665  666666433   2222222456777788888887775  3456666777777777777777755  223


Q ss_pred             cCCC--cCcEEEeeccccccccc------hhHhhhcccccccc
Q 046438          157 FNIS--TLKILQLTNNTLSGSIS------SSIRLALPNLELFS  191 (851)
Q Consensus       157 ~~l~--~L~~L~L~~n~l~~~~~------~~~~~~l~~L~~L~  191 (851)
                      ..+.  +|++|+|++|.+.+.++      ..++..+|+|+.||
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            3333  77777777777765444      22344566666554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.50  E-value=1.7e-08  Score=97.34  Aligned_cols=68  Identities=15%  Similarity=0.183  Sum_probs=31.5

Q ss_pred             cccCCCCccEEeccccccccc----cchhhcCcccccEEEccCccccCC----CCccccCCCcCcEEEe--ecccccc
Q 046438          107 EIGNLTSLTSIDLSENHLMGE----IPHEIGNLRNLQALGLLSNNLVGV----VPATLFNISTLKILQL--TNNTLSG  174 (851)
Q Consensus       107 ~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L--~~n~l~~  174 (851)
                      .+...++|++|+|++|.+...    +.+.+...++|++|+|++|+|...    +...+...++|++|+|  ++|.+.+
T Consensus        60 ~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A           60 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            334445555555555555421    223333344555555555555432    1233344445555555  4555543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.50  E-value=1.1e-08  Score=98.51  Aligned_cols=42  Identities=14%  Similarity=0.122  Sum_probs=18.5

Q ss_pred             cCCCCCccEEEc--cCcccCCC----CcccccCCCCCCEEECCCCccc
Q 046438          451 IGGLKNLQNLSL--GDNNLQGS----IPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       451 ~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +...+.|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       117 L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          117 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            334444555555  44555422    1222333344555555555443

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.43  E-value=1.9e-06  Score=90.25  Aligned_cols=137  Identities=14%  Similarity=0.083  Sum_probs=95.6

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCC---cccceeeeee-cCCeeEEEEeccCC
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR---NLVRIISSCT-NDDFKALVLDYMPK  706 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  706 (851)
                      ++.++.|....||+.    |..+++|+...  ......+.+|+++++.+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            467889999999987    57789998532  23446789999999999752   3556666663 44567899999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG--------------------------------------------  742 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~--------------------------------------------  742 (851)
                      .++......   .++......++.++++.++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888653211   123444445555555555555432                                            


Q ss_pred             -------------CCCCcEecCCCCCCEEECC---CCc-EEEeeccCcccc
Q 046438          743 -------------HPNPVVHCDIKPSNVLLDE---DMV-ARLGDFGIAKLL  776 (851)
Q Consensus       743 -------------h~~~ivH~Dl~~~Nill~~---~~~-~kl~Dfg~a~~~  776 (851)
                                   ....++|||+++.||+++.   ++. +.|+||+.+...
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                         3346799999999999987   455 589999988754

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.39  E-value=1.1e-07  Score=96.14  Aligned_cols=91  Identities=23%  Similarity=0.223  Sum_probs=58.6

Q ss_pred             cccchhhhh--hhccCCcccccCCc----ccCCCCCccEEEccCcccCC--CCcccccCCCCCCEEECCCCcccccCCcc
Q 046438          427 IGNLKVLVE--LYLSRNNLSGDIPT----TIGGLKNLQNLSLGDNNLQG--SIPNSIGDLISLECLDLSNNILSGIIPSS  498 (851)
Q Consensus       427 ~~~l~~L~~--L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  498 (851)
                      |...+.|+.  ++++.|+.. .++.    ....+++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            344455665  666777443 2222    22456778888888888876  3345666778888888888888754  33


Q ss_pred             ccccc--cccceeccCccccccCC
Q 046438          499 LEKLL--YLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       499 l~~l~--~L~~l~l~~N~l~~~~p  520 (851)
                      +..+.  +|++|+|++|++++.+|
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhhcccCCcceEEccCCcCccccC
Confidence            44444  77888888888877655

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=2.2e-06  Score=88.20  Aligned_cols=137  Identities=21%  Similarity=0.107  Sum_probs=97.8

Q ss_pred             ceeccccce-EEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCeeEEEEeccCCCC
Q 046438          632 NLIGSGSFG-SVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGS  708 (851)
Q Consensus       632 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  708 (851)
                      +.+..|..| .||+.... ++..+++|+-..   .....+.+|+++++.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            455666665 69988764 466799998653   23466888999998885 3346788899988899999999999988


Q ss_pred             hhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 046438          709 LEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG----------------------------------------------  742 (851)
Q Consensus       709 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~----------------------------------------------  742 (851)
                      +.+.....     ......+..++++.++.||..                                              
T Consensus       107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            76654221     122334555666666666521                                              


Q ss_pred             ---------CCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          743 ---------HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       743 ---------h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                               +...++|||+++.||+++.++.+-|+||+.+...
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                     1224899999999999998877789999988653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.22  E-value=1.6e-06  Score=93.40  Aligned_cols=80  Identities=11%  Similarity=0.033  Sum_probs=56.4

Q ss_pred             ccee-ccccceEEEEEEEc-------CCcEEEEEEEeecch--h-hHHHHHHHHHHHhhcCC---CcccceeeeeecC--
Q 046438          631 NNLI-GSGSFGSVYRGRFL-------DGMEVAIKVFHLQLE--G-ALESFNAECEVLRSIRH---RNLVRIISSCTND--  694 (851)
Q Consensus       631 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~-~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--  694 (851)
                      .+.| +.|....+|++...       +++.+++|+......  . ....+.+|+++++.+..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3677 88999999998764       267899998654320  0 12457888999888853   3466788777655  


Q ss_pred             -CeeEEEEeccCCCChh
Q 046438          695 -DFKALVLDYMPKGSLE  710 (851)
Q Consensus       695 -~~~~lv~e~~~~g~L~  710 (851)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.11  E-value=6.5e-07  Score=83.65  Aligned_cols=101  Identities=17%  Similarity=0.214  Sum_probs=67.4

Q ss_pred             cccccccccccccccCCCccccCCCCccEEeccccc-cccccchhhcCc----ccccEEEccCcc-ccCCCCccccCCCc
Q 046438           88 PFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH-LMGEIPHEIGNL----RNLQALGLLSNN-LVGVVPATLFNIST  161 (851)
Q Consensus        88 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~~~~l~~l~~  161 (851)
                      .+|++|||+++.|+..--..+.++++|++|+|++|. +++.--..++.+    ++|++|+|++|. |++..-..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            457777887777775544567788888888888885 664444455554    478888888874 76554456677888


Q ss_pred             CcEEEeeccc-cccc--cchhHhhhccccc
Q 046438          162 LKILQLTNNT-LSGS--ISSSIRLALPNLE  188 (851)
Q Consensus       162 L~~L~L~~n~-l~~~--~~~~~~~~l~~L~  188 (851)
                      |++|+|++|. +++.  ....+...+|+++
T Consensus       141 L~~L~L~~c~~Itd~gl~~~~L~~~lP~l~  170 (176)
T 3e4g_A          141 LKYLFLSDLPGVKEKEKIVQAFKTSLPSLE  170 (176)
T ss_dssp             CCEEEEESCTTCCCHHHHHHHHHHHCTTCE
T ss_pred             CCEEECCCCCCCCchHHHHHHHHHHCCCcE
Confidence            8888888885 4432  1233334556554

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.03  E-value=1.2e-05  Score=87.64  Aligned_cols=75  Identities=17%  Similarity=0.170  Sum_probs=49.6

Q ss_pred             cceeccccceEEEEEEEc-CCcEEEEEEEeecch-------hhHHHHHHHHHHHhhcCC--Cccc-ceeeeeecCCeeEE
Q 046438          631 NNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-------GALESFNAECEVLRSIRH--RNLV-RIISSCTNDDFKAL  699 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~~~~~~~~~~~~~l  699 (851)
                      .+.+|.|..+.||+++.. +++.+++|.......       ...+++..|.++++.+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999753 468899998653211       123456789999988742  4444 45543  3345689


Q ss_pred             EEeccCCC
Q 046438          700 VLDYMPKG  707 (851)
Q Consensus       700 v~e~~~~g  707 (851)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.92  E-value=5.6e-05  Score=80.57  Aligned_cols=139  Identities=14%  Similarity=0.093  Sum_probs=80.8

Q ss_pred             ceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCC--Ccccceeee------eecCCeeEEEEec
Q 046438          632 NLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRH--RNLVRIISS------CTNDDFKALVLDY  703 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~------~~~~~~~~lv~e~  703 (851)
                      +.++.|..+.||++...+ ..+++|+.....    ..+..|.++++.+..  -.+.+++..      ....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            456667789999998744 459999987531    334455666665532  123444431      1345677899999


Q ss_pred             cCCCChh-----H---------Hhhc--CCC--C---------cCHHHH-------------------------------
Q 046438          704 MPKGSLE-----A---------CLYS--DNS--N---------LDIFKR-------------------------------  725 (851)
Q Consensus       704 ~~~g~L~-----~---------~l~~--~~~--~---------~~~~~~-------------------------------  725 (851)
                      ++|..+.     .         .++.  ...  +         ..|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         0111  100  0         112110                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          726 LNIVIDIALALEYLHF----------GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       726 ~~i~~~i~~~l~~L~~----------~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ..+..++..++++|+.          ....+++|||+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345566642          1357899999999999998888999999998864

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.89  E-value=7.1e-06  Score=73.28  Aligned_cols=84  Identities=21%  Similarity=0.241  Sum_probs=60.1

Q ss_pred             cEEEccCcccC-CCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcc--ccc
Q 046438          458 QNLSLGDNNLQ-GSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSE--SFM  534 (851)
Q Consensus       458 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~--~~~  534 (851)
                      ..++.++++++ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|+|.|++.......++...  ...
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~~~~~   88 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAP   88 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSSCSGG
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCccccc
Confidence            37888999886 35665443  47999999999999877888999999999999999999998643322222221  112


Q ss_pred             CCcCccCCC
Q 046438          535 GNDLLCGSP  543 (851)
Q Consensus       535 ~n~~~c~~~  543 (851)
                      .....|..|
T Consensus        89 ~~~~~C~~P   97 (130)
T 3rfe_A           89 YRDLRCVAP   97 (130)
T ss_dssp             GTTCBCCBS
T ss_pred             ccCcEeCcC
Confidence            334567666

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.85  E-value=2.4e-05  Score=86.01  Aligned_cols=81  Identities=9%  Similarity=0.083  Sum_probs=50.4

Q ss_pred             CCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccccccccCccccCccccccCC---CCcchhhHHHHHHHHH
Q 046438          743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ---ISTEGDVYSFGIMLME  819 (851)
Q Consensus       743 h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslG~il~e  819 (851)
                      +...++|||+++.||+++.++ ++++||+.+....+..+.......-...|.+|+......   .....++.+....+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            578899999999999998876 999999998754221111110000123466666543211   1223455678888888


Q ss_pred             HHhCC
Q 046438          820 IFTRK  824 (851)
Q Consensus       820 l~~g~  824 (851)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.74  E-value=1.1e-05  Score=75.37  Aligned_cols=37  Identities=8%  Similarity=0.173  Sum_probs=17.2

Q ss_pred             ccEEEccCccccCCCCccccCCCcCcEEEeeccc-ccc
Q 046438          138 LQALGLLSNNLVGVVPATLFNISTLKILQLTNNT-LSG  174 (851)
Q Consensus       138 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~  174 (851)
                      |++||++++.++...-..+.++++|++|+|++|. +++
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD  100 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED  100 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH
Confidence            4444444444333333334455556666666553 443

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.74  E-value=0.00022  Score=74.13  Aligned_cols=136  Identities=15%  Similarity=0.090  Sum_probs=91.6

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC---CCcccceeeeeecCCeeEEEEeccCCC
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR---HRNLVRIISSCTNDDFKALVLDYMPKG  707 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  707 (851)
                      .+.++.|....+|+... ++..+++|+....   ....+..|++.++.+.   ...+++++.+....+..++||||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46799999999999975 5778999987643   3467889999998884   356788888888778899999999988


Q ss_pred             ChhH-----------HhhcCCC--C-------------------cCHHHHH---HHHH----------------HHHHH-
Q 046438          708 SLEA-----------CLYSDNS--N-------------------LDIFKRL---NIVI----------------DIALA-  735 (851)
Q Consensus       708 ~L~~-----------~l~~~~~--~-------------------~~~~~~~---~i~~----------------~i~~~-  735 (851)
                      ....           .++....  .                   -+|....   ++..                ++++. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222111  0                   1232211   1111                11111 


Q ss_pred             HHHHHh-cCCCCcEecCCCCCCEEECCCCcEEEeecc
Q 046438          736 LEYLHF-GHPNPVVHCDIKPSNVLLDEDMVARLGDFG  771 (851)
Q Consensus       736 l~~L~~-~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg  771 (851)
                      ...|.. .....++|||+.+.|++++.++ +.|+|++
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            123311 1256799999999999999887 8899984

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.62  E-value=0.00014  Score=76.61  Aligned_cols=157  Identities=16%  Similarity=0.178  Sum_probs=90.2

Q ss_pred             ccHHHHHHHhcCCCc-----cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCc--cccee
Q 046438          616 FSYQELLQATDQFNV-----NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN--LVRII  688 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~  688 (851)
                      ++.+++.....+|.+     .+.++.|....+|++...+| .+++|+.....  ..+.+..|.++++.+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            455666666666765     34577788899999987555 68899887531  2244667888877774322  23333


Q ss_pred             ee------eecCCeeEEEEeccCCCChhH-----H---------hhcC--C--CC----cC---HHHHHH----------
Q 046438          689 SS------CTNDDFKALVLDYMPKGSLEA-----C---------LYSD--N--SN----LD---IFKRLN----------  727 (851)
Q Consensus       689 ~~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~--~--~~----~~---~~~~~~----------  727 (851)
                      ..      ....+..+++|+|++|..+..     +         ++..  .  ..    ..   |.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            22      122356789999999865321     0         1110  0  00    01   111000          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          728 --IVIDIALALEYLHFG----HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       728 --i~~~i~~~l~~L~~~----h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                        +...+.+.++.+...    ...+++|+|+++.||+++.++.+.++||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011234445555321    246899999999999998876668999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.60  E-value=0.0002  Score=74.12  Aligned_cols=79  Identities=14%  Similarity=0.123  Sum_probs=57.3

Q ss_pred             CCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCC---cccceeeeeecCCeeEEEEec
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR---NLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~  703 (851)
                      +..-++.+|.|..+.||+++..+|++|++|+...........+..|++.++.+...   .+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            44556789999999999999999999999986543333335678899999988532   244555432    23789999


Q ss_pred             cCCCCh
Q 046438          704 MPKGSL  709 (851)
Q Consensus       704 ~~~g~L  709 (851)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.42  E-value=6.8e-05  Score=71.41  Aligned_cols=123  Identities=9%  Similarity=0.135  Sum_probs=56.6

Q ss_pred             hhcCcccccEEEccCc-cccCC----CCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccc
Q 046438          131 EIGNLRNLQALGLLSN-NLVGV----VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFI  205 (851)
Q Consensus       131 ~~~~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  205 (851)
                      .+.+-+.|++|+|++| +|...    +...+..-+.|+.|+|++|+|.+.....+.                     ..+
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA---------------------~aL   94 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLI---------------------ELI   94 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHH---------------------HHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHH---------------------HHH
Confidence            3444556666666654 44321    122333445566666666655533222222                     222


Q ss_pred             cccCCCcEEecCCCCCccccC----ccccCCCCcceEeccCccccCCCCc--chhhhhccccccccEEeccCCCc
Q 046438          206 FNASKLSICELPDNSFSGFIP----NRFHNMRNLKELNLEYNYITSSNHE--LSFISSLANSKKLKVLSLTGNPL  274 (851)
Q Consensus       206 ~~~~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~~~l~~l~~L~~L~Ls~N~l  274 (851)
                      ...+.|+.|+|+.|.|+....    +++..-+.|++|+|++|....++..  ..+...+...+.|+.|+++.|.+
T Consensus        95 ~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A           95 ETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             hcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            234455555555555543222    2333345566666654422111111  12334555666666666665543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.36  E-value=0.001  Score=70.22  Aligned_cols=157  Identities=10%  Similarity=0.074  Sum_probs=90.3

Q ss_pred             ccHHHHHHHhcCCCc-----cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCc--cccee
Q 046438          616 FSYQELLQATDQFNV-----NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN--LVRII  688 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~  688 (851)
                      .+.+.+....+.|.+     .+.++ |....||++...+|+.+++|+..... ...+.+..|.++++.+....  +++++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence            444555555444433     34576 88889999877667789999986431 12356777888888774322  34444


Q ss_pred             ee-----eecCCeeEEEEeccCCCChh-----HH---------hhc--C------CCCcCHHHH----HH----------
Q 046438          689 SS-----CTNDDFKALVLDYMPKGSLE-----AC---------LYS--D------NSNLDIFKR----LN----------  727 (851)
Q Consensus       689 ~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~--~------~~~~~~~~~----~~----------  727 (851)
                      ..     ....+..+++|||++|..+.     .+         ++.  .      ....++...    ..          
T Consensus        89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            43     12244567899999875432     00         111  0      001111110    00          


Q ss_pred             -----HHHHHHHHHHHHHh----cCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          728 -----IVIDIALALEYLHF----GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       728 -----i~~~i~~~l~~L~~----~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                           +...+.+.++.+..    .....++|||+++.||+++ + .+.++||+.+...
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                 01111122222221    1456789999999999999 4 8999999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.35  E-value=0.00046  Score=73.81  Aligned_cols=139  Identities=17%  Similarity=0.209  Sum_probs=82.8

Q ss_pred             ceeccccceEEEEEEEc--------CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEEe
Q 046438          632 NLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVLD  702 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  702 (851)
                      +.+..|....+|++...        +++.|++|+.... ........+|.++++.+...++ .++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            57778889999999864        2478999986332 1233556789999988853333 556666643    38999


Q ss_pred             ccCCCChhHH-----------------hhcC----CCCcC--HHHHHHHHHHHHH-------------------HHHHH-
Q 046438          703 YMPKGSLEAC-----------------LYSD----NSNLD--IFKRLNIVIDIAL-------------------ALEYL-  739 (851)
Q Consensus       703 ~~~~g~L~~~-----------------l~~~----~~~~~--~~~~~~i~~~i~~-------------------~l~~L-  739 (851)
                      |++|.++..-                 ++.-    .+...  +.++.++..++..                   .++.| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998654310                 1111    11122  2333333333211                   12222 


Q ss_pred             ---H-hcCCCCcEecCCCCCCEEECCC----CcEEEeeccCccc
Q 046438          740 ---H-FGHPNPVVHCDIKPSNVLLDED----MVARLGDFGIAKL  775 (851)
Q Consensus       740 ---~-~~h~~~ivH~Dl~~~Nill~~~----~~~kl~Dfg~a~~  775 (851)
                         . ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               1 1244579999999999999876    7899999999864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.00046  Score=75.61  Aligned_cols=73  Identities=16%  Similarity=0.283  Sum_probs=50.7

Q ss_pred             cceeccccceEEEEEEEcC--------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEE
Q 046438          631 NNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVL  701 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  701 (851)
                      ++.|+.|....||++...+        ++.+++|+....  ...+.+.+|..+++.+...++ .++++.+.+    ++||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3678889999999998753        578999998542  111445579999888854444 566665542    3899


Q ss_pred             eccCCCCh
Q 046438          702 DYMPKGSL  709 (851)
Q Consensus       702 e~~~~g~L  709 (851)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.26  E-value=7.5e-05  Score=71.10  Aligned_cols=74  Identities=11%  Similarity=0.211  Sum_probs=44.3

Q ss_pred             ccCCCCccEEecccc-cccc----ccchhhcCcccccEEEccCccccCCCC----ccccCCCcCcEEEeeccccccccch
Q 046438          108 IGNLTSLTSIDLSEN-HLMG----EIPHEIGNLRNLQALGLLSNNLVGVVP----ATLFNISTLKILQLTNNTLSGSISS  178 (851)
Q Consensus       108 l~~l~~L~~L~Ls~n-~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~n~l~~~~~~  178 (851)
                      +.+-+.|++|+|++| .|..    .+.+.+..-+.|+.|+|++|+|.....    ..+..-+.|++|+|++|.|.+....
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344456777777764 5542    244556666777777777777754332    2333456777777777777654444


Q ss_pred             hHh
Q 046438          179 SIR  181 (851)
Q Consensus       179 ~~~  181 (851)
                      .+.
T Consensus       117 ala  119 (197)
T 1pgv_A          117 RLL  119 (197)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.26  E-value=0.00026  Score=73.70  Aligned_cols=137  Identities=15%  Similarity=0.148  Sum_probs=77.6

Q ss_pred             cceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEEecc-CCCC
Q 046438          631 NNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVLDYM-PKGS  708 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~  708 (851)
                      ++.++.|....+|++     ..+++|+....... .....+|+++++.+...++ .+++++.  .+.-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            688999999999998     56899987643221 1223568888887754333 4555543  33347899999 6654


Q ss_pred             hhHH------------------hhcCCCC----cCHHH-HHHHH--------------HHHHHHH----HHHH-hcCCCC
Q 046438          709 LEAC------------------LYSDNSN----LDIFK-RLNIV--------------IDIALAL----EYLH-FGHPNP  746 (851)
Q Consensus       709 L~~~------------------l~~~~~~----~~~~~-~~~i~--------------~~i~~~l----~~L~-~~h~~~  746 (851)
                      +...                  ++.....    ..... ...+.              ..+.+.+    +.+. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4210                  1111110    01110 00000              0011111    1111 123456


Q ss_pred             cEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          747 VVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       747 ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ++|+|+.+.||+ ..++.+.++||..+...
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 56677899999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.22  E-value=0.0012  Score=69.84  Aligned_cols=140  Identities=13%  Similarity=0.065  Sum_probs=73.8

Q ss_pred             ceeccccceE-EEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCC--cccceeeeeecCCeeEEEEeccCCCC
Q 046438          632 NLIGSGSFGS-VYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHR--NLVRIISSCTNDDFKALVLDYMPKGS  708 (851)
Q Consensus       632 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~  708 (851)
                      +.++.|.... +|+....+++.+++|......   .+.+..|+++++.+...  .+.+++.+..+.+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4566666555 667764346778787643321   13345677777776432  3456666543333  68999997765


Q ss_pred             hhHHhh---------------------cCC----CCcCHHHHH---------H-----------HHHHHHHHHHHHH---
Q 046438          709 LEACLY---------------------SDN----SNLDIFKRL---------N-----------IVIDIALALEYLH---  740 (851)
Q Consensus       709 L~~~l~---------------------~~~----~~~~~~~~~---------~-----------i~~~i~~~l~~L~---  740 (851)
                      +.+.+.                     ...    ...+.....         .           ....+.+.++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            543221                     100    011111100         0           0011112222221   


Q ss_pred             hcCCCCcEecCCCCCCEEECCC----CcEEEeeccCcccc
Q 046438          741 FGHPNPVVHCDIKPSNVLLDED----MVARLGDFGIAKLL  776 (851)
Q Consensus       741 ~~h~~~ivH~Dl~~~Nill~~~----~~~kl~Dfg~a~~~  776 (851)
                      ..+...++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1246789999999999999875    68999999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.15  E-value=0.0013  Score=72.31  Aligned_cols=74  Identities=12%  Similarity=0.169  Sum_probs=49.1

Q ss_pred             cceeccccceEEEEEEEcC-CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEEeccCCCC
Q 046438          631 NNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVLDYMPKGS  708 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  708 (851)
                      ++.|+.|....+|++...+ +..+++|+........ -+..+|..+++.+...++ .++++.+.  +  +.||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678889999999998754 4789999875432211 122578999998875555 45666663  2  36999998754


Q ss_pred             h
Q 046438          709 L  709 (851)
Q Consensus       709 L  709 (851)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.98  E-value=0.0012  Score=70.86  Aligned_cols=73  Identities=12%  Similarity=0.255  Sum_probs=45.3

Q ss_pred             ceeccccceEEEEEEEcC---------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEE
Q 046438          632 NLIGSGSFGSVYRGRFLD---------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVL  701 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  701 (851)
                      +.++.|....+|++...+         ++.+++|+....... ......|.++++.+...++ .++++...    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            567888899999998743         268899987543221 1234678888888854343 45665442    26899


Q ss_pred             eccCCCCh
Q 046438          702 DYMPKGSL  709 (851)
Q Consensus       702 e~~~~g~L  709 (851)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.91  E-value=0.00098  Score=59.23  Aligned_cols=55  Identities=24%  Similarity=0.370  Sum_probs=27.5

Q ss_pred             EEEcCCCccc-ccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccccccc
Q 046438           45 ILDLSNNQLS-GSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF  100 (851)
Q Consensus        45 ~L~Ls~n~l~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i  100 (851)
                      .++.++++++ ..+|-.-.++|++|||++|+|+ .+|..+|..+++|++|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCCcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence            4555555554 1222223344555555555555 55555555555555555555544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.79  E-value=0.007  Score=63.90  Aligned_cols=33  Identities=24%  Similarity=0.314  Sum_probs=29.0

Q ss_pred             CCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       744 ~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      ...++|+|+.+.||+++.++.+.++||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            357999999999999998888999999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.12  E-value=0.0058  Score=66.22  Aligned_cols=74  Identities=14%  Similarity=0.243  Sum_probs=49.6

Q ss_pred             cceeccccceEEEEEEEcC--------CcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEE
Q 046438          631 NNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVL  701 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  701 (851)
                      ++.+..|....+|++...+        ++.|++|+....... .-+..+|.++++.+...++ .++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3677888999999998753        578999986443211 1234678888888854334 45555332    26899


Q ss_pred             eccCCCCh
Q 046438          702 DYMPKGSL  709 (851)
Q Consensus       702 e~~~~g~L  709 (851)
                      ||++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.49  E-value=0.098  Score=56.46  Aligned_cols=30  Identities=30%  Similarity=0.360  Sum_probs=25.7

Q ss_pred             CcEecCCCCCCEEE------CCCCcEEEeeccCccc
Q 046438          746 PVVHCDIKPSNVLL------DEDMVARLGDFGIAKL  775 (851)
Q Consensus       746 ~ivH~Dl~~~Nill------~~~~~~kl~Dfg~a~~  775 (851)
                      .++|+|+.+.||++      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567899999999864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=93.58  E-value=0.16  Score=48.49  Aligned_cols=102  Identities=15%  Similarity=0.057  Sum_probs=68.5

Q ss_pred             ChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccccc
Q 046438          708 SLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT  787 (851)
Q Consensus       708 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  787 (851)
                      +|.+.+...+.+++++++|.++.|.+.++.-.-.  ++.-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            7889998889999999999999999999877632  11111333456889999999887653 1110             


Q ss_pred             ccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 046438          788 LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP  826 (851)
Q Consensus       788 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  826 (851)
                      .....+.+||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            1233466888763 4557888999999999998874444

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.48  E-value=2.3  Score=40.52  Aligned_cols=123  Identities=11%  Similarity=0.162  Sum_probs=80.4

Q ss_pred             CCCcccceeeeeecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       680 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      .||++++. .+..+++...+.++.-+  ...++-  .-+..+...+++++.+|+....++   +  .=+|--++|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~---~--~r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD--NIKSFTKNEKLRYLLNIKNLEEVN---R--TRYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG--GGGGSCHHHHHHHHHHGGGGGGGG---G--SSEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH--HHHhcCHHHHHHHHHHHHHHHHHh---c--CceEEEEecceEEE
Confidence            57888876 45556666666666543  222221  124567788999999999877554   3  35788999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCcc
Q 046438          760 DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEM  835 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~  835 (851)
                      +.++.+++.--|.-..+.                  |.     ..++..=.-.+=+++..+++++..|+..-.|..
T Consensus       113 ~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l  165 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL  165 (215)
T ss_dssp             CTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred             cCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence            999999998776533221                  11     122223344566788888999999876544433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	851
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-13
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-11
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 3e-59
 Identities = 68/230 (29%), Positives = 116/230 (50%), Gaps = 12/230 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRN 683
            Q  V   IGSGSFG+VY+G++    +VA+K+ ++       L++F  E  VLR  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           ++  +   T     A+V  +    SL   L+   +  ++ K ++I    A  ++YLH   
Sbjct: 66  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPEY---G 799
              ++H D+K +N+ L ED+  ++GDFG+A + S        + L+ +I +MAPE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
            +   S + DVY+FGI+L E+ T + P   I + +  +       L   +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 5e-56
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 8/216 (3%)

Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRH 681
             D F   + +G+G+ G V++      G+ +A K+ HL++          E +VL     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             +V    +  +D   ++ +++M  GSL+  L      +       + I +   L YL  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLR- 121

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
              + ++H D+KPSN+L++     +L DFG++  L    +      + T  YM+PE  + 
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 177

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSL 837
              S + D++S G+ L+E+   + P     + E+ L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 7e-56
 Identities = 55/223 (24%), Positives = 108/223 (48%), Gaps = 6/223 (2%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           +   +   +G+G FG V+ G +    +VA+K        + ++F AE  +++ ++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNS-NLDIFKRLNIVIDIALALEYLHFGHP 744
           R+ +  T +    ++ +YM  GSL   L + +   L I K L++   IA  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI 804
              +H D++ +N+L+ + +  ++ DFG+A+L+  +E          I + APE    G  
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 805 STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPI 847
           + + DV+SFGI+L EI T  R      +    ++        +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 5e-54
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 4/218 (1%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
            +      IGSG FG V+ G +L+  +VAIK          E F  E EV+  + H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           ++   C       LV ++M  G L   L +          L + +D+   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
            V+H D+   N L+ E+ V ++ DFG+ + +  D+    T T   + + +PE     + S
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND 843
           ++ DV+SFG+++ E+F+  +   E  S    ++     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 9e-54
 Identities = 49/218 (22%), Positives = 98/218 (44%), Gaps = 4/218 (1%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
                   +G+G FG V  G++    +VAIK+         + F  E +V+ ++ H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           ++   CT      ++ +YM  G L   L          + L +  D+  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQIS 805
             +H D+   N L+++  V ++ DFG+++ +  DE      +   + +  PE     + S
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 806 TEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND 843
           ++ D+++FG+++ EI++  +   E F+   + +     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 51/229 (22%), Positives = 105/229 (45%), Gaps = 21/229 (9%)

Query: 616 FSYQELLQATDQFN---------VNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL 662
           F++++  +A  +F          +  +IG+G FG V  G         + VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 663 -EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLD 721
            E     F +E  ++    H N++ +    T      ++ ++M  GSL++ L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
           + + + ++  IA  ++YL        VH D+   N+L++ ++V ++ DFG+++ L  D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 782 MKHTQT----LATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                +       I + APE  +  + ++  DV+S+GI++ E+ +    
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-53
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 6/222 (2%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
           +   +   +G G FG V+ G +     VAIK          E+F  E +V++ +RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFK-RLNIVIDIALALEYLHFGHP 744
           ++ +  + +    +V +YM KGSL   L  +          +++   IA  + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQI 804
              VH D++ +N+L+ E++V ++ DFG+A+L+  +E          I + APE    G+ 
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 805 STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
           + + DV+SFGI+L E+ T+ R           L +       
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-52
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 11/215 (5%)

Query: 619 QELLQATDQFNVNNL-IGSGSFGSVYRGRFL---DGMEVAIKVFHLQL-EGALESFNAEC 673
           ++L    D   + ++ +G G+FGSV +G +      ++VAIKV      +   E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
           +++  + +  +VR+I  C  +    LV++    G L   L      + +     ++  ++
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA--TI 791
           + ++YL        VH D+   NVLL     A++ DFG++K L  D+S    ++     +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            + APE     + S+  DV+S+G+ + E  +  + 
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-51
 Identities = 71/223 (31%), Positives = 107/223 (47%), Gaps = 12/223 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLV 685
            +  +   IG G FG V  G    G +VA+K   ++ +   ++F AE  V+  +RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 686 RIISSCTNDDFK-ALVLDYMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +++     +     +V +YM KGSL   L S   S L     L   +D+  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
            N  VH D+   NVL+ ED VA++ DFG+ K  S  +          + + APE  RE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALREKK 176

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
            ST+ DV+SFGI+L EI++  R        +  + R       
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-51
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 12/231 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
           + + V   IG+GS+G   + R   DG  +  K        E   +   +E  +LR ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 683 NLVRIISSCT--NDDFKALVLDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALE 737
           N+VR         +    +V++Y   G L + +     +   LD    L ++  + LAL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 738 YLHFGHP--NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
             H      + V+H D+KP+NV LD     +LGDFG+A++L+ D S        T  YM+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMS 182

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
           PE       + + D++S G +L E+     P       E+   +       
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFR 232

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (452), Expect = 6e-51
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 6/232 (2%)

Query: 614 RRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAE 672
              +Y +         + + +G G +G VY G +    + VA+K         +E F  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 673 CEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVID 731
             V++ I+H NLV+++  CT +    ++ ++M  G+L   L   N   +     L +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           I+ A+EYL        +H D+   N L+ E+ + ++ DFG+++L++GD    H      I
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVND 843
            + APE     + S + DV++FG++L EI T               +    D
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-51
 Identities = 55/234 (23%), Positives = 109/234 (46%), Gaps = 10/234 (4%)

Query: 622 LQATDQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIR 680
           L   D + +   +G G+FG VY+ +  +  +  A KV   + E  LE +  E ++L S  
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N+V+++ +   ++   +++++   G+++A +      L   +   +      AL YLH
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY-- 798
               N ++H D+K  N+L   D   +L DFG++   +     + +    T  +MAPE   
Sbjct: 128 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183

Query: 799 ---GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
               ++     + DV+S GI L+E+   + P  E+    + LK   ++   ++ 
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-49
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 8/228 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL-QLEGALESFNAECEVLRSIRHRN 683
           + +++   +G G++G V           VA+K+  + +     E+   E  + + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +V+        + + L L+Y   G L   +   +  +           +   + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPEYGREG 802
              + H DIKP N+LLDE    ++ DFG+A +   +   +    +  T+ Y+APE  +  
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 803 QISTEG-DVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
           +   E  DV+S GI+L  +   + P D+          W      ++ 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-49
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 14/230 (6%)

Query: 628 FNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNL 684
              +  IG GSF +VY+G   +  +EVA      +   +   + F  E E+L+ ++H N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 685 VRIISSC----TNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           VR   S            LV + M  G+L+  L      + I    +    I   L++LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 129

Query: 741 FGHPNPVVHCDIKPSNVLL-DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
              P P++H D+K  N+ +       ++GD G+A L     +      + T  +MAPE  
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM- 184

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
            E +     DVY+FG+ ++E+ T + P  E  +     +R  +   P S 
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 7e-49
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 12/232 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG-----MEVAIKVFHLQL-EGALESFNAECEVLRSI 679
                  +IG+G FG VY+G          + VAIK       E     F  E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYL 739
            H N++R+    +      ++ +YM  G+L+  L   +    + + + ++  IA     +
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA---AGM 123

Query: 740 HFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA--TIGYMAPE 797
            +      VH D+   N+L++ ++V ++ DFG++++L  D    +T +     I + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
                + ++  DV+SFGI++ E+ T         S    + + +ND   +  
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPT 234

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (438), Expect = 1e-48
 Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 16/230 (6%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL---QLEGALESFNAECEVLRSIR 680
              F+    IG GSFG+VY  R + +   VAIK       Q     +    E   L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H N ++       +    LV++Y    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH 132

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY-- 798
               + ++H D+K  N+LL E  + +LGDFG A +++   S      + T  +MAPE   
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVIL 184

Query: 799 -GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPI 847
              EGQ   + DV+S GI  +E+  RK P   + +         N+S  +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-48
 Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 12/203 (5%)

Query: 631 NNLIGSGSFGSVYRGRFLD---GMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLV 685
           +  +GSG+FG+V +G +        VA+K+   +       +   AE  V++ + +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
           R+I  C  + +  LV++    G L   L   N ++     + +V  +++ ++YL     +
Sbjct: 72  RMIGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---S 126

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA--TIGYMAPEYGREGQ 803
             VH D+   NVLL     A++ DFG++K L  DE+    QT     + + APE     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 804 ISTEGDVYSFGIMLMEIFTRKRP 826
            S++ DV+SFG+++ E F+  + 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK 209

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 7/226 (3%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRN 683
             ++     IG G+ G+VY    +  G EVAI+  +LQ +   E    E  V+R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +V  + S    D   +V++Y+  GSL   +     +    +   +  +   ALE+L   H
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFL---H 133

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
            N V+H DIK  N+LL  D   +L DFG    ++ ++S K +  + T  +MAPE      
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA 192

Query: 804 ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
              + D++S GIM +E+   + P               N +  +  
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-48
 Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 20/233 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFH---LQLEGALESFNAECEVLRSIRH 681
           + F +   +G G FG+VY  R       +A+KV     L+  G       E E+   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
            N++R+     +     L+L+Y P G++   L    S  D  +    + ++A AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS 124

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                V+H DIKP N+LL      ++ DFG +                T+ Y+ PE    
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG---TLDYLPPEMIEG 178

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRPTD---------EIFSGEMSLKRWVNDSL 845
                + D++S G++  E    K P +          I   E +   +V +  
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 3e-48
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 18/237 (7%)

Query: 623 QATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVF---HLQLEGALESFNAECEVLRS 678
           +  + F    ++G GSF +V   R L    E AIK+    H+  E  +     E +V+  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + H   V++  +  +D+     L Y   G L   +    S    F         A  +  
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSA 120

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIGYMAPE 797
           L + H   ++H D+KP N+LL+EDM  ++ DFG AK+LS +       +   T  Y++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 798 YGREGQISTEGDVYSFGIMLMEIFTRKRP---------TDEIFSGEMSLKRWVNDSL 845
              E       D+++ G ++ ++     P           +I   E           
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  172 bits (436), Expect = 6e-48
 Identities = 46/204 (22%), Positives = 92/204 (45%), Gaps = 8/204 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           D ++++  +G+G+FG V+R      G   A K      E   E+   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           V +  +  +D+   ++ ++M  G L   +  +++ +   + +  +  +   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--- 142

Query: 745 NPVVHCDIKPSNVLL--DEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           N  VH D+KP N++         +L DFG+   L   +S+K T    T  + APE     
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
            +    D++S G++   + +   P
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSP 224

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-48
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 9/226 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIR 680
           ++  +   IG G FG V++G ++      + VAIK       +   E F  E   +R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H ++V++I   T ++   ++++    G L + L     +LD+   +     ++ AL YL 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                  VH DI   NVL+  +   +LGDFG+++ +      K ++    I +MAPE   
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
             + ++  DV+ FG+ + EI        +       + R  N    
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-47
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 12/207 (5%)

Query: 629 NVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFH-LQLEGALESFNAECEVLRSIRHRN 683
           + N +IG G FG VY G  LD     +  A+K  + +   G +  F  E  +++   H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 684 LVRIISSCTNDDFKA-LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           ++ ++  C   +    +VL YM  G L   + ++  N  +   +   + +A  +    F 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFL 146

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH---TQTLATIGYMAPEYG 799
                VH D+   N +LDE    ++ DFG+A+ +   E       T     + +MA E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRP 826
           +  + +T+ DV+SFG++L E+ TR  P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP 233

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-46
 Identities = 56/255 (21%), Positives = 103/255 (40%), Gaps = 34/255 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRS 678
           +      ++GSG+FG V              ++VA+K+   +      E+  +E +++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 679 I-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS---------------------- 715
           +  H N+V ++ +CT      L+ +Y   G L   L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 716 DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
           D + L     L     +A  +E+L F      VH D+   NVL+    V ++ DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 776 LSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
           +  D +          + +MAPE   EG  + + DV+S+GI+L EIF+           +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 835 MSLKRWVNDSLPISI 849
            +  + + +   +  
Sbjct: 274 ANFYKLIQNGFKMDQ 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-46
 Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 22/235 (9%)

Query: 634 IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN 693
           IG G FG V+RG+   G EVA+K+F  + E +     AE      +RH N++  I++   
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 694 DDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH-----FGHP 744
           D+       LV DY   GSL   L  +   + +   + + +  A  L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 745 NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE---SMKHTQTLATIGYMAPEY--- 798
             + H D+K  N+L+ ++    + D G+A           +     + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 799 ---GREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISIM 850
               +  +     D+Y+ G++  EI  R          ++     V     +  M
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 7e-46
 Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 13/233 (5%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL---EGALESFNAECEVLRS 678
               +   +G GSFG V RG +       + VA+K     +     A++ F  E   + S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           + HRNL+R+         K +V +  P GSL   L     +  +       + +A  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA--TIGYMAP 796
           L        +H D+   N+LL    + ++GDFG+ + L  ++     Q        + AP
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
           E  +    S   D + FG+ L E+FT  +      +G   L +   +   +  
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 8e-46
 Identities = 55/252 (21%), Positives = 101/252 (40%), Gaps = 34/252 (13%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRS 678
           +       IG G+FG V++ R            VA+K+   +        F  E  ++  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSN------------------- 719
             + N+V+++  C       L+ +YM  G L   L S + +                   
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 720 ----LDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL 775
               L   ++L I   +A  + YL        VH D+   N L+ E+MV ++ DFG+++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 776 LSGDESMKHTQTLA-TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGE 834
           +   +  K     A  I +M PE     + +TE DV+++G++L EIF+         + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 835 MSLKRWVNDSLP 846
             +    + ++ 
Sbjct: 250 EVIYYVRDGNIL 261

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  165 bits (419), Expect = 1e-45
 Identities = 43/204 (21%), Positives = 93/204 (45%), Gaps = 8/204 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           D +++   +GSG+FG V+R      G     K  +        +   E  ++  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           + +  +  +     L+L+++  G L   + +++  +   + +N +      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--- 145

Query: 745 NPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           + +VH DIKP N++ +  +    ++ DFG+A  L+ DE +K T    T  + APE     
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDRE 203

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
            +    D+++ G++   + +   P
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSP 227

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 12/214 (5%)

Query: 620 ELLQATDQFNVNNLIGSGSFGSVYRGRFLD-----GMEVAIKVFHLQL-EGALESFNAEC 673
            +L+ T+ F    ++GSG+FG+VY+G ++       + VAIK         A +    E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 674 EVLRSIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIA 733
            V+ S+ + ++ R++  C     + L+   MP G L   +     N+     LN  + IA
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 734 LALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLA-TIG 792
             + YL       +VH D+   NVL+      ++ DFG+AKLL  +E   H +     I 
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 793 YMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           +MA E       + + DV+S+G+ + E+ T    
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-45
 Identities = 51/250 (20%), Positives = 98/250 (39%), Gaps = 29/250 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHL-QLEGALESFNAECEVLRS 678
           ++ +    +G+G+FG V              M VA+K+          E+  +E +VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 679 I-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY-----------------SDNSNL 720
           +  H N+V ++ +CT      ++ +Y   G L   L                   D   L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 721 DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE 780
           D+   L+    +A  + +L        +H D+   N+LL    + ++ DFG+A+ +  D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 781 S-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
           + +        + +MAPE       + E DV+S+GI L E+F+           +    +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 840 WVNDSLPISI 849
            + +   +  
Sbjct: 260 MIKEGFRMLS 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-44
 Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 25/241 (10%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDG---MEVAIKVFHLQL-EGALESFNAECEVLRSI-R 680
           +     ++IG G+FG V + R       M+ AIK       +     F  E EVL  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLE---------------ACLYSDNSNLDIFKR 725
           H N++ ++ +C +  +  L ++Y P G+L                A   S  S L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 726 LNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT 785
           L+   D+A  ++YL        +H D+   N+L+ E+ VA++ DFG+++    +  +K T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184

Query: 786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSL 845
                + +MA E       +T  DV+S+G++L EI +         +     ++      
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 846 P 846
            
Sbjct: 245 L 245

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 6e-43
 Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 20/238 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRF------LDGMEVAIKVFHL-QLEGALESFNAECEVLRS 678
           ++  ++  +G GSFG VY G             VAIK  +          F  E  V++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLY---------SDNSNLDIFKRLNIV 729
               ++VR++   +      ++++ M +G L++ L             +   + K + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 730 IDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL-SGDESMKHTQTL 788
            +IA  + YL+    N  VH D+   N ++ ED   ++GDFG+ + +   D   K  + L
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 789 ATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLP 846
             + +M+PE  ++G  +T  DV+SFG++L EI T      +  S E  L+  +   L 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (389), Expect = 2e-42
 Identities = 52/234 (22%), Positives = 107/234 (45%), Gaps = 14/234 (5%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIR 680
           +D++ +  ++G G    V+  R L    +VA+KV    L         F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 681 HRNLVRIISSCTNDDFKA----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           H  +V +  +   +        +V++Y+   +L   ++++   +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL--SGDESMKHTQTLATIGYM 794
            + H    N ++H D+KP+N+++      ++ DFGIA+ +  SG+   +    + T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPIS 848
           +PE  R   +    DVYS G +L E+ T + P        ++ +    D +P S
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 21/233 (9%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRH 681
             F +   +G+GSFG V+  R   +G   A+KV   ++      +E  N E  +L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             ++R+  +  +     +++DY+  G     L   +             ++ LALEYLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+LLD++   ++ DFG AK +             T  Y+APE    
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST 175

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP---------TDEIFSGEMSLKRWVNDSL 845
              +   D +SFGI++ E+     P          ++I + E+    + N+ +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 5/204 (2%)

Query: 625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQ-LEGALESFNAECEVLRSIRHR 682
            D ++  +++G+G+F  V           VAIK    + LEG   S   E  VL  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V +     +     L++  +  G L   +  +           ++  +  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
                           LDED    + DFG++K+   D     +    T GY+APE   + 
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQK 184

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             S   D +S G++   +     P
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPP 208

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 5e-41
 Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 29/247 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL--------DGMEVAIKVFHLQL-EGALESFNAECEVL 676
           D+  +   +G G+FG V     +           +VA+K+      E  L    +E E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 677 RSI-RHRNLVRIISSCTNDDFKALVLDYMPKGSLEACL---------------YSDNSNL 720
           + I +H+N++ ++ +CT D    ++++Y  KG+L   L               ++    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 721 DIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE 780
                ++    +A  +EYL        +H D+   NVL+ ED V ++ DFG+A+ +   +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 781 SMKHTQTLA-TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR 839
             K T      + +MAPE   +   + + DV+SFG++L EIFT           E   K 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 840 WVNDSLP 846
                  
Sbjct: 250 LKEGHRM 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 23/218 (10%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL---------QLEGALESFNAECEV 675
           + +    ++G G    V R        E A+K+  +         +++   E+   E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 676 LRSIR-HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           LR +  H N++++  +   + F  LV D M KG L   L ++   L   +   I+  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYM 794
            +  LH      +VH D+KP N+LLD+DM  +L DFG +  L  D   K  +   T  Y+
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYL 176

Query: 795 APEYGREGQ------ISTEGDVYSFGIMLMEIFTRKRP 826
           APE               E D++S G+++  +     P
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-40
 Identities = 40/204 (19%), Positives = 89/204 (43%), Gaps = 9/204 (4%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           +++ +   +G G FG V+R            K   ++          E  +L   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           + +  S  + +   ++ +++    +   + +    L+  + ++ V  +  AL++LH    
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--- 120

Query: 745 NPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
           + + H DI+P N++         ++ +FG A+ L   ++ +   T     Y APE  +  
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHD 178

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
            +ST  D++S G ++  + +   P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 7e-40
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 10/206 (4%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFH---LQLEGALESFNAECEVL-RSIR 680
           + F ++ ++G GSFG V+   F       AIK      + ++  +E    E  VL  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 681 HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLH 740
           H  L  +  +    +    V++Y+  G L   + S     D+ +      +I L L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120

Query: 741 FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGR 800
                 +V+ D+K  N+LLD+D   ++ DFG+ K     ++ K      T  Y+APE   
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILL 176

Query: 801 EGQISTEGDVYSFGIMLMEIFTRKRP 826
             + +   D +SFG++L E+   + P
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  148 bits (374), Expect = 1e-39
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 15/232 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHL------QLEGALESFNAECEVLRS 678
           + F+V+ +IG G FG VY  R  D G   A+K          Q E    +      ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
                +V +  +    D  + +LD M  G L   L S +             +I L LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
           +H      VV+ D+KP+N+LLDE    R+ D G+A   S  +      ++ T GYMAPE 
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176

Query: 799 GREGQ-ISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
            ++G    +  D +S G ML ++     P  +  + +      +  ++ + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 228

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 5e-39
 Identities = 45/204 (22%), Positives = 89/204 (43%), Gaps = 6/204 (2%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
           + F     IG G++G VY+ R    G  VA+K   L    EG   +   E  +L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+V+++     ++   LV +++ +   +    S  + + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
             + V+H D+KP N+L++ +   +L DFG+A+           + +              
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             ST  D++S G +  E+ TR+  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL 202

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  143 bits (362), Expect = 8e-39
 Identities = 41/203 (20%), Positives = 86/203 (42%), Gaps = 6/203 (2%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRN 683
           ++++    IG G++G VY+ +   G   A+K   L+   EG   +   E  +L+ ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 684 LVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGH 743
           +V++           LV +++    L+  L      L+     + ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-- 118

Query: 744 PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQ 803
              V+H D+KP N+L++ +   ++ DFG+A+           + +              +
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 804 ISTEGDVYSFGIMLMEIFTRKRP 826
            ST  D++S G +  E+      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 17/212 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL------EGALESFNAECEVLRS 678
           D ++    +GSG F  V + R    G++ A K    +         + E    E  +L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 679 IRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEY 738
           I+H N++ +     N     L+L+ +  G L     ++  +L   +    +  I   +  
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGV-- 126

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVAR----LGDFGIAKLLSGDESMKHTQTLATIGYM 794
            ++ H   + H D+KP N++L +  V +    + DFG+A  +  D   +      T  ++
Sbjct: 127 -YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFV 183

Query: 795 APEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           APE      +  E D++S G++   + +   P
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 3e-38
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 10/214 (4%)

Query: 620 ELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFH-LQLEGALESFNAECEVLR 677
           ++     ++   + IG G++G V       + + VAIK     + +   +    E ++L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 678 SIRHRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYS--DNSNLDIFKRLNIVIDIALA 735
             RH N++ I         + +   Y+    + A LY      +L        +  I   
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 736 LEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQT--LATIGY 793
           L+Y+H      V+H D+KPSN+LL+     ++ DFG+A++   D       T  +AT  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 794 MAPEYGREGQISTE-GDVYSFGIMLMEIFTRKRP 826
            APE     +  T+  D++S G +L E+ + +  
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 5e-38
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 632 NLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-----EGALESFNAECEVLRSIRHRNLV 685
           + +G G F +VY+ R       VAIK   L       +G   +   E ++L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 686 RIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPN 745
            ++ +  +    +LV D+M    LE  +  ++  L        ++     LEYLH    +
Sbjct: 64  GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPE-YGREGQI 804
            ++H D+KP+N+LLDE+ V +L DFG+AK   G  +  +T  + T  Y APE        
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 805 STEGDVYSFGIMLMEIFTRKRP 826
               D+++ G +L E+  R   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPF 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 6e-38
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 20/234 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL------EGALESFNAECEVLRS 678
            Q+ V  L+GSG FGSVY G  + D + VAIK                     E  +L+ 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 679 IR--HRNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           +      ++R++      D   L+L+            ++   L      +    +  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
            + H      V+H DIK  N+L+D +    +L DFG   LL       +T    T  Y  
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 177

Query: 796 PEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRP---TDEIFSGEMSLKRWVNDSL 845
           PE+ R  +       V+S GI+L ++     P    +EI  G++  ++ V+   
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 48/234 (20%), Positives = 91/234 (38%), Gaps = 15/234 (6%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
           +++ +   IGSGSFG +Y G  +  G EVAIK+  ++ +      + E ++ + ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  I  C  +    +++  +   SLE      +    +   L +   +   +EY+H    
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 121

Query: 745 NPVVHCDIKPSNVL---LDEDMVARLGDFGIAKLLSGDESMKH------TQTLATIGYMA 795
              +H D+KP N L     +  +  + DFG+AK      + +H           T  Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
                  + S   D+ S G +LM       P   + +     K        +S 
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 2e-37
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 17/215 (7%)

Query: 624 ATDQFNVNNLIGSGSFGSVYRGRFL--DGMEVAIKVFHLQL--EGALESFNAECEVLR-- 677
           A  Q+     IG G++G V++ R L   G  VA+K   +Q   EG   S   E  VLR  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 678 -SIRHRNLVRIISSCTNDDFKA-----LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
            +  H N+VR+   CT           LV +++ +             +      +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATI 791
           +   L++LH    + VVH D+KP N+L+      +L DFG+A++      M  T  + T+
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTL 179

Query: 792 GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
            Y APE   +   +T  D++S G +  E+F RK  
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 51/249 (20%), Positives = 98/249 (39%), Gaps = 28/249 (11%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHL-QLEGALESFNAECEVLRS 678
           D+  +   +G G+FG V                VA+K+           +  +E ++L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 679 IRHR-NLVRIISSCTNDDFK-ALVLDYMPKGSLEACLYSDNSN---------------LD 721
           I H  N+V ++ +CT       +++++   G+L   L S  +                L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 722 IFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES 781
           +   +     +A  +E+L        +H D+   N+LL E  V ++ DFG+A+ +  D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 782 MKHTQTLA-TIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRW 840
                     + +MAPE   +   + + DV+SFG++L EIF+           +    R 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 841 VNDSLPISI 849
           + +   +  
Sbjct: 250 LKEGTRMRA 258

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 1e-36
 Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 7/204 (3%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
            ++     IG G++G+V++ +       VA+K   L    EG   S   E  +L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 683 NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG 742
           N+VR+     +D    LV ++  +   +    S N +LD     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119

Query: 743 HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREG 802
               V+H D+KP N+L++ +   +L +FG+A+           + +              
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 803 QISTEGDVYSFGIMLMEIFTRKRP 826
             ST  D++S G +  E+    RP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP 201

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-35
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 18/211 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
             +    +IG+GSFG VY+ +  D G  VAIK             N E +++R + H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNI 75

Query: 685 VRIISSCT------NDDFKALVLDYMPKGSLEACLYSDNSN--LDIFKRLNIVIDIALAL 736
           VR+           ++ +  LVLDY+P+       +   +   L +      +  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDED-MVARLGDFGIAKLLSGDESMKHTQTLATIGYMA 795
            Y+   H   + H DIKP N+LLD D  V +L DFG AK L   E    +   +      
Sbjct: 136 AYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAP 191

Query: 796 PEYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
                    ++  DV+S G +L E+   +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-35
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 20/207 (9%)

Query: 630 VNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVL-RSIRHRNLVRI 687
            + ++G G  G V +        + A+K+              E E+  R+ +  ++VRI
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 70

Query: 688 ISSC----TNDDFKALVLDYMPKGSLEACLYSDNSN-LDIFKRLNIVIDIALALEYLHFG 742
           +              +V++ +  G L + +           +   I+  I  A++YLH  
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 743 HPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYG 799
               + H D+KP N+L      + + +L DFG AK  +   S+       T  Y+APE  
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 800 REGQISTEGDVYSFGIMLMEIFTRKRP 826
              +     D++S G+++  +     P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 4e-35
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 9/205 (4%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRH 681
           + F+   L+G G+FG V   R    G   A+K+   ++   +  +     E  VL++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             L  +  +    D    V++Y   G L   L  +     +F         A  +  L +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
            H   VV+ DIK  N++LD+D   ++ DFG+ K    D +   T    T  Y+APE   +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP 826
                  D +  G+++ E+   + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 9e-35
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 19/216 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
            ++     IG G+FG V++ R    G +VA+K   ++   EG   +   E ++L+ ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 683 NLVRIISSCTNDDFKA--------LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIAL 734
           N+V +I  C               LV D+                L  F    I   + +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125

Query: 735 ALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES---MKHTQTLATI 791
            L  L++ H N ++H D+K +NVL+  D V +L DFG+A+  S  ++    ++T  + T+
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 792 GYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRP 826
            Y  PE     +      D++  G ++ E++TR   
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (334), Expect = 2e-34
 Identities = 53/239 (22%), Positives = 98/239 (41%), Gaps = 21/239 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRH 681
           DQF+    +G+GSFG V   +    G   A+K+   Q       +E    E  +L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 682 RNLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHF 741
             LV++  S  ++    +V++Y+  G + + L                  I L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 742 GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGRE 801
                +++ D+KP N+L+D+    ++ DFG AK        +      T   +APE    
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILS 212

Query: 802 GQISTEGDVYSFGIMLMEIFTRKRP---------TDEIFSGEMSLKRWVNDSLPISIMN 851
              +   D ++ G+++ E+     P          ++I SG++      +  L   + N
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-34
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 15/212 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFH----LQLEGALESFNAECEVLR 677
           + F +  ++G+G++G V+  R +     G   A+KV      +Q     E    E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 678 SIRHR-NLVRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
            IR    LV +  +   +    L+LDY+  G L   L         F    + I +   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
             L   H   +++ DIK  N+LLD +    L DFG++K    DE+ +      TI YMAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 797 EYGREGQ--ISTEGDVYSFGIMLMEIFTRKRP 826
           +  R G        D +S G+++ E+ T   P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (325), Expect = 8e-34
 Identities = 39/215 (18%), Positives = 72/215 (33%), Gaps = 17/215 (7%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL 684
             + V   IG GSFG ++ G  L +  +VAIK    + +        E    + +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 685 VRIISSCTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP 744
           +  +     +    +++  +   SLE  L        +         +   ++ +H    
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119

Query: 745 NPVVHCDIKPSNVLLDEDMV-----ARLGDFGIAKLLSGDESMKHTQT------LATIGY 793
             +V+ DIKP N L+            + DFG+ K      + +H           T  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 794 MAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTD 828
           M+       + S   D+ + G + M       P  
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 3e-32
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 24/225 (10%)

Query: 616 FSYQELLQAT----DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALES 668
           F  QE+ +        +     +GSG++G+V        G +VAIK  +     E   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 669 FNAECEVLRSIRHRNLVRIISSCTNDDFKA------LVLDYMPKGSLEACLYSDNSNLDI 722
              E  +L+ +RH N++ ++   T D+         LV+ +M     +      +  L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120

Query: 723 FKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM 782
            +   +V  +   L Y+H        H D+KP N+ ++ED   ++ DFG+A+        
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS---- 173

Query: 783 KHTQTLATIGYMAPE-YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           + T  + T  Y APE      + +   D++S G ++ E+ T K  
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (306), Expect = 6e-31
 Identities = 47/231 (20%), Positives = 99/231 (42%), Gaps = 18/231 (7%)

Query: 602 SNIQANMPLVAWRRFSYQELLQATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHL 660
           +++  + P   W   S+       D + +   +G G +  V+    + +  +V +K+   
Sbjct: 11  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 70

Query: 661 QLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFK--ALVLDYMPKGSLEACLYSDN 717
             +   +    E ++L ++R   N++ +     +   +  ALV +++     +       
Sbjct: 71  VKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---- 123

Query: 718 SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLL 776
             L  +     + +I  AL+Y H      ++H D+KP NV++D E    RL D+G+A+  
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

Query: 777 SGDESMKHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRP 826
              +  ++   +A+  +  PE   + Q      D++S G ML  +  RK P
Sbjct: 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-29
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 20/223 (8%)

Query: 616 FSYQELLQA----TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALES 668
           F  QEL +      +++   + +GSG++GSV        G+ VA+K            + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 669 FNAECEVLRSIRHRNLVRIISSCTND----DFKALVLDYMPKGSLEACLYSDNSNLDIFK 724
              E  +L+ ++H N++ ++   T      +F  + L     G+    +      L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDH 122

Query: 725 RLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH 784
              ++  I   L+Y+H      ++H D+KPSN+ ++ED   ++ DFG    L+     + 
Sbjct: 123 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEM 175

Query: 785 TQTLATIGYMAPE-YGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           T  +AT  Y APE        +   D++S G ++ E+ T +  
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-29
 Identities = 42/210 (20%), Positives = 84/210 (40%), Gaps = 18/210 (8%)

Query: 626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHR 682
            ++     IGSG+ G V           VAIK        +   +    E  +++ + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 683 NLVRIISSCTNDDFK------ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALAL 736
           N++ +++  T            LV++ M     +      +      +   ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQMLCGI 132

Query: 737 EYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAP 796
           ++LH       +H D+KPSN+++  D   ++ DFG+A+  +   S   T  + T  Y AP
Sbjct: 133 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187

Query: 797 EYGREGQISTEGDVYSFGIMLMEIFTRKRP 826
           E           D++S G ++ E+   K  
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (279), Expect = 3e-27
 Identities = 44/242 (18%), Positives = 88/242 (36%), Gaps = 25/242 (10%)

Query: 628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVR 686
           + +   +G G F +V+  + + +   VA+K+     +   E+   E ++L+ +   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTK 73

Query: 687 IISSCTNDDFK---------------ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVID 731
             S   N   K                +V + + +  L      ++  + +     I   
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 732 IALALEYLHFGHPNPVVHCDIKPSNVLLD-EDMVARLGDFGIAKLLSGDESMKHTQTLAT 790
           + L L+Y+H      ++H DIKP NVL++  D    L    IA L +     +H      
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 791 I-GYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKRWVNDSLPISI 849
              Y +PE           D++S   ++ E+ T        F  +       +D     I
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQI 247

Query: 850 MN 851
           + 
Sbjct: 248 IE 249

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  100 bits (249), Expect = 3e-23
 Identities = 79/386 (20%), Positives = 142/386 (36%), Gaps = 28/386 (7%)

Query: 134 NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLA 193
            L       L   N+   V  +  ++  +  LQ     +  SI     L   NL   + +
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGVEYL--NNLTQINFS 74

Query: 194 NNNFSGKIPSFIFNASKL-SICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHEL 252
           NN  +   P  + N +KL  I    +            N+  L   N +   I    +  
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 253 SFISSLANSKKLKVLSLTG-----NPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKE 307
           +      +S  +  +S          L      + +  L+       L   + + S    
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYL 367
           +  L NL  +    N+++   P  +     L  L L  NQL+   +  +  L  L+ + L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 368 DHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI 427
            +N++S   P     L  L +L   +N+++ +      LT +  ++L+ N L       I
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLED--ISPI 303

Query: 428 GNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLS 487
            NLK L  L L  NN+S   P  +  L  LQ L   +N +     +S+ +L ++  L   
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 488 NNILSGIIPSSLEKLLYLKYLNVSFN 513
           +N +S + P  L  L  +  L ++  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 93.9 bits (232), Expect = 5e-21
 Identities = 81/391 (20%), Positives = 144/391 (36%), Gaps = 29/391 (7%)

Query: 57  FPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTS 116
           F    ++      L    ++  +       +  +Q   L      G     +  L +LT 
Sbjct: 16  FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQ 70

Query: 117 IDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI 176
           I+ S N L    P  + NL  L  + + +N +  + P       T   L     T    +
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 177 SSSIRLALPNLELFSL------ANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFH 230
            +   L    L   ++      +      ++           +  L          N+  
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 231 NMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSM 290
           ++  L +L    + I ++N  +S I+ L     L  LSL GN L D     ++ +L+ ++
Sbjct: 189 DISVLAKLTNLESLIATNNQ-ISDITPLGILTNLDELSLNGNQLKD---IGTLASLT-NL 243

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEG 350
               L N  I    P  +  L  L  ++LG N+++   P              E N+ + 
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQL 297

Query: 351 RILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNIL 410
             +  I  L  L+ + L  N +S   P    +L  L++L FA+N+++ V S   NLTNI 
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS-LANLTNIN 354

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRN 441
            +    N +S   PL   NL  + +L L+  
Sbjct: 355 WLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 91.6 bits (226), Expect = 3e-20
 Identities = 76/380 (20%), Positives = 140/380 (36%), Gaps = 38/380 (10%)

Query: 110 NLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTN 169
           +L  +T++      +  +    +  L NL  +   +N L  + P  L N++ L  + + N
Sbjct: 42  DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97

Query: 170 NTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRF 229
           N                        +       + +   +  +      +          
Sbjct: 98  NQ---------------------IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136

Query: 230 HNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS 289
             + +    ++      +S  +LSF + + + K L  L+      +     S I  L+  
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196

Query: 290 MERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLE 349
                L   N + S    +G L NL  + L  N+L      TL+ L  L  L L NNQ+ 
Sbjct: 197 TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 254

Query: 350 GRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
              L  +  L +L+ + L  N++S   P     L +L  L    N+     S   NL N+
Sbjct: 255 N--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ-LEDISPISNLKNL 309

Query: 410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG 469
             + L  N +S   P  + +L  L  L+ + N +S    +++  L N+  LS G N +  
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365

Query: 470 SIPNSIGDLISLECLDLSNN 489
             P  + +L  +  L L++ 
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.9 bits (219), Expect = 2e-19
 Identities = 74/392 (18%), Positives = 141/392 (35%), Gaps = 40/392 (10%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR 74
           +L+      L    +  T+  +   ++ +  L      +        +++L  I+ S+N+
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQ 77

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPH---- 130
           L+   P      L  +  + +  NQ A   P       +  ++  ++   +  + +    
Sbjct: 78  LTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 131 --------EIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
                    I ++  L  L  L     G     L  ++ L  L+  + + +     S+  
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
            L NLE     NN  S   P  I   + L    L  N           ++ NL +L+L  
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 243 NYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRG 302
           N I++       ++ L+   KL  L L  N + +    S +  L+         N     
Sbjct: 251 NQISN-------LAPLSGLTKLTELKLGANQISNI---SPLAGLTALTNLELNENQLED- 299

Query: 303 SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARL 362
                + NL NL  + L +N ++   P  +S L KLQ L   NN++    +  +  L  +
Sbjct: 300 --ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASN 394
           + +   HN++S   P    NL  + +L     
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.3 bits (150), Expect = 8e-11
 Identities = 17/66 (25%), Positives = 35/66 (53%), Gaps = 2/66 (3%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
           +  S + SL+ LQ L  + N++  +  SS+ ++  +  L   +NQ+S   P  N++ +  
Sbjct: 320 SDISPVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQ 377

Query: 68  IDLSDN 73
           + L+D 
Sbjct: 378 LGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 8e-04
 Identities = 16/68 (23%), Positives = 25/68 (36%), Gaps = 4/68 (5%)

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSF 512
            L       LG  N+  ++  +  DL  +  L      +  I    +E L  L  +N S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 513 NRLEGEIP 520
           N+L    P
Sbjct: 76  NQLTDITP 83

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.8 bits (222), Expect = 4e-21
 Identities = 27/201 (13%), Positives = 61/201 (30%), Gaps = 24/201 (11%)

Query: 630 VNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL----------EGALESFNAECEVLRSI 679
           +  L+G G   +V+        E  +K   +            +     F+         
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 680 RHRNLVRIISSCTNDDFKALVLDYMPKGSL-EACLYSDNSNLDIFKRLNIVIDIALALEY 738
             R L ++        +      +     L E     +   + +     ++  I   +  
Sbjct: 64  EFRALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 739 LHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEY 798
               +   +VH D+   NVL+ E+ +  + DF  +  +   E          +  +   +
Sbjct: 119 F---YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV--GEEGWREILERDVRNIITYF 172

Query: 799 GREGQISTEGDVYSFGIMLME 819
            R     TE D+ S    +++
Sbjct: 173 SRTY--RTEKDINSAIDRILQ 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 88.3 bits (217), Expect = 2e-19
 Identities = 71/296 (23%), Positives = 113/296 (38%), Gaps = 28/296 (9%)

Query: 256 SSLANSKKLKVLSLTGNPL-LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINL 314
            +   + ++  L L+G  L     +PSS+ NL      +     N+ G IP  +  L  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 315 IIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSG 374
             + + +  ++G+IP  LS+++ L  L    N L G +   I  L  L  +  D N++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 375 SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLV 434
           +IP  +G+ + L      S                L     S  +       +       
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 435 ELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
           +      N        +G  KNL  L L +N + G++P  +  L  L  L++S N L   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-- 281

Query: 495 IPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPHLQVPPC 550
                                 GEIP+GG L  F   ++  N  LCGSP   +P C
Sbjct: 282 ----------------------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.0 bits (193), Expect = 2e-16
 Identities = 49/259 (18%), Positives = 84/259 (32%), Gaps = 21/259 (8%)

Query: 109 GNLTSLTSIDLSENHLMG--EIPHEIGNLRNLQALGLLSN-NLVGVVPATLFNISTLKIL 165
                + ++DLS  +L     IP  + NL  L  L +    NLVG +P  +  ++ L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 166 QLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFI 225
            +T+              +  L     + N  SG +P  I +   L       N  SG I
Sbjct: 107 YITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 226 PNRFHNMRNLKELNLEYN----------------YITSSNHELSFISSLANSKKLKVLSL 269
           P+ + +   L                             +  +    +       K    
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 270 TGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIP 329
                           LS ++    L N  I G++P+ +  L  L  + + +N L G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 330 STLSRLEKLQILGLENNQL 348
                L++  +    NN+ 
Sbjct: 286 Q-GGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 1e-13
 Identities = 52/278 (18%), Positives = 89/278 (32%), Gaps = 10/278 (3%)

Query: 150 GVVPATLFNISTLKILQLTNNTLSGSISSSIRLA-LPNLELFSLANN-NFSGKIPSFIFN 207
           GV+  T      +  L L+   L         LA LP L    +    N  G IP  I  
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 208 ASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVL 267
            ++L    +   + SG IP+    ++ L  L+  YN         +   S+++   L  +
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN-----ALSGTLPPSISSLPNLVGI 154

Query: 268 SLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGS 327
           +  GN +   +  S      L        N   R +           +        +   
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGKIPPTFANLNLAFVDLSRNMLEG 211

Query: 328 IPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR 387
             S L   +K               L  +     L+ + L +N++ G++P     L  L 
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL 425
            L+ + N L        NL    +   ++N      PL
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 1e-13
 Identities = 53/276 (19%), Positives = 94/276 (34%), Gaps = 16/276 (5%)

Query: 6   TGTVPSQLGSLSSLQYLDLSFNQLLG--TIPSSIFSINTLEILDLSNNQ---LSGSFPFF 60
            G +         +  LDLS   L     IPSS+ ++  L  L +               
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS 120
            ++ L  + ++   +SG +P  +      V      +N  +G LP  I +L +L  I   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS-YNALSGTLPPSISSLPNLVGITFD 157

Query: 121 ENHLMGEIPHEIGNLRNLQA-LGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSS 179
            N + G IP   G+   L   + +  N L G +P T  N++   +    N     +    
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF 217

Query: 180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELN 239
                           N        +  +  L+  +L +N   G +P     ++ L  LN
Sbjct: 218 GSDKNTQKIHL---AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 240 LEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLL 275
           + +N +         I    N ++  V +   N  L
Sbjct: 275 VSFNNLCGE------IPQGGNLQRFDVSAYANNKCL 304

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.5 bits (145), Expect = 2e-10
 Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 1/65 (1%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP-FFNMSSLQVIDLSDNRL 75
            +L  LDL  N++ GT+P  +  +  L  L++S N L G  P   N+    V   ++N+ 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303

Query: 76  SGELP 80
               P
Sbjct: 304 LCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.0 bits (141), Expect = 7e-10
 Identities = 17/54 (31%), Positives = 27/54 (50%), Gaps = 1/54 (1%)

Query: 5   LTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP 58
           + GT+P  L  L  L  L++SFN L G IP    ++   ++   +NN+     P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 39/184 (21%), Positives = 66/184 (35%), Gaps = 2/184 (1%)

Query: 19  LQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGE 78
           L  LD S+N L GT+P SI S+  L  +    N++SG+ P    S  ++        +  
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186

Query: 79  LPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNL 138
                 ++                     +      T       + +     ++G  +NL
Sbjct: 187 TGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246

Query: 139 QALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS 198
             L L +N + G +P  L  +  L  L ++ N L G I       L   ++ + ANN   
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN--LQRFDVSAYANNKCL 304

Query: 199 GKIP 202
              P
Sbjct: 305 CGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.8 bits (216), Expect = 2e-19
 Identities = 47/261 (18%), Positives = 88/261 (33%), Gaps = 32/261 (12%)

Query: 285 NLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE 344
           +L        L N  I      +  NL NL  + L  NK++   P   + L KL+ L L 
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 345 NNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFW 404
            NQL+         L  L     +  K+  S+      +  +   +            F 
Sbjct: 88  KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147

Query: 405 NLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGD 464
            +  +  + ++   ++    +  G    L EL+L  N ++     ++ GL NL  L L  
Sbjct: 148 GMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 465 NNLQG-----------------------SIPNSIGDLISLECLDLSNNILSGIIPSS--- 498
           N++                          +P  + D   ++ + L NN +S I  +    
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 499 ---LEKLLYLKYLNVSFNRLE 516
                K      +++  N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.8 bits (216), Expect = 2e-19
 Identities = 51/278 (18%), Positives = 102/278 (36%), Gaps = 12/278 (4%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSL 65
            VP  L        LDL  N++         ++  L  L L NN++S   P  F  +  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           + + LS N+L  ELP  +   L  ++       +    +   +  +  +  +  +     
Sbjct: 82  ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSS 139

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
           G        ++ L  + +   N+  +         +L  L L  N ++   ++S++  L 
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLK-GLN 195

Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           NL    L+ N+ S      + N   L    L +N     +P    + + ++ + L  N I
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254

Query: 246 TS-SNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSS 282
           ++  +++               +SL  NP+    +  S
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.3 bits (207), Expect = 3e-18
 Identities = 53/292 (18%), Positives = 102/292 (34%), Gaps = 23/292 (7%)

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH 123
            L+V+  SD  L  ++P ++         L L  N+       +  NL +L ++ L  N 
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPPDT---ALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66

Query: 124 LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLA 183
           +    P     L  L+ L L  N L  +       +  L++ +     +  S+ +   L 
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN--GLN 124

Query: 184 LPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYN 243
              +          SG          KLS   + D + +           +L EL+L+ N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGN 181

Query: 244 YITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGS 303
            IT  +      +SL     L  L L+ N +      S      L     +L+N  +   
Sbjct: 182 KITKVDA-----ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL--RELHLNNNKLV-K 233

Query: 304 IPKEMGNLINLIIIRLGYNKLNG------SIPSTLSRLEKLQILGLENNQLE 349
           +P  + +   + ++ L  N ++         P   ++      + L +N ++
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.9 bits (206), Expect = 3e-18
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 5/218 (2%)

Query: 327 SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL 386
            +P  L       +L L+NN++      D   L  L ++ L +NK+S   P  F  L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGD 446
            +L  + N+L  +P         L V  +             N  ++VEL  +    SG 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 447 IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLK 506
                 G+K L  + + D N+  +IP  +    SL  L L  N ++ +  +SL+ L  L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 507 YLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLCGSPH 544
            L +SFN +               E  + N+ L   P 
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.4 bits (202), Expect = 1e-17
 Identities = 49/304 (16%), Positives = 91/304 (29%), Gaps = 31/304 (10%)

Query: 185 PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY 244
           P+  L  L NN  +        N   L    L +N  S   P  F  +  L+ L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 245 ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSI 304
           +     ++          + ++  +  +          +            +     G  
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--------ELGTNPLKSSGIE 142

Query: 305 PKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS 364
                 +  L  IR+    +          L +L    L+ N++       +  L  L+ 
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKITKVDAASLKGLNNLAK 199

Query: 365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLP 424
           + L  N +S        N   LR+L   +N+L  VP    +   I +V L +N +S    
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS---- 255

Query: 425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS--IPNSIGDLISLE 482
                         +  +     P       +   +SL  N +Q     P++   +    
Sbjct: 256 --------------AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301

Query: 483 CLDL 486
            + L
Sbjct: 302 AVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 9e-17
 Identities = 54/260 (20%), Positives = 96/260 (36%), Gaps = 7/260 (2%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
            C+  G   +PK++    +  ++ L  NK+          L+ L  L L NN++      
Sbjct: 16  QCSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73

Query: 355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDL 414
               L +L  +YL  N+L          L  LR       ++        N   ++ +  
Sbjct: 74  AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133

Query: 415 SSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS 474
           +    SG        +K L  + ++  N++  IP   G   +L  L L  N +      S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190

Query: 475 IGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFM 534
           +  L +L  L LS N +S +   SL    +L+ L+++ N+L                   
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250

Query: 535 GNDLLCGSPHLQVPPCKSTK 554
            N++     +   PP  +TK
Sbjct: 251 NNNISAIGSNDFCPPGYNTK 270

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.3 bits (181), Expect = 6e-15
 Identities = 56/276 (20%), Positives = 96/276 (34%), Gaps = 22/276 (7%)

Query: 152 VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKL 211
           VP  L       +L L NN ++       +  L NL    L NN  S   P       KL
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFK-NLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 212 SICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTG 271
               L  N            ++ L+    E   +          S      ++ V+ L  
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKV--------RKSVFNGLNQMIVVELGT 133

Query: 272 NPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPST 331
           NPL    + +        +    + + NI  +IP+  G   +L  + L  NK+     ++
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190

Query: 332 LSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSF 391
           L  L  L  LGL  N +       +     L  ++L++NKL   +P    +   ++ +  
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249

Query: 392 ASNELTFVPST-------FWNLTNILMVDLSSNPLS 420
            +N ++ + S             +   V L SNP+ 
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (195), Expect = 6e-17
 Identities = 58/255 (22%), Positives = 92/255 (36%), Gaps = 6/255 (2%)

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNK 323
            + + L GN +   V  +S          +   N   R       G  +   +      +
Sbjct: 34  SQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 324 LNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNL 383
           L    P+T   L +L  L L+   L+         LA L  +YL  N L       F +L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 384 ASLRKLSFASNELTFVP-STFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNN 442
            +L  L    N ++ VP   F  L ++  + L  N ++   P    +L  L+ LYL  NN
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 443 LSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKL 502
           LS      +  L+ LQ L L DN               L+    S++ +   +P  L   
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG- 270

Query: 503 LYLKYLNVSFNRLEG 517
                  ++ N L+G
Sbjct: 271 --RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (195), Expect = 6e-17
 Identities = 51/261 (19%), Positives = 86/261 (32%), Gaps = 9/261 (3%)

Query: 185 PNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNY 244
              +   L  N  S    +       L+I  L  N  +      F  +  L++L+L  N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 245 ITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSI 304
              S    +F        +L  L L         L   +     +++  YL +  ++   
Sbjct: 92  QLRSVDPATF----HGLGRLHTLHLDRCG--LQELGPGLFRGLAALQYLYLQDNALQALP 145

Query: 305 PKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSS 364
                +L NL  + L  N+++         L  L  L L  N++          L RL +
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 365 VYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLP 424
           +YL  N LS         L +L+ L    N              +     SS+ +  SLP
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

Query: 425 LEIGNLKVLVELYLSRNNLSG 445
             +    +     L+ N+L G
Sbjct: 266 QRLAGRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (189), Expect = 3e-16
 Identities = 58/262 (22%), Positives = 94/262 (35%), Gaps = 11/262 (4%)

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
              + + L  N I+          S    + L +L    + +L  +  ++   L+L  + 
Sbjct: 32  AASQRIFLHGNRISHVPAA-----SFRACRNLTILW-LHSNVLARIDAAAFTGLALLEQL 85

Query: 293 FYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
               N  +R   P     L  L  + L    L    P     L  LQ L L++N L+   
Sbjct: 86  DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145

Query: 353 LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNE-LTFVPSTFWNLTNILM 411
            D    L  L+ ++L  N++S      F  L SL +L    N      P  F +L  ++ 
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSI 471
           + L +N LS      +  L+ L  L L+ N    D          LQ      + +  S+
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSL 264

Query: 472 PNSIGDLISLECLDLSNNILSG 493
           P     L   +   L+ N L G
Sbjct: 265 PQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.8 bits (187), Expect = 6e-16
 Identities = 59/251 (23%), Positives = 90/251 (35%), Gaps = 6/251 (2%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
           +C  +G  ++P  +        I L  N+++    ++      L IL L +N L      
Sbjct: 17  SCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 355 DICRLARLSSVYLDHNKLSGSI-PACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV- 412
               LA L  + L  N    S+ PA F  L  L  L      L  +    +     L   
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP 472
            L  N L         +L  L  L+L  N +S        GL +L  L L  N +    P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 473 NSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSES 532
           ++  DL  L  L L  N LS +   +L  L  L+YL ++ N    +       A      
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254

Query: 533 FMGNDLLCGSP 543
              +++ C  P
Sbjct: 255 GSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (172), Expect = 6e-14
 Identities = 53/284 (18%), Positives = 88/284 (30%), Gaps = 36/284 (12%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDL--SNNQLSGSFPFFNMSSL 65
            VP  + +  + Q + L  N++     +S  +   L IL L  +      +  F  ++ L
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           + +DLSDN     +    F  L  +  L L         P     L +L  + L +N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALP 185
                   +L NL  L L  N +  V                                L 
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG-------------------------LH 177

Query: 186 NLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYI 245
           +L+   L  N  +   P    +  +L    L  N+ S         +R L+ L L  N  
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

Query: 246 TSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLS 289
                     +       L+    + + +  C LP  +    L 
Sbjct: 238 VCDCRARPLWA------WLQKFRGSSSEVP-CSLPQRLAGRDLK 274

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 1e-11
 Identities = 48/198 (24%), Positives = 76/198 (38%), Gaps = 8/198 (4%)

Query: 4   FLTGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFN 61
            L    P+    L  L  L L    L    P     +  L+ L L +N L       F +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 62  MSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE 121
           + +L  + L  NR+S  +P   F  L  +  L L  N+ A   P    +L  L ++ L  
Sbjct: 152 LGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 122 NHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIR 181
           N+L       +  LR LQ L L  N  V    A     + L+  + +++ +  S+   + 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLA 269

Query: 182 LALPNLELFSLANNNFSG 199
                 +L  LA N+  G
Sbjct: 270 ----GRDLKRLAANDLQG 283

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (165), Expect = 5e-13
 Identities = 41/298 (13%), Positives = 86/298 (28%), Gaps = 27/298 (9%)

Query: 20  QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGS-FPFFNMSSLQVIDLSDNRLSGE 78
           Q LDL+   L   +   + S   +       + +       F+   +Q +DLS++ +   
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 79  LPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNL 138
               I S    +Q LSL   + +  +   +   ++L  ++LS      E   +       
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 139 QALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFS 198
           +                L  ++       T   +  +++                N   S
Sbjct: 122 R----------------LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS 165

Query: 199 GKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSL 258
                     + + +               F  +  L+ L+L   Y          +  L
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP----ETLLEL 221

Query: 259 ANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLII 316
                LK L + G      V   ++  L  ++    ++  +        +GN  N  I
Sbjct: 222 GEIPTLKTLQVFG-----IVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 41/272 (15%), Positives = 89/272 (32%), Gaps = 10/272 (3%)

Query: 115 TSIDLSENHLMGEIPHEIGNLRNLQALGL-LSNNLVGVVPATLFNISTLKILQLTNNTLS 173
            ++DL+  +L  ++    G L +   +      + +    A  F+   ++ + L+N+ + 
Sbjct: 3   QTLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 174 GSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP--DNSFSGFIPNRFHN 231
            S    I      L+  SL     S  I + +   S L    L          +     +
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 232 MRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSME 291
              L ELNL + +  +  H    ++ ++ +     LS     L    L + +      + 
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGY-NKLNGSIPSTLSRLEKLQILGLENNQLEG 350
                +  ++    +E   L  L  + L     +       L  +  L+ L +     +G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 351 RILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
            +      L  L    ++ +  +       GN
Sbjct: 240 TLQLLKEALPHLQ---INCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 3e-06
 Identities = 44/261 (16%), Positives = 88/261 (33%), Gaps = 20/261 (7%)

Query: 267 LSLTGNPLLDCVLPSSIGNL-SLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLN 325
           L LTG  L     P   G L S  +  F      +   + +       +  + L  + + 
Sbjct: 5   LDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIE 59

Query: 326 G-SIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH--NKLSGSIPACFGN 382
             ++   LS+  KLQ L LE  +L   I++ + + + L  + L         ++     +
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 383 LASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRN- 441
            + L +L+ +             + ++     +   LSG       +    +        
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 442 --------NLSGDIPTTIGGLKNLQNLSLGD-NNLQGSIPNSIGDLISLECLDLSNNILS 492
                    L  D       L  LQ+LSL    ++       +G++ +L+ L +   +  
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 493 GIIPSSLEKLLYLKYLNVSFN 513
           G +    E L +L+     F 
Sbjct: 239 GTLQLLKEALPHLQINCSHFT 259

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 31/286 (10%), Positives = 81/286 (28%), Gaps = 26/286 (9%)

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
           +L   +    +  R  + + +       +++         ++   +  +++ + L+ + +
Sbjct: 6   DLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQP------LAEHFSPFRVQHMDLSNSVI 58

Query: 275 LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSR 334
               L   +   S  ++   L    +   I   +    NL+ + L               
Sbjct: 59  EVSTLHGILSQCS-KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 335 LEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASN 394
               ++  L  +         +       S  +    LSG       +            
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS------------ 165

Query: 395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR-NNLSGDIPTTIGG 453
                         + +    S  L      E   L  L  L LSR  ++  +    +G 
Sbjct: 166 --DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223

Query: 454 LKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSL 499
           +  L+ L +      G++        +L  L ++ +  + I   ++
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKE---ALPHLQINCSHFTTIARPTI 266

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 32/239 (13%), Positives = 77/239 (32%), Gaps = 14/239 (5%)

Query: 295 LHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
           L   N+   +   + +   +I  R   + ++  +    S   ++Q + L N+ +E   L 
Sbjct: 7   LTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLH 64

Query: 355 DI-CRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV---PSTFWNLTNIL 410
            I  + ++L ++ L+  +LS  I       ++L +L+ +           +   + + + 
Sbjct: 65  GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124

Query: 411 MVD-------LSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLG 463
            ++          +       +     ++ +  Y      S            +      
Sbjct: 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184

Query: 464 DNNLQGSIPNSIGDLISLECLDLSN-NILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR 521
              L+         L  L+ L LS    +       L ++  LK L V     +G +  
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (154), Expect = 1e-11
 Identities = 43/220 (19%), Positives = 68/220 (30%), Gaps = 15/220 (6%)

Query: 61  NMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLS 120
            ++S   ++     L+  LP ++         L L+ N         +   T LT ++L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 121 ENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSI 180
              L        G L  L  L L  N L  +        +   +    N   S  +    
Sbjct: 64  RAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGA 119

Query: 181 RLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNL 240
              L  L+   L  N      P  +    KL    L +N+ +       + + NL  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 241 EYNYITSSNHELSFISSLANSKKLKVLSLTGNPLL-DCVL 279
                   N   +       S  L    L GNP L +C +
Sbjct: 180 ------QENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.6 bits (140), Expect = 6e-10
 Identities = 41/185 (22%), Positives = 60/185 (32%), Gaps = 25/185 (13%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
            +P  L        L LS N L     +++     L  L+L   +L+       +  L  
Sbjct: 24  ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 68  IDLSDNRLS----------------------GELPANIFSYLPFVQFLSLAFNQFAGHLP 105
           +DLS N+L                         LP      L  +Q L L  N+     P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 106 REIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKIL 165
             +     L  + L+ N+L       +  L NL  L LL  N +  +P   F    L   
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL-LLQENSLYTIPKGFFGSHLLPFA 200

Query: 166 QLTNN 170
            L  N
Sbjct: 201 FLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (139), Expect = 9e-10
 Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 6/209 (2%)

Query: 307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVY 366
           E+  + + + +      L  ++P  L +     IL L  N L    L  +    RL+ + 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 367 LDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE 426
           LD  +   +     G L  L  L  + N+L  +P     L  + ++D+S N L+      
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 427 IGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDL 486
           +  L  L ELYL  N L    P  +     L+ LSL +NNL       +  L +L+ L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 487 SNNILSGIIPSSLEKLLYLKYLNVSFNRL 515
             N L   IP        L +  +  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.1 bits (131), Expect = 8e-09
 Identities = 33/187 (17%), Positives = 64/187 (34%), Gaps = 10/187 (5%)

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
           ++   L+L  N + + +      ++L    +L  L+L    L    +  ++  L      
Sbjct: 31  KDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS 85

Query: 293 FYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI 352
                                  ++ + +N+L       L  L +LQ L L+ N+L+   
Sbjct: 86  HNQLQSLPLLGQTLPALT-----VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 353 LDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV 412
              +    +L  + L +N L+         L +L  L    N L  +P  F+    +   
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFA 200

Query: 413 DLSSNPL 419
            L  NP 
Sbjct: 201 FLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 38/196 (19%), Positives = 66/196 (33%), Gaps = 27/196 (13%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
           NC+ R   ++P ++    +  I+ L  N L     +TL    +L  L L+  +L    +D
Sbjct: 16  NCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD 73

Query: 355 DICRLARLSSVYLDHNK---------------------LSGSIPACFGNLASLRKLSFAS 393
               +     +  +  +                     L+         L  L++L    
Sbjct: 74  GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133

Query: 394 NELTFV-PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
           NEL  + P        +  + L++N L+      +  L+ L  L L  N+L   IP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 453 GLKNLQNLSLGDNNLQ 468
           G   L    L  N   
Sbjct: 193 GSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 6e-06
 Identities = 30/231 (12%), Positives = 68/231 (29%), Gaps = 20/231 (8%)

Query: 158 NISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP 217
            +++   +      L+ ++   +     +  +  L+ N       + +   ++L+   L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC 277
               +    +    +    +L+           +     ++ +    ++ SL    L   
Sbjct: 64  RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 278 VLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEK 337
                       ++  YL    ++   P  +     L  + L  N L       L+ LE 
Sbjct: 124 G----------ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173

Query: 338 LQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRK 388
           L  L L+ N L   I         L   +L  N        C   +   R+
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL-----CNCEILYFRR 218

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 15/48 (31%), Positives = 17/48 (35%), Gaps = 1/48 (2%)

Query: 6   TGTVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQL 53
           T      L  L +L  L L  N L  TIP   F  + L    L  N  
Sbjct: 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 62.5 bits (150), Expect = 7e-11
 Identities = 48/347 (13%), Positives = 97/347 (27%), Gaps = 34/347 (9%)

Query: 112 TSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNT 171
                ++L+   L   +P    +L +L      S N +  +P    ++ +L +       
Sbjct: 38  RQAHELELNNLGL-SSLPELPPHLESLV----ASCNSLTELPELPQSLKSLLVDNNNLKA 92

Query: 172 LSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHN 231
           LS                  L     S      +      S  ++ D   +         
Sbjct: 93  LSDLPPL-------------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139

Query: 232 MRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSME 291
                              +     +   +    +  L   PL    + +    L    E
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199

Query: 292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGR 351
              L       +    +  L +L       N  +  +       +        +      
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQ--------SLTFLDV 251

Query: 352 ILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILM 411
             +    L+ L       N  S  I +      SL +L+ ++N+L  +P+    L  +  
Sbjct: 252 SENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERL-- 309

Query: 412 VDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQ 458
              S N L+  +P    NLK   +L++  N L    P     +++L+
Sbjct: 310 -IASFNHLA-EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.5 bits (137), Expect = 3e-09
 Identities = 51/331 (15%), Positives = 97/331 (29%), Gaps = 24/331 (7%)

Query: 17  SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLS 76
                L+L+   L  ++P        LE L  S N L+   P     SL+ + + +N L 
Sbjct: 38  RQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPEL-PQSLKSLLVDNNNLK 91

Query: 77  GELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLR 136
                        V    L       +            S+    +          GN +
Sbjct: 92  ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151

Query: 137 NLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNN 196
             +   L +   +  + A   ++  L  L L+  ++    +    L       F      
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211

Query: 197 FSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFIS 256
            +  + +       L    + DN  +                N+         +     +
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271

Query: 257 S-------LANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMG 309
           S             L+ L+++ N L++  LP+    L    ER      ++   +P+   
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLIE--LPALPPRL----ERLIASFNHL-AEVPELPQ 324

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQI 340
           NL  L    + YN L    P     +E L++
Sbjct: 325 NLKQL---HVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.6 bits (132), Expect = 1e-08
 Identities = 59/343 (17%), Positives = 100/343 (29%), Gaps = 35/343 (10%)

Query: 162 LKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSF 221
              L+L N  LS     S+    P+LE    + N+ + ++P    +   L +      + 
Sbjct: 40  AHELELNNLGLS-----SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPS 281
           S   P   +   +  +L        SS  ++  +                    +  L  
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVD-------------------NNSLKK 134

Query: 282 SIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQIL 341
                         +N        + +  L  +        KL     S  S +    IL
Sbjct: 135 LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL 194

Query: 342 GLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS 401
                      L  I     L     D      ++      L  L +L  +   L    +
Sbjct: 195 EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSEN 254

Query: 402 TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLS 461
            F  L+ +       N  S  +         L EL +S N L  ++P        L+ L 
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLI 310

Query: 462 LGDNNLQGSIPNSIGDLISLECLDLSNNILSGI--IPSSLEKL 502
              N+L   +P       +L+ L +  N L     IP S+E L
Sbjct: 311 ASFNHLA-EVPELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.7 bits (127), Expect = 4e-08
 Identities = 57/350 (16%), Positives = 99/350 (28%), Gaps = 41/350 (11%)

Query: 63  SSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSEN 122
                ++L++  LS                           LP    +L SL     S N
Sbjct: 38  RQAHELELNNLGLS--------------------------SLPELPPHLESL---VASCN 68

Query: 123 HLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL 182
            L  E+P    +L++L         L  + P   +   +   L+      + S    I +
Sbjct: 69  SLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 127

Query: 183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEY 242
              +L+       +                +  LP  +      N    + +L       
Sbjct: 128 DNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESI 187

Query: 243 ---NYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCN 299
              N I     EL  +  L        L  T   L   +   ++ +  L+       +  
Sbjct: 188 VAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLT 247

Query: 300 IRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRL 359
                      L  L       N  +  I S       L+ L + NN+L   +     RL
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL 306

Query: 360 ARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNI 409
            RL       N L+  +P    N   L++L    N L   P    ++ ++
Sbjct: 307 ERL---IASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 18/70 (25%), Positives = 34/70 (48%), Gaps = 8/70 (11%)

Query: 16  LSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRL 75
             SL+ L++S N+L+  +P+       LE L  S N L+   P     +L+ + +  N L
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL-PQNLKQLHVEYNPL 336

Query: 76  SG--ELPANI 83
               ++P ++
Sbjct: 337 REFPDIPESV 346

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.7 bits (114), Expect = 2e-06
 Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 9/84 (10%)

Query: 437 YLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIP 496
               N  S +I +      +L+ L++ +N L   +P        LE L  S N L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VP 320

Query: 497 SSLEKLLYLKYLNVSFNRLEGEIP 520
              +    LK L+V +N L  E P
Sbjct: 321 ELPQN---LKQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 14/56 (25%), Positives = 23/56 (41%), Gaps = 7/56 (12%)

Query: 14  GSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQV 67
                L+ L  SFN  L  +P    +   L+ L +  N L   FP    ++  L++
Sbjct: 301 ALPPRLERLIASFNH-LAEVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 2e-08
 Identities = 14/89 (15%), Positives = 28/89 (31%), Gaps = 4/89 (4%)

Query: 64  SLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQF----AGHLPREIGNLTSLTSIDL 119
            +Q +D+    LS    A +   L   Q + L            +   +    +L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 120 SENHLMGEIPHEIGNLRNLQALGLLSNNL 148
             N L     H +       +  +   +L
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 5e-08
 Identities = 16/89 (17%), Positives = 34/89 (38%), Gaps = 10/89 (11%)

Query: 433 LVELYLSRNNLS-GDIPTTIGGLKNLQNLSLGDNNLQG----SIPNSIGDLISLECLDLS 487
           +  L +    LS       +  L+  Q + L D  L       I +++    +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 488 NNILSGIIPSSLEKLL-----YLKYLNVS 511
           +N L  +    + + L      ++ L++ 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 2e-07
 Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 9/87 (10%)

Query: 429 NLKVLVELYLSRNNLSGD----IPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLI----- 479
              VL  L+L+  ++S      +  T+    +L+ L L +N L  +    + + +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 480 SLECLDLSNNILSGIIPSSLEKLLYLK 506
            LE L L +   S  +   L+ L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 5/91 (5%)

Query: 408 NILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGD----IPTTIGGLKNLQNLSL 462
           +I  +D+    LS +   E+   L+    + L    L+      I + +     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 463 GDNNLQGSIPNSIGDLISLECLDLSNNILSG 493
             N L     + +   +      +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 2e-06
 Identities = 11/78 (14%), Positives = 27/78 (34%), Gaps = 7/78 (8%)

Query: 18 SLQYLDLSFNQLLGTIPSSIFS-INTLEILDLSNNQLSGSFP------FFNMSSLQVIDL 70
           +Q LD+   +L     + +   +   +++ L +  L+ +             +L  ++L
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 71 SDNRLSGELPANIFSYLP 88
            N L       +   L 
Sbjct: 63 RSNELGDVGVHCVLQGLQ 80

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 3e-06
 Identities = 17/78 (21%), Positives = 33/78 (42%), Gaps = 11/78 (14%)

Query: 17  SSLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNNQLSGSFPFF-------NMSSL 65
           S L+ L L+   +      ++ +++ + ++L  LDLSNN L  +               L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 66  QVIDLSDNRLSGELPANI 83
           + + L D   S E+   +
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 9e-06
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 8/111 (7%)

Query: 214 CELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNP 273
             L D                L+ L L    ++ S+   S  ++L  +  L+ L L+ N 
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNC 408

Query: 274 LLD---CVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLI----NLIII 317
           L D     L  S+      +E+  L++      +   +  L     +L +I
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 18/111 (16%), Positives = 32/111 (28%), Gaps = 20/111 (18%)

Query: 162 LKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSF 221
           ++ L +    LS +  + +   L   ++  L +   +      I +A             
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50

Query: 222 SGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGN 272
                        L ELNL  N +               S K++ LSL   
Sbjct: 51  -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 18/76 (23%), Positives = 29/76 (38%), Gaps = 9/76 (11%)

Query: 455 KNLQNLSLGDNNLQG----SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLL-----YL 505
             L+ L L D ++      S+  ++    SL  LDLSNN L       L + +      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 506 KYLNVSFNRLEGEIPR 521
           + L +       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 5/71 (7%)

Query: 456 NLQNLSLGDNNLQGS-IPNSIGDLISLECLDLSNNILSGI----IPSSLEKLLYLKYLNV 510
           ++Q+L +    L  +     +  L   + + L +  L+      I S+L     L  LN+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 511 SFNRLEGEIPR 521
             N L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 26/104 (25%)

Query: 39  SINTLEILDLSNNQLSGSFP------FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQF 92
             + L +L L++  +S S             SL+ +DLS+N L       +   +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR---- 422

Query: 93  LSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLR 136
                                L  + L + +   E+   +  L 
Sbjct: 423 ----------------QPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 17/99 (17%), Positives = 32/99 (32%), Gaps = 5/99 (5%)

Query: 287 SLSMERFYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNG----SIPSTLSRLEKLQIL 341
           SL ++   +    +  +   E+   L    ++RL    L       I S L     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 342 GLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACF 380
            L +N+L    +  + +  +  S  +    L        
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 16/100 (16%), Positives = 34/100 (34%), Gaps = 4/100 (4%)

Query: 137 NLQALGLLSNNLVGVVPATLF-NISTLKILQLTNNTLSGSISSSIRLAL---PNLELFSL 192
           ++Q+L +    L     A L   +   ++++L +  L+ +    I  AL   P L   +L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 193 ANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
            +N         +    +   C++   S            
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 16/72 (22%), Positives = 24/72 (33%), Gaps = 4/72 (5%)

Query: 9  VPSQLGSLSSLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSS 64
              L  L   Q + L    L       I S++     L  L+L +N+L        +  
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78

Query: 65 LQVIDLSDNRLS 76
          LQ       +LS
Sbjct: 79 LQTPSCKIQKLS 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 18/92 (19%), Positives = 38/92 (41%), Gaps = 8/92 (8%)

Query: 211 LSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT 270
           +   EL D  ++  +P     ++  + + L+   +T +  +    S+L  +  L  L+L 
Sbjct: 9   IQCEELSDARWAELLPL----LQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNLR 63

Query: 271 GNPLLD---CVLPSSIGNLSLSMERFYLHNCN 299
            N L D     +   +   S  +++  L NC 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 5e-04
 Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 14/99 (14%)

Query: 377 PACFGNLASLRKLSFASNELT-----FVPSTFWNLTNILMVDLSSNPLSGSLPLEIG--- 428
                  + LR L  A  +++      + +T     ++  +DLS+N L  +  L++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 429 --NLKVLVELYLSRNNLSGDIPTTIGGLK----NLQNLS 461
                +L +L L     S ++   +  L+    +L+ +S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 5e-04
 Identities = 19/117 (16%), Positives = 34/117 (29%), Gaps = 30/117 (25%)

Query: 58  PFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSI 117
                S L+V+ L+D  +S                           L   +    SL  +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDS---------------------SCSSLAATLLANHSLREL 402

Query: 118 DLSENHLMGEIPHEIG-----NLRNLQALGLLSNNLVGVVPATL----FNISTLKIL 165
           DLS N L      ++          L+ L L        +   L     +  +L+++
Sbjct: 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 23/119 (19%)

Query: 153 PATLFNISTLKILQLTNNTLSGSISSSIRLAL---PNLELFSLANNNFSGKIPSFIFNAS 209
                  S L++L L +  +S S  SS+   L    +L    L+NN         +  + 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 210 KLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLS 268
           +                        L++L L   Y +    +    +   +   L+V+S
Sbjct: 422 R-------------------QPGCLLEQLVLYDIYWSEEMEDR-LQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 12/90 (13%), Positives = 27/90 (30%), Gaps = 6/90 (6%)

Query: 362 LSSVYLDHNKLSGS-IPACFGNLASLRKLSFASNELT-----FVPSTFWNLTNILMVDLS 415
           + S+ +   +LS +        L   + +      LT      + S       +  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 416 SNPLSGSLPLEIGNLKVLVELYLSRNNLSG 445
           SN L       +          + + +L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 18/104 (17%), Positives = 39/104 (37%), Gaps = 10/104 (9%)

Query: 312 INLIIIRLGYNKLNGS-IPSTLSRLEKLQILGLENNQLEGRILDDICR----LARLSSVY 366
           +++  + +   +L+ +     L  L++ Q++ L++  L      DI         L+ + 
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 367 LDHNKLSGSIPACFG-----NLASLRKLSFASNELTFVPSTFWN 405
           L  N+L      C           ++KLS  +  LT       +
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 14/55 (25%), Positives = 20/55 (36%), Gaps = 5/55 (9%)

Query: 9   VPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSI-----NTLEILDLSNNQLSGSFP 58
           + + L +  SL+ LDLS N L       +          LE L L +   S    
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 8/96 (8%), Positives = 34/96 (35%), Gaps = 8/96 (8%)

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD---CVLPSSIGNLSLSM 290
           +++ L+++   ++ +     +   L   ++ +V+ L    L +     + S++     ++
Sbjct: 3   DIQSLDIQCEELSDA----RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP-AL 57

Query: 291 ERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG 326
               L +  +       +   +     ++    L  
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 22/114 (19%), Positives = 37/114 (32%), Gaps = 13/114 (11%)

Query: 290 MERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNG----SIPSTLSRLEKLQILGLEN 345
           +    L +  +R            L ++ L    ++     S+ +TL     L+ L L N
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406

Query: 346 NQLEGRILDDICRLAR-----LSSVYLDHNKLSGSIPACFGNLA----SLRKLS 390
           N L    +  +    R     L  + L     S  +      L     SLR +S
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 8e-08
 Identities = 23/120 (19%), Positives = 49/120 (40%), Gaps = 6/120 (5%)

Query: 20  QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGEL 79
           + L L+   L  T+   +  +  +  LDLS+N+L    P    ++L+ +++     +   
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL--AALRCLEVLQASDNALE 56

Query: 80  PANIFSYLPFVQFLSLAFNQFAG-HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNL 138
             +  + LP +Q L L  N+       + + +   L  ++L  N L  +       L  +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.6 bits (115), Expect = 2e-07
 Identities = 26/117 (22%), Positives = 40/117 (34%), Gaps = 6/117 (5%)

Query: 366 YLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPL 425
           +L H  L+  +      L  +  L  + N L  +P     L  + ++  S N L      
Sbjct: 4   HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN--VD 59

Query: 426 EIGNLKVLVELYLSRNNL-SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISL 481
            + NL  L EL L  N L        +     L  L+L  N+L          L  +
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 2/107 (1%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQV 67
           TV   L  L  + +LDLS N+L    P+ + ++  LE+L  S+N L       N+  LQ 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQE 69

Query: 68  IDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSL 114
           + L +NRL            P +  L+L  N            L  +
Sbjct: 70  LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 4e-07
 Identities = 26/126 (20%), Positives = 49/126 (38%), Gaps = 8/126 (6%)

Query: 339 QILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF 398
           ++L L +  L   +L  + +L  ++ + L HN+L    P     L  L  L  + N L  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 399 VPSTFWNLTNILMVDLSSNPL-SGSLPLEIGNLKVLVELYLSRNNLSGD---IPTTIGGL 454
           V         +  + L +N L   +    + +   LV L L  N+L  +          L
Sbjct: 58  VDGVANL-PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 455 KNLQNL 460
            ++ ++
Sbjct: 117 PSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 6e-06
 Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 8/110 (7%)

Query: 411 MVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGS 470
           ++ L+   L+      +  L ++  L LS N L    P     L  L+ L +   +    
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55

Query: 471 I-PNSIGDLISLECLDLSNN-ILSGIIPSSLEKLLYLKYLNVSFNRLEGE 518
              + + +L  L+ L L NN +        L     L  LN+  N L  E
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 23/118 (19%), Positives = 50/118 (42%), Gaps = 6/118 (5%)

Query: 294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRIL 353
           +L + ++  ++   +  L+ +  + L +N+L    P+ L+ L  L++L  + +      +
Sbjct: 4   HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALENV 58

Query: 354 DDICRLARLSSVYLDHNKL-SGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNIL 410
           D +  L RL  + L +N+L   +      +   L  L+   N L         L  +L
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 9e-05
 Identities = 30/126 (23%), Positives = 46/126 (36%), Gaps = 9/126 (7%)

Query: 66  QVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM 125
           +V+ L+   L+  L       L  V  L L+ N+     P  +  L  L  +  S+N L 
Sbjct: 1   RVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE 56

Query: 126 GEIPHEIGNLRNLQALGLLSNNLVGV-VPATLFNISTLKILQLTNNTLSG--SISSSIRL 182
                       LQ L L +N L        L +   L +L L  N+L     I   +  
Sbjct: 57  NVDGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 183 ALPNLE 188
            LP++ 
Sbjct: 115 MLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 0.001
 Identities = 22/112 (19%), Positives = 40/112 (35%), Gaps = 10/112 (8%)

Query: 163 KILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFS 222
           ++L L +  L+          L  +    L++N      P+       L + +  DN+  
Sbjct: 1   RVLHLAHKDLTVLCHLE---QLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALE 56

Query: 223 GFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
                        +EL L  N +       + I  L +  +L +L+L GN L
Sbjct: 57  NVDGVANLPRL--QELLLCNNRLQQ----SAAIQPLVSCPRLVLLNLQGNSL 102

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 4e-07
 Identities = 39/217 (17%), Positives = 76/217 (35%), Gaps = 23/217 (10%)

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
            L N I I  G + +  ++  T + L+ +  L      +    ++ +  L  L  + L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 370 NKLSG--------SIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSG 421
           N+++          I     +   L+ +S  +   +       +     +  L+      
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 422 SLPLEIGNLKVLVEL-------YLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNS 474
            L L++  +  +  L       YLS  N      T +  L  L  L   DN +    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 475 IGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
           +  L +L  + L NN +S + P  L     L  + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 9e-07
 Identities = 31/225 (13%), Positives = 65/225 (28%), Gaps = 24/225 (10%)

Query: 215 ELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPL 274
               ++ +  +     ++  +  L+     +T+       I  +     L  L L  N +
Sbjct: 25  AAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-------IEGVQYLNNLIGLELKDNQI 75

Query: 275 LDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSR 334
            D     ++  ++               +  + +  L            L G        
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ--- 132

Query: 335 LEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASN 394
                           +I +        +  YL       S      NL+ L  L    N
Sbjct: 133 ---------VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 395 ELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLS 439
           +++ +     +L N++ V L +N +S   PL   N   L  + L+
Sbjct: 184 KISDISP-LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 6e-06
 Identities = 36/239 (15%), Positives = 79/239 (33%), Gaps = 26/239 (10%)

Query: 35  SSIFSINTLE---ILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQ 91
           + IF    L     +    + ++ +    ++  +  +      ++  +      YL  + 
Sbjct: 10  NVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG--VQYLNNLI 66

Query: 92  FLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGV 151
            L L  NQ     P +     +   +  +    +  I               +++     
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 152 VPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKL 211
             + L  +          + L+G  +               +  N      + + N SKL
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYL-----------SIGNAQVSDLTPLANLSKL 175

Query: 212 SICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLT 270
           +  +  DN  S   P    ++ NL E++L+ N I+        +S LAN+  L +++LT
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-------VSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 8e-06
 Identities = 19/63 (30%), Positives = 32/63 (50%), Gaps = 2/63 (3%)

Query: 10  PSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVID 69
            + L +LS L  L    N++    P  + S+  L  + L NNQ+S   P  N S+L ++ 
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223

Query: 70  LSD 72
           L++
Sbjct: 224 LTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 30/217 (13%), Positives = 64/217 (29%), Gaps = 12/217 (5%)

Query: 134 NLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLA 193
            L N   +    +N+   V  T  ++  +  L      ++   +      L NL    L 
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLELK 71

Query: 194 NNNF-----SGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSS 248
           +N          +          +  +                             +++ 
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 249 NHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEM 308
                 ++ + N   L  L+      +     S +  L+   +   L   + + S    +
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL 191

Query: 309 GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLEN 345
            +L NLI + L  N+++   P  L+    L I+ L N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 13/68 (19%), Positives = 33/68 (48%), Gaps = 4/68 (5%)

Query: 32  TIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQ 91
           +  + + +++ L  L   +N++S   P  ++ +L  + L +N++S   P    +    + 
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP---LANTSNLF 220

Query: 92  FLSLAFNQ 99
            ++L  NQ
Sbjct: 221 IVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 29/227 (12%), Positives = 66/227 (29%), Gaps = 18/227 (7%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR 74
           +L++   +    + +  T+  +   ++ +  L      ++       +++L  ++L DN+
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQ 74

Query: 75  LSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGN 134
           ++          L  +  L L+ N                  +  ++   +  +      
Sbjct: 75  IT---DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 135 LRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN 194
                 L  ++N         L  +S           L+             L      +
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANL---------SKLTTLKADD 182

Query: 195 NNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLE 241
           N  S   P  + +   L    L +N  S   P    N  NL  + L 
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 13/43 (30%), Positives = 22/43 (51%), Gaps = 2/43 (4%)

Query: 8   TVPSQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSN 50
           +  S L SL +L  + L  NQ+    P  + + + L I+ L+N
Sbjct: 186 SDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 5e-07
 Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 15/202 (7%)

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
                I   L    +  ++  T + L  +  +   N+ ++   +  I  L  ++ ++L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 370 NKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGN 429
           NKL+         LA+L+ L +   +   V           +  LS      S    + +
Sbjct: 78  NKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132

Query: 430 LKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN 489
           L  L  LYL  N ++     +   L  L  LSL DN +   +P  +  L  L+ L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188

Query: 490 ILSGIIPSSLEKLLYLKYLNVS 511
            +S +   +L  L  L  L + 
Sbjct: 189 HISDL--RALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 6/63 (9%), Positives = 27/63 (42%), Gaps = 2/63 (3%)

Query: 15 SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNR 74
          + +     +L    +   +  +   +N+++ +  +N+ +        + ++  + L+ N+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNK 79

Query: 75 LSG 77
          L+ 
Sbjct: 80 LTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 26/175 (14%), Positives = 54/175 (30%), Gaps = 22/175 (12%)

Query: 110 NLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVV------PATLFNISTLK 163
            L S+  I  + + +       I  L N+  L L  N L  +             +   K
Sbjct: 44  ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101

Query: 164 ILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSG 223
           +  L++      + S         ++  L +      +       + +++        + 
Sbjct: 102 VKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL 161

Query: 224 FIPNR-------FHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTG 271
            + +           +  L+ L L  N+I+        + +LA  K L VL L  
Sbjct: 162 SLEDNQISDIVPLAGLTKLQNLYLSKNHISD-------LRALAGLKNLDVLELFS 209

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.3 bits (108), Expect = 3e-06
 Identities = 39/176 (22%), Positives = 66/176 (37%), Gaps = 6/176 (3%)

Query: 46  LDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLP 105
           +D +   L    P         + L+DN L       +F  LP +  L L  NQ  G  P
Sbjct: 13  VDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71

Query: 106 REIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKIL 165
                 + +  + L EN +          L  L+ L L  N +  V+P +  ++++L  L
Sbjct: 72  NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131

Query: 166 QLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSF 221
            L +N  + +    +      L   SL         PS + +   + I +LP + F
Sbjct: 132 NLASNPFNCNC--HLAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.6 bits (106), Expect = 6e-06
 Identities = 41/152 (26%), Positives = 63/152 (41%), Gaps = 3/152 (1%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDIPTTI 451
              L  +P       +   + L+ N L       + G L  LV+L L RN L+G  P   
Sbjct: 17  GRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74

Query: 452 GGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
            G  ++Q L LG+N ++         L  L+ L+L +N +S ++P S E L  L  LN++
Sbjct: 75  EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134

Query: 512 FNRLEGEIPRGGTLANFTSESFMGNDLLCGSP 543
            N                 +S  G    CG+P
Sbjct: 135 SNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 41.7 bits (96), Expect = 1e-04
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 10/184 (5%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTL-SRLEKLQILGLENNQLEGRIL 353
           +C  RG   IP+++    +   + L  N+L       L  RL  L  L L+ NQL G   
Sbjct: 14  DCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71

Query: 354 DDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-PSTFWNLTNILMV 412
           +     + +  + L  NK+       F  L  L+ L+   N+++ V P +F +L ++  +
Sbjct: 72  NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131

Query: 413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP 472
           +L+SNP + +  L     + L +  L+        P+    ++++Q   L  +  + S  
Sbjct: 132 NLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187

Query: 473 NSIG 476
           NS G
Sbjct: 188 NSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 37/188 (19%), Positives = 67/188 (35%), Gaps = 13/188 (6%)

Query: 144 LSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPS 203
            +   +  +P  +        L L +N L    S  +   LP+L    L  N  +G  P+
Sbjct: 15  CTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72

Query: 204 FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK 263
               AS +   +L +N         F  +  LK LNL  N I+          S  +   
Sbjct: 73  AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFEHLNS 127

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNK 323
           L  L+L  NP         +   +  + +  L+    R   P +   + ++ I  L +++
Sbjct: 128 LTSLNLASNP---FNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSE 181

Query: 324 LNGSIPST 331
              S  ++
Sbjct: 182 FKCSSENS 189

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.4 bits (108), Expect = 9e-06
 Identities = 53/334 (15%), Positives = 108/334 (32%), Gaps = 33/334 (9%)

Query: 234 NLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDC---VLPSSIGNLSLSM 290
           +++  +L+ + IT+ + + S  + L     +K + L+GN +       L  +I +    +
Sbjct: 4   SIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DL 61

Query: 291 ERFYLHNC---NIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQ 347
           E     +     ++  IP+ +  L+  ++     + +  S  +     ++  I  L  + 
Sbjct: 62  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121

Query: 348 LEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLT 407
               +      L   +   +       ++     N   LR +    N L       W  T
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181

Query: 408 NILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLS--------------GDIPTTIGG 453
                 L +  +  +     G   +L+E       L                 +   +  
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 454 LKNLQNLSLGDNNLQGSIPNSIGD------LISLECLDLSNNILSGIIPSSL-----EKL 502
             NL+ L L D  L      ++ D       I L+ L L  N +      +L     EK+
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 503 LYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGN 536
             L +L ++ NR   E      +    S    G 
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 32/309 (10%), Positives = 86/309 (27%), Gaps = 24/309 (7%)

Query: 104 LPREIGNLTSLTSIDLSENHLMGE----IPHEIGNLRNLQALGLLSNNLVGVVPATLFNI 159
           +   +    S+  I LS N +  E    +   I + ++L+           V       +
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 160 STLKILQLTNNTLS--GSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELP 217
             L    L    L       ++         +  L+ +     +          +  ++ 
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 218 DNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLAN------SKKLKVLSLTG 271
                  +  +  N   L+ +    N + + + +    +  ++            +   G
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 272 NPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPST 331
              L     +    L +   +          ++   + +  NL  + L    L+    + 
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262

Query: 332 LSR------LEKLQILGLENNQLEGRILDDIC-----RLARLSSVYLDHNKLSGSIPACF 380
           +           LQ L L+ N++E   +  +      ++  L  + L+ N+         
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVV 321

Query: 381 GNLASLRKL 389
             +  +   
Sbjct: 322 DEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (100), Expect = 9e-05
 Identities = 40/328 (12%), Positives = 91/328 (27%), Gaps = 32/328 (9%)

Query: 18  SLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNNQLSGSFP------FFNMSSLQV 67
           S++   L  + +      ++ + +   ++++ + LS N +             +   L++
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 68  IDLSDN---RLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHL 124
            + SD    R+  E+P      L          +                    LS++  
Sbjct: 64  AEFSDIFTGRVKDEIP-EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 125 MGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL---SGSISSSIR 181
           +  +      L       +        V     N   L+ +    N L   S    +   
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 182 LALPNLELFSLANNNFSGKIPSFIFNASKLSICEL---------PDNSFSGFIPNRFHNM 232
            +   L    +  N    +    +         EL           +  S  +     + 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 233 RNLKELNLEYNYITSSNHE-LSFISSLANSKKLKVLSLTGNPLLD---CVLPSSIGNLSL 288
            NL+EL L    +++     +    S   +  L+ L L  N +       L + I     
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 289 SMERFYLHNCNIR--GSIPKEMGNLINL 314
            +    L+         +  E+  + + 
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.2 bits (97), Expect = 2e-04
 Identities = 42/334 (12%), Positives = 85/334 (25%), Gaps = 30/334 (8%)

Query: 204 FIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKK 263
           F      L +  +                 ++KE+ L  N I +         ++A+ K 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAV-LLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKD 60

Query: 264 LKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHN-CNIRGSIPKEMGNLINLIIIRLGYN 322
           L++   +                 L            +R S           +I  L  +
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120

Query: 323 KLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGN 382
                +    + L       +     E  +         L S+    N+L       +  
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180

Query: 383 LASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLS--------------GSLPLEIG 428
                +L      +            +L        L                +L + + 
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 429 NLKVLVELYLSRNNLSGDIPTTIG------GLKNLQNLSLGDNNLQGSIPNSIGDLI--- 479
           +   L EL L+   LS      +           LQ L L  N ++     ++  +I   
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 480 --SLECLDLSNNILS--GIIPSSLEKLLYLKYLN 509
              L  L+L+ N  S    +   + ++   +   
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 42/294 (14%), Positives = 73/294 (24%), Gaps = 26/294 (8%)

Query: 9   VPSQLGSLSSLQYLDLSFNQL----LGTIPSSIFSINTLEILDLSNN---QLSGSFP--- 58
           V + L    S++ + LS N +       +  +I S   LEI + S+    ++    P   
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 59  ------FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLT 112
                       L  + LSDN         +  +L     L   +    G  P+    + 
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 113 SLTSIDLSENHLMGEIPHEI----GNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLT 168
                           P        N     ++   +             +    I    
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 169 NNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPN- 227
              L     +  +         +   +  S  +   + +   L    L D   S      
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262

Query: 228 -----RFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLD 276
                       L+ L L+YN I                  L  L L GN   +
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 33/325 (10%), Positives = 84/325 (25%), Gaps = 17/325 (5%)

Query: 141 LGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLAL---PNLELFSLANNNF 197
           L  ++      V A L    ++K + L+ NT+    +  +   +    +LE+   ++   
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 198 SGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISS 257
                        L    L          +        +E  +++    +    L   ++
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 258 LANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIII 317
               +    ++     L       +   L   +               K   +   L  +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 318 RLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIP 377
           ++  N +       L          L+   L+      +   A   ++    N     + 
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251

Query: 378 ACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-----GNLKV 432
            C         LS           +      +  + L  N +       +       +  
Sbjct: 252 DC--------LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNL 457
           L+ L L+ N    +    +  ++ +
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREV 327

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (104), Expect = 1e-05
 Identities = 18/134 (13%), Positives = 52/134 (38%), Gaps = 4/134 (2%)

Query: 11  SQLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDL 70
           +Q  +    + LDL   ++   I +   +++  + +D S+N++     F  +  L+ + +
Sbjct: 12  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 70

Query: 71  SDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE---NHLMGE 127
           ++NR+         +     + +    +         + +L SLT + +      +    
Sbjct: 71  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130

Query: 128 IPHEIGNLRNLQAL 141
             + I  +  ++ L
Sbjct: 131 RLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 5e-04
 Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 6/134 (4%)

Query: 380 FGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLS 439
           + N    R+L     ++  + +    L     +D S N +          L+ L  L ++
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVN 71

Query: 440 RNNLSGDIPTTIGGLKNLQNLSLGDNNLQG-SIPNSIGDLISLECLDLSN---NILSGII 495
            N +          L +L  L L +N+L      + +  L SL  L +            
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 496 PSSLEKLLYLKYLN 509
              + K+  ++ L+
Sbjct: 132 LYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 6e-04
 Identities = 21/144 (14%), Positives = 48/144 (33%), Gaps = 7/144 (4%)

Query: 48  LSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPRE 107
           L+   +  +  + N    + +DL   ++   +  N+ + L     +  + N+        
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEI--RKLDG 58

Query: 108 IGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGV---VPATLFNISTLKI 164
              L  L ++ ++ N +          L +L  L L +N+LV +    P       T   
Sbjct: 59  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118

Query: 165 LQLTNNTLSGSISSSIRLALPNLE 188
           +     T        +   +P + 
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVR 142

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (83), Expect = 0.004
 Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 3/102 (2%)

Query: 393 SNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIG 452
           + EL    + + N      +DL    +   +      L     +  S N +         
Sbjct: 4   TAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFP 60

Query: 453 GLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI 494
            L+ L+ L + +N +          L  L  L L+NN L  +
Sbjct: 61  LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 102

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 36/199 (18%), Positives = 77/199 (38%), Gaps = 15/199 (7%)

Query: 310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDH 369
            L   +   LG   +  ++  + + L+++  L  +   ++   +D +  L  L+ +   +
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71

Query: 370 NKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGN 429
           N+L+        NL  L  +   +N++  +           +   ++          + N
Sbjct: 72  NQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 430 LKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNN 489
           L  L     + +++S     T     N  +  + D          + +L +LE LD+S+N
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKPLANLTTLERLDISSN 182

Query: 490 ILSGIIPSSLEKLLYLKYL 508
            +S I  S L KL  L+ L
Sbjct: 183 KVSDI--SVLAKLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 2e-05
 Identities = 31/154 (20%), Positives = 55/154 (35%), Gaps = 5/154 (3%)

Query: 367 LDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE 426
           L   ++   +           + +     L   P       NI +V    + ++ +L + 
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPD--LVAQNIDVVLNRRSSMAATLRII 60

Query: 427 IGNLKVLVELYLSRNNLSG--DIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECL 484
             N+  L+ L LS N L    D+ + +    NL+ L+L  N L+          + LE L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 485 DLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGE 518
            L  N LS         +  ++       RL+G 
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 7/114 (6%)

Query: 409 ILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQ 468
              +DL        L        + V L    ++++  +      +  L +L+L +N L 
Sbjct: 24  QQALDLKGLRSDPDL----VAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLY 78

Query: 469 G--SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP 520
               + + +    +L+ L+LS N L         K L L+ L +  N L     
Sbjct: 79  RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.5 bits (98), Expect = 4e-05
 Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 2/109 (1%)

Query: 433 LVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIP-NSIGDLISLECLDLSNNIL 491
              L  +R+    D    + G +NL  L + +      +    +  L  L  L +  + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 492 SGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSESFMGNDLLC 540
             + P +      L  LN+SFN LE    +     +       GN L C
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 4e-04
 Identities = 20/137 (14%), Positives = 38/137 (27%), Gaps = 1/137 (0%)

Query: 385 SLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNL 443
               L    +             N+  + + +      L L     L  L  L + ++ L
Sbjct: 9   GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 444 SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLL 503
               P        L  L+L  N L+     ++  L   E +   N +        L++  
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 504 YLKYLNVSFNRLEGEIP 520
                 V   +L+    
Sbjct: 129 EEGLGGVPEQKLQCHGQ 145

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 27/148 (18%), Positives = 47/148 (31%), Gaps = 3/148 (2%)

Query: 313 NLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICR-LARLSSVYLDHNK 371
               +R   +         L   E L  L +EN Q    +     R L  L ++ +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 372 LSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLE-IGNL 430
           L    P  F     L +L+ + N L  +        ++  + LS NPL  S  L  +   
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 431 KVLVELYLSRNNLSGDIPTTIGGLKNLQ 458
           +      +    L       +  + N  
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 24/149 (16%), Positives = 42/149 (28%), Gaps = 7/149 (4%)

Query: 15  SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFF---NMSSLQVIDLS 71
                  L  + +  L      +     L  L + N Q            +  L+ + + 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 72  DNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLM-GEIPH 130
            + L    P       P +  L+L+FN     L  +     SL  + LS N L       
Sbjct: 65  KSGLRFVAPDAFHFT-PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALR 122

Query: 131 EIGNLRNLQALGLLSNNLVGVVPATLFNI 159
            +         G+    L       L ++
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 6e-05
 Identities = 37/236 (15%), Positives = 75/236 (31%), Gaps = 9/236 (3%)

Query: 113 SLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTL 172
           S       E+ +  EIP ++   RN   L  +   L  +          L+ ++++ N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 173 SGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNM 232
              I + +   LP L    +   N    I    F         L  N+    +P+     
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 233 RNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMER 292
              K L    + I     E +    L+    +  L+  G   +     +           
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLD-----E 180

Query: 293 FYLHNCNIRGSIPKEM-GNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQ 347
             L + N    +P ++       +I+ +   +++      L  L+KL+     N +
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 1e-04
 Identities = 25/231 (10%), Positives = 59/231 (25%), Gaps = 10/231 (4%)

Query: 42  TLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFA 101
           +  +     ++++   P     +   +     +L   +    FS    ++ + ++ N   
Sbjct: 9   SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 66

Query: 102 GHL---PREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFN 158
             +               I+ + N L                L   +          + +
Sbjct: 67  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126

Query: 159 ISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPD 218
           +  + +    N  +     +S         +  L  N                 +    +
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186

Query: 219 NSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSL 269
           N+      + FH       L++    I S          L N KKL+  S 
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSY-----GLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 31/241 (12%), Positives = 70/241 (29%), Gaps = 9/241 (3%)

Query: 161 TLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNS 220
           + ++     + ++  I S +     N              I    F  S     E  + S
Sbjct: 9   SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRV-IQKGAF--SGFGDLEKIEIS 61

Query: 221 FSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLP 280
            +  +     ++ +      E     ++N       +  N   L+ L ++   +      
Sbjct: 62  QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121

Query: 281 SSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQI 340
             I +L   +     +           +G     +I+ L  N +        +  +  ++
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181

Query: 341 LGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVP 400
              +NN LE    D     +    + +   ++         NL  LR  S     L  +P
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239

Query: 401 S 401
           +
Sbjct: 240 T 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 2e-04
 Identities = 31/222 (13%), Positives = 60/222 (27%), Gaps = 9/222 (4%)

Query: 297 NCNIRG--SIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILD 354
            C       IP ++    N I +R    KL        S    L+ + +  N +   I  
Sbjct: 14  LCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71

Query: 355 DICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFV-----PSTFWNLTNI 409
           D+                +                    +                   +
Sbjct: 72  DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131

Query: 410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG 469
           L +  + N  +      +G     V L+L++N +         G +  +     +NNL+ 
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191

Query: 470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVS 511
              +          LD+S   +  +    LE L  L+  +  
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 5e-04
 Identities = 33/227 (14%), Positives = 72/227 (31%), Gaps = 7/227 (3%)

Query: 18  SLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRL 75
           S +      +++   IPS +        L     +L       F     L+ I++S N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 76  SGEL-PANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGN 134
              +      +     +      N      P    NL +L  + +S   +         +
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 135 LRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLAN 194
                 L +  N  +  +    F   + + + L  N        +       L+  +L++
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 195 NNFSGKIPSFIF-NASKLSICELPDNSFSGFIPNRFHNMRNLKELNL 240
           NN   ++P+ +F  AS   I ++              N++ L+  + 
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 8e-04
 Identities = 12/60 (20%), Positives = 22/60 (36%), Gaps = 14/60 (23%)

Query: 59  FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSID 118
           F   S   ++D+S  R+   LP+     L  ++  S               NL  L +++
Sbjct: 197 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY-------------NLKKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 4/86 (4%)

Query: 389 LSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEI-GNLKVLVELYLSRNNLSGDI 447
           L    N +  + +  +N T +  ++LS N     LP ++       V L +SR  +    
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 448 PTTIGGLKNLQNLSLGDNNLQGSIPN 473
              +  LK L+  S    NL+  +P 
Sbjct: 218 SYGLENLKKLRARST--YNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.002
 Identities = 6/40 (15%), Positives = 13/40 (32%)

Query: 13  LGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQ 52
               S    LD+S  ++       + ++  L      N +
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 11/52 (21%), Positives = 21/52 (40%), Gaps = 3/52 (5%)

Query: 98  NQFAGHLPREI-GNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNL 148
           N     LP ++    +    +D+S   +     + + NL+ L+A      NL
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL 235

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	851
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.98
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.83
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.62
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.55
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.53
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.42
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.35
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.58
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.58
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.46
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.91
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.74
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.67
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.57
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.15
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.15
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.13
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.89

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=364.01  Aligned_cols=199  Identities=30%  Similarity=0.433  Sum_probs=180.6

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999884 69999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      +||+|.+++..  ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+....... ..
T Consensus       100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (293)
T ss_dssp             TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence            99999988754  3589999999999999999999   889999999999999999999999999999987654332 34


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  219 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence            4568999999999999999999999999999999999999999763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=363.17  Aligned_cols=211  Identities=22%  Similarity=0.365  Sum_probs=180.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++.... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            367999999999999999999985 689999999976532 234568999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-C
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-S  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  781 (851)
                      |+++|+|.+++.. ...+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||+|+...... .
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999998854 45789999999999999999999   88899999999999999999999999999998764332 2


Q ss_pred             ccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCccCcCccchhh
Q 046438          782 MKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLKR  839 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  839 (851)
                      ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+.......
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~  218 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD  218 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            23345689999999999988776 57899999999999999999999875544443333

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-43  Score=356.54  Aligned_cols=198  Identities=27%  Similarity=0.460  Sum_probs=177.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999985 58899999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+++|+|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|......  
T Consensus        86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            999999999988653 4689999999999999999999   8899999999999999999999999999999865432  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  207 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  207 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence             234567999999999999999999999999999999999999999763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=364.78  Aligned_cols=202  Identities=26%  Similarity=0.422  Sum_probs=180.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      +.|++.+.||+|+||+||+|++. +++.||+|+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999985 58899999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCccc
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKH  784 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  784 (851)
                      ++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|+..... ....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cccc
Confidence            99999998876667799999999999999999999   8889999999999999999999999999999765322 1123


Q ss_pred             cccccCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGR-----EGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....||+.|+|||++.     +..|+.++||||+||++|||++|+.||.+..
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence            4567999999999873     5568999999999999999999999997643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=358.34  Aligned_cols=201  Identities=27%  Similarity=0.445  Sum_probs=176.4

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999984 68999999997542   334567999999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-  780 (851)
                      ||++||+|.+++... +.+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||+|+...... 
T Consensus        88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999999987543 5689999999999999999999   88999999999999999999999999999998775332 


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence            22334567999999999999999999999999999999999999999763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-42  Score=354.01  Aligned_cols=202  Identities=34%  Similarity=0.559  Sum_probs=171.0

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++.  ..||||+++...  ....+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999863  369999987542  4456789999999999999999999998754 56799999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC-C
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE-S  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  781 (851)
                      |+++|+|.+++......+++..+..++.||++|++||   |+++|+||||||+||+++.++.+||+|||+|+...... .
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999987777899999999999999999999   78899999999999999999999999999998764322 2


Q ss_pred             ccccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          782 MKHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      .......||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+...
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence            23345679999999999864   3589999999999999999999999986443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=353.44  Aligned_cols=200  Identities=29%  Similarity=0.488  Sum_probs=168.3

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||+||+|++.+++.||||+++... ...+++.+|++++++++|||||++++++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788999999999999999999888899999987643 334679999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +|+|.+++......+++..+..++.||++|++||   |+++|+||||||+||++++++.+||+|||+|+...........
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9999999887777889999999999999999999   8889999999999999999999999999999876544433344


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDE  829 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~  829 (851)
                      ...||+.|+|||++.+..++.++|||||||++|||+|+ +.||..
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence            46789999999999999999999999999999999995 555544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=354.30  Aligned_cols=204  Identities=28%  Similarity=0.449  Sum_probs=165.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec--CCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN--DDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||+|+++...  +...+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999985 58999999997653  3345678999999999999999999999865  4568999


Q ss_pred             EeccCCCChhHHhhc---CCCCcCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          701 LDYMPKGSLEACLYS---DNSNLDIFKRLNIVIDIALALEYLHFGH--PNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L~~~h--~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      |||+++|+|.+++..   ....+++..++.++.||++|++|||..+  ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999998864   3567999999999999999999995422  23599999999999999999999999999987


Q ss_pred             cCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~  217 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  217 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence            654332 234568999999999999999999999999999999999999999764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.4e-42  Score=363.91  Aligned_cols=201  Identities=22%  Similarity=0.368  Sum_probs=182.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            368999999999999999999984 6899999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC--CCCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~--~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+||+|.+++......+++..+..++.||+.||+||   |++||+||||||+||+++  .++.+||+|||+|+...... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            999999999877667799999999999999999999   889999999999999995  46889999999998765432 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  228 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  228 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence             334568999999999999999999999999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=365.97  Aligned_cols=199  Identities=25%  Similarity=0.389  Sum_probs=176.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++++.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999984 68999999997653 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHP-NPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~-~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |++||+|.+++... ..+++..+..++.|+++|++||   |+ +||+||||||+||+++.++.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yL---H~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH---HHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            99999999998654 4689999999999999999999   54 48999999999999999999999999999865322  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             233568999999999999999999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-41  Score=362.07  Aligned_cols=201  Identities=21%  Similarity=0.344  Sum_probs=182.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999984 6999999999877666667889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC--CCCcEEEeeccCccccCCCCC
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD--EDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~--~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+||+|.+.+......+++..++.++.||+.|++||   |++||+||||||+|||++  .++.+||+|||+|+...... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            999999988877777799999999999999999999   889999999999999997  67899999999998875433 


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  231 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE  231 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence             334467999999999999999999999999999999999999999763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=347.49  Aligned_cols=203  Identities=24%  Similarity=0.467  Sum_probs=184.0

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccC
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMP  705 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  705 (851)
                      ++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57999999999999999999998888999999986533 34679999999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcccc
Q 046438          706 KGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMKHT  785 (851)
Q Consensus       706 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  785 (851)
                      +|++..++......+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||+|+...........
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999999877777889999999999999999999   7889999999999999999999999999999876655444444


Q ss_pred             ccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          786 QTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       786 ~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~  207 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN  207 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence            5678999999999999999999999999999999998 8999986543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=358.31  Aligned_cols=200  Identities=27%  Similarity=0.369  Sum_probs=179.7

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++++..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999998 469999999997643   334577889999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |||+||+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++++|.+||+|||+|+.......
T Consensus        85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999988654 4678889999999999999999   889999999999999999999999999999987543322


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~  208 (337)
T d1o6la_         161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence             344578999999999999999999999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-41  Score=345.29  Aligned_cols=197  Identities=28%  Similarity=0.438  Sum_probs=169.4

Q ss_pred             CCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec----CCeeEEE
Q 046438          628 FNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN----DDFKALV  700 (851)
Q Consensus       628 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  700 (851)
                      |++.+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            366778999999999999985 58899999987543  3345678999999999999999999999865    3467999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCEEEC-CCCcEEEeeccCccccC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNP--VVHCDIKPSNVLLD-EDMVARLGDFGIAKLLS  777 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~--ivH~Dl~~~Nill~-~~~~~kl~Dfg~a~~~~  777 (851)
                      |||+++|+|.+++... ..+++..+..++.||++|++||   |+++  |+||||||+||+++ +++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999998653 4688999999999999999999   7777  99999999999996 57899999999998653


Q ss_pred             CCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          778 GDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       778 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ..   ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+..+
T Consensus       167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~  217 (270)
T d1t4ha_         167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN  217 (270)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence            32   2345689999999999865 599999999999999999999999976443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-42  Score=357.49  Aligned_cols=202  Identities=27%  Similarity=0.502  Sum_probs=179.3

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||++++++.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3467899999999999999999985 58899999987543 345779999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhc-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          703 YMPKGSLEACLYS-DNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       703 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      |+++|++.+++.. ....+++..+..++.||++|++||   |++||+||||||+||++++++.+||+|||+|+.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999999865 356789999999999999999999   788999999999999999999999999999987765444


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .......|++.|+|||++.+..|+.++|||||||++|||++|..||..
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            444445688999999999999999999999999999999997777644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-41  Score=353.62  Aligned_cols=197  Identities=27%  Similarity=0.416  Sum_probs=177.2

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999984 58999999997543   234577899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||++||++..++.. ....++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            99999999887754 45678888889999999999999   8999999999999999999999999999999876432  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  204 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  204 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence              33568999999999999999999999999999999999999999763

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-41  Score=355.19  Aligned_cols=200  Identities=25%  Similarity=0.365  Sum_probs=162.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .+.|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999985 58899999997553 2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEEC---CCCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLD---EDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~---~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||+||+|.+++.. ...+++..+..++.||+.|++||   |++||+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999864 45789999999999999999999   889999999999999994   5789999999999866432


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .  .....+||+.|+|||++.+..|++++||||+||++|||++|+.||.+.
T Consensus       164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence            2  234567999999999999999999999999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=350.74  Aligned_cols=200  Identities=28%  Similarity=0.500  Sum_probs=174.5

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||+||+|++.+++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46789999999999999999999888899999997543 334679999999999999999999998865 5678999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ...+++..+..++.||++|++||   |+++|+||||||+||++++++.+||+|||+|+.........
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            999999877543 33589999999999999999999   78899999999999999999999999999999876544444


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .....+|+.|+|||++.+..++.++|||||||++|||+||..|+..
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~  212 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP  212 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            4456789999999999989999999999999999999996655443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-41  Score=350.99  Aligned_cols=203  Identities=25%  Similarity=0.486  Sum_probs=166.8

Q ss_pred             cCCCccceeccccceEEEEEEEcC-C---cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-G---MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++.. +   ..||||++.... ....+++.+|++++++++|||||++++++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457888999999999999998843 3   358899876543 34556799999999999999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      ||||++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999999887777899999999999999999999   78899999999999999999999999999998765332


Q ss_pred             Cc----cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          781 SM----KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       781 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ..    ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            21    1122457899999999999999999999999999999998 899997643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.1e-41  Score=350.17  Aligned_cols=195  Identities=29%  Similarity=0.405  Sum_probs=172.5

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .|+.++.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4899999999999999999984 68889999997543   2344678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ||++|++..++.. ...+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+....    
T Consensus        96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            9999998766543 46789999999999999999999   888999999999999999999999999999986532    


Q ss_pred             cccccccCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGRE---GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .....||+.|+|||++.+   ..|+.++||||+||++|||++|+.||.+.
T Consensus       168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~  217 (309)
T d1u5ra_         168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (309)
T ss_dssp             -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence             234579999999999853   46899999999999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=345.13  Aligned_cols=202  Identities=25%  Similarity=0.495  Sum_probs=175.1

Q ss_pred             cCCCccce-eccccceEEEEEEEc---CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNL-IGSGSFGSVYRGRFL---DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||+++... ....+++.+|++++++++|||||++++++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666674 999999999999774   35579999997654 3345789999999999999999999999875 467899


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999999877777899999999999999999999   78899999999999999999999999999998765433


Q ss_pred             C--ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          781 S--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       781 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      .  .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence            2  12234568999999999999999999999999999999998 999998654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-40  Score=345.25  Aligned_cols=200  Identities=23%  Similarity=0.363  Sum_probs=178.0

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch------hhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE------GALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++....      ...+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999984 689999999975431      2357799999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC----cEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM----VARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~----~~kl~Dfg~a  773 (851)
                      ++|||||++|+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999998654 4689999999999999999999   889999999999999998776    5999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  219 (293)
T d1jksa_         165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  219 (293)
T ss_dssp             EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence            8764332  334567899999999999999999999999999999999999999763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-40  Score=351.87  Aligned_cols=197  Identities=25%  Similarity=0.338  Sum_probs=177.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  701 (851)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999984 69999999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES  781 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~  781 (851)
                      ||+.+|++..++... ..+++..++.++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999988654 4689999999999999999999   8889999999999999999999999999999876432  


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence              23467999999999999999999999999999999999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-40  Score=346.18  Aligned_cols=201  Identities=19%  Similarity=0.324  Sum_probs=179.5

Q ss_pred             HhcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++.... ....+.+|++++++++|||||++++++++++..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3578999999999999999999985 588999999986543 34568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC--CCcEEEeeccCccccCCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE--DMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~--~~~~kl~Dfg~a~~~~~~~  780 (851)
                      ||+||+|.+++......+++.+++.++.||++|++||   |++||+||||||+||+++.  ...+||+|||+++......
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999999977666799999999999999999999   8889999999999999985  4589999999998764322


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                        ......+|+.|+|||...+..|+.++||||+||++|||++|+.||...
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~  206 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence              334467899999999999999999999999999999999999999764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-40  Score=344.49  Aligned_cols=200  Identities=27%  Similarity=0.422  Sum_probs=175.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHh-hcCCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLR-SIRHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999985 68999999997542   334456677777665 68999999999999999999999


Q ss_pred             EeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCC
Q 046438          701 LDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDE  780 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~  780 (851)
                      |||+++|+|.+++... ..+++..+..++.||+.|++||   |++||+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999998653 4688899999999999999999   88899999999999999999999999999998654332


Q ss_pred             CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          781 SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                       .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence             2344568999999999999999999999999999999999999999753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-40  Score=342.35  Aligned_cols=201  Identities=29%  Similarity=0.503  Sum_probs=168.7

Q ss_pred             hcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEecc
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYM  704 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  704 (851)
                      .++|++.+.||+|+||+||+|++.+++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            36799999999999999999999888899999997543 344779999999999999999999999865 5578999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|++..++... ...+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|+.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999999887653 35689999999999999999999   78899999999999999999999999999998765444444


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~  217 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  217 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence            44567899999999999999999999999999999999976665443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-40  Score=340.15  Aligned_cols=201  Identities=25%  Similarity=0.472  Sum_probs=168.1

Q ss_pred             cCCCccceeccccceEEEEEEEcCC-----cEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDG-----MEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      ++|++.+.||+|+||+||+|++..+     ..||||+++... +.....+.+|++++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688889999999999999987542     369999997543 3344578999999999999999999999999999999


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+.++++.+++......+++..+..++.||+.|++||   |+++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999998887778899999999999999999999   8889999999999999999999999999999876443


Q ss_pred             CC--ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          780 ES--MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       780 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence            22  122334689999999999999999999999999999999997666544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=347.69  Aligned_cols=205  Identities=27%  Similarity=0.465  Sum_probs=173.9

Q ss_pred             hcCCCccceeccccceEEEEEEEcC-C-----cEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD-G-----MEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||+||+|++.. +     ..||+|++.... ......+.+|++++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3679999999999999999998743 2     359999886543 33456789999999998 89999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC----------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 046438          697 KALVLDYMPKGSLEACLYSDN----------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKP  754 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~  754 (851)
                      .++|||||++|+|.+++....                      ..+++..++.++.||++|++||   |+++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCch
Confidence            999999999999999986543                      2478889999999999999999   788999999999


Q ss_pred             CCEEECCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          755 SNVLLDEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       755 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      +||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999866433322 2334568999999999999999999999999999999998 8999976443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-39  Score=349.50  Aligned_cols=199  Identities=28%  Similarity=0.371  Sum_probs=171.5

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHH---HHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESF---NAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....   ......+   .+|+++++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999985 58999999997532   1112223   34466777788999999999999999999


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||++||+|.+++... ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999998654 5678899999999999999999   889999999999999999999999999999987643


Q ss_pred             CCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          779 DESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       779 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .   ......||+.|+|||++.. ..|+.++||||+||++|||++|+.||....
T Consensus       160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence            3   2334679999999999864 568999999999999999999999997643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-39  Score=334.35  Aligned_cols=201  Identities=27%  Similarity=0.386  Sum_probs=176.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---------hhhHHHHHHHHHHHhhcC-CCcccceeeeeec
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---------EGALESFNAECEVLRSIR-HRNLVRIISSCTN  693 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  693 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...         ....+.+.+|++++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999984 68999999997543         122346889999999997 9999999999999


Q ss_pred             CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCc
Q 046438          694 DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIA  773 (851)
Q Consensus       694 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a  773 (851)
                      ++..|+||||+++|+|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999999654 4689999999999999999999   8889999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGR------EGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      +......  ......||+.|+|||++.      ...++.++||||+||++|||++|+.||.+..
T Consensus       158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            8765432  334567999999999875      3457889999999999999999999998654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-39  Score=338.31  Aligned_cols=203  Identities=23%  Similarity=0.456  Sum_probs=169.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC----e
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDD----F  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  696 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++...   ....+.+.+|+++++.++|||||++++++.+.+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            468999999999999999999984 68999999997543   233467899999999999999999999987654    4


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .|+||||++|++|.+++... ..+++..+..++.||++|++||   |++||+||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            78999999999999887543 5689999999999999999999   8899999999999999999999999999998755


Q ss_pred             CCCC--CccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          777 SGDE--SMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       777 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....  ........||+.|+|||++.+..+++++||||+||++|||++|+.||.+..
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence            3222  223345679999999999999999999999999999999999999997643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-40  Score=337.36  Aligned_cols=195  Identities=28%  Similarity=0.483  Sum_probs=165.6

Q ss_pred             ceeccccceEEEEEEEcC---CcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEeccCC
Q 046438          632 NLIGSGSFGSVYRGRFLD---GMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDYMPK  706 (851)
Q Consensus       632 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  706 (851)
                      +.||+|+||+||+|.+..   ++.||||+++...  ....+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998743   4679999996543  2345679999999999999999999999865 457899999999


Q ss_pred             CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc--cc
Q 046438          707 GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM--KH  784 (851)
Q Consensus       707 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~  784 (851)
                      |+|.+++.. ...+++..+..++.||+.|++||   |+++|+||||||+||+++.++.+||+|||+|+........  ..
T Consensus        92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999998865 45689999999999999999999   7889999999999999999999999999999876543322  22


Q ss_pred             cccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          785 TQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       785 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~  215 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  215 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence            23568999999999999999999999999999999998 899998643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-39  Score=343.15  Aligned_cols=196  Identities=23%  Similarity=0.335  Sum_probs=170.8

Q ss_pred             hcCCCccc-eeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhc-CCCcccceeeeeec----CCee
Q 046438          625 TDQFNVNN-LIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSI-RHRNLVRIISSCTN----DDFK  697 (851)
Q Consensus       625 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~  697 (851)
                      .++|++.+ .||+|+||+||+|++ .+++.||||+++..     ..+.+|++++.++ +|||||++++++++    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            36798875 599999999999998 46899999998743     5577899987655 89999999999865    3578


Q ss_pred             EEEEeccCCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCc
Q 046438          698 ALVLDYMPKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIA  773 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a  773 (851)
                      |+|||||+||+|.+++... ...+++..++.++.||+.|++||   |++||+||||||+||+++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccccccccccccccccccccccccee
Confidence            9999999999999999764 35689999999999999999999   8899999999999999975   567999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      +......  ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~  216 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  216 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence            8765433  334567999999999999999999999999999999999999999764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=336.09  Aligned_cols=204  Identities=26%  Similarity=0.461  Sum_probs=166.2

Q ss_pred             hcCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .++|++.+.||+|+||+||+|++..    +..||||+++... +...+.+.+|++++++++|||||++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4679999999999999999998743    3468888886543 334567999999999999999999999996 467899


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      ||||+++|++.+++......+++..+..++.||++|++||   |+++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998877777899999999999999999999   8899999999999999999999999999999876544


Q ss_pred             CCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          780 ESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       780 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~  215 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  215 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence            4444445678999999999999999999999999999999998 8999977544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-39  Score=336.87  Aligned_cols=201  Identities=26%  Similarity=0.416  Sum_probs=172.7

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecch--hhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLE--GALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++++.||+|+||+||+|++ .+|+.||||+++....  ...+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999998 4689999999965432  235678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      |++++.+..........+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            9976655544444566799999999999999999999   889999999999999999999999999999987654332 


Q ss_pred             cccccccCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          783 KHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ......||+.|+|||+..... ++.++||||+||++|||++|+.||.+.
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence            344567999999999877665 578999999999999999999999753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=336.03  Aligned_cols=203  Identities=29%  Similarity=0.474  Sum_probs=170.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCc----EEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGM----EVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKAL  699 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  699 (851)
                      .+|++++.||+|+||+||+|++. +|+    +||+|.++... ....+.+.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999884 343    58888886543 33457899999999999999999999999865 5678


Q ss_pred             EEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 046438          700 VLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       700 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~  779 (851)
                      +|||+.+|+|.+.+......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999998888888899999999999999999999   7889999999999999999999999999999876543


Q ss_pred             CCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccCc
Q 046438          780 ESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIFS  832 (851)
Q Consensus       780 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~  832 (851)
                      ... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||++...
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~  219 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  219 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence            322 2233468999999999999999999999999999999998 8999976543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.1e-39  Score=335.65  Aligned_cols=207  Identities=26%  Similarity=0.442  Sum_probs=176.2

Q ss_pred             HHHhcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecch-hhHHHHHHHHHHHhhcCCCcccceeeeeecC
Q 046438          622 LQATDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQLE-GALESFNAECEVLRSIRHRNLVRIISSCTND  694 (851)
Q Consensus       622 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  694 (851)
                      +...++|++.+.||+|+||+||+|++.      +++.||||+++.... ...+++.+|++++++++||||+++++++.+.
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            334578999999999999999999874      356899999875443 3456799999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCC-----------------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 046438          695 DFKALVLDYMPKGSLEACLYSDN-----------------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCD  751 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~D  751 (851)
                      +..++||||+++|+|.+++....                       ..+++..+..++.|++.|++||   |+++|+|||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivHrD  165 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRD  165 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc---ccCCeEeeE
Confidence            99999999999999999886432                       2478889999999999999999   889999999


Q ss_pred             CCCCCEEECCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCc
Q 046438          752 IKPSNVLLDEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK-RPTDE  829 (851)
Q Consensus       752 l~~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~pf~~  829 (851)
                      |||+||+++.++.+||+|||+|+....... .......+++.|+|||++.+..|+.++|||||||++|||++|. .||..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999999999999999999986643322 2333467899999999999999999999999999999999985 56765


Q ss_pred             cC
Q 046438          830 IF  831 (851)
Q Consensus       830 ~~  831 (851)
                      ..
T Consensus       246 ~~  247 (301)
T d1lufa_         246 MA  247 (301)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=334.26  Aligned_cols=196  Identities=27%  Similarity=0.356  Sum_probs=166.1

Q ss_pred             ccceeccccceEEEEEEEc-CCcEEEEEEEeecchh-----hHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          630 VNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEG-----ALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       630 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      .+++||+|+||+||+|++. +|+.||||+++.....     ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999984 5899999998654322     134688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++++++..+. .....+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+....... .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~  156 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A  156 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence            9888776554 4556788899999999999999999   889999999999999999999999999999987644322 3


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+.
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            344679999999998865 56899999999999999999999999753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-39  Score=327.21  Aligned_cols=195  Identities=36%  Similarity=0.554  Sum_probs=164.0

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeec-CCeeEEEEecc
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTN-DDFKALVLDYM  704 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  704 (851)
                      ++|++.+.||+|+||.||+|++ .|..||||+++..  ...+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5688999999999999999998 6789999999754  344779999999999999999999998855 45689999999


Q ss_pred             CCCChhHHhhcC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          705 PKGSLEACLYSD-NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       705 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      ++|+|.+++... ...+++..++.++.||++|++||   |+++|+||||||+||+++.++.+|++|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            999999998654 34589999999999999999999   7889999999999999999999999999999865332    


Q ss_pred             ccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      .....+++.|+|||++.+..+++++|||||||++|||+| |+.||...
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~  204 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  204 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence            233467899999999999999999999999999999998 78888654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-38  Score=328.79  Aligned_cols=201  Identities=25%  Similarity=0.451  Sum_probs=165.0

Q ss_pred             cCCCccceeccccceEEEEEEEcC----CcEEEEEEEeecc---hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD----GMEVAIKVFHLQL---EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKA  698 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  698 (851)
                      ++|++.+.||+|+||.||+|++..    ...||||+++...   +...+++.+|++++++++||||+++++++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            569999999999999999998632    2368999986542   33456799999999999999999999999764 678


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      +||||+++|++.+++......+++..+..++.||++|++||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999998877777799999999999999999999   788999999999999999999999999999987654


Q ss_pred             CCCc--cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 046438          779 DESM--KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEI  830 (851)
Q Consensus       779 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  830 (851)
                      ....  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~  218 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL  218 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence            3321  2233467889999999999999999999999999999998 89999754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-38  Score=327.08  Aligned_cols=201  Identities=27%  Similarity=0.390  Sum_probs=163.9

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecCC----eeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTNDD----FKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  701 (851)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++.+++    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677889999999999999997 7899999999754321 122334445556789999999999987654    678999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG-----HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~-----h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      |||++|+|.+++.+.  .+++..+..++.|++.|++|+|..     |.+||+||||||+||+++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999753  588999999999999999999742     4689999999999999999999999999999876


Q ss_pred             CCCCC---ccccccccCccccCccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDES---MKHTQTLATIGYMAPEYGREGQ------ISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....   .......||+.|+|||++.+..      ++.++|||||||++|||+||..||...
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~  221 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence            43322   1233467999999999987542      567899999999999999999887543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=327.71  Aligned_cols=198  Identities=27%  Similarity=0.341  Sum_probs=169.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecch------hhHHHHHHHHHHHhhcC--CCcccceeeeeecCC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLE------GALESFNAECEVLRSIR--HRNLVRIISSCTNDD  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  695 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++....      ....++.+|++++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999984 689999999875421      11234678999999996  899999999999999


Q ss_pred             eeEEEEeccCC-CChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-CCcEEEeeccCc
Q 046438          696 FKALVLDYMPK-GSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-DMVARLGDFGIA  773 (851)
Q Consensus       696 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-~~~~kl~Dfg~a  773 (851)
                      ..++||||+.+ +++.+++.. ...+++..++.++.||++|++||   |++||+||||||+||+++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 567666644 45689999999999999999999   8899999999999999985 479999999999


Q ss_pred             cccCCCCCccccccccCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          774 KLLSGDESMKHTQTLATIGYMAPEYGREGQI-STEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       774 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      +.....   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            865332   3345689999999999987765 5678999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.5e-38  Score=326.10  Aligned_cols=200  Identities=23%  Similarity=0.378  Sum_probs=171.9

Q ss_pred             cCCCccceeccccceEEEEEEEcCCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLDY  703 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  703 (851)
                      ++|+++++||+|+||+||+|++.+|+.||||+++...  +...+.+.+|+.++++++||||+++++++.+++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999889999999997653  22357899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCcc
Q 046438          704 MPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESMK  783 (851)
Q Consensus       704 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  783 (851)
                      +.++.+..+. .....+++..+..++.||+.||+||   |++||+||||||+||+++.++.+|++|||.|........ .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  156 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence            9877665554 5567799999999999999999999   788999999999999999999999999999987654322 3


Q ss_pred             ccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          784 HTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       784 ~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            334578999999999865 45689999999999999999999999754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-38  Score=330.09  Aligned_cols=201  Identities=29%  Similarity=0.424  Sum_probs=170.8

Q ss_pred             hcCCCccceeccccceEEEEEEEc-C-CcEEEEEEEeecchh--hHHHHHHHHHHHhhc---CCCcccceeeeeec----
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-D-GMEVAIKVFHLQLEG--ALESFNAECEVLRSI---RHRNLVRIISSCTN----  693 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  693 (851)
                      .++|++++.||+|+||+||+|++. + ++.||||+++.....  ....+.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999984 4 567999999765322  233466777777665   79999999998853    


Q ss_pred             -CCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccC
Q 046438          694 -DDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGI  772 (851)
Q Consensus       694 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~  772 (851)
                       ....+++|||++++.+..........+++..++.++.||+.|++||   |++||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             3478999999998877666656677789999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          773 AKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       773 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ++....  ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            876532  22345578999999999999999999999999999999999999999754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=325.76  Aligned_cols=198  Identities=28%  Similarity=0.514  Sum_probs=170.4

Q ss_pred             cceeccccceEEEEEEEcCC----cEEEEEEEeec-chhhHHHHHHHHHHHhhcCCCcccceeeeeec-CCeeEEEEecc
Q 046438          631 NNLIGSGSFGSVYRGRFLDG----MEVAIKVFHLQ-LEGALESFNAECEVLRSIRHRNLVRIISSCTN-DDFKALVLDYM  704 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  704 (851)
                      .++||+|+||+||+|++.++    ..||||+++.. .....+++.+|++++++++||||+++++++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999987432    35899998743 34456789999999999999999999999865 45889999999


Q ss_pred             CCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCC---
Q 046438          705 PKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDES---  781 (851)
Q Consensus       705 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  781 (851)
                      ++|++.+++.......++..+..++.|+++|+.|+   |+++|+||||||+||++++++.+||+|||+++.......   
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999987777888899999999999999999   888999999999999999999999999999987643322   


Q ss_pred             ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          782 MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       782 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~  238 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  238 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence            12223568999999999999999999999999999999999888876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=328.07  Aligned_cols=215  Identities=23%  Similarity=0.405  Sum_probs=179.7

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  696 (851)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            367899999999999999999863      35679999997543 33456789999999999 69999999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCC-----------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          697 KALVLDYMPKGSLEACLYSDN-----------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      .++||||+++|++.+++....                 ..+++..+..++.||++|++||   |+++|+||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccccccccc
Confidence            999999999999999986532                 2578899999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccCcCccchh
Q 046438          760 DEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIFSGEMSLK  838 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  838 (851)
                      +.++.+|++|||.++....... .......+|+.|+|||++.+..++.++|||||||++|||+|+..|+....+....+.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332 233446789999999999999999999999999999999995555444344444444


Q ss_pred             hhcc
Q 046438          839 RWVN  842 (851)
Q Consensus       839 ~~~~  842 (851)
                      +.++
T Consensus       259 ~~i~  262 (311)
T d1t46a_         259 KMIK  262 (311)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            4443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-38  Score=328.48  Aligned_cols=205  Identities=25%  Similarity=0.450  Sum_probs=163.8

Q ss_pred             HhcCCCccceeccccceEEEEEEEcC------CcEEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecC-
Q 046438          624 ATDQFNVNNLIGSGSFGSVYRGRFLD------GMEVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTND-  694 (851)
Q Consensus       624 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-  694 (851)
                      ..++|++.+.||+|+||+||+|++..      ++.||||+++... ....+.+.+|.+++.++ +|+||+.+++++.++ 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            34789999999999999999998742      4679999987543 33456677888888777 689999999987664 


Q ss_pred             CeeEEEEeccCCCChhHHhhcC---------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 DFKALVLDYMPKGSLEACLYSD---------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      ...++|||||++|+|.+++...               ...+++..+..++.||++|++||   |+++|+||||||+||++
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCCCcCCcCCccceeE
Confidence            4689999999999999998653               23478899999999999999999   88899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCccC
Q 046438          760 DEDMVARLGDFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTR-KRPTDEIF  831 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~~~  831 (851)
                      ++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++| ..||....
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999986643332 233456799999999999999999999999999999999986 56776543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-37  Score=326.32  Aligned_cols=199  Identities=28%  Similarity=0.507  Sum_probs=167.8

Q ss_pred             cCCCccceeccccceEEEEEEEcC-Cc--EEEEEEEeecc-hhhHHHHHHHHHHHhhc-CCCcccceeeeeecCCeeEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFLD-GM--EVAIKVFHLQL-EGALESFNAECEVLRSI-RHRNLVRIISSCTNDDFKALV  700 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  700 (851)
                      ++|++.+.||+|+||+||+|++.+ |.  .||||+++... ....+.+.+|+++++++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578999999999999999998853 44  47788875433 33456799999999998 799999999999999999999


Q ss_pred             EeccCCCChhHHhhcC---------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcE
Q 046438          701 LDYMPKGSLEACLYSD---------------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVA  765 (851)
Q Consensus       701 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~  765 (851)
                      |||+++|+|.+++...               ...+++..+..++.||++|++|+   |+++|+||||||+||+++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCccccccccceEEEcCCCce
Confidence            9999999999998643               46789999999999999999999   88899999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCc
Q 046438          766 RLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK-RPTDE  829 (851)
Q Consensus       766 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~pf~~  829 (851)
                      ||+|||+|+......  ......+|+.|+|||.+.+..++.++|||||||++|||++|. .||.+
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence            999999997653221  223456899999999999999999999999999999999965 56754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.8e-37  Score=318.86  Aligned_cols=201  Identities=20%  Similarity=0.279  Sum_probs=175.4

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCC-CcccceeeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRH-RNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999985 588999999865432  2457889999999976 899999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC-----CCcEEEeeccCccccC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE-----DMVARLGDFGIAKLLS  777 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~-----~~~~kl~Dfg~a~~~~  777 (851)
                      |+ +++|.+++......++...+..++.|++.|++||   |++||+||||||+||+++.     ++.+||+|||+|+...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 7899998877777899999999999999999999   8999999999999999964     5789999999998764


Q ss_pred             CCCC------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          778 GDES------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       778 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ....      .......||+.|+|||++.+..+++++||||+||++|||++|+.||.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            3221      12334679999999999999999999999999999999999999997543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=321.83  Aligned_cols=204  Identities=28%  Similarity=0.495  Sum_probs=171.3

Q ss_pred             hcCCCccceeccccceEEEEEEEcC--------CcEEEEEEEeecch-hhHHHHHHHHHHHhhc-CCCcccceeeeeecC
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFLD--------GMEVAIKVFHLQLE-GALESFNAECEVLRSI-RHRNLVRIISSCTND  694 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  694 (851)
                      .++|++.+.||+|+||.||+|+...        +..||||+++.... .....+.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4679999999999999999998632        24699999976543 3456788899999888 799999999999999


Q ss_pred             CeeEEEEeccCCCChhHHhhcCC---------------CCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEE
Q 046438          695 DFKALVLDYMPKGSLEACLYSDN---------------SNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLL  759 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill  759 (851)
                      +..++||||+++|++.+++....               ..+++..+..++.||+.|++||   |+++||||||||+||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hhCCEEeeeecccceee
Confidence            99999999999999999986543               3579999999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-cccccccCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccC
Q 046438          760 DEDMVARLGDFGIAKLLSGDESM-KHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFT-RKRPTDEIF  831 (851)
Q Consensus       760 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  831 (851)
                      +.++.+||+|||+++........ ......+++.|+|||.+.+..|++++|||||||++|||++ |+.||.+..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999999999999876443322 2334578999999999999999999999999999999998 788887543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-37  Score=322.57  Aligned_cols=202  Identities=27%  Similarity=0.464  Sum_probs=173.9

Q ss_pred             hcCCCccceeccccceEEEEEEEc------CCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCee
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL------DGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFK  697 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  697 (851)
                      .++|++.+.||+|+||+||+|++.      ++..||||+++... ......+.+|++++++++|||||++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367899999999999999999873      25689999997543 33445689999999999999999999999999999


Q ss_pred             EEEEeccCCCChhHHhhcC---------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEe
Q 046438          698 ALVLDYMPKGSLEACLYSD---------NSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLG  768 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~  768 (851)
                      ++||||+++|+|.+++...         ....++..+..++.|+++|++||   |+++|+||||||+||++++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999987532         24468889999999999999999   78899999999999999999999999


Q ss_pred             eccCccccCCCCC-ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCc
Q 046438          769 DFGIAKLLSGDES-MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRK-RPTDE  829 (851)
Q Consensus       769 Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~pf~~  829 (851)
                      |||+|+....... .......+|+.|+|||.+.+..++.++|||||||++|||+||. .||.+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~  238 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  238 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence            9999986643322 2233456899999999999999999999999999999999985 67755

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-37  Score=323.52  Aligned_cols=203  Identities=30%  Similarity=0.413  Sum_probs=175.0

Q ss_pred             cCCCccceeccccceEEEEEEEc----CCcEEEEEEEeecc----hhhHHHHHHHHHHHhhcCC-CcccceeeeeecCCe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL----DGMEVAIKVFHLQL----EGALESFNAECEVLRSIRH-RNLVRIISSCTNDDF  696 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  696 (851)
                      ++|++.+.||+|+||+||+|+..    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999873    37899999986532    2234668899999999977 899999999999999


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .++||||+.+|+|.+++.... ..++..+..++.||+.|++|+   |+++|+||||||+||+++.++.+||+|||+|+..
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999886543 466788889999999999999   8899999999999999999999999999999877


Q ss_pred             CCCCCccccccccCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCccCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREG--QISTEGDVYSFGIMLMEIFTRKRPTDEIFS  832 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~  832 (851)
                      ............|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.....
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~  237 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE  237 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            55444455567899999999998654  468899999999999999999999976543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=319.17  Aligned_cols=200  Identities=26%  Similarity=0.403  Sum_probs=166.9

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec--------C
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN--------D  694 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  694 (851)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...  +....++.+|++++++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68999999999999999999984 69999999986543  3345678899999999999999999998755        3


Q ss_pred             CeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcc
Q 046438          695 DFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAK  774 (851)
Q Consensus       695 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~  774 (851)
                      +..++||||++++.+... .......+...++.++.||++|++||   |++||+||||||+||+++.++.+|++|||+|+
T Consensus        90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchheeecCCCcEEeeecceee
Confidence            467899999987766543 34556788999999999999999999   88999999999999999999999999999997


Q ss_pred             ccCCCCC---ccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          775 LLSGDES---MKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       775 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .......   .......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            6643221   122335799999999998754 689999999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-36  Score=320.12  Aligned_cols=201  Identities=24%  Similarity=0.304  Sum_probs=166.9

Q ss_pred             hcCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecc-hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC----eeE
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQL-EGALESFNAECEVLRSIRHRNLVRIISSCTNDD----FKA  698 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  698 (851)
                      +++|++++.||+|+||+||+|++ .+|+.||||+++... ....+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999988 479999999997543 344567899999999999999999999987643    234


Q ss_pred             EEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCC
Q 046438          699 LVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSG  778 (851)
Q Consensus       699 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~  778 (851)
                      ++++++.+|+|.+++..  ..+++..+..++.||+.|++||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            45566779999999864  3689999999999999999999   888999999999999999999999999999986543


Q ss_pred             CCC--ccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          779 DES--MKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       779 ~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...  ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            221  12344679999999999854 56788999999999999999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-36  Score=321.24  Aligned_cols=195  Identities=30%  Similarity=0.417  Sum_probs=164.4

Q ss_pred             CCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccceeeeeecC------CeeEE
Q 046438          627 QFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRIISSCTND------DFKAL  699 (851)
Q Consensus       627 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  699 (851)
                      +|+..++||+|+||+||+|++. +|+.||||+++....    ...+|++++++++||||+++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999985 589999999976432    235799999999999999999988542      35789


Q ss_pred             EEeccCCCChhHHhh--cCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCcccc
Q 046438          700 VLDYMPKGSLEACLY--SDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLL  776 (851)
Q Consensus       700 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~  776 (851)
                      ||||++++.+..+..  .....+++..++.++.||+.||+||   |++||+||||||+||+++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998775444432  3456789999999999999999999   889999999999999999775 8999999999876


Q ss_pred             CCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ....  ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            4332  2344679999999998765 57899999999999999999999999753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-36  Score=314.03  Aligned_cols=201  Identities=22%  Similarity=0.335  Sum_probs=169.2

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcccce-eeeeecCCeeEEEEe
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNLVRI-ISSCTNDDFKALVLD  702 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e  702 (851)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+|+++++.++|++++.. .+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            367999999999999999999984 589999999876533  2457889999999987765554 555677778899999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECC---CCcEEEeeccCccccCCC
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDE---DMVARLGDFGIAKLLSGD  779 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~---~~~~kl~Dfg~a~~~~~~  779 (851)
                      |+ ++++...+......+++..+..++.|++.|++||   |++||+||||||+||+++.   +..+|++|||+|+.....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 5667676666677899999999999999999999   8899999999999999864   557999999999876533


Q ss_pred             CC------ccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          780 ES------MKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       780 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                      ..      .......||+.|+|||++.+..+++++|||||||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence            21      12334679999999999999999999999999999999999999997643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-35  Score=310.85  Aligned_cols=199  Identities=24%  Similarity=0.357  Sum_probs=174.0

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCCeeEEEEe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDDFKALVLD  702 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  702 (851)
                      ++|++++.||+|+||+||+|++. +++.||||+++...  +....++.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999984 68899999997543  3346789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 046438          703 YMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLLSGDESM  782 (851)
Q Consensus       703 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  782 (851)
                      ++.++++..++. ..+..++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccc-cccccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999988877664 456788999999999999999999   888999999999999999999999999999987654332 


Q ss_pred             cccccccCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          783 KHTQTLATIGYMAPEYGREGQ-ISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       783 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ......+++.|+|||++.... ++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            233446788999999887654 68999999999999999999999744

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=319.18  Aligned_cols=196  Identities=26%  Similarity=0.352  Sum_probs=164.6

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecCC------
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTNDD------  695 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  695 (851)
                      .++|++++.||+|+||+||+|++. +|+.||||+++...  +...+.+.+|++++++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999984 59999999997543  334567889999999999999999999987654      


Q ss_pred             eeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          696 FKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       696 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      +.++||||+ ++++..+...  ..+++..++.++.||+.||+||   |++||+||||||+||+++.++.+|++|||.|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 6677776643  4689999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          776 LSGDESMKHTQTLATIGYMAPEYGRE-GQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       776 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      ...    ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            643    2345679999999999876 45789999999999999999999999763

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-35  Score=314.94  Aligned_cols=194  Identities=22%  Similarity=0.363  Sum_probs=168.2

Q ss_pred             cCCCccceeccccceEEEEEEE-cCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecC--CeeEEEE
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRF-LDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTND--DFKALVL  701 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  701 (851)
                      ++|++++.||+|+||+||+|++ .+|+.||+|+++..   ..+++.+|++++++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6799999999999999999998 46899999998754   2467889999999995 99999999998743  5789999


Q ss_pred             eccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC-cEEEeeccCccccCCCC
Q 046438          702 DYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM-VARLGDFGIAKLLSGDE  780 (851)
Q Consensus       702 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~-~~kl~Dfg~a~~~~~~~  780 (851)
                      ||+++++|..+.    +.+++..+..++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997653    4689999999999999999999   889999999999999998654 69999999998765432


Q ss_pred             CccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCccC
Q 046438          781 SMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDEIF  831 (851)
Q Consensus       781 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~  831 (851)
                        ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence              33456789999999997765 57999999999999999999999997643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-35  Score=314.31  Aligned_cols=195  Identities=22%  Similarity=0.284  Sum_probs=159.8

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeec------CCe
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTN------DDF  696 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  696 (851)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...  .....++.+|+.++++++|||||++++++..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999985 59999999997553  3344678899999999999999999999854      368


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .|+||||+.++.+... .   ..+++..++.++.||+.|++||   |++||+||||||+||+++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~~~-~---~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHhh-h---cCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccccccceeeechhhhhcc
Confidence            8999999977655443 2   4578999999999999999999   8889999999999999999999999999998765


Q ss_pred             CCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      ...  .......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+
T Consensus       170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence            432  233456789999999999999999999999999999999999999965

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=311.59  Aligned_cols=196  Identities=23%  Similarity=0.335  Sum_probs=165.5

Q ss_pred             hcCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecc--hhhHHHHHHHHHHHhhcCCCcccceeeeeecC-----Ce
Q 046438          625 TDQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQL--EGALESFNAECEVLRSIRHRNLVRIISSCTND-----DF  696 (851)
Q Consensus       625 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  696 (851)
                      .++|++++.||+|+||+||+|++. +|+.||||+++...  ....+++.+|++++++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999984 69999999997543  23446788999999999999999999988643     34


Q ss_pred             eEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeeccCcccc
Q 046438          697 KALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKLL  776 (851)
Q Consensus       697 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~~  776 (851)
                      .+++|+|+.+|+|.+++..  ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+|++|||.|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccccccccccccccchhccc
Confidence            4667778889999998843  4689999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCCccccccccCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 046438          777 SGDESMKHTQTLATIGYMAPEYGREG-QISTEGDVYSFGIMLMEIFTRKRPTDE  829 (851)
Q Consensus       777 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  829 (851)
                      .    .......|++.|+|||+..+. .++.++||||+||++|||++|+.||.+
T Consensus       172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            3    233456789999999987665 468899999999999999999999965

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.98  E-value=2.5e-32  Score=289.03  Aligned_cols=258  Identities=33%  Similarity=0.591  Sum_probs=237.7

Q ss_pred             cccEEEeecCcccc--CCCcccccccCCcEEEecC-CCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEE
Q 046438          289 SMERFYLHNCNIRG--SIPKEMGNLINLIIIRLGY-NKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSV  365 (851)
Q Consensus       289 ~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  365 (851)
                      .+++|+|++|.+.+  .+|..++++++|++|+|++ |.+.|.+|..|.++++|++|+|++|++.+..+..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46777777777776  4789999999999999986 88999999999999999999999999999999999999999999


Q ss_pred             EccCcccCCCCCccccCCccccceecccCcCc-cCchhhcccCcc-eEEEecCCCCCCCCccccccchhhhhhhccCCcc
Q 046438          366 YLDHNKLSGSIPACFGNLASLRKLSFASNELT-FVPSTFWNLTNI-LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNL  443 (851)
Q Consensus       366 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  443 (851)
                      ++++|.+.+.+|..+.+++.|+.+++++|+++ .+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            99999999999999999999999999999998 789888888886 899999999999999888887655 699999999


Q ss_pred             cccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCC
Q 046438          444 SGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGG  523 (851)
Q Consensus       444 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~  523 (851)
                      .+.+|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|..+..+++|++|+|++|+++|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            99999999999999999999999997655 68999999999999999999999999999999999999999999999988


Q ss_pred             cccccCcccccCCcCccCCCCCCCCCCC
Q 046438          524 TLANFTSESFMGNDLLCGSPHLQVPPCK  551 (851)
Q Consensus       524 ~~~~l~~~~~~~n~~~c~~~~~~~~~c~  551 (851)
                      .+..+...++.+|+.+||.|   +|+|.
T Consensus       289 ~L~~L~~l~l~~N~~l~g~p---lp~c~  313 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSP---LPACT  313 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred             cCCCCCHHHhCCCccccCCC---CCCCC
Confidence            89999999999999999998   67774

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.6e-29  Score=275.92  Aligned_cols=194  Identities=27%  Similarity=0.357  Sum_probs=119.9

Q ss_pred             ccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCc
Q 046438          227 NRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPK  306 (851)
Q Consensus       227 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~  306 (851)
                      ..+..+++++.+++++|.++.+.       .....++|++|++++|++.+                            +.
T Consensus       191 ~~~~~l~~~~~l~l~~n~i~~~~-------~~~~~~~L~~L~l~~n~l~~----------------------------~~  235 (384)
T d2omza2         191 SVLAKLTNLESLIATNNQISDIT-------PLGILTNLDELSLNGNQLKD----------------------------IG  235 (384)
T ss_dssp             GGGGGCTTCSEEECCSSCCCCCG-------GGGGCTTCCEEECCSSCCCC----------------------------CG
T ss_pred             cccccccccceeeccCCccCCCC-------cccccCCCCEEECCCCCCCC----------------------------cc
Confidence            34455666666666666665432       22334455555555554422                            12


Q ss_pred             ccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccc
Q 046438          307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL  386 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  386 (851)
                      .+..+++|+.|++++|.+++..+  +..+++|++|++++|++++..  .+..++.++.+++++|.+.+  ...+..++++
T Consensus       236 ~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l  309 (384)
T d2omza2         236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNL  309 (384)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTC
T ss_pred             hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhccc
Confidence            34455566666666666654332  555666666666666665432  35556666667777776664  2345666777


Q ss_pred             cceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcc
Q 046438          387 RKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNN  466 (851)
Q Consensus       387 ~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  466 (851)
                      +.|++++|+++.++. +..+++|++|++++|++++ ++ .++++++|++|++++|+|++..|  +.++++|+.|+|++|.
T Consensus       310 ~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         310 TYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             SEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            777777777776653 6677777777777777763 33 47777777778887777775433  7778888888888773

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=5.6e-29  Score=271.63  Aligned_cols=356  Identities=24%  Similarity=0.350  Sum_probs=227.0

Q ss_pred             cCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccc
Q 046438           48 LSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE  127 (851)
Q Consensus        48 Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~  127 (851)
                      ++.+.+++.++...+.+|++|++++|.|+ .+.  -++.+++|++|+|++|+|++..  .++++++|++|++++|.+.+.
T Consensus        29 l~~~~~~~~~~~~~l~~l~~L~l~~~~I~-~l~--gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i  103 (384)
T d2omza2          29 LGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADI  103 (384)
T ss_dssp             TTCSSTTSEECHHHHTTCCEEECCSSCCC-CCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred             hCCCCCCCccCHHHhCCCCEEECCCCCCC-Ccc--ccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccc
Confidence            33344443333334444555555555554 222  1344555555555555554321  255555555555555555532


Q ss_pred             cchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCccccc
Q 046438          128 IPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFN  207 (851)
Q Consensus       128 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  207 (851)
                      .  .++.+++|+.|++++|.+++..+  ......+..+....|.+....                         +.....
T Consensus       104 ~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~-------------------------~~~~~~  154 (384)
T d2omza2         104 T--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-------------------------ALSGLT  154 (384)
T ss_dssp             G--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG-------------------------GGTTCT
T ss_pred             c--ccccccccccccccccccccccc--ccccccccccccccccccccc-------------------------cccccc
Confidence            2  25555555555555555553322  223344555555555443111                         111000


Q ss_pred             cCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCcccccc
Q 046438          208 ASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLS  287 (851)
Q Consensus       208 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~  287 (851)
                      ............     ....+.............|....       ......+++++.+++++|.+.            
T Consensus       155 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~~~~l~l~~n~i~------------  210 (384)
T d2omza2         155 SLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQIS------------  210 (384)
T ss_dssp             TCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCCC-------CGGGGGCTTCSEEECCSSCCC------------
T ss_pred             cccccccccccc-----hhhhhcccccccccccccccccc-------ccccccccccceeeccCCccC------------
Confidence            111111111111     11223344455555555555443       233455666777776666553            


Q ss_pred             ccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEc
Q 046438          288 LSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYL  367 (851)
Q Consensus       288 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  367 (851)
                                    +..|  +..+++|+.|++++|.++..  +.+..+++|+.|++++|.+++..  .+..+++|+.|++
T Consensus       211 --------------~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l  270 (384)
T d2omza2         211 --------------DITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKL  270 (384)
T ss_dssp             --------------CCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred             --------------CCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeec
Confidence                          2222  45677899999999999753  46888999999999999998654  4778899999999


Q ss_pred             cCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccC
Q 046438          368 DHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDI  447 (851)
Q Consensus       368 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  447 (851)
                      ++|++.+..  .+..++.++.+.+++|+++.++ .+..+++++.|++++|++++..  .+..+++|++|++++|+|++ +
T Consensus       271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l  344 (384)
T d2omza2         271 GANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-V  344 (384)
T ss_dssp             CSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-C
T ss_pred             cCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-C
Confidence            999998543  3778889999999999999875 4788999999999999999653  38889999999999999984 4


Q ss_pred             CcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCc
Q 046438          448 PTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNI  490 (851)
Q Consensus       448 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  490 (851)
                      + .++++++|++|++++|+|++..|  +.++++|+.|+|++|.
T Consensus       345 ~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         345 S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            4 68999999999999999996544  8999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=2e-30  Score=280.31  Aligned_cols=198  Identities=19%  Similarity=0.295  Sum_probs=158.1

Q ss_pred             cCCCccceeccccceEEEEEEEc-CCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-----------CCcccceeeeeec
Q 046438          626 DQFNVNNLIGSGSFGSVYRGRFL-DGMEVAIKVFHLQLEGALESFNAECEVLRSIR-----------HRNLVRIISSCTN  693 (851)
Q Consensus       626 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  693 (851)
                      .+|+++++||+|+||+||+|++. +|+.||||+++... ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999984 68999999998653 23466788999888875           5789999988765


Q ss_pred             C--CeeEEEEeccCCCChh--HHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCC------
Q 046438          694 D--DFKALVLDYMPKGSLE--ACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDM------  763 (851)
Q Consensus       694 ~--~~~~lv~e~~~~g~L~--~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~------  763 (851)
                      .  ...+++|+++..+...  ..........++..+..++.||+.|++|||  +.+||+||||||+||+++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCChhHeeeeccCcccccc
Confidence            3  4556666665544322  222334567888999999999999999995  348999999999999997654      


Q ss_pred             cEEEeeccCccccCCCCCccccccccCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 046438          764 VARLGDFGIAKLLSGDESMKHTQTLATIGYMAPEYGREGQISTEGDVYSFGIMLMEIFTRKRPTDEI  830 (851)
Q Consensus       764 ~~kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  830 (851)
                      .++++|||.|.....    ......||+.|+|||++....++.++|+||+||+++||++|+.||...
T Consensus       170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            499999999876532    223457999999999999999999999999999999999999999753

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=1.2e-29  Score=268.31  Aligned_cols=254  Identities=31%  Similarity=0.490  Sum_probs=224.1

Q ss_pred             cccEEeccCCCccCC-CCCCccccccccccEEEeec-CccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcE
Q 046438          263 KLKVLSLTGNPLLDC-VLPSSIGNLSLSMERFYLHN-CNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQI  340 (851)
Q Consensus       263 ~L~~L~Ls~N~l~~~-~~p~~~~~~~~~L~~L~L~~-n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  340 (851)
                      +++.|+|++|.+... .+|+.++.+. +|++|+|++ |++.|.+|..++++++|++|+|++|++.+..+..+..++.|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            466666666666433 4778888776 889999986 7899999999999999999999999999988999999999999


Q ss_pred             EEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccc-cceecccCcCcc-CchhhcccCcceEEEecCCC
Q 046438          341 LGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASL-RKLSFASNELTF-VPSTFWNLTNILMVDLSSNP  418 (851)
Q Consensus       341 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~-~p~~~~~l~~L~~L~Ls~N~  418 (851)
                      +++++|.+.+.+|..+..++.++.+++++|.+.+.+|..+..+.++ +.+++++|+++. .|..+..+. ...+++++|.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            9999999999999999999999999999999999999999988886 889999999984 455666654 4579999999


Q ss_pred             CCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcc
Q 046438          419 LSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSS  498 (851)
Q Consensus       419 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  498 (851)
                      ..+.+|..+..+++++.+++++|.+++.+ ..++.+++|+.|+|++|+++|.+|.+|+++++|++|||++|+|+|.+|. 
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-  286 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-  286 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence            99999999999999999999999999655 4689999999999999999999999999999999999999999999984 


Q ss_pred             ccccccccceeccCccccccCC
Q 046438          499 LEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       499 l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      +.++++|+.+++++|+..|..|
T Consensus       287 ~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         287 GGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             STTGGGSCGGGTCSSSEEESTT
T ss_pred             cccCCCCCHHHhCCCccccCCC
Confidence            6889999999999998555443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.2e-27  Score=245.46  Aligned_cols=247  Identities=23%  Similarity=0.234  Sum_probs=196.5

Q ss_pred             EeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEcc-Cccc
Q 046438          294 YLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLD-HNKL  372 (851)
Q Consensus       294 ~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~N~l  372 (851)
                      +.++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....+..+..+..+..++.. .|.+
T Consensus        17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~   93 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL   93 (284)
T ss_dssp             ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred             EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence            34444444 3444332  456777777777776666677777888888888888777777777777777777654 5666


Q ss_pred             CCCCCccccCCccccceecccCcCccCch-hhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCccc
Q 046438          373 SGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTI  451 (851)
Q Consensus       373 ~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  451 (851)
                      ....+..|.++++|++|++++|.+..++. .+....+|+.+++++|.+++..+..|..+++|++|++++|++++..+..|
T Consensus        94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f  173 (284)
T d1ozna_          94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF  173 (284)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence            66667788888888888888888876644 56678888999999999987777888888999999999999998778899


Q ss_pred             CCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCCCCcccccCcc
Q 046438          452 GGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLANFTSE  531 (851)
Q Consensus       452 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~  531 (851)
                      .++++|+.+++++|++++..|..|..+++|++||+++|++++..|..|..+++|++|++++|+|.|+|+..+...+++..
T Consensus       174 ~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~  253 (284)
T d1ozna_         174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKF  253 (284)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHC
T ss_pred             ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhC
Confidence            99999999999999999888999999999999999999999888889999999999999999999999865555566666


Q ss_pred             cccCCcCccCCC
Q 046438          532 SFMGNDLLCGSP  543 (851)
Q Consensus       532 ~~~~n~~~c~~~  543 (851)
                      ....+...|..|
T Consensus       254 ~~~~~~~~C~~p  265 (284)
T d1ozna_         254 RGSSSEVPCSLP  265 (284)
T ss_dssp             CSEECCCBEEES
T ss_pred             cCCCCceEeCCc
Confidence            666677778665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=2.3e-25  Score=234.08  Aligned_cols=111  Identities=25%  Similarity=0.323  Sum_probs=62.1

Q ss_pred             cccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCcccc
Q 046438          308 MGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLR  387 (851)
Q Consensus       308 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  387 (851)
                      +..+++|+.+++++|.+.. +|..+  +++|+.|++++|.+.+..+..+..++.++.|++++|.+.+..+..|.++++|+
T Consensus       146 ~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~  222 (305)
T d1xkua_         146 FQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR  222 (305)
T ss_dssp             GGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCC
T ss_pred             cccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccce
Confidence            3344444445555444442 22221  34555566666655555555555555566666666666555555566666666


Q ss_pred             ceecccCcCccCchhhcccCcceEEEecCCCCCC
Q 046438          388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSG  421 (851)
Q Consensus       388 ~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~  421 (851)
                      +|+|++|+|+.+|.++..+++|++|+|++|+|+.
T Consensus       223 ~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         223 ELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             EEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             eeecccccccccccccccccCCCEEECCCCccCc
Confidence            6666666666666666666666666666666653

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=1.5e-25  Score=235.59  Aligned_cols=205  Identities=21%  Similarity=0.264  Sum_probs=143.1

Q ss_pred             ccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccC--CCCCccccCCc
Q 046438          307 EMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLS--GSIPACFGNLA  384 (851)
Q Consensus       307 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~  384 (851)
                      .|.++++|+.|++++|+++.. |..+  ...++.|++.+|.+.+..+..+.....+..++...|...  ...+..|..++
T Consensus        74 ~f~~l~~L~~L~l~~n~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~  150 (305)
T d1xkua_          74 AFAPLVKLERLYLSKNQLKEL-PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK  150 (305)
T ss_dssp             TTTTCTTCCEEECCSSCCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred             hhhCCCccCEecccCCccCcC-ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccccc
Confidence            344444444444444444422 2211  234555555555555544444555555555666555432  23345667777


Q ss_pred             cccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccC
Q 046438          385 SLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGD  464 (851)
Q Consensus       385 ~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  464 (851)
                      +|+.+++++|.++.+|..+  +++|+.|++++|.+.+..+..|.+++.++.|++++|.+++..+..|.++++|++|+|++
T Consensus       151 ~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~  228 (305)
T d1xkua_         151 KLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN  228 (305)
T ss_dssp             TCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS
T ss_pred             ccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccc
Confidence            7888888888887776543  57788888888888878888888888888899999988877788888889999999999


Q ss_pred             cccCCCCcccccCCCCCCEEECCCCcccccCCcc------ccccccccceeccCccccc
Q 046438          465 NNLQGSIPNSIGDLISLECLDLSNNILSGIIPSS------LEKLLYLKYLNVSFNRLEG  517 (851)
Q Consensus       465 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~------l~~l~~L~~l~l~~N~l~~  517 (851)
                      |+|+ .+|.+|.++++|++|+|++|+|+......      +..+++|+.|+|++|+|+.
T Consensus       229 N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             SCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             cccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence            9998 67888888999999999999988543333      3467889999999999863

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.9e-25  Score=229.23  Aligned_cols=206  Identities=25%  Similarity=0.282  Sum_probs=179.0

Q ss_pred             cccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccce
Q 046438          310 NLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKL  389 (851)
Q Consensus       310 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  389 (851)
                      +...+.+++.+++.++ .+|..+.  +++++|+|++|.|++..+..|..+++|+.|+|++|+|+. ++ .++.+++|++|
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L   82 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTL   82 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEE
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccc
Confidence            4455666788888887 4565553  468888888888887777788888888888888888874 33 45778999999


Q ss_pred             ecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCC
Q 046438          390 SFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQG  469 (851)
Q Consensus       390 ~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  469 (851)
                      +|++|+++..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|++
T Consensus        83 ~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             ECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             ccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            99999999888889999999999999999998888888999999999999999997777888999999999999999998


Q ss_pred             CCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCCC
Q 046438          470 SIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPR  521 (851)
Q Consensus       470 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~  521 (851)
                      ..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|||.|+|..
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~  213 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence            88888999999999999999999 7898899999999999999999999864

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.2e-25  Score=227.53  Aligned_cols=250  Identities=26%  Similarity=0.279  Sum_probs=215.7

Q ss_pred             EeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcc-c
Q 046438          267 LSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLE-N  345 (851)
Q Consensus       267 L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~  345 (851)
                      ++.+++++.  .+|..+   +.++++|+|++|+|+...+.+|.++++|++|++++|.+....+..+..++.++.+... .
T Consensus        16 v~c~~~~L~--~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          16 TSCPQQGLQ--AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EECCSSCCS--SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEcCCCCCC--ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            455555553  345433   3467889999999987777889999999999999999998888889999999999865 6


Q ss_pred             ccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCch-hhcccCcceEEEecCCCCCCCCc
Q 046438          346 NQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPS-TFWNLTNILMVDLSSNPLSGSLP  424 (851)
Q Consensus       346 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p  424 (851)
                      |.++...+..|..+++|+.|++++|.+....+..+...++|+.+++++|+++.+|. .|..+++|+.|++++|++++..+
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            67877778899999999999999999998888889999999999999999999864 67889999999999999998888


Q ss_pred             cccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCcccccccc
Q 046438          425 LEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLY  504 (851)
Q Consensus       425 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  504 (851)
                      ..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|+++++|++|+|++|.+.+.-+ ...-...
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~  249 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAW  249 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHH
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHH
Confidence            999999999999999999998889999999999999999999998888999999999999999999996533 2222345


Q ss_pred             ccceeccCccccccCCCC
Q 046438          505 LKYLNVSFNRLEGEIPRG  522 (851)
Q Consensus       505 L~~l~l~~N~l~~~~p~~  522 (851)
                      ++.+....+++.|..|..
T Consensus       250 l~~~~~~~~~~~C~~p~~  267 (284)
T d1ozna_         250 LQKFRGSSSEVPCSLPQR  267 (284)
T ss_dssp             HHHCCSEECCCBEEESGG
T ss_pred             HHhCcCCCCceEeCCchH
Confidence            777888889999987753

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.1e-23  Score=215.79  Aligned_cols=205  Identities=27%  Similarity=0.238  Sum_probs=183.2

Q ss_pred             cCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEE
Q 046438          333 SRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMV  412 (851)
Q Consensus       333 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L  412 (851)
                      .+...+.+++.+++.++. +|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+|. ++.+++|++|
T Consensus         7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L   82 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTL   82 (266)
T ss_dssp             ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEE
T ss_pred             cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccccc
Confidence            456677889999999995 565553  579999999999998777899999999999999999998875 5789999999


Q ss_pred             EecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccc
Q 046438          413 DLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       413 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|+
T Consensus        83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            99999998 56778999999999999999999878888999999999999999999877888899999999999999999


Q ss_pred             ccCCccccccccccceeccCccccccCCC-CCcccccCcccccCCcCccCCC
Q 046438          493 GIIPSSLEKLLYLKYLNVSFNRLEGEIPR-GGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       493 ~~~p~~l~~l~~L~~l~l~~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      +..+..|..+++|+.|+|++|+|+ .+|. ...+..+..+.+.|||+.|++.
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            888889999999999999999999 5554 4557788889999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=1.9e-22  Score=195.16  Aligned_cols=163  Identities=16%  Similarity=0.130  Sum_probs=120.0

Q ss_pred             CccceeccccceEEEEEEEcCCcEEEEEEEeecch------------------hhHHHHHHHHHHHhhcCCCcccceeee
Q 046438          629 NVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLE------------------GALESFNAECEVLRSIRHRNLVRIISS  690 (851)
Q Consensus       629 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  690 (851)
                      .+.++||+|+||+||+|++.+|++||||+++....                  .......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            46789999999999999998899999998763210                  112345678889999999999988765


Q ss_pred             eecCCeeEEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCEEECCCCcEEEeec
Q 046438          691 CTNDDFKALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFGHPNPVVHCDIKPSNVLLDEDMVARLGDF  770 (851)
Q Consensus       691 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~h~~~ivH~Dl~~~Nill~~~~~~kl~Df  770 (851)
                      ..    .+++|||++++....        ++......++.|++++++||   |++||+||||||+||+++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC-CEEEEEC
Confidence            42    379999998866543        23344567899999999999   88899999999999999865 5899999


Q ss_pred             cCccccCCCCCccccccccCccccCcc-----ccccCCCCcchhhHHHHHH
Q 046438          771 GIAKLLSGDESMKHTQTLATIGYMAPE-----YGREGQISTEGDVYSFGIM  816 (851)
Q Consensus       771 g~a~~~~~~~~~~~~~~~~t~~y~aPE-----~~~~~~~~~~~DvwslG~i  816 (851)
                      |.|.....+...         .|....     ....+.|+.++|+||..--
T Consensus       147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            999765322211         111100     0123567889999997543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=1.2e-19  Score=194.11  Aligned_cols=95  Identities=25%  Similarity=0.260  Sum_probs=54.2

Q ss_pred             CCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccc
Q 046438           42 TLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSE  121 (851)
Q Consensus        42 ~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~  121 (851)
                      ++++|||++|+++..++  .+++|++|+|++|+|+ ++|..    +.+|+.|++++|.++. +++ +  .+.|++|++++
T Consensus        39 ~l~~LdLs~~~L~~lp~--~~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~  107 (353)
T d1jl5a_          39 QAHELELNNLGLSSLPE--LPPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSN  107 (353)
T ss_dssp             TCSEEECTTSCCSCCCS--CCTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCS-C--CTTCCEEECCS
T ss_pred             CCCEEEeCCCCCCCCCC--CCCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch-hhh-h--ccccccccccc
Confidence            56677777777764332  3456777777777776 56543    3456666666666652 221 1  12466666666


Q ss_pred             cccccccchhhcCcccccEEEccCcccc
Q 046438          122 NHLMGEIPHEIGNLRNLQALGLLSNNLV  149 (851)
Q Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~n~l~  149 (851)
                      |.+. .+|. ++.+++|+.|++++|.+.
T Consensus       108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         108 NQLE-KLPE-LQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             SCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred             cccc-cccc-hhhhccceeecccccccc
Confidence            6665 3342 455666666666666554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=3.2e-19  Score=190.84  Aligned_cols=313  Identities=23%  Similarity=0.278  Sum_probs=194.0

Q ss_pred             CCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc
Q 046438           17 SSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA   96 (851)
Q Consensus        17 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~   96 (851)
                      .++++|||++|.++ .+|+.   .++|++|+|++|+|+..+.  .+.+|++|++++|+++ .++.-    .+.|++|+|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~--~~~~L~~L~l~~n~l~-~l~~l----p~~L~~L~L~  106 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPE--LPQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVS  106 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCC--CCTTCCEEECCSSCCS-CCCSC----CTTCCEEECC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccccc--chhhhhhhhhhhcccc-hhhhh----cccccccccc
Confidence            46999999999998 57854   5789999999999996543  3679999999999998 55531    3579999999


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeecccccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSI  176 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  176 (851)
                      +|.+. .+|. ++.+++|++|++++|.+.. .+.   ....+..+.+..+....  ...+..++.++.|++++|.+.. .
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~-~  177 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKK-L  177 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSS-C
T ss_pred             ccccc-cccc-hhhhccceeeccccccccc-ccc---ccccccchhhccccccc--cccccccccceecccccccccc-c
Confidence            99998 4553 6889999999999999874 333   34566777776666543  3456778889999999988763 2


Q ss_pred             chhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhh
Q 046438          177 SSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFIS  256 (851)
Q Consensus       177 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~  256 (851)
                      +..    ....+.+...++.+. .++ .+..++.|+.+++++|......    ....++..+.+.+|.+...+.      
T Consensus       178 ~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~~l~~~~~~~~~~~~~~~------  241 (353)
T d1jl5a_         178 PDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVRDNYLTDLPE------  241 (353)
T ss_dssp             CCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCTTCCEEECCSSCCSCCCC------
T ss_pred             ccc----ccccccccccccccc-ccc-cccccccccccccccccccccc----ccccccccccccccccccccc------
Confidence            211    122334444444433 122 2344555666666655544321    123345555555555443211      


Q ss_pred             hccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCCcccccc-cCCcEEEecCCCCCCCcCccccCC
Q 046438          257 SLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIPKEMGNL-INLIIIRLGYNKLNGSIPSTLSRL  335 (851)
Q Consensus       257 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l  335 (851)
                         ..+.+...++.                          .+.+.+     +..+ ......++..+.+.+    ....+
T Consensus       242 ---~~~~l~~~~~~--------------------------~~~~~~-----l~~l~~~~~~~~~~~~~~~~----~~~~~  283 (353)
T d1jl5a_         242 ---LPQSLTFLDVS--------------------------ENIFSG-----LSELPPNLYYLNASSNEIRS----LCDLP  283 (353)
T ss_dssp             ---CCTTCCEEECC--------------------------SSCCSE-----ESCCCTTCCEEECCSSCCSE----ECCCC
T ss_pred             ---ccccccccccc--------------------------cccccc-----cccccchhcccccccCcccc----ccccC
Confidence               11223333333                          333221     1111 223344555554442    12234


Q ss_pred             CCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEe
Q 046438          336 EKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDL  414 (851)
Q Consensus       336 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~L  414 (851)
                      ++|++|++++|+++. +|.   .+++|+.|+|++|+|+ .+|..   +++|++|++++|+|+.+|...   .+|+.|.+
T Consensus       284 ~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp~~~---~~L~~L~~  351 (353)
T d1jl5a_         284 PSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPDIP---ESVEDLRM  351 (353)
T ss_dssp             TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCCCC---TTCCEEEC
T ss_pred             CCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCCccc---cccCeeEC
Confidence            677777777777763 332   3567777888888777 34433   457888888888888887633   24555544

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=2.8e-23  Score=231.59  Aligned_cols=112  Identities=21%  Similarity=0.223  Sum_probs=67.5

Q ss_pred             cccccccccccccccCC-CccccCCCCccEEecccccccc----ccchhhcCcccccEEEccCccccCCC----Ccccc-
Q 046438           88 PFVQFLSLAFNQFAGHL-PREIGNLTSLTSIDLSENHLMG----EIPHEIGNLRNLQALGLLSNNLVGVV----PATLF-  157 (851)
Q Consensus        88 ~~L~~L~L~~N~i~~~~-~~~l~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~l~-  157 (851)
                      ++|+.||+++|+|++.. .+.+..+++++.|+|++|.++.    .++..+..+++|++|+|++|+|+...    ...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            46778888888887422 3345567778888888887763    23455667777888888777765321    12222 


Q ss_pred             CCCcCcEEEeeccccccccchhH---hhhcccccccccccccccc
Q 046438          158 NISTLKILQLTNNTLSGSISSSI---RLALPNLELFSLANNNFSG  199 (851)
Q Consensus       158 ~l~~L~~L~L~~n~l~~~~~~~~---~~~l~~L~~L~L~~N~i~~  199 (851)
                      ...+|++|+|++|++++.....+   +..+++|++|++++|.++.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            22467777777777764332222   2245556666666666543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=6.3e-23  Score=228.68  Aligned_cols=124  Identities=19%  Similarity=0.131  Sum_probs=61.6

Q ss_pred             CCCEEEccCcccCCCCCc----cccCCccccceecccCcCcc-----Cchhhc-ccCcceEEEecCCCCCCC----Cccc
Q 046438          361 RLSSVYLDHNKLSGSIPA----CFGNLASLRKLSFASNELTF-----VPSTFW-NLTNILMVDLSSNPLSGS----LPLE  426 (851)
Q Consensus       361 ~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~-----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~  426 (851)
                      .|+.+++++|.++.....    .+...++|++|+|++|+++.     ++..+. ..+.|++|+|++|.|++.    +++.
T Consensus       313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~  392 (460)
T d1z7xw1         313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  392 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence            455555555554432211    22233455566666555541     222332 234566666666666532    2233


Q ss_pred             cccchhhhhhhccCCcccccCCcc----cC-CCCCccEEEccCcccCCCCcccc----cCCCCCCEE
Q 046438          427 IGNLKVLVELYLSRNNLSGDIPTT----IG-GLKNLQNLSLGDNNLQGSIPNSI----GDLISLECL  484 (851)
Q Consensus       427 ~~~l~~L~~L~L~~N~l~~~~~~~----~~-~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L  484 (851)
                      +..+++|++|+|++|+|+......    +. ....|+.|++.+|.+.......+    ...++|+.|
T Consensus       393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~  459 (460)
T d1z7xw1         393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI  459 (460)
T ss_dssp             HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred             HhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence            444556666666666665332222    22 23468888888888864444333    234555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=1.9e-20  Score=181.06  Aligned_cols=175  Identities=22%  Similarity=0.256  Sum_probs=102.8

Q ss_pred             CEEEccCcccCCCCCccccCCccccceecccCcCcc-C-chhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccC
Q 046438          363 SSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTF-V-PSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSR  440 (851)
Q Consensus       363 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  440 (851)
                      +.++.++++++ .+|..+.  +++++|+|++|+|+. + +..|.++++|+.|+|++|.+.+..+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            45666666666 3444332  456666666666653 3 23456666666666666666666666666666666666666


Q ss_pred             CcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccCccccccCC
Q 046438          441 NNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       441 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      |+|++..|+.|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+....+ ...-...++.+.++.|.++|..|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCC
Confidence            66665555666666666666666666665556666666666666666666653322 11112335555666666666555


Q ss_pred             CCCcccccCcccccCCcCccCCC
Q 046438          521 RGGTLANFTSESFMGNDLLCGSP  543 (851)
Q Consensus       521 ~~~~~~~l~~~~~~~n~~~c~~~  543 (851)
                      .  .+..+.-.++..|...|.++
T Consensus       167 ~--~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         167 S--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             T--TTTTSBGGGSCTTTCCCCCC
T ss_pred             h--hhcCCEeeecCHhhCcCCCC
Confidence            3  23333444455555555544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=5e-19  Score=178.36  Aligned_cols=217  Identities=19%  Similarity=0.222  Sum_probs=141.9

Q ss_pred             EEEeecCccccCCCcccccccCCcEEEecCCCCCCCcCccccCCCCCcEEEcccccccccc-cccccccCCCCEEEccC-
Q 046438          292 RFYLHNCNIRGSIPKEMGNLINLIIIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRI-LDDICRLARLSSVYLDH-  369 (851)
Q Consensus       292 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~-  369 (851)
                      .++.++.+++ .+|..+.  +++++|++++|.|+...+.+|.++++|++|++++|.+...+ +..|..++.++.+++.. 
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            3444444444 3343332  35666666666666444455666666666666666665432 34556666666666543 


Q ss_pred             cccCCCCCccccCCccccceecccCcCccCch--hhcccCcceEEEecCCCCCCCCccccccch-hhhhhhccCCccccc
Q 046438          370 NKLSGSIPACFGNLASLRKLSFASNELTFVPS--TFWNLTNILMVDLSSNPLSGSLPLEIGNLK-VLVELYLSRNNLSGD  446 (851)
Q Consensus       370 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~  446 (851)
                      |.+....+..|.++++|+++++++|+++..+.  .+..+..+..+..+++.+....+..|.+++ .++.|++++|+++..
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i  168 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  168 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence            55555566667777777777777777765543  334566677777777777755566666654 678888888888854


Q ss_pred             CCcccCCCCCcc-EEEccCcccCCCCcccccCCCCCCEEECCCCcccccCCccccccccccceeccC
Q 046438          447 IPTTIGGLKNLQ-NLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGIIPSSLEKLLYLKYLNVSF  512 (851)
Q Consensus       447 ~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~  512 (851)
                      .+..| ...+++ .+++++|+|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus       169 ~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         169 HNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            44444 445544 446788888855556688999999999999999966666788888888887754

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=4.1e-19  Score=176.87  Aligned_cols=204  Identities=23%  Similarity=0.313  Sum_probs=97.6

Q ss_pred             CEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccc
Q 046438           20 QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQ   99 (851)
Q Consensus        20 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~   99 (851)
                      ...+++.+++++..  .++.+.+|+.|++++|+|++..++..+++|++|++++|++++ +++  +..+++|+++++++|.
T Consensus        22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l~~l~~l~~L~~L~ls~n~i~~-~~~--l~~l~~l~~l~~~~n~   96 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITD-LAP--LKNLTKITELELSGNP   96 (227)
T ss_dssp             HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCC
T ss_pred             HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcchhHhcCCCCcEeecCCceeec-ccc--cccccccccccccccc
Confidence            33445555554432  234455555555555555544444555555555555555542 221  4445555555555554


Q ss_pred             cccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchh
Q 046438          100 FAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSS  179 (851)
Q Consensus       100 i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  179 (851)
                      ++..  ..+.++++|+.+++++|...+.  ..+...+.++.+.++.+.+...  ..+.++++|+.|++++|.+.      
T Consensus        97 ~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~------  164 (227)
T d1h6ua2          97 LKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS------  164 (227)
T ss_dssp             CSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC------
T ss_pred             cccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc------
Confidence            4421  2344455555555555544321  1233444444444444444322  12334444444444444443      


Q ss_pred             HhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchhhhhcc
Q 046438          180 IRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSFISSLA  259 (851)
Q Consensus       180 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~  259 (851)
                                         +..  .+.++++|+.|+|++|+++++.  .|+++++|++|+|++|++++++       .++
T Consensus       165 -------------------~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~-------~l~  214 (227)
T d1h6ua2         165 -------------------DLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS-------PLA  214 (227)
T ss_dssp             -------------------CCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG-------GGT
T ss_pred             -------------------cch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc-------ccc
Confidence                               221  1344455555555555555432  2555666666666666665432       355


Q ss_pred             ccccccEEecc
Q 046438          260 NSKKLKVLSLT  270 (851)
Q Consensus       260 ~l~~L~~L~Ls  270 (851)
                      .+++|+.|+++
T Consensus       215 ~l~~L~~L~ls  225 (227)
T d1h6ua2         215 NTSNLFIVTLT  225 (227)
T ss_dssp             TCTTCCEEEEE
T ss_pred             cCCCCCEEEee
Confidence            56666666665

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.1e-19  Score=179.00  Aligned_cols=219  Identities=20%  Similarity=0.182  Sum_probs=111.6

Q ss_pred             CEEeCcCCCCccCCCccccCCCCCCEEEcCCCccccccc--CCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccc-
Q 046438           20 QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFP--FFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLA-   96 (851)
Q Consensus        20 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~-   96 (851)
                      +.++.+++.++ .+|..+.  +++++|+|++|+|+...+  |..+++|++|++++|.+.+.+++..|..++.+++|.+. 
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 4554442  456666666666664433  45566666666666666544555556666666666554 


Q ss_pred             ccccccCCCccccCCCCccEEeccccccccccc-hhhcCcccccEEEccCccccCCCCccccCCC-cCcEEEeecccccc
Q 046438           97 FNQFAGHLPREIGNLTSLTSIDLSENHLMGEIP-HEIGNLRNLQALGLLSNNLVGVVPATLFNIS-TLKILQLTNNTLSG  174 (851)
Q Consensus        97 ~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~  174 (851)
                      .|.+....+..|.++++|++|++++|.+....+ ..+..++.+..+...++++....+..+.+++ .++.|++++|+++ 
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-  166 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-  166 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred             cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-
Confidence            345555555556666666666666665543221 1223344444444444455444444444432 4555555555554 


Q ss_pred             ccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCccccCCCCcchh
Q 046438          175 SISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYITSSNHELSF  254 (851)
Q Consensus       175 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  254 (851)
                      .++...+. .+++                       ++.+.+.+|+++.+.+..|.++++|++|+|++|+|+.++..   
T Consensus       167 ~i~~~~~~-~~~l-----------------------~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~---  219 (242)
T d1xwdc1         167 EIHNCAFN-GTQL-----------------------DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY---  219 (242)
T ss_dssp             EECTTTTT-TCCE-----------------------EEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSS---
T ss_pred             cccccccc-chhh-----------------------hccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHH---
Confidence            23333321 2222                       22223444555555445555555555555555555554422   


Q ss_pred             hhhccccccccEEeccC
Q 046438          255 ISSLANSKKLKVLSLTG  271 (851)
Q Consensus       255 ~~~l~~l~~L~~L~Ls~  271 (851)
                        .+.++++|+.+++.+
T Consensus       220 --~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         220 --GLENLKKLRARSTYN  234 (242)
T ss_dssp             --SCTTCCEEESSSEES
T ss_pred             --HHcCCcccccCcCCC
Confidence              244455555555443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=6.1e-19  Score=175.64  Aligned_cols=187  Identities=22%  Similarity=0.297  Sum_probs=118.3

Q ss_pred             CcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEE
Q 046438           87 LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQ  166 (851)
Q Consensus        87 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~  166 (851)
                      +.+|++|++.+|.|+..  ..++.+++|++|++++|.+++..|  +..+++|+++++++|.++..  ..+.++++|+.++
T Consensus        40 l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~  113 (227)
T d1h6ua2          40 LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD  113 (227)
T ss_dssp             HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred             cCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccccc
Confidence            44444444444444422  234555555555555555543222  55555555555555555432  2345555666666


Q ss_pred             eeccccccccchhHhhhcccccccccccccccccCCccccccCCCcEEecCCCCCccccCccccCCCCcceEeccCcccc
Q 046438          167 LTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIFNASKLSICELPDNSFSGFIPNRFHNMRNLKELNLEYNYIT  246 (851)
Q Consensus       167 L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  246 (851)
                      +++|...+..+   +...+.++.+.++++.+...  ..+.++++|+.|++++|.++...  .|+++++|++|+|++|+++
T Consensus       114 l~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~  186 (227)
T d1h6ua2         114 LTSTQITDVTP---LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS  186 (227)
T ss_dssp             CTTSCCCCCGG---GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccch---hccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccC
Confidence            65555442211   22455666666666666432  33667889999999999998654  4889999999999999998


Q ss_pred             CCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeec
Q 046438          247 SSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHN  297 (851)
Q Consensus       247 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~  297 (851)
                      +++       .+..+++|+.|++++|++++.  + .+..+. +|+.|++++
T Consensus       187 ~l~-------~l~~l~~L~~L~Ls~N~lt~i--~-~l~~l~-~L~~L~lsn  226 (227)
T d1h6ua2         187 DIS-------PLASLPNLIEVHLKNNQISDV--S-PLANTS-NLFIVTLTN  226 (227)
T ss_dssp             CCG-------GGGGCTTCCEEECTTSCCCBC--G-GGTTCT-TCCEEEEEE
T ss_pred             CCh-------hhcCCCCCCEEECcCCcCCCC--c-ccccCC-CCCEEEeeC
Confidence            743       477889999999999999753  3 244444 899999874

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.3e-18  Score=167.95  Aligned_cols=156  Identities=22%  Similarity=0.252  Sum_probs=117.2

Q ss_pred             CEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccc
Q 046438           44 EILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENH  123 (851)
Q Consensus        44 ~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~  123 (851)
                      +.+++++++++. +|-.-.+++++|+|++|+|++.++...|..+++|++|+|++|.+....+..|..+++|++|+|++|+
T Consensus        11 ~~v~Cs~~~L~~-iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~   89 (192)
T d1w8aa_          11 TTVDCTGRGLKE-IPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CEEEEeCCCcCc-cCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence            356666666663 2323346777778888877655777778888888888888888888888888888899999999999


Q ss_pred             cccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCC
Q 046438          124 LMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIP  202 (851)
Q Consensus       124 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  202 (851)
                      ++...+++|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|.+........+.  ..++.+.+..|.++...|
T Consensus        90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCSS
T ss_pred             ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--hhhhhhcccCCCeEeCCC
Confidence            88777888888999999999999998888888888999999999999887544333332  235566666666654433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.7e-18  Score=169.76  Aligned_cols=179  Identities=21%  Similarity=0.316  Sum_probs=89.7

Q ss_pred             eCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccccccccc
Q 046438           23 DLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAG  102 (851)
Q Consensus        23 ~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~  102 (851)
                      +++.+.+++.++.  ..+.+|++|++++|++++..++..+++|++|++++|+++ .+++  ++.+++|++|++++|+|++
T Consensus        30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~l~~l~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~l~~n~i~~  104 (210)
T d1h6ta2          30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLDENKVKD  104 (210)
T ss_dssp             HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             HhCcCccCCccCH--HHhcCccEEECcCCCCCCchhHhhCCCCCEEeCCCcccc-Cccc--cccCccccccccccccccc
Confidence            4444444433331  234455555555555554444445555555555555554 2332  3445555555555555543


Q ss_pred             CCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhh
Q 046438          103 HLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRL  182 (851)
Q Consensus       103 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~  182 (851)
                       +| .+.++++|+.|++++|.+.. + ..+..+++|+++++++|.+++.  ..+..+++|+.+++++|++++ ++.  +.
T Consensus       105 -l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~--l~  175 (210)
T d1h6ta2         105 -LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--LA  175 (210)
T ss_dssp             -GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG--GT
T ss_pred             -cc-cccccccccccccccccccc-c-cccccccccccccccccccccc--ccccccccccccccccccccc-ccc--cc
Confidence             22 35555555555555555542 2 2355555555555555555432  234455555555555555552 221  33


Q ss_pred             hcccccccccccccccccCCccccccCCCcEEecC
Q 046438          183 ALPNLELFSLANNNFSGKIPSFIFNASKLSICELP  217 (851)
Q Consensus       183 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L~  217 (851)
                      .+++|++|+|++|++++. + .+.++++|+.|+|+
T Consensus       176 ~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         176 GLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             TCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             CCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            555566666666655532 2 35556666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.9e-18  Score=169.27  Aligned_cols=165  Identities=26%  Similarity=0.359  Sum_probs=105.2

Q ss_pred             CCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEe
Q 046438          335 LEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDL  414 (851)
Q Consensus       335 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~L  414 (851)
                      +.+|+.|++++|.++...  .+..+++|++|++++|++++..  .++.+++|+.|++++|+++.+| .+..+++|+.|++
T Consensus        45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred             hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-ccccccccccccc
Confidence            445555555555554321  2445556666666666665432  2455666666666666666665 3666667777777


Q ss_pred             cCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCCCccccc
Q 046438          415 SSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSNNILSGI  494 (851)
Q Consensus       415 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  494 (851)
                      ++|.+.. + ..+..++.++.+++++|.+++  +..+..+++|+.+++++|++++ ++ .++++++|++|+|++|+|+. 
T Consensus       120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-  192 (210)
T d1h6ta2         120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-  192 (210)
T ss_dssp             TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-
T ss_pred             ccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-
Confidence            7776652 2 346666777777777777763  3346667778888888888874 33 37778888888888888873 


Q ss_pred             CCccccccccccceeccC
Q 046438          495 IPSSLEKLLYLKYLNVSF  512 (851)
Q Consensus       495 ~p~~l~~l~~L~~l~l~~  512 (851)
                      +| .+..+++|++|+|++
T Consensus       193 l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CG-GGTTCTTCSEEEEEE
T ss_pred             Ch-hhcCCCCCCEEEccC
Confidence            44 477788888888764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=8.3e-19  Score=170.44  Aligned_cols=178  Identities=28%  Similarity=0.421  Sum_probs=123.3

Q ss_pred             EEEecCCCCCCCcCccccCCCCCcEEEcccccccccccccccccCCCCEEEccCcccCCCCCccccCCccccceecccCc
Q 046438          316 IIRLGYNKLNGSIPSTLSRLEKLQILGLENNQLEGRILDDICRLARLSSVYLDHNKLSGSIPACFGNLASLRKLSFASNE  395 (851)
Q Consensus       316 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  395 (851)
                      ...++.+.+++..+  ...++++++|++++|.++..  +.+..+++|++|++++|++++..+  ++++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            34455555553322  23456777777777777642  346667777777777777775432  7777788888888887


Q ss_pred             CccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCcccCCCCcccc
Q 046438          396 LTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSI  475 (851)
Q Consensus       396 l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  475 (851)
                      +..++. +.++++|+.|++++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++ ++ .+
T Consensus        96 ~~~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~-l~-~l  168 (199)
T d2omxa2          96 IADITP-LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTD-LK-PL  168 (199)
T ss_dssp             CCCCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-GG
T ss_pred             cccccc-cccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccC-Cc-cc
Confidence            777763 67778888888888877643  346677888888888888763 3 357778888888888888874 33 37


Q ss_pred             cCCCCCCEEECCCCcccccCCccccccccccce
Q 046438          476 GDLISLECLDLSNNILSGIIPSSLEKLLYLKYL  508 (851)
Q Consensus       476 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l  508 (851)
                      +++++|++|++++|++++ ++ .+..+++|+.|
T Consensus       169 ~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         169 ANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             TTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             cCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            788888888888888874 43 46777777764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=4.2e-18  Score=165.34  Aligned_cols=148  Identities=28%  Similarity=0.402  Sum_probs=75.0

Q ss_pred             CCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccc
Q 046438           15 SLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLS   94 (851)
Q Consensus        15 ~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~   94 (851)
                      .+.++++|++++|.++. + +.+..+++|++|+|++|++++..++..+++|++|++++|.+. .++.  ++++++|+.|+
T Consensus        38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~  112 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIA-DITP--LANLTNLTGLT  112 (199)
T ss_dssp             HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEE
T ss_pred             HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCcccccCCcccccccccccccc-cccc--ccccccccccc
Confidence            34555555555555553 2 235555555555555555555555555555555555555554 3332  44555555555


Q ss_pred             ccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCccccCCCCccccCCCcCcEEEeeccccc
Q 046438           95 LAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLS  173 (851)
Q Consensus        95 L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  173 (851)
                      +++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|++|++.+|++++..  .+.++++|++|++++|+++
T Consensus       113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             ccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence            555554422  234455555555555555542 2 23445555555555555554331  2445555555555555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=4.1e-17  Score=167.79  Aligned_cols=223  Identities=18%  Similarity=0.145  Sum_probs=128.8

Q ss_pred             CEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccc-cCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccccccc
Q 046438           20 QYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSF-PFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFN   98 (851)
Q Consensus        20 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N   98 (851)
                      +.|||+++.+.......+.. ..+..+.++...+.... ......+|++||++++.+++.....++..+++|++|+|+++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            46788888775322222211 24556677666655322 24456678888888887764444456778888888888888


Q ss_pred             ccccCCCccccCCCCccEEecccc-ccccc-cchhhcCcccccEEEccCcc-ccCC-CCcccc-CCCcCcEEEeecc--c
Q 046438           99 QFAGHLPREIGNLTSLTSIDLSEN-HLMGE-IPHEIGNLRNLQALGLLSNN-LVGV-VPATLF-NISTLKILQLTNN--T  171 (851)
Q Consensus        99 ~i~~~~~~~l~~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~-~~~~l~-~l~~L~~L~L~~n--~  171 (851)
                      .+++..+..+..+++|++|++++| .++.. +...+..+++|++|+++++. +++. ....+. ..++|+.|+++++  .
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~  161 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN  161 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred             CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence            877666677777888888888875 44422 22334567778888877753 3211 111222 2456777777754  3


Q ss_pred             cccccchhHhhhcccccccccccc-cccccCCccccccCCCcEEecCCC-CCccccCccccCCCCcceEeccCc
Q 046438          172 LSGSISSSIRLALPNLELFSLANN-NFSGKIPSFIFNASKLSICELPDN-SFSGFIPNRFHNMRNLKELNLEYN  243 (851)
Q Consensus       172 l~~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N  243 (851)
                      +++.....+...+|+|++|++++| .+++.....+.++++|+.|+|+++ .+++.....++++++|++|+++++
T Consensus       162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            443334444455666666666664 355444445555555555555552 344433344444455555555443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=2.1e-16  Score=146.74  Aligned_cols=128  Identities=19%  Similarity=0.190  Sum_probs=97.1

Q ss_pred             CCCCCCCCCEEeCcCCCCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccc
Q 046438           12 QLGSLSSLQYLDLSFNQLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQ   91 (851)
Q Consensus        12 ~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~   91 (851)
                      ++.++.++++|||++|+|+ .++..+..+++|++|+|++|+|+...++..+++|++|++++|+++ .++..++..+++|+
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~   90 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT   90 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCccCCcccCcchhhhhccccccc-CCCccccccccccc
Confidence            3567788999999999998 457777888999999999999987766888889999999999987 77777777788888


Q ss_pred             cccccccccccCCC-ccccCCCCccEEeccccccccccc----hhhcCcccccEEE
Q 046438           92 FLSLAFNQFAGHLP-REIGNLTSLTSIDLSENHLMGEIP----HEIGNLRNLQALG  142 (851)
Q Consensus        92 ~L~L~~N~i~~~~~-~~l~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~  142 (851)
                      +|+|++|+|+.... ..+..+++|++|++++|.++. .|    ..+..+++|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            88888888774321 356677777777777777763 33    2355556666554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=5.6e-16  Score=143.84  Aligned_cols=134  Identities=16%  Similarity=0.178  Sum_probs=91.5

Q ss_pred             ccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhh
Q 046438           53 LSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEI  132 (851)
Q Consensus        53 l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~  132 (851)
                      +...+.+.++.++++|||++|+|+ .++ ..+..+++|++|+|++|.|+..  +.|..+++|++|++++|+++...+..+
T Consensus         8 i~~~~~~~n~~~lr~L~L~~n~I~-~i~-~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~   83 (162)
T d1a9na_           8 IEQAAQYTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLD   83 (162)
T ss_dssp             HHTSCEEECTTSCEEEECTTSCCC-SCC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHH
T ss_pred             HhhhHhccCcCcCcEEECCCCCCC-ccC-ccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccc
Confidence            333334566677777777777776 555 3466677777888888777743  247777888888888888875555566


Q ss_pred             cCcccccEEEccCccccCCCC-ccccCCCcCcEEEeeccccccccc---hhHhhhcccccccc
Q 046438          133 GNLRNLQALGLLSNNLVGVVP-ATLFNISTLKILQLTNNTLSGSIS---SSIRLALPNLELFS  191 (851)
Q Consensus       133 ~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~---~~~~~~l~~L~~L~  191 (851)
                      ..+++|++|++++|++..... ..+..+++|++|++++|.++. .+   ..++..+|+|++||
T Consensus        84 ~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          84 QALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             HHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             ccccccccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            777888888888888775432 456777888888888887763 33   23445677777765

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=2.4e-15  Score=132.46  Aligned_cols=101  Identities=32%  Similarity=0.363  Sum_probs=49.9

Q ss_pred             ceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEccCccc
Q 046438          388 KLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSLGDNNL  467 (851)
Q Consensus       388 ~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  467 (851)
                      .|+|++|+++.++. +..+++|++|++++|+++ .+|..++.+++|+.|++++|+|++ +| .++.+++|+.|++++|+|
T Consensus         2 ~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           2 VLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred             EEEcCCCCCCCCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCcc
Confidence            34444444444432 444445555555555554 334444445555555555555542 22 255555555555555555


Q ss_pred             CCCC-cccccCCCCCCEEECCCCccc
Q 046438          468 QGSI-PNSIGDLISLECLDLSNNILS  492 (851)
Q Consensus       468 ~~~~-~~~~~~l~~L~~L~Ls~N~l~  492 (851)
                      +... ...++.+++|+.|++++|+++
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCC
Confidence            5322 134555555555555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=1.9e-15  Score=155.17  Aligned_cols=248  Identities=19%  Similarity=0.229  Sum_probs=140.6

Q ss_pred             cEEeccccccccccchhhcCc--ccccEEEccCccccCCCCccccCCCcCcEEEeeccccccccchhHhhhccccccccc
Q 046438          115 TSIDLSENHLMGEIPHEIGNL--RNLQALGLLSNNLVGVVPATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSL  192 (851)
Q Consensus       115 ~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  192 (851)
                      ++|||+++.+..   +.+..+  ..+..+.+....+..... ......+|++|++++|.+++.....++..+++|++|+|
T Consensus         3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L   78 (284)
T d2astb2           3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL   78 (284)
T ss_dssp             SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred             CEEECCCCCCCc---hHHHHHHhccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence            467777776542   222222  234455555555443222 23345688888888888876666666777888888888


Q ss_pred             ccccccccCCccccccCCCcEEecCCC-CCccccCc-cccCCCCcceEeccCc-cccCCCCcchhhhhccccccccEEec
Q 046438          193 ANNNFSGKIPSFIFNASKLSICELPDN-SFSGFIPN-RFHNMRNLKELNLEYN-YITSSNHELSFISSLANSKKLKVLSL  269 (851)
Q Consensus       193 ~~N~i~~~~~~~~~~~~~L~~L~L~~n-~l~~~~~~-~~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~l~~l~~L~~L~L  269 (851)
                      +++.+++..+..+..+++|+.|+++++ .+++..-. .+.++++|++|+++++ .+++                      
T Consensus        79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~----------------------  136 (284)
T d2astb2          79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE----------------------  136 (284)
T ss_dssp             TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH----------------------
T ss_pred             cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccccccccc----------------------
Confidence            888777666666666666777776663 44432211 2234566666666654 2221                      


Q ss_pred             cCCCccCCCCCCccccccccccEEEeecC--ccccC-CCcccccccCCcEEEecCC-CCCCCcCccccCCCCCcEEEccc
Q 046438          270 TGNPLLDCVLPSSIGNLSLSMERFYLHNC--NIRGS-IPKEMGNLINLIIIRLGYN-KLNGSIPSTLSRLEKLQILGLEN  345 (851)
Q Consensus       270 s~N~l~~~~~p~~~~~~~~~L~~L~L~~n--~i~~~-~p~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~  345 (851)
                             ..+...+......|+.|+++++  .++.. +.....++++|++|++++| .+++.....+.++++|++|++++
T Consensus       137 -------~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~  209 (284)
T d2astb2         137 -------KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR  209 (284)
T ss_dssp             -------HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             -------ccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence                   1111122222223444444432  12211 1222355777888888775 36656666777788888888888


Q ss_pred             c-cccccccccccccCCCCEEEccCcccC-CCCCccccCCccccceecccCcCccC
Q 046438          346 N-QLEGRILDDICRLARLSSVYLDHNKLS-GSIPACFGNLASLRKLSFASNELTFV  399 (851)
Q Consensus       346 n-~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~  399 (851)
                      | .+++.....++.+++|+.|+++++ ++ +..+....   .+..|.+..+.++.+
T Consensus       210 C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~---~lp~L~i~~~~ls~~  261 (284)
T d2astb2         210 CYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKE---ALPHLQINCSHFTTI  261 (284)
T ss_dssp             CTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHH---HSTTSEESCCCSCCT
T ss_pred             CCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHH---hCccccccCccCCCC
Confidence            4 576666667777888888888776 32 12222222   344455666666644

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=8.3e-15  Score=128.95  Aligned_cols=118  Identities=28%  Similarity=0.405  Sum_probs=67.0

Q ss_pred             EEeCCCCCCCCCCCcchhcCCcccccccccccccccCCCccccCCCCccEEeccccccccccchhhcCcccccEEEccCc
Q 046438           67 VIDLSDNRLSGELPANIFSYLPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIPHEIGNLRNLQALGLLSN  146 (851)
Q Consensus        67 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  146 (851)
                      +|||++|+++ .++.  ++.+++|++|++++|+|+ .+|..++.+++|+.|++++|.+++ +| .+..+++|++|++++|
T Consensus         2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            4555555554 4432  455555555555555555 344456666666666666666653 33 3566666666666666


Q ss_pred             cccCCCC-ccccCCCcCcEEEeecccccc--ccchhHhhhccccccc
Q 046438          147 NLVGVVP-ATLFNISTLKILQLTNNTLSG--SISSSIRLALPNLELF  190 (851)
Q Consensus       147 ~l~~~~~-~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~~l~~L~~L  190 (851)
                      ++.+... ..+..+++|+.|++++|++++  .....+...+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            6654432 455666667777777766653  2344455556666554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.54  E-value=2.3e-16  Score=167.55  Aligned_cols=256  Identities=20%  Similarity=0.174  Sum_probs=136.5

Q ss_pred             CccccCCCCcceEeccCccccCCCCcchhhhhccccccccEEeccCCCccCCCCCCccccccccccEEEeecCccccCCC
Q 046438          226 PNRFHNMRNLKELNLEYNYITSSNHELSFISSLANSKKLKVLSLTGNPLLDCVLPSSIGNLSLSMERFYLHNCNIRGSIP  305 (851)
Q Consensus       226 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p  305 (851)
                      ...+....+|++|+|++|.|..... ..+...+...+.|+.++++++....  ........             + ..+.
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~-~~l~~~l~~~~~L~~l~l~~~~~~~--~~~~~~~~-------------~-~~l~   86 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAA-RWLSENIASKKDLEIAEFSDIFTGR--VKDEIPEA-------------L-RLLL   86 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHH-HHHHHTTTTCTTCCEEECCSCCTTS--CGGGSHHH-------------H-HHHH
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHH-HHHHHHHHhCCCCCEEECCCCcccc--cccccchH-------------H-HHHH
Confidence            3456667888888888888764321 1333456677888888887765421  00000000             0 0122


Q ss_pred             cccccccCCcEEEecCCCCCCCc----CccccCCCCCcEEEcccccccccccccc-------------cccCCCCEEEcc
Q 046438          306 KEMGNLINLIIIRLGYNKLNGSI----PSTLSRLEKLQILGLENNQLEGRILDDI-------------CRLARLSSVYLD  368 (851)
Q Consensus       306 ~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------~~l~~L~~L~L~  368 (851)
                      ..+..+++|+.|+|++|.++...    ...+...++|++|++++|.+.......+             ...+.|+.++++
T Consensus        87 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~  166 (344)
T d2ca6a1          87 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG  166 (344)
T ss_dssp             HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred             HHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecc
Confidence            34556778888888888886542    2334556788888888887753222111             123344555555


Q ss_pred             CcccCCCCCccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCC-----CccccccchhhhhhhccCCcc
Q 046438          369 HNKLSGSIPACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGS-----LPLEIGNLKVLVELYLSRNNL  443 (851)
Q Consensus       369 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l  443 (851)
                      +|++......                   .+...+...+.|+.|+|++|.+...     +...+..+++|+.|+|++|.+
T Consensus       167 ~n~i~~~~~~-------------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i  227 (344)
T d2ca6a1         167 RNRLENGSMK-------------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  227 (344)
T ss_dssp             SSCCTGGGHH-------------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             cccccccccc-------------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccc
Confidence            5544311111                   1222334445555555555555421     122344455566666666655


Q ss_pred             ccc----CCcccCCCCCccEEEccCcccCCCCcc----cccC--CCCCCEEECCCCccccc----CCcccc-ccccccce
Q 046438          444 SGD----IPTTIGGLKNLQNLSLGDNNLQGSIPN----SIGD--LISLECLDLSNNILSGI----IPSSLE-KLLYLKYL  508 (851)
Q Consensus       444 ~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~--l~~L~~L~Ls~N~l~~~----~p~~l~-~l~~L~~l  508 (851)
                      +..    +...+..+++|+.|+|++|.|++....    .+..  .+.|++|++++|+|+..    +...+. .+++|+.|
T Consensus       228 ~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L  307 (344)
T d2ca6a1         228 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL  307 (344)
T ss_dssp             HHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred             cccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEE
Confidence            422    233455666677777777766543222    2222  24577777777776532    222232 45667777


Q ss_pred             eccCccccc
Q 046438          509 NVSFNRLEG  517 (851)
Q Consensus       509 ~l~~N~l~~  517 (851)
                      +|++|++..
T Consensus       308 ~l~~N~~~~  316 (344)
T d2ca6a1         308 ELNGNRFSE  316 (344)
T ss_dssp             ECTTSBSCT
T ss_pred             ECCCCcCCC
Confidence            777777654

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.53  E-value=7.9e-16  Score=163.34  Aligned_cols=39  Identities=18%  Similarity=0.100  Sum_probs=17.6

Q ss_pred             cCCccccccccccccccc----CCCccccCCCCccEEeccccc
Q 046438           85 SYLPFVQFLSLAFNQFAG----HLPREIGNLTSLTSIDLSENH  123 (851)
Q Consensus        85 ~~l~~L~~L~L~~N~i~~----~~~~~l~~l~~L~~L~Ls~n~  123 (851)
                      .....|++|+|++|.|..    .+...+...++|+.|+++++.
T Consensus        28 ~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~   70 (344)
T d2ca6a1          28 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF   70 (344)
T ss_dssp             HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCC
T ss_pred             hhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCc
Confidence            334455555555555431    122233444555555555443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=3.3e-14  Score=130.74  Aligned_cols=131  Identities=21%  Similarity=0.155  Sum_probs=89.4

Q ss_pred             eEEEecCCCCCCCCccccccchhhhhhhccCC-cccccCCcccCCCCCccEEEccCcccCCCCcccccCCCCCCEEECCC
Q 046438          410 LMVDLSSNPLSGSLPLEIGNLKVLVELYLSRN-NLSGDIPTTIGGLKNLQNLSLGDNNLQGSIPNSIGDLISLECLDLSN  488 (851)
Q Consensus       410 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  488 (851)
                      +.++.+++.+. ..|..+..+++|++|++++| .|+...++.|.++++|+.|+|++|+|+...|.+|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            34555555555 34555556666777777655 47655567788888899999999999877788888999999999999


Q ss_pred             CcccccCCccccccccccceeccCccccccCCCCCcccc---cCcccccCCcCccCCC
Q 046438          489 NILSGIIPSSLEKLLYLKYLNVSFNRLEGEIPRGGTLAN---FTSESFMGNDLLCGSP  543 (851)
Q Consensus       489 N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~---l~~~~~~~n~~~c~~~  543 (851)
                      |+|+...+..+ ...+|+.|+|++|+|.|+|-.. ++..   ........+...|..|
T Consensus        90 N~l~~l~~~~~-~~~~l~~L~L~~Np~~C~C~~~-~l~~~~~~~~~~~~~~~~~C~~p  145 (156)
T d2ifga3          90 NALESLSWKTV-QGLSLQELVLSGNPLHCSCALR-WLQRWEEEGLGGVPEQKLQCHGQ  145 (156)
T ss_dssp             SCCSCCCSTTT-CSCCCCEEECCSSCCCCCGGGH-HHHHHHHTTCSSCGGGCCCCSSS
T ss_pred             CCCcccChhhh-ccccccccccCCCcccCCchHH-HHHHHHHhccCccCcCCcEECcC
Confidence            99985444444 4457999999999999888432 2211   1222233455677666

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=1.4e-15  Score=146.43  Aligned_cols=128  Identities=19%  Similarity=0.260  Sum_probs=81.3

Q ss_pred             CCCCEEeCcCC--CCccCCCccccCCCCCCEEEcCCCcccccccCCCCCCCcEEeCCCCCCCCCCCcchhcCCccccccc
Q 046438           17 SSLQYLDLSFN--QLLGTIPSSIFSINTLEILDLSNNQLSGSFPFFNMSSLQVIDLSDNRLSGELPANIFSYLPFVQFLS   94 (851)
Q Consensus        17 ~~L~~L~ls~n--~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~   94 (851)
                      ..++.++++++  .++ .+|.++..+++|++|+|++|+|+...++..+++|++|+|++|+|+ .+|. .+..+++|++|+
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~-~i~~-~~~~~~~L~~L~   99 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIEN-LDAVADTLEELW   99 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCCCCHHHHTTCCEEECCEEEEC-SCSS-HHHHHHHCCEEE
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCcccccCCccccChhhcccccc-cccc-cccccccccccc
Confidence            34556666654  243 456677788888888888888876655667777777777777776 5553 244456677777


Q ss_pred             ccccccccCCCccccCCCCccEEeccccccccccc-hhhcCcccccEEEccCcccc
Q 046438           95 LAFNQFAGHLPREIGNLTSLTSIDLSENHLMGEIP-HEIGNLRNLQALGLLSNNLV  149 (851)
Q Consensus        95 L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~  149 (851)
                      +++|+|+..  ..+..+++|+.|+|++|+++.... ..|..+++|+.|++++|++.
T Consensus       100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         100 ISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             CSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            777766632  235566666666666666653211 34566666666666666554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.42  E-value=2e-15  Score=145.30  Aligned_cols=128  Identities=23%  Similarity=0.314  Sum_probs=69.7

Q ss_pred             ccccCCccccceecccCcCccCchhhcccCcceEEEecCCCCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCc
Q 046438          378 ACFGNLASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNL  457 (851)
Q Consensus       378 ~~~~~l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  457 (851)
                      ..+..+++|++|+|++|+|+.++ .+.++++|+.|+|++|+++ .+|..+..+++|++|++++|+|+. + +.+..+++|
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L  117 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL  117 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred             hHHhcccccceeECcccCCCCcc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence            34455555555555555555553 3555555555555555555 334333444555666666666553 2 235555666


Q ss_pred             cEEEccCcccCCCCc-ccccCCCCCCEEECCCCcccccCCcc----------cccccccccee
Q 046438          458 QNLSLGDNNLQGSIP-NSIGDLISLECLDLSNNILSGIIPSS----------LEKLLYLKYLN  509 (851)
Q Consensus       458 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~~l~  509 (851)
                      +.|++++|+|+.... ..+..+++|+.|+|++|+++...+..          +..+|+|+.||
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            666666666653211 34666666666666666665433322          45566776654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=5.4e-13  Score=122.50  Aligned_cols=136  Identities=17%  Similarity=0.039  Sum_probs=103.7

Q ss_pred             ccccceecccCcCccCchhhcccCcceEEEecCC-CCCCCCccccccchhhhhhhccCCcccccCCcccCCCCCccEEEc
Q 046438          384 ASLRKLSFASNELTFVPSTFWNLTNILMVDLSSN-PLSGSLPLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNLSL  462 (851)
Q Consensus       384 ~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  462 (851)
                      ...+.++.+++.+..+|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|
T Consensus         8 ~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3456688888888888888888899999999766 488667778999999999999999999777888999999999999


Q ss_pred             cCcccCCCCcccccCCCCCCEEECCCCccccc-CCccccccccccceeccCccccccCC
Q 046438          463 GDNNLQGSIPNSIGDLISLECLDLSNNILSGI-IPSSLEKLLYLKYLNVSFNRLEGEIP  520 (851)
Q Consensus       463 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~l~l~~N~l~~~~p  520 (851)
                      ++|+|+...+..|. ..+|+.|+|++|.+... --.++..+.......+..++++|.-|
T Consensus        88 s~N~l~~l~~~~~~-~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p  145 (156)
T d2ifga3          88 SFNALESLSWKTVQ-GLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ  145 (156)
T ss_dssp             CSSCCSCCCSTTTC-SCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred             cCCCCcccChhhhc-cccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcC
Confidence            99999944444454 45799999999998621 11233333334445555677777655

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.58  E-value=1.3e-07  Score=94.54  Aligned_cols=150  Identities=13%  Similarity=0.123  Sum_probs=104.4

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcC-CCcccceeeeeecCCee
Q 046438          619 QELLQATDQFNVNNLIGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIR-HRNLVRIISSCTNDDFK  697 (851)
Q Consensus       619 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  697 (851)
                      .++....++|++.+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +-.+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            34555667888777655555678998864 67778899887655545556788888888774 33367788888888889


Q ss_pred             EEEEeccCCCChhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 046438          698 ALVLDYMPKGSLEACLYSDNSNLDIFKRLNIVIDIALALEYLHFG-----------------------------------  742 (851)
Q Consensus       698 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~~~-----------------------------------  742 (851)
                      ++||++++|.++.+.....      .....++.++++.++.||..                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            9999999998775543211      11223444555555555421                                   


Q ss_pred             ---------------------CCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          743 ---------------------HPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       743 ---------------------h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                                           ....++|+|+.|.||++++++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 122489999999999999877777999998764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.58  E-value=2.5e-09  Score=98.24  Aligned_cols=86  Identities=22%  Similarity=0.068  Sum_probs=39.1

Q ss_pred             CccccceecccCcCccCchhhcccCcceEEEecCCCCCCCC--ccccccchhhhhhhccCCcccccCCcccCCCCCccEE
Q 046438          383 LASLRKLSFASNELTFVPSTFWNLTNILMVDLSSNPLSGSL--PLEIGNLKVLVELYLSRNNLSGDIPTTIGGLKNLQNL  460 (851)
Q Consensus       383 l~~L~~L~L~~N~l~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  460 (851)
                      +..+..++..++....++.....+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+.+..+|+.|
T Consensus        41 ~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L  120 (162)
T d1koha1          41 QNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL  120 (162)
T ss_dssp             TTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSC
T ss_pred             ccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccccee
Confidence            33444444444444444444445666666666666665321  2233444455555555555542221122222334444


Q ss_pred             EccCcccC
Q 046438          461 SLGDNNLQ  468 (851)
Q Consensus       461 ~L~~N~l~  468 (851)
                      ++++|.+.
T Consensus       121 ~L~~Npl~  128 (162)
T d1koha1         121 WLDGNSLS  128 (162)
T ss_dssp             CCTTSTTS
T ss_pred             ecCCCCcC
Confidence            44444443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.46  E-value=1.4e-08  Score=93.20  Aligned_cols=63  Identities=25%  Similarity=0.210  Sum_probs=27.9

Q ss_pred             CcccccccccccccccCCCccccCCCCccEEeccccccccc--cchhhcCcccccEEEccCccccC
Q 046438           87 LPFVQFLSLAFNQFAGHLPREIGNLTSLTSIDLSENHLMGE--IPHEIGNLRNLQALGLLSNNLVG  150 (851)
Q Consensus        87 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~  150 (851)
                      +..+..++..++.+. .++..+..+++|++|+||+|+|+..  ++..+..+++|+.|++++|+|+.
T Consensus        41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~  105 (162)
T d1koha1          41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS  105 (162)
T ss_dssp             TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred             ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc
Confidence            333444444444332 2233334455555555555555532  12334444444455554444443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.91  E-value=1.7e-05  Score=78.23  Aligned_cols=132  Identities=19%  Similarity=0.138  Sum_probs=86.3

Q ss_pred             ceeccccc-eEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCC--CcccceeeeeecCCeeEEEEeccCCCC
Q 046438          632 NLIGSGSF-GSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRH--RNLVRIISSCTNDDFKALVLDYMPKGS  708 (851)
Q Consensus       632 ~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~  708 (851)
                      +.+..|.. +.||+....++..+++|......   ...+..|.+.++.+..  -.+.+++.+..+++..++|||+++|.+
T Consensus        16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            34555654 68999988778889999865442   2456778888877743  335667888888888899999998876


Q ss_pred             hhHHhhcCCCCcCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 046438          709 LEACLYSDNSNLDIFKRLNIVIDIALALEYLH------------------------------------------------  740 (851)
Q Consensus       709 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L~------------------------------------------------  740 (851)
                      +.+..      ...   ...+.++.+.++.||                                                
T Consensus        93 ~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          93 LLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            53210      000   011112222222222                                                


Q ss_pred             ---h----cCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          741 ---F----GHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       741 ---~----~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                         .    .....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               1    1223489999999999999877778999998764

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.74  E-value=6.3e-06  Score=75.29  Aligned_cols=16  Identities=6%  Similarity=0.248  Sum_probs=8.9

Q ss_pred             ccCCCCcceEeccCcc
Q 046438          229 FHNMRNLKELNLEYNY  244 (851)
Q Consensus       229 ~~~l~~L~~L~L~~N~  244 (851)
                      +...++|+.|+++.+.
T Consensus       127 L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_         127 IEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHCSSCCEEECCCCC
T ss_pred             HHhCCCccEeeCcCCC
Confidence            3344566666665553

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.67  E-value=1.2e-05  Score=73.42  Aligned_cols=66  Identities=6%  Similarity=0.130  Sum_probs=38.5

Q ss_pred             cCCCcEEecCCCCCcccc----CccccCCCCcceEeccCccccCCCCc--chhhhhccccccccEEeccCCC
Q 046438          208 ASKLSICELPDNSFSGFI----PNRFHNMRNLKELNLEYNYITSSNHE--LSFISSLANSKKLKVLSLTGNP  273 (851)
Q Consensus       208 ~~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~~~l~~l~~L~~L~Ls~N~  273 (851)
                      .+.|+.|+|++|.++...    ..++...++|++|+|++|.+..++.+  ..+...+...+.|+.|+++.+.
T Consensus        71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            445555555555555322    23455556778888877766654322  1245556667777777776654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.57  E-value=8.6e-05  Score=77.84  Aligned_cols=76  Identities=16%  Similarity=0.121  Sum_probs=49.3

Q ss_pred             cceeccccceEEEEEEEcC-CcEEEEEEEeecc-------hhhHHHHHHHHHHHhhcC-C-C-cccceeeeeecCCeeEE
Q 046438          631 NNLIGSGSFGSVYRGRFLD-GMEVAIKVFHLQL-------EGALESFNAECEVLRSIR-H-R-NLVRIISSCTNDDFKAL  699 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~l  699 (851)
                      .+.||.|....||+++..+ ++.|+||.-....       .....+...|.++++.+. + | .+++++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            3578999999999998754 6789999754321       112345667888888773 3 3 344555443  345578


Q ss_pred             EEeccCCCC
Q 046438          700 VLDYMPKGS  708 (851)
Q Consensus       700 v~e~~~~g~  708 (851)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.15  E-value=3.2e-05  Score=70.42  Aligned_cols=42  Identities=12%  Similarity=0.123  Sum_probs=20.4

Q ss_pred             cccCCCCccEEeccccccccc----cchhhcCcccccEEEccCccc
Q 046438          107 EIGNLTSLTSIDLSENHLMGE----IPHEIGNLRNLQALGLLSNNL  148 (851)
Q Consensus       107 ~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~n~l  148 (851)
                      ++...++|++|+|++|.++..    +.+.+...++++.+++++|.+
T Consensus        41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~   86 (166)
T d1io0a_          41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI   86 (166)
T ss_dssp             HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred             HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence            344555566666666655422    222333445555555555544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.15  E-value=0.00061  Score=69.15  Aligned_cols=135  Identities=12%  Similarity=0.093  Sum_probs=79.4

Q ss_pred             cceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc--cceee-----eeecCCeeEEEEeccCCCChh
Q 046438          638 SFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL--VRIIS-----SCTNDDFKALVLDYMPKGSLE  710 (851)
Q Consensus       638 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~g~L~  710 (851)
                      ..-.||+++..+|..|++|+.+.. ....+.+..|.+.+..+....+  +..+.     .+...+..+.++++++|..+.
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            346899999889999999998754 2234668889988888853322  22221     223455778899999875331


Q ss_pred             -----HH---------hhc--------CCCCcCH-------------------H---HHHHHHHHHHHHHHHHH-hcCCC
Q 046438          711 -----AC---------LYS--------DNSNLDI-------------------F---KRLNIVIDIALALEYLH-FGHPN  745 (851)
Q Consensus       711 -----~~---------l~~--------~~~~~~~-------------------~---~~~~i~~~i~~~l~~L~-~~h~~  745 (851)
                           .+         ++.        .....+.                   .   .....+.++...+.-.- ..-..
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 00         000        0011111                   1   11122233333332221 11246


Q ss_pred             CcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          746 PVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       746 ~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      +++|||+.+.||+++++  ..++||+-|..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            89999999999999744  45899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.13  E-value=0.00091  Score=67.59  Aligned_cols=157  Identities=15%  Similarity=0.115  Sum_probs=86.7

Q ss_pred             ccHHHHHHHhcCCCccce-----eccccceEEEEEEEcCCcEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc--ccee
Q 046438          616 FSYQELLQATDQFNVNNL-----IGSGSFGSVYRGRFLDGMEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL--VRII  688 (851)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~  688 (851)
                      .+.+++.....+|.+.+.     |..|.--+.|+.+..+| .+++|++....  ..+.+..|.+++..+...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            355778888888877543     45677788999987554 58999986532  22455667777777743222  2221


Q ss_pred             e------eeecCCeeEEEEeccCCCChhH-----------H---hhc--C----C--CCc------------------CH
Q 046438          689 S------SCTNDDFKALVLDYMPKGSLEA-----------C---LYS--D----N--SNL------------------DI  722 (851)
Q Consensus       689 ~------~~~~~~~~~lv~e~~~~g~L~~-----------~---l~~--~----~--~~~------------------~~  722 (851)
                      .      +....+..+.++.++.+.....           .   ++.  .    .  ...                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1222345667777776643310           0   000  0    0  000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCCEEECCCCcEEEeeccCccc
Q 046438          723 FKRLNIVIDIALALEYLH-FGHPNPVVHCDIKPSNVLLDEDMVARLGDFGIAKL  775 (851)
Q Consensus       723 ~~~~~i~~~i~~~l~~L~-~~h~~~ivH~Dl~~~Nill~~~~~~kl~Dfg~a~~  775 (851)
                      ......+..+...+.... ..-..|++|+|+.+.||+++.+...-|+||+.|..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            001112222222222221 12457899999999999999887778999999864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.02  E-value=8.8e-05  Score=67.34  Aligned_cols=121  Identities=12%  Similarity=0.119  Sum_probs=60.7

Q ss_pred             hcCcccccEEEccC-ccccCCC----CccccCCCcCcEEEeeccccccccchhHhhhcccccccccccccccccCCcccc
Q 046438          132 IGNLRNLQALGLLS-NNLVGVV----PATLFNISTLKILQLTNNTLSGSISSSIRLALPNLELFSLANNNFSGKIPSFIF  206 (851)
Q Consensus       132 ~~~l~~L~~L~L~~-n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  206 (851)
                      ..+.++|++|++++ +.++...    -..+...+.|++|+|++|.++......+.                     ..+.
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~---------------------~~l~   71 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA---------------------EMLK   71 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH---------------------HHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHH---------------------HHHh
Confidence            34556677777765 3343221    12333456666666666666543322222                     1222


Q ss_pred             ccCCCcEEecCCCCCcccc----CccccCCCCcceEec--cCccccCCCCcchhhhhccccccccEEeccCCCc
Q 046438          207 NASKLSICELPDNSFSGFI----PNRFHNMRNLKELNL--EYNYITSSNHELSFISSLANSKKLKVLSLTGNPL  274 (851)
Q Consensus       207 ~~~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L--~~N~i~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  274 (851)
                      ..++++.+++++|.++...    ...+...++|+.++|  ++|.+.+... ..+...+...++|+.|+++.+..
T Consensus        72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~-~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE-MEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH-HHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH-HHHHHHHHhCCCcCEEeCcCCCC
Confidence            3345555555555554322    234555666766444  4555543211 12344566677777777766543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.89  E-value=0.0017  Score=67.70  Aligned_cols=73  Identities=18%  Similarity=0.278  Sum_probs=50.8

Q ss_pred             cceeccccceEEEEEEEcCC--------cEEEEEEEeecchhhHHHHHHHHHHHhhcCCCcc-cceeeeeecCCeeEEEE
Q 046438          631 NNLIGSGSFGSVYRGRFLDG--------MEVAIKVFHLQLEGALESFNAECEVLRSIRHRNL-VRIISSCTNDDFKALVL  701 (851)
Q Consensus       631 ~~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  701 (851)
                      ++.|+.|-.-.+|++...++        +.|.+++.-. ... .....+|.++++.+.-.++ .++++++.+    ++||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            36788899999999987542        4577777653 222 2456688999988854454 467776653    6899


Q ss_pred             eccCCCCh
Q 046438          702 DYMPKGSL  709 (851)
Q Consensus       702 e~~~~g~L  709 (851)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544